Citrus Sinensis ID: 014038

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430--
Protein Sequence
MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDMEQAEAKTPTSTHLREESVDSTADTYEL
Secondary Structure (PSIPRED)
cccccccEEEEHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHcccccccccEEEEccccEEEEEEEccccccHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccEEccccccccHHHHHcccccccccccHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHccccccccccccccccccccHHHHHcccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEcHHHHHHHHcccHHHcccccccEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHEEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEcccHHHEEcccccccHHcHcccEEEcccccEEEEEEEccccccHHHHHHccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHcccHHHHccccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mkgessglIIGISIGVVIGVLLAISALFCFRyhrkrsqignsssrraatlpirangvdscsilsdstvgpespvksgrngngksmwlegfkrsnvvsasgipeysykdLQKATCNFTtligqgafgpvykaqmstgeTVAVKVLAtdskqgekEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKgslashlydenygpltWNLRVHIALDVARgleylhdgavppvihrdikssniLLDQSMRARVADFGLSREEMVDKHAAnirgtfgyldpeyistrnftkksdvYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCvnraprkrpsmRDIVQVLSRILKMRhnrkhhrksqsttadeVSIDmeqaeaktptsthlreesvdstadtyel
Flexible Loop (DISEMBL)
MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRkrsqignsssrraatlpirangvdSCSILSdstvgpespvksgrngngksmwlEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLAtdskqgekEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKssnilldqsMRARVADFGLSREEMVDKHAanirgtfgyldpeYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYkcvnraprkrpsmrdIVQVLSRILkmrhnrkhhrksqsttadevsidmeqaeaktptsthlreesvdstadtyel
Low Complexity Region (SEG)
MKGEssgliigisigvvigvllaisALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDMEQAEAKTPTSTHLREESVDSTADTYEL
Disordered region (IsUnstruct)
******GLIIGISIGVVIGVLLAISALFCFRYHR***************************************************WLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD*****KEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRA********DIVQVLSRIL***************************************************
Disordered Region (DISOPRED)
*****SG**IGISIGVVIGVLLAISALFCFR***********************************************************************EYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAV*************FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR*****************************************************
Disordered Region (DISEMBL)
MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRS*********AATLPIRANGVDSCSI****************NGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR*****************SIDMEQ*************************
Disordered Region (DISPRO)
****SSGLIIGISIGVVIGVLLAISALFCFRYHRKR***************************************************************GIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI****************************************************
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDMEQAEAKTPTSTHLREESVDSTADTYEL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	432	2.2.26 [Sep-21-2011]
Q9LFV3	436	Probable leucine-rich rep	no	no	0.918	0.910	0.476	2e-99
Q9SR05	850	Receptor-like protein kin	no	no	0.814	0.414	0.396	5e-66
Q3E8W4	858	Receptor-like protein kin	no	no	0.842	0.424	0.386	6e-66
Q9FX99	663	Probable receptor-like pr	no	no	0.673	0.438	0.444	2e-63
O22187	834	Probable receptor-like pr	no	no	0.673	0.348	0.440	6e-63
C0LGI2	929	Probable LRR receptor-lik	no	no	0.636	0.296	0.450	1e-62
Q9T020	878	Probable receptor-like pr	no	no	0.717	0.353	0.415	2e-62
Q9LX66	830	Receptor-like protein kin	no	no	0.807	0.420	0.385	5e-62
Q9SFT7	414	Serine/threonine-protein	no	no	0.780	0.814	0.397	1e-61
Q8L4H4	925	Nodulation receptor kinas	N/A	no	0.773	0.361	0.404	2e-61

>sp|Q9LFV3|Y5157_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730 OS=Arabidopsis thaliana GN=At5g15730 PE=2 SV=1

 Score =  362 bits (930), Expect = 2e-99,   Method: Compositional matrix adjust.
 Identities = 196/411 (47%), Positives = 274/411 (66%), Gaps = 14/411 (3%)

Query: 1   MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGN-SSSRRAATLPIRANGVDS 59
           M   S  ++IGIS+G+ +G+LLA+   F  +++  RS +   ++ + + TLP+       
Sbjct: 1   MVNRSDLVVIGISVGLALGLLLALLLFFAIKWYYGRSHLRRCANEQNSPTLPVHT--AKR 58

Query: 60  CSILSDSTVGPES--PVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFT 117
             ++ D     ES  P ++G     +  W     +   VSASGIP Y+YKD+QKAT NFT
Sbjct: 59  GVVIPDDRANTESSQPPENGAPTQHQPWW-NNHTKDLTVSASGIPRYNYKDIQKATQNFT 117

Query: 118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           T++GQG+FGPVYKA M  GE  A KV  ++S QG++EFQTEV LLGRLHHRNLVNL GYC
Sbjct: 118 TVLGQGSFGPVYKAVMPNGELAAAKVHGSNSSQGDREFQTEVSLLGRLHHRNLVNLTGYC 177

Query: 178 AEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
            +K   ML+Y FMS GSL + LY  E    L W  R+ IALD++ G+EYLH+GAVPPVIH
Sbjct: 178 VDKSHRMLIYEFMSNGSLENLLYGGEGMQVLNWEERLQIALDISHGIEYLHEGAVPPVIH 237

Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVY 296
           RD+KS+NILLD SMRA+VADFGLS+E ++D+  + ++GT GY+DP YIST  +T KSD+Y
Sbjct: 238 RDLKSANILLDHSMRAKVADFGLSKEMVLDRMTSGLKGTHGYMDPTYISTNKYTMKSDIY 297

Query: 297 SFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLA 356
           SFGV++ ELI    P Q LMEY+ LA+M+ +   G +EI+D +L G   +EE+  +A +A
Sbjct: 298 SFGVIILELITAIHPQQNLMEYINLASMSPD---GIDEILDQKLVGNASIEEVRLLAKIA 354

Query: 357 YKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDMEQ 407
            +CV++ PRKRPS+ ++ Q    ILK++ +R   R+ Q T +    +  E+
Sbjct: 355 NRCVHKTPRKRPSIGEVTQF---ILKIKQSRSRGRR-QDTMSSSFGVGYEE 401

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SR05|ANX1_ARATH Receptor-like protein kinase ANXUR1 OS=Arabidopsis thaliana GN=ANX1 PE=2 SV=1

 Score =  252 bits (643), Expect = 5e-66,   Method: Compositional matrix adjust.
 Identities = 151/381 (39%), Positives = 221/381 (58%), Gaps = 29/381 (7%)

Query: 14  IGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDSTVGPESP 73
           IG   GVL  +    CF  ++K+       S  ++ LPI  N          +T G +S 
Sbjct: 433 IGSAGGVLAVLIGALCFTAYKKKQGYQGGDSHTSSWLPIYGN---------STTSGTKST 483

Query: 74  VKSGRNGNGKSMWLEGFKRSNVVSASGIPE-YSYKDLQKATCNF--TTLIGQGAFGPVYK 130
           + SG++ NG  +       SN+  A+G+   +S  +++  T NF  + +IG G FG VYK
Sbjct: 484 I-SGKSNNGSHL-------SNL--AAGLCRRFSLPEIKHGTQNFDDSNVIGVGGFGKVYK 533

Query: 131 AQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM 190
             +     VAVK    +S+QG  EF+TE+ LL RL H++LV+L+GYC E G+  LVY +M
Sbjct: 534 GVIDGTTKVAVKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLVYDYM 593

Query: 191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM 250
           + G+L  HLY+     LTW  R+ IA+  ARGL YLH GA   +IHRD+K++NIL+D++ 
Sbjct: 594 AFGTLREHLYNTKKPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILVDENW 653

Query: 251 RARVADFGLSR--EEMVDKHAAN-IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
            A+V+DFGLS+    M   H    ++G+FGYLDPEY   +  T+KSDVYSFGV+LFE++ 
Sbjct: 654 VAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILC 713

Query: 308 GRSPLQGLM--EYVELA--AMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRA 363
            R  L   +  E V L   AMN + K   E+I+D  L G  + E L + A  A KC+N +
Sbjct: 714 ARPALNPSLPKEQVSLGDWAMNCKRKGNLEDIIDPNLKGKINAECLKKFADTAEKCLNDS 773

Query: 364 PRKRPSMRDIVQVLSRILKMR 384
             +RP+M D++  L   L+++
Sbjct: 774 GLERPTMGDVLWNLEFALQLQ 794

Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3E8W4|ANX2_ARATH Receptor-like protein kinase ANXUR2 OS=Arabidopsis thaliana GN=ANX2 PE=2 SV=1

 Score =  251 bits (642), Expect = 6e-66,   Method: Compositional matrix adjust.
 Identities = 152/393 (38%), Positives = 223/393 (56%), Gaps = 29/393 (7%)

Query: 9   IIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDSTV 68
           I    IG   GV   +    CF  ++++ +   S S  ++ LPI  N   S +    ST+
Sbjct: 432 ITAFVIGSAGGVAAVLFCALCFTMYQRKRKFSGSDSHTSSWLPIYGNSHTSAT---KSTI 488

Query: 69  GPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPE-YSYKDLQKATCNF--TTLIGQGAF 125
                  SG++ NG  +       SN+  A+G+   +S  +++  T NF  + +IG G F
Sbjct: 489 -------SGKSNNGSHL-------SNL--AAGLCRRFSLSEIKHGTHNFDESNVIGVGGF 532

Query: 126 GPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML 185
           G VYK  +  G  VA+K    +S+QG  EF+TE+ LL RL H++LV+L+GYC E G+  L
Sbjct: 533 GKVYKGVIDGGTKVAIKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCL 592

Query: 186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNIL 245
           +Y +MS G+L  HLY+     LTW  R+ IA+  ARGL YLH GA   +IHRD+K++NIL
Sbjct: 593 IYDYMSLGTLREHLYNTKRPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNIL 652

Query: 246 LDQSMRARVADFGLSR--EEMVDKHAAN-IRGTFGYLDPEYISTRNFTKKSDVYSFGVLL 302
           LD++  A+V+DFGLS+    M   H    ++G+FGYLDPEY   +  T+KSDVYSFGV+L
Sbjct: 653 LDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 712

Query: 303 FELIAGRSPLQGLM--EYVELA--AMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYK 358
           FE++  R  L   +  E V L   AMN + K   E+I+D  L G  + E L + A  A K
Sbjct: 713 FEVLCARPALNPSLSKEQVSLGDWAMNCKRKGTLEDIIDPNLKGKINPECLKKFADTAEK 772

Query: 359 CVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHR 391
           C++ +   RP+M D++  L   L+++      R
Sbjct: 773 CLSDSGLDRPTMGDVLWNLEFALQLQETADGSR 805

Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FX99|Y1497_ARATH Probable receptor-like protein kinase At1g49730 OS=Arabidopsis thaliana GN=At1g49730 PE=1 SV=1

 Score =  243 bits (621), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 133/299 (44%), Positives = 186/299 (62%), Gaps = 8/299 (2%)

Query: 87  LEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLAT 146
           L  FK     S+S   ++SYK++  AT +F T+IGQG FG VYKA+ + G   AVK +  
Sbjct: 300 LPVFKIHEDDSSSAFRKFSYKEMTNATNDFNTVIGQGGFGTVYKAEFNDGLIAAVKKMNK 359

Query: 147 DSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP 206
            S+Q E++F  E+ LL +LHHRNLV L G+C  K +  LVY +M  GSL  HL+     P
Sbjct: 360 VSEQAEQDFCREIGLLAKLHHRNLVALKGFCINKKERFLVYDYMKNGSLKDHLHAIGKPP 419

Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL---SREE 263
            +W  R+ IA+DVA  LEYLH    PP+ HRDIKSSNILLD++  A+++DFGL   SR+ 
Sbjct: 420 PSWGTRMKIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLSDFGLAHSSRDG 479

Query: 264 MVDKHAAN--IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
            V     N  IRGT GY+DPEY+ T+  T+KSDVYS+GV+L ELI GR  +      VE+
Sbjct: 480 SVCFEPVNTDIRGTPGYVDPEYVVTQELTEKSDVYSYGVVLLELITGRRAVDEGRNLVEM 539

Query: 322 AAMNTEGKTGWEEIVDSRL-DGIFDV--EELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
           +      K+   E+VD R+ D I D   ++L+ V ++   C  +  R RPS++ ++++L
Sbjct: 540 SQRFLLAKSKHLELVDPRIKDSINDAGGKQLDAVVTVVRLCTEKEGRSRPSIKQVLRLL 598

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22187|Y2232_ARATH Probable receptor-like protein kinase At2g23200 OS=Arabidopsis thaliana GN=At2g23200 PE=3 SV=1

 Score =  241 bits (616), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 133/302 (44%), Positives = 183/302 (60%), Gaps = 11/302 (3%)

Query: 106 YKDLQKATCNF--TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLG 163
           + D+  AT NF    LIG+G FG VYKA +  G   A+K   T S QG  EFQTE+ +L 
Sbjct: 478 FTDILSATNNFDEQLLIGKGGFGYVYKAILPDGTKAAIKRGKTGSGQGILEFQTEIQVLS 537

Query: 164 RLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
           R+ HR+LV+L GYC E  + +LVY FM KG+L  HLY  N   LTW  R+ I +  ARGL
Sbjct: 538 RIRHRHLVSLTGYCEENSEMILVYEFMEKGTLKEHLYGSNLPSLTWKQRLEICIGAARGL 597

Query: 224 EYLH-DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH--AANIRGTFGYLD 280
           +YLH  G+   +IHRD+KS+NILLD+   A+VADFGLS+    D+   + NI+GTFGYLD
Sbjct: 598 DYLHSSGSEGAIIHRDVKSTNILLDEHNIAKVADFGLSKIHNQDESNISINIKGTFGYLD 657

Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA----AMNTEGKTGWEEIV 336
           PEY+ T   T+KSDVY+FGV+L E++  R  +   + + E+      M  + K   +EI+
Sbjct: 658 PEYLQTHKLTEKSDVYAFGVVLLEVLFARPAIDPYLPHEEVNLSEWVMFCKSKGTIDEIL 717

Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI--LKMRHNRKHHRKSQ 394
           D  L G  +   L +   +A KC+     +RPSMRD++  L  +  L+M  NR+   +  
Sbjct: 718 DPSLIGQIETNSLKKFMEIAEKCLKEYGDERPSMRDVIWDLEYVLQLQMMTNRREAHEED 777

Query: 395 ST 396
           ST
Sbjct: 778 ST 779

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1

 Score =  241 bits (614), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 127/282 (45%), Positives = 182/282 (64%), Gaps = 7/282 (2%)

Query: 109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR 168
           L++AT NF+  +G+G+FG VY  +M  G+ VAVK+ A  S    ++F TEV LL R+HHR
Sbjct: 601 LEEATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHR 660

Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLY-DENYGPLTWNLRVHIALDVARGLEYLH 227
           NLV L+GYC E  + +LVY +M  GSL  HL+   +Y PL W  R+ IA D A+GLEYLH
Sbjct: 661 NLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYLH 720

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANI-RGTFGYLDPEYIS 285
            G  P +IHRD+KSSNILLD +MRA+V+DFGLSR+   D  H +++ +GT GYLDPEY +
Sbjct: 721 TGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYA 780

Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA----AMNTEGKTGWEEIVDSRLD 341
           ++  T+KSDVYSFGV+LFEL++G+ P+       EL     A +   K     I+D  + 
Sbjct: 781 SQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGIIDPCIA 840

Query: 342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM 383
               +E +  VA +A +CV +    RP M++++  +   +++
Sbjct: 841 SNVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRI 882

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1

 Score =  240 bits (613), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 133/320 (41%), Positives = 192/320 (60%), Gaps = 10/320 (3%)

Query: 89  GFKRSNVVSAS-GIPEY-SYKDLQKATCNF--TTLIGQGAFGPVYKAQMSTGETVAVKVL 144
           G ++SN  +++ G+  Y S  +LQ+AT NF  + +IG G FG VY   +  G  VAVK  
Sbjct: 497 GSQKSNFYNSTLGLGRYFSLSELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRG 556

Query: 145 ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENY 204
              S+QG  EFQTE+ +L +L HR+LV+L+GYC E  + +LVY FMS G    HLY +N 
Sbjct: 557 NPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNL 616

Query: 205 GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264
            PLTW  R+ I +  ARGL YLH G    +IHRD+KS+NILLD+++ A+VADFGLS++  
Sbjct: 617 APLTWKQRLEICIGSARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKDVA 676

Query: 265 VDKH--AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM--EYVE 320
             ++  +  ++G+FGYLDPEY   +  T KSDVYSFGV+L E +  R  +   +  E V 
Sbjct: 677 FGQNHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVN 736

Query: 321 LA--AMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS 378
           LA  AM  + K   E+I+D  L G  + E + + A  A KC+      RP+M D++  L 
Sbjct: 737 LAEWAMQWKRKGLLEKIIDPHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLE 796

Query: 379 RILKMRHNRKHHRKSQSTTA 398
             L+++      +  ++  A
Sbjct: 797 YALQLQEAFTQGKAEETENA 816

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1

 Score =  238 bits (608), Expect = 5e-62,   Method: Compositional matrix adjust.
 Identities = 149/387 (38%), Positives = 212/387 (54%), Gaps = 38/387 (9%)

Query: 7   GLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDS 66
           GLI+G +IG ++ V+  + + F     RKR Q G+S +     +P   NG    S  S+ 
Sbjct: 405 GLIVGSAIGSLLAVVF-LGSCFVLYKKRKRGQDGHSKTW----MPFSINGTSMGSKYSNG 459

Query: 67  TVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNF--TTLIGQGA 124
           T    +      N N +                 IP  + KD   AT NF  +  IG G 
Sbjct: 460 T----TLTSITTNANYR-----------------IPFAAVKD---ATNNFDESRNIGVGG 495

Query: 125 FGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM 184
           FG VYK +++ G  VAVK     S+QG  EF+TE+ +L +  HR+LV+L+GYC E  + +
Sbjct: 496 FGKVYKGELNDGTKVAVKRGNPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMI 555

Query: 185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNI 244
           L+Y +M  G++ SHLY      LTW  R+ I +  ARGL YLH G   PVIHRD+KS+NI
Sbjct: 556 LIYEYMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSANI 615

Query: 245 LLDQSMRARVADFGLSR--EEMVDKHAAN-IRGTFGYLDPEYISTRNFTKKSDVYSFGVL 301
           LLD++  A+VADFGLS+   E+   H +  ++G+FGYLDPEY   +  T KSDVYSFGV+
Sbjct: 616 LLDENFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVV 675

Query: 302 LFELIAGRSPLQGLM--EYVELA--AMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAY 357
           LFE++  R  +   +  E V LA  AM  + K   ++I+D  L G    + L + A    
Sbjct: 676 LFEVLCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLRKFAETGE 735

Query: 358 KCVNRAPRKRPSMRDIVQVLSRILKMR 384
           KC+      RPSM D++  L   L+++
Sbjct: 736 KCLADYGVDRPSMGDVLWNLEYALQLQ 762

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1

 Score =  238 bits (606), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 147/370 (39%), Positives = 211/370 (57%), Gaps = 33/370 (8%)

Query: 24  ISALFCFRYHRKR--SQIGNSSSRRAATLPIRANGVDSCSILSDSTVGPESP-VKSGRNG 80
           ++   CF +H K+   +  ++S RR   +  R N          +   PE+P   + +N 
Sbjct: 1   MNCFSCFYFHEKKKVPRDSDNSYRRNGEVTGRDN----------NKTHPENPKTVNEQNK 50

Query: 81  NGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNF--TTLIGQGAFGPVYKAQMS-TGE 137
           N      E  + +N ++A     +S+++L  AT NF    LIG+G FG VYK ++  TG 
Sbjct: 51  NND----EDKEVTNNIAAQ---TFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGM 103

Query: 138 TVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLAS 197
            VAVK L  +  QG KEF  EV++L  LHH++LVNL+GYCA+  Q +LVY +MS+GSL  
Sbjct: 104 IVAVKQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLED 163

Query: 198 HLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA 255
           HL D   +  PL W+ R+ IAL  A GLEYLHD A PPVI+RD+K++NILLD    A+++
Sbjct: 164 HLLDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLS 223

Query: 256 DFGLSREEMV-DKH--AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
           DFGL++   V DK   ++ + GT+GY  PEY  T   T KSDVYSFGV+L ELI GR  +
Sbjct: 224 DFGLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVI 283

Query: 313 -----QGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
                +     V  A    +  + + E+ D  L+G+F  + LN+  ++A  C+      R
Sbjct: 284 DTTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVR 343

Query: 368 PSMRDIVQVL 377
           P M D+V  L
Sbjct: 344 PLMSDVVTAL 353

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L4H4|NORK_MEDTR Nodulation receptor kinase OS=Medicago truncatula GN=NORK PE=1 SV=2

 Score =  236 bits (603), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 146/361 (40%), Positives = 202/361 (55%), Gaps = 27/361 (7%)

Query: 83  KSMWLEGFKRSNVVSASGIPEYSYKD----------------LQKATCNFTTLIGQGAFG 126
           KS+ LEGF ++  ++ + I     KD                +++AT  + TLIG+G FG
Sbjct: 549 KSITLEGFGKTYPMATNIIFSLPSKDDFFIKSVSVKPFTLEYIEQATEQYKTLIGEGGFG 608

Query: 127 PVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186
            VY+  +  G+ VAVKV ++ S QG +EF  E+ LL  + H NLV L+GYC E  Q +LV
Sbjct: 609 SVYRGTLDDGQEVAVKVRSSTSTQGTREFDNELNLLSAIQHENLVPLLGYCNEYDQQILV 668

Query: 187 YVFMSKGSLASHLYDE--NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNI 244
           Y FMS GSL   LY E      L W  R+ IAL  ARGL YLH      VIHRD+KSSNI
Sbjct: 669 YPFMSNGSLLDRLYGEASKRKILDWPTRLSIALGAARGLAYLHTFPGRSVIHRDVKSSNI 728

Query: 245 LLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVL 301
           LLDQSM A+VADFG S+   +E     +  +RGT GYLDPEY  T+  ++KSDV+SFGV+
Sbjct: 729 LLDQSMCAKVADFGFSKYAPQEGDSYVSLEVRGTAGYLDPEYYKTQQLSEKSDVFSFGVV 788

Query: 302 LFELIAGRSPLQGLMEYVELAAMNTEGK----TGWEEIVDSRLDGIFDVEELNEVASLAY 357
           L E+++GR PL      +E + +         +  +EIVD  + G +  E L  V  +A 
Sbjct: 789 LLEIVSGREPLNIKRPRIEWSLVEWAKPYIRASKVDEIVDPGIKGGYHAEALWRVVEVAL 848

Query: 358 KCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTT--ADEVSIDMEQAEAKTPTS 415
           +C+      RP M DIV+ L   L + +N   + KS  +   ++  SI M++    + TS
Sbjct: 849 QCLEPYSTYRPCMVDIVRELEDALIIENNASEYMKSIDSLGGSNRYSIVMDKRALPSTTS 908

Query: 416 T 416
           T
Sbjct: 909 T 909

Involved in the perception of symbiotic fungi and bacteria. Part of the perception/transduction system leading to nodulation or mycorrhizal infection.

Medicago truncatula (taxid: 3880)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	432
225461166	430	PREDICTED: probable leucine-rich repeat	0.995	1.0	0.854	0.0
255563627	431	serine/threonine-specific protein kinase	0.993	0.995	0.861	0.0
224115180	430	predicted protein [Populus trichocarpa]	0.986	0.990	0.849	0.0
356549811	431	PREDICTED: probable leucine-rich repeat	0.993	0.995	0.850	0.0
359806757	431	probable leucine-rich repeat receptor-li	0.993	0.995	0.843	0.0
449531988	430	PREDICTED: LOW QUALITY PROTEIN: probable	0.995	1.0	0.773	0.0
449463168	430	PREDICTED: probable leucine-rich repeat	0.995	1.0	0.773	0.0
297792925	437	kinase family protein [Arabidopsis lyrat	0.981	0.970	0.783	0.0
255644575	429	unknown [Glycine max]	0.990	0.997	0.792	0.0
358249148	430	probable leucine-rich repeat receptor-li	0.990	0.995	0.790	0.0

>gi|225461166|ref|XP_002282916.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730 [Vitis vinifera] gi|302143190|emb|CBI20485.3| unnamed protein product [Vitis vinifera]

 Score =  779 bits (2011), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/432 (85%), Positives = 404/432 (93%), Gaps = 2/432 (0%)

Query: 1   MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
           MKGESSGLIIGISIG+VIGVLLAI ALFCFRYHRKRSQIGNSSSRRAAT+PIR+NG DSC
Sbjct: 1   MKGESSGLIIGISIGLVIGVLLAILALFCFRYHRKRSQIGNSSSRRAATIPIRSNGADSC 60

Query: 61  SILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLI 120
           +ILSDST+GP+SP  SGRNG   S WLEGFKRSNVVS SGIPEYSYKDLQKAT NFTTLI
Sbjct: 61  TILSDSTIGPDSPKASGRNG--MSFWLEGFKRSNVVSVSGIPEYSYKDLQKATYNFTTLI 118

Query: 121 GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180
           GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEV LLGRLHHRNLVNLVGYCAEK
Sbjct: 119 GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVHLLGRLHHRNLVNLVGYCAEK 178

Query: 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIK 240
           GQHML+YV+MSKGSLASHLYDE Y PL+W+LR++IALDVARGLEYLHDGAVPPVIHRDIK
Sbjct: 179 GQHMLIYVYMSKGSLASHLYDEKYEPLSWDLRIYIALDVARGLEYLHDGAVPPVIHRDIK 238

Query: 241 SSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGV 300
           SSNILLDQSMRARVADFGLSREEMV KHA+NIRGTFGYLDPEY+STR FTKKSDVYSFGV
Sbjct: 239 SSNILLDQSMRARVADFGLSREEMVSKHASNIRGTFGYLDPEYVSTRAFTKKSDVYSFGV 298

Query: 301 LLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCV 360
           LLFELIAGR+P QGLMEYVELAAMNTEGK GWEEIVDSRLDG FD +ELN++A+LAYKC+
Sbjct: 299 LLFELIAGRNPQQGLMEYVELAAMNTEGKVGWEEIVDSRLDGKFDTQELNDMAALAYKCI 358

Query: 361 NRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDMEQAEAKTPTSTHLRE 420
           NR P+KRPSMRDIVQVLSRI KMRH+RKHH +S S+TA++++ID++Q ++ TP S H RE
Sbjct: 359 NRVPKKRPSMRDIVQVLSRIPKMRHSRKHHTQSLSSTANDIAIDVDQPDSHTPVSEHKRE 418

Query: 421 ESVDSTADTYEL 432
           ES+DSTADT+E+
Sbjct: 419 ESMDSTADTFEV 430

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255563627|ref|XP_002522815.1| serine/threonine-specific protein kinase, putative [Ricinus communis] gi|223537899|gb|EEF39513.1| serine/threonine-specific protein kinase, putative [Ricinus communis]

 Score =  739 bits (1909), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 373/433 (86%), Positives = 398/433 (91%), Gaps = 4/433 (0%)

Query: 1   MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
           MKGESSGLIIGISIGVVIGVLLAI  LFCFRYHRKRSQIGNSSSRRAAT+PIRANG DSC
Sbjct: 1   MKGESSGLIIGISIGVVIGVLLAILGLFCFRYHRKRSQIGNSSSRRAATIPIRANGADSC 60

Query: 61  SILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLI 120
           +ILSDST+GPESPVKSGRNG   S WL+GFK+SNVV+ SGIPEYSYKDLQKAT NFTTLI
Sbjct: 61  TILSDSTLGPESPVKSGRNGT--SFWLDGFKKSNVVAVSGIPEYSYKDLQKATYNFTTLI 118

Query: 121 GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180
           GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEF TEVMLLGRLHHRNLVNLVGYCAEK
Sbjct: 119 GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFHTEVMLLGRLHHRNLVNLVGYCAEK 178

Query: 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIK 240
           GQHML+YVFMSKGSLASHLY EN+  L+W+ RV+IALDVARGLEYLHDGAVPPVIHRDIK
Sbjct: 179 GQHMLIYVFMSKGSLASHLYSENHETLSWDWRVYIALDVARGLEYLHDGAVPPVIHRDIK 238

Query: 241 SSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGV 300
           SSNILLD SMRARVADFGLSREEMVD+ A NIRGTFGYLDPEYIS+R FTKKSDVYS+GV
Sbjct: 239 SSNILLDHSMRARVADFGLSREEMVDRRADNIRGTFGYLDPEYISSRTFTKKSDVYSYGV 298

Query: 301 LLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCV 360
           LLFELIAGR+P QGLMEYVELAAMNTEGK GWEEIVDSRLDG FDV+ELNEVA LAYKC+
Sbjct: 299 LLFELIAGRNPQQGLMEYVELAAMNTEGKVGWEEIVDSRLDGKFDVQELNEVAVLAYKCI 358

Query: 361 NRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDMEQAEAKTPTS-THLR 419
           NR P+KRP+MRDIVQVL+RILK RH+R+HH+KS S TADEVSIDM+Q E KTP S  H R
Sbjct: 359 NRVPKKRPAMRDIVQVLARILKSRHSRRHHKKSLSATADEVSIDMDQLEVKTPVSECHRR 418

Query: 420 EESVDSTADTYEL 432
           EES+DS ADT E 
Sbjct: 419 EESMDS-ADTCEF 430

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224115180|ref|XP_002316964.1| predicted protein [Populus trichocarpa] gi|222860029|gb|EEE97576.1| predicted protein [Populus trichocarpa]

 Score =  724 bits (1870), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 367/432 (84%), Positives = 397/432 (91%), Gaps = 6/432 (1%)

Query: 4   ESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSCSIL 63
           ESSGLIIGISIGVVIGV LAI ALFC RYHRKRSQIG+SSSRRAA +PIRANG D+C+++
Sbjct: 2   ESSGLIIGISIGVVIGVFLAILALFCLRYHRKRSQIGSSSSRRAAKIPIRANGADACTVM 61

Query: 64  SDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQG 123
           SDST+ PESPVK+GRN     +WLEGFKRSNVVS SGIPE+SYKDLQKAT NFTTLIGQG
Sbjct: 62  SDSTIDPESPVKAGRNR--VPLWLEGFKRSNVVSVSGIPEFSYKDLQKATYNFTTLIGQG 119

Query: 124 AFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 183
           AFGPVYKAQ++T ETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH
Sbjct: 120 AFGPVYKAQITTDETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH 179

Query: 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSN 243
           ML+YV+MS+GSLASHLY E+  PL W+LRV+IALDVARGLEYLH+GAVPPVIHRDIKSSN
Sbjct: 180 MLIYVYMSEGSLASHLYREDLKPLNWDLRVYIALDVARGLEYLHNGAVPPVIHRDIKSSN 239

Query: 244 ILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLF 303
           ILLDQ MRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIS+R FTKKSDVYS+GVLLF
Sbjct: 240 ILLDQCMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISSRTFTKKSDVYSYGVLLF 299

Query: 304 ELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRA 363
           ELIAGR+P QGL+EYVELAAMNTEGK GWEEIVDSRLDG FDV+ELNEVA LAYKCVNRA
Sbjct: 300 ELIAGRNPQQGLLEYVELAAMNTEGKVGWEEIVDSRLDGKFDVQELNEVAVLAYKCVNRA 359

Query: 364 PRKRPSMRDIVQVLSRILKMRHNRKHHRKSQS-TTADEVSIDMEQAEAKTPTST--HLRE 420
           PRKRPSMRDIVQVLSRILK+RHN+KHH+KS S TTADEVSIDM+Q E +TP S   H RE
Sbjct: 360 PRKRPSMRDIVQVLSRILKLRHNKKHHKKSLSATTADEVSIDMDQQEIRTPLSEHHHRRE 419

Query: 421 ESVDSTADTYEL 432
           ESVDS ADT E+
Sbjct: 420 ESVDS-ADTGEV 430

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356549811|ref|XP_003543284.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730-like [Glycine max]

 Score =  723 bits (1866), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/434 (85%), Positives = 395/434 (91%), Gaps = 5/434 (1%)

Query: 1   MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
           MK ES+GLIIGISIGVVIGV LAISALFC RYHRKRSQIGNSSSRRA T+PIR NGVDSC
Sbjct: 1   MKEESTGLIIGISIGVVIGVGLAISALFCLRYHRKRSQIGNSSSRRAHTIPIRENGVDSC 60

Query: 61  SILSDSTVGPESPVKSGRNGNGKSMWLEGFKRS-NVVSASGIPEYSYKDLQKATCNFTTL 119
           +ILSDST+GPESPV+SGRNG   S WL+GFK+S N+VSASGIPEYSYKDLQKAT NFTTL
Sbjct: 61  NILSDSTLGPESPVRSGRNG--MSFWLDGFKKSSNMVSASGIPEYSYKDLQKATYNFTTL 118

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IGQGAFGPVYKAQMSTGETVAVKVLAT+SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE
Sbjct: 119 IGQGAFGPVYKAQMSTGETVAVKVLATNSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 178

Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           KGQHMLVYV+MSKGSLASHLY E  G L W+LRVHIALDVARG+EYLHDGAVPPVIHRDI
Sbjct: 179 KGQHMLVYVYMSKGSLASHLYSEENGALGWDLRVHIALDVARGIEYLHDGAVPPVIHRDI 238

Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFG 299
           KSSNILLDQSMRARVADFGLSREEMVDKHAA IRGTFGYLDPEYIS+  FTKKSDVYSFG
Sbjct: 239 KSSNILLDQSMRARVADFGLSREEMVDKHAA-IRGTFGYLDPEYISSGTFTKKSDVYSFG 297

Query: 300 VLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKC 359
           VLLFELIAGR+P QGLMEYVELAAM+TEGK GWEEIVDSRL+G  D +ELNEVA+LAYKC
Sbjct: 298 VLLFELIAGRNPQQGLMEYVELAAMDTEGKVGWEEIVDSRLEGKCDFQELNEVAALAYKC 357

Query: 360 VNRAPRKRPSMRDIVQVLSRILKMRHNRKHHR-KSQSTTADEVSIDMEQAEAKTPTSTHL 418
           +NRAP+KRPSMRDIVQVL+RILK RH R HH  KS S TADEVSID++Q E K   + H 
Sbjct: 358 INRAPKKRPSMRDIVQVLTRILKSRHQRNHHHNKSLSATADEVSIDVDQLETKNSVTDHR 417

Query: 419 REESVDSTADTYEL 432
           REES+DSTAD Y+L
Sbjct: 418 REESIDSTADIYDL 431

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359806757|ref|NP_001241300.1| probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730-like [Glycine max] gi|223452504|gb|ACM89579.1| protein kinase family protein [Glycine max]

 Score =  722 bits (1863), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 366/434 (84%), Positives = 396/434 (91%), Gaps = 5/434 (1%)

Query: 1   MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
           MK ES+GLIIGISIGVVIGV LAISALFC RYHRKRSQIGNSSSRRA T+PIR NGVDSC
Sbjct: 1   MKEESTGLIIGISIGVVIGVGLAISALFCLRYHRKRSQIGNSSSRRAHTIPIRENGVDSC 60

Query: 61  SILSDSTVGPESPVKSGRNGNGKSMWLEGFKRS-NVVSASGIPEYSYKDLQKATCNFTTL 119
           +ILSDST+GPESPV+SGRNG   S+WL+GFK+S N+VSASGIPEYSYKDLQKAT NFTTL
Sbjct: 61  NILSDSTLGPESPVRSGRNG--MSLWLDGFKKSSNMVSASGIPEYSYKDLQKATYNFTTL 118

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IGQGAFGPVYKAQMSTGETVAVKVLAT+SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE
Sbjct: 119 IGQGAFGPVYKAQMSTGETVAVKVLATNSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 178

Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           KGQHMLVYV+MSKGSLASHLY E  G L W+LRVHIALDVARG+EYLHDGAVPPVIHRDI
Sbjct: 179 KGQHMLVYVYMSKGSLASHLYSEENGALGWDLRVHIALDVARGIEYLHDGAVPPVIHRDI 238

Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFG 299
           KSSNILLDQSMRARVADFGLSREEMVDKHAA IRGTFGYLDPEYIS+  FTKKSDVYSFG
Sbjct: 239 KSSNILLDQSMRARVADFGLSREEMVDKHAA-IRGTFGYLDPEYISSGTFTKKSDVYSFG 297

Query: 300 VLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKC 359
           VLLFELIAGR+P QGLMEYVELAAMNTEGK GWEEIVDSRL+G  D +ELN+VA+LAYKC
Sbjct: 298 VLLFELIAGRNPQQGLMEYVELAAMNTEGKVGWEEIVDSRLEGKCDFQELNQVAALAYKC 357

Query: 360 VNRAPRKRPSMRDIVQVLSRILKMRHNRK-HHRKSQSTTADEVSIDMEQAEAKTPTSTHL 418
           +NRAP+KRPSMRDIVQV +RILK R+ R  HH+KS S T DEVSID++Q E K+  + H 
Sbjct: 358 INRAPKKRPSMRDIVQVFTRILKSRYQRNHHHKKSLSATVDEVSIDVDQLETKSSVTDHR 417

Query: 419 REESVDSTADTYEL 432
           REES+DSTAD Y+L
Sbjct: 418 REESIDSTADIYDL 431

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449531988|ref|XP_004172967.1| PREDICTED: LOW QUALITY PROTEIN: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730-like [Cucumis sativus]

 Score =  707 bits (1824), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 334/432 (77%), Positives = 382/432 (88%), Gaps = 2/432 (0%)

Query: 1   MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
           MK ES+GL IGISIGVVIGVLLAI ALFCFRYHRKR QIGNSSSRRAA LPIR NG DSC
Sbjct: 1   MKEESTGLAIGISIGVVIGVLLAILALFCFRYHRKRLQIGNSSSRRAANLPIRTNGADSC 60

Query: 61  SILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLI 120
           +ILSDSTVGPESP+K+ RN    S W +GFKRS+V+SASG+PEYS KDLQKAT NFT++I
Sbjct: 61  TILSDSTVGPESPMKTSRNS--MSSWFDGFKRSSVISASGMPEYSIKDLQKATGNFTSVI 118

Query: 121 GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180
           GQGAFGPVYKA + +GETVAVKVLAT+SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE+
Sbjct: 119 GQGAFGPVYKATLPSGETVAVKVLATNSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAER 178

Query: 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIK 240
           G+HMLVYV+MSKGSLASHLY +  G L WN+RV +ALDVARGLEYLHDGAVPPVIHRDIK
Sbjct: 179 GEHMLVYVYMSKGSLASHLYSDKNGLLGWNMRVRVALDVARGLEYLHDGAVPPVIHRDIK 238

Query: 241 SSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGV 300
           S+NILLD+SMRARVADFGLSREEMVD  AANIRGTFGYLDPEY+S+R F KKSDVYSFGV
Sbjct: 239 SANILLDESMRARVADFGLSREEMVDSQAANIRGTFGYLDPEYMSSRAFNKKSDVYSFGV 298

Query: 301 LLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCV 360
           LLFE++AGR+P QGLMEYVELAAMN +GK GWEE+ DSRL+G FDV+ELNEVA+LAYKCV
Sbjct: 299 LLFEIVAGRNPQQGLMEYVELAAMNFDGKVGWEELADSRLEGNFDVQELNEVAALAYKCV 358

Query: 361 NRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDMEQAEAKTPTSTHLRE 420
           NR P+KRPSMRD VQVLSRILK RH++  ++ + STT DEV++D++Q E ++P   H R+
Sbjct: 359 NRXPKKRPSMRDSVQVLSRILKQRHSKNXNQNTLSTTTDEVAVDVDQLEGRSPRPEHRRQ 418

Query: 421 ESVDSTADTYEL 432
           +S DST ++ E+
Sbjct: 419 QSADSTTESCEV 430

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449463168|ref|XP_004149306.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730-like [Cucumis sativus]

 Score =  705 bits (1820), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 334/432 (77%), Positives = 382/432 (88%), Gaps = 2/432 (0%)

Query: 1   MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
           MK ES+GL IGISIGVVIGVLLAI ALFCFRYHRKR QIGNSSSRRAA LPIR NG DSC
Sbjct: 1   MKEESTGLAIGISIGVVIGVLLAILALFCFRYHRKRLQIGNSSSRRAANLPIRTNGADSC 60

Query: 61  SILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLI 120
           +ILSDSTVGPESP+K+ RN    S W +GFKRS+V+SASG+PEYS KDLQKAT NFT++I
Sbjct: 61  TILSDSTVGPESPMKTSRNS--MSSWFDGFKRSSVISASGMPEYSIKDLQKATGNFTSVI 118

Query: 121 GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180
           GQGAFGPVYKA + +GETVAVKVLAT+SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE+
Sbjct: 119 GQGAFGPVYKATLPSGETVAVKVLATNSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAER 178

Query: 181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIK 240
           G+HMLVYV+MSKGSLASHLY +  G L WN+RV +ALDVARGLEYLHDGAVPPVIHRDIK
Sbjct: 179 GEHMLVYVYMSKGSLASHLYSDKNGLLGWNMRVRVALDVARGLEYLHDGAVPPVIHRDIK 238

Query: 241 SSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGV 300
           S+NILLD+SMRARVADFGLSREEMVD  AANIRGTFGYLDPEY+S+R F KKSDVYSFGV
Sbjct: 239 SANILLDESMRARVADFGLSREEMVDSRAANIRGTFGYLDPEYMSSRAFNKKSDVYSFGV 298

Query: 301 LLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCV 360
           LLFE++AGR+P QGLMEYVELAAMN +GK GWEE+ DSRL+G FDV+ELNEVA+LAYKCV
Sbjct: 299 LLFEIVAGRNPQQGLMEYVELAAMNFDGKVGWEELADSRLEGNFDVQELNEVAALAYKCV 358

Query: 361 NRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDMEQAEAKTPTSTHLRE 420
           NR  +KRPSMRD VQVLSRILK RH++K ++ + STT DEV++D++Q E ++P   H R+
Sbjct: 359 NRVQKKRPSMRDSVQVLSRILKQRHSKKRNQNTLSTTTDEVAVDVDQLEGRSPRPEHRRQ 418

Query: 421 ESVDSTADTYEL 432
           +S DST ++ E+
Sbjct: 419 QSADSTTESCEV 430

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297792925|ref|XP_002864347.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297310182|gb|EFH40606.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  702 bits (1813), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/434 (78%), Positives = 385/434 (88%), Gaps = 10/434 (2%)

Query: 1   MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
           M+GES GLI+GIS+G+VIGV LAISALFCFRYHRKRSQI NS SRR+AT+PIR NG DSC
Sbjct: 1   MEGESFGLIVGISLGLVIGVALAISALFCFRYHRKRSQIVNSGSRRSATIPIRENGADSC 60

Query: 61  SILSDSTVGPESPVKSGRNGNGKSMWLEGF-KRSNVVSASGIPEYSYKDLQKATCNFTTL 119
           +++SDST+GP+SPVKS +NG  +S+WLEGF KRSNV+SASGI EYSY+DLQKATCNFTTL
Sbjct: 61  NVMSDSTIGPDSPVKSSKNG--RSVWLEGFNKRSNVISASGILEYSYRDLQKATCNFTTL 118

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IGQGAFGPVYKAQMSTGE VAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL+GYCAE
Sbjct: 119 IGQGAFGPVYKAQMSTGEIVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLIGYCAE 178

Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           KGQHML+YV+MSKGSLASHLY E + PL+W+LRV+IALDVARGLEYLHDGAVPPVIHRDI
Sbjct: 179 KGQHMLIYVYMSKGSLASHLYSEKHEPLSWDLRVYIALDVARGLEYLHDGAVPPVIHRDI 238

Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFG 299
           KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR FTKKSDVY FG
Sbjct: 239 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRTFTKKSDVYGFG 298

Query: 300 VLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKC 359
           VLLFELIAGR+P QGLME VELAAMN E K GWEEIVDSRLDG FD++E+NEVA+ AYKC
Sbjct: 299 VLLFELIAGRNPQQGLMELVELAAMNAEEKVGWEEIVDSRLDGRFDLQEVNEVAAFAYKC 358

Query: 360 VNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDM-EQAEAKTP----- 413
           ++RAPRKRP+MRDIVQVL+R++K+RH RK  + S S +   +   + E++E +       
Sbjct: 359 ISRAPRKRPNMRDIVQVLTRVIKVRHCRKRQKNSPSPSPRPLPPPIVEESEGELTANGSL 418

Query: 414 -TSTHLREESVDST 426
            + TH R+ SVDS+
Sbjct: 419 RSETHRRDNSVDSS 432

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255644575|gb|ACU22790.1| unknown [Glycine max]

 Score =  699 bits (1805), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 343/433 (79%), Positives = 383/433 (88%), Gaps = 5/433 (1%)

Query: 1   MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
           MK ES GLIIG+SIGVVIG++LAI A FC RYHRKRSQIGNSSSRRAAT+PIR NG DSC
Sbjct: 1   MKEESVGLIIGVSIGVVIGLVLAIFAFFCHRYHRKRSQIGNSSSRRAATIPIRTNGADSC 60

Query: 61  SILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSN-VVSASGIPEYSYKDLQKATCNFTTL 119
           +ILSDST+GPESP+KS R+G     WL+GFK+S+ ++ ASG+PEY+YKDLQKAT NFTT+
Sbjct: 61  TILSDSTLGPESPIKSDRHG--MPFWLDGFKKSSSMIPASGLPEYAYKDLQKATHNFTTV 118

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG+GAFGPVYKAQMSTGETVAVKVLAT+SKQGEKEF TEVMLLGRLHHRNLVNLVGYCAE
Sbjct: 119 IGEGAFGPVYKAQMSTGETVAVKVLATNSKQGEKEFNTEVMLLGRLHHRNLVNLVGYCAE 178

Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           KG+HMLVYV+MS GSLASHLY +    L+W+LRV IALDVARGLEYLH+GAVPPVIHRDI
Sbjct: 179 KGKHMLVYVYMSNGSLASHLYSDVNEALSWDLRVPIALDVARGLEYLHNGAVPPVIHRDI 238

Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFG 299
           KSSNILLDQSMRARVADFGLSREEMVDKHAA IRGTFGYLDPEYIS+  FTKKSDVYSFG
Sbjct: 239 KSSNILLDQSMRARVADFGLSREEMVDKHAA-IRGTFGYLDPEYISSGTFTKKSDVYSFG 297

Query: 300 VLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKC 359
           VLLFE+IAGR+P QGLMEYVELAAMNTEGK GWEEIVDSRL G FDV+ELNE+A+LAYKC
Sbjct: 298 VLLFEIIAGRNPQQGLMEYVELAAMNTEGKVGWEEIVDSRLQGNFDVKELNEMAALAYKC 357

Query: 360 VNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDMEQAEAKTPTSTHLR 419
           +NRAP KRPSMRDIVQVL+RILK R++  HH+ S S T DEV ID +Q E K   + H R
Sbjct: 358 INRAPSKRPSMRDIVQVLTRILKSRNHGSHHKNSLSAT-DEVFIDTDQLENKISVTDHRR 416

Query: 420 EESVDSTADTYEL 432
           EES+DS A+ YE+
Sbjct: 417 EESLDSVAEVYEV 429

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358249148|ref|NP_001239745.1| probable leucine-rich repeat receptor-like serine/threonine-protein kinase At5g15730-like [Glycine max] gi|223452385|gb|ACM89520.1| serine/threonine protein kinase [Glycine max]

 Score =  699 bits (1805), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 343/434 (79%), Positives = 383/434 (88%), Gaps = 6/434 (1%)

Query: 1   MKGESSGLIIGISIGVVIGVLLAISALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSC 60
           MK ES GLIIG+SIGVVIG++LAI A FC RYHRKRSQIGNSSSRRAAT+PIR NG DSC
Sbjct: 1   MKEESVGLIIGVSIGVVIGLVLAIFAFFCHRYHRKRSQIGNSSSRRAATIPIRTNGADSC 60

Query: 61  SILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSN--VVSASGIPEYSYKDLQKATCNFTT 118
           +ILSDST+GPESP+KS R+G     WL+GFK+S+  ++ ASG+PEY+YKDLQKAT NFTT
Sbjct: 61  TILSDSTLGPESPIKSDRHG--MPFWLDGFKKSSSSMIPASGLPEYAYKDLQKATHNFTT 118

Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +IG+GAFGPVYKAQMSTGETVAVKVLAT+SKQGEKEF TEVMLLGRLHHRNLVNLVGYCA
Sbjct: 119 VIGEGAFGPVYKAQMSTGETVAVKVLATNSKQGEKEFNTEVMLLGRLHHRNLVNLVGYCA 178

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
           EKG+HMLVYV+MS GSLASHLY +    L+W+LRV IALDVARGLEYLH+GAVPPVIHRD
Sbjct: 179 EKGKHMLVYVYMSNGSLASHLYSDVNEALSWDLRVPIALDVARGLEYLHNGAVPPVIHRD 238

Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSF 298
           IKSSNILLDQSMRARVADFGLSREEMVDKHAA IRGTFGYLDPEYIS+  FTKKSDVYSF
Sbjct: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAA-IRGTFGYLDPEYISSGTFTKKSDVYSF 297

Query: 299 GVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYK 358
           GVLLFE+IAGR+P QGLMEYVELAAMNTEGK GWEEIVDSRL G FDV+ELNE+A+LAYK
Sbjct: 298 GVLLFEIIAGRNPQQGLMEYVELAAMNTEGKVGWEEIVDSRLQGNFDVKELNEMAALAYK 357

Query: 359 CVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDMEQAEAKTPTSTHL 418
           C+NRAP KRPSMRDIVQVL+RILK R++  HH+ S S T DEV ID +Q E K   + H 
Sbjct: 358 CINRAPSKRPSMRDIVQVLTRILKSRNHGSHHKNSLSAT-DEVFIDTDQLENKISVTDHR 416

Query: 419 REESVDSTADTYEL 432
           REES+DS A+ YE+
Sbjct: 417 REESLDSVAEVYEV 430

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	432
TAIR|locus:2172149	440	CRLK1 "calcium/calmodulin-regu	0.912	0.895	0.791	5.2e-168
TAIR|locus:2143166	436	CRLK2 "calcium/calmodulin-regu	0.851	0.844	0.484	3.9e-92
TAIR|locus:2008565	929	AT1G67720 [Arabidopsis thalian	0.719	0.334	0.424	1e-61
TAIR|locus:2148830	858	ANX2 "ANXUR2" [Arabidopsis tha	0.796	0.400	0.394	1.2e-60
TAIR|locus:2084953	850	ANX1 "ANXUR1" [Arabidopsis tha	0.817	0.415	0.388	3.1e-60
TAIR|locus:2058636	834	AT2G23200 [Arabidopsis thalian	0.745	0.386	0.421	6.4e-60
TAIR|locus:2090634	663	AT3G19300 [Arabidopsis thalian	0.643	0.419	0.445	5.7e-59
TAIR|locus:2136338	878	AT4G39110 [Arabidopsis thalian	0.759	0.373	0.408	5.8e-59
TAIR|locus:2012191	693	AT1G49730 [Arabidopsis thalian	0.666	0.415	0.445	1.5e-58
TAIR|locus:2181017	951	AT5G01950 [Arabidopsis thalian	0.717	0.325	0.414	3.7e-58

TAIR|locus:2172149 CRLK1 "calcium/calmodulin-regulated receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1634 (580.3 bits), Expect = 5.2e-168, P = 5.2e-168
 Identities = 316/399 (79%), Positives = 355/399 (88%)

Query:    26 ALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSM 85
             ALFCFRYHRK+SQI NS SRR+AT+PIR NG DSC+I+SDST+GP+SPVKS +NG  +S+
Sbjct:    26 ALFCFRYHRKKSQIVNSGSRRSATIPIRENGADSCNIMSDSTIGPDSPVKSSKNG--RSV 83

Query:    86 WLEGF-KRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVL 144
             WLEGF KRSNV+SASGI EYSY+DLQKATCNFTTLIGQGAFGPVYKAQMSTGE VAVKVL
Sbjct:    84 WLEGFSKRSNVISASGILEYSYRDLQKATCNFTTLIGQGAFGPVYKAQMSTGEIVAVKVL 143

Query:   145 ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENY 204
             ATDSKQGEKEFQTEVMLLGRLHHRNLVNL+GYCAEKGQHML+YV+MSKGSLASHLY E +
Sbjct:   144 ATDSKQGEKEFQTEVMLLGRLHHRNLVNLIGYCAEKGQHMLIYVYMSKGSLASHLYSEKH 203

Query:   205 GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264
              PL+W+LRV+IALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM
Sbjct:   204 EPLSWDLRVYIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 263

Query:   265 VDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM 324
             VDKHAANIRGTFGYLDPEYISTR FTKKSDVY FGVLLFELIAGR+P QGLME VELAAM
Sbjct:   264 VDKHAANIRGTFGYLDPEYISTRTFTKKSDVYGFGVLLFELIAGRNPQQGLMELVELAAM 323

Query:   325 NTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR 384
             N E K GWEEIVDSRLDG +D++E+NEVA+ AYKC++RAPRKRP+MRDIVQVL+R++K+R
Sbjct:   324 NAEEKVGWEEIVDSRLDGRYDLQEVNEVAAFAYKCISRAPRKRPNMRDIVQVLTRVIKVR 383

Query:   385 HNRKHHRKSQSTTA--DEVSIDMEQAEAKTPTSTHLREE 421
             H RK  + S S +         +E++E +   +  LR E
Sbjct:   384 HCRKRQKNSPSPSPRLPPPPPIVEESEGELTANGSLRSE 422

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005516 "calmodulin binding" evidence=IDA

GO:0009409 "response to cold" evidence=IEP

TAIR|locus:2143166 CRLK2 "calcium/calmodulin-regulated receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 918 (328.2 bits), Expect = 3.9e-92, P = 3.9e-92
 Identities = 187/386 (48%), Positives = 258/386 (66%)

Query:    28 FCFRYHRKRSQIGN-SSSRRAATLPIRA--NGVDSCSILSDSTVGPES--PVKSGRNGNG 82
             F  +++  RS +   ++ + + TLP+     GV    ++ D     ES  P ++G     
Sbjct:    28 FAIKWYYGRSHLRRCANEQNSPTLPVHTAKRGV----VIPDDRANTESSQPPENGAPTQH 83

Query:    83 KSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVK 142
             +  W     +   VSASGIP Y+YKD+QKAT NFTT++GQG+FGPVYKA M  GE  A K
Sbjct:    84 QPWW-NNHTKDLTVSASGIPRYNYKDIQKATQNFTTVLGQGSFGPVYKAVMPNGELAAAK 142

Query:   143 VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD- 201
             V  ++S QG++EFQTEV LLGRLHHRNLVNL GYC +K   ML+Y FMS GSL + LY  
Sbjct:   143 VHGSNSSQGDREFQTEVSLLGRLHHRNLVNLTGYCVDKSHRMLIYEFMSNGSLENLLYGG 202

Query:   202 ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261
             E    L W  R+ IALD++ G+EYLH+GAVPPVIHRD+KS+NILLD SMRA+VADFGLS+
Sbjct:   203 EGMQVLNWEERLQIALDISHGIEYLHEGAVPPVIHRDLKSANILLDHSMRAKVADFGLSK 262

Query:   262 EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
             E ++D+  + ++GT GY+DP YIST  +T KSD+YSFGV++ ELI    P Q LMEY+ L
Sbjct:   263 EMVLDRMTSGLKGTHGYMDPTYISTNKYTMKSDIYSFGVIILELITAIHPQQNLMEYINL 322

Query:   322 AAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
             A+M+ +G    +EI+D +L G   +EE+  +A +A +CV++ PRKRPS+ ++ Q    IL
Sbjct:   323 ASMSPDGI---DEILDQKLVGNASIEEVRLLAKIANRCVHKTPRKRPSIGEVTQF---IL 376

Query:   382 KMRHNRKHHRKSQSTTADEVSIDMEQ 407
             K++ +R   R+ Q T +    +  E+
Sbjct:   377 KIKQSRSRGRR-QDTMSSSFGVGYEE 401

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)]

 Score = 634 (228.2 bits), Expect = 1.0e-61, P = 1.0e-61
 Identities = 137/323 (42%), Positives = 201/323 (62%)

Query:   109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR 168
             L++AT NF+  +G+G+FG VY  +M  G+ VAVK+ A  S    ++F TEV LL R+HHR
Sbjct:   601 LEEATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHR 660

Query:   169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLY-DENYGPLTWNLRVHIALDVARGLEYLH 227
             NLV L+GYC E  + +LVY +M  GSL  HL+   +Y PL W  R+ IA D A+GLEYLH
Sbjct:   661 NLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYLH 720

Query:   228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANI-RGTFGYLDPEYIS 285
              G  P +IHRD+KSSNILLD +MRA+V+DFGLSR+   D  H +++ +GT GYLDPEY +
Sbjct:   721 TGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYA 780

Query:   286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA----AMNTEGKTGWEEIVDSRLD 341
             ++  T+KSDVYSFGV+LFEL++G+ P+       EL     A +   K     I+D  + 
Sbjct:   781 SQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGIIDPCIA 840

Query:   342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEV 401
                 +E +  VA +A +CV +    RP M++++  +   +++    ++  KS S+++ + 
Sbjct:   841 SNVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSSSSSKA 900

Query:   402 SIDMEQAEAKTPTSTHLREESVD 424
                  Q+  KT  ++ L  ES D
Sbjct:   901 -----QSSRKTLLTSFLELESPD 918

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007267 "cell-cell signaling" evidence=RCA

GO:0009616 "virus induced gene silencing" evidence=RCA

GO:0010267 "production of ta-siRNAs involved in RNA interference" evidence=RCA

GO:0035196 "production of miRNAs involved in gene silencing by miRNA" evidence=RCA

TAIR|locus:2148830 ANX2 "ANXUR2" [Arabidopsis thaliana (taxid:3702)]

 Score = 621 (223.7 bits), Expect = 1.2e-60, P = 1.2e-60
 Identities = 148/375 (39%), Positives = 218/375 (58%)

Query:    29 CFRYHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLE 88
             CF  ++++ +   S S  ++ LPI  N   S +    ST+       SG++ NG  +   
Sbjct:   452 CFTMYQRKRKFSGSDSHTSSWLPIYGNSHTSAT---KSTI-------SGKSNNGSHL--- 498

Query:    89 GFKRSNVVSASGI-PEYSYKDLQKATCNF--TTLIGQGAFGPVYKAQMSTGETVAVKVLA 145
                 SN+  A+G+   +S  +++  T NF  + +IG G FG VYK  +  G  VA+K   
Sbjct:   499 ----SNL--AAGLCRRFSLSEIKHGTHNFDESNVIGVGGFGKVYKGVIDGGTKVAIKKSN 552

Query:   146 TDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYG 205
              +S+QG  EF+TE+ LL RL H++LV+L+GYC E G+  L+Y +MS G+L  HLY+    
Sbjct:   553 PNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLIYDYMSLGTLREHLYNTKRP 612

Query:   206 PLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--E 263
              LTW  R+ IA+  ARGL YLH GA   +IHRD+K++NILLD++  A+V+DFGLS+    
Sbjct:   613 QLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPN 672

Query:   264 MVDKHAANI-RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM--EYVE 320
             M   H   + +G+FGYLDPEY   +  T+KSDVYSFGV+LFE++  R  L   +  E V 
Sbjct:   673 MNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNPSLSKEQVS 732

Query:   321 LA--AMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS 378
             L   AMN + K   E+I+D  L G  + E L + A  A KC++ +   RP+M D++  L 
Sbjct:   733 LGDWAMNCKRKGTLEDIIDPNLKGKINPECLKKFADTAEKCLSDSGLDRPTMGDVLWNLE 792

Query:   379 RILKMRHNR--KHHR 391
               L+++       HR
Sbjct:   793 FALQLQETADGSRHR 807

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009860 "pollen tube growth" evidence=IGI

GO:0016324 "apical plasma membrane" evidence=IDA

GO:0090404 "pollen tube tip" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2084953 ANX1 "ANXUR1" [Arabidopsis thaliana (taxid:3702)]

 Score = 617 (222.3 bits), Expect = 3.1e-60, P = 3.1e-60
 Identities = 149/384 (38%), Positives = 220/384 (57%)

Query:    29 CFRYHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLE 88
             CF  ++K+       S  ++ LPI  N          +T G +S + SG++ NG  +   
Sbjct:   448 CFTAYKKKQGYQGGDSHTSSWLPIYGNS---------TTSGTKSTI-SGKSNNGSHL--- 494

Query:    89 GFKRSNVVSASGI-PEYSYKDLQKATCNF--TTLIGQGAFGPVYKAQMSTGETVAVKVLA 145
                 SN+  A+G+   +S  +++  T NF  + +IG G FG VYK  +     VAVK   
Sbjct:   495 ----SNL--AAGLCRRFSLPEIKHGTQNFDDSNVIGVGGFGKVYKGVIDGTTKVAVKKSN 548

Query:   146 TDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYG 205
              +S+QG  EF+TE+ LL RL H++LV+L+GYC E G+  LVY +M+ G+L  HLY+    
Sbjct:   549 PNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLVYDYMAFGTLREHLYNTKKP 608

Query:   206 PLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--E 263
              LTW  R+ IA+  ARGL YLH GA   +IHRD+K++NIL+D++  A+V+DFGLS+    
Sbjct:   609 QLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILVDENWVAKVSDFGLSKTGPN 668

Query:   264 MVDKHAANI-RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM--EYVE 320
             M   H   + +G+FGYLDPEY   +  T+KSDVYSFGV+LFE++  R  L   +  E V 
Sbjct:   669 MNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALNPSLPKEQVS 728

Query:   321 LA--AMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS 378
             L   AMN + K   E+I+D  L G  + E L + A  A KC+N +  +RP+M D++  L 
Sbjct:   729 LGDWAMNCKRKGNLEDIIDPNLKGKINAECLKKFADTAEKCLNDSGLERPTMGDVLWNLE 788

Query:   379 RILKMRHNRK--HHRKSQSTTADE 400
               L+++       HR   +  + E
Sbjct:   789 FALQLQETADGTRHRTPNNGGSSE 812

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009860 "pollen tube growth" evidence=IGI;RCA

GO:0016324 "apical plasma membrane" evidence=IDA

GO:0090404 "pollen tube tip" evidence=IDA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2058636 AT2G23200 [Arabidopsis thaliana (taxid:3702)]

 Score = 614 (221.2 bits), Expect = 6.4e-60, P = 6.4e-60
 Identities = 143/339 (42%), Positives = 198/339 (58%)

Query:    72 SPVKSGRNGNGKSMWLEGFKRS---NVVSASGIPEYSYKDLQKATCNFTT--LIGQGAFG 126
             SP+   R G+  +  +  +  S   N+     IP   + D+  AT NF    LIG+G FG
Sbjct:   444 SPLPLHRGGSSDNRPISQYHNSPLRNLHLGLTIP---FTDILSATNNFDEQLLIGKGGFG 500

Query:   127 PVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV 186
              VYKA +  G   A+K   T S QG  EFQTE+ +L R+ HR+LV+L GYC E  + +LV
Sbjct:   501 YVYKAILPDGTKAAIKRGKTGSGQGILEFQTEIQVLSRIRHRHLVSLTGYCEENSEMILV 560

Query:   187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNIL 245
             Y FM KG+L  HLY  N   LTW  R+ I +  ARGL+YLH  G+   +IHRD+KS+NIL
Sbjct:   561 YEFMEKGTLKEHLYGSNLPSLTWKQRLEICIGAARGLDYLHSSGSEGAIIHRDVKSTNIL 620

Query:   246 LDQSMRARVADFGLSREEMVDKH--AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLF 303
             LD+   A+VADFGLS+    D+   + NI+GTFGYLDPEY+ T   T+KSDVY+FGV+L 
Sbjct:   621 LDEHNIAKVADFGLSKIHNQDESNISINIKGTFGYLDPEYLQTHKLTEKSDVYAFGVVLL 680

Query:   304 ELIAGRSPLQGLM--EYVELA--AMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKC 359
             E++  R  +   +  E V L+   M  + K   +EI+D  L G  +   L +   +A KC
Sbjct:   681 EVLFARPAIDPYLPHEEVNLSEWVMFCKSKGTIDEILDPSLIGQIETNSLKKFMEIAEKC 740

Query:   360 VNRAPRKRPSMRDIVQVLSRILK--MRHNRKHHRKSQST 396
             +     +RPSMRD++  L  +L+  M  NR+   +  ST
Sbjct:   741 LKEYGDERPSMRDVIWDLEYVLQLQMMTNRREAHEEDST 779

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2090634 AT3G19300 [Arabidopsis thaliana (taxid:3702)]

 Score = 605 (218.0 bits), Expect = 5.7e-59, P = 5.7e-59
 Identities = 126/283 (44%), Positives = 177/283 (62%)

Query:   100 GIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEV 159
             G  ++SYK+++KAT +F  +IG+G FG VYKA+ S G   AVK +   S+Q E EF  E+
Sbjct:   312 GFRKFSYKEIRKATEDFNAVIGRGGFGTVYKAEFSNGLVAAVKKMNKSSEQAEDEFCREI 371

Query:   160 MLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDV 219
              LL RLHHR+LV L G+C +K +  LVY +M  GSL  HL+     PL+W  R+ IA+DV
Sbjct:   372 ELLARLHHRHLVALKGFCNKKNERFLVYEYMENGSLKDHLHSTEKSPLSWESRMKIAIDV 431

Query:   220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL---SREEMVDKHAAN--IRG 274
             A  LEYLH    PP+ HRDIKSSNILLD+   A++ADFGL   SR+  +     N  IRG
Sbjct:   432 ANALEYLHFYCDPPLCHRDIKSSNILLDEHFVAKLADFGLAHASRDGSICFEPVNTDIRG 491

Query:   275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEE 334
             T GY+DPEY+ T   T+KSDVYS+GV+L E+I G+  +      VEL+      ++   +
Sbjct:   492 TPGYVDPEYVVTHELTEKSDVYSYGVVLLEIITGKRAVDEGRNLVELSQPLLVSESRRID 551

Query:   335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
             +VD R+    D E+L  V ++   C  +    RPS++ ++++L
Sbjct:   552 LVDPRIKDCIDGEQLETVVAVVRWCTEKEGVARPSIKQVLRLL 594

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2136338 AT4G39110 [Arabidopsis thaliana (taxid:3702)]

 Score = 607 (218.7 bits), Expect = 5.8e-59, P = 5.8e-59
 Identities = 140/343 (40%), Positives = 201/343 (58%)

Query:    89 GFKRSNVVSAS-GIPEY-SYKDLQKATCNF--TTLIGQGAFGPVYKAQMSTGETVAVKVL 144
             G ++SN  +++ G+  Y S  +LQ+AT NF  + +IG G FG VY   +  G  VAVK  
Sbjct:   497 GSQKSNFYNSTLGLGRYFSLSELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRG 556

Query:   145 ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENY 204
                S+QG  EFQTE+ +L +L HR+LV+L+GYC E  + +LVY FMS G    HLY +N 
Sbjct:   557 NPQSEQGITEFQTEIQMLSKLRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNL 616

Query:   205 GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264
              PLTW  R+ I +  ARGL YLH G    +IHRD+KS+NILLD+++ A+VADFGLS++  
Sbjct:   617 APLTWKQRLEICIGSARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKDVA 676

Query:   265 VDK-HAAN-IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM--EYVE 320
               + H +  ++G+FGYLDPEY   +  T KSDVYSFGV+L E +  R  +   +  E V 
Sbjct:   677 FGQNHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVN 736

Query:   321 LA--AMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS 378
             LA  AM  + K   E+I+D  L G  + E + + A  A KC+      RP+M D++  L 
Sbjct:   737 LAEWAMQWKRKGLLEKIIDPHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLE 796

Query:   379 RILKMRHNRKHHRKSQSTTA--DEV---SIDMEQAEAKTPTST 416
               L+++      +  ++  A  D V   S+ +      TP+ T
Sbjct:   797 YALQLQEAFTQGKAEETENAKPDVVTPGSVPVSDPSPITPSVT 839

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

GO:0030048 "actin filament-based movement" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2012191 AT1G49730 [Arabidopsis thaliana (taxid:3702)]

 Score = 601 (216.6 bits), Expect = 1.5e-58, P = 1.5e-58
 Identities = 132/296 (44%), Positives = 185/296 (62%)

Query:    90 FKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK 149
             FK     S+S   ++SYK++  AT +F T+IGQG FG VYKA+ + G   AVK +   S+
Sbjct:   333 FKIHEDDSSSAFRKFSYKEMTNATNDFNTVIGQGGFGTVYKAEFNDGLIAAVKKMNKVSE 392

Query:   150 QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTW 209
             Q E++F  E+ LL +LHHRNLV L G+C  K +  LVY +M  GSL  HL+     P +W
Sbjct:   393 QAEQDFCREIGLLAKLHHRNLVALKGFCINKKERFLVYDYMKNGSLKDHLHAIGKPPPSW 452

Query:   210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL---SREEMVD 266
               R+ IA+DVA  LEYLH    PP+ HRDIKSSNILLD++  A+++DFGL   SR+  V 
Sbjct:   453 GTRMKIAIDVANALEYLHFYCDPPLCHRDIKSSNILLDENFVAKLSDFGLAHSSRDGSVC 512

Query:   267 KHAAN--IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM 324
                 N  IRGT GY+DPEY+ T+  T+KSDVYS+GV+L ELI GR  +      VE++  
Sbjct:   513 FEPVNTDIRGTPGYVDPEYVVTQELTEKSDVYSYGVVLLELITGRRAVDEGRNLVEMSQR 572

Query:   325 NTEGKTGWEEIVDSRL-DGIFDV--EELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
                 K+   E+VD R+ D I D   ++L+ V ++   C  +  R RPS++ ++++L
Sbjct:   573 FLLAKSKHLELVDPRIKDSINDAGGKQLDAVVTVVRLCTEKEGRSRPSIKQVLRLL 628

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2181017 AT5G01950 [Arabidopsis thaliana (taxid:3702)]

 Score = 603 (217.3 bits), Expect = 3.7e-58, P = 3.7e-58
 Identities = 136/328 (41%), Positives = 195/328 (59%)

Query:    99 SGIPEYSYKDLQKATCNFT--TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQ 156
             SGI  +S+K+L +AT +F+  TL+G+G +G VY+  +S     A+K     S QGEKEF 
Sbjct:   609 SGIRGFSFKELAEATDDFSSSTLVGRGGYGKVYRGVLSDNTVAAIKRADEGSLQGEKEFL 668

Query:   157 TEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIA 216
              E+ LL RLHHRNLV+L+GYC E+ + MLVY FMS G+L   L  +    L++ +R+ +A
Sbjct:   669 NEIELLSRLHHRNLVSLIGYCDEESEQMLVYEFMSNGTLRDWLSAKGKESLSFGMRIRVA 728

Query:   217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR-------EEMVDKHA 269
             L  A+G+ YLH  A PPV HRDIK+SNILLD +  A+VADFGLSR       EE V KH 
Sbjct:   729 LGAAKGILYLHTEANPPVFHRDIKASNILLDPNFNAKVADFGLSRLAPVLEDEEDVPKHV 788

Query:   270 ANI-RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG 328
             + + RGT GYLDPEY  T   T KSDVYS GV+  EL+ G   +      V       E 
Sbjct:   789 STVVRGTPGYLDPEYFLTHKLTDKSDVYSIGVVFLELLTGMHAISHGKNIVR-EVKTAEQ 847

Query:   329 KTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM---RH 385
             +     ++D R++  + +E + + A+LA +C + +P  RP M ++V+ L  +L+    R 
Sbjct:   848 RDMMVSLIDKRMEP-WSMESVEKFAALALRCSHDSPEMRPGMAEVVKELESLLQASPDRE 906

Query:   386 NRKHHRKSQS---TTADEVSIDMEQAEA 410
              R     S S   T++  V+ D+ ++ +
Sbjct:   907 TRVELASSSSVLSTSSSNVTRDLYESSS 934

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00027443001 SubName- Full=Chromosome chr19 scaffold_4, whole genome shotgun sequence; (430 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	432
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-60
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-58
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-58
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-56
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-55
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-55
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-49
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-42
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-35
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-34
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-33
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-33
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-33
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-33
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-32
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-32
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-32
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-32
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-32
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-31
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-31
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-30
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-30
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-30
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-30
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-30
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-30
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-29
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-29
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-29
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-29
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-28
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-28
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-28
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-28
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-28
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-28
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-28
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-28
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-28
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-27
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-27
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-27
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-27
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-27
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-26
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-26
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-26
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-26
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-26
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-26
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-26
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-25
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-25
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-25
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-25
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-25
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-25
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-25
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-25
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-24
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-24
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-24
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-24
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-24
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-24
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-24
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-24
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-24
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-23
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-23
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-23
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-23
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-23
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-23
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-23
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-23
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-23
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-23
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-22
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-22
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-22
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-22
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-22
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-21
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-21
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-21
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-21
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-21
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-21
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-21
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-21
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-21
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-21
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-21
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-20
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-20
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-20
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-20
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-20
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-20
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-20
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-20
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-20
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-20
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-19
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-19
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-19
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-19
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-19
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-19
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-19
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-19
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-19
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-18
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-18
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-18
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-18
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-18
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-18
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-18
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-18
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-17
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-17
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-17
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-17
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-17
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-17
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-16
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-16
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-16
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-16
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-16
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-16
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-15
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-15
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-15
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-14
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-14
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-14
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-14
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-13
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-13
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-13
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	7e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-13
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-13
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-12
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-11
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-11
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-11
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-11
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-10
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	5e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.004
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.004

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  195 bits (498), Expect = 8e-60
 Identities = 85/276 (30%), Positives = 134/276 (48%), Gaps = 34/276 (12%)

Query: 116 FTTLIGQGAFGPVYKAQ-----MSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRN 169
               +G+GAFG VYK             VAVK L  D S+Q  +EF  E  ++ +L H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V L+G C E+   M+V  +M  G L  +L       L+ +  +  AL +ARG+EYL   
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGYLDPEYISTR 287
                IHRD+ + N L+ +++  +++DFGLSR+  +         +    ++ PE +   
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 288 NFTKKSDVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRLD 341
            FT KSDV+SFGVLL+E+   G  P  G+     +EY++      +G          RL 
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK------KGY---------RLP 224

Query: 342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
              +     E+  L  +C    P  RP+  ++V++L
Sbjct: 225 KPPNCPP--ELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  191 bits (489), Expect = 1e-58
 Identities = 81/280 (28%), Positives = 132/280 (47%), Gaps = 43/280 (15%)

Query: 116 FTTLIGQGAFGPVYKAQ-----MSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRN 169
               +G+GAFG VYK +           VAVK L  D S+Q  +EF  E  ++ +L H N
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V L+G C E+    +V  +M  G L S+L   N   L+ +  +  AL +ARG+EYL   
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK-NRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--KHAANIRGTFGYLDPEYISTR 287
                IHRD+ + N L+ +++  +++DFGLSR+   D        +    ++ PE +   
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
            FT KSDV+SFGVLL+E+                    T G+  +  + +  +  +  ++
Sbjct: 179 KFTSKSDVWSFGVLLWEIF-------------------TLGEQPYPGMSNEEV--LEYLK 217

Query: 348 ELN----------EVASLAYKCVNRAPRKRPSMRDIVQVL 377
                        E+  L  +C    P  RP+  ++V++L
Sbjct: 218 NGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  191 bits (489), Expect = 2e-58
 Identities = 85/286 (29%), Positives = 134/286 (46%), Gaps = 55/286 (19%)

Query: 120 IGQGAFGPVYKAQMSTGET----VAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           +G+GAFG VYK ++   +     VAVK L    S++  K+F  E  ++ +L H N+V L+
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHL-------YDENYGPLTWNLRVHIALDVARGLEYLH 227
           G C E+    LV  +M  G L  +L              L+    +  A+ +A+G+EYL 
Sbjct: 63  GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-------IRGTFGYLD 280
                  +HRD+ + N L+ + +  +++DFGLSR+   D +          IR    ++ 
Sbjct: 123 S---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----WMA 175

Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEE 334
           PE +    FT KSDV+SFGVLL+E+   G +P  GL     +EY+       +G      
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR------KG------ 223

Query: 335 IVDSRL---DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
               RL   +   D     E+  L   C    P  RP+  ++V+ L
Sbjct: 224 ---YRLPKPEYCPD-----ELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  185 bits (472), Expect = 5e-56
 Identities = 90/261 (34%), Positives = 135/261 (51%), Gaps = 16/261 (6%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           +G G+FG VYKA+   TG+ VAVK+L   S   + ++  + E+ +L RL H N+V L+  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
             +K    LV  +   G L  +L     GPL+ +    IAL + RGLEYLH   +   IH
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSNGI---IH 121

Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRN-FTKKSD 294
           RD+K  NILLD++   ++ADFGL+++ +    +     GT  Y+ PE +   N +  K D
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVD 181

Query: 295 VYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVAS 354
           V+S GV+L+EL+ G+ P  G     +L  +        E       D         E   
Sbjct: 182 VWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEF------DEPKWSSGSEEAKD 235

Query: 355 LAYKCVNRAPRKRPSMRDIVQ 375
           L  KC+N+ P KRP+  +I+Q
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  183 bits (468), Expect = 2e-55
 Identities = 76/260 (29%), Positives = 124/260 (47%), Gaps = 18/260 (6%)

Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
            +G+G+FG VY A+   TG+ VA+KV+     K+  +    E+ +L +L H N+V L   
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVI 235
             ++ +  LV  +   G L   L  +  G L+ +        +   LEYLH  G    ++
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHSKG----IV 119

Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K  NILLD+    ++ADFGL+R+    +      GT  Y+ PE +  + + K  D+
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179

Query: 296 YSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASL 355
           +S GV+L+EL+ G+ P  G  + +EL     + K             I       E   L
Sbjct: 180 WSLGVILYELLTGKPPFPGDDQLLELFKKIGKPK----PPFPPPEWDISP-----EAKDL 230

Query: 356 AYKCVNRAPRKRPSMRDIVQ 375
             K + + P KR +  + +Q
Sbjct: 231 IRKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  182 bits (464), Expect = 7e-55
 Identities = 83/273 (30%), Positives = 132/273 (48%), Gaps = 36/273 (13%)

Query: 120 IGQGAFGPVYKAQM-----STGETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+GAFG VYK  +      T   VAVK L    S++  +EF  E  ++ +L H N+V L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           +G C +     +V  +M  G L   L       LT    + +AL +A+G+EYL       
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHG-EKLTLKDLLQMALQIAKGMEYLESK---N 122

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG---YLDPEYISTRNFT 290
            +HRD+ + N L+ +++  +++DFGLSR+   D +     G      ++ PE +    FT
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182

Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRLDGIF 344
            KSDV+SFGVLL+E+   G  P  G+     +E +E      +G          RL    
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE------DGY---------RLPRPE 227

Query: 345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
           +  +  E+  L  +C    P  RP+  ++V+ L
Sbjct: 228 NCPD--ELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  167 bits (425), Expect = 1e-49
 Identities = 82/263 (31%), Positives = 126/263 (47%), Gaps = 53/263 (20%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +G+G FG VY A+   TG+ VA+K++   DS    +E   E+ +L +L+H N+V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
            ++    LV  +   GSL   L  EN G L+ +  + I L +  GLEYLH      +IHR
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL-KENEGKLSEDEILRILLQILEGLEYLHSN---GIIHR 116

Query: 238 DIKSSNILLDQ-SMRARVADFGLSRE-EMVDKHAANIRGTFGYLDPEYISTR-NFTKKSD 294
           D+K  NILLD  + + ++ADFGLS+           I GT  Y+ PE +  +  +++KSD
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176

Query: 295 VYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVAS 354
           ++S GV+L+                                            EL E+  
Sbjct: 177 IWSLGVILY--------------------------------------------ELPELKD 192

Query: 355 LAYKCVNRAPRKRPSMRDIVQVL 377
           L  K + + P KRPS ++I++ L
Sbjct: 193 LIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  150 bits (380), Expect = 2e-42
 Identities = 81/262 (30%), Positives = 132/262 (50%), Gaps = 29/262 (11%)

Query: 119 LIGQGAFGPVYKAQM-STGETVAVKV--LATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           L+G+G+FG VY A    TGE +AVK   L+ DS++  +  + E+ +L  L H N+V   G
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 176 YCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAV 231
              ++ ++ L  +F+   S GSL+S L  + +G L   +       +  GL YLH  G  
Sbjct: 67  SERDEEKNTL-NIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQILEGLAYLHSNG-- 121

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN----IRGTFGYLDPEYISTR 287
             ++HRDIK +NIL+D     ++ADFG ++  + D         +RGT  ++ PE I   
Sbjct: 122 --IVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYWMAPEVIRGE 178

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
            + + +D++S G  + E+  G+ P   L     +AA+   G +G    +   L      E
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGSSGEPPEIPEHLS-----E 231

Query: 348 ELNEVASLAYKCVNRAPRKRPS 369
           E  +      KC+ R P+KRP+
Sbjct: 232 EAKDFLR---KCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  130 bits (330), Expect = 2e-35
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 41/283 (14%)

Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH 166
           K+L+         IG+G FG V       G+ VAVK L  DS   +  F  E  ++  L 
Sbjct: 6   KELKLGAT-----IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLR 58

Query: 167 HRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYL 226
           H NLV L+G   +     +V  +M+KGSL  +L       +T   ++  ALDV  G+EYL
Sbjct: 59  HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118

Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN--IRGTFGYLDPEYI 284
            +      +HRD+ + N+L+ + + A+V+DFGL++E    + +    ++ T     PE +
Sbjct: 119 EEKNF---VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEAL 171

Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSP-----LQGLMEYVELAAMNTEGKTGWE-EIVD 337
             + F+ KSDV+SFG+LL+E+ + GR P     L+ ++ +VE          G+  E  +
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE---------KGYRMEAPE 222

Query: 338 SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
                ++ V            C    P KRP+ + + + L+ I
Sbjct: 223 GCPPEVYKV---------MKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  130 bits (330), Expect = 2e-35
 Identities = 83/259 (32%), Positives = 126/259 (48%), Gaps = 31/259 (11%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           IG+G FG VYKA    TG+ VA+KV+  +SK+ +++   E+ +L +  H N+V   G   
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
           +K +  +V  F S GSL   L       LT +   ++  ++ +GLEYLH   +   IHRD
Sbjct: 68  KKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI---IHRD 123

Query: 239 IKSSNILLDQSMRARVADFGLS--------REEMVDKHAANIRGTFGYLDPEYISTRNFT 290
           IK++NILL      ++ DFGLS        R  MV        GT  ++ PE I+ + + 
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--------GTPYWMAPEVINGKPYD 175

Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
            K+D++S G+   EL  G+ P      Y EL  M    K         R +     +E  
Sbjct: 176 YKADIWSLGITAIELAEGKPP------YSELPPMKALFKIATNGPPGLR-NPEKWSDEFK 228

Query: 351 EVASLAYKCVNRAPRKRPS 369
           +      KC+ + P KRP+
Sbjct: 229 DFLK---KCLQKNPEKRPT 244

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  130 bits (330), Expect = 2e-35
 Identities = 72/214 (33%), Positives = 111/214 (51%), Gaps = 19/214 (8%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVK--VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           LIG+GAFG VYK   + TG+ VA+K   L    ++  K    E+ LL  L H N+V  +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 176 YCAEKGQHMLVYV-FMSKGSLASHLYDENYGPLTWNL-RVHIALDVARGLEYLHDGAVPP 233
              E    + + + +   GSL   +  + +GP   +L  V++   V +GL YLH+  V  
Sbjct: 67  -SIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVY-QVLQGLAYLHEQGV-- 120

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLS-REEMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
            IHRDIK++NIL  +    ++ADFG++ +   V K  A++ GT  ++ PE I     +  
Sbjct: 121 -IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA 179

Query: 293 SDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT 326
           SD++S G  + EL+ G  P      Y +L  M  
Sbjct: 180 SDIWSLGCTVIELLTGNPP------YYDLNPMAA 207

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  130 bits (327), Expect = 5e-34
 Identities = 76/277 (27%), Positives = 120/277 (43%), Gaps = 21/277 (7%)

Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD---SKQGEKEFQTEVMLLGRL-HHRNL 170
                +G+G+FG VY A+    + VA+KVLA       +  + F  E+ +L  L H  N+
Sbjct: 3   RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-YDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           V L  +  ++G   LV  ++  GSL   L      GPL+ +  + I   +   LEYLH  
Sbjct: 61  VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120

Query: 230 AVPPVIHRDIKSSNILLDQ-SMRARVADFGLSRE-------EMVDKHAANIRGTFGYLDP 281
               +IHRDIK  NILLD+     ++ DFGL++          +    +   GT GY+ P
Sbjct: 121 ---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 282 EYI---STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDS 338
           E +   S    +  SD++S G+ L+EL+ G  P +G       +             + S
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 339 RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
            L            + L  K + + P+ R S    + 
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  127 bits (320), Expect = 1e-33
 Identities = 80/283 (28%), Positives = 130/283 (45%), Gaps = 31/283 (10%)

Query: 120 IGQGAFGPVYKA-----QMSTGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+G FG V          +TGE VAVK L     +Q   +F+ E+ +L  L H N+V  
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 174 VGYCAEKGQ--HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            G C + G     L+  ++  GSL  +L   +   +     +  +  + +G++YL     
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQICKGMDYLGSQRY 130

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRG---TFGYLDPEYIST 286
              IHRD+ + NIL++     +++DFGL++   E  D +     G    F Y  PE + T
Sbjct: 131 ---IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRT 186

Query: 287 RNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             F+  SDV+SFGV L+EL   G        E++ +      G    + IV   L+ + +
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMI-----GIAQGQMIVTRLLELLKE 241

Query: 346 VEEL-------NEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            E L       +EV  L   C    P+ RPS  D++ ++ R+ 
Sbjct: 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  125 bits (316), Expect = 2e-33
 Identities = 67/200 (33%), Positives = 106/200 (53%), Gaps = 9/200 (4%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +G G FG V++        VA+K+L +D    +++FQ EV  L RL H++L++L   C+ 
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
                ++   M KGSL + L       L     + +A  VA G+ YL +      IHRD+
Sbjct: 74  GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDL 130

Query: 240 KSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVY 296
            + NIL+ + +  +VADFGL+R   E++       I   + +  PE  S   F+ KSDV+
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKSDVW 188

Query: 297 SFGVLLFELIA-GRSPLQGL 315
           SFG+LL+E+   G+ P  G+
Sbjct: 189 SFGILLYEMFTYGQVPYPGM 208

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  125 bits (316), Expect = 5e-33
 Identities = 85/300 (28%), Positives = 133/300 (44%), Gaps = 58/300 (19%)

Query: 88  EGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLAT 146
                 ++VS  G P   YK+L+K        IG+GA G VYKA   +TG+ VA+K +  
Sbjct: 4   LKAALKDIVSE-GDPRELYKNLEK--------IGEGASGEVYKATDRATGKEVAIKKMRL 54

Query: 147 DSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYG 205
             +  E     E++++    H N+V+        G  + +V  +M  GSL   +  +N+ 
Sbjct: 55  RKQNKELIIN-EILIMKDCKHPNIVDYYD-SYLVGDELWVVMEYMDGGSLTD-IITQNFV 111

Query: 206 PLTWNLRVHIA---LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS-- 260
            +       IA    +V +GLEYLH      VIHRDIKS NILL +    ++ADFG +  
Sbjct: 112 RMN---EPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQ 165

Query: 261 -------REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
                  R  +V        GT  ++ PE I  +++  K D++S G++  E+  G  P  
Sbjct: 166 LTKEKSKRNSVV--------GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP-- 215

Query: 314 GLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASL----AYKCVNRAPRKRPS 369
             +    L A+          I      GI  ++   + +        KC+ + P KRPS
Sbjct: 216 -YLREPPLRALFL--------ITTK---GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  124 bits (313), Expect = 9e-33
 Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 47/276 (17%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL-ATDSKQGEKEF-QTEVMLLGRLHHRNLVNLVG 175
            IG+G+FG VY  +  S G+   +K +  ++  + E+E    EV +L +L+H N++    
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 176 YCAEKGQHMLVYVFM---SKGSLASHL--YDENYGPLT----WNLRVHIALDVARGLEYL 226
              EKG    + + M     G L+  +    +   P       +  V + L     L+YL
Sbjct: 67  SFEEKG---KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----ALKYL 119

Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYI 284
           H   +   +HRDIK  NI L  +   ++ DFG+S+     VD  A  + GT  YL PE  
Sbjct: 120 HSRKI---LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD-LAKTVVGTPYYLSPELC 175

Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF 344
             + +  KSD++S G +L+EL   + P +G                   E+    L G  
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEG---------------ENLLELALKILKG-- 218

Query: 345 DVEELN-----EVASLAYKCVNRAPRKRPSMRDIVQ 375
               +      E+ +L    + + P +RPS+  I+Q
Sbjct: 219 QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 1e-32
 Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 22/206 (10%)

Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ------TEVMLLGRLHHRNLVN 172
           +G+G+FG V   +   TG+  A+KVL    K+   + +      TE  +L R++H  +V 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVL---KKKKIIKRKEVEHTLTERNILSRINHPFIVK 57

Query: 173 LVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-G 229
           L  + A + +  L  V  +   G L SHL  E         R + A ++   LEYLH  G
Sbjct: 58  L--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER-ARFYAA-EIVLALEYLHSLG 113

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRN 288
               +I+RD+K  NILLD     ++ DFGL++E   +    N   GT  YL PE +  + 
Sbjct: 114 ----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG 169

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
           + K  D +S GVLL+E++ G+ P   
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYA 195

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  124 bits (312), Expect = 2e-32
 Identities = 87/297 (29%), Positives = 140/297 (47%), Gaps = 58/297 (19%)

Query: 120 IGQGAFGPVYKAQ---MSTGE---TVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVN 172
           IGQGAFG V++A+   +   E    VAVK+L  + S   + +FQ E  L+    H N+V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--------------------YDENYGPLTWNLR 212
           L+G CA      L++ +M+ G L   L                       N  PL+   +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 213 VHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAAN 271
           + IA  VA G+ YL +      +HRD+ + N L+ ++M  ++ADFGLSR     D + A+
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 272 ------IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMN 325
                 IR    ++ PE I    +T +SDV+++GV+L+E+ +      G+  Y  +A   
Sbjct: 190 ENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFS-----YGMQPYYGMAH-- 238

Query: 326 TEGKTGWEEIVDSRLDG-IFDVEE--LNEVASLAYKCVNRAPRKRPSMRDIVQVLSR 379
                  EE++    DG +    +    E+ +L   C ++ P  RPS   I ++L R
Sbjct: 239 -------EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  122 bits (308), Expect = 5e-32
 Identities = 87/296 (29%), Positives = 133/296 (44%), Gaps = 46/296 (15%)

Query: 109 LQKATCNFTTLIGQGAFGPVYKAQMSTGET------VAVKVLA-TDSKQGEKEFQTEVML 161
           +Q+ T      +G+GAFG V+  +    E       VAVK L  T S    K+F+ E  L
Sbjct: 2   VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61

Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------------YDENYGPLTW 209
           L    H N+V   G C E    ++V+ +M  G L   L             D   G LT 
Sbjct: 62  LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121

Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE------E 263
           +  + IA+ +A G+ YL   A    +HRD+ + N L+   +  ++ DFG+SR+       
Sbjct: 122 SQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178

Query: 264 MVDKHAA-NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVEL 321
            V  H    IR    ++ PE I  R FT +SDV+SFGV+L+E+   G+ P      +  L
Sbjct: 179 RVGGHTMLPIR----WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP------WYGL 228

Query: 322 AAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
           +  N E      E +             +EV  +   C  R P++R +++DI + L
Sbjct: 229 S--NEEVI----ECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  121 bits (306), Expect = 7e-32
 Identities = 77/270 (28%), Positives = 125/270 (46%), Gaps = 30/270 (11%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           IG+G+FG V K +  S G+ +  K +       EKE Q   +EV +L  L H N+V    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDY-GNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 176 YCAEKGQHMLVYVFM---SKGSLASHL--YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
              ++     +Y+ M     G LA  +    +    +       I   +   L   H+ +
Sbjct: 67  RIIDRSNQ-TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125

Query: 231 VPP--VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYIS 285
            P   V+HRD+K +NI LD +   ++ DFGL++  ++      A    GT  Y+ PE ++
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSFAKTYVGTPYYMSPEQLN 183

Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             ++ +KSD++S G L++EL A   P       ++LA+   EGK         R+   + 
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIKEGKF-------RRIPYRYS 235

Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
             ELNEV       +N  P KRPS  +++Q
Sbjct: 236 -SELNEVIKS---MLNVDPDKRPSTEELLQ 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  122 bits (307), Expect = 9e-32
 Identities = 91/294 (30%), Positives = 149/294 (50%), Gaps = 51/294 (17%)

Query: 119 LIGQGAFGPVYKAQ------MSTGETVAVKVLATDSKQGEKEF-----QTEVM-LLGRLH 166
            +G+GAFG V KA+       +   TVAVK+L  D+   EK+      + E+M ++G+  
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGK-- 74

Query: 167 HRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-------YDENY-------GPLTWNLR 212
           H+N++NL+G C ++G   +V  + + G+L   L          +          LT    
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 213 VHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVD--KHA 269
           V  A  VARG+E+L   A    IHRD+ + N+L+ +    ++ADFGL+R+   +D  +  
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191

Query: 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL-MEYVELAAMNTE 327
            N R    ++ PE +  R +T +SDV+SFGVLL+E+   G SP  G+ +E  EL  +  E
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--ELFKLLKE 249

Query: 328 GKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
           G          R++   +     E+  L   C +  P +RP+ + +V+ L R+L
Sbjct: 250 GY---------RMEKPQNCT--QELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  118 bits (299), Expect = 8e-31
 Identities = 85/282 (30%), Positives = 126/282 (44%), Gaps = 41/282 (14%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE---KEFQTEVMLLGRLHHRNLVNLVG 175
           I +GA+G V+ A+  STG+  A+KV+       +    +  TE  +L +     +V L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58

Query: 176 YCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           Y + +G+  L  V  ++  G LAS L  EN G L  ++      ++   LEYLH   +  
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLL--ENVGSLDEDVARIYIAEIVLALEYLHSNGI-- 114

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVD---------KHAANIRGTFGYLDPEYI 284
            IHRD+K  NIL+D +   ++ DFGLS+  +V          K    I GT  Y+ PE I
Sbjct: 115 -IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMN-TEGKTGWEEIVDSRLDGI 343
             +  +K  D +S G +L+E + G  P  G  E  E    N   GK  W E         
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPPFHG--ETPEEIFQNILNGKIEWPE--------- 222

Query: 344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH 385
            DVE  +E   L  K +   P KR   + I ++        H
Sbjct: 223 -DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI------KNH 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  118 bits (298), Expect = 9e-31
 Identities = 70/202 (34%), Positives = 102/202 (50%), Gaps = 13/202 (6%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGE---KEFQTEVMLLGRLHHRNLVNLVGY 176
           +G G FG V+    +    VAVK L    K G    + F  E  ++ +L H  LV L   
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
           C+E+    +V  +MSKGSL   L       L     V +A  +A G+ YL        IH
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY---IH 126

Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSD 294
           RD+ + NIL+ +++  ++ADFGL+R    D++ A     F   +  PE  +   FT KSD
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSD 186

Query: 295 VYSFGVLLFELIA-GRSPLQGL 315
           V+SFG+LL E++  GR P  G+
Sbjct: 187 VWSFGILLTEIVTYGRVPYPGM 208

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  118 bits (297), Expect = 1e-30
 Identities = 86/277 (31%), Positives = 137/277 (49%), Gaps = 32/277 (11%)

Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           +LQK T     +IG+G FG V + +  TG+ VAVK +  D     + F  E  ++ +LHH
Sbjct: 4   NLQKLT--LGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHH 58

Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           +NLV L+G     G + +V   MSKG+L + L       ++    +  +LDVA G+EYL 
Sbjct: 59  KNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
                 ++HRD+ + NIL+ +   A+V+DFGL+R         N +    +  PE +  +
Sbjct: 118 S---KKLVHRDLAARNILVSEDGVAKVSDFGLARVG--SMGVDNSKLPVKWTAPEALKHK 172

Query: 288 NFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV 346
            F+ KSDV+S+GVLL+E+ + GR+P                 K   +E+ +    G + +
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYP---------------KMSLKEVKECVEKG-YRM 216

Query: 347 EELNE----VASLAYKCVNRAPRKRPSMRDIVQVLSR 379
           E        V  L   C    P+KRPS   + + L +
Sbjct: 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  118 bits (297), Expect = 2e-30
 Identities = 75/272 (27%), Positives = 127/272 (46%), Gaps = 34/272 (12%)

Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLA-TDSKQGEKEFQTEVMLLGRL 165
           DL++        +GQG+ G VYK +   TG+  A+K +     ++  K+   E+  L   
Sbjct: 2   DLERVKV-----LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC 56

Query: 166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEY 225
               +V   G   ++G+  +V  +M  GSLA  L     G +   +  +IA  + +GL+Y
Sbjct: 57  ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDY 114

Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEY 283
           LH      +IHRDIK SN+L++     ++ADFG+S+  E  +D+    + GT  Y+ PE 
Sbjct: 115 LH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPER 171

Query: 284 ISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI 343
           I   +++  +D++S G+ L E   G+ P                G+  + E++ +  DG 
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFPFLPP------------GQPSFFELMQAICDG- 218

Query: 344 FDVEELN------EVASLAYKCVNRAPRKRPS 369
                L       E       C+ + P+KRPS
Sbjct: 219 -PPPSLPAEEFSPEFRDFISACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  117 bits (296), Expect = 2e-30
 Identities = 64/205 (31%), Positives = 106/205 (51%), Gaps = 15/205 (7%)

Query: 117 TTLIGQGAFGPVYKAQMSTG----ETVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLV 171
             +IG G FG V + ++         VA+K L   S   ++ +F TE  ++G+  H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GA 230
            L G   +    M++  +M  GSL   L  EN G  T    V +   +A G++YL +   
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127

Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG---TFGYLDPEYISTR 287
           V    HRD+ + NIL++ ++  +V+DFGLSR     +     +G      +  PE I+ R
Sbjct: 128 V----HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183

Query: 288 NFTKKSDVYSFGVLLFELIA-GRSP 311
            FT  SDV+SFG++++E+++ G  P
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 5e-30
 Identities = 80/272 (29%), Positives = 128/272 (47%), Gaps = 37/272 (13%)

Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNLVGYC 177
            IG+G FG VYK  +     VAVK   +      K  F  E  +L +  H N+V L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
            +K    +V   +  GSL + L  +    LT    + ++LD A G+EYL        IHR
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLESKNC---IHR 117

Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-------IRGTFGYLDPEYISTRNFT 290
           D+ + N L+ ++   +++DFG+SREE    +  +       I+ T     PE ++   +T
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT----APEALNYGRYT 173

Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDS--RLDGIFDVE 347
            +SDV+S+G+LL+E  + G +P  G+         N + +    E ++S  R+       
Sbjct: 174 SESDVWSYGILLWETFSLGDTPYPGM--------SNQQTR----ERIESGYRM----PAP 217

Query: 348 EL--NEVASLAYKCVNRAPRKRPSMRDIVQVL 377
           +L   E+  L  +C    P  RPS  +I   L
Sbjct: 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  116 bits (292), Expect = 6e-30
 Identities = 79/262 (30%), Positives = 129/262 (49%), Gaps = 20/262 (7%)

Query: 120 IGQGAFGPVYKAQMST-GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G G +G VY+        TVAVK L  D+ + E EF  E  ++  + H NLV L+G C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            +    ++  FM+ G+L  +L + N   +   + +++A  ++  +EYL        IHRD
Sbjct: 73  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRD 129

Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVY 296
           + + N L+ ++   +VADFGLSR    D + A+    F   +  PE ++   F+ KSDV+
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 189

Query: 297 SFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASL 355
           +FGVLL+E+   G SP  G    ++L+ +    + G+      R++         +V  L
Sbjct: 190 AFGVLLWEIATYGMSPYPG----IDLSQVYELLEKGY------RMERPEGCPP--KVYEL 237

Query: 356 AYKCVNRAPRKRPSMRDIVQVL 377
              C    P  RPS  +I Q  
Sbjct: 238 MRACWQWNPSDRPSFAEIHQAF 259

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  117 bits (294), Expect = 8e-30
 Identities = 99/326 (30%), Positives = 164/326 (50%), Gaps = 53/326 (16%)

Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    ++ +        +G+G FG V  A+         +    VAVK+L +D
Sbjct: 2   VSEYELPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD 61

Query: 148 SKQGEKEF-----QTEVM-LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-- 199
           +   EK+      + E+M ++G+  H+N++NL+G C + G   ++  + SKG+L  +L  
Sbjct: 62  AT--EKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 117

Query: 200 ---------YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD 247
                    Y+    P   L++   V  A  VARG+EYL   A    IHRD+ + N+L+ 
Sbjct: 118 RRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVT 174

Query: 248 QSMRARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFE 304
           +    ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVLL+E
Sbjct: 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 234

Query: 305 LIA-GRSPLQGL-MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNR 362
           +   G SP  G+ +E  EL  +  EG          R+D   +    NE+  +   C + 
Sbjct: 235 IFTLGGSPYPGVPVE--ELFKLLKEGH---------RMDKPSNCT--NELYMMMRDCWHA 281

Query: 363 APRKRPSMRDIVQVLSRILKMRHNRK 388
            P +RP+ + +V+ L RIL +  N++
Sbjct: 282 VPSQRPTFKQLVEDLDRILALTSNQE 307

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  114 bits (288), Expect = 3e-29
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 16/208 (7%)

Query: 119 LIGQGAFGPVYKAQMST--GET--VAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNL 173
            +G G+FG V + + ST  G+   VAVK L +D       +F  E  ++  L H NL+ L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
            G        M+V      GSL   L  +  G    +     A+ +A G+ YL       
Sbjct: 62  YGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF-- 118

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSR-----EEMVDKHAANIRGTFGYLDPEYISTRN 288
            IHRD+ + NILL    + ++ DFGL R     E+       +++  F +  PE + TR 
Sbjct: 119 -IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY-VMEEHLKVPFAWCAPESLRTRT 176

Query: 289 FTKKSDVYSFGVLLFELIA-GRSPLQGL 315
           F+  SDV+ FGV L+E+   G  P  GL
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWAGL 204

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score =  115 bits (289), Expect = 4e-29
 Identities = 94/301 (31%), Positives = 151/301 (50%), Gaps = 51/301 (16%)

Query: 120 IGQGAFGPVYKAQM--------STGETVAVKVLATDSKQGEKEF-----QTEVM-LLGRL 165
           +G+G FG V  A+             TVAVK+L  D+   EK+      + E+M ++G+ 
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGK- 79

Query: 166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-----------YDENYGP---LTWNL 211
            H+N++NL+G C + G   ++  + SKG+L  +L           YD    P   +T+  
Sbjct: 80  -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 212 RVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVD--KH 268
            V     VARG+EYL   A    IHRD+ + N+L+ ++   ++ADFGL+R+   +D  K 
Sbjct: 139 LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195

Query: 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTE 327
             N R    ++ PE +  R +T +SDV+SFGVL++E+   G SP  G+    EL  +  E
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKE 254

Query: 328 GKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNR 387
           G          R+D   +    NE+  +   C +  P  RP+ + +V+ L RIL +  N 
Sbjct: 255 GH---------RMDKPANCT--NELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTNE 303

Query: 388 K 388
           +
Sbjct: 304 E 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  114 bits (286), Expect = 4e-29
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 7/199 (3%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +G G FG V++   +    VAVK L   +    K+F  E  ++ +L H  L+ L   C  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +    +V   M  GSL  +L       L     + +A  VA G+ YL        IHRD+
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDL 129

Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVYS 297
            + N+L+ ++   +VADFGL+R    D + A     F   +  PE      F+ KSDV+S
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWS 189

Query: 298 FGVLLFELIA-GRSPLQGL 315
           FG+LL E++  GR P  G+
Sbjct: 190 FGILLTEIVTYGRMPYPGM 208

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score =  115 bits (288), Expect = 6e-29
 Identities = 88/292 (30%), Positives = 148/292 (50%), Gaps = 47/292 (16%)

Query: 120 IGQGAFGPVYKAQM--------STGETVAVKVL---ATDSKQGEKEFQTEVM-LLGRLHH 167
           +G+G FG V +A+             TVAVK+L   ATD    +   + E+M L+G+  H
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK--H 77

Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLY-------DENY-------GPLTWNLRV 213
           +N++NL+G C ++G   ++  + +KG+L   L        D  +         L++   V
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 214 HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVD--KHAA 270
             A  VARG+EYL        IHRD+ + N+L+ +    ++ADFGL+R    +D  K  +
Sbjct: 138 SCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
           N R    ++ PE +  R +T +SDV+SFG+L++E+   G SP  G+    EL  +  EG 
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELFKLLREGH 253

Query: 330 TGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
                    R+D   +    +E+  L  +C +  P +RP+ + +V+ L ++L
Sbjct: 254 ---------RMDKPSNCT--HELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  112 bits (282), Expect = 1e-28
 Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 29/261 (11%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKV--LATDSKQGE---KEFQTEVMLLGRLHHRNLVN 172
           L+G G+FG VY+   +  G+  AVK   LA D + G+   K+ + E+ LL +L H N+V 
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 173 LVGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
            +G   E+     +Y+F+     GSLA  L  + YG     +       +  GLEYLHD 
Sbjct: 67  YLGTEREEDN---LYIFLELVPGGSLAKLL--KKYGSFPEPVIRLYTRQILLGLEYLHDR 121

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYI-STRN 288
                +HRDIK +NIL+D +   ++ADFG++++ +    A + +G+  ++ PE I     
Sbjct: 122 NT---VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGG 178

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
           +   +D++S G  + E+  G+ P     +   +AA+   G++     +   L        
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWS---QLEGVAAVFKIGRSKELPPIPDHLS------- 228

Query: 349 LNEVASLAYKCVNRAPRKRPS 369
            +E      KC+ R P  RP+
Sbjct: 229 -DEAKDFILKCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  113 bits (284), Expect = 2e-28
 Identities = 64/235 (27%), Positives = 107/235 (45%), Gaps = 43/235 (18%)

Query: 116 FTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQ------GEKEFQTEVMLLGRL-HH 167
           F  +IG+G+F  V  A+   T +  A+K+L    K+        K  + E  +L RL  H
Sbjct: 5   FGKIIGEGSFSTVVLAKEKETNKEYAIKIL---DKRQLIKEKKVKYVKIEKEVLTRLNGH 61

Query: 168 RNLVNLVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEY 225
             ++ L  Y   + +  L +V  +   G L  ++    YG L        A ++   LEY
Sbjct: 62  PGIIKL--YYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLALEY 117

Query: 226 LHD-GAVPPVIHRDIKSSNILLDQSMRARVADFG----LSREEMVD-------------- 266
           LH  G    +IHRD+K  NILLD+ M  ++ DFG    L      +              
Sbjct: 118 LHSKG----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 267 ---KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEY 318
              +  A+  GT  Y+ PE ++ +   K SD+++ G ++++++ G+ P +G  EY
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  112 bits (282), Expect = 2e-28
 Identities = 73/207 (35%), Positives = 114/207 (55%), Gaps = 20/207 (9%)

Query: 119 LIGQGAFGPVYKAQMSTGET----VAVKVLA--TDSKQGEKEFQTEVMLLGRLHHRNLVN 172
           +IG+G FG VY   +   +      AVK L   TD ++ E+ F  E +++    H N+++
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVLS 60

Query: 173 LVGYC-AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
           L+G C   +G  ++V  +M  G L + +  E + P   +L +   L VA+G+EYL   A 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-IGFGLQVAKGMEYL---AS 116

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP------EYIS 285
              +HRD+ + N +LD+S   +VADFGL+R+ + DK   ++    G   P      E + 
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARD-IYDKEYYSVHNHTGAKLPVKWMALESLQ 175

Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSP 311
           T+ FT KSDV+SFGVLL+EL+  G  P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPP 202

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  112 bits (281), Expect = 2e-28
 Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 22/263 (8%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG+G FG V       G  VAVK +  D+    + F  E  ++ +L H NLV L+G   E
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 180 -KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            KG   +V  +M+KGSL  +L       L  +  +  +LDV   +EYL        +HRD
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRD 127

Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSF 298
           + + N+L+ +   A+V+DFGL++E    +    +     +  PE +  + F+ KSDV+SF
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWSF 185

Query: 299 GVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAY 357
           G+LL+E+ + GR P       + L  +    + G++  +D+  DG   V     V  +  
Sbjct: 186 GILLWEIYSFGRVP----YPRIPLKDVVPRVEKGYK--MDAP-DGCPPV-----VYDVMK 233

Query: 358 KCVNRAPRKRPSMRDIVQVLSRI 380
           +C +     RPS   + + L  I
Sbjct: 234 QCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  112 bits (282), Expect = 2e-28
 Identities = 83/277 (29%), Positives = 122/277 (44%), Gaps = 34/277 (12%)

Query: 120 IGQGAFGPVYKAQMS------TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVN 172
           +G GAFG VY+              VAVK L    S+Q E +F  E +++ + +H+N+V 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYD-----ENYGPLTWNLRVHIALDVARGLEYLH 227
           L+G   E+    ++   M+ G L S L +     E    LT    +  A DVA+G +YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVA---DFGLSRE-EMVDKHAANIRGTF--GYLDP 281
           +      IHRDI + N LL      RVA   DFG++R+      +    R      ++ P
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190

Query: 282 EYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL 340
           E      FT K+DV+SFGVLL+E+ + G  P  G     E+    T G          RL
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-EVMEFVTGG---------GRL 240

Query: 341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
           D          V  +   C    P  RP+   I++ +
Sbjct: 241 DPPKGCP--GPVYRIMTDCWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  112 bits (282), Expect = 2e-28
 Identities = 81/290 (27%), Positives = 130/290 (44%), Gaps = 52/290 (17%)

Query: 120 IGQGAFGPVYKAQMST------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+GAFG V+ A+            VAVK L   S+   ++FQ E  LL  L H+++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 174 VGYCAEKGQHMLVYVFMSKGSLA---------SHLYDENY----GPLTWNLRVHIALDVA 220
            G C E    ++V+ +M  G L          + +         G LT    + IA  +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANIRGTFG-- 277
            G+ YL   A    +HRD+ + N L+ Q +  ++ DFG+SR+    D +    R      
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD 337
           ++ PE I  R FT +SD++SFGV+L+E+                    T GK  W ++ +
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIF-------------------TYGKQPWYQLSN 230

Query: 338 SR-LDGIFDVEEL-------NEVASLAYKCVNRAPRKRPSMRDIVQVLSR 379
           +  ++ I    EL        EV ++   C  R P++R  ++DI   L  
Sbjct: 231 TEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score =  113 bits (283), Expect = 4e-28
 Identities = 101/329 (30%), Positives = 162/329 (49%), Gaps = 62/329 (18%)

Query: 120 IGQGAFGPVYKAQM--------STGETVAVKVL---ATDSKQGEKEFQTEVM-LLGRLHH 167
           +G+G FG V  A+         +   TVAVK+L   ATD    +   + E+M ++G+  H
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK--H 77

Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-----------YDENYGP---LTWNLRV 213
           +N++NL+G C + G   ++  + SKG+L  +L           +D    P   LT+   V
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 214 HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVD--KHAA 270
             A  VARG+EYL   A    IHRD+ + N+L+ +    ++ADFGL+R+   +D  K   
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
           N R    ++ PE +  R +T +SDV+SFGVLL+E+   G SP  G+    EL  +  EG 
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFKLLKEGH 253

Query: 330 TGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKH 389
                    R+D   +    +E+  +  +C +  P +RP+ + +V+ L R+L +      
Sbjct: 254 ---------RMDKPANCT--HELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV------ 296

Query: 390 HRKSQSTTADE---VSIDMEQAEAKTPTS 415
                 T+ DE   +S+  EQ     P S
Sbjct: 297 ------TSTDEYLDLSVPFEQYSPGCPDS 319

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  111 bits (278), Expect = 4e-28
 Identities = 63/199 (31%), Positives = 105/199 (52%), Gaps = 8/199 (4%)

Query: 116 FTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
               IG G FG V+         VA+K +  +    E++F  E  ++ +L H  LV L G
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
            C E+    LV+ FM  G L+ +L  +  G  +    + + LDV  G+ YL       VI
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VI 122

Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKS 293
           HRD+ + N L+ ++   +V+DFG++R  + D++ ++    F   +  PE  S   ++ KS
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182

Query: 294 DVYSFGVLLFELIA-GRSP 311
           DV+SFGVL++E+ + G++P
Sbjct: 183 DVWSFGVLMWEVFSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  111 bits (279), Expect = 8e-28
 Identities = 80/281 (28%), Positives = 134/281 (47%), Gaps = 35/281 (12%)

Query: 116 FTTLIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
           F   +G+G FG V        Q +TGE VAVK L   + +  ++F+ E+ +L  L H N+
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67

Query: 171 VNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           V   G C   G+    LV  ++  GSL  +L  ++   L     +  A  + +G+EYL  
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQICKGMEYL-- 124

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG-----TFGYLDPEY 283
                 +HRD+ + NIL++   R ++ DFGL++    DK    +R       F Y  PE 
Sbjct: 125 -GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PES 182

Query: 284 ISTRNFTKKSDVYSFGVLLFELIA----GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           ++   F+  SDV+SFGV+L+EL        SP     E++ +   + +G+     IV   
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFTYSDKSCSP---PAEFMRMMGNDKQGQM----IVYHL 235

Query: 340 LDGIFDVEEL-------NEVASLAYKCVNRAPRKRPSMRDI 373
           ++ + +   L        E+ ++  +C N  P +RPS  ++
Sbjct: 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  110 bits (275), Expect = 2e-27
 Identities = 81/264 (30%), Positives = 129/264 (48%), Gaps = 28/264 (10%)

Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ---GEKEF---QTEVMLLGRLHHRNLVN 172
           ++G+GA+G VY    + G+ +AVK +  D+      EKE+   Q EV LL  L H N+V 
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
            +G C +     +   F+  GS++S L    +GPL   +       +  G+ YLH+  V 
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLHNNCV- 123

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAA------NIRGTFGYLDPEYIS 285
             +HRDIK +N++L  +   ++ DFG +R    V  H        ++ GT  ++ PE I+
Sbjct: 124 --VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181

Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
              + +KSD++S G  +FE+  G+ PL  +     LAAM      G    +  RL   F 
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPLASM---DRLAAMFY---IGAHRGLMPRLPDSFS 235

Query: 346 VEELNEVASLAYKCVNRAPRKRPS 369
              ++ V S    C+ R   +RPS
Sbjct: 236 AAAIDFVTS----CLTRDQHERPS 255

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score =  110 bits (277), Expect = 2e-27
 Identities = 91/299 (30%), Positives = 147/299 (49%), Gaps = 35/299 (11%)

Query: 106 YKDLQKATCNFTTLIGQGAFGPVYKAQMSTG---ETVAVKVLAT-DSKQGEKEFQTEVML 161
           Y  L+     F  +IG+G FG V KA++         A+K +    SK   ++F  E+ +
Sbjct: 1   YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60

Query: 162 LGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSL--------------ASHLYDENYGP 206
           L +L HH N++NL+G C  +G   L   +   G+L              A  + +     
Sbjct: 61  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120

Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266
           L+    +H A DVARG++YL   +    IHRD+ + NIL+ ++  A++ADFGLSR + V 
Sbjct: 121 LSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 177

Query: 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMN 325
                 R    ++  E ++   +T  SDV+S+GVLL+E+++ G +P  G M   EL    
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKL 236

Query: 326 TEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR 384
            +G          RL+   + ++  EV  L  +C    P +RPS   I+  L+R+L+ R
Sbjct: 237 PQG---------YRLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  110 bits (277), Expect = 2e-27
 Identities = 79/278 (28%), Positives = 134/278 (48%), Gaps = 26/278 (9%)

Query: 116 FTTLIGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRL-HH 167
           F   +G GAFG V +A      +      VAVK+L   +   E+E   +E+ ++  L +H
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
            N+VNL+G C   G  +++  +   G L + L  +    LT    +  +  VA+G+ +L 
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL- 157

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYI 284
             A    IHRD+ + N+LL      ++ DFGL+R+ M D +     N R    ++ PE I
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215

Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI 343
               +T +SDV+S+G+LL+E+ + G +P  G+    +   +  EG          R+   
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG---------YRMAQP 266

Query: 344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
                  E+  +   C +  P KRP+ + IVQ++ + L
Sbjct: 267 EHAPA--EIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  109 bits (275), Expect = 2e-27
 Identities = 78/294 (26%), Positives = 137/294 (46%), Gaps = 52/294 (17%)

Query: 111 KATCNFTTLIGQGAFGPVYKAQ------MSTGETVAVKVLATD-SKQGEKEFQTEVMLLG 163
            +   F   +G+GAFG VYK +        +  +VA+K L  +   + ++EF+ E  L+ 
Sbjct: 4   LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS 63

Query: 164 RLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL--------------ASHLYDENYGPLTW 209
            L H N+V L+G C ++    +++ +++ G L              A    +     L  
Sbjct: 64  DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123

Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE------- 262
           +  +HIA+ +A G+EYL   +    +HRD+ + N L+ + +  +++DFGLSR+       
Sbjct: 124 SDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180

Query: 263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL--MEYV 319
            +  K    +R    ++ PE I    FT +SD++SFGV+L+E+ + G  P  G    E +
Sbjct: 181 RVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236

Query: 320 ELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDI 373
           E+              + SR       +    V +L  +C N  P +RP  +DI
Sbjct: 237 EM--------------IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  108 bits (273), Expect = 3e-27
 Identities = 64/197 (32%), Positives = 99/197 (50%), Gaps = 10/197 (5%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY-- 176
           +G G  G V K     TG+ +AVK +  +    E   +  +  L  LH  N   +VG+  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 177 -CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
                G   +   +M  GSL   +  E  G +   +   IA+ V +GL YLH+     +I
Sbjct: 67  AFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKII 123

Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNIL++   + ++ DFG+S + +V+  A    GT  Y+ PE I   +++ KSD+
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQ-LVNSLAKTFVGTSSYMAPERIQGNDYSVKSDI 182

Query: 296 YSFGVLLFELIAGRSPL 312
           +S G+ L EL  GR P 
Sbjct: 183 WSLGLSLIELATGRFPY 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 3e-27
 Identities = 65/211 (30%), Positives = 109/211 (51%), Gaps = 25/211 (11%)

Query: 120 IGQGAFGPVYKAQ-MSTGET----VAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G GAFG VYK   +  GE     VA+KVL  ++  +  KE   E  ++  + H ++V L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGP---LTWNLRVHIALDVARGLEYLHD 228
           +G C    Q  L+   M  G L  ++ +  +N G    L W       + +A+G+ YL +
Sbjct: 75  LGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLEE 127

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYIS 285
             +   +HRD+ + N+L+      ++ DFGL++   VD+   HA   +    ++  E I 
Sbjct: 128 KRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
            R +T KSDV+S+GV ++EL+  G  P +G+
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  107 bits (269), Expect = 1e-26
 Identities = 71/266 (26%), Positives = 131/266 (49%), Gaps = 20/266 (7%)

Query: 116 FTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           F   +G G FG V+  +      VA+K +  +    E++F  E  ++ +L H  LV L G
Sbjct: 8   FMKELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
            C ++    +V  FM  G L ++L  +  G L+ ++ + +  DV  G+EYL   +    I
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLERNSF---I 122

Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKS 293
           HRD+ + N L+  +   +V+DFG++R  + D++ ++    F   +  PE  +   ++ KS
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182

Query: 294 DVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEV 352
           DV+SFGVL++E+   G+ P +    Y E+  M + G   +   + S             V
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMISRGFRLYRPKLAS-----------MTV 230

Query: 353 ASLAYKCVNRAPRKRPSMRDIVQVLS 378
             + Y C +  P  RP+  ++++ ++
Sbjct: 231 YEVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  107 bits (268), Expect = 1e-26
 Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 18/206 (8%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLA----TDSKQGE--KEFQTEVMLLGRLHHRNLV 171
            +G GAF   Y+A+ + TG  +AVK +     T S+Q E  +  + E+ L+ RL+H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            ++G   E     L   +M+ GS++  L    YG     + ++    + RGL YLH+   
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLL--SKYGAFKEAVIINYTEQLLRGLSYLHENQ- 123

Query: 232 PPVIHRDIKSSNILLDQS-MRARVADFGLSREEMVDKHAAN-----IRGTFGYLDPEYIS 285
             +IHRD+K +N+L+D +  R R+ADFG +         A      + GT  ++ PE + 
Sbjct: 124 --IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSP 311
              + +  DV+S G ++ E+   + P
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  106 bits (265), Expect = 4e-26
 Identities = 63/211 (29%), Positives = 111/211 (52%), Gaps = 24/211 (11%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKE-------FQTEVMLLGRLHHR 168
           LIG G+FG VY     S+GE +AVK +   S     +            E+ LL  L H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 169 NLVNLVGYCAEKGQHMLVYV-FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           N+V  +G  +    H+ +++ ++  GS+A+ L   NYG     L  +    + +GL YLH
Sbjct: 67  NIVQYLG-SSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILKGLNYLH 123

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-------KHAANIRGTFGYLD 280
           +  +   IHRDIK +NIL+D     +++DFG+S++   +           +++G+  ++ 
Sbjct: 124 NRGI---IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180

Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
           PE +   ++T+K+D++S G L+ E++ G+ P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  106 bits (266), Expect = 4e-26
 Identities = 80/280 (28%), Positives = 128/280 (45%), Gaps = 35/280 (12%)

Query: 118 TLIGQGAFGPVYKAQM-----STGET-VAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNL 170
           T +G+G FG V+ A+        GET V VK L  T  +  + EF+ E+ +  +L H+N+
Sbjct: 11  TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70

Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSL-----ASHLYDENYG--PLTWNLRVHIALDVARGL 223
           V L+G C E   H ++  +   G L     A+   DE     PL+   +V +   +A G+
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANIRGTFGYLDP 281
           ++L +      +HRD+ + N L+      +V+   LS++    +     N      +L P
Sbjct: 131 DHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187

Query: 282 EYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWE--EIVDS 338
           E +   +F+ KSDV+SFGVL++E+   G  P  GL +   L  +   GK      E   S
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ-AGKLELPVPEGCPS 246

Query: 339 RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS 378
           RL              L  +C    P+ RPS  ++V  L 
Sbjct: 247 RL------------YKLMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 6e-26
 Identities = 66/204 (32%), Positives = 105/204 (51%), Gaps = 17/204 (8%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQT---EVMLLGRLHHRNLVN 172
           L+GQGAFG VY    + TG  +AVK +    DS + +KE      E+ LL  L H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 173 LVGYCAEKGQHMLVYV-FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
             G C    + + +++ +M  GS+   L  + YG LT  +       +  G+EYLH   +
Sbjct: 69  YYG-CLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHSNMI 125

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLS-REEMVDKHAANIR---GTFGYLDPEYISTR 287
              +HRDIK +NIL D +   ++ DFG S R + +      ++   GT  ++ PE IS  
Sbjct: 126 ---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182

Query: 288 NFTKKSDVYSFGVLLFELIAGRSP 311
            + +K+DV+S G  + E++  + P
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  106 bits (265), Expect = 7e-26
 Identities = 87/289 (30%), Positives = 144/289 (49%), Gaps = 35/289 (12%)

Query: 116 FTTLIGQGAFGPVYKAQMSTG---ETVAVKVLAT-DSKQGEKEFQTEVMLLGRL-HHRNL 170
           F  +IG+G FG V +A +         A+K+L    S+   ++F  E+ +L +L HH N+
Sbjct: 6   FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----------YDENYGP---LTWNLRVHIA 216
           +NL+G C  +G   +   +   G+L   L           + + +G    LT    +  A
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF 276
            DVA G++YL +      IHRD+ + N+L+ +++ +++ADFGLSR E V       R   
Sbjct: 126 SDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPV 182

Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEI 335
            ++  E ++   +T KSDV+SFGVLL+E+++ G +P  G M   EL     +G       
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQG------- 234

Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR 384
              R++   + ++  EV  L  +C    P +RP    I   LSR+L+ R
Sbjct: 235 --YRMEKPRNCDD--EVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 7e-26
 Identities = 83/286 (29%), Positives = 132/286 (46%), Gaps = 41/286 (14%)

Query: 119 LIGQGAFGPVYKAQMSTGET----VAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G+G FG V + Q+S  +     VAVK +  D  +    +EF +E   +    H N++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 173 LVGYCAEKGQH------MLVYVFMSKGSLASHLYDENYGPLTWNLRVH----IALDVARG 222
           L+G C E          M++  FM  G L S L     G L   L +       +D+A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT---FGYL 279
           +EYL +      IHRD+ + N +L + M   VADFGLS++     +    R       ++
Sbjct: 126 MEYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDS 338
             E ++ R +T KSDV++FGV ++E+   G++P  G+                  EI D 
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV---------------ENHEIYDY 227

Query: 339 RLDG--IFDVEE-LNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
              G  +   E+ L+E+  L Y C    P+ RP+   + +VL  IL
Sbjct: 228 LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 1e-25
 Identities = 77/271 (28%), Positives = 129/271 (47%), Gaps = 40/271 (14%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQG---EKEFQTEVMLLGRLHHRNLVNLVGY 176
           +G G FG V+  +      VA+K++    ++G   E +F  E  ++ +L H NLV L G 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
           C ++    +V  +M+ G L ++L  E  G L     + +  DV   +EYL        IH
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123

Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSD 294
           RD+ + N L+ +    +V+DFGL+R  + D++ ++    F   +  PE      F+ KSD
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183

Query: 295 VYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWE-----EIVDSRLDGI-FDVEE 348
           V+SFGVL++E+                    +EGK  +E     E+V+S   G      +
Sbjct: 184 VWSFGVLMWEVF-------------------SEGKMPYERFSNSEVVESVSAGYRLYRPK 224

Query: 349 L--NEVASLAYKCVNRAPRKRPSMRDIVQVL 377
           L   EV ++ Y C +  P  RP+ + ++  L
Sbjct: 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 1e-25
 Identities = 80/266 (30%), Positives = 125/266 (46%), Gaps = 32/266 (12%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEF-QTEVMLLGRLHHRNLVNLVGY 176
            IG+G+FG VYKA    T + VA+KV+  +  + E E  Q E+  L +     +    G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG- 66

Query: 177 CAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              KG  + ++  +   GS    L     G L       I  +V  GLEYLH+      I
Sbjct: 67  SFLKGSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAFILREVLLGLEYLHEEGK---I 120

Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-G---YLDPEYISTRNFTK 291
           HRDIK++NILL +    ++ADFG+S +        + R TF G   ++ PE I    + +
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQL---TSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177

Query: 292 KSDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL 349
           K+D++S G+   EL  G  PL  L  M  + L   N              L+G    +  
Sbjct: 178 KADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP----------PSLEGNKFSKPF 227

Query: 350 NEVASLAYKCVNRAPRKRPSMRDIVQ 375
            +  SL   C+N+ P++RPS +++++
Sbjct: 228 KDFVSL---CLNKDPKERPSAKELLK 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  104 bits (261), Expect = 2e-25
 Identities = 78/276 (28%), Positives = 137/276 (49%), Gaps = 34/276 (12%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVK---VLATDSKQGE-------KEFQTEVMLLGRLHH 167
           LIG+G +G VY A  ++TGE +AVK   + AT + + +       K  ++E+  L  L H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 168 RNLVNLVGYCAEKGQHML-VYV-FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEY 225
            N+V  +G+  E  +  L +++ ++  GS+ S L    YG     L       V  GL Y
Sbjct: 68  LNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRFFTEQVLEGLAY 123

Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAA-NIRGTFGYLDPE 282
           LH   +   +HRD+K+ N+L+D     +++DFG+S+  +++ D     +++G+  ++ PE
Sbjct: 124 LHSKGI---LHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 283 YIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL 340
            I +  + ++ K D++S G ++ E+ AGR P     E +  AAM   G       +   +
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW-SDEEAI--AAMFKLGNKRSAPPIPPDV 237

Query: 341 DGIFDVEELNEVA-SLAYKCVNRAPRKRPSMRDIVQ 375
                   L+ VA      C    P  RP+ R+++Q
Sbjct: 238 -----SMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  105 bits (262), Expect = 2e-25
 Identities = 82/297 (27%), Positives = 144/297 (48%), Gaps = 48/297 (16%)

Query: 118 TLIGQGAFGPVYKAQ------MSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNL 170
             +G+G FG V KA        +   TVAVK+L  ++   E ++  +E  LL +++H ++
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL--------------------YDENYG--PLT 208
           + L G C++ G  +L+  +   GSL S L                    Y +N     LT
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 209 WNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMV 265
               +  A  ++RG++YL   A   ++HRD+ + N+L+ +  + +++DFGLSR   EE  
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182

Query: 266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAM 324
               +  R    ++  E +    +T +SDV+SFGVLL+E++  G +P  G+        +
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLL 242

Query: 325 NTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
               KTG+      R++   +  E  E+ +L   C  + P KRP+  DI + L +++
Sbjct: 243 ----KTGY------RMERPENCSE--EMYNLMLTCWKQEPDKRPTFADISKELEKMM 287

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  104 bits (261), Expect = 2e-25
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 9/206 (4%)

Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG V   Q+ +TG+  A K L       ++GE+    E  +L ++  R +V+L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 176 YCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           Y  E    + LV   M+ G L  H+Y+           +  A  +  GLE+LH   +   
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI--- 116

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
           ++RD+K  N+LLD     R++D GL+ E    K      GT GY+ PE +    +    D
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176

Query: 295 VYSFGVLLFELIAGRSPLQGLMEYVE 320
            ++ G  L+E+IAGRSP +   E VE
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVE 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 2e-25
 Identities = 70/212 (33%), Positives = 104/212 (49%), Gaps = 31/212 (14%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-F-QT---EVMLLGRLHHRNLVNL 173
           IG+G +G VYKA+   TGE VA+K +  ++   EKE F  T   E+ LL +L H N+V L
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRL 63

Query: 174 VGYCAEK--GQHMLVYVFMS---KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
                 K  G   +V+ +M     G L S          T +        +  GL+YLH 
Sbjct: 64  KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV-----KFTESQIKCYMKQLLEGLQYLHS 118

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-----IRGTFGYLDPEY 283
             +   +HRDIK SNIL++     ++ADFGL+R     +++A+     I  T  Y  PE 
Sbjct: 119 NGI---LHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADYTNRVI--TLWYRPPEL 172

Query: 284 I-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           +     +  + D++S G +L EL  G+   QG
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELFLGKPIFQG 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  103 bits (258), Expect = 4e-25
 Identities = 76/274 (27%), Positives = 137/274 (50%), Gaps = 28/274 (10%)

Query: 119 LIGQGAFGPVYKAQMSTG----ETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +IG G FG V++  +         VA+K L    +++  ++F +E  ++G+  H N++ L
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
            G   +    M++  +M  G+L  +L D + G  +    V +   +A G++YL D     
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNY-- 128

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG-----YLDPEYISTRN 288
            +HRD+ + NIL++ ++  +V+DFGLSR  + D        + G     +  PE I+ R 
Sbjct: 129 -VHRDLAARNILVNSNLECKVSDFGLSRV-LEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186

Query: 289 FTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
           FT  SDV+SFG++++E+++ G  P   +  +  + A+N +G          RL    D  
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DG---------FRLPAPMDCP 236

Query: 348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
             + V  L  +C  +   +RP   DIV +L ++L
Sbjct: 237 --SAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  102 bits (256), Expect = 7e-25
 Identities = 84/284 (29%), Positives = 126/284 (44%), Gaps = 43/284 (15%)

Query: 119 LIGQGAFGPVYKAQM------STGET-VAVKVL---ATDSKQGEKEFQTEVMLLGRLHHR 168
            +G GAFG VY+          +G   VAVK L   ATD ++  KEF  E  L+   +H 
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHP 59

Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD----ENYGP-LTWNLRVHIALDVARGL 223
           N+V L+G C       ++   M  G L S+L D        P LT    + I LDVA+G 
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 224 EYLHDGAVPPVIHRDIKSSNILL-----DQSMRARVADFGLSREEMVDKHAANIRG---- 274
            YL        IHRD+ + N L+     D     ++ DFGL+R ++         G    
Sbjct: 120 VYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKSDYYRKEGEGLL 175

Query: 275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWE 333
              ++ PE +    FT +SDV+SFGVL++E++  G+ P   L     L  +   G     
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG----- 230

Query: 334 EIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
                RL    +  +  ++  L   C  + P +RP+   I ++L
Sbjct: 231 -----RLQKPENCPD--KIYQLMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score =  102 bits (256), Expect = 8e-25
 Identities = 80/283 (28%), Positives = 134/283 (47%), Gaps = 35/283 (12%)

Query: 119 LIGQGAFGPVYKAQM----STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G+G FG V +AQ+     + + VAVK+L  D  S    +EF  E   +    H N++ 
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 173 LVGYCAE---KGQ---HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHI----ALDVARG 222
           L+G       KG+    M++  FM  G L + L     G   + L +       +D+A G
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD---KHAANIRGTFGYL 279
           +EYL        IHRD+ + N +L+++M   VADFGLS++       +     +    +L
Sbjct: 126 MEYLSSKNF---IHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDS 338
             E ++   +T  SDV++FGV ++E++  G++P  G+ E  E+     +G         +
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV-ENSEIYNYLIKG---------N 232

Query: 339 RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
           RL    D   L +V  L  +C +  P+ RPS + +   L  I 
Sbjct: 233 RLKQPPDC--LEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  102 bits (256), Expect = 1e-24
 Identities = 63/194 (32%), Positives = 101/194 (52%), Gaps = 7/194 (3%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +G G  G V K + + TG  +A KV+   +K    K+   E+ ++       +V+  G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
             +    +   FM  GSL   +Y +  GP+   +   IA+ V  GL YL++  V  ++HR
Sbjct: 73  LNENNICMCMEFMDCGSL-DRIYKK-GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHR 128

Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
           DIK SNIL++   + ++ DFG+S  E+++  A    GT  Y+ PE I    +T KSDV+S
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWS 187

Query: 298 FGVLLFELIAGRSP 311
            G+ + EL  G+ P
Sbjct: 188 LGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  101 bits (255), Expect = 1e-24
 Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 11/202 (5%)

Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           IG G +G VYKA+  +TGE VA+KV+  +     +  Q E+ +L    H N+V   G   
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            + +  +V  +   GSL   +Y    GPL+     ++  +  +GL YLH+      IHRD
Sbjct: 71  RRDKLWIVMEYCGGGSL-QDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK---IHRD 126

Query: 239 IKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGYLDPEYISTRN---FTKKS 293
           IK +NILL +    ++ADFG+S +    + K  + I GT  ++ PE  +      +  K 
Sbjct: 127 IKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGYDGKC 185

Query: 294 DVYSFGVLLFELIAGRSPLQGL 315
           D+++ G+   EL   + P+  L
Sbjct: 186 DIWALGITAIELAELQPPMFDL 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 2e-24
 Identities = 80/272 (29%), Positives = 124/272 (45%), Gaps = 28/272 (10%)

Query: 120 IGQGAFGPVYKA--QMSTGE--TVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           +G G FG V K    M +G+   VAVK L       G+KEF  E  ++ +L H  +V L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C  +   MLV      G L  +L      P++ +L+  +A  VA G+ YL        
Sbjct: 63  GVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVS-DLKE-LAHQVAMGMAYLESKHF--- 116

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVD----KHAANIRGTFGYLDPEYISTRNFT 290
           +HRD+ + N+LL    +A+++DFG+SR         +     R    +  PE I+   F+
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176

Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL 349
            KSDV+S+GV L+E  + G  P    M+  E+ AM   G+         RL    +  + 
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPYGE-MKGAEVIAMLESGE---------RLPRPEECPQ- 225

Query: 350 NEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            E+ S+   C    P  RP+  ++     R  
Sbjct: 226 -EIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  101 bits (253), Expect = 2e-24
 Identities = 81/286 (28%), Positives = 133/286 (46%), Gaps = 47/286 (16%)

Query: 120 IGQGAFGPVYKAQ------MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+GAFG V+ A+            VAVK L   +    K+FQ E  LL  L H ++V  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 174 VGYCAEKGQHMLVYVFMSKGSL----------ASHLYD----ENYGPLTWNLRVHIALDV 219
            G C +    ++V+ +M  G L          A  L D    +  G L  +  +HIA  +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG-- 277
           A G+ YL   A    +HRD+ + N L+  ++  ++ DFG+SR    D ++ +     G  
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGHT 185

Query: 278 -----YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTG 331
                ++ PE I  R FT +SDV+SFGV+L+E+   G+ P   L     +  + T+G+  
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI-TQGRVL 244

Query: 332 WEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
               V  +           EV  +   C  R P++R ++++I ++L
Sbjct: 245 ERPRVCPK-----------EVYDIMLGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 3e-24
 Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 34/212 (16%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE--FQT---EVMLLGRLHHRNLVNL 173
           +G+G +G VYKA+   TGE VA+K +  D+   E+E    T   E+ LL  L H N+V L
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDN---EEEGIPSTALREISLLKELKHPNIVKL 63

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           +     + +  LV+ +     L  +L D+  GPL+ NL   I   + RGL Y H   +  
Sbjct: 64  LDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI-- 119

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSRE----------EMVDKHAANIRGTFGYLDPEY 283
            +HRD+K  NIL+++    ++ADFGL+R           E+V         T  Y  PE 
Sbjct: 120 -LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV---------TLWYRAPEI 169

Query: 284 I-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           +  +++++   D++S G +  E+I G+    G
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  100 bits (250), Expect = 5e-24
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 12/202 (5%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG GA   VY A  +   E VA+K +  +  Q    E + EV  + + +H N+V      
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 178 AEKGQHMLVYVFMSKGSLASHL-YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
               +  LV  ++S GSL   +      G L   +   +  +V +GLEYLH       IH
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IH 125

Query: 237 RDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAA--NIRGTFGYLDPEYISTRN-FT 290
           RDIK+ NILL +    ++ADFG+S    +             GT  ++ PE +   + + 
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185

Query: 291 KKSDVYSFGVLLFELIAGRSPL 312
            K+D++SFG+   EL  G +P 
Sbjct: 186 FKADIWSFGITAIELATGAAPY 207

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 99.7 bits (249), Expect = 6e-24
 Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 11/200 (5%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLAT---DSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           IG+GAFG V   Q   T +  A+K +       K   +    E  +L  L+H  LVNL  
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW- 66

Query: 176 YCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           Y  +  ++M LV   +  G L  HL        +         ++   LEYLH   +   
Sbjct: 67  YSFQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICEIVLALEYLHSKGI--- 121

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
           IHRDIK  NILLD+     + DF ++ +   D    +  GT GY+ PE +  + ++   D
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVD 181

Query: 295 VYSFGVLLFELIAGRSPLQG 314
            +S GV  +E + G+ P +G
Sbjct: 182 WWSLGVTAYECLRGKRPYRG 201

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  100 bits (250), Expect = 6e-24
 Identities = 80/296 (27%), Positives = 135/296 (45%), Gaps = 50/296 (16%)

Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQ-----MSTGETVAVKVLAT-DSKQGEKEFQTEVML 161
           +L  +   F   +G+ AFG +YK       M   + VA+K L   ++ Q   EFQ E  L
Sbjct: 1   ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60

Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLY------------DENYGPLTW 209
           +  LHH N+V L+G   ++    +++ ++++G L   L             DE+ G +  
Sbjct: 61  MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED-GTVKS 119

Query: 210 NLR----VHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--- 262
           +L     +HIA+ +A G+EYL   +    +H+D+ + NIL+ + +  +++D GLSRE   
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176

Query: 263 ----EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317
                +  K    IR    ++ PE I    F+  SD++SFGV+L+E+ + G  P  G   
Sbjct: 177 ADYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232

Query: 318 YVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDI 373
              +  +         E    R+             SL  +C    P +RP  +DI
Sbjct: 233 QEVIEMVRKRQLLPCSEDCPPRM------------YSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 99.5 bits (248), Expect = 7e-24
 Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 14/202 (6%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKE---FQTEVMLLGRLHHRNLVNLVGY 176
           +G G FG V+    +    VA+K L    KQG      F  E  L+ +L H  LV L   
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
             ++  + ++  +M  GSL   L       LT N  + +A  +A G+ ++        IH
Sbjct: 70  VTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125

Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSD 294
           RD++++NIL+ +++  ++ADFGL+R    +++ A     F   +  PE I+   FT KSD
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185

Query: 295 VYSFGVLLFELIA-GRSPLQGL 315
           V+SFG+LL E++  GR P  G+
Sbjct: 186 VWSFGILLTEIVTYGRIPYPGM 207

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  100 bits (249), Expect = 8e-24
 Identities = 81/286 (28%), Positives = 128/286 (44%), Gaps = 40/286 (13%)

Query: 120 IGQGAFGPVYKAQM------STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+GAFG V+ A+            VAVK L   S    K+F  E  LL  L H ++V  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP-------------LTWNLRVHIALDVA 220
            G C E    ++V+ +M  G L   L    +GP             LT +  +HIA  +A
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFL--RAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH---AANIRGTFG 277
            G+ YL   A    +HRD+ + N L+ +++  ++ DFG+SR+     +     +      
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           ++ PE I  R FT +SDV+S GV+L+E+   G+ P   L    E+    T+G+       
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EVIECITQGRVLQRPRT 246

Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             +           EV  L   C  R P  R ++++I  +L  + K
Sbjct: 247 CPK-----------EVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 99.4 bits (248), Expect = 1e-23
 Identities = 81/282 (28%), Positives = 135/282 (47%), Gaps = 42/282 (14%)

Query: 119 LIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQ-----TEVMLLGRLHHR 168
           L+ +G FG ++       +    E V VK +    K    E Q      E  LL  L H+
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTV----KDHASEIQVTLLLQESCLLYGLSHQ 68

Query: 169 NLVNLVGYCAEKGQH-MLVYVFMSKGSLASHLYDENYGP------LTWNLRVHIALDVAR 221
           N++ ++  C E G+   ++Y +M+ G+L   L     G       L+    VH+A+ +A 
Sbjct: 69  NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128

Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKH--AANIRGTFGY 278
           G+ YLH   V   IH+DI + N ++D+ ++ ++ D  LSR+   +D H    N      +
Sbjct: 129 GMSYLHKRGV---IHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKW 185

Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVD 337
           +  E +  + ++  SDV+SFGVLL+EL+  G++P   +  + E+AA   +G         
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-EMAAYLKDGY-------- 236

Query: 338 SRLDGIFDV-EELNEVASLAYKCVNRAPRKRPSMRDIVQVLS 378
            RL    +  +EL  V  +A  C    P +RPS   +VQ L+
Sbjct: 237 -RLAQPINCPDELFAV--MAC-CWALDPEERPSFSQLVQCLT 274

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 99.8 bits (249), Expect = 1e-23
 Identities = 75/268 (27%), Positives = 123/268 (45%), Gaps = 23/268 (8%)

Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +G+GA G V K ++     + A+K + TD     +K+   E+ +        +V   G  
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 178 AEKGQHMLVYV--FMSKGSLASHLYDE---NYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
            ++    +     +   GSL S +Y +     G +   +   IA  V +GL YLH   + 
Sbjct: 69  LDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKI- 126

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
             IHRDIK SNILL +  + ++ DFG+S  E+V+  A    GT  Y+ PE I  + ++  
Sbjct: 127 --IHRDIKPSNILLTRKGQVKLCDFGVS-GELVNSLAGTFTGTSFYMAPERIQGKPYSIT 183

Query: 293 SDVYSFGVLLFELIAGRSPL-----QGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
           SDV+S G+ L E+   R P        L   +EL +          E+ D   +GI   E
Sbjct: 184 SDVWSLGLTLLEVAQNRFPFPPEGEPPLGP-IELLSYIVNMPN--PELKDEPGNGIKWSE 240

Query: 348 ELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
           E         +C+ + P +RP+  D+++
Sbjct: 241 EFK---DFIKQCLEKDPTRRPTPWDMLE 265

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 98.9 bits (246), Expect = 1e-23
 Identities = 77/228 (33%), Positives = 112/228 (49%), Gaps = 21/228 (9%)

Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVM 160
           IP  S + ++K        +G G FG V+    +    VAVK L   +   E  F  E  
Sbjct: 3   IPRESLQLIKK--------LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQ 53

Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++ +L H  LV L    +E+  + +V  +MSKGSL   L D     L     V +A  VA
Sbjct: 54  IMKKLRHDKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVA 112

Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
            G+ Y+        IHRD++S+NIL+   +  ++ADFGL+R    +++ A     F   +
Sbjct: 113 AGMAYIERMNY---IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169

Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL-----MEYVE 320
             PE      FT KSDV+SFG+LL EL+  GR P  G+     +E VE
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 217

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 98.4 bits (245), Expect = 2e-23
 Identities = 70/258 (27%), Positives = 123/258 (47%), Gaps = 20/258 (7%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +G G FG V   +      VA+K++   S   E EF  E  ++ +L H  LV L G C +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +    +V  +MS G L ++L +         L + +  DV  G+ YL        IHRD+
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEGMAYLESKQF---IHRDL 126

Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVYS 297
            + N L+D     +V+DFGLSR  + D++ +++   F   +  PE +    F+ KSDV++
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186

Query: 298 FGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLA 356
           FGVL++E+ + G+ P +      E     ++G   +   + S            +V ++ 
Sbjct: 187 FGVLMWEVYSLGKMPYE-RFNNSETVEKVSQGLRLYRPHLAS-----------EKVYAIM 234

Query: 357 YKCVNRAPRKRPSMRDIV 374
           Y C +    +RP+ + ++
Sbjct: 235 YSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 23/207 (11%)

Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD----SKQGEKEFQTEVMLLGRLHHRN 169
            F   +G G+FG V   +   +G+  A+K+L+       KQ  +    E  +L  + H  
Sbjct: 4   EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPF 62

Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLE 224
           LVNL G   +     LV  ++  G L SHL     + E         R + A  V   LE
Sbjct: 63  LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA------RFYAA-QVVLALE 115

Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYI 284
           YLH   +   ++RD+K  N+LLD     ++ DFG ++   V      + GT  YL PE I
Sbjct: 116 YLHSLDI---VYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYTLCGTPEYLAPEII 170

Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSP 311
            ++ + K  D ++ G+L++E++AG  P
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 98.2 bits (244), Expect = 3e-23
 Identities = 66/218 (30%), Positives = 111/218 (50%), Gaps = 15/218 (6%)

Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVM 160
           IP  S K ++K        +G G FG V+    +    VAVK L   +   +  F  E  
Sbjct: 3   IPRESIKLVKK--------LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEAN 53

Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           L+  L H  LV L     ++    ++  +M+KGSL   L  +  G +     +  +  +A
Sbjct: 54  LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 113

Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
            G+ Y+        IHRD++++N+L+ +S+  ++ADFGL+R    +++ A     F   +
Sbjct: 114 EGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 170

Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             PE I+  +FT KSDV+SFG+LL+E++  G+ P  G+
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 98.6 bits (246), Expect = 4e-23
 Identities = 68/207 (32%), Positives = 106/207 (51%), Gaps = 16/207 (7%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT--EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VY+A+  ++GE VA+K +  D+++      +  E+ LL  L H N+V L   
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 177 CAEKGQHMLVYVFMSKG----SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
               G+H L  +F+        LAS L D    P + +    + L + RGL+YLH+  + 
Sbjct: 75  VV--GKH-LDSIFLVMEYCEQDLAS-LLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI- 129

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANIRGTFGYLDPEYI-STRNFT 290
             IHRD+K SN+LL      ++ADFGL+R   +  K       T  Y  PE +     +T
Sbjct: 130 --IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYT 187

Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLME 317
              D+++ G +L EL+A +  L G  E
Sbjct: 188 TAIDMWAVGCILAELLAHKPLLPGKSE 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 97.9 bits (244), Expect = 5e-23
 Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 17/202 (8%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G GAFG VYKAQ   TG   A K++  +S++  ++F  E+ +L    H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            + +  ++  F   G+L S +  E    LT     ++   +   L +LH   V   IHRD
Sbjct: 73  YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLHSHKV---IHRD 128

Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF----GYLDPEYISTRNFTK--- 291
           +K+ NILL      ++ADFG+S +   +K     R TF     ++ PE ++   F     
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAK---NKSTLQKRDTFIGTPYWMAPEVVACETFKDNPY 185

Query: 292 --KSDVYSFGVLLFELIAGRSP 311
             K+D++S G+ L EL     P
Sbjct: 186 DYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 97.5 bits (243), Expect = 5e-23
 Identities = 79/286 (27%), Positives = 118/286 (41%), Gaps = 51/286 (17%)

Query: 119 LIGQGAFGPVYKA--QMSTGE--TVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNL 173
            IG+G FG VY+        E   VAVK     +    +E F  E  ++ +  H ++V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 174 VGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           +G   E      V++ M     G L S+L    Y  L     +  +  ++  L YL    
Sbjct: 73  IGVITE----NPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALAYLES-- 125

Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTRN 288
               +HRDI + N+L+      ++ DFGLSR  E+     A+  +    ++ PE I+ R 
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184

Query: 289 FTKKSDVYSFGVLLFE-LIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
           FT  SDV+ FGV ++E L+ G  P QG                     V +  D I  +E
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQG---------------------VKNN-DVIGRIE 222

Query: 348 ELNEVA----------SLAYKCVNRAPRKRPSMRDIVQVLSRILKM 383
               +           SL  KC    P KRP   ++   LS IL+ 
Sbjct: 223 NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 97.2 bits (242), Expect = 6e-23
 Identities = 77/270 (28%), Positives = 124/270 (45%), Gaps = 33/270 (12%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           ++G+G +G VY A+ +ST   +A+K +     +  +    E+ L   L HRN+V  +G  
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHI--ALDVARGLEYLHDGAVPPVI 235
           +E G    +++    G   S L    +GPL  N +  I     +  GL+YLHD     ++
Sbjct: 75  SENG-FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IV 130

Query: 236 HRDIKSSNILLDQ-SMRARVADFGLS-REEMVDKHAANIRGTFGYLDPEYIS--TRNFTK 291
           HRDIK  N+L++  S   +++DFG S R   ++       GT  Y+ PE I    R +  
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGA 190

Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV----- 346
            +D++S G  + E+  G+ P   L E    AAM                 G+F +     
Sbjct: 191 PADIWSLGCTIVEMATGKPPFIELGE--PQAAMFKV--------------GMFKIHPEIP 234

Query: 347 EELNEVA-SLAYKCVNRAPRKRPSMRDIVQ 375
           E L+  A +   +C    P KR S  D++Q
Sbjct: 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 97.5 bits (242), Expect = 6e-23
 Identities = 87/284 (30%), Positives = 140/284 (49%), Gaps = 35/284 (12%)

Query: 119 LIGQGAFGPVYKAQMSTG---ETVAVKVLAT-DSKQGEKEFQTEVMLLGRL-HHRNLVNL 173
           +IG+G FG V KA++         A+K +    SK   ++F  E+ +L +L HH N++NL
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHL-----------YDENYGP---LTWNLRVHIALDV 219
           +G C  +G   L   +   G+L   L           +         L+    +H A DV
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL 279
           ARG++YL        IHRD+ + NIL+ ++  A++ADFGLSR + V       R    ++
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 178

Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDS 338
             E ++   +T  SDV+S+GVLL+E+++ G +P  G M   EL     +G          
Sbjct: 179 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQG---------Y 228

Query: 339 RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
           RL+   + ++  EV  L  +C    P +RPS   I+  L+R+L+
Sbjct: 229 RLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 96.6 bits (240), Expect = 1e-22
 Identities = 68/207 (32%), Positives = 108/207 (52%), Gaps = 22/207 (10%)

Query: 120 IGQGAFGPVY--KAQMSTGETVAVKVLATDSKQGEKEF-QTEVMLLGRLHHRNLVNLVGY 176
           IG+G+FG +Y  KA+  +   V  ++  T     EKE  + EV+LL ++ H N+V     
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 177 CAEKGQHMLVYVFMSKGSLASH-------LYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
             E G+  +V  +   G L          L+ E+   L+W   V I+L    GL+++HD 
Sbjct: 68  FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ-ILSW--FVQISL----GLKHIHDR 120

Query: 230 AVPPVIHRDIKSSNILLDQS-MRARVADFGLSRE-EMVDKHAANIRGTFGYLDPEYISTR 287
            +   +HRDIKS NI L ++ M A++ DFG++R+     + A    GT  YL PE    R
Sbjct: 121 KI---LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR 177

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQG 314
            +  K+D++S G +L+EL   + P +G
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEG 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 79/287 (27%), Positives = 134/287 (46%), Gaps = 50/287 (17%)

Query: 120 IGQGAFGPVYK---AQMSTGE---TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
           +GQG+FG VY+     +  GE    VA+K +  ++   E+ EF  E  ++   +  ++V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 173 LVGYCAEKGQHMLVYV-FMSKGSLASHL--------YDENYGPLTWNLRVHIALDVARGL 223
           L+G  +  GQ  LV +  M+KG L S+L         +   GP T    + +A ++A G+
Sbjct: 74  LLGVVS-TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL---- 279
            YL        +HRD+ + N ++ + +  ++ DFG++R+  + +     +G  G L    
Sbjct: 133 AYLAAKKF---VHRDLAARNCMVAEDLTVKIGDFGMTRD--IYETDYYRKGGKGLLPVRW 187

Query: 280 -DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVD 337
             PE +    FT KSDV+SFGV+L+E+      P QGL                 EE++ 
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---------------EEVLK 232

Query: 338 SRLDGIFDVEEL-----NEVASLAYKCVNRAPRKRPSMRDIVQVLSR 379
             +DG     +L     +++  L   C    P+ RP+  +IV  L  
Sbjct: 233 FVIDG--GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 96.0 bits (239), Expect = 1e-22
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 7/196 (3%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKV--LATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG+G+FG V+K  + +     A+K   L+  +++  +E   E  +L +L    ++     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
             +KG+  +V  +   G L   L  +   PL  +      + +  GL +LH   +   +H
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKI---LH 124

Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRNFTKKSDV 295
           RDIKS N+ LD     ++ D G+++    + + AN I GT  YL PE    + + +KSDV
Sbjct: 125 RDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDV 184

Query: 296 YSFGVLLFELIAGRSP 311
           ++ GV+L+E   G+ P
Sbjct: 185 WALGVVLYECCTGKHP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 10/200 (5%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
            +G+G++G VYKA    TG+ VA+KV+  +     +E   E+ +L +     +V   G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
            +     +V  +   GS+ S +       LT      I     +GLEYLH       IHR
Sbjct: 68  FKNTDLWIVMEYCGAGSV-SDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKK---IHR 123

Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHA-AN-IRGTFGYLDPEYISTRNFTKKSDV 295
           DIK+ NILL++  +A++ADFG+S  ++ D  A  N + GT  ++ PE I    +  K+D+
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADI 182

Query: 296 YSFGVLLFELIAGRSPLQGL 315
           +S G+   E+  G+ P   +
Sbjct: 183 WSLGITAIEMAEGKPPYSDI 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 95.5 bits (237), Expect = 2e-22
 Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 8/200 (4%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  + +V  +MSKGSL   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 73  EPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 128

Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVYS 297
           +++NIL+ +++  +VADFGL+R    +++ A     F   +  PE      FT KSDV+S
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188

Query: 298 FGVLLFELIA-GRSPLQGLM 316
           FG+LL EL   GR P  G++
Sbjct: 189 FGILLTELTTKGRVPYPGMV 208

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 94.9 bits (236), Expect = 4e-22
 Identities = 61/205 (29%), Positives = 110/205 (53%), Gaps = 16/205 (7%)

Query: 119 LIGQGAFGPVYKAQMSTG----ETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +IG G FG V + ++         VA+K L +  +++  ++F +E  ++G+  H N+++L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
            G   +    M++  FM  G+L S L  +N G  T    V +   +A G++YL +     
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY-- 127

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPEYISTR 287
            +HRD+ + NIL++ ++  +V+DFGLSR    D        + G      +  PE I+ R
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 288 NFTKKSDVYSFGVLLFELIA-GRSP 311
            FT  SDV+S+G++++E+++ G  P
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 94.7 bits (235), Expect = 4e-22
 Identities = 67/200 (33%), Positives = 104/200 (52%), Gaps = 8/200 (4%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  + +V  FM KGSL   L + +   L     V +A  +A G+ Y+        IHRD+
Sbjct: 73  EPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY---IHRDL 128

Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVYS 297
           +++NIL+  ++  ++ADFGL+R    +++ A     F   +  PE      FT KSDV+S
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188

Query: 298 FGVLLFELIA-GRSPLQGLM 316
           FG+LL EL+  GR P  G++
Sbjct: 189 FGILLTELVTKGRVPYPGMV 208

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 95.9 bits (239), Expect = 4e-22
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 26/214 (12%)

Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLA---------TDSKQGEKE-FQTEVMLLG 163
               ++G+G FG V  A+   TGE  A+K L           +S   EK  F+T      
Sbjct: 2   RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFET----AN 57

Query: 164 RLHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYG-PLTWNLRVHIALDVAR 221
              H  LVNL   C +   H+  V  + + G L  H++ + +  P      V  A  V  
Sbjct: 58  SERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA----VFYAACVVL 112

Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYLD 280
           GL+YLH+  +   ++RD+K  N+LLD     ++ADFGL +E M      +   GT  +L 
Sbjct: 113 GLQYLHENKI---VYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLA 169

Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           PE ++  ++T+  D +  GVL++E++ G SP  G
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 94.5 bits (235), Expect = 6e-22
 Identities = 66/197 (33%), Positives = 97/197 (49%), Gaps = 13/197 (6%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTE-VMLLGRLHHRNLVNLV 174
           I +GAFG VY A+  STG+  A+KVL      +K      + E  +++ +     +  L 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
                K    LV  +++ G  AS +      P  W  + +IA +V  G+E LH   +   
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVEDLHQRGI--- 118

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
           IHRDIK  N+L+DQ+   ++ DFGLSR  + +K      GT  YL PE I      K SD
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK---KFVGTPDYLAPETILGVGDDKMSD 175

Query: 295 VYSFGVLLFELIAGRSP 311
            +S G ++FE + G  P
Sbjct: 176 WWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 94.2 bits (234), Expect = 8e-22
 Identities = 82/289 (28%), Positives = 132/289 (45%), Gaps = 43/289 (14%)

Query: 120 IGQGAFGPVYKAQM-----STGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNL 173
           +G+G FG V   +      +TGE VAVK L  +S      + + E+ +L  L+H N+V  
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 174 VGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            G C E G +   L+  F+  GSL  +L   N   +    ++  A+ + +G++YL     
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYL---GS 127

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG-----TFGYLDPEYIST 286
              +HRD+ + N+L++   + ++ DFGL++    DK    ++       F Y  PE +  
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA-PECLIQ 186

Query: 287 RNFTKKSDVYSFGVLLFELI----AGRSPL----------QGLMEYVELAAMNTEGKTGW 332
             F   SDV+SFGV L+EL+    +  SP+           G M    L  +  EGK   
Sbjct: 187 SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK--- 243

Query: 333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
                 RL    +  E  EV  L  KC    P KR + +++++    IL
Sbjct: 244 ------RLPRPPNCPE--EVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 93.8 bits (233), Expect = 1e-21
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 12/209 (5%)

Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G+G FG V   QM +TG+  A K L     +  K ++    E  +L ++H R +V+L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLY--DENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
               K    LV   M+ G L  H+Y  DE                +  GLE+LH   +  
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI-- 118

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN--IRGTFGYLDPEYISTRNFTK 291
            I+RD+K  N+LLD     R++D GL+  E+ D  +      GT G++ PE +    +  
Sbjct: 119 -IYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176

Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVE 320
             D ++ GV L+E+IA R P +   E VE
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVE 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 93.6 bits (232), Expect = 1e-21
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 34/281 (12%)

Query: 120 IGQGAFGPVYKAQMSTGET---VAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           +G+G FG V + Q++  ++   VAVK +  A  ++   ++F +E + +    H N++ L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 175 GYCAEKGQH------MLVYVFMSKGSLASHLYDENYGP----LTWNLRVHIALDVARGLE 224
           G C +  +       +++  FM  G L S L     G     L   + V    D+A G+E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT---FGYLDP 281
           YL   +    IHRD+ + N +L+++M   VADFGLS++     +    R       ++  
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 282 EYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL 340
           E ++ R +T KSDV+SFGV ++E+   G++P  G+ E  E+     +G    ++  D  L
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV-ENSEIYDYLRQGNR-LKQPPDC-L 240

Query: 341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
           DG++         SL   C    P+ RPS   +   L + L
Sbjct: 241 DGLY---------SLMSSCWLLNPKDRPSFETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 93.6 bits (232), Expect = 1e-21
 Identities = 70/218 (32%), Positives = 108/218 (49%), Gaps = 20/218 (9%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKE---FQTEVMLLGRLHHRNLVN 172
           L+GQGAFG VY    + TG  +A K +  D  S +  KE    + E+ LL  L H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 173 LVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
             G   ++ +  L     +M  GS+   L  + YG LT ++       +  G+ YLH   
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSYLHSNM 126

Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLS-REEMVDKHAANIR---GTFGYLDPEYIST 286
           +   +HRDIK +NIL D +   ++ DFG S R + +      IR   GT  ++ PE IS 
Sbjct: 127 I---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183

Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM 324
             + +K+DV+S G  + E++  + P     EY  +AA+
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKPPWA---EYEAMAAI 218

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 93.9 bits (233), Expect = 1e-21
 Identities = 63/199 (31%), Positives = 97/199 (48%), Gaps = 7/199 (3%)

Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           ++G+G FG V   Q+ +TG+  A K L       ++GE     E  +L +++ R +V+L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
                K    LV   M+ G L  H+Y            V  A ++  GLE LH      +
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERI 123

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
           ++RD+K  NILLD     R++D GL+      +      GT GY+ PE +    +T   D
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 183

Query: 295 VYSFGVLLFELIAGRSPLQ 313
            ++ G LL+E+IAG+SP Q
Sbjct: 184 WWALGCLLYEMIAGQSPFQ 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 92.8 bits (230), Expect = 2e-21
 Identities = 73/266 (27%), Positives = 125/266 (46%), Gaps = 24/266 (9%)

Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVGYC 177
           L+G+G FG V+K  +     VAVK    D  Q  K +F +E  +L +  H N+V L+G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
            ++    +V   +  G   S L  +     T  L V  ALD A G+ YL        IHR
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL-VKFALDAAAGMAYLES---KNCIHR 117

Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG----TFGYLDPEYISTRNFTKKS 293
           D+ + N L+ ++   +++DFG+SR+E  D    +  G       +  PE ++   ++ +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQE--DDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 294 DVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEV 352
           DV+S+G+LL+E  + G  P  G+         N + +   E+    R+       +  +V
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGM--------TNQQAREQVEK--GYRMSCPQKCPD--DV 223

Query: 353 ASLAYKCVNRAPRKRPSMRDIVQVLS 378
             +  +C +  P  RP   ++ + L+
Sbjct: 224 YKVMQRCWDYKPENRPKFSELQKELA 249

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 92.4 bits (229), Expect = 2e-21
 Identities = 78/270 (28%), Positives = 123/270 (45%), Gaps = 34/270 (12%)

Query: 120 IGQGAFGPVYKAQMSTGET-VAVK----VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           IG+G FG V+  ++    T VAVK     L  D K    +F  E  +L +  H N+V L+
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA---KFLQEARILKQYSHPNIVRLI 59

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGP-LTWNLRVHIALDVARGLEYLHDGAVPP 233
           G C +K    +V   +  G   + L  E  GP L     + +  + A G+EYL       
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKHC-- 115

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN---IRGTFGYLDPEYISTRNFT 290
            IHRD+ + N L+ +    +++DFG+SREE    +A+     +    +  PE ++   ++
Sbjct: 116 -IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174

Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL 349
            +SDV+SFG+LL+E  + G  P      Y  L+   T       E ++          EL
Sbjct: 175 SESDVWSFGILLWEAFSLGAVP------YANLSNQQT------REAIEQ--GVRLPCPEL 220

Query: 350 --NEVASLAYKCVNRAPRKRPSMRDIVQVL 377
             + V  L  +C    P +RPS   + Q L
Sbjct: 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 92.8 bits (230), Expect = 2e-21
 Identities = 69/218 (31%), Positives = 110/218 (50%), Gaps = 20/218 (9%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKE---FQTEVMLLGRLHHRNLVN 172
           L+G+GAFG VY      TG  +AVK +  D  S++  KE    + E+ LL  L H  +V 
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 173 LVGYCAEKGQHML-VYV-FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
             G   +  +  L ++V +M  GS+   L  + YG LT N+       + +G+ YLH   
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVSYLHSNM 126

Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSRE----EMVDKHAANIRGTFGYLDPEYIST 286
           +   +HRDIK +NIL D +   ++ DFG S+      M      ++ GT  ++ PE IS 
Sbjct: 127 I---VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183

Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM 324
             + +K+DV+S    + E++  + P     EY  +AA+
Sbjct: 184 EGYGRKADVWSVACTVVEMLTEKPPWA---EYEAMAAI 218

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 92.4 bits (229), Expect = 3e-21
 Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 25/219 (11%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKE---FQTEVMLLGRLHHRNLVN 172
           L+GQGAFG VY      TG  +AVK +  D  S +  KE    + E+ LL  L H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 173 LVGYCAEKGQHMLVYVFMS---KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
             G C        + +FM     GS+   L  ++YG LT N+       +  G+ YLH  
Sbjct: 69  YYG-CLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVSYLHSN 125

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREE----MVDKHAANIRGTFGYLDPEYIS 285
            +   +HRDIK +NIL D     ++ DFG S+      +      ++ GT  ++ PE IS
Sbjct: 126 MI---VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM 324
              + +K+D++S G  + E++  + P      + E  AM
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPP------WAEFEAM 215

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 92.3 bits (229), Expect = 4e-21
 Identities = 65/203 (32%), Positives = 111/203 (54%), Gaps = 14/203 (6%)

Query: 119 LIGQGAFGPVYKAQMSTGE----TVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +IG G FG V   ++         VA+K L A  +++  ++F +E  ++G+  H N+++L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
            G   +    M+V  +M  GSL + L  ++ G  T    V +   +A G++YL D     
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFL-RKHDGQFTVIQLVGMLRGIASGMKYLSDMGY-- 127

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TFGYLDPEYISTRNF 289
            +HRD+ + NIL++ ++  +V+DFGLSR    D  AA   RG      +  PE I+ R F
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186

Query: 290 TKKSDVYSFGVLLFELIA-GRSP 311
           T  SDV+S+G++++E+++ G  P
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 92.0 bits (228), Expect = 4e-21
 Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 8/211 (3%)

Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + +      +G G FG V+ A  +    VAVK +   S   E  F  E  ++  L H
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQH 60

Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
             LV L     ++  +++   FM+KGSL   L  +          +  +  +A G+ ++ 
Sbjct: 61  DKLVKLHAVVTKEPIYIITE-FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYIS 285
                  IHRD++++NIL+  S+  ++ADFGL+R    +++ A     F   +  PE I+
Sbjct: 120 QRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 176

Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             +FT KSDV+SFG+LL E++  GR P  G+
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 92.3 bits (229), Expect = 4e-21
 Identities = 79/284 (27%), Positives = 122/284 (42%), Gaps = 43/284 (15%)

Query: 120 IGQGAFGPV--YK---AQMSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+G FG V  Y    A   TGE VAVK L  +  +Q    ++ E+ +L  L+H N+V  
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 174 VGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            G C+E+G     L+  ++  GSL  +L           L    A  +  G+ YLH    
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL---FAQQICEGMAYLHSQHY 128

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSRE----EMVDKHAANIRGTFGYLDPEYISTR 287
              IHRD+ + N+LLD     ++ DFGL++         +   +      +   E +   
Sbjct: 129 ---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN 185

Query: 288 NFTKKSDVYSFGVLLFELI----AGRSP----------LQGLMEYVELAAMNTEGKTGWE 333
            F+  SDV+SFGV L+EL+    + +SP           QG M  V L  +   G     
Sbjct: 186 KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM---- 241

Query: 334 EIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
                RL    +  +  EV  L   C     + RP+ R ++ +L
Sbjct: 242 -----RLPCPKNCPQ--EVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 91.6 bits (228), Expect = 5e-21
 Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 32/215 (14%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGE--KEFQTEVMLLGRLHHRNLVNLVGY 176
           IG G FG VY A  + TGE +AVK +       +  KE   E+ +L  L H NLV   G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 177 CAEKGQHMLVYVFM---SKGSLASHLY-----DENYGPLTWNLRVHIALDVARGLEYLHD 228
              + +   VY+FM   S G+L   L      DE+       +RV+  L +  GL YLH 
Sbjct: 68  EVHREK---VYIFMEYCSGGTLEELLEHGRILDEHV------IRVY-TLQLLEGLAYLHS 117

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLS-----REEMVDKHAANIRGTFGYLDPEY 283
             +   +HRDIK +NI LD +   ++ DFG +         + +   ++ GT  Y+ PE 
Sbjct: 118 HGI---VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 284 ISTRNFTKK---SDVYSFGVLLFELIAGRSPLQGL 315
           I+          +D++S G ++ E+  G+ P   L
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 91.6 bits (228), Expect = 6e-21
 Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 28/214 (13%)

Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGY 176
           +IG+G +G VYKA+   TG+ VA+K++     + E+E + E  +L +  +H N+    G 
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGA 71

Query: 177 CAEKG------QHMLVYVFMSKGS---LASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
             +K       Q  LV      GS   L   L  +    L      +I  +  RGL YLH
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-KRLKEEWIAYILRETLRGLAYLH 130

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-G---YLDPEY 283
           +  V   IHRDIK  NILL ++   ++ DFG+S +          R TF G   ++ PE 
Sbjct: 131 ENKV---IHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRNTFIGTPYWMAPEV 184

Query: 284 IS-----TRNFTKKSDVYSFGVLLFELIAGRSPL 312
           I+       ++  +SDV+S G+   EL  G+ PL
Sbjct: 185 IACDEQPDASYDARSDVWSLGITAIELADGKPPL 218

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 92.1 bits (229), Expect = 8e-21
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 25/209 (11%)

Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATD---------SKQGEKEFQTEVMLLGRLHHR 168
           ++G+G+FG V  A++  T E  AVKVL  D             EK     V+ L    H 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKR----VLALAG-KHP 56

Query: 169 NLVNLVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYL 226
            L  L  +   + +  L +V  +++ G L  H+  +  G          A ++  GL++L
Sbjct: 57  FLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAEIVLGLQFL 112

Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYIS 285
           H+  +   I+RD+K  N+LLD     ++ADFG+ +E ++     +   GT  Y+ PE +S
Sbjct: 113 HERGI---IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS 169

Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            + +    D ++ GVLL+E++AG+SP +G
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEG 198

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 92.1 bits (228), Expect = 8e-21
 Identities = 67/219 (30%), Positives = 112/219 (51%), Gaps = 19/219 (8%)

Query: 109 LQKATCNFTTLIGQGAFGPVYKA-QMSTGETV----AVKVL-ATDSKQGEKEFQTEVMLL 162
           L++       ++G GAFG VYK   +  GETV    A+K+L  T   +   EF  E +++
Sbjct: 4   LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63

Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVA 220
             + H +LV L+G C       LV   M  G L  ++++  +N G     L ++  + +A
Sbjct: 64  ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGS---QLLLNWCVQIA 119

Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG---TFG 277
           +G+ YL +  +   +HRD+ + N+L+      ++ DFGL+R    D+   N  G      
Sbjct: 120 KGMMYLEERRL---VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176

Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
           ++  E I  R FT +SDV+S+GV ++EL+  G  P  G+
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 91.2 bits (227), Expect = 9e-21
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 31/208 (14%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLA--TDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +    +S+   K    E+ LL  L+H N++ L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              KG   LV+ FM    L   L  +    L  +L       + +GL + H   +   +H
Sbjct: 67  FRHKGDLYLVFEFM-DTDLY-KLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI---LH 121

Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR--------- 287
           RD+K  N+L++     ++ADFGL+R                     Y+ TR         
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARS---------FGSPVRPYT-HYVVTRWYRAPELLL 171

Query: 288 ---NFTKKSDVYSFGVLLFELIAGRSPL 312
               ++   D++S G +  EL++ R PL
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRR-PL 198

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 91.8 bits (228), Expect = 1e-20
 Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 25/213 (11%)

Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATD---------SKQGEKEFQTEVMLLGR 164
           NF  ++G+G+FG V  A +  T E  A+K+L  D             EK     + L G+
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRV---LALPGK 59

Query: 165 LHHRNLVNLVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARG 222
                L  L  +   +    L +V  +++ G L  H+  +  G       V  A ++A G
Sbjct: 60  PPF--LTQL--HSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGKFKEPHAVFYAAEIAIG 113

Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDP 281
           L +LH   +   I+RD+K  N++LD     ++ADFG+ +E +   K      GT  Y+ P
Sbjct: 114 LFFLHSKGI---IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAP 170

Query: 282 EYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           E I+ + + K  D ++FGVLL+E++AG+ P  G
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 91.6 bits (227), Expect = 1e-20
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 11/206 (5%)

Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
           NF  ++G+G+FG V  A+   T E  A+K+L  D    + + +    E  +L        
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF 62

Query: 171 VNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +  +  C +    +  V  +++ G L  H+  +  G       V  A +++ GL +LH  
Sbjct: 63  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRGTFGYLDPEYISTRN 288
            +   I+RD+K  N++LD     ++ADFG+ +E MVD        GT  Y+ PE I+ + 
Sbjct: 121 GI---IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP 177

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
           + K  D +++GVLL+E++AG+ P  G
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 90.8 bits (225), Expect = 1e-20
 Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 7/206 (3%)

Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           ++G+G FG V   Q+ +TG+  A K L       ++GE     E  +L +++ + +VNL 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
                K    LV   M+ G L  H+Y+           +  A ++  GLE LH       
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT--- 123

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
           ++RD+K  NILLD     R++D GL+ +    +      GT GY+ PE ++ + +T   D
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPD 183

Query: 295 VYSFGVLLFELIAGRSPLQGLMEYVE 320
            +  G L++E+I G+SP +G  E V+
Sbjct: 184 YWGLGCLIYEMIEGQSPFRGRKEKVK 209

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 94/346 (27%), Positives = 148/346 (42%), Gaps = 94/346 (27%)

Query: 116 FTTLIGQGAFGPVYKAQ-MSTGE-----TVAVKVLATDSKQGEKE-FQTEVMLLGRL-HH 167
           F   +G GAFG V +A     G+      VAVK+L   +   E+E   +E+ +L  L  H
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101

Query: 168 RNLVNLVG-------------YCA---------EKGQHMLVYV----------------- 188
           +N+VNL+G             YC          +K +  L +V                 
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNIT 161

Query: 189 -----------FMSKG--------------SLASHLYDENYGPLTWNLRV----HIALDV 219
                      F S+G              S +S   DE     +W L +      +  V
Sbjct: 162 LEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQV 221

Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH---AANIRGTF 276
           A+G+++L   A    IHRD+ + N+LL     A++ DFGL+R+ M D +     N R   
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278

Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEI 335
            ++ PE I    +T +SDV+S+G+LL+E+ + G+SP  G++   +   M    K G++  
Sbjct: 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV---KRGYQM- 334

Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
             SR D         E+ S+   C N  P +RP+   I Q++ R L
Sbjct: 335 --SRPD-----FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 90.0 bits (223), Expect = 2e-20
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 9/206 (4%)

Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG V   Q+ +TG+  A K L       K GEK    E  +L +++   +VNL  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59

Query: 176 YCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           Y  E   H+ LV   M+ G L  H+Y+     L     +H +  +  G+ +LH   +   
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI--- 116

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
           ++RD+K  N+LLD     R++D GL+ E    K      GT GY+ PE +    ++   D
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVD 176

Query: 295 VYSFGVLLFELIAGRSPLQGLMEYVE 320
            ++ G  ++E++AGR+P +   E V 
Sbjct: 177 WFAMGCSIYEMVAGRTPFKDHKEKVA 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 90.4 bits (224), Expect = 3e-20
 Identities = 75/269 (27%), Positives = 127/269 (47%), Gaps = 35/269 (13%)

Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRL-----HHRNLVN 172
           ++G+G+FG V+ A++  T +  A+K L  D    + + +   M+  R+      H  L +
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVEC-TMVEKRVLSLAWEHPFLTH 60

Query: 173 LVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           L  YC  + +  L +V  +++ G L  H+  ++            A ++  GL++LH   
Sbjct: 61  L--YCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICGLQFLHSKG 116

Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPEYISTRNF 289
           +   ++RD+K  NILLD     ++ADFG+ +E M+ D       GT  Y+ PE +  + +
Sbjct: 117 I---VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY 173

Query: 290 TKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDS-RLDGIFDVEE 348
               D +SFGVLL+E++ G+SP  G  E               EE+  S R+D       
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHDE---------------EELFQSIRMDNPCYPRW 218

Query: 349 LN-EVASLAYKCVNRAPRKRPSMR-DIVQ 375
           L  E   +  K   R P +R  ++ DI Q
Sbjct: 219 LTREAKDILVKLFVREPERRLGVKGDIRQ 247

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 89.4 bits (222), Expect = 4e-20
 Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 13/206 (6%)

Query: 117 TTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLV 174
             LIG+GA+G VY+   + TG  VA+K++  D+   +  + Q EV LL +L      N+ 
Sbjct: 6   LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65

Query: 175 GY--CAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            Y     KG  + ++  +   GS+ + +     GP+       I  +V   L+Y+H    
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSVRTLM---KAGPIAEKYISVIIREVLVALKYIHKV-- 120

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANIRGTFGYLDPEYIST-RNF 289
             VIHRDIK++NIL+  +   ++ DFG++          +   GT  ++ PE I+  + +
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179

Query: 290 TKKSDVYSFGVLLFELIAGRSPLQGL 315
             K+D++S G+ ++E+  G  P   +
Sbjct: 180 DTKADIWSLGITIYEMATGNPPYSDV 205

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 89.1 bits (221), Expect = 5e-20
 Identities = 69/229 (30%), Positives = 106/229 (46%), Gaps = 25/229 (10%)

Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLA---TDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           ++G+G FG V   Q+ +TG+  A K L       ++GE     E  +L +++ R +V+L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
                K    LV   M+ G L  H+Y+           V  A ++  GLE LH      +
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERI 123

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG---TFGYLDPEYISTRNFTK 291
           ++RD+K  NILLD     R++D GL+ E         IRG   T GY+ PE +    +T 
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEI---PEGETIRGRVGTVGYMAPEVVKNERYTF 180

Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL 340
             D +  G L++E+I G+SP +   E           K   EE V+ R+
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKE-----------KVKREE-VERRV 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 89.6 bits (222), Expect = 7e-20
 Identities = 66/205 (32%), Positives = 108/205 (52%), Gaps = 17/205 (8%)

Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGR---LHHRN--LVN 172
           ++G+G+FG V  A++   GE  AVK L  D    + + +   M+  R   L   N  L +
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVEC-TMVEKRVLALAWENPFLTH 60

Query: 173 LVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           L  YC  + +  L +V  F++ G L  H+ D+  G          A ++  GL++LH   
Sbjct: 61  L--YCTFQTKEHLFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKG 116

Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPEYISTRNF 289
           +   I+RD+K  N++LD+    ++ADFG+ +E +  D  A+   GT  Y+ PE +    +
Sbjct: 117 I---IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY 173

Query: 290 TKKSDVYSFGVLLFELIAGRSPLQG 314
           T   D +SFGVLL+E++ G+SP  G
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHG 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 88.4 bits (219), Expect = 7e-20
 Identities = 65/262 (24%), Positives = 119/262 (45%), Gaps = 19/262 (7%)

Query: 117 TTLIGQGAFGPVYKAQMSTGET-VAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNL 173
             ++G+GAFG V+  +    +  V +K +  +  +K      Q E  +L  L H N++  
Sbjct: 5   IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                E    M+V  +   G+LA ++       L  +  +H  + +   L ++H   +  
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLI-- 122

Query: 234 VIHRDIKSSNILLDQ-SMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
            +HRD+K+ NILLD+  M  ++ DFG+S+       A  + GT  Y+ PE    + + +K
Sbjct: 123 -LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQK 181

Query: 293 SDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEV 352
           SD+++ G +L+EL +    L+   E   L A+  +  +G    +  R           ++
Sbjct: 182 SDIWALGCVLYELAS----LKRAFEAANLPALVLKIMSGTFAPISDRYS--------PDL 229

Query: 353 ASLAYKCVNRAPRKRPSMRDIV 374
             L    +N  P KRP +  I+
Sbjct: 230 RQLILSMLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 89.5 bits (222), Expect = 7e-20
 Identities = 67/203 (33%), Positives = 112/203 (55%), Gaps = 12/203 (5%)

Query: 119 LIGQGAFGPVYKAQMSTGETV----AVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++GQG+FG V+  +  TG       A+KVL  AT   +     + E  +L  ++H  +V 
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      +G+  L+  F+  G L + L  E       +++ ++A ++A  L++LH   + 
Sbjct: 63  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-DVKFYLA-ELALALDHLHSLGI- 119

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYLDPEYISTRNFTK 291
             I+RD+K  NILLD+    ++ DFGLS+E +  +K A +  GT  Y+ PE ++ R  T+
Sbjct: 120 --IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 177

Query: 292 KSDVYSFGVLLFELIAGRSPLQG 314
            +D +SFGVL+FE++ G  P QG
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQG 200

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 89.1 bits (221), Expect = 8e-20
 Identities = 81/286 (28%), Positives = 127/286 (44%), Gaps = 44/286 (15%)

Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQ---T 157
           PE  + DL++        IG G+FG VY A+   T E VA+K ++   KQ  +++Q    
Sbjct: 13  PEKLFTDLRE--------IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK 64

Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL 217
           EV  L +L H N +   G C  +     + +    GS AS + + +  PL       I  
Sbjct: 65  EVRFLQQLRHPNTIEYKG-CYLREHTAWLVMEYCLGS-ASDILEVHKKPLQEVEIAAICH 122

Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
              +GL YLH       IHRDIK+ NILL +    ++ADFG +   +V   A +  GT  
Sbjct: 123 GALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSA--SLVSP-ANSFVGTPY 176

Query: 278 YLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMN---TEGK 329
           ++ PE I   +   +  K DV+S G+   EL   + PL  +  M  +   A N   T   
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSS 236

Query: 330 TGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
             W +   + +D                 C+ + P+ RPS  ++++
Sbjct: 237 NDWSDYFRNFVD----------------SCLQKIPQDRPSSEELLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 76/269 (28%), Positives = 125/269 (46%), Gaps = 35/269 (13%)

Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKE-----FQTEVMLLGRLHHRNLVN 172
           ++G+G+FG V  A++  T E  A+K L  D    + +      +  V+ L    H  L +
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTH 60

Query: 173 LVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           L  +C  + +  L +V  +++ G L  H+     G          A ++  GL++LH   
Sbjct: 61  L--FCTFQTKEHLFFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKG 116

Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPEYISTRNF 289
           +   I+RD+K  N+LLD+    ++ADFG+ +E M  +  A+   GT  Y+ PE +  + +
Sbjct: 117 I---IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY 173

Query: 290 TKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI--FDVE 347
            +  D +SFGVLL+E++ G+SP  G  E               +E+ DS L+    F   
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDE---------------DELFDSILNDRPHFPRW 218

Query: 348 ELNEVASLAYKCVNRAPRKRPSMR-DIVQ 375
              E      K   R P KR  +  DI Q
Sbjct: 219 ISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 46/217 (21%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           ++G+GA+G V K +  +TGE VA+K    + D +  +K    EV +L +L H N+VNL  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPL--------TWNLRVHIALDVARGLEYLH 227
               KG+  LV+ ++ +  L   L + + G L         W L         + + Y H
Sbjct: 68  AFRRKGRLYLVFEYVERTLL--ELLEASPGGLPPDAVRSYIWQL--------LQAIAYCH 117

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
              +   IHRDIK  NIL+ +S   ++ DFG +R       A   R      D  Y++TR
Sbjct: 118 SHNI---IHRDIKPENILVSESGVLKLCDFGFAR-------ALRARPASPLTD--YVATR 165

Query: 288 ------------NFTKKSDVYSFGVLLFELIAGRSPL 312
                       N+ K  DV++ G ++ EL+ G  PL
Sbjct: 166 WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE-PL 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 87.8 bits (217), Expect = 1e-19
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 20/209 (9%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGY 176
           L+G G +G VYK + + TG+  A+KV+     + E+E + E+ +L +  HHRN+    G 
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 177 CAEKG------QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
             +K       Q  LV  F   GS+   + +     L      +I  ++ RGL +LH   
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 131

Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGYLDPEYIST-- 286
           V   IHRDIK  N+LL ++   ++ DFG+S +    V +    I GT  ++ PE I+   
Sbjct: 132 V---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 187

Query: 287 ---RNFTKKSDVYSFGVLLFELIAGRSPL 312
                +  KSD++S G+   E+  G  PL
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 77/259 (29%), Positives = 121/259 (46%), Gaps = 28/259 (10%)

Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLA---TDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           ++G+G FG V   Q+ +TG+  A K L       ++GE     E  +L +++ R +V+L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL- 65

Query: 175 GYCAE-KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
            Y  E K    LV   M+ G L  H+Y+           +  A ++  GLE L       
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ER 122

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKS 293
           +++RD+K  NILLD     R++D GL+ +    +      GT GY+ PE I+   +T   
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSP 182

Query: 294 DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVA 353
           D +  G L++E+I G+SP +   E V+            EE VD R+    D EE +E  
Sbjct: 183 DWWGLGCLIYEMIQGQSPFRKRKERVK-----------REE-VDRRVKE--DQEEYSEKF 228

Query: 354 SLAYKCVNRA-----PRKR 367
           S   K + R      P++R
Sbjct: 229 SEDAKSICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 89.1 bits (221), Expect = 1e-19
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 21/203 (10%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG GA G VYK     TG   A+KV+  + +    ++   E+ +L  ++H N+V      
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141

Query: 178 AEKGQHMLVYVFMSKGSL-ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              G+  ++  FM  GSL  +H+ DE +          +A  +  G+ YLH   +   +H
Sbjct: 142 DHNGEIQVLLEFMDGGSLEGTHIADEQF-------LADVARQILSGIAYLHRRHI---VH 191

Query: 237 RDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTR-NFTK-- 291
           RDIK SN+L++ +   ++ADFG+SR   + +D   +++ GT  Y+ PE I+T  N     
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYD 250

Query: 292 --KSDVYSFGVLLFELIAGRSPL 312
               D++S GV + E   GR P 
Sbjct: 251 GYAGDIWSLGVSILEFYLGRFPF 273

Length = 353

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 69/278 (24%), Positives = 125/278 (44%), Gaps = 41/278 (14%)

Query: 115 NFTTL--IGQGAFGPVYKAQ-MSTGETVAVKVLATDS-KQGEKEFQ-TEVMLLGRLHHRN 169
           +F  L  +G+G++G VYK + +S  +  A+K +   S  Q E+E    E+ +L  ++H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 170 LV---------NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++         N +    E      +   +SK      L  E      W     I + + 
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQ---EIWR----IFIQLL 113

Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYL 279
           RGL+ LH+  +   +HRD+KS+NILL  +   ++ D G+S+  ++ K+ A  + GT  Y+
Sbjct: 114 RGLQALHEQKI---LHRDLKSANILLVANDLVKIGDLGISK--VLKKNMAKTQIGTPHYM 168

Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG-LMEYVELAAMNTEGKTGWEEIVDS 338
            PE    R ++ KSD++S G LL+E+     P +   M+ +       +           
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY---------P 219

Query: 339 RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV 376
            +  I+  +  N + S     +   P+ RP+   I+  
Sbjct: 220 PIPPIYSQDLQNFIRS----MLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 86.7 bits (215), Expect = 3e-19
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 41/279 (14%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           IG+G F  VYKA  +  G  VA+K +      D+K  +   + E+ LL +L H N++  +
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDHPNVIKYL 68

Query: 175 GYCAEKGQHMLVYVFMSKGSLA---------SHLYDENYGPLTWNLRVHIALDVARGLEY 225
               E  +  +V      G L+           L  E      W   V +       LE+
Sbjct: 69  ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE---RTIWKYFVQLC----SALEH 121

Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           +H   +   +HRDIK +N+ +  +   ++ D GL R    +    H+  + GT  Y+ PE
Sbjct: 122 MHSKRI---MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 176

Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQG-LMEYVELAAMNTEGKTGWEEIVDSRLD 341
            I    +  KSD++S G LL+E+ A +SP  G  M    L     +            L 
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY-------PPLP 229

Query: 342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
                EEL ++ S    C+N  P KRP +  ++QV   +
Sbjct: 230 ADHYSEELRDLVSR---CINPDPEKRPDISYVLQVAKEM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 87.1 bits (216), Expect = 3e-19
 Identities = 76/236 (32%), Positives = 109/236 (46%), Gaps = 47/236 (19%)

Query: 116 FTTL--IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-FQT----EVMLLGRLHH 167
           F  +  IG+G +G VYKA+   TGE VA+K +  D+   EKE F      E+ +L +L+H
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN---EKEGFPITAIREIKILRQLNH 65

Query: 168 RNLVNL----------VGYCAEKGQHMLVYVFMSK---GSLASHLYDENYGPLTWNLRVH 214
           RN+VNL          + +  +KG   LV+ +M     G L S L   +          H
Sbjct: 66  RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFS--------EDH 117

Query: 215 IA------LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268
           I       L+   GL Y H       +HRDIK SNILL+   + ++ADFGL+R    ++ 
Sbjct: 118 IKSFMKQLLE---GLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171

Query: 269 A--ANIRGTFGYLDPE-YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
               N   T  Y  PE  +    +    DV+S G +L EL   +   Q   E  +L
Sbjct: 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL 227

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 87.0 bits (215), Expect = 4e-19
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 20/209 (9%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGY 176
           ++G G +G VYK + + TG+  A+KV+     + E+E + E+ +L +  HHRN+    G 
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 177 CAEKG------QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
             +K       Q  LV  F   GS+   + +     L  +   +I  ++ RGL +LH   
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH--- 138

Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGYLDPEYIST-- 286
              VIHRDIK  N+LL ++   ++ DFG+S +    V +    I GT  ++ PE I+   
Sbjct: 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 197

Query: 287 ---RNFTKKSDVYSFGVLLFELIAGRSPL 312
                +  +SD++S G+   E+  G  PL
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 86.3 bits (213), Expect = 5e-19
 Identities = 73/267 (27%), Positives = 123/267 (46%), Gaps = 27/267 (10%)

Query: 116 FTTL--IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLV 171
           FT L  IG+G+FG VYK     T E VA+K++  +  + E E  Q E+ +L +     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
              G   +  +  ++  ++  GS    L     GPL       I  ++ +GL+YLH    
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHS--- 119

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRNFT 290
              IHRDIK++N+LL +    ++ADFG++ +    +   N   GT  ++ PE I    + 
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179

Query: 291 KKSDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
            K+D++S G+   EL  G  P   L  M  + L   N+             L+G +    
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP----------PTLEGQYS--- 226

Query: 349 LNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                     C+N+ PR RP+ +++++
Sbjct: 227 -KPFKEFVEACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 86.4 bits (214), Expect = 9e-19
 Identities = 90/338 (26%), Positives = 142/338 (42%), Gaps = 92/338 (27%)

Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRL-HHRNLV 171
           +G+GAFG V +A      + ++  TVAVK+L   +   E K   TE+ +L  + HH N+V
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 172 N--------------LVGYC----------------------AEKGQHMLVYVFM----- 190
           N              +V YC                      + + + M           
Sbjct: 75  NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134

Query: 191 ---SKGSLASHLYDENYG----------------PLTWNLRVHIALDVARGLEYLHDGAV 231
              S  S AS  + E+                  PLT    +  +  VARG+E+L   A 
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---AS 191

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSRE-----EMVDKHAANIRGTFGYLDPEYIST 286
              IHRD+ + NILL ++   ++ DFGL+R+     + V K  A  R    ++ PE I  
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA--RLPLKWMAPESIFD 249

Query: 287 RNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEG-KTGWEEIVDSRLDGIF 344
           + +T +SDV+SFGVLL+E+ + G SP  G+    E      EG +    E          
Sbjct: 250 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPE---------- 299

Query: 345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                 E+ S+   C +  P  RP+  ++V++L  +L+
Sbjct: 300 --YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 86.0 bits (213), Expect = 9e-19
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 17/203 (8%)

Query: 119 LIGQGAFGPVYKAQMSTGET-VAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
            +G G FG V+  +    E   A+KV+A       KQ E+    E  +L  + H  ++ L
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVSHPFIIRL 66

Query: 174 VGYCAEKGQHML--VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
             +  E  Q  L  +  ++  G L S+L   N G  + +  +  A ++   LEYLH   +
Sbjct: 67  --FWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLHSKEI 122

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTK 291
              ++RD+K  NILLD+    ++ DFG +++ + D+    + GT  YL PE I ++   K
Sbjct: 123 ---VYRDLKPENILLDKEGHIKLTDFGFAKK-LRDR-TWTLCGTPEYLAPEVIQSKGHNK 177

Query: 292 KSDVYSFGVLLFELIAGRSPLQG 314
             D ++ G+L++E++ G  P   
Sbjct: 178 AVDWWALGILIYEMLVGYPPFFD 200

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 11/206 (5%)

Query: 115 NFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
           NF  ++G+G+FG V  A+   T E  A+K+L  D    + + +    E  +L        
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62

Query: 171 VNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +  +  C +    +  V  +++ G L   +  +  G       V  A ++A GL +LH  
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLMYQI--QQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRGTFGYLDPEYISTRN 288
            +   I+RD+K  N++LD     ++ADFG+ +E M D        GT  Y+ PE I+ + 
Sbjct: 121 GI---IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP 177

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
           + K  D ++FGVLL+E++AG++P +G
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 75/302 (24%), Positives = 126/302 (41%), Gaps = 50/302 (16%)

Query: 115 NFTTLIGQGAFGPVYKAQM----------------STGET-VAVKVLATD-SKQGEKEFQ 156
           NF   +G+G FG V+  +                 +     VAVKVL  D S    ++F 
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67

Query: 157 TEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD---------ENYGPL 207
            EV +L RL   N+  L+G C       ++  +M  G L   L            N   L
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267
           +++  +++A  +A G+ YL        +HRD+ + N L+ ++   ++ADFG+SR  +   
Sbjct: 128 SFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRN-LYSS 183

Query: 268 HAANIRGT----FGYLDPEYISTRNFTKKSDVYSFGVLLFEL--IAGRSPLQGLM-EYVE 320
               ++G       ++  E +    FT KSDV++FGV L+E+  +    P + L  + V 
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI 243

Query: 321 LAAMNTEGKTGWEEIVDSR---LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
             A +     G +  +         I++         L  +C  R    RP+ R+I   L
Sbjct: 244 ENAGHFFRDDGRQIYLPRPPNCPKDIYE---------LMLECWRRDEEDRPTFREIHLFL 294

Query: 378 SR 379
            R
Sbjct: 295 QR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 89/344 (25%), Positives = 138/344 (40%), Gaps = 97/344 (28%)

Query: 119 LIGQGAFGPVYKAQM------STGETVAVKVL---ATDSKQGEKEFQTEVMLLGRL-HHR 168
           ++G GAFG V +A        S+  TVAVK+L   AT S+   K   +E+ +L  + +H 
Sbjct: 14  VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEH--KALMSELKILIHIGNHL 71

Query: 169 NLVNL--------------VGYC-------------------AEKGQHMLVYVF------ 189
           N+VNL              V +C                    EK               
Sbjct: 72  NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS 131

Query: 190 ----MSKGSLASHLYDENY------------------GPLTWNLRVHIALDVARGLEYLH 227
                 +   AS L+                       PLT    +  +  VARG+E+L 
Sbjct: 132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL- 190

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYI 284
             A    IHRD+ + NILL ++   ++ DFGL+R+   D       + R    ++ PE I
Sbjct: 191 --ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248

Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI 343
             + +T +SDV+SFGVLL+E+ + G SP  G+        +N       EE      DG 
Sbjct: 249 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ-------IN-------EEFCQRLKDGT 294

Query: 344 -FDVEELN--EVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR 384
                E    E+  +   C    P++RP+   +V++L  +L+  
Sbjct: 295 RMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQEN 338

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 60/194 (30%), Positives = 100/194 (51%), Gaps = 12/194 (6%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +G G  G VYKA  + T   +AVKV+  D + + +K+  +E+ +L +     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
             + +  +   FM  GSL      + Y  +  ++   IA+ V +GL YL       ++HR
Sbjct: 69  FVENRISICTEFMDGGSL------DVYRKIPEHVLGRIAVAVVKGLTYLWS---LKILHR 119

Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
           D+K SN+L++   + ++ DFG+S + +V+  A    GT  Y+ PE IS   +   SDV+S
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQ-LVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWS 178

Query: 298 FGVLLFELIAGRSP 311
            G+   EL  GR P
Sbjct: 179 LGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 85.3 bits (212), Expect = 2e-18
 Identities = 68/227 (29%), Positives = 106/227 (46%), Gaps = 63/227 (27%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL------ATDSKQGEKEFQTEVMLLGRL-HHRNLV 171
           +G+GA+G V+KA    T E VA+K +      ATD+   ++ F+ E+M L  L  H N+V
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDA---QRTFR-EIMFLQELGDHPNIV 70

Query: 172 NLVG-YCAEKGQHM-LVYVFMS--------KGSLASHLYDENYGPLTWNLRVH---IALD 218
            L+    AE  + + LV+ +M            L                 VH   I   
Sbjct: 71  KLLNVIKAENDKDIYLVFEYMETDLHAVIRANIL---------------EDVHKRYIMYQ 115

Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY 278
           + + L+Y+H G V   IHRD+K SNILL+   R ++ADFGL+R        + +      
Sbjct: 116 LLKALKYIHSGNV---IHRDLKPSNILLNSDCRVKLADFGLARS------LSELEENPEN 166

Query: 279 LD-PEYISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
               +Y++TR             +TK  D++S G +L E++ G+ PL
Sbjct: 167 PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK-PL 212

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 73/274 (26%), Positives = 128/274 (46%), Gaps = 27/274 (9%)

Query: 119 LIGQGAFGPVYKA-QMSTGET----VAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE     VA+KVL  + S +  KE   E  ++  +    +  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L+G C       LV   M  G L  ++  EN   +     ++  + +A+G+ YL +    
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYV-RENKDRIGSQDLLNWCVQIAKGMSYLEE---V 128

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNF 289
            ++HRD+ + N+L+      ++ DFGL+R   +D+   HA   +    ++  E I  R F
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188

Query: 290 TKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
           T +SDV+S+GV ++EL+  G  P  G+    E+  +  +G+   +  + +          
Sbjct: 189 THQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTI--------- 238

Query: 349 LNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             +V  +  KC       RP  R++V   SR+ +
Sbjct: 239 --DVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 83.9 bits (208), Expect = 5e-18
 Identities = 66/230 (28%), Positives = 99/230 (43%), Gaps = 41/230 (17%)

Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVK-VLATDSKQGEKEF----QTEVMLLGRLHHR 168
                +G+G FG VYKA Q+ TG  VA+K +L  + K G   F      E+ +L +L H 
Sbjct: 11  EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHP 67

Query: 169 NLVNLVGYCAEKG---QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVH--------IAL 217
           N+V L+    E+    +     V+M      +   D +   L  N  V           L
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYM-----VTPYMDHDLSGLLENPSVKLTESQIKCYML 122

Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
            +  G+ YLH+  +   +HRDIK++NIL+D     ++ADFGL+R            G  G
Sbjct: 123 QLLEGINYLHENHI---LHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179

Query: 278 ------------YLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
                       Y  PE +   R +T   D++  G +  E+   R  LQG
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 83.1 bits (205), Expect = 5e-18
 Identities = 69/226 (30%), Positives = 112/226 (49%), Gaps = 29/226 (12%)

Query: 120 IGQGAFGPVYKA--QMSTGE-TVAVKVLATDSKQG--EKEFQTEVMLLGRLHHRNLVNLV 174
           +G G FG V K   +M   E TVAVK+L  D+     + E   E  ++ +L +  +V ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 175 GYCAEKGQHMLVYVFMSKGSLAS------HLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           G C E    MLV      G L        H+ ++N   L     VH    V+ G++YL +
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITEL-----VH---QVSMGMKYLEE 113

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT----FGYLDPEYI 284
                 +HRD+ + N+LL     A+++DFGLS+    D++    +        +  PE +
Sbjct: 114 TNF---VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170

Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
           +   F+ KSDV+SFGVL++E  + G+ P +G M+  E+  M   G+
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGE 215

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 83.2 bits (205), Expect = 6e-18
 Identities = 77/295 (26%), Positives = 134/295 (45%), Gaps = 48/295 (16%)

Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQM---STGE---TVAVKVLATDSKQG--EKEFQTEV 159
           ++  +T  F   +G+  FG VYK  +   + GE    VA+K L  D  +G   +EF+ E 
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEA 59

Query: 160 MLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLY-----------DENY---G 205
           M+  RL H N+V L+G   ++    +++ + S   L   L            D++     
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 206 PLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265
            L     VHI   +A G+E+L       V+H+D+ + N+L+   +  +++D GL RE   
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFRE--- 173

Query: 266 DKHAANIRGTFG-------YLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEY 318
             +AA+     G       ++ PE I    F+  SD++S+GV+L+E+ +      GL  Y
Sbjct: 174 -VYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS-----YGLQPY 227

Query: 319 VELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDI 373
              +  +        E++ +R       +    V +L  +C N  P +RP  +DI
Sbjct: 228 CGYSNQDV------IEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 83.0 bits (206), Expect = 7e-18
 Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 47/216 (21%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT--------EVMLLGRL-HHRN 169
           +G G FG VY A+   TGE VA+K +       +K+F +        EV  L +L  H N
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD- 228
           +V L     E  +   V+ +M +G+L   + D    P + ++   I   + +GL ++H  
Sbjct: 60  IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR- 287
           G      HRD+K  N+L+      ++ADFGL+RE         IR    Y D  Y+STR 
Sbjct: 119 G----FFHRDLKPENLLVSGPEVVKIADFGLARE---------IRSRPPYTD--YVSTRW 163

Query: 288 -----------NFTKKSDVYSFGVLLFELIAGRSPL 312
                      +++   D+++ G ++ EL   R PL
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYTLR-PL 198

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 83.4 bits (206), Expect = 8e-18
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 21/210 (10%)

Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLV 174
           ++G+G+FG V  A++  +G   AVKVL  D    + + +   TE  +L    +   +  +
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 175 GYCAEKGQHML-VYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHD 228
             C +    +  V  F++ G L  H+     +DE             A ++   L +LHD
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-------YAAEITSALMFLHD 114

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTR 287
             +   I+RD+K  N+LLD     ++ADFG+ +E + + K  +   GT  Y+ PE +   
Sbjct: 115 KGI---IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEM 171

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
            +    D ++ GVLL+E++ G +P +   E
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 82.7 bits (205), Expect = 8e-18
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 20/203 (9%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT--EVMLLGRLHHRNLVNLVGY 176
           IG+GA G V+KA+   TGETVA+K +A    +G    Q   E+  L    H  +V L+  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 177 CAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
               G    LV  +M    L+  L DE   PL           + +G+ Y+H   +   +
Sbjct: 68  FPH-GSGFVLVMEYMP-SDLSEVLRDEER-PLPEAQVKSYMRMLLKGVAYMHANGI---M 121

Query: 236 HRDIKSSNILLDQSMRARVADFGLSR-----EEMVDKHAANIRGTFGYLDPEYI-STRNF 289
           HRD+K +N+L+      ++ADFGL+R     E  +  H      T  Y  PE +   R +
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV---ATRWYRAPELLYGARKY 178

Query: 290 TKKSDVYSFGVLLFELIAGRSPL 312
               D+++ G +  EL+ G SPL
Sbjct: 179 DPGVDLWAVGCIFAELLNG-SPL 200

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 83.3 bits (206), Expect = 9e-18
 Identities = 64/201 (31%), Positives = 97/201 (48%), Gaps = 13/201 (6%)

Query: 118 TLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVM-----LLGRLHHRNLV 171
            +IG+G+FG V  A+  + G+  AVKVL   +   +KE Q  +M     LL  + H  LV
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLV 59

Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            L        +   V  +++ G L  HL  E   P     R + A ++A  L YLH    
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-RARFYAA-EIASALGYLHS--- 114

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYLDPEYISTRNFT 290
             +I+RD+K  NILLD      + DFGL +E +   K  +   GT  YL PE +  + + 
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174

Query: 291 KKSDVYSFGVLLFELIAGRSP 311
           +  D +  G +L+E++ G  P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 83.2 bits (205), Expect = 1e-17
 Identities = 81/265 (30%), Positives = 120/265 (45%), Gaps = 30/265 (11%)

Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           IG G+FG VY A  S T E VAVK ++   KQ  +++Q    EV  L +L H N +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
            C  K     + +    GS AS L + +  PL       I     +GL YLH   +   I
Sbjct: 89  -CYLKEHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM---I 143

Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN---FTKK 292
           HRDIK+ NILL +  + ++ADFG +        A +  GT  ++ PE I   +   +  K
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSAS---KSSPANSFVGTPYWMAPEVILAMDEGQYDGK 200

Query: 293 SDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
            DV+S G+   EL   + PL  +  M  +   A N        E  DS   G  D     
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDS-FRGFVDY---- 255

Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQ 375
                   C+ + P++RP+  ++++
Sbjct: 256 --------CLQKIPQERPASAELLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 61/237 (25%), Positives = 110/237 (46%), Gaps = 41/237 (17%)

Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGET-----------------VAVKVLATD-SK 149
              +    F   +G+G FG V+  ++   +                  VAVK+L  D +K
Sbjct: 1   KFPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK 60

Query: 150 QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL----ASHLYDENYG 205
               +F  EV +L RL   N++ L+G C ++    ++  +M  G L    +SH  D+   
Sbjct: 61  NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEE 120

Query: 206 P-------------LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA 252
                         ++++  +H+AL +A G++YL   +    +HRD+ + N L+ +++  
Sbjct: 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTI 177

Query: 253 RVADFGLSREEMV-DKHAANIRGTFG--YLDPEYISTRNFTKKSDVYSFGVLLFELI 306
           ++ADFG+SR     D +    R      ++  E I    FT  SDV++FGV L+E++
Sbjct: 178 KIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 22/215 (10%)

Query: 105 SYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT-EVMLL 162
           ++K L+K        +G+G +  VYK +  +TGE VA+K +  D+++G       E+ L+
Sbjct: 1   NFKQLEK--------LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLM 52

Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFMS---KGSLASHLYDENYGPLTWNLRVHIALDV 219
             L H N+V L      + + MLV+ +M    K  + +H      G L  N        +
Sbjct: 53  KELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTH---GVRGALDPNTVKSFTYQL 109

Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA-ANIRGTFGY 278
            +G+ + H+  V   +HRD+K  N+L+++    ++ADFGL+R   +  +  +N   T  Y
Sbjct: 110 LKGIAFCHENRV---LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWY 166

Query: 279 LDPE-YISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
             P+  + +R ++   D++S G ++ E+I GR PL
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR-PL 200

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 72/279 (25%), Positives = 129/279 (46%), Gaps = 33/279 (11%)

Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGE-KEFQTEV 159
           PE  +  L+K        IG+G+FG V+K     T + VA+K++  +  + E ++ Q E+
Sbjct: 2   PEELFTKLEK--------IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI 53

Query: 160 MLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDV 219
            +L +     +    G   +  +  ++  ++  GS    L     GPL       I  ++
Sbjct: 54  TVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREI 110

Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGY 278
            +GL+YLH       IHRDIK++N+LL +    ++ADFG++ +    +   N   GT  +
Sbjct: 111 LKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 167

Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMNTEGKTGWEEIV 336
           + PE I    +  K+D++S G+   EL  G  P   L  M+ + L   N           
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP--------- 218

Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
              L+G +  + L E       C+N+ P  RP+ +++++
Sbjct: 219 -PTLEGNYS-KPLKEFVE---ACLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 83.2 bits (205), Expect = 2e-17
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 18/201 (8%)

Query: 187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL 246
           Y   +   + + L D+    LT    +     VARG+E+L   A    +HRD+ + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270

Query: 247 DQSMRARVADFGLSREEMVDKHAANIRGTF---GYLDPEYISTRNFTKKSDVYSFGVLLF 303
            Q    ++ DFGL+R+ M D +  +   TF    ++ PE I    +T  SDV+S+G+LL+
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330

Query: 304 ELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNR 362
           E+ + G +P  G++  V+    N + K+G+     ++ D         EV  +  KC N 
Sbjct: 331 EIFSLGGTPYPGMI--VDSTFYN-KIKSGYRM---AKPD-----HATQEVYDIMVKCWNS 379

Query: 363 APRKRPSMRDIVQVLSRILKM 383
            P KRPS   +  ++  +L  
Sbjct: 380 EPEKRPSFLHLSDIVESLLPS 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 68/234 (29%), Positives = 110/234 (47%), Gaps = 39/234 (16%)

Query: 91  KRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSK 149
           K   +VS  G P+  Y   +K        IGQGA G VY A  ++TG+ VA+K +    +
Sbjct: 7   KLRTIVSV-GDPKKKYTRFEK--------IGQGASGTVYTAIDVATGQEVAIKQMNL-QQ 56

Query: 150 QGEKEFQ-TEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDE--NYGP 206
           Q +KE    E++++    H N+VN +       +  +V  +++ GSL   + +   + G 
Sbjct: 57  QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ 116

Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL------- 259
           +    R     +  + LE+LH   V   IHRDIKS NILL      ++ DFG        
Sbjct: 117 IAAVCR-----ECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168

Query: 260 --SREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
              R  MV        GT  ++ PE ++ + +  K D++S G++  E++ G  P
Sbjct: 169 QSKRSTMV--------GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 23/205 (11%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           L+G+G++G V K +   TG+ VA+K    + D K  +K    E+ +L +L H NLVNL+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENY-GPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
               K +  LV+ F+    L      E Y   L  +        + RG+E+ H   +   
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSHNI--- 121

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSR------EEMVDKHAANIRGTFGYLDPEY-ISTR 287
           IHRDIK  NIL+ QS   ++ DFG +R      E   D  A     T  Y  PE  +   
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-----TRWYRAPELLVGDT 176

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPL 312
            + +  D+++ G L+ E++ G  PL
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTG-EPL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 42/224 (18%)

Query: 120 IGQGAFGPVYKAQMSTGET---VAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNLVNL 173
           IG+G +G VYKA+   G+     A+K    D +Q     Q+   E+ LL  L H N+V+L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 174 VGYCAEKGQHMLVYVF------------MSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           V    E     +  +F              + +    +       L W +     L+   
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI-----LN--- 119

Query: 222 GLEYLHDGAVPPVIHRDIKSSNILL--DQSMRARV--ADFGLSREEMVD---KHAANIRG 274
           G+ YLH   V   +HRD+K +NIL+  +   R  V   D GL+R  + +   K  A++  
Sbjct: 120 GVHYLHSNWV---LHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDP 174

Query: 275 ---TFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
              T  Y  PE +   R++TK  D+++ G +  EL+      +G
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 60/213 (28%), Positives = 108/213 (50%), Gaps = 27/213 (12%)

Query: 119 LIGQGAFGPVYKA-QMSTGET----VAVKVLATDSKQGEKEFQ--TEVML-LGRLHHRNL 170
           L+G G FG V+K   +  G++    VA+K +    + G + FQ  T+ ML +G L H  +
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAMGSLDHAYI 71

Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           V L+G C       LV      GSL  H+  ++   L     ++  + +A+G+ YL +  
Sbjct: 72  VRLLGICP-GASLQLVTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQIAKGMYYLEEHR 129

Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPEY 283
           +   +HR++ + NILL      ++ADFG++       ++    +H   I+    ++  E 
Sbjct: 130 M---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK----WMALES 182

Query: 284 ISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
           I    +T +SDV+S+GV ++E+++ G  P  G+
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 81.1 bits (200), Expect = 3e-17
 Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 28/212 (13%)

Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLV 174
           +IG+G FG VY  + + TG+  A+K L       KQGE     E ++L  +   +   +V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVH----------IALDVARGLE 224
             C       + Y F +   L+  L   N G L ++L  H           A ++  GLE
Sbjct: 61  --C-------MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE 111

Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYI 284
           ++H+  V   ++RD+K +NILLD+    R++D GL+ +    K  A++ GT GY+ PE +
Sbjct: 112 HMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVL 167

Query: 285 ST-RNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
                +   +D +S G +LF+L+ G SP +  
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 81.7 bits (201), Expect = 3e-17
 Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 34/281 (12%)

Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---T 157
           PE  + DL++        IG G+FG VY A+ + T E VA+K ++   KQ  +++Q    
Sbjct: 23  PEKLFTDLRE--------IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK 74

Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL 217
           EV  L R+ H N +   G C  +     + +    GS AS L + +  PL       I  
Sbjct: 75  EVKFLQRIKHPNSIEYKG-CYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAITH 132

Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
              +GL YLH   +   IHRDIK+ NILL +  + ++ADFG +    +   A +  GT  
Sbjct: 133 GALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSAS---IASPANSFVGTPY 186

Query: 278 YLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEE 334
           ++ PE I   +   +  K DV+S G+   EL   + PL            N    +    
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-----------FNMNAMSALYH 235

Query: 335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
           I  +    +   E  +   +    C+ + P+ RP+  ++++
Sbjct: 236 IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 81.8 bits (203), Expect = 4e-17
 Identities = 67/236 (28%), Positives = 95/236 (40%), Gaps = 70/236 (29%)

Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQT---------EVMLLGR 164
                IG GA+G V  A    TG  VA+K +          F           E+ LL  
Sbjct: 3   ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRH 55

Query: 165 LHHRNLVNLVGYCAEKGQHML----------VYV---FMSKGSLASHLYDENYGPLTWNL 211
           L H N++ L+         +L          VY+    M    L   +      PLT   
Sbjct: 56  LRHENIIGLL--------DILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQ--PLT--- 101

Query: 212 RVHIAL---DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268
             HI      + RGL+YLH   V   IHRD+K SNIL++ +   ++ DFGL+R    D+ 
Sbjct: 102 DDHIQYFLYQILRGLKYLHSANV---IHRDLKPSNILVNSNCDLKICDFGLARGVDPDE- 157

Query: 269 AANIRGTFGYLDPEYISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
                   G+L  EY+ TR             +TK  D++S G +  EL+  + PL
Sbjct: 158 -----DEKGFLT-EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK-PL 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 56/194 (28%), Positives = 103/194 (53%), Gaps = 13/194 (6%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G GAFG VYKA+   TG   A KV+ T S++  +++  E+ +L   +H  +V L+G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
             G+  ++  F   G++ + + + + G     ++V I   +   L+YLH      +IHRD
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIHRD 135

Query: 239 IKSSNILLDQSMRARVADFGLSREEM--VDKHAANIRGTFGYLDPEYISTRN-----FTK 291
           +K+ N+LL      ++ADFG+S + +  + +  + I GT  ++ PE +         +  
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTPYDY 194

Query: 292 KSDVYSFGVLLFEL 305
           K+D++S G+ L E+
Sbjct: 195 KADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 83.7 bits (207), Expect = 4e-17
 Identities = 65/273 (23%), Positives = 121/273 (44%), Gaps = 25/273 (9%)

Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +I +G  G  YK +        ++ +  +         +E+  +G+L H N+V L+G C 
Sbjct: 697 VISRGKKGASYKGKSIKNG---MQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCR 753

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            +    L++ ++   +L+  L +     L+W  R  IA+ +A+ L +LH    P V+  +
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808

Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSF 298
           +    I++D      +    LS   ++         +  Y+ PE   T++ T+KSD+Y F
Sbjct: 809 LSPEKIIIDGKDEPHLR---LSLPGLLCTDTKCFISS-AYVAPETRETKDITEKSDIYGF 864

Query: 299 GVLLFELIAGRSPL-------QGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV--EEL 349
           G++L EL+ G+SP          ++E+      +      W   +D  + G   V   E+
Sbjct: 865 GLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM-W---IDPSIRGDVSVNQNEI 920

Query: 350 NEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
            EV +LA  C    P  RP   D+++ L    +
Sbjct: 921 VEVMNLALHCTATDPTARPCANDVLKTLESASR 953

Length = 968

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 80.5 bits (198), Expect = 6e-17
 Identities = 70/275 (25%), Positives = 132/275 (48%), Gaps = 36/275 (13%)

Query: 120 IGQGAFGPVYKAQMSTG------ET-VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLV 171
           +GQG+FG VY+  ++ G      ET VA+K +   +   E+ EF  E  ++   +  ++V
Sbjct: 14  LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLY--------DENYGPLTWNLRVHIALDVARGL 223
            L+G  ++    +++   M++G L S+L         +    P +    + +A ++A G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANIRGTFG--YLD 280
            YL+       +HRD+ + N ++ +    ++ DFG++R+    D +    +G     ++ 
Sbjct: 133 AYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189

Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SDV+SFGV+L+E+      P QG M   ++     EG  G  +  D+ 
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-MSNEQVLRFVMEG--GLLDKPDNC 246

Query: 340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIV 374
            D +F++  +         C    P+ RPS  +I+
Sbjct: 247 PDMLFELMRM---------CWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 80.7 bits (200), Expect = 6e-17
 Identities = 66/237 (27%), Positives = 104/237 (43%), Gaps = 33/237 (13%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKE---FQT--EVMLLGRLHHRNLVN 172
            +G+G +  VYKA    TG  VA+K +    ++  K+   F    E+ LL  L H N++ 
Sbjct: 7   KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHI---ALDVARGLEYLHDG 229
           L+     K    LV+ FM    L   +  +    LT      I    L   RGLEYLH  
Sbjct: 67  LLDVFGHKSNINLVFEFME-TDL-EKVIKDKSIVLT---PADIKSYMLMTLRGLEYLHSN 121

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSR------EEMVDKHAANIRGTFGYLDPEY 283
            +   +HRD+K +N+L+      ++ADFGL+R       +M  +       T  Y  PE 
Sbjct: 122 WI---LHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-----TRWYRAPEL 173

Query: 284 I-STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVEL----AAMNTEGKTGWEEI 335
           +   R++    D++S G +  EL+     L G  +  +L     A+ T  +  W  +
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 80.1 bits (197), Expect = 7e-17
 Identities = 69/262 (26%), Positives = 124/262 (47%), Gaps = 20/262 (7%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           IG G +G VYKA+ ++TGE  A+KV+  +  +     Q E++++    H N+V   G   
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            + +  +   F   GSL   +Y    GPL+ +   +++ +  +GL YLH       +HRD
Sbjct: 77  RRDKLWICMEFCGGGSLQD-IYHVT-GPLSESQIAYVSRETLQGLYYLHSKGK---MHRD 131

Query: 239 IKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGYLDPEYISTR---NFTKKS 293
           IK +NILL  +   ++ADFG+S +    + K  + I GT  ++ PE  +      + +  
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYNQLC 190

Query: 294 DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVA 353
           D+++ G+   EL   + P+  L     L  M T+      ++ D        ++  N   
Sbjct: 191 DIWAVGITAIELAELQPPMFDLHPMRALFLM-TKSNFQPPKLKDK-------MKWSNSFH 242

Query: 354 SLAYKCVNRAPRKRPSMRDIVQ 375
                 + + P+KRP+   ++Q
Sbjct: 243 HFVKMALTKNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 80.6 bits (199), Expect = 8e-17
 Identities = 61/196 (31%), Positives = 94/196 (47%), Gaps = 11/196 (5%)

Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V  A+   TGE  A+K L        K+ Q    E  +L  L H  +VN++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              ++ +   +  F+  G L +HL     G    ++      ++    EYLH   +   I
Sbjct: 86  SFQDENRVYFLLEFVVGGELFTHL--RKAGRFPNDVAKFYHAELVLAFEYLHSKDI---I 140

Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+LLD     +V DFG +++  V      + GT  YL PE I ++   K  D 
Sbjct: 141 YRDLKPENLLLDNKGHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQSKGHGKAVDW 198

Query: 296 YSFGVLLFELIAGRSP 311
           ++ GVLL+E IAG  P
Sbjct: 199 WTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 28/207 (13%)

Query: 120 IGQGAFGPVYKAQMSTGETVA---VKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           IG G FG V   +   G + A   VK L A+ +   +  F  EV     L+H N++  +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDEN---YGPLTWNLRVHIALDVARGLEYLHDGAVP 232
            C E   ++LV  F   G L ++L             ++   +A +VA GL +LH     
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSRE-------EMVDKHAANIRGTFGYLDPEYIS 285
             IH D+   N  L   +  ++ D+GL+ E          D HA  +R    +L PE + 
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----WLAPELVE 175

Query: 286 TR-------NFTKKSDVYSFGVLLFEL 305
            R       + TKKS+++S GV ++EL
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 79.4 bits (195), Expect = 1e-16
 Identities = 78/298 (26%), Positives = 136/298 (45%), Gaps = 49/298 (16%)

Query: 91  KRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSK 149
           K  ++VS  G P+  Y   +K        IGQGA G VY A  ++TG+ VA++ +    +
Sbjct: 8   KLRSIVSV-GDPKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58

Query: 150 QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDE--NYGPL 207
             ++    E++++    + N+VN +       +  +V  +++ GSL   + +   + G +
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 118

Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL-------- 259
               R     +  + LE+LH   V   IHRDIKS NILL      ++ DFG         
Sbjct: 119 AAVCR-----ECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170

Query: 260 -SREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEY 318
             R  MV        GT  ++ PE ++ + +  K D++S G++  E+I G  P    +  
Sbjct: 171 SKRSTMV--------GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP---YLNE 219

Query: 319 VELAAMNTEGKTGWEEIVD-SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
             L A+      G  E+ +  +L  IF  + LN       +C++    KR S ++++Q
Sbjct: 220 NPLRALYLIATNGTPELQNPEKLSAIFR-DFLN-------RCLDMDVEKRGSAKELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 17/203 (8%)

Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           +G G FG V   ++ S   T A+K +      ++ Q ++   +E  +L   +H  +V L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKLY 59

Query: 175 GYCAEKGQHMLVYVFMSK---GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
               +K ++  +Y+ M     G L + L D       +  R +IA  V    EYLH+  +
Sbjct: 60  RTFKDK-KY--IYMLMEYCLGGELWTILRDRGLFD-EYTARFYIAC-VVLAFEYLHNRGI 114

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTK 291
              I+RD+K  N+LLD +   ++ DFG +++    +      GT  Y+ PE I  + +  
Sbjct: 115 ---IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDF 171

Query: 292 KSDVYSFGVLLFELIAGRSPLQG 314
             D +S G+LL+EL+ GR P   
Sbjct: 172 SVDYWSLGILLYELLTGRPPFGE 194

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 12/196 (6%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           IG+G+ G V  A +  TG+ VAVK +    +Q  +    EV+++   HH N+V++     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
              +  +V  F+  G+L   +    +  +       + L V R L YLH+  V   IHRD
Sbjct: 90  VGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHNQGV---IHRD 143

Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHA---ANIRGTFGYLDPEYISTRNFTKKSDV 295
           IKS +ILL    R +++DFG   +  V K      ++ GT  ++ PE IS   +  + D+
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201

Query: 296 YSFGVLLFELIAGRSP 311
           +S G+++ E+I G  P
Sbjct: 202 WSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 70/266 (26%), Positives = 126/266 (47%), Gaps = 22/266 (8%)

Query: 116 FTTLIGQGAFGPVYKAQMST-GETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
           F  ++G+G++G V   +  T G+   +K L     S++  K  + E  LL +L H N+V 
Sbjct: 4   FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63

Query: 173 LV-GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
               +  E G   +V  F   G L   L ++    L  N  V   + +A  L+YLH+   
Sbjct: 64  YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE--- 120

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTRNF 289
             ++HRD+K+ N+ L ++   +V D G++R  E   D  A+ + GT  Y+ PE  S + +
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM-ASTLIGTPYYMSPELFSNKPY 179

Query: 290 TKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL 349
             KSDV++ G  ++E+   +              MN+        I++ +L  +   +  
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNA-------KDMNSL----VYRIIEGKLPPM-PKDYS 227

Query: 350 NEVASLAYKCVNRAPRKRPSMRDIVQ 375
            E+  L    +++ P KRPS++ I++
Sbjct: 228 PELGELIATMLSKRPEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 34/216 (15%)

Query: 120 IGQGAFGPVYKAQ---------MSTGE------TVAVKVLATD-SKQGEKEFQTEVMLLG 163
           +G+G FG V+  +             E       VAVK+L  D +K    +F  E+ ++ 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 164 RLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL----------YDENYGPLTWNLRV 213
           RL + N++ L+G C       ++  +M  G L   L          +  N   ++    +
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 214 HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR 273
           ++A+ +A G++YL   A    +HRD+ + N L+      ++ADFG+SR  +       I+
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR-NLYSGDYYRIQ 188

Query: 274 G----TFGYLDPEYISTRNFTKKSDVYSFGVLLFEL 305
           G       ++  E I    FT  SDV++FGV L+E+
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 22/207 (10%)

Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +IG+G FG VY  + + TG+  A+K L    K+  K  Q E +    L+ R +++LV   
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETL---ALNERIMLSLVSTG 54

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVH----------IALDVARGLEYLH 227
                  + Y F +   L   L   N G L ++L  H           A ++  GLE++H
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH 114

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
           +  V   ++RD+K +NILLD+    R++D GL+ +    K  A++ GT GY+ PE +   
Sbjct: 115 NRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKG 170

Query: 288 N-FTKKSDVYSFGVLLFELIAGRSPLQ 313
             +   +D +S G +LF+L+ G SP +
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFR 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 59/266 (22%), Positives = 118/266 (44%), Gaps = 33/266 (12%)

Query: 120 IGQGAFGP--VYKAQMSTGETVAVKV-LATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           +G+GAFG   +Y+        V  +V L   S++  ++   E+++L  L H N++    +
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 177 CAEKGQHMLVYVFMSKGSLA-------SHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
             +    ++   + + G+L          L++E    + W L       +   + Y+H  
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEM--VLWYL-----FQIVSAVSYIHKA 120

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRGTFGYLDPEYISTRN 288
            +   +HRDIK+ NI L ++   ++ DFG+S+    +   A  + GT  Y+ PE      
Sbjct: 121 GI---LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
           +  KSD+++ G +L+EL+     L+   +      +  +   G    V S          
Sbjct: 178 YNFKSDIWALGCVLYELLT----LKRTFDATNPLNLVVKIVQGNYTPVVSVYS------- 226

Query: 349 LNEVASLAYKCVNRAPRKRPSMRDIV 374
            +E+ SL +  + + P KRP+  +++
Sbjct: 227 -SELISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 72/235 (30%), Positives = 112/235 (47%), Gaps = 42/235 (17%)

Query: 106 YKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQGEKEFQT----EV 159
           Y+ L K        IGQG FG V+KA+   T + VA+K VL  + K+G   F      E+
Sbjct: 14  YEKLAK--------IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREI 62

Query: 160 MLLGRLHHRNLVNLVGYCAE--------KGQHMLVYVFMSKGSLASHLYDENYGPLTWNL 211
            +L  L H N+VNL+  C          KG   LV+ F     LA  L   +   + + L
Sbjct: 63  KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL---SNKNVKFTL 118

Query: 212 RV--HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269
                +   +  GL Y+H   +   +HRD+K++NIL+ +    ++ADFGL+R   + K++
Sbjct: 119 SEIKKVMKMLLNGLYYIHRNKI---LHRDMKAANILITKDGILKLADFGLARAFSLSKNS 175

Query: 270 ANIR-----GTFGYLDPE-YISTRNFTKKSDVYSFGVLLFELIAGRSPL-QGLME 317
              R      T  Y  PE  +  R++    D++  G ++ E+   RSP+ QG  E
Sbjct: 176 KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTE 229

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 78.8 bits (194), Expect = 3e-16
 Identities = 67/202 (33%), Positives = 98/202 (48%), Gaps = 14/202 (6%)

Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           IG+G FG VY+ +   T    A+KVL+      +KE      E  +L R        +VG
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 176 --YCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
             +  +    + LV  +MS G L  HL  E         + +IA ++   LE+LH     
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-RAKFYIA-ELVLALEHLHKY--- 115

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPE-YISTRNFT 290
            +++RD+K  NILLD +    + DFGLS+  + D    N   GT  YL PE  +  + +T
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175

Query: 291 KKSDVYSFGVLLFELIAGRSPL 312
           K  D +S GVL+FE+  G SP 
Sbjct: 176 KHVDFWSLGVLVFEMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 78.0 bits (193), Expect = 4e-16
 Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 42/229 (18%)

Query: 104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-FQT---- 157
             Y+ L +        I +G +G VY+A+   TGE VA+K L  +    EKE F      
Sbjct: 5   DEYEKLNR--------IEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFPITSLR 53

Query: 158 EVMLLGRLHHRNLVNL----VGYCAEKGQHMLVYVFMS------KGSLASHLYDENYGPL 207
           E+ +L +L H N+V +    VG   +K     +Y+ M       K      L +    P 
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLDK-----IYMVMEYVEHDLKS-----LMETMKQPF 103

Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVD 266
             +    + L +  G+ +LHD  +   +HRD+K+SN+LL+     ++ DFGL+RE     
Sbjct: 104 LQSEVKCLMLQLLSGVAHLHDNWI---LHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160

Query: 267 KHAANIRGTFGYLDPE-YISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           K    +  T  Y  PE  +  + ++   D++S G +  EL+  +    G
Sbjct: 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 77.9 bits (192), Expect = 4e-16
 Identities = 69/213 (32%), Positives = 104/213 (48%), Gaps = 22/213 (10%)

Query: 115 NFTTL--IGQGAFGPVYKAQM----STGETVAVKVL-----ATDSKQGEKEFQTEVMLLG 163
           NF  L  +G GA+G V+  +       G+  A+KVL        +K  E   +TE  +L 
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT-RTERQVLE 59

Query: 164 RLHHRN-LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARG 222
            +     LV L        +  L+  +++ G L +HLY   +   +  +RV+IA ++   
Sbjct: 60  AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLA 117

Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANIRGTFGYLD 280
           L++LH   +   I+RDIK  NILLD      + DFGLS+E + ++   A +  GT  Y+ 
Sbjct: 118 LDHLHQLGI---IYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Query: 281 PEYIST--RNFTKKSDVYSFGVLLFELIAGRSP 311
           PE I        K  D +S GVL FEL+ G SP
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 77/281 (27%), Positives = 132/281 (46%), Gaps = 42/281 (14%)

Query: 120 IGQGAFGPVYKA---QMSTGET---VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
           +GQG+FG VY+     +  GE    VAVK +   +   E+ EF  E  ++      ++V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 173 LVGYCAEKGQHMLVYV-FMSKGSLASHLY------DENYGPLTWNLR--VHIALDVARGL 223
           L+G  + KGQ  LV +  M+ G L S+L       + N G     L+  + +A ++A G+
Sbjct: 74  LLGVVS-KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANIRGTF--GYLD 280
            YL+       +HRD+ + N ++      ++ DFG++R+    D +    +G     ++ 
Sbjct: 133 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SD++SFGV+L+E+ +    P QGL                 E+++   
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------------EQVLKFV 234

Query: 340 LDGIFDVEELN---EVASLAYKCVNRAPRKRPSMRDIVQVL 377
           +DG +  +  N    V  L   C    P+ RP+  +IV +L
Sbjct: 235 MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.5 bits (191), Expect = 5e-16
 Identities = 67/281 (23%), Positives = 124/281 (44%), Gaps = 39/281 (13%)

Query: 119 LIGQGAFGPVYKAQM--STGETVAVK-------VLATDSKQGEKEFQ---TEVMLLG-RL 165
            +G GAFG VYK +   +    +A+K           D ++ +K      +EV ++  +L
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGPLT----WNLRVHIALDV 219
            H N+V       E  +  +V   +    L  H     E     T    WN+ V + L  
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL-- 124

Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL 279
              L YLH      ++HRD+  +NI+L +  +  + DFGL++++  +    ++ GT  Y 
Sbjct: 125 --ALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180

Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
            PE +    + +K+DV++FG +L+++      LQ       + ++ T       +IV++ 
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCT----LQPPFYSTNMLSLAT-------KIVEAV 229

Query: 340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
            + + +     +V  +   C+      RP   DI+QV + I
Sbjct: 230 YEPLPEGMYSEDVTDVITSCLTPDAEARP---DIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 29/234 (12%)

Query: 88  EGFKRS-NVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLA 145
           E F+ +  +V   G P     +  K        IG+G+ G V  A   STG  VAVK + 
Sbjct: 2   EQFRAALQLVVDPGDPRSYLDNFVK--------IGEGSTGIVCIATDKSTGRQVAVKKMD 53

Query: 146 TDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYG 205
              +Q  +    EV+++    H N+V +        +  +V  F+  G+L          
Sbjct: 54  LRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-------- 105

Query: 206 PLTWNLRVH------IALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL 259
            +  + R++      + L V + L +LH   V   IHRDIKS +ILL    R +++DFG 
Sbjct: 106 -IVTHTRMNEEQIATVCLAVLKALSFLHAQGV---IHRDIKSDSILLTSDGRVKLSDFGF 161

Query: 260 SREEMVD-KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
             +   +     ++ GT  ++ PE IS   +  + D++S G+++ E++ G  P 
Sbjct: 162 CAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 77.5 bits (190), Expect = 6e-16
 Identities = 60/225 (26%), Positives = 111/225 (49%), Gaps = 21/225 (9%)

Query: 91  KRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSK 149
           K  ++VS  G P+  Y   +K        IGQGA G VY A  ++TG+ VA+K +    +
Sbjct: 7   KLRSIVSV-GDPKKKYTRFEK--------IGQGASGTVYTAIDIATGQEVAIKQMNLQQQ 57

Query: 150 QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDE--NYGPL 207
             ++    E++++    + N+VN +       +  +V  +++ GSL   + +   + G +
Sbjct: 58  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 117

Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267
               R     +  + L++LH   V   IHRDIKS NILL      ++ DFG   +   ++
Sbjct: 118 AAVCR-----ECLQALDFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169

Query: 268 HA-ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
              + + GT  ++ PE ++ + +  K D++S G++  E++ G  P
Sbjct: 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 78.1 bits (193), Expect = 7e-16
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 28/210 (13%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG GA+G V  A    +G+ VA+K +  A D     K    E+ +L    H N++ +   
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72

Query: 177 CAEKGQHML-VYVFMS-KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
               G     VYV M    S   H+   +  PLT     +    + RGL+Y+H   V   
Sbjct: 73  LRPPGADFKDVYVVMDLMESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANV--- 128

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR------- 287
           IHRD+K SN+L+++    R+ DFG++R        ++      Y   EY++TR       
Sbjct: 129 IHRDLKPSNLLVNEDCELRIGDFGMARG------LSSSPTEHKYFMTEYVATRWYRAPEL 182

Query: 288 -----NFTKKSDVYSFGVLLFELIAGRSPL 312
                 +T   D++S G +  E++ GR  L
Sbjct: 183 LLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 77.0 bits (189), Expect = 8e-16
 Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 11/199 (5%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G GAFG VYKAQ   TG   A KV+ T S++  +++  E+ +L    H N+V L+    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            +    ++  F + G++ + +  E   PLT      +       L YLH+  +   IHRD
Sbjct: 73  YENNLWILIEFCAGGAVDAVML-ELERPLTEPQIRVVCKQTLEALNYLHENKI---IHRD 128

Query: 239 IKSSNILLDQSMRARVADFGLS-REEMVDKHAANIRGTFGYLDPEYI-----STRNFTKK 292
           +K+ NIL       ++ADFG+S +     +   +  GT  ++ PE +       R +  K
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 188

Query: 293 SDVYSFGVLLFELIAGRSP 311
           +DV+S G+ L E+     P
Sbjct: 189 ADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.3 bits (190), Expect = 9e-16
 Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 27/213 (12%)

Query: 119 LIGQGAFGPVYKA-QMSTGET----VAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLV 171
           ++G GAFG VYK   +  GE     VA+K L  AT S +  KE   E  ++  + + ++ 
Sbjct: 14  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVC 72

Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYL 226
            L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL
Sbjct: 73  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 125

Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEY 283
            +  +   +HRD+ + N+L+      ++ DFGL++    D+   HA   +    ++  E 
Sbjct: 126 EERRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182

Query: 284 ISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
           I  R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 77.4 bits (190), Expect = 9e-16
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 14/201 (6%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLV 174
           L+G+G FG V    + ++G+  A+K+L  +    + E     TE  +L    H  L +L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
                K +   V  +++ G L  HL  E     + +       ++   L+YLH G +   
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERV--FSEDRTRFYGAEIVSALDYLHSGKI--- 116

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLDPEYISTRNFTK 291
           ++RD+K  N++LD+    ++ DFGL +E + D  AA ++   GT  YL PE +   ++ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 292 KSDVYSFGVLLFELIAGRSPL 312
             D +  GV+++E++ GR P 
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 77.1 bits (189), Expect = 1e-15
 Identities = 59/229 (25%), Positives = 111/229 (48%), Gaps = 22/229 (9%)

Query: 88  EGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLAT 146
           E  ++   + + G P+  Y   +K        IGQGA G V+ A  ++TG+ VA+K +  
Sbjct: 3   EIMEKLRTIVSIGDPKKKYTRYEK--------IGQGASGTVFTAIDVATGQEVAIKQINL 54

Query: 147 DSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP 206
             +  ++    E++++  L + N+VN +       +  +V  +++ GSL   + +     
Sbjct: 55  QKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE----- 109

Query: 207 LTWNLRVHIAL---DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263
            T      IA    +  + LE+LH   V   IHRDIKS N+LL      ++ DFG   + 
Sbjct: 110 -TCMDEAQIAAVCRECLQALEFLHANQV---IHRDIKSDNVLLGMDGSVKLTDFGFCAQI 165

Query: 264 MVDKHA-ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
             ++   + + GT  ++ PE ++ + +  K D++S G++  E++ G  P
Sbjct: 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 64/233 (27%), Positives = 97/233 (41%), Gaps = 47/233 (20%)

Query: 118 TLIGQGAFGPVYKAQMS-TGETVAVKVLATD----SKQGEKEFQTEVMLLGRLHHRNLVN 172
            +IG+GAFG V+  +   TG+  A+KVL         Q     + E  +L       +V 
Sbjct: 7   KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVK 65

Query: 173 LVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-G 229
           L  Y + + +  L  V  +M  G L + L  ++  P     R +IA  V   L+ +H  G
Sbjct: 66  L--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVL-ALDSVHKLG 121

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS----------------------------- 260
                IHRDIK  NIL+D     ++ADFGL                              
Sbjct: 122 ----FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177

Query: 261 REEMVDKHAAN-IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
           R+    +  AN   GT  Y+ PE +    +  + D +S GV+L+E++ G  P 
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 27/204 (13%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT---------EVMLLGRLHHRN 169
           +G GAFG V  A+   TG+ VA+K +        K F T         E+ LL  L H N
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIM-------KPFSTPVLAKRTYRELKLLKHLRHEN 70

Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +++L        + +     +    L   L      PL      +    + RGL+Y+H  
Sbjct: 71  IISLSDIFISPLEDIYFVTELLGTDLHRLL---TSRPLEKQFIQYFLYQILRGLKYVHSA 127

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST-RN 288
            V   +HRD+K SNIL++++   ++ DFGL+R +  D        T  Y  PE + T + 
Sbjct: 128 GV---VHRDLKPSNILINENCDLKICDFGLARIQ--DPQMTGYVSTRYYRAPEIMLTWQK 182

Query: 289 FTKKSDVYSFGVLLFELIAGRSPL 312
           +  + D++S G +  E++ G+ PL
Sbjct: 183 YDVEVDIWSAGCIFAEMLEGK-PL 205

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 62/216 (28%), Positives = 108/216 (50%), Gaps = 21/216 (9%)

Query: 120 IGQGAFGPVYKA--QMSTGET-VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVG 175
           +G G FG V K   +M   +  VA+KVL  ++++  + E   E  ++ +L +  +V ++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
            C E    MLV    S G L   L  +       N+ V +   V+ G++YL        +
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNV-VELMHQVSMGMKYLEGKNF---V 117

Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG-----YLDPEYISTRNFT 290
           HRD+ + N+LL     A+++DFGLS+    D      R + G     +  PE I+ R F+
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR-SAGKWPLKWYAPECINFRKFS 176

Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGL-----MEYVE 320
            +SDV+S+G+ ++E  + G+ P + +     M ++E
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE 212

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 23/218 (10%)

Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---T 157
           PE  + DL++        IG G+FG VY A+ +   E VA+K ++   KQ  +++Q    
Sbjct: 13  PEKLFSDLRE--------IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64

Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL 217
           EV  L +L H N +   G C  +     + +    GS AS L + +  PL       +  
Sbjct: 65  EVRFLQKLRHPNTIQYRG-CYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTH 122

Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
              +GL YLH   +   IHRD+K+ NILL +    ++ DFG +    +   A    GT  
Sbjct: 123 GALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSAS---IMAPANXFVGTPY 176

Query: 278 YLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPL 312
           ++ PE I   +   +  K DV+S G+   EL   + PL
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 75.9 bits (186), Expect = 2e-15
 Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 13/202 (6%)

Query: 116 FTTL--IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLV 171
           FT L  IG+G+FG V+K     T + VA+K++  +  + E E  Q E+ +L +     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
              G   +  +  ++  ++  GS    L     GP        +  ++ +GL+YLH    
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLL---RAGPFDEFQIATMLKEILKGLDYLHS--- 119

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA--NIRGTFGYLDPEYISTRNF 289
              IHRDIK++N+LL +    ++ADFG++  ++ D         GT  ++ PE I    +
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178

Query: 290 TKKSDVYSFGVLLFELIAGRSP 311
             K+D++S G+   EL  G  P
Sbjct: 179 DSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 12/196 (6%)

Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           IG+G+ G V  A + S+G+ VAVK +    +Q  +    EV+++    H N+V +     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
              +  +V  F+  G+L   +    +  +       + L V + L  LH   V   IHRD
Sbjct: 88  VGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALSVLHAQGV---IHRD 141

Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHA---ANIRGTFGYLDPEYISTRNFTKKSDV 295
           IKS +ILL    R +++DFG   +  V K      ++ GT  ++ PE IS   +  + D+
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDI 199

Query: 296 YSFGVLLFELIAGRSP 311
           +S G+++ E++ G  P
Sbjct: 200 WSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 62/197 (31%), Positives = 92/197 (46%), Gaps = 10/197 (5%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           IG+G+FG V +  +  T    A+K +      S+        E  +L +++   +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
                 +  LV  F++ G L  HL  E    L+   R + A ++   LE LH   V   I
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLS-RARFYTA-ELLCALENLHKFNV---I 115

Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYISTRNFTKKSD 294
           +RD+K  NILLD      + DFGL +  M D    N   GT  YL PE +    +TK  D
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175

Query: 295 VYSFGVLLFELIAGRSP 311
            ++ GVLL+E++ G  P
Sbjct: 176 WWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 77.6 bits (191), Expect = 4e-15
 Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 22/196 (11%)

Query: 135 TGETVAVKVLATDSKQGEKE---FQTEVMLLGRLHHRNLVNLV--GYCAEKGQHMLVYVF 189
           TG  VA+K+L TD+ + E +   F+ E  L  RL+H N+V L+  G     G    V+ +
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60

Query: 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS 249
           +   +L   L     G L       + L V   L   H+  +   +HRD+K  NI++ Q+
Sbjct: 61  VPGRTLREVL--AADGALPAGETGRLMLQVLDALACAHNQGI---VHRDLKPQNIMVSQT 115

Query: 250 ---MRARVADFGLS------REEMVDK--HAANIRGTFGYLDPEYISTRNFTKKSDVYSF 298
                A+V DFG+       R+  V        + GT  Y  PE +     T  SD+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 299 GVLLFELIAGRSPLQG 314
           G++  E + G+  +QG
Sbjct: 176 GLIFLECLTGQRVVQG 191

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 75.2 bits (185), Expect = 5e-15
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 10/198 (5%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLV 174
           L+G+G FG V    + +TG+  A+K+L  +    + E     TE  +L    H  L  L 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
                  +   V  + + G L  HL  E     + +       ++   L YLH   V   
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDV--- 116

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTRNFTKKS 293
           ++RD+K  N++LD+    ++ DFGL +E + D        GT  YL PE +   ++ +  
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176

Query: 294 DVYSFGVLLFELIAGRSP 311
           D +  GV+++E++ GR P
Sbjct: 177 DWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 69/272 (25%), Positives = 125/272 (45%), Gaps = 27/272 (9%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK---VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           IG+G F  VY+A  +   + VA+K   +      +  ++   E+ LL +L+H N++  + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-YDENYGPL-----TWNLRVHIALDVARGLEYLHDG 229
              E  +  +V      G L+  + Y +    L      W   V +       +E++H  
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEHMHSR 125

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRGTFGYLDPEYISTRN 288
            V   +HRDIK +N+ +  +   ++ D GL R       AA ++ GT  Y+ PE I    
Sbjct: 126 RV---MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
           +  KSD++S G LL+E+ A +SP  G  + + L ++  +     E+     L      E+
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLFSLCQK----IEQCDYPPLPTEHYSEK 236

Query: 349 LNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           L E+ S+   C+   P +RP +  + Q+  ++
Sbjct: 237 LRELVSM---CIYPDPDQRPDIGYVHQIAKQM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 74.7 bits (184), Expect = 6e-15
 Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 17/206 (8%)

Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLA-TDSKQGEKEFQTEVMLLGRLHH-RNLVNLVG 175
            IG G  G VYK +   TG  +AVK +  T +K+  K    ++ ++ + H    +V   G
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81

Query: 176 YCAEKGQHMLVYVFMSK-GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           Y         V++ M    +    L     GP+  ++   + + + + L YL +     V
Sbjct: 82  YFITDSD---VFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GV 136

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR--GTFGYLDPEYISTRNFTKK 292
           IHRD+K SNILLD S   ++ DFG+S   +VD   A  R  G   Y+ PE I   +   K
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGIS-GRLVDSK-AKTRSAGCAAYMAPERIDPPDPNPK 194

Query: 293 ----SDVYSFGVLLFELIAGRSPLQG 314
               +DV+S G+ L EL  G+ P + 
Sbjct: 195 YDIRADVWSLGISLVELATGQFPYKN 220

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 74.4 bits (183), Expect = 6e-15
 Identities = 77/279 (27%), Positives = 128/279 (45%), Gaps = 50/279 (17%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL-ATDSKQGEKEFQTEVMLLGR-LHHRNLVNLVGY 176
           +G+GA+G V K + + TG  +AVK + AT + Q +K    ++ +  R +     V   G 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 177 CAEKGQHMLVYVFMS--KGSLASHLYDENYGPLTWNLRV------HIALDVARGLEYLHD 228
              +G    V++ M     SL    Y + Y      L +       IA+ + + LEYLH 
Sbjct: 69  LFREGD---VWICMEVMDTSL-DKFYKKVYDK---GLTIPEDILGKIAVSIVKALEYLHS 121

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYI--- 284
                VIHRD+K SN+L++++ + ++ DFG+S   +VD  A  I  G   Y+ PE I   
Sbjct: 122 KL--SVIHRDVKPSNVLINRNGQVKLCDFGIS-GYLVDSVAKTIDAGCKPYMAPERINPE 178

Query: 285 -STRNFTKKSDVYSFGVLLFELIAGR-------SPLQGLMEYVELAAMNTEGKTGWEEIV 336
            + + +  KSDV+S G+ + EL  GR       +P Q L + VE  +     +    E  
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQ 238

Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
           D                    KC+ +  ++RP+  +++Q
Sbjct: 239 D-----------------FVNKCLKKNYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 27/216 (12%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKV--LATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K   L T+++        E+ LL  L+H N+V L+  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 68  IHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 123

Query: 237 RDIKSSNILLDQSMRARVADFGLSR----------EEMVDKHAANIRGTFGYLDPE-YIS 285
           RD+K  N+L++     ++ADFGL+R           E+V         T  Y  PE  + 
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEILLG 174

Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
            + ++   D++S G +  E++  R+   G  E  +L
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 20/217 (9%)

Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVM 160
           P++ Y+ +Q+        +G G +G VYKA+ + TGE  AVK++  +        Q E+ 
Sbjct: 7   PQHDYELIQR--------VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIF 58

Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++    H N+V   G    + +  +   +   GSL   +Y    GPL+     ++  +  
Sbjct: 59  MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVT-GPLSELQIAYVCRETL 116

Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGY 278
           +GL YLH       +HRDIK +NILL  +   ++ADFG++ +    + K  + I GT  +
Sbjct: 117 QGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYW 172

Query: 279 LDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPL 312
           + PE  +      + +  D+++ G+   EL   + P+
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 7/195 (3%)

Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +G G  G V K Q   +G  +A K++  + K     +   E+ +L   +   +V   G  
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
              G+  +    M  GSL   L +    P     +V IA  V RGL YL +     ++HR
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKH--QIMHR 128

Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
           D+K SNIL++     ++ DFG+S  +++D  A +  GT  Y+ PE +   +++ +SD++S
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 187

Query: 298 FGVLLFELIAGRSPL 312
            G+ L EL  GR P+
Sbjct: 188 MGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 49/220 (22%)

Query: 115 NFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQT---------EVMLLGR 164
              + +G GA+G V  A  + TG  VA+K L+       + FQ+         E+ LL  
Sbjct: 18  QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKH 70

Query: 165 LHHRNLVNLV-----GYCAEKGQHMLVYVFMSKGSLASHLYDENYG------PLTWNLRV 213
           + H N++ L+         E  Q   VY+         HL   +         L+ +   
Sbjct: 71  MDHENVIGLLDVFTPASSLEDFQD--VYLVT-------HLMGADLNNIVKCQKLSDDHIQ 121

Query: 214 HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAA 270
            +   + RGL+Y+H   +   IHRD+K SNI +++    ++ DFGL+R   +EM    A 
Sbjct: 122 FLVYQILRGLKYIHSAGI---IHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVA- 177

Query: 271 NIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGR 309
               T  Y  PE + +  ++ +  D++S G ++ EL+ G+
Sbjct: 178 ----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 66/267 (24%), Positives = 117/267 (43%), Gaps = 27/267 (10%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           ++G+G+FG     Q +++ +  A+K +    S    ++ + E +LL ++ H N+V     
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
               G   +V  +   G L   +  +       +  +   + +  G++++H+  V   +H
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV---LH 123

Query: 237 RDIKSSNILLDQSMRARVADFGLSR-EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           RDIKS NI L Q+ + ++ DFG +R       +A    GT  Y+ PE      +  KSD+
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDI 183

Query: 296 YSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN---EV 352
           +S G +L+EL   + P Q                  W+ ++     G +     +   E+
Sbjct: 184 WSLGCILYELCTLKHPFQA---------------NSWKNLILKVCQGSYKPLPSHYSYEL 228

Query: 353 ASLAYKCVNRAPRKRPSMRDIVQVLSR 379
            SL  +   R PR RPS   I   LSR
Sbjct: 229 RSLIKQMFKRNPRSRPSATTI---LSR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 27/209 (12%)

Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQ---TE--VMLLGRLHHRNLVN 172
           ++G+G+FG V  A++  T E  A+KVL  D    + +     TE  ++ L    H  L  
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTA 60

Query: 173 LVGYCAEKGQHMLVYV--FMSKGSLA-----SHLYDENYGPLTWNLRVHIALDVARGLEY 225
           L  +C  + +  L +V  +++ G L      S  +DE             A +V   L +
Sbjct: 61  L--HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-------YAAEVTLALMF 111

Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPEYI 284
           LH   V   I+RD+K  NILLD     ++ADFG+ +E ++         GT  Y+ PE +
Sbjct: 112 LHRHGV---IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL 168

Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
               +    D ++ GVL++E++AG+ P +
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 36/98 (36%), Positives = 61/98 (62%), Gaps = 3/98 (3%)

Query: 215 IALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG 274
           I++ V RGL YL +     ++HRD+K SNIL++     ++ DFG+S  +++D  A +  G
Sbjct: 104 ISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-GQLIDSMANSFVG 160

Query: 275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
           T  Y+ PE +   ++T +SD++S G+ L E+  GR P+
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 30/187 (16%)

Query: 206 PLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265
            LT    +  +  VA+G+E+L   A    IHRD+ + NILL ++   ++ DFGL+R+   
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231

Query: 266 DK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVEL 321
           D       + R    ++ PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E 
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 291

Query: 322 AAMNTEG------KTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                EG           E+  + LD                 C +  P +RP+  ++V+
Sbjct: 292 CRRLKEGTRMRAPDYTTPEMYQTMLD-----------------CWHGEPSQRPTFSELVE 334

Query: 376 VLSRILK 382
            L  +L+
Sbjct: 335 HLGNLLQ 341

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 76/274 (27%), Positives = 119/274 (43%), Gaps = 31/274 (11%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           IG+G F  VY+A  +  G  VA+K +      D+K    +   E+ LL +L+H N++   
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK-ARADCIKEIDLLKQLNHPNVIKYY 68

Query: 175 GYCAEKGQHMLVYVFMSKGSLAS---HLYDENY---GPLTWNLRVHIALDVARGLEYLHD 228
               E  +  +V      G L+    H   +         W   V +       LE++H 
Sbjct: 69  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMHS 124

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRGTFGYLDPEYISTR 287
             V   +HRDIK +N+ +  +   ++ D GL R       AA ++ GT  Y+ PE I   
Sbjct: 125 RRV---MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD-SRLDGIFDV 346
            +  KSD++S G LL+E+ A +SP  G         MN        E  D   L      
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYG-------DKMNLYSLCKKIEQCDYPPLPSDHYS 234

Query: 347 EELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           EEL ++ ++   C+N  P KRP +  +  V  R+
Sbjct: 235 EELRQLVNM---CINPDPEKRPDITYVYDVAKRM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 69/203 (33%), Positives = 99/203 (48%), Gaps = 17/203 (8%)

Query: 119 LIGQGAFGPVYKAQMST-GETVAVKVLATDSKQGEKEFQTEVM-----LLGRLHHRNLVN 172
           +IG+G+FG V  A+  + G   AVKVL   +   +KE Q  +M     LL  L H  LV 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVG 60

Query: 173 L--VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           L      AEK   +L YV  + G L  HL  E    L    R + A +VA  + YLH   
Sbjct: 61  LHYSFQTAEKLYFVLDYV--NGGELFFHLQRERCF-LEPRARFYAA-EVASAIGYLHS-- 114

Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYLDPEYISTRNF 289
              +I+RD+K  NILLD      + DFGL +E +  ++  +   GT  YL PE +    +
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPY 173

Query: 290 TKKSDVYSFGVLLFELIAGRSPL 312
            +  D +  G +L+E++ G  P 
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 19/212 (8%)

Query: 115 NFTTL--IGQGAFGPVYKAQMSTG----ETVAVKVL---ATDSKQGEKEF-QTEVMLLGR 164
           NF  L  +G GA+G V+  +  TG    +  A+KVL   A   K    E  +TE  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 165 LHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
           +     +  + Y  +    + L+  ++S G + +HLY  +       +R +   ++   L
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED-EVRFYSG-EIILAL 118

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR--GTFGYLDP 281
           E+LH   +   ++RDIK  NILLD      + DFGLS+E + ++        GT  Y+ P
Sbjct: 119 EHLHKLGI---VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175

Query: 282 EYISTRN-FTKKSDVYSFGVLLFELIAGRSPL 312
           E I  +    K  D +S G+L+FEL+ G SP 
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 72.6 bits (178), Expect = 5e-14
 Identities = 51/168 (30%), Positives = 83/168 (49%), Gaps = 20/168 (11%)

Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH---AANIRGT 275
           VA+G+ +L   A    IHRD+ + NILL      ++ DFGL+R+   D +     N R  
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 276 FGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             ++ PE I    +T +SDV+S+G+LL+E+ + G SP  G+    +   M  EG      
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG------ 333

Query: 335 IVDSRLDGI-FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
               R+        E+ ++      C +  P KRP+ + IVQ++ + L
Sbjct: 334 ---YRMLSPECAPSEMYDIMK---SCWDADPLKRPTFKQIVQLIEQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 64/201 (31%), Positives = 91/201 (45%), Gaps = 13/201 (6%)

Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVM-----LLGRLHHRNLVN 172
           +IG+G+FG V  A+    G+  AVKVL        KE Q  +M     LL  + H  LV 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE-QKHIMAERNVLLKNVKHPFLVG 60

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L        +   V  F++ G L  HL  E   P     R + A ++A  L YLH     
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-RARFYAA-EIASALGYLHS---I 115

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYLDPEYISTRNFTK 291
            +++RD+K  NILLD      + DFGL +E +          GT  YL PE I  + +  
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 292 KSDVYSFGVLLFELIAGRSPL 312
             D +  G +L+E++ G  P 
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 7/195 (3%)

Query: 120 IGQGAFGPVYK-AQMSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +G G  G V+K +   +G  +A K++  + K     +   E+ +L   +   +V   G  
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
              G+  +    M  GSL   L  +  G +   +   +++ V +GL YL +     ++HR
Sbjct: 73  YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 128

Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
           D+K SNIL++     ++ DFG+S  +++D  A +  GT  Y+ PE +   +++ +SD++S
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 187

Query: 298 FGVLLFELIAGRSPL 312
            G+ L E+  GR P+
Sbjct: 188 MGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 70.7 bits (173), Expect = 8e-14
 Identities = 67/282 (23%), Positives = 126/282 (44%), Gaps = 24/282 (8%)

Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQM---STGE-TVAVKVL-ATDSKQGEKEFQTEVMLL 162
           +L   +     ++G G FG + +  +   S  E  VA+  L A  S +  + F  E + L
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60

Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARG 222
           G+  H N+V L G        M+V  +MS G+L S L  ++ G L     + +   +A G
Sbjct: 61  GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMGMLPGLASG 119

Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL--D 280
           ++YL +      +H+ + +  +L++  +  +++ F   +E+  +     + G    L   
Sbjct: 120 MKYLSEMGY---VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAA 176

Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDS-R 339
           PE I   +F+  SDV+SFG++++E+          M Y E    +  G+   + + D  R
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEV----------MSYGERPYWDMSGQDVIKAVEDGFR 226

Query: 340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
           L    +    N +  L   C  +   +RP    I  +LS+++
Sbjct: 227 LPAPRNCP--NLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 71.6 bits (175), Expect = 9e-14
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 14/201 (6%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLV 174
           L+G+G FG V    + +TG   A+K+L  +    + E     TE  +L    H  L  L 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
                  +   V  + + G L  HL  E     T         ++   LEYLH      V
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHS---RDV 116

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLDPEYISTRNFTK 291
           ++RDIK  N++LD+    ++ DFGL +E + D   A ++   GT  YL PE +   ++ +
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 292 KSDVYSFGVLLFELIAGRSPL 312
             D +  GV+++E++ GR P 
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 18/204 (8%)

Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G+G +G VYK     TG T+A+K +  +    E +F   +M L  LH      +V +  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELD--ESKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 179 EKGQHMLVYV---FMSKGSLASHLYDENY--GPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                  VY+   +M  GSL   LY        +  ++   I   V +GL++L +     
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--N 123

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN----- 288
           +IHRD+K +N+L++ + + ++ DFG+S   +      NI G   Y+ PE I +       
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-GCQSYMAPERIKSGGPNQNP 182

Query: 289 -FTKKSDVYSFGVLLFELIAGRSP 311
            +T +SDV+S G+ + E+  GR P
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 63/200 (31%), Positives = 96/200 (48%), Gaps = 11/200 (5%)

Query: 119 LIGQGAFGPVYKAQMSTGETV-AVKVL---ATDSKQGEKEFQTEV-MLLGRLHHRNLVNL 173
           +IG+G+FG V  A+    E   AVKVL   A   K+ EK   +E  +LL  + H  LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                   +   V  +++ G L  HL  E    L    R + A ++A  L YLH      
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCF-LEPRARFYAA-EIASALGYLHS---LN 116

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPEYISTRNFTKK 292
           +++RD+K  NILLD      + DFGL +E +  +   +   GT  YL PE +  + + + 
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176

Query: 293 SDVYSFGVLLFELIAGRSPL 312
            D +  G +L+E++ G  P 
Sbjct: 177 VDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 58/218 (26%), Positives = 89/218 (40%), Gaps = 32/218 (14%)

Query: 118 TLIG----QGAFGPVYKAQMSTGETVAVKVLATDSKQGE--KEFQTEVMLLGRLHHRNLV 171
           TLIG          + K +  T   VAVK +  DS   E  K  Q E++   +L H N++
Sbjct: 4   TLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62

Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNL-RVHIAL---DVARGLEYLH 227
             V       +  +V   M+ GS    L   ++      L  + IA    DV   L+Y+H
Sbjct: 63  PYVTSFIVDSELYVVSPLMAYGS-CEDLLKTHF---PEGLPELAIAFILKDVLNALDYIH 118

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY--------- 278
                  IHR +K+S+ILL    +  ++    S    + KH    R    +         
Sbjct: 119 SKGF---IHRSVKASHILLSGDGKVVLSGLRYSVS--MIKHGKRQRVVHDFPKSSVKNLP 173

Query: 279 -LDPE--YISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
            L PE    + + + +KSD+YS G+   EL  G  P +
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 14/205 (6%)

Query: 119 LIGQGAFGPVYKAQMSTG----ETVAVKVL--ATDSKQGEKEFQT--EVMLLGRLHHRNL 170
           ++G+G +G V++ +  TG    +  A+KVL  AT  +  +    T  E  +L  + H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           V+L+      G+  L+  ++S G L  HL  E  G    +       +++  LE+LH   
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHL--EREGIFMEDTACFYLSEISLALEHLHQQG 120

Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYISTRNF 289
           +   I+RD+K  NILLD     ++ DFGL +E + +    +   GT  Y+ PE +     
Sbjct: 121 I---IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH 177

Query: 290 TKKSDVYSFGVLLFELIAGRSPLQG 314
            K  D +S G L+++++ G  P   
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTA 202

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 8/194 (4%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           IG+G+ G V  A +  +G  VAVK++    +Q  +    EV+++    H+N+V +     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
              +  ++  F+  G+L   +       L       +   V + L YLH   V   IHRD
Sbjct: 89  VGEELWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALCYLHSQGV---IHRD 142

Query: 239 IKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
           IKS +ILL    R +++DFG   +   D     ++ GT  ++ PE IS   +  + D++S
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWS 202

Query: 298 FGVLLFELIAGRSP 311
            G+++ E++ G  P
Sbjct: 203 LGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 72/269 (26%), Positives = 124/269 (46%), Gaps = 49/269 (18%)

Query: 118 TLIGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNL- 173
             +G GA+G V  A    TGE VA+K L+    S+   K    E+ LL  + H N++ L 
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80

Query: 174 -VGYCAEKGQHM----LVYVFMS---KGSLASHLYDENYGPLTWNLRVHIALDVARGLEY 225
            V   A  G       LV  +M    +  +   L ++    L + +          GL+Y
Sbjct: 81  DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM--------LCGLKY 132

Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA-ANIRG---TFGYLDP 281
           +H   +   IHRD+K  N+ +++    ++ DFGL+R      HA A + G   T  Y  P
Sbjct: 133 IHSAGI---IHRDLKPGNLAVNEDCELKILDFGLAR------HADAEMTGYVVTRWYRAP 183

Query: 282 EYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVE--LAAMNTEGKTGWEEIVDS 338
           E I +  ++ +  D++S G ++ E++ G++  +G  +Y++     +   G  G E     
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG-KDYLDQLTQILKVTGVPGPE----- 237

Query: 339 RLDGIFDVEELNEVASLAY-KCVNRAPRK 366
                F V++L + A+ +Y K + + PRK
Sbjct: 238 -----F-VQKLEDKAAKSYIKSLPKYPRK 260

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 68/262 (25%), Positives = 117/262 (44%), Gaps = 23/262 (8%)

Query: 120 IGQGAFGPVYKAQMST-GETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG+G+FG     +    G+   +K +     S +  +E + EV +L  + H N+V     
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
             E G   +V  +   G L   +  +       +  +   + +   L+++HD  +   +H
Sbjct: 68  FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKI---LH 124

Query: 237 RDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
           RDIKS NI L +    ++ DFG++R     V+     I GT  YL PE    R +  KSD
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENRPYNNKSD 183

Query: 295 VYSFGVLLFELIAGRSPLQ-GLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVA 353
           +++ G +L+E+   +   + G M+ + L  +      G    V S     +D+  L  V+
Sbjct: 184 IWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR-----GSYPPVSSHYS--YDLRNL--VS 234

Query: 354 SLAYKCVNRAPRKRPSMRDIVQ 375
            L      R PR RPS+  I++
Sbjct: 235 QL----FKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 69.5 bits (170), Expect = 5e-13
 Identities = 38/158 (24%), Positives = 72/158 (45%), Gaps = 21/158 (13%)

Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLV--------YVFMSKGSLASHLYDENYGPLTW 209
           E MLL  ++H +++ +           +V        Y +++K             PL  
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTK----------RSRPLPI 156

Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269
           +  + I   +  GL YLH   +   IHRD+K+ NI ++   +  + D G ++  +V    
Sbjct: 157 DQALIIEKQILEGLRYLHAQRI---IHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF 213

Query: 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
             + GT     PE ++   +  K+D++S G++LFE++A
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 68.5 bits (168), Expect = 5e-13
 Identities = 63/234 (26%), Positives = 111/234 (47%), Gaps = 39/234 (16%)

Query: 104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQM---STGETVAVK-VLATDSKQGEKEFQTEV 159
           ++ +DL+         IG+GAFG V K  M    +G  +AVK + +T  ++ +K    ++
Sbjct: 1   FTAEDLKD-----LGEIGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53

Query: 160 MLLGRLHHRNLVNLVGY------------CAEKGQHMLVYVFMSKGSLASHLYDENYGPL 207
            ++ R    +   +V +            C E     L+ + + K     ++Y+     +
Sbjct: 54  DVVMR--SSDCPYIVKFYGALFREGDCWICME-----LMDISLDK--FYKYVYEVLKSVI 104

Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267
              +   IA+   + L YL +     +IHRD+K SNILLD++   ++ DFG+S  ++VD 
Sbjct: 105 PEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGIS-GQLVDS 161

Query: 268 HAANIR-GTFGYLDPEYI--STRN-FTKKSDVYSFGVLLFELIAGRSPLQGLME 317
            A     G   Y+ PE I  S R+ +  +SDV+S G+ L+E+  G+ P      
Sbjct: 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS 215

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 68/257 (26%), Positives = 115/257 (44%), Gaps = 24/257 (9%)

Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVGYC 177
           +G+G +  V+K +   T   VA+K +  + ++G       EV LL  L H N+V L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
                  LV+ ++ K  L  ++ D        N+++ +   + RGL Y H   V   +HR
Sbjct: 74  HTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL-YQILRGLAYCHRRKV---LHR 128

Query: 238 DIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPE-YISTRNFTKKSDV 295
           D+K  N+L+++    ++ADFGL+R + V  K  +N   T  Y  P+  + +  ++ + D+
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDM 188

Query: 296 YSFGVLLFELIAGRSPLQGLMEYVEL----AAMNTEGKTGWEEIVDSRLDGIFDVEELNE 351
           +  G + FE+ +GR    G     EL      + T  +  W         GI   +E   
Sbjct: 189 WGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP--------GISSNDEFKN 240

Query: 352 VASLAYK---CVNRAPR 365
                YK    +N APR
Sbjct: 241 YNFPKYKPQPLINHAPR 257

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 68.6 bits (167), Expect = 7e-13
 Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 19/218 (8%)

Query: 105 SYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQT--EVML 161
           SY+ L+K        +G+G++  VYK +    G+ VA+KV+    ++G   F    E  L
Sbjct: 6   SYEKLEK--------LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASL 56

Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           L  L H N+V L      K    LV+ ++    L  ++     G    N+++ +   + R
Sbjct: 57  LKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFL-FQLLR 114

Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA-ANIRGTFGYLD 280
           GL Y+H   +   +HRD+K  N+L+  +   ++ADFGL+R + V  H  +N   T  Y  
Sbjct: 115 GLSYIHQRYI---LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRP 171

Query: 281 PE-YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
           P+  + +  ++   D++  G +  E+I G +   G+ +
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 67.9 bits (166), Expect = 7e-13
 Identities = 67/282 (23%), Positives = 130/282 (46%), Gaps = 49/282 (17%)

Query: 120 IGQGAFGPVYKA----QMSTGET----VAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLV 171
           +GQG F  ++K         GE     V +KVL    +   + F     ++ +L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHL-YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
              G C    + ++V  ++  GSL ++L  ++N   ++W L V  A  +A  L +L D  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV--AKQLAWALHFLEDKG 120

Query: 231 VPPVIHRDIKSSNILLDQSMRA--------RVADFG-----LSREEMVDKHAANIRGTFG 277
           +    H ++ + N+LL +            +++D G     L +E ++++          
Sbjct: 121 LT---HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER--------IP 169

Query: 278 YLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           ++ PE I   +N +  +D +SFG  L+E+ +G     G      L+A++++ K    +  
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFSG-----GDK---PLSALDSQKKL---QFY 218

Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS 378
           + R        +  E+A+L  +C++  P  RPS R I++ L+
Sbjct: 219 EDRHQ--LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 68.5 bits (167), Expect = 7e-13
 Identities = 67/212 (31%), Positives = 99/212 (46%), Gaps = 27/212 (12%)

Query: 120 IGQGAFGPVYK-AQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVG-- 175
           IG+G +G VYK      G   AVK+L   S   E E + E  +L  L +H N+V   G  
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 176 YCAEK---GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV------HIALDVARGLEYL 226
           Y A+K   GQ  LV    + GS+   +     G L    R+      +I      GL++L
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVK----GLLICGQRLDEAMISYILYGALLGLQHL 144

Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYIS 285
           H+  +   IHRD+K +NILL      ++ DFG+S +    +   N   GT  ++ PE I+
Sbjct: 145 HNNRI---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201

Query: 286 TR-----NFTKKSDVYSFGVLLFELIAGRSPL 312
                  ++  + DV+S G+   EL  G  PL
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 68.7 bits (168), Expect = 8e-13
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 22/212 (10%)

Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL---ATDSKQGEKEFQTEVMLLGRLHHRNL 170
           +  +L+G+G FG V    + +TG+  A+KV+      +++    F+ E  +L   +   +
Sbjct: 4   DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWI 63

Query: 171 VNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNL-RVHIALDVARGLEYLHD 228
             L  Y  +   ++ LV  +   G L S L +        ++ + ++A ++   +  +H 
Sbjct: 64  PQLQ-YAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLA-ELVLAIHSVHQ 120

Query: 229 -GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR--GTFGYLDPEYIS 285
            G V    HRDIK  N+L+D++   ++ADFG +     +K   +    GT  Y+ PE ++
Sbjct: 121 MGYV----HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 286 TRNFTKKS------DVYSFGVLLFELIAGRSP 311
           T N   K       D +S GV+ +E+I GRSP
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 16/204 (7%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT--EVMLLGRLH---HRNLVNL 173
           IG GA+G VYKA+   +G  VA+K +   + +      T  EV LL RL    H N+V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 174 VGYCA-----EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +  CA      + +  LV+  + +  L ++L       L       +     RGL++LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
             +   +HRD+K  NIL+    + ++ADFGL+R          +  T  Y  PE +    
Sbjct: 127 NCI---VHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST 183

Query: 289 FTKKSDVYSFGVLLFELIAGRSPL 312
           +    D++S G +  E+   R PL
Sbjct: 184 YATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 68.1 bits (166), Expect = 9e-13
 Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 30/218 (13%)

Query: 115 NFTTL--IGQGAFGPVYKAQM----STGETVAVKVL--ATDSKQGE--KEFQTEVMLLGR 164
           NF  L  +G GA+G V+  +      +G+  A+KVL  AT  ++ +  +  +TE  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 165 LHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALD 218
           +     +  + Y  +    + L+  +++ G L +HL     + E        ++++   +
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ------EVQIYSG-E 113

Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--KHAANIRGTF 276
           +   LE+LH   +   I+RDIK  NILLD +    + DFGLS+E   D  + A +  GT 
Sbjct: 114 IVLALEHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170

Query: 277 GYLDPEYIS--TRNFTKKSDVYSFGVLLFELIAGRSPL 312
            Y+ P+ +        K  D +S GVL++EL+ G SP 
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 28/207 (13%)

Query: 120 IGQGAFGPVYKAQMSTGET---VAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           IG G FG V   ++++G T   V VK L  + S Q + +F  E      L H NL+  +G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGP-LTWNLRV--HIALDVARGLEYLHDGAVP 232
            C E   ++LV  F   G L  +L        +T +      +A ++A GL +LH     
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLS----REE---MVDKHAANIRGTFGYLDPEYIS 285
             IH D+   N LL   +  ++ D+GLS    +E+     D+    +R    ++ PE + 
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR----WIAPELVD 175

Query: 286 -------TRNFTKKSDVYSFGVLLFEL 305
                    + TK+S+V+S GV ++EL
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 27/219 (12%)

Query: 120 IGQGAFGPVYKAQ---MSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLH-HRNLVNL 173
           +GQGA+G V  A+    S  ETVA+K +      K   K    E+ LL     H+N+  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 174 VGY-CAEKGQHMLVYVFMS--KGSLASHLYDENYGPLTWNLRVHIA---LDVARGLEYLH 227
                   G    +Y++    +  L   +      PLT     H       +  GL+Y+H
Sbjct: 68  YDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ--PLT---DAHFQSFIYQILCGLKYIH 122

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR-----EEMVDKHAANIRGTFGYLDPE 282
              V   +HRD+K  N+L++     ++ DFGL+R                  T  Y  PE
Sbjct: 123 SANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179

Query: 283 -YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVE 320
             +S +++TK  DV+S G +L EL+  +   +G  +YV+
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG-KDYVD 217

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 55/215 (25%), Positives = 105/215 (48%), Gaps = 14/215 (6%)

Query: 119 LIGQGAFGPVYKAQMSTGETV-AVKVLATDSKQGEKEF---QTEVMLLGRLHHRN-LVNL 173
           +IG+G++  V   ++   + + A+KV+  +    +++    QTE  +  +      LV L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                   +  LV  +++ G L  H+  +   P   + R + A ++   L +LH+  +  
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLP-EEHARFYAA-EICIALNFLHERGI-- 117

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYLDPEYISTRNFTKK 292
            I+RD+K  N+LLD     ++ D+G+ +E +      +   GT  Y+ PE +    +   
Sbjct: 118 -IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS 176

Query: 293 SDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE 327
            D ++ GVL+FE++AGRSP   + +  +   MNTE
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITDNPD---MNTE 208

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 79/290 (27%), Positives = 124/290 (42%), Gaps = 72/290 (24%)

Query: 118 TLIGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQGEKEFQT-EVMLLGRL---HHRNLV 171
             IG+GA+G VYKA+ ++TG  VA+K V    S++G       E+ LL +L    H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 172 NLVGYCA----EKGQHM-LVYVFMSKGSLASHLYDENY---GPLTWNLRVHIALDVARGL 223
            L+  C     ++   + LV+  + +  LA++L        G     ++  +   + RG+
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL--SKCPKPGLPPETIK-DLMRQLLRGV 120

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEM------VDKHAANIRG 274
           ++LH      ++HRD+K  NIL+    + ++ADFGL+R    EM      V         
Sbjct: 121 DFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--------- 168

Query: 275 TFGYLDPEYI--STRNFTKKSDVYSFGVLLFELIAGRSPL-QGLMEYVELAAMNTEGKTG 331
           T  Y  PE +  S+       D++S G +  EL   R PL +G           +E    
Sbjct: 169 TLWYRAPEVLLQSSYATP--VDMWSVGCIFAEL-FRRRPLFRG----------TSEAD-- 213

Query: 332 WEEIVDSRLDGIFDV------EELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                  +LD IFDV      EE     SL          +  S +  V 
Sbjct: 214 -------QLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPR--SFKSFVP 254

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 53/200 (26%), Positives = 101/200 (50%), Gaps = 11/200 (5%)

Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEF---QTEVMLLGRL-HHRNLVNL 173
           +IG+G++  V   ++  T    A+KV+  +    +++    QTE  +  +  +H  LV L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                 + +   V  +++ G L  H+  +   P   + R + A +++  L YLH+  +  
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-EEHARFYSA-EISLALNYLHERGI-- 117

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYLDPEYISTRNFTKK 292
            I+RD+K  N+LLD     ++ D+G+ +E +      +   GT  Y+ PE +   ++   
Sbjct: 118 -IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176

Query: 293 SDVYSFGVLLFELIAGRSPL 312
            D ++ GVL+FE++AGRSP 
Sbjct: 177 VDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 12/216 (5%)

Query: 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEF---QTEVMLLGRL-HHRNLVN 172
            +IG+G++  V   ++  T    A+KV+  +    +++    QTE  +     +H  LV 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      + +   V  F+S G L  H+  +   P   + R + A +++  L +LH+  + 
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLP-EEHARFYSA-EISLALNFLHERGI- 117

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTRNFTK 291
             I+RD+K  N+LLD     ++ D+G+ +E +      +   GT  Y+ PE +   ++  
Sbjct: 118 --IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE 327
             D ++ GVL+FE++AGRSP   ++   +    NTE
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD-IVGMSDNPDQNTE 210

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 35/222 (15%)

Query: 116 FTTLIGQGAFGPVYKAQMSTGET-----------------VAVKVLATDS-KQGEKEFQT 157
           F   +G+G FG V+  +    E                  VAVK+L  D+ K    +F  
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68

Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL---------YDENYGPLT 208
           E+ ++ RL   N++ L+  C       ++  +M  G L   L            +   ++
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 209 WNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268
           ++  + +A  +A G++YL   +    +HRD+ + N L+ ++   ++ADFG+SR  +    
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR-NLYSGD 184

Query: 269 AANIRG----TFGYLDPEYISTRNFTKKSDVYSFGVLLFELI 306
              I+G       ++  E I    FT  SDV++FGV L+E++
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 38/218 (17%)

Query: 115 NFTTLIGQGAFGPVYKAQMSTGETV-AVKVLATDS--KQGEKEF---QTEVMLLGRLHHR 168
           +   +IG+GAFG V   +  + + V A+K+L+     K+ +  F   + ++M      H 
Sbjct: 46  DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA-----HA 100

Query: 169 N---LVNLVGYCA---EKGQHMLVYVFMSKGSLASHLYDENYG-PLTWNLRVHIALDVAR 221
           N   +V L  + A   +K  +M V  +M  G L + +   NY  P  W  R + A +V  
Sbjct: 101 NSEWIVQL--HYAFQDDKYLYM-VMEYMPGGDLVNLM--SNYDIPEKWA-RFYTA-EVVL 153

Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFG----LSREEMVDKHAANIRGTFG 277
            L+ +H       IHRD+K  N+LLD+S   ++ADFG    +    MV        GT  
Sbjct: 154 ALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV--RCDTAVGTPD 208

Query: 278 YLDPEYISTRN----FTKKSDVYSFGVLLFELIAGRSP 311
           Y+ PE + ++     + ++ D +S GV L+E++ G +P
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 13/201 (6%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLV 174
           L+G+G FG V    + +TG   A+K+L  +    + E     TE  +L    H  L  L 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
                  +   V  + + G L  HL  E     + +       ++   L+YLH  +   V
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLH--SEKNV 117

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLDPEYISTRNFTK 291
           ++RD+K  N++LD+    ++ DFGL +E + D   A ++   GT  YL PE +   ++ +
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGR 175

Query: 292 KSDVYSFGVLLFELIAGRSPL 312
             D +  GV+++E++ GR P 
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 35/223 (15%)

Query: 106 YKDLQKATCNFTTLIGQGAFGPV-YKAQMSTGETVAVKVLAT--DSKQGEKEFQTEVMLL 162
           Y+DL++        +G GA+G V       TG  VA+K L     S+   K    E+ LL
Sbjct: 17  YRDLKQ--------VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 68

Query: 163 GRLHHRNLVNLVG-YCAEKG-----QHMLVYVFMSK--GSLASH--LYDENYGPLTWNLR 212
             + H N++ L+  +  +          LV  FM    G L  H  L ++    L + + 
Sbjct: 69  KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM- 127

Query: 213 VHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI 272
                   +GL+Y+H   +   IHRD+K  N+ +++    ++ DFGL+R+   D      
Sbjct: 128 -------LKGLKYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQ--TDSEMTGY 175

Query: 273 RGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
             T  Y  PE I +  ++T+  D++S G ++ E++ G+   +G
Sbjct: 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 9/199 (4%)

Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVGYC 177
           +G+G +  VYK +   T   VA+K +  + ++G       EV LL  L H N+V L    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
             +    LV+ ++ K  L  +L D        N+++ +   + RGL Y H      V+HR
Sbjct: 74  HTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCHR---RKVLHR 128

Query: 238 DIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPE-YISTRNFTKKSDV 295
           D+K  N+L+++    ++ADFGL+R + +  K  +N   T  Y  P+  + + +++ + D+
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDM 188

Query: 296 YSFGVLLFELIAGRSPLQG 314
           +  G + +E+  GR    G
Sbjct: 189 WGVGCIFYEMSTGRPLFPG 207

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 54/223 (24%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQT-------EVMLLGRLHHRNL 170
            IG+GA+G V  A    TG  VA+K      K    E QT       E+ +L R  H N+
Sbjct: 12  YIGEGAYGMVCSATHKPTGVKVAIK------KISPFEHQTFCQRTLREIKILRRFKHENI 65

Query: 171 VNLVG-YCAEKGQHM----LVYVFMS----KGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           + ++        +      +V   M     K     HL +++     +         + R
Sbjct: 66  IGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ--------ILR 117

Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
           GL+Y+H   V   +HRD+K SN+LL+ +   ++ DFGL+R             T G+L  
Sbjct: 118 GLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLAR-----IADPEHDHT-GFL-T 167

Query: 282 EYISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
           EY++TR             +TK  D++S G +L E+++ R PL
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G V+KA+   T E VA+K V   D  +G       E+ LL  L H+N+V L  Y
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL--Y 65

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                   L  VF          +D   G +   +       + +GL + H   V   +H
Sbjct: 66  DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV---LH 122

Query: 237 RDIKSSNILLDQSMRARVADFGLSREE--MVDKHAANIRGTFGYLDPEYI-STRNFTKKS 293
           RD+K  N+L++++   ++ADFGL+R     V  ++A +  T  Y  P+ +   + ++   
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSI 181

Query: 294 DVYSFGVLLFELIAGRSPL 312
           D++S G +  EL     PL
Sbjct: 182 DMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 77/284 (27%), Positives = 116/284 (40%), Gaps = 41/284 (14%)

Query: 113 TCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNL 170
           T      IG+G +G V+K      G   AVK+L       E E + E  +L  L  H N+
Sbjct: 19  TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE-EIEAEYNILKALSDHPNV 77

Query: 171 VNLVGYCAEKG-----QHMLVYVFMSKGSLASHLYDENYGPLTWNLRV------HIALDV 219
           V   G   +K      Q  LV    + GS+     D   G L    R+      +I  + 
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVT----DLVKGFLKRGERMEEPIIAYILHEA 133

Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGY 278
             GL++LH       IHRD+K +NILL      ++ DFG+S +    +   N   GT  +
Sbjct: 134 LMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 190

Query: 279 LDPEYISTR-----NFTKKSDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMNTEGKTG 331
           + PE I+        +  + DV+S G+   EL  G  PL  L  M  +     N      
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH 250

Query: 332 WEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
             E+  +         E N+      KC+ +   KRP++ D++Q
Sbjct: 251 QPELWSN---------EFNDFIR---KCLTKDYEKRPTVSDLLQ 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 66.7 bits (163), Expect = 4e-12
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 32/218 (14%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G G+ G V+ A      + VAVK +     Q  K    E+ ++ RL H N+V +     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 179 EKGQHM-----------LVYVFMS--KGSLASHLYDENYGPLTWNLRVHIALDVARGLEY 225
             G  +            VY+     +  LA+ L     GPL+          + RGL+Y
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVL---EQGPLSEEHARLFMYQLLRGLKY 129

Query: 226 LHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLSREEMVDKHAANIRG-------TFG 277
           +H   V   +HRD+K +N+ ++   +  ++ DFGL+R  +VD H ++ +G       T  
Sbjct: 130 IHSANV---LHRDLKPANVFINTEDLVLKIGDFGLAR--IVDPHYSH-KGYLSEGLVTKW 183

Query: 278 YLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           Y  P  + S  N+TK  D+++ G +  E++ G+    G
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 34/220 (15%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLVG 175
           IG+G +G VYKA+   T ET+A+K +  + ++ E    T   E+ LL  + H N+V L  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLE-QEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV--HIALDVARGLEYLHDGAVPP 233
               + +  LV+ ++    L  H+  ++      N R+       + RG+ Y H   V  
Sbjct: 69  VVHSEKRLYLVFEYLDL-DLKKHM--DSSPDFAKNPRLIKTYLYQILRGIAYCHSHRV-- 123

Query: 234 VIHRDIKSSNILLDQSMRA-RVADFGLSR----------EEMVDKHAANIRGTFGYLDPE 282
            +HRD+K  N+L+D+   A ++ADFGL+R           E+V         T  Y  PE
Sbjct: 124 -LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV---------TLWYRAPE 173

Query: 283 -YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
             + +R+++   D++S G +  E++  +    G  E  EL
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL 213

Length = 294

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 65/244 (26%), Positives = 104/244 (42%), Gaps = 33/244 (13%)

Query: 105 SYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVK--VLATDSKQGEKEFQTEVML 161
           +Y+ L+K        IG+G +G VYKA+  +TG+ VA+K   L  D +        E+ L
Sbjct: 2   AYEKLEK--------IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISL 53

Query: 162 LGRLHHRN----LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYG----PLTWNLRV 213
           L  L        L+++     + G+  L  VF    S      D N      PL      
Sbjct: 54  LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIK 113

Query: 214 HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-MRARVADFGLSREEM--VDKHAA 270
                + +G+ + H   V   +HRD+K  N+L+D+     ++AD GL R     V  +  
Sbjct: 114 SFMYQLLKGVAHCHKHGV---MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170

Query: 271 NIRGTFGYLDPE-YISTRNFTKKSDVYSFGVLLFELI------AGRSPLQGLMEYVELAA 323
            I  T  Y  PE  + + +++   D++S G +  E+        G S LQ L+   +L  
Sbjct: 171 EIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229

Query: 324 MNTE 327
             TE
Sbjct: 230 TPTE 233

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 6e-12
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 17/207 (8%)

Query: 116 FTTL--IGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRN 169
           F  L  +GQG +G V+ A+   TGE VA+K +           +   TE  +L       
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 170 LVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWN-LRVHIALDVARGLEYLH 227
           LV L+ Y  +  +++ L   ++  G   + L   N G L+ +  R ++A      ++ LH
Sbjct: 63  LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AVDALH 118

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
           +      IHRD+K  N L+D S   ++ DFGLS+   +  +A ++ G+  Y+ PE +  +
Sbjct: 119 ELGY---IHRDLKPENFLIDASGHIKLTDFGLSKG--IVTYANSVVGSPDYMAPEVLRGK 173

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQG 314
            +    D +S G +L+E + G  P  G
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSG 200

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 68/294 (23%), Positives = 132/294 (44%), Gaps = 35/294 (11%)

Query: 62  ILSDSTVGPESPVKSGRNG------NGKSMWLEGFKRSNVVSASGIPEYSYK-DLQKA-- 112
           I  D  +  E   K+ + G      N K +  E    +N        E     D+ ++  
Sbjct: 6   IDEDINIYEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPN 65

Query: 113 -TCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
            +     +IG G+FG VY+A  + T E VA+K +  D +   +E    ++++  L+H N+
Sbjct: 66  KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRE----LLIMKNLNHINI 121

Query: 171 VNLVGY----CAEKGQ-HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHI----ALDVAR 221
           + L  Y    C +K + ++ + V M       H Y ++Y      L + +    +  + R
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181

Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVDKHAANIRGTFGYLD 280
            L Y+H   +    HRD+K  N+L+D  +   ++ DFG ++  +  + + +   +  Y  
Sbjct: 182 ALAYIHSKFI---CHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRA 238

Query: 281 PE-YISTRNFTKKSDVYSFGVLLFELI------AGRSPLQGLMEYVELAAMNTE 327
           PE  +   N+T   D++S G ++ E+I      +G+S +  L+  +++    TE
Sbjct: 239 PELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292

Length = 440

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 66.8 bits (163), Expect = 7e-12
 Identities = 45/145 (31%), Positives = 72/145 (49%), Gaps = 27/145 (18%)

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRNFT 290
           +IHRDIKS+NILL  +   ++ DFG S+     + D       GT  Y+ PE    + ++
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223

Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD----- 345
           KK+D++S GVLL+EL+  + P  G         M        EE++   L G +D     
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFDG-------ENM--------EEVMHKTLAGRYDPLPPS 268

Query: 346 -VEELNEVASLAYKCVNRAPRKRPS 369
              E+ E+ +     ++  P++RPS
Sbjct: 269 ISPEMQEIVTA---LLSSDPKRRPS 290

Length = 496

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 11/200 (5%)

Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVGYC 177
           +G+G +  V+K +   T   VA+K +  + ++G       EV LL  L H N+V L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL-DVARGLEYLHDGAVPPVIH 236
             +    LV+ ++    L  +L  +N G L     V I +  + RGL Y H   +   +H
Sbjct: 73  HTERCLTLVFEYLDS-DLKQYL--DNCGNLMSMHNVKIFMFQLLRGLSYCHKRKI---LH 126

Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L+++    ++ADFGL+R + V  K  +N   T  Y  P+  + +  ++   D
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186

Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++  G +L+E+  GR    G
Sbjct: 187 MWGVGCILYEMATGRPMFPG 206

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 44/225 (19%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLVG 175
           IG+G +G VYK +   TG+ VA+K +  +S++ E    T   E+ LL  L H N+V L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH---DGAV- 231
              ++ +  L++ F+S   L  +L          +L     +D      YL+    G + 
Sbjct: 67  VLMQESRLYLIFEFLSM-DLKKYLD---------SLPKGQYMDAELVKSYLYQILQGILF 116

Query: 232 ---PPVIHRDIKSSNILLDQSMRARVADFGLSR----------EEMVDKHAANIRGTFGY 278
                V+HRD+K  N+L+D     ++ADFGL+R           E+V         T  Y
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV---------TLWY 167

Query: 279 LDPEYI--STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
             PE +  S R ++   D++S G +  E+   +    G  E  +L
Sbjct: 168 RAPEVLLGSPR-YSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 66.7 bits (162), Expect = 1e-11
 Identities = 62/233 (26%), Positives = 107/233 (45%), Gaps = 32/233 (13%)

Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEK-EFQTEVMLLGRLHHRNLVNLVGY 176
           IG G FG V+  +   T E    K ++    K+ EK +   EV ++  L H+N+V  +  
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 177 CAEKGQHMLVYVFMS---KGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
              K    L Y+ M     G L+ ++    + +G +  +  V I   +   L Y H+   
Sbjct: 81  FLNKANQKL-YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD 139

Query: 232 PP----VIHRDIKSSNILLDQSMR-----------------ARVADFGLSREEMVDKHAA 270
            P    V+HRD+K  NI L   +R                 A++ DFGLS+   ++  A 
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH 199

Query: 271 NIRGTFGYLDPEYI--STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
           +  GT  Y  PE +   T+++  KSD+++ G +++EL +G++P      + +L
Sbjct: 200 SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252

Length = 1021

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 12/209 (5%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLV 174
           ++G+GA+G V K +   T E VA+K    DS++ E+  +T   E+ +L  L   N+V L 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQENIVELK 66

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
                +G+  LV+ ++ K  L   L +   G     +R +I   + + + + H   +   
Sbjct: 67  EAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKNDI--- 121

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
           +HRDIK  N+L+  +   ++ DFG +R   E  + +      T  Y  PE +    + K 
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181

Query: 293 SDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
            D++S G +L EL  G+    G  E  +L
Sbjct: 182 VDMWSVGCILGELSDGQPLFPGESEIDQL 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 58/222 (26%), Positives = 109/222 (49%), Gaps = 21/222 (9%)

Query: 105 SYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQT--EVML 161
           SY +L+K        +G+G++  VYK      G+ VA+KV++  +++G   F    E  L
Sbjct: 6   SYLNLEK--------LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASL 56

Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           L  L H N+V L      K     V+ +M    LA ++     G   +N+R+ +   + R
Sbjct: 57  LKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFM-FQLLR 114

Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV--DKHAANIRGTFGYL 279
           GL Y+H   +   +HRD+K  N+L+      ++ADFGL+R + +    +++ +  T  Y 
Sbjct: 115 GLAYIHGQHI---LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYR 170

Query: 280 DPE-YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVE 320
            P+  +   +++   D++  G +  E++ G+    G+ +  E
Sbjct: 171 PPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE 212

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 45/217 (20%)

Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNL--V 174
           IG+GA+G V  A+ S T E VA+K +  A D++   K    E+ LL  L H N++ +  +
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENY-------GPLTWNLRVHIALDVARGLEYLH 227
                +     VY       +   L D +          L+ +   +    + RGL+Y+H
Sbjct: 73  MPPPHREAFNDVY-------IVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
              V   +HRD+K SN+LL+ +   ++ DFGL+R         + +G F     EY+ TR
Sbjct: 126 SANV---LHRDLKPSNLLLNANCDLKICDFGLAR-------TTSEKGDFM---TEYVVTR 172

Query: 288 ------------NFTKKSDVYSFGVLLFELIAGRSPL 312
                        +T   DV+S G +  EL+ GR PL
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 14/204 (6%)

Query: 115 NFTTLIGQGAFGPVYKAQMSTGE--TVAVKVLAT----DSKQGEKEFQTEVMLLGRLHHR 168
           NF   +G G+FG V  A     +   VA+K          KQ +  F +E  +L  ++H 
Sbjct: 33  NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYINHP 91

Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
             VNL G   ++    LV  F+  G   + L      P   ++    A  +    EYL  
Sbjct: 92  FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN--DVGCFYAAQIVLIFEYLQS 149

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
                +++RD+K  N+LLD+    ++ DFG ++  +VD     + GT  Y+ PE +    
Sbjct: 150 ---LNIVYRDLKPENLLLDKDGFIKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNVG 204

Query: 289 FTKKSDVYSFGVLLFELIAGRSPL 312
             K +D ++ G+ ++E++ G  P 
Sbjct: 205 HGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 29/207 (14%)

Query: 120 IGQGAFGPVYKAQMSTGETVA-VKVLATDSKQGEKEFQTEVMLLGR----LHHRNLVNLV 174
           IG G FG V  +++ T   VA V V    +    KE Q E +  G     L H N++  +
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE-QNEFLQQGDPYRILQHPNILQCL 61

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHL--YDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           G C E   ++LV+ +   G L S+L     +       L   +A ++A G+ ++H     
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-- 119

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLS----REEMV---DKHAANIRGTFGYLDPEYIS 285
             +H D+   N  L   +  +V D+G+     +E+ +   D     +R    +L PE + 
Sbjct: 120 -FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----WLAPELVG 174

Query: 286 TRN-------FTKKSDVYSFGVLLFEL 305
             +        TK S+V++ GV L+EL
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 43/145 (29%), Positives = 74/145 (51%), Gaps = 8/145 (5%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK--VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG+G++G V+K +   TG+ VA+K  V + D    +K    E+ +L +L H NLVNL+  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              K +  LV+ +     L  +  ++N   +  +L   I     + + + H       IH
Sbjct: 69  FRRKRKLHLVFEYCDHTVL--NELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC---IH 123

Query: 237 RDIKSSNILLDQSMRARVADFGLSR 261
           RD+K  NIL+ +  + ++ DFG +R
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 19/210 (9%)

Query: 105 SYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQT--EVML 161
           +YK L K        +G+G++  VYK +   TG+ VA+K +  + ++G   F    E  L
Sbjct: 6   TYKKLDK--------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASL 56

Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           L  L H N+V L      K    LV+ ++    L  ++ D   G    N+R+ +   + R
Sbjct: 57  LKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFL-FQLLR 114

Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA-ANIRGTFGYLD 280
           GL Y H   V   +HRD+K  N+L+ +    ++ADFGL+R + V     +N   T  Y  
Sbjct: 115 GLAYCHQRRV---LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRP 171

Query: 281 PE-YISTRNFTKKSDVYSFGVLLFELIAGR 309
           P+  + +  ++   D++  G + +E+  GR
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 72/285 (25%), Positives = 116/285 (40%), Gaps = 54/285 (18%)

Query: 120 IGQGAFGPVYKA---QMSTGETVA----VKVLATDSKQGEK---EFQTEVMLLGRLHHRN 169
           +GQG F  +YK      S  + V     V V+        +    F     L+ +L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP-LTWNLRVHIALDVARGLEYLHD 228
           LV L G C     +++V  ++  G L   L+ E     L W L V  A  +A  L YL D
Sbjct: 63  LVKLYGVCVRDE-NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDV--AKQLASALHYLED 119

Query: 229 GAVPPVIHRDIKSSNILLDQ-------SMRARVADFG-----LSREEMVDKHAANIRGTF 276
             +   +H ++   NIL+ +           +++D G     LSREE V++         
Sbjct: 120 KKL---VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP------- 169

Query: 277 GYLDPEYI--STRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWE 333
            ++ PE I     + T  +D +SFG  L E+ + G  PL  L      +      +    
Sbjct: 170 -WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL----SSSEKERFYQDQ-- 222

Query: 334 EIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS 378
                       + +  E+A+L  +C    P KRPS R I++ L+
Sbjct: 223 --------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 23/208 (11%)

Query: 120 IGQGAFGPVYKAQ--MSTGETVAVKVLATDSKQGEKEFQT--EVMLLGRLH---HRNLVN 172
           IG+GA+G V+KA+   + G  VA+K +   + +      T  EV +L  L    H N+V 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 173 LVGYCA-----EKGQHMLVYVFMSKGSLASHLY---DENYGPLTWNLRVHIALDVARGLE 224
           L   C       + +  LV+  + +  L ++L    +      T      +   + RGL+
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK---DMMFQLLRGLD 124

Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYI 284
           +LH   V   +HRD+K  NIL+  S + ++ADFGL+R         ++  T  Y  PE +
Sbjct: 125 FLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 181

Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSPL 312
              ++    D++S G +  E+   R PL
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 35/234 (14%)

Query: 103 EYSYKDLQKATCNFTTL--------IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQG 151
           +  +  +Q A   FT L        IG GA G V  A     G  VAVK L+    ++  
Sbjct: 4   DSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 63

Query: 152 EKEFQTEVMLLGRLHHRNLVNLVG-YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWN 210
            K    E++LL  ++H+N+++L+  +  +K       V+     L   L D N   +   
Sbjct: 64  AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY-----LVMELMDANLCQV--- 115

Query: 211 LRVHIALDVAR----------GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS 260
             +H+ LD  R          G+++LH   +   IHRD+K SNI++      ++ DFGL+
Sbjct: 116 --IHMELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLA 170

Query: 261 REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           R    +        T  Y  PE I    + +  D++S G ++ EL+ G    QG
Sbjct: 171 RTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 63/266 (23%), Positives = 110/266 (41%), Gaps = 27/266 (10%)

Query: 120 IGQGAFGPVY-----KAQMSTGETVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNL 173
           +G+G+FG VY     KA       V  ++   +    E  +   E  LL +L H  +V  
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
                E+    ++  +     L   L         L+ N      + +  G+ Y+H    
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---Q 124

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTRNFT 290
             ++HRD+K+ NI L  ++  ++ DFG+SR  M     A    GT  Y+ PE +  + + 
Sbjct: 125 RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYD 183

Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT-GWEEIVDSRLDGIFDVEEL 349
            KSD++S G +L+E+       +G   ++ +     EG T    E    +L+ I      
Sbjct: 184 SKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ---- 238

Query: 350 NEVASLAYKCVNRAPRKRPSMRDIVQ 375
                     +N+ P  RPS  +I++
Sbjct: 239 --------SMLNKDPSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 64/235 (27%), Positives = 97/235 (41%), Gaps = 47/235 (20%)

Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVL-----ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
           L+G+G  G V+  ++  TG+  A+KVL        +K   K   TE  +L  L H  L  
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKV--KRVLTEQEILATLDHPFLPT 65

Query: 173 LVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH-DG 229
           L  Y + + +  L  V  +   G L   L  +    L+  +    A +V   LEYLH  G
Sbjct: 66  L--YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG 123

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-----REEMVDKHAANIR----------- 273
               +++RD+K  NILL +S    ++DF LS         V K                 
Sbjct: 124 ----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179

Query: 274 --------------GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
                         GT  Y+ PE IS        D ++ G+LL+E++ G +P +G
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 51/183 (27%), Positives = 86/183 (46%), Gaps = 26/183 (14%)

Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266
           L++   V  +  VA G+E+L   A    +HRD+ + N+L+ +    ++ DFGL+R+ M D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292

Query: 267 KHAANIRGTF---GYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELA 322
            +  +   TF    ++ PE I    +T  SDV+SFG+LL+E+   G +P      Y EL 
Sbjct: 293 SNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP------YPEL- 345

Query: 323 AMNTEG----KTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS 378
            MN +     K G+     +           +E+  +  KC       RP    +V ++ 
Sbjct: 346 PMNEQFYNAIKRGYRMAKPAHAS--------DEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397

Query: 379 RIL 381
            +L
Sbjct: 398 DLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 62.3 bits (152), Expect = 8e-11
 Identities = 58/213 (27%), Positives = 88/213 (41%), Gaps = 50/213 (23%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ-TEVMLLGRL-HHRNLVNLVGY 176
           IG+G F  V KAQ   TG+  A+K +    K  E+     E+  L RL  H N++ L+  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWN-------LRV-HIALDVARGLEYLHD 228
             ++    L  VF         L D N   L           RV      + + L+++H 
Sbjct: 67  LFDRKTGRLALVF--------ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP--EYIST 286
             +    HRDIK  NIL+      ++ADFG            + RG +    P  EYIST
Sbjct: 119 NGI---FHRDIKPENILIKDD-ILKLADFG------------SCRGIYSKP-PYTEYIST 161

Query: 287 R------------NFTKKSDVYSFGVLLFELIA 307
           R             +  K D+++ G + FE+++
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 21/206 (10%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYG------PLTWNLRVHIALDVARGLEYLHDG 229
           +   +       V+     L +HL   +         LT +    +   + RGL+Y+H  
Sbjct: 85  FTPARSLEEFNDVY-----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 139

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRN 288
            +   IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  +
Sbjct: 140 DI---IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 194

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
           + +  D++S G ++ EL+ GR+   G
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPG 220

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 62.9 bits (153), Expect = 9e-11
 Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 9/167 (5%)

Query: 151 GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWN 210
           G K    E+ +L  + HR ++NL+     K     V + M K       Y +  GPL   
Sbjct: 129 GGKTPGREIDILKTISHRAIINLIHAYRWKS---TVCMVMPKYKCDLFTYVDRSGPLPLE 185

Query: 211 LRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA 270
             + I   +   L YLH   +   IHRD+K+ NI LD+   A + DFG + +        
Sbjct: 186 QAITIQRRLLEALAYLHGRGI---IHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242

Query: 271 NIRGTFGYLD---PEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
              G  G L+   PE ++   +  K+D++S G++LFE+      L G
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289

Length = 392

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 22/207 (10%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           +IG+GAFG V   +  ST +  A+K+L+     K+ +  F  E   +    +   V  + 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 176 YCAEKGQHM-LVYVFMSKGSLASHLYDENYG-PLTWNLRVHIALDVARGLEYLHDGAVPP 233
           Y  +  +++ +V  +M  G L + +   NY  P  W  R + A +V   L+ +H      
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EVVLALDAIHSMGF-- 163

Query: 234 VIHRDIKSSNILLDQSMRARVADFG----LSREEMVDKHAANIRGTFGYLDPEYISTRN- 288
            IHRD+K  N+LLD+S   ++ADFG    +++E MV    A   GT  Y+ PE + ++  
Sbjct: 164 -IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGG 220

Query: 289 ---FTKKSDVYSFGVLLFELIAGRSPL 312
              + ++ D +S GV L+E++ G +P 
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 46/252 (18%), Positives = 110/252 (43%), Gaps = 26/252 (10%)

Query: 136 GETVAVKVLATDSKQGEK---EFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM----LVYV 188
            + V ++      K  +      + E+  L R+   N++ + G+  +    +    L+  
Sbjct: 43  NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102

Query: 189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ 248
           + ++G L   L  E    L++  ++ +A+D  +GL  L+     P  ++++ S + L+ +
Sbjct: 103 YCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTE 158

Query: 249 SMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELI 306
           + + ++   GL  E+++            Y   + ++     +T K D+YS GV+L+E+ 
Sbjct: 159 NYKLKIICHGL--EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216

Query: 307 AGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRK 366
            G+ P +  +   E+  +          I++        ++   E+  +   C +    K
Sbjct: 217 TGKIPFEN-LTTKEIYDL----------IINKNNSLKLPLDCPLEIKCIVEACTSHDSIK 265

Query: 367 RPSMRDIVQVLS 378
           RP++++I+  LS
Sbjct: 266 RPNIKEILYNLS 277

Length = 283

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 12/104 (11%)

Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--KHAANIRGTFGY 278
           RGL+YLH   +   +HRDIK  N+L++ +   ++ DFGL+R E  D  KH      T  Y
Sbjct: 114 RGLKYLHSAGI---LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170

Query: 279 LDPEYI-STRNFTKKSDVYSFGVLLFELIAGR------SPLQGL 315
             PE +  +R++T   D++S G +  EL+  R      SP+Q L
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL 214

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 22/207 (10%)

Query: 119 LIGQGAFGPVYKAQMSTGETV-AVKVLAT---DSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           +IG+GAFG V   +  + + V A+K+L+      +     F  E  ++   +   +V L 
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 108

Query: 175 GYCAEKGQHMLVYV--FMSKGSLASHLYDENYG-PLTWNLRVHIALDVARGLEYLHDGAV 231
            +CA +    L  V  +M  G L + +   NY  P  W  + + A +V   L+ +H   +
Sbjct: 109 -FCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKW-AKFYTA-EVVLALDAIHSMGL 163

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFG--LSREEMVDKHAANIRGTFGYLDPEYISTRN- 288
              IHRD+K  N+LLD+    ++ADFG  +  +E          GT  Y+ PE + ++  
Sbjct: 164 ---IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 289 ---FTKKSDVYSFGVLLFELIAGRSPL 312
              + ++ D +S GV LFE++ G +P 
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 31/161 (19%)

Query: 176 YCA-EKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNL-RVHIALDVARGLEYLHDGAVP 232
           +C+ E  +H+ +V  ++  G  A+ L  +N G L  ++ R++ A  V   LEYLH+  + 
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFAETVL-ALEYLHNYGI- 122

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSR-------------------EEMVDKHAANIR 273
             +HRD+K  N+L+      ++ DFGLS+                    E +DK    + 
Sbjct: 123 --VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ---VC 177

Query: 274 GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           GT  Y+ PE I  + + K  D ++ G++L+E + G  P  G
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 41/218 (18%)

Query: 118 TLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQT---------EVMLLGRLHH 167
           T +G GA+G V  A      + VAVK L+       + FQ+         E+ LL  + H
Sbjct: 21  TPVGSGAYGSVCSAYDTRLRQKVAVKKLS-------RPFQSLIHARRTYRELRLLKHMKH 73

Query: 168 RNLVNL--VGYCAEKGQHM----LVYVFMSKG----SLASHLYDENYGPLTWNLRVHIAL 217
            N++ L  V   A   ++     LV   M            L DE+   L + L      
Sbjct: 74  ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL------ 127

Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
              RGL+Y+H   +   IHRD+K SN+ +++    R+ DFGL+R+   D        T  
Sbjct: 128 --LRGLKYIHSAGI---IHRDLKPSNVAVNEDCELRILDFGLARQ--ADDEMTGYVATRW 180

Query: 278 YLDPE-YISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           Y  PE  ++  ++ +  D++S G ++ EL+ G++   G
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 8e-10
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 34/210 (16%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEF--QT---EVMLLGRLHHRNLVNL 173
           IG+G +G VYKA+   TGE VA+K +  ++   E E    T   E+ LL  L+H N+V L
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLET---EDEGVPSTAIREISLLKELNHPNIVRL 63

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           +     + +  LV+ F+    L  ++       L   L       + +G+ Y H   V  
Sbjct: 64  LDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV-- 120

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSR----------EEMVDKHAANIRGTFGYLDPE- 282
            +HRD+K  N+L+D+    ++ADFGL+R           E+V         T  Y  PE 
Sbjct: 121 -LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV---------TLWYRAPEI 170

Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
            + +R ++   D++S G +  E++  R PL
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 33/225 (14%)

Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGE--KEFQTEVMLLGR 164
           ++ +  CN T+         VY A+ + TG  V V++   ++   E  K  Q EV+L   
Sbjct: 5   EIGRGFCNLTS---------VYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHF 55

Query: 165 LHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP--LTWNLRVHIALDVARG 222
             H N++             ++  FM+ GS A+ L  + Y P  ++  L  +I     RG
Sbjct: 56  FRHPNIMTSWTVFTTGSWLWVISPFMAYGS-ANSLL-KTYFPEGMSEALIGNILFGALRG 113

Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY---- 278
           L YLH       IHR+IK+S+IL+  S    V+  GLS    + ++    +  + +    
Sbjct: 114 LNYLHQNGY---IHRNIKASHILI--SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFS 168

Query: 279 ------LDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
                 L PE +      +  KSD+YS G+   EL  GR P Q +
Sbjct: 169 TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 59/250 (23%), Positives = 97/250 (38%), Gaps = 41/250 (16%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQGEKE-----------FQT--EVMLLGR 164
           +G+G +G V KA    TG+ VA+K V   +      +           F T  E+ ++  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 165 LHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLE 224
           + H N++ LV    E     LV   M+   L   +  +    LT +    I L +  GL 
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV--DRKIRLTESQVKCILLQILNGLN 133

Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---------EEMVDKHAANIRG- 274
            LH       +HRD+  +NI ++     ++ADFGL+R             D+        
Sbjct: 134 VLHKWYF---MHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190

Query: 275 -----TFGYLDPEYISTRN-FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAA----M 324
                T  Y  PE +     +    D++S G +  EL+ G+    G  E  +L      +
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL 250

Query: 325 NTEGKTGWEE 334
            T  +  W +
Sbjct: 251 GTPNEDNWPQ 260

Length = 335

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 57.6 bits (140), Expect = 2e-09
 Identities = 41/153 (26%), Positives = 64/153 (41%), Gaps = 21/153 (13%)

Query: 166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGL 223
            + N + L         H+L+  ++  G L    +D  +  G L+      I   +   L
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEAL 122

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSR----EEMVDKHAANIRGTFGY 278
             LH   +   IH DIK  N+L D++  R  + D+GL +        D       GT  Y
Sbjct: 123 NDLHKHNI---IHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD-------GTLDY 172

Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
             PE I   N+    D ++ GVL +EL+ G+ P
Sbjct: 173 FSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 30/84 (35%), Positives = 52/84 (61%), Gaps = 3/84 (3%)

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSRE---EMVDKHAANIRGTFGYLDPEYISTRNFT 290
           ++HRD+KS+NI L  +   ++ DFG S++    +    A++  GT  YL PE    + ++
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249

Query: 291 KKSDVYSFGVLLFELIAGRSPLQG 314
           KK+D++S GV+L+EL+    P +G
Sbjct: 250 KKADMWSLGVILYELLTLHRPFKG 273

Length = 478

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 43/212 (20%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLA------TDSKQGEKEFQTEVMLLGRLHHRNLVN 172
           IG GA G V  A    TG+ VA+K L+      T +K+  +E     +L+  ++H+N++ 
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYREL----VLMKLVNHKNIIG 79

Query: 173 LVGYCAEKGQHML-----VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR------ 221
           L+       Q  L     VY+ M        L D N   +     + + LD  R      
Sbjct: 80  LLN--VFTPQKSLEEFQDVYLVM-------ELMDANLCQV-----IQMDLDHERMSYLLY 125

Query: 222 ----GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
               G+++LH   +   IHRD+K SNI++      ++ DFGL+R             T  
Sbjct: 126 QMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 182

Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIAGR 309
           Y  PE I    + +  D++S G ++ E+I G 
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 59/253 (23%), Positives = 111/253 (43%), Gaps = 44/253 (17%)

Query: 139 VAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASH 198
           V +KVL    +     F     ++ ++ H+++V L G C    ++++V  F+  G L   
Sbjct: 35  VILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLF 94

Query: 199 LYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL-------DQSMR 251
           ++ ++   LT   +  +A  +A  L YL D     ++H ++ + NILL       +    
Sbjct: 95  MHRKS-DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPF 150

Query: 252 ARVADFG-----LSREEMVDKHAANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFEL 305
            +++D G     LSR+E V++          ++ PE +  ++N +  +D +SFG  L+E+
Sbjct: 151 IKLSDPGIPITVLSRQECVER--------IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Query: 306 -IAGRSPLQG--LMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNR 362
              G  PL+   L E               E   + +   +       E+A L   C+N 
Sbjct: 203 CYNGEIPLKDKTLAEK--------------ERFYEGQCMLV--TPSCKELADLMTHCMNY 246

Query: 363 APRKRPSMRDIVQ 375
            P +RP  R I++
Sbjct: 247 DPNQRPFFRAIMR 259

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 31/212 (14%)

Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKE-FQTEVMLLGRLHHRNLVNLV 174
           +IG+GAFG V   +M +TG+  A+K+L      K+ E   F+ E  +L     R + NL 
Sbjct: 8   VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL- 66

Query: 175 GYCAEKGQHM-LVYVFMSKGSLASHL--YDENYGPLTWNLRVH---IALDVARGLEYLHD 228
            Y  +   ++ LV  +   G L + L  +++          +    +A+D    L Y   
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY--- 123

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFG----LSREEMVDKHAANIRGTFGYLDPEYI 284
                 +HRDIK  N+LLD++   R+ADFG    L  +  V  + A   GT  Y+ PE +
Sbjct: 124 ------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VGTPDYISPEIL 175

Query: 285 -----STRNFTKKSDVYSFGVLLFELIAGRSP 311
                    +  + D +S GV ++E++ G +P
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 54.7 bits (132), Expect = 4e-08
 Identities = 60/247 (24%), Positives = 95/247 (38%), Gaps = 68/247 (27%)

Query: 118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQT-----EVMLLGRLHHRNLV 171
            +IG+GAFG V   Q   TG   A+K L   S+  EKE Q      E  +L    +  +V
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKE-QVAHVRAERDILAEADNPWVV 64

Query: 172 NLVGYCA--EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNL-RVHI-----ALDVARGL 223
            L  Y +  ++    L+  ++  G + + L  ++    T    R +I     A+D    L
Sbjct: 65  KL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKL 120

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR----------EEMVDKHAANIR 273
            Y         IHRDIK  N+LLD     +++DFGL              ++     +  
Sbjct: 121 GY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171

Query: 274 -----------------------------GTFGYLDPEYISTRNFTKKSDVYSFGVLLFE 304
                                        GT  Y+ PE      + K+ D +S GV+++E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231

Query: 305 LIAGRSP 311
           ++ G  P
Sbjct: 232 MLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 31/206 (15%)

Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  E  VA+K L+    ++   K    E++L+  ++H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91

Query: 176 YCAEKG--QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR----------GL 223
           +  +K   +   VY+ M        L D N   +     + + LD  R          G+
Sbjct: 92  FTPQKSLEEFQDVYIVM-------ELMDANLCQV-----IQMELDHERMSYLLYQMLCGI 139

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEY 283
           ++LH   +   IHRD+K SNI++      ++ DFGL+R             T  Y  PE 
Sbjct: 140 KHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196

Query: 284 ISTRNFTKKSDVYSFGVLLFELIAGR 309
           I    + +  D++S G ++ E+I G 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 45/163 (27%), Positives = 81/163 (49%), Gaps = 17/163 (10%)

Query: 154 EFQTEVMLLGRLHHRNLVNLVGYC-AEKGQHMLV--YVFMSKGSLASHLYDENY----GP 206
           + + E++ LGRL+H N++ +     +E   +M+   Y F     L S +YDE +     P
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRP 264

Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFG--LSREEM 264
           L    R  I   +   +EY+HD  +   IHRDIK  NI L+   +  + DFG  +  E+ 
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDKKL---IHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320

Query: 265 VDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
            +       GT     PE ++   + + +D++S G++L ++++
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 65/255 (25%), Positives = 112/255 (43%), Gaps = 42/255 (16%)

Query: 139 VAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASH 198
           V +KVL    +     F     L+ ++ H +L  + G C    ++++V  F+  G L   
Sbjct: 47  VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106

Query: 199 LYDEN-YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA----- 252
           L  E    P+ W + V  A  +A  L YL D     ++H ++ + NILL +   A     
Sbjct: 107 LRKEKGRVPVAWKITV--AQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSP 161

Query: 253 --RVADFG-----LSREEMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFE 304
             +++D G     LSREE V++          ++ PE +    + +  +D +SFG  L E
Sbjct: 162 FIKLSDPGVSFTALSREERVER--------IPWIAPECVPGGNSLSTAADKWSFGTTLLE 213

Query: 305 L-IAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRA 363
           +   G  PL+            +E +  +E+    RL          E+A+L  +C+   
Sbjct: 214 ICFDGEVPLKERTP--------SEKERFYEK--KHRLPE----PSCKELATLISQCLTYE 259

Query: 364 PRKRPSMRDIVQVLS 378
           P +RPS R I++ L+
Sbjct: 260 PTQRPSFRTILRDLT 274

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 16/105 (15%)

Query: 215 IALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANI 272
           IA+D    L Y         +HRDIK  NIL+D +   R+ADFG   + M D    ++  
Sbjct: 113 IAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 163

Query: 273 RGTFGYLDPEYISTRN-----FTKKSDVYSFGVLLFELIAGRSPL 312
            GT  Y+ PE +         +  + D +S GV ++E++ G +P 
Sbjct: 164 VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 46/191 (24%), Positives = 89/191 (46%), Gaps = 7/191 (3%)

Query: 120 IGQGAFGPVYKAQMST-GETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +     VA+K L+    ++   K    E++L+  ++H+N+++L+  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 85  FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 141

Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 201

Query: 296 YSFGVLLFELI 306
           +S G ++ E++
Sbjct: 202 WSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 51.1 bits (122), Expect = 5e-07
 Identities = 42/159 (26%), Positives = 72/159 (45%), Gaps = 10/159 (6%)

Query: 157 TEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIA 216
           TE  +L  ++H +++ L G         L+ +   K  L  +L  +    +   L   I 
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI-LPRYKTDLYCYLAAKRNIAICDILA--IE 188

Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF 276
             V R ++YLH+  +   IHRDIK+ NI ++      + DFG +    VD +A    G  
Sbjct: 189 RSVLRAIQYLHENRI---IHRDIKAENIFINHPGDVCLGDFGAACFP-VDINANKYYGWA 244

Query: 277 GYL---DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
           G +    PE ++   +    D++S G++LFE+      L
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 36/144 (25%), Positives = 62/144 (43%), Gaps = 48/144 (33%)

Query: 212 RVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL------------ 259
           R +IA ++   +E +H       IHRDIK  NIL+D+    ++ DFGL            
Sbjct: 104 RFYIA-ELTCAIESVHKMGF---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159

Query: 260 ------SREEMVD----------------------KH----AANIRGTFGYLDPEYISTR 287
                  R++ ++                      +H    A ++ GT  Y+ PE +   
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219

Query: 288 NFTKKSDVYSFGVLLFELIAGRSP 311
            +T+  D +S GV+L+E++ G+ P
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 32/89 (35%), Positives = 53/89 (59%), Gaps = 9/89 (10%)

Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRL-HHRNLV 171
           +G+GAFG V +A      + +T  TVAVK+L   +   E +   +E+ +L  + HH N+V
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74

Query: 172 NLVGYCAEKGQHMLVYV-FMSKGSLASHL 199
           NL+G C + G  ++V V F   G+L+++L
Sbjct: 75  NLLGACTKPGGPLMVIVEFCKFGNLSNYL 103

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 47/221 (21%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           +IG+G++G V  A    TGE VA+K +    +          E+ LL  L H ++V +  
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI-- 64

Query: 176 YCAEKGQHML----------VYVFMSKGSLASH--------LYDENYGPLTWNLRVHIAL 217
                 +H++          +YV         H        L  E++    + L      
Sbjct: 65  ------KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQL------ 112

Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA----NIR 273
              R L+Y+H   V    HRD+K  NIL +   + ++ DFGL+R    D   A    +  
Sbjct: 113 --LRALKYIHTANV---FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167

Query: 274 GTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPL 312
            T  Y  PE   +    +T   D++S G +  E++ G+ PL
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PL 207

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 27/85 (31%), Positives = 44/85 (51%), Gaps = 7/85 (8%)

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANIRGTFGYLDPEYISTR----- 287
           +HRDIK  N+LLD +   R+ADFG   +   D    ++   GT  Y+ PE +        
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPL 312
            +  + D +S GV ++E++ G +P 
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 37/213 (17%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNL----- 173
           +G+G +G VYKA+   G+      L      G       E+ LL  L H N+++L     
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 174 ------VGYCAEKGQHMLVYVF-MSKGSLASHLYDENYGP--LTWNLRVHIALDVARGLE 224
                 V    +  +H L ++    + S A      N  P  L   +   +   +  G+ 
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKA------NKKPVQLPRGMVKSLLYQILDGIH 122

Query: 225 YLHDGAVPPVIHRDIKSSNILL----DQSMRARVADFGLSR------EEMVDKHAANIRG 274
           YLH   V   +HRD+K +NIL+     +  R ++AD G +R      + + D     +  
Sbjct: 123 YLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-- 177

Query: 275 TFGYLDPE-YISTRNFTKKSDVYSFGVLLFELI 306
           TF Y  PE  +  R++TK  D+++ G +  EL+
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 37/213 (17%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNL----- 173
           +G+G +G VYKA+   G+      L      G       E+ LL  L H N++ L     
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 174 ------VGYCAEKGQHMLVYVF-MSKGSLASHLYDENYGP--LTWNLRVHIALDVARGLE 224
                 V    +  +H L ++    + S A      N  P  L  ++   +   +  G+ 
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKA------NKKPMQLPRSMVKSLLYQILDGIH 122

Query: 225 YLHDGAVPPVIHRDIKSSNILL----DQSMRARVADFGLSR------EEMVDKHAANIRG 274
           YLH   V   +HRD+K +NIL+     +  R ++AD G +R      + + D     +  
Sbjct: 123 YLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-- 177

Query: 275 TFGYLDPE-YISTRNFTKKSDVYSFGVLLFELI 306
           TF Y  PE  +  R++TK  D+++ G +  EL+
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 58/234 (24%), Positives = 93/234 (39%), Gaps = 45/234 (19%)

Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVL-ATDSKQGEK--EFQTEVMLLGRLHHRNLVNLV 174
           +IG+GAFG V   Q   TG   A+K+L   D  + E+    + E  +L       +V + 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
               +K    L+  F+  G + + L  ++   LT         +    ++ +H       
Sbjct: 68  YSFQDKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGF--- 122

Query: 235 IHRDIKSSNILLDQSMRARVADFGL------------------------SREEMVDKHAA 270
           IHRDIK  N+LLD     +++DFGL                        + + M  K  A
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 271 -----NIR-------GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
                N R       GT  Y+ PE      + K  D +S GV+++E++ G  P 
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 56/233 (24%), Positives = 92/233 (39%), Gaps = 51/233 (21%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGE---KEFQTEVMLLGRLHHRNLVNLV 174
           LIG+G  G VY A        VA+K +  D  +     K F  E  +   L H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 175 GYCAEKGQHMLVYVFM----------------SKGSLASHLYD-ENYGPLTWNLRVHIAL 217
             C++      VY  M                 K SL+  L +  + G       + I  
Sbjct: 69  SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF-----LSIFH 120

Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS------REEMVDKHA-- 269
            +   +EY+H   V   +HRD+K  NILL       + D+G +       E+++D     
Sbjct: 121 KICATIEYVHSKGV---LHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 270 -----------ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
                        I GT  Y+ PE +     ++ +D+Y+ GV+L++++    P
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 59/235 (25%), Positives = 93/235 (39%), Gaps = 47/235 (20%)

Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKE----FQTEVMLLGRLHHRNLVNL 173
           +IG+GAFG V   Q   TG   A+K+L   +   EKE     + E  +L       +V +
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKIL-RKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                +K    L+  F+  G + + L  ++   L+         +    ++ +H      
Sbjct: 67  FYSFQDKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGF-- 122

Query: 234 VIHRDIKSSNILLDQSMRARVADFGL------------------------SREEMVDKHA 269
            IHRDIK  N+LLD     +++DFGL                        S + M  K  
Sbjct: 123 -IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181

Query: 270 A-----NIR-------GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
           A     N R       GT  Y+ PE      + K  D +S GV+++E++ G  P 
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 9/149 (6%)

Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           I +GAFG VY  +  +  +  AVKV+      +K    + Q E   L       +V+L  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
                    LV  ++  G + S L+   YG     + V    +VA  L+YLH   +   I
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLH--IYGYFDEEMAVKYISEVALALDYLHRHGI---I 126

Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEM 264
           HRD+K  N+L+      ++ DFGLS+  +
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKVTL 155

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 58/245 (23%), Positives = 94/245 (38%), Gaps = 57/245 (23%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           +G GAFG V  A ++ T    A+K L      ++      + E  +L    +  +V L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +K     V  ++  G + S L      P     R +IA ++   +E +H       I
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL-ARFYIA-ELTLAIESVHKMGF---I 123

Query: 236 HRDIKSSNILLDQSMRARVADFGL------------------------------------ 259
           HRDIK  NIL+D     ++ DFGL                                    
Sbjct: 124 HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNC 183

Query: 260 -------SREEMVDKH-----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
                  + E+   K      A ++ GT  Y+ PE +  + +T+  D +S GV+LFE++ 
Sbjct: 184 RCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLV 243

Query: 308 GRSPL 312
           G+ P 
Sbjct: 244 GQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 63/263 (23%), Positives = 104/263 (39%), Gaps = 83/263 (31%)

Query: 115 NFTTL--IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH---- 167
           +F T+  IG+GAFG V   Q   TG+  A+K L           ++E+    +L H    
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL----------LKSEMFKKDQLAHVKAE 51

Query: 168 RNL---------VNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNL-RVHIA 216
           R++         V+L  Y  +  Q++ L+  F+  G L + L    Y   + ++ R ++A
Sbjct: 52  RDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLI--KYDTFSEDVTRFYMA 108

Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS---------------- 260
            +    +E +H       IHRDIK  NIL+D+    +++DFGLS                
Sbjct: 109 -ECVLAIEAVHKLGF---IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164

Query: 261 ------------REEMVD--------------------KHAANIRGTFGYLDPEYISTRN 288
                           VD                      A +  GT  Y+ PE    + 
Sbjct: 165 QGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG 224

Query: 289 FTKKSDVYSFGVLLFELIAGRSP 311
           + ++ D +S G ++FE + G  P
Sbjct: 225 YGQECDWWSLGAIMFECLIGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 32/126 (25%), Positives = 52/126 (41%), Gaps = 48/126 (38%)

Query: 235 IHRDIKSSNILLDQSMRARVADFGLS------------------REEMVD---------- 266
           IHRDIK  NIL+D+    ++ DFGL                   R++ +D          
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 267 ----------------KH----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELI 306
                           +H    A ++ GT  Y+ PE +    +T+  D +S GV+L+E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 307 AGRSPL 312
            G+ P 
Sbjct: 243 VGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 45.3 bits (107), Expect = 4e-05
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 8/92 (8%)

Query: 116 FTTLIGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRL-HH 167
           F   +G GAFG V +A      +     TVAVK+L   +   E+E   +E+ +L  L +H
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98

Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL 199
            N+VNL+G C   G  +++  +   G L + L
Sbjct: 99  INIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 36/126 (28%), Positives = 61/126 (48%), Gaps = 14/126 (11%)

Query: 120 IGQGAFGPVYKAQ---MSTGET---VAVKVLATDSKQGEKE-FQTEVMLLGRLH-HRNLV 171
           +G GAFG V +A    +S  ++   VAVK+L + ++  EK+   +E+ ++  L  H N+V
Sbjct: 45  LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104

Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
           NL+G C + G   ++  +   G L  +L+   +  L +       LD  R    L  G  
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYY------LDKNRDDGSLISGGS 158

Query: 232 PPVIHR 237
            P+  R
Sbjct: 159 TPLSQR 164

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 33/202 (16%)

Query: 135 TGETVAVKVLATDSKQGE--KEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192
           TGE V V+ +  ++   E     Q E+ +    +H N+V          +  +V  FM+ 
Sbjct: 24  TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83

Query: 193 GS----LASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ 248
           GS    + +H  D     L      +I   V + L+Y+H       +HR +K+S+IL+  
Sbjct: 84  GSAKDLICTHFMD-GMSELAI---AYILQGVLKALDYIHHMGY---VHRSVKASHILI-- 134

Query: 249 SMRARVADFGL----------SREEMVD---KHAANIRGTFGYLDPEYI--STRNFTKKS 293
           S+  +V   GL           R  +V    K++  +     +L PE +  + + +  KS
Sbjct: 135 SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKV---LPWLSPEVLQQNLQGYDAKS 191

Query: 294 DVYSFGVLLFELIAGRSPLQGL 315
           D+YS G+   EL  G  P + +
Sbjct: 192 DIYSVGITACELANGHVPFKDM 213

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 54/227 (23%), Positives = 91/227 (40%), Gaps = 30/227 (13%)

Query: 107 KDLQKATCNFT--TLIGQGAFGPVYKA-QMSTGETVAVKVLA-----TDSKQGEKEFQTE 158
           +D+  +T  F   +L+G+G FG V +A      E  AVK++      T   + E +F  +
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEK 181

Query: 159 VMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALD 218
           V          L+ +  Y   +  HM +   M K       +   +GP +      I   
Sbjct: 182 VRQADPADRFPLMKIQRYFQNETGHMCI--VMPKYGPCLLDWIMKHGPFSHRHLAQIIFQ 239

Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQS----------------MRARVADFGLSRE 262
               L+Y H      ++H D+K  NIL++ S                 R R+ D G   +
Sbjct: 240 TGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD 297

Query: 263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGR 309
           E   + A  I  T  Y  PE +    +   +D++S G +++EL  G+
Sbjct: 298 ERHSRTA--IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 40/151 (26%), Positives = 60/151 (39%), Gaps = 19/151 (12%)

Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP----LTWNLRVHIALDVARGLE 224
           N+V L  Y   +    LV      G L SH+      P      W   + +ALD      
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100

Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGYLDPE 282
            LH   +   + RD+  +NILLD     ++  F    E  +  D  A        Y  PE
Sbjct: 101 -LHREGI---VCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE 152

Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
                  T+  D +S G +LFEL+ G++ ++
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKTLVE 183

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 46/226 (20%), Positives = 91/226 (40%), Gaps = 37/226 (16%)

Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL----- 173
           LIG G FG VY+ Q ++   +  + +A       +    E ++   ++  + + L     
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH 78

Query: 174 ----VGY-----CAEKGQHMLVYVFM-------SKGSLASHLYDENYGPLTWNLRVHIAL 217
               +G      C    +  + Y F+       +   +   +  +N   L  N    I  
Sbjct: 79  NIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKN-KKLIKN----IMK 133

Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-------KHAA 270
           D+   LEY+H+  +    H DIK  NI++D + R  + D+G++   ++        K   
Sbjct: 134 DMLTTLEYIHEHGIS---HGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190

Query: 271 NI-RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
           ++ RGT  Y   +  +    T++ D+ S G  + +    + P +G 
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236

Length = 294

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 10/93 (10%)

Query: 219 VARGL----EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFG---LSREEMVDKHAAN 271
           VAR L    +Y+H   +   IHRDIK+ N+L++      + DFG    +R          
Sbjct: 265 VARQLLSAIDYIHGEGI---IHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFE 304
           I GT     PE ++   +T   D++S G+++FE
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 37.4 bits (87), Expect = 0.004
 Identities = 29/145 (20%), Positives = 55/145 (37%), Gaps = 14/145 (9%)

Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLV--NLVGY 176
           L+  G    VY    +  E   +K+  +  K    + + EV +L  L  + L    ++  
Sbjct: 5   LLKGGLTNRVYLLG-TKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLAS 61

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
               G   L+  ++ +G     + +E         +  IA  +A  L  LH   +  + H
Sbjct: 62  GESDGWSYLLMEWI-EGETLDEVSEEE--------KEDIAEQLAELLAKLHQLPLLVLCH 112

Query: 237 RDIKSSNILLDQSMRARVADFGLSR 261
            D+   NIL+D      + D+  + 
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAG 137

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 37.8 bits (88), Expect = 0.004
 Identities = 26/97 (26%), Positives = 41/97 (42%), Gaps = 15/97 (15%)

Query: 215 IALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG 274
           + L     L  LH  A         KS NILL  +    +   G     +  K     R 
Sbjct: 22  VCLQCLGALRELHRQA---------KSGNILL--TWDGLLKLDG----SVAFKTPEQSRP 66

Query: 275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
              ++ PE I  +++T+K+D+YS G+ L+E +    P
Sbjct: 67  DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	432
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.86
PRK10345	210	hypothetical protein; Provisional	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
smart00090	237	RIO RIO-like kinase.	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.72
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.65
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.63
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.59
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.56
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.46
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.41
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.38
KOG1243	690	consensus Protein kinase [General function predict	99.36
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.34
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.33
KOG3087	229	consensus Serine/threonine protein kinase [General	99.28
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.25
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.19
COG4248	637	Uncharacterized protein with protein kinase and he	99.16
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.13
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.1
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.05
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.93
PRK09902	216	hypothetical protein; Provisional	98.84
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.75
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.74
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.73
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.6
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.6
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.49
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.46
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.46
PF01636	239	APH: Phosphotransferase enzyme family This family	98.43
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.39
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.35
PLN02876	822	acyl-CoA dehydrogenase	98.32
PRK10593	297	hypothetical protein; Provisional	98.18
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.15
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.13
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.09
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.05
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.0
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.92
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.9
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.63
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.62
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.58
PRK05231	319	homoserine kinase; Provisional	97.48
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.43
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.43
KOG2270	520	consensus Serine/threonine protein kinase involved	97.39
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.39
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.26
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.22
PLN02236	344	choline kinase	97.22
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.1
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.01
PF01102	122	Glycophorin_A: Glycophorin A; InterPro: IPR001195	96.9
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.76
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.67
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.67
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.53
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.52
COG2334	331	Putative homoserine kinase type II (protein kinase	96.5
PTZ00382	96	Variant-specific surface protein (VSP); Provisiona	96.38
PLN02756	418	S-methyl-5-thioribose kinase	96.37
PF02439	38	Adeno_E3_CR2: Adenovirus E3 region protein CR2; In	96.28
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	96.07
PRK06148	1013	hypothetical protein; Provisional	96.01
PRK11768	325	serine/threonine protein kinase; Provisional	95.97
PF04478	154	Mid2: Mid2 like cell wall stress sensor; InterPro:	95.8
PRK12396	409	5-methylribose kinase; Reviewed	95.67

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-57  Score=438.39  Aligned_cols=282  Identities=50%  Similarity=0.843  Sum_probs=242.8

Q ss_pred             CCCCcCHHHHHHHhcccc--ccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeee
Q 014038          100 GIPEYSYKDLQKATCNFT--TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC  177 (432)
Q Consensus       100 ~~~~~~~~~l~~~~~~~~--~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  177 (432)
                      ....|++.++..+|.+|.  +.||+|+||.||+|.+.+|..||||++.....+...+|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            567799999999999998  699999999999999999999999988765443145699999999999999999999999


Q ss_pred             eeCC-eEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEee
Q 014038          178 AEKG-QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVAD  256 (432)
Q Consensus       178 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~D  256 (432)
                      .+.+ +.+||||||++|+|.++|+.....+++|..|++||.++|+||+|||....++||||||||+|||||+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9998 599999999999999999875543899999999999999999999999888999999999999999999999999


Q ss_pred             cCCcccccc-ccccccc-ccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChh-----HHHHHHHhhhcCC
Q 014038          257 FGLSREEMV-DKHAANI-RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM-----EYVELAAMNTEGK  329 (432)
Q Consensus       257 fgl~~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~-----~~~~~~~~~~~~~  329 (432)
                      ||+++.... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+...     ....+.. .....
T Consensus       221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~-~~~~~  299 (361)
T KOG1187|consen  221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK-PLLEE  299 (361)
T ss_pred             ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH-HHHHC
Confidence            999976554 3333333 89999999999999999999999999999999999998876421     1222221 12222


Q ss_pred             CchhhhccccCC-CCCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          330 TGWEEIVDSRLD-GIFDV-EELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       330 ~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      ..+.+++|+.+. +.++. .....+..++.+|++.+|++||+|.+|+++|+.+..
T Consensus       300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            267899999987 66665 678889999999999999999999999999966543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-53  Score=405.79  Aligned_cols=257  Identities=36%  Similarity=0.616  Sum_probs=216.9

Q ss_pred             ccccccccCceeEEEEEeCCCcEEEEEEeccCChh--hHHHHHHHHHHHhhcCCCccceEEeeeeeCC-eEEEEEEeccC
Q 014038          116 FTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ--GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-QHMLVYVFMSK  192 (432)
Q Consensus       116 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~  192 (432)
                      +.+.||+|+||+||+|.+.....||||++......  ..+.|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            34569999999999999965455999999765322  2568999999999999999999999999887 79999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC-cEEEeecCCccccccc-cccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVD-KHAA  270 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~-~~~~  270 (432)
                      |+|.++++......+++..+++|+.|||+||.|||+++.  ||||||||+||||+.++ ++||+|||+++..... ....
T Consensus       125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~  202 (362)
T KOG0192|consen  125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMT  202 (362)
T ss_pred             CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccccccc
Confidence            999999987556789999999999999999999999874  89999999999999998 9999999999865543 2333


Q ss_pred             ccccCCCCCCccccc--cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          271 NIRGTFGYLDPEYIS--TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      ...||+.|||||++.  ...|+.|+|||||||++|||+||+.||.+............           ...+...+...
T Consensus       203 ~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~-----------~~~Rp~~p~~~  271 (362)
T KOG0192|consen  203 SVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVV-----------GGLRPPIPKEC  271 (362)
T ss_pred             CCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-----------cCCCCCCCccC
Confidence            478999999999999  66999999999999999999999999998776322222221           12233334446


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                      +..+..+|.+||+.||..||++.+++..|+.+.....
T Consensus       272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            6789999999999999999999999999999977544

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-53  Score=384.53  Aligned_cols=251  Identities=32%  Similarity=0.481  Sum_probs=210.4

Q ss_pred             cCHHHHHHHhccccccccccCceeEEEEEe-CCCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC
Q 014038          104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG  181 (432)
Q Consensus       104 ~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  181 (432)
                      ++..|+.     ..+.||+|..|+||++.. .+++.+|+|.+... .....+++.+|++++++.+|||||.+||.|...+
T Consensus        76 i~~~dle-----~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~  150 (364)
T KOG0581|consen   76 ISLSDLE-----RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG  150 (364)
T ss_pred             cCHHHhh-----hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence            4555554     346799999999999964 47899999999655 4455678999999999999999999999999988


Q ss_pred             -eEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCeeecCCCcEEEeecCC
Q 014038          182 -QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGL  259 (432)
Q Consensus       182 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl  259 (432)
                       ...++||||++|+|+.++..  .+.+++....+|+.+|++||.|||+ .+   ||||||||+|||++..|.+||||||.
T Consensus       151 ~~isI~mEYMDgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGV  225 (364)
T KOG0581|consen  151 EEISICMEYMDGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGV  225 (364)
T ss_pred             ceEEeehhhcCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccc
Confidence             59999999999999999954  3679999999999999999999996 66   99999999999999999999999999


Q ss_pred             cccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCCh----hHHHHHHHhhhcCCCchhhh
Q 014038          260 SREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL----MEYVELAAMNTEGKTGWEEI  335 (432)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~----~~~~~~~~~~~~~~~~~~~~  335 (432)
                      +...... ...+++||..|||||.+.+..|+.++||||||+.++|+.+|+.||...    .++..+.          ..+
T Consensus       226 S~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll----------~~I  294 (364)
T KOG0581|consen  226 SGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL----------CAI  294 (364)
T ss_pred             cHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH----------HHH
Confidence            9865444 667899999999999999999999999999999999999999999763    1222221          122


Q ss_pred             ccccCCCCCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          336 VDSRLDGIFDV-EELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       336 ~~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ++... +..+. ..+.++.+|+..||++||.+||++.++++.
T Consensus       295 v~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  295 VDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             hcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            22111 12222 366789999999999999999999999863

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-52  Score=397.14  Aligned_cols=261  Identities=29%  Similarity=0.478  Sum_probs=223.4

Q ss_pred             HHHHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       107 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      .++......+.+.||+|.||.||.|.++....||+|.++... ...+.|.+|+++|.+|+|+|||+++|+|..++..+||
T Consensus       201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV  279 (468)
T KOG0197|consen  201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV  279 (468)
T ss_pred             eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence            344455556778999999999999999777799999997653 3456899999999999999999999999998899999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      ||||+.|+|.++|....+..+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+||||++....+
T Consensus       280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC
Confidence            99999999999998767788999999999999999999999999   999999999999999999999999999954333


Q ss_pred             ccc--cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCC
Q 014038          267 KHA--ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       267 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                      ...  ....-...|.|||.+....|+.|||||||||+||||+| |+.||.+......+.....+            .+-+
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G------------yRlp  424 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG------------YRLP  424 (468)
T ss_pred             ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc------------CcCC
Confidence            222  22334668999999999999999999999999999999 99999987766555444332            2223


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      .|..++.++.++|..||+.+|++||||+.+...|+.+...
T Consensus       425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            4555677999999999999999999999999999988653

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-50  Score=371.67  Aligned_cols=247  Identities=27%  Similarity=0.468  Sum_probs=204.3

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      .|.+.+.||+|+||+||+|+. .++..||||.+...  .+...+-+..|+.+|+.++|||||++++++.+++..|+||||
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy   90 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY   90 (429)
T ss_pred             cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence            455667799999999999965 46799999999765  555667789999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC------CcEEEeecCCcccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS------MRARVADFGLSREE  263 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~------~~~kl~Dfgl~~~~  263 (432)
                      |++|+|..+++..  +.+++..+..++.|+|.||++||+++   ||||||||+||||+..      -.+||+|||+++..
T Consensus        91 C~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   91 CNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             CCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            9999999999544  57999999999999999999999999   9999999999999764      56899999999988


Q ss_pred             cccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCC
Q 014038          264 MVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                      .......+.+|+|.|||||++..++|+.|+|+||+|+|+|+|++|+.||.......-+.......          .....
T Consensus       166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~----------~~~~~  235 (429)
T KOG0595|consen  166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN----------EIVPV  235 (429)
T ss_pred             CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc----------cccCc
Confidence            87777888999999999999999999999999999999999999999998654332222221111          11112


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIV  374 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl  374 (432)
                      .+......+.+++...++.+|.+|-++.+-.
T Consensus       236 ~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  236 LPAELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             hhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence            2223334556777778888888887665543

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.7e-50  Score=403.22  Aligned_cols=260  Identities=32%  Similarity=0.549  Sum_probs=218.8

Q ss_pred             HHHHhccccccccccCceeEEEEEeC------CCcEEEEEEeccCChh-hHHHHHHHHHHHhhcCCCccceEEeeeeeCC
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG  181 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  181 (432)
                      +......+.+.||+|+||.||+|+..      +...||||.++..... ...+|.+|++++..++|||||+|+|.|.+++
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            33444567789999999999999643      3457999999887554 7789999999999999999999999999999


Q ss_pred             eEEEEEEeccCCChhhhcccC--------C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC
Q 014038          182 QHMLVYVFMSKGSLASHLYDE--------N----YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS  249 (432)
Q Consensus       182 ~~~lv~e~~~~g~L~~~l~~~--------~----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~  249 (432)
                      ..++|+|||..|||.+||...        .    ..+|+..+.+.||.|||.||.||-++.   ++||||..+|+||.++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence            999999999999999999642        1    234889999999999999999999999   9999999999999999


Q ss_pred             CcEEEeecCCccccccccccc---ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhh
Q 014038          250 MRARVADFGLSREEMVDKHAA---NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMN  325 (432)
Q Consensus       250 ~~~kl~Dfgl~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~  325 (432)
                      ..|||+|||+++.........   ...-..+|||||.+..++||.+||||||||+|||+++ |+.||.+..+...+..+.
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~  719 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR  719 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence            999999999998654332221   2234679999999999999999999999999999999 999999877654443332


Q ss_pred             hcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          326 TEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      ..           .+ -..|..++.++++||..||+.+|.+||+++||-..|+...+.
T Consensus       720 ~g-----------~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  720 AG-----------QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             cC-----------Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            21           22 234556677999999999999999999999999999887653

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-50  Score=386.57  Aligned_cols=245  Identities=26%  Similarity=0.460  Sum_probs=211.5

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      +|...+.||+|||+.||.++. .+|+.||+|++...   .....+.+.+|+++.++|+|||||+++++|++.+..|+|.|
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE   98 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE   98 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence            566678999999999999976 89999999999763   33445678899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-c
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-K  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~  267 (432)
                      +|++++|..++.  ..+++++.++..++.||+.||.|||+++   |+|||||..|+||++++++||+|||||.....+ .
T Consensus        99 LC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   99 LCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             ecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            999999999995  5578999999999999999999999999   999999999999999999999999999876544 6


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ...+.+|||.|.|||++.....+..+||||+||+||-|++|++||+...-......+....             -.+|..
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~-------------Y~~P~~  240 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE-------------YSMPSH  240 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC-------------cccccc
Confidence            6778999999999999999999999999999999999999999998643222222221111             112334


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+.+..+||..+|+.||.+|||+.+|+.
T Consensus       241 ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  241 LSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             cCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            4567899999999999999999999986

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-50  Score=353.07  Aligned_cols=256  Identities=28%  Similarity=0.422  Sum_probs=209.3

Q ss_pred             HhccccccccccCceeEEEE-EeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEe-eeeeCCe-EEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVG-YCAEKGQ-HMLV  186 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv  186 (432)
                      +.|.+.++||+|+||+||++ +..+|..||.|.+..+  +.....+...|+.+|++|+|||||++++ -+.++.+ .++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            35566789999999999999 5679999999998754  3444567899999999999999999999 4555555 8999


Q ss_pred             EEeccCCChhhhcc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          187 YVFMSKGSLASHLY--DENYGPLTWNLRVHIALDVARGLEYLHDGAVPP--VIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       187 ~e~~~~g~L~~~l~--~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      ||||..|+|.+.+.  .+..+.+++..+++++.|++.||..+|+.- +.  |+||||||.||+|+.+|.+||+||||++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            99999999999885  355667999999999999999999999932 22  99999999999999999999999999987


Q ss_pred             ccccc-cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCC
Q 014038          263 EMVDK-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       263 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ..... .....+|||.||+||.+....|+.||||||+||++|||+.-++||.+. +...+......+          ...
T Consensus       178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~~KI~qg----------d~~  246 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLCKKIEQG----------DYP  246 (375)
T ss_pred             hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHHHHHHcC----------CCC
Confidence            65443 345679999999999999999999999999999999999999999886 333333322221          111


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR  379 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~  379 (432)
                      +..+.-.+..+..++..|+..||+.||+...+++.+..
T Consensus       247 ~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  247 PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            12224567789999999999999999996555555444

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-50  Score=369.38  Aligned_cols=252  Identities=25%  Similarity=0.422  Sum_probs=207.1

Q ss_pred             HHHhccccccccccCceeEEEE-EeCCCcEEEEEEeccCCh-------hhHHHHHHHHHHHhhcCCCccceEEeeeeeCC
Q 014038          110 QKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSK-------QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG  181 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  181 (432)
                      ....|-+.+.||+|+||.|-+| ..++|+.||||++.....       .......+|+++|++|+|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4456677899999999999999 456899999999976421       11234579999999999999999999999999


Q ss_pred             eEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC---CcEEEeecC
Q 014038          182 QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS---MRARVADFG  258 (432)
Q Consensus       182 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~---~~~kl~Dfg  258 (432)
                      ..|+||||++||+|.+++-..  +.+.+.....+++|++.|+.|||++|   |+||||||+|||+..+   ..+||+|||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence            999999999999999999544  45777888889999999999999999   9999999999999766   789999999


Q ss_pred             CcccccccccccccccCCCCCCccccccCC---CCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhh
Q 014038          259 LSREEMVDKHAANIRGTFGYLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEI  335 (432)
Q Consensus       259 l~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (432)
                      +|+.........+.+|||.|.|||++.++.   +..+.|+||+||+||-+++|.+||.+......+.          +++
T Consensus       325 lAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~----------eQI  394 (475)
T KOG0615|consen  325 LAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLK----------EQI  394 (475)
T ss_pred             hhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHH----------HHH
Confidence            999887777888999999999999997654   3358899999999999999999998643221111          111


Q ss_pred             ccccC--CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          336 VDSRL--DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       336 ~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ...+.  .+......+++..++|.+||..||++|||+.|+++.
T Consensus       395 ~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  395 LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            11111  112233456789999999999999999999998863

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-48  Score=353.69  Aligned_cols=239  Identities=27%  Similarity=0.454  Sum_probs=201.7

Q ss_pred             hccccccccccCceeEEEEE-eCCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .+++.++||+|+||.||.++ .++++.+|+|++++..   ....+....|..+|.+++||.||+++..|++.+.+|+|+|
T Consensus        26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld  105 (357)
T KOG0598|consen   26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLD  105 (357)
T ss_pred             heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEe
Confidence            55678999999999999995 4578999999997652   3345678899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DK  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~  267 (432)
                      |+.||.|..+|.  +.+.+++..+.-++.+|+.||.|||+.+   ||||||||+|||||.+|+++|+|||||+.... ..
T Consensus       106 ~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  106 YLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             ccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            999999999994  4567999999999999999999999999   99999999999999999999999999986443 34


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      .+.+++||+-|||||++.+..|+..+|.|||||++|||++|.+||.+.........+..           ..+ ...+.-
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~-----------~k~-~~~p~~  248 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK-----------GKL-PLPPGY  248 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc-----------CcC-CCCCcc
Confidence            56678999999999999999999999999999999999999999986442221111111           110 111222


Q ss_pred             HHHHHHHHHHHhhccCCCCCC
Q 014038          348 ELNEVASLAYKCVNRAPRKRP  368 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RP  368 (432)
                      .+.+..+++.+.|..||++|-
T Consensus       249 ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  249 LSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CCHHHHHHHHHHhccCHHHhc
Confidence            345789999999999999995

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-47  Score=363.20  Aligned_cols=269  Identities=25%  Similarity=0.394  Sum_probs=218.0

Q ss_pred             cCHHHHHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChh-hHHHHHHHHHHHhhcCCCccceEEeeeeeCCe
Q 014038          104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       104 ~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  182 (432)
                      -...++.+....|.++||+|-||.|.++....+..||||.++..... ..++|.+|+++|.+++||||+.++|+|..++.
T Consensus       530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP  609 (807)
T KOG1094|consen  530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP  609 (807)
T ss_pred             cchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence            34556666677788999999999999999877899999999887544 45899999999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .++|+|||++|+|.+++.......+.-....+|+.||+.||+||.+.+   ++||||.++|||+|.++++||+|||+++.
T Consensus       610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRN  686 (807)
T ss_pred             hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccc
Confidence            999999999999999997654344455667889999999999999999   99999999999999999999999999986


Q ss_pred             ccccccc---cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh--CCCCCCChhHHHHHHHhhhcCCCchhhhcc
Q 014038          263 EMVDKHA---ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA--GRSPLQGLMEYVELAAMNTEGKTGWEEIVD  337 (432)
Q Consensus       263 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      .......   ...+-..+|||+|.+..+++|.++|||+||+++||+++  ...||....+.........-....-...  
T Consensus       687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~--  764 (807)
T KOG1094|consen  687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV--  764 (807)
T ss_pred             cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce--
Confidence            5443322   23456789999999999999999999999999999765  8899987766543332211111000111  


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          338 SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       338 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                         -...|.-++..++++|.+||..|-++||+++++...|.+.
T Consensus       765 ---~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  765 ---VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ---eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence               1112334556889999999999999999999999887653

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-49  Score=384.26  Aligned_cols=262  Identities=26%  Similarity=0.486  Sum_probs=222.7

Q ss_pred             HHHHHhccccccccccCceeEEEEEeC----CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe
Q 014038          108 DLQKATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       108 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  182 (432)
                      |+..+...+.++||.|.||.||+|+++    ....||||.++... .....+|+.|+.+|.+++||||++|.|+......
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P  704 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP  704 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence            344444455679999999999999875    23579999998764 4456789999999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .++|+|||++|+|+.||+.+. +.+++.+...+.++|+.||.||-+.+   ++||||..+|||++.+..+|++||||++.
T Consensus       705 vMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceee
Confidence            999999999999999997655 56999999999999999999999999   99999999999999999999999999986


Q ss_pred             cccccc----ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhcc
Q 014038          263 EMVDKH----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVD  337 (432)
Q Consensus       263 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      ...+..    +....-..+|.|||.+..+++|.++|||||||+|||.++ |..||.++.+...+..+..           
T Consensus       781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~-----------  849 (996)
T KOG0196|consen  781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ-----------  849 (996)
T ss_pred             cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh-----------
Confidence            544331    111223578999999999999999999999999999887 9999998877665555432           


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          338 SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       338 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                       ..+-+.|.+++..|.+||+.||++|-.+||.|.+|+..|.++...-.
T Consensus       850 -gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~  896 (996)
T KOG0196|consen  850 -GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN  896 (996)
T ss_pred             -ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence             23334556677899999999999999999999999999999976544

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-47  Score=350.82  Aligned_cols=258  Identities=26%  Similarity=0.375  Sum_probs=212.4

Q ss_pred             HhccccccccccCceeEEEEE-eCCCcEEEEEEeccCCh-hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ..|.+.+.||.|..++||+|+ .+.++.||||++..+.- ...+.+.+|+..|+.++||||++++..|..+..+|+||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            367788999999999999994 56789999999987643 3357899999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc-
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH-  268 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-  268 (432)
                      |.+|++.+.++..-...+++..+..|.+++++||.|||++|   .||||||+.||||+.+|.|||+|||.+........ 
T Consensus       106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R  182 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR  182 (516)
T ss_pred             hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence            99999999997655556999999999999999999999999   99999999999999999999999998754332211 


Q ss_pred             ----ccccccCCCCCCccccc--cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          269 ----AANIRGTFGYLDPEYIS--TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       269 ----~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                          ..+++||++|||||++.  -..|+.|+|||||||+..||.+|..||........+....++......   -..++.
T Consensus       183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~---t~~~~~  259 (516)
T KOG0582|consen  183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL---TSGLDK  259 (516)
T ss_pred             eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc---cccCCh
Confidence                15678999999999953  346999999999999999999999999887665554443333221111   111222


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .........+.+++..||+.||++|||++++++
T Consensus       260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            222234468999999999999999999999986

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-47  Score=363.91  Aligned_cols=243  Identities=26%  Similarity=0.443  Sum_probs=210.5

Q ss_pred             cccccccCceeEEEE-EeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCCh
Q 014038          117 TTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  195 (432)
                      ..+||+|+.|.||.| +..+++.||||++........+-+.+|+.+|+..+|+|||+++..|..++.+|+|||||++|+|
T Consensus       278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL  357 (550)
T KOG0578|consen  278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL  357 (550)
T ss_pred             hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence            357999999999999 5668899999999877666667789999999999999999999999989999999999999999


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-ccccccc
Q 014038          196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRG  274 (432)
Q Consensus       196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~~g  274 (432)
                      .+.+..   ..+++.++..|++++++||+|||.++   |+|||||.+|||++.+|.+||+|||+|....... ...+.+|
T Consensus       358 TDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVG  431 (550)
T KOG0578|consen  358 TDVVTK---TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVG  431 (550)
T ss_pred             hhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccC
Confidence            998843   34999999999999999999999999   9999999999999999999999999997654433 5567889


Q ss_pred             CCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHH
Q 014038          275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVAS  354 (432)
Q Consensus       275 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  354 (432)
                      ||.|||||+.....|.+|.||||||++++||+-|++||-.......+..+..++...+          ..+...+.++.+
T Consensus       432 TPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~l----------k~~~klS~~~kd  501 (550)
T KOG0578|consen  432 TPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKL----------KNPEKLSPELKD  501 (550)
T ss_pred             CCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCc----------CCccccCHHHHH
Confidence            9999999999999999999999999999999999999976555444444433333211          223345578999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 014038          355 LAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       355 li~~cl~~dp~~RPs~~~vl~  375 (432)
                      |+.+||+.|+++||++.|+|+
T Consensus       502 FL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  502 FLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             HHHHHhhcchhcCCCHHHHhc
Confidence            999999999999999999987

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-47  Score=353.16  Aligned_cols=249  Identities=28%  Similarity=0.469  Sum_probs=201.3

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC--eEEEEEEec
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG--QHMLVYVFM  190 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~  190 (432)
                      +...+.||+|+||.||++... +|+..|||.+........+.+.+|+.+|.+++|||||+++|......  .++++|||+
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~   98 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA   98 (313)
T ss_pred             hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence            345578999999999999654 58999999987654333667899999999999999999999855544  689999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC-CCcEEEeecCCcccccc----
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLSREEMV----  265 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~-~~~~kl~Dfgl~~~~~~----  265 (432)
                      ++|+|.+++....+ .|++..+..++.||++||.|||+++   |+||||||+||||+. ++.+||+|||+++....    
T Consensus        99 ~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   99 PGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             CCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            99999999976554 8999999999999999999999999   999999999999999 79999999999876542    


Q ss_pred             cccccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCCh-hHHHHHHHhhhcCCCchhhhccccCCCC
Q 014038          266 DKHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGL-MEYVELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                      ........||+.|||||++..+ ....++|||||||++.||+||+.||... ........+....           ..+.
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-----------~~P~  243 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-----------SLPE  243 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-----------CCCC
Confidence            1223457899999999999853 3335999999999999999999999863 1111111111111           1113


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                      .+...+.+..+|+.+|++.||++|||+.++++..
T Consensus       244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            3444556899999999999999999999998753

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=358.59  Aligned_cols=260  Identities=26%  Similarity=0.383  Sum_probs=218.0

Q ss_pred             HHhccccccccccCceeEEEEE-eCCCcEEEEEEeccCChhh-HHHHHHHHHHHhhcC-CCccceEEeeeeeCC-eEEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLH-HRNLVNLVGYCAEKG-QHMLV  186 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv  186 (432)
                      ..+|...++||.|.||.||+|+ ..+|+.||||.++..-..- +..=++|+..|++++ ||||+++..++.+.+ .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            3577788999999999999995 4578999999987653332 223468999999998 999999999998887 99999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      ||||+ .+|+++++.+ ...|++..+..|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+|||+|+.....
T Consensus        89 fE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   89 FEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             HHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccC
Confidence            99996 5999999877 789999999999999999999999999   999999999999998889999999999988777


Q ss_pred             ccccccccCCCCCCcccc-ccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh----cCCCchhh------h
Q 014038          267 KHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT----EGKTGWEE------I  335 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~~------~  335 (432)
                      ......+.|.+|+|||++ +...|+.+.|+||+|||++|+.+-++.|.+..+.+++..+..    ..++.|.+      .
T Consensus       164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~  243 (538)
T KOG0661|consen  164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA  243 (538)
T ss_pred             CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence            777888999999999986 677899999999999999999999999999888877766533    23333322      1


Q ss_pred             ccccCC--------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          336 VDSRLD--------GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       336 ~~~~~~--------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      +.-.++        ...+ ..+.+..++|.+|+..||.+|||+.+.++.
T Consensus       244 mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  244 MNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             hccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            111111        1112 245789999999999999999999999874

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-48  Score=365.34  Aligned_cols=252  Identities=29%  Similarity=0.469  Sum_probs=212.4

Q ss_pred             CCCCcCHHHHHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeee
Q 014038          100 GIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE  179 (432)
Q Consensus       100 ~~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  179 (432)
                      ...++.|+++..-.     -||.|+.|.||+|++ .++.||||+++...       ..+|+-|++|+||||+.+.|+|..
T Consensus       117 e~WeiPFe~IsELe-----WlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq  183 (904)
T KOG4721|consen  117 ELWEIPFEEISELE-----WLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ  183 (904)
T ss_pred             hhccCCHHHhhhhh-----hhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC
Confidence            34456666665433     499999999999999 56899999874321       357888999999999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCC
Q 014038          180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL  259 (432)
Q Consensus       180 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl  259 (432)
                      ...+|+|||||..|-|.+.|+  ...+++......|..+||.|+.|||.+.   |||||||+-||||..+..|||+|||-
T Consensus       184 sPcyCIiMEfCa~GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGT  258 (904)
T KOG4721|consen  184 SPCYCIIMEFCAQGQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGT  258 (904)
T ss_pred             CceeEEeeeccccccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccc
Confidence            999999999999999999995  4467899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          260 SREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ++..........++||..|||||+++....++|.|||||||+||||+||..||.+......+    ...       -...
T Consensus       259 S~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----wGV-------GsNs  327 (904)
T KOG4721|consen  259 SKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----WGV-------GSNS  327 (904)
T ss_pred             hHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----Eec-------cCCc
Confidence            98766666667899999999999999999999999999999999999999999864432111    111       1223


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      +.-+.+..++.-+.-|+.+||+..|.+||+|.+++..|+-.
T Consensus       328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            44455666777889999999999999999999999887543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1e-46  Score=361.55  Aligned_cols=264  Identities=27%  Similarity=0.491  Sum_probs=211.7

Q ss_pred             CHHHHHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe
Q 014038          105 SYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       105 ~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  182 (432)
                      .++++......+...||+|+||+||+|.+.  ..||||++....  ....+.|++|+.++++-+|.||+-+.|||...+.
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            344444444456778999999999999984  469999998763  4456789999999999999999999999998777


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                       .+|+.||+|-+|+.+++... ..|+....+.|+.||++|+.|||.++   |||||||+.||+|.+++.|||+||||+..
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             -eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence             99999999999999998755 56899999999999999999999999   99999999999999999999999999864


Q ss_pred             ccc---cccccccccCCCCCCcccccc---CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhc
Q 014038          263 EMV---DKHAANIRGTFGYLDPEYIST---RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIV  336 (432)
Q Consensus       263 ~~~---~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      ...   ........|...|||||+++.   .+|++.+||||||+++|||+||..||. .....++..+...+..      
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l------  610 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYL------  610 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEeccccc------
Confidence            222   223344568889999999964   469999999999999999999999998 3332222222222210      


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      .+.+. .....++.++.+|+..||..++++||.+.+|+..|+.++..
T Consensus       611 ~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  611 MPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             Cccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            00000 01223456899999999999999999999999988888653

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9.4e-47  Score=334.06  Aligned_cols=256  Identities=24%  Similarity=0.345  Sum_probs=206.0

Q ss_pred             cccccccccCceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          115 NFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      +-..++|+|+||+||+++.+ +|+.||||++....  +.-.+-.++|+++|++++|||+|.++.+|......+||+|||+
T Consensus         5 E~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~d   84 (396)
T KOG0593|consen    5 EKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCD   84 (396)
T ss_pred             hhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecc
Confidence            33457999999999999654 79999999986543  3334567899999999999999999999999999999999998


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc-cccccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~-~~~~~~  270 (432)
                      ..-|.+ |. .....++...+.+++.|++.|+.|+|+++   +|||||||+||||+.++.+||||||+|+... .+....
T Consensus        85 hTvL~e-Le-~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT  159 (396)
T KOG0593|consen   85 HTVLHE-LE-RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT  159 (396)
T ss_pred             hHHHHH-HH-hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence            854444 42 33445899999999999999999999999   9999999999999999999999999999765 344456


Q ss_pred             ccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCch---hhhc----------
Q 014038          271 NIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW---EEIV----------  336 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~----------  336 (432)
                      ..+.|.+|.|||.+.+ .+|....||||+||++.||++|.+-|++..+..++..+...-....   ..++          
T Consensus       160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~  239 (396)
T KOG0593|consen  160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR  239 (396)
T ss_pred             hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence            6788999999999876 7899999999999999999999999999888877765543222111   1111          


Q ss_pred             cccCCCCCCH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          337 DSRLDGIFDV-----EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       337 ~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      -|......+.     ..+.-+.+|+..||+.||.+|++.++++.
T Consensus       240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1111111111     12347889999999999999999999875

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-46  Score=357.46  Aligned_cols=247  Identities=26%  Similarity=0.438  Sum_probs=209.0

Q ss_pred             HhccccccccccCceeEEEEE-eCCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD---SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  186 (432)
                      .++.|.+.||+|+|++|++|+ ..+++.||||++.+.   .....+....|-.+|.+| .||.|++|+..|++...+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            356788999999999999995 558899999998654   223345677899999999 799999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      +||+++|+|.++|.  ..+.|++.....++.+|+.||+|||++|   ||||||||+|||||.||++||+|||-++.....
T Consensus       153 Le~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             EEecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            99999999999994  4578999999999999999999999999   999999999999999999999999988743211


Q ss_pred             ------------cc--ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCch
Q 014038          267 ------------KH--AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW  332 (432)
Q Consensus       267 ------------~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  332 (432)
                                  ..  ...++||..|.+||++.....+..+|+|+||||||+|+.|++||.+..++.....+..-.    
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~----  303 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD----  303 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc----
Confidence                        11  245899999999999999999999999999999999999999999988876655443211    


Q ss_pred             hhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                           -.+...+    ++...+|+.+.|..||.+|++..+|-+.
T Consensus       304 -----y~fp~~f----p~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  304 -----YEFPEGF----PEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -----ccCCCCC----CHHHHHHHHHHHccCccccccHHHHhhC
Confidence                 1122222    3578899999999999999999887763

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.2e-46  Score=359.60  Aligned_cols=260  Identities=32%  Similarity=0.550  Sum_probs=204.8

Q ss_pred             HHHhccccccccccCceeEEEEEe------CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeC-
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK-  180 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  180 (432)
                      ....+.+.+.||+|+||.||+|..      .+++.||||++.... ......+.+|+.++..+ +||||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            345677889999999999999963      235689999987543 23346789999999999 899999999988764 


Q ss_pred             CeEEEEEEeccCCChhhhcccCC---------------------------------------------------------
Q 014038          181 GQHMLVYVFMSKGSLASHLYDEN---------------------------------------------------------  203 (432)
Q Consensus       181 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  203 (432)
                      +..+++|||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            46889999999999998885421                                                         


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc---cccccccCCC
Q 014038          204 ---YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFG  277 (432)
Q Consensus       204 ---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~  277 (432)
                         ..++++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......   ......+++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               135888899999999999999999998   9999999999999999999999999987543221   1123345678


Q ss_pred             CCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHH
Q 014038          278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLA  356 (432)
Q Consensus       278 y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  356 (432)
                      |+|||++.+..++.++|||||||++|||++ |..||.+.............+.           ....+...+.++.+++
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~li  310 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT-----------RMRAPENATPEIYRIM  310 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC-----------CCCCCCCCCHHHHHHH
Confidence            999999998999999999999999999997 9999976432111111111110           0011222345789999


Q ss_pred             HHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          357 YKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       357 ~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      .+||+.||.+|||+.+|++.|++++..
T Consensus       311 ~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         311 LACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-46  Score=361.60  Aligned_cols=264  Identities=31%  Similarity=0.488  Sum_probs=218.5

Q ss_pred             HHHHHHhccccccccccCceeEEEEEeC--CC--cE-EEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeee
Q 014038          107 KDLQKATCNFTTLIGQGAFGPVYKAQMS--TG--ET-VAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA  178 (432)
Q Consensus       107 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  178 (432)
                      +++...+..+.++||+|+||.||+|++.  ++  .. ||||..+..   .....++|++|+++|+.++|||||+++|++.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            5566666677789999999999999654  22  23 899998853   4566789999999999999999999999999


Q ss_pred             eCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecC
Q 014038          179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFG  258 (432)
Q Consensus       179 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg  258 (432)
                      ....+++|||+|.||+|.++|.... ..++..+++.++.+.|.||+|||+++   +|||||-.+|||++.++.+||+|||
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence            9999999999999999999996543 36999999999999999999999999   9999999999999999999999999


Q ss_pred             Cccccccccccc-ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhc
Q 014038          259 LSREEMVDKHAA-NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV  336 (432)
Q Consensus       259 l~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      +++......... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+.........+...         
T Consensus       308 Ls~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~---------  378 (474)
T KOG0194|consen  308 LSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN---------  378 (474)
T ss_pred             cccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc---------
Confidence            987653211111 1235678999999999999999999999999999999 89999987665433333222         


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                        ..+...+...+.++..++.+||..+|++||+|.++.+.|+.+.....
T Consensus       379 --~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  379 --GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             --CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence              12222333455688999999999999999999999999999976544

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-45  Score=344.99  Aligned_cols=259  Identities=29%  Similarity=0.377  Sum_probs=208.2

Q ss_pred             HhccccccccccCceeEEEE-EeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeC--CeEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHMLV  186 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  186 (432)
                      ..|+-.++||+|.||.||+| +..+|+.||+|+++.+.  .....-..+||.+|++|+||||++|.+...+.  +..|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            44555678999999999999 46789999999998764  34445678999999999999999999988776  789999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      +|||++ +|.-++.. ..-.|++.++..++.|++.||+|+|+++   |+|||||.+|||||.+|.+||+|||||+.....
T Consensus       197 FeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             Eecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            999987 88887743 3457999999999999999999999999   999999999999999999999999999854433


Q ss_pred             c--cccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcC----CCchhhhcccc
Q 014038          267 K--HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG----KTGWEEIVDSR  339 (432)
Q Consensus       267 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  339 (432)
                      .  .....+.|.+|.|||++.+ ..|+.+.|+||.||||.||++|++.|++..+..++..+-..-    ...|...--+.
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~  351 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH  351 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence            2  3566788999999999865 479999999999999999999999999988877766543221    12233100000


Q ss_pred             ---CC--CCCCH-------HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          340 ---LD--GIFDV-------EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       340 ---~~--~~~~~-------~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                         +.  ..+..       ..+....+|+..+|..||.+|.|+.++++
T Consensus       352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence               00  11111       11356788999999999999999999875

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=379.81  Aligned_cols=258  Identities=32%  Similarity=0.539  Sum_probs=217.2

Q ss_pred             HhccccccccccCceeEEEEEeC--CCc----EEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS--TGE----TVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  184 (432)
                      ....+.+.||+|+||.||.|...  +|.    .||||.+... +.+...+|.+|..+|+.++|||||+++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            34467788999999999999653  333    4999999775 5566789999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhcccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCC
Q 014038          185 LVYVFMSKGSLASHLYDEN-----YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL  259 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl  259 (432)
                      +++|||++|+|..+|++.+     ...++....+.++.|||+|+.||++++   +|||||..+|+||+....+||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999997542     345888999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccc-cc--ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhh
Q 014038          260 SREEMVDKH-AA--NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEI  335 (432)
Q Consensus       260 ~~~~~~~~~-~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (432)
                      |+....... ..  ...-...|||||.+..+.|+.|+|||||||++||++| |..||.+..+...+......++      
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR------  922 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR------  922 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc------
Confidence            995333221 11  1234568999999999999999999999999999999 9999998887766654443332      


Q ss_pred             ccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                          +  ..|..++..+.++|..||+.+|++||+|..|++.+..+....
T Consensus       923 ----L--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  923 ----L--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             ----c--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence                2  234445568999999999999999999999999999887644

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-45  Score=351.12  Aligned_cols=252  Identities=27%  Similarity=0.394  Sum_probs=210.1

Q ss_pred             HHhccccccccccCceeEEEEE-eCCCcEEEEEEeccC----Ch-hhHHHHHHHHHHHhhcC-CCccceEEeeeeeCCeE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD----SK-QGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQH  183 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  183 (432)
                      ...|.+.+.||+|+||.|++|. ..+++.||+|++...    .. ...+.+.+|+.++++++ ||||++++.++......
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~   95 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI   95 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence            3467788899999999999994 457899999977653    12 23456678999999998 99999999999999999


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC-CcEEEeecCCccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-MRARVADFGLSRE  262 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~-~~~kl~Dfgl~~~  262 (432)
                      ++||||+.+|+|.+++..  .+++.+..+.+++.|++.|++|||+++   |+||||||+|||+|.+ +++||+|||++..
T Consensus        96 ~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   96 YIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            999999999999999965  578999999999999999999999999   9999999999999999 9999999999987


Q ss_pred             c-cccccccccccCCCCCCccccccCC-CC-chhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          263 E-MVDKHAANIRGTFGYLDPEYISTRN-FT-KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       263 ~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      . .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||........... ...+.-.        
T Consensus       171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-i~~~~~~--------  241 (370)
T KOG0583|consen  171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-IRKGEFK--------  241 (370)
T ss_pred             cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-HhcCCcc--------
Confidence            6 4556778899999999999999877 86 799999999999999999999987432222111 1111111        


Q ss_pred             CCCCCCHHH-HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 014038          340 LDGIFDVEE-LNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL  381 (432)
Q Consensus       340 ~~~~~~~~~-~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~  381 (432)
                          ++... +.++..++.+||..||.+|+++.+|+ .-..+.
T Consensus       242 ----~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~  279 (370)
T KOG0583|consen  242 ----IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ  279 (370)
T ss_pred             ----CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence                11111 45889999999999999999999999 444443

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.5e-45  Score=343.50  Aligned_cols=259  Identities=20%  Similarity=0.328  Sum_probs=205.7

Q ss_pred             CCCcCHHHHHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhh---HHHHHHHHHHHhhcCCCccceEEeee
Q 014038          101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG---EKEFQTEVMLLGRLHHRNLVNLVGYC  177 (432)
Q Consensus       101 ~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~  177 (432)
                      +..++..++...+   ...||+|++|.||+|.+ +|+.||||.+.......   .+.|.+|+.+|.+++||||++++|++
T Consensus        12 ~~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~   87 (283)
T PHA02988         12 IKCIESDDIDKYT---SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI   87 (283)
T ss_pred             ceecCHHHcCCCC---CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence            3445555553221   14699999999999988 78999999987643322   46788999999999999999999998


Q ss_pred             ee----CCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCeeecCCCcE
Q 014038          178 AE----KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRA  252 (432)
Q Consensus       178 ~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlkp~Nill~~~~~~  252 (432)
                      .+    ....++||||+++|+|.+++...  ..+++.....++.+++.||.|||+. +   ++||||||+|||+++++.+
T Consensus        88 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~  162 (283)
T PHA02988         88 IDIVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKL  162 (283)
T ss_pred             EecccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcE
Confidence            76    34789999999999999999643  5689999999999999999999984 6   7899999999999999999


Q ss_pred             EEeecCCcccccccccccccccCCCCCCcccccc--CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCC
Q 014038          253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT  330 (432)
Q Consensus       253 kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  330 (432)
                      ||+|||+++.....  .....++..|+|||++.+  ..++.++|||||||++|||++|+.||.+..............  
T Consensus       163 kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~--  238 (283)
T PHA02988        163 KIICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKN--  238 (283)
T ss_pred             EEcccchHhhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC--
Confidence            99999998753322  223467899999999976  689999999999999999999999998654322111111111  


Q ss_pred             chhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 014038          331 GWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL  381 (432)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~  381 (432)
                               .....+...+.++.+++.+||+.||++|||+.++++.|+.+.
T Consensus       239 ---------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        239 ---------NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             ---------CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence                     111122234568999999999999999999999999998763

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.3e-45  Score=343.18  Aligned_cols=250  Identities=26%  Similarity=0.421  Sum_probs=201.8

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      |...+.||+|+||.||+|.. .+|+.||+|.+....   ......+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            45568899999999999964 578999999986432   22334678999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA  269 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  269 (432)
                      +++|+|..++.......+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.........
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV  158 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence            99999998886555557999999999999999999999999   999999999999999999999999998764333333


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...............       +.  .....++...+
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-------~~--~~~~~~~~~~s  229 (285)
T cd05631         159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR-------VK--EDQEEYSEKFS  229 (285)
T ss_pred             cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH-------hh--cccccCCccCC
Confidence            4567899999999999999999999999999999999999999764321111110000       00  00111222334


Q ss_pred             HHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPS-----MRDIVQ  375 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs-----~~~vl~  375 (432)
                      .++.+|+.+||+.||.+||+     ++++++
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         230 EDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            57899999999999999997     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-45  Score=354.13  Aligned_cols=245  Identities=27%  Similarity=0.428  Sum_probs=211.9

Q ss_pred             ccccccccccCceeEEEEE-eCCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          114 CNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      |.+.+.||+|+.|.|-+|+ ..+|+.+|||++....   ......+.+|+.+|+-+.|||++++++++.+..++|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            4556789999999999994 5689999999997652   23345678999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA  269 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  269 (432)
                      +++|.|.+++..  .+++++.++.+++.||+.|+.|+|..+   |+||||||+|+|||..+++||+|||+|.....+...
T Consensus        94 v~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL  168 (786)
T KOG0588|consen   94 VPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL  168 (786)
T ss_pred             cCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence            999999999954  468999999999999999999999999   999999999999999999999999999988888888


Q ss_pred             cccccCCCCCCccccccCCCC-chhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      .+.||+|.|.|||++.+..|+ .++||||.|||||.|+||+.||++..-..-+... ..+.-            ..|...
T Consensus       169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV-~~G~f------------~MPs~I  235 (786)
T KOG0588|consen  169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV-QRGVF------------EMPSNI  235 (786)
T ss_pred             cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH-HcCcc------------cCCCcC
Confidence            999999999999999999996 7999999999999999999999864332222222 22211            123344


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      +.+..+|+.+|+..||+.|-|+++|++.
T Consensus       236 s~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  236 SSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             CHHHHHHHHHHhccCccccccHHHHhhC
Confidence            5688999999999999999999999874

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-46  Score=346.04  Aligned_cols=242  Identities=27%  Similarity=0.432  Sum_probs=204.8

Q ss_pred             cccccccCceeEEEEE-eCCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCC
Q 014038          117 TTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS  194 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  194 (432)
                      .+.||+|+||.||+|. ..+++.||+|++..+. ....+++.+|+.+|.+++++||.++||.+..+..++++||||.+|+
T Consensus        18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs   97 (467)
T KOG0201|consen   18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS   97 (467)
T ss_pred             chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence            3689999999999994 5578999999998763 4456789999999999999999999999999999999999999999


Q ss_pred             hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-ccccccc
Q 014038          195 LASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR  273 (432)
Q Consensus       195 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~~  273 (432)
                      +.+.|.  .+..+++..+.-++++++.||.|||.++   .+|||||+.|||+..+|.+||+|||++-..... ....+++
T Consensus        98 v~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfv  172 (467)
T KOG0201|consen   98 VLDLLK--SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFV  172 (467)
T ss_pred             hhhhhc--cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcccccc
Confidence            999994  4445688888889999999999999999   999999999999999999999999998765443 3347899


Q ss_pred             cCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHH
Q 014038          274 GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVA  353 (432)
Q Consensus       274 gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  353 (432)
                      |||.|||||++....|+.|+||||||++.+||.+|.+|+........            --++....++......+..+.
T Consensus       173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv------------lflIpk~~PP~L~~~~S~~~k  240 (467)
T KOG0201|consen  173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV------------LFLIPKSAPPRLDGDFSPPFK  240 (467)
T ss_pred             ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE------------EEeccCCCCCccccccCHHHH
Confidence            99999999999988999999999999999999999999976443111            111122222222234456799


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 014038          354 SLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       354 ~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +|+..||++||+.||++.++++
T Consensus       241 EFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  241 EFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             HHHHHHhhcCcccCcCHHHHhh
Confidence            9999999999999999999986

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.1e-45  Score=347.89  Aligned_cols=243  Identities=27%  Similarity=0.438  Sum_probs=206.4

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      |.+.+.||+|+||.||||+. .+.+.||+|.+.+..  +...+.+.+|++++++++||||+.++++|+...+.++|+||+
T Consensus         4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a   83 (808)
T KOG0597|consen    4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA   83 (808)
T ss_pred             hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence            45567899999999999954 478999999997643  344567899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc-c
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH-A  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-~  269 (432)
                      .| +|..+|  ...+.+++..+..++.+++.||.|||+++   |+|||+||.|||++.++.+|+||||+++.+..... .
T Consensus        84 ~g-~L~~il--~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl  157 (808)
T KOG0597|consen   84 VG-DLFTIL--EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL  157 (808)
T ss_pred             hh-hHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence            77 999999  44567999999999999999999999999   99999999999999999999999999997766543 3


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....|||.|||||+..++.|+..+|.||+|||+|||++|++||....- ..+........            ..++...+
T Consensus       158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si-~~Lv~~I~~d~------------v~~p~~~S  224 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI-TQLVKSILKDP------------VKPPSTAS  224 (808)
T ss_pred             eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH-HHHHHHHhcCC------------CCCccccc
Confidence            457899999999999999999999999999999999999999975322 22222211111            11233556


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.+|+...|.+||.+|-+..+++.
T Consensus       225 ~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  225 SSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HHHHHHHHHHhhcChhhcccHHHHhc
Confidence            78999999999999999999999875

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=351.98  Aligned_cols=240  Identities=27%  Similarity=0.463  Sum_probs=206.4

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ..+.|.++||+|+||+|+++..+ +++.+|||.++++   ...+.+..+.|.+++... +||.+++++..|++..+.|+|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            35677899999999999999654 6789999999876   345566788888888877 599999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc-c
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-V  265 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~-~  265 (432)
                      |||+.||++..+.   ..+.+++..+.-++..|+.||+|||+++   ||+||||.+|||||.+|++||+|||+++... .
T Consensus       448 mey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  448 MEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCC
Confidence            9999999954444   3456999999999999999999999999   9999999999999999999999999999766 5


Q ss_pred             cccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      +..+.+++|||-|||||++.+..|+...|.|||||+||||+.|+.||.+..+......+...             ...+|
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-------------~~~yP  588 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-------------EVRYP  588 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------CCCCC
Confidence            66788999999999999999999999999999999999999999999987664443333211             11244


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSM  370 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~  370 (432)
                      .-.+.+..+++.++|.++|++|.-+
T Consensus       589 ~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  589 RFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CcccHHHHHHHHHHhccCcccccCC
Confidence            4556789999999999999999754

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=319.79  Aligned_cols=234  Identities=27%  Similarity=0.410  Sum_probs=199.7

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      +++.+.||.|+||.|.+++.+ +|..+|+|++....-   ...+...+|..+|+.+.||+++++++.|.+.+..++||||
T Consensus        46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey  125 (355)
T KOG0616|consen   46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY  125 (355)
T ss_pred             hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence            356678999999999999754 688999999976532   3345678999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA  269 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  269 (432)
                      ++||.|..+++  ..++++++.+.-++.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||+++....  .+
T Consensus       126 v~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--rT  198 (355)
T KOG0616|consen  126 VPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--RT  198 (355)
T ss_pred             cCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC--cE
Confidence            99999999994  4567999999999999999999999999   99999999999999999999999999987543  36


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      -+.+|||.|+|||++..+.|..++|.|||||++|||+.|.+||.........           +.++...+  .+|.-..
T Consensus       199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY-----------~KI~~~~v--~fP~~fs  265 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY-----------EKILEGKV--KFPSYFS  265 (355)
T ss_pred             EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH-----------HHHHhCcc--cCCcccC
Confidence            7889999999999999999999999999999999999999999875542211           22222222  1333344


Q ss_pred             HHHHHHHHHhhccCCCCC
Q 014038          350 NEVASLAYKCVNRAPRKR  367 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~R  367 (432)
                      .++.+|+...|+.|-.+|
T Consensus       266 ~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  266 SDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHHHHHHHHHHhhhhHhh
Confidence            578999999999999988

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.9e-44  Score=313.07  Aligned_cols=257  Identities=25%  Similarity=0.389  Sum_probs=209.3

Q ss_pred             ccccccccccCceeEEEE-EeCCCcEEEEEEeccCCh--hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          114 CNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      |.-.++||+|.||.||+| +..+|+.||||+++....  .......+|++.|+.++|+||+.++++|...+...+|+|||
T Consensus         4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm   83 (318)
T KOG0659|consen    4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM   83 (318)
T ss_pred             hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence            444578999999999999 456899999999976532  22346789999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc-c
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH-A  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-~  269 (432)
                      +. +|+..++++. ..++...+..++.++++||+|||.+.   |+||||||.|+|++.+|.+||+|||+++....... .
T Consensus        84 ~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~  158 (318)
T KOG0659|consen   84 PT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ  158 (318)
T ss_pred             cc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence            75 9999987644 67999999999999999999999999   99999999999999999999999999997654432 2


Q ss_pred             cccccCCCCCCccccc-cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh----cCCCchhhhc--------
Q 014038          270 ANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT----EGKTGWEEIV--------  336 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~~~~--------  336 (432)
                      ...+.|.+|.|||.+. .+.|+...|+||.|||+.||+-|.+-|.+..+..++..+-.    .....|.++.        
T Consensus       159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~  238 (318)
T KOG0659|consen  159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI  238 (318)
T ss_pred             ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence            3347899999999875 46799999999999999999999999999888777665432    2223333221        


Q ss_pred             ----cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          337 ----DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       337 ----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                          .+.+...++ ....+..+++..+|..||.+|.++.|.++.
T Consensus       239 ~~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  239 QQFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             hcCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                011111122 234567999999999999999999998863

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.7e-44  Score=352.03  Aligned_cols=258  Identities=30%  Similarity=0.493  Sum_probs=204.6

Q ss_pred             HHHHhccccccccccCceeEEEEEe------CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeC
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK  180 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  180 (432)
                      +....+.+.+.||+|+||.||+|..      .++..||||++.... ....+.+.+|+.++..+ +||||++++++|...
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            3345677889999999999999953      245689999986542 33446788999999999 899999999999999


Q ss_pred             CeEEEEEEeccCCChhhhcccCC---------------------------------------------------------
Q 014038          181 GQHMLVYVFMSKGSLASHLYDEN---------------------------------------------------------  203 (432)
Q Consensus       181 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  203 (432)
                      +..++||||+++|+|.+++....                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            99999999999999998885321                                                         


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          204 ----------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       204 ----------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                                      ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                            125788999999999999999999998   9999999999999999999999999987543222


Q ss_pred             c---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCC
Q 014038          268 H---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       268 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                      .   .....++..|+|||.+.+..++.++|||||||++|||++ |..||...............+.           ...
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-----------~~~  337 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY-----------RML  337 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc-----------cCC
Confidence            1   112334667999999999999999999999999999998 8999976433222222111111           011


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      .+...+.++.+++.+||+.||++||++.+|++.|++.
T Consensus       338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            1111235789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.3e-44  Score=332.19  Aligned_cols=254  Identities=22%  Similarity=0.420  Sum_probs=206.3

Q ss_pred             HHhccccccccccCceeEEEEEeC----CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      ...+.+.+.||+|+||.||+|.+.    .+..||+|.+.... ......|.+|+..+..++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            456778899999999999999643    45689999987653 3334678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+++|+|.+++... ...+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+|++|||.+.....
T Consensus        84 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          84 VTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            99999999999998643 347899999999999999999999998   99999999999999999999999998764322


Q ss_pred             ccc--ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          266 DKH--AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       266 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ...  .....++..|+|||.+.+..++.++|||||||++||+++ |+.||.+.............            ...
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~------------~~~  227 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG------------FRL  227 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC------------CCC
Confidence            211  122345678999999998999999999999999999775 99999865443222222111            011


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      ..+...+..+.+++.+||+.+|.+||++.+|++.|.++
T Consensus       228 ~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            11223445789999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1e-43  Score=338.44  Aligned_cols=260  Identities=27%  Similarity=0.453  Sum_probs=201.3

Q ss_pred             HHhccccccccccCceeEEEEEeCC-----------------CcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccce
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMST-----------------GETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVN  172 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  172 (432)
                      ...|.+.+.||+|+||.||++.+.+                 +..||+|.+.... .....+|.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3467788899999999999996532                 3479999987643 344567999999999999999999


Q ss_pred             EEeeeeeCCeEEEEEEeccCCChhhhcccCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 014038          173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDEN-----------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVI  235 (432)
Q Consensus       173 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ii  235 (432)
                      +++++.+.+..++||||+++|+|.+++....                 ...+++..+.+++.||+.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999999885321                 134788899999999999999999999   99


Q ss_pred             eccCCCCCeeecCCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh--CCC
Q 014038          236 HRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA--GRS  310 (432)
Q Consensus       236 H~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt--g~~  310 (432)
                      ||||||+|||++.++.+||+|||+++......   ......++..|+|||.+....++.++||||||+++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            99999999999999999999999987532221   1223345788999999988899999999999999999987  567


Q ss_pred             CCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          311 PLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       311 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                      ||......................     .....+...+..+.+++.+||+.||++|||+.+|.+.|+
T Consensus       241 p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQVIENAGEFFRDQGRQ-----VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHHHHHHHHHHhhhcccc-----ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            887644322221111000000000     000011223457899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.3e-44  Score=341.70  Aligned_cols=246  Identities=25%  Similarity=0.364  Sum_probs=198.9

Q ss_pred             ccccccccccCceeEEEEE-eCCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          114 CNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      +++...||+|+||.||+|+ ..+|..+|+|++++..   ....+..+.|-.+|...++|+||+|+..|++...+||||||
T Consensus       143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy  222 (550)
T KOG0605|consen  143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY  222 (550)
T ss_pred             chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence            4455789999999999995 4589999999998753   34456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc----
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV----  265 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~----  265 (432)
                      ++||++..+|.  ..+.|++..+..++.+++.|+.-||+.|   +|||||||+|+|||..|++||+|||||.....    
T Consensus       223 lPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  223 LPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             cCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence            99999999994  4568999999999999999999999999   99999999999999999999999999851100    


Q ss_pred             -----------------c---c------c------------------ccccccCCCCCCccccccCCCCchhHhHHHHHH
Q 014038          266 -----------------D---K------H------------------AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVL  301 (432)
Q Consensus       266 -----------------~---~------~------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvi  301 (432)
                                       .   .      .                  ....+|||.|||||++.+..|+..+|.||||||
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I  377 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI  377 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence                             0   0      0                  011359999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHH
Q 014038          302 LFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPS---MRDIV  374 (432)
Q Consensus       302 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~~vl  374 (432)
                      +||||.|.+||.+......+..+....     .    .+.-+.......+..+||.+|+. ||++|--   +.||-
T Consensus       378 myEmLvGyPPF~s~tp~~T~rkI~nwr-----~----~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  378 MYEMLVGYPPFCSETPQETYRKIVNWR-----E----TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK  443 (550)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHh-----h----hccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence            999999999998765544333322111     1    11111122233688999999999 9999964   44444

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.1e-44  Score=350.47  Aligned_cols=259  Identities=31%  Similarity=0.530  Sum_probs=205.2

Q ss_pred             HHHHhccccccccccCceeEEEEEe------CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeC
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK  180 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  180 (432)
                      +....+.+.+.||+|+||.||+|..      .++..||+|.+.... ......+.+|+.+++.+ +|+||++++++|...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            4455677889999999999999863      234579999997543 33345788999999999 899999999999999


Q ss_pred             CeEEEEEEeccCCChhhhcccCC---------------------------------------------------------
Q 014038          181 GQHMLVYVFMSKGSLASHLYDEN---------------------------------------------------------  203 (432)
Q Consensus       181 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  203 (432)
                      +..++||||+++|+|.+++....                                                         
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            99999999999999998874321                                                         


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc---c
Q 014038          204 -----------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH---A  269 (432)
Q Consensus       204 -----------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~---~  269 (432)
                                 ..++++..+++++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++.......   .
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                       135788999999999999999999998   99999999999999999999999999875432211   1


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      ....++..|+|||++....++.++|||||||++|||++ |+.||...............+           .....+...
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~-----------~~~~~~~~~  340 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG-----------YQMSRPDFA  340 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc-----------cCccCCCCC
Confidence            12235668999999988899999999999999999997 999997643322211111111           111111112


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL  381 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~  381 (432)
                      +.++.+++.+||+.||.+||++.+|++.|++++
T Consensus       341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            357999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4e-44  Score=333.37  Aligned_cols=248  Identities=36%  Similarity=0.620  Sum_probs=196.9

Q ss_pred             cccccccccCceeEEEEEeC-----CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          115 NFTTLIGQGAFGPVYKAQMS-----TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      ++.+.||.|.||.||+|.+.     .+..|+||.+... .....+.|.+|++.+++++||||++++|+|...+..++|||
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            34578999999999999765     3568999999654 33446889999999999999999999999998888999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc--
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--  266 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~--  266 (432)
                      |+++|+|.++|.......+++..+..|+.||+.||.|||+++   ++|+||+++|||++.++.+||+|||++......  
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            999999999998775678999999999999999999999998   999999999999999999999999998765221  


Q ss_pred             -ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCC
Q 014038          267 -KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       267 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                       ...........|+|||.+....++.++||||||+++|||++ |+.||.................            ...
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~------------~~~  226 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR------------LPI  226 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE------------TTS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------------cee
Confidence             11233456778999999998889999999999999999999 7899987644332222211111            111


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                      +...+..+.+++..||+.||++||++.++++.|
T Consensus       227 ~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  227 PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            112335789999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.7e-44  Score=343.64  Aligned_cols=240  Identities=25%  Similarity=0.383  Sum_probs=197.9

Q ss_pred             ccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCC
Q 014038          118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG  193 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  193 (432)
                      +.||+|+||.||++.. .+|+.||+|++....   ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999965 578999999987532   233456788999999999999999999999999999999999999


Q ss_pred             ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-ccccccc
Q 014038          194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANI  272 (432)
Q Consensus       194 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~  272 (432)
                      +|.+++..  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.... .......
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  155 (323)
T cd05571          81 ELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence            99998854  357899999999999999999999999   99999999999999999999999999875322 2233456


Q ss_pred             ccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHH
Q 014038          273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEV  352 (432)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  352 (432)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||............. ...            ..++...+.++
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~-~~~------------~~~p~~~~~~~  222 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEE------------IRFPRTLSPEA  222 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH-cCC------------CCCCCCCCHHH
Confidence            79999999999999999999999999999999999999997643322111111 111            01122334578


Q ss_pred             HHHHHHhhccCCCCCC-----CHHHHHH
Q 014038          353 ASLAYKCVNRAPRKRP-----SMRDIVQ  375 (432)
Q Consensus       353 ~~li~~cl~~dp~~RP-----s~~~vl~  375 (432)
                      .+++.+||+.||++||     ++.++++
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         223 KSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            9999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=346.99  Aligned_cols=265  Identities=28%  Similarity=0.433  Sum_probs=226.3

Q ss_pred             cCHHHHHHHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe
Q 014038          104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       104 ~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  182 (432)
                      ..-+++.+..+.+..+||-|.||.||.|.|+ -.-.||||.++.+. ...++|++|..+|+.++|||+|+|+|+|..+..
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            4556777777777899999999999999876 45689999997654 446789999999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      +|+|+|||.+|+|.++|+..+...++-...++++.||..||.||..++   +|||||..+|+|+.++..+||+||||++.
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence            999999999999999998877777888899999999999999999999   99999999999999999999999999998


Q ss_pred             ccccccccc--cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          263 EMVDKHAAN--IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       263 ~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      +..+..+..  ..-...|.|||-+....++.|+|||+|||+|||+.| |..||.+..-..            ...++...
T Consensus       415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq------------VY~LLEkg  482 (1157)
T KOG4278|consen  415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYGLLEKG  482 (1157)
T ss_pred             hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH------------HHHHHhcc
Confidence            765544322  233568999999999999999999999999999999 999998754221            12223333


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      .+-..+..+++.+++||..||+.+|.+||++.|+.+.++.+....
T Consensus       483 yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  483 YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            444445567779999999999999999999999999999887543

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.4e-43  Score=338.87  Aligned_cols=259  Identities=24%  Similarity=0.358  Sum_probs=202.8

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ..|.+.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            45667789999999999999654 68899999987643 33456799999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      +++|+|.+++..  ...+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++..... ..
T Consensus        85 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~  158 (331)
T cd06649          85 MDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SM  158 (331)
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCcccccccc-cc
Confidence            999999999854  34689999999999999999999985 5   99999999999999999999999999875432 23


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcC---CCc--------------
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG---KTG--------------  331 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~--------------  331 (432)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||................   ...              
T Consensus       159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence            344578999999999998899999999999999999999999997533211111000000   000              


Q ss_pred             --------------hhh----hccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          332 --------------WEE----IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       332 --------------~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                                    +.+    +.............+.++.+|+.+||+.||++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                          000    000000011111234679999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-44  Score=329.66  Aligned_cols=249  Identities=26%  Similarity=0.424  Sum_probs=213.5

Q ss_pred             HHHhccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      .+-+|+|.+.||+|.||.|-+|.. ..|+.||||.++.+   ++++.-.+.+|+++|..|+||||+.++.+|...+...+
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            356788889999999999999954 68999999999875   34555578899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||..+|.|++++.  .++.|++.++..+++||..|+.|+|.++   ++|||||.+|||||.++++||+||||+.....
T Consensus       131 vMEYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  131 VMEYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEEecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            999999999999994  4567999999999999999999999999   99999999999999999999999999988877


Q ss_pred             cccccccccCCCCCCccccccCCCC-chhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCC
Q 014038          266 DKHAANIRGTFGYLDPEYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                      .....+++|+|-|.+||++++..|. +..|-|||||+||-|+.|..||++..-......+. .+          ..+.  
T Consensus       206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs-~G----------aYrE--  272 (668)
T KOG0611|consen  206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS-RG----------AYRE--  272 (668)
T ss_pred             ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh-cc----------cccC--
Confidence            7888899999999999999999986 79999999999999999999998754221111111 11          1111  


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                       ++.+....-||.+||..+|+.|.|+.+|....
T Consensus       273 -P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  273 -PETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             -CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence             11223567799999999999999999998754

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=354.18  Aligned_cols=256  Identities=22%  Similarity=0.346  Sum_probs=212.2

Q ss_pred             hccccccccccCceeEEEEEeCCC-cEEEEEEeccCChhhHHHHHHHHHHHhhcC-CCccceEEe-eeee------CCeE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTG-ETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVG-YCAE------KGQH  183 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~------~~~~  183 (432)
                      +..+.+.|.+|||+.||+|+...+ ..||+|++-..++...+.+.+|+.+|+.|+ |+|||.+++ ....      .-+.
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            345668999999999999977655 999999998878888889999999999996 999999999 3221      1367


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      +|+||||.+|+|-+++..+-...|++.++++|+.|+++|+++||... +||||||||-+||||+.+++.||||||-+...
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~  196 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTK  196 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence            89999999999999997665666999999999999999999999986 78999999999999999999999999988643


Q ss_pred             cccccc----------cccccCCCCCCcccc---ccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCC
Q 014038          264 MVDKHA----------ANIRGTFGYLDPEYI---STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT  330 (432)
Q Consensus       264 ~~~~~~----------~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  330 (432)
                      ......          -....|+.|+|||.+   ++...++|+|||+|||+||-||....||++...             
T Consensus       197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------------  263 (738)
T KOG1989|consen  197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------------  263 (738)
T ss_pred             cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------------
Confidence            222211          112479999999987   577899999999999999999999999976321             


Q ss_pred             chhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          331 GWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                        ..+++....-+....++..|.+||..||+.||.+||++-+|++.+.++....
T Consensus       264 --laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  264 --LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             --eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence              2233333333333567789999999999999999999999999988886544

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.7e-43  Score=327.53  Aligned_cols=254  Identities=29%  Similarity=0.448  Sum_probs=207.5

Q ss_pred             HHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ...+.+.+.||+|+||.||+|.. .+++.||+|.+..+. .....+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            34567788999999999999965 468899999986543 3456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA  269 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  269 (432)
                      +++++|.+++.......+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            99999999997655567999999999999999999999998   999999999999999999999999998754332211


Q ss_pred             --cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          270 --ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       270 --~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                        ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+............            ......+.
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~------------~~~~~~~~  228 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------GYRMERPE  228 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC------------CCCCCCCC
Confidence              12234568999999998999999999999999999998 9999976432221111111            11111222


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      ..+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus       229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            3346899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5e-43  Score=326.08  Aligned_cols=253  Identities=26%  Similarity=0.452  Sum_probs=208.4

Q ss_pred             HHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      ...+.+.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            44677889999999999999988788899999986543 23568899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc--
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH--  268 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~--  268 (432)
                      ++|+|.+++.......+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++........  
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence            9999999997665667899999999999999999999998   99999999999999999999999999875432211  


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      .....++..|+|||.+....++.++|||||||++|||++ |+.||................            ..+....
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~------------~~~~~~~  228 (261)
T cd05072         161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY------------RMPRMEN  228 (261)
T ss_pred             cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC------------CCCCCCC
Confidence            122345678999999988889999999999999999998 999997654332222221110            0011112


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR  379 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~  379 (432)
                      .+.++.+++.+||+.+|++||++.++.+.|++
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         229 CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            33578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=335.95  Aligned_cols=243  Identities=23%  Similarity=0.348  Sum_probs=199.7

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            3567789999999999999654 78999999986432   2334568899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+++|+|.+++..  .+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.....  .
T Consensus        82 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~--~  154 (291)
T cd05612          82 YVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--R  154 (291)
T ss_pred             CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC--C
Confidence            9999999999854  356899999999999999999999999   99999999999999999999999999875432  2


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.+............ ...            .++...
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~-~~~------------~~~~~~  221 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA-GKL------------EFPRHL  221 (291)
T ss_pred             cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCc------------CCCccC
Confidence            2345789999999999988999999999999999999999999986543222221111 110            112222


Q ss_pred             HHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRPS-----MRDIVQ  375 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs-----~~~vl~  375 (432)
                      ...+.+++.+||+.||.+||+     +.++++
T Consensus       222 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         222 DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             CHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            357899999999999999995     777664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-43  Score=324.58  Aligned_cols=255  Identities=27%  Similarity=0.429  Sum_probs=209.7

Q ss_pred             HHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      +...++++.+.||+|++|.||+|...+++.||+|.+.... ...+++.+|+.++++++||||+++++++...+..+++||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            3445678889999999999999987778899999986543 335678999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+++++|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999996655567999999999999999999999998   99999999999999999999999999875432211


Q ss_pred             c--cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          269 A--ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       269 ~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      .  .....+..|+|||.+.+..++.++||||||+++|||++ |+.||.+..............            ....+
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------~~~~~  226 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY------------RMPCP  226 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------CCCCC
Confidence            1  11223457999999998899999999999999999999 999998755433222221111            01112


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR  379 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~  379 (432)
                      ...+..+.+++.+||+.+|++||++.++++.|++
T Consensus       227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            2234579999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6.3e-43  Score=325.36  Aligned_cols=253  Identities=29%  Similarity=0.491  Sum_probs=211.9

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      ..|.+.+.||.|+||.||+|...++..+|+|.+..........+.+|+.+++.++||||+++++++......++||||++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME   85 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence            45677789999999999999887899999999987666566789999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc-cc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH-AA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~  270 (432)
                      +|+|.+++.......+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++........ ..
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~  162 (261)
T cd05148          86 KGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS  162 (261)
T ss_pred             cCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccccc
Confidence            999999997766677999999999999999999999998   99999999999999999999999999875432221 12


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ...++..|+|||.+....++.++||||||+++|+|++ |+.||..............            ......+...+
T Consensus       163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~------------~~~~~~~~~~~  230 (261)
T cd05148         163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA------------GYRMPCPAKCP  230 (261)
T ss_pred             CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh------------CCcCCCCCCCC
Confidence            3345678999999988899999999999999999998 8999976543222222111            11111223344


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQVLSR  379 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~~L~~  379 (432)
                      .++.+++.+||+.||++|||+.++++.|+.
T Consensus       231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         231 QEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-43  Score=329.22  Aligned_cols=249  Identities=29%  Similarity=0.415  Sum_probs=201.0

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC--------------hhhHHHHHHHHHHHhhcCCCccceEEee
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--------------KQGEKEFQTEVMLLGRLHHRNLVNLVGY  176 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~l~~~  176 (432)
                      ..|.+.+.||+|.||.|-+|+. .+++.||||++.+..              ....+...+|+.+|++++|||||+|+.+
T Consensus        97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv  176 (576)
T KOG0585|consen   97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV  176 (576)
T ss_pred             hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence            4677788999999999999954 578999999986431              0123578899999999999999999999


Q ss_pred             eee--CCeEEEEEEeccCCChhhhcccCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEE
Q 014038          177 CAE--KGQHMLVYVFMSKGSLASHLYDENYGP-LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR  253 (432)
Q Consensus       177 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~-l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~k  253 (432)
                      ..+  .+..|+|+|||..|.+...=   ..++ +++.++++++.+++.||+|||.++   ||||||||+|+||+++|++|
T Consensus       177 LDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VK  250 (576)
T KOG0585|consen  177 LDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVK  250 (576)
T ss_pred             ecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEE
Confidence            876  46899999999998876543   3344 999999999999999999999999   99999999999999999999


Q ss_pred             EeecCCcccc------cccccccccccCCCCCCccccccCC----CCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHH
Q 014038          254 VADFGLSREE------MVDKHAANIRGTFGYLDPEYISTRN----FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAA  323 (432)
Q Consensus       254 l~Dfgl~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~  323 (432)
                      |+|||.+...      ..+......+|||.|+|||...++.    ...+.||||+||+||+|+.|+.||.+.......  
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~--  328 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF--  328 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH--
Confidence            9999998743      2222334478999999999987633    347899999999999999999999876554332  


Q ss_pred             hhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          324 MNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                               ..++...+.-+...+..+++.+||.++|++||++|-+..+|....
T Consensus       329 ---------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  329 ---------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             ---------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence                     223333333223334567899999999999999999999887644

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.3e-43  Score=336.97  Aligned_cols=241  Identities=24%  Similarity=0.399  Sum_probs=197.5

Q ss_pred             ccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCC
Q 014038          118 TLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG  193 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  193 (432)
                      +.||+|+||.||++.. .+|+.||+|++...   .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999964 47899999998753   2234457889999999999999999999999999999999999999


Q ss_pred             ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-ccccccc
Q 014038          194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANI  272 (432)
Q Consensus       194 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~~  272 (432)
                      +|..++..  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.... .......
T Consensus        81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  155 (328)
T cd05593          81 ELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF  155 (328)
T ss_pred             CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence            99988853  356899999999999999999999999   99999999999999999999999999875322 2233446


Q ss_pred             ccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHH
Q 014038          273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEV  352 (432)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  352 (432)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||............. ...            ..++...+.++
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~-~~~------------~~~p~~~~~~~  222 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MED------------IKFPRTLSADA  222 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc-cCC------------ccCCCCCCHHH
Confidence            79999999999998899999999999999999999999997643322111111 010            01122234578


Q ss_pred             HHHHHHhhccCCCCCC-----CHHHHHHH
Q 014038          353 ASLAYKCVNRAPRKRP-----SMRDIVQV  376 (432)
Q Consensus       353 ~~li~~cl~~dp~~RP-----s~~~vl~~  376 (432)
                      .+++.+||+.||++||     ++.++++.
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         223 KSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            9999999999999997     88888763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.1e-42  Score=322.92  Aligned_cols=248  Identities=27%  Similarity=0.495  Sum_probs=203.0

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      ++.+.+.||+|+||.||++...++..+|+|.+.... .....|.+|+.++++++||||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            466778999999999999998888899999886432 3346788999999999999999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc--cc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH--AA  270 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~--~~  270 (432)
                      |+|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.......  ..
T Consensus        84 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05114          84 GCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS  159 (256)
T ss_pred             CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence            99999886433 46899999999999999999999999   99999999999999999999999999875432211  12


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |+.||..................            ..+...+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~------------~~~~~~~  227 (256)
T cd05114         160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL------------YRPKLAS  227 (256)
T ss_pred             CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC------------CCCCCCC
Confidence            2235568999999988899999999999999999999 89999765443322222111110            0111123


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                      .++.+++.+||+.+|++||++.++++.|
T Consensus       228 ~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         228 MTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            4789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2e-43  Score=339.21  Aligned_cols=240  Identities=26%  Similarity=0.413  Sum_probs=196.5

Q ss_pred             ccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCC
Q 014038          118 TLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG  193 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  193 (432)
                      +.||+|+||.||++.. .+|+.||+|.+...   .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3689999999999965 47899999998753   2233456788999999999999999999999999999999999999


Q ss_pred             ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cccccc
Q 014038          194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANI  272 (432)
Q Consensus       194 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~  272 (432)
                      +|..++..  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..... ......
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  155 (323)
T cd05595          81 ELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             cHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence            99988853  346899999999999999999999999   999999999999999999999999998753222 223346


Q ss_pred             ccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHH
Q 014038          273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEV  352 (432)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  352 (432)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||................           .  .++...+.++
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-----------~--~~p~~~~~~~  222 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-----------I--RFPRTLSPEA  222 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------C--CCCCCCCHHH
Confidence            79999999999999999999999999999999999999997543322111111110           0  1122234578


Q ss_pred             HHHHHHhhccCCCCCC-----CHHHHHH
Q 014038          353 ASLAYKCVNRAPRKRP-----SMRDIVQ  375 (432)
Q Consensus       353 ~~li~~cl~~dp~~RP-----s~~~vl~  375 (432)
                      .+++.+||+.||++||     ++.++++
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         223 KSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            9999999999999998     7888775

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.6e-43  Score=351.91  Aligned_cols=247  Identities=22%  Similarity=0.336  Sum_probs=203.2

Q ss_pred             ccccccccccCceeEEEEEeC-C-CcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-T-GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      |.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            677889999999999999543 4 67899998766555555678899999999999999999999999999999999999


Q ss_pred             CCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--
Q 014038          192 KGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--  267 (432)
Q Consensus       192 ~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--  267 (432)
                      +|+|.+++..  ....++++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            9999988753  23457899999999999999999999998   9999999999999999999999999997543221  


Q ss_pred             -cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          268 -HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       268 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                       .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+...............            ...+.
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~------------~~~~~  293 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY------------DPFPC  293 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------CCCCc
Confidence             23445799999999999999999999999999999999999999976543222211111110            01122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.++.+++.+||+.||++||++.+++.
T Consensus       294 ~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        294 PVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            23457899999999999999999999875

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4e-43  Score=330.75  Aligned_cols=252  Identities=30%  Similarity=0.543  Sum_probs=204.0

Q ss_pred             hccccccccccCceeEEEEEeCC------CcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMST------GETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      .+.+.+.||+|+||.||+|....      ...||+|.+.... ......|.+|+.++..++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   85 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM   85 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence            55677899999999999996532      2579999987543 3344678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc
Q 014038          186 VYVFMSKGSLASHLYDENY--------------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR  251 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~  251 (432)
                      +|||+++|+|.+++.....              ..+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.
T Consensus        86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence            9999999999999864321              45889999999999999999999999   999999999999999999


Q ss_pred             EEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhc
Q 014038          252 ARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTE  327 (432)
Q Consensus       252 ~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  327 (432)
                      +||+|||+++......   ......+++.|+|||.+....++.++|||||||++|||++ |..||.+.........+.  
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~--  240 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR--  240 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH--
Confidence            9999999987532221   1223456788999999988899999999999999999998 999997644322111111  


Q ss_pred             CCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 014038          328 GKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR  379 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~  379 (432)
                                .......+...+.++.+|+.+||+.||.+||++.+|++.|+.
T Consensus       241 ----------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         241 ----------SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ----------cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                      111112233445689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-43  Score=332.10  Aligned_cols=250  Identities=27%  Similarity=0.417  Sum_probs=202.4

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      |+..+.||+|+||.||++.. .+++.||+|.+....   ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            55678999999999999965 478999999986532   22234678899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA  269 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  269 (432)
                      +++|+|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence            99999998886655567999999999999999999999998   999999999999999999999999998764433333


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||.+............        .+.. ....++...+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~--------~~~~-~~~~~~~~~~  229 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER--------RVKE-DQEEYSEKFS  229 (285)
T ss_pred             ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH--------Hhhh-cccccCcccC
Confidence            445789999999999988999999999999999999999999976433211111100        0000 1111223344


Q ss_pred             HHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRP-----SMRDIVQ  375 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RP-----s~~~vl~  375 (432)
                      ..+.+++.+||+.||.+||     ++.++++
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         230 EAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             HHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            5789999999999999999     7777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-43  Score=338.23  Aligned_cols=236  Identities=27%  Similarity=0.361  Sum_probs=193.0

Q ss_pred             ccccCceeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCCh
Q 014038          120 IGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       120 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  195 (432)
                      ||+|+||.||+|... +++.||+|.+...   .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999654 6789999998643   233446788999999999999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cccccccc
Q 014038          196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRG  274 (432)
Q Consensus       196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~~g  274 (432)
                      .+++..  .+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..... .......|
T Consensus        81 ~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  155 (312)
T cd05585          81 FHHLQR--EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG  155 (312)
T ss_pred             HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence            999854  356899999999999999999999999   999999999999999999999999998753222 23345679


Q ss_pred             CCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHH
Q 014038          275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVAS  354 (432)
Q Consensus       275 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  354 (432)
                      |+.|+|||.+.+..++.++|||||||++|||++|+.||.+........... ...            ..++...+.++.+
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~-~~~------------~~~~~~~~~~~~~  222 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL-QEP------------LRFPDGFDRDAKD  222 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH-cCC------------CCCCCcCCHHHHH
Confidence            999999999999999999999999999999999999997643322111111 110            0122233457899


Q ss_pred             HHHHhhccCCCCCCCHHHH
Q 014038          355 LAYKCVNRAPRKRPSMRDI  373 (432)
Q Consensus       355 li~~cl~~dp~~RPs~~~v  373 (432)
                      ++.+||+.||.+||++..+
T Consensus       223 li~~~L~~dp~~R~~~~~~  241 (312)
T cd05585         223 LLIGLLSRDPTRRLGYNGA  241 (312)
T ss_pred             HHHHHcCCCHHHcCCCCCH
Confidence            9999999999999864333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.8e-43  Score=330.89  Aligned_cols=259  Identities=25%  Similarity=0.373  Sum_probs=198.0

Q ss_pred             hccccccccccCceeEEEEEe-C-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhc---CCCccceEEeeeee-----C
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-S-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRL---HHRNLVNLVGYCAE-----K  180 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~  180 (432)
                      +|.+.+.||+|+||.||+|.. . +++.||+|.+....  ......+.+|+.+++.+   +||||++++++|..     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            466778999999999999965 2 46889999886542  22234566777777665   69999999998852     4


Q ss_pred             CeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCc
Q 014038          181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS  260 (432)
Q Consensus       181 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~  260 (432)
                      ...++||||+. ++|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccce
Confidence            56899999996 69999886655566899999999999999999999999   999999999999999999999999998


Q ss_pred             ccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcC----CCchhhh-
Q 014038          261 REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG----KTGWEEI-  335 (432)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~~~-  335 (432)
                      +............||+.|+|||.+....++.++|||||||++|||++|+.||.+..+...+.......    ...|... 
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  237 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence            76544444445678999999999988899999999999999999999999998765443332221110    1111100 


Q ss_pred             ------ccccCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 ------VDSRLDGI---FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 ------~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                            ........   .....+..+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                  00000000   00112356789999999999999999999884

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-43  Score=340.41  Aligned_cols=244  Identities=26%  Similarity=0.400  Sum_probs=200.5

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            35677889999999999999764 68899999986532   233456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+++|+|.+++..  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++.....  
T Consensus        98 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~--  170 (329)
T PTZ00263         98 EFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD--  170 (329)
T ss_pred             cCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC--
Confidence            99999999999854  356899999999999999999999999   99999999999999999999999999875432  


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+........... .+..            .++..
T Consensus       171 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~-~~~~------------~~p~~  237 (329)
T PTZ00263        171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL-AGRL------------KFPNW  237 (329)
T ss_pred             CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh-cCCc------------CCCCC
Confidence            2234578999999999999999999999999999999999999997654332222111 1110            01111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPS-----MRDIVQ  375 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs-----~~~vl~  375 (432)
                      ....+.+++.+||+.||.+||+     +.+++.
T Consensus       238 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        238 FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            2346889999999999999997     566664

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.3e-42  Score=335.08  Aligned_cols=260  Identities=23%  Similarity=0.377  Sum_probs=201.9

Q ss_pred             HHHhccccccccccCceeEEEEEeC-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ....|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|+++++.++||||++++++|.+.+..++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            3456778889999999999999654 6788999988754 2334467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      ||+++|+|.+++..  .+.+++..+..++.|++.||.|||+. +   ++||||||+|||++.++.+||+|||++..... 
T Consensus        83 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-  156 (333)
T cd06650          83 EHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  156 (333)
T ss_pred             ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh-
Confidence            99999999999854  34689999999999999999999974 5   99999999999999999999999999865322 


Q ss_pred             ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh--cCCCc-------------
Q 014038          267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT--EGKTG-------------  331 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~--~~~~~-------------  331 (432)
                      .......|+..|+|||++.+..++.++|||||||++|||++|+.||..............  .+...             
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (333)
T cd06650         157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR  236 (333)
T ss_pred             hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence            222345689999999999988999999999999999999999999975432111110000  00000             


Q ss_pred             --------------hhhhcc---ccCCCCCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          332 --------------WEEIVD---SRLDGIFD-VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       332 --------------~~~~~~---~~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                                    ...+.+   .......+ .....++.+|+.+||+.||++|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                          000000   00000000 012357899999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.7e-43  Score=344.09  Aligned_cols=259  Identities=28%  Similarity=0.466  Sum_probs=205.0

Q ss_pred             HHHhccccccccccCceeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcC-CCccceEEeeeeeCC
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKG  181 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  181 (432)
                      ....+.+.+.||+|+||.||+|...      .+..||||++.... ....+.|.+|+.+++++. ||||++++++|.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3446677789999999999999642      23469999997543 333467899999999996 999999999999999


Q ss_pred             eEEEEEEeccCCChhhhcccCC----------------------------------------------------------
Q 014038          182 QHMLVYVFMSKGSLASHLYDEN----------------------------------------------------------  203 (432)
Q Consensus       182 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  203 (432)
                      ..++||||+++|+|.+++....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999998875321                                                          


Q ss_pred             ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec
Q 014038          204 ------------------------------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD  247 (432)
Q Consensus       204 ------------------------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~  247 (432)
                                                          ...+++..+..++.|++.||.|||+.+   |+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence                                                124788889999999999999999998   99999999999999


Q ss_pred             CCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHH
Q 014038          248 QSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAA  323 (432)
Q Consensus       248 ~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~  323 (432)
                      .++.+||+|||+++......   ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...........
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~  351 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN  351 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence            99999999999987543221   1223346788999999988899999999999999999997 9999976432211111


Q ss_pred             hhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          324 MNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      ....+           .....+...+.++.+++.+||+.||++||++.+|.+.|+++++
T Consensus       352 ~~~~~-----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         352 KIKSG-----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             HHhcC-----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            11111           1111122334678999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.8e-44  Score=305.77  Aligned_cols=247  Identities=27%  Similarity=0.422  Sum_probs=211.5

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .+++.+.||+|.||.||+|+. +++..||+|++...   ......++.+|+++-..|+||||++++++|.+....||++|
T Consensus        23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE  102 (281)
T KOG0580|consen   23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE  102 (281)
T ss_pred             hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence            457788999999999999965 46789999998654   23445689999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |..+|+|...|..+....+++.....++.|+|.||.|+|..+   +|||||||+|+|++.++.+||+|||-+-... ...
T Consensus       103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~k  178 (281)
T KOG0580|consen  103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNK  178 (281)
T ss_pred             ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-CCC
Confidence            999999999998778888999999999999999999999998   9999999999999999999999999886554 455


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      ..+.+||..|.|||...+..++...|+|++|++.||++.|.+||...........+.           ..  +-.++...
T Consensus       179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~-----------k~--~~~~p~~i  245 (281)
T KOG0580|consen  179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR-----------KV--DLKFPSTI  245 (281)
T ss_pred             ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH-----------Hc--cccCCccc
Confidence            678899999999999999999999999999999999999999998654222211111           11  11123344


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      +....++|.+|+..+|.+|.+..|++..
T Consensus       246 s~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  246 SGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ChhHHHHHHHHhccCccccccHHHHhhh
Confidence            5678999999999999999999998863

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.9e-43  Score=337.73  Aligned_cols=258  Identities=33%  Similarity=0.550  Sum_probs=203.8

Q ss_pred             HHhccccccccccCceeEEEEEe------CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeC-C
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK-G  181 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  181 (432)
                      ..+|.+.+.||+|+||.||+|..      .+++.||+|++.... ....+.+..|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            44677889999999999999953      235789999987543 23345678899999999 899999999988654 5


Q ss_pred             eEEEEEEeccCCChhhhcccCC----------------------------------------------------------
Q 014038          182 QHMLVYVFMSKGSLASHLYDEN----------------------------------------------------------  203 (432)
Q Consensus       182 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  203 (432)
                      ..+++|||+++|+|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            6889999999999998885321                                                          


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc---ccccccCCCCC
Q 014038          204 -YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH---AANIRGTFGYL  279 (432)
Q Consensus       204 -~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~---~~~~~gt~~y~  279 (432)
                       ..++++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++........   .....++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             136899999999999999999999998   99999999999999999999999999875432211   22334567899


Q ss_pred             CccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHH
Q 014038          280 DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYK  358 (432)
Q Consensus       280 aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  358 (432)
                      |||++.+..++.++|||||||++|||++ |..||.+......+.......           .....+...+.++.+++.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~~  311 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG-----------TRMRAPEYATPEIYSIMLD  311 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc-----------CCCCCCccCCHHHHHHHHH
Confidence            9999999999999999999999999998 999997533221111111111           1111122234578999999


Q ss_pred             hhccCCCCCCCHHHHHHHHHHHHh
Q 014038          359 CVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       359 cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      ||+.+|++||++.+|++.|+++++
T Consensus       312 cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         312 CWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.6e-42  Score=326.26  Aligned_cols=258  Identities=29%  Similarity=0.498  Sum_probs=208.4

Q ss_pred             HHhccccccccccCceeEEEEEe------CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  184 (432)
                      +..+.+.+.||+|+||.||++..      .++..+|+|.+..........+.+|+.++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            34566778999999999999964      234569999987666566678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhcccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEE
Q 014038          185 LVYVFMSKGSLASHLYDEN-----------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR  253 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~k  253 (432)
                      +||||+++++|.+++....           ...+++..++.++.|++.||+|||+++   ++||||||+|||+++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999999885322           235899999999999999999999999   99999999999999999999


Q ss_pred             EeecCCccccccccc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCC
Q 014038          254 VADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK  329 (432)
Q Consensus       254 l~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  329 (432)
                      |+|||++........   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.................
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~  240 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV  240 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence            999999875432211   122345778999999998899999999999999999998 9999976543322222211110


Q ss_pred             CchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          330 TGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      .        ..    +...+.++.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus       241 ~--------~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         241 L--------QR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             C--------CC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            0        01    111234799999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-43  Score=338.61  Aligned_cols=252  Identities=25%  Similarity=0.362  Sum_probs=203.5

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+|... +++.||+|++....   ......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            3567789999999999999764 68899999986532   2334578899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+++|+|.+++..  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....  .
T Consensus        82 ~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~  154 (333)
T cd05600          82 YVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--Y  154 (333)
T ss_pred             CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--c
Confidence            9999999999953  356899999999999999999999999   99999999999999999999999999875432  3


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||................     ...............
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~~~~  229 (333)
T cd05600         155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK-----ETLQRPVYDDPRFNL  229 (333)
T ss_pred             cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc-----ccccCCCCCcccccc
Confidence            345678999999999998999999999999999999999999997654322222111110     000000000000123


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      +.++.+++.+||..+|.+||++.++++.
T Consensus       230 s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         230 SDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            4578999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.3e-42  Score=326.63  Aligned_cols=253  Identities=30%  Similarity=0.539  Sum_probs=205.3

Q ss_pred             HHhccccccccccCceeEEEEEeC------CCcEEEEEEeccCChh-hHHHHHHHHHHHhhcCCCccceEEeeeeeCCeE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH  183 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  183 (432)
                      ..++.+.+.||+|+||.||+|...      ++..||+|.+...... ..+.|.+|+++++.++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            346677889999999999999653      3478999998765443 457899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhcccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc
Q 014038          184 MLVYVFMSKGSLASHLYDEN------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR  251 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~  251 (432)
                      +++|||+++|+|.+++....            ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999986432            245889999999999999999999998   999999999999999999


Q ss_pred             EEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhc
Q 014038          252 ARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTE  327 (432)
Q Consensus       252 ~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  327 (432)
                      +||+|||++.......   ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.............. 
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~-  239 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ-  239 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-
Confidence            9999999987432221   1123345788999999999999999999999999999998 9999876443322222111 


Q ss_pred             CCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          328 GKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                      +.           ....+...+..+.+++.+||+.||++||++.||++.|+
T Consensus       240 ~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         240 GR-----------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             CC-----------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            10           01112223457899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.7e-43  Score=333.59  Aligned_cols=257  Identities=24%  Similarity=0.432  Sum_probs=203.7

Q ss_pred             HHhccccccccccCceeEEEEEeC-CCc----EEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-TGE----TVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  184 (432)
                      ..+|...+.||+|+||.||+|.+. ++.    .||+|.+.... ....+++.+|+.+++.++||||++++|+|... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            345677789999999999999753 343    38999986543 34456789999999999999999999999864 578


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      ++++|+++|+|.+++... ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        85 ~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          85 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            999999999999998643 345889999999999999999999999   9999999999999999999999999997543


Q ss_pred             ccccc---cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          265 VDKHA---ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       265 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .....   ....++..|+|||.+....++.++|||||||++|||++ |+.||.+..... ........           .
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~-----------~  228 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKG-----------E  228 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCC-----------C
Confidence            32221   12234678999999999999999999999999999998 999997643221 11111111           0


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      ....+...+.++.+++.+||+.+|.+||++.+++..|..+....
T Consensus       229 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         229 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            11111122347899999999999999999999999998886544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=305.27  Aligned_cols=259  Identities=24%  Similarity=0.385  Sum_probs=208.5

Q ss_pred             HhccccccccccCceeEEEEE-eCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC-----eEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-----QHML  185 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l  185 (432)
                      .+|.+.+.||+|||+-||+++ ..+++.+|+|++.-...++.+..++|++..++++|||++++++++..+.     ..|+
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            467888999999999999995 6789999999998777777888999999999999999999999875543     5899


Q ss_pred             EEEeccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          186 VYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      +++|...|+|.+.+..  ..+..+++.+++.|+.+|++||++||+.. ++++||||||.|||+.+++.++|.|||.+...
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a  179 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQA  179 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcccc
Confidence            9999999999998854  23446999999999999999999999976 67999999999999999999999999987653


Q ss_pred             ccccc----------ccccccCCCCCCccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCC
Q 014038          264 MVDKH----------AANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT  330 (432)
Q Consensus       264 ~~~~~----------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  330 (432)
                      .....          ......|..|.|||.+.   +...++++|||||||+||+|+.|..||+...+        .++..
T Consensus       180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------~GgSl  251 (302)
T KOG2345|consen  180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------QGGSL  251 (302)
T ss_pred             ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--------cCCeE
Confidence            32211          12345789999999985   34578999999999999999999999975332        11111


Q ss_pred             chhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          331 GWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      .+ .+......-+-....++.+.+++.+|++.||.+||++.+++..+..+
T Consensus       252 aL-Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  252 AL-AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             EE-eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            00 11111111111122567899999999999999999999999988765

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.9e-43  Score=329.11  Aligned_cols=258  Identities=21%  Similarity=0.293  Sum_probs=200.5

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      .|.+.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            3567789999999999999764 67899999987542  23346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--  267 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--  267 (432)
                      ++++.+..+..  ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......  
T Consensus        82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          82 VEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            99877765442  2356899999999999999999999998   9999999999999999999999999987643221  


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc-CCCc------------hhh
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE-GKTG------------WEE  334 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~-~~~~------------~~~  334 (432)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||.+............. +...            +..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence            223456899999999998888999999999999999999999999865443332221110 0000            000


Q ss_pred             hccccCCCC------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 IVDSRLDGI------FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 ~~~~~~~~~------~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...+.....      .....+.++.+++.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000      01113457999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-43  Score=337.60  Aligned_cols=249  Identities=23%  Similarity=0.371  Sum_probs=213.8

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe-EEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ-HMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e  188 (432)
                      .|...+++|+|+||.+++.+. .++..+++|.+....  .........|+.++++++|||||.+.+.|.+++. .++||+
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~   84 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME   84 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence            466778999999999999953 467899999987643  3334467899999999999999999999998888 999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-  267 (432)
                      |++||+|.+.+..+++..+++..+..|+.|++.|+.|||++.   |+|||||+.|||++.+..|||+|||+++...... 
T Consensus        85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence            999999999998877788999999999999999999999888   9999999999999999999999999999876665 


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ...+..||+.||.||.+.+.+|..|+|||||||++|||++-+++|....-..-...+           .. ....+.+..
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki-----------~~-~~~~Plp~~  229 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI-----------NR-GLYSPLPSM  229 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH-----------hh-ccCCCCCcc
Confidence            667889999999999999999999999999999999999999999864321111111           11 112334556


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      .+.++..++..|++.+|+.||++.+++..
T Consensus       230 ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  230 YSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            67799999999999999999999999986

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.2e-42  Score=326.13  Aligned_cols=256  Identities=29%  Similarity=0.492  Sum_probs=208.6

Q ss_pred             HhccccccccccCceeEEEEEeC------CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      ..+.+.+.||+|+||.||+|...      ++..+++|.+........+.+.+|+.++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45667789999999999999632      345799999876666666789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc
Q 014038          186 VYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR  251 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~  251 (432)
                      ||||+++++|.+++....              ...+++..++.++.||+.||+|||+++   ++||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999985432              234899999999999999999999999   999999999999999999


Q ss_pred             EEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhc
Q 014038          252 ARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTE  327 (432)
Q Consensus       252 ~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  327 (432)
                      ++|+|||++.......   ......++..|+|||.+.+..++.++||||||+++|||+| |+.||...............
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  241 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG  241 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence            9999999987543221   1223446788999999998999999999999999999999 99998765433222211111


Q ss_pred             CCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          328 GKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      ..            ...+...+..+.+++.+||+.+|++||++.+|++.|+.+.+
T Consensus       242 ~~------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         242 RV------------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             CC------------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            10            01111234578999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.2e-42  Score=321.01  Aligned_cols=249  Identities=27%  Similarity=0.452  Sum_probs=202.1

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      ..+.+.+.||+|+||.||+|+..++..+|+|.+.... .....|.+|+.++.+++||||+++++++...+..+++|||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            3567788999999999999988777789999987543 334678999999999999999999999998889999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc--
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA--  269 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~--  269 (432)
                      +|+|.+++.... ..+++..++.++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||+++........  
T Consensus        83 ~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          83 NGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence            999999986433 36899999999999999999999998   999999999999999999999999998754322211  


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      ....++..|+|||.+.+..++.++|||||||++|||++ |+.||.................            ...+...
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------~~~~~~~  226 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR------------LYRPHLA  226 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC------------CCCCCCC
Confidence            12235678999999988889999999999999999999 9999976443222221111111            0011112


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                      +..+.+++.+||+.+|.+||++.+|++.|
T Consensus       227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         227 SEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence            35789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.2e-43  Score=338.31  Aligned_cols=245  Identities=22%  Similarity=0.343  Sum_probs=200.5

Q ss_pred             HhccccccccccCceeEEEEEeC-C-CcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-T-GETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ..|.+.+.||+|+||.||+|... + +..||+|.+...   .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            46778899999999999999653 3 368999998643   223345688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....  
T Consensus       110 ~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~--  182 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD--  182 (340)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC--
Confidence            9999999999998543  46899999999999999999999999   9999999999999999999999999987542  


Q ss_pred             ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+............ ..          .  .++.
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~-~~----------~--~~p~  249 (340)
T PTZ00426        183 TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE-GI----------I--YFPK  249 (340)
T ss_pred             CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc-CC----------C--CCCC
Confidence            223456799999999999988899999999999999999999999986543322222111 11          0  0112


Q ss_pred             HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRP-----SMRDIVQV  376 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RP-----s~~~vl~~  376 (432)
                      ..+..+.+++.+||+.||++|+     +++++++.
T Consensus       250 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        250 FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            2234678999999999999995     78887753

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1e-42  Score=334.42  Aligned_cols=240  Identities=25%  Similarity=0.432  Sum_probs=196.2

Q ss_pred             ccccccCceeEEEEEe----CCCcEEEEEEeccC----ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          118 TLIGQGAFGPVYKAQM----STGETVAVKVLATD----SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      +.||+|+||.||+++.    .+++.||+|.+...    .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999964    36789999998643    122335678899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KH  268 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~  268 (432)
                      +++|+|.+++..  .+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..... ..
T Consensus        82 ~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (323)
T cd05584          82 LSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV  156 (323)
T ss_pred             CCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc
Confidence            999999998854  356888999999999999999999999   999999999999999999999999998743222 22


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||............... .          .  ..+...
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~-~----------~--~~~~~~  223 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-K----------L--NLPPYL  223 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-C----------C--CCCCCC
Confidence            33457999999999999888999999999999999999999999865433222222111 1          0  111222


Q ss_pred             HHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRP-----SMRDIVQ  375 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RP-----s~~~vl~  375 (432)
                      +.++.+++.+||+.||++||     ++.++++
T Consensus       224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            35789999999999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.5e-42  Score=326.37  Aligned_cols=258  Identities=23%  Similarity=0.327  Sum_probs=198.8

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .|.+.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL   85 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence            466778999999999999965 478899999986543 233456789999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-ccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~  269 (432)
                      ++ +|.+++... ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..... ...
T Consensus        86 ~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          86 DS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             Cc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence            74 898887543 345789999999999999999999999   999999999999999999999999998754322 222


Q ss_pred             cccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc----CCCchhhh---------
Q 014038          270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE----GKTGWEEI---------  335 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~~~---------  335 (432)
                      ....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+......+......    ....|..+         
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY  240 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence            34568999999998865 56899999999999999999999999765433222221111    11111111         


Q ss_pred             ccccCCCCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 VDSRLDGIF----DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 ~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+......    ......++.+++.+||+.||.+|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            111100000    0012346889999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-41  Score=372.01  Aligned_cols=265  Identities=26%  Similarity=0.465  Sum_probs=206.4

Q ss_pred             cCHHHHHHHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe
Q 014038          104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       104 ~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  182 (432)
                      +++.++.. .+...+.||+|+||.||+|.. .++..||||.+......    ..+|+..+++++||||++++|+|.+.+.
T Consensus       683 ~~~~~~~~-~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~  757 (968)
T PLN00113        683 ITINDILS-SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKG  757 (968)
T ss_pred             hhHHHHHh-hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence            44555543 344557899999999999975 57899999998643322    1346888999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .++||||+++|+|.++++     .++|..+.+++.|++.||+|||....++|+||||||+||+++.++..++. ||....
T Consensus       758 ~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        758 AYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             CEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence            999999999999999994     38999999999999999999996655569999999999999999888876 665433


Q ss_pred             ccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChh----HHHHHHHhhhcCCCchhhhccc
Q 014038          263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM----EYVELAAMNTEGKTGWEEIVDS  338 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      ...   .....+|+.|+|||++.+..++.++|||||||++|||+||+.||....    ....+..... .......++++
T Consensus       832 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  907 (968)
T PLN00113        832 LCT---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCY-SDCHLDMWIDP  907 (968)
T ss_pred             ccc---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhc-CccchhheeCc
Confidence            211   122367899999999999999999999999999999999999985321    1112221111 11123344455


Q ss_pred             cCCC--CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          339 RLDG--IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       339 ~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      .+..  ..+.....++.+++.+||+.||++||+|.++++.|+++.+.
T Consensus       908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            4433  23445667899999999999999999999999999988653

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-42  Score=334.85  Aligned_cols=256  Identities=23%  Similarity=0.352  Sum_probs=194.3

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC-----CeEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-----GQHML  185 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l  185 (432)
                      |.+.+.||+|+||.||+|.. .+|+.||||.+...  .......+.+|+.+++.++||||+++++++...     ...++
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            56778999999999999964 47899999998643  223345788999999999999999999987543     35799


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+. ++|.+++..  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        82 v~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          82 VFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            999995 689888843  346999999999999999999999999   99999999999999999999999999875322


Q ss_pred             cc----cccccccCCCCCCcccccc--CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCch-------
Q 014038          266 DK----HAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW-------  332 (432)
Q Consensus       266 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------  332 (432)
                      ..    ......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+......+..+........       
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            21    1234578999999999865  6789999999999999999999999976443222111100000000       


Q ss_pred             -----hhhcc---ccCCCCCC---HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          333 -----EEIVD---SRLDGIFD---VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       333 -----~~~~~---~~~~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                           .....   ......+.   ...+..+.+++.+||+.||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                 00000   00000000   012346789999999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.4e-42  Score=323.59  Aligned_cols=246  Identities=26%  Similarity=0.412  Sum_probs=195.7

Q ss_pred             ccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCCh
Q 014038          120 IGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       120 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  195 (432)
                      ||+|+||.||++.. .+|+.||+|.+....   ......+..|++++++++||||+++++++.+....++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999965 468999999986431   22234566799999999999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccccccccC
Q 014038          196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT  275 (432)
Q Consensus       196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt  275 (432)
                      ..++.......+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.............|+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  157 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGT  157 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCC
Confidence            98886655567999999999999999999999999   999999999999999999999999998754433333345689


Q ss_pred             CCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHH
Q 014038          276 FGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASL  355 (432)
Q Consensus       276 ~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  355 (432)
                      +.|+|||++.+..++.++|||||||++|||++|+.||...............       ........ .....+.++.++
T Consensus       158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~-~~~~~~~~~~~l  229 (277)
T cd05607         158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR-------TLEDEVKF-EHQNFTEESKDI  229 (277)
T ss_pred             CCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHH-------hhcccccc-ccccCCHHHHHH
Confidence            9999999998888999999999999999999999999753221111111000       00000000 001234578999


Q ss_pred             HHHhhccCCCCCCCHHHHHHH
Q 014038          356 AYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       356 i~~cl~~dp~~RPs~~~vl~~  376 (432)
                      +.+||+.||++||++.++++.
T Consensus       230 i~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         230 CRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             HHHHhccCHhhCCCCccchhh
Confidence            999999999999999877643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.2e-42  Score=324.69  Aligned_cols=259  Identities=32%  Similarity=0.515  Sum_probs=204.7

Q ss_pred             hccccccccccCceeEEEEEeC-CCc--EEEEEEeccC-ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGE--TVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      .+.+.+.||+|+||.||+|... ++.  .+++|.+... .....+.|.+|+.++.++ +||||+++++++...+..+++|
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~   82 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI   82 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence            3567789999999999999764 333  4788888643 334456789999999999 7999999999999999999999


Q ss_pred             EeccCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEE
Q 014038          188 VFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR  253 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~k  253 (432)
                      ||+++|+|.+++....              ...+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+|
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEE
Confidence            9999999999985421              135889999999999999999999998   99999999999999999999


Q ss_pred             EeecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCch
Q 014038          254 VADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGW  332 (432)
Q Consensus       254 l~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  332 (432)
                      |+|||++..............+..|+|||.+....++.++|||||||++|||++ |..||..............      
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~------  233 (297)
T cd05089         160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ------  233 (297)
T ss_pred             ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc------
Confidence            999999864322111122233567999999988889999999999999999998 9999976443221111110      


Q ss_pred             hhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhccc
Q 014038          333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHN  386 (432)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~  386 (432)
                            ......+...+.++.+|+.+||+.+|.+||++.++++.|..+...+..
T Consensus       234 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         234 ------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             ------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence                  011111222345789999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-42  Score=319.41  Aligned_cols=253  Identities=27%  Similarity=0.484  Sum_probs=204.9

Q ss_pred             HhccccccccccCceeEEEEEeC----CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ..+.+.+.||+|+||.||+|.+.    +...||||.+.... ......|.+|+.+++.++||||+++++++...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            35677889999999999999764    24579999987543 33456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||+++++|.+++.... ..+++..++.++.|++.||.|||+.+   |+|+||||+|||+++++.++|+|||++......
T Consensus        84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          84 TEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999986533 47899999999999999999999998   999999999999999999999999998765311


Q ss_pred             -cc--ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          267 -KH--AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       267 -~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                       ..  .....++..|+|||.+.+..++.++||||||+++|||++ |..||................            ..
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~------------~~  227 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY------------RL  227 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC------------CC
Confidence             11  112334678999999998899999999999999999998 999997544322221111110            00


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      +.+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       228 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11122345789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.7e-42  Score=330.67  Aligned_cols=243  Identities=27%  Similarity=0.449  Sum_probs=194.2

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHH---hhcCCCccceEEeeeeeCCeEEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLL---GRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      |.+.+.||+|+||.||+|.. .+++.||||.+....   ....+.+.+|+.++   ..++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            35678899999999999965 478999999986532   22334566676655   566899999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-  265 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-  265 (432)
                      |||+++|+|...+..   ..+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++.... 
T Consensus        81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            999999999988743   46999999999999999999999999   99999999999999999999999999875322 


Q ss_pred             cccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      ........|++.|+|||.+.+..++.++|||||||++|||++|+.||.+..............           .  .++
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-----------~--~~p  221 (324)
T cd05589         155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE-----------V--RYP  221 (324)
T ss_pred             CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------C--CCC
Confidence            223345679999999999999999999999999999999999999998654322222111110           0  111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRP-----SMRDIVQ  375 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RP-----s~~~vl~  375 (432)
                      ...+..+.+++.+||+.||.+||     ++.++++
T Consensus       222 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         222 RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            22345788999999999999999     4555554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.5e-43  Score=336.09  Aligned_cols=241  Identities=25%  Similarity=0.390  Sum_probs=196.1

Q ss_pred             ccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCC
Q 014038          118 TLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG  193 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  193 (432)
                      +.||+|+||.||++.. .+|+.||+|.+...   .......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999964 57899999998753   2233456788999999999999999999999999999999999999


Q ss_pred             ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cccccc
Q 014038          194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN  271 (432)
Q Consensus       194 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~  271 (432)
                      +|..++..  ...+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++.... ......
T Consensus        81 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          81 ELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            99988843  3468999999999999999999997 67   99999999999999999999999999875322 223344


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.+............ ..        .    .++...+.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-~~--------~----~~p~~~~~~  222 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-EE--------I----RFPRTLSPE  222 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc-CC--------C----CCCCCCCHH
Confidence            5799999999999999999999999999999999999999976433221111111 10        0    111223357


Q ss_pred             HHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014038          352 VASLAYKCVNRAPRKRP-----SMRDIVQV  376 (432)
Q Consensus       352 l~~li~~cl~~dp~~RP-----s~~~vl~~  376 (432)
                      +.+++.+||+.||++|+     ++.++++.
T Consensus       223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             HHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            89999999999999996     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8.4e-42  Score=318.27  Aligned_cols=254  Identities=29%  Similarity=0.450  Sum_probs=206.0

Q ss_pred             HHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      ...|.+.+.||+|+||.||+|...++..||+|.+.... ...+.|.+|+.+++.++||||+++++++.+ ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            34678889999999999999987777789999987533 234678999999999999999999998754 5679999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc-
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA-  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-  269 (432)
                      ++|+|.+++.......+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++......... 
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            9999999997654556899999999999999999999998   999999999999999999999999998654322211 


Q ss_pred             -cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          270 -ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       270 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                       ....++..|+|||...+..++.++||||||+++|||++ |..||.+.............            .....+..
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~------------~~~~~~~~  227 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG------------YRMPCPPE  227 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC------------CCCCCccc
Confidence             22345678999999988899999999999999999999 88899765432222111110            01112233


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL  381 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~  381 (432)
                      .+..+.+++.+||+.+|++||++.++++.|+..+
T Consensus       228 ~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         228 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            4567899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.3e-42  Score=322.69  Aligned_cols=252  Identities=28%  Similarity=0.496  Sum_probs=201.7

Q ss_pred             HhccccccccccCceeEEEEEe-----CCCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      ..+.+.+.||+|+||.||+|..     .++..||+|.+... .......|.+|+.++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            3567788999999999999964     25578999998753 33444678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC
Q 014038          186 VYVFMSKGSLASHLYDEN---------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM  250 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~---------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~  250 (432)
                      +|||+++|+|.+++....               ...+++..+..++.|++.||.|||+++   ++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999885321               234789999999999999999999998   99999999999999999


Q ss_pred             cEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhh
Q 014038          251 RARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNT  326 (432)
Q Consensus       251 ~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~  326 (432)
                      .+||+|||+++......   ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+............
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  241 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK  241 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            99999999987543221   1223345678999999988889999999999999999998 9999976433211111111


Q ss_pred             cCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          327 EGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                      ...            ...+...+.++.+++.+||+.||.+||++.+|++.|.
T Consensus       242 ~~~------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         242 RQL------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             CCc------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence            110            0111223357899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-43  Score=336.16  Aligned_cols=258  Identities=30%  Similarity=0.482  Sum_probs=214.9

Q ss_pred             HHHHhccccccccccCceeEEEEEeC---CCc--EEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQMS---TGE--TVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  182 (432)
                      +.++...+.++||+|.||.||+|.+.   .|+  .||||..+.+ .....+.|+.|.-+|+.++||||++++|+|.+ ..
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P  464 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP  464 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence            44555567789999999999999643   232  5999999875 44556789999999999999999999999985 57


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .++|||.++.|.|..+|..+ ...|+......++.||+.||+|||+..   ++||||..+|||+.....+||+|||+++.
T Consensus       465 ~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             eeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence            89999999999999999644 356888889999999999999999998   99999999999999999999999999987


Q ss_pred             ccccccc--cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          263 EMVDKHA--ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       263 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      .......  +...-...|||||.++-+.++.++|||-|||++||++. |..||.+..+...+..+..+            
T Consensus       541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG------------  608 (974)
T KOG4257|consen  541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG------------  608 (974)
T ss_pred             ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC------------
Confidence            6544332  23344678999999999999999999999999999888 99999876543332222222            


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      -+.+.|+.+++.|+.++.+||..||.+||.+.++...|+.+++.
T Consensus       609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence            22345566778999999999999999999999999999999874

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.4e-42  Score=318.57  Aligned_cols=254  Identities=28%  Similarity=0.441  Sum_probs=207.7

Q ss_pred             HHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      +...++++.++||+|+||.||+|...+++.||+|.+.... .....+.+|+.++++++|+||+++++++. .+..+++||
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            4456788899999999999999998889999999987543 33467899999999999999999999874 467899999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+.+++|.+++.......+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            999999999987666667999999999999999999999998   99999999999999999999999999865432211


Q ss_pred             --ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          269 --AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       269 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                        .....++..|+|||.+....++.++||||||+++|||++ |+.||.+.............            .....+
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~------------~~~~~~  225 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG------------YRMPRP  225 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC------------CCCCCC
Confidence              122345678999999988889999999999999999999 99999765432222221111            011111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR  379 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~  379 (432)
                      ...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            2233579999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=8e-42  Score=317.90  Aligned_cols=252  Identities=29%  Similarity=0.451  Sum_probs=204.9

Q ss_pred             HHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      ...+++.+.||+|+||.||+|...++..+|+|.+..... ..+.|.+|+.++++++|+|++++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            346677889999999999999888888999999875433 3467899999999999999999999885 45689999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc--
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH--  268 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~--  268 (432)
                      ++++|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++........  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            9999999997655566899999999999999999999998   99999999999999999999999999875432221  


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+.........+...            .....+..
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~------------~~~~~~~~  227 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG------------YRMPCPQD  227 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC------------CCCCCCCc
Confidence            122335568999999988889999999999999999999 89999764432222221111            11112223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR  379 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~  379 (432)
                      .+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         228 CPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            34579999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.9e-42  Score=328.30  Aligned_cols=259  Identities=32%  Similarity=0.533  Sum_probs=204.7

Q ss_pred             hccccccccccCceeEEEEEeC-CCc--EEEEEEeccC-ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGE--TVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      .+.+.+.||+|+||.||+|... ++.  .+|+|.+... .......+.+|+.++.++ +||||+++++++..++..++||
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~   87 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI   87 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence            4567789999999999999753 454  4677776543 334456788999999999 8999999999999999999999


Q ss_pred             EeccCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEE
Q 014038          188 VFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR  253 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~k  253 (432)
                      ||+++|+|.+++....              ...+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+|
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~k  164 (303)
T cd05088          88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAK  164 (303)
T ss_pred             EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEE
Confidence            9999999999986432              235889999999999999999999998   99999999999999999999


Q ss_pred             EeecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCch
Q 014038          254 VADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGW  332 (432)
Q Consensus       254 l~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  332 (432)
                      |+|||++.............++..|+|||.+.+..++.++|||||||++|||+| |..||..............      
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~------  238 (303)
T cd05088         165 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ------  238 (303)
T ss_pred             eCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc------
Confidence            999999864322112222234678999999988889999999999999999998 9999975433221111110      


Q ss_pred             hhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhccc
Q 014038          333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHN  386 (432)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~  386 (432)
                            ......+...+.++.+++.+||+.+|++||++.++++.|..++..+..
T Consensus       239 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~  286 (303)
T cd05088         239 ------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  286 (303)
T ss_pred             ------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence                  001111112335789999999999999999999999999998776553

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.3e-42  Score=334.95  Aligned_cols=242  Identities=28%  Similarity=0.406  Sum_probs=191.4

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      +++.+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+.+++.++|+||+++++++...+..++||||++
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  155 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD  155 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence            34567899999999999965 478999999986543 3334678999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~  270 (432)
                      +|+|....      ..++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++..... ....
T Consensus       156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  226 (353)
T PLN00034        156 GGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN  226 (353)
T ss_pred             CCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccccccc
Confidence            99986533      3567788899999999999999999   999999999999999999999999998754322 1223


Q ss_pred             ccccCCCCCCcccccc-----CCCCchhHhHHHHHHHHHHHhCCCCCCChh--HHHHHHHhhhcCCCchhhhccccCCCC
Q 014038          271 NIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLM--EYVELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                      ...||..|+|||.+..     ...+.++|||||||++|||++|+.||....  ++.........           .....
T Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-----------~~~~~  295 (353)
T PLN00034        227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM-----------SQPPE  295 (353)
T ss_pred             ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc-----------cCCCC
Confidence            4578999999998743     234568999999999999999999996321  11111110000           00111


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+...+.++.+|+.+||+.||++||++.|+++
T Consensus       296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        296 APATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            12233457999999999999999999999986

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.5e-42  Score=325.75  Aligned_cols=257  Identities=29%  Similarity=0.505  Sum_probs=206.3

Q ss_pred             HHHhccccccccccCceeEEEEEe------CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCC
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKG  181 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  181 (432)
                      ....+.+.+.||+|+||.||++..      ..+..||+|.+.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            345677889999999999999963      134579999987543 33346789999999999 7999999999999999


Q ss_pred             eEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          182 QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       182 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                      ..+++|||+.+|+|.+++.......+++.++..++.|++.||+|||+++   ++|+||||+|||++.++.++|+|||+++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999997555455899999999999999999999998   9999999999999999999999999987


Q ss_pred             ccccccc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhcc
Q 014038          262 EEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVD  337 (432)
Q Consensus       262 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      .......   .....++..|+|||.+....++.++|||||||++|||++ |..||...............+         
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~---------  260 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG---------  260 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC---------
Confidence            5433221   122345778999999998899999999999999999998 999987643322211111111         


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          338 SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       338 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                        .....+...+.++.+++.+||+.+|++||++.++++.|+++
T Consensus       261 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 --YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence              11111112235799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7e-42  Score=326.28  Aligned_cols=263  Identities=31%  Similarity=0.519  Sum_probs=208.7

Q ss_pred             HHHHHhccccccccccCceeEEEEEeC--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEeee
Q 014038          108 DLQKATCNFTTLIGQGAFGPVYKAQMS--------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYC  177 (432)
Q Consensus       108 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  177 (432)
                      ++....|.+.+.||+|+||.||++...        ++..+|+|.+.... ......+.+|+.++..+ +||||++++++|
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            344567888899999999999999642        23579999987542 33445788899999999 799999999999


Q ss_pred             eeCCeEEEEEEeccCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCC
Q 014038          178 AEKGQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSN  243 (432)
Q Consensus       178 ~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~N  243 (432)
                      ...+..++||||+++|+|.+++....              ...+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence            99999999999999999999996532              135899999999999999999999998   9999999999


Q ss_pred             eeecCCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHH
Q 014038          244 ILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYV  319 (432)
Q Consensus       244 ill~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~  319 (432)
                      |+++.++.+||+|||++.......   ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... 
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~-  249 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  249 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-
Confidence            999999999999999987543211   1112234568999999988889999999999999999998 88898754321 


Q ss_pred             HHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          320 ELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                      .........           .....+...+.++.+++.+||+.+|++||++.++++.|.++++...
T Consensus       250 ~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         250 ELFKLLKEG-----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             HHHHHHHcC-----------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence            111111111           1111222334588999999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.1e-41  Score=326.04  Aligned_cols=239  Identities=29%  Similarity=0.461  Sum_probs=191.8

Q ss_pred             ccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +.||+|+||.||+|.. .+++.||+|.+....   ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999965 467899999987532   22334556677777654 899999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN  271 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~  271 (432)
                      |+|..++..  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.... ......
T Consensus        81 g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          81 GDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence            999988854  346899999999999999999999998   99999999999999999999999999875332 223345


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.+............ ..            ..++...+.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-~~------------~~~~~~~~~~  222 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-DR------------PHFPRWISKE  222 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CC------------CCCCCCCCHH
Confidence            6789999999999988999999999999999999999999986543222221111 10            1112223457


Q ss_pred             HHHHHHHhhccCCCCCCCHH-HHH
Q 014038          352 VASLAYKCVNRAPRKRPSMR-DIV  374 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~~-~vl  374 (432)
                      +.+++.+||+.||++||++. +++
T Consensus       223 ~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         223 AKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             HHHHHHHHccCCHHHcCCChHHHH
Confidence            88999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.4e-42  Score=323.07  Aligned_cols=250  Identities=26%  Similarity=0.441  Sum_probs=200.8

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      |...+.||+|+||+||+|.. .+++.||+|.+....   ......+.+|+.+++.++|+|++++.+++..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            44567899999999999965 478899999986532   22334578899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA  269 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  269 (432)
                      +++++|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI  158 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence            99999998887655567999999999999999999999998   999999999999999999999999998654333333


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....|+..|+|||.+.+..++.++|+|||||++|||++|+.||....+.............       .  ...++...+
T Consensus       159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~-------~--~~~~~~~~~  229 (285)
T cd05632         159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE-------T--EEVYSAKFS  229 (285)
T ss_pred             cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhc-------c--ccccCccCC
Confidence            4457899999999999889999999999999999999999999765432221111110000       0  011122233


Q ss_pred             HHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPS-----MRDIVQ  375 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs-----~~~vl~  375 (432)
                      .++.+|+..||+.||++||+     +.+++.
T Consensus       230 ~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         230 EEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             HHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            57889999999999999999     556554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.7e-42  Score=321.10  Aligned_cols=254  Identities=24%  Similarity=0.422  Sum_probs=201.9

Q ss_pred             HHHhccccccccccCceeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  182 (432)
                      ....|.+.+.||+|+||.||+|...      ++..||+|.+.... .....+|.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4456788899999999999998642      35679999986432 2344578999999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEE
Q 014038          183 HMLVYVFMSKGSLASHLYDEN--------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV  254 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl  254 (432)
                      .++||||+++|+|.+++....        ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            999999999999999885422        234678899999999999999999998   999999999999999999999


Q ss_pred             eecCCccccccccc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCC
Q 014038          255 ADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKT  330 (432)
Q Consensus       255 ~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  330 (432)
                      +|||++........   .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+............... 
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-  239 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL-  239 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-
Confidence            99999864322211   112345778999999998899999999999999999999 7889876543222221111110 


Q ss_pred             chhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          331 GWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                                 ...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       240 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         240 -----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                       0111223357899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.4e-42  Score=331.30  Aligned_cols=235  Identities=26%  Similarity=0.421  Sum_probs=192.2

Q ss_pred             ccccccCceeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +.||+|+||.||+|... +++.||+|++...   .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999654 6889999998653   223345677888888876 799999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN  271 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~  271 (432)
                      |+|..++..  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.... ......
T Consensus        81 g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          81 GDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             chHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence            999988854  346899999999999999999999999   99999999999999999999999999875322 223345


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.. ...            ..+...+.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-~~~------------~~~~~~~~~  222 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-DEV------------VYPTWLSQD  222 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc-CCC------------CCCCCCCHH
Confidence            6799999999999988999999999999999999999999986543322222111 110            111123357


Q ss_pred             HHHHHHHhhccCCCCCCCH
Q 014038          352 VASLAYKCVNRAPRKRPSM  370 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~  370 (432)
                      +.+++.+||+.||++||++
T Consensus       223 ~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         223 AVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             HHHHHHHHcccCHHHCCCC
Confidence            8999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7.9e-42  Score=325.31  Aligned_cols=258  Identities=24%  Similarity=0.381  Sum_probs=196.9

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (303)
T cd07869           6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV   85 (303)
T ss_pred             cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence            5677789999999999999764 788999999875432 23346788999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-ccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~  269 (432)
                      . ++|.+++... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++...... ...
T Consensus        86 ~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  160 (303)
T cd07869          86 H-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY  160 (303)
T ss_pred             C-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence            5 6888777543 356899999999999999999999999   999999999999999999999999998643222 222


Q ss_pred             cccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHH-Hhh----hcCCCchhhh------cc
Q 014038          270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMN----TEGKTGWEEI------VD  337 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~-~~~----~~~~~~~~~~------~~  337 (432)
                      ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..+..... ...    ......|...      ..
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP  240 (303)
T ss_pred             CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence            34568999999998865 458899999999999999999999998654322111 110    0000001000      00


Q ss_pred             ccCCCCCCH---------HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          338 SRLDGIFDV---------EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       338 ~~~~~~~~~---------~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .......+.         ..+..+.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000000000         01246789999999999999999999885

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-42  Score=317.43  Aligned_cols=249  Identities=31%  Similarity=0.508  Sum_probs=206.0

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      ..+.+.+.||.|+||.||+|.. .|+.||+|.+..... ..+.+.+|+.++++++|+||+++++++.+....++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            3566778999999999999987 478999999976544 56789999999999999999999999998899999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN  271 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  271 (432)
                      +++|.+++.......+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.......  .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--~  158 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--S  158 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--c
Confidence            999999997655557999999999999999999999999   99999999999999999999999999876532221  2


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN  350 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (432)
                      ...+..|+|||.+....++.++||||||+++|||++ |..||.............. .           .....+...+.
T Consensus       159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~-----------~~~~~~~~~~~  226 (256)
T cd05039         159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-G-----------YRMEAPEGCPP  226 (256)
T ss_pred             CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-C-----------CCCCCccCCCH
Confidence            344668999999988889999999999999999997 9999876532211111111 0           01111222345


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 014038          351 EVASLAYKCVNRAPRKRPSMRDIVQVLSR  379 (432)
Q Consensus       351 ~l~~li~~cl~~dp~~RPs~~~vl~~L~~  379 (432)
                      ++.+++.+||..+|++||++.++++.|+.
T Consensus       227 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         227 EVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            78999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.7e-42  Score=331.16  Aligned_cols=241  Identities=27%  Similarity=0.404  Sum_probs=195.8

Q ss_pred             ccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      ++||+|+||.||+|... +++.||+|++....   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999654 67899999987532   23345677888888876 799999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN  271 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~  271 (432)
                      |+|...+..  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++..... ......
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          81 GDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence            999988853  356899999999999999999999999   99999999999999999999999999875322 222345


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||................ .            .++...+.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~-~------------~~p~~~~~~  222 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD-V------------LYPVWLSKE  222 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-C------------CCCCCCCHH
Confidence            678999999999998899999999999999999999999998755433222221110 0            011112357


Q ss_pred             HHHHHHHhhccCCCCCC-------CHHHHHHH
Q 014038          352 VASLAYKCVNRAPRKRP-------SMRDIVQV  376 (432)
Q Consensus       352 l~~li~~cl~~dp~~RP-------s~~~vl~~  376 (432)
                      +.+++.+||+.||++||       ++.++++.
T Consensus       223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             HHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            88999999999999999       77777653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-43  Score=317.21  Aligned_cols=252  Identities=28%  Similarity=0.395  Sum_probs=200.3

Q ss_pred             cccccccCceeEEEEE-eCCCcEEEEEEec--cCChhhHHHHHHHHHHHhhcCCCccceEEeeeee-----CCeEEEEEE
Q 014038          117 TTLIGQGAFGPVYKAQ-MSTGETVAVKVLA--TDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-----KGQHMLVYV  188 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e  188 (432)
                      .+.||+|+||.|+.+. ..+|+.||||++.  .......++-.+|+++|+.++|+||+.+++.+..     -+..|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            4679999999999994 4588999999997  4466667888999999999999999999998765     357899999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc---
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV---  265 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~---  265 (432)
                      +|+ .+|.+.++.  +..|+...+..++.|+++||.|+|+.+   |+||||||+|+|++.+..+||||||+|+....   
T Consensus       107 lMe-tDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~  180 (359)
T KOG0660|consen  107 LME-TDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE  180 (359)
T ss_pred             HHh-hHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCc
Confidence            994 599998843  345999999999999999999999999   99999999999999999999999999987543   


Q ss_pred             cccccccccCCCCCCcccc-ccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCc----hhhh-----
Q 014038          266 DKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG----WEEI-----  335 (432)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~-----  335 (432)
                      ....+..+.|.+|.|||++ ....||...||||.|||+.||++|++-|.+.....++..+......+    +..+     
T Consensus       181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a  260 (359)
T KOG0660|consen  181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA  260 (359)
T ss_pred             ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence            3344567889999999987 56789999999999999999999999998755444433222111111    1111     


Q ss_pred             ---ccc---cCCCC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 ---VDS---RLDGI----FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 ---~~~---~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                         +..   ..+.+    ++ ...+...+|+.+||..||.+|+|++|.++
T Consensus       261 r~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  261 RPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence               000   00000    11 12357889999999999999999999886

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=315.48  Aligned_cols=248  Identities=27%  Similarity=0.489  Sum_probs=201.3

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      ++.+.+.||+|+||.||+|...++..+|+|.+.... .....|.+|+.+++.++||||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            456778899999999999988777889999986432 2345788999999999999999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc--c
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA--A  270 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~--~  270 (432)
                      ++|.+++.... ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++........  .
T Consensus        84 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (256)
T cd05059          84 GCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ  159 (256)
T ss_pred             CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence            99999986433 36899999999999999999999999   999999999999999999999999998754322111  1


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |+.||...............            .....+...+
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~------------~~~~~~~~~~  227 (256)
T cd05059         160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG------------YRLYRPKLAP  227 (256)
T ss_pred             CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC------------CcCCCCCCCC
Confidence            1223457999999998899999999999999999999 89999764432222221111            0111122234


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                      .++.+++.+||+.+|++|||+.++++.|
T Consensus       228 ~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         228 TEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            5899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.9e-41  Score=313.81  Aligned_cols=245  Identities=28%  Similarity=0.437  Sum_probs=197.6

Q ss_pred             ccccccCceeEEEEEe-CCCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCCh
Q 014038          118 TLIGQGAFGPVYKAQM-STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  195 (432)
                      +.||+|+||.||+|.. .+++.||+|.+... .......|.+|+++++.++||||++++++|......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            3699999999999965 47899999987644 234456789999999999999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc---ccc
Q 014038          196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA---ANI  272 (432)
Q Consensus       196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~---~~~  272 (432)
                      .+++... ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.........   ...
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          81 LTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            9998543 346899999999999999999999998   999999999999999999999999998753321111   111


Q ss_pred             ccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      ..+..|+|||.+.+..++.++||||||+++|||++ |..||..............            ......+...+..
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~  224 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ------------GVRLPCPELCPDA  224 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc------------CCCCCCcccCCHH
Confidence            23456999999998899999999999999999998 8899875443221111111            1111122233457


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          352 VASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                      +.+++.+||+.+|++||++.++++.|.
T Consensus       225 ~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         225 VYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.6e-41  Score=314.69  Aligned_cols=247  Identities=24%  Similarity=0.386  Sum_probs=204.4

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      |.+.+.||+|++|.||+|.. .+++.|++|.+...  .......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            45668899999999999965 46889999998643  3345567899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~  269 (432)
                      ++++|.+++.......+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++...... ..
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~  158 (256)
T cd08529          82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA  158 (256)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence            9999999997655567999999999999999999999998   9999999999999999999999999987543322 22


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....+++.|+|||++.+..++.++|+||||+++|||++|+.||................            ....+...+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------~~~~~~~~~  226 (256)
T cd08529         159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV------------FPPVSQMYS  226 (256)
T ss_pred             hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------CCCCccccC
Confidence            34468899999999998899999999999999999999999997654322222111110            111122334


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.+++.+||+.+|++||++.++++
T Consensus       227 ~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         227 QQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHhh
Confidence            57999999999999999999999886

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7.7e-42  Score=335.95  Aligned_cols=261  Identities=26%  Similarity=0.458  Sum_probs=206.0

Q ss_pred             HHHHHHhccccccccccCceeEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHhhcC-CCccceEEeeee
Q 014038          107 KDLQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDSK-QGEKEFQTEVMLLGRLH-HRNLVNLVGYCA  178 (432)
Q Consensus       107 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  178 (432)
                      .++....+.+.+.||+|+||.||+|.+.      .+..||+|++..... .....+.+|+.+|.++. ||||++++++|.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3444455667789999999999999753      346899999975432 22357889999999997 999999999999


Q ss_pred             eCCeEEEEEEeccCCChhhhcccCC-------------------------------------------------------
Q 014038          179 EKGQHMLVYVFMSKGSLASHLYDEN-------------------------------------------------------  203 (432)
Q Consensus       179 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  203 (432)
                      ..+..++||||+++|+|.++++...                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999885421                                                       


Q ss_pred             -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCC
Q 014038          204 -----------------------------------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSS  242 (432)
Q Consensus       204 -----------------------------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~  242 (432)
                                                               ...+++..++.++.|++.||.|||+.+   ++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence                                                     124677888999999999999999988   999999999


Q ss_pred             CeeecCCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHH
Q 014038          243 NILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEY  318 (432)
Q Consensus       243 Nill~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~  318 (432)
                      |||+++++.+||+|||+++......   ......++..|+|||.+....++.++|||||||++|||++ |..||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            9999999999999999987532221   1122356788999999988889999999999999999998 89998754322


Q ss_pred             HHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 014038          319 VELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL  381 (432)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~  381 (432)
                      .........+           .....+...+.++.+++.+||+.+|.+||++.+|++.|+.++
T Consensus       349 ~~~~~~~~~~-----------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 EQFYNAIKRG-----------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHHHHHcC-----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            2221111111           111112223458999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-41  Score=322.14  Aligned_cols=254  Identities=28%  Similarity=0.493  Sum_probs=203.1

Q ss_pred             ccccccccccCceeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      +.+.+.||+|+||.||+|...      ....+|+|.+.... ......+.+|+.+++.++||||+++++.|...+..+++
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI   81 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence            345678999999999999642      23579999886543 33446788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCe
Q 014038          187 YVFMSKGSLASHLYDE----------------------NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNI  244 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~----------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Ni  244 (432)
                      |||+.+|+|.+++...                      ...++++..++.++.|++.||.|||+.+   ++||||||+||
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~ni  158 (290)
T cd05045          82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNV  158 (290)
T ss_pred             EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheE
Confidence            9999999999987431                      1245889999999999999999999998   99999999999


Q ss_pred             eecCCCcEEEeecCCccccccccc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHH
Q 014038          245 LLDQSMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVE  320 (432)
Q Consensus       245 ll~~~~~~kl~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~  320 (432)
                      |+++++.+||+|||+++.......   .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+......
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  238 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL  238 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            999999999999999875322211   122345678999999988889999999999999999999 9999976543221


Q ss_pred             HHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          321 LAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      ......            ......+...+.++.+++.+||+.+|++||++.++++.|++++.
T Consensus       239 ~~~~~~------------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         239 FNLLKT------------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHHHhC------------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            111111            11111122234579999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.6e-42  Score=323.59  Aligned_cols=252  Identities=27%  Similarity=0.451  Sum_probs=201.9

Q ss_pred             HhccccccccccCceeEEEEEeC------CCcEEEEEEeccCCh-hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  184 (432)
                      .++.+.+.||+|+||.||+|...      ++..||+|++..... .....|.+|+.++..++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            34567788999999999999653      347899999975533 23456889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC
Q 014038          185 LVYVFMSKGSLASHLYDE--------------NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM  250 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~  250 (432)
                      +++||+.+++|.+++...              ....+++..+..++.|++.||.|||+.+   ++||||||+|||+++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            999999999999987421              1235888999999999999999999998   99999999999999999


Q ss_pred             cEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhh
Q 014038          251 RARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNT  326 (432)
Q Consensus       251 ~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~  326 (432)
                      .+||+|||+++......   ......+++.|+|||.+....++.++|||||||++|||++ |..||.+............
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN  241 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            99999999987543221   1223345789999999988889999999999999999998 8889876443222211111


Q ss_pred             cCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          327 EGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                      ..            ....+...+..+.+++.+||+.+|.+||++.+|+..|+
T Consensus       242 ~~------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         242 RQ------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             CC------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            11            11122234457899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.4e-42  Score=337.37  Aligned_cols=249  Identities=25%  Similarity=0.304  Sum_probs=195.5

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      |.+.+.||+|+||+||+|.. .+++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~   82 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence            45678899999999999954 578899999996532   23345788999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc---
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD---  266 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~---  266 (432)
                      +++|+|.+++..  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        83 ~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          83 IPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            999999999854  346899999999999999999999999   999999999999999999999999987521100   


Q ss_pred             ---------------------------------------------ccccccccCCCCCCccccccCCCCchhHhHHHHHH
Q 014038          267 ---------------------------------------------KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVL  301 (432)
Q Consensus       267 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvi  301 (432)
                                                                   .......||+.|+|||.+.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                         00123469999999999998899999999999999


Q ss_pred             HHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHH--hhccCCCCCCCHHHHHHH
Q 014038          302 LFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYK--CVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       302 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dp~~RPs~~~vl~~  376 (432)
                      +|||++|+.||.................         .+..+.....+.++.+++.+  |+..+|..||++.+++..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~~---------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWEN---------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHcccc---------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            9999999999976443222211111000         00001111123467788877  556667779999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.3e-42  Score=329.32  Aligned_cols=240  Identities=29%  Similarity=0.445  Sum_probs=195.4

Q ss_pred             ccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +.||+|+||.||+|... +++.||+|.+....   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999654 67899999987532   23345677888999888 799999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN  271 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~  271 (432)
                      |+|..++..  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.... ......
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          81 GDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence            999988853  346999999999999999999999999   99999999999999999999999999865322 222344


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.+............ ..            ..++...+.+
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-~~------------~~~~~~~~~~  222 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-DE------------VRYPRWLSKE  222 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc-CC------------CCCCCcCCHH
Confidence            5789999999999999999999999999999999999999976543222211111 10            0112223457


Q ss_pred             HHHHHHHhhccCCCCCCCH-----HHHHH
Q 014038          352 VASLAYKCVNRAPRKRPSM-----RDIVQ  375 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~-----~~vl~  375 (432)
                      +.+++.+||+.||.+||++     .++++
T Consensus       223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         223 AKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             HHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            8999999999999999999     77664

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.2e-41  Score=314.38  Aligned_cols=244  Identities=27%  Similarity=0.426  Sum_probs=196.3

Q ss_pred             cccccCceeEEEEEe---CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCC
Q 014038          119 LIGQGAFGPVYKAQM---STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG  193 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  193 (432)
                      .||+|+||.||+|.+   .++..+|+|++....  ....+.+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999954   367899999986543  334567899999999999999999999886 45678999999999


Q ss_pred             ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc----c
Q 014038          194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH----A  269 (432)
Q Consensus       194 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~----~  269 (432)
                      +|.+++..  ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++........    .
T Consensus        81 ~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            99999853  346899999999999999999999999   99999999999999999999999999875432221    1


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      ....++..|+|||.+....++.++|+|||||++|||++ |+.||............. .+           .....+...
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~-----------~~~~~~~~~  223 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SG-----------ERMECPQRC  223 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CC-----------CCCCCCCCC
Confidence            12234578999999988889999999999999999998 999997654322222211 11           111122233


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      +.++.+++.+||+.||++||++.+|.+.|++.
T Consensus       224 ~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         224 PPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            45789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.8e-43  Score=319.33  Aligned_cols=251  Identities=26%  Similarity=0.364  Sum_probs=198.3

Q ss_pred             cccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC-----eEEEEEEec
Q 014038          117 TTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-----QHMLVYVFM  190 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~  190 (432)
                      .+++|.|+||.||+|... +++.||||+...+..    .-.+|+++|+.++|||||++..+|....     ...+|||||
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym  104 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM  104 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence            478999999999999654 578999999865433    2247999999999999999998886532     346899999


Q ss_pred             cCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC-CcEEEeecCCcccccccc
Q 014038          191 SKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-MRARVADFGLSREEMVDK  267 (432)
Q Consensus       191 ~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~-~~~kl~Dfgl~~~~~~~~  267 (432)
                      +. +|.+.++.  ..+..++...+.-++.||.+||.|||+.+   |+||||||.|+|+|.+ |.+||||||.|+....+.
T Consensus       105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            86 99988863  23456888888889999999999999988   9999999999999987 899999999999877777


Q ss_pred             cccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCch-hhh----------
Q 014038          268 HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW-EEI----------  335 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~----------  335 (432)
                      .......|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.....++..+..--..+- +++          
T Consensus       181 pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~  260 (364)
T KOG0658|consen  181 PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEF  260 (364)
T ss_pred             CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccc
Confidence            7777788999999998865 5799999999999999999999999998766555543322111111 111          


Q ss_pred             ccccCC-----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 VDSRLD-----GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 ~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      -.+.+.     ..+....+.+..+|+.++|+.+|.+|.++.+++.
T Consensus       261 ~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  261 KFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            011111     1122234568999999999999999999999885

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.3e-42  Score=343.53  Aligned_cols=256  Identities=23%  Similarity=0.383  Sum_probs=194.2

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC--------Ce
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--------GQ  182 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~  182 (432)
                      ..|.+.+.||+|+||.||+|.. .+++.||||.+....    ....+|+.+++.++||||+++++++...        ..
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  141 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF  141 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence            3577789999999999999965 478899999885432    2345799999999999999999876432        24


Q ss_pred             EEEEEEeccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC-cEEEeecCC
Q 014038          183 HMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGL  259 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~-~~kl~Dfgl  259 (432)
                      .++||||+++ +|.+++..  .....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++ .+||+|||+
T Consensus       142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGl  217 (440)
T PTZ00036        142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGS  217 (440)
T ss_pred             EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecccc
Confidence            6789999975 77766642  34467999999999999999999999999   99999999999998665 799999999


Q ss_pred             cccccccccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc-CCCchhhh--
Q 014038          260 SREEMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE-GKTGWEEI--  335 (432)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~--  335 (432)
                      ++............||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+......+...... +......+  
T Consensus       218 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~  297 (440)
T PTZ00036        218 AKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE  297 (440)
T ss_pred             chhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            986544444455678999999998865 46999999999999999999999999875543333222111 10000000  


Q ss_pred             -------------ccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 -------------VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 -------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                                   ....+...++...+.++.+|+.+||+.||.+|||+.++++
T Consensus       298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                         0000111112223457899999999999999999999985

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.3e-41  Score=320.12  Aligned_cols=251  Identities=30%  Similarity=0.487  Sum_probs=203.3

Q ss_pred             hccccccccccCceeEEEEEeC------CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      .+.+.+.||+|+||.||++...      ++..+|+|.+..........|.+|+++++.++|+||+++++++...+..+++
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV   85 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence            4556789999999999999532      4568999998766666677899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEE
Q 014038          187 YVFMSKGSLASHLYDENY-------------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR  253 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~k  253 (432)
                      |||+++|+|.+++.....             ..+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+|
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~k  162 (280)
T cd05092          86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVK  162 (280)
T ss_pred             EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEE
Confidence            999999999999864321             35899999999999999999999999   99999999999999999999


Q ss_pred             EeecCCccccccccc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCC
Q 014038          254 VADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK  329 (432)
Q Consensus       254 l~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  329 (432)
                      |+|||++........   .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.................
T Consensus       163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  242 (280)
T cd05092         163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE  242 (280)
T ss_pred             ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc
Confidence            999999864332211   122335678999999998899999999999999999998 9999976543322222111110


Q ss_pred             CchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          330 TGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                                  ...+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus       243 ------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         243 ------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                        0111123357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=337.52  Aligned_cols=249  Identities=25%  Similarity=0.341  Sum_probs=202.7

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+|... +|+.||+|++....   ......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            4667789999999999999654 78999999987532   2344678899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-  267 (432)
                      |+++|+|.+++...  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          82 YMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            99999999999644  57999999999999999999999998   9999999999999999999999999987543222 


Q ss_pred             -----------------------------cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHH
Q 014038          268 -----------------------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEY  318 (432)
Q Consensus       268 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~  318 (432)
                                                   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                         223456899999999999999999999999999999999999999865433


Q ss_pred             HHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 014038          319 VELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPS-MRDIVQV  376 (432)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~~vl~~  376 (432)
                      ..........         ..+.-+.....+.++.+++.+||. ||.+||+ +.++++.
T Consensus       237 ~~~~~i~~~~---------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         237 ETYNKIINWK---------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHHHhccC---------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            2222211100         000000011134578999999997 9999999 9999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.5e-41  Score=314.58  Aligned_cols=252  Identities=28%  Similarity=0.434  Sum_probs=204.7

Q ss_pred             HHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      ...+.+.+.||+|++|.||+|....+..+|+|.+.... ...+.+.+|+.+++.++|||++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            34677888999999999999988777789999886543 33467889999999999999999999875 45688999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc--
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH--  268 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~--  268 (432)
                      .+|+|.+++.......+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++........  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            9999999997655556899999999999999999999998   99999999999999999999999999865432221  


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      .....++..|+|||...+..++.++||||||+++|||++ |+.||.+..............            ....+..
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------~~~~~~~  227 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY------------RMPCPQG  227 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------CCCCCcc
Confidence            122345678999999988889999999999999999999 999998754432222211110            1111223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR  379 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~  379 (432)
                      .+..+.+++.+||+.||++||++.+|++.|++
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            34679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7e-42  Score=322.00  Aligned_cols=244  Identities=28%  Similarity=0.428  Sum_probs=193.8

Q ss_pred             ccccCceeEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCCh
Q 014038          120 IGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       120 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  195 (432)
                      ||+|+||+||++.. .+++.||+|.+.....   ...+.+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999965 4788999999865322   2335678899999999999999999999999999999999999999


Q ss_pred             hhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cccccc
Q 014038          196 ASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANI  272 (432)
Q Consensus       196 ~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~  272 (432)
                      ...+..  .....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++...... ......
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence            887743  23456999999999999999999999999   999999999999999999999999998654322 223345


Q ss_pred             ccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHH
Q 014038          273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEV  352 (432)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  352 (432)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||..............       ......  ...+...+.++
T Consensus       158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~-------~~~~~~--~~~~~~~~~~~  228 (280)
T cd05608         158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-------RILNDS--VTYPDKFSPAS  228 (280)
T ss_pred             CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH-------hhcccC--CCCcccCCHHH
Confidence            789999999999999999999999999999999999999975322111100000       000000  11222344678


Q ss_pred             HHHHHHhhccCCCCCC-----CHHHHHH
Q 014038          353 ASLAYKCVNRAPRKRP-----SMRDIVQ  375 (432)
Q Consensus       353 ~~li~~cl~~dp~~RP-----s~~~vl~  375 (432)
                      .+++.+||+.||++||     +++++++
T Consensus       229 ~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         229 KSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            9999999999999999     5666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.7e-42  Score=324.11  Aligned_cols=258  Identities=31%  Similarity=0.519  Sum_probs=206.4

Q ss_pred             HHHHhccccccccccCceeEEEEEeC------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeC
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK  180 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  180 (432)
                      +....+.+.+.||+|+||.||++...      ....+|+|.+... .......+.+|+.++.++ +|+||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            33456677889999999999999653      3368999998754 233445788999999999 899999999999999


Q ss_pred             CeEEEEEEeccCCChhhhccc--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee
Q 014038          181 GQHMLVYVFMSKGSLASHLYD--------------ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL  246 (432)
Q Consensus       181 ~~~~lv~e~~~~g~L~~~l~~--------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill  246 (432)
                      +..+++|||+++|+|..++..              .....+++..++.++.|++.||.|||+.+   |+||||||+|||+
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence            999999999999999999853              23456899999999999999999999998   9999999999999


Q ss_pred             cCCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHH
Q 014038          247 DQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELA  322 (432)
Q Consensus       247 ~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~  322 (432)
                      +.++.+||+|||+++......   ......++..|+|||.+.+..++.++|||||||++|||++ |..||..........
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            999999999999987543221   1122335678999999988899999999999999999998 999987643322111


Q ss_pred             HhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 014038          323 AMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL  381 (432)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~  381 (432)
                      .....            .....+...+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       246 ~~~~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         246 LLKEG------------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHcC------------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            11110            011112223457899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3e-42  Score=309.30  Aligned_cols=256  Identities=25%  Similarity=0.349  Sum_probs=203.8

Q ss_pred             cccccccccCceeEEEEEe-CCCcEEEEEEeccCCh--hhHHHHHHHHHHHhhcCCCccceEEeeeee--CCeEEEEEEe
Q 014038          115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHMLVYVF  189 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~  189 (432)
                      +..+.|++|+||.||+|+. .+++.||+|+++.+..  .-.-.-.+||.+|.+.+|||||.+..+...  -+..|+||||
T Consensus        79 e~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~  158 (419)
T KOG0663|consen   79 EKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEY  158 (419)
T ss_pred             HHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHH
Confidence            3456899999999999954 5789999999976532  112345799999999999999999887654  3579999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KH  268 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~  268 (432)
                      |+. +|...+..-. .++...++.-++.|+++|++|||.+.   |+|||||++|+|++..|.+||+|||+|+..... ..
T Consensus       159 ~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~  233 (419)
T KOG0663|consen  159 VEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP  233 (419)
T ss_pred             HHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence            987 8988886443 67999999999999999999999999   999999999999999999999999999976554 33


Q ss_pred             ccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh----cCCCchhhhccc-----
Q 014038          269 AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT----EGKTGWEEIVDS-----  338 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~-----  338 (432)
                      ....+.|.+|.|||++.+ ..|+...|+||+|||+.||+++++-|.+..+..++..+-.    .....|..+...     
T Consensus       234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~  313 (419)
T KOG0663|consen  234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK  313 (419)
T ss_pred             CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence            456778999999998865 5799999999999999999999999998877766554422    222223222111     


Q ss_pred             ---------cCCCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          339 ---------RLDGIFDVE-ELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       339 ---------~~~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                               .++..+... ....-++|+...|..||.+|-|+++.|+
T Consensus       314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                     111222222 3457789999999999999999999875

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1e-41  Score=321.20  Aligned_cols=261  Identities=26%  Similarity=0.412  Sum_probs=201.9

Q ss_pred             cccccccccCceeEEEEEe-----CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeC--CeEEEE
Q 014038          115 NFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHMLV  186 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  186 (432)
                      .+.+.||+|+||+||++..     .++..||+|.+.... ......|.+|+.++++++||||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            5678899999999988642     367899999987643 23456788999999999999999999988653  367899


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||+++|+|.+++..   ..+++..+..++.|++.||.|||+++   ++||||||+|||+++++.+||+|||++......
T Consensus        87 ~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          87 MEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             ecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            999999999999854   35999999999999999999999998   999999999999999999999999998754332


Q ss_pred             cc----ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHH-HHHHhhh--cCCCchhhhcccc
Q 014038          267 KH----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV-ELAAMNT--EGKTGWEEIVDSR  339 (432)
Q Consensus       267 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~  339 (432)
                      ..    .....++..|+|||.+....++.++||||||+++|||++|..||....... .......  .....+.+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence            21    122345667999999988889999999999999999999999986533211 1111000  0001111222222


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL  381 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~  381 (432)
                      .....+...+.++.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            222222334568999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5e-42  Score=329.76  Aligned_cols=239  Identities=28%  Similarity=0.440  Sum_probs=194.2

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCC-CccceEEeeeeeCCeEEEEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHH-RNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  188 (432)
                      |.+.+.||+|+||.||+|... +++.||+|++...   .....+.+..|..++..++| ++|+++++++...+..++|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            567789999999999999654 6789999998753   22344567889999999976 568889999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DK  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~  267 (432)
                      |+++|+|.+++..  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..... ..
T Consensus        82 ~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          82 YVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            9999999998853  356899999999999999999999998   99999999999999999999999999864322 22


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+............ ..            ..++..
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~-~~------------~~~~~~  223 (324)
T cd05587         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME-HN------------VSYPKS  223 (324)
T ss_pred             ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CC------------CCCCCC
Confidence            33456799999999999999999999999999999999999999986543322222211 11            111222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSM  370 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~  370 (432)
                      .+.++.+++.+||+.||.+|++.
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         224 LSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCC
Confidence            34578899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-41  Score=316.17  Aligned_cols=249  Identities=33%  Similarity=0.539  Sum_probs=197.4

Q ss_pred             ccccccCceeEEEEEeC-CCc--EEEEEEeccC-ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQMS-TGE--TVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +.||+|+||.||+|... ++.  .+|+|.+... .....+.+.+|+.++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999764 343  5788888643 334456789999999999 799999999999999999999999999


Q ss_pred             CChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecC
Q 014038          193 GSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFG  258 (432)
Q Consensus       193 g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg  258 (432)
                      |+|.+++....              ...+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999985422              235889999999999999999999998   9999999999999999999999999


Q ss_pred             CcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhcc
Q 014038          259 LSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVD  337 (432)
Q Consensus       259 l~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      ++..............+..|+|||++....++.++|||||||++|||++ |..||.+............           
T Consensus       158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-----------  226 (270)
T cd05047         158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-----------  226 (270)
T ss_pred             CccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC-----------
Confidence            9863222111222234567999999988889999999999999999997 9999975432211111110           


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 014038          338 SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL  381 (432)
Q Consensus       338 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~  381 (432)
                       ......+...+.++.+++.+||+.+|.+|||+.+++..|..++
T Consensus       227 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         227 -GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence             0000111123357899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=321.07  Aligned_cols=265  Identities=28%  Similarity=0.464  Sum_probs=204.6

Q ss_pred             CCCCcCHHHHHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhh--cCCCccceEEeee
Q 014038          100 GIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGR--LHHRNLVNLVGYC  177 (432)
Q Consensus       100 ~~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~  177 (432)
                      +.|.+--..+ ..+..+.+.||+|.||.||+|++ .|+.||||++..   .++..+.+|.++.+.  |+|+||+.+++.-
T Consensus       200 GlplLVQRTi-arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD  274 (513)
T KOG2052|consen  200 GLPLLVQRTI-ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAAD  274 (513)
T ss_pred             CchhHhHHhh-hheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhcc
Confidence            4444333333 33567789999999999999999 689999999964   345567788888875  4999999999865


Q ss_pred             eeCC----eEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeeeccCCCCCeeecC
Q 014038          178 AEKG----QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-----GAVPPVIHRDIKSSNILLDQ  248 (432)
Q Consensus       178 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-----~~~~~iiH~dlkp~Nill~~  248 (432)
                      ..+.    +++||++|.+.|||.++|..   ..++....++++..+|.||++||.     +|.|.|.|||||++|||+..
T Consensus       275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk  351 (513)
T KOG2052|consen  275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK  351 (513)
T ss_pred             ccCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence            4432    78999999999999999944   569999999999999999999996     57799999999999999999


Q ss_pred             CCcEEEeecCCccccccc-----ccccccccCCCCCCccccccCC----C--CchhHhHHHHHHHHHHHhC---------
Q 014038          249 SMRARVADFGLSREEMVD-----KHAANIRGTFGYLDPEYISTRN----F--TKKSDVYSFGVLLFELIAG---------  308 (432)
Q Consensus       249 ~~~~kl~Dfgl~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~SlGvil~elltg---------  308 (432)
                      ++.+.|+|+|||-.....     ......+||.+|||||++...-    |  -..+||||||.++||++..         
T Consensus       352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee  431 (513)
T KOG2052|consen  352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE  431 (513)
T ss_pred             CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence            999999999998654332     2345678999999999986431    2  2569999999999998753         


Q ss_pred             -CCCCCChhHHHHHHHhhhcCCCchhh----hccccCCCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          309 -RSPLQGLMEYVELAAMNTEGKTGWEE----IVDSRLDGIF-----DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       309 -~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                       +.||.+...          ....+++    +...++++..     ..+.+..+.++|..||..+|.-|-|+-.+-+.|.
T Consensus       432 y~~Pyyd~Vp----------~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~  501 (513)
T KOG2052|consen  432 YQLPYYDVVP----------SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLA  501 (513)
T ss_pred             hcCCcccCCC----------CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHH
Confidence             356654221          1111111    1222333322     3356788999999999999999999999999888


Q ss_pred             HHHh
Q 014038          379 RILK  382 (432)
Q Consensus       379 ~i~~  382 (432)
                      ++.+
T Consensus       502 ~l~~  505 (513)
T KOG2052|consen  502 KLSN  505 (513)
T ss_pred             HHhc
Confidence            8854

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3e-41  Score=317.54  Aligned_cols=253  Identities=25%  Similarity=0.426  Sum_probs=198.8

Q ss_pred             hccccccccccCceeEEEEEeC-CCc----EEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGE----TVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      .+.+.+.||+|+||.||+|.+. +++    .+++|.+.... .....++..|+..+++++||||+++++++. ....+++
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i   86 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLV   86 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEE
Confidence            4556789999999999999753 444    47888875432 233457788888999999999999999886 4567889


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      +||+++|+|.+++... ...+++..+..++.||+.||.|||+.+   ++||||||+|||+++++.+||+|||+++.....
T Consensus        87 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          87 TQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            9999999999999643 356899999999999999999999998   999999999999999999999999998754322


Q ss_pred             c---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          267 K---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       267 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .   ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+...... ......+...           
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~-----------  230 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERL-----------  230 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcC-----------
Confidence            1   1223456778999999988899999999999999999998 9999976533211 1111111100           


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      ..+......+.+++.+||..+|++|||+.++++.|..+..
T Consensus       231 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         231 AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            0011123467889999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-42  Score=332.87  Aligned_cols=237  Identities=30%  Similarity=0.430  Sum_probs=194.2

Q ss_pred             ccccccCceeEEEEEe----CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          118 TLIGQGAFGPVYKAQM----STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      +.||+|+||.||+++.    .+|+.||+|++....  ......+..|+.++++++||||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4699999999999854    367899999987532  2233467789999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~  270 (432)
                      +|+|.+++..  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..... ....
T Consensus        82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~  156 (318)
T cd05582          82 GGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY  156 (318)
T ss_pred             CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCcee
Confidence            9999998854  346899999999999999999999999   999999999999999999999999998754333 2334


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN  350 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (432)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||.............. ..          .  ..+...+.
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~-~~----------~--~~p~~~~~  223 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK-AK----------L--GMPQFLSP  223 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc-CC----------C--CCCCCCCH
Confidence            56789999999999988899999999999999999999999976543222221111 11          0  11222335


Q ss_pred             HHHHHHHHhhccCCCCCCCHHH
Q 014038          351 EVASLAYKCVNRAPRKRPSMRD  372 (432)
Q Consensus       351 ~l~~li~~cl~~dp~~RPs~~~  372 (432)
                      .+.+++.+||+.||++||++.+
T Consensus       224 ~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         224 EAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             HHHHHHHHHhhcCHhHcCCCCC
Confidence            7889999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=6.3e-42  Score=334.19  Aligned_cols=249  Identities=22%  Similarity=0.307  Sum_probs=193.5

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      |++.+.||+|+||+||++.. .+++.||+|++....   ......+.+|+.++.+++||||+++++.+.+....++||||
T Consensus         3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~   82 (363)
T cd05628           3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF   82 (363)
T ss_pred             ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence            56678999999999999964 468999999986532   22335678899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--  267 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--  267 (432)
                      +++|+|.+++..  .+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......  
T Consensus        83 ~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          83 LPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            999999999854  357999999999999999999999999   9999999999999999999999999986422110  


Q ss_pred             ----------------------------------cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCC
Q 014038          268 ----------------------------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ  313 (432)
Q Consensus       268 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~  313 (432)
                                                        .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                              0123579999999999999999999999999999999999999997


Q ss_pred             ChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhc--cCCCCCCCHHHHHHH
Q 014038          314 GLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVN--RAPRKRPSMRDIVQV  376 (432)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dp~~RPs~~~vl~~  376 (432)
                      +............... .   +   ..+...  ....++.+++.+++.  .++..||++.+|++.
T Consensus       238 ~~~~~~~~~~i~~~~~-~---~---~~p~~~--~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         238 SETPQETYKKVMNWKE-T---L---IFPPEV--PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCHHHHHHHHHcCcC-c---c---cCCCcC--CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            6543322222111000 0   0   011111  122456777776443  334456899999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.1e-42  Score=329.79  Aligned_cols=248  Identities=24%  Similarity=0.411  Sum_probs=193.5

Q ss_pred             ccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +.||+|+||.||++.. .+++.||+|++...   .......+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3689999999999965 46889999999753   223345678899999998 799999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN  271 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~  271 (432)
                      |+|..++..  .+.+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++.... ......
T Consensus        81 g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence            999988843  357999999999999999999999999   99999999999999999999999999874322 223345


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCC-chhhhccccCCCCCCHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT-GWEEIVDSRLDGIFDVEELN  350 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  350 (432)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ...... ....+.....  ..+...+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~--~~p~~~~~  230 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP---DQNTEDYLFQVILEKQI--RIPRSLSV  230 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccc---cccchHHHHHHHHcCCC--CCCCCCCH
Confidence            67999999999999999999999999999999999999999632100000   000000 0001111111  11222345


Q ss_pred             HHHHHHHHhhccCCCCCCC------HHHHHH
Q 014038          351 EVASLAYKCVNRAPRKRPS------MRDIVQ  375 (432)
Q Consensus       351 ~l~~li~~cl~~dp~~RPs------~~~vl~  375 (432)
                      ++.+++.+||+.||.+||+      +.++++
T Consensus       231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            7899999999999999997      556653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-41  Score=310.87  Aligned_cols=260  Identities=25%  Similarity=0.360  Sum_probs=208.3

Q ss_pred             hccccccccccCceeEEEEE-eCCCcEEEEEEeccCCh--hhHHHHHHHHHHHhhcCCCc-cceEEeeeeeCC------e
Q 014038          113 TCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRN-LVNLVGYCAEKG------Q  182 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~  182 (432)
                      .+...++||+|+||+||+|+ ..+|+.||+|+++....  .......+|+.+|++++|+| |+++++++...+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            34445679999999999995 45789999999987643  23456689999999999999 999999998877      8


Q ss_pred             EEEEEEeccCCChhhhcccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCc
Q 014038          183 HMLVYVFMSKGSLASHLYDENY--GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS  260 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~  260 (432)
                      .++||||++. +|..++.....  ..++...+..++.||+.||+|||+++   |+||||||.||||+++|.+||+|||++
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence            8999999965 99999865432  35777889999999999999999999   999999999999999999999999999


Q ss_pred             ccccccc-cccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhh----hcCCCchhh
Q 014038          261 REEMVDK-HAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMN----TEGKTGWEE  334 (432)
Q Consensus       261 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~----~~~~~~~~~  334 (432)
                      +...... .....++|.+|.|||++.+. .|+...||||+|||+.||++++.-|.+..+..++..+-    ......|+.
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            8655333 35567899999999998765 79999999999999999999999999988877665542    233344443


Q ss_pred             hc---ccc--CCCCC-CHH----H---HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          335 IV---DSR--LDGIF-DVE----E---LNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       335 ~~---~~~--~~~~~-~~~----~---~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ..   +-.  ..... +..    .   .....+++.+|++.+|.+|.|++..++.
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            32   111  11100 001    1   1378899999999999999999998864

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.6e-41  Score=315.49  Aligned_cols=251  Identities=27%  Similarity=0.474  Sum_probs=197.3

Q ss_pred             cccccccccCceeEEEEEeCCC-c--EEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC------CeE
Q 014038          115 NFTTLIGQGAFGPVYKAQMSTG-E--TVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQH  183 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~~~~-~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  183 (432)
                      .+.+.||+|+||.||+|...+. .  .+|+|.+...  .....+.+.+|+.+++.++||||++++++|...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            3567899999999999976543 3  5899988654  344456789999999999999999999987532      256


Q ss_pred             EEEEEeccCCChhhhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCC
Q 014038          184 MLVYVFMSKGSLASHLYD----ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL  259 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl  259 (432)
                      +++|||+++|+|.+++..    .....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            899999999999988742    12345899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccccc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhh
Q 014038          260 SREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEI  335 (432)
Q Consensus       260 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (432)
                      ++.......   .....+++.|+|||......++.++||||||+++|||++ |+.||.+...............      
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR------  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC------
Confidence            875432221   122345678999999998899999999999999999999 8999976443221111111110      


Q ss_pred             ccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                            ...+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       233 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 ------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  011112335789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-42  Score=337.26  Aligned_cols=248  Identities=23%  Similarity=0.309  Sum_probs=197.8

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+|.. .+|+.||||++....   ......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            356678999999999999965 468999999986532   2334567889999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-  267 (432)
                      |+++|+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          82 YLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            9999999999854  346999999999999999999999999   9999999999999999999999999986422110 


Q ss_pred             --------------------------------------cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCC
Q 014038          268 --------------------------------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGR  309 (432)
Q Consensus       268 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~  309 (432)
                                                            .....+||+.|+|||++....++.++|||||||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence                                                  011246899999999999999999999999999999999999


Q ss_pred             CCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 014038          310 SPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPS---MRDIVQ  375 (432)
Q Consensus       310 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~~vl~  375 (432)
                      .||................ .        .+..+.....+.++.+++.+|+. +|.+|++   +.++++
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~-~--------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         237 PPFCSDNPQETYRKIINWK-E--------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCHHHHHHHHHcCC-C--------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9998654332222211110 0        00000111223578899999996 9999998   888776

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.6e-42  Score=327.23  Aligned_cols=239  Identities=28%  Similarity=0.477  Sum_probs=192.7

Q ss_pred             ccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +.||+|+||.||+|... +++.||+|.+....   ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36899999999999754 67899999987542   22334566778888764 899999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN  271 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~  271 (432)
                      |+|..++..  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..... ......
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          81 GDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence            999998853  356899999999999999999999999   99999999999999999999999999875322 223345


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||............... .        +    .++.....+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-~--------~----~~~~~~~~~  222 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-N--------P----CYPRWLTRE  222 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-C--------C----CCCccCCHH
Confidence            67899999999999889999999999999999999999999764432221111110 0        1    111123357


Q ss_pred             HHHHHHHhhccCCCCCCCHH-HHH
Q 014038          352 VASLAYKCVNRAPRKRPSMR-DIV  374 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~~-~vl  374 (432)
                      +.+++.+||+.||++||++. +++
T Consensus       223 ~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         223 AKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             HHHHHHHHhccCHhhcCCChHHHH
Confidence            88999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-41  Score=343.42  Aligned_cols=250  Identities=26%  Similarity=0.351  Sum_probs=201.4

Q ss_pred             HhccccccccccCceeEEEEE-eCCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC-------
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-------  181 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  181 (432)
                      ..|.+.+.||+|+||+||+|. ..+|+.||||.+...  .......+.+|+..+..++|+|+++++..+....       
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            367788999999999999995 457899999998654  3344567889999999999999999988765432       


Q ss_pred             -eEEEEEEeccCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecC
Q 014038          182 -QHMLVYVFMSKGSLASHLYDE--NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFG  258 (432)
Q Consensus       182 -~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg  258 (432)
                       ..++||||+++|+|.+++...  ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecc
Confidence             367999999999999988642  3457899999999999999999999998   9999999999999999999999999


Q ss_pred             Cccccccc---ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhh
Q 014038          259 LSREEMVD---KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEI  335 (432)
Q Consensus       259 l~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (432)
                      +++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..............       
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~-------  261 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR-------  261 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-------
Confidence            98753321   22345679999999999999999999999999999999999999997643322111111110       


Q ss_pred             ccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                           ....+...+.++.+++.+||+.||.+||++.+++..
T Consensus       262 -----~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        262 -----YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                 011222334579999999999999999999998863

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.1e-41  Score=315.04  Aligned_cols=255  Identities=23%  Similarity=0.366  Sum_probs=204.8

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+|.. .+++.||||.+...   .......+.+|+.+++.++||||+++++++.+.+..++++|
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence            456778999999999999965 47899999987542   23334578899999999999999999999999999999999


Q ss_pred             eccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          189 FMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       189 ~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |+++|+|.+++..  .....+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            9999999988743  23356889999999999999999999998   999999999999999999999999998754322


Q ss_pred             c-cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhH-HHHHHHhhhcCCCchhhhccccCCCCC
Q 014038          267 K-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME-YVELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                      . ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||..... ..........          .......
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~----------~~~~~~~  229 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ----------CDYPPLP  229 (267)
T ss_pred             hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc----------CCCCCCC
Confidence            2 12234688899999999888899999999999999999999999864321 1111111000          0111111


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      ....+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus       230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            223446799999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.1e-42  Score=322.79  Aligned_cols=250  Identities=28%  Similarity=0.450  Sum_probs=199.8

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      |...+.||+|+||.||++.. .+++.||+|.+....   ......+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            44567899999999999965 478899999986532   22234577899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA  269 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  269 (432)
                      +++++|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.........
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence            99999999886555556999999999999999999999998   999999999999999999999999998754333333


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....|++.|+|||.+.+..++.++|||||||++|||++|+.||............        ..+... ....++...+
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~--------~~~~~~-~~~~~~~~~~  229 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV--------ERLVKE-VQEEYSEKFS  229 (285)
T ss_pred             cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH--------Hhhhhh-hhhhcCccCC
Confidence            3457899999999999999999999999999999999999999753221100000        000000 0001112233


Q ss_pred             HHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPS-----MRDIVQ  375 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs-----~~~vl~  375 (432)
                      .++.+++.+||+.||++|||     +.++++
T Consensus       230 ~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         230 PDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             HHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            57899999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.6e-42  Score=329.28  Aligned_cols=239  Identities=27%  Similarity=0.427  Sum_probs=194.3

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      |++.+.||+|+||.||+|... +++.||+|.+....   ......+..|..++..+ +|++|+++++++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            456789999999999999654 67899999987542   22334567788888877 58999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DK  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~  267 (432)
                      |+++|+|...+..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.... ..
T Consensus        82 ~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          82 YVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            9999999988853  346899999999999999999999999   99999999999999999999999999875332 22


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+............ ..            ..++..
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-~~------------~~~p~~  223 (323)
T cd05616         157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-HN------------VAYPKS  223 (323)
T ss_pred             ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh-CC------------CCCCCc
Confidence            33456789999999999999999999999999999999999999986543322222111 11            112223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSM  370 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~  370 (432)
                      .+.++.+++.+||+.||.+|++.
T Consensus       224 ~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         224 MSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCHHHHHHHHHHcccCHHhcCCC
Confidence            34578999999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.4e-41  Score=315.81  Aligned_cols=255  Identities=26%  Similarity=0.392  Sum_probs=205.8

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+|.. .+++.+|||.+...   ......++.+|+.+++.++||||+++++++...+..+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            455678899999999999964 58899999987643   22334678899999999999999999999999999999999


Q ss_pred             eccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          189 FMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       189 ~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |+++++|.+++..  .....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999998853  23456899999999999999999999999   999999999999999999999999988654332


Q ss_pred             c-cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHH-HHHHHhhhcCCCchhhhccccCCCCC
Q 014038          267 K-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEY-VELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                      . ......++..|+|||.+.+..++.++|+||||+++|||++|..||.+.... ......          +.........
T Consensus       160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----------~~~~~~~~~~  229 (267)
T cd08229         160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----------IEQCDYPPLP  229 (267)
T ss_pred             CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhh----------hhcCCCCCCC
Confidence            2 223456889999999998888999999999999999999999999643211 111110          0000111111


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      ....+.++.+++.+||+.||++|||+.+|++.++++
T Consensus       230 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         230 SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            223456899999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.6e-41  Score=319.45  Aligned_cols=258  Identities=27%  Similarity=0.462  Sum_probs=206.5

Q ss_pred             HHHhccccccccccCceeEEEEEeCC-----CcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeee-CCe
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQMST-----GETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-KGQ  182 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  182 (432)
                      ...+|.+.+.||+|+||.||+|....     +..|++|.+... .......+.+|+.++++++||||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34567788999999999999997654     688999998754 33445678899999999999999999998876 467


Q ss_pred             EEEEEEeccCCChhhhcccCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEee
Q 014038          183 HMLVYVFMSKGSLASHLYDENY------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVAD  256 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~D  256 (432)
                      .+++++|+++|+|.+++.....      ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            8999999999999999854322      46899999999999999999999998   99999999999999999999999


Q ss_pred             cCCccccccccc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCch
Q 014038          257 FGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGW  332 (432)
Q Consensus       257 fgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  332 (432)
                      ||+++.......   .....++..|+|||.+....++.++||||||+++||+++ |+.||....... +......+.   
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~---  236 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAYLKDGY---  236 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHHHHHcCC---
Confidence            999875422211   122345678999999988889999999999999999999 999997643322 111111110   


Q ss_pred             hhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                              ....+...+.++.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       237 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         237 --------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             --------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                    001111223578999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-41  Score=314.27  Aligned_cols=255  Identities=29%  Similarity=0.469  Sum_probs=209.3

Q ss_pred             HHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      +....+.+.+.||+|+||.||+|...++..||||.+.... ...+++.+|+.++++++|+||+++++++......+++||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            3345677889999999999999988788899999987543 335678999999999999999999999998899999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+++++|.+++.......+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++........
T Consensus        82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            999999999997655567999999999999999999999998   99999999999999999999999999875432211


Q ss_pred             --ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          269 --AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       269 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                        ......+..|+|||.+.+..++.++|+||||+++|||++ |+.||.+..............            ....+
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~------------~~~~~  226 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY------------RMPRP  226 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------CCCCC
Confidence              112234568999999998889999999999999999999 999997654433222221110            11111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR  379 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~  379 (432)
                      ...+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1224579999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.2e-41  Score=326.73  Aligned_cols=264  Identities=30%  Similarity=0.500  Sum_probs=208.6

Q ss_pred             HHHHHHhccccccccccCceeEEEEEeC--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEee
Q 014038          107 KDLQKATCNFTTLIGQGAFGPVYKAQMS--------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGY  176 (432)
Q Consensus       107 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~  176 (432)
                      .++...+|.+.+.||+|+||.||+|...        .+..||+|.+.... ......+.+|+.++.++ +||||++++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            3455567888999999999999999532        12368999887542 33456789999999999 79999999999


Q ss_pred             eeeCCeEEEEEEeccCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCC
Q 014038          177 CAEKGQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSS  242 (432)
Q Consensus       177 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~  242 (432)
                      |...+..+++|||+++|+|.+++....              ...+++..++.++.|++.||.|||+++   ++||||||+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~  163 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR  163 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence            999999999999999999999986422              235888999999999999999999998   999999999


Q ss_pred             CeeecCCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHH
Q 014038          243 NILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEY  318 (432)
Q Consensus       243 Nill~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~  318 (432)
                      |||++.++.+||+|||+++......   ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+....
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            9999999999999999987543221   1122334567999999999999999999999999999998 88998764322


Q ss_pred             HHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          319 VELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                      .........            .....+...+.++.+++.+||+.+|.+||++.++++.|.++.....
T Consensus       244 ~~~~~~~~~------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         244 ELFKLLKEG------------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             HHHHHHHcC------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence            211111110            0111122234578999999999999999999999999999975443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.4e-41  Score=326.56  Aligned_cols=236  Identities=28%  Similarity=0.384  Sum_probs=189.1

Q ss_pred             ccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHH-HHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVM-LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +.||+|+||+||+|.. .+|+.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            3699999999999965 478999999986432   222344555554 56778999999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN  271 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~  271 (432)
                      |+|..++..  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.... ......
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence            999998854  356899999999999999999999999   99999999999999999999999999875322 223345


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.............. ..        ..+    +...+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~-~~--------~~~----~~~~~~~  222 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN-KP--------LRL----KPNISVS  222 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc-CC--------CCC----CCCCCHH
Confidence            6799999999999999999999999999999999999999976432211111111 10        011    1122457


Q ss_pred             HHHHHHHhhccCCCCCCCHH
Q 014038          352 VASLAYKCVNRAPRKRPSMR  371 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~~  371 (432)
                      +.+++.+||+.||.+||++.
T Consensus       223 ~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         223 ARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHHHHHHhhcCHHhCCCCC
Confidence            89999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-41  Score=323.19  Aligned_cols=260  Identities=30%  Similarity=0.528  Sum_probs=207.9

Q ss_pred             HHHHhccccccccccCceeEEEEEe--------CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEeeee
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCA  178 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  178 (432)
                      +....+.+.+.||+|+||.||+|+.        .++..||+|.+.... ......+.+|+.++..+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            4456777889999999999999963        134579999986542 34456789999999999 8999999999999


Q ss_pred             eCCeEEEEEEeccCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCe
Q 014038          179 EKGQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNI  244 (432)
Q Consensus       179 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Ni  244 (432)
                      .....+++|||+++|+|.+++....              ...+++..+..++.||+.||.|||+++   ++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence            9999999999999999999986532              235788999999999999999999998   99999999999


Q ss_pred             eecCCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHH
Q 014038          245 LLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVE  320 (432)
Q Consensus       245 ll~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~  320 (432)
                      +++.++.+||+|||+++......   ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+......
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            99999999999999987543221   1222345678999999988889999999999999999998 8888875432221


Q ss_pred             HHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          321 LAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      ..... ...           ....+...+.++.+++.+||+.+|.+||++.++++.|.++...
T Consensus       249 ~~~~~-~~~-----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         249 FKLLK-EGH-----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             HHHHH-cCC-----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            11111 110           0111223345799999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=334.19  Aligned_cols=249  Identities=24%  Similarity=0.337  Sum_probs=195.8

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||++.. .+++.||||.+....   ......+.+|+.++..++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            356678999999999999954 578999999986432   2334568899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-  267 (432)
                      |+++|+|.+++..  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          82 FLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            9999999999853  356899999999999999999999999   9999999999999999999999999985211000 


Q ss_pred             -----------------------------------------------cccccccCCCCCCccccccCCCCchhHhHHHHH
Q 014038          268 -----------------------------------------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGV  300 (432)
Q Consensus       268 -----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv  300 (432)
                                                                     ......||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence                                                           001246899999999999899999999999999


Q ss_pred             HHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 014038          301 LLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR---PSMRDIVQV  376 (432)
Q Consensus       301 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---Ps~~~vl~~  376 (432)
                      ++|||++|+.||...........+..... .+      .+..  ....+.++.+++.+|+. +|.+|   +++.+++..
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~------~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYRKIINWRE-TL------YFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHHccCC-cc------CCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            99999999999976543322222111000 00      0000  01123578899999997 77765   599888764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-41  Score=315.50  Aligned_cols=251  Identities=29%  Similarity=0.505  Sum_probs=199.9

Q ss_pred             cccccccccCceeEEEEEeC-C---CcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe------
Q 014038          115 NFTTLIGQGAFGPVYKAQMS-T---GETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ------  182 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  182 (432)
                      .+.+.||+|+||.||+|... +   +..||+|.+....  ......+.+|+..++.++||||+++++++.....      
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            45678999999999999653 2   3679999987542  3345678999999999999999999998866544      


Q ss_pred             EEEEEEeccCCChhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecC
Q 014038          183 HMLVYVFMSKGSLASHLYDE----NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFG  258 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg  258 (432)
                      .+++|||+++|+|..++...    ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCcc
Confidence            79999999999999888542    2246899999999999999999999998   9999999999999999999999999


Q ss_pred             Cccccccccc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhh
Q 014038          259 LSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEE  334 (432)
Q Consensus       259 l~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  334 (432)
                      +++.......   ......+..|+|||.+....++.++|||||||++|||++ |..||.+...............     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-----  233 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR-----  233 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            9875432221   112234678999999988889999999999999999999 8999976543322221111110     


Q ss_pred             hccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                             ...+...+.++.+++.+||+.||++||++.++++.|+++
T Consensus       234 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         234 -------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                   011223345899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.1e-41  Score=312.10  Aligned_cols=245  Identities=26%  Similarity=0.410  Sum_probs=196.5

Q ss_pred             cccccCceeEEEEEeC---CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCC
Q 014038          119 LIGQGAFGPVYKAQMS---TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS  194 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  194 (432)
                      .||+|+||.||+|.+.   ++..||+|.+.... ....+.|.+|+.++++++||||+++++++. ....++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999653   45579999987653 333467899999999999999999999886 457899999999999


Q ss_pred             hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc----cc
Q 014038          195 LASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH----AA  270 (432)
Q Consensus       195 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~----~~  270 (432)
                      |.+++... ...+++..+++++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++........    ..
T Consensus        81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99988543 356899999999999999999999998   99999999999999999999999999875332211    11


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ...++..|+|||.+....++.++|||||||++|||++ |..||................            ....+...+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------~~~~~~~~~  224 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK------------RLDCPAECP  224 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC------------CCCCCCCCC
Confidence            1233578999999988889999999999999999996 999997654432222211111            111222334


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      .++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus       225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            6889999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.3e-41  Score=312.99  Aligned_cols=248  Identities=29%  Similarity=0.473  Sum_probs=200.9

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeee-eCCeEEEEEEec
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA-EKGQHMLVYVFM  190 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~  190 (432)
                      ..+.+.+.||+|+||.||++.. .|..||+|.+....  ..+.|.+|+.++++++|+|++++++++. ..+..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            3567788999999999999976 47889999986432  3457899999999999999999999764 456789999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA  270 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  270 (432)
                      ++++|.+++.......+++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||++.......  .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~  157 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--D  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--C
Confidence            9999999987655556899999999999999999999998   9999999999999999999999999987543222  2


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ...++..|+|||++....++.++|||||||++|||++ |+.||.............. .           .....+...+
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~-----------~~~~~~~~~~  225 (256)
T cd05082         158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-G-----------YKMDAPDGCP  225 (256)
T ss_pred             CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-C-----------CCCCCCCCCC
Confidence            3344678999999998899999999999999999998 9999875332111111111 0           0111122234


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQVLSR  379 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~~L~~  379 (432)
                      ..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       226 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         226 PVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            578999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-41  Score=329.49  Aligned_cols=260  Identities=32%  Similarity=0.520  Sum_probs=202.4

Q ss_pred             HHHhccccccccccCceeEEEEEe------CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeC-
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK-  180 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  180 (432)
                      ...+|.+.+.||+|+||.||+|..      .+++.||||.+.... ......+.+|+.++.++ +||||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            345678889999999999999953      356889999997543 23345788999999999 689999999988654 


Q ss_pred             CeEEEEEEeccCCChhhhcccCC---------------------------------------------------------
Q 014038          181 GQHMLVYVFMSKGSLASHLYDEN---------------------------------------------------------  203 (432)
Q Consensus       181 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  203 (432)
                      ...+++|||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            46789999999999998885321                                                         


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc---cccc
Q 014038          204 --------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH---AANI  272 (432)
Q Consensus       204 --------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~---~~~~  272 (432)
                              ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++........   ....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                    124788889999999999999999998   99999999999999999999999999875422211   1123


Q ss_pred             ccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      .++..|+|||.+.+..++.++||||||+++|||++ |..||...............+.           ....+...+.+
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~  310 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-----------RMRAPDYTTPE  310 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC-----------CCCCCCCCCHH
Confidence            45678999999988899999999999999999997 9999875432111111111110           00111112347


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          352 VASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      +.+++.+||+.||++||++.+|++.|+.+++.
T Consensus       311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            89999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.1e-41  Score=328.06  Aligned_cols=244  Identities=23%  Similarity=0.388  Sum_probs=189.9

Q ss_pred             ccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +.||+|+||.||+|.. .+++.||+|.+...   .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            3699999999999965 46789999998753   223345677899888877 899999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN  271 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~  271 (432)
                      |+|..++..  ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.... ......
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          81 GDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence            999888743  356999999999999999999999999   99999999999999999999999999875322 223345


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...........  ......+..+....  ...+...+.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~--~~~~~~~~~i~~~~--~~~p~~~~~~  231 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--NTEDYLFQVILEKQ--IRIPRSLSVK  231 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccc--ccHHHHHHHHhcCC--CCCCCCCCHH
Confidence            6799999999999999999999999999999999999999953110000000  00000000011111  1122233457


Q ss_pred             HHHHHHHhhccCCCCCCCH
Q 014038          352 VASLAYKCVNRAPRKRPSM  370 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~  370 (432)
                      +.+++.+||+.||++||++
T Consensus       232 ~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         232 AASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHHHHhcCCHHHcCCC
Confidence            8899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.9e-41  Score=330.36  Aligned_cols=257  Identities=25%  Similarity=0.312  Sum_probs=197.4

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC------e
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG------Q  182 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  182 (432)
                      ..|.+.+.||+|+||.||++.. .+|..||+|.+...  .......+.+|+.+++.++||||+++++++....      .
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            4677789999999999999965 46899999998643  2334567889999999999999999999886443      5


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .++||||+++ +|.+.+.    ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       101 ~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~  172 (359)
T cd07876         101 VYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART  172 (359)
T ss_pred             eEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccc
Confidence            7999999975 6666653    24888999999999999999999999   99999999999999999999999999975


Q ss_pred             ccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCc-----------
Q 014038          263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG-----------  331 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------  331 (432)
                      ...........+|+.|+|||.+.+..++.++|||||||++|||++|+.||.+......+.........+           
T Consensus       173 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (359)
T cd07876         173 ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT  252 (359)
T ss_pred             cccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence            444334445678999999999999999999999999999999999999998654322221111000000           


Q ss_pred             ---------------hhhhccccCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          332 ---------------WEEIVDSRLD---GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       332 ---------------~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                                     +.+.......   ...+.....++.+++.+||+.||++|||+.|+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                           0000000000   00011123578999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-41  Score=326.85  Aligned_cols=236  Identities=27%  Similarity=0.381  Sum_probs=188.4

Q ss_pred             ccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHH-HHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVM-LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      ++||+|+||.||+|+. .+++.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999965 468899999986432   222344555554 57888999999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN  271 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~  271 (432)
                      |+|...+..  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.... ......
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05603          81 GELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST  155 (321)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence            999888743  356889999999999999999999998   99999999999999999999999999875322 223345


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.............           ....  ..+.....+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~-----------~~~~--~~~~~~~~~  222 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL-----------HKPL--QLPGGKTVA  222 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh-----------cCCC--CCCCCCCHH
Confidence            678999999999998899999999999999999999999997643221111111           1000  112223357


Q ss_pred             HHHHHHHhhccCCCCCCCHH
Q 014038          352 VASLAYKCVNRAPRKRPSMR  371 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~~  371 (432)
                      +.+++.+||+.||.+||++.
T Consensus       223 ~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         223 ACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHHHHHHccCCHhhcCCCC
Confidence            89999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.1e-41  Score=327.68  Aligned_cols=237  Identities=26%  Similarity=0.378  Sum_probs=189.8

Q ss_pred             ccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHH-HHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVM-LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +.||+|+||.||+|.. .+|+.||+|++...   .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3689999999999964 47899999998653   2233345556655 46778999999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN  271 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~  271 (432)
                      |+|..++..  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.... ......
T Consensus        81 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (325)
T cd05604          81 GELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT  155 (325)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence            999988843  457899999999999999999999999   99999999999999999999999999875322 223345


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.............. .          .+  ..+...+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~-~----------~~--~~~~~~~~~  222 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH-K----------PL--VLRPGASLT  222 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc-C----------Cc--cCCCCCCHH
Confidence            6799999999999999999999999999999999999999976433221111111 0          00  011122347


Q ss_pred             HHHHHHHhhccCCCCCCCHHH
Q 014038          352 VASLAYKCVNRAPRKRPSMRD  372 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~~~  372 (432)
                      +.+++.+|++.+|.+||++.+
T Consensus       223 ~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         223 AWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             HHHHHHHHhccCHHhcCCCCC
Confidence            889999999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.1e-41  Score=312.90  Aligned_cols=248  Identities=25%  Similarity=0.370  Sum_probs=203.8

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      |.+.+.||+|+||.||++.. .+++.+|+|.+... .....+.+.+|+.+++.++|+||+++++.+.+++..+++|||++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD   81 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence            45678999999999999965 47889999998643 33445678899999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-ccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~  270 (432)
                      +|+|.+++.......+++..+..++.|++.||.|||+++   ++|+||||+||++++++.++|+|||++....... ...
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence            999999886655567899999999999999999999999   9999999999999999999999999987543222 223


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN  350 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (432)
                      ...+++.|+|||++.+..++.++|+||||+++|+|++|+.||.................            ...+...+.
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------~~~~~~~~~  226 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY------------KPLPSHYSY  226 (255)
T ss_pred             cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC------------CCCCcccCH
Confidence            45688999999999888899999999999999999999999976432222111111111            111222345


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          351 EVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       351 ~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      .+.+++.+||+.||++||++.+++..
T Consensus       227 ~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         227 ELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            78899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.1e-42  Score=331.54  Aligned_cols=245  Identities=29%  Similarity=0.417  Sum_probs=195.0

Q ss_pred             ccccccccccCceeEEEEEe----CCCcEEEEEEeccC----ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQM----STGETVAVKVLATD----SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  184 (432)
                      |.+.+.||+|+||.||+++.    .+++.||+|++...    .....+.+..|+.++..+ +||||+++++++...+..+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            56778999999999999864    36789999998643    122345678899999999 5999999999999999999


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      +||||+++|+|.+++..  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        82 lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          82 LILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999854  346899999999999999999999999   9999999999999999999999999987532


Q ss_pred             cc--ccccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHH---HHHHHhhhcCCCchhhhccc
Q 014038          265 VD--KHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEY---VELAAMNTEGKTGWEEIVDS  338 (432)
Q Consensus       265 ~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~  338 (432)
                      ..  .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......   ......          +.. 
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~----------~~~-  225 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR----------ILK-  225 (332)
T ss_pred             ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH----------Hhc-
Confidence            22  223346799999999998765 4789999999999999999999999642210   111100          000 


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 014038          339 RLDGIFDVEELNEVASLAYKCVNRAPRKRP-----SMRDIVQ  375 (432)
Q Consensus       339 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~~vl~  375 (432)
                       .....+...+..+.+++.+||+.||++||     ++.++++
T Consensus       226 -~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 -CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence             01112222345788999999999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8.7e-42  Score=326.89  Aligned_cols=239  Identities=29%  Similarity=0.467  Sum_probs=192.7

Q ss_pred             ccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +.||+|+||.||+|... +|+.||+|.+....   ......+..|..++... +||||+++++++.+.+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36999999999999654 68899999987532   22344567788888765 899999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN  271 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~  271 (432)
                      |+|..++..  ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.... ......
T Consensus        81 g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          81 GDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence            999988854  356899999999999999999999999   99999999999999999999999999874322 223345


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.+............ ..        +    .++...+.+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-~~--------~----~~~~~~~~~  222 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-DT--------P----HYPRWITKE  222 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CC--------C----CCCCCCCHH
Confidence            6789999999999999999999999999999999999999976543222221111 00        0    111123357


Q ss_pred             HHHHHHHhhccCCCCCCCHH-HHH
Q 014038          352 VASLAYKCVNRAPRKRPSMR-DIV  374 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~~-~vl  374 (432)
                      +.+++.+||+.||++||++. +++
T Consensus       223 ~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         223 SKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             HHHHHHHHccCCHHHcCCChHHHH
Confidence            88999999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.7e-41  Score=316.86  Aligned_cols=252  Identities=24%  Similarity=0.396  Sum_probs=201.2

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      ..|.+.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++.+++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            3567778999999999999975 578899999987655445567889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~  269 (432)
                      ++++|.+++..  ..++++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++....... ..
T Consensus        89 ~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06646          89 GGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR  163 (267)
T ss_pred             CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence            99999998853  356899999999999999999999998   9999999999999999999999999987543221 22


Q ss_pred             cccccCCCCCCccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          270 ANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      ....+++.|+|||.+.   ...++.++|||||||++|||++|+.||...........+...      .+..+...  ...
T Consensus       164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~--~~~  235 (267)
T cd06646         164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS------NFQPPKLK--DKT  235 (267)
T ss_pred             CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC------CCCCCCCc--ccc
Confidence            3456889999999874   345788999999999999999999998653322111111000      00001111  111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ..+..+.+++.+||+.+|++||+++++++.
T Consensus       236 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         236 KWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            234588999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7e-41  Score=309.56  Aligned_cols=245  Identities=27%  Similarity=0.470  Sum_probs=199.4

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCCh-hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCChh
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLA  196 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  196 (432)
                      ++||+|+||.||+|...++..+|+|.+..... .....|.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999888889999999876532 33457889999999999999999999999999999999999999999


Q ss_pred             hhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc--ccccc
Q 014038          197 SHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA--ANIRG  274 (432)
Q Consensus       197 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~--~~~~g  274 (432)
                      +++... ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.........  ....+
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          81 SFLRKK-KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            988543 346899999999999999999999998   999999999999999999999999998643222111  12234


Q ss_pred             CCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHH
Q 014038          275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVA  353 (432)
Q Consensus       275 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  353 (432)
                      +..|+|||++.+..++.++||||||+++|||++ |..||...............            .....+...+..+.
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~  224 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG------------YRMSCPQKCPDDVY  224 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC------------CCCCCCCCCCHHHH
Confidence            567999999998899999999999999999998 99999765433222211111            01111222345799


Q ss_pred             HHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          354 SLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       354 ~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                      +++.+||+.+|++||++.++++.|.
T Consensus       225 ~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         225 KVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHcccCcccCCCHHHHHHHhc
Confidence            9999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.6e-41  Score=314.13  Aligned_cols=253  Identities=28%  Similarity=0.500  Sum_probs=203.1

Q ss_pred             HhccccccccccCceeEEEEEeC-CC---cEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TG---ETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ..++..+.||+|+||.||+|... ++   ..+|+|.+.... ......+..|+.++..++|||++++++++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            34566789999999999999764 33   379999986542 33456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||+++++|.+++... .+.+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus        85 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          85 TEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            9999999999998643 357899999999999999999999998   999999999999999999999999998754322


Q ss_pred             ccc----cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCC
Q 014038          267 KHA----ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       267 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ...    .....+..|+|||.+....++.++|||||||++|||++ |+.||...........+....            .
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~------------~  228 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF------------R  228 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC------------C
Confidence            111    11223457999999988889999999999999999998 999997544322222111110            1


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      .+.+...+.++.+++.+||+.+|++||++.+|++.|+++
T Consensus       229 ~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         229 LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111122345789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-41  Score=334.61  Aligned_cols=253  Identities=22%  Similarity=0.276  Sum_probs=194.7

Q ss_pred             HHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ...|.+.+.||+|+||.||++.. .+++.||+|...      ...+.+|+.++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            34577889999999999999954 578999999753      23567899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc--c
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--K  267 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~--~  267 (432)
                      +. ++|..++...  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....  .
T Consensus       165 ~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        165 YK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             CC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            95 6888887543  46899999999999999999999998   999999999999999999999999998643221  2


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChh-------HHHHHHHhhh-cCCC---------
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM-------EYVELAAMNT-EGKT---------  330 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~-------~~~~~~~~~~-~~~~---------  330 (432)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||....       ....+..+.. .+..         
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            2334579999999999998999999999999999999999998864311       0011111100 0000         


Q ss_pred             -chhhhc----ccc--CCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          331 -GWEEIV----DSR--LDGIFD-----VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       331 -~~~~~~----~~~--~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                       .+....    ...  .....+     ...+.++.+++.+||+.||++|||+.|+++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence             000000    000  000000     123457899999999999999999999985

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.6e-41  Score=317.66  Aligned_cols=264  Identities=27%  Similarity=0.428  Sum_probs=201.6

Q ss_pred             hccccccccccCceeEEEEEe-----CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeee--CCeEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHML  185 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  185 (432)
                      .+.+.+.||+|+||.||++..     .++..||+|.+........+.|.+|+++++.++||||+++++++..  ....++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   84 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL   84 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence            456678999999999999964     3578999999977666666789999999999999999999998754  346899


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.....
T Consensus        85 v~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          85 VMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            99999999999998543 346899999999999999999999999   99999999999999999999999999875432


Q ss_pred             cccc----cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHH-HHHHhhhcCCCc---hhhhcc
Q 014038          266 DKHA----ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV-ELAAMNTEGKTG---WEEIVD  337 (432)
Q Consensus       266 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~---~~~~~~  337 (432)
                      ....    ....++..|+|||.+.+..++.++|||||||++|||++|..|+....... ............   +.+.+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            2211    11223456999999988899999999999999999999887764332110 000000000000   001111


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          338 SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       338 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      .......+...+.++.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1111111223345799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=335.32  Aligned_cols=243  Identities=29%  Similarity=0.526  Sum_probs=208.0

Q ss_pred             cccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCChhh
Q 014038          119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLAS  197 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  197 (432)
                      +||+|.||+||-|+.. +...+|||.+.........-+.+|+.+-+.|+|.|||+++|.|.+++..-+.||.++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999654 556799999987766667778999999999999999999999999999999999999999999


Q ss_pred             hcccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec-CCCcEEEeecCCcccc-cccccccccc
Q 014038          198 HLYDENYGPL--TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREE-MVDKHAANIR  273 (432)
Q Consensus       198 ~l~~~~~~~l--~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~-~~~~~kl~Dfgl~~~~-~~~~~~~~~~  273 (432)
                      +|.. .++++  ++..+-.+.+||++||.|||++.   |+|||||-+|||++ -.|.+||+|||-+++. .....+.++.
T Consensus       662 LLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT  737 (1226)
T KOG4279|consen  662 LLRS-KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT  737 (1226)
T ss_pred             HHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence            9964 57888  78888999999999999999999   99999999999995 6889999999998764 3456778899


Q ss_pred             cCCCCCCccccccC--CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          274 GTFGYLDPEYISTR--NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       274 gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      ||..|||||++..+  .|...+|||||||++.||.||++||-...+...  ++-.-+        --...++.|.+.+.+
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--AMFkVG--------myKvHP~iPeelsae  807 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--AMFKVG--------MYKVHPPIPEELSAE  807 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--hhhhhc--------ceecCCCCcHHHHHH
Confidence            99999999999755  588999999999999999999999976543211  111000        112345677888899


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 014038          352 VASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...+|.+|+..||.+||+++++++
T Consensus       808 ak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  808 AKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHcCCCcccCccHHHhcc
Confidence            999999999999999999999986

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.5e-41  Score=319.26  Aligned_cols=258  Identities=27%  Similarity=0.356  Sum_probs=195.2

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhc---CCCccceEEeeeee-----CCe
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRL---HHRNLVNLVGYCAE-----KGQ  182 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~~  182 (432)
                      |.+.+.||+|+||.||+|.. .+++.||+|.+....  ......+.+|+.+++.+   +||||+++++++..     ...
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            56678899999999999965 478899999986532  22233556777777655   79999999998864     245


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .+++|||+. ++|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++..
T Consensus        82 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          82 VTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             EEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcccc
Confidence            799999997 48988886655556999999999999999999999999   99999999999999999999999999876


Q ss_pred             ccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc----CCCchhhh---
Q 014038          263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE----GKTGWEEI---  335 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~~~---  335 (432)
                      ...........+|..|+|||++.+..++.++|||||||++|||++|++||.+......+......    ....|...   
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07863         158 YSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL  237 (288)
T ss_pred             ccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence            44333334456899999999998889999999999999999999999999765433222221110    01111100   


Q ss_pred             ----ccccCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 ----VDSRLDG---IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 ----~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                          ..+....   ........++.+++.+||+.||++|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                0000000   000123357889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=8.3e-42  Score=335.71  Aligned_cols=247  Identities=25%  Similarity=0.329  Sum_probs=194.0

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      |.+.+.||+|+||.||+|.. .+++.||+|.+....   ......+.+|+.++++++||||+++++.+.+.+..++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~   82 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY   82 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence            55678999999999999964 578899999986532   23345788999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc---
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD---  266 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~---  266 (432)
                      +++|+|.+++...  +.+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......   
T Consensus        83 ~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          83 IPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            9999999988543  46899999999999999999999999   999999999999999999999999997421100   


Q ss_pred             ---------------------------------------------ccccccccCCCCCCccccccCCCCchhHhHHHHHH
Q 014038          267 ---------------------------------------------KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVL  301 (432)
Q Consensus       267 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvi  301 (432)
                                                                   ......+||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                         00123468999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 014038          302 LFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPS---MRDIVQ  375 (432)
Q Consensus       302 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~~vl~  375 (432)
                      +|||++|+.||................         .....+.....+.++.+++.+|+ .+|.+|++   +.++++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~---------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINWQ---------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHccC---------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999999999998654332222211100         00111111122346777887765 59999987   777664

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.1e-41  Score=317.31  Aligned_cols=256  Identities=27%  Similarity=0.446  Sum_probs=202.3

Q ss_pred             HHhccccccccccCceeEEEEEe-CCCc----EEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM-STGE----TVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  184 (432)
                      ...+.+.+.||+|+||+||+|.+ .+|.    .||+|.+... .......+.+|+.++..++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            34566778999999999999964 3444    4899998754 33445678899999999999999999999875 4578


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      ++|+|+++|+|.+++... ...+++..++.++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++...
T Consensus        85 l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence            999999999999998643 346899999999999999999999998   9999999999999999999999999987543


Q ss_pred             cccc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          265 VDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       265 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ....   .....+++.|+|||.+.+..++.++|||||||++|||++ |..||............. ...           
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~-----------  228 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGE-----------  228 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCC-----------
Confidence            2221   112234678999999988899999999999999999998 999997643321111111 110           


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      ....+...+.++.+++.+||+.||++||++.++++.|..+...
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         229 RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            0111122345789999999999999999999999998877543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-41  Score=313.83  Aligned_cols=261  Identities=28%  Similarity=0.457  Sum_probs=196.1

Q ss_pred             ccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhh--cCCCccceEEeeeeeCC----eEEEEEEe
Q 014038          116 FTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGR--LHHRNLVNLVGYCAEKG----QHMLVYVF  189 (432)
Q Consensus       116 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e~  189 (432)
                      +.++||+|.||.||+|++ +++.||||++..   +....|.+|-++.+.  ++|+||++++++-....    +++||++|
T Consensus       214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f  289 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF  289 (534)
T ss_pred             hHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence            446799999999999999 569999999853   455678888887765  58999999999865544    89999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA------VPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      .++|+|.++|..   ..++|....+|+..+++||+|||+.-      .|+|+|||||++||||.+|+++.|+||||+...
T Consensus       290 h~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~  366 (534)
T KOG3653|consen  290 HPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL  366 (534)
T ss_pred             ccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence            999999999954   46999999999999999999999743      478999999999999999999999999999764


Q ss_pred             ccc---ccccccccCCCCCCccccccC-CCC-----chhHhHHHHHHHHHHHhCCCCCC-ChhHHHHHHHh-hhcCCCch
Q 014038          264 MVD---KHAANIRGTFGYLDPEYISTR-NFT-----KKSDVYSFGVLLFELIAGRSPLQ-GLMEYVELAAM-NTEGKTGW  332 (432)
Q Consensus       264 ~~~---~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~Dv~SlGvil~elltg~~p~~-~~~~~~~~~~~-~~~~~~~~  332 (432)
                      ...   ......+||.+|||||++.+. ++.     .+.||||+|.+||||++....+. +.....+++.. ..+....+
T Consensus       367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~  446 (534)
T KOG3653|consen  367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL  446 (534)
T ss_pred             cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence            432   233457899999999998654 222     47899999999999998643331 11110000000 00111111


Q ss_pred             ----hhhccccCCCCCCH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          333 ----EEIVDSRLDGIFDV-----EELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       333 ----~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                          ..++..+.++.++.     ..+.-+.+.+..||+.||+-|-|+.=+-+++.++...
T Consensus       447 e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  447 EEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             HHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence                11222333333333     2356799999999999999999999888888777543

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.8e-41  Score=323.48  Aligned_cols=239  Identities=28%  Similarity=0.451  Sum_probs=194.0

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcC-CCccceEEeeeeeCCeEEEEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      +++.+.||+|+||.||+|.. .+|+.||+|++....   ....+.+..|..++..+. |++|+++++++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            56778999999999999965 478899999987532   233456778899998885 5788889999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-c
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-K  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~  267 (432)
                      |+++|+|.+++..  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..... .
T Consensus        82 y~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          82 YVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            9999999998843  356999999999999999999999999   999999999999999999999999998753322 2


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..............           .  .++..
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------~--~~p~~  223 (323)
T cd05615         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------V--SYPKS  223 (323)
T ss_pred             cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------C--CCCcc
Confidence            2344568999999999998899999999999999999999999998754332222211110           0  11222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSM  370 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~  370 (432)
                      .+.++.+++.+||+.+|.+|++.
T Consensus       224 ~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         224 LSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CCHHHHHHHHHHcccCHhhCCCC
Confidence            33578899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.1e-41  Score=332.86  Aligned_cols=251  Identities=22%  Similarity=0.332  Sum_probs=200.1

Q ss_pred             HHhccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ...|.+.+.||+|+||.||+++. .+++.||+|.+...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            45677889999999999999965 46889999998642   223345578899999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||+++|+|.+++..   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       122 ~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         122 MEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999998853   35888899999999999999999999   999999999999999999999999998754322


Q ss_pred             c--cccccccCCCCCCccccccC----CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          267 K--HAANIRGTFGYLDPEYISTR----NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       267 ~--~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .  ......||+.|+|||.+...    .++.++|||||||++|||++|+.||.+............. ..        .+
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~--------~~  266 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH-KN--------SL  266 (370)
T ss_pred             CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CC--------cC
Confidence            1  22346799999999998643    4789999999999999999999999865432222221111 00        00


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRK--RPSMRDIVQV  376 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~~vl~~  376 (432)
                      .-+.....+.++.+++.+||+.+|.+  ||++.++++.
T Consensus       267 ~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         267 TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            00111123457899999999999987  9999998764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.3e-41  Score=317.88  Aligned_cols=252  Identities=29%  Similarity=0.469  Sum_probs=200.4

Q ss_pred             HhccccccccccCceeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  184 (432)
                      ..+.+.+.||+|+||.||+|...      .+..||+|.+.... ......|.+|+.+++.++|+||+++++++.+.+..+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            34667789999999999999664      35689999886543 334567999999999999999999999999989999


Q ss_pred             EEEEeccCCChhhhcccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC---cEEEee
Q 014038          185 LVYVFMSKGSLASHLYDEN-----YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM---RARVAD  256 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~---~~kl~D  256 (432)
                      +||||+++++|.+++....     ...+++..++.++.||+.||+|||+.+   ++||||||+||+++.++   .+||+|
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEecc
Confidence            9999999999999986432     135899999999999999999999998   99999999999998754   599999


Q ss_pred             cCCccccccccc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCch
Q 014038          257 FGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGW  332 (432)
Q Consensus       257 fgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  332 (432)
                      ||+++.......   ......+..|+|||++.+..++.++|||||||++|||++ |..||.+..............    
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~----  238 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG----  238 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC----
Confidence            999875422111   112233567999999998899999999999999999997 999997654322221111111    


Q ss_pred             hhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                              ....+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       239 --------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         239 --------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             --------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                    11122233457899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-41  Score=319.41  Aligned_cols=260  Identities=24%  Similarity=0.392  Sum_probs=200.2

Q ss_pred             HHhccccccccccCceeEEEEEeCC---------------CcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMST---------------GETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLV  174 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~  174 (432)
                      ...|.+.+.||+|+||.||++....               ...||+|.+... .......|.+|++++.+++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4467788899999999999986432               235899998764 333446799999999999999999999


Q ss_pred             eeeeeCCeEEEEEEeccCCChhhhcccCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCe
Q 014038          175 GYCAEKGQHMLVYVFMSKGSLASHLYDEN----------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNI  244 (432)
Q Consensus       175 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Ni  244 (432)
                      +++...+..++||||+++++|.+++....          ...+++..++.++.|++.||+|||+.+   ++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            99999999999999999999999885421          124788999999999999999999999   99999999999


Q ss_pred             eecCCCcEEEeecCCccccccccc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh--CCCCCCChhHHH
Q 014038          245 LLDQSMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA--GRSPLQGLMEYV  319 (432)
Q Consensus       245 ll~~~~~~kl~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt--g~~p~~~~~~~~  319 (432)
                      ++++++.+||+|||++........   .....++..|+|||.+....++.++|||||||++|||++  |..||.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999875332211   122345678999999988889999999999999999998  667887543322


Q ss_pred             HHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          320 ELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                      ...............     .....+...+..+.+++.+||+.||++||++.+|++.|.
T Consensus       241 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIENTGEFFRNQGRQ-----IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHhhhhcccc-----ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            211111000000000     000011122357999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.3e-41  Score=312.44  Aligned_cols=254  Identities=27%  Similarity=0.458  Sum_probs=206.6

Q ss_pred             HHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      +...++.+.+.||+|+||.||++...++..+|+|.+.... .....|.+|+.+++.++|+||+++++++.+ ...+++||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            3456778889999999999999987777889999886543 334678899999999999999999999887 77899999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+++|+|.+++.......+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            999999999997655567899999999999999999999998   99999999999999999999999998865332211


Q ss_pred             --ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          269 --AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       269 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                        .....++..|+|||.+....++.++|+|||||++|++++ |+.||...............            .....+
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~------------~~~~~~  225 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG------------YRMPRP  225 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC------------CCCCCc
Confidence              122345677999999988889999999999999999999 99999765432222211111            001111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR  379 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~  379 (432)
                      ...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            2234578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=9e-41  Score=311.67  Aligned_cols=256  Identities=26%  Similarity=0.398  Sum_probs=206.8

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+|... +|+.||+|.+...   .....+.+.+|+.++++++|+|++++++++.+.+..+++||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            4667789999999999999765 8899999988642   23335678999999999999999999999999999999999


Q ss_pred             eccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          189 FMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       189 ~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |+++|+|..++..  .....+++..+..++.+++.||.|||+.+   ++||||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            9999999998853  23456899999999999999999999999   999999999999999999999999998654322


Q ss_pred             c-cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhH-HHHHHHhhhcCCCchhhhccccCCCCC
Q 014038          267 K-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME-YVELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                      . ......++..|+|||.+.+..++.++|||||||++|+|++|+.||..... .......          +.........
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----------~~~~~~~~~~  229 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----------IEKCDYPPLP  229 (267)
T ss_pred             CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhh----------hhcCCCCCCC
Confidence            2 22345688899999999888899999999999999999999999864321 1111100          0000111111


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL  381 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~  381 (432)
                      ....+..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus       230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            1234457899999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.6e-41  Score=318.78  Aligned_cols=259  Identities=26%  Similarity=0.431  Sum_probs=202.9

Q ss_pred             HhccccccccccCceeEEEEEeCC-----------------CcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMST-----------------GETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNL  173 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  173 (432)
                      ..|.+.+.||+|+||.||+|....                 +..||+|.+.... ....+.+.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            466778899999999999986532                 2468999987653 3445688999999999999999999


Q ss_pred             EeeeeeCCeEEEEEEeccCCChhhhcccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCe
Q 014038          174 VGYCAEKGQHMLVYVFMSKGSLASHLYDEN---------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNI  244 (432)
Q Consensus       174 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Ni  244 (432)
                      ++++..++..+++|||+++++|.+++....         ...+++..++.++.|++.||.|||+.+   ++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence            999999999999999999999999985432         236899999999999999999999998   99999999999


Q ss_pred             eecCCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh--CCCCCCChhHHH
Q 014038          245 LLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA--GRSPLQGLMEYV  319 (432)
Q Consensus       245 ll~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt--g~~p~~~~~~~~  319 (432)
                      +++.++.++|+|||+++......   ......+++.|+|||.+....++.++|||||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            99999999999999987533221   1223446778999999988889999999999999999998  778887644322


Q ss_pred             HHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          320 ELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                      .+..........     ........+...+.++.+++.+||+.||.+|||+.+|++.|+
T Consensus       242 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         242 VIENAGHFFRDD-----GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHhccccc-----cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            222211110000     000000111223358999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-41  Score=319.54  Aligned_cols=261  Identities=25%  Similarity=0.359  Sum_probs=203.6

Q ss_pred             HHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      ...+.+.+.||+|+||+||++.. .+|+.||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            34566778999999999999965 468899999886543 3445788999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      |+++++|.+++..  .+.+++..+..++.+++.||.|||+ .+   ++||||+|+||++++++.++|+|||++..... .
T Consensus        84 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~-~  157 (284)
T cd06620          84 FMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN-S  157 (284)
T ss_pred             cCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhh-h
Confidence            9999999988854  3568999999999999999999997 46   99999999999999999999999999864322 2


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ......++..|+|||.+.+..++.++|||||||++|||++|+.||...................+..+............
T Consensus       158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd06620         158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD  237 (284)
T ss_pred             ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence            22345789999999999888999999999999999999999999975432110000000000001111111111111122


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                      .+.++.+++.+||+.||++||++.++++..
T Consensus       238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         238 FPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            446789999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.2e-42  Score=335.47  Aligned_cols=249  Identities=23%  Similarity=0.306  Sum_probs=195.8

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+|+. .+++.||+|.+....   ......+.+|+.++.+++||||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            356778999999999999964 468999999986432   2234568899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc--
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--  266 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~--  266 (432)
                      |+++|+|.+++..  .+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......  
T Consensus        82 ~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          82 YIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            9999999999854  356899999999999999999999999   999999999999999999999999997421000  


Q ss_pred             ------------------------------------------ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHH
Q 014038          267 ------------------------------------------KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFE  304 (432)
Q Consensus       267 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~e  304 (432)
                                                                .......||+.|+|||++.+..++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                      00113469999999999999999999999999999999


Q ss_pred             HHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCC---CHHHHHHH
Q 014038          305 LIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRP---SMRDIVQV  376 (432)
Q Consensus       305 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP---s~~~vl~~  376 (432)
                      |++|+.||.+...............         ..........+.++.+++.+|+ .+|.+|+   ++.++++.
T Consensus       237 ll~G~~Pf~~~~~~~~~~~i~~~~~---------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         237 MLVGQPPFLADTPAETQLKVINWET---------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHHHhccCc---------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999999986543322221111000         0000011122346778888876 5999999   88888754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.1e-41  Score=322.68  Aligned_cols=257  Identities=21%  Similarity=0.309  Sum_probs=195.7

Q ss_pred             cccccccc--CceeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          116 FTTLIGQG--AFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       116 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      +.++||+|  +|++||++.. .+|+.||+|.+....  ......+.+|+.+++.++||||++++++|..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45689999  7899999954 578999999987542  233456778999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc---
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---  267 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~---  267 (432)
                      ++|+|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++++||+.........   
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9999999986544456999999999999999999999999   9999999999999999999999998653221110   


Q ss_pred             -----cccccccCCCCCCcccccc--CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCc--------h
Q 014038          268 -----HAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG--------W  332 (432)
Q Consensus       268 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--------~  332 (432)
                           ......++..|+|||++.+  ..++.++|||||||++|||++|+.||...................        .
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                 1122346778999999875  468999999999999999999999997644322211111100000        0


Q ss_pred             hhh--------ccc-----------------cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          333 EEI--------VDS-----------------RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       333 ~~~--------~~~-----------------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +++        .+.                 ............++.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            000        000                 0000111223457899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-41  Score=328.34  Aligned_cols=249  Identities=22%  Similarity=0.310  Sum_probs=199.3

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||++.. .+|+.||+|.+....   ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            356778999999999999965 478999999987532   2344568899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+++|+|.+++... ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          82 YQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            99999999998543 357999999999999999999999999   99999999999999999999999999875433221


Q ss_pred             --ccccccCCCCCCccccc------cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          269 --AANIRGTFGYLDPEYIS------TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       269 --~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                        .....||+.|+|||++.      ...++.++|||||||++|||++|+.||.................         .+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~---------~~  228 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR---------FL  228 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC---------cc
Confidence              22346899999999986      45678999999999999999999999976543322222111100         00


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .-+.....+.++.+++..||+ +|.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         229 KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            000111233578899999998 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-41  Score=311.83  Aligned_cols=247  Identities=27%  Similarity=0.461  Sum_probs=200.3

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-----hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-----KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      |...+.||+|++|.||++.. .+++.||+|.+....     ......+.+|+.++++++||||+++++++.+.+..+++|
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   83 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM   83 (263)
T ss_pred             ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence            45668999999999999964 478999999886432     122356889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+++++|.+++..  .+.+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++......
T Consensus        84 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          84 EYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence            99999999998854  346899999999999999999999999   9999999999999999999999999986533221


Q ss_pred             cc----cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCC
Q 014038          268 HA----ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       268 ~~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                      ..    ....++..|+|||.+.+..++.++||||||+++|||++|+.||...............           .....
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-----------~~~~~  227 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ-----------PTNPQ  227 (263)
T ss_pred             cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc-----------CCCCC
Confidence            11    2345788999999999888999999999999999999999999764332222211111           01111


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      .+......+.+++.+||..+|.+||++.++++.
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         228 LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            222334578999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-41  Score=315.68  Aligned_cols=254  Identities=26%  Similarity=0.465  Sum_probs=203.8

Q ss_pred             HHHhccccccccccCceeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  182 (432)
                      ....+.+.+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.++..++||||+++++++.....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            3456777889999999999999653      34689999986543 3344678899999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEE
Q 014038          183 HMLVYVFMSKGSLASHLYDEN--------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV  254 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl  254 (432)
                      .++||||+++|+|.+++....        ...+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence            999999999999999985422        234788999999999999999999998   999999999999999999999


Q ss_pred             eecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCC
Q 014038          255 ADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKT  330 (432)
Q Consensus       255 ~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  330 (432)
                      +|||+++......   ......++..|+|||.+....++.++|||||||++|||++ |..||................  
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--  238 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG--  238 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC--
Confidence            9999987533221   1223446788999999988889999999999999999998 999997644322221111110  


Q ss_pred             chhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          331 GWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                                ....+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus       239 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         239 ----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                      01112223468999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.8e-41  Score=314.24  Aligned_cols=253  Identities=27%  Similarity=0.507  Sum_probs=202.6

Q ss_pred             HhccccccccccCceeEEEEEeC-CC---cEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TG---ETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      +++.+.+.||+|+||.||+|... ++   ..||||.+... .......|..|+.+++.++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            45678899999999999999754 33   36999998754 334456899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||+++|+|.+++... .+.+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus        84 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          84 TEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence            9999999999988643 356899999999999999999999998   999999999999999999999999998643322


Q ss_pred             cccc----cc--ccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          267 KHAA----NI--RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       267 ~~~~----~~--~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ....    ..  ..+..|+|||.+....++.++|||||||++|||++ |..||...............            
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~------------  227 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD------------  227 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC------------
Confidence            1111    11  12457999999998999999999999999999887 99999765432221111110            


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      ...+.+...+..+.+++.+||+.+|.+||++.+|+..|+++
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            01111223345789999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.4e-41  Score=328.15  Aligned_cols=257  Identities=23%  Similarity=0.289  Sum_probs=197.5

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC------Ce
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQ  182 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  182 (432)
                      ..|.+.+.||+|+||.||++.. ..++.||||.+...  .......+.+|+.+++.++||||+++++++...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   96 (355)
T cd07874          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD   96 (355)
T ss_pred             hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence            4677788999999999999964 46889999998653  233346778999999999999999999987643      35


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .++||||+++ +|.+.+.    ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        97 ~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~  168 (355)
T cd07874          97 VYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_pred             eEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCccccc
Confidence            7999999975 6766663    24889999999999999999999999   99999999999999999999999999976


Q ss_pred             ccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCc-----------
Q 014038          263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG-----------  331 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------  331 (432)
                      ...........+|+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..........           
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (355)
T cd07874         169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_pred             CCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence            544444455678999999999999899999999999999999999999997644322221111000000           


Q ss_pred             hhhhcc---------------ccC---CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          332 WEEIVD---------------SRL---DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       332 ~~~~~~---------------~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      +..+..               ...   ....+.....++.+++.+||+.||++|||+.++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            000000               000   000111123578999999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=9.4e-41  Score=311.99  Aligned_cols=253  Identities=27%  Similarity=0.494  Sum_probs=203.1

Q ss_pred             HhccccccccccCceeEEEEEeC-C---CcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-T---GETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      .++.+.+.||+|+||.||+|... +   +..+|+|.+.... ....+.|.+|+.++.+++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            45677889999999999999653 2   3379999986543 33356789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||+++++|.+++... ...+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++......
T Consensus        84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          84 TEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            9999999999998643 356899999999999999999999999   999999999999999999999999998754322


Q ss_pred             cc----ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCC
Q 014038          267 KH----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       267 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ..    .....++..|+|||.+.+..++.++|+||||+++||+++ |..||.............. ..           .
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~-----------~  227 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE-GY-----------R  227 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC-CC-----------c
Confidence            11    111223568999999998899999999999999999887 9999976443221111111 00           0


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      .+.+...+..+.+++.+||+.+|.+||++.++++.|.++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            111122345789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-41  Score=323.32  Aligned_cols=250  Identities=27%  Similarity=0.411  Sum_probs=213.0

Q ss_pred             HHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhhcC-CCccceEEeeeeeCCeEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK---QGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  185 (432)
                      ...|.+.+.||+|.||.||++..+ +|+.+|+|.+.....   ...+.+.+|+.+|+++. |||||.+++.+.+....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            346777789999999999999655 599999999976533   23468899999999998 9999999999999999999


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC----CCcEEEeecCCcc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ----SMRARVADFGLSR  261 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~----~~~~kl~Dfgl~~  261 (432)
                      |||++.||.|.+.+...   .+++..+..++.|++.++.|||+.+   |+||||||+|+|+..    ++.+|++|||++.
T Consensus       114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            99999999999999665   3999999999999999999999999   999999999999953    3579999999998


Q ss_pred             cccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCC
Q 014038          262 EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ...........+||+.|+|||++....|+..+||||+||++|.|++|..||.+..+............         ...
T Consensus       188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~---------~f~  258 (382)
T KOG0032|consen  188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF---------DFT  258 (382)
T ss_pred             EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC---------CCC
Confidence            77666667788999999999999999999999999999999999999999998776544443322221         111


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+.-...+..+.+++..|+..||..|+|+.++++
T Consensus       259 ~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  259 SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             CCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            2222233568899999999999999999999998

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.9e-41  Score=310.88  Aligned_cols=246  Identities=30%  Similarity=0.507  Sum_probs=199.9

Q ss_pred             ccccccCceeEEEEEeCC--Cc--EEEEEEeccCCh-hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQMST--GE--TVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +.||+|++|.||+|.+.+  ++  .||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...+++|||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999997532  33  699999987655 556789999999999999999999999988 889999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc----c
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK----H  268 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~----~  268 (432)
                      |+|.+++.......+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++.......    .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999986544357899999999999999999999998   9999999999999999999999999987543321    1


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      .....++..|+|||.+....++.++|||||||++|||++ |+.||.................           ....+..
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~  225 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE-----------RLERPEA  225 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------cCCCCcc
Confidence            123456788999999998899999999999999999999 9999975443322222111100           0011122


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                      .+..+.+++.+||+.+|++||++.++++.|.
T Consensus       226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            3457999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.8e-41  Score=318.28  Aligned_cols=247  Identities=24%  Similarity=0.396  Sum_probs=203.1

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      +|.+.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||++
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~  100 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence            566778899999999999964 5788999999877655556778999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-ccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~  270 (432)
                      +++|.+++..   ..+++.++..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++....... ...
T Consensus       101 ~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654         101 GGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             CCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence            9999998843   35899999999999999999999999   9999999999999999999999999987533221 223


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN  350 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (432)
                      ...+++.|+|||.+.+..++.++|||||||++|||++|+.||.................          .....+.....
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~  244 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT----------PELQNPEKLSA  244 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC----------CCCCCccccCH
Confidence            45688999999999888899999999999999999999999976543222211111110          00011223345


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          351 EVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       351 ~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+.+++.+||..+|++||++.++++
T Consensus       245 ~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         245 IFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             HHHHHHHHHCcCCcccCcCHHHHhh
Confidence            7889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.5e-41  Score=316.27  Aligned_cols=249  Identities=26%  Similarity=0.398  Sum_probs=196.5

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      +.+.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.++.+++||||+++++++...+..++||||++
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   82 (279)
T cd06619           3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD   82 (279)
T ss_pred             chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence            45668899999999999954 57889999998654 33345678999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN  271 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  271 (432)
                      +++|..+.      .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++..... .....
T Consensus        83 ~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~-~~~~~  152 (279)
T cd06619          83 GGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-SIAKT  152 (279)
T ss_pred             CCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc-ccccC
Confidence            99996542      4788899999999999999999999   99999999999999999999999999875432 22334


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      ..++..|+|||.+.+..++.++||||||+++|||++|+.||............    ........+...........+.+
T Consensus       153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  228 (279)
T cd06619         153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP----LQLLQCIVDEDPPVLPVGQFSEK  228 (279)
T ss_pred             CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch----HHHHHHHhccCCCCCCCCcCCHH
Confidence            57899999999999889999999999999999999999999653211000000    00000001111111111123357


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          352 VASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      +.+++.+||+.+|++||++.++++.
T Consensus       229 ~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         229 FVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HHHHHHHHhhCChhhCCCHHHHhcC
Confidence            8999999999999999999998864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6e-41  Score=312.52  Aligned_cols=239  Identities=23%  Similarity=0.394  Sum_probs=189.7

Q ss_pred             ccccccCceeEEEEEeCC-------------CcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEE
Q 014038          118 TLIGQGAFGPVYKAQMST-------------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  184 (432)
                      +.||+|+||.||+|...+             ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999996432             2258999887655555567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc-------EEEeec
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR-------ARVADF  257 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~-------~kl~Df  257 (432)
                      ++|||+++|+|..++... ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.       ++++||
T Consensus        81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            999999999999887543 356899999999999999999999998   999999999999987664       899999


Q ss_pred             CCcccccccccccccccCCCCCCccccc-cCCCCchhHhHHHHHHHHHHH-hCCCCCCChhHHHHHHHhhhcCCCchhhh
Q 014038          258 GLSREEMVDKHAANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELI-AGRSPLQGLMEYVELAAMNTEGKTGWEEI  335 (432)
Q Consensus       258 gl~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (432)
                      |++.....   .....++..|+|||.+. +..++.++|||||||++|||+ +|..||........ ....          
T Consensus       157 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~----------  222 (262)
T cd05077         157 GIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFY----------  222 (262)
T ss_pred             CCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHH----------
Confidence            98864322   22345788899999886 567899999999999999998 58888865322111 0000          


Q ss_pred             ccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                       ......  ......++.+++.+||+.||++||++.+|++.+
T Consensus       223 -~~~~~~--~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         223 -EGQCML--VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -hcCccC--CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence             000000  011134788999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.6e-41  Score=326.42  Aligned_cols=239  Identities=27%  Similarity=0.373  Sum_probs=190.1

Q ss_pred             ccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHH-HHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVM-LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +.||+|+||.||+|... +++.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999654 67889999986432   222334444444 56778999999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN  271 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~  271 (432)
                      |+|.+++..  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.... ......
T Consensus        81 ~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          81 GELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             CcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence            999998854  346888889999999999999999999   99999999999999999999999999875322 223345


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.+.............           ..  ..+...+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-----------~~--~~~~~~~~~  222 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-----------PL--QLKPNITNS  222 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-----------Cc--CCCCCCCHH
Confidence            67999999999999999999999999999999999999999765433222211110           00  011123357


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHH
Q 014038          352 VASLAYKCVNRAPRKRPSMRDIV  374 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~~~vl  374 (432)
                      +.+++.+||+.||.+||++.+.+
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         223 ARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             HHHHHHHHcccCHHHCCCCCCCH
Confidence            89999999999999999987533

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=308.83  Aligned_cols=245  Identities=29%  Similarity=0.450  Sum_probs=196.6

Q ss_pred             ccccccCceeEEEEEeC-C---CcEEEEEEeccCCh-hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQMS-T---GETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +.||+|+||.||+|.+. .   +..+|+|.+..... ...+.+.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            36999999999999542 2   26899999876543 34567899999999999999999999876 4568999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc---
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA---  269 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~---  269 (432)
                      |+|.+++...  ..+++..+..++.|++.||.|||..+   ++|+||||+|||++.++.+||+|||+++........   
T Consensus        80 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            9999999643  37899999999999999999999998   999999999999999999999999998754332211   


Q ss_pred             -cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          270 -ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       270 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                       ....++..|+|||.+....++.++||||||+++|||++ |..||.................            ...+..
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~------------~~~~~~  222 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER------------LPRPEE  222 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc------------CCCCCC
Confidence             11223567999999998899999999999999999998 9999976543222111111100            011222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      .+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            335789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=309.26  Aligned_cols=245  Identities=32%  Similarity=0.553  Sum_probs=202.3

Q ss_pred             ccccccCceeEEEEEeCC----CcEEEEEEeccCChh-hHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQMST----GETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +.||+|+||.||+|....    +..||+|.+...... ..+.+.+|+..+..++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            369999999999997643    789999999765433 367889999999999999999999999999999999999999


Q ss_pred             CChhhhcccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          193 GSLASHLYDEN-------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       193 g~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ++|.+++....       ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999986532       367999999999999999999999998   99999999999999999999999999876543


Q ss_pred             cc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCC
Q 014038          266 DK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       266 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ..   ......++..|+|||.+....++.++||||||+++|||++ |..||.............. .           ..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~-----------~~  225 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-G-----------YR  225 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-C-----------CC
Confidence            21   2334557889999999988899999999999999999999 6999987543222111111 0           01


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                      ...+...+.++.+++.+||+.+|++|||+.++++.|
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         226 LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            112223356899999999999999999999999876

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.6e-41  Score=320.20  Aligned_cols=259  Identities=29%  Similarity=0.516  Sum_probs=205.3

Q ss_pred             HHHhccccccccccCceeEEEEEeC--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEeeeee
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQMS--------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE  179 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  179 (432)
                      ...++.+.+.||+|+||.||++...        ....+|+|.+.... ......+.+|+.++.++ +||||++++++|..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3456778899999999999999631        24579999987543 33456788999999999 69999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCee
Q 014038          180 KGQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNIL  245 (432)
Q Consensus       180 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nil  245 (432)
                      .+..+++|||+++|+|.+++....              ...+++..+..++.|++.||.|||+++   ++||||||+|||
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence            999999999999999999985422              245899999999999999999999998   999999999999


Q ss_pred             ecCCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHH
Q 014038          246 LDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVEL  321 (432)
Q Consensus       246 l~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~  321 (432)
                      ++.++.+||+|||+++......   ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.......
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999997543211   1122234567999999988899999999999999999999 89999764322111


Q ss_pred             HHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          322 AAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      .... ...           ....+...+.++.+++.+||+.+|++||++.++++.|.++...
T Consensus       247 ~~~~-~~~-----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         247 KLLR-EGH-----------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             HHHH-cCC-----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            1111 110           0011222335788999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-43  Score=302.84  Aligned_cols=250  Identities=24%  Similarity=0.382  Sum_probs=205.2

Q ss_pred             HhccccccccccCceeEEEE-EeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      ..|++.+.||+|.|+.||+. ...+|+.+|+|++...  +..+.+++.+|+.+-+.|+||||+++...+.+.+..++|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            34566678999999999998 5668999999988654  33456788999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec---CCCcEEEeecCCcccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD---QSMRARVADFGLSREEMV  265 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~---~~~~~kl~Dfgl~~~~~~  265 (432)
                      +|.|++|..-+-.+  --+++..+...+.||+.+|.|+|.++   |+|||+||.|+||.   ...-+||+|||++.....
T Consensus        91 ~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   91 LVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             cccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            99999998766433  34678888899999999999999999   99999999999993   455799999999998775


Q ss_pred             cccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      +.....+.|||+|||||++...+|+..+|||+.|||||-|+.|.+||.+.........+.....         ..++..-
T Consensus       166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~y---------d~~~~~w  236 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAY---------DYPSPEW  236 (355)
T ss_pred             ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcccc---------CCCCccc
Confidence            5566678999999999999999999999999999999999999999988544333222222211         1111111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ....++..+|+.+||..||.+|.|+.|.+.
T Consensus       237 ~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  237 DTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            223457899999999999999999988764

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.3e-41  Score=315.87  Aligned_cols=252  Identities=31%  Similarity=0.513  Sum_probs=201.0

Q ss_pred             HhccccccccccCceeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  184 (432)
                      ..+.+.+.||+|+||.||+|...      ++..||+|.+.... ......|.+|+.++++++||||+++++++..+...+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            35667789999999999999753      46789999987543 344567999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhcccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCe
Q 014038          185 LVYVFMSKGSLASHLYDEN--------------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNI  244 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~--------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Ni  244 (432)
                      ++|||+++|+|.+++....                    ...+++..++.++.|++.||.|||+.+   ++||||||+||
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ni  161 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNC  161 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhhe
Confidence            9999999999999985321                    235788999999999999999999998   99999999999


Q ss_pred             eecCCCcEEEeecCCccccccccc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHH
Q 014038          245 LLDQSMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVE  320 (432)
Q Consensus       245 ll~~~~~~kl~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~  320 (432)
                      +++.++.++|+|||++........   ......+..|+|||.+.+..++.++|||||||++|||++ |..||.+......
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~  241 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV  241 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999864322211   122234667999999988899999999999999999998 8889865433221


Q ss_pred             HHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          321 LAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                      ..... .+.          .. ..+...+.++.+++.+||+.+|.+|||+.|+++.|+
T Consensus       242 ~~~~~-~~~----------~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         242 IYYVR-DGN----------VL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             HHHHh-cCC----------CC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            11111 111          00 011123457999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5e-41  Score=315.14  Aligned_cols=238  Identities=25%  Similarity=0.429  Sum_probs=187.9

Q ss_pred             cccccCceeEEEEEeCC-------------------------CcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceE
Q 014038          119 LIGQGAFGPVYKAQMST-------------------------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL  173 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  173 (432)
                      .||+|+||.||+|....                         ...||+|.+..........|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999996421                         13589998866544455678899999999999999999


Q ss_pred             EeeeeeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC---
Q 014038          174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM---  250 (432)
Q Consensus       174 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~---  250 (432)
                      +++|.+....++||||+++|+|..++... .+.+++..+..++.||+.||+|||+.+   |+||||||+|||++..+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999888542 356899999999999999999999998   99999999999997644   


Q ss_pred             ----cEEEeecCCcccccccccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHH-hCCCCCCChhHHHHHHHh
Q 014038          251 ----RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELI-AGRSPLQGLMEYVELAAM  324 (432)
Q Consensus       251 ----~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~ell-tg~~p~~~~~~~~~~~~~  324 (432)
                          .+|++|||++......   ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||............
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~  234 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY  234 (274)
T ss_pred             CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence                3899999987543211   22356788999998865 56899999999999999985 699999754322111110


Q ss_pred             hhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          325 NTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                      ..          ......    .....+.+++.+||+.+|++||++.+|++.|
T Consensus       235 ~~----------~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         235 EK----------KHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             Hh----------ccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            00          000111    1123688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.6e-41  Score=324.14  Aligned_cols=236  Identities=23%  Similarity=0.383  Sum_probs=190.2

Q ss_pred             ccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +.||+|+||.||+|.. .+++.||+|++....   ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            3699999999999965 467899999997542   23345678899999888 699999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN  271 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~  271 (432)
                      |+|..++..  .+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.... ......
T Consensus        81 ~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          81 GDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             CcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence            999988743  346999999999999999999999999   99999999999999999999999999875322 223345


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhH------HHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME------YVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.....      .......          +....  ...+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~----------~~~~~--~~~p  223 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV----------ILEKP--IRIP  223 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH----------HHhCC--CCCC
Confidence            6799999999999999999999999999999999999999963211      0000000          00100  0112


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSM  370 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~  370 (432)
                      ...+..+.+++.+||+.||++|+++
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCC
Confidence            2233578899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.1e-40  Score=314.02  Aligned_cols=248  Identities=27%  Similarity=0.406  Sum_probs=200.7

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      |++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            345678999999999999664 5778999998766666667889999999999999999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-ccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAAN  271 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~  271 (432)
                      ++|..++... ..++++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...... .....
T Consensus        87 ~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (282)
T cd06643          87 GAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  162 (282)
T ss_pred             CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence            9998887542 357999999999999999999999998   999999999999999999999999998654322 12234


Q ss_pred             cccCCCCCCccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          272 IRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       272 ~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      ..+++.|+|||++.     ...++.++|||||||++|||++|+.||..................        ..  ..+.
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--------~~--~~~~  232 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP--------TL--AQPS  232 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC--------CC--CCcc
Confidence            56899999999873     445788999999999999999999999765433322222111110        00  1112


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.++.+++.+||+.+|.+||++.++++
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         233 RWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            23457899999999999999999998875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.4e-40  Score=317.49  Aligned_cols=257  Identities=25%  Similarity=0.374  Sum_probs=199.8

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      |.+.+.||+|+||.||++.. .++..+|+|.+.... .....++.+|++++.+++||||++++++|.+++..++||||++
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~   82 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD   82 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence            56678999999999999965 467889999886542 3334568899999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  270 (432)
                      +++|.+++...  ..+++..+..++.|++.||.|||+ .+   ++|+||||+|||++.++.+||+|||++..... ....
T Consensus        83 ~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~~~  156 (308)
T cd06615          83 GGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMAN  156 (308)
T ss_pred             CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccc-cccc
Confidence            99999998543  568999999999999999999997 46   99999999999999999999999999865322 2234


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCC--------------------
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT--------------------  330 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------------------  330 (432)
                      ...+++.|+|||.+.+..++.++|+||||+++|||++|+.||..................                    
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (308)
T cd06615         157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP  236 (308)
T ss_pred             cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccch
Confidence            457899999999998888999999999999999999999998653321111111000000                    


Q ss_pred             -chhhhccccC---CCCCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          331 -GWEEIVDSRL---DGIFD-VEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       331 -~~~~~~~~~~---~~~~~-~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                       .+.+..+...   ....+ ...+.++.+++.+||+.+|++||++.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0000000000   00000 1134578999999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.5e-41  Score=313.05  Aligned_cols=251  Identities=30%  Similarity=0.519  Sum_probs=200.2

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHH--HHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEK--EFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      |++.+.||+|+||+||+++.. +++.||+|.+.........  ...+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            467789999999999999765 5668999999876543332  3456999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc-cccccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE-MVDKHA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~-~~~~~~  269 (432)
                      ++++|.+++.  ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||.+... ......
T Consensus        81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEB
T ss_pred             cccccccccc--cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            9999999996  3456899999999999999999999999   999999999999999999999999998752 223344


Q ss_pred             cccccCCCCCCccccc-cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          270 ANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      ....++..|+|||.+. +..++.++||||||+++|+|++|..||......................   ....   ....
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~---~~~~  229 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS---SSQQ---SREK  229 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH---HTTS---HTTS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc---cccc---cchh
Confidence            5567899999999998 8889999999999999999999999998752111111111100000000   0000   0001


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..++.+++.+||+.||++||++.++++
T Consensus       230 ~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  230 SEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             HHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            258999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.2e-41  Score=317.26  Aligned_cols=260  Identities=24%  Similarity=0.417  Sum_probs=200.4

Q ss_pred             HHhccccccccccCceeEEEEEeC-----------------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccce
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-----------------TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVN  172 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~  172 (432)
                      ...|.+.+.||+|+||.||++...                 ++..||+|.+... ......+|.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            345778889999999999998532                 2346999998754 3344568999999999999999999


Q ss_pred             EEeeeeeCCeEEEEEEeccCCChhhhcccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCC
Q 014038          173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDEN---------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSN  243 (432)
Q Consensus       173 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~N  243 (432)
                      +++++...+..+++|||+++|+|.+++....         ...+++..+..++.|++.||+|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            9999999999999999999999999886432         134778899999999999999999999   9999999999


Q ss_pred             eeecCCCcEEEeecCCccccccccc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh--CCCCCCChhHH
Q 014038          244 ILLDQSMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA--GRSPLQGLMEY  318 (432)
Q Consensus       244 ill~~~~~~kl~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt--g~~p~~~~~~~  318 (432)
                      ||++.++.++|+|||+++.......   .....++..|++||....+.++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999875432211   112234678999999888889999999999999999998  77888754332


Q ss_pred             HHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          319 VELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                      .........    +..... ....+.+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus       241 ~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 QVIENTGEF----FRDQGR-QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHHHH----Hhhccc-cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            221111000    000000 0000111123357899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.3e-40  Score=311.28  Aligned_cols=249  Identities=25%  Similarity=0.404  Sum_probs=191.4

Q ss_pred             cccccCceeEEEEEeCC---CcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCC
Q 014038          119 LIGQGAFGPVYKAQMST---GETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS  194 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  194 (432)
                      .||+|+||.||+|...+   ...+|+|.+.... ......|.+|+..++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999996433   3468888876443 3334678899999999999999999999999999999999999999


Q ss_pred             hhhhcccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc---c
Q 014038          195 LASHLYDEN---YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---H  268 (432)
Q Consensus       195 L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~---~  268 (432)
                      |.+++....   ....++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.......   .
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999986533   233567888999999999999999998   9999999999999999999999999986432221   1


Q ss_pred             ccccccCCCCCCcccccc-------CCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          269 AANIRGTFGYLDPEYIST-------RNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||....+..............   +..+. 
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~-  234 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK---LPKPQ-  234 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc---CCCCc-
Confidence            122345678999998743       356889999999999999999 788987655433332222222111   11111 


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                         .+...+..+.+++..|| .||++||++++|++.|.
T Consensus       235 ---~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         235 ---LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ---ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence               12223356788999999 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.6e-40  Score=310.87  Aligned_cols=249  Identities=27%  Similarity=0.406  Sum_probs=191.5

Q ss_pred             cccccCceeEEEEEeCC---CcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCC
Q 014038          119 LIGQGAFGPVYKAQMST---GETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS  194 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  194 (432)
                      .||+|+||.||+|...+   +..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            58999999999997543   4579999887543 3344578899999999999999999999999899999999999999


Q ss_pred             hhhhcccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc---c
Q 014038          195 LASHLYDEN---YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---H  268 (432)
Q Consensus       195 L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~---~  268 (432)
                      |.+++....   ....++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......   .
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999986432   234677888899999999999999998   9999999999999999999999999986433221   1


Q ss_pred             ccccccCCCCCCccccccC-------CCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          269 AANIRGTFGYLDPEYISTR-------NFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .....++..|+|||++...       .++.++|+||||+++|||++ |+.||.................   ..+..+.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~  235 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ---LKLPKPRL  235 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc---CCCCCCcc
Confidence            1234567889999988532       35789999999999999996 9999976543322211111111   01111111


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                      .    ......+.+++..|| .+|++|||+.+|+..|+
T Consensus       236 ~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         236 K----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             C----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1    112346788999999 68999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.3e-41  Score=326.92  Aligned_cols=256  Identities=23%  Similarity=0.299  Sum_probs=197.3

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC------Ce
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQ  182 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  182 (432)
                      ..|.+.+.||+|+||.||++.. ..++.||||.+...  .......+.+|+.+++.++||||+++++++...      ..
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~  103 (364)
T cd07875          24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  103 (364)
T ss_pred             cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence            4677788999999999999964 46889999998653  233446788999999999999999999987543      35


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .++||||+++ +|.+.+.    ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  175 (364)
T cd07875         104 VYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART  175 (364)
T ss_pred             EEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence            7999999965 7777663    24889999999999999999999998   99999999999999999999999999976


Q ss_pred             ccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCc-----------
Q 014038          263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG-----------  331 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------  331 (432)
                      ...........+|+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..........           
T Consensus       176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (364)
T cd07875         176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  255 (364)
T ss_pred             cCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence            544434445678999999999999999999999999999999999999997654332222111100000           


Q ss_pred             ---------------hhhhccccC---CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          332 ---------------WEEIVDSRL---DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       332 ---------------~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                                     +........   ....+.....++.+++.+||+.||.+|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                           000000000   00011112347889999999999999999999886

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.6e-40  Score=308.22  Aligned_cols=248  Identities=20%  Similarity=0.344  Sum_probs=204.3

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      |++.+.||.|+||.||.++. .+++.+++|.+...  .......+.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~   81 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA   81 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence            56678999999999999954 56889999987653  3444567889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~  269 (432)
                      ++|+|.+++.......+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++....... ..
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~  158 (256)
T cd08221          82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA  158 (256)
T ss_pred             CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence            9999999997654567899999999999999999999998   9999999999999999999999999987543332 23


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....+++.|+|||.+.+..++.++||||||+++|||++|+.||................           .. ..+...+
T Consensus       159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-----------~~-~~~~~~~  226 (256)
T cd08221         159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-----------YT-PVVSVYS  226 (256)
T ss_pred             cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-----------CC-CCccccC
Confidence            34568999999999988889999999999999999999999997643322221111111           10 1112234


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      .++.+++.+||+.+|.+||++.++++.
T Consensus       227 ~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         227 SELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            578999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.4e-40  Score=314.39  Aligned_cols=257  Identities=26%  Similarity=0.425  Sum_probs=202.3

Q ss_pred             HHHhccccccccccCceeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  182 (432)
                      ...+|.+.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3456778899999999999999542      24589999886543 2334568899999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEE
Q 014038          183 HMLVYVFMSKGSLASHLYDEN--------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV  254 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl  254 (432)
                      .++||||+++|+|.+++....        ...+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            999999999999999996421        234567888999999999999999998   999999999999999999999


Q ss_pred             eecCCccccccccc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCC
Q 014038          255 ADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKT  330 (432)
Q Consensus       255 ~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  330 (432)
                      +|||+++.......   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+............... 
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-  239 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-  239 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-
Confidence            99999875322211   122335678999999988899999999999999999998 7889876443221111111100 


Q ss_pred             chhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 014038          331 GWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL  381 (432)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~  381 (432)
                                 ...+...+..+.+++.+||+.||++|||+.++++.|.+.+
T Consensus       240 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         240 -----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence                       0111122358999999999999999999999999888763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-40  Score=316.33  Aligned_cols=247  Identities=24%  Similarity=0.416  Sum_probs=203.7

Q ss_pred             hccccccccccCceeEEEEE-eCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      +|.+.+.||.|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+||++
T Consensus        20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   99 (296)
T cd06655          20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA   99 (296)
T ss_pred             eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence            46677899999999999995 45789999999876655556778999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-ccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~  270 (432)
                      +++|..++..   ..+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....... ...
T Consensus       100 ~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  173 (296)
T cd06655         100 GGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS  173 (296)
T ss_pred             CCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence            9999998843   35899999999999999999999999   9999999999999999999999999987543222 223


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN  350 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (432)
                      ...++..|+|||.+.+..++.++|||||||++|+|++|+.||...................        +  ..+...+.
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~--------~--~~~~~~~~  243 (296)
T cd06655         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE--------L--QNPEKLSP  243 (296)
T ss_pred             CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc--------c--CCcccCCH
Confidence            4568899999999998889999999999999999999999998754433322221111100        0  01122335


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          351 EVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       351 ~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+.+++.+||..||++||++.++++
T Consensus       244 ~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         244 IFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             HHHHHHHHHhhcChhhCCCHHHHhh
Confidence            7889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.2e-40  Score=308.34  Aligned_cols=249  Identities=28%  Similarity=0.496  Sum_probs=194.0

Q ss_pred             ccccccCceeEEEEEeC----CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeee-eCCeEEEEEEecc
Q 014038          118 TLIGQGAFGPVYKAQMS----TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA-EKGQHMLVYVFMS  191 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  191 (432)
                      +.||+|+||.||+|...    +...||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            36899999999999653    2357999988543 3344568889999999999999999999876 4556899999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc----
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK----  267 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~----  267 (432)
                      +|+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++......    
T Consensus        81 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            99999998643 234678888999999999999999998   9999999999999999999999999987432211    


Q ss_pred             -cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhC-CCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          268 -HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAG-RSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       268 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                       ......++..|+|||.+....++.++|||||||++|||++| ..||............. .+.           ....+
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~-----------~~~~~  224 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGR-----------RLLQP  224 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCC-----------CCCCC
Confidence             11233456789999999888999999999999999999995 56676543222111111 110           00011


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      ...+..+.+++.+||+.+|++||++.+|++.|+++..
T Consensus       225 ~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         225 EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            1223578999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8.4e-41  Score=319.16  Aligned_cols=258  Identities=24%  Similarity=0.360  Sum_probs=197.8

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      +|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||+
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   86 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL   86 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence            4667789999999999999654 67899999987543 233456788999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~  269 (432)
                      ++ +|.+++... ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++....... ..
T Consensus        87 ~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          87 DK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             CC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence            75 888877543 345889999999999999999999999   9999999999999999999999999987533222 22


Q ss_pred             cccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh----cCCCchhhhc------cc
Q 014038          270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT----EGKTGWEEIV------DS  338 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~~~~------~~  338 (432)
                      ....+++.|+|||.+.+ ..++.++|||||||++|||+||+.||.+............    .....|..+.      +.
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            34567899999998864 5689999999999999999999999976443222211111    0011111110      00


Q ss_pred             cCCCC-------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          339 RLDGI-------FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       339 ~~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .....       .....+.++.+++.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00000       00112457889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.8e-41  Score=328.90  Aligned_cols=251  Identities=22%  Similarity=0.324  Sum_probs=197.4

Q ss_pred             HHhccccccccccCceeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ...|++.+.||+|+||.||++... +++.||+|.+...   .......+.+|+.+++.++||||+++++++.++...++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            356777889999999999999754 6789999998642   223345678999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||+++|+|.+++..   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       122 ~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         122 MEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            999999999998843   35889999999999999999999999   999999999999999999999999998754322


Q ss_pred             c--cccccccCCCCCCccccccC----CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          267 K--HAANIRGTFGYLDPEYISTR----NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       267 ~--~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .  ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.................         .+
T Consensus       196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~---------~~  266 (370)
T cd05621         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN---------SL  266 (370)
T ss_pred             CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc---------cc
Confidence            2  22356799999999998654    378999999999999999999999976543222222111100         01


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRK--RPSMRDIVQV  376 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~~vl~~  376 (432)
                      .-+.....+..+.+++..|+..++..  ||++.++++.
T Consensus       267 ~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         267 NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            11111123457888999999855543  8899988864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-40  Score=308.68  Aligned_cols=247  Identities=27%  Similarity=0.440  Sum_probs=202.4

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .|.+.+.||+|+||.||+|... +++.+++|.+.....  .+.+.+|+.++++++||||+++++++......++++||++
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            4566788999999999999765 478999999865432  6789999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-ccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~  270 (432)
                      +++|.+++... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++....... ...
T Consensus        82 ~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          82 AGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             CCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence            99999998543 357899999999999999999999998   9999999999999999999999999987543332 223


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN  350 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (432)
                      ...++..|+|||.+.+..++.++||||||+++|||++|+.||.................        +..  ..+.....
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~--~~~~~~~~  227 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPP--------PTL--SDPEKWSP  227 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCC--------CCC--CchhhcCH
Confidence            44578899999999988999999999999999999999999976443222211111000        000  11222345


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          351 EVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       351 ~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ++.+++.+||+.+|++|||+.++++
T Consensus       228 ~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         228 EFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             HHHHHHHHHHhcChhhCcCHHHHhc
Confidence            7899999999999999999999885

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.5e-41  Score=350.11  Aligned_cols=256  Identities=24%  Similarity=0.414  Sum_probs=200.9

Q ss_pred             HHHHHhccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeee--CCe
Q 014038          108 DLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQ  182 (432)
Q Consensus       108 ~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~  182 (432)
                      ++....|.+.+.||+|+||+||+|.. .++..||+|.+...  .......|..|+.+++.++||||++++++|..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            34445788889999999999999965 46778999988653  23345678999999999999999999998854  357


Q ss_pred             EEEEEEeccCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeeeccCCCCCeeecC--------
Q 014038          183 HMLVYVFMSKGSLASHLYDE--NYGPLTWNLRVHIALDVARGLEYLHDGAV----PPVIHRDIKSSNILLDQ--------  248 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~----~~iiH~dlkp~Nill~~--------  248 (432)
                      .++||||+++|+|.++|...  ....+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            89999999999999988542  23579999999999999999999998542    23999999999999964        


Q ss_pred             ---------CCcEEEeecCCcccccccccccccccCCCCCCcccccc--CCCCchhHhHHHHHHHHHHHhCCCCCCChhH
Q 014038          249 ---------SMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGLME  317 (432)
Q Consensus       249 ---------~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~  317 (432)
                               .+.+||+|||++.............||+.|+|||++.+  ..++.++||||||||||||++|+.||.....
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~  248 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN  248 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                     33589999999976544444445679999999999853  4589999999999999999999999976443


Q ss_pred             HHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          318 YVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...+........         .+.   ....+.++.+||..||+.+|.+||++.+++.
T Consensus       249 ~~qli~~lk~~p---------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        249 FSQLISELKRGP---------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HHHHHHHHhcCC---------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            333222211110         000   0112357899999999999999999999984

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2e-40  Score=310.16  Aligned_cols=255  Identities=27%  Similarity=0.418  Sum_probs=204.5

Q ss_pred             HHhccccccccccCceeEEEEEeCC----CcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMST----GETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      ..++.+.+.||+|+||.||+|...+    ...||||...... ....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            4456778899999999999996533    2469999887654 4455689999999999999999999998875 55789


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          84 VMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            99999999999998543 345899999999999999999999998   99999999999999999999999999875432


Q ss_pred             ccc--ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          266 DKH--AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       266 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ...  .....++..|+|||.+....++.++||||||+++|||++ |..||.................            .
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~------------~  227 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER------------L  227 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc------------C
Confidence            211  112234568999999988889999999999999999986 9999976554332222211110            0


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      ..+...+.++.+++.+||..+|++|||+.++++.|+++..
T Consensus       228 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            1122234579999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.3e-40  Score=310.51  Aligned_cols=247  Identities=27%  Similarity=0.483  Sum_probs=200.2

Q ss_pred             ccccccccccCceeEEEEEeCCCcEEEEEEeccCC------hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS------KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      |...+.||+|+||.||+|...+++.+|+|.+....      ......+.+|+.++++++|+||+++++++.+.+..+++|
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            44567899999999999988789999999886432      122356889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc--
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV--  265 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~--  265 (432)
                      ||+++++|.+++...  .++++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.....  
T Consensus        82 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          82 EFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            999999999998543  46899999999999999999999998   99999999999999999999999998864321  


Q ss_pred             -----cccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          266 -----DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       266 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                           ........++..|+|||.+.+..++.++||||||+++|||++|+.||............... ..         .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~---------~  226 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH-RG---------L  226 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc-cC---------C
Confidence                 11122346889999999999888999999999999999999999999764433222111110 00         0


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ....+...+.++.+++.+||+.+|.+||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            01112223457899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.3e-41  Score=316.10  Aligned_cols=264  Identities=26%  Similarity=0.423  Sum_probs=200.7

Q ss_pred             hccccccccccCceeEEEEEe-----CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeC--CeEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHM  184 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  184 (432)
                      .+.+.+.||+|+||.||++..     .++..||+|.+.... ......+.+|+.+++.++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            455668899999999999964     357889999987543 33446789999999999999999999998775  5689


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      +||||+++++|.+++... ...+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++...
T Consensus        85 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccc
Confidence            999999999999998543 246899999999999999999999999   9999999999999999999999999987543


Q ss_pred             cccc----ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchh---hhcc
Q 014038          265 VDKH----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWE---EIVD  337 (432)
Q Consensus       265 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~  337 (432)
                      ....    .....++..|+|||.+.+..++.++||||||+++|||++++.|+...............+...+.   ....
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE  240 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence            2221    12345677899999998888999999999999999999987765321110000000000000000   0001


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          338 SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       338 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      .......+...+..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0111111222346899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.7e-40  Score=309.95  Aligned_cols=245  Identities=27%  Similarity=0.494  Sum_probs=199.5

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCChh---------hHHHHHHHHHHHhhcCCCccceEEeeeeeCCeE
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQ---------GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH  183 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  183 (432)
                      |.+...||+|+||.||+|.. .+++.+|+|.+......         ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            45667899999999999964 46789999988654221         125688999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      +++|||+++++|.+++..  .+.+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||+++..
T Consensus        82 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          82 NIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             EEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            999999999999999954  356899999999999999999999998   999999999999999999999999998754


Q ss_pred             cccc-------cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhc
Q 014038          264 MVDK-------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIV  336 (432)
Q Consensus       264 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      ....       ......++..|+|||.+.+..++.++|+||||+++|||++|+.||...............         
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------  227 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN---------  227 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc---------
Confidence            3211       112345788999999999888999999999999999999999999875443222211110         


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                         .....+...+..+.+++.+||+.||.+||++.++++
T Consensus       228 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 ---ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ---CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence               111122233467899999999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.5e-40  Score=311.21  Aligned_cols=249  Identities=27%  Similarity=0.459  Sum_probs=197.7

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeC------CeE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK------GQH  183 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~~~  183 (432)
                      +.|++.+.||+|+||.||+|.. .+++.||+|.+.... .....+..|+.++.++ +||||+++++++...      ...
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            3456667899999999999965 467899999986543 3345788999999998 799999999998753      468


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      +++|||+.+|+|.+++.......+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||++...
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            99999999999999987655567999999999999999999999998   999999999999999999999999998753


Q ss_pred             ccc-ccccccccCCCCCCccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcc
Q 014038          264 MVD-KHAANIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD  337 (432)
Q Consensus       264 ~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      ... .......|+..|+|||++.     ...++.++|||||||++|||++|+.||................         
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~---------  232 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---------  232 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC---------
Confidence            322 2233456899999999885     3468889999999999999999999997543322221111100         


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          338 SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       338 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                        .....+...+.++.+++.+||+.+|.+|||+.++++
T Consensus       233 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         233 --APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             --CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence              000111123357899999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-40  Score=307.61  Aligned_cols=251  Identities=27%  Similarity=0.436  Sum_probs=205.1

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .|.+.+.||+|+||.||+|.. .+++.+|+|.+........+.+.+|+.++++++||||+++++++......+++|||++
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~   83 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG   83 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence            566778999999999999965 4678999999987655566789999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-ccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~  270 (432)
                      +++|.+++... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++....... ...
T Consensus        84 ~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          84 GGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             CCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence            99999988543 256899999999999999999999998   9999999999999999999999999987543222 223


Q ss_pred             ccccCCCCCCccccccC---CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          271 NIRGTFGYLDPEYISTR---NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ...++..|+|||.+...   .++.++|+||||+++|||++|+.||.................      ....+  .....
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~------~~~~~--~~~~~  231 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF------PPPKL--KDKEK  231 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------CCccc--cchhh
Confidence            45678899999998776   889999999999999999999999976543322222111100      00011  11233


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+.++.+++.+||+.+|.+||++.+|+.
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         232 WSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             hhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            4568999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-40  Score=307.18  Aligned_cols=245  Identities=29%  Similarity=0.476  Sum_probs=199.4

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChh-hHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCChh
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLA  196 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  196 (432)
                      ++||+|+||.||++...+++.||+|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            369999999999998766999999998765333 4568999999999999999999999999999999999999999999


Q ss_pred             hhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc---cccc
Q 014038          197 SHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA---ANIR  273 (432)
Q Consensus       197 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~---~~~~  273 (432)
                      +++... ...+++..+..++.+++.||.|||+++   ++||||||+||+++.++.+||+|||++.........   ....
T Consensus        81 ~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          81 TFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            998543 346889999999999999999999999   999999999999999999999999998754321111   1123


Q ss_pred             cCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHH
Q 014038          274 GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEV  352 (432)
Q Consensus       274 gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  352 (432)
                      .+..|+|||.+.+..++.++|+|||||++|||++ |..||..............            ......+...+.++
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~  224 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES------------GYRMPAPQLCPEEI  224 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc------------CCCCCCCccCCHHH
Confidence            3567999999988899999999999999999999 8889876443221111111            00111222334589


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          353 ASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       353 ~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                      .+++.+||+.+|++||++.++++.|.
T Consensus       225 ~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         225 YRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHhccChhhCcCHHHHHHHhh
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9.8e-41  Score=346.92  Aligned_cols=258  Identities=23%  Similarity=0.290  Sum_probs=203.1

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.++||+|+||.||+|.. .+|+.||+|++....   ....+.|.+|+.++++++||||+++++++.+.+..+++||
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME   82 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP   82 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence            467788999999999999965 468999999987542   2334679999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCC
Q 014038          189 FMSKGSLASHLYDE---------NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL  259 (432)
Q Consensus       189 ~~~~g~L~~~l~~~---------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl  259 (432)
                      |+++|+|.+++...         ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCc
Confidence            99999999988531         1234667788999999999999999998   99999999999999999999999999


Q ss_pred             ccccccc-------------------ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHH
Q 014038          260 SREEMVD-------------------KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVE  320 (432)
Q Consensus       260 ~~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~  320 (432)
                      ++.....                   .......||+.|+|||.+.+..++.++|||||||++|||+||+.||........
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            8753110                   001124689999999999999999999999999999999999999976332111


Q ss_pred             HHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHHhh
Q 014038          321 LAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRP-SMRDIVQVLSRILKM  383 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~~vl~~L~~i~~~  383 (432)
                      .....         ...+... ......+..+.+++.+||+.||++|| ++.++++.|+..++.
T Consensus       240 ~~~~~---------i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        240 SYRDV---------ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhhhh---------ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            10000         0000000 00112345788999999999999995 677788888887664

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.6e-41  Score=328.67  Aligned_cols=256  Identities=25%  Similarity=0.359  Sum_probs=196.3

Q ss_pred             cccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC-----eEEEE
Q 014038          115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-----QHMLV  186 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  186 (432)
                      .+.+.||+|+||.||++.. .+|+.||+|.+...  .....+.+.+|+.+++.++||||+++++++...+     ..++|
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   82 (372)
T cd07853           3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV   82 (372)
T ss_pred             cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence            4567899999999999965 57899999998643  2334567889999999999999999999998766     78999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||+. ++|.+.+..  ...+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++.....
T Consensus        83 ~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          83 TELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             eeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            99996 578877743  356999999999999999999999999   999999999999999999999999998754322


Q ss_pred             c--cccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc-CCCchhhh-------
Q 014038          267 K--HAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE-GKTGWEEI-------  335 (432)
Q Consensus       267 ~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~-------  335 (432)
                      .  ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+......+..+... +......+       
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  236 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA  236 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence            1  22334678999999998764 5899999999999999999999999865443332222110 10000000       


Q ss_pred             ---ccccC-CC-------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          336 ---VDSRL-DG-------IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       336 ---~~~~~-~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                         +.... ..       ......+.++.+++.+||+.||++|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence               00000 00       0011124578899999999999999999998863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.8e-40  Score=312.90  Aligned_cols=249  Identities=25%  Similarity=0.393  Sum_probs=201.3

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .|.+.+.||.|+||.||+|... ++..+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus        13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   92 (292)
T cd06644          13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP   92 (292)
T ss_pred             hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence            4667788999999999999764 588999999987666667789999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~  270 (432)
                      +++|..++... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...... ....
T Consensus        93 ~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  168 (292)
T cd06644          93 GGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD  168 (292)
T ss_pred             CCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence            99998877543 356899999999999999999999998   999999999999999999999999988653222 1223


Q ss_pred             ccccCCCCCCccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          271 NIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      ...+++.|+|||.+.     ...++.++|||||||++|||++|+.||.................        +.  ...+
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--------~~--~~~~  238 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP--------PT--LSQP  238 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCC--------cc--CCCC
Confidence            456889999999884     34578899999999999999999999976443222222111110        00  0112


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...+.++.+++.+||+.+|++||++.++++
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         239 SKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             cccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            223457899999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.6e-41  Score=313.23  Aligned_cols=240  Identities=25%  Similarity=0.442  Sum_probs=190.7

Q ss_pred             ccccccCceeEEEEEeC-C-------CcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          118 TLIGQGAFGPVYKAQMS-T-------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      +.||+|+||.||+|... .       ...+|+|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            36999999999999643 2       234888888655555567889999999999999999999999998999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc--------EEEeecCCcc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR--------ARVADFGLSR  261 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~--------~kl~Dfgl~~  261 (432)
                      +++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.        ++++|||++.
T Consensus        81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            99999999986443 36899999999999999999999999   999999999999987765        6999999886


Q ss_pred             cccccccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCC-CCCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          262 EEMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGR-SPLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ....   .....++..|+|||.+.+ ..++.++|||||||++|||++|. .||..............            .
T Consensus       157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~------------~  221 (258)
T cd05078         157 TVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED------------R  221 (258)
T ss_pred             ccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc------------c
Confidence            4322   233467889999999976 45899999999999999999984 66654332211111110            0


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                        ...+.....++.+++.+||+.||++|||+.++++.|+
T Consensus       222 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 --HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             --ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence              0111122347899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.2e-40  Score=306.22  Aligned_cols=248  Identities=29%  Similarity=0.506  Sum_probs=200.6

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      .+.+.+.||+|+||.||+|...++..+|+|.+.... .....|.+|++++++++|||++++++++......+++|||+++
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            456778999999999999987778899999886433 2345789999999999999999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc--cc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH--AA  270 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~--~~  270 (432)
                      ++|.+++... ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++........  ..
T Consensus        84 ~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (256)
T cd05112          84 GCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST  159 (256)
T ss_pred             CcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence            9999988543 246899999999999999999999998   99999999999999999999999999875432211  11


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |+.||.................     ...       +...+
T Consensus       160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----~~~-------~~~~~  227 (256)
T cd05112         160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR-----LYK-------PRLAS  227 (256)
T ss_pred             CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC-----CCC-------CCCCC
Confidence            2234678999999998899999999999999999998 9999975432221111111000     000       11123


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                      .++.+++.+||+.+|++||++.++++.|
T Consensus       228 ~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         228 QSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            5799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-40  Score=309.91  Aligned_cols=246  Identities=28%  Similarity=0.468  Sum_probs=201.6

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      +|.+.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            3556678999999999999654 68899999987543 344567889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-ccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~  269 (432)
                      ++++|.+++...   ++++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++..... ...
T Consensus        82 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  155 (274)
T cd06609          82 GGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR  155 (274)
T ss_pred             CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence            999999998543   7899999999999999999999998   999999999999999999999999998765433 233


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....+++.|+|||.+.+..++.++||||||+++|||++|+.||................        .+.+...   ..+
T Consensus       156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~---~~~  224 (274)
T cd06609         156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--------PPSLEGN---KFS  224 (274)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--------CCCCccc---ccC
Confidence            44568889999999998889999999999999999999999997543221111111110        0111110   134


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .++.+++.+||..+|++||+++++++
T Consensus       225 ~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         225 KPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             HHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            57899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.3e-41  Score=326.92  Aligned_cols=261  Identities=27%  Similarity=0.383  Sum_probs=208.6

Q ss_pred             HHHHHhccccccccccCceeEEEE-EeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC-C-----CccceEEeeeeeC
Q 014038          108 DLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-H-----RNLVNLVGYCAEK  180 (432)
Q Consensus       108 ~l~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~  180 (432)
                      |....+|.+.++||+|+||.|.+| +..+++.||||+++... ....+-..|+.+|..|+ |     -|+|++++||...
T Consensus       182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            333346677899999999999999 55689999999997643 33456678999999997 4     4899999999999


Q ss_pred             CeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC--CcEEEeecC
Q 014038          181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS--MRARVADFG  258 (432)
Q Consensus       181 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~--~~~kl~Dfg  258 (432)
                      ++.|+|+|.++. +|+++++..+...|+...+..|+.||+.||.+||..+   |||+||||+||||.+-  ..+||+|||
T Consensus       261 ~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  261 NHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             cceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecc
Confidence            999999999964 9999999888888999999999999999999999999   9999999999999543  379999999


Q ss_pred             CcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCch------
Q 014038          259 LSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW------  332 (432)
Q Consensus       259 l~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  332 (432)
                      .++.......  ...-+..|.|||++.+..|+.+.|+||||||+.||++|.+.|.+..+..++..+...-..+-      
T Consensus       337 SSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  337 SSCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             cccccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            9986543333  56678999999999999999999999999999999999999998877766654422111000      


Q ss_pred             ----hhhccc-----------------------------cCC--CC---------CCHHHHHHHHHHHHHhhccCCCCCC
Q 014038          333 ----EEIVDS-----------------------------RLD--GI---------FDVEELNEVASLAYKCVNRAPRKRP  368 (432)
Q Consensus       333 ----~~~~~~-----------------------------~~~--~~---------~~~~~~~~l~~li~~cl~~dp~~RP  368 (432)
                          ..+++.                             ...  .+         .....-..+.+++.+||..||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence                000111                             000  00         0111235789999999999999999


Q ss_pred             CHHHHHH
Q 014038          369 SMRDIVQ  375 (432)
Q Consensus       369 s~~~vl~  375 (432)
                      |..+.++
T Consensus       495 tp~qal~  501 (586)
T KOG0667|consen  495 TPAQALN  501 (586)
T ss_pred             CHHHHhc
Confidence            9999876

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.6e-40  Score=308.90  Aligned_cols=250  Identities=26%  Similarity=0.428  Sum_probs=199.5

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .|.+.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++++...+..+++|||++
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~   89 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG   89 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence            556677899999999999964 4688999999876655555678899999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~  270 (432)
                      +++|.+++..  .+.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++...... ....
T Consensus        90 ~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          90 GGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            9999998853  356899999999999999999999999   999999999999999999999999998654322 1223


Q ss_pred             ccccCCCCCCccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          271 NIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ...|++.|+|||.+.   ...++.++|+|||||++|||++|+.||.................      ..+.....  ..
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~--~~  236 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF------QPPKLKDK--MK  236 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCC------CCCccccc--CC
Confidence            457899999999874   45688999999999999999999999865432222111111100      00011100  01


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+..+.+++.+||+.+|++||++.+|++
T Consensus       237 ~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         237 WSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            2346889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-40  Score=308.35  Aligned_cols=237  Identities=27%  Similarity=0.489  Sum_probs=189.2

Q ss_pred             ccccccCceeEEEEEeCCCc-----------EEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          118 TLIGQGAFGPVYKAQMSTGE-----------TVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      +.||+|+||.||+|...+..           .+++|.+...... ...|.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            36899999999999765332           5788877654333 6788999999999999999999999988 788999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC-------cEEEeecCC
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-------RARVADFGL  259 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~-------~~kl~Dfgl  259 (432)
                      |||+++|+|.+++.... ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++       .+||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          79 EEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            99999999999986533 26899999999999999999999998   99999999999999888       799999999


Q ss_pred             cccccccccccccccCCCCCCccccccC--CCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhc
Q 014038          260 SREEMVDKHAANIRGTFGYLDPEYISTR--NFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV  336 (432)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      +.....   .....++..|+|||++...  .++.++||||||+++|||++ |..||...............         
T Consensus       155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~---------  222 (259)
T cd05037         155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ---------  222 (259)
T ss_pred             cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC---------
Confidence            875432   2234567789999999776  78999999999999999999 57787654211111110000         


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                       ....    ......+.+++.+||..+|.+||++.++++.|
T Consensus       223 -~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         223 -HRLP----MPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             -CCCC----CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence             0000    00115789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2e-41  Score=296.19  Aligned_cols=249  Identities=26%  Similarity=0.423  Sum_probs=204.6

Q ss_pred             hccccccccccCceeEEEE-EeCCCcEEEEEEeccCC-----hh---hHHHHHHHHHHHhhc-CCCccceEEeeeeeCCe
Q 014038          113 TCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS-----KQ---GEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~-----~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  182 (432)
                      .|.-.+.||.|..++|-++ ...+|+.+|+|++....     +.   -.+.-.+|+.+|+++ .||||+.+.++++.+..
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF   97 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF   97 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence            3444578999999999988 44578899999885421     11   123456799999998 69999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .++|+|.|+.|.|.++|.+  .-.+++....+|++|+..|++|||..+   |+||||||+|||+|++.++||+|||+++.
T Consensus        98 ~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~  172 (411)
T KOG0599|consen   98 VFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQ  172 (411)
T ss_pred             hhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeec
Confidence            9999999999999999954  457999999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccccccccccCCCCCCcccccc------CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhc
Q 014038          263 EMVDKHAANIRGTFGYLDPEYIST------RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIV  336 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      ...+......+|||+|.|||.+..      ..|+...|.|++|||+|-|+.|.+||........+ .+...++-.+    
T Consensus       173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlML-R~ImeGkyqF----  247 (411)
T KOG0599|consen  173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLML-RMIMEGKYQF----  247 (411)
T ss_pred             cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHH-HHHHhccccc----
Confidence            888888888999999999998843      35889999999999999999999999865443322 2233332111    


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                          ..+.-.+.+....++|.+||+.||.+|-|++|++.
T Consensus       248 ----~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  248 ----RSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ----CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                11111233457889999999999999999999886

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.3e-40  Score=305.90  Aligned_cols=247  Identities=24%  Similarity=0.382  Sum_probs=202.8

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      |++.+.||+|+||.||++.. .+++.+|+|.+...  .......+.+|+.++++++|||++++++.+...+..++||||+
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            56678999999999999954 47889999998654  2334567899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC-CcEEEeecCCcccccccccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-MRARVADFGLSREEMVDKHA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~-~~~kl~Dfgl~~~~~~~~~~  269 (432)
                      ++++|.+++.......+++..+..++.+++.||.|||+++   ++|+||+|+||+++++ +.+||+|||++.........
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~  158 (256)
T cd08220          82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA  158 (256)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence            9999999997655567899999999999999999999998   9999999999999855 46899999998765544444


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.................            ...+...+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~  226 (256)
T cd08220         159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF------------APISDRYS  226 (256)
T ss_pred             cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC------------CCCCCCcC
Confidence            456788999999999988899999999999999999999999976432221111111110            01111234


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.+++.+||+.+|++|||+.++++
T Consensus       227 ~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         227 PDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhh
Confidence            57899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.8e-40  Score=311.60  Aligned_cols=258  Identities=24%  Similarity=0.318  Sum_probs=197.1

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      |.+.+.||+|++|.||+|... ++..||+|.+....  ....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            456788999999999999754 78999999986532  233467889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-c
Q 014038          191 SKGSLASHLYDEN-YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-H  268 (432)
Q Consensus       191 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~  268 (432)
                      + ++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++....... .
T Consensus        82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV  157 (285)
T ss_pred             C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence            7 68888875432 357999999999999999999999998   9999999999999999999999999986533221 1


Q ss_pred             ccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc----CCCchh---------h
Q 014038          269 AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE----GKTGWE---------E  334 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~---------~  334 (432)
                      .....+++.|+|||.+.+ ..++.++|||||||++|||+||+.||.+..+..........    ....|.         .
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN  237 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence            223456889999998765 45789999999999999999999999865443322221110    000000         0


Q ss_pred             hccccCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 IVDSRLDGI---FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 ~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .........   .....+.++.+++.+||+.||++|||+.+|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000000   00112457889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-40  Score=308.90  Aligned_cols=255  Identities=26%  Similarity=0.473  Sum_probs=203.3

Q ss_pred             HhccccccccccCceeEEEEEeC-CCc----EEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGE----TVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      ..+.+.+.||+|+||.||+|... +|.    .+|+|.+.... ......+.+|+.++++++||||++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            45677789999999999999653 333    58999886553 3445678999999999999999999999987 78899


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++....
T Consensus        86 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            99999999999998653 345899999999999999999999988   99999999999999999999999999875432


Q ss_pred             cccc---cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCC
Q 014038          266 DKHA---ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       266 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ....   ....++..|+|||.+....++.++|+||||+++||+++ |+.||.+..... +........           .
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~-----------~  229 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-IPDLLEKGE-----------R  229 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-HHHHHhCCC-----------C
Confidence            2211   11223568999999988889999999999999999999 999997643221 111111110           0


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      ...+......+.+++.+||..+|.+||++.++++.|+.+.+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            011111234788999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.5e-40  Score=325.00  Aligned_cols=251  Identities=22%  Similarity=0.315  Sum_probs=196.5

Q ss_pred             HHhccccccccccCceeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ...|.+.+.||+|+||.||++... +++.||+|.+...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  121 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            457788899999999999999654 6789999998642   223345678999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||+++|+|.+++..   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       122 ~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         122 MEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence            999999999998853   34888999999999999999999999   999999999999999999999999998754322


Q ss_pred             c--cccccccCCCCCCccccccC----CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          267 K--HAANIRGTFGYLDPEYISTR----NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       267 ~--~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .  ......||+.|+|||++...    .++.++|||||||++|||++|+.||...........+.....         .+
T Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------~~  266 (371)
T cd05622         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN---------SL  266 (371)
T ss_pred             CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------cc
Confidence            1  22356799999999998653    378999999999999999999999986543222222111100         00


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRK--RPSMRDIVQV  376 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~~vl~~  376 (432)
                      .-+.....+..+.+++..|+..++.+  ||++.++++.
T Consensus       267 ~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         267 TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            00111123457889999999843332  6788888764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.3e-40  Score=304.86  Aligned_cols=247  Identities=26%  Similarity=0.425  Sum_probs=200.4

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeee-CCeEEEEEEe
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-KGQHMLVYVF  189 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  189 (432)
                      |.+.+.||+|++|.||++... +++.||+|.+....  ....+.+.+|+.++++++|+|++++++.+.. ....+++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            567789999999999999654 67899999986542  3344578899999999999999999988764 4468999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KH  268 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~  268 (432)
                      +++++|.+++.......+++.++..++.+++.||.|||+.+   ++||||||+||+++.++.++|+|||++...... ..
T Consensus        82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM  158 (257)
T ss_pred             cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence            99999999997655567999999999999999999999999   999999999999999999999999998754322 22


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      .....+++.|+|||.+.+..++.++||||||++++||++|+.||............. .+          .+ ...+...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~----------~~-~~~~~~~  226 (257)
T cd08223         159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EG----------KL-PPMPKDY  226 (257)
T ss_pred             cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hc----------CC-CCCcccc
Confidence            334568899999999999999999999999999999999999997543221111111 11          01 1122234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +.++.+++.+||+.+|++||++.++++
T Consensus       227 ~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         227 SPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            468999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.7e-40  Score=307.83  Aligned_cols=246  Identities=31%  Similarity=0.513  Sum_probs=199.7

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .+|.+.+.||+|+||.||++.. +++.||+|.+....  ....+.+|+.++.+++|||++++++++... ..+++|||+.
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            3567788999999999999975 67889999986532  345788999999999999999999998754 4799999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN  271 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  271 (432)
                      +++|.+++.......+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......  ...
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~  156 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDN  156 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc--CCC
Confidence            999999997655557899999999999999999999998   999999999999999999999999998653221  122


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN  350 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (432)
                      ...+..|+|||.+.+..++.++|+||||+++|||++ |+.||...............            .....+...+.
T Consensus       157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~------------~~~~~~~~~~~  224 (254)
T cd05083         157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG------------YRMEPPEGCPA  224 (254)
T ss_pred             CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC------------CCCCCCCcCCH
Confidence            334568999999988899999999999999999998 99999764332211111110            11111223345


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          351 EVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       351 ~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                      ++.+++.+||+.+|++||++.++++.|+
T Consensus       225 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         225 DVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            7899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.7e-40  Score=315.22  Aligned_cols=248  Identities=23%  Similarity=0.387  Sum_probs=203.1

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      ..|.+.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            4667788999999999999964 578999999997665555677889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~  269 (432)
                      ++++|.+++..   ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++....... ..
T Consensus        99 ~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  172 (297)
T cd06656          99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (297)
T ss_pred             CCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence            99999998843   35899999999999999999999998   9999999999999999999999999986543222 22


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...............+          ......+...+
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~----------~~~~~~~~~~~  242 (297)
T cd06656         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG----------TPELQNPERLS  242 (297)
T ss_pred             CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC----------CCCCCCccccC
Confidence            34568899999999998889999999999999999999999997543221111110000          00011122334


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.+++.+||+.+|++||++.++++
T Consensus       243 ~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         243 AVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            57889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=324.96  Aligned_cols=239  Identities=28%  Similarity=0.425  Sum_probs=203.3

Q ss_pred             ccccccCceeEEEEE-eCCCcEEEEEEeccCCh---hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCC
Q 014038          118 TLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG  193 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  193 (432)
                      +.||.|+||.||.|+ ..+.+.||||.+....+   ....++.+|+..|++++|||++.+.|+|..+...|||||||- |
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence            469999999999995 45788999999976544   345688999999999999999999999999999999999995 5


Q ss_pred             ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccccccc
Q 014038          194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR  273 (432)
Q Consensus       194 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  273 (432)
                      +-.+++.- ..+++.+..+..|+.+.+.||+|||+.+   .||||||..||||++.|.|||+|||.+..   ......++
T Consensus       111 SAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi---~~PAnsFv  183 (948)
T KOG0577|consen  111 SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASI---MAPANSFV  183 (948)
T ss_pred             cHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhh---cCchhccc
Confidence            77777743 2467999999999999999999999999   99999999999999999999999998753   23456789


Q ss_pred             cCCCCCCcccc---ccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHH
Q 014038          274 GTFGYLDPEYI---STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN  350 (432)
Q Consensus       274 gt~~y~aPE~~---~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (432)
                      |||.|||||++   ..+.|+-|+|||||||+..||.-.++|+..+.....+..+..+....+           ...+.+.
T Consensus       184 GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtL-----------qs~eWS~  252 (948)
T KOG0577|consen  184 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL-----------QSNEWSD  252 (948)
T ss_pred             CCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCC-----------CCchhHH
Confidence            99999999987   468999999999999999999999999887766555555544433221           1345667


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          351 EVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       351 ~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+++|+..||++-|.+|||.++++.
T Consensus       253 ~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  253 YFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             HHHHHHHHHHhhCcccCCcHHHHhh
Confidence            8999999999999999999998875

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.6e-40  Score=310.88  Aligned_cols=258  Identities=22%  Similarity=0.324  Sum_probs=199.5

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      .|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.+++.++|||++++++++......++||||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            3567788999999999999765 68999999886432  22345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-c
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-H  268 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~  268 (432)
                      ++++.|..++..  ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++....... .
T Consensus        82 ~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          82 CDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             cCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence            999888877643  346899999999999999999999998   9999999999999999999999999987543322 2


Q ss_pred             ccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCC---chhhhc--------
Q 014038          269 AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT---GWEEIV--------  336 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~--------  336 (432)
                      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.+................   ......        
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence            234457889999999865 56889999999999999999999999865443332222111000   000000        


Q ss_pred             --cccCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          337 --DSRLDGIFD-----VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       337 --~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                        .+......+     ...+..+.+++.+||+.+|++||++.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence              000000001     012457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-40  Score=305.24  Aligned_cols=249  Identities=27%  Similarity=0.344  Sum_probs=206.0

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .+++.+.||+|.-|+||++++. ++..+|+|++.+..   .....+...|-++|+.++||.+..||+.++.+...|++||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            3455678999999999999875 45899999997653   2334566789999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc---
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV---  265 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~---  265 (432)
                      ||+||+|..+++.+..+.+++..+.-++.+|+.||+|||..|   ||.|||||+||||.++|++.|+||.|+.....   
T Consensus       158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence            999999999999888899999999999999999999999999   99999999999999999999999998742100   


Q ss_pred             --------------------------------c----------------------ccccccccCCCCCCccccccCCCCc
Q 014038          266 --------------------------------D----------------------KHAANIRGTFGYLDPEYISTRNFTK  291 (432)
Q Consensus       266 --------------------------------~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~  291 (432)
                                                      .                      .....++||--|.|||++.+..-+.
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs  314 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS  314 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence                                            0                      0112356899999999999999999


Q ss_pred             hhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC--
Q 014038          292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPS--  369 (432)
Q Consensus       292 ~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs--  369 (432)
                      +.|.|+|||++|||+.|+.||.+......+..+..           ..+.-+.....+..+.+||.+.|.+||++|--  
T Consensus       315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~-----------~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~  383 (459)
T KOG0610|consen  315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG-----------QPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSK  383 (459)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc-----------CCCcCCCCCcchhHHHHHHHHHhccChhhhhccc
Confidence            99999999999999999999998766554444332           22221112244568999999999999999987  


Q ss_pred             --HHHHHH
Q 014038          370 --MRDIVQ  375 (432)
Q Consensus       370 --~~~vl~  375 (432)
                        +.||-+
T Consensus       384 rGA~eIK~  391 (459)
T KOG0610|consen  384 RGAAEIKR  391 (459)
T ss_pred             cchHHhhc
Confidence              666543

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=310.70  Aligned_cols=250  Identities=26%  Similarity=0.395  Sum_probs=203.0

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .|.+.+.||.|+||.||+|... ++..+|+|.+........+.|.+|+.++++++||||+++++++......++||||++
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD   85 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence            4566788999999999999764 688999999977666666789999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~  270 (432)
                      +++|.+++... ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++...... ....
T Consensus        86 ~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          86 GGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             CCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence            99999988543 346999999999999999999999999   999999999999999999999999987653322 2223


Q ss_pred             ccccCCCCCCccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          271 NIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      ...+++.|+|||.+.     ...++.++|+||||+++|||++|+.||.................        +.+  ..+
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~--~~~  231 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP--------PTL--DQP  231 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC--------CCc--CCc
Confidence            456899999999874     34577899999999999999999999976543322222211111        000  011


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ...+.++.+++.+||+.+|.+||++.++++.
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         232 SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            2233578899999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.6e-40  Score=305.19  Aligned_cols=246  Identities=27%  Similarity=0.488  Sum_probs=201.1

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-----KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      |...+.||+|+||.||+|... +++.|++|.+....     ....+.+.+|+.+++.++|+||+++++++......+++|
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            445678999999999999765 78999999886532     234567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+++++|.+++..  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        82 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          82 ELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999854  346899999999999999999999998   9999999999999999999999999987644333


Q ss_pred             cccccccCCCCCCccccccCC-CCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          268 HAANIRGTFGYLDPEYISTRN-FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||.................           ....+.
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------~~~~~~  225 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-----------LPPIPD  225 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-----------CCCcCC
Confidence            344566889999999987766 89999999999999999999999976543222222111000           011122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .....+.+++.+||+.+|.+||++.+++.
T Consensus       226 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         226 HLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            23357889999999999999999999885

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-43  Score=309.00  Aligned_cols=247  Identities=24%  Similarity=0.411  Sum_probs=206.4

Q ss_pred             ccccccccccCceeEEEE-EeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          114 CNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +++.++||+|+||.||+| ....|+.+|||.+..+  .+..++.+|+.++++.+.|++|++||.|.....+++|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            356689999999999999 4558999999998654  3456789999999999999999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-ccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAAN  271 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~  271 (432)
                      |+..+.++.+ +++|++.++..++...++||+|||...   -||||||..||||+.+|.+||+|||++-..... ....+
T Consensus       113 GSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  113 GSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             CcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            9999998654 578999999999999999999999987   799999999999999999999999998654332 23456


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      ..|||.|||||++..-.|+.++||||||++..||..|++||.+......+..+.....        +.+  ..+...+.+
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PP--------PTF--~KPE~WS~~  258 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPP--------PTF--KKPEEWSSE  258 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCC--------CCC--CChHhhhhH
Confidence            7899999999999999999999999999999999999999986543211111111110        111  124456778


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          352 VASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      +.+++..||-+.|++|.|+.++++.
T Consensus       259 F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  259 FNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             HHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            9999999999999999999998763

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7e-41  Score=326.49  Aligned_cols=247  Identities=23%  Similarity=0.326  Sum_probs=193.6

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      |++.+.||+|+||.||++.. .+++.||+|++...   .......+.+|+.++..++||||+++++.+.+.+..++||||
T Consensus         3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~   82 (360)
T cd05627           3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF   82 (360)
T ss_pred             ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            56678999999999999965 46899999998643   223345688899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--  267 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--  267 (432)
                      +++|+|.+++..  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  
T Consensus        83 ~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          83 LPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             CCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence            999999999854  356899999999999999999999999   9999999999999999999999999986321110  


Q ss_pred             ----------------------------------cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCC
Q 014038          268 ----------------------------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ  313 (432)
Q Consensus       268 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~  313 (432)
                                                        .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence                                              0113469999999999999999999999999999999999999997


Q ss_pred             ChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 014038          314 GLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPS---MRDIVQ  375 (432)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~~vl~  375 (432)
                      +............... .   +   .....  ...+.++.+++.+|+ .||.+|++   +.++++
T Consensus       238 ~~~~~~~~~~i~~~~~-~---~---~~p~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         238 SETPQETYRKVMNWKE-T---L---VFPPE--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCHHHHHHHHHcCCC-c---e---ecCCC--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            6543322221111000 0   0   00000  112346788888876 49999986   455543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.7e-40  Score=309.69  Aligned_cols=246  Identities=26%  Similarity=0.437  Sum_probs=200.2

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .|...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            344557899999999999965 467899999987543 344567899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~  269 (432)
                      ++++|.+++..   ..+++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++|+|||++....... ..
T Consensus        85 ~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06642          85 GGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             CCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence            99999998843   46899999999999999999999998   9999999999999999999999999986543222 22


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....++..|+|||.+.+..++.++|||||||++|||++|+.||.............            .......+...+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~------------~~~~~~~~~~~~  226 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP------------KNSPPTLEGQYS  226 (277)
T ss_pred             hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh------------cCCCCCCCcccC
Confidence            23467889999999998899999999999999999999999987543222111110            011111222334


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      .++.+++.+||+.+|++||++.++++.
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         227 KPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            578999999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1e-39  Score=306.64  Aligned_cols=246  Identities=24%  Similarity=0.413  Sum_probs=202.4

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .|...+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            3445578999999999999754 68899999987543 344567899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~  269 (432)
                      ++|+|.+++..   .++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        85 ~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06640          85 GGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence            99999998843   46899999999999999999999998   9999999999999999999999999986543322 22


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....++..|+|||.+.+..++.++|+|||||++|||++|+.||............            ............+
T Consensus       159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------------~~~~~~~~~~~~~  226 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI------------PKNNPPTLTGEFS  226 (277)
T ss_pred             ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh------------hcCCCCCCchhhh
Confidence            3346788999999998888999999999999999999999999754332111111            1111122334456


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ..+.+++.+||+.+|++||++.++++.
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         227 KPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            789999999999999999999999865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-41  Score=323.08  Aligned_cols=239  Identities=30%  Similarity=0.411  Sum_probs=187.0

Q ss_pred             ccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhc---CCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          120 IGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRL---HHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       120 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      ||+|+||+||+|+. .+++.||+|++....   ......+..|..++...   +||||+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999965 468999999986432   12223455666776655   699999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN  271 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~  271 (432)
                      |+|..++..  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..... ......
T Consensus        81 g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~  155 (330)
T cd05586          81 GELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT  155 (330)
T ss_pred             ChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence            999988853  456899999999999999999999999   99999999999999999999999999875322 223345


Q ss_pred             cccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHH
Q 014038          272 IRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN  350 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (432)
                      ..||+.|+|||.+.+. .++.++|||||||++|||++|+.||.............. +..        .+.   ....+.
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~-~~~--------~~~---~~~~~~  223 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF-GKV--------RFP---KNVLSD  223 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc-CCC--------CCC---CccCCH
Confidence            6799999999998654 589999999999999999999999976432221111111 110        010   011234


Q ss_pred             HHHHHHHHhhccCCCCCC----CHHHHHH
Q 014038          351 EVASLAYKCVNRAPRKRP----SMRDIVQ  375 (432)
Q Consensus       351 ~l~~li~~cl~~dp~~RP----s~~~vl~  375 (432)
                      ++.+++.+||+.||.+||    ++.++++
T Consensus       224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         224 EGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             HHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            788999999999999998    4566554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.4e-40  Score=313.29  Aligned_cols=254  Identities=28%  Similarity=0.495  Sum_probs=198.8

Q ss_pred             hccccccccccCceeEEEEEe-CCCc----EEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGE----TVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      .+...+.||+|+||.||+|.. .+|.    .||+|.+.... ......+.+|+.+++.++||||++++++|... ..+++
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v   86 (303)
T cd05110           8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLV   86 (303)
T ss_pred             hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceee
Confidence            345567899999999999965 3444    47899886543 23344788999999999999999999998754 56799


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      ++|+++|+|.+++... ...+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.....
T Consensus        87 ~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          87 TQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             ehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCc
Confidence            9999999999998543 346899999999999999999999998   999999999999999999999999998754322


Q ss_pred             cc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          267 KH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       267 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ..   .....++..|+|||.+.+..++.++|||||||++|||++ |+.||.+..... ..........         .  
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~---------~--  230 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGER---------L--  230 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCC---------C--
Confidence            21   122345678999999998899999999999999999997 999997643211 1111111110         0  


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      ..+...+..+.+++..||..+|++||++.++++.|..+...
T Consensus       231 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         231 PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            01111234788999999999999999999999999987544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-41  Score=326.77  Aligned_cols=244  Identities=25%  Similarity=0.428  Sum_probs=199.4

Q ss_pred             ccccccccCceeEEEE-EeCCCcEEEEEEeccC----ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe--EEEEEE
Q 014038          116 FTTLIGQGAFGPVYKA-QMSTGETVAVKVLATD----SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ--HMLVYV  188 (432)
Q Consensus       116 ~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e  188 (432)
                      |..+||+|+|-+||+| +..+|-.||.-.++..    .....+.|..|+.+|+.|+||||++++.++.+...  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            4567999999999999 4457778886554432    34445789999999999999999999999987654  789999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC-CCcEEEeecCCcccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLSREEMVDK  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~-~~~~kl~Dfgl~~~~~~~~  267 (432)
                      .|..|+|..++.  ..+.++...+..|++||++||.|||++. |||||||||-+||+|+. .|.|||+|+|||..... .
T Consensus       124 L~TSGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~-s  199 (632)
T KOG0584|consen  124 LFTSGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK-S  199 (632)
T ss_pred             cccCCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc-c
Confidence            999999999994  4467889999999999999999999986 88999999999999965 58999999999986433 3


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ......|||-|||||... ..|++..||||||++++||+|+..||.......++......+..+          ..+..-
T Consensus       200 ~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP----------~sl~kV  268 (632)
T KOG0584|consen  200 HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP----------AALSKV  268 (632)
T ss_pred             ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH----------HHhhcc
Confidence            344478999999999887 889999999999999999999999998776655554444333211          001111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .-+++.+||.+|+.. .++|||+.|+|.
T Consensus       269 ~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  269 KDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            124899999999999 999999999986

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=9e-40  Score=303.10  Aligned_cols=248  Identities=33%  Similarity=0.549  Sum_probs=200.6

Q ss_pred             cccccccccCceeEEEEEeCC-----CcEEEEEEeccCChh-hHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          115 NFTTLIGQGAFGPVYKAQMST-----GETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .+.+.||.|+||.||++....     +..||+|.+...... ..+.+..|+..+..++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            356789999999999997643     388999999765433 56789999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+++++|.+++.......+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            999999999986544333899999999999999999999998   99999999999999999999999999875443311


Q ss_pred             cc--ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          269 AA--NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       269 ~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      ..  ...+++.|+|||.+....++.++||||||++++||++ |..||................            ....+
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~------------~~~~~  226 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY------------RLPKP  226 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC------------CCCCC
Confidence            11  2336789999999988889999999999999999998 888887533222111111110            01111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                      ...+.++.+++.+||..+|++|||+.++++.|
T Consensus       227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      227 ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            22445799999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.4e-40  Score=308.34  Aligned_cols=245  Identities=31%  Similarity=0.509  Sum_probs=196.6

Q ss_pred             cccccCceeEEEEEeCC-------CcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          119 LIGQGAFGPVYKAQMST-------GETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .||+|+||.||+|...+       +..+|+|.+.... ......+.+|+.+++.++||||++++++|...+..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            68999999999996532       2579999876543 234567899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC-----cEEEeecCCc
Q 014038          191 SKGSLASHLYDE-----NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-----RARVADFGLS  260 (432)
Q Consensus       191 ~~g~L~~~l~~~-----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~-----~~kl~Dfgl~  260 (432)
                      ++++|.+++...     ....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++     .++|+|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999998643     2234889999999999999999999988   99999999999999887     8999999998


Q ss_pred             ccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhc
Q 014038          261 REEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV  336 (432)
Q Consensus       261 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      .......   ......++..|+|||.+.+..++.++|||||||++|||++ |+.||................        
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--------  230 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG--------  230 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC--------
Confidence            6533221   1122345678999999998999999999999999999998 999997654332222111110        


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                          ....+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus       231 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 ----RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ----ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                01112233467899999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.7e-40  Score=312.24  Aligned_cols=258  Identities=24%  Similarity=0.365  Sum_probs=198.3

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~   86 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   86 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence            5667789999999999999654 68899999986543 233456788999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~  269 (432)
                      + ++|.+++... ...+++..+..++.|++.||.|||+.+   ++|+||||+|||++.++.+||+|||++....... ..
T Consensus        87 ~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (301)
T cd07873          87 D-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  161 (301)
T ss_pred             c-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence            7 5898887543 346899999999999999999999999   9999999999999999999999999987533222 22


Q ss_pred             cccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh----cCCCchhhhccc------
Q 014038          270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT----EGKTGWEEIVDS------  338 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~------  338 (432)
                      ....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..............    .....|..+...      
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY  241 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence            33457899999998765 4578999999999999999999999976443222211111    111112111110      


Q ss_pred             ---cCCCC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          339 ---RLDGI----FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       339 ---~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                         .....    .....+..+.+++.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               00000    00112347889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=7.6e-40  Score=303.70  Aligned_cols=247  Identities=23%  Similarity=0.356  Sum_probs=201.8

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      |.+.+.||+|+||.||++.. .+|+.||+|.+...  .....+++.+|+.++++++||||+++++++...+..++||||+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            56678999999999999954 47889999998643  2334567899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~  269 (432)
                      .+++|.+++.......+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  158 (256)
T cd08218          82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA  158 (256)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence            9999999886655556899999999999999999999998   9999999999999999999999999987543322 12


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....+++.|+|||.+.+..++.++|+|||||++++|++|+.||...............           . ....+...+
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~-----------~-~~~~~~~~~  226 (256)
T cd08218         159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-----------S-YPPVSSHYS  226 (256)
T ss_pred             hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC-----------C-CCCCcccCC
Confidence            2345788999999998888999999999999999999999999653322111111111           0 011122334


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .++.+++.+||+.+|.+||++.+|++
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         227 YDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             HHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            57899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.2e-40  Score=309.64  Aligned_cols=253  Identities=28%  Similarity=0.491  Sum_probs=202.0

Q ss_pred             HhccccccccccCceeEEEEEeC------CCcEEEEEEeccCChh-hHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  184 (432)
                      ..+...+.||+|+||.||+|+..      +.+.|++|.+...... ....+.+|+.++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            34556678999999999999753      3467999988654433 4567999999999999999999999999989999


Q ss_pred             EEEEeccCCChhhhcccCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeec
Q 014038          185 LVYVFMSKGSLASHLYDENY-------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADF  257 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Df  257 (432)
                      +||||+++|+|.+++.....       ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999864431       26899999999999999999999999   999999999999999999999999


Q ss_pred             CCcccccccc--cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhh
Q 014038          258 GLSREEMVDK--HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEE  334 (432)
Q Consensus       258 gl~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  334 (432)
                      |++.......  ......++..|+|||.+.+..++.++||||||+++|||++ |..||............. .....+  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~--  238 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ-AGKLEL--  238 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH-cCCcCC--
Confidence            9986432211  1223456778999999988889999999999999999999 888997644322222111 111111  


Q ss_pred             hccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                              ..+...+..+.+++.+||+.+|++||++.+++..|.
T Consensus       239 --------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         239 --------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                    111123357999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.9e-40  Score=311.14  Aligned_cols=263  Identities=28%  Similarity=0.465  Sum_probs=203.5

Q ss_pred             hccccccccccCceeEEEEEeC-----CCcEEEEEEeccCChh-hHHHHHHHHHHHhhcCCCccceEEeeeee--CCeEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-----TGETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHM  184 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  184 (432)
                      .+.+.+.||+|+||.||+|...     ++..+|||.+...... ..+.|.+|+.+++.++||||+++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4556688999999999999753     4678999999765443 46789999999999999999999999877  55789


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      ++|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        85 lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999996432 35999999999999999999999998   9999999999999999999999999987644


Q ss_pred             cccc----ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHH-HHHHhhhcC---CCchhhhc
Q 014038          265 VDKH----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV-ELAAMNTEG---KTGWEEIV  336 (432)
Q Consensus       265 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~-~~~~~~~~~---~~~~~~~~  336 (432)
                      ....    .....++..|+|||.+....++.++||||||+++|||++|+.|+....... ..... ...   ...+.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  239 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLLELL  239 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHHHHH
Confidence            2211    112234567999999988899999999999999999999999986432110 00000 000   00011111


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      ........+...+.++.+++.+||+.+|++||++.+|+++|+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11111112223346899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.5e-39  Score=304.16  Aligned_cols=249  Identities=24%  Similarity=0.384  Sum_probs=189.8

Q ss_pred             cccccCceeEEEEEeCCC---cEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCC
Q 014038          119 LIGQGAFGPVYKAQMSTG---ETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS  194 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  194 (432)
                      .||+|+||.||+|...++   ..+++|.+.... ....+.|.+|+.+++.++||||++++++|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999965433   346677765443 3445689999999999999999999999999999999999999999


Q ss_pred             hhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc---ccc
Q 014038          195 LASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD---KHA  269 (432)
Q Consensus       195 L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~---~~~  269 (432)
                      |.+++....  ...+++..+..++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||++......   ...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999986532  234677788899999999999999998   999999999999999999999999997542221   112


Q ss_pred             cccccCCCCCCcccccc-------CCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCC
Q 014038          270 ANIRGTFGYLDPEYIST-------RNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ....++..|+|||++..       ..++.++|||||||++|||++ |..||....+............   ..+.++...
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~  235 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ---VKLFKPQLE  235 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcc---cccCCCccC
Confidence            34567889999998743       245789999999999999997 5778865443322222111111   112222222


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                      ..    ....+.+++..|| .+|++||++.+|++.|.
T Consensus       236 ~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         236 LP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            22    2346788999999 67999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.8e-40  Score=306.74  Aligned_cols=244  Identities=27%  Similarity=0.466  Sum_probs=195.2

Q ss_pred             ccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCChh
Q 014038          118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLA  196 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  196 (432)
                      ..||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++|+||+++++++...+..++++||+++++|.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence            5799999999999964 467889999987766666778999999999999999999999999999999999999999999


Q ss_pred             hhcccCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC-CCcEEEeecCCccccccc-cccccc
Q 014038          197 SHLYDENYGPL--TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLSREEMVD-KHAANI  272 (432)
Q Consensus       197 ~~l~~~~~~~l--~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~-~~~~kl~Dfgl~~~~~~~-~~~~~~  272 (432)
                      +++.... .++  ++..+..++.||+.||+|||+.+   |+||||||+||+++. ++.++|+|||++...... ......
T Consensus        94 ~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  169 (268)
T cd06624          94 ALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF  169 (268)
T ss_pred             HHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccC
Confidence            9986432 345  78889999999999999999998   999999999999976 679999999998654322 222334


Q ss_pred             ccCCCCCCccccccC--CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHH
Q 014038          273 RGTFGYLDPEYISTR--NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN  350 (432)
Q Consensus       273 ~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (432)
                      .+++.|+|||.+...  .++.++||||||+++|||++|+.||..............         . .......+.....
T Consensus       170 ~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~---------~-~~~~~~~~~~~~~  239 (268)
T cd06624         170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG---------M-FKIHPEIPESLSA  239 (268)
T ss_pred             CCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh---------h-hccCCCCCcccCH
Confidence            578999999998654  378999999999999999999999965322111000000         0 0011112233445


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          351 EVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       351 ~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ++.+++.+||+.+|.+|||+.++++
T Consensus       240 ~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         240 EAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHHh
Confidence            7899999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-40  Score=314.17  Aligned_cols=249  Identities=27%  Similarity=0.353  Sum_probs=201.2

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|++.+.||+|+||.||+|... +++.||+|.+.....   ...+.+.+|+++++.++||||+++++.+......++|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            3566788999999999999654 589999999876432   244678899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-  267 (432)
                      |+.+++|.+++.......+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            999999999987655567999999999999999999999998   9999999999999999999999999876432111 


Q ss_pred             -----------------------------cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHH
Q 014038          268 -----------------------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEY  318 (432)
Q Consensus       268 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~  318 (432)
                                                   ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence                                         111245788999999999888999999999999999999999999765443


Q ss_pred             HHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 014038          319 VELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPS----MRDIVQ  375 (432)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~~~vl~  375 (432)
                      .......           .....-......+.++.+++.+||+.||++||+    +.+++.
T Consensus       239 ~~~~~~~-----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         239 ETFSNIL-----------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHHHHHh-----------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            2222211           111111111114468999999999999999999    555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.3e-40  Score=307.10  Aligned_cols=251  Identities=22%  Similarity=0.401  Sum_probs=199.5

Q ss_pred             ccccccccccCceeEEEEEeCC--CcEEEEEEeccC----------ChhhHHHHHHHHHHHhh-cCCCccceEEeeeeeC
Q 014038          114 CNFTTLIGQGAFGPVYKAQMST--GETVAVKVLATD----------SKQGEKEFQTEVMLLGR-LHHRNLVNLVGYCAEK  180 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~  180 (432)
                      |.+.+.||+|+||.||+|....  ++.+|+|.+...          ......++..|+.++.+ ++||||+++++++...
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            4556789999999999997654  688999987532          12233457788888875 6999999999999999


Q ss_pred             CeEEEEEEeccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCeeecCCCcEEEeec
Q 014038          181 GQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADF  257 (432)
Q Consensus       181 ~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlkp~Nill~~~~~~kl~Df  257 (432)
                      +..+++|||+++++|.+++..  .....+++..++.++.|++.||.|||+ .+   ++|+||+|+||+++.++.+||+||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecc
Confidence            999999999999999988743  234568999999999999999999996 56   999999999999999999999999


Q ss_pred             CCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcc
Q 014038          258 GLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD  337 (432)
Q Consensus       258 gl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      |++.............++..|+|||.+.+..++.++||||||+++|||++|+.||...............          
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----------  228 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA----------  228 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhc----------
Confidence            9987644433334566889999999999888999999999999999999999999654322111111111          


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          338 SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       338 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                       ..........+..+.+++.+||+.||++||++.++..+++
T Consensus       229 -~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 -VYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -cCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence             1111111122357899999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-40  Score=320.68  Aligned_cols=255  Identities=24%  Similarity=0.318  Sum_probs=193.4

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeC------Ce
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQ  182 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  182 (432)
                      ..|.+.+.||+|+||.||+|.. .+++.||||.+....  ......+.+|+.++++++||||+++++++...      ..
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            3566778999999999999964 578899999986532  23345678899999999999999999987543      35


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .+++++++ +++|.+++.   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        95 ~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  167 (343)
T cd07878          95 VYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ  167 (343)
T ss_pred             EEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcccee
Confidence            68999988 778988774   246999999999999999999999999   99999999999999999999999999875


Q ss_pred             ccccccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcc----
Q 014038          263 EMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD----  337 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----  337 (432)
                      ...  ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......+............+...    
T Consensus       168 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         168 ADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             cCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence            432  2334578999999999876 578999999999999999999999997643322222111100000000000    


Q ss_pred             -------ccCCCCCCH-------HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          338 -------SRLDGIFDV-------EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       338 -------~~~~~~~~~-------~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                             ..+......       .....+.+++.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   000000000       11235789999999999999999999986

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.6e-40  Score=308.57  Aligned_cols=250  Identities=25%  Similarity=0.427  Sum_probs=198.8

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .+++.+.||+|+||.||++... ++..||+|.+... .......+.+|+.++++++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            3567789999999999999765 7899999988654 3333467889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          191 SKGSLASHLYDEN-YGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       191 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      ++++|..++.... ...+++..+..++.|++.||.|||+ .+   ++|+||||+||+++.++.+||+|||++..... ..
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~  157 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-SL  157 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccC-Cc
Confidence            9999998885431 3468999999999999999999997 46   99999999999999999999999999865422 22


Q ss_pred             ccccccCCCCCCccccccC------CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          269 AANIRGTFGYLDPEYISTR------NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .....+++.|+|||.+.+.      .++.++|+|||||++|||++|+.||............        ..+... ...
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~--------~~~~~~-~~~  228 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL--------SAIVDG-DPP  228 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH--------HHHhhc-CCC
Confidence            3344678899999998544      3588999999999999999999999653221111110        011111 111


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+...+.++.+++.+||+.+|++||++.+++.
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         229 TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            122335568899999999999999999999886

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.3e-39  Score=312.01  Aligned_cols=191  Identities=25%  Similarity=0.400  Sum_probs=157.7

Q ss_pred             ccccccCceeEEEEEeC---CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeee--CCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQMS---TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  192 (432)
                      ++||+|+||.||+|...   +++.||+|.+....  ....+.+|+.++++++||||+++++++..  ....+++|||+. 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            57999999999999754   56789999986432  23457789999999999999999998854  456889999986 


Q ss_pred             CChhhhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee----cCCCcEEEeecCCcc
Q 014038          193 GSLASHLYDE-------NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL----DQSMRARVADFGLSR  261 (432)
Q Consensus       193 g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill----~~~~~~kl~Dfgl~~  261 (432)
                      ++|.+++...       ....+++..+..++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            4787766421       2235899999999999999999999999   9999999999999    456789999999997


Q ss_pred             ccccc----ccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCC
Q 014038          262 EEMVD----KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQG  314 (432)
Q Consensus       262 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~  314 (432)
                      .....    .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            54322    12234578999999999876 4689999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=324.68  Aligned_cols=248  Identities=25%  Similarity=0.393  Sum_probs=207.8

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +++...||.|+||.||+|..+ ++-..|.|++...+....++|+-|+.+|...+||+||+|++.|...+.++++.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            445567999999999999655 4455678888888888889999999999999999999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAAN  271 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~~~~~  271 (432)
                      |-....+..- ..+|++.++..+++|++.||.|||+++   |||||||..|||++-+|.++|+|||++..... ......
T Consensus       114 GAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs  189 (1187)
T KOG0579|consen  114 GAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS  189 (1187)
T ss_pred             chHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence            9998877543 457999999999999999999999999   99999999999999999999999999864332 234567


Q ss_pred             cccCCCCCCcccc-----ccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          272 IRGTFGYLDPEYI-----STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       272 ~~gt~~y~aPE~~-----~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      +.|||.|||||+.     ...+|+.++|||||||+|.||..+.+|.........+..+......        .+.  -|.
T Consensus       190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePP--------TLl--qPS  259 (1187)
T KOG0579|consen  190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP--------TLL--QPS  259 (1187)
T ss_pred             ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCC--------ccc--Ccc
Confidence            8899999999986     3568999999999999999999999998876655555444332221        111  133


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+..+.+|+.+||.+||+.||++.++++
T Consensus       260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            44568999999999999999999999876

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-41  Score=325.12  Aligned_cols=247  Identities=26%  Similarity=0.440  Sum_probs=208.6

Q ss_pred             cccccccccCceeEEEEEeC--CCc--EEEEEEeccCChh-hHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          115 NFTTLIGQGAFGPVYKAQMS--TGE--TVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      .+.++||+|+||.|++|.|.  +|+  .||||.++.+... ...+|.+|+.+|.+|+|||+++|||+..+ ....+|||.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            34578999999999999664  454  5899999887544 56799999999999999999999999887 678899999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA  269 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  269 (432)
                      ++.|+|.+.|++.....|.......++.|||.||.||.+++   +|||||..+|+||.....||||||||.+........
T Consensus       192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            99999999998866677888999999999999999999999   999999999999999999999999999865544332


Q ss_pred             c----ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCC
Q 014038          270 A----NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       270 ~----~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                      .    .......|+|||.++.+.|+.++|||+|||+||||+| |+.||.+......+..+..            .-+-.-
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~------------~erLpR  336 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA------------GERLPR  336 (1039)
T ss_pred             eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc------------cccCCC
Confidence            2    2234568999999999999999999999999999999 8999998776655544431            112223


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                      +..+++++++++..||..+|.+||||..|.+.+
T Consensus       337 Pk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  337 PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             CCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            455677999999999999999999999997543

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.5e-40  Score=319.12  Aligned_cols=191  Identities=24%  Similarity=0.393  Sum_probs=164.4

Q ss_pred             HHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ...|.+.+.||+|+||.||+|... +++.||+|.....      ....|+.++++++||||+++++++...+..++||||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            345778899999999999999654 5678999975332      235689999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA  269 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  269 (432)
                      +. ++|.+++.. ...++++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       139 ~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        139 YS-SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             cC-CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence            95 688888754 3457999999999999999999999999   999999999999999999999999998754433344


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCC
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL  312 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~  312 (432)
                      ....||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            4567899999999999999999999999999999999865544

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.9e-39  Score=326.87  Aligned_cols=256  Identities=23%  Similarity=0.372  Sum_probs=189.9

Q ss_pred             HHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCC------CccceEEeeeeeC-Ce
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH------RNLVNLVGYCAEK-GQ  182 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~-~~  182 (432)
                      ...|.+.+.||+|+||+||+|.. .+++.||||++.... .....+..|+.+++.++|      .+++++++++... ..
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            34677788999999999999965 467899999986432 223345667777776654      4588898888764 46


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCeeecCCC-----------
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSM-----------  250 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlkp~Nill~~~~-----------  250 (432)
                      .++||+++ +++|.+++..  .+.+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++           
T Consensus       207 ~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             EEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccccccc
Confidence            88899988 6788888854  3579999999999999999999998 47   99999999999998765           


Q ss_pred             -----cEEEeecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhh
Q 014038          251 -----RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMN  325 (432)
Q Consensus       251 -----~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~  325 (432)
                           .+||+|||++....  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+......+..+.
T Consensus       281 ~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  358 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME  358 (467)
T ss_pred             CCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence                 49999999876422  22345679999999999999999999999999999999999999998654433222211


Q ss_pred             hcCC---Cchh---------hhcccc--CCCCCC---------------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          326 TEGK---TGWE---------EIVDSR--LDGIFD---------------VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       326 ~~~~---~~~~---------~~~~~~--~~~~~~---------------~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ....   ..|.         .+++..  +.....               ......+.+|+.+||+.||++|||+.|+++
T Consensus       359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            1100   0000         000000  000000               011246789999999999999999999986

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1e-39  Score=304.45  Aligned_cols=252  Identities=27%  Similarity=0.409  Sum_probs=202.9

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .|++.+.||.|+||+||+|.. .++..+|+|.+.... ......+.+|+..++.++|+|++++++.+...+..+++|||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   81 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL   81 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence            356778999999999999964 467899999986543 234578899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc-
Q 014038          191 SKGSLASHLYDENY-GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH-  268 (432)
Q Consensus       191 ~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-  268 (432)
                      ++++|.+++..... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            99999999865433 56899999999999999999999999   99999999999999999999999999865433222 


Q ss_pred             ----ccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCC
Q 014038          269 ----AANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       269 ----~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                          .....++..|+|||.+... .++.++|+|||||++|||++|+.||.................        +.....
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~  230 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP--------PSLETG  230 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC--------CCcCCc
Confidence                1334688999999998776 789999999999999999999999976543322222111111        011111


Q ss_pred             C-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          344 F-DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       344 ~-~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      . ....+.++.+++.+||+.||++||++.++++
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            1 1123457899999999999999999999885

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.6e-39  Score=303.56  Aligned_cols=245  Identities=26%  Similarity=0.451  Sum_probs=194.0

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-----hhhHHHHHHHHHHHhhcCCCccceEEeeeee--CCeEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-----KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHML  185 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  185 (432)
                      |...+.||+|+||.||+|.. .++..||+|.+....     ......+.+|+.++++++||||+++++++.+  ....++
T Consensus         4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   83 (266)
T cd06651           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI   83 (266)
T ss_pred             ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence            45567899999999999965 468899999886432     2234568899999999999999999998875  357889


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      +|||+++++|.+++...  ..+++.....++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++.....
T Consensus        84 ~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          84 FMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            99999999999998543  45899999999999999999999998   99999999999999999999999999875322


Q ss_pred             c----ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCC
Q 014038          266 D----KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       266 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      .    .......++..|+|||.+.+..++.++|||||||++|||++|+.||................           ..
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~-----------~~  227 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP-----------TN  227 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC-----------CC
Confidence            1    11223457889999999998889999999999999999999999997654332222111110           11


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...+......+.+++ +||..+|++||++++|++
T Consensus       228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         228 PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            122223334667777 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-39  Score=318.69  Aligned_cols=259  Identities=24%  Similarity=0.334  Sum_probs=197.9

Q ss_pred             HHHHHHhccccccccccCceeEEEEEeC---CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeE
Q 014038          107 KDLQKATCNFTTLIGQGAFGPVYKAQMS---TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH  183 (432)
Q Consensus       107 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  183 (432)
                      ..+...+|.+.+.||+|+||.||++...   .+..||+|.+...     ..+.+|+.+++.++||||+++++++......
T Consensus        87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            3444557888899999999999999643   4578999987543     2456899999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      +++||++. ++|.+++  .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       162 ~lv~e~~~-~~l~~~l--~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        162 CMVMPKYK-CDLFTYV--DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEEehhcC-CCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            99999995 6888888  33467999999999999999999999999   999999999999999999999999998754


Q ss_pred             cccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhH---HHHHHHhh---hcCC-----
Q 014038          264 MVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME---YVELAAMN---TEGK-----  329 (432)
Q Consensus       264 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~---~~~~~~~~---~~~~-----  329 (432)
                      ....   ......||+.|+|||++....++.++|||||||++|||++|+.||.+...   ...+....   ....     
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            3222   22345799999999999999999999999999999999999999965321   01111100   0000     


Q ss_pred             ---Cchhh-h--ccccCCCCCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          330 ---TGWEE-I--VDSRLDGIFD-------VEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       330 ---~~~~~-~--~~~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                         ..+.. +  .....+..+.       .....++.+++.+||..||++||++.+++..
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence               00000 0  0000011010       0123468899999999999999999999864

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.1e-40  Score=309.83  Aligned_cols=243  Identities=26%  Similarity=0.423  Sum_probs=198.7

Q ss_pred             ccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCChh
Q 014038          118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLA  196 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  196 (432)
                      ..||+|+||.||++.. .++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|.
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT  107 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence            5699999999999965 468899999987655555677899999999999999999999999999999999999999999


Q ss_pred             hhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cccccccC
Q 014038          197 SHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRGT  275 (432)
Q Consensus       197 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~~gt  275 (432)
                      +++..   ..+++..+..++.||+.||.|||+.+   ++||||||+||++++++.++|+|||++....... ......++
T Consensus       108 ~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~  181 (292)
T cd06658         108 DIVTH---TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGT  181 (292)
T ss_pred             HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecC
Confidence            98743   35899999999999999999999998   9999999999999999999999999986432221 22345688


Q ss_pred             CCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHH
Q 014038          276 FGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASL  355 (432)
Q Consensus       276 ~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  355 (432)
                      ..|+|||.+.+..++.++||||||+++|||++|+.||...............        ..+....  ....+..+.++
T Consensus       182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~--~~~~~~~~~~l  251 (292)
T cd06658         182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN--------LPPRVKD--SHKVSSVLRGF  251 (292)
T ss_pred             ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--------CCCcccc--ccccCHHHHHH
Confidence            9999999998888999999999999999999999999764433222221111        1111111  11223478899


Q ss_pred             HHHhhccCCCCCCCHHHHHHH
Q 014038          356 AYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       356 i~~cl~~dp~~RPs~~~vl~~  376 (432)
                      +.+||..||.+|||+.++++.
T Consensus       252 i~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         252 LDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HHHHccCChhHCcCHHHHhhC
Confidence            999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-40  Score=315.46  Aligned_cols=252  Identities=23%  Similarity=0.326  Sum_probs=194.1

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||++.. .+++.||+|++...   .....+.+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            456778999999999999975 46899999998642   22334568899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+++|+|.+++... ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          82 YYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             cCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            99999999998542 346899999999999999999999999   99999999999999999999999999865432221


Q ss_pred             --ccccccCCCCCCcccccc-----CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCC
Q 014038          269 --AANIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       269 --~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                        .....||+.|+|||++..     ..++.++|||||||++|||++|+.||................ ..+      .+.
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~------~~~  230 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-EHF------QFP  230 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC-Ccc------cCC
Confidence              223468999999999863     457889999999999999999999997643322211111100 000      000


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCC--CCCCCHHHHHHH
Q 014038          342 GIFDVEELNEVASLAYKCVNRAP--RKRPSMRDIVQV  376 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp--~~RPs~~~vl~~  376 (432)
                      . .....+..+.+++.+|+..++  ..||++.++++.
T Consensus       231 ~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         231 P-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             C-ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0 011134567888888775433  347899888864

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-39  Score=309.46  Aligned_cols=243  Identities=23%  Similarity=0.382  Sum_probs=198.4

Q ss_pred             ccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCChh
Q 014038          118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLA  196 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  196 (432)
                      ..||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++..++||||+++++++..++..+++|||+++++|.
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~  106 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT  106 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence            4799999999999965 478999999987655455667889999999999999999999999999999999999999999


Q ss_pred             hhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cccccccC
Q 014038          197 SHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRGT  275 (432)
Q Consensus       197 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~~gt  275 (432)
                      .++..   ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....... ......++
T Consensus       107 ~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~  180 (297)
T cd06659         107 DIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT  180 (297)
T ss_pred             HHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecC
Confidence            87743   45899999999999999999999999   9999999999999999999999999986433221 22345688


Q ss_pred             CCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHH
Q 014038          276 FGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASL  355 (432)
Q Consensus       276 ~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  355 (432)
                      ..|+|||.+.+..++.++|||||||++|||++|+.||...................+        .  .....+..+.++
T Consensus       181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------~--~~~~~~~~l~~~  250 (297)
T cd06659         181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL--------K--NAHKISPVLRDF  250 (297)
T ss_pred             ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCc--------c--ccCCCCHHHHHH
Confidence            999999999988899999999999999999999999975443322222211110000        0  011123468899


Q ss_pred             HHHhhccCCCCCCCHHHHHHH
Q 014038          356 AYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       356 i~~cl~~dp~~RPs~~~vl~~  376 (432)
                      +.+||+.+|++||++.++++.
T Consensus       251 i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         251 LERMLTREPQERATAQELLDH  271 (297)
T ss_pred             HHHHhcCCcccCcCHHHHhhC
Confidence            999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.5e-39  Score=306.82  Aligned_cols=250  Identities=27%  Similarity=0.397  Sum_probs=195.6

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeee-----eCCeEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCA-----EKGQHML  185 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~~~~~l  185 (432)
                      +|.+.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +||||+++++++.     .++..++
T Consensus        19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   97 (286)
T cd06638          19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL   97 (286)
T ss_pred             ceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence            556778899999999999965 467899999875432 2235678899999999 6999999999874     3457899


Q ss_pred             EEEeccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          186 VYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ||||+++++|.+++..  .....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~  174 (286)
T cd06638          98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQL  174 (286)
T ss_pred             EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeec
Confidence            9999999999988753  23456899999999999999999999998   999999999999999999999999998754


Q ss_pred             cccc-cccccccCCCCCCcccccc-----CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcc
Q 014038          264 MVDK-HAANIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD  337 (432)
Q Consensus       264 ~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      .... ......|++.|+|||.+..     ..++.++|||||||++|||++|+.||.................   .... 
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~-  250 (286)
T cd06638         175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP---PTLH-  250 (286)
T ss_pred             ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC---Cccc-
Confidence            3222 2234568999999998753     4578999999999999999999999976543322222111100   0000 


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          338 SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       338 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                            .+......+.+++.+||+.||++|||+.++++.
T Consensus       251 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         251 ------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence                  011123478999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1e-39  Score=307.34  Aligned_cols=249  Identities=26%  Similarity=0.440  Sum_probs=197.6

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeee------CCeE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE------KGQH  183 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~  183 (432)
                      ..|.+.+.||.|+||.||+|.. .+++.+|+|.+.... .....+..|+.++.++ +|+||+++++++..      ....
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            3556678999999999999965 568899999986543 3345688899999998 79999999999853      4578


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      +++|||+++|+|.+++.......+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++...
T Consensus        95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            99999999999999987655567899999999999999999999999   999999999999999999999999998653


Q ss_pred             ccc-ccccccccCCCCCCccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcc
Q 014038          264 MVD-KHAANIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD  337 (432)
Q Consensus       264 ~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      ... .......+++.|+|||.+.     ...++.++|||||||++|||++|+.||...............          
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~----------  241 (282)
T cd06636         172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN----------  241 (282)
T ss_pred             hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC----------
Confidence            321 2233456899999999875     346888999999999999999999999754332222111110          


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          338 SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       338 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                       ..........+.++.+++.+||+.||.+||++.++++
T Consensus       242 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         242 -PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             -CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence             0011111123457999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.1e-40  Score=326.07  Aligned_cols=252  Identities=20%  Similarity=0.272  Sum_probs=190.4

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .|.+.+.||+|+||.||+|... .++.||||...      ...+.+|+++|++++|+||+++++++...+..++||+++.
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~  243 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR  243 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence            4667789999999999999654 57899999642      2345689999999999999999999999999999999995


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc---c
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---H  268 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~---~  268 (432)
                       ++|..++... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......   .
T Consensus       244 -~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        244 -SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             -CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence             6888887543 347999999999999999999999999   9999999999999999999999999987532221   1


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhH-------HHHHHHhhhcCC---Cchhh----
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME-------YVELAAMNTEGK---TGWEE----  334 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~-------~~~~~~~~~~~~---~~~~~----  334 (432)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..|+.....       ...+..+.....   ..+..    
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~  398 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS  398 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence            2245699999999999999999999999999999999998765422110       011111111000   00000    


Q ss_pred             -----hcc---ccCCCCCC----H---HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 -----IVD---SRLDGIFD----V---EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 -----~~~---~~~~~~~~----~---~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                           ...   ........    .   .....+.+|+.+||+.||.+|||+.|+++
T Consensus       399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence                 000   00000000    0   11236889999999999999999999986

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-39  Score=307.55  Aligned_cols=258  Identities=25%  Similarity=0.333  Sum_probs=198.6

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      |+..+.||.|++|.||+|.. .+|+.||||.+....  ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            45667899999999999965 478999999886542  223357889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~  269 (432)
                      . ++|..++.......+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++....... ..
T Consensus        82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  157 (284)
T cd07860          82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY  157 (284)
T ss_pred             c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence            6 68988887655677999999999999999999999998   9999999999999999999999999986543221 22


Q ss_pred             cccccCCCCCCccccccCC-CCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhh-------------
Q 014038          270 ANIRGTFGYLDPEYISTRN-FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEI-------------  335 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------  335 (432)
                      ....+++.|+|||.+.+.. ++.++||||||+++|||+||+.||....+..................             
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            3345688999999886544 68899999999999999999999976544333322211111000000             


Q ss_pred             ccccCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 VDSRLDGI---FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 ~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +.......   .......++.+++.+||+.||++||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00000000   00112356889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.1e-39  Score=308.06  Aligned_cols=250  Identities=25%  Similarity=0.399  Sum_probs=193.5

Q ss_pred             ccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcC-CCccceEEeeeeeCCeEEEEEEeccC
Q 014038          116 FTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       116 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +.+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||+..
T Consensus         8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~   87 (288)
T cd06616           8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI   87 (288)
T ss_pred             HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence            446799999999999964 468999999987543 334567889999999996 99999999999999999999999864


Q ss_pred             CChhhh---cccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          193 GSLASH---LYDENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       193 g~L~~~---l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                       ++.++   +.......+++..+..++.|++.||+|||+. +   ++||||||+||+++.++.+||+|||++........
T Consensus        88 -~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  163 (288)
T cd06616          88 -SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA  163 (288)
T ss_pred             -CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence             55443   3333346799999999999999999999975 6   99999999999999999999999999875433333


Q ss_pred             ccccccCCCCCCccccccC---CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          269 AANIRGTFGYLDPEYISTR---NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      .....++..|+|||.+...   .++.++|||||||++|||++|+.||.................       .+.+.....
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~  236 (288)
T cd06616         164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD-------PPILSNSEE  236 (288)
T ss_pred             cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCC-------CCcCCCcCC
Confidence            3344688999999998765   689999999999999999999999975432111111100000       011111111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ...+.++.+++.+||+.+|++|||+.+|+..
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         237 REFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            2345679999999999999999999998863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.5e-39  Score=302.72  Aligned_cols=247  Identities=26%  Similarity=0.389  Sum_probs=200.2

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeee--CCeEEEEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHMLVYV  188 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  188 (432)
                      |++.+.||.|+||.||++.. .+++.||+|.+...  .....+.+..|+.+++.++||||+++++++..  ....+++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            45668899999999999954 57889999998653  33445678899999999999999999998754  456799999


Q ss_pred             eccCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          189 FMSKGSLASHLYDE--NYGPLTWNLRVHIALDVARGLEYLH-----DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       189 ~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH-----~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                      |+++++|.+++...  ...++++..++.++.|++.||.|||     +.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~  158 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAK  158 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccc
Confidence            99999999988542  2467999999999999999999999     666   9999999999999999999999999987


Q ss_pred             ccccccc-ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          262 EEMVDKH-AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       262 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ....... .....+++.|+|||.+....++.++|+||||+++|+|++|+.||...... ........           ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~-----------~~  226 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-QLASKIKE-----------GK  226 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-HHHHHHhc-----------CC
Confidence            6544332 34456899999999999888999999999999999999999999765321 11111111           11


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ....+...+..+.+++.+||+.+|++||++.+|++
T Consensus       227 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         227 FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            11223334568999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.8e-39  Score=308.18  Aligned_cols=257  Identities=26%  Similarity=0.356  Sum_probs=198.3

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCChh-----hHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQ-----GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      |++.+.||+|+||.||+|.. .+|+.||||.+......     ....+..|+.++++++|+||+++++++.+.+..++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            45667899999999999975 46899999998754322     2346778999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-  266 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-  266 (432)
                      ||+ +|+|.+++.... ..+++..+..++.||++||.|||+++   ++|+||+|+||+++.++.++|+|||++...... 
T Consensus        82 e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          82 EFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             ccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            999 899999986433 47999999999999999999999999   999999999999999999999999998754332 


Q ss_pred             ccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcC----CCchh------hh
Q 014038          267 KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG----KTGWE------EI  335 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~------~~  335 (432)
                      .......+++.|+|||.+.+ ..++.++|||||||++|||++|..||.+..+...........    ...+.      ..
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (298)
T cd07841         157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY  236 (298)
T ss_pred             ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence            12233456788999998854 467899999999999999999988887644433222211100    00000      00


Q ss_pred             ccccCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 VDSRLDGIFD-----VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 ~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .........+     ...+.++.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            0000000111     122467899999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-40  Score=309.36  Aligned_cols=246  Identities=25%  Similarity=0.407  Sum_probs=209.9

Q ss_pred             hccccccccccCceeEEEEE-eCCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      -|++.+.||+|.|+.|-+|+ .-+|..||||++.+..  ......+..|++.|+-++|||||++|.+......+|||.|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            46677889999999999994 4589999999997653  33345788999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee-cCCCcEEEeecCCccccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL-DQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill-~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      -++|+|.+++-... ..+.+..+.+++.||+.|+.|+|+..   ++||||||+||.+ ..-|-+||.|||++.....+..
T Consensus        99 GD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k  174 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK  174 (864)
T ss_pred             cCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence            99999999996543 45899999999999999999999999   9999999999976 5668899999999988777778


Q ss_pred             ccccccCCCCCCccccccCCCC-chhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ..+.+|+..|-|||++.+..|+ ++.||||||||||-|++|+.||+...+...+..+           +|=.  -..|.-
T Consensus       175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI-----------mDCK--YtvPsh  241 (864)
T KOG4717|consen  175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI-----------MDCK--YTVPSH  241 (864)
T ss_pred             hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh-----------hccc--ccCchh
Confidence            8899999999999999999887 6899999999999999999999876554333222           2211  113445


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+.+..+||..||..||.+|.+.++|..
T Consensus       242 vS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  242 VSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            5678999999999999999999999875

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.2e-39  Score=302.45  Aligned_cols=251  Identities=29%  Similarity=0.495  Sum_probs=196.8

Q ss_pred             cccccccccCceeEEEEEeC----CCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC------e
Q 014038          115 NFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG------Q  182 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  182 (432)
                      .+.+.||+|+||.||+|...    +++.||||.+...  .....+++.+|+.+++.++||||+++++++....      .
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            45678999999999999643    4678999998654  2344567889999999999999999999886532      3


Q ss_pred             EEEEEEeccCCChhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecC
Q 014038          183 HMLVYVFMSKGSLASHLYDE----NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFG  258 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg  258 (432)
                      .+++++|+.+|+|..++...    ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECccc
Confidence            47889999999998877432    2235789999999999999999999998   9999999999999999999999999


Q ss_pred             Ccccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhh
Q 014038          259 LSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEE  334 (432)
Q Consensus       259 l~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  334 (432)
                      +++......   ......+++.|++||.+....++.++||||||+++|||++ |+.||.+...............     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-----  233 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR-----  233 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc-----
Confidence            987543221   1123345678999999988889999999999999999999 8999876543221111111100     


Q ss_pred             hccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                           +  ..+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       234 -----~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 -----L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -----C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                 0  01112335799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.3e-39  Score=301.87  Aligned_cols=246  Identities=24%  Similarity=0.435  Sum_probs=200.6

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .|.+.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++.+++||||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            455667899999999999965 478899999876432 334467889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~  269 (432)
                      ++++|.+++..   ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06641          85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence            99999998843   46899999999999999999999998   9999999999999999999999999986543221 22


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....++..|+|||.+.+..++.++|+|||||++|+|++|..||................            ....+...+
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------~~~~~~~~~  226 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN------------PPTLEGNYS  226 (277)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC------------CCCCCcccC
Confidence            33467889999999988889999999999999999999999997644322211111110            111122234


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      .++.+++.+||+.+|.+||++.++++.
T Consensus       227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         227 KPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            578899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.2e-39  Score=300.46  Aligned_cols=245  Identities=26%  Similarity=0.438  Sum_probs=195.8

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-----hhhHHHHHHHHHHHhhcCCCccceEEeeeeeC--CeEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-----KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHML  185 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  185 (432)
                      |.+.+.||+|+||.||+|.. .++..||+|.+....     ....+.+.+|+.++++++||||+++++++.+.  ...++
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI   83 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence            45678999999999999965 468999999885431     22345788999999999999999999988763  46789


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      +|||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          84 FMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             EEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence            99999999999988533  45889999999999999999999999   99999999999999999999999999874321


Q ss_pred             c----ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCC
Q 014038          266 D----KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       266 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      .    .......++..|+|||.+.+..++.++|||||||++|||++|+.||...............           ...
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-----------~~~  227 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ-----------PTN  227 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC-----------CCC
Confidence            1    1223346889999999998888999999999999999999999999764333222211111           111


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...+......+.+++.+||. +|++||++++|++
T Consensus       228 ~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         228 PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            22334445678899999995 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.7e-39  Score=302.79  Aligned_cols=250  Identities=26%  Similarity=0.452  Sum_probs=196.4

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCCh----------hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK----------QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  182 (432)
                      |...+.||.|+||.||+|.. .+|+.+|+|.+.....          ...+.+.+|+.+++.++|||++++++++...+.
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            34457899999999999954 4789999998753211          112467889999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .++||||+++++|.+++...  +.+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++..
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             eEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccc
Confidence            99999999999999998543  57999999999999999999999998   99999999999999999999999999875


Q ss_pred             ccccc---cccccccCCCCCCccccccCC--CCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcc
Q 014038          263 EMVDK---HAANIRGTFGYLDPEYISTRN--FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD  337 (432)
Q Consensus       263 ~~~~~---~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      .....   ......++..|+|||.+....  ++.++|+||||+++|||++|..||.................       .
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~  230 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS-------A  230 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc-------C
Confidence            33211   123346789999999987654  88999999999999999999999965433222211110000       0


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          338 SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       338 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...........+.++.+++.+||+.+|++||++.+|++
T Consensus       231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         231 PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            00111111123468999999999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1e-39  Score=304.32  Aligned_cols=247  Identities=28%  Similarity=0.455  Sum_probs=200.3

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      +++.+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++++++||||+++++++...+..++++||++
T Consensus         3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (265)
T cd06605           3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD   82 (265)
T ss_pred             chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence            456678999999999999765 68999999987653 3445678999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  270 (432)
                      +++|.+++.... ..+++..+..++.|++.||+|||+ .+   ++|+||||+||++++++.++|+|||.+........ .
T Consensus        83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~  157 (265)
T cd06605          83 GGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-K  157 (265)
T ss_pred             CCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-h
Confidence            999999986433 678999999999999999999999 88   99999999999999999999999999865432221 2


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChh----HHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM----EYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|+.||....    .......          .............
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~  227 (265)
T cd06605         158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ----------YIVNEPPPRLPSG  227 (265)
T ss_pred             cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHH----------HHhcCCCCCCChh
Confidence            2678899999999998899999999999999999999999996542    1111110          0111111111111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.++.+++.+||..+|++|||+.+++.
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         228 KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            14457899999999999999999999885

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.2e-39  Score=312.25  Aligned_cols=252  Identities=21%  Similarity=0.308  Sum_probs=195.3

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+++.. +++.||+|.+...   .......+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            3567789999999999999654 6789999998642   22233457889999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+++|+|.+++... ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        82 y~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          82 YYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             CCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            99999999999642 346899999999999999999999999   99999999999999999999999999875433221


Q ss_pred             --ccccccCCCCCCcccccc-----CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCC
Q 014038          269 --AANIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       269 --~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                        .....||+.|+|||++.+     +.++.++|||||||++|||++|+.||................. .+      .+.
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~------~~p  230 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE-RF------QFP  230 (331)
T ss_pred             eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC-cc------cCC
Confidence              223569999999999865     5688999999999999999999999976443222222111110 00      000


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRK--RPSMRDIVQV  376 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~~vl~~  376 (432)
                      . .....+.++.+++.+|+..++++  |+++.++++.
T Consensus       231 ~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         231 S-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             C-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            0 00122457889999999865544  4678777653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.4e-39  Score=305.32  Aligned_cols=257  Identities=25%  Similarity=0.345  Sum_probs=200.7

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      |.+.+.||+|+||.||+|.. .+|+.||+|.+....  ......+.+|+.++++++||||+++++++......++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            56778899999999999975 478999999987643  333567899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--c
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--H  268 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--~  268 (432)
                       +++|.+++.... .++++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......  .
T Consensus        82 -~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          82 -PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             -CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence             999999886443 67999999999999999999999999   9999999999999999999999999987544332  2


Q ss_pred             ccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc----CCCchhh---------
Q 014038          269 AANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE----GKTGWEE---------  334 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~~---------  334 (432)
                      .....++..|+|||.+.+. .++.++||||||+++|||++|.+||.+..+...+......    ....|.+         
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK  236 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence            3345689999999988654 5689999999999999999998888765443222211110    0001111         


Q ss_pred             hccccCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 IVDSRLDG----IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 ~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +..+....    ........++.+++.+||+.+|++||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00000000    000112368999999999999999999999885

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.4e-39  Score=306.56  Aligned_cols=248  Identities=25%  Similarity=0.412  Sum_probs=192.0

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHH-HhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVML-LGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      .+.+.+.||+|+||.||+|... +|+.||+|.+.... ......+..|+.. ++.++||||+++++++..++..+++|||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~   81 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV   81 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence            3566788999999999999654 68999999987542 2334456666665 5666899999999999999999999999


Q ss_pred             ccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          190 MSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       190 ~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      ++ |+|.+++..  .....+++..++.++.|++.||.|||++ +   ++||||||+||+++.++.+||+|||++......
T Consensus        82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            96 688777643  2335689999999999999999999987 7   999999999999999999999999998754333


Q ss_pred             ccccccccCCCCCCcccccc----CCCCchhHhHHHHHHHHHHHhCCCCCCChhH-HHHHHHhhhcCCCchhhhccccCC
Q 014038          267 KHAANIRGTFGYLDPEYIST----RNFTKKSDVYSFGVLLFELIAGRSPLQGLME-YVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      .......++..|+|||.+.+    ..++.++|+||||+++|||++|+.||..... ...+.......           ..
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------~~  226 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP-----------SP  226 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC-----------CC
Confidence            22233568889999998854    4578999999999999999999999964221 11111111100           00


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .......+.++.+++.+||..+|++||++.++++
T Consensus       227 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         227 QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0011123457899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=305.97  Aligned_cols=258  Identities=25%  Similarity=0.400  Sum_probs=200.1

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      +|++.+.||+|+||.||+|... +++.||+|.+...  .....+.+.+|++++++++|+||+++++++...+..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            4677889999999999999764 6789999988653  233446789999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--  267 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--  267 (432)
                      ++++.+..+..  ....+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||++.......  
T Consensus        82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          82 VERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            99877765553  2345899999999999999999999998   9999999999999999999999999987644332  


Q ss_pred             cccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh---cCCCchhhhc--cccC-
Q 014038          268 HAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT---EGKTGWEEIV--DSRL-  340 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~--~~~~-  340 (432)
                      ......++..|+|||++.+. .++.++||||||+++|+|++|+.||.+......+.....   ..........  ++.. 
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            23345678899999999887 889999999999999999999999976443322211110   0000000000  0000 


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          341 -------------DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       341 -------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                                   ...++...+.++.+++.+||+.+|++||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                         00111122568999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.8e-39  Score=300.21  Aligned_cols=248  Identities=27%  Similarity=0.460  Sum_probs=199.3

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCCh--hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      |...+.||+|+||.||+|.. .+++.||+|.+.....  ...+.+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            55668899999999999965 4788999999876543  35678999999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc--
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH--  268 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~--  268 (432)
                      ++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++........  
T Consensus        82 ~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          82 SGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            999999998543  45889999999999999999999999   99999999999999999999999999875433222  


Q ss_pred             ---ccccccCCCCCCccccccCC---CCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          269 ---AANIRGTFGYLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       269 ---~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                         .....++..|+|||.+....   ++.++||||||+++|||++|+.||.................       .+.+..
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------~~~~~~  229 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-------KPPIPD  229 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCC-------CCCCCc
Confidence               12346788999999998766   88999999999999999999999975432211111111110       000110


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                        .......+.+++.+||+.+|.+||++.+++.
T Consensus       230 --~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         230 --SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             --ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence              1112457889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2e-39  Score=304.73  Aligned_cols=244  Identities=29%  Similarity=0.433  Sum_probs=194.6

Q ss_pred             ccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCCh
Q 014038          120 IGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       120 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  195 (432)
                      ||+|+||+||++.. .+|+.||+|.+....   ......+..|+.+++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999954 478899999986432   22344677899999999999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccccccccC
Q 014038          196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT  275 (432)
Q Consensus       196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt  275 (432)
                      .+++.......+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++.............++
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  157 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT  157 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCC
Confidence            99997655557999999999999999999999999   999999999999999999999999998754333333445678


Q ss_pred             CCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHH
Q 014038          276 FGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASL  355 (432)
Q Consensus       276 ~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  355 (432)
                      ..|+|||.+.+..++.++|||||||++|+|++|+.||.................         ......+...+..+.++
T Consensus       158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l  228 (277)
T cd05577         158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL---------EMAVEYPDKFSPEAKDL  228 (277)
T ss_pred             CCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc---------cccccCCccCCHHHHHH
Confidence            899999999888899999999999999999999999975432111111100000         00111122234578999


Q ss_pred             HHHhhccCCCCCC-----CHHHHHH
Q 014038          356 AYKCVNRAPRKRP-----SMRDIVQ  375 (432)
Q Consensus       356 i~~cl~~dp~~RP-----s~~~vl~  375 (432)
                      +.+||+.+|.+||     ++.+++.
T Consensus       229 i~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         229 CEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHccCChhHccCCCcccHHHHHh
Confidence            9999999999999     5555553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.2e-39  Score=314.27  Aligned_cols=252  Identities=21%  Similarity=0.307  Sum_probs=195.3

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||++... +++.+|+|.+...   .......+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            3567789999999999999754 5788999998542   12223458889999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-  267 (432)
                      |+++|+|.+++... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        82 y~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          82 YYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             ccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            99999999999642 346899999999999999999999999   9999999999999999999999999986533222 


Q ss_pred             -cccccccCCCCCCccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCC
Q 014038          268 -HAANIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       268 -~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                       ......||+.|+|||++.     ...++.++|||||||++|||++|+.||................. .+      ...
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~------~~p  230 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-RF------QFP  230 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc-cc------cCC
Confidence             123357999999999985     34688999999999999999999999976543322222211110 00      000


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCC--CCCCHHHHHHH
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPR--KRPSMRDIVQV  376 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~--~RPs~~~vl~~  376 (432)
                       ......+.++.+++.+|+..++.  .|+++.++++.
T Consensus       231 -~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         231 -AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence             00112345788899998865444  36889888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-41  Score=329.63  Aligned_cols=250  Identities=27%  Similarity=0.472  Sum_probs=206.1

Q ss_pred             cccccccCceeEEEEE-eCCCc----EEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          117 TTLIGQGAFGPVYKAQ-MSTGE----TVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~-~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .++||.|+||+||+|. .+.|+    +||||++... ......++++|+-+|.+++|||+++++|+|..+. ..||++||
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            3689999999999995 44554    6999998765 3445678999999999999999999999998765 88999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc--
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH--  268 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~--  268 (432)
                      +.|+|.++++. ...++..+..+.|..|||+||.|||.+.   ++||||-.+||||..-..+||.|||+++....+..  
T Consensus       780 P~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  780 PLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             ccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            99999999975 4467889999999999999999999988   99999999999999999999999999986544332  


Q ss_pred             -ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          269 -AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       269 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                       .......+.|||-|.+....|+.++|||||||++||++| |..|+.+..... +           .+++..-.+-..|+
T Consensus       856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-I-----------~dlle~geRLsqPp  923 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-I-----------PDLLEKGERLSQPP  923 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-h-----------hHHHhccccCCCCC
Confidence             223344678999999999999999999999999999999 999998764321 1           11111111122344


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      -++.++..++.+||..|+..||+|+++...+.++.+.
T Consensus       924 iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  924 ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            4556899999999999999999999999998888654

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.8e-39  Score=304.31  Aligned_cols=249  Identities=27%  Similarity=0.407  Sum_probs=196.7

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeC-----CeEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK-----GQHML  185 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----~~~~l  185 (432)
                      .|.+.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.+++++ +|||++++++++...     +..++
T Consensus        23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l  101 (291)
T cd06639          23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL  101 (291)
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence            466778999999999999965 478899999986432 2245678899999999 899999999998753     36899


Q ss_pred             EEEeccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          186 VYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ||||+++|+|.+++..  .....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++...
T Consensus       102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~  178 (291)
T cd06639         102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQL  178 (291)
T ss_pred             EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence            9999999999998753  23456899999999999999999999998   999999999999999999999999998754


Q ss_pred             cccc-cccccccCCCCCCccccccC-----CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcc
Q 014038          264 MVDK-HAANIRGTFGYLDPEYISTR-----NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD  337 (432)
Q Consensus       264 ~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      .... ......++..|+|||.+...     .++.++|||||||++|||++|+.||..................       
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~-------  251 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP-------  251 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC-------
Confidence            3222 22345688999999987543     3689999999999999999999999765443333222111110       


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          338 SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       338 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                       ..  ..+......+.+++.+||+.+|++||++.++++
T Consensus       252 -~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         252 -TL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -CC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             00  011223357899999999999999999999885

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.2e-39  Score=306.99  Aligned_cols=249  Identities=24%  Similarity=0.392  Sum_probs=202.3

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .+|.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            3667778999999999999964 477899999987555555567899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~  269 (432)
                      ++++|.+++..   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++....... ..
T Consensus        99 ~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~  172 (293)
T cd06647          99 AGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (293)
T ss_pred             CCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence            99999999853   35889999999999999999999999   9999999999999999999999999876433222 22


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....+++.|+|||.+....++.++|+||||+++|||++|+.||.................          .....+...+
T Consensus       173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~----------~~~~~~~~~~  242 (293)
T cd06647         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT----------PELQNPEKLS  242 (293)
T ss_pred             ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC----------CCCCCccccC
Confidence            334688899999999888899999999999999999999999976433221111111110          0001122234


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ..+.+++.+||+.+|++||++.+++..
T Consensus       243 ~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         243 AIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            578999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.3e-39  Score=300.53  Aligned_cols=247  Identities=29%  Similarity=0.461  Sum_probs=204.1

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      +++.+.||+|++|.||+|... +++.|++|.+..... .....+.+|+..+.+++|+|++++++++...+..++||||++
T Consensus         3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06623           3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD   82 (264)
T ss_pred             ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence            456789999999999999665 589999999876543 445789999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc-
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA-  269 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-  269 (432)
                      +++|.+++...  .++++..++.++.|++.||+|||+ .+   ++|+||+|+||+++.++.++|+|||++......... 
T Consensus        83 ~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~  157 (264)
T cd06623          83 GGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC  157 (264)
T ss_pred             CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence            99999999543  679999999999999999999999 88   999999999999999999999999998754333222 


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChh--HHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM--EYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ....++..|+|||.+....++.++|+||||+++|||++|+.||....  ..........          .... ...+..
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----------~~~~-~~~~~~  226 (264)
T cd06623         158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----------DGPP-PSLPAE  226 (264)
T ss_pred             cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----------cCCC-CCCCcc
Confidence            24567899999999998899999999999999999999999997653  2222111111          1011 111222


Q ss_pred             -HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          348 -ELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       348 -~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                       .+..+.+++.+||+.+|++||++.++++.
T Consensus       227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         227 EFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             44689999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3e-39  Score=309.40  Aligned_cols=191  Identities=25%  Similarity=0.400  Sum_probs=157.2

Q ss_pred             ccccccCceeEEEEEeC---CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeee--CCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQMS---TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  192 (432)
                      .+||+|+||.||+|...   ++..||+|.+....  ....+.+|+.++++++||||+++++++..  ....++||||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            47999999999999754   45789999886432  23467889999999999999999998854  5678999999875


Q ss_pred             CChhhhccc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee----cCCCcEEEeecCCcc
Q 014038          193 GSLASHLYD-------ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL----DQSMRARVADFGLSR  261 (432)
Q Consensus       193 g~L~~~l~~-------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill----~~~~~~kl~Dfgl~~  261 (432)
                       +|.+++..       .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             77766532       12235889999999999999999999999   9999999999999    566799999999997


Q ss_pred             cccccc----cccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCC
Q 014038          262 EEMVDK----HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQG  314 (432)
Q Consensus       262 ~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~  314 (432)
                      ......    ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||..
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            543221    2234568999999999876 4589999999999999999999999964

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.4e-39  Score=303.14  Aligned_cols=243  Identities=25%  Similarity=0.390  Sum_probs=198.6

Q ss_pred             cccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCCh
Q 014038          117 TTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  195 (432)
                      .+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.+++.++||||+++++++...+..++++||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L  103 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL  103 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence            36899999999999964 47889999998765555566788999999999999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-ccccccc
Q 014038          196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRG  274 (432)
Q Consensus       196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~~g  274 (432)
                      .+++..   .++++..+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++....... ......+
T Consensus       104 ~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  177 (285)
T cd06648         104 TDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVG  177 (285)
T ss_pred             HHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccC
Confidence            998854   46899999999999999999999999   9999999999999999999999999876433221 2233468


Q ss_pred             CCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHH
Q 014038          275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVAS  354 (432)
Q Consensus       275 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  354 (432)
                      ++.|+|||.+.+..++.++||||||+++|||++|+.||.................        +...  .+...+..+.+
T Consensus       178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~--------~~~~--~~~~~~~~l~~  247 (285)
T cd06648         178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP--------PKLK--NLHKVSPRLRS  247 (285)
T ss_pred             CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCC--------CCCc--ccccCCHHHHH
Confidence            8999999999888899999999999999999999999875433222111111100        0110  01113357999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 014038          355 LAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       355 li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ++.+||+.+|++||++.++++
T Consensus       248 li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         248 FLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HHHHHcccChhhCcCHHHHcc
Confidence            999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.9e-39  Score=301.97  Aligned_cols=256  Identities=23%  Similarity=0.314  Sum_probs=194.2

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcC-CCccceEEeeeeeC--CeEEEEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEK--GQHMLVYV  188 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  188 (432)
                      |.+.+.||+|+||.||+|.. .+++.||+|.+.... ........+|+..+.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            34667899999999999964 478899999987542 222334557899999885 99999999999987  88999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |++ |+|.+++... ...+++..+..++.|++.||.|||+.+   ++||||+|+||+++. +.+||+|||++........
T Consensus        81 ~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          81 LMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             cCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            997 5888887543 256899999999999999999999998   999999999999999 9999999999876544333


Q ss_pred             ccccccCCCCCCccccc-cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh---cCCCchhhhcccc-----
Q 014038          269 AANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT---EGKTGWEEIVDSR-----  339 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~-----  339 (432)
                      .....++..|+|||.+. +..++.++|||||||++|||++|..||.+............   .....+.......     
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07831         155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY  234 (282)
T ss_pred             cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence            34456789999999764 45678999999999999999999999976543222111111   0011010000000     


Q ss_pred             -CCCC-------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          340 -LDGI-------FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       340 -~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                       ....       .....+.++.+++.+||+.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence             0000       01123568999999999999999999999885

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-39  Score=303.78  Aligned_cols=257  Identities=26%  Similarity=0.346  Sum_probs=197.3

Q ss_pred             cccccccccCceeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      ++.+.||.|++|.||+|.. .+|..||+|++....  ......+.+|+.+++.++|||++++++++.+.+..+++|||++
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~   81 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD   81 (283)
T ss_pred             chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence            4567899999999999965 478999999987543  2233568899999999999999999999999999999999995


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-ccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~  270 (432)
                       ++|.+++.......+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++....... ...
T Consensus        82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  157 (283)
T cd07835          82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT  157 (283)
T ss_pred             -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence             68999886554457999999999999999999999998   9999999999999999999999999987543221 122


Q ss_pred             ccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCc----h------hhhcccc
Q 014038          271 NIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG----W------EEIVDSR  339 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----~------~~~~~~~  339 (432)
                      ...++..|+|||.+.+. .++.++|+||||+++|||++|+.||...................    |      .+.....
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF  237 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence            33568899999987654 57899999999999999999999997654433322221111000    0      0000000


Q ss_pred             C--C----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          340 L--D----GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       340 ~--~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .  .    .......+..+.+++.+||+.+|++||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0  0    0001112357889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.9e-39  Score=304.87  Aligned_cols=243  Identities=28%  Similarity=0.414  Sum_probs=198.8

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||++... +++.||+|.+....   ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            3567789999999999999654 68999999986532   2334678899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||+|+|||++.++.+||+|||++......  
T Consensus        82 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          82 YVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            99999999998543  57899999999999999999999998   999999999999999999999999998764332  


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||............. .+.            ...+...
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~------------~~~~~~~  221 (290)
T cd05580         155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL-EGK------------VRFPSFF  221 (290)
T ss_pred             CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCC------------ccCCccC
Confidence            344568899999999988888999999999999999999999997644221111111 111            0111222


Q ss_pred             HHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRP-----SMRDIVQ  375 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RP-----s~~~vl~  375 (432)
                      ...+.+++.+||+.||.+||     +++++++
T Consensus       222 ~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         222 SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            45789999999999999998     6666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.5e-39  Score=304.79  Aligned_cols=258  Identities=25%  Similarity=0.348  Sum_probs=197.1

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhhcCCCccceEEeeeeeC--CeEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHMLVY  187 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  187 (432)
                      .|.+.+.||.|+||.||+|... +++.+|+|.+.....  .....+.+|+.++.+++||||+++++++...  +..++||
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            4566788999999999999765 688999999875432  2234577899999999999999999998877  8899999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-  266 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-  266 (432)
                      ||+. ++|.+++.... ..+++..+..++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||++...... 
T Consensus        86 e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          86 EYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             hhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            9997 48988875433 36899999999999999999999999   999999999999999999999999998754433 


Q ss_pred             ccccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc----CCCch---------
Q 014038          267 KHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE----GKTGW---------  332 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~---------  332 (432)
                      .......+++.|+|||.+.+. .++.++|+||||+++|||++|..||...............    ....|         
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence            222334578899999988654 4689999999999999999999999764432222111100    00001         


Q ss_pred             -----hhhccccCCCCCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          333 -----EEIVDSRLDGIFDVE-ELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       333 -----~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                           .......+...++.. ....+.+++.+||+.+|++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                 000011111112211 3457889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-39  Score=301.14  Aligned_cols=250  Identities=28%  Similarity=0.436  Sum_probs=198.9

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCC------eE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKG------QH  183 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------~~  183 (432)
                      ..|.+.+.||+|++|.||+|... +++.+++|.+..... ....+.+|+.+++++ +|+||+++++++....      ..
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL   84 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence            45677889999999999999764 678999999875543 346789999999999 7999999999997644      48


Q ss_pred             EEEEEeccCCChhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          184 MLVYVFMSKGSLASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                      ++||||+++++|.+++....  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~  161 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSA  161 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccce
Confidence            99999999999999885432  467999999999999999999999999   9999999999999999999999999986


Q ss_pred             ccccc-ccccccccCCCCCCcccccc-----CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhh
Q 014038          262 EEMVD-KHAANIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEI  335 (432)
Q Consensus       262 ~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (432)
                      ..... .......++..|+|||.+..     ..++.++|||||||++|||++|+.||.................      
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------  235 (275)
T cd06608         162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP------  235 (275)
T ss_pred             ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC------
Confidence            53322 22234568899999998753     3578899999999999999999999975433222222211110      


Q ss_pred             ccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                        +.  ...+...+.++.+++.+||..||++|||+.++++
T Consensus       236 --~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         236 --PT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             --CC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence              00  0112224468899999999999999999999885

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.6e-39  Score=302.11  Aligned_cols=249  Identities=25%  Similarity=0.486  Sum_probs=198.4

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC------hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS------KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      |...+.||+|++|.||+|.. .+++.||+|.+....      ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v   81 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF   81 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence            34557899999999999964 578999999986432      12346789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC-cEEEeecCCcccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMV  265 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~-~~kl~Dfgl~~~~~~  265 (432)
                      |||+++++|.+++..  .+++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          82 VEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999854  357899999999999999999999999   99999999999998776 599999999865432


Q ss_pred             cc-----cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          266 DK-----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       266 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ..     ......++..|+|||.+.+..++.++||||||+++|+|++|..||............        ........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~  228 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI--------FKIASATT  228 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH--------HHHhccCC
Confidence            21     122346788999999998888999999999999999999999999642211000000        00001111


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ....+.....++.+++.+||+.+|.+||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            22333445568999999999999999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.5e-39  Score=306.73  Aligned_cols=258  Identities=27%  Similarity=0.382  Sum_probs=197.6

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      +|++.+.||+|+||.||+|... +++.||+|.+....  ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            4567789999999999999764 68999999876532  22346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KH  268 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~  268 (432)
                      +++++|..+...  ...+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.++|+|||++...... ..
T Consensus        82 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          82 VDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             CCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence            999988887643  345899999999999999999999998   999999999999999999999999998754322 22


Q ss_pred             ccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh---cCCCchhhhc--------
Q 014038          269 AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT---EGKTGWEEIV--------  336 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~--------  336 (432)
                      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..............   ..........        
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            233457889999998865 4578899999999999999999999975443222111110   0000000000        


Q ss_pred             --cccCCCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          337 --DSRLDGIF-----DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       337 --~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                        .+......     ....+..+.+++.+||+.+|++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence              00000000     0122457999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5e-39  Score=306.37  Aligned_cols=251  Identities=22%  Similarity=0.346  Sum_probs=198.4

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      |.+.+.||+|+||.||++... +++.||+|.+....   ......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (305)
T cd05609           3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY   82 (305)
T ss_pred             ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence            566789999999999999654 67899999986543   23345788999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--  267 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--  267 (432)
                      +++++|.+++..  .+.+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++......  
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          83 VEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             CCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            999999999954  356899999999999999999999998   9999999999999999999999999886311100  


Q ss_pred             --------------cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchh
Q 014038          268 --------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWE  333 (432)
Q Consensus       268 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  333 (432)
                                    ......++..|+|||.+....++.++|+||||+++|||++|+.||.+...............    
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~----  233 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI----  233 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----
Confidence                          01123578899999999888899999999999999999999999976433211111111100    


Q ss_pred             hhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 014038          334 EIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR  379 (432)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~  379 (432)
                        ..+..    ....+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       234 --~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         234 --EWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             --CCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence              00000    11233578999999999999999997766666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.5e-39  Score=306.57  Aligned_cols=257  Identities=23%  Similarity=0.320  Sum_probs=193.6

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      |.+.+.||+|+||.||+|.. .+|+.||+|.+....  ......+.+|+.++++++||||+++++++.+....++++||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            55678899999999999965 478999999986532  222356788999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-ccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~  269 (432)
                      + ++|.+++... ...+++..+..++.||++||.|||+.+   ++||||||+||+++.++.+||+|||++...... ...
T Consensus        82 ~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  156 (284)
T cd07839          82 D-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY  156 (284)
T ss_pred             C-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence            7 5888777543 356999999999999999999999999   999999999999999999999999998754322 122


Q ss_pred             cccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhH-HHHHHHhhh----cCCCchhh---hccc--
Q 014038          270 ANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLME-YVELAAMNT----EGKTGWEE---IVDS--  338 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~-~~~~~~~~~----~~~~~~~~---~~~~--  338 (432)
                      ....+++.|+|||.+.+. .++.++|||||||++|||++|..|+....+ ...+.....    .....|..   ..+.  
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP  236 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence            334578899999988664 478999999999999999999988643221 111111100    00000100   0000  


Q ss_pred             --cCCC-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          339 --RLDG-----IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       339 --~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                        ....     ......+.++.+++.+||+.||.+|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence              0000     001113457889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.9e-39  Score=300.94  Aligned_cols=240  Identities=25%  Similarity=0.362  Sum_probs=196.2

Q ss_pred             ccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCCh
Q 014038          120 IGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       120 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  195 (432)
                      ||.|++|.||++... +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++.++...+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999764 58999999986542   23446789999999999999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccccccccC
Q 014038          196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT  275 (432)
Q Consensus       196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt  275 (432)
                      .+++...  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.............++
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~  155 (262)
T cd05572          81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT  155 (262)
T ss_pred             HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence            9999543  45899999999999999999999998   999999999999999999999999998765443333345688


Q ss_pred             CCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChh--HHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHH
Q 014038          276 FGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM--EYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVA  353 (432)
Q Consensus       276 ~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  353 (432)
                      +.|++||.+....++.++|+||||+++|||++|..||....  .......           +........++...+.++.
T Consensus       156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~  224 (262)
T cd05572         156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND-----------ILKGNGKLEFPNYIDKAAK  224 (262)
T ss_pred             cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH-----------HhccCCCCCCCcccCHHHH
Confidence            99999999988889999999999999999999999997644  1111111           1111111122222356899


Q ss_pred             HHHHHhhccCCCCCCC-----HHHHHH
Q 014038          354 SLAYKCVNRAPRKRPS-----MRDIVQ  375 (432)
Q Consensus       354 ~li~~cl~~dp~~RPs-----~~~vl~  375 (432)
                      +++.+||+.+|++||+     +.|+++
T Consensus       225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         225 DLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHccCChhhCcCCcccCHHHHhc
Confidence            9999999999999999     666664

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6.1e-39  Score=297.59  Aligned_cols=247  Identities=26%  Similarity=0.440  Sum_probs=199.6

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      |.+.+.||+|+||.||+|... +|..+|+|.+....  ....+.+.+|+.+++.++|+||+++++.+...+..++|+||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            456788999999999999654 67899999986532  234457889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC-cEEEeecCCccccccccc-
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKH-  268 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~~~-  268 (432)
                      ++++|.+++.......+++..+..++.|++.||.|||+.+   ++|+||||+||++++++ .+||+|||.+........ 
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~  158 (257)
T cd08225          82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL  158 (257)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence            9999999987655556899999999999999999999998   99999999999998885 469999998875433221 


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      .....|++.|+|||.+....++.++|+||||+++|||++|..||..............           .... ......
T Consensus       159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----------~~~~-~~~~~~  226 (257)
T cd08225         159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-----------GYFA-PISPNF  226 (257)
T ss_pred             ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-----------ccCC-CCCCCC
Confidence            2234588999999999888899999999999999999999999975432221111111           0110 111122


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +.++.+++.+||+.+|++|||+.+++.
T Consensus       227 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         227 SRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            357899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-38  Score=300.79  Aligned_cols=253  Identities=28%  Similarity=0.393  Sum_probs=197.9

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeC--CeEEEEEEe
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHMLVYVF  189 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~  189 (432)
                      +++.+.||.|++|.||++.. .+++.+|+|.+.... ......+.+|++++++++||||++++++|.+.  +..++||||
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   82 (287)
T cd06621           3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY   82 (287)
T ss_pred             eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence            45678899999999999976 468899999987543 24456789999999999999999999988653  468999999


Q ss_pred             ccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          190 MSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       190 ~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      +++++|.+++..  .....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...... 
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~-  158 (287)
T cd06621          83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS-  158 (287)
T ss_pred             cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccc-
Confidence            999999887643  23456899999999999999999999999   999999999999999999999999998654322 


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChh----HHHHHHHhhhcCCCchhhhccccCCCC
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM----EYVELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.||....    .............  ...+ ....  .
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~--~  233 (287)
T cd06621         159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP--NPEL-KDEP--G  233 (287)
T ss_pred             ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC--chhh-ccCC--C
Confidence            2224457889999999998999999999999999999999999997541    1111111111100  0000 0000  0


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .....+.++.+++.+||+.+|.+|||+.++++
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            01123467899999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.4e-38  Score=293.56  Aligned_cols=248  Identities=33%  Similarity=0.530  Sum_probs=204.2

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      |...+.||+|++|.||++... ++..+++|++..........+.+|+..++.++|+|++++++++......++++||+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   81 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG   81 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence            455678999999999999764 6889999999776555667899999999999999999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI  272 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  272 (432)
                      ++|.+++.... ..+++..+..++.|++.||.|||..+   ++||||+|+||++++++.++|+|||.+............
T Consensus        82 ~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  157 (253)
T cd05122          82 GSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM  157 (253)
T ss_pred             CcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence            99999885532 57999999999999999999999988   999999999999999999999999998765433323456


Q ss_pred             ccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHH
Q 014038          273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEV  352 (432)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  352 (432)
                      .++..|+|||.+....++.++||||||+++|+|++|+.||.................   ..     ..  .+...+..+
T Consensus       158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~-----~~--~~~~~~~~~  227 (253)
T cd05122         158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP---PG-----LR--NPEKWSDEF  227 (253)
T ss_pred             ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCC---CC-----cC--cccccCHHH
Confidence            788999999999888899999999999999999999999976532222222111110   00     00  111124579


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 014038          353 ASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       353 ~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+++.+||+.||++|||+.++++
T Consensus       228 ~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         228 KDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             HHHHHHHccCChhhCCCHHHHhc
Confidence            99999999999999999999885

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.1e-39  Score=301.16  Aligned_cols=244  Identities=28%  Similarity=0.421  Sum_probs=201.4

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      |++.+.||.|+||.||+|... +++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+....++|+||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            566789999999999999764 68999999986532   23457889999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA  269 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  269 (432)
                      +.+++|.+++...  .++++..+..++.|++.||.|||+++   ++|+||+|+||++++++.++|+|||++.........
T Consensus        82 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          82 LLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             CCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCccc
Confidence            9999999998543  57999999999999999999999998   999999999999999999999999998765444334


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhH--HHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME--YVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ....++..|+|||.+....++.++|+||||+++|+|++|+.||.....  ..........            .....+..
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------~~~~~~~~  224 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------------ADVLYPAT  224 (258)
T ss_pred             cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------------ccccCccc
Confidence            456688899999999888899999999999999999999999976442  1111111100            11122223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCH--HHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSM--RDIV  374 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~--~~vl  374 (432)
                      .+..+.+++.+||+.||.+||++  .+++
T Consensus       225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         225 WSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             CcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            34689999999999999999999  5544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.7e-38  Score=302.99  Aligned_cols=245  Identities=28%  Similarity=0.391  Sum_probs=196.1

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+|... +++.||+|.+....   ......+.+|+.+++.++||||++++++|...+..++|||
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   95 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME   95 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence            3556678999999999999654 68999999886432   2334578899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+. |+|.+.+... ...+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++.....   
T Consensus        96 ~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~---  167 (307)
T cd06607          96 YCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP---  167 (307)
T ss_pred             hhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC---
Confidence            997 5777766432 346899999999999999999999998   99999999999999999999999998864322   


Q ss_pred             ccccccCCCCCCccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          269 AANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      .....+++.|+|||.+.   ...++.++||||||+++|||++|+.||................           ......
T Consensus       168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-----------~~~~~~  236 (307)
T cd06607         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-----------SPTLSS  236 (307)
T ss_pred             CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC-----------CCCCCc
Confidence            23446788999999874   4568899999999999999999999997654322221111110           011112


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ...+..+.+++.+||+.+|++||++.+|+..
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             hhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            2345679999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=301.69  Aligned_cols=258  Identities=25%  Similarity=0.410  Sum_probs=194.8

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .|.+.+.||+|++|.||+|... +++.||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (291)
T cd07844           6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL   85 (291)
T ss_pred             ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence            4667789999999999999754 688999999865432 22345778999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~  269 (432)
                      .+ +|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++...... ..
T Consensus        86 ~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          86 DT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             CC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence            74 8998885433 46899999999999999999999998   9999999999999999999999999986532221 11


Q ss_pred             cccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHH-HHHHhhh----cCCCchhhhcc------
Q 014038          270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV-ELAAMNT----EGKTGWEEIVD------  337 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~-~~~~~~~----~~~~~~~~~~~------  337 (432)
                      ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+.....    .....|.....      
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP  240 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence            22346889999998865 568999999999999999999999997543211 1111100    00001100000      


Q ss_pred             ccCCCC--------C-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          338 SRLDGI--------F-DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       338 ~~~~~~--------~-~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ......        . .......+.+++.+||+.+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            000000        0 0011257789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-38  Score=300.45  Aligned_cols=247  Identities=29%  Similarity=0.448  Sum_probs=201.7

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      |.+.+.||+|++|.||+|... ++..|++|.+..... ..+.+.+|+..++.++|+|++++++++......++++||+++
T Consensus        21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   99 (286)
T cd06614          21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG   99 (286)
T ss_pred             chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence            445568999999999999765 688999999876544 566788999999999999999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAAN  271 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~  271 (432)
                      ++|.+++.... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus       100 ~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  175 (286)
T cd06614         100 GSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS  175 (286)
T ss_pred             CcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcc
Confidence            99999996543 47999999999999999999999988   9999999999999999999999999876433221 2233


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      ..++..|+|||.+.+..++.++|+|||||++|+|++|+.||...................        .  ......+..
T Consensus       176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------~--~~~~~~~~~  245 (286)
T cd06614         176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP--------L--KNPEKWSPE  245 (286)
T ss_pred             ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------C--cchhhCCHH
Confidence            457889999999988889999999999999999999999997654432222211111100        0  011113457


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 014038          352 VASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +.+++.+||+.+|.+||++.++++
T Consensus       246 l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         246 FKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhh
Confidence            899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-39  Score=294.57  Aligned_cols=259  Identities=27%  Similarity=0.439  Sum_probs=207.0

Q ss_pred             HHHHhccccccccccCceeEEEEEeC------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC-
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-  180 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  180 (432)
                      +.+.+..+..++-+|.||.||.|.+.      +.+.|.+|.++.. +.-....|..|--.+..+.|||+.++.+++.+. 
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~  360 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY  360 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence            34445556678999999999999443      3456778887654 344456788999999999999999999998764 


Q ss_pred             CeEEEEEEeccCCChhhhcc-----c-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEE
Q 014038          181 GQHMLVYVFMSKGSLASHLY-----D-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV  254 (432)
Q Consensus       181 ~~~~lv~e~~~~g~L~~~l~-----~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl  254 (432)
                      ...+++|.++.-|+|..||.     + ...+.++..+...++.|++.|++|||.++   +||.||..+|++||+..++||
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkl  437 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKL  437 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEe
Confidence            57899999999999999996     2 22345778888999999999999999999   999999999999999999999


Q ss_pred             eecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCC
Q 014038          255 ADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKT  330 (432)
Q Consensus       255 ~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  330 (432)
                      +|-.+++......   ...+......||+||.+....|+..+|||||||+||||+| |+.||....... +..+...+. 
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-m~~ylkdGy-  515 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-MEHYLKDGY-  515 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-HHHHHhccc-
Confidence            9999998643322   1233445678999999999999999999999999999999 999998765432 222222221 


Q ss_pred             chhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          331 GWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                              ++..++  .++.+|+.+|.-||..+|++||++++++..|.++..
T Consensus       516 --------RlaQP~--NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  516 --------RLAQPF--NCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             --------eecCCC--CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence                    222233  345689999999999999999999999999998854

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1e-38  Score=310.42  Aligned_cols=256  Identities=25%  Similarity=0.318  Sum_probs=197.4

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC------Ce
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQ  182 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  182 (432)
                      ..|...+.||+|+||.||+|.. .+++.||+|.+...  .......+.+|+.++++++||||+++++++...      ..
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            4677778999999999999964 47899999998643  233345678899999999999999999987643      35


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .++||||+. ++|.+.+..    .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        96 ~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  167 (353)
T cd07850          96 VYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART  167 (353)
T ss_pred             EEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcccee
Confidence            799999996 588887742    2889999999999999999999998   99999999999999999999999999976


Q ss_pred             ccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCC-------------
Q 014038          263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGK-------------  329 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------------  329 (432)
                      ...........+++.|+|||.+.+..++.++|||||||++|+|++|+.||........+........             
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T cd07850         168 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT  247 (353)
T ss_pred             CCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence            5443333445688999999999999999999999999999999999999975433222111110000             


Q ss_pred             -------------CchhhhccccCC----CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          330 -------------TGWEEIVDSRLD----GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       330 -------------~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                                   ..+.+.......    ...+...+.++.+++.+||+.||++|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                         001111111100    0001123457899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-39  Score=308.05  Aligned_cols=247  Identities=24%  Similarity=0.415  Sum_probs=197.1

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      ..|++.++||+||.+.||++...+.+.+|+|++...  +.+....|..|+..|.+| .|.+|++|++|-..++.+|+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            445667899999999999998888889999987643  455567899999999999 59999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |-+ .+|..+|.........| .+..+..|++.++.++|+++   |||.||||.|+|+-. |.+||+|||+|.....+..
T Consensus       441 ~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  441 CGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             ccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence            874 59999997665555556 67788999999999999999   999999999999964 5999999999986554432


Q ss_pred             ---ccccccCCCCCCccccccC-----------CCCchhHhHHHHHHHHHHHhCCCCCCChhHH-HHHHHhhhcCCCchh
Q 014038          269 ---AANIRGTFGYLDPEYISTR-----------NFTKKSDVYSFGVLLFELIAGRSPLQGLMEY-VELAAMNTEGKTGWE  333 (432)
Q Consensus       269 ---~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~  333 (432)
                         ....+||+.||+||.+...           +.++++||||||||||+|+-|+.||....+. ..+.++         
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI---------  585 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAI---------  585 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhh---------
Confidence               3457899999999988432           2568999999999999999999999876532 222222         


Q ss_pred             hhccccCCCCCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          334 EIVDSRLDGIFDV-EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       334 ~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                        .++.-.-+|+. ....++.++|..||+.||++||+..++|+
T Consensus       586 --~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  586 --TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             --cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence              22211111111 11124899999999999999999999986

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-39  Score=300.30  Aligned_cols=245  Identities=25%  Similarity=0.486  Sum_probs=197.1

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcC---CCccceEEeeeeeCCeEEEEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLH---HRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      |.+.+.||+|+||.||+|.. .+++.||+|.+... ......++.+|+.++++++   |||++++++++..+...++|||
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e   82 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME   82 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence            34567899999999999965 57899999998654 3344567889999999996   9999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-  267 (432)
                      |+++++|.+++..   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        83 ~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          83 YAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             cCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            9999999998843   36899999999999999999999999   9999999999999999999999999987543322 


Q ss_pred             cccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          268 HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...............        ..+.+..   .
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~---~  225 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--------KPPRLED---N  225 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--------CCCCCCc---c
Confidence            2234568899999998865 45789999999999999999999999764332111110000        0011111   1


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.++.+++.+||+.||++||++.+++.
T Consensus       226 ~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         226 GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            13457899999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-40  Score=286.13  Aligned_cols=246  Identities=26%  Similarity=0.452  Sum_probs=197.5

Q ss_pred             ccccccccCceeEEEEEeC-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          116 FTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       116 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +...||.|+.|.||+++.. +|...|||.+... .....++++..+.++..- ++|+||+.+|||..+...++.||.|.-
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~  175 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST  175 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence            4457999999999999654 6899999998765 455567788888877665 489999999999999999999999853


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI  272 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  272 (432)
                       .+..++ .+..+++++..+-++...+++||.||.++..  |+|||+||+|||+|+.|++|+||||++-...........
T Consensus       176 -C~ekLl-krik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrs  251 (391)
T KOG0983|consen  176 -CAEKLL-KRIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRS  251 (391)
T ss_pred             -HHHHHH-HHhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeecccccccc
Confidence             444444 3455789999999999999999999988653  999999999999999999999999999876666556667


Q ss_pred             ccCCCCCCcccccc---CCCCchhHhHHHHHHHHHHHhCCCCCCChh-HHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          273 RGTFGYLDPEYIST---RNFTKKSDVYSFGVLLFELIAGRSPLQGLM-EYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       273 ~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      .|.+.|||||.+..   ..|+.++|||||||.++||.||+.||.+.. +...+........        +.+++..  ..
T Consensus       252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP--------P~L~~~~--gF  321 (391)
T KOG0983|consen  252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP--------PLLPGHM--GF  321 (391)
T ss_pred             cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC--------CCCCccc--Cc
Confidence            79999999999854   468999999999999999999999998743 3333332222111        2222221  13


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +..+.+|+..||++|+.+||...++++
T Consensus       322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  322 SPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            468999999999999999999999886

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.7e-38  Score=305.80  Aligned_cols=255  Identities=25%  Similarity=0.348  Sum_probs=193.8

Q ss_pred             ccccc--CceeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCC
Q 014038          119 LIGQG--AFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG  193 (432)
Q Consensus       119 ~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  193 (432)
                      .||+|  +||+||++.. .+|+.||+|.+....  ....+.+.+|+.+++.++||||++++++|..++..++||||+.+|
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  9999999965 478999999987542  233467889999999999999999999999999999999999999


Q ss_pred             ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc-----
Q 014038          194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH-----  268 (432)
Q Consensus       194 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-----  268 (432)
                      +|.+++.......+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.++++||+.+........     
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            9999886554456899999999999999999999998   99999999999999999999999985432211100     


Q ss_pred             ---ccccccCCCCCCccccccC--CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcC-CCchh---------
Q 014038          269 ---AANIRGTFGYLDPEYISTR--NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG-KTGWE---------  333 (432)
Q Consensus       269 ---~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~---------  333 (432)
                         .....++..|+|||++.+.  .++.++|||||||++|||++|+.||................ ...+.         
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES  241 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence               1112345679999998763  47899999999999999999999998654332222111100 00000         


Q ss_pred             ------------------------hhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          334 ------------------------EIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       334 ------------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                                              ......+...........+.+|+.+||+.||++|||+.++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                                    0001111112223455689999999999999999999999853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1e-38  Score=302.51  Aligned_cols=259  Identities=24%  Similarity=0.352  Sum_probs=196.2

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      .|.+.+.||+|++|.||+|... +|+.||+|.+....  ....+.+.+|+.++++++||||+++++++......++||||
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY   82 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence            4567789999999999999654 78899999986542  23345788999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC-CCcEEEeecCCcccccccc-
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLSREEMVDK-  267 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~-~~~~kl~Dfgl~~~~~~~~-  267 (432)
                      ++ ++|.+++.......+++..+..++.||+.||+|||+++   ++|+||+|+||+++. ++.+||+|||++....... 
T Consensus        83 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         83 LD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             cc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            96 58888775544445788889999999999999999998   999999999999985 5679999999987543221 


Q ss_pred             cccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc----CCCchh------hhc
Q 014038          268 HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE----GKTGWE------EIV  336 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~------~~~  336 (432)
                      ......+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||....+..........    ....|.      ...
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK  238 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence            2233457889999998865 46789999999999999999999999765443332221110    000010      000


Q ss_pred             c--ccCCCC----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          337 D--SRLDGI----FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       337 ~--~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .  +.....    .....+.++.+++.+||+.+|++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0  000000    01112357889999999999999999999986

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.1e-38  Score=303.23  Aligned_cols=255  Identities=23%  Similarity=0.288  Sum_probs=194.0

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCCh
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  195 (432)
                      +.+|.|+++.||++.. +++.||+|++...  .....+.+.+|+.+++.++|+||+++++++.+.+..+++|||+++|+|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3455555555555554 7899999998754  344556899999999999999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--------
Q 014038          196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--------  267 (432)
Q Consensus       196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--------  267 (432)
                      .+++.......+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||.+.......        
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            99997655567899999999999999999999999   9999999999999999999999999876432211        


Q ss_pred             cccccccCCCCCCcccccc--CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCC------chhh-----
Q 014038          268 HAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT------GWEE-----  334 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~------~~~~-----  334 (432)
                      ......++..|+|||.+..  ..++.++|+|||||++|||++|+.||..................      .+..     
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM  243 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence            1223456788999999865  35889999999999999999999999865433222211110000      0000     


Q ss_pred             ------hccc----cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          335 ------IVDS----RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       335 ------~~~~----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                            ..++    ............++.+++.+||+.||++|||+.++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                  0000    00111222334678999999999999999999999873

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-38  Score=297.65  Aligned_cols=258  Identities=28%  Similarity=0.363  Sum_probs=197.0

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhhc---CCCccceEEeeeeeCCe-----
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK--QGEKEFQTEVMLLGRL---HHRNLVNLVGYCAEKGQ-----  182 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  182 (432)
                      |++.+.||+|+||.||+|... +++.||+|.+.....  .....+.+|+.++.++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            345678999999999999765 589999999874322  2234566787777665   59999999999988776     


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .+++|||+. ++|.+++.......+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999997 48988886544456999999999999999999999998   99999999999999999999999999876


Q ss_pred             ccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcC----CCchhh----
Q 014038          263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG----KTGWEE----  334 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~~----  334 (432)
                      ...........++..|+|||.+.+..++.++|+|||||++|||++|..||................    ...+..    
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             ccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence            544433344557889999999998899999999999999999999999998655433222221100    000000    


Q ss_pred             ---hccccCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 ---IVDSRLDGI---FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 ---~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                         .........   ........+.+++.+||+.||++||++.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence               000000000   01123467889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.2e-38  Score=298.67  Aligned_cols=258  Identities=23%  Similarity=0.360  Sum_probs=194.2

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCCh-hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .|.+.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus         6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~   85 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM   85 (291)
T ss_pred             eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence            456778999999999999964 4788999999865432 22346788999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~  269 (432)
                      . ++|.+++... ...+++..+..++.|++.||.|||+.+   ++|+||||+|||++.++.+||+|||+++...... ..
T Consensus        86 ~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          86 H-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             c-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence            5 6887776433 346788889999999999999999998   9999999999999999999999999987532221 22


Q ss_pred             cccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHH-Hhhh-cC---CCch------hhhcc
Q 014038          270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNT-EG---KTGW------EEIVD  337 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~-~~~~-~~---~~~~------~~~~~  337 (432)
                      ....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....+..... .... .+   ...+      .....
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            33457899999999865 457899999999999999999999997654321111 1000 00   0000      00000


Q ss_pred             ccCCCCCC---------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          338 SRLDGIFD---------VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       338 ~~~~~~~~---------~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .......+         ......+.+++.+|++.||++|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00000000         011357889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.8e-38  Score=294.11  Aligned_cols=247  Identities=28%  Similarity=0.455  Sum_probs=203.5

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhhcCCCccceEEeeeeeC--CeEEEEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHMLVYV  188 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  188 (432)
                      |...+.||+|++|.||+|... +++.|++|.+.....  ...+.+.+|+..+++++||||+++++.+...  ...++++|
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            345678999999999999765 788999999876542  4467889999999999999999999999988  88999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          82 YVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             ecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            99999999998644  37999999999999999999999988   99999999999999999999999999876544432


Q ss_pred             ---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          269 ---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       269 ---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                         .....++..|+|||.+....++.++||||||+++|+|++|..||....+.........          ........+
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------~~~~~~~~~  226 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIG----------SSGEPPEIP  226 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcc----------ccCCCcCCC
Confidence               3455688999999999888899999999999999999999999976542211111110          001111222


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...+..+.+++.+||+.+|++||++.+++.
T Consensus       227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            233568999999999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.7e-38  Score=299.36  Aligned_cols=242  Identities=24%  Similarity=0.393  Sum_probs=197.8

Q ss_pred             ccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCChh
Q 014038          118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLA  196 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  196 (432)
                      .+||+|+||.||++.. .+++.||+|.+..........+.+|+.+++.++|+|++++++++...+..+++|||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            5799999999999965 478999999986655555677899999999999999999999999999999999999999999


Q ss_pred             hhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cccccccC
Q 014038          197 SHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRGT  275 (432)
Q Consensus       197 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~~gt  275 (432)
                      +++..   ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++....... ......++
T Consensus       106 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  179 (292)
T cd06657         106 DIVTH---TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT  179 (292)
T ss_pred             HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence            88743   35899999999999999999999998   9999999999999999999999999876543222 22335688


Q ss_pred             CCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHH
Q 014038          276 FGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASL  355 (432)
Q Consensus       276 ~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  355 (432)
                      +.|+|||.+.+..++.++|+||||+++|||++|..||.+...............        +.+..  ....+..+.++
T Consensus       180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~~l~~l  249 (292)
T cd06657         180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP--------PKLKN--LHKVSPSLKGF  249 (292)
T ss_pred             ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC--------cccCC--cccCCHHHHHH
Confidence            999999999888899999999999999999999999976443322221111111        11100  11123468899


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 014038          356 AYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       356 i~~cl~~dp~~RPs~~~vl~  375 (432)
                      +.+||+.+|.+||++.++++
T Consensus       250 i~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         250 LDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHhCCcccCcCHHHHhc
Confidence            99999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-40  Score=304.12  Aligned_cols=244  Identities=29%  Similarity=0.418  Sum_probs=204.2

Q ss_pred             cccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      ...++||+||||.||-++. .+|+-+|.|.+...   ....+.-.++|-.+|.+++.+.||.+-..|.+.+.+|+|+..|
T Consensus       188 ~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlM  267 (591)
T KOG0986|consen  188 RVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLM  267 (591)
T ss_pred             eeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEee
Confidence            3347899999999999854 47999999988543   2344556688999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA  270 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  270 (432)
                      .||+|.-+|+......+++..+..++.+|+.||++||...   |+.|||||+|||||+.|+++|+|.|||..........
T Consensus       268 NGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~  344 (591)
T KOG0986|consen  268 NGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR  344 (591)
T ss_pred             cCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCccc
Confidence            9999999998877778999999999999999999999999   9999999999999999999999999999877777777


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN  350 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (432)
                      ..+||.+|||||++..+.|+...|.|||||+||||+.|+.||....+-+..........+         -...++...++
T Consensus       345 ~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~---------~~~ey~~kFS~  415 (591)
T KOG0986|consen  345 GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE---------DPEEYSDKFSE  415 (591)
T ss_pred             cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc---------chhhcccccCH
Confidence            779999999999999999999999999999999999999999754332221111111110         11223444556


Q ss_pred             HHHHHHHHhhccCCCCCCCH
Q 014038          351 EVASLAYKCVNRAPRKRPSM  370 (432)
Q Consensus       351 ~l~~li~~cl~~dp~~RPs~  370 (432)
                      +..+|....|++||.+|.-.
T Consensus       416 eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  416 EAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             HHHHHHHHHHccCHHHhccC
Confidence            88999999999999999643

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=299.29  Aligned_cols=256  Identities=25%  Similarity=0.366  Sum_probs=199.0

Q ss_pred             cccccccccCceeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          115 NFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .+.+.||.|++|.||+|... +++.+++|.+.....  .....+.+|+.++++++|+||+++++++..++..++||||++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD   81 (283)
T ss_pred             ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence            45578999999999999654 788999999865432  245678899999999999999999999999999999999997


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-ccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~  270 (432)
                      + +|.+++.... ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||.+....... ...
T Consensus        82 ~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~  156 (283)
T cd05118          82 T-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT  156 (283)
T ss_pred             C-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence            5 8888875533 57999999999999999999999999   9999999999999999999999999886543332 223


Q ss_pred             ccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcC----CCchhhhcc--------
Q 014038          271 NIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG----KTGWEEIVD--------  337 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~--------  337 (432)
                      ...++..|+|||.+.+. .++.++|+||||+++|+|++|+.||................    ...+..+.+        
T Consensus       157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05118         157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS  236 (283)
T ss_pred             CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence            34578899999998766 78999999999999999999999997654433222211110    001111110        


Q ss_pred             -cc-CC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          338 -SR-LD---GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       338 -~~-~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                       +. ..   .......+.++.+++.+||+.||.+||++.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence             00 00   0011224568999999999999999999999885

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=300.23  Aligned_cols=258  Identities=27%  Similarity=0.403  Sum_probs=197.8

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhhcC-CCccceEEeeeeeCCeEEEEEEec
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      |.+.+.||+|++|.||+|... +++.||||.+..... .......+|+..+.+++ |+|++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            346678999999999999765 578999999865422 22334567999999998 999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA  270 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  270 (432)
                       +|+|.+.+.......+++..+..++.|++.+|.|||+++   ++|+||+|+||++++++.++|+|||++..........
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  156 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT  156 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC
Confidence             889999886655457899999999999999999999999   9999999999999999999999999987654433334


Q ss_pred             ccccCCCCCCccccc-cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcC----CCchhh------hcccc
Q 014038          271 NIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG----KTGWEE------IVDSR  339 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~~------~~~~~  339 (432)
                      ...++..|+|||.+. ...++.++|+||||+++|||++|+.||................    ...|.+      .....
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07830         157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR  236 (283)
T ss_pred             CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence            456788999999874 4567899999999999999999999997654322221111000    000000      00000


Q ss_pred             CCCC-------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          340 LDGI-------FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       340 ~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ....       ........+.+++.+||+.+|++||++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000       00011357999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=295.23  Aligned_cols=243  Identities=28%  Similarity=0.388  Sum_probs=189.4

Q ss_pred             ccccccCceeEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHH-hhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVMLL-GRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +.||+|+||.||+|.. .+|+.||+|.+.....   .....+..|..++ ...+|+|++++++++...+..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4689999999999965 4688999999865422   2223344555444 445899999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI  272 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  272 (432)
                      ++|.+++..  ..++++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++.....   ....
T Consensus        82 ~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~  153 (260)
T cd05611          82 GDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKF  153 (260)
T ss_pred             CCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc---cccC
Confidence            999999853  356899999999999999999999998   99999999999999999999999998875332   2344


Q ss_pred             ccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHH
Q 014038          273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEV  352 (432)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  352 (432)
                      .+++.|+|||.+.+..++.++||||||+++|||++|..||.............. ....+        ........+..+
T Consensus       154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~--------~~~~~~~~~~~~  224 (260)
T cd05611         154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-RRINW--------PEEVKEFCSPEA  224 (260)
T ss_pred             CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-cccCC--------CCcccccCCHHH
Confidence            688899999999888899999999999999999999999976443222211111 11000        001111234578


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          353 ASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       353 ~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                      .+++.+||+.+|++||++.++.+.|
T Consensus       225 ~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         225 VDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             HHHHHHHccCCHHHccCCCcHHHHH
Confidence            9999999999999999876555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-39  Score=328.33  Aligned_cols=264  Identities=30%  Similarity=0.501  Sum_probs=211.2

Q ss_pred             HHHHHHHhccccccccccCceeEEEEEeC----C----CcEEEEEEeccC-ChhhHHHHHHHHHHHhhc-CCCccceEEe
Q 014038          106 YKDLQKATCNFTTLIGQGAFGPVYKAQMS----T----GETVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVG  175 (432)
Q Consensus       106 ~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~  175 (432)
                      ..++......+.+.||+|.||.|++|...    .    ...||||.++.. .....+.+..|+++|..+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34444444456679999999999999532    1    357999999765 335567899999999999 6999999999


Q ss_pred             eeeeCCeEEEEEEeccCCChhhhcccCC------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCC
Q 014038          176 YCAEKGQHMLVYVFMSKGSLASHLYDEN------------Y--GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKS  241 (432)
Q Consensus       176 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~--~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp  241 (432)
                      +|..++..++|+||+..|+|.++|+...            .  ..++....+.++.|||.|++||++..   ++||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999996543            0  13888999999999999999999988   99999999


Q ss_pred             CCeeecCCCcEEEeecCCcccccccccc--cccc--cCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChh
Q 014038          242 SNILLDQSMRARVADFGLSREEMVDKHA--ANIR--GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM  316 (432)
Q Consensus       242 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~  316 (432)
                      +|||+.++..+||+|||+++........  ....  -...|||||.+....|+.|+|||||||+|||++| |..||.+..
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999864433222  1112  3456999999999999999999999999999999 999998743


Q ss_pred             HHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          317 EYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      ....+......+           .+...|..+..+++++|..||+.+|++||++.++.+.++..+..
T Consensus       527 ~~~~l~~~l~~G-----------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~  582 (609)
T KOG0200|consen  527 PTEELLEFLKEG-----------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD  582 (609)
T ss_pred             cHHHHHHHHhcC-----------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence            222222222222           12223334456899999999999999999999999999997653

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.7e-38  Score=298.78  Aligned_cols=240  Identities=28%  Similarity=0.406  Sum_probs=185.9

Q ss_pred             cccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHh---hcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          119 LIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLG---RLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .||+|+||.||++.. .+++.+|+|.+....   ......+.+|..+++   ..+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999965 468899999886532   122233445544333   3479999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN  271 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  271 (432)
                      +|+|.+++..  .+.+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.++|+|||++...... ....
T Consensus        81 ~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~  154 (279)
T cd05633          81 GGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHA  154 (279)
T ss_pred             CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccC
Confidence            9999988853  356999999999999999999999999   999999999999999999999999998643322 2233


Q ss_pred             cccCCCCCCccccc-cCCCCchhHhHHHHHHHHHHHhCCCCCCChhH--HHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          272 IRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLME--YVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       272 ~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      ..|+..|+|||.+. +..++.++|||||||++|||++|..||.....  .........            ......+...
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------------~~~~~~~~~~  222 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL------------TVNVELPDSF  222 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh------------cCCcCCcccc
Confidence            46899999999886 45689999999999999999999999964321  111111000            0111122334


Q ss_pred             HHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRP-----SMRDIVQV  376 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RP-----s~~~vl~~  376 (432)
                      +.++.+++.+||+.||.+||     +++++++.
T Consensus       223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            46889999999999999999     58887763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.2e-38  Score=302.48  Aligned_cols=247  Identities=28%  Similarity=0.403  Sum_probs=197.1

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      +...+.||+|+||.||+|.. .++..||+|.+....   ......+.+|+.+++.++|||++++++++.++...++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            44557899999999999965 468899999986432   23345788999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA  269 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  269 (432)
                      +. |+|.+.+... ..++++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++....   ..
T Consensus       107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~---~~  178 (317)
T cd06635         107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS---PA  178 (317)
T ss_pred             CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccC---Cc
Confidence            96 5787776432 456999999999999999999999999   9999999999999999999999999876432   22


Q ss_pred             cccccCCCCCCccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          270 ANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      ....+++.|+|||.+.   .+.++.++|||||||++|||++|+.||.................           ......
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~  247 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----------PTLQSN  247 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC-----------CCCCCc
Confidence            3456888999999873   45789999999999999999999999876433222222211111           111112


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR  379 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~  379 (432)
                      ..+..+.+++.+||+.+|.+||++.++++.+..
T Consensus       248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             cccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence            234578999999999999999999999976543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-38  Score=298.51  Aligned_cols=256  Identities=30%  Similarity=0.423  Sum_probs=197.1

Q ss_pred             cccccccccCceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeC--CeEEEEEEe
Q 014038          115 NFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHMLVYVF  189 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~  189 (432)
                      ++.+.||.|+||.||+|... +++.+|+|.+....  ......+.+|+.+++.++|||++++++++...  +..++||||
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   81 (287)
T cd07840           2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY   81 (287)
T ss_pred             eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence            45678999999999999765 57899999997653  33345788999999999999999999999888  899999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--  267 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--  267 (432)
                      +++ +|.+++.... ..+++..++.++.||+.||+|||+.+   ++|+||+|+||++++++.+||+|||++.......  
T Consensus        82 ~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          82 MDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             ccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            975 8888885432 57999999999999999999999998   9999999999999999999999999987543332  


Q ss_pred             cccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc----CCCchhhhcc-----
Q 014038          268 HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE----GKTGWEEIVD-----  337 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~-----  337 (432)
                      ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...............    ....|..+.+     
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence            1233456888999997754 46789999999999999999999999765433222221110    0001111000     


Q ss_pred             ---------ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          338 ---------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       338 ---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                               ..+...+....+.++.+++.+||+.+|++||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                     00000011112467899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.7e-38  Score=301.03  Aligned_cols=259  Identities=23%  Similarity=0.304  Sum_probs=194.8

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcC-CCccceEEeeeeeCCe-----E
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQ-----H  183 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----~  183 (432)
                      .|.+.+.||+|+||.||+|... +++.||+|.+....  ......+.+|+.+++.++ ||||+++++++...+.     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            3556788999999999999754 68999999876542  223457888999999995 6999999999877655     8


Q ss_pred             EEEEEeccCCChhhhcccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC-CCcEEEeecCC
Q 014038          184 MLVYVFMSKGSLASHLYDEN---YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGL  259 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~-~~~~kl~Dfgl  259 (432)
                      ++||||+++ +|.+++....   ...+++..+..++.||+.||.|||+.+   ++||||||+||+++. ++.+||+|||+
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeeccc
Confidence            999999985 8888875432   346899999999999999999999998   999999999999998 88999999999


Q ss_pred             ccccccc-ccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc----CCCchh
Q 014038          260 SREEMVD-KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE----GKTGWE  333 (432)
Q Consensus       260 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~  333 (432)
                      +...... .......+++.|+|||.+.+ ..++.++||||||+++|||++|..||.+..+..........    ....|.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (295)
T cd07837         158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP  237 (295)
T ss_pred             ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            8753222 11223356889999998754 46799999999999999999999999765444333222111    011111


Q ss_pred             hhcc-------ccCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          334 EIVD-------SRLDG----IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       334 ~~~~-------~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ....       +....    ......+.++.+++.+||+.||.+||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000       00000    000123457899999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3e-38  Score=301.48  Aligned_cols=258  Identities=29%  Similarity=0.382  Sum_probs=195.3

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCCh--hhHHHHHHHHHHHhhcCCCccceEEeeeeeC--CeEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHMLVY  187 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  187 (432)
                      .|++.+.||+|+||.||+|.. .+|+.||+|.+.....  .....+.+|+.++++++|+||+++++++...  +..++||
T Consensus         8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (309)
T cd07845           8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM   87 (309)
T ss_pred             ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence            466778999999999999965 4689999999865422  2233567899999999999999999998754  5689999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-  266 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-  266 (432)
                      ||+.+ +|.+++... ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++...... 
T Consensus        88 e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          88 EYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             ecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            99974 888877543 357999999999999999999999999   999999999999999999999999998754332 


Q ss_pred             ccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCC----Cchhhhccc---
Q 014038          267 KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGK----TGWEEIVDS---  338 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~---  338 (432)
                      .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.................    ..|..+...   
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence            12223345788999998865 5688999999999999999999999986554433322211110    001000000   


Q ss_pred             ---cCC-CCCC------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          339 ---RLD-GIFD------VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       339 ---~~~-~~~~------~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                         ... ....      ...+.++.+++.+||+.||++|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence               000 0000      012457889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.5e-38  Score=290.82  Aligned_cols=247  Identities=26%  Similarity=0.424  Sum_probs=202.5

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      |.+.+.||+|+||.||++... ++..||+|.+.....  .....+.+|+++++.++|||++++++.+...+..++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~   81 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA   81 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence            456678999999999999654 688999999876532  45567889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-
Q 014038          191 SKGSLASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-  267 (432)
Q Consensus       191 ~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-  267 (432)
                      ++++|.+++....  ...+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD  158 (258)
T ss_pred             CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence            9999999886543  467999999999999999999999998   9999999999999999999999999987543332 


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ......+++.|+|||......++.++|+||||+++|+|++|+.||................            ....+..
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~------------~~~~~~~  226 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ------------YPPIPSQ  226 (258)
T ss_pred             eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC------------CCCCCCC
Confidence            2234568889999999988889999999999999999999999997543211111111100            1111223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+.++.+++.+||..+|++||++.++++
T Consensus       227 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         227 YSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            3457899999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-38  Score=290.05  Aligned_cols=245  Identities=29%  Similarity=0.482  Sum_probs=202.5

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      |.+.+.||+|++|.||++... +++.|++|.+.....  .....+.+|++++.+++|||++++++++.+.+..+++|||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            456688999999999999654 678999999876543  44567899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc-c
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH-A  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-~  269 (432)
                      ++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++........ .
T Consensus        82 ~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  156 (254)
T cd06627          82 ENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD  156 (254)
T ss_pred             CCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence            999999988543  57999999999999999999999998   99999999999999999999999999875443322 2


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....++..|+|||...+..++.++||||||+++|+|++|+.||.................            ...+...+
T Consensus       157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------~~~~~~~~  224 (254)
T cd06627         157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH------------PPLPEGIS  224 (254)
T ss_pred             cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC------------CCCCCCCC
Confidence            345678899999999888889999999999999999999999976543332222211111            11122234


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.+++.+||..+|++||++.+++.
T Consensus       225 ~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         225 PELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             HHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            57899999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.1e-38  Score=300.50  Aligned_cols=259  Identities=17%  Similarity=0.251  Sum_probs=183.8

Q ss_pred             HHHHHhccccccccccCceeEEEEEeCC----CcEEEEEEeccCChhh--H---------HHHHHHHHHHhhcCCCccce
Q 014038          108 DLQKATCNFTTLIGQGAFGPVYKAQMST----GETVAVKVLATDSKQG--E---------KEFQTEVMLLGRLHHRNLVN  172 (432)
Q Consensus       108 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~h~niv~  172 (432)
                      ++....|.+.++||+|+||.||+|...+    +..+|+|.........  +         .....+...+..++|+|+++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            3444567888999999999999997643    4566777643322111  0         11223444566778999999


Q ss_pred             EEeeeeeCC----eEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC
Q 014038          173 LVGYCAEKG----QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ  248 (432)
Q Consensus       173 l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~  248 (432)
                      +++++....    ..+++++++. .++.+.+..  ....++..+..++.|++.||+|||+.+   |+||||||+|||++.
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~  161 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG  161 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhc-cCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence            999765543    3456777664 356555532  234678889999999999999999998   999999999999999


Q ss_pred             CCcEEEeecCCccccccc--------ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHH
Q 014038          249 SMRARVADFGLSREEMVD--------KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVE  320 (432)
Q Consensus       249 ~~~~kl~Dfgl~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~  320 (432)
                      ++.++|+|||+++.....        .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+......
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            999999999998754221        112234699999999999999999999999999999999999999986532111


Q ss_pred             HHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          321 LAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                      .......  ..+..+......   ....+.++.+++..||+.+|++||++.++++.|
T Consensus       242 ~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        242 LIHAAKC--DFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHhHH--HHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1110000  000111111110   111245799999999999999999999999876

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.7e-38  Score=296.95  Aligned_cols=258  Identities=25%  Similarity=0.395  Sum_probs=197.1

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh-hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      |.+.+.||.|++|.||+|... +|..||||.+..... .....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD   81 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence            456789999999999999764 688999999876532 234567889999999999999999999999999999999998


Q ss_pred             CCChhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cc
Q 014038          192 KGSLASHLYDEN-YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA  269 (432)
Q Consensus       192 ~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~  269 (432)
                      + +|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++....... ..
T Consensus        82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence            5 8888775432 356899999999999999999999998   9999999999999999999999999986533221 22


Q ss_pred             cccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh----cCCCchhhhcc-ccCCCC
Q 014038          270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT----EGKTGWEEIVD-SRLDGI  343 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~-~~~~~~  343 (432)
                      ....++..|++||.+.+ ..++.++|||||||++|||++|+.||.+............    .....|..+.+ +.....
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            33457889999998765 4578999999999999999999999976443222111110    01111111110 000000


Q ss_pred             -----------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          344 -----------FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       344 -----------~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                                 .....+..+.+++.+||+.||.+||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                       01122457889999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-39  Score=287.63  Aligned_cols=238  Identities=25%  Similarity=0.408  Sum_probs=199.1

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .++|.++||+|.||.|-+++- .+|+.+|+|++++.-   +.....-..|-++|+..+||.+..+...|+..+.+|+|||
T Consensus       169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe  248 (516)
T KOG0690|consen  169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME  248 (516)
T ss_pred             hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence            456788999999999999964 489999999998763   3333455678899999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DK  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~  267 (432)
                      |..||.|.-+|.  ....+++.....+...|+.||.|||+++   |+.||||.+|.|||.+|++||+|||+++.... ..
T Consensus       249 yanGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~  323 (516)
T KOG0690|consen  249 YANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD  323 (516)
T ss_pred             EccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccccc
Confidence            999999999884  3457999999999999999999999999   99999999999999999999999999987543 45


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ...+++|||-|+|||++....|....|.|.+||++|||++|+.||..........-+           +-..+  .+|..
T Consensus       324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI-----------l~ed~--kFPr~  390 (516)
T KOG0690|consen  324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI-----------LMEDL--KFPRT  390 (516)
T ss_pred             eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH-----------Hhhhc--cCCcc
Confidence            678899999999999999999999999999999999999999999754322111111           11111  13334


Q ss_pred             HHHHHHHHHHHhhccCCCCCC
Q 014038          348 ELNEVASLAYKCVNRAPRKRP  368 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RP  368 (432)
                      .+.+...|+...|.+||.+|.
T Consensus       391 ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  391 LSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             CCHHHHHHHHHHhhcChHhhc
Confidence            445788999999999999994

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=306.76  Aligned_cols=257  Identities=24%  Similarity=0.361  Sum_probs=193.2

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC-----CeEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-----GQHML  185 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l  185 (432)
                      .|.+.+.||+|+||.||+|.. .+|+.||+|.+... .......+.+|+.++++++||||+++++++...     ...++
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   85 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI   85 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence            567788999999999999964 57899999998643 233445688899999999999999999987543     35799


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ++||+.+ +|.+.+..   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        86 v~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          86 VQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADP  158 (336)
T ss_pred             Eehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence            9999964 88777733   46999999999999999999999999   99999999999999999999999999875432


Q ss_pred             cc----cccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh----cCCCchhhhc
Q 014038          266 DK----HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT----EGKTGWEEIV  336 (432)
Q Consensus       266 ~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~~~~  336 (432)
                      ..    ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.........+..    .....+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            21    1123468899999998654 5689999999999999999999999975432221111110    0000011100


Q ss_pred             ccc-------C--CCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          337 DSR-------L--DGIFD-----VEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       337 ~~~-------~--~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ...       .  ....+     ...+.++.+++.+||+.+|++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000       0  00000     1123578999999999999999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-38  Score=291.64  Aligned_cols=246  Identities=25%  Similarity=0.426  Sum_probs=197.5

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC-----ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC--CeEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHM  184 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  184 (432)
                      .|.+.+.||+|+||.||+|.. .++..||+|.+...     .......+.+|+.++++++|+||+++++++.+.  ...+
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            356778999999999999965 46899999987532     123345788999999999999999999998764  4688


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      +++||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++...
T Consensus        83 ~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          83 IFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            999999999999988543  45889999999999999999999999   9999999999999999999999999987532


Q ss_pred             cc----ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          265 VD----KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       265 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ..    .......++..|+|||.+.+..++.++|+|||||++|||++|+.||..............           ...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----------~~~  226 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT-----------QPT  226 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc-----------CCC
Confidence            21    112234688999999999888899999999999999999999999976543332222111           111


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ....+.....++.+++.+||+ +|..||++.+++.
T Consensus       227 ~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            122334445689999999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.3e-38  Score=294.68  Aligned_cols=243  Identities=31%  Similarity=0.482  Sum_probs=196.0

Q ss_pred             ccccCceeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCCh
Q 014038          120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       120 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  195 (432)
                      ||.|+||.||++... +|+.+++|.+.....   ...+.+.+|++++++++||||+++++.+......+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999765 589999999865433   3456788999999999999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--------
Q 014038          196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--------  267 (432)
Q Consensus       196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--------  267 (432)
                      .+++...  ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.......        
T Consensus        81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            9998643  37899999999999999999999999   9999999999999999999999999987543221        


Q ss_pred             -cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          268 -HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       268 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                       ......++..|+|||......++.++||||||+++|||++|+.||.............. +...+.          ...
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~----------~~~  224 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN-GKIEWP----------EDV  224 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCcCCC----------ccc
Confidence             22334578899999999888899999999999999999999999975443222111111 111110          011


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                      ..+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            12457899999999999999999966555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.1e-38  Score=298.06  Aligned_cols=249  Identities=28%  Similarity=0.444  Sum_probs=192.5

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      .+.+.+.||+|+||.||+|... +++.||||.+.... ......+..|+.++.+. .||||++++++|.+....+++|||
T Consensus        16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   95 (296)
T cd06618          16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL   95 (296)
T ss_pred             hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence            4567789999999999999775 48999999987543 23345667788777776 499999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      +. ++|..++... ..++++..+..++.|++.||+|||+ .+   |+||||+|+||++++++.+||+|||++........
T Consensus        96 ~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          96 MS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             cC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            85 4676665432 3479999999999999999999997 46   99999999999999999999999999875433333


Q ss_pred             ccccccCCCCCCccccccCC----CCchhHhHHHHHHHHHHHhCCCCCCChhHHH-HHHHhhhcCCCchhhhccccCCCC
Q 014038          269 AANIRGTFGYLDPEYISTRN----FTKKSDVYSFGVLLFELIAGRSPLQGLMEYV-ELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                      .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||....... ............        ..  
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~--  240 (296)
T cd06618         171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS--------LP--  240 (296)
T ss_pred             ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC--------CC--
Confidence            33445788999999987554    7899999999999999999999997532211 111111111000        00  


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      .....+.++.+++.+||+.||++||++.++++.
T Consensus       241 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            001123578999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.4e-38  Score=292.33  Aligned_cols=246  Identities=22%  Similarity=0.347  Sum_probs=201.8

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      |.+.+.||+|+||.||++.. .+++.+|+|.+...  .......+.+|+.+++.++|+||+++++++.+....++||||+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA   81 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence            45678899999999999954 47889999998653  2333457789999999999999999999999999999999999


Q ss_pred             cCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          191 SKGSLASHLYDE--NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       191 ~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      ++++|.+++...  ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++...... .
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~  157 (256)
T cd08530          82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-M  157 (256)
T ss_pred             CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-C
Confidence            999999988542  2356899999999999999999999999   999999999999999999999999998765433 3


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      .....+++.|+|||.+.+..++.++|+||||+++|||++|+.||..............            ......+...
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------~~~~~~~~~~  225 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR------------GKYPPIPPIY  225 (256)
T ss_pred             cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------CCCCCCchhh
Confidence            3345678999999999988999999999999999999999999976443211111111            1111222344


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +.++.+++.+||+.+|++||++.++++
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         226 SQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            568999999999999999999999885

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2e-38  Score=306.06  Aligned_cols=259  Identities=23%  Similarity=0.318  Sum_probs=196.2

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeee----CCeEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE----KGQHM  184 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  184 (432)
                      ..|.+.+.||+|+||.||+|.. .+|+.||+|.+....  ......+.+|+.++++++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            3566678899999999999964 478999999987542  2334667889999999999999999998753    35689


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      +||||+. |+|.+++..  ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        85 lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          85 VVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            9999996 689888853  345999999999999999999999998   9999999999999999999999999987543


Q ss_pred             cccc-----ccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhc--
Q 014038          265 VDKH-----AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIV--  336 (432)
Q Consensus       265 ~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  336 (432)
                      ....     .....++..|+|||.+.. ..++.++|||||||++|||++|+.||.+......+............++.  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence            2211     123468899999998755 56889999999999999999999999764332222111111111111110  


Q ss_pred             ----------cc-cCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          337 ----------DS-RLDGIFD-----VEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       337 ----------~~-~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                                +. ......+     ...+.++.+++.+||+.+|++||++.+++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                      00 0000111     1234689999999999999999999998863

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-38  Score=307.67  Aligned_cols=244  Identities=27%  Similarity=0.422  Sum_probs=205.5

Q ss_pred             HhccccccccccCceeEEEEE-eCCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .-|.+...||+|.|+.|.+|+ ..++..||||.+....  ......+.+|+++|..++|||||+++.+......+|+|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            345667899999999999995 4579999999997653  3333458899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+.+|.+.+++..  .+.+.+..+..++.|+..|++|||+++   |+|||||++||||+.+.++||+|||++........
T Consensus       136 ya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~  210 (596)
T KOG0586|consen  136 YASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM  210 (596)
T ss_pred             eccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccccc
Confidence            9999999999954  455777889999999999999999999   99999999999999999999999999988777777


Q ss_pred             ccccccCCCCCCccccccCCCC-chhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCC--C
Q 014038          269 AANIRGTFGYLDPEYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF--D  345 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  345 (432)
                      ..+.+|++.|.|||++.+..|+ +++|+||+|+++|-|+.|..||++..               +.++.+..+.+.+  +
T Consensus       211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~---------------lk~Lr~rvl~gk~rIp  275 (596)
T KOG0586|consen  211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN---------------LKELRPRVLRGKYRIP  275 (596)
T ss_pred             ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc---------------cccccchheeeeeccc
Confidence            8889999999999999998875 89999999999999999999998632               1111111222211  1


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .....+..+++.+++-.+|.+|+++.++.+
T Consensus       276 ~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  276 FYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            112346788999999999999999999875

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-38  Score=300.51  Aligned_cols=258  Identities=23%  Similarity=0.351  Sum_probs=192.8

Q ss_pred             ccccccccccCceeEEEEEeC---CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeC--CeEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS---TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHML  185 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  185 (432)
                      |.+.+.||+|+||.||+|...   +++.||+|.+....   ......+.+|+.++..++||||+++++++.+.  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            566788999999999999754   47899999987632   33346678899999999999999999999888  78999


Q ss_pred             EEEeccCCChhhhccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC----CCcEEEeecC
Q 014038          186 VYVFMSKGSLASHLYD---ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ----SMRARVADFG  258 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~----~~~~kl~Dfg  258 (432)
                      ||||+++ +|.+.+..   .....+++..+..++.|++.||.|||+.+   ++||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999975 67666532   22247899999999999999999999999   999999999999999    9999999999


Q ss_pred             Ccccccccc----cccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHH---------HHHHh
Q 014038          259 LSREEMVDK----HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV---------ELAAM  324 (432)
Q Consensus       259 l~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~---------~~~~~  324 (432)
                      ++.......    ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.....         .+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            987543221    1233467889999998765 458999999999999999999999997432211         00000


Q ss_pred             ----hhcCCC---------chhhhccccCCCCCC---------H--HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          325 ----NTEGKT---------GWEEIVDSRLDGIFD---------V--EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       325 ----~~~~~~---------~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                          ......         .+....+......++         .  ....++.+++.+||+.||++|||+.++++
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                000000         000000000011111         0  12346889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.7e-38  Score=297.14  Aligned_cols=259  Identities=28%  Similarity=0.391  Sum_probs=196.3

Q ss_pred             HHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC------
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG------  181 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  181 (432)
                      ...|.+.+.||+|+||.||+|... +|+.||+|.+....  ......+.+|+.+++.++||||+++++++.+..      
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            446677889999999999999764 68899999987543  233356788999999999999999999987654      


Q ss_pred             ----eEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeec
Q 014038          182 ----QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADF  257 (432)
Q Consensus       182 ----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Df  257 (432)
                          ..++|+||+++ +|...+... ...+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+||
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~df  160 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADF  160 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcc
Confidence                78999999976 777766433 356999999999999999999999998   999999999999999999999999


Q ss_pred             CCcccccccc--cccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcC----CC
Q 014038          258 GLSREEMVDK--HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG----KT  330 (432)
Q Consensus       258 gl~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~~  330 (432)
                      |++.......  ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........+.......    ..
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            9987543322  1222346788999998764 457899999999999999999999997654333322221110    00


Q ss_pred             chhhhccc--------------cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          331 GWEEIVDS--------------RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       331 ~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+..+...              .....+ ...+..+.+++.+||+.||.+||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11111000              000000 012457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-38  Score=304.07  Aligned_cols=257  Identities=27%  Similarity=0.337  Sum_probs=199.4

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC-----eEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-----QHML  185 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l  185 (432)
                      |.+.+.||.|++|.||+|... +++.||+|.+....  ....+.+.+|+.+++.++||||+++++++....     ..++
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            566789999999999999764 58999999987543  344567899999999999999999999988765     7899


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      +|+|+. ++|.+++...  .++++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++.....
T Consensus        82 v~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          82 VTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             Eecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            999997 5888888543  47999999999999999999999999   99999999999999999999999999876443


Q ss_pred             cc----cccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCC----------
Q 014038          266 DK----HAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT----------  330 (432)
Q Consensus       266 ~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----------  330 (432)
                      ..    ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.+................          
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence            32    23345678899999999877 8899999999999999999999999765432221111110000          


Q ss_pred             --chhhhccc-cCCCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          331 --GWEEIVDS-RLDGIF-----DVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       331 --~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                        .....+.. ......     ....+..+.+++.+||+.+|++||++.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              00000000 000000     01124578999999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.6e-37  Score=296.35  Aligned_cols=258  Identities=26%  Similarity=0.342  Sum_probs=191.4

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC--------
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG--------  181 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  181 (432)
                      .|.+.+.||+|+||.||+|.. .+++.||||.+....  ......+.+|+.++++++||||++++++|...+        
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   92 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG   92 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence            577788999999999999965 478999999886532  222345678999999999999999999987654        


Q ss_pred             eEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          182 QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       182 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                      ..++||||+.+ +|.+.+... ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++.
T Consensus        93 ~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          93 SFYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             eEEEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence            45999999964 787777433 346899999999999999999999998   9999999999999999999999999987


Q ss_pred             cccccc-----cccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhh
Q 014038          262 EEMVDK-----HAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEI  335 (432)
Q Consensus       262 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (432)
                      ......     ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.+....................+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV  247 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            543221     11234578899999987654 478999999999999999999999976543222211111000000000


Q ss_pred             ---------ccc-cCCCCC---------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 ---------VDS-RLDGIF---------DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 ---------~~~-~~~~~~---------~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                               .+. ......         +......+.+++.+||+.||.+|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                     000 000000         0001246789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=9e-38  Score=301.91  Aligned_cols=258  Identities=27%  Similarity=0.371  Sum_probs=194.7

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeC--CeEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD--SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK--GQHML  185 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~l  185 (432)
                      ..|.+.+.||+|+||.||+|... +++.+|+|.+...  .......+.+|+.+++++ +||||++++++|...  ...++
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            45667789999999999999754 6889999988542  223345677899999999 999999999988653  36899


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||++ ++|.+++...   .+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        87 v~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          87 VFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             Eecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            999997 5998888432   6899999999999999999999998   99999999999999999999999999875432


Q ss_pred             cc------cccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCc----h--
Q 014038          266 DK------HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG----W--  332 (432)
Q Consensus       266 ~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----~--  332 (432)
                      ..      ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.+.................    +  
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            21      2223468899999998754 567899999999999999999999997644332222111110000    0  


Q ss_pred             ------hhhccccCCC------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          333 ------EEIVDSRLDG------IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       333 ------~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                            ..+++.....      ......+.++.+++.+||+.||++|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                  0001000000      0000124578999999999999999999999963

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.2e-37  Score=292.80  Aligned_cols=239  Identities=27%  Similarity=0.396  Sum_probs=186.2

Q ss_pred             cccccCceeEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHH---HHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          119 LIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVM---LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .||+|+||.||+|.. .+++.||+|.+.....   .....+..|..   .++...||||+.+++++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999964 4688999999865321   22223444443   3444579999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN  271 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  271 (432)
                      +|+|..++..  .+.+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...... ....
T Consensus        81 g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~  154 (278)
T cd05606          81 GGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHA  154 (278)
T ss_pred             CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcC
Confidence            9999988843  357999999999999999999999998   999999999999999999999999998653222 2234


Q ss_pred             cccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHH--HHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          272 IRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEY--VELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      ..|+..|+|||.+.++ .++.++|||||||++|||++|+.||......  ........            ......+...
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------~~~~~~~~~~  222 (278)
T cd05606         155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL------------TMAVELPDSF  222 (278)
T ss_pred             cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh------------ccCCCCCCcC
Confidence            5689999999998754 6899999999999999999999999754211  11100000            0011122223


Q ss_pred             HHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRP-----SMRDIVQ  375 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RP-----s~~~vl~  375 (432)
                      +.++.+++.+||..+|.+||     ++.++++
T Consensus       223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            45899999999999999999     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=311.48  Aligned_cols=264  Identities=27%  Similarity=0.416  Sum_probs=205.1

Q ss_pred             ccccccccCceeEEEEE-eCCCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC------CeEEEEE
Q 014038          116 FTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQHMLVY  187 (432)
Q Consensus       116 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~  187 (432)
                      ..+.||+|+||.||+|+ ..+|+.||||.++.. .....+...+|+++|++++|+|||++++.-.+.      ....++|
T Consensus        17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm   96 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM   96 (732)
T ss_pred             ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence            34679999999999997 568999999999764 345567789999999999999999999976543      3678999


Q ss_pred             EeccCCChhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec--CCC--cEEEeecCCccc
Q 014038          188 VFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD--QSM--RARVADFGLSRE  262 (432)
Q Consensus       188 e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~--~~~--~~kl~Dfgl~~~  262 (432)
                      |||.+|||...|.+ .+...|++.+.+.+..++..||.|||+++   |+||||||.||++-  .+|  .-||+|||.|+.
T Consensus        97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            99999999999975 44567999999999999999999999999   99999999999983  333  479999999998


Q ss_pred             ccccccccccccCCCCCCccccc-cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHH----HHHHhhhcC---------
Q 014038          263 EMVDKHAANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV----ELAAMNTEG---------  328 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~----~~~~~~~~~---------  328 (432)
                      ...+......+||+.|.+||... .+.|+..+|.|||||++|+++||..||.......    .........         
T Consensus       174 l~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~  253 (732)
T KOG4250|consen  174 LDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQ  253 (732)
T ss_pred             CCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeee
Confidence            88888888999999999999998 4889999999999999999999999996432211    111111111         


Q ss_pred             -----CCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHHHHhhc
Q 014038          329 -----KTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRP--SMRDIVQVLSRILKMR  384 (432)
Q Consensus       329 -----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP--s~~~vl~~L~~i~~~~  384 (432)
                           ...|...+..  ...........+...+..+|..+|++|-  .+.+....+..|+...
T Consensus       254 ~~eNgpv~~s~~lP~--p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~  314 (732)
T KOG4250|consen  254 EEENGPVEWSSTLPQ--PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK  314 (732)
T ss_pred             cccCCceeeeccCCC--cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence                 1111111111  1111223334566777888888999998  7777777777776544

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-37  Score=315.76  Aligned_cols=265  Identities=21%  Similarity=0.297  Sum_probs=186.7

Q ss_pred             HHHHHhccccccccccCceeEEEEEeC--CCcEEEEEEe--------------c---cCChhhHHHHHHHHHHHhhcCCC
Q 014038          108 DLQKATCNFTTLIGQGAFGPVYKAQMS--TGETVAVKVL--------------A---TDSKQGEKEFQTEVMLLGRLHHR  168 (432)
Q Consensus       108 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~h~  168 (432)
                      +.....|.+.+.||+|+||+||++...  ++...++|.+              .   .........+.+|+.+|++++||
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence            334567888999999999999998543  2222222211              0   01122345688999999999999


Q ss_pred             ccceEEeeeeeCCeEEEEEEeccCCChhhhcccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCee
Q 014038          169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDEN---YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNIL  245 (432)
Q Consensus       169 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nil  245 (432)
                      ||+++++++...+..+++++++. ++|.+++....   ........+..++.||+.||.|||+++   |+||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence            99999999999999999999985 57777764321   122345667789999999999999999   999999999999


Q ss_pred             ecCCCcEEEeecCCcccccccc--cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCC-CCCCh--hHHHH
Q 014038          246 LDQSMRARVADFGLSREEMVDK--HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRS-PLQGL--MEYVE  320 (432)
Q Consensus       246 l~~~~~~kl~Dfgl~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~-p~~~~--~~~~~  320 (432)
                      ++.++.+||+|||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|.. |+...  .....
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            9999999999999997543322  2234579999999999999999999999999999999999875 44321  11111


Q ss_pred             HHHhhhcCCCchh----------hhcccc-CC---CCCCH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          321 LAAMNTEGKTGWE----------EIVDSR-LD---GIFDV-----EELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       321 ~~~~~~~~~~~~~----------~~~~~~-~~---~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      +............          ..++.. ..   ...+.     .....+.+++.+||+.||.+|||+.|+++.
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            1111110000000          000000 00   00000     112357788999999999999999999863

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.6e-37  Score=296.32  Aligned_cols=245  Identities=26%  Similarity=0.380  Sum_probs=194.4

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      ++...+.||+|+||.||+|.. .++..+|+|.+...   ......++.+|+.+++.++|+|++++++++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            444557899999999999975 46789999988642   22334578899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+. |+|.+.+... ..++++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.....   
T Consensus        96 ~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---  167 (308)
T cd06634          96 YCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (308)
T ss_pred             ccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence            996 6887776433 346899999999999999999999998   99999999999999999999999999865322   


Q ss_pred             ccccccCCCCCCccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          269 AANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      .....+++.|+|||.+.   ...++.++|||||||++|||++|+.||.................           .....
T Consensus       168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----------~~~~~  236 (308)
T cd06634         168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----------PALQS  236 (308)
T ss_pred             cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-----------CCcCc
Confidence            23446788999999874   35678999999999999999999999876433222211111110           01111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ...+..+.+++.+||+.+|++||++.++++.
T Consensus       237 ~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             ccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            2234578999999999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7e-38  Score=302.65  Aligned_cols=258  Identities=24%  Similarity=0.339  Sum_probs=194.5

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC-----CeEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-----GQHM  184 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  184 (432)
                      .|.+.+.||+|+||.||+|.. .+++.||||.+...  .......+.+|+.+++.++|+||+++++++...     ...+
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            456678999999999999964 57899999998653  233345677899999999999999999987644     3579


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      ++|||+. ++|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        86 lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          86 IVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             EEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence            9999996 689888843  357999999999999999999999998   9999999999999999999999999987543


Q ss_pred             cc-ccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh---c-CCCch------
Q 014038          265 VD-KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT---E-GKTGW------  332 (432)
Q Consensus       265 ~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~---~-~~~~~------  332 (432)
                      .. .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+............   . ....+      
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            32 22234567889999998764 5689999999999999999999999975422111110000   0 00000      


Q ss_pred             --hhhcccc---CCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          333 --EEIVDSR---LDGI---FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       333 --~~~~~~~---~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                        .......   ....   .....+.++.+++.+||+.+|++|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence              0000000   0000   011234578999999999999999999999875

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.6e-37  Score=298.47  Aligned_cols=253  Identities=23%  Similarity=0.320  Sum_probs=192.3

Q ss_pred             cccccccCceeEEEEEe-CCCcEEEEEEeccCChhh--------------HHHHHHHHHHHhhcCCCccceEEeeeeeCC
Q 014038          117 TTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQG--------------EKEFQTEVMLLGRLHHRNLVNLVGYCAEKG  181 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  181 (432)
                      .+.||.|+||.||+|.. .+++.||||.+.......              ...+.+|+.+++.++|+||+++++++...+
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            46799999999999965 478999999886432211              125778999999999999999999999999


Q ss_pred             eEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          182 QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       182 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                      ..++||||+. |+|.+++..  ...+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~  167 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR  167 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcccee
Confidence            9999999997 689988843  346899999999999999999999998   9999999999999999999999999986


Q ss_pred             cccc---------------cccccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhh
Q 014038          262 EEMV---------------DKHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMN  325 (432)
Q Consensus       262 ~~~~---------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~  325 (432)
                      ....               ........+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+..+...+....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~  247 (335)
T PTZ00024        168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF  247 (335)
T ss_pred             ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            5331               1111223467889999998654 47899999999999999999999998655433322211


Q ss_pred             h----cCCCchhhhcc--------ccCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          326 T----EGKTGWEEIVD--------SRLDGI---FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       326 ~----~~~~~~~~~~~--------~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .    .....|.....        ......   .....+.++.+++.+||+.+|++||++.+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            1    00111111000        000000   00112357889999999999999999999986

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.7e-37  Score=293.58  Aligned_cols=248  Identities=27%  Similarity=0.385  Sum_probs=192.7

Q ss_pred             ccccccccccCceeEEEEEe----CCCcEEEEEEeccCC----hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQM----STGETVAVKVLATDS----KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  184 (432)
                      |.+.+.||+|+||.||++..    .+|+.||+|++....    ....+.+.+|+.++.++ +|+||+++++++..+...+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            45667899999999999965    378899999986532    22345678899999999 6999999999999999999


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      +||||+++++|.+++...  .++++..+..++.|++.||.|||+.+   ++||||+|+|||++.++.+||+|||++....
T Consensus        82 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          82 LILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            999999999999998543  46889999999999999999999998   9999999999999999999999999987543


Q ss_pred             ccc--cccccccCCCCCCccccccC--CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          265 VDK--HAANIRGTFGYLDPEYISTR--NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       265 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ...  ......++..|+|||.+...  .++.++||||||+++|+|++|+.||...........+..       .+..  .
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-------~~~~--~  227 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR-------RILK--S  227 (290)
T ss_pred             cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH-------Hhhc--c
Confidence            221  22245688999999998653  467899999999999999999999863211100000000       0000  0


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRP-----SMRDIVQ  375 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~~vl~  375 (432)
                      ...++......+.+++.+||+.||++||     ++.+++.
T Consensus       228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            1112223345789999999999999997     5666554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9.5e-37  Score=291.69  Aligned_cols=240  Identities=29%  Similarity=0.433  Sum_probs=192.4

Q ss_pred             cccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          117 TTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      .+.||+|+||.||+|.. .+++.|++|.+....   ......+.+|+.+++.++|||++++++++.+....++||||+. 
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  104 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-  104 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence            46799999999999965 468899999986532   2334568899999999999999999999999999999999996 


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI  272 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  272 (432)
                      |+|.+++... ..++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++....   .....
T Consensus       105 ~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~~~  177 (313)
T cd06633         105 GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSF  177 (313)
T ss_pred             CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC---CCCCc
Confidence            5777776433 356899999999999999999999998   9999999999999999999999999886432   22345


Q ss_pred             ccCCCCCCccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          273 RGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       273 ~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      .++..|+|||.+.   ...++.++|||||||++|||++|..||.................           ........+
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~  246 (313)
T cd06633         178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS-----------PTLQSNEWT  246 (313)
T ss_pred             cccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-----------CCCCccccC
Confidence            6889999999974   45688999999999999999999999976543322222211111           001111223


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.+++.+||+.+|.+||++.+++.
T Consensus       247 ~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         247 DSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            46889999999999999999999885

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=293.46  Aligned_cols=242  Identities=28%  Similarity=0.457  Sum_probs=203.0

Q ss_pred             HHHHhccccccccccCceeEEEEE-eCCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeE
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQH  183 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  183 (432)
                      +....++|..+||+|+||.|.+|. ..+.+.+|||+++.+-   ..+.+--+.|-++|+.. +-|.+++++.+++.-+.+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            334567899999999999999994 4467889999998762   22223335677777766 578899999999999999


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      |+||||+.||+|--++  ++.+.+.++.+..++.+||-||-+||+++   ||.||||.+|||||.+|++||+|||+++..
T Consensus       426 yFVMEyvnGGDLMyhi--QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHI--QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eeEEEEecCchhhhHH--HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence            9999999999998777  55678999999999999999999999999   999999999999999999999999999876


Q ss_pred             ccc-ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          264 MVD-KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       264 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ... ..+.+++|||.|+|||++..++|...+|.|||||+||||+.|++||++..+......+...           .  -
T Consensus       501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh-----------n--v  567 (683)
T KOG0696|consen  501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH-----------N--V  567 (683)
T ss_pred             ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-----------c--C
Confidence            544 4567899999999999999999999999999999999999999999987665443333211           1  1


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCC
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRP  368 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RP  368 (432)
                      .+|...+.+...++...+.+.|.+|.
T Consensus       568 syPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  568 SYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             cCcccccHHHHHHHHHHhhcCCcccc
Confidence            24556667889999999999999994

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.4e-37  Score=293.75  Aligned_cols=253  Identities=28%  Similarity=0.390  Sum_probs=196.8

Q ss_pred             ccccccccccCceeEEEEEe----CCCcEEEEEEeccCC----hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQM----STGETVAVKVLATDS----KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  184 (432)
                      |.+.+.||+|++|.||++..    .+++.||||.+....    ....+.+.+|+.++.++ +||||+++++.+......+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            45668899999999999864    357889999986432    22345688999999999 6999999999999999999


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      +||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++....
T Consensus        82 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          82 LILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            999999999999988543  46899999999999999999999988   9999999999999999999999999987533


Q ss_pred             cccc--ccccccCCCCCCccccccCC--CCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          265 VDKH--AANIRGTFGYLDPEYISTRN--FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       265 ~~~~--~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ....  .....++..|+|||.+.+..  .+.++||||||+++|||++|..||..............       .+...  
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-------~~~~~--  227 (288)
T cd05583         157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR-------RILKS--  227 (288)
T ss_pred             cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH-------HHHcc--
Confidence            2221  22346889999999987654  78899999999999999999999863211100000000       00000  


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      ....+......+.+++.+||+.||++|||+.++.+.|+..
T Consensus       228 ~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         228 KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            0111222335788999999999999999998888776543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=291.16  Aligned_cols=256  Identities=28%  Similarity=0.404  Sum_probs=197.7

Q ss_pred             cccccccccCceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          115 NFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .+.+.||+|++|.||+|... +++.||+|.+....  ....+.+..|+.++++++|+|++++++++.+.+..++||||++
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD   81 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence            34568999999999999654 58999999987653  3334678899999999999999999999999999999999997


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-ccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~  270 (432)
                       ++|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++....... ...
T Consensus        82 -~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  156 (282)
T cd07829          82 -MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT  156 (282)
T ss_pred             -cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence             58999986432 46999999999999999999999998   9999999999999999999999999987543322 223


Q ss_pred             ccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc----CCCchhhhc-----cccC
Q 014038          271 NIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE----GKTGWEEIV-----DSRL  340 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~~~~-----~~~~  340 (432)
                      ...++..|+|||.+.+. .++.++|||||||++|||++|+.||...............    ....|....     +...
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence            34567889999998766 7899999999999999999999999765433222211110    000011000     0000


Q ss_pred             C----CCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          341 D----GIF---DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       341 ~----~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .    ...   -......+.+++.+||+.+|++||++.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0    000   0011457999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=283.20  Aligned_cols=261  Identities=25%  Similarity=0.378  Sum_probs=201.3

Q ss_pred             CCCcCHHHHHHHhccccccccccCceeEEEEE-eCCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEeee
Q 014038          101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYC  177 (432)
Q Consensus       101 ~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  177 (432)
                      ...|+-.+|...     ..||.|+||+|++-. .+.|+..|||+++... ....++++.|.+...+- +.||||+++|.+
T Consensus        58 ~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~  132 (361)
T KOG1006|consen   58 LHTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL  132 (361)
T ss_pred             ccccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence            445555555432     369999999999984 5589999999998764 35567888888866554 799999999999


Q ss_pred             eeCCeEEEEEEeccCCChhhhc---ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEE
Q 014038          178 AEKGQHMLVYVFMSKGSLASHL---YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV  254 (432)
Q Consensus       178 ~~~~~~~lv~e~~~~g~L~~~l---~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl  254 (432)
                      ..++..|+.||.|+ -||..+.   +.-....+++...-+|+.-.+.||.||...-.  |||||+||+|||||..|.+||
T Consensus       133 F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKL  209 (361)
T KOG1006|consen  133 FSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKL  209 (361)
T ss_pred             hcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEee
Confidence            99999999999995 3665443   34445679999999999999999999987543  999999999999999999999


Q ss_pred             eecCCcccccccccccccccCCCCCCccccc--cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCch
Q 014038          255 ADFGLSREEMVDKHAANIRGTFGYLDPEYIS--TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW  332 (432)
Q Consensus       255 ~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  332 (432)
                      ||||++-.....-....-.|...|||||.+.  ...|+.+|||||||++|||+.||+.||.+.....+.......+..  
T Consensus       210 CDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdp--  287 (361)
T KOG1006|consen  210 CDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDP--  287 (361)
T ss_pred             ecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCC--
Confidence            9999987654443344456888999999985  335999999999999999999999999876553332222222211  


Q ss_pred             hhhccccCCC-CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          333 EEIVDSRLDG-IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       333 ~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                           +.+.. .........+..++..|+-+|-++||.+.++.+.
T Consensus       288 -----p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  288 -----PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             -----CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence                 11111 1112345689999999999999999999988764

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=334.62  Aligned_cols=242  Identities=27%  Similarity=0.400  Sum_probs=197.3

Q ss_pred             cccccccCceeEEEE-EeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCC
Q 014038          117 TTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG  193 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  193 (432)
                      ..+||.|.||.||-| ...+|+..|+|.+....  ....+...+|+.++..++|||+|+++|+-.+.+..++.||||++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            358999999999999 56789999999887543  333456889999999999999999999999999999999999999


Q ss_pred             ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-----c
Q 014038          194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-----H  268 (432)
Q Consensus       194 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-----~  268 (432)
                      +|.+.+.  .++-.++.....+..|++.|++|||++|   ||||||||.||+|+.+|.+|++|||.|.......     .
T Consensus      1320 sLa~ll~--~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1320 SLASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             cHHHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            9999983  3445777777788999999999999999   9999999999999999999999999987543332     2


Q ss_pred             ccccccCCCCCCccccccCC---CCchhHhHHHHHHHHHHHhCCCCCCChhHHHHH-HHhhhcCCCchhhhccccCCCCC
Q 014038          269 AANIRGTFGYLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVEL-AAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                      .....||+.|||||++.+.+   -..++||||+||+++||+||+.||....+.-.+ ........            +..
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~------------Pq~ 1462 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK------------PQI 1462 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC------------CCC
Confidence            33567999999999997644   346899999999999999999999865543222 22222221            223


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      |...+.+-.+|+.+||+.||+.|-++.|+++
T Consensus      1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            3445668899999999999999988877665

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2e-37  Score=300.12  Aligned_cols=257  Identities=22%  Similarity=0.314  Sum_probs=192.9

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC----------
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK----------  180 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----------  180 (432)
                      .+|.+.+.||.|+||.||+|.. .+|+.||+|.+........+.+.+|+.+++.++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            4567788999999999999965 57899999998766555567788999999999999999999776543          


Q ss_pred             ----CeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec-CCCcEEEe
Q 014038          181 ----GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVA  255 (432)
Q Consensus       181 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~-~~~~~kl~  255 (432)
                          ...++||||++ ++|.+++..   ..+++..+..++.||+.||.|||+.+   ++||||||+||+++ .++.+||+
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEEC
Confidence                35789999997 588887742   35899999999999999999999999   99999999999997 45678999


Q ss_pred             ecCCccccccc----ccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCC
Q 014038          256 DFGLSREEMVD----KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT  330 (432)
Q Consensus       256 Dfgl~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  330 (432)
                      |||+++.....    .......++..|+|||.+.. ..++.++|||||||++|||++|+.||..................
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99998643211    11123357889999997644 56889999999999999999999999765433322221111000


Q ss_pred             ch----h-------hhcc-ccCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          331 GW----E-------EIVD-SRLDGIFD-----VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       331 ~~----~-------~~~~-~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..    .       .... .......+     .....++.+++.+||+.||++|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            00    0       0000 00000000     112357889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.9e-37  Score=295.53  Aligned_cols=255  Identities=25%  Similarity=0.345  Sum_probs=193.1

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeee-CCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-KGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  187 (432)
                      ..|.+.+.||.|+||.||+|.. .+++.||+|.+...  .....+.+.+|+.++..++||||+++++++.. ....++++
T Consensus        10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            3566778999999999999964 47899999987543  22334678899999999999999999998865 55789999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+ +++|..++..   .++++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++....  .
T Consensus        90 e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~--~  160 (328)
T cd07856          90 ELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD--P  160 (328)
T ss_pred             ehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccC--C
Confidence            998 5688887742   45888889999999999999999999   9999999999999999999999999987432  2


Q ss_pred             cccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh---cCCCch---------hh
Q 014038          268 HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT---EGKTGW---------EE  334 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~~---------~~  334 (432)
                      ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..............   .....+         .+
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd07856         161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR  240 (328)
T ss_pred             CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence            2234467889999998765 5789999999999999999999999975432111111100   000000         00


Q ss_pred             hccc-cCCCCCCH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 IVDS-RLDGIFDV-----EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 ~~~~-~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +... ......+.     ..+.++.+++.+||+.+|++||++.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000 00111111     12357899999999999999999998875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.1e-37  Score=287.48  Aligned_cols=240  Identities=23%  Similarity=0.353  Sum_probs=185.3

Q ss_pred             hcccccc--ccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTL--IGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~--lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .+.+.+.  ||+|+||.||++.. .++..+|+|.+........     |+.....+ +||||+++++++...+..++|||
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            3345454  49999999999964 4788999999864321111     22222222 79999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC-cEEEeecCCcccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDK  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~~  267 (432)
                      |+++|+|.+++...  .++++..+..++.|++.||.|||+.+   ++||||||+||+++.++ .++|+|||++.....  
T Consensus        90 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~--  162 (267)
T PHA03390         90 YIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT--  162 (267)
T ss_pred             cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCC--
Confidence            99999999998543  37999999999999999999999999   99999999999999998 999999999865432  


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHH-HHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV-ELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                       .....++..|+|||++.+..++.++||||||+++|||++|+.||....+.. ........        ....  .....
T Consensus       163 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~--~~~~~  231 (267)
T PHA03390        163 -PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR--------QQKK--LPFIK  231 (267)
T ss_pred             -CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh--------hccc--CCccc
Confidence             223468899999999998899999999999999999999999997432211 11111100        0000  01112


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPS-MRDIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs-~~~vl~  375 (432)
                      ..+..+.+++.+||+.+|.+||+ ++++++
T Consensus       232 ~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        232 NVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            34467999999999999999996 588874

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.9e-37  Score=291.17  Aligned_cols=245  Identities=26%  Similarity=0.449  Sum_probs=199.9

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcC-CCccceEEeeeeeCCeEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  187 (432)
                      .|.+.+.||+|+||.||+|... +++.||+|++...   .......+.+|+.++++++ ||||+++++++...+..++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            3566788999999999999654 7899999998653   2233467889999999998 999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          82 EYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            999999999998543  47999999999999999999999999   9999999999999999999999999886432211


Q ss_pred             ---------------------cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh
Q 014038          268 ---------------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT  326 (432)
Q Consensus       268 ---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~  326 (432)
                                           ......++..|+|||......++.++|+||||++++++++|+.||..............
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  236 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK  236 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence                                 12234578899999999888899999999999999999999999986554332222111


Q ss_pred             cCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 014038          327 EGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSM----RDIVQ  375 (432)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~----~~vl~  375 (432)
                      .             ....+...+..+.+++.+||+.+|.+||++    +++++
T Consensus       237 ~-------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         237 L-------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             c-------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            0             111222234578999999999999999999    77654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-37  Score=297.72  Aligned_cols=253  Identities=23%  Similarity=0.363  Sum_probs=190.4

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeC------CeE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQH  183 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  183 (432)
                      .|...+.||+|+||.||+|.. .+|+.||+|.+....  ......+.+|+.+++.++||||+++++++...      ...
T Consensus        16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   95 (342)
T cd07879          16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF   95 (342)
T ss_pred             ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence            455668999999999999965 478999999986532  22345688999999999999999999988654      346


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ++|+||+.. +|...+    ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++..
T Consensus        96 ~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879          96 YLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             EEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence            899999964 676654    235899999999999999999999999   999999999999999999999999998753


Q ss_pred             cccccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCc---hhh-----
Q 014038          264 MVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG---WEE-----  334 (432)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~-----  334 (432)
                      ..  ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+......+..........   +.+     
T Consensus       168 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (342)
T cd07879         168 DA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK  245 (342)
T ss_pred             CC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence            22  2234567889999999865 468999999999999999999999998644322222111100000   000     


Q ss_pred             ----hcc--cc-CCCCCC---HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 ----IVD--SR-LDGIFD---VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 ----~~~--~~-~~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                          ...  +. ......   .....++.+++.+||+.||.+||++.+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                000  00 000000   012346889999999999999999999985

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.5e-37  Score=286.60  Aligned_cols=246  Identities=23%  Similarity=0.370  Sum_probs=194.2

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccC-----ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      |.+.+.||+|+||.||++... .+..+++|.++..     .......+..|+.+++.++||||+++++++.+....++||
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            567789999999999999654 3445666655431     2233346778999999999999999999999989999999


Q ss_pred             EeccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          188 VFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       188 e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||+++++|.+++..  .....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++. +.+||+|||++.....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCC
Confidence            99999999988853  33457999999999999999999999998   999999999999976 4699999999865432


Q ss_pred             cc-cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCC
Q 014038          266 DK-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       266 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                      .. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...............            .....
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~------------~~~~~  225 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG------------PTPSL  225 (260)
T ss_pred             CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC------------CCCCC
Confidence            22 223456788999999998888999999999999999999999999754332222111110            11112


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +...+.++.+++.+||+.+|++||++.++++
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         226 PETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            3344568899999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=8.5e-38  Score=320.30  Aligned_cols=244  Identities=28%  Similarity=0.442  Sum_probs=185.4

Q ss_pred             cccccccCceeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeC--------------
Q 014038          117 TTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--------------  180 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------------  180 (432)
                      .+.||+||||.||+++.+ ||+.||||++.... ......+.+|+.+|++|+|||||+++..+.+.              
T Consensus       484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~  563 (1351)
T KOG1035|consen  484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS  563 (1351)
T ss_pred             HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence            368999999999999765 89999999997663 33345688999999999999999987321000              


Q ss_pred             --------------------------------------------------------------------------------
Q 014038          181 --------------------------------------------------------------------------------  180 (432)
Q Consensus       181 --------------------------------------------------------------------------------  180 (432)
                                                                                                      
T Consensus       564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d  643 (1351)
T KOG1035|consen  564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD  643 (1351)
T ss_pred             hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence                                                                                            


Q ss_pred             -------------------------CeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 014038          181 -------------------------GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI  235 (432)
Q Consensus       181 -------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ii  235 (432)
                                               -.+|+=||||+...|.++++.+.... .....++++++|+.||.|+|+++   ||
T Consensus       644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~g---iI  719 (1351)
T KOG1035|consen  644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQG---II  719 (1351)
T ss_pred             cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhCc---ee
Confidence                                     02356688888877777775443221 46778999999999999999999   99


Q ss_pred             eccCCCCCeeecCCCcEEEeecCCccccc-------------------ccccccccccCCCCCCccccccC---CCCchh
Q 014038          236 HRDIKSSNILLDQSMRARVADFGLSREEM-------------------VDKHAANIRGTFGYLDPEYISTR---NFTKKS  293 (432)
Q Consensus       236 H~dlkp~Nill~~~~~~kl~Dfgl~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~  293 (432)
                      ||||||.||+||++..|||+|||+++...                   .....+..+||..|+|||++.+.   +|+.|+
T Consensus       720 HRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~Ki  799 (1351)
T KOG1035|consen  720 HRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKI  799 (1351)
T ss_pred             eccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchh
Confidence            99999999999999999999999997511                   01123456799999999999755   499999


Q ss_pred             HhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 014038          294 DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDI  373 (432)
Q Consensus       294 Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~v  373 (432)
                      |+||||||++||+-   ||....+..........+..+..        ..+.....+.=..+|.++++.||.+|||+.|+
T Consensus       800 DmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~--------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL  868 (1351)
T KOG1035|consen  800 DMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP--------ADFFDPEHPEEASLIRWLLSHDPSKRPTATEL  868 (1351)
T ss_pred             hhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC--------cccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence            99999999999985   68776665544433332221111        11222223355789999999999999999998


Q ss_pred             HH
Q 014038          374 VQ  375 (432)
Q Consensus       374 l~  375 (432)
                      |.
T Consensus       869 L~  870 (1351)
T KOG1035|consen  869 LN  870 (1351)
T ss_pred             hh
Confidence            85

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=282.45  Aligned_cols=243  Identities=22%  Similarity=0.331  Sum_probs=196.7

Q ss_pred             ccccccCceeEEEE-EeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeee----CCeEEEEEEecc
Q 014038          118 TLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE----KGQHMLVYVFMS  191 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~~~  191 (432)
                      ++||-|-.|.|-.+ ...+|+.+|+|++...     ...++|+++--.. .|||||.++++|..    ...+++|||.|+
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me  142 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME  142 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence            68999999999988 4458999999998543     3446788876665 59999999998764    346788999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec---CCCcEEEeecCCccccccccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD---QSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~---~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      ||.|...+.++....+++.++..|+.||+.|+.|||+.+   |.||||||+|+|..   .|..+||+|||+++.......
T Consensus       143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~  219 (400)
T KOG0604|consen  143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGD  219 (400)
T ss_pred             chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCCCcc
Confidence            999999998888889999999999999999999999999   99999999999995   456799999999998766666


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcccc--CCCCCCH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR--LDGIFDV  346 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  346 (432)
                      ..+.+.||.|.|||++...+|+..+|+||+||++|-|++|.+||........-..+..       .+....  ++.+.-.
T Consensus       220 L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~-------rI~~gqy~FP~pEWs  292 (400)
T KOG0604|consen  220 LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKR-------RIRTGQYEFPEPEWS  292 (400)
T ss_pred             ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHh-------HhhccCccCCChhHh
Confidence            7788899999999999999999999999999999999999999964321100001110       011111  1111122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+++..++|..+|..+|.+|-|+.+++.
T Consensus       293 ~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  293 CVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             HHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            34678899999999999999999999876

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-37  Score=297.62  Aligned_cols=255  Identities=24%  Similarity=0.344  Sum_probs=193.6

Q ss_pred             HhccccccccccCceeEEEEE-eCCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC------e
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG------Q  182 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  182 (432)
                      .+|.+.+.||+|+||.||+|. ..++..||||.+...  .......+.+|+.++++++||||+++++++....      .
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            356677899999999999995 457899999998543  2233456889999999999999999999887543      4


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .++||+|+ +++|..++..   ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        95 ~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~  167 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ  167 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccc
Confidence            58999999 6789887743   46899999999999999999999999   99999999999999999999999999875


Q ss_pred             ccccccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcc----
Q 014038          263 EMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD----  337 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----  337 (432)
                      ...  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||......................+..    
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         168 TDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             ccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence            422  2234467899999998865 458899999999999999999999997654322221111100000000000    


Q ss_pred             -------ccCCCC-------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          338 -------SRLDGI-------FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       338 -------~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                             ..+...       ........+.+++.+|++.||++|||+.+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   000000       00112346889999999999999999999884

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.9e-37  Score=295.52  Aligned_cols=256  Identities=25%  Similarity=0.330  Sum_probs=191.8

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC------Ce
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQ  182 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  182 (432)
                      .+|.+.+.||+|+||.||+|.. .+++.||+|++...  .....+.+.+|+.++.+++||||+++++++...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            3566678999999999999964 57899999998653  223345688899999999999999999987643      34


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .+++++++ +++|.+++..   ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++..
T Consensus        97 ~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~  169 (345)
T cd07877          97 VYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH  169 (345)
T ss_pred             EEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccc
Confidence            67788876 7899887743   35899999999999999999999999   99999999999999999999999999875


Q ss_pred             ccccccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhc-----
Q 014038          263 EMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIV-----  336 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  336 (432)
                      ..  .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......................+.     
T Consensus       170 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         170 TD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             cc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence            32  22334567899999998765 56889999999999999999999999754332221111100000000000     


Q ss_pred             ----------cccCCCCCC---HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          337 ----------DSRLDGIFD---VEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       337 ----------~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                                .......+.   .....++.+++.+||+.||.+||++.+++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                      000000000   0123578899999999999999999998864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6e-37  Score=292.43  Aligned_cols=259  Identities=27%  Similarity=0.384  Sum_probs=191.3

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh--hhHHHHHHHHHHHhhcCCCccceEEeeeeeC--------
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--------  180 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  180 (432)
                      ..|.+.+.||+|+||.||+|... +++.+|+|.+.....  .....+.+|++++++++||||+++++++.+.        
T Consensus         8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   87 (311)
T cd07866           8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR   87 (311)
T ss_pred             ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence            35677889999999999999654 688999998865422  2234677899999999999999999987543        


Q ss_pred             CeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCc
Q 014038          181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS  260 (432)
Q Consensus       181 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~  260 (432)
                      ...++||+|+.+ +|...+... ...+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.+||+|||++
T Consensus        88 ~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          88 GSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             ceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccc
Confidence            346999999975 677666432 346999999999999999999999999   999999999999999999999999998


Q ss_pred             cccccccc------------ccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc
Q 014038          261 REEMVDKH------------AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE  327 (432)
Q Consensus       261 ~~~~~~~~------------~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  327 (432)
                      ........            .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.............
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            64322111            122356888999998764 45889999999999999999999999765443222211110


Q ss_pred             C----CCchh------hhc----cccCCCCCC---HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          328 G----KTGWE------EIV----DSRLDGIFD---VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       328 ~----~~~~~------~~~----~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .    ...+.      ...    .........   ......+.+++.+||+.||++|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            0    00000      000    000000000   011257889999999999999999998874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.9e-37  Score=294.35  Aligned_cols=256  Identities=26%  Similarity=0.330  Sum_probs=189.7

Q ss_pred             ccccccccccCceeEEEEEeC-C--CcEEEEEEeccC--ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeC----CeE
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-T--GETVAVKVLATD--SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK----GQH  183 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~  183 (432)
                      |.+.+.||+|+||.||++... +  +..||+|.+...  .....+.+.+|+.+++++ +||||+++++++...    ...
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            456788999999999999754 3  779999998643  222345788999999999 599999999875432    456


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      +++++|+. ++|.+++..  ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||+++..
T Consensus        82 ~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          82 YLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            78888886 689888843  456999999999999999999999999   999999999999999999999999998753


Q ss_pred             cccc-----cccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCc----hh
Q 014038          264 MVDK-----HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG----WE  333 (432)
Q Consensus       264 ~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~  333 (432)
                      ....     ......|++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||........+..........    +.
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            3211     1233568999999998765 568999999999999999999999997643222111110000000    00


Q ss_pred             hh-----------ccccCCCCCC---HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          334 EI-----------VDSRLDGIFD---VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       334 ~~-----------~~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+           ........++   ......+.+++.+||+.||++|||+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00           0000000000   012357899999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=280.99  Aligned_cols=235  Identities=29%  Similarity=0.414  Sum_probs=192.9

Q ss_pred             ccccCceeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCCh
Q 014038          120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       120 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  195 (432)
                      ||.|+||.||++... +++.+|+|.+.....   .....+..|+.++++++||||+++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999654 588999999875432   2455788999999999999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cccccccc
Q 014038          196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRG  274 (432)
Q Consensus       196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~~g  274 (432)
                      .+++...  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...... .......+
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (250)
T cd05123          81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG  155 (250)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence            9998543  46899999999999999999999988   999999999999999999999999998764332 23344567


Q ss_pred             CCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHH
Q 014038          275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVAS  354 (432)
Q Consensus       275 t~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  354 (432)
                      +..|+|||...+...+.++|+||||+++|||++|+.||.............. ..            ...+...+..+.+
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~l~~  222 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DP------------LRFPEFLSPEARD  222 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CC------------CCCCCCCCHHHHH
Confidence            8899999999888899999999999999999999999975443111111111 10            1112222457899


Q ss_pred             HHHHhhccCCCCCCCHHH
Q 014038          355 LAYKCVNRAPRKRPSMRD  372 (432)
Q Consensus       355 li~~cl~~dp~~RPs~~~  372 (432)
                      ++.+||..||++||++.+
T Consensus       223 ~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         223 LISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHhcCCHhhCCCccc
Confidence            999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.9e-37  Score=298.12  Aligned_cols=254  Identities=26%  Similarity=0.357  Sum_probs=194.1

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe------E
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ------H  183 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~  183 (432)
                      .|.+.+.||+|+||.||+|... +++.||+|.+...  .......+.+|+.+++.++|||++++++++...+.      .
T Consensus        16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07851          16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV   95 (343)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence            4667789999999999999764 6789999998643  22334567889999999999999999998766544      8


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ++|+||+ +++|.+++..   ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        96 ~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (343)
T cd07851          96 YLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT  168 (343)
T ss_pred             EEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccc
Confidence            9999998 6699888853   46999999999999999999999998   999999999999999999999999998754


Q ss_pred             cccccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhc------
Q 014038          264 MVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIV------  336 (432)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  336 (432)
                      ...  .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....................+.      
T Consensus       169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (343)
T cd07851         169 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE  246 (343)
T ss_pred             ccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence            322  334467889999998864 36789999999999999999999999764433222211111000000100      


Q ss_pred             ------ccc---CCCCCC---HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          337 ------DSR---LDGIFD---VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       337 ------~~~---~~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                            ...   ....+.   ...+.++.+++.+||+.+|++|||+.+|++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                  000   000000   012457899999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=301.64  Aligned_cols=249  Identities=26%  Similarity=0.424  Sum_probs=208.4

Q ss_pred             hccccccccccCceeEEEEE-eCCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeee-----CCeEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE-----KGQHML  185 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~~~~l  185 (432)
                      ++.|.+.||.|.+|.||+++ .++++.+|+|++..... ..+++..|.++|+.+ +|||++.++|++..     ++++||
T Consensus        20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL   98 (953)
T KOG0587|consen   20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL   98 (953)
T ss_pred             ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence            45678899999999999994 56889999999876543 345677899999988 69999999998864     579999


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      |||||.+||..+++....+..+.|..+..|++.++.||.+||.+.   ++|||||=.|||++.++.|||+|||++.....
T Consensus        99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen   99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS  175 (953)
T ss_pred             EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence            999999999999998766788999999999999999999999998   99999999999999999999999999876543


Q ss_pred             c-ccccccccCCCCCCcccccc-----CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          266 D-KHAANIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       266 ~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      . ....+..|||.|||||++..     ..|+..+|+||||++..||.-|.+|+.++.....+..+..+..          
T Consensus       176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP----------  245 (953)
T KOG0587|consen  176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP----------  245 (953)
T ss_pred             ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC----------
Confidence            3 34567789999999999853     3578899999999999999999999987665444433322221          


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..-.-+.....++.++|..||.+|-.+||++.++++
T Consensus       246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            111224556789999999999999999999999875

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=292.53  Aligned_cols=241  Identities=25%  Similarity=0.423  Sum_probs=202.0

Q ss_pred             ccccccCceeEEEE-EeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCC
Q 014038          118 TLIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS  194 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  194 (432)
                      ++||+|.||+||-| ..++|+.||||++.+.  ....+.++++|+.+|+++.||.||.+...|+..+..++|||-+. |+
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GD  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GD  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-ch
Confidence            68999999999999 4568999999999764  34556789999999999999999999999999999999999995 57


Q ss_pred             hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC---CcEEEeecCCcccccccccccc
Q 014038          195 LASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS---MRARVADFGLSREEMVDKHAAN  271 (432)
Q Consensus       195 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~---~~~kl~Dfgl~~~~~~~~~~~~  271 (432)
                      ..+.+.....+.|++.....+..||+.||.|||.++   |+|+||||+||||...   -++||||||+++..........
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrs  725 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRS  725 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhhhh
Confidence            666666667788999999999999999999999999   9999999999999543   4699999999998777777788


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHH--hhhcCCCchhhhccccCCCCCCHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAA--MNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      .+|||.|+|||+++.+.|+..-|+||.|||+|--++|..||....+..+...  .-.....+|             .+..
T Consensus       726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW-------------~eis  792 (888)
T KOG4236|consen  726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPW-------------SEIS  792 (888)
T ss_pred             hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCch-------------hhcC
Confidence            8999999999999999999999999999999999999999986443211110  001111122             2344


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+..+||...|+..-++|-|..+-+.
T Consensus       793 ~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  793 PEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             HHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            57889999999999999999877543

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1e-35  Score=310.34  Aligned_cols=144  Identities=30%  Similarity=0.415  Sum_probs=128.4

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+|... +++.||||++....   ......+.+|+.++..++||||+++++++...+..++|||
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE   84 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME   84 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence            4667789999999999999764 68999999986532   2334678899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                      |+.+++|.+++..  .+.+++..++.++.||+.||.|||..+   |+||||||+||||+.++.+||+|||+++
T Consensus        85 y~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          85 YLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999854  346889999999999999999999998   9999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=281.89  Aligned_cols=269  Identities=25%  Similarity=0.367  Sum_probs=211.3

Q ss_pred             CCCCcCHHHHHHHhccccccccccCceeEEEEE-eCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC--CCc----cce
Q 014038          100 GIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH--HRN----LVN  172 (432)
Q Consensus       100 ~~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~n----iv~  172 (432)
                      +-..+...|....+|.+...+|+|.||.|-.+. ...+..||||+++.-.+ ..+..+-|+++|+++.  .|+    +|.
T Consensus        77 GH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~  155 (415)
T KOG0671|consen   77 GHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQ  155 (415)
T ss_pred             ceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence            334566677778889999999999999999994 34578999999865332 2345577999999994  233    688


Q ss_pred             EEeeeeeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec-----
Q 014038          173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-----  247 (432)
Q Consensus       173 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~-----  247 (432)
                      +.+||...+..|+|+|.+ |-|+.++|..++..+++...+..|+.|++++++|||+.+   ++|-||||+|||+.     
T Consensus       156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~  231 (415)
T KOG0671|consen  156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYF  231 (415)
T ss_pred             eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceE
Confidence            888999999999999998 559999999888899999999999999999999999999   99999999999982     


Q ss_pred             ---------------CCCcEEEeecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCC
Q 014038          248 ---------------QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL  312 (432)
Q Consensus       248 ---------------~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~  312 (432)
                                     .+..+||+|||-+....  ......+.|..|.|||++.+..++..+||||+||||+|++||...|
T Consensus       232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF  309 (415)
T KOG0671|consen  232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF  309 (415)
T ss_pred             EEeccCCccceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence                           23468999999987543  2336778999999999999999999999999999999999999999


Q ss_pred             CChhHHHHHHHhhhcCCCchhhhcccc----------C---------------CCC--------CCHHHHHHHHHHHHHh
Q 014038          313 QGLMEYVELAAMNTEGKTGWEEIVDSR----------L---------------DGI--------FDVEELNEVASLAYKC  359 (432)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~---------------~~~--------~~~~~~~~l~~li~~c  359 (432)
                      +...+...++.|...-.+....++...          +               ...        ....+..+|++|+.+|
T Consensus       310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m  389 (415)
T KOG0671|consen  310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM  389 (415)
T ss_pred             ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence            876654444433222111111111100          0               001        1123446899999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 014038          360 VNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       360 l~~dp~~RPs~~~vl~  375 (432)
                      |..||.+|+|+.|++.
T Consensus       390 L~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  390 LEFDPARRITLREALS  405 (415)
T ss_pred             HccCccccccHHHHhc
Confidence            9999999999999875

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.4e-36  Score=275.49  Aligned_cols=220  Identities=22%  Similarity=0.209  Sum_probs=176.5

Q ss_pred             cCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCChhhhccc
Q 014038          123 GAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD  201 (432)
Q Consensus       123 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  201 (432)
                      |.+|.||++.. .+++.||+|.+....     .+.+|...+....||||+++++++.+....+++|||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999954 578999999986543     233455556666799999999999999999999999999999998854


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccccccccCCCCCCc
Q 014038          202 ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP  281 (432)
Q Consensus       202 ~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aP  281 (432)
                      .  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++++|||.+.....  ......++..|+||
T Consensus        79 ~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~--~~~~~~~~~~y~aP  151 (237)
T cd05576          79 F--LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED--SCDGEAVENMYCAP  151 (237)
T ss_pred             h--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc--ccccCCcCccccCC
Confidence            3  45899999999999999999999998   99999999999999999999999998754322  22334567789999


Q ss_pred             cccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhc
Q 014038          282 EYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVN  361 (432)
Q Consensus       282 E~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  361 (432)
                      |.+....++.++||||||+++|||++|+.|+......             ...    ......+...+..+.+++.+||+
T Consensus       152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------------~~~----~~~~~~~~~~~~~~~~li~~~l~  214 (237)
T cd05576         152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------------INT----HTTLNIPEWVSEEARSLLQQLLQ  214 (237)
T ss_pred             cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------------ccc----ccccCCcccCCHHHHHHHHHHcc
Confidence            9998888999999999999999999999887532110             000    00001122234578999999999


Q ss_pred             cCCCCCCCHH
Q 014038          362 RAPRKRPSMR  371 (432)
Q Consensus       362 ~dp~~RPs~~  371 (432)
                      .||++||++.
T Consensus       215 ~dp~~R~~~~  224 (237)
T cd05576         215 FNPTERLGAG  224 (237)
T ss_pred             CCHHHhcCCC
Confidence            9999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-37  Score=274.18  Aligned_cols=261  Identities=23%  Similarity=0.424  Sum_probs=200.0

Q ss_pred             CHHHHHHHhccccccccccCceeEEEE-EeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCe
Q 014038          105 SYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       105 ~~~~l~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  182 (432)
                      ++.|+-+-|   .+.||+|+|+.|--+ .+.+|..+|||++.+...-...+..+|++++... .|+||++++.||+++..
T Consensus        74 ~F~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~  150 (463)
T KOG0607|consen   74 KFEDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR  150 (463)
T ss_pred             hHHHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence            355555444   368999999999988 5779999999999887666678889999999998 49999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC---cEEEeecCC
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM---RARVADFGL  259 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~---~~kl~Dfgl  259 (432)
                      +|||||-|.||+|..++..+  ..+++.++.++.++|+.||.|||.++   |.||||||+|||-..-.   -+|||||.|
T Consensus       151 FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  151 FYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             EEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccc
Confidence            99999999999999999544  56999999999999999999999999   99999999999985433   489999998


Q ss_pred             ccccccc--------ccccccccCCCCCCccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh
Q 014038          260 SREEMVD--------KHAANIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT  326 (432)
Q Consensus       260 ~~~~~~~--------~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~  326 (432)
                      .......        ....+.+|+.-|||||+..     ...|+.++|.||||||+|-|++|.+||.+.=...  -.|..
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d--CGWdr  303 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD--CGWDR  303 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc--CCccC
Confidence            7532211        2233457888999999762     3468999999999999999999999997532100  00000


Q ss_pred             cCC--CchhhhccccCCC--CCCHH----HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          327 EGK--TGWEEIVDSRLDG--IFDVE----ELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       327 ~~~--~~~~~~~~~~~~~--~~~~~----~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...  .--..++.....+  ++|..    .+.+..+++...+..|+.+|-++.+++.
T Consensus       304 Ge~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  304 GEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            000  0001111111111  12332    3457788999999999999999988876

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=281.68  Aligned_cols=258  Identities=25%  Similarity=0.359  Sum_probs=198.4

Q ss_pred             HHHHHhccccccccccCceeEEEE-EeCCCcEEEEEEeccC--Ch-----hhHHHHHHHHHHHhhcCCCccceEEeeee-
Q 014038          108 DLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATD--SK-----QGEKEFQTEVMLLGRLHHRNLVNLVGYCA-  178 (432)
Q Consensus       108 ~l~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~-  178 (432)
                      -++..+|-+..+||+|||+.||+| ++...+.||||+-..+  ..     ...+...+|.++-+.|+||.||++|+|+. 
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            344556666789999999999999 5667889999986433  11     12345678999999999999999999986 


Q ss_pred             eCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec---CCCcEEEe
Q 014038          179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD---QSMRARVA  255 (432)
Q Consensus       179 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~---~~~~~kl~  255 (432)
                      +.+.+|-|.|||+|.+|.-+|.  ....+++.++..|+.||+.||.||.... +||||-||||.||||-   .-|.+||+
T Consensus       539 DtdsFCTVLEYceGNDLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             ccccceeeeeecCCCchhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence            4567899999999999998884  4567999999999999999999999876 7899999999999994   45789999


Q ss_pred             ecCCcccccccc--------cccccccCCCCCCcccccc----CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHH
Q 014038          256 DFGLSREEMVDK--------HAANIRGTFGYLDPEYIST----RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAA  323 (432)
Q Consensus       256 Dfgl~~~~~~~~--------~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~  323 (432)
                      ||||++.+..+.        .+....||.+|++||++--    .+.+.|.||||.|||+|..+-|+.||........+..
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq  695 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ  695 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence            999998654332        2455789999999998843    3578999999999999999999999986543333322


Q ss_pred             hhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          324 MNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+.....  .+     ..-+..+..+.+...||.+||+..-++|....++..
T Consensus       696 eNTIlkA--tE-----VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  696 ENTILKA--TE-----VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hhchhcc--ee-----ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            2111100  00     000111233457889999999999999988776653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4.3e-35  Score=268.38  Aligned_cols=238  Identities=31%  Similarity=0.475  Sum_probs=194.9

Q ss_pred             CceeEEEEEeC-CCcEEEEEEeccCChhh-HHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCChhhhccc
Q 014038          124 AFGPVYKAQMS-TGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD  201 (432)
Q Consensus       124 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  201 (432)
                      +||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++......+++|||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999775 58999999997665444 67899999999999999999999999999999999999999999999854


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccccccccCCCCCCc
Q 014038          202 ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP  281 (432)
Q Consensus       202 ~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aP  281 (432)
                      ..  .+++..+..++.+++.++.|||+.+   ++|+||+|+||+++.++.++|+|||.+.............++..|++|
T Consensus        81 ~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~p  155 (244)
T smart00220       81 RG--RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAP  155 (244)
T ss_pred             cc--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCH
Confidence            33  3899999999999999999999998   999999999999999999999999998765544344556788999999


Q ss_pred             cccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhc
Q 014038          282 EYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVN  361 (432)
Q Consensus       282 E~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  361 (432)
                      |.+....++.++||||||+++++|++|..||....+...............         .......+.++.+++.+||.
T Consensus       156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~  226 (244)
T smart00220      156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF---------PPPEWKISPEAKDLIRKLLV  226 (244)
T ss_pred             HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC---------ccccccCCHHHHHHHHHHcc
Confidence            999888899999999999999999999999976322222221111111000         00000033579999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 014038          362 RAPRKRPSMRDIVQ  375 (432)
Q Consensus       362 ~dp~~RPs~~~vl~  375 (432)
                      .+|++||++.++++
T Consensus       227 ~~p~~Rp~~~~~~~  240 (244)
T smart00220      227 KDPEKRLTAEEALQ  240 (244)
T ss_pred             CCchhccCHHHHhh
Confidence            99999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.6e-36  Score=268.56  Aligned_cols=260  Identities=24%  Similarity=0.339  Sum_probs=191.9

Q ss_pred             hccccccccccCceeEEEEEe-C--C--CcEEEEEEeccCCh--hhHHHHHHHHHHHhhcCCCccceEEeeeee-CCeEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-S--T--GETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-KGQHM  184 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~--~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~  184 (432)
                      .|+....||+|.||.||+|.- +  +  ...+|||.++....  .......+|+.+++.++|||++.+..++.. +...+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~  104 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW  104 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence            466678899999999999932 2  2  23799999976522  223456789999999999999999998877 77899


Q ss_pred             EEEEeccCCChhhhccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC----CcEEEeec
Q 014038          185 LVYVFMSKGSLASHLYD---ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS----MRARVADF  257 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~----~~~kl~Df  257 (432)
                      +++||.+. +|.+.++-   .....++...+..|+.||+.|+.|||++-   |+||||||.|||+..+    |.|||+||
T Consensus       105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecc
Confidence            99999987 88887753   22356888999999999999999999998   9999999999999877    89999999


Q ss_pred             CCccccccc----ccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhH---------HHHHHH
Q 014038          258 GLSREEMVD----KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME---------YVELAA  323 (432)
Q Consensus       258 gl~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~---------~~~~~~  323 (432)
                      |+++.....    ......+.|.+|.|||++.+ +.||.+.|||+.|||+.||+|-++-|.+..+         ..++..
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            999864332    12345678999999998865 5799999999999999999998877754211         111111


Q ss_pred             h----hhcCCCchhhhcc---------ccCCCCCCH----H-------HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          324 M----NTEGKTGWEEIVD---------SRLDGIFDV----E-------ELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       324 ~----~~~~~~~~~~~~~---------~~~~~~~~~----~-------~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      +    .......|..+..         ..-...++.    .       .....++|+.++|..||.+|-|+++.++.
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            1    1111112221110         000000000    0       01247789999999999999999987763

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=309.05  Aligned_cols=249  Identities=24%  Similarity=0.332  Sum_probs=200.0

Q ss_pred             HHHhccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      ...+|.+.++||+|+||.|.+++. .+++.||+|++...   ......-|.+|-.+|..-+.+=|++++..|++..++|+
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl  152 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL  152 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence            345677889999999999999965 47899999999763   23344568999999998899999999999999999999


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      |||||+||+|..++...  .++++..+..++..|+-||.-||+.|   +|||||||+|||||..|++||+|||-|-....
T Consensus       153 VMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~  227 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA  227 (1317)
T ss_pred             EEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence            99999999999999543  37999999999999999999999999   99999999999999999999999998866554


Q ss_pred             cc--cccccccCCCCCCccccc----c-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccc
Q 014038          266 DK--HAANIRGTFGYLDPEYIS----T-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDS  338 (432)
Q Consensus       266 ~~--~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      +.  .....+|||.|.+||++.    + +.|...+|.||+||++|||+.|..||....-....           ..+++.
T Consensus       228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY-----------~KIm~h  296 (1317)
T KOG0612|consen  228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY-----------GKIMNH  296 (1317)
T ss_pred             CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH-----------HHHhch
Confidence            43  345678999999999984    3 57999999999999999999999999754322111           112222


Q ss_pred             cCCCCCC--HHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 014038          339 RLDGIFD--VEELNEVASLAYKCVNRAPRKRPS---MRDIVQ  375 (432)
Q Consensus       339 ~~~~~~~--~~~~~~l~~li~~cl~~dp~~RPs---~~~vl~  375 (432)
                      ...-.||  ...+.+..+||.+.+. +|+.|-.   ++++-.
T Consensus       297 k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  297 KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            1111122  2356788899988775 6788876   665543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=292.11  Aligned_cols=237  Identities=24%  Similarity=0.357  Sum_probs=193.8

Q ss_pred             hccccccccccCceeEEEE-EeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .|.+...+|.|+|+.|-.+ ...+++..++|++....    .+-.+|+.++... +||||+++.+.+.+..+.++|||.+
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l  398 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL  398 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence            4566777999999999988 45678999999997652    2234567666665 7999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee-cCCCcEEEeecCCcccccccccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL-DQSMRARVADFGLSREEMVDKHA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill-~~~~~~kl~Dfgl~~~~~~~~~~  269 (432)
                      .++-|.+.+....   .....+..|+.+|+.++.|||.++   ++||||||+|||+ +..++++|+|||.++.....  .
T Consensus       399 ~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~  470 (612)
T KOG0603|consen  399 DGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--C  470 (612)
T ss_pred             cccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh--h
Confidence            9998888775432   233778889999999999999999   9999999999999 68999999999998764433  3


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      .+.+-|..|.|||+.....|++++|+||||++||+|++|+.||.......++.              .....+.+....+
T Consensus       471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~--------------~~i~~~~~s~~vS  536 (612)
T KOG0603|consen  471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIH--------------TRIQMPKFSECVS  536 (612)
T ss_pred             cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHH--------------HhhcCCccccccC
Confidence            45567899999999999999999999999999999999999997544332222              2222333344556


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+..+|+.+||+.||.+||++.++..
T Consensus       537 ~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  537 DEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             HHHHHHHHHhccCChhhCcChhhhcc
Confidence            68999999999999999999999875

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=243.12  Aligned_cols=253  Identities=26%  Similarity=0.374  Sum_probs=197.0

Q ss_pred             ccccccCceeEEEEE-eCCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCC
Q 014038          118 TLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS  194 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  194 (432)
                      ++||+|.||+||+|+ ..+++.||+|+++.+.  ........+|+-+|+.++|.|||++++....+...-+|+|||.. +
T Consensus         8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d   86 (292)
T KOG0662|consen    8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D   86 (292)
T ss_pred             HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence            579999999999995 4578899999987653  33346778999999999999999999999999999999999964 7


Q ss_pred             hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cccccc
Q 014038          195 LASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIR  273 (432)
Q Consensus       195 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~~  273 (432)
                      |..+... -++.++...+..++.|+++||.|+|+++   +.||||||.|.||+.+|++|++|||+++...... ..+..+
T Consensus        87 lkkyfds-lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcysaev  162 (292)
T KOG0662|consen   87 LKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEV  162 (292)
T ss_pred             HHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEeeecee
Confidence            8777643 4567999999999999999999999999   9999999999999999999999999998655443 455667


Q ss_pred             cCCCCCCccccccC-CCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHh----hhcCCCchhh---hccccCCCCC
Q 014038          274 GTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAM----NTEGKTGWEE---IVDSRLDGIF  344 (432)
Q Consensus       274 gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~----~~~~~~~~~~---~~~~~~~~~~  344 (432)
                      .|.+|.+|.++.+. -|+...|+||-|||+.|+.. |++.|++..-..++..+    ....++.|..   +-|-..-+.+
T Consensus       163 vtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~y  242 (292)
T KOG0662|consen  163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIY  242 (292)
T ss_pred             eeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCc
Confidence            89999999998654 58999999999999999987 77778775433333322    2223333432   2222222223


Q ss_pred             CHH-----H----HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          345 DVE-----E----LNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       345 ~~~-----~----~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +..     .    ...=++++.+.+.-+|.+|.++++.++
T Consensus       243 pattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  243 PATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             cccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            221     1    123356777777779999999988765

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-34  Score=288.61  Aligned_cols=262  Identities=20%  Similarity=0.300  Sum_probs=179.8

Q ss_pred             HHhccccccccccCceeEEEEEe-----------------CCCcEEEEEEeccCChhhHHHH--------------HHHH
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM-----------------STGETVAVKVLATDSKQGEKEF--------------QTEV  159 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E~  159 (432)
                      ...|.+.++||+|+||+||+|..                 ..++.||||++........++|              ..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            34566778999999999999953                 2356799999875433323333              3466


Q ss_pred             HHHhhcCCCcc-----ceEEeeeee--------CCeEEEEEEeccCCChhhhcccCC----------------------C
Q 014038          160 MLLGRLHHRNL-----VNLVGYCAE--------KGQHMLVYVFMSKGSLASHLYDEN----------------------Y  204 (432)
Q Consensus       160 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------------~  204 (432)
                      ..+.+++|.|+     ++++++|..        .+..++||||+++|+|.++++...                      .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777766554     677787753        356899999999999999886421                      1


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccccc--ccccCCCCCCcc
Q 014038          205 GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA--NIRGTFGYLDPE  282 (432)
Q Consensus       205 ~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~--~~~gt~~y~aPE  282 (432)
                      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..........  ...+|+.|+|||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            23567788999999999999999998   9999999999999999999999999986543322222  233578999999


Q ss_pred             ccccCC--------------------C--CchhHhHHHHHHHHHHHhCCC-CCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          283 YISTRN--------------------F--TKKSDVYSFGVLLFELIAGRS-PLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       283 ~~~~~~--------------------~--~~~~Dv~SlGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      .+....                    |  ..+.||||+||+++||++|.. ||...................|.......
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            875322                    1  235799999999999999875 77543211111110001111111111111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCC---CCCCCHHHHHH
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAP---RKRPSMRDIVQ  375 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp---~~RPs~~~vl~  375 (432)
                      ..-...........+++.++|..+|   .+|+|+.|+++
T Consensus       461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            1111111234578899999999866   68999999885

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-35  Score=262.45  Aligned_cols=245  Identities=22%  Similarity=0.399  Sum_probs=194.5

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      .+++.++||+|+|+.|.++++ ++.+.+|+|++++.   ...+..-...|-.+..+- +||.+|.++.+|+.+..+++|.
T Consensus       251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi  330 (593)
T KOG0695|consen  251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI  330 (593)
T ss_pred             cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence            456678999999999999965 47789999998764   333344456677777766 7999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-c
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-D  266 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~  266 (432)
                      ||+++|+|--++  +.+..|++..+..+...|+-||.|||+.+   ||.||||.+|||+|..|++||+|||+++.... .
T Consensus       331 eyv~ggdlmfhm--qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  331 EYVNGGDLMFHM--QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEecCcceeeeh--hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence            999999998777  45567999999999999999999999999   99999999999999999999999999986443 4


Q ss_pred             ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCch-hhhccccCCCCCC
Q 014038          267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW-EEIVDSRLDGIFD  345 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  345 (432)
                      ..+++++|||.|.|||++++..|....|.|+|||+++||+.|+.||+-..    ......+...-+ .-++....+  .|
T Consensus       406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg----m~n~d~ntedylfqvilekqir--ip  479 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG----MDNPDMNTEDYLFQVILEKQIR--IP  479 (593)
T ss_pred             cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec----CCCcccchhHHHHHHHhhhccc--cc
Confidence            56788999999999999999999999999999999999999999996211    000000111111 111222222  22


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCC
Q 014038          346 VEELNEVASLAYKCVNRAPRKRP  368 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RP  368 (432)
                      ...+.....++..-|++||.+|.
T Consensus       480 rslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  480 RSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ceeehhhHHHHHHhhcCCcHHhc
Confidence            23334567788999999999984

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=244.47  Aligned_cols=194  Identities=28%  Similarity=0.446  Sum_probs=163.7

Q ss_pred             ccccccCceeEEEEE-eCCCcEEEEEEeccC-ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEeccCCC
Q 014038          118 TLIGQGAFGPVYKAQ-MSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGS  194 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~  194 (432)
                      ..||+|++|.|=+-+ ..+|...|+|.+... ..+..++.++|+.+..+. .+|.+|.++|.+...+..++.||.|. .|
T Consensus        52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tS  130 (282)
T KOG0984|consen   52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TS  130 (282)
T ss_pred             hhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hh
Confidence            469999999998885 458999999999765 345567788899887665 79999999999999999999999996 47


Q ss_pred             hhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccccccc
Q 014038          195 LASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI  272 (432)
Q Consensus       195 L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  272 (432)
                      |..+...  ..++.+++..+-+|+..|+.||.|||++-.  +||||+||+|||++.+|++|+||||++-.....-.....
T Consensus       131 ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~d  208 (282)
T KOG0984|consen  131 LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMD  208 (282)
T ss_pred             HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHh
Confidence            8766543  456789999999999999999999999753  999999999999999999999999998654433333335


Q ss_pred             ccCCCCCCcccccc----CCCCchhHhHHHHHHHHHHHhCCCCCCC
Q 014038          273 RGTFGYLDPEYIST----RNFTKKSDVYSFGVLLFELIAGRSPLQG  314 (432)
Q Consensus       273 ~gt~~y~aPE~~~~----~~~~~~~Dv~SlGvil~elltg~~p~~~  314 (432)
                      .|...|||||.+..    ..|+.|+||||||+++.||.+++.||..
T Consensus       209 aGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  209 AGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             cCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            67889999998853    4699999999999999999999999975

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=278.64  Aligned_cols=237  Identities=22%  Similarity=0.330  Sum_probs=201.2

Q ss_pred             cccccccCceeEEEEEeCCCc-EEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          117 TTLIGQGAFGPVYKAQMSTGE-TVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      ...||-||||.|=+++..... .+|+|++++.   ....++.+..|-.+|...+.|.||++|-.|.+....|++||-|-|
T Consensus       425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG  504 (732)
T KOG0614|consen  425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG  504 (732)
T ss_pred             hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence            357999999999999875444 4899988654   344456788999999999999999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI  272 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  272 (432)
                      |.|-..|++  .+.++......++.-+++|++|||.++   ||.|||||+|++||.+|-+||.|||+++....+..+-++
T Consensus       505 GElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTF  579 (732)
T KOG0614|consen  505 GELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTF  579 (732)
T ss_pred             chhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCceeee
Confidence            999999954  467999999999999999999999999   999999999999999999999999999998888889999


Q ss_pred             ccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHH
Q 014038          273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEV  352 (432)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  352 (432)
                      +|||-|.|||++..+.-+..+|.||||+++|||++|.+||.+.........+... -+          .-.+|.......
T Consensus       580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-id----------~i~~Pr~I~k~a  648 (732)
T KOG0614|consen  580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-ID----------KIEFPRRITKTA  648 (732)
T ss_pred             cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-hh----------hhhcccccchhH
Confidence            9999999999999998999999999999999999999999986543332222111 10          112344445678


Q ss_pred             HHHHHHhhccCCCCCCC
Q 014038          353 ASLAYKCVNRAPRKRPS  369 (432)
Q Consensus       353 ~~li~~cl~~dp~~RPs  369 (432)
                      .+++.+.+..+|.+|.-
T Consensus       649 ~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  649 TDLIKKLCRDNPTERLG  665 (732)
T ss_pred             HHHHHHHHhcCcHhhhc
Confidence            89999999999999965

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.3e-33  Score=287.79  Aligned_cols=255  Identities=18%  Similarity=0.263  Sum_probs=168.0

Q ss_pred             HhccccccccccCceeEEEEEeC-C----CcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEee------eeeC
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-T----GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY------CAEK  180 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~~~  180 (432)
                      ..|.+.+.||+|+||.||+|... +    +..||+|.+......  +.+..|  .+....+.++..++..      +...
T Consensus       132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence            45677789999999999999764 4    689999987543211  111111  1222223333222221      2456


Q ss_pred             CeEEEEEEeccCCChhhhcccCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCC
Q 014038          181 GQHMLVYVFMSKGSLASHLYDENYG------------------PLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSS  242 (432)
Q Consensus       181 ~~~~lv~e~~~~g~L~~~l~~~~~~------------------~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~  242 (432)
                      ...++||||+.+++|.+++......                  ...+..+..++.|++.||.|||+.+   |+||||||+
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~  284 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQ  284 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHH
Confidence            7899999999999999988543210                  1123345679999999999999998   999999999


Q ss_pred             CeeecC-CCcEEEeecCCccccccc--ccccccccCCCCCCccccccC----------------------CCCchhHhHH
Q 014038          243 NILLDQ-SMRARVADFGLSREEMVD--KHAANIRGTFGYLDPEYISTR----------------------NFTKKSDVYS  297 (432)
Q Consensus       243 Nill~~-~~~~kl~Dfgl~~~~~~~--~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv~S  297 (432)
                      |||++. ++.+||+|||+++.....  .......+++.|+|||.+...                      .++.++||||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            999986 579999999999754322  233456789999999965321                      3456779999


Q ss_pred             HHHHHHHHHhCCCCCCChhHHHHHHHhhh---cCCCchhhhccccCCCC----CC--HHHHHHHHHHHHHhhccCCCCCC
Q 014038          298 FGVLLFELIAGRSPLQGLMEYVELAAMNT---EGKTGWEEIVDSRLDGI----FD--VEELNEVASLAYKCVNRAPRKRP  368 (432)
Q Consensus       298 lGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~----~~--~~~~~~l~~li~~cl~~dp~~RP  368 (432)
                      |||++|||+++..++....  ..+.....   .....|.....+.....    +.  ........+|+.+||+.||++||
T Consensus       365 lGviL~el~~~~~~~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~  442 (566)
T PLN03225        365 AGLIFLQMAFPNLRSDSNL--IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI  442 (566)
T ss_pred             HHHHHHHHHhCcCCCchHH--HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence            9999999999877765321  11111111   11111222222211100    00  00112456899999999999999


Q ss_pred             CHHHHHH
Q 014038          369 SMRDIVQ  375 (432)
Q Consensus       369 s~~~vl~  375 (432)
                      |+.++++
T Consensus       443 ta~e~L~  449 (566)
T PLN03225        443 SAKAALA  449 (566)
T ss_pred             CHHHHhC
Confidence            9999987

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=279.68  Aligned_cols=238  Identities=26%  Similarity=0.389  Sum_probs=183.2

Q ss_pred             ccccccCcee-EEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEeccCCCh
Q 014038          118 TLIGQGAFGP-VYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       118 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  195 (432)
                      +++|.|+.|+ ||+|.+ +|+.||||++-...   ..-..+|+..|+.- +|||||++++.-.+....|+..|.|. .+|
T Consensus       515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL  589 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSL  589 (903)
T ss_pred             HHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhH
Confidence            5689999876 699988 78999999885432   33457899999988 69999999999888999999999995 599


Q ss_pred             hhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC---C--CcEEEeecCCccccccccc
Q 014038          196 ASHLYDE--NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---S--MRARVADFGLSREEMVDKH  268 (432)
Q Consensus       196 ~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~---~--~~~kl~Dfgl~~~~~~~~~  268 (432)
                      .+++...  ..........+.+..|++.||++||+.+   |+||||||.||||+.   +  ..++|+|||+|+....+..
T Consensus       590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s  666 (903)
T KOG1027|consen  590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS  666 (903)
T ss_pred             HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence            9998653  1111111334678899999999999988   999999999999965   2  5799999999997655432


Q ss_pred             ----ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCC
Q 014038          269 ----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       269 ----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                          ..+..||-+|+|||++....-+..+|||||||++|+.++ |..||....+..  ..+..... .+.     .+...
T Consensus       667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~-~L~-----~L~~~  738 (903)
T KOG1027|consen  667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNY-TLV-----HLEPL  738 (903)
T ss_pred             hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCcc-cee-----eeccC
Confidence                345679999999999998888889999999999999998 599998754321  11111111 000     01111


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .  ++  +..+||.+|++.+|..||++.+|+.
T Consensus       739 ~--d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  739 P--DC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             c--hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            1  11  6789999999999999999999975

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-34  Score=273.06  Aligned_cols=193  Identities=28%  Similarity=0.439  Sum_probs=166.2

Q ss_pred             ccccccCceeEEEE-EeCCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCC
Q 014038          118 TLIGQGAFGPVYKA-QMSTGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKG  193 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  193 (432)
                      +.||-|+||.|.++ +.++...+|.|.+++.+   .......+.|-.+|..-+.+=||+||..|.+++.+|+||+|++||
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG  714 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence            46999999999999 45567789999987653   233456788999999999999999999999999999999999999


Q ss_pred             ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc---------c
Q 014038          194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE---------M  264 (432)
Q Consensus       194 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~---------~  264 (432)
                      ++-.+|..  .+-|.+..+..++.++..|+++.|..|   +|||||||+|||||.+|++||+|||||.-.         .
T Consensus       715 DmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq  789 (1034)
T KOG0608|consen  715 DMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  789 (1034)
T ss_pred             cHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence            99998854  356889999999999999999999999   999999999999999999999999998510         0


Q ss_pred             cc------------------c----------------cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCC
Q 014038          265 VD------------------K----------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRS  310 (432)
Q Consensus       265 ~~------------------~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~  310 (432)
                      .+                  .                .....+||+.|+|||++....|+..+|.||.|||||||+.|+.
T Consensus       790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~  869 (1034)
T KOG0608|consen  790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQP  869 (1034)
T ss_pred             CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCC
Confidence            00                  0                0112359999999999999999999999999999999999999


Q ss_pred             CCCCh
Q 014038          311 PLQGL  315 (432)
Q Consensus       311 p~~~~  315 (432)
                      ||-..
T Consensus       870 pf~~~  874 (1034)
T KOG0608|consen  870 PFLAD  874 (1034)
T ss_pred             CccCC
Confidence            99653

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-35  Score=253.16  Aligned_cols=254  Identities=27%  Similarity=0.402  Sum_probs=193.8

Q ss_pred             cccccccCceeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC--------CeEEE
Q 014038          117 TTLIGQGAFGPVYKAQMS-TGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--------GQHML  185 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~~~l  185 (432)
                      ..+||+|.||.||+|+.+ +|+.||+|++-.+  .........+|+++|..++|+|++.++..|...        ..+++
T Consensus        22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl  101 (376)
T KOG0669|consen   22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL  101 (376)
T ss_pred             HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence            457999999999999654 6778898875432  222234567899999999999999999988542        46899


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||.+|+. +|.-+|.+. ...++..++.+++.++..||.|+|...   |+|||+||.|+||+.++.+||+|||+++....
T Consensus       102 Vf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~  176 (376)
T KOG0669|consen  102 VFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFST  176 (376)
T ss_pred             eHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceec
Confidence            9999987 888877433 356899999999999999999999999   99999999999999999999999999974332


Q ss_pred             c-----ccccccccCCCCCCccccc-cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh----cCCCchhhh
Q 014038          266 D-----KHAANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT----EGKTGWEEI  335 (432)
Q Consensus       266 ~-----~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~~~  335 (432)
                      .     ....+.+.|.+|.+||.+. .+.|+++.|||.-|||+.||.||.+-+.+..+...+..+..    ..++.|...
T Consensus       177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~  256 (376)
T KOG0669|consen  177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV  256 (376)
T ss_pred             ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence            2     2234556799999999875 46899999999999999999999999988777665544322    122233222


Q ss_pred             cc-----c-----cCCCCCCH--HH------HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 VD-----S-----RLDGIFDV--EE------LNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 ~~-----~-----~~~~~~~~--~~------~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..     .     ...+.+..  ..      ..+..+++..++..||.+|+++.+++.
T Consensus       257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            11     0     00011000  01      126789999999999999999988765

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-32  Score=254.42  Aligned_cols=147  Identities=24%  Similarity=0.355  Sum_probs=124.4

Q ss_pred             ccCCCCCCcCHHHHHH-HhccccccccccCceeEEEE-EeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC-----C-
Q 014038           96 VSASGIPEYSYKDLQK-ATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-----H-  167 (432)
Q Consensus        96 ~~~~~~~~~~~~~l~~-~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h-  167 (432)
                      ....++......|+.. ++|.+.++||.|.|++||++ +..+.+.||+|+.+.... ..+..+.||++|++++     | 
T Consensus        61 Y~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~  139 (590)
T KOG1290|consen   61 YRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDP  139 (590)
T ss_pred             hhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCC
Confidence            4455677777788877 89999999999999999999 556778999999876432 2345678999999883     3 


Q ss_pred             --CccceEEeeeee----CCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCC
Q 014038          168 --RNLVNLVGYCAE----KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKS  241 (432)
Q Consensus       168 --~niv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp  241 (432)
                        .+||+|+++|..    +.+.|+|+|++ |.+|..++.....+.++...+.+|++||+.||.|||..+  +|||-||||
T Consensus       140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKP  216 (590)
T KOG1290|consen  140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKP  216 (590)
T ss_pred             CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCc
Confidence              369999999865    45889999999 679999998888889999999999999999999999975  399999999


Q ss_pred             CCeee
Q 014038          242 SNILL  246 (432)
Q Consensus       242 ~Nill  246 (432)
                      +|||+
T Consensus       217 ENvLl  221 (590)
T KOG1290|consen  217 ENVLL  221 (590)
T ss_pred             ceeee
Confidence            99999

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=6.7e-31  Score=234.79  Aligned_cols=209  Identities=37%  Similarity=0.653  Sum_probs=182.3

Q ss_pred             ccccCceeEEEEEeCC-CcEEEEEEeccCChh-hHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCChhh
Q 014038          120 IGQGAFGPVYKAQMST-GETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLAS  197 (432)
Q Consensus       120 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  197 (432)
                      ||+|++|.||++...+ ++.+++|.+...... ....+.+|+..++.++|++++++++++......++++||+.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999997753 899999998765432 35678999999999999999999999999999999999999999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC-CCcEEEeecCCcccccccc-cccccccC
Q 014038          198 HLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLSREEMVDK-HAANIRGT  275 (432)
Q Consensus       198 ~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~-~~~~kl~Dfgl~~~~~~~~-~~~~~~gt  275 (432)
                      ++.... ..+++..+..++.++++++.|||+.+   ++|+||+|.||+++. ++.++|+|||.+....... ......+.
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence            985432 46899999999999999999999998   999999999999999 8999999999987543322 13345578


Q ss_pred             CCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHH
Q 014038          276 FGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVAS  354 (432)
Q Consensus       276 ~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  354 (432)
                      ..|++||.+... .++.++|+|+||+++++|                                            ..+.+
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------~~~~~  192 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------PELKD  192 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------HHHHH
Confidence            899999999877 888999999999999998                                            26889


Q ss_pred             HHHHhhccCCCCCCCHHHHHHH
Q 014038          355 LAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       355 li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ++..|++.+|++||++.++++.
T Consensus       193 ~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         193 LIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHhhCCcccCcCHHHHhhC
Confidence            9999999999999999998864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-33  Score=245.62  Aligned_cols=255  Identities=25%  Similarity=0.348  Sum_probs=190.3

Q ss_pred             cccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC-----CeEEEEEE
Q 014038          117 TTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-----GQHMLVYV  188 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e  188 (432)
                      .+.||.|+||.||-+.. .+|+.||.|++..-  .-...+.+.+|+++|..++|.|++..++...-.     .+.|+++|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            46799999999999954 48999999988542  234457888999999999999999988866543     25678888


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc--
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--  266 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~--  266 (432)
                      .|.. +|...+-  ...+++...+.-+..||++||.|||+.+   |.||||||.|.|++.+..+||||||+++....+  
T Consensus       138 LmQS-DLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  138 LMQS-DLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHh-hhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            8854 7887773  4467888999999999999999999999   999999999999999999999999999865433  


Q ss_pred             ccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc-CCCchhh----------
Q 014038          267 KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE-GKTGWEE----------  334 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~----------  334 (432)
                      ......+.|..|.|||++.+ +.|+...||||.|||+.||+..+..|.......++..+..- +....+.          
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence            23345567899999999875 57999999999999999999999888754443333222111 1111110          


Q ss_pred             -hccccCCCC---------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          335 -IVDSRLDGI---------FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       335 -~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                       ++....+.+         .+.....+...+...++..||++|.+..+.+..+
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence             010000000         0111223567788889999999999988877643

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.1e-31  Score=229.53  Aligned_cols=249  Identities=18%  Similarity=0.367  Sum_probs=197.4

Q ss_pred             HhccccccccccCceeEEEE-EeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC-CCccceEEeeeeeC--CeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEK--GQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  187 (432)
                      ..|++.+++|+|.++.||.| ...+++.++||+++.   ...+.+.+|+.+|+.|. ||||+++++...+.  ....||+
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            35667789999999999999 456788999999964   44567899999999996 99999999988764  5678999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC-CcEEEeecCCccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-MRARVADFGLSREEMVD  266 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~-~~~kl~Dfgl~~~~~~~  266 (432)
                      ||+++.+...+.     ..|+.-.+...+.+++.||.|+|+.|   |.|||+||.|+++|.. ..++|+|+|++......
T Consensus       115 E~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  115 EYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            999987776554     45788888999999999999999999   9999999999999864 56999999999876655


Q ss_pred             ccccccccCCCCCCccccc-cCCCCchhHhHHHHHHHHHHHhCCCCCC-ChhHHHHHHHh--------------------
Q 014038          267 KHAANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQ-GLMEYVELAAM--------------------  324 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltg~~p~~-~~~~~~~~~~~--------------------  324 (432)
                      ......+.+..|--||++- -+.|+..-|+|||||++..|+..+.||- +..+..++..+                    
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            5555667788899999885 4568899999999999999999999974 33333332221                    


Q ss_pred             --------hhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          325 --------NTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       325 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                              ....+..|..++.+......    .++..+++.+.|..|-.+|||+.|.+.
T Consensus       267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~----~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  267 DPQFEDILGRHSRKPWSRFINSENQHLV----SPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             ChhHhhHhhccccccHHHhCCccccccC----ChHHHHHHHHHHhhccccccchHHHhc
Confidence                    11223345555544433333    247889999999999999999999775

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=9.1e-33  Score=267.75  Aligned_cols=250  Identities=26%  Similarity=0.411  Sum_probs=207.3

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .|++...+|.|.||.||+++. ..++..|+|.++........-...|+-+++..+||||+.++|-+......++.||||.
T Consensus        16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg   95 (829)
T KOG0576|consen   16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG   95 (829)
T ss_pred             chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence            455667899999999999954 5789999999988877777778899999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~  270 (432)
                      +|+|.+..+  ..+++++.++...++..++||.|||+.+   -+|||||-.|||+++.|.+|++|||.+...... ....
T Consensus        96 ggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk  170 (829)
T KOG0576|consen   96 GGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK  170 (829)
T ss_pred             CCcccceee--ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence            999999874  4578999999999999999999999999   799999999999999999999999998654332 3445


Q ss_pred             ccccCCCCCCcccc---ccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          271 NIRGTFGYLDPEYI---STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       271 ~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      .+.||+.|||||+.   +.+.|.+++|||++|+...|+---++|.........+.-+...+..+      +.+..  ...
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qp------p~lkD--k~k  242 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQP------PTLKD--KTK  242 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCC------CcccC--Ccc
Confidence            67899999999976   56779999999999999999988888876655444444433332211      11211  123


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.+.+|++.|+.++|++||+++.+++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee
Confidence            3457889999999999999999998765

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=3.1e-30  Score=233.75  Aligned_cols=196  Identities=35%  Similarity=0.553  Sum_probs=171.5

Q ss_pred             cccccccccCceeEEEEEeCC-CcEEEEEEeccCChh-hHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          115 NFTTLIGQGAFGPVYKAQMST-GETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      .+.+.||.|++|.||++...+ ++.+|+|.+...... ..+.+.+|+..+++++|+|++++++++......++++||+++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   81 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG   81 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence            456789999999999997754 889999999766544 567889999999999999999999999998999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--ccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAA  270 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~  270 (432)
                      ++|.+++..... .+++..+..++.+++.++.|||+.+   ++|+||+|.||+++.++.++|+|||++.......  ...
T Consensus        82 ~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       82 GDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence            999999854322 2889999999999999999999998   9999999999999999999999999987654432  334


Q ss_pred             ccccCCCCCCcccc-ccCCCCchhHhHHHHHHHHHHHhCCCCCCC
Q 014038          271 NIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG  314 (432)
Q Consensus       271 ~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~elltg~~p~~~  314 (432)
                      ...++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            45678899999998 667788899999999999999999999976

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=2.4e-31  Score=251.21  Aligned_cols=274  Identities=23%  Similarity=0.263  Sum_probs=210.8

Q ss_pred             ccCCCCCCcCHHHHHHHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCC------C
Q 014038           96 VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH------R  168 (432)
Q Consensus        96 ~~~~~~~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~  168 (432)
                      ..+.++..+.+.+++..+|.+....|+|-|++|.+|.. ..|+.||||++..+.. -.+.=++|+++|++|+.      -
T Consensus       416 dDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~  494 (752)
T KOG0670|consen  416 DDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKF  494 (752)
T ss_pred             ccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhh
Confidence            44567778889999999999999999999999999954 4678999999976532 23444689999999963      4


Q ss_pred             ccceEEeeeeeCCeEEEEEEeccCCChhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec
Q 014038          169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD  247 (432)
Q Consensus       169 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~  247 (432)
                      |+++++-.|...+++|+|+|-+. .+|.+.|.. ...-.|....+..++.|+.-||..|...+   |+|.||||+|||++
T Consensus       495 Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVN  570 (752)
T KOG0670|consen  495 HCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVN  570 (752)
T ss_pred             HHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEec
Confidence            79999999999999999999884 599999864 23345888889999999999999999999   99999999999998


Q ss_pred             CCC-cEEEeecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHH-Hhh
Q 014038          248 QSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMN  325 (432)
Q Consensus       248 ~~~-~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~-~~~  325 (432)
                      +.- .+||||||.|..... ........+..|.|||++.+..|+...|+||.||+||||.||+..|++..+...+- .+.
T Consensus       571 E~k~iLKLCDfGSA~~~~e-neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me  649 (752)
T KOG0670|consen  571 ESKNILKLCDFGSASFASE-NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME  649 (752)
T ss_pred             cCcceeeeccCcccccccc-ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence            764 689999998765332 23344556788999999999999999999999999999999999998755432221 111


Q ss_pred             hcCCCc---------hhhhcccc--------------------------------CCC--CCC---HHHHHHHHHHHHHh
Q 014038          326 TEGKTG---------WEEIVDSR--------------------------------LDG--IFD---VEELNEVASLAYKC  359 (432)
Q Consensus       326 ~~~~~~---------~~~~~~~~--------------------------------~~~--~~~---~~~~~~l~~li~~c  359 (432)
                      ..++-+         ..+.+|..                                +.+  .++   ......|.+|+..|
T Consensus       650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm  729 (752)
T KOG0670|consen  650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM  729 (752)
T ss_pred             hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence            111100         01111100                                000  011   22356899999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 014038          360 VNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       360 l~~dp~~RPs~~~vl~  375 (432)
                      |..||++|-|..+.|.
T Consensus       730 l~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  730 LILDPEKRITVNQALK  745 (752)
T ss_pred             hccChhhcCCHHHHhc
Confidence            9999999999998774

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=238.86  Aligned_cols=249  Identities=25%  Similarity=0.331  Sum_probs=191.2

Q ss_pred             ccccccCceeEEEE-EeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC------CeEEEEEE
Q 014038          118 TLIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQHMLVYV  188 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e  188 (432)
                      ..+|.|.- .|--+ +.-.+++||+|.+...  .....++..+|..++..++|+||++++.++.-.      ...|+|||
T Consensus        23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e  101 (369)
T KOG0665|consen   23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME  101 (369)
T ss_pred             cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence            46788887 55555 4447899999987543  334456778999999999999999999988533      46799999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      +|. ++|.+.+.    ..++-..+.+|..|++.|++|||+.+   |+||||||+||++..+..+||+|||+++.....-.
T Consensus       102 ~m~-~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~  173 (369)
T KOG0665|consen  102 LMD-ANLCQVIL----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFM  173 (369)
T ss_pred             hhh-hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcccc
Confidence            995 58988875    34777889999999999999999999   99999999999999999999999999987666545


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCC-------------------
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGK-------------------  329 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------------------  329 (432)
                      .+..+.|..|.|||++-+-.|.+.+||||.||++.||++|+.-|.+..-..++..+...-.                   
T Consensus       174 mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~  253 (369)
T KOG0665|consen  174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE  253 (369)
T ss_pred             cCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh
Confidence            5677889999999999888899999999999999999999999986443333322211110                   


Q ss_pred             -------Cchhhhcccc-CCCC--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          330 -------TGWEEIVDSR-LDGI--FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       330 -------~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                             ..+.+.+... .+..  .+......+.+++.+||-.||++|-++.++|+
T Consensus       254 ~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  254 NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                   1111111111 1110  11112346789999999999999999999885

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=222.19  Aligned_cols=243  Identities=20%  Similarity=0.329  Sum_probs=180.4

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEee-eeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGY-CAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~e~  189 (432)
                      .|++.+.||+|.||.+.++.. ...+.+++|.+... ....++|.+|..---.| .|.||+.-++. |+..+..++++||
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~  103 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF  103 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence            467888999999999999965 46678999988654 34467899998765555 58999988764 6677888999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec--CCCcEEEeecCCcccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD--QSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~--~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ++.|+|.+.+..   ..+.+....+++.|++.|+.|+|+.+   ++|||||.+||||-  +...+||||||+++....  
T Consensus       104 aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~--  175 (378)
T KOG1345|consen  104 APRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT--  175 (378)
T ss_pred             CccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc--
Confidence            999999998843   45788888999999999999999999   99999999999992  344899999999875322  


Q ss_pred             cccccccCCCCCCccccccC-----CCCchhHhHHHHHHHHHHHhCCCCCCCh----hHHHHHHHhhhcCCCchhhhccc
Q 014038          268 HAANIRGTFGYLDPEYISTR-----NFTKKSDVYSFGVLLFELIAGRSPLQGL----MEYVELAAMNTEGKTGWEEIVDS  338 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGvil~elltg~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .......+..|.+||.....     ...+.+|+|.||+++|.++||+.||+..    ..+.++..+.....        +
T Consensus       176 tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~--------~  247 (378)
T KOG1345|consen  176 TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN--------P  247 (378)
T ss_pred             eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC--------c
Confidence            22233456779999976432     3468899999999999999999999732    12333333322222        2


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 014038          339 RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDI  373 (432)
Q Consensus       339 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~v  373 (432)
                      .++..+.. .++.+..+..+-+..+|++|--..++
T Consensus       248 ~~P~~F~~-fs~~a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  248 ALPKKFNP-FSEKALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             cCchhhcc-cCHHHHHHHHHhcCCcccccchhHHH
Confidence            22222221 12356778888899999999433333

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-30  Score=226.02  Aligned_cols=249  Identities=23%  Similarity=0.399  Sum_probs=198.3

Q ss_pred             ccccccccccCceeEEEEEeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          114 CNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .++..+|.+...|..|+|++. |..+++|++...  ......+|.+|.-.|+-+.||||++++|.|.....+.++..||+
T Consensus       192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            356678999999999999995 555666777543  33445689999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEe--ecCCcccccccccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA--DFGLSREEMVDKHA  269 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~--Dfgl~~~~~~~~~~  269 (432)
                      .|+|+..|+....-..+..++.+++.++++|++|||+.. |-|.---|.+..|++|++.+++|+  |--++.      +.
T Consensus       271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf------qe  343 (448)
T KOG0195|consen  271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF------QE  343 (448)
T ss_pred             chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee------ec
Confidence            999999999887777888999999999999999999975 323344689999999999998885  222211      22


Q ss_pred             cccccCCCCCCccccccCCCC---chhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          270 ANIRGTFGYLDPEYISTRNFT---KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~---~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      ......|.||+||.++.++-+   ..+|+|||++++|||.|...||.+.....-..           ++.-+.++...|+
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-----------kialeglrv~ipp  412 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-----------KIALEGLRVHIPP  412 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-----------hhhhccccccCCC
Confidence            233457899999999876543   68999999999999999999998654322111           1122234444555


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL  381 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~  381 (432)
                      ..+..+.++|.-|+..||.+||.+..|+-.|+++.
T Consensus       413 gis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            66678999999999999999999999999998763

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=5.4e-30  Score=244.86  Aligned_cols=196  Identities=22%  Similarity=0.361  Sum_probs=164.1

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh--------hhHHHHHHHHHHHhhcC---CCccceEEeeeeeC
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK--------QGEKEFQTEVMLLGRLH---HRNLVNLVGYCAEK  180 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  180 (432)
                      .|...+.+|+|+||.|++|..+ +...|+||.+.+..-        ...-..-.|+.+|..++   |+||++++++|+++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            3455578999999999999654 566899998865321        11112446999999997   99999999999999


Q ss_pred             CeEEEEEEec-cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCC
Q 014038          181 GQHMLVYVFM-SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL  259 (432)
Q Consensus       181 ~~~~lv~e~~-~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl  259 (432)
                      +.+|++||-. ++-+|.+++.  ....+++.++..|++||+.|+++||+++   |+|||||-+||.++.+|-+||+|||.
T Consensus       642 d~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccc
Confidence            9999999964 4668888884  3456999999999999999999999999   99999999999999999999999998


Q ss_pred             cccccccccccccccCCCCCCccccccCCCC-chhHhHHHHHHHHHHHhCCCCCCC
Q 014038          260 SREEMVDKHAANIRGTFGYLDPEYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQG  314 (432)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~elltg~~p~~~  314 (432)
                      +... .......++||..|.|||++.+.+|- ..-|||++|++||-++....||.+
T Consensus       717 aa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            7643 33455678999999999999998875 568999999999999988888753

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.5e-29  Score=270.07  Aligned_cols=193  Identities=19%  Similarity=0.220  Sum_probs=140.0

Q ss_pred             hcCC-CccceEEeee-------eeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 014038          164 RLHH-RNLVNLVGYC-------AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI  235 (432)
Q Consensus       164 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ii  235 (432)
                      .++| +||++++++|       .....+++++||+ +++|.++|... ...+++..++.++.||+.||.|||+++   |+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            4556 6888888877       2234567788887 56999999643 356999999999999999999999999   99


Q ss_pred             eccCCCCCeeecC-------------------CCcEEEeecCCcccccccc-----------------cccccccCCCCC
Q 014038          236 HRDIKSSNILLDQ-------------------SMRARVADFGLSREEMVDK-----------------HAANIRGTFGYL  279 (432)
Q Consensus       236 H~dlkp~Nill~~-------------------~~~~kl~Dfgl~~~~~~~~-----------------~~~~~~gt~~y~  279 (432)
                      ||||||+||||+.                   ++.+|++|||+++......                 ......||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999954                   4456666666664321000                 001135788999


Q ss_pred             CccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHh
Q 014038          280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKC  359 (432)
Q Consensus       280 aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  359 (432)
                      |||++.+..|+.++|||||||+||||++|..|+...........  .       ....+.     ..........++.+|
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~--~-------~~~~~~-----~~~~~~~~~~~~~~~  248 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLR--H-------RVLPPQ-----ILLNWPKEASFCLWL  248 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHH--H-------hhcChh-----hhhcCHHHHHHHHHh
Confidence            99999999999999999999999999999988764322111000  0       000110     011123566889999


Q ss_pred             hccCCCCCCCHHHHHH
Q 014038          360 VNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       360 l~~dp~~RPs~~~vl~  375 (432)
                      |+.+|.+||++.++++
T Consensus       249 L~~~P~~Rps~~eil~  264 (793)
T PLN00181        249 LHPEPSCRPSMSELLQ  264 (793)
T ss_pred             CCCChhhCcChHHHhh
Confidence            9999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=3.6e-28  Score=212.35  Aligned_cols=169  Identities=25%  Similarity=0.283  Sum_probs=127.1

Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccccccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI  272 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~  272 (432)
                      |+|.+++... ..++++..++.++.||+.||.|||+++         ||+|||++.++.+|+  ||++......    ..
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~   64 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----QS   64 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----cC
Confidence            6899988643 456999999999999999999999865         999999999999999  9998754322    22


Q ss_pred             ccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHH--
Q 014038          273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN--  350 (432)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  350 (432)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||..................   .. .+. ....+.....  
T Consensus        65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~~-~~~-~~~~~~~~~~~~  139 (176)
T smart00750       65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP---AD-DPR-DRSNLESVSAAR  139 (176)
T ss_pred             CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc---cC-Ccc-ccccHHHHHhhh
Confidence            6889999999999999999999999999999999999999754332111111100000   00 000 0011122222  


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          351 EVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       351 ~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      ++.+++.+||+.+|.+||++.++++.+..+..
T Consensus       140 ~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      140 SFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             hHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            69999999999999999999999998877643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=1e-27  Score=222.42  Aligned_cols=191  Identities=28%  Similarity=0.425  Sum_probs=158.1

Q ss_pred             hccccccccccCceeEEEEEeC----CCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      .+...++||+|.|++||++.+.    .++.||+|.+...+.  ...+.+|++.|..+ -+.||+++.+++...+...+|+
T Consensus        37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl  114 (418)
T KOG1167|consen   37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL  114 (418)
T ss_pred             hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence            3455689999999999999532    467899999865433  34688999999999 5999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC-CcEEEeecCCccccc--
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-MRARVADFGLSREEM--  264 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~-~~~kl~Dfgl~~~~~--  264 (432)
                      ||++...-.+++.     .++...+..++..++.||.++|.+|   ||||||||.|+|.+.. +.-.|.|||++....  
T Consensus       115 p~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~  186 (418)
T KOG1167|consen  115 PYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY  186 (418)
T ss_pred             cccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhh
Confidence            9999988888873     3678888999999999999999999   9999999999999754 567999999986100  


Q ss_pred             --------------cc-----------------------------ccccccccCCCCCCccccc-cCCCCchhHhHHHHH
Q 014038          265 --------------VD-----------------------------KHAANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGV  300 (432)
Q Consensus       265 --------------~~-----------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGv  300 (432)
                                    ..                             .......||++|.|||++. ...-+.+.||||-||
T Consensus       187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV  266 (418)
T KOG1167|consen  187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV  266 (418)
T ss_pred             hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence                          00                             0011234999999999875 456789999999999


Q ss_pred             HHHHHHhCCCCCC
Q 014038          301 LLFELIAGRSPLQ  313 (432)
Q Consensus       301 il~elltg~~p~~  313 (432)
                      |++-+++++.||-
T Consensus       267 I~Lslls~~~PFf  279 (418)
T KOG1167|consen  267 ILLSLLSRRYPFF  279 (418)
T ss_pred             eeehhhccccccc
Confidence            9999999999985

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=5.4e-26  Score=217.72  Aligned_cols=261  Identities=21%  Similarity=0.302  Sum_probs=198.1

Q ss_pred             hccccccccccCceeEEEEEeCCC--cEEEEEEeccCChhhHHHHHHHHHHHhhcCC----CccceEEeee-eeCCeEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTG--ETVAVKVLATDSKQGEKEFQTEVMLLGRLHH----RNLVNLVGYC-AEKGQHML  185 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  185 (432)
                      .|.+.+.||+|+||.||++.....  ..+|+|............+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            567788999999999999975443  4799998766543333367889999988863    6889999888 47778899


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC-----CcEEEeecCCc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-----MRARVADFGLS  260 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~-----~~~kl~Dfgl~  260 (432)
                      ||+.+ |.+|.++......+.++....++|+.|++.+|.+||+.|   ++||||||.|+++...     ..+.|.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99987 779999775555678999999999999999999999999   9999999999999765     46999999999


Q ss_pred             c--cccccc--------c-ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCC
Q 014038          261 R--EEMVDK--------H-AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGK  329 (432)
Q Consensus       261 ~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  329 (432)
                      +  ......        . ...+.||..|.++....+...+++.|+||++.++.|++.|..||.................
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8  321111        1 2345699999999999999999999999999999999999999976443211111111100


Q ss_pred             CchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          330 TGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                         ......     .....+.++.++...+-..+..++|....+...|........
T Consensus       255 ---~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~  302 (322)
T KOG1164|consen  255 ---KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG  302 (322)
T ss_pred             ---hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence               000000     111123456677777777899999999999999888876653

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.4e-25  Score=214.65  Aligned_cols=161  Identities=19%  Similarity=0.167  Sum_probs=125.2

Q ss_pred             HhccccccccccCceeEEEEEeC--CCcEEEEEEeccC-----ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS--TGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  184 (432)
                      ..|.+.+.||+|+||+||+|...  +++.||||++...     .......|.+|+++|++++|+|+++.+..   .+..+
T Consensus        18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~   94 (365)
T PRK09188         18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG   94 (365)
T ss_pred             CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence            35777889999999999999654  5778899987533     12234568999999999999999853322   24679


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC-CCCCeeecCCCcEEEeecCCcccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI-KSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dl-kp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      +||||+++++|....   .   ..   ...++.++++||.|||+.+   |+|||| ||+|||++.++.+||+|||+++..
T Consensus        95 LVmE~~~G~~L~~~~---~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         95 LVRGWTEGVPLHLAR---P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             EEEEccCCCCHHHhC---c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence            999999999996321   1   11   1467889999999999999   999999 999999999999999999999854


Q ss_pred             ccccc---------ccccccCCCCCCccccccC
Q 014038          264 MVDKH---------AANIRGTFGYLDPEYISTR  287 (432)
Q Consensus       264 ~~~~~---------~~~~~gt~~y~aPE~~~~~  287 (432)
                      .....         ..+..+++.|+|||.+...
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            32221         1345688899999998543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=1.2e-23  Score=200.53  Aligned_cols=255  Identities=30%  Similarity=0.442  Sum_probs=195.3

Q ss_pred             ccccccccccCceeEEEEEeCCCcEEEEEEeccCChh---hHHHHHHHHHHHhhcCCC-ccceEEeeeeeCCeEEEEEEe
Q 014038          114 CNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ---GEKEFQTEVMLLGRLHHR-NLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  189 (432)
                      +.+.+.||.|+||.||++...  ..+++|.+......   ....|.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            345678999999999999765  88999998765332   367899999999999988 799999999777778999999


Q ss_pred             ccCCChhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC-cEEEeecCCcccccccc
Q 014038          190 MSKGSLASHLYDENY-GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDK  267 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~~  267 (432)
                      +.++++.+++..... ..++......+..|++.++.|+|..+   ++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966643221 26889999999999999999999999   99999999999999988 79999999987433322


Q ss_pred             -------cccccccCCCCCCcccccc---CCCCchhHhHHHHHHHHHHHhCCCCCCChhH---HHHHHHhhhcCCCchhh
Q 014038          268 -------HAANIRGTFGYLDPEYIST---RNFTKKSDVYSFGVLLFELIAGRSPLQGLME---YVELAAMNTEGKTGWEE  334 (432)
Q Consensus       268 -------~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~  334 (432)
                             ......|+..|++||.+..   ..++...|+||+|++++++++|..||.....   ..............   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence                   2356789999999999987   5788999999999999999999999876542   11111111111100   


Q ss_pred             hccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      .................+.+++..|+..+|..|.+..+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            000000000001223478899999999999999998877654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=3.7e-24  Score=192.92  Aligned_cols=258  Identities=20%  Similarity=0.268  Sum_probs=200.6

Q ss_pred             hccccccccccCceeEEEE-EeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .|.+.++||+|+||..+.| .+-++++||||.-...+  ...++..|.+..+.| ..++|..++.|..++-...||+|.+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            4567889999999999999 45689999999865433  335678888888888 4799999998888888889999988


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC-----CcEEEeecCCcccccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-----MRARVADFGLSREEMV  265 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~-----~~~kl~Dfgl~~~~~~  265 (432)
                       |-||+++.. -.+..|+...++.+|.|++.-++|+|++.   +|.|||||+|+||..-     ..+-|+|||+++....
T Consensus       107 -GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  107 -GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             -CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence             668887663 34567999999999999999999999999   9999999999999543     3589999999986543


Q ss_pred             ccc--------ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh----cCCCchh
Q 014038          266 DKH--------AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT----EGKTGWE  333 (432)
Q Consensus       266 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~  333 (432)
                      ...        .....||.+||+-....+++-+.+.|+-|||-++++.+.|..||.++.....-.....    ...++++
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~  261 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE  261 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence            322        2345699999999999999999999999999999999999999987542211111111    1111222


Q ss_pred             hhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhccc
Q 014038          334 EIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHN  386 (432)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~  386 (432)
                      ++..         ..+.++..-+...-..+-.+-|...-+...+..++.+...
T Consensus       262 ~Lc~---------g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~  305 (449)
T KOG1165|consen  262 VLCE---------GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE  305 (449)
T ss_pred             HHHh---------cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence            2222         1245777777777788899999999988888888776543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=7.1e-25  Score=189.36  Aligned_cols=261  Identities=22%  Similarity=0.303  Sum_probs=197.8

Q ss_pred             HHHHhccccccccccCceeEEEE-EeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCC-CccceEEeeeeeCCeEEEE
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH-RNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv  186 (432)
                      +....|.+.++||.|+||.+|.| ...+|..||||.-...  ....++..|..+...|++ ..|..+..|..+.....+|
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            34556788899999999999999 5678999999986543  233467789999999975 6777778888888899999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC---CcEEEeecCCcccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS---MRARVADFGLSREE  263 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~---~~~kl~Dfgl~~~~  263 (432)
                      |+.+ |-+|.+++. -....++..+++-++-|++.-++|+|.++   ++||||||+|+|..-+   ..+-++|||+++..
T Consensus        90 MdLL-GPsLEdLfn-fC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFN-FCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             eecc-CccHHHHHH-HHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            9988 678887663 23356899999999999999999999999   9999999999999644   35899999999854


Q ss_pred             cccc--------cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhh
Q 014038          264 MVDK--------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEI  335 (432)
Q Consensus       264 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (432)
                      ....        ......||.+|.+--...+..-+...|+-|+|.+|.++..|..||++..........        +.+
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy--------EkI  236 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY--------EKI  236 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH--------HHH
Confidence            3221        223457999999988887778889999999999999999999999986543222111        111


Q ss_pred             ccccCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          336 VDSRLDGI---FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       336 ~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      ......-.   .....+.++.-.+..|-..--++-|...-+.+...-++...
T Consensus       237 ~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l  288 (341)
T KOG1163|consen  237 SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL  288 (341)
T ss_pred             HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence            11111100   01122457888999999999999999887777666555443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=8.5e-24  Score=188.55  Aligned_cols=174  Identities=14%  Similarity=0.186  Sum_probs=135.5

Q ss_pred             HHHHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHH---H------HHHHHHHHhhcCCCccceEEeee
Q 014038          107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEK---E------FQTEVMLLGRLHHRNLVNLVGYC  177 (432)
Q Consensus       107 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~l~~~~  177 (432)
                      .++...+|...++||.|+||.||+... ++..+|||.+.........   .      +.+|+..+.+++|++|..+..++
T Consensus        26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            556677888889999999999999866 5778999999754332222   2      67999999999999999998886


Q ss_pred             eeC--------CeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC
Q 014038          178 AEK--------GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS  249 (432)
Q Consensus       178 ~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~  249 (432)
                      ...        +..+++|||++|.+|.++.      .++.    ....+++.+|..||..+   ++|||++|.||+++++
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~  171 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN  171 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence            533        3578999999999998764      1232    24569999999999999   9999999999999999


Q ss_pred             CcEEEeecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHH
Q 014038          250 MRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELI  306 (432)
Q Consensus       250 ~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ell  306 (432)
                      + ++|+|||............           .+.....|..++|+||||+++..+.
T Consensus       172 g-i~liDfg~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             C-EEEEECCCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence            8 9999999875432111111           1334455778999999999988754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=1.3e-24  Score=221.27  Aligned_cols=246  Identities=22%  Similarity=0.325  Sum_probs=181.4

Q ss_pred             cccccccCceeEEEEE-eCCCcEEEEEEec----c-CCh-hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          117 TTLIGQGAFGPVYKAQ-MSTGETVAVKVLA----T-DSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~----~-~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ..++|.|++|.|+... ......++.|...    . ... .....+..|+.+-..+.|||++..+..+.+.....-.|||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~  402 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY  402 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence            4689999999888774 3344445555432    1 111 1112366788888899999998888777776666666999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc---
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD---  266 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~---  266 (432)
                      |++ +|..++...  ..+....+..++.|++.|+.|||+.|   |.|||+|++|++++.+|.+||+|||.+......   
T Consensus       403 ~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  403 CPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             ccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            999 999988543  46888889999999999999999999   999999999999999999999999987643222   


Q ss_pred             --ccccccccCCCCCCccccccCCCCc-hhHhHHHHHHHHHHHhCCCCCCChhHHHHH-HHhhhcCCCchhhhccccCCC
Q 014038          267 --KHAANIRGTFGYLDPEYISTRNFTK-KSDVYSFGVLLFELIAGRSPLQGLMEYVEL-AAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       267 --~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~SlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  342 (432)
                        ......+|+..|+|||.+.+..|++ ..||||.|+++..|.+|+.||......... .......   +..    ...+
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~---~~~----~~~~  549 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSD---QRN----IFEG  549 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccc---ccc----cccC
Confidence              2345678999999999999999985 689999999999999999999643221111 0000000   000    0011


Q ss_pred             C--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          343 I--FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       343 ~--~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .  .....+.+...+|.++|+.||.+|-|+++|++
T Consensus       550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            1  11123457888999999999999999999986

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=4.5e-23  Score=181.69  Aligned_cols=137  Identities=24%  Similarity=0.271  Sum_probs=107.5

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChh--h-------HHH-----------------HHHHHHHHhhcCCCccc
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ--G-------EKE-----------------FQTEVMLLGRLHHRNLV  171 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~niv  171 (432)
                      ..||+|+||.||+|...+|+.||||+++.....  .       ...                 ...|+.++.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            579999999999998778999999999754211  1       112                 23599999999888764


Q ss_pred             eEEeeeeeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeccCCCCCeeecCCC
Q 014038          172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYL-HDGAVPPVIHRDIKSSNILLDQSM  250 (432)
Q Consensus       172 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~iiH~dlkp~Nill~~~~  250 (432)
                      ....+..  ...++||||++++++.....  ...++++..+..++.|++.+|.|| |+.+   |+||||||+|||++ ++
T Consensus        83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~  154 (190)
T cd05147          83 CPEPILL--KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCcEEEe--cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CC
Confidence            4333222  23489999999887765432  235689999999999999999999 6888   99999999999998 47


Q ss_pred             cEEEeecCCccc
Q 014038          251 RARVADFGLSRE  262 (432)
Q Consensus       251 ~~kl~Dfgl~~~  262 (432)
                      .++|+|||++..
T Consensus       155 ~v~LiDFG~a~~  166 (190)
T cd05147         155 KLYIIDVSQSVE  166 (190)
T ss_pred             cEEEEEcccccc
Confidence            899999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.88  E-value=4e-23  Score=201.29  Aligned_cols=214  Identities=27%  Similarity=0.418  Sum_probs=161.4

Q ss_pred             HhhcCCCccceEEeeeeeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCC
Q 014038          162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKS  241 (432)
Q Consensus       162 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp  241 (432)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....++|.....+.++|+.||+|||...  -..|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence            4578999999999999999999999999999999999975 3456899999999999999999999865  139999999


Q ss_pred             CCeeecCCCcEEEeecCCccccccc---ccccccccCCCCCCccccccC-------CCCchhHhHHHHHHHHHHHhCCCC
Q 014038          242 SNILLDQSMRARVADFGLSREEMVD---KHAANIRGTFGYLDPEYISTR-------NFTKKSDVYSFGVLLFELIAGRSP  311 (432)
Q Consensus       242 ~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlGvil~elltg~~p  311 (432)
                      .|+++|..+.+||+|||+.......   ..........-|.|||.++..       ..+.++||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999997654211   111122345679999998763       147789999999999999999999


Q ss_pred             CCChhHH---HHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          312 LQGLMEY---VELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       312 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      |......   .++......+.   ...+.|.....  .+...++..++..||..+|.+||++.+|-..++.+...
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~---~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGG---SNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             cccccccCChHHHHHHHHhcC---CCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            9752211   11111111100   11111111100  03334799999999999999999999999888877654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=1.7e-23  Score=213.60  Aligned_cols=245  Identities=23%  Similarity=0.305  Sum_probs=180.1

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCC-hhhHHHHHHHHHH--HhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS-KQGEKEFQTEVML--LGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      .+.+.+.||++.|=.|.+|+.+.|. |+||++.... ......|.++++-  ...++|||++++..+-......|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            4567789999999999999987776 8899886543 3333444443333  4556899999988887777777888888


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc--ccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM--VDK  267 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~--~~~  267 (432)
                      ..+ +|++.+.  .+.-+...+...|+.|++.||.-+|..+   |+|||||.+||||+.-..+.|+||.--+...  .+.
T Consensus       103 vkh-nLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  103 VKH-NLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             Hhh-hhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            865 8999883  2334667778889999999999999999   9999999999999999999999998654211  111


Q ss_pred             --cc----cccccCCCCCCccccccC-----------CCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCC
Q 014038          268 --HA----ANIRGTFGYLDPEYISTR-----------NFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK  329 (432)
Q Consensus       268 --~~----~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  329 (432)
                        ..    .+...-.+|.|||.+...           ..+++-||||+||++.||++ |++||.    ..++......+.
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~~  252 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGNA  252 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccCc
Confidence              11    111223479999987431           15789999999999999998 788885    334444433333


Q ss_pred             CchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          330 TGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ...+.++.....        ..+++++..|++.||++|-++++.|+.
T Consensus       253 ~~~e~~Le~Ied--------~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  253 DDPEQLLEKIED--------VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             cCHHHHHHhCcC--------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence            222332222111        268899999999999999999999986

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=8.3e-22  Score=174.17  Aligned_cols=139  Identities=21%  Similarity=0.215  Sum_probs=110.1

Q ss_pred             cccccccCceeEEEEEeCCCcEEEEEEeccCChh---------------------h-----HHHHHHHHHHHhhcCCCcc
Q 014038          117 TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ---------------------G-----EKEFQTEVMLLGRLHHRNL  170 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~ni  170 (432)
                      ...||+|+||.||+|...+|+.||||+++.....                     .     ...+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3579999999999998778999999998764211                     0     1224578999999999987


Q ss_pred             ceEEeeeeeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCeeecCC
Q 014038          171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQS  249 (432)
Q Consensus       171 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlkp~Nill~~~  249 (432)
                      .....+...  ..++||||++++++.....  ....++......++.|++.++.+||+ .+   |+||||||+|||++ +
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-C
Confidence            544444332  2489999999886544321  22457888899999999999999999 88   99999999999999 7


Q ss_pred             CcEEEeecCCcccc
Q 014038          250 MRARVADFGLSREE  263 (432)
Q Consensus       250 ~~~kl~Dfgl~~~~  263 (432)
                      +.++|+|||++...
T Consensus       154 ~~~~liDFG~a~~~  167 (190)
T cd05145         154 GKPYIIDVSQAVEL  167 (190)
T ss_pred             CCEEEEEcccceec
Confidence            89999999998753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=9.5e-22  Score=180.64  Aligned_cols=229  Identities=22%  Similarity=0.330  Sum_probs=146.5

Q ss_pred             ccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCC----------CccceEEee-----
Q 014038          116 FTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHH----------RNLVNLVGY-----  176 (432)
Q Consensus       116 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~-----  176 (432)
                      ..+.||.|+++.||.+.. .+|+.+|+|......   ....+++.+|.-....+.+          -.++-.++.     
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~   95 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG   95 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred             EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence            456899999999999965 468999999876543   2345677777766655432          111111111     


Q ss_pred             ----eeeCC--------eEEEEEEeccCCChhhhcc---cC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC
Q 014038          177 ----CAEKG--------QHMLVYVFMSKGSLASHLY---DE--NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI  239 (432)
Q Consensus       177 ----~~~~~--------~~~lv~e~~~~g~L~~~l~---~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dl  239 (432)
                          .....        ..+++|+-+ .++|.+++.   ..  ....+....++.+..|+++.+++||..|   ++|+||
T Consensus        96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi  171 (288)
T PF14531_consen   96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI  171 (288)
T ss_dssp             S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred             CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence                11111        336777777 458877653   21  1223445667788899999999999999   999999


Q ss_pred             CCCCeeecCCCcEEEeecCCcccccccccccccccCCCCCCcccccc--------CCCCchhHhHHHHHHHHHHHhCCCC
Q 014038          240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST--------RNFTKKSDVYSFGVLLFELIAGRSP  311 (432)
Q Consensus       240 kp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlGvil~elltg~~p  311 (432)
                      +|+|++++.+|.+.|+||+...........  ...+..|.+||....        -.++.+.|.|+||+++|.|.+|+.|
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP  249 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP  249 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence            999999999999999999876543322221  344578999997743        2578999999999999999999999


Q ss_pred             CCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCC
Q 014038          312 LQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR  367 (432)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  367 (432)
                      |......         ....+      .+.. .. ..++.+..||..+|+.+|.+|
T Consensus       250 f~~~~~~---------~~~~~------~f~~-C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  250 FGLSSPE---------ADPEW------DFSR-CR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             TCCCGGG---------STSGG------GGTT-SS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCcc---------ccccc------cchh-cC-CcCHHHHHHHHHHccCCcccC
Confidence            9753221         00000      1111 22 556789999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=2.6e-21  Score=168.95  Aligned_cols=181  Identities=14%  Similarity=0.113  Sum_probs=138.2

Q ss_pred             cccccccCceeEEEEEeCCCcEEEEEEeccCChh----hHHHHHHHHHHHhhcC-CCccceEEeeeeeCCeEEEEEEecc
Q 014038          117 TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ----GEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      ...|++|+||+||.+.. .+..++.+.+.....-    ....|.+|+++|++++ |+++.+++++    +..+++|+|+.
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            45799999999998866 6788888877654321    1235789999999995 5889999886    34699999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC-CCCCeeecCCCcEEEeecCCccccccccc--
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI-KSSNILLDQSMRARVADFGLSREEMVDKH--  268 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dl-kp~Nill~~~~~~kl~Dfgl~~~~~~~~~--  268 (432)
                      |.+|.+.+..        . ...++.|++.+|.++|+++   |+|||| ||.|||++.++.++|+|||++........  
T Consensus        82 G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         82 GAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             CccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence            9888654311        1 1357789999999999999   999999 79999999999999999999974332221  


Q ss_pred             ------------ccccccCCCCCCccccccC-CCC-chhHhHHHHHHHHHHHhCCCCCCC
Q 014038          269 ------------AANIRGTFGYLDPEYISTR-NFT-KKSDVYSFGVLLFELIAGRSPLQG  314 (432)
Q Consensus       269 ------------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~SlGvil~elltg~~p~~~  314 (432)
                                  ..-...++.|++|+...-. ..+ ...+.++-|.-+|.++|++.++.+
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                        0012357788888754322 233 577888999999999999998754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.2e-22  Score=198.02  Aligned_cols=225  Identities=29%  Similarity=0.397  Sum_probs=180.7

Q ss_pred             cccccCceeEEEEE----eCCCcEEEEEEeccCCh--hhHHHHHHHHHHHhhcC-CCccceEEeeeeeCCeEEEEEEecc
Q 014038          119 LIGQGAFGPVYKAQ----MSTGETVAVKVLATDSK--QGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .+|.|+||.|++++    .+.|..+|+|.+.....  ........|..++...+ ||.++++...++.+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999873    23567899998865421  11114556788888886 9999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN  271 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  271 (432)
                      +|.|...+..  ...+++.....+...++-+++++|+.+   ++|||+|++||+++.+|++++.|||+++........  
T Consensus        81 gg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--  153 (612)
T KOG0603|consen   81 GGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--  153 (612)
T ss_pred             cchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence            9999988843  345777777778889999999999999   999999999999999999999999999865433322  


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                       +||.-|||||+++  .....+|.||||++++||+||..||....     ...          +  ......++.+....
T Consensus       154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~-----~~~----------I--l~~~~~~p~~l~~~  213 (612)
T KOG0603|consen  154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT-----MKR----------I--LKAELEMPRELSAE  213 (612)
T ss_pred             -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH-----HHH----------H--hhhccCCchhhhHH
Confidence             8999999999998  45688999999999999999999998611     111          1  11223456667778


Q ss_pred             HHHHHHHhhccCCCCCCCH
Q 014038          352 VASLAYKCVNRAPRKRPSM  370 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~  370 (432)
                      ..+++..++..+|.+|--.
T Consensus       214 a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  214 ARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             HHHHHHHHHhhCHHHHhcc
Confidence            8999999999999999654

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=2.1e-20  Score=166.32  Aligned_cols=133  Identities=17%  Similarity=0.240  Sum_probs=105.2

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-----CCCccceEEeeeeeCC---eEE-EEEE
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-----HHRNLVNLVGYCAEKG---QHM-LVYV  188 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-lv~e  188 (432)
                      +.||+|+||.||. ...++.. +||++........+.+.+|+.++..+     +||||++++|++.++.   ..+ +|+|
T Consensus         8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e   85 (210)
T PRK10345          8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD   85 (210)
T ss_pred             ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence            5799999999996 3334444 79988765444567899999999999     5799999999998863   433 7899


Q ss_pred             e--ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeeccCCCCCeeecC----CCcEEEeecCCc
Q 014038          189 F--MSKGSLASHLYDENYGPLTWNLRVHIALDVARGL-EYLHDGAVPPVIHRDIKSSNILLDQ----SMRARVADFGLS  260 (432)
Q Consensus       189 ~--~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l-~yLH~~~~~~iiH~dlkp~Nill~~----~~~~kl~Dfgl~  260 (432)
                      |  +.+|+|.+++...   .+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    +..++|+||+.+
T Consensus        86 ~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         86 FDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             CCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            9  5579999999442   36655  35678888787 9999999   999999999999974    347999995533

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=2.1e-20  Score=194.51  Aligned_cols=251  Identities=20%  Similarity=0.261  Sum_probs=180.6

Q ss_pred             HHHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC---CCccceEEeeeeeCCeEE
Q 014038          108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH---HRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       108 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~  184 (432)
                      ++-...+.+.+.||+|+||+||+|...+|+.||+|+-+....-   +|.--.+++.+|+   -+.|..+...+...+..+
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            3444556677899999999999998778999999987654322   2333334444554   234555555566677889


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec-------CCCcEEEeec
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-------QSMRARVADF  257 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~-------~~~~~kl~Df  257 (432)
                      +|++|.+.|+|.+++.  ..+.++|..++.++.|+++-+..||..+   |||+||||+|+||.       ++..++|+||
T Consensus       771 lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             eeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence            9999999999999995  5677999999999999999999999999   99999999999993       3446899999


Q ss_pred             CCccccccc---ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhh
Q 014038          258 GLSREEMVD---KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEE  334 (432)
Q Consensus       258 gl~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  334 (432)
                      |.+..+..-   ......++|-.+-.+|...++.++..+|.|.|+-+++-|+.|+.--             ..+...|..
T Consensus       846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------------~~~g~~~~~  912 (974)
T KOG1166|consen  846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------------VKNGSSWMV  912 (974)
T ss_pred             ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------------hcCCcceec
Confidence            998765432   2345567899999999999999999999999999999999987431             011111111


Q ss_pred             hccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                        +..++.....+.   ..+|...+|..|-..=|...++...+++++...
T Consensus       913 --~~~~~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~  957 (974)
T KOG1166|consen  913 --KTNFPRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH  957 (974)
T ss_pred             --cccchhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence              111111122222   334445555544444477777777777776543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=2.6e-19  Score=161.11  Aligned_cols=134  Identities=19%  Similarity=0.320  Sum_probs=113.0

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCCh--------hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSK--------QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      +.||+|++|.||+|.. +|..+++|.......        .....+.+|+.++..+.|+|+.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4689999999999987 678899998654321        1124578899999999999988877777777888999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      ++|++|.+.+...     .+ .+..++.+++.+|.+||+.+   ++|||++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988432     12 77889999999999999999   99999999999999 78999999998753

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1.1e-19  Score=167.87  Aligned_cols=194  Identities=23%  Similarity=0.319  Sum_probs=138.2

Q ss_pred             CCCccceEEeeeeeC---------------------------CeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHH
Q 014038          166 HHRNLVNLVGYCAEK---------------------------GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALD  218 (432)
Q Consensus       166 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~  218 (432)
                      +|||||++.++|.++                           ...|+||.-++. +|.+++..+   ..+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC---CCchHHHHHHHHH
Confidence            599999999876442                           367888887754 898888543   3556666778999


Q ss_pred             HHHHHHHHHhCCCCCeeeccCCCCCeee--cCCC--cEEEeecCCcccccc-------cccccccccCCCCCCccccccC
Q 014038          219 VARGLEYLHDGAVPPVIHRDIKSSNILL--DQSM--RARVADFGLSREEMV-------DKHAANIRGTFGYLDPEYISTR  287 (432)
Q Consensus       219 i~~~l~yLH~~~~~~iiH~dlkp~Nill--~~~~--~~kl~Dfgl~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~  287 (432)
                      +++|+.|||.++   |.|||+|++||||  |+|+  .+.|+|||++-....       .+......|.-.-||||+....
T Consensus       350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            999999999999   9999999999998  4444  578999998743211       1222334577788999988543


Q ss_pred             C------CCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhc
Q 014038          288 N------FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVN  361 (432)
Q Consensus       288 ~------~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  361 (432)
                      .      --.|+|.|+.|.+.||+++...||.+..+.. +..      ..+.    +..-+..+...+..+.+++...|+
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~------r~Yq----e~qLPalp~~vpp~~rqlV~~lL~  495 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDT------RTYQ----ESQLPALPSRVPPVARQLVFDLLK  495 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-ech------hhhh----hhhCCCCcccCChHHHHHHHHHhc
Confidence            2      1369999999999999999999997522110 000      0011    111122344455678999999999


Q ss_pred             cCCCCCCCHHHHHHHH
Q 014038          362 RAPRKRPSMRDIVQVL  377 (432)
Q Consensus       362 ~dp~~RPs~~~vl~~L  377 (432)
                      .||++|++..-....|
T Consensus       496 r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  496 RDPSKRVSPNIAANVL  511 (598)
T ss_pred             CCccccCCccHHHhHH
Confidence            9999999876544444

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=2.5e-20  Score=178.64  Aligned_cols=170  Identities=25%  Similarity=0.410  Sum_probs=128.5

Q ss_pred             eEEEEEEeccCCChhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCc
Q 014038          182 QHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS  260 (432)
Q Consensus       182 ~~~lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~  260 (432)
                      ..++.|++|...+|.++|.. ......++...+.++.|++.|+.|   ++   .+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            57899999999999999963 344567888999999999999999   66   899999999999999999999999998


Q ss_pred             ccccccc-------cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCch
Q 014038          261 REEMVDK-------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGW  332 (432)
Q Consensus       261 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  332 (432)
                      .......       ......||..||+||.+.+..|+.|+||||||++|+||+. =..++..    ...          +
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t----------~  469 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IAT----------L  469 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHh----------h
Confidence            6544333       3445679999999999999999999999999999999987 2222221    111          1


Q ss_pred             hhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 014038          333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRD  372 (432)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~  372 (432)
                      .++.+..+++.+-.+. ++=..|+.+++...|.+||++.+
T Consensus       470 ~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  470 TDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             hhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence            1122222221111111 23457999999999999995443

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=9.4e-19  Score=159.47  Aligned_cols=140  Identities=20%  Similarity=0.212  Sum_probs=109.2

Q ss_pred             ccccccccccCceeEEEEE--eCCCcEEEEEEeccCChh------------------------hHHHHHHHHHHHhhcCC
Q 014038          114 CNFTTLIGQGAFGPVYKAQ--MSTGETVAVKVLATDSKQ------------------------GEKEFQTEVMLLGRLHH  167 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~h  167 (432)
                      +.+.+.||+|+||.||+|.  ..+|+.||+|.+......                        ....+..|+.++.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            4567899999999999997  568999999998753210                        11235689999999975


Q ss_pred             Cc--cceEEeeeeeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCee
Q 014038          168 RN--LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNIL  245 (432)
Q Consensus       168 ~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nil  245 (432)
                      .+  +.+++++    ...++||||+++++|...+..  ...+.......++.|++.++.+||+.+.  ++||||||+||+
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NIl  181 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNIL  181 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhEE
Confidence            33  3444443    235899999999888765522  2345666778999999999999998763  999999999999


Q ss_pred             ecCCCcEEEeecCCccc
Q 014038          246 LDQSMRARVADFGLSRE  262 (432)
Q Consensus       246 l~~~~~~kl~Dfgl~~~  262 (432)
                      ++ ++.++|+|||.+..
T Consensus       182 i~-~~~i~LiDFg~a~~  197 (237)
T smart00090      182 VH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             EE-CCCEEEEEChhhhc
Confidence            99 88999999998764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=1.5e-18  Score=154.56  Aligned_cols=134  Identities=19%  Similarity=0.178  Sum_probs=106.8

Q ss_pred             ccccccccccCceeEEEEEeCCCcEEEEEEeccCCh----------------------hhHHHHHHHHHHHhhcCCCc--
Q 014038          114 CNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK----------------------QGEKEFQTEVMLLGRLHHRN--  169 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~n--  169 (432)
                      +.+.+.||+|+||.||++...+|+.||||++.....                      .....+..|+.++..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            556789999999999999888899999998754321                      01123677899999998774  


Q ss_pred             cceEEeeeeeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC
Q 014038          170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS  249 (432)
Q Consensus       170 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~  249 (432)
                      +...++    ....++||||+++++|......        .....++.+++.++.++|+.+   ++||||||+||+++++
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~  161 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCC
Confidence            444443    2456899999999998765421        234678899999999999988   9999999999999999


Q ss_pred             CcEEEeecCCccc
Q 014038          250 MRARVADFGLSRE  262 (432)
Q Consensus       250 ~~~kl~Dfgl~~~  262 (432)
                      +.++|+|||++..
T Consensus       162 ~~~~liDfg~~~~  174 (198)
T cd05144         162 EKIYIIDWPQMVS  174 (198)
T ss_pred             CcEEEEECCcccc
Confidence            9999999999854

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=1e-18  Score=155.76  Aligned_cols=130  Identities=22%  Similarity=0.359  Sum_probs=106.6

Q ss_pred             cccccCceeEEEEEeCCCcEEEEEEeccCCh--------hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSK--------QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .||+|+||.||+|.. +|..+++|.......        .....+.+|+.++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 678899998654321        11256778999999999887665555666667789999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      ++++|.+.+....  .       .++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN--D-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH--H-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998874321  1       78999999999999999   99999999999999 78999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=2.6e-18  Score=175.56  Aligned_cols=132  Identities=20%  Similarity=0.299  Sum_probs=108.3

Q ss_pred             ccccccccCceeEEEEEeCCCcEEEEEEe-ccC-C------hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          116 FTTLIGQGAFGPVYKAQMSTGETVAVKVL-ATD-S------KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       116 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~-~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..+.||+|+||+||+|.+.... +++|+. ... .      ....+.+.+|++++..++|+|++....++......++||
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~  415 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM  415 (535)
T ss_pred             ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence            3578999999999999875443 444432 211 1      112356889999999999999998888888777889999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      ||+++++|.+++.          ....++.+++.+|.|||+.+   ++||||||+|||+ .++.++|+|||+++.
T Consensus       416 E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        416 EYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            9999999998884          35678999999999999999   9999999999999 577999999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.73  E-value=3e-18  Score=175.47  Aligned_cols=203  Identities=27%  Similarity=0.452  Sum_probs=139.7

Q ss_pred             ccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      ++.++.|-.|+||.||..+.+ +.+.+|+|+ ..+.     .+.+-  ++.....|.+|                     
T Consensus        85 f~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv---------------------  135 (1205)
T KOG0606|consen   85 FNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV---------------------  135 (1205)
T ss_pred             cceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee---------------------
Confidence            345678999999999999654 567788843 2211     11111  22222233322                     


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc------
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD------  266 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~------  266 (432)
                      |+-...+.  +.++++...        +.+++|||+.+   |+|||+||+|.+|+.-|++|+.|||+++.....      
T Consensus       136 gDc~tllk--~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  136 GDCATLLK--NIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             chhhhhcc--cCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence            45555552  334444332        77899999999   999999999999999999999999998632110      


Q ss_pred             ----------ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhc
Q 014038          267 ----------KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIV  336 (432)
Q Consensus       267 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (432)
                                -.....+|||.|.|||++..+.|..-.|.|++|+|+||.+-|..||.+.....-+..... ....|    
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis-d~i~w----  277 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-DDIEW----  277 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh-hhccc----
Confidence                      012345899999999999999999999999999999999999999988643322221111 11111    


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHhhccCCCCCC
Q 014038          337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRP  368 (432)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  368 (432)
                           .+.+.....+..+++.+.|+.+|.+|-
T Consensus       278 -----pE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  278 -----PEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             -----cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence                 112333446889999999999999994

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.72  E-value=6.1e-17  Score=136.98  Aligned_cols=134  Identities=20%  Similarity=0.241  Sum_probs=113.6

Q ss_pred             cccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCC--CccceEEeeeeeCCeEEEEEEeccCCC
Q 014038          117 TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH--RNLVNLVGYCAEKGQHMLVYVFMSKGS  194 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~  194 (432)
                      .+.||.|.++.||++...+ ..+++|.......  ...+.+|+..+..++|  .++.++++++...+..+++|||++++.
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            3579999999999998744 7899999865433  4678899999999976  589999998888889999999999877


Q ss_pred             hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          195 LASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       195 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      +..+         +......++.+++.++++||.....+++|+|++|+||++++++.+++.|||.+..
T Consensus        80 ~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            7654         5566778899999999999986444599999999999999989999999998763

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=5e-17  Score=143.31  Aligned_cols=135  Identities=24%  Similarity=0.286  Sum_probs=97.5

Q ss_pred             cccccccCceeEEEEEeCCCcEEEEEEeccCChh--hHHH----------------------HHHHHHHHhhcCCCc--c
Q 014038          117 TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ--GEKE----------------------FQTEVMLLGRLHHRN--L  170 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i  170 (432)
                      .+.||+|+||.||+|...+|+.||||++......  ....                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4579999999999998778999999998653211  1111                      135566666664432  4


Q ss_pred             ceEEeeeeeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCeeecCC
Q 014038          171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQS  249 (432)
Q Consensus       171 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlkp~Nill~~~  249 (432)
                      .+.+++    ...++||||++++.+.........  .. ..+..++.+++.++.++|. .+   |+|+||||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-C
Confidence            444443    246899999999654322111110  11 5678899999999999999 88   99999999999999 8


Q ss_pred             CcEEEeecCCccc
Q 014038          250 MRARVADFGLSRE  262 (432)
Q Consensus       250 ~~~kl~Dfgl~~~  262 (432)
                      +.++|+|||.+..
T Consensus       151 ~~~~liDfg~a~~  163 (187)
T cd05119         151 GKVYIIDVPQAVE  163 (187)
T ss_pred             CcEEEEECccccc
Confidence            8999999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=3.4e-16  Score=142.97  Aligned_cols=134  Identities=19%  Similarity=0.236  Sum_probs=104.7

Q ss_pred             cccc-ccCceeEEEEEeCCCcEEEEEEeccCC-------------hhhHHHHHHHHHHHhhcCCCcc--ceEEeeeeeCC
Q 014038          118 TLIG-QGAFGPVYKAQMSTGETVAVKVLATDS-------------KQGEKEFQTEVMLLGRLHHRNL--VNLVGYCAEKG  181 (432)
Q Consensus       118 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~  181 (432)
                      ..|| .||.|+||++.. ++..++||.+....             ......+.+|+.++..++|++|  +..+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4688 899999999987 47789999874311             1223567889999999998875  66777654322


Q ss_pred             ----eEEEEEEeccC-CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEee
Q 014038          182 ----QHMLVYVFMSK-GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVAD  256 (432)
Q Consensus       182 ----~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~D  256 (432)
                          ..++||||+++ .+|.+++..   .+++..    .+.+++.+|.+||+.+   |+||||||.|||++.++.++|+|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEE
Confidence                23599999997 688888743   245544    3568999999999999   99999999999999999999999


Q ss_pred             cCCccc
Q 014038          257 FGLSRE  262 (432)
Q Consensus       257 fgl~~~  262 (432)
                      ||.+..
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            998764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.65  E-value=1.1e-16  Score=144.79  Aligned_cols=201  Identities=23%  Similarity=0.316  Sum_probs=142.2

Q ss_pred             HHHHHhhcCCCccceEEeeeeeC-----CeEEEEEEeccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 014038          158 EVMLLGRLHHRNLVNLVGYCAEK-----GQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGA  230 (432)
Q Consensus       158 E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~  230 (432)
                      -...|-.+.|.|||+++.|+.+.     ....+++|||+.|+|.++|++  .....+......+|+.||+.||.|||+..
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            34456667899999999998654     457899999999999999975  34456888888999999999999999976


Q ss_pred             CCCeeeccCCCCCeeecCCCcEEEeecCCccccc-----ccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHH
Q 014038          231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-----VDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFEL  305 (432)
Q Consensus       231 ~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el  305 (432)
                       |+|+|+++..+.|++..++-+|+.--.-.....     .........+-++|.+||.-...+.+..+|||+||...+||
T Consensus       197 -PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 -PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             -CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence             889999999999999999999986322111110     01112223467899999988777888999999999999999


Q ss_pred             HhCCCCCC-ChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          306 IAGRSPLQ-GLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       306 ltg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+..--. +......            ++-+.....+..+    ..=+.++..|++..|..||+|.+++.
T Consensus       276 ailEiq~tnseS~~~~------------ee~ia~~i~~len----~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEV------------EENIANVIIGLEN----GLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHheeccCCCcceeeh------------hhhhhhheeeccC----ccccCcCcccccCCCCCCcchhhhhc
Confidence            88765422 1111000            0000000000000    01134678899999999999998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=2.3e-17  Score=168.42  Aligned_cols=251  Identities=24%  Similarity=0.328  Sum_probs=181.8

Q ss_pred             ccccccccccCceeEEEEEeC--CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcC-CCccceEEeeeeeCCeEEEEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS--TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      +.+.+.||+|+|+.|-.....  ....+|+|.+....  ....+....|..+-..+. |+|++.+++...+.+..+++.+
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~  101 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS  101 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence            344566999999999888543  34456777665433  223344556777777776 9999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeeccCCCCCeeecCCC-cEEEeecCCcccccc-
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH-DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMV-  265 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~iiH~dlkp~Nill~~~~-~~kl~Dfgl~~~~~~-  265 (432)
                      |..++++...+........+....-.++.|+..++.|+| ..+   +.|+|+||+|.+++..+ .++++|||++..... 
T Consensus       102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             cccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            999999998884222224566667788999999999999 777   99999999999999999 999999999975444 


Q ss_pred             c---cccccccc-CCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          266 D---KHAANIRG-TFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       266 ~---~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .   ......+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........       ....|...-.. .
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-------~~~~~~~~~~~-~  250 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-------RYSSWKSNKGR-F  250 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-------cceeecccccc-c
Confidence            2   22334567 9999999999875 446789999999999999999999875332110       00011110000 0


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .............+++.+++..+|..|.+.+++-.
T Consensus       251 ~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  251 TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ccCccccCChhhhhcccccccCCchhccccccccc
Confidence            00001111235677888899999999999887653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.59  E-value=7.8e-15  Score=145.36  Aligned_cols=139  Identities=20%  Similarity=0.249  Sum_probs=99.5

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChhh----------------------------------------HHHHHH
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG----------------------------------------EKEFQT  157 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~  157 (432)
                      +.||.|++|.||+|++.+|+.||||+.+......                                        +-+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            4699999999999999999999999986542100                                        013555


Q ss_pred             HHHHHhhcC----CCccceEEeee-eeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 014038          158 EVMLLGRLH----HRNLVNLVGYC-AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR-GLEYLHDGAV  231 (432)
Q Consensus       158 E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~-~l~yLH~~~~  231 (432)
                      |...+.++.    |.+-+.+-..+ ......++||||++|++|.+....... ..+   +..++..++. .+..+|..+ 
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g-  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDG-  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCC-
Confidence            666666552    32223332333 224567999999999999887643211 122   3456666665 478889988 


Q ss_pred             CCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          232 PPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       232 ~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                        ++|+|++|.||+++.++.++++|||++...
T Consensus       278 --~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       278 --FFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             --ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence              999999999999999999999999998653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=4.3e-15  Score=145.43  Aligned_cols=252  Identities=20%  Similarity=0.244  Sum_probs=186.3

Q ss_pred             HHHHHHHhccccccccc--cCceeEEEEEe---CCCcEEEEEEecc--CChhhHHHHHHHHHHHhhc-CCCccceEEeee
Q 014038          106 YKDLQKATCNFTTLIGQ--GAFGPVYKAQM---STGETVAVKVLAT--DSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYC  177 (432)
Q Consensus       106 ~~~l~~~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  177 (432)
                      ..+.......+...+|.  |.+|.||.+..   .++..+|+|.-+.  ........=.+|+.-...+ .|+|.++.+..+
T Consensus       108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~  187 (524)
T KOG0601|consen  108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW  187 (524)
T ss_pred             ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence            34455556677889999  99999999965   4678899997432  2233333445677767777 599999988888


Q ss_pred             eeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeeeccCCCCCeeecCC-CcE
Q 014038          178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR----GLEYLHDGAVPPVIHRDIKSSNILLDQS-MRA  252 (432)
Q Consensus       178 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~----~l~yLH~~~~~~iiH~dlkp~Nill~~~-~~~  252 (432)
                      ...+..++-+|++. .+|..+.+.. ..-++....+....+...    ||.++|+.+   ++|-|+||.||++..+ ...
T Consensus       188 e~~~~lfiqtE~~~-~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~  262 (524)
T KOG0601|consen  188 EGSGILFIQTELCG-ESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSC  262 (524)
T ss_pred             ccCCcceeeecccc-chhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheeccccccee
Confidence            88899999999885 6888877532 234777888888888888    999999999   9999999999999999 889


Q ss_pred             EEeecCCcccccccccc------cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh
Q 014038          253 RVADFGLSREEMVDKHA------ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT  326 (432)
Q Consensus       253 kl~Dfgl~~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~  326 (432)
                      +++|||+..........      ....+...|++||..+ +-++..+|+|++|.++++..+|..+...-           
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g-----------  330 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVG-----------  330 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCC-----------
Confidence            99999998765443311      1225778899999876 46789999999999999999887665321           


Q ss_pred             cCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          327 EGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                       -...|.++....+..++......++...+..+++.+|..|++.+.+..
T Consensus       331 -~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  331 -KNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             -CCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence             112233332222333333333446777999999999999999876653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.46  E-value=3.5e-13  Score=116.70  Aligned_cols=129  Identities=16%  Similarity=0.167  Sum_probs=96.3

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccc-eEEeeeeeCCeEEEEEEeccCCChh
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLV-NLVGYCAEKGQHMLVYVFMSKGSLA  196 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L~  196 (432)
                      +.|+.|.++.||+++.. ++.|++|....... ....+..|+.+++.+.+.+++ +++.+.  ....++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            46899999999999874 78899998755432 223567899999988665554 444443  33458999999998876


Q ss_pred             hhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          197 SHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA--VPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       197 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                      ...       ..   ...++.+++++|+.||..+  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        80 ~~~-------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          80 TED-------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc-------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            531       11   1235678999999999977  22359999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.41  E-value=3.3e-13  Score=135.45  Aligned_cols=135  Identities=19%  Similarity=0.174  Sum_probs=90.4

Q ss_pred             ccccccCceeEEEEEeCC-CcEEEEEEeccCChh----------------------------------hH------HHHH
Q 014038          118 TLIGQGAFGPVYKAQMST-GETVAVKVLATDSKQ----------------------------------GE------KEFQ  156 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~------~~~~  156 (432)
                      +.||+|++|.||+|++.+ |+.||||+++..-..                                  ..      -+|.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            579999999999999877 999999999754110                                  01      1244


Q ss_pred             HHHHHHhhcC----CCccceEEeeeee-CCeEEEEEEeccCCChhhhcccCCCC----CCCHHHHHHHHHHHHHHHHHHH
Q 014038          157 TEVMLLGRLH----HRNLVNLVGYCAE-KGQHMLVYVFMSKGSLASHLYDENYG----PLTWNLRVHIALDVARGLEYLH  227 (432)
Q Consensus       157 ~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~----~l~~~~~~~i~~~i~~~l~yLH  227 (432)
                      +|+..+.++.    +.+.+.+-.++.+ ....++||||++|+.+.+.-.-...+    .+....+..++.|+       +
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence            5555555552    3333433333332 45678999999999997742111111    13333333333443       3


Q ss_pred             hCCCCCeeeccCCCCCeeecCCC----cEEEeecCCccc
Q 014038          228 DGAVPPVIHRDIKSSNILLDQSM----RARVADFGLSRE  262 (432)
Q Consensus       228 ~~~~~~iiH~dlkp~Nill~~~~----~~kl~Dfgl~~~  262 (432)
                      ..|   ++|+|++|.||+++.++    .++++|||++..
T Consensus       278 ~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~  313 (537)
T PRK04750        278 RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGS  313 (537)
T ss_pred             hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence            467   99999999999999988    999999999864

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.38  E-value=1e-11  Score=108.70  Aligned_cols=134  Identities=22%  Similarity=0.240  Sum_probs=97.8

Q ss_pred             ccccccCceeEEEEEeCC-------CcEEEEEEeccCC----------------------hhhHHHHH----HHHHHHhh
Q 014038          118 TLIGQGAFGPVYKAQMST-------GETVAVKVLATDS----------------------KQGEKEFQ----TEVMLLGR  164 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~~  164 (432)
                      ..||.|--+.||.|...+       +..+|||+.+...                      ....+.+.    +|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999996543       4799999874320                      00112233    89999999


Q ss_pred             cCC--CccceEEeeeeeCCeEEEEEEeccCCChhh-hcccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeccCC
Q 014038          165 LHH--RNLVNLVGYCAEKGQHMLVYVFMSKGSLAS-HLYDENYGPLTWNLRVHIALDVARGLEYL-HDGAVPPVIHRDIK  240 (432)
Q Consensus       165 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~iiH~dlk  240 (432)
                      +..  -++..++++    ...++||||+.++.+.. .+.+   ..++......+..+++.+|..| |..+   ++||||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            853  456666654    56789999997754432 2221   2355556677889999999999 8888   9999999


Q ss_pred             CCCeeecCCCcEEEeecCCccc
Q 014038          241 SSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       241 p~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      +.|||+++ +.+.|+|||.+-.
T Consensus       153 ~~NIL~~~-~~v~iIDF~qav~  173 (197)
T cd05146         153 EYNMLWHD-GKVWFIDVSQSVE  173 (197)
T ss_pred             HHHEEEEC-CcEEEEECCCcee
Confidence            99999974 6899999998753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.36  E-value=9.6e-12  Score=123.38  Aligned_cols=166  Identities=20%  Similarity=0.257  Sum_probs=124.5

Q ss_pred             EeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCChhhhcccCCCCCCCHHH
Q 014038          132 QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNL  211 (432)
Q Consensus       132 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~  211 (432)
                      +..++.+|.|...............+-++.|+.++||||++++..+..++..|+|+|-+.  .|...+..     +....
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~  105 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEE  105 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHH
Confidence            445788888888876655334456777889999999999999999999999999999873  56666633     23555


Q ss_pred             HHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc-ccccccCCCCCCccccccCCCC
Q 014038          212 RVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH-AANIRGTFGYLDPEYISTRNFT  290 (432)
Q Consensus       212 ~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~  290 (432)
                      ...-+.||+.||.|||+.+.  ++|++|.-+.|+++..|..||++|-++........ ......--.|..|+.+....  
T Consensus       106 v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--
Confidence            66678999999999986553  99999999999999999999999988754322111 11111222456666543322  


Q ss_pred             chhHhHHHHHHHHHHHhC
Q 014038          291 KKSDVYSFGVLLFELIAG  308 (432)
Q Consensus       291 ~~~Dv~SlGvil~elltg  308 (432)
                      -..|.|-||++++|++.|
T Consensus       182 ~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cchhhhhHHHHHHHHhCc
Confidence            346999999999999999

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.34  E-value=1.9e-11  Score=110.58  Aligned_cols=141  Identities=18%  Similarity=0.255  Sum_probs=111.1

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCCh-hhHHHHHHHHHHHhhcCC--CccceEEeeeeeC---CeEEEEEEecc
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHH--RNLVNLVGYCAEK---GQHMLVYVFMS  191 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~~  191 (432)
                      +.|+.|.++.||++...+|+.+++|....... .....+..|+.+++.+.+  .++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            46899999999999887678999999765432 234578899999999965  4467778877654   36789999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA-----------------------------------------  230 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----------------------------------------  230 (432)
                      +.++...+..   ..++......++.+++++|.+||+..                                         
T Consensus        84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            9988876632   35777888888999999999998531                                         


Q ss_pred             ------------CCCeeeccCCCCCeeecC--CCcEEEeecCCcc
Q 014038          231 ------------VPPVIHRDIKSSNILLDQ--SMRARVADFGLSR  261 (432)
Q Consensus       231 ------------~~~iiH~dlkp~Nill~~--~~~~kl~Dfgl~~  261 (432)
                                  ...++|+|+.|.||+++.  ++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                        135799999999999998  6678999999775

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.33  E-value=9.1e-13  Score=129.26  Aligned_cols=244  Identities=19%  Similarity=0.203  Sum_probs=171.9

Q ss_pred             hccccccccccCceeEEEEEe--CCCcEEEEEEeccCChhhHHH--HHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM--STGETVAVKVLATDSKQGEKE--FQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ++.+...||.|.|+.|+....  .++..|++|.+.........+  -..|+.+...+ .|.++++.+..+...+..++=-
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~  345 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL  345 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence            344567899999999999843  467889999876543222211  24566666666 5888888877777777777889


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC-CcEEEeecCCccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-MRARVADFGLSREEMVD  266 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~-~~~kl~Dfgl~~~~~~~  266 (432)
                      ||++++++....  .....+++..++++..|++.++.++|+..   ++|+|+||+||++..+ +..++.|||+.......
T Consensus       346 e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  346 EFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             hhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccccee
Confidence            999999987766  33345778888999999999999999888   9999999999999876 78899999988642211


Q ss_pred             ccccccccCCCC-CCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          267 KHAANIRGTFGY-LDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       267 ~~~~~~~gt~~y-~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                       .......+..| .+++......+..+.|+||||.-+.|.++|..--.....              |..+..........
T Consensus       421 -~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------------~~~i~~~~~p~~~~  485 (524)
T KOG0601|consen  421 -SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------------SLTIRSGDTPNLPG  485 (524)
T ss_pred             -cccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------------ceeeecccccCCCc
Confidence             11112223334 356666677788999999999999999998754332111              12222221111111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS  378 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~  378 (432)
                      .  ...+..+...+...++..||.+.++.....
T Consensus       486 ~--~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  486 L--KLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             h--HHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            1  146777888899999999999888765543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.28  E-value=3.8e-11  Score=101.12  Aligned_cols=141  Identities=23%  Similarity=0.249  Sum_probs=105.8

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEe-ccC-------ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVL-ATD-------SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ..|-+|+-+.|+++.+ .|+.+.||.- .+.       ..-...+..+|++.|.++.--.|.-..=++.+.....++|||
T Consensus        13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            5688999999999988 6777777743 221       122345678899999998765665555566677778899999


Q ss_pred             ccC-CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC---cEEEeecCCccc
Q 014038          190 MSK-GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM---RARVADFGLSRE  262 (432)
Q Consensus       190 ~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~---~~kl~Dfgl~~~  262 (432)
                      +++ -++.+++...-...........++..|-..+.-||.++   |||+||..+||+|..++   .+.++|||++..
T Consensus        92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            976 36777775543333344444788999999999999999   99999999999996554   458999999753

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=8.8e-11  Score=99.43  Aligned_cols=130  Identities=24%  Similarity=0.341  Sum_probs=99.2

Q ss_pred             cccccCceeEEEEEeCCCcEEEEEEeccCC--------hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          119 LIGQGAFGPVYKAQMSTGETVAVKVLATDS--------KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .+++|+-+.+|.+.+. |..+.+|.-....        .-......+|..++.++.--.|.-.+=+..+.+...++|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            5789999999999774 4456666432211        112245678999999987656655555666777888999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      +|..|.+.+...         ...++..+-.-+.-||..+   |+|+||.++||++..+. +.++||||+..
T Consensus        82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            998888888433         2456777888888999999   99999999999998774 99999999863

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.19  E-value=5.9e-10  Score=107.62  Aligned_cols=169  Identities=20%  Similarity=0.236  Sum_probs=127.5

Q ss_pred             CceeEEEEE-eCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeee----CCeEEEEEEeccC-CChhh
Q 014038          124 AFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE----KGQHMLVYVFMSK-GSLAS  197 (432)
Q Consensus       124 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~  197 (432)
                      -..+.|++. .-+|..|++|+++.+..........-++.++++.|+|+|++..++..    +...++||+|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            346778884 44899999999965544433334456788999999999999987752    4578999999985 56766


Q ss_pred             hccc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          198 HLYD-------------ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       198 ~l~~-------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      .-+.             ..+...++...|.++.|++.||.++|+.|   +..+-|.+.+||++.+.+++|+..|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            5532             12345788999999999999999999999   8889999999999999999998877654332


Q ss_pred             ccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCC
Q 014038          265 VDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP  311 (432)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p  311 (432)
                      .+..             |-+.   --++-|.=.||.+++.|.||..-
T Consensus       445 ~d~~-------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT-------------EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC-------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            2220             1111   13567999999999999998543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.16  E-value=1.9e-09  Score=101.78  Aligned_cols=258  Identities=16%  Similarity=0.228  Sum_probs=159.7

Q ss_pred             ccccccccCceeEEEE-EeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEee------eeeCCe-EEEE
Q 014038          116 FTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGY------CAEKGQ-HMLV  186 (432)
Q Consensus       116 ~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~~~~-~~lv  186 (432)
                      ....||+|+.+.+|-. ...  . .+-|+..........+.   +..|... .||-+-.=+.+      ..+.+. .-++
T Consensus        15 ~gr~LgqGgea~ly~l~e~~--d-~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVR--D-QVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecchhh--c-hhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            3467999999999965 321  1 24466654443333332   2334444 56644331221      112222 5677


Q ss_pred             EEeccCCChhhhcc-----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          187 YVFMSKGSLASHLY-----DENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       187 ~e~~~~g~L~~~l~-----~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                      |..+.+..--..++     .+......|...++.++.++.+.+-||..|   .+-+|+.++|+|+++++.+.|.|-.--.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence            77776542222222     244556899999999999999999999999   8889999999999999999998744322


Q ss_pred             cccccccccccccCCCCCCccccc-----cCCCCchhHhHHHHHHHHHHHhC-CCCCCChhHHH--------HHHHhhhc
Q 014038          262 EEMVDKHAANIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAG-RSPLQGLMEYV--------ELAAMNTE  327 (432)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg-~~p~~~~~~~~--------~~~~~~~~  327 (432)
                      ....+......+|.+.|.+||..+     +...+...|-|.|||++++++.| +.||.+.....        .+..-...
T Consensus       166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~  245 (637)
T COG4248         166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA  245 (637)
T ss_pred             eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence            222333344567889999999764     33457889999999999999885 99998753211        11100000


Q ss_pred             CCCchhhhccccCCCCCCHH-HHHHHHHHHHHhhccC--CCCCCCHHHHHHHHHHHHhh
Q 014038          328 GKTGWEEIVDSRLDGIFDVE-ELNEVASLAYKCVNRA--PRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~d--p~~RPs~~~vl~~L~~i~~~  383 (432)
                      -...-..-..+ .+...+.+ .+..+..+..+|+...  +.-|||++..+..|..+...
T Consensus       246 ya~~~~~g~~p-~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         246 YASDQRRGLKP-PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             echhccCCCCC-CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            00000000000 01112222 2457788888998754  56899999988888777543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.13  E-value=1.6e-11  Score=126.91  Aligned_cols=240  Identities=22%  Similarity=0.283  Sum_probs=161.7

Q ss_pred             cccccccCceeEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          117 TTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      .+-+-+|.++.++.+.- ..|...++|.......   ...+....+-.++-...||-++....-+......+|+++|..+
T Consensus       809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~  888 (1205)
T KOG0606|consen  809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG  888 (1205)
T ss_pred             cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence            34678899999988742 2454555555433221   1112222233333333455555544444456678999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc-cc------
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE-MV------  265 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~-~~------  265 (432)
                      ++|...|+...  +.+..-.......+..+++|||...   +.|+|++|.|.|...+++.+++|||..... ..      
T Consensus       889 ~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~  963 (1205)
T KOG0606|consen  889 GDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL  963 (1205)
T ss_pred             CCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence            99999996543  4555555666777889999999987   899999999999999999999999832210 00      


Q ss_pred             ---------------------c----ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHH
Q 014038          266 ---------------------D----KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVE  320 (432)
Q Consensus       266 ---------------------~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~  320 (432)
                                           .    .......+|+.|.+||...+..-...+|.|++|++++|.++|..||........
T Consensus       964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~ 1043 (1205)
T KOG0606|consen  964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQI 1043 (1205)
T ss_pred             ccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhh
Confidence                                 0    001234689999999999998888999999999999999999999986543222


Q ss_pred             HHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 014038          321 LAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMR  371 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  371 (432)
                      ...+. .....|         ...+.+...+..+++...+..+|.+|-.+.
T Consensus      1044 f~ni~-~~~~~~---------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1044 FENIL-NRDIPW---------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhccc-cCCCCC---------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            21111 111111         112233445788899999999999997665

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.10  E-value=1.8e-09  Score=99.84  Aligned_cols=138  Identities=16%  Similarity=0.128  Sum_probs=99.3

Q ss_pred             ccccCceeEEEEEeCCCcEEEEEEeccCChh-----------hHHHHHHHHHHHhhcCCCc--cceEEeeeee-----CC
Q 014038          120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQ-----------GEKEFQTEVMLLGRLHHRN--LVNLVGYCAE-----KG  181 (432)
Q Consensus       120 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~~  181 (432)
                      +-......|++..+ +|+.|.||........           ....+.+|...+.++..-+  ...++++...     ..
T Consensus        30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            33333445667766 6788999976433211           1114778999988885333  3445555543     23


Q ss_pred             eEEEEEEeccCC-ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC-------CCcEE
Q 014038          182 QHMLVYVFMSKG-SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-------SMRAR  253 (432)
Q Consensus       182 ~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~-------~~~~k  253 (432)
                      ..++|||++++. +|.+++......+.+......++.+++..+.-||..|   |+|+|+++.|||++.       +..+.
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEE
Confidence            578999999876 7888874322244566777889999999999999999   999999999999975       46899


Q ss_pred             EeecCCcc
Q 014038          254 VADFGLSR  261 (432)
Q Consensus       254 l~Dfgl~~  261 (432)
                      ++||+.+.
T Consensus       186 LIDl~r~~  193 (268)
T PRK15123        186 VIDLHRAQ  193 (268)
T ss_pred             EEECCccc
Confidence            99999774

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.05  E-value=1.4e-09  Score=94.91  Aligned_cols=124  Identities=24%  Similarity=0.338  Sum_probs=82.1

Q ss_pred             eEEEEEeCCCcEEEEEEeccCC--------------h------------hhHHHHHHHHHHHhhcCCC--ccceEEeeee
Q 014038          127 PVYKAQMSTGETVAVKVLATDS--------------K------------QGEKEFQTEVMLLGRLHHR--NLVNLVGYCA  178 (432)
Q Consensus       127 ~Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  178 (432)
                      .||.|...+|..+|+|+.+...              .            .......+|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998899999999874320              0            0113467899999999765  456666442 


Q ss_pred             eCCeEEEEEEecc--CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeeeccCCCCCeeecCCCcEEEe
Q 014038          179 EKGQHMLVYVFMS--KGSLASHLYDENYGPLTWNLRVHIALDVARGLEY-LHDGAVPPVIHRDIKSSNILLDQSMRARVA  255 (432)
Q Consensus       179 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~y-LH~~~~~~iiH~dlkp~Nill~~~~~~kl~  255 (432)
                         ..++||||++  +..+..+. ...   ++......++.+++..+.. +|..+   |+|+||.+.|||++++ .+.|+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~-~~~---~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLK-DVD---LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHH-HCG---GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHH-hcc---ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence               4579999998  54444433 211   2234456677888886665 57888   9999999999999988 99999


Q ss_pred             ecCCccc
Q 014038          256 DFGLSRE  262 (432)
Q Consensus       256 Dfgl~~~  262 (432)
                      |||.+..
T Consensus       149 Df~qav~  155 (188)
T PF01163_consen  149 DFGQAVD  155 (188)
T ss_dssp             -GTTEEE
T ss_pred             ecCccee
Confidence            9998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.93  E-value=9.5e-09  Score=92.38  Aligned_cols=133  Identities=21%  Similarity=0.186  Sum_probs=96.8

Q ss_pred             cccccccccCceeEEEEEeCCCcEEEEEEeccCC----------------------hhhHHHHHHHHHHHhhcCCC--cc
Q 014038          115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS----------------------KQGEKEFQTEVMLLGRLHHR--NL  170 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--ni  170 (432)
                      .+...||-|--+.||.|..+.|..+|||.=+...                      ........+|.++|.+|.-.  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            3567899999999999999999999999643211                      01123456899999998654  66


Q ss_pred             ceEEeeeeeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC
Q 014038          171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM  250 (432)
Q Consensus       171 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~  250 (432)
                      .+.++    -+...+||||+++-.|...-       ++....-.++..|+.-+.-+-..|   |+|+|+++=||+++++|
T Consensus       174 P~P~~----~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg  239 (304)
T COG0478         174 PKPIA----WNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCccc----cccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCC
Confidence            66655    35778999999986665432       122233345555555555555667   99999999999999999


Q ss_pred             cEEEeecCCcc
Q 014038          251 RARVADFGLSR  261 (432)
Q Consensus       251 ~~kl~Dfgl~~  261 (432)
                      .+.++||-.+.
T Consensus       240 ~~~vIDwPQ~v  250 (304)
T COG0478         240 DIVVIDWPQAV  250 (304)
T ss_pred             CEEEEeCcccc
Confidence            99999997553

>PRK09902 hypothetical protein; Provisional

Probab=98.84  E-value=9.7e-08  Score=83.92  Aligned_cols=138  Identities=19%  Similarity=0.183  Sum_probs=104.8

Q ss_pred             ccccCceeEEEEEeCCCcEEEEEEeccC---C---hhhHHHHHHHHHHHhhcCC--CccceEEeeee-e----CCeEEEE
Q 014038          120 IGQGAFGPVYKAQMSTGETVAVKVLATD---S---KQGEKEFQTEVMLLGRLHH--RNLVNLVGYCA-E----KGQHMLV  186 (432)
Q Consensus       120 lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~-~----~~~~~lv  186 (432)
                      -|+||-+-|+...+ +|..+-+|.-...   +   +-....|.+|+..|.+|..  -.+.+++ ++. .    .-..+||
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            36799999999887 4557889976421   1   3456789999999999853  2344444 332 2    1246899


Q ss_pred             EEeccC-CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc--EEEeecCCccc
Q 014038          187 YVFMSK-GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR--ARVADFGLSRE  262 (432)
Q Consensus       187 ~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~--~kl~Dfgl~~~  262 (432)
                      +|-+.+ -+|.+++......+.+...+..+..+++..+.-||+.+   +.|+|+-+.|||++.++.  ++++||--++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997763 57888875544456678888899999999999999999   999999999999986667  99999986653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.75  E-value=1.1e-07  Score=84.99  Aligned_cols=106  Identities=25%  Similarity=0.246  Sum_probs=83.2

Q ss_pred             HHHHHHHHHHHhhcCC--CccceEEeeeeeC----CeEEEEEEeccCC-ChhhhcccCCCCCCCHHHHHHHHHHHHHHHH
Q 014038          152 EKEFQTEVMLLGRLHH--RNLVNLVGYCAEK----GQHMLVYVFMSKG-SLASHLYDENYGPLTWNLRVHIALDVARGLE  224 (432)
Q Consensus       152 ~~~~~~E~~~l~~l~h--~niv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~  224 (432)
                      .....+|...+..+..  -...+.+++....    ...++|+|++++. +|.+++....  .++......++.+++..+.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence            3467788888888753  3345666666543    2458999999874 7888885422  2566777889999999999


Q ss_pred             HHHhCCCCCeeeccCCCCCeeecCCC---cEEEeecCCccc
Q 014038          225 YLHDGAVPPVIHRDIKSSNILLDQSM---RARVADFGLSRE  262 (432)
Q Consensus       225 yLH~~~~~~iiH~dlkp~Nill~~~~---~~kl~Dfgl~~~  262 (432)
                      -||..+   |+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999   99999999999999887   899999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.74  E-value=3.2e-09  Score=106.10  Aligned_cols=149  Identities=21%  Similarity=0.328  Sum_probs=100.0

Q ss_pred             HHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc----------ccccccCCCCCCccccc
Q 014038          216 ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH----------AANIRGTFGYLDPEYIS  285 (432)
Q Consensus       216 ~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~----------~~~~~gt~~y~aPE~~~  285 (432)
                      +.+++.|+.|+|..-  .+||++|.|++|.++.++..||+.|+.+........          ..-..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            345559999999854  499999999999999999999999998753222111          01112346799999999


Q ss_pred             cCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCC
Q 014038          286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAP  364 (432)
Q Consensus       286 ~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp  364 (432)
                      ....+.++|+||+|+++|-+.. |+.-+..........         .....+......+....+.++.+=+.+++..++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~---------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~  253 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS---------FSRNLLNAGAFGYSNNLPSELRESLKKLLNGDS  253 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhh---------hhhcccccccccccccCcHHHHHHHHHHhcCCc
Confidence            8888999999999999999985 444433211000000         000011111112223445688899999999999


Q ss_pred             CCCCCHHHHHH
Q 014038          365 RKRPSMRDIVQ  375 (432)
Q Consensus       365 ~~RPs~~~vl~  375 (432)
                      ..||++.++..
T Consensus       254 ~~rp~~~~l~~  264 (700)
T KOG2137|consen  254 AVRPTLDLLLS  264 (700)
T ss_pred             ccCcchhhhhc
Confidence            99997766543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.73  E-value=5.7e-08  Score=97.32  Aligned_cols=139  Identities=19%  Similarity=0.243  Sum_probs=93.0

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChh----------------------------------------hHHHHHH
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ----------------------------------------GEKEFQT  157 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~~~~  157 (432)
                      +-|+.++-|.||+|++++|+.||||+.+.+-..                                        .+-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            468999999999999999999999998543100                                        1113555


Q ss_pred             HHHHHhhcC-----CCccceEEeeeeeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 014038          158 EVMLLGRLH-----HRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP  232 (432)
Q Consensus       158 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~  232 (432)
                      |...+.++.     .+++.=..=|+...+...++|||++|-.+.+...-+. ..++...+.....++.  +..+-..+  
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dg--  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDG--  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcC--
Confidence            666666552     3443222223334678899999999998888753222 3355333322222222  23333346  


Q ss_pred             CeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          233 PVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       233 ~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                       ++|.|..|-||+++.++.+.+.|||+...
T Consensus       286 -ffHaDpHpGNi~v~~~g~i~~lDfGi~g~  314 (517)
T COG0661         286 -FFHADPHPGNILVRSDGRIVLLDFGIVGR  314 (517)
T ss_pred             -ccccCCCccceEEecCCcEEEEcCcceec
Confidence             99999999999999999999999998754

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.60  E-value=9.3e-07  Score=80.06  Aligned_cols=138  Identities=13%  Similarity=0.184  Sum_probs=84.7

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCc--cceEEeeeeeCCeEEEEEEeccCCC-
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN--LVNLVGYCAEKGQHMLVYVFMSKGS-  194 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~-  194 (432)
                      ..||.|..+.||+.   .|..+++|......  ......+|.++++.+..-+  +.+.++++...+...+||++++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            46899999999984   25567888876432  2345688999999886433  4667778777778889999999863 


Q ss_pred             hhhhc---------------------ccCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHh-CCCCCeeeccCC
Q 014038          195 LASHL---------------------YDENYGPLTWNLRV-HIAL----------DVAR-GLEYLHD-GAVPPVIHRDIK  240 (432)
Q Consensus       195 L~~~l---------------------~~~~~~~l~~~~~~-~i~~----------~i~~-~l~yLH~-~~~~~iiH~dlk  240 (432)
                      +...+                     |.-.....+..... .+..          .+.. ...+|.. ...+.++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            21111                     11000011111100 0000          0111 1122221 122457899999


Q ss_pred             CCCeeecCCCcEEEeecCCcc
Q 014038          241 SSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       241 p~Nill~~~~~~kl~Dfgl~~  261 (432)
                      |.||++++++ +.|+||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999988 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.60  E-value=1.2e-06  Score=77.45  Aligned_cols=140  Identities=12%  Similarity=0.154  Sum_probs=91.7

Q ss_pred             HHHHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHH---------HHHHHHHhhcCC---CccceEE
Q 014038          107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEF---------QTEVMLLGRLHH---RNLVNLV  174 (432)
Q Consensus       107 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h---~niv~l~  174 (432)
                      +++....+...+++-......|.+-.. +|+.+.+|..+......++.|         .+++..+.++..   .....++
T Consensus        26 ~~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y  104 (229)
T PF06176_consen   26 EKILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY  104 (229)
T ss_pred             HHHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence            344555555666676666667777666 678899998876543333222         234444444432   2222322


Q ss_pred             eee-----eeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC
Q 014038          175 GYC-----AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS  249 (432)
Q Consensus       175 ~~~-----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~  249 (432)
                      ...     ......+++|||++|..|.+...      +++    .++..+.+++.-||..|   +.|+|..|.|++++++
T Consensus       105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC
Confidence            222     22345678999999988876541      232    24566778899999999   9999999999999966


Q ss_pred             CcEEEeecCCcc
Q 014038          250 MRARVADFGLSR  261 (432)
Q Consensus       250 ~~~kl~Dfgl~~  261 (432)
                      + +++.||+..+
T Consensus       172 ~-i~iID~~~k~  182 (229)
T PF06176_consen  172 G-IRIIDTQGKR  182 (229)
T ss_pred             c-EEEEECcccc
Confidence            4 9999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.49  E-value=2.5e-06  Score=76.20  Aligned_cols=134  Identities=23%  Similarity=0.278  Sum_probs=93.9

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChh-------------------hHH-----HHHHHHHHHhhcC--CCccc
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ-------------------GEK-----EFQTEVMLLGRLH--HRNLV  171 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~-----~~~~E~~~l~~l~--h~niv  171 (432)
                      ..|..|--+.||+|...++..+|||+.+.....                   ..+     -..+|+..|.++.  +-.+.
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            357788889999998888999999998543110                   111     1346777787774  33444


Q ss_pred             eEEeeeeeCCeEEEEEEeccCC-ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCeeecCC
Q 014038          172 NLVGYCAEKGQHMLVYVFMSKG-SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQS  249 (432)
Q Consensus       172 ~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlkp~Nill~~~  249 (432)
                      +.+++.    ...|||||+... .-.-.|.+   -++.......+..++++.+.-|-. .+   ++|+||+.=|||+. +
T Consensus       134 ~Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~  202 (268)
T COG1718         134 EPIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-D  202 (268)
T ss_pred             Cceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-C
Confidence            445443    457999999654 22223322   223333677788889999888877 66   99999999999999 7


Q ss_pred             CcEEEeecCCccc
Q 014038          250 MRARVADFGLSRE  262 (432)
Q Consensus       250 ~~~kl~Dfgl~~~  262 (432)
                      +.+.|+|||.+-.
T Consensus       203 ~~p~iID~~QaV~  215 (268)
T COG1718         203 GEPYIIDVSQAVT  215 (268)
T ss_pred             CeEEEEECccccc
Confidence            7999999997753

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.46  E-value=2.9e-06  Score=77.97  Aligned_cols=138  Identities=17%  Similarity=0.168  Sum_probs=84.9

Q ss_pred             ccccCc-eeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC-CCccceEEeeeeeCCeEEEEEEeccCCChhh
Q 014038          120 IGQGAF-GPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFMSKGSLAS  197 (432)
Q Consensus       120 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  197 (432)
                      |..|.. ..||+.... +..+.+|+.....   ...+.+|+.++..+. +--+.+++++....+..++||++++|.+|..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444544 889999764 4788888875443   345678998888883 4445677777776677899999999887764


Q ss_pred             hc-------------------ccCC--CCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----CC
Q 014038          198 HL-------------------YDEN--YGPLTWN--LRVHIAL--------------------DVARGLEYLHD----GA  230 (432)
Q Consensus       198 ~l-------------------~~~~--~~~l~~~--~~~~i~~--------------------~i~~~l~yLH~----~~  230 (432)
                      ..                   +...  ..++...  .......                    .+...+..|-.    ..
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            32                   1110  0011100  0000000                    01111222211    12


Q ss_pred             CCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          231 VPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       231 ~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                      .+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            3458999999999999998888999998663

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.46  E-value=3.8e-08  Score=97.62  Aligned_cols=251  Identities=18%  Similarity=0.144  Sum_probs=159.9

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCc-cceEEeeeeeCCeEEEEEEeccCC-Ch
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN-LVNLVGYCAEKGQHMLVYVFMSKG-SL  195 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-~L  195 (432)
                      .-+++|+++.+||.+-...+....+.+...     ....-++++|.+++||| .+..++-+..+...++.++++..+ +-
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~  322 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS  322 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence            357899999999996533333345554322     34456888999999999 677677677777889999999877 22


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccccccccC
Q 014038          196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT  275 (432)
Q Consensus       196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt  275 (432)
                      ..... ...-.+...+...+.+.-+++++|||+..   -+|+|    ||+..+ +..|..||+...............++
T Consensus       323 ~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~  393 (829)
T KOG0576|consen  323 ALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGT  393 (829)
T ss_pred             cccCC-hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcccccccCCCC
Confidence            22221 11122444455667777888999999864   48998    877766 58899999988765544455677899


Q ss_pred             CCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHH
Q 014038          276 FGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASL  355 (432)
Q Consensus       276 ~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  355 (432)
                      +.|+|||+.....+..+.|+|++|+-..+|.-|-+|-.....  ...... .+. .-..+.+......      ..=.++
T Consensus       394 ~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g-~~p-~s~~L~~~~aw~~------~~~~~~  463 (829)
T KOG0576|consen  394 PEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIG-NGP-NSPMLTDKSAWSP------VFHRDF  463 (829)
T ss_pred             CCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCC-CCC-CccccchhhhcCc------ccccCC
Confidence            999999999999999999999999987777777777543110  000000 000 0000000000000      000124


Q ss_pred             HHHhhccCCCCCCCHHHHHHHHHHHHhhccccccccCCC
Q 014038          356 AYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQ  394 (432)
Q Consensus       356 i~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~~~~~~~~~  394 (432)
                      -..|+...|..|+.....+  +.++++....+.+...++
T Consensus       464 ~~~~~~g~P~~pkv~mgac--fsKvfngCpl~i~~aasw  500 (829)
T KOG0576|consen  464 PAPCLNGLPPTPKVHMGAC--FSKVFNGCPLRIHCAASW  500 (829)
T ss_pred             cccccCCCCCCCcchhhHH--HHHHhccCcccceecccc
Confidence            5668888888888766543  466666655554444433

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.43  E-value=5.3e-06  Score=75.32  Aligned_cols=141  Identities=18%  Similarity=0.262  Sum_probs=83.9

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCC--ccceEEeeeee---CCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR--NLVNLVGYCAE---KGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~~  192 (432)
                      +.|+.|..+.||+....+ ..+++|.....  .....+.+|..+++.+...  .+.+++.++..   ....+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            468999999999999866 69999987543  4456778899998888533  35566664432   3457899999999


Q ss_pred             CChhh----------------hc---ccC--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 014038          193 GSLAS----------------HL---YDE--NYGPLTWNL---------RVHI------------ALDVAR-GLEYLHD-  228 (432)
Q Consensus       193 g~L~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~i~~-~l~yLH~-  228 (432)
                      ..+..                .+   +..  ...++.+..         ....            ...+.. .+..++. 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            87777                11   111  111111111         0000            111222 2333332 


Q ss_pred             ---CCCCCeeeccCCCCCeeec-CCCcEEEeecCCcc
Q 014038          229 ---GAVPPVIHRDIKSSNILLD-QSMRARVADFGLSR  261 (432)
Q Consensus       229 ---~~~~~iiH~dlkp~Nill~-~~~~~kl~Dfgl~~  261 (432)
                         .....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence               1334599999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.39  E-value=1.7e-06  Score=86.48  Aligned_cols=138  Identities=17%  Similarity=0.168  Sum_probs=90.2

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChh-------------------------------------hHHHHHHHHH
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQ-------------------------------------GEKEFQTEVM  160 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------------------~~~~~~~E~~  160 (432)
                      +.||.-+.|.||+|++++|+.||||+-+..-+.                                     .+-+|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            569999999999999999999999987543110                                     1124566666


Q ss_pred             HHhhc----CCCc------cceEEeeeeeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 014038          161 LLGRL----HHRN------LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA  230 (432)
Q Consensus       161 ~l~~l----~h~n------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~  230 (432)
                      ...++    .|-+      |.+++-  .-.....|+||||+|..+.+.-.-.. ..++...+..-+.++..-+-+  ..|
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~qIf--~~G  321 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLEQIF--KTG  321 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHHHHH--hcC
Confidence            55544    3444      222222  22457899999999988877543222 224544433333332221112  235


Q ss_pred             CCCeeeccCCCCCeeecC----CCcEEEeecCCcccc
Q 014038          231 VPPVIHRDIKSSNILLDQ----SMRARVADFGLSREE  263 (432)
Q Consensus       231 ~~~iiH~dlkp~Nill~~----~~~~kl~Dfgl~~~~  263 (432)
                         ++|+|-.|-||++..    ++.+.+.|||+....
T Consensus       322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             ---CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence               899999999999983    678999999997643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.35  E-value=2.5e-06  Score=74.79  Aligned_cols=102  Identities=24%  Similarity=0.343  Sum_probs=81.8

Q ss_pred             HHHHHHHhhcCC-CccceEEeeeeeCCeEEEEEEeccCCChhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 014038          156 QTEVMLLGRLHH-RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPP  233 (432)
Q Consensus       156 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~  233 (432)
                      ..|.-+++.+++ +++.+++|+|.    .+++.||...+++...-.. ......+|..+.+|+.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458888999975 69999999994    3678999987766422100 12234689999999999999999999865555


Q ss_pred             eeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          234 VIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       234 iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                      +.-.|++++|+-+++++++|+.|..-..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcc
Confidence            8889999999999999999999998653

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.32  E-value=1.1e-05  Score=87.01  Aligned_cols=78  Identities=14%  Similarity=0.353  Sum_probs=57.6

Q ss_pred             ccccccCceeEEEEEeCCC---cEEEEEEeccCC-hhhHHHHHHHHHHHhhcC-CCcc--ceEEeeeeeC---CeEEEEE
Q 014038          118 TLIGQGAFGPVYKAQMSTG---ETVAVKVLATDS-KQGEKEFQTEVMLLGRLH-HRNL--VNLVGYCAEK---GQHMLVY  187 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv~  187 (432)
                      +.++.|.+..+|+....++   ..+++|+..... ......+.+|+.+|+.+. |.++  .+++++|.+.   +..|+||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            5689999999999876554   367777764432 123357889999999995 6665  7788888764   4689999


Q ss_pred             EeccCCCh
Q 014038          188 VFMSKGSL  195 (432)
Q Consensus       188 e~~~~g~L  195 (432)
                      ||+++..+
T Consensus       124 E~v~G~~~  131 (822)
T PLN02876        124 EYLEGRIF  131 (822)
T ss_pred             EecCCccc
Confidence            99987654

>PRK10593 hypothetical protein; Provisional

Probab=98.18  E-value=5e-05  Score=71.82  Aligned_cols=75  Identities=15%  Similarity=0.130  Sum_probs=56.1

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCC---CccceEEeeeee---CCeEEEEEEecc
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH---RNLVNLVGYCAE---KGQHMLVYVFMS  191 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e~~~  191 (432)
                      +.||.|..+.||+....++ .+.+|..+..  .....|..|...|+.+.-   -.+.+++++|..   .+..++|||+++
T Consensus        20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~   96 (297)
T PRK10593         20 ECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR   96 (297)
T ss_pred             eecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence            5799999999999976555 4666774321  123578899999998843   367888888754   367899999999


Q ss_pred             CCCh
Q 014038          192 KGSL  195 (432)
Q Consensus       192 ~g~L  195 (432)
                      ++++
T Consensus        97 G~~~  100 (297)
T PRK10593         97 GVSV  100 (297)
T ss_pred             CEec
Confidence            8765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.15  E-value=1.1e-05  Score=85.68  Aligned_cols=196  Identities=19%  Similarity=0.203  Sum_probs=138.6

Q ss_pred             HHHHHHHHhhcCCCccceEEeeeeeCCeE----EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 014038          155 FQTEVMLLGRLHHRNLVNLVGYCAEKGQH----MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA  230 (432)
Q Consensus       155 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~  230 (432)
                      ...|+..+....|+|++.+++|-.+....    .+..+++..-++...+  +.-+.++....+.+..+...||.|+|...
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~--q~v~~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL--QSVGSIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH--hhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            34567778888999999999987654322    2445677777777766  34456788888889999999999999986


Q ss_pred             CCCeeeccCCCC---CeeecCCCcEEEe--ecCCcccccccccccccccCCCCCCccccccCCCC--chhHhHHHHHHHH
Q 014038          231 VPPVIHRDIKSS---NILLDQSMRARVA--DFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT--KKSDVYSFGVLLF  303 (432)
Q Consensus       231 ~~~iiH~dlkp~---Nill~~~~~~kl~--Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~Dv~SlGvil~  303 (432)
                         ..|.-|..+   +...+.++.+.++  ||+.++.............+..|.+||......++  ...|+|.+|..+.
T Consensus       307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             ---cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence               666666665   6666777888887  99888765554444444556678888887666555  4479999999999


Q ss_pred             HHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          304 ELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       304 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                      .+..|..+-.....              ...+++.    ...    ..+.+....|+..++++|+++.+++...
T Consensus       384 ~~~~~~~i~~~~~~--------------~~~~l~~----~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  384 QLSQGEDISEKSAV--------------PVSLLDV----LST----SELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhcCcccccccc--------------hhhhhcc----ccc----hhhhhhhhhhcchhhhhccchhhhhhch
Confidence            99987665321100              0111111    111    1577888999999999999999988653

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.13  E-value=3.3e-05  Score=67.59  Aligned_cols=125  Identities=26%  Similarity=0.435  Sum_probs=89.5

Q ss_pred             HhccccccccccCc-eeEEEEEeCCCcEEEEEEecc---CC--------h----------hhHHHHHHHHHHHhhcC---
Q 014038          112 ATCNFTTLIGQGAF-GPVYKAQMSTGETVAVKVLAT---DS--------K----------QGEKEFQTEVMLLGRLH---  166 (432)
Q Consensus       112 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~--------~----------~~~~~~~~E~~~l~~l~---  166 (432)
                      ..++|.+.||.|.- |.||+++. +|+.+|+|++..   ..        .          ....-|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            56788899999999 99999998 678999999422   00        0          11235888999888875   


Q ss_pred             CCcc--ceEEeeeeeC------------------CeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 014038          167 HRNL--VNLVGYCAEK------------------GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYL  226 (432)
Q Consensus       167 h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yL  226 (432)
                      +.++  |+.+||..-.                  ....+|.||++...           .++.    .-+.+|.+-|..+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~~  180 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKIL  180 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHHH
Confidence            4566  8899987322                  12356777665432           1222    2356777888999


Q ss_pred             HhCCCCCeeeccCCCCCeeecCCCcEEEeecCCc
Q 014038          227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS  260 (432)
Q Consensus       227 H~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~  260 (432)
                      |..+   |+-+|+++.|..     .-||+|||.+
T Consensus       181 ~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 HKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHCC---eeeccCcccccc-----CCEEEecccC
Confidence            9999   999999999986     3489999854

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.09  E-value=3.6e-05  Score=70.26  Aligned_cols=74  Identities=14%  Similarity=0.211  Sum_probs=46.2

Q ss_pred             ccccccCce-eEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCC---ccceEEeeeeeC---CeEEEEEEec
Q 014038          118 TLIGQGAFG-PVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR---NLVNLVGYCAEK---GQHMLVYVFM  190 (432)
Q Consensus       118 ~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~  190 (432)
                      +.|+.|+.. .||+.    +..+++|.....  .....+.+|.+++..+...   -+.++++.....   +..+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            357777766 58876    235677765432  2345788999999887532   234444444332   2458899999


Q ss_pred             cCCChhh
Q 014038          191 SKGSLAS  197 (432)
Q Consensus       191 ~~g~L~~  197 (432)
                      +|.++..
T Consensus        77 ~G~~l~~   83 (235)
T cd05155          77 EGETATA   83 (235)
T ss_pred             cCCCCCc
Confidence            9877753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.05  E-value=4.7e-05  Score=64.57  Aligned_cols=126  Identities=17%  Similarity=0.212  Sum_probs=86.3

Q ss_pred             cccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccce-EEeeeeeCCeEEEEEEeccCCCh
Q 014038          117 TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVN-LVGYCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g~L  195 (432)
                      .+.|++|.+|.||++.+ .|..+|+|+-+.+++  ...+..|.++|..+.-.++.+ ++.|-    ..++.|||+.|-+|
T Consensus        27 ~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L   99 (201)
T COG2112          27 EKELAKGTTSVVYLGEW-RGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhcccccEEEEeec-cCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcch
Confidence            35799999999999998 456899998765543  457889999999998776654 34332    23455999998888


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC-CCCeeecCCCcEEEeecCCcc
Q 014038          196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIK-SSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk-p~Nill~~~~~~kl~Dfgl~~  261 (432)
                      .+.-...     +-.+    ...++..---|...|   |-|+.|. |...+|..+..+.|+||.-++
T Consensus       100 ~~~~~~~-----~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112         100 GKLEIGG-----DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             hhhhhcc-----cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence            7655211     2222    334445544455556   8898886 444444444499999999775

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.00  E-value=0.00011  Score=67.07  Aligned_cols=74  Identities=18%  Similarity=0.223  Sum_probs=48.4

Q ss_pred             ccccccCceeEEEEEeCC--CcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCcc-ceEEeeeeeCCeEEEEEEeccCCC
Q 014038          118 TLIGQGAFGPVYKAQMST--GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL-VNLVGYCAEKGQHMLVYVFMSKGS  194 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~  194 (432)
                      +.|..|-...+|+....+  ++.|++|+....... .-+..+|+.++..+...++ .++++.+.    ..++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            457788889999998764  678899976543221 1223478888888854344 44444332    247999999876


Q ss_pred             hh
Q 014038          195 LA  196 (432)
Q Consensus       195 L~  196 (432)
                      +.
T Consensus        79 l~   80 (235)
T cd05157          79 LE   80 (235)
T ss_pred             CC
Confidence            63

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.92  E-value=0.00024  Score=62.66  Aligned_cols=130  Identities=23%  Similarity=0.342  Sum_probs=90.4

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCC----------------hhhHHHHHHHHHHHhhcC------CCccceEEe
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDS----------------KQGEKEFQTEVMLLGRLH------HRNLVNLVG  175 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~~  175 (432)
                      ..||+|+.=.||.-  +++....||+.....                ....+++.+|+.-...+.      +.+|.+++|
T Consensus         7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            46999999999875  344556888876544                223456677777666555      788999999


Q ss_pred             eeeeCCeEEEEEEeccC--C----ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC
Q 014038          176 YCAEKGQHMLVYVFMSK--G----SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS  249 (432)
Q Consensus       176 ~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~  249 (432)
                      +..++--.-+|+|.+.+  |    +|.+++..   +.++. .   +...+-+-..||-.++   |+.+|++|.||++..+
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQRR  154 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEEec
Confidence            99999889999998753  2    46666632   23554 2   3333444556777777   9999999999999432


Q ss_pred             ---C-cEEEee-cCC
Q 014038          250 ---M-RARVAD-FGL  259 (432)
Q Consensus       250 ---~-~~kl~D-fgl  259 (432)
                         . .+.|+| ||-
T Consensus       155 ~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  155 DSGEFRLVLIDGLGE  169 (199)
T ss_pred             CCCceEEEEEeCCCC
Confidence               2 577777 453

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.90  E-value=0.00012  Score=67.67  Aligned_cols=137  Identities=15%  Similarity=0.167  Sum_probs=78.8

Q ss_pred             cccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCcc-ceEEeeeeeCCeEEEEEEeccCCChhh
Q 014038          119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL-VNLVGYCAEKGQHMLVYVFMSKGSLAS  197 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~~  197 (432)
                      .+..|-...+|+... ++..+++|..........-...+|..+++.+....+ .++++.+.    .++||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            356688889999874 567888887654322211235678888888864333 33444332    368999999876643


Q ss_pred             h-----------------cccCC--CCCCCHHH-HHHHHHHH---------HHHHHHHHhC-----CCCCeeeccCCCCC
Q 014038          198 H-----------------LYDEN--YGPLTWNL-RVHIALDV---------ARGLEYLHDG-----AVPPVIHRDIKSSN  243 (432)
Q Consensus       198 ~-----------------l~~~~--~~~l~~~~-~~~i~~~i---------~~~l~yLH~~-----~~~~iiH~dlkp~N  243 (432)
                      .                 +|...  ..+++... ...+..++         ...+..+-..     ..+.++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11111  11222211 11111111         1112222111     12348999999999


Q ss_pred             eeecCCCcEEEeecCCcc
Q 014038          244 ILLDQSMRARVADFGLSR  261 (432)
Q Consensus       244 ill~~~~~~kl~Dfgl~~  261 (432)
                      |++++++ +.|+||..+.
T Consensus       158 il~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEEeCCC-CEEEeccccC
Confidence            9999887 7899998765

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.63  E-value=0.00048  Score=65.39  Aligned_cols=139  Identities=24%  Similarity=0.339  Sum_probs=82.3

Q ss_pred             ccccccCceeEEEEEeCC-------CcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCcc-ceEEeeeeeCCeEEEEEEe
Q 014038          118 TLIGQGAFGPVYKAQMST-------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL-VNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  189 (432)
                      +.|..|-...+|+....+       ++.+++|+...... ...+..+|..++..+...++ .++++++. +   ..|++|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence            345667777999987654       57899998755432 22345678888888753333 34555543 2   358999


Q ss_pred             ccCCChhhh-----------------cccCCCC-------CCC--HHHHHH--------------------------HHH
Q 014038          190 MSKGSLASH-----------------LYDENYG-------PLT--WNLRVH--------------------------IAL  217 (432)
Q Consensus       190 ~~~g~L~~~-----------------l~~~~~~-------~l~--~~~~~~--------------------------i~~  217 (432)
                      ++|..+...                 +|.....       ..+  |.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            998766431                 1111111       011  111111                          111


Q ss_pred             HHHHHHHHHHh------CCCCCeeeccCCCCCeeecCC----CcEEEeecCCcc
Q 014038          218 DVARGLEYLHD------GAVPPVIHRDIKSSNILLDQS----MRARVADFGLSR  261 (432)
Q Consensus       218 ~i~~~l~yLH~------~~~~~iiH~dlkp~Nill~~~----~~~kl~Dfgl~~  261 (432)
                      .+..-+.+|..      .....++|+|+.+.|||++++    +.+.++||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22223334432      133468999999999999985    789999999774

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.62  E-value=0.0014  Score=64.11  Aligned_cols=74  Identities=19%  Similarity=0.165  Sum_probs=52.7

Q ss_pred             ccccccCceeEEEEEeCCC-cEEEEEEeccC------C-hhhHHHHHHHHHHHhhcC---CCccceEEeeeeeCCeEEEE
Q 014038          118 TLIGQGAFGPVYKAQMSTG-ETVAVKVLATD------S-KQGEKEFQTEVMLLGRLH---HRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  186 (432)
                      +.||.|.+..||++...+| +.++||.-...      . +...+.+..|.+.|..+.   -.++.+++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4689999999999988776 48999974321      1 223456777888888763   2456666666  34567899


Q ss_pred             EEeccCC
Q 014038          187 YVFMSKG  193 (432)
Q Consensus       187 ~e~~~~g  193 (432)
                      |||+++.
T Consensus       110 ME~L~~~  116 (401)
T PRK09550        110 MEDLSDH  116 (401)
T ss_pred             EecCCCc
Confidence            9999864

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.58  E-value=0.00097  Score=63.07  Aligned_cols=140  Identities=19%  Similarity=0.183  Sum_probs=84.3

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCc--cceEEee------eeeCCeEEEEEEe
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN--LVNLVGY------CAEKGQHMLVYVF  189 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~  189 (432)
                      +.|..|....+|+....+ ..+++|+...   ........|+.++..+.+.+  +.+++..      ....+..++|++|
T Consensus        20 ~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~   95 (296)
T cd05153          20 EGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF   95 (296)
T ss_pred             ecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence            457788888999987644 5788898754   22345667888888774332  4444432      1234567899999


Q ss_pred             ccCCChhh----hc----------cc--CC--C-----CCCCHHHHH----------HHHHHHHHHHHHHHhC----CCC
Q 014038          190 MSKGSLAS----HL----------YD--EN--Y-----GPLTWNLRV----------HIALDVARGLEYLHDG----AVP  232 (432)
Q Consensus       190 ~~~g~L~~----~l----------~~--~~--~-----~~l~~~~~~----------~i~~~i~~~l~yLH~~----~~~  232 (432)
                      ++|..+..    ..          |.  ..  .     ....|....          .....+...+.++...    ...
T Consensus        96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~  175 (296)
T cd05153          96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR  175 (296)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence            99876543    00          11  00  0     111222111          0111233344555431    123


Q ss_pred             CeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          233 PVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       233 ~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                      .++|+|+.|.|||+++++.+.|.||+.+.
T Consensus       176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         176 GVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            48999999999999998778899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.48  E-value=0.0026  Score=60.91  Aligned_cols=140  Identities=16%  Similarity=0.197  Sum_probs=76.3

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCc--cceEEe------eeeeCCeEEEEEEe
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN--LVNLVG------YCAEKGQHMLVYVF  189 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lv~e~  189 (432)
                      +.|+.|....+|+....+| .+++|+.....   .+....|+.++..|...+  +.+.+.      +....+..+++++|
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            3567788789999987555 68889875212   233344555555553211  333332      12235678999999


Q ss_pred             ccCCChhhh--------------cccCC---------CCCCCH-HHHHH------------HHHH-HHHHHHHHHhC---
Q 014038          190 MSKGSLASH--------------LYDEN---------YGPLTW-NLRVH------------IALD-VARGLEYLHDG---  229 (432)
Q Consensus       190 ~~~g~L~~~--------------l~~~~---------~~~l~~-~~~~~------------i~~~-i~~~l~yLH~~---  229 (432)
                      ++|..+...              +|...         ...+.| .....            ...+ +...+..+...   
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            998754210              11100         001112 11111            1111 11122233211   


Q ss_pred             -CCCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          230 -AVPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       230 -~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                       -...+||+|+.|.||+++.+...-|+||+.+.
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence             12359999999999999977666899999775

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.43  E-value=0.0023  Score=60.44  Aligned_cols=129  Identities=19%  Similarity=0.271  Sum_probs=78.6

Q ss_pred             eeEEEEEeCCCcEEEEEEec-cCChhhHHHHHHHHHHHhhcCC--CccceEEeeeeeCC--eEEEEEEeccCCChhhhcc
Q 014038          126 GPVYKAQMSTGETVAVKVLA-TDSKQGEKEFQTEVMLLGRLHH--RNLVNLVGYCAEKG--QHMLVYVFMSKGSLASHLY  200 (432)
Q Consensus       126 g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~~g~L~~~l~  200 (432)
                      -.+|.... +++.+++..-. ...........+|+.+++.+.-  .-+...+++|.++.  ..+.||+|++|..+.+.+.
T Consensus        39 n~t~~~~~-~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~  117 (321)
T COG3173          39 NDTFRLGD-TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP  117 (321)
T ss_pred             cceEEEec-CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence            34444443 37788888221 1222334456778888887742  33455677787665  7899999999854433331


Q ss_pred             cCCCCCCCHHHHHHHH-HHHHHHH--------------------------------------------------HHHHhC
Q 014038          201 DENYGPLTWNLRVHIA-LDVARGL--------------------------------------------------EYLHDG  229 (432)
Q Consensus       201 ~~~~~~l~~~~~~~i~-~~i~~~l--------------------------------------------------~yLH~~  229 (432)
                      ....   .    .+++ ..++..|                                                  .||+.+
T Consensus       118 ~~~~---~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~  190 (321)
T COG3173         118 PESL---G----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN  190 (321)
T ss_pred             cccc---h----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence            1110   0    0111 1333333                                                  344332


Q ss_pred             C-----CCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          230 A-----VPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       230 ~-----~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .     .+.++|+|+.+.|++++++..+-|.||+++..
T Consensus       191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             CCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            2     24699999999999999999999999998864

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.43  E-value=0.0003  Score=65.41  Aligned_cols=131  Identities=17%  Similarity=0.171  Sum_probs=91.6

Q ss_pred             cccccccccCceeEEEEEeCCCcEEEEEEeccCC-----------------hhh-----HHHHHHHHHHHhhcC-CCc-c
Q 014038          115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS-----------------KQG-----EKEFQTEVMLLGRLH-HRN-L  170 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~~-----~~~~~~E~~~l~~l~-h~n-i  170 (432)
                      .+.+.||-|--+.+|.+-..+|++.++|.-+...                 ...     .-...+|...|+.|. |-. +
T Consensus        95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV  174 (465)
T KOG2268|consen   95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV  174 (465)
T ss_pred             hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence            4568899999999999998899999998642210                 000     112457888888874 322 3


Q ss_pred             ceEEeeeeeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC
Q 014038          171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM  250 (432)
Q Consensus       171 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~  250 (432)
                      .+.++    .+..++|||++.+-.|.+.-+-.     +...   +...+..-+.-|-.+|   +||+|..-=||++++++
T Consensus       175 PkpiD----~~RH~Vvmelv~g~Pl~~v~~v~-----d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~  239 (465)
T KOG2268|consen  175 PKPID----HNRHCVVMELVDGYPLRQVRHVE-----DPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDD  239 (465)
T ss_pred             CCccc----ccceeeHHHhhcccceeeeeecC-----ChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEecCC
Confidence            33333    45789999999998887654222     2233   3334444456666778   99999999999999999


Q ss_pred             cEEEeecCCc
Q 014038          251 RARVADFGLS  260 (432)
Q Consensus       251 ~~kl~Dfgl~  260 (432)
                      .++++||-..
T Consensus       240 ~i~vIDFPQm  249 (465)
T KOG2268|consen  240 KIVVIDFPQM  249 (465)
T ss_pred             CEEEeechHh
Confidence            9999999754

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.39  E-value=0.0023  Score=60.68  Aligned_cols=136  Identities=22%  Similarity=0.246  Sum_probs=93.8

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCC---------------------hhh----HH-HHHHHHHHHhhcCCCccc
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDS---------------------KQG----EK-EFQTEVMLLGRLHHRNLV  171 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---------------------~~~----~~-~~~~E~~~l~~l~h~niv  171 (432)
                      ..|..|--+.||.|.-.+|..+|||+.+..-                     ...    .+ -...|++.|.+++...|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            4678899999999988899999999874320                     000    01 134678888888765543


Q ss_pred             eEEeeeeeCCeEEEEEEeccCCCh-hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC
Q 014038          172 NLVGYCAEKGQHMLVYVFMSKGSL-ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM  250 (432)
Q Consensus       172 ~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~  250 (432)
                      -.--+..  ....|||+|+..... .-.|.   ...++...+..+-.+++.-+.-|.+.+.  +||.||.-=|+|+.+ |
T Consensus       230 ~PePIlL--k~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyhd-G  301 (520)
T KOG2270|consen  230 CPEPILL--KNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYHD-G  301 (520)
T ss_pred             CCCceee--ecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEEC-C
Confidence            1111111  245799999964322 22332   2347777788888899999988877553  999999999999965 5


Q ss_pred             cEEEeecCCcc
Q 014038          251 RARVADFGLSR  261 (432)
Q Consensus       251 ~~kl~Dfgl~~  261 (432)
                      .+.|+|.+.+-
T Consensus       302 ~lyiIDVSQSV  312 (520)
T KOG2270|consen  302 KLYIIDVSQSV  312 (520)
T ss_pred             EEEEEEccccc
Confidence            89999988764

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.39  E-value=0.0034  Score=59.71  Aligned_cols=141  Identities=19%  Similarity=0.246  Sum_probs=81.5

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCC--ccceEEeee------eeCCeEEEEEEe
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR--NLVNLVGYC------AEKGQHMLVYVF  189 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~------~~~~~~~lv~e~  189 (432)
                      +.++.|....+|+....+| .+++|+.....  .......|+.++..|...  .+.+++...      ...+..+++++|
T Consensus        28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~  104 (307)
T TIGR00938        28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF  104 (307)
T ss_pred             cccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence            4577777789999876555 57788765422  123455667777776422  234444321      224567899999


Q ss_pred             ccCCChhhh--------------cccCCCC----------CCCHHHHH------------HHHHHHHHHHHHHHh----C
Q 014038          190 MSKGSLASH--------------LYDENYG----------PLTWNLRV------------HIALDVARGLEYLHD----G  229 (432)
Q Consensus       190 ~~~g~L~~~--------------l~~~~~~----------~l~~~~~~------------~i~~~i~~~l~yLH~----~  229 (432)
                      ++|..+...              +|....+          .-.|....            .....+...++++..    .
T Consensus       105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~  184 (307)
T TIGR00938       105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD  184 (307)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            988654211              1110000          01111110            011123344555543    1


Q ss_pred             CCCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       230 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                      ....+||+|+.+.||++++++.+.|+||+.+.
T Consensus       185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            23459999999999999998877899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.26  E-value=0.0041  Score=58.11  Aligned_cols=30  Identities=23%  Similarity=0.543  Sum_probs=24.9

Q ss_pred             CCeeeccCCCCCeeecCCCc-EEEeecCCcc
Q 014038          232 PPVIHRDIKSSNILLDQSMR-ARVADFGLSR  261 (432)
Q Consensus       232 ~~iiH~dlkp~Nill~~~~~-~kl~Dfgl~~  261 (432)
                      +.++|+|+.|.|||+++++. .-|.||+.+.
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            45899999999999997555 5699999764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.22  E-value=0.003  Score=59.19  Aligned_cols=137  Identities=20%  Similarity=0.289  Sum_probs=72.6

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC---CCccceEEeeeeeCCeEEEEEEeccCCC
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH---HRNLVNLVGYCAEKGQHMLVYVFMSKGS  194 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g~  194 (432)
                      +.++-|....+|+.+ .+++.+.||.-.   ......|..|..-|+.|.   --.+.+++++....+..+||+||++.+.
T Consensus        23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~~   98 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMGS   98 (288)
T ss_dssp             EEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE------
T ss_pred             EecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCCC
Confidence            468889999999988 577899999865   233456788888888873   4457788888877777899999998761


Q ss_pred             hh-----------hhccc-CCCC-------------------CCCHHHH-----HHH--------------HHHHHHHH-
Q 014038          195 LA-----------SHLYD-ENYG-------------------PLTWNLR-----VHI--------------ALDVARGL-  223 (432)
Q Consensus       195 L~-----------~~l~~-~~~~-------------------~l~~~~~-----~~i--------------~~~i~~~l-  223 (432)
                      ..           ..||. ....                   .-+|..-     +..              ...+...+ 
T Consensus        99 ~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~~~  178 (288)
T PF03881_consen   99 PSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVERLP  178 (288)
T ss_dssp             --CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHHHH
T ss_pred             CCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHHHH
Confidence            11           01222 1111                   1233221     111              11112211 


Q ss_pred             HHHHhC-CCCCeeeccCCCCCeeecCCCcEEEeecC
Q 014038          224 EYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFG  258 (432)
Q Consensus       224 ~yLH~~-~~~~iiH~dlkp~Nill~~~~~~kl~Dfg  258 (432)
                      ..|+.. -.|.++||||-+.|++.+.++.+.|.|=.
T Consensus       179 ~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa  214 (288)
T PF03881_consen  179 SLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA  214 (288)
T ss_dssp             HCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred             HHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence            122322 24679999999999999999989998854

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=97.22  E-value=0.0047  Score=59.74  Aligned_cols=138  Identities=15%  Similarity=0.243  Sum_probs=80.3

Q ss_pred             cccccCceeEEEEEeCC-----CcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccc-eEEeeeeeCCeEEEEEEeccC
Q 014038          119 LIGQGAFGPVYKAQMST-----GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLV-NLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      .|-.|-.-.+|+....+     ++.|++|+......... +-.+|..++..+..-++. ++++++.. +   .|++|+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence            45557788999987532     36789998765432222 236788888888644443 45565533 2   58999987


Q ss_pred             CChhhh-----------------cccCC----CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-C
Q 014038          193 GSLASH-----------------LYDEN----YGPLTWNLRVHIALDV-----------------ARGLEYL----HD-G  229 (432)
Q Consensus       193 g~L~~~-----------------l~~~~----~~~l~~~~~~~i~~~i-----------------~~~l~yL----H~-~  229 (432)
                      .+|...                 +|...    .....+..+.++..++                 ...+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            666421                 11111    0011233333332221                 1112222    21 1


Q ss_pred             CCCCeeeccCCCCCeeecC-CCcEEEeecCCcc
Q 014038          230 AVPPVIHRDIKSSNILLDQ-SMRARVADFGLSR  261 (432)
Q Consensus       230 ~~~~iiH~dlkp~Nill~~-~~~~kl~Dfgl~~  261 (432)
                      ....++|+|+++.|||+++ ++.+.++||..+.
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            1235899999999999986 4689999998774

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.10  E-value=5.6e-05  Score=82.38  Aligned_cols=158  Identities=12%  Similarity=-0.014  Sum_probs=114.1

Q ss_pred             HHHHHHHhhcCCCccceEEeeeee--CCeEEEEEEeccCCChhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 014038          156 QTEVMLLGRLHHRNLVNLVGYCAE--KGQHMLVYVFMSKGSLASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDG--  229 (432)
Q Consensus       156 ~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~--  229 (432)
                      ..|...++...|+++.....-...  ..+.+..++|+.+|.+.+.+.+..  ..+++..-+.....+.+.+..-.|+.  
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            445555666789988765554332  346688999999999999885432  23343333333333334555554442  


Q ss_pred             CCCCeeeccCCCCCeeecCCCcEEEeecCCcc-cccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhC
Q 014038          230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSR-EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAG  308 (432)
Q Consensus       230 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg  308 (432)
                      +....+|+++|+.|.+|..+.++|++++|+.+ ............+++.|+.|++.+.-.++.++|+|..|+-+|+...|
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred             CCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence            22346899999999999999999999999998 44344444556788899999999888999999999999999999888


Q ss_pred             CCCCC
Q 014038          309 RSPLQ  313 (432)
Q Consensus       309 ~~p~~  313 (432)
                      ..+|.
T Consensus      1437 n~~fi 1441 (2724)
T KOG1826|consen 1437 NAYFI 1441 (2724)
T ss_pred             cHHHH
Confidence            87764

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.01  E-value=0.012  Score=56.01  Aligned_cols=30  Identities=17%  Similarity=0.316  Sum_probs=26.9

Q ss_pred             CCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          232 PPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       232 ~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                      ..+||+|+.+.|||+++++.+.++||..+.
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            359999999999999999999999998765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane

Probab=96.90  E-value=0.00076  Score=53.70  Aligned_cols=35  Identities=40%  Similarity=0.569  Sum_probs=22.5

Q ss_pred             CCCCcceeeehhHHHHHHHHHHHH-HHHHHhhhccc
Q 014038            2 KGESSGLIIGISIGVVIGVLLAIS-ALFCFRYHRKR   36 (432)
Q Consensus         2 ~~~~~~~ii~i~~~~~~~~~~~~~-~~~~~~~~r~~   36 (432)
                      ++++.+.+++|++|++++++++++ ++||+||+|||
T Consensus        59 h~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk   94 (122)
T PF01102_consen   59 HRFSEPAIIGIIFGVMAGVIGIILLISYCIRRLRKK   94 (122)
T ss_dssp             SSSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred             cCccccceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence            467788999999999998866554 44444444444

Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.76  E-value=0.014  Score=55.51  Aligned_cols=29  Identities=31%  Similarity=0.386  Sum_probs=24.9

Q ss_pred             CCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          232 PPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       232 ~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                      ..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            45899999999999988 578999999653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.67  E-value=0.0048  Score=60.95  Aligned_cols=185  Identities=23%  Similarity=0.249  Sum_probs=98.8

Q ss_pred             EEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC-CeEEEEEEeccCCChhhhcccCCCCC
Q 014038          128 VYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-GQHMLVYVFMSKGSLASHLYDENYGP  206 (432)
Q Consensus       128 Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~  206 (432)
                      .+.|...+|..+ .--+..  .....++.-....++.+.|+|+...+.+.... ....+|+|++ +.||++.+..+.   
T Consensus         5 ~~~a~~~~~~~c-~nglpl--t~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---   77 (725)
T KOG1093|consen    5 TFFAQEKPGDVC-SNGLPL--TPNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---   77 (725)
T ss_pred             EEehhcCCCccc-cCCCcC--CCcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---
Confidence            455555555544 221211  12234566677889999999999999887654 3467888988 569988885432   


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccccccccCCCCCCcccccc
Q 014038          207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST  286 (432)
Q Consensus       207 l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~  286 (432)
                      +-...             ++ .++   +.|-     |+       .+++| -+...    .             |-    
T Consensus        78 l~~~s-------------~~-~~~---~~~~-----~~-------~~~td-~~~t~----~-------------~~----  106 (725)
T KOG1093|consen   78 LKDES-------------LL-AHG---VLHL-----NI-------IYITD-HFLTK----Y-------------PS----  106 (725)
T ss_pred             cchhh-------------hc-ccc---ccee-----hh-------hhccc-ccccc----C-------------CC----
Confidence            11110             00 111   2221     11       22333 00000    0             00    


Q ss_pred             CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCC
Q 014038          287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRK  366 (432)
Q Consensus       287 ~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  366 (432)
                       ...+|+||||+|.++.|+.-|...+....+.............+.....-... ..+-.+....+..+...|+-..|..
T Consensus       107 -~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e-~~~~~~~d~~~~~~~~~c~~~~~~i  184 (725)
T KOG1093|consen  107 -PIGPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAME-HLIQLLADKKRLPLLKKCLWLEPII  184 (725)
T ss_pred             -CCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHH-HHHHHhhhHhHHHHhccCCcccccc
Confidence             01149999999999999999987776544433333222211111110000000 0122234457788889999999988


Q ss_pred             CCCHHH
Q 014038          367 RPSMRD  372 (432)
Q Consensus       367 RPs~~~  372 (432)
                      ||...+
T Consensus       185 r~l~~~  190 (725)
T KOG1093|consen  185 RPLPME  190 (725)
T ss_pred             ccchhH
Confidence            875443

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.67  E-value=0.019  Score=55.15  Aligned_cols=73  Identities=18%  Similarity=0.094  Sum_probs=47.0

Q ss_pred             cccccCceeEEEEEeCCC-cEEEEEEecc-------CChhhHHHHHHHHHHHhhcC--CCccceEEeeeeeCCeEEEEEE
Q 014038          119 LIGQGAFGPVYKAQMSTG-ETVAVKVLAT-------DSKQGEKEFQTEVMLLGRLH--HRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .||.|....||++..++| +.|+||.-..       .-+-...+..-|...|+...  -|..++-+- +.+.....+|||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy-~~D~e~~~~vME   80 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF-HFDTEMAVTVME   80 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE-EEccccceehHh
Confidence            479999999999987654 5899996421       11333445556777776653  354444332 234556779999


Q ss_pred             eccC
Q 014038          189 FMSK  192 (432)
Q Consensus       189 ~~~~  192 (432)
                      +++.
T Consensus        81 dL~~   84 (370)
T TIGR01767        81 DLSH   84 (370)
T ss_pred             hCcc
Confidence            9864

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.53  E-value=0.0091  Score=53.40  Aligned_cols=29  Identities=24%  Similarity=0.496  Sum_probs=20.9

Q ss_pred             CeeeccCCCCCeee-cCCCcEEEeecCCcc
Q 014038          233 PVIHRDIKSSNILL-DQSMRARVADFGLSR  261 (432)
Q Consensus       233 ~iiH~dlkp~Nill-~~~~~~kl~Dfgl~~  261 (432)
                      .++|+|+.|.|||+ +.++.++++||..|.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            48999999999999 888999999999875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.52  E-value=0.031  Score=53.78  Aligned_cols=138  Identities=17%  Similarity=0.262  Sum_probs=77.8

Q ss_pred             cccccCceeEEEEEeCC----CcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCcc-ceEEeeeeeCCeEEEEEEeccCC
Q 014038          119 LIGQGAFGPVYKAQMST----GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL-VNLVGYCAEKGQHMLVYVFMSKG  193 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g  193 (432)
                      .|..|=...+|+....+    +..|++|+........ -+-.+|..+++.+..-++ .++++++. .+   +|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence            45557777888886533    2378889875543221 223578888888865555 34565553 22   589999776


Q ss_pred             Chhhh-----------------cccCC---C-CCCCHHHHHHHHHHH----------------------HHHHH----HH
Q 014038          194 SLASH-----------------LYDEN---Y-GPLTWNLRVHIALDV----------------------ARGLE----YL  226 (432)
Q Consensus       194 ~L~~~-----------------l~~~~---~-~~l~~~~~~~i~~~i----------------------~~~l~----yL  226 (432)
                      .|...                 +|...   . .+-.|..+.++..++                      ..-+.    ++
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            55321                 11111   0 011233332222221                      11111    12


Q ss_pred             HhC-CCCCeeeccCCCCCeeecC-CCcEEEeecCCcc
Q 014038          227 HDG-AVPPVIHRDIKSSNILLDQ-SMRARVADFGLSR  261 (432)
Q Consensus       227 H~~-~~~~iiH~dlkp~Nill~~-~~~~kl~Dfgl~~  261 (432)
                      ... ....++|+|+.+.|||+++ ++.++++||..|.
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            111 1234799999999999975 5789999999774

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.50  E-value=0.044  Score=52.36  Aligned_cols=139  Identities=18%  Similarity=0.248  Sum_probs=82.8

Q ss_pred             cccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC---CCccce---EEee--eeeCC--eEEEEEE
Q 014038          119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH---HRNLVN---LVGY--CAEKG--QHMLVYV  188 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~---l~~~--~~~~~--~~~lv~e  188 (432)
                      .|.+ .-..+|+....+|+. ++|+....  ....++..|+..|..|.   .+-.++   +=|-  ..-.+  ..+-+++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            3444 567899998877776 88887665  33455667777777773   222222   1111  11123  7888999


Q ss_pred             eccCCChhh-hc--------------cc--CC--------CCCCCHHH-------------HHHHHHHHHHHHHHHHhCC
Q 014038          189 FMSKGSLAS-HL--------------YD--EN--------YGPLTWNL-------------RVHIALDVARGLEYLHDGA  230 (432)
Q Consensus       189 ~~~~g~L~~-~l--------------~~--~~--------~~~l~~~~-------------~~~i~~~i~~~l~yLH~~~  230 (432)
                      |++|..+.. .-              +.  +.        .....|..             ......++...+..+...-
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999988873 11              10  00        11233431             0112334444445444421


Q ss_pred             ----CCC---eeeccCCCCCeeecCCCc-EEEeecCCcc
Q 014038          231 ----VPP---VIHRDIKSSNILLDQSMR-ARVADFGLSR  261 (432)
Q Consensus       231 ----~~~---iiH~dlkp~Nill~~~~~-~kl~Dfgl~~  261 (432)
                          ...   +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                112   899999999999999875 8999999765

>PTZ00382 Variant-specific surface protein (VSP); Provisional

Probab=96.38  E-value=0.0016  Score=49.94  Aligned_cols=33  Identities=36%  Similarity=0.353  Sum_probs=21.6

Q ss_pred             CCCCcceeeehhHHHHHHHHHHHHHHHHHhhhc
Q 014038            2 KGESSGLIIGISIGVVIGVLLAISALFCFRYHR   34 (432)
Q Consensus         2 ~~~~~~~ii~i~~~~~~~~~~~~~~~~~~~~~r   34 (432)
                      .+.+.++|+||++|+++++.+++.+++||+.+|
T Consensus        61 ~~ls~gaiagi~vg~~~~v~~lv~~l~w~f~~r   93 (96)
T PTZ00382         61 SGLSTGAIAGISVAVVAVVGGLVGFLCWWFVCR   93 (96)
T ss_pred             CCcccccEEEEEeehhhHHHHHHHHHhheeEEe
Confidence            356788999999988877655444444444333

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.37  E-value=0.062  Score=52.64  Aligned_cols=72  Identities=11%  Similarity=0.115  Sum_probs=48.9

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccC-----C--hhhHHHHHHHHHHHhhcC---CCccceEEeeeeeCCeEEEEE
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATD-----S--KQGEKEFQTEVMLLGRLH---HRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  187 (432)
                      +.||.|....||+.... +..++||.-...     .  +-...+-..|...|+.+.   ..++.+++.++.  +..+++|
T Consensus        38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM  114 (418)
T PLN02756         38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM  114 (418)
T ss_pred             EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence            46899999999999764 567889975421     1  112333344566666553   247778888887  4567889


Q ss_pred             EeccC
Q 014038          188 VFMSK  192 (432)
Q Consensus       188 e~~~~  192 (432)
                      ||+++
T Consensus       115 E~L~~  119 (418)
T PLN02756        115 RYLEP  119 (418)
T ss_pred             eecCC
Confidence            99976

>PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host []

Probab=96.28  E-value=0.0068  Score=36.85  Aligned_cols=29  Identities=28%  Similarity=0.521  Sum_probs=18.8

Q ss_pred             eeeehhHHHHHHHHHHHHHHHHHhhhccc
Q 014038            8 LIIGISIGVVIGVLLAISALFCFRYHRKR   36 (432)
Q Consensus         8 ~ii~i~~~~~~~~~~~~~~~~~~~~~r~~   36 (432)
                      ..++|++|++++++++++.+++|-+++||
T Consensus         4 s~IaIIv~V~vg~~iiii~~~~YaCcykk   32 (38)
T PF02439_consen    4 STIAIIVAVVVGMAIIIICMFYYACCYKK   32 (38)
T ss_pred             chhhHHHHHHHHHHHHHHHHHHHHHHHcc
Confidence            35677788888777776666665444433

This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain.

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=96.07  E-value=0.0023  Score=39.67  Aligned_cols=27  Identities=26%  Similarity=0.544  Sum_probs=13.3

Q ss_pred             CCcceeeehhHHHHHHHHHHHHHHHHH
Q 014038            4 ESSGLIIGISIGVVIGVLLAISALFCF   30 (432)
Q Consensus         4 ~~~~~ii~i~~~~~~~~~~~~~~~~~~   30 (432)
                      .+.+..|++++++-++++++++++++|
T Consensus         7 ~~~~vaIa~~VvVPV~vI~~vl~~~l~   33 (40)
T PF08693_consen    7 NSNTVAIAVGVVVPVGVIIIVLGAFLF   33 (40)
T ss_pred             CCceEEEEEEEEechHHHHHHHHHHhh
Confidence            355566666555545444444433444

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>PRK06148 hypothetical protein; Provisional

Probab=96.01  E-value=0.12  Score=57.38  Aligned_cols=151  Identities=20%  Similarity=0.287  Sum_probs=82.0

Q ss_pred             HHHHHHhcccc---ccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC-------CCccceEE-e
Q 014038          107 KDLQKATCNFT---TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-------HRNLVNLV-G  175 (432)
Q Consensus       107 ~~l~~~~~~~~---~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-------h~niv~l~-~  175 (432)
                      .++....|.+.   +.|+ |..-.+|+.+..+|..+++|+.+....  ......|...|..|.       -|.+++-. |
T Consensus        17 ~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G   93 (1013)
T PRK06148         17 EALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSG   93 (1013)
T ss_pred             HHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCC
Confidence            34444455443   3464 456788999887888999999875432  223334555555442       23333321 1


Q ss_pred             ----eeee-CC--eEEEEEEeccCCChhhhc-----------------cc--------CCCCCCCHHH------------
Q 014038          176 ----YCAE-KG--QHMLVYVFMSKGSLASHL-----------------YD--------ENYGPLTWNL------------  211 (432)
Q Consensus       176 ----~~~~-~~--~~~lv~e~~~~g~L~~~l-----------------~~--------~~~~~l~~~~------------  211 (432)
                          .... ++  ..+-+++|++|..+.+..                 +.        .....+.|..            
T Consensus        94 ~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~  173 (1013)
T PRK06148         94 ASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHF  173 (1013)
T ss_pred             CeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhh
Confidence                1111 22  456789999987775411                 00        0011233321            


Q ss_pred             -----HHHHHHHHHHHHH-----HHHhCCCCCeeeccCCCCCeeecCCC--cEE-EeecCCcc
Q 014038          212 -----RVHIALDVARGLE-----YLHDGAVPPVIHRDIKSSNILLDQSM--RAR-VADFGLSR  261 (432)
Q Consensus       212 -----~~~i~~~i~~~l~-----yLH~~~~~~iiH~dlkp~Nill~~~~--~~k-l~Dfgl~~  261 (432)
                           ...++.+++....     .|.. -...+||+|+.+.|||++.+.  .+. |+|||-+.
T Consensus       174 i~d~~~r~~l~~~~~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        174 IDDPEDRALVERFLARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence                 1122223332222     1211 112399999999999999875  454 99999765

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.97  E-value=0.27  Score=47.20  Aligned_cols=72  Identities=14%  Similarity=0.145  Sum_probs=45.0

Q ss_pred             cCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCC--ccceEE---e--eeeeCCeEEEEEEeccCCCh
Q 014038          123 GAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR--NLVNLV---G--YCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       123 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~---~--~~~~~~~~~lv~e~~~~g~L  195 (432)
                      +.-..||+....+|..+++|+.+... ....++..|+..+..|...  .++...   |  +...++..+.++++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            34567999988788899999875332 2345566777777766321  122211   2  12234677889999987643

>PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region

Probab=95.80  E-value=0.0035  Score=51.37  Aligned_cols=31  Identities=32%  Similarity=0.473  Sum_probs=18.3

Q ss_pred             CCcceeeehhHHHHHHHHHHHHHHHHHhhhc
Q 014038            4 ESSGLIIGISIGVVIGVLLAISALFCFRYHR   34 (432)
Q Consensus         4 ~~~~~ii~i~~~~~~~~~~~~~~~~~~~~~r   34 (432)
                      ....++||++||+-+.++++++++++++|+|
T Consensus        46 knknIVIGvVVGVGg~ill~il~lvf~~c~r   76 (154)
T PF04478_consen   46 KNKNIVIGVVVGVGGPILLGILALVFIFCIR   76 (154)
T ss_pred             CCccEEEEEEecccHHHHHHHHHhheeEEEe
Confidence            3445889998887666555544444333333

The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway [].

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.67  E-value=0.055  Score=52.74  Aligned_cols=73  Identities=19%  Similarity=0.139  Sum_probs=48.0

Q ss_pred             ccccccCceeEEEEEeCC-CcEEEEEEecc------CChhhHHHHHHHHHHHhhcC--CCccce-EEeeeeeCCeEEEEE
Q 014038          118 TLIGQGAFGPVYKAQMST-GETVAVKVLAT------DSKQGEKEFQTEVMLLGRLH--HRNLVN-LVGYCAEKGQHMLVY  187 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--h~niv~-l~~~~~~~~~~~lv~  187 (432)
                      +.||-|.-..||++...+ ++.|+||.-..      +-+-..++..-|...|+...  -|..|+ ++.  .+.....+||
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~vM  112 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCVM  112 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHHH
Confidence            468999999999998743 56899996421      11334456667777877663  454444 443  3345667888


Q ss_pred             EeccC
Q 014038          188 VFMSK  192 (432)
Q Consensus       188 e~~~~  192 (432)
                      |+++.
T Consensus       113 EdL~~  117 (409)
T PRK12396        113 EDLSD  117 (409)
T ss_pred             HhCcc
Confidence            88854

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	432
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-52
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-51
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-48
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-48
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-35
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-35
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-35
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-32
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-32
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-31
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-31
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-29
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-28
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-28
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-28
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-28
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-28
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-28
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-28
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-27
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-27
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-27
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-27
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-27
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-27
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-27
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-27
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-27
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-26
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-26
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-26
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-26
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-26
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-26
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-26
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-26
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-25
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-25
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-25
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-25
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-25
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-25
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-25
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-25
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-25
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-25
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-25
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-25
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		9e-25
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-25
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-25
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-25
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		9e-25
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-24
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-24
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-24
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-24
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-24
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-24
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-24
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-24
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-24
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-24
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-24
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-24
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-24
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-24
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-24
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-24
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-24
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-24
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-24
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-24
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-24
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-24
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-24
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-24
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-24
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-24
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-23
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-23
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-23
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-23
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-23
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-23
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-23
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-23
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-23
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-23
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-23
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-23
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-23
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-23
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-23
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-23
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-23
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-23
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-22
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-22
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-22
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-22
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-22
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-22
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-22
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-22
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-22
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-22
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-22
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-22
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-22
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-22
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-22
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-22
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-22
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-22
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-22
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-22
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-22
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-22
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-22
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-22
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-22
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-22
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-22
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-21
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-21
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-21
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-21
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-21
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-21
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-21
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-21
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-21
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-21
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-21
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-21
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-21
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-21
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-21
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-21
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-21
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-21
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-21
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-21
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-20
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-20
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-20
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-20
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-20
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-20
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-20
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-20
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-20
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-20
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-20
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-20
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-20
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-20
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-20
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-20
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		9e-20
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-19
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-19
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-19
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-19
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-19
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-19
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-19
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-19
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-19
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-19
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-19
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-19
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-19
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-19
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-19
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-19
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-19
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-19
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-19
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-19
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-19
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-19
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-19
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		5e-19
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-19
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-19
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-19
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-19
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-19
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-19
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-19
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-19
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-19
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-19
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-18
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-18
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-18
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-18
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-18
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-18
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-18
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-18
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-18
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-18
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-18
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-18
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-18
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-18
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-18
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-18
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-17
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-17
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-17
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-17
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-17
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-17
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-17
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-17
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-17
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-17
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-17
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-17
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-17
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-17
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-17
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-17
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-17
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-17
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-17
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-17
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-17
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-17
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-17
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-17
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-17
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-16
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-16
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-16
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-16
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-16
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-16
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-16
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-16
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		8e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		8e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-15
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-15
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-15
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-15
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-15
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-15
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-15
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-15
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-15
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-15
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-15
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-15
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-15
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-15
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-15
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-15
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-15
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-15
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-15
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-15
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-15
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-15
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-15
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		9e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-15
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		9e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-14
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-14
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-14
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-14
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-14
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-14
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-14
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-14
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-14
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-14
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-14
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-14
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-14
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-14
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-14
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-13
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-13
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-13
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-13
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-13
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-13
3soa_A	444	Full-Length Human Camkii Length = 444		3e-13
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-13
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-13
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-13
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-13
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-13
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-13
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-13
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-13
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-13
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-13
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-13
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-13
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-13
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-13
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-13
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-13
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-13
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-13
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-12
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-12
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-12
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-12
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-12
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-12
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-12
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-12
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-12
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-12
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-12
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-12
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-12
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-12
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-12
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-12
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-12
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-12
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-12
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-12
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-12
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-12
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-12
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-12
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-12
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-12
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		8e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-12
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		9e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-12
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		9e-12
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-11
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-11
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-11
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-11
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-11
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-11
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-11
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-11
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-11
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-11
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-11
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-11
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-11
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-11
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-11
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-11
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-11
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		8e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-11
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-11
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		9e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-10
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-10
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-10
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-10
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-10
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		9e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-09
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		2e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-09
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-09
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		7e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-08
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-08
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		8e-08
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		9e-08
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-07
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-07
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-07

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  201 bits (511), Expect = 7e-52,   Method: Compositional matrix adjust.
 Identities = 117/300 (39%), Positives = 174/300 (58%), Gaps = 21/300 (7%)
Query: 96  VSASGIPEYSYKDLQKATCNFTT--LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-E 152
           V    +  +S ++LQ A+ NF+   ++G+G FG VYK +++ G  VAVK L  +  QG E
Sbjct: 20  VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGE 79
Query: 153 KEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWN 210
            +FQTEV ++    HRNL+ L G+C    + +LVY +M+ GS+AS L +  E+  PL W 
Sbjct: 80  LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 139
Query: 211 LRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR-EEMVDKHA 269
            R  IAL  ARGL YLHD   P +IHRD+K++NILLD+   A V DFGL++  +  D H 
Sbjct: 140 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHV 199
Query: 270 AN-IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG 328
              +RGT G++ PEY+ST   ++K+DV+ +GV+L ELI G    Q   +   LA  +   
Sbjct: 200 XXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG----QRAFDLARLANDDDVM 255
Query: 329 KTGW----------EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS 378
              W          E +VD  L G +  EE+ ++  +A  C   +P +RP M ++V++L 
Sbjct: 256 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  198 bits (504), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 115/292 (39%), Positives = 174/292 (59%), Gaps = 21/292 (7%)
Query: 104 YSYKDLQKATCNFTT--LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-EKEFQTEVM 160
           +S ++LQ A+ NF    ++G+G FG VYK +++ G  VAVK L  +  QG E +FQTEV 
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALD 218
           ++    HRNL+ L G+C    + +LVY +M+ GS+AS L +  E+  PL W  R  IAL 
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR-EEMVDKHAAN-IRGTF 276
            ARGL YLHD   P +IHRD+K++NILLD+   A V DFGL++  +  D H    +RG  
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXI 199
Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ----------GLMEYVELAAMNT 326
           G++ PEY+ST   ++K+DV+ +GV+L ELI G+               L+++V+   +  
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK--GLLK 257
Query: 327 EGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS 378
           E K   E +VD  L G +  EE+ ++  +A  C   +P +RP M ++V++L 
Sbjct: 258 EKKL--EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  190 bits (483), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 121/299 (40%), Positives = 174/299 (58%), Gaps = 18/299 (6%)
Query: 101 IPEYSYK----DLQKATCNF--TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKE 154
           +P  SY+    DL++AT NF    LIG G FG VYK  +  G  VA+K    +S QG +E
Sbjct: 22  VPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE 81
Query: 155 FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLY--DENYGPLTWNLR 212
           F+TE+  L    H +LV+L+G+C E+ + +L+Y +M  G+L  HLY  D     ++W  R
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 213 VHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAA 270
           + I +  ARGL YLH  A   +IHRD+KS NILLD++   ++ DFG+S++  E+   H  
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLX 198
Query: 271 N-IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL-QGL-MEYVELA--AMN 325
             ++GT GY+DPEY      T+KSDVYSFGV+LFE++  RS + Q L  E V LA  A+ 
Sbjct: 199 XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 326 TEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR 384
           +      E+IVD  L      E L +    A KC+  +   RPSM D++  L   L+++
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 121/299 (40%), Positives = 174/299 (58%), Gaps = 18/299 (6%)
Query: 101 IPEYSYK----DLQKATCNF--TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKE 154
           +P  SY+    DL++AT NF    LIG G FG VYK  +  G  VA+K    +S QG +E
Sbjct: 22  VPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE 81
Query: 155 FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLY--DENYGPLTWNLR 212
           F+TE+  L    H +LV+L+G+C E+ + +L+Y +M  G+L  HLY  D     ++W  R
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 213 VHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAA 270
           + I +  ARGL YLH  A   +IHRD+KS NILLD++   ++ DFG+S++  E+   H  
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLX 198
Query: 271 N-IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL-QGL-MEYVELA--AMN 325
             ++GT GY+DPEY      T+KSDVYSFGV+LFE++  RS + Q L  E V LA  A+ 
Sbjct: 199 XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 326 TEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR 384
           +      E+IVD  L      E L +    A KC+  +   RPSM D++  L   L+++
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  145 bits (367), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 102/310 (32%), Positives = 166/310 (53%), Gaps = 37/310 (11%)
Query: 96  VSASGIPEYSYKDLQKATCNFT--------TLIGQGAFGPVYKAQMSTGETVAVKVLAT- 146
           VS +    +S+ +L+  T NF           +G+G FG VYK  ++   TVAVK LA  
Sbjct: 7   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAM 65
Query: 147 ---DSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD-E 202
               +++ +++F  E+ ++ +  H NLV L+G+ ++     LVYV+M  GSL   L   +
Sbjct: 66  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125
Query: 203 NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262
              PL+W++R  IA   A G+ +LH+      IHRDIKS+NILLD++  A+++DFGL+R 
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 263 EMVDKHA-----ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAG-------RS 310
              +K A     + I GT  Y+ PE +     T KSD+YSFGV+L E+I G       R 
Sbjct: 183 S--EKFAQTVMXSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 311 PLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSM 370
           P Q L++  E      +    +   +D +++   D   +  + S+A +C++    KRP +
Sbjct: 240 P-QLLLDIKEEIEDEEKTIEDY---IDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDI 294
Query: 371 RDIVQVLSRI 380
           + + Q+L  +
Sbjct: 295 KKVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 102/310 (32%), Positives = 165/310 (53%), Gaps = 37/310 (11%)
Query: 96  VSASGIPEYSYKDLQKATCNFT--------TLIGQGAFGPVYKAQMSTGETVAVKVLAT- 146
           VS +    +S+ +L+  T NF           +G+G FG VYK  ++   TVAVK LA  
Sbjct: 7   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAM 65
Query: 147 ---DSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD-E 202
               +++ +++F  E+ ++ +  H NLV L+G+ ++     LVYV+M  GSL   L   +
Sbjct: 66  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125
Query: 203 NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262
              PL+W++R  IA   A G+ +LH+      IHRDIKS+NILLD++  A+++DFGL+R 
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 263 EMVDKHAAN-----IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAG-------RS 310
              +K A       I GT  Y+ PE +     T KSD+YSFGV+L E+I G       R 
Sbjct: 183 S--EKFAQTVMXXRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 311 PLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSM 370
           P Q L++  E      +    +   +D +++   D   +  + S+A +C++    KRP +
Sbjct: 240 P-QLLLDIKEEIEDEEKTIEDY---IDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDI 294
Query: 371 RDIVQVLSRI 380
           + + Q+L  +
Sbjct: 295 KKVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  144 bits (363), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 102/310 (32%), Positives = 165/310 (53%), Gaps = 37/310 (11%)
Query: 96  VSASGIPEYSYKDLQKATCNFT--------TLIGQGAFGPVYKAQMSTGETVAVKVLAT- 146
           VS +    +S+ +L+  T NF           +G+G FG VYK  ++   TVAVK LA  
Sbjct: 1   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAM 59
Query: 147 ---DSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD-E 202
               +++ +++F  E+ ++ +  H NLV L+G+ ++     LVYV+M  GSL   L   +
Sbjct: 60  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 119
Query: 203 NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262
              PL+W++R  IA   A G+ +LH+      IHRDIKS+NILLD++  A+++DFGL+R 
Sbjct: 120 GTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 176
Query: 263 EMVDKHA-----ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAG-------RS 310
              +K A       I GT  Y+ PE +     T KSD+YSFGV+L E+I G       R 
Sbjct: 177 S--EKFAQXVMXXRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHRE 233
Query: 311 PLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSM 370
           P Q L++  E      +    +   +D +++   D   +  + S+A +C++    KRP +
Sbjct: 234 P-QLLLDIKEEIEDEEKTIEDY---IDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDI 288
Query: 371 RDIVQVLSRI 380
           + + Q+L  +
Sbjct: 289 KKVQQLLQEM 298

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 96/282 (34%), Positives = 147/282 (52%), Gaps = 23/282 (8%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEK--EFQTEVMLLGRL 165
           D+     N    IG G+FG V++A+   G  VAVK+L       E+  EF  EV ++ RL
Sbjct: 33  DIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENY-GPLTWNLRVHIALDVARGLE 224
            H N+V  +G   +     +V  ++S+GSL   L+       L    R+ +A DVA+G+ 
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE----MVDKHAANIRGTFGYLD 280
           YLH+   PP++HRD+KS N+L+D+    +V DFGLSR +    +  K AA   GT  ++ 
Sbjct: 152 YLHNRN-PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA---GTPEWMA 207
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL 340
           PE +      +KSDVYSFGV+L+EL   + P   L     +AA+  + K         RL
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK---------RL 258
Query: 341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
           +   ++    +VA++   C    P KRPS   I+ +L  ++K
Sbjct: 259 EIPRNLNP--QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 99/299 (33%), Positives = 155/299 (51%), Gaps = 37/299 (12%)
Query: 104 YSYKDLQKATCNFT--------TLIGQGAFGPVYKAQMSTGETVAVKVLAT----DSKQG 151
           +S+ +L+  T NF            G+G FG VYK  ++   TVAVK LA      +++ 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 152 EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWN 210
           +++F  E+ +  +  H NLV L+G+ ++     LVYV+   GSL   L   +   PL+W+
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 211 LRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA- 269
            R  IA   A G+ +LH+      IHRDIKS+NILLD++  A+++DFGL+R    +K A 
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARAS--EKFAQ 179
Query: 270 ----ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAG-------RSPLQGLMEY 318
               + I GT  Y  PE +     T KSD+YSFGV+L E+I G       R P Q L++ 
Sbjct: 180 XVXXSRIVGTTAYXAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDI 237
Query: 319 VELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
            E      +    +   +D + +   D   +    S+A +C++    KRP ++ + Q+L
Sbjct: 238 KEEIEDEEKTIEDY---IDKKXNDA-DSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/282 (33%), Positives = 147/282 (52%), Gaps = 23/282 (8%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEK--EFQTEVMLLGRL 165
           D+     N    IG G+FG V++A+   G  VAVK+L       E+  EF  EV ++ RL
Sbjct: 33  DIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENY-GPLTWNLRVHIALDVARGLE 224
            H N+V  +G   +     +V  ++S+GSL   L+       L    R+ +A DVA+G+ 
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE----MVDKHAANIRGTFGYLD 280
           YLH+   PP++HR++KS N+L+D+    +V DFGLSR +    +  K AA   GT  ++ 
Sbjct: 152 YLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA---GTPEWMA 207
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL 340
           PE +      +KSDVYSFGV+L+EL   + P   L     +AA+  + K         RL
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK---------RL 258
Query: 341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
           +   ++    +VA++   C    P KRPS   I+ +L  ++K
Sbjct: 259 EIPRNLNP--QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 96/288 (33%), Positives = 138/288 (47%), Gaps = 34/288 (11%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS----KQGEKEFQTEVMLLG 163
           ++  A      +IG G FG VY+A    G+ VAVK    D      Q  +  + E  L  
Sbjct: 3   EIDFAELTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 164 RLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
            L H N++ L G C ++    LV  F   G L   L  +   P   ++ V+ A+ +ARG+
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP---DILVNWAVQIARGM 118
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMR--------ARVADFGLSRE-EMVDKHAANIRG 274
            YLHD A+ P+IHRD+KSSNIL+ Q +          ++ DFGL+RE     K +A   G
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA--AG 176
Query: 275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMNTEGKTGW 332
            + ++ PE I    F+K SDV+S+GVLL+EL+ G  P +G+  +      AMN       
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP-- 234
Query: 333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
              + S     F        A L   C N  P  RPS  +I+  L+ I
Sbjct: 235 ---IPSTCPEPF--------AKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 87/305 (28%), Positives = 155/305 (50%), Gaps = 40/305 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETV-AVKVLATDSKQGE-- 152
           +  S  P+     L      +   IG+G FG V+K ++   ++V A+K L     +GE  
Sbjct: 3   MGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 153 -----KEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPL 207
                +EFQ EV ++  L+H N+V L G      +  +V  F+  G L   L D+ + P+
Sbjct: 63  MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH-PI 119
Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL-----DQSMRARVADFGLSRE 262
            W++++ + LD+A G+EY+ +   PP++HRD++S NI L     +  + A+VADFGLS++
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178
Query: 263 EMVDKHAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQ----GLM 316
            +     + + G F ++ PE I     ++T+K+D YSF ++L+ ++ G  P      G +
Sbjct: 179 SV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236
Query: 317 EYVELAAMNTEG-KTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
           +++ +  +  EG +    E    RL  + ++            C +  P+KRP    IV+
Sbjct: 237 KFINM--IREEGLRPTIPEDCPPRLRNVIEL------------CWSGDPKKRPHFSYIVK 282
Query: 376 VLSRI 380
            LS +
Sbjct: 283 ELSEL 287

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 97/327 (29%), Positives = 162/327 (49%), Gaps = 43/327 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +  +        +G+GAFG V  A+             TVAVK+L  D
Sbjct: 19  VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 78
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L      
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                YD N  P   +T+   V     +ARG+EYL   A    IHRD+ + N+L+ ++  
Sbjct: 139 GMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNV 195
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVL++E+   
Sbjct: 196 MKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 256 GGSPYPGI-PVEELFKLLKEG---------HRMDKPANCT--NELYMMMRDCWHAVPSQR 303
Query: 368 PSMRDIVQVLSRILKMRHNRKHHRKSQ 394
           P+ + +V+ L RIL +  N ++   SQ
Sbjct: 304 PTFKQLVEDLDRILTLTTNEEYLDLSQ 330

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 154/305 (50%), Gaps = 40/305 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETV-AVKVLATDSKQGE-- 152
           +  S  P+     L      +   IG+G FG V+K ++   ++V A+K L     +GE  
Sbjct: 3   MGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 153 -----KEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPL 207
                +EFQ EV ++  L+H N+V L G      +  +V  F+  G L   L D+ + P+
Sbjct: 63  MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH-PI 119
Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL-----DQSMRARVADFGLSRE 262
            W++++ + LD+A G+EY+ +   PP++HRD++S NI L     +  + A+VADFG S++
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ 178
Query: 263 EMVDKHAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQ----GLM 316
            +     + + G F ++ PE I     ++T+K+D YSF ++L+ ++ G  P      G +
Sbjct: 179 SV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236
Query: 317 EYVELAAMNTEG-KTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
           +++ +  +  EG +    E    RL  + ++            C +  P+KRP    IV+
Sbjct: 237 KFINM--IREEGLRPTIPEDCPPRLRNVIEL------------CWSGDPKKRPHFSYIVK 282
Query: 376 VLSRI 380
            LS +
Sbjct: 283 ELSEL 287

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 97/327 (29%), Positives = 162/327 (49%), Gaps = 43/327 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +  +        +G+GAFG V  A+             TVAVK+L  D
Sbjct: 19  VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 78
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L      
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                YD N  P   +T+   V     +ARG+EYL   A    IHRD+ + N+L+ ++  
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNV 195
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVL++E+   
Sbjct: 196 MKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 256 GGSPYPGI-PVEELFKLLKEG---------HRMDKPANCT--NELYMMMRDCWHAVPSQR 303
Query: 368 PSMRDIVQVLSRILKMRHNRKHHRKSQ 394
           P+ + +V+ L RIL +  N ++   SQ
Sbjct: 304 PTFKQLVEDLDRILTLTTNEEYLDLSQ 330

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 154/305 (50%), Gaps = 40/305 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETV-AVKVLATDSKQGE-- 152
           +  S  P+     L      +   IG+G FG V+K ++   ++V A+K L     +GE  
Sbjct: 3   MGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 153 -----KEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPL 207
                +EFQ EV ++  L+H N+V L G      +  +V  F+  G L   L D+ + P+
Sbjct: 63  MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH-PI 119
Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL-----DQSMRARVADFGLSRE 262
            W++++ + LD+A G+EY+ +   PP++HRD++S NI L     +  + A+VADF LS++
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ 178
Query: 263 EMVDKHAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQ----GLM 316
            +     + + G F ++ PE I     ++T+K+D YSF ++L+ ++ G  P      G +
Sbjct: 179 SV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236
Query: 317 EYVELAAMNTEG-KTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
           +++ +  +  EG +    E    RL  + ++            C +  P+KRP    IV+
Sbjct: 237 KFINM--IREEGLRPTIPEDCPPRLRNVIEL------------CWSGDPKKRPHFSYIVK 282
Query: 376 VLSRI 380
            LS +
Sbjct: 283 ELSEL 287

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 96/321 (29%), Positives = 159/321 (49%), Gaps = 43/321 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +  +        +G+GAFG V  A+             TVAVK+L  D
Sbjct: 19  VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 78
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L      
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                YD N  P   +T+   V     +ARG+EYL   A    IHRD+ + N+L+ ++  
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNV 195
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            R+ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVL++E+   
Sbjct: 196 MRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 256 GGSPYPGI-PVEELFKLLKEG---------HRMDKPANCT--NELYMMMRDCWHAVPSQR 303
Query: 368 PSMRDIVQVLSRILKMRHNRK 388
           P+ + +V+ L RIL +  N +
Sbjct: 304 PTFKQLVEDLDRILTLTTNEE 324

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 95/321 (29%), Positives = 159/321 (49%), Gaps = 43/321 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +  +        +G+GAFG V  A+             TVAVK+L  D
Sbjct: 19  VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 78
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L      
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPP 138
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                YD N  P   +T+   V     +ARG+EYL   A    IHRD+ + N+L+ ++  
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNV 195
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVL++E+   
Sbjct: 196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 256 GGSPYPGI-PVEELFKLLKEG---------HRMDKPANCT--NELYMMMRDCWHAVPSQR 303
Query: 368 PSMRDIVQVLSRILKMRHNRK 388
           P+ + +V+ L RIL +  N +
Sbjct: 304 PTFKQLVEDLDRILTLTTNEE 324

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 95/321 (29%), Positives = 160/321 (49%), Gaps = 43/321 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +  +        +G+GAFG V  A+             TVAVK+L  D
Sbjct: 19  VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 78
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L      
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                YD N  P   +T+   V     +ARG+EYL   A    IHRD+ + N+L+ ++  
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNV 195
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K+  N R    ++ PE +  R +T +SDV+SFGVL++E+   
Sbjct: 196 MKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 256 GGSPYPGI-PVEELFKLLKEG---------HRMDKPANCT--NELYMMMRDCWHAVPSQR 303
Query: 368 PSMRDIVQVLSRILKMRHNRK 388
           P+ + +V+ L RIL +  N +
Sbjct: 304 PTFKQLVEDLDRILTLTTNEE 324

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 95/321 (29%), Positives = 159/321 (49%), Gaps = 43/321 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +  +        +G+GAFG V  A+             TVAVK+L  D
Sbjct: 19  VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 78
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L      
Sbjct: 79  ATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                YD N  P   +T+   V     +ARG+EYL   A    IHRD+ + N+L+ ++  
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNV 195
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVL++E+   
Sbjct: 196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 256 GGSPYPGI-PVEELFKLLKEG---------HRMDKPANCT--NELYMMMRDCWHAVPSQR 303
Query: 368 PSMRDIVQVLSRILKMRHNRK 388
           P+ + +V+ L RIL +  N +
Sbjct: 304 PTFKQLVEDLDRILTLTTNEE 324

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 95/321 (29%), Positives = 159/321 (49%), Gaps = 43/321 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +  +        +G+GAFG V  A+             TVAVK+L  D
Sbjct: 19  VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 78
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L      
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPP 138
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                YD N  P   +T+   V     +ARG+EYL   A    IHRD+ + N+L+ ++  
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNV 195
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVL++E+   
Sbjct: 196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 256 GGSPYPGI-PVEELFKLLKEG---------HRMDKPANCT--NELYMMMRDCWHAVPSQR 303
Query: 368 PSMRDIVQVLSRILKMRHNRK 388
           P+ + +V+ L RIL +  N +
Sbjct: 304 PTFKQLVEDLDRILTLTTNEE 324

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 94/321 (29%), Positives = 159/321 (49%), Gaps = 43/321 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +  +        +G+G FG V  A+             TVAVK+L  D
Sbjct: 6   VSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 65
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L      
Sbjct: 66  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 125
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                YD N  P   +T+   V     +ARG+EYL   A    IHRD+ + N+L+ ++  
Sbjct: 126 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNV 182
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVL++E+   
Sbjct: 183 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 242
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 243 GGSPYPGI-PVEELFKLLKEG---------HRMDKPANCT--NELYMMMRDCWHAVPSQR 290
Query: 368 PSMRDIVQVLSRILKMRHNRK 388
           P+ + +V+ L RIL +  N++
Sbjct: 291 PTFKQLVEDLDRILTLTTNQE 311

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 94/321 (29%), Positives = 158/321 (49%), Gaps = 43/321 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +  +        +G+G FG V  A+             TVAVK+L  D
Sbjct: 8   VSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 67
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L      
Sbjct: 68  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 127
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                YD N  P   +T+   V     +ARG+EYL   A    IHRD+ + N+L+ ++  
Sbjct: 128 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNV 184
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVL++E+   
Sbjct: 185 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 244
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 245 GGSPYPGI-PVEELFKLLKEG---------HRMDKPANCT--NELYMMMRDCWHAVPSQR 292
Query: 368 PSMRDIVQVLSRILKMRHNRK 388
           P+ + +V+ L RIL +  N +
Sbjct: 293 PTFKQLVEDLDRILTLTTNEE 313

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 94/321 (29%), Positives = 158/321 (49%), Gaps = 43/321 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +  +        +G+G FG V  A+             TVAVK+L  D
Sbjct: 65  VSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 124
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L      
Sbjct: 125 ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 184
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                YD N  P   +T+   V     +ARG+EYL   A    IHRD+ + N+L+ ++  
Sbjct: 185 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNV 241
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVL++E+   
Sbjct: 242 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 301
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 302 GGSPYPGI-PVEELFKLLKEG---------HRMDKPANCT--NELYMMMRDCWHAVPSQR 349
Query: 368 PSMRDIVQVLSRILKMRHNRK 388
           P+ + +V+ L RIL +  N +
Sbjct: 350 PTFKQLVEDLDRILTLTTNEE 370

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 94/321 (29%), Positives = 158/321 (49%), Gaps = 43/321 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +  +        +G+G FG V  A+             TVAVK+L  D
Sbjct: 11  VSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 70
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L      
Sbjct: 71  ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 130
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                YD N  P   +T+   V     +ARG+EYL   A    IHRD+ + N+L+ ++  
Sbjct: 131 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNV 187
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVL++E+   
Sbjct: 188 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 247
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 248 GGSPYPGI-PVEELFKLLKEG---------HRMDKPANCT--NELYMMMRDCWHAVPSQR 295
Query: 368 PSMRDIVQVLSRILKMRHNRK 388
           P+ + +V+ L RIL +  N +
Sbjct: 296 PTFKQLVEDLDRILTLTTNEE 316

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 94/321 (29%), Positives = 158/321 (49%), Gaps = 43/321 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +  +        +G+GAFG V  A+             TVAVK+L  D
Sbjct: 19  VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 78
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++ L+G C + G   ++  + SKG+L  +L      
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                YD N  P   +T+   V     +ARG+EYL   A    IHRD+ + N+L+ ++  
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNV 195
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVL++E+   
Sbjct: 196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 256 GGSPYPGI-PVEELFKLLKEG---------HRMDKPANCT--NELYMMMRDCWHAVPSQR 303
Query: 368 PSMRDIVQVLSRILKMRHNRK 388
           P+ + +V+ L RIL +  N +
Sbjct: 304 PTFKQLVEDLDRILTLTTNEE 324

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 94/321 (29%), Positives = 159/321 (49%), Gaps = 43/321 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +  +        +G+GAFG V  A+             TVAVK+L  D
Sbjct: 19  VSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 78
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N+++L+G C + G   ++  + SKG+L  +L      
Sbjct: 79  ATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                YD N  P   +T+   V     +ARG+EYL   A    IHRD+ + N+L+ ++  
Sbjct: 139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNV 195
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVL++E+   
Sbjct: 196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 256 GGSPYPGI-PVEELFKLLKEG---------HRMDKPANCT--NELYMMMRDCWHAVPSQR 303
Query: 368 PSMRDIVQVLSRILKMRHNRK 388
           P+ + +V+ L RIL +  N +
Sbjct: 304 PTFKQLVEDLDRILTLTTNEE 324

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 95/322 (29%), Positives = 163/322 (50%), Gaps = 43/322 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +L +        +G+GAFG V  A+         +    VAVK+L +D
Sbjct: 12  VSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD 71
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L      
Sbjct: 72  ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 131
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                Y+ ++ P   L+    V  A  VARG+EYL   A    IHRD+ + N+L+ +   
Sbjct: 132 GLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNV 188
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVLL+E+   
Sbjct: 189 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 248
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 249 GGSPYPGV-PVEELFKLLKEG---------HRMDKPSNCT--NELYMMMRDCWHAVPSQR 296
Query: 368 PSMRDIVQVLSRILKMRHNRKH 389
           P+ + +V+ L RI+ +  N+++
Sbjct: 297 PTFKQLVEDLDRIVALTSNQEY 318

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 95/321 (29%), Positives = 162/321 (50%), Gaps = 43/321 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +L +        +G+GAFG V  A+         +    VAVK+L +D
Sbjct: 5   VSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD 64
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L      
Sbjct: 65  ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 124
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                Y+ ++ P   L+    V  A  VARG+EYL   A    IHRD+ + N+L+ +   
Sbjct: 125 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNV 181
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVLL+E+   
Sbjct: 182 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 241
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 242 GGSPYPGV-PVEELFKLLKEG---------HRMDKPSNCT--NELYMMMRDCWHAVPSQR 289
Query: 368 PSMRDIVQVLSRILKMRHNRK 388
           P+ + +V+ L RI+ +  N++
Sbjct: 290 PTFKQLVEDLDRIVALTSNQE 310

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 95/321 (29%), Positives = 162/321 (50%), Gaps = 43/321 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +L +        +G+GAFG V  A+         +    VAVK+L +D
Sbjct: 4   VSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD 63
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L      
Sbjct: 64  ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 123
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                Y+ ++ P   L+    V  A  VARG+EYL   A    IHRD+ + N+L+ +   
Sbjct: 124 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNV 180
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVLL+E+   
Sbjct: 181 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 240
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 241 GGSPYPGV-PVEELFKLLKEG---------HRMDKPSNCT--NELYMMMRDCWHAVPSQR 288
Query: 368 PSMRDIVQVLSRILKMRHNRK 388
           P+ + +V+ L RI+ +  N++
Sbjct: 289 PTFKQLVEDLDRIVALTSNQE 309

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 95/321 (29%), Positives = 162/321 (50%), Gaps = 43/321 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +L +        +G+GAFG V  A+         +    VAVK+L +D
Sbjct: 12  VSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD 71
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L      
Sbjct: 72  ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPP 131
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                Y+ ++ P   L+    V  A  VARG+EYL   A    IHRD+ + N+L+ +   
Sbjct: 132 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNV 188
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVLL+E+   
Sbjct: 189 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 248
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 249 GGSPYPGV-PVEELFKLLKEG---------HRMDKPSNCT--NELYMMMRDCWHAVPSQR 296
Query: 368 PSMRDIVQVLSRILKMRHNRK 388
           P+ + +V+ L RI+ +  N++
Sbjct: 297 PTFKQLVEDLDRIVALTSNQE 317

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 95/321 (29%), Positives = 162/321 (50%), Gaps = 43/321 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +L +        +G+GAFG V  A+         +    VAVK+L +D
Sbjct: 12  VSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD 71
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L      
Sbjct: 72  ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 131
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                Y+ ++ P   L+    V  A  VARG+EYL   A    IHRD+ + N+L+ +   
Sbjct: 132 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNV 188
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVLL+E+   
Sbjct: 189 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 248
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 249 GGSPYPGV-PVEELFKLLKEG---------HRMDKPSNCT--NELYMMMRDCWHAVPSQR 296
Query: 368 PSMRDIVQVLSRILKMRHNRK 388
           P+ + +V+ L RI+ +  N++
Sbjct: 297 PTFKQLVEDLDRIVALTSNQE 317

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 95/321 (29%), Positives = 162/321 (50%), Gaps = 43/321 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +L +        +G+GAFG V  A+         +    VAVK+L +D
Sbjct: 53  VSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD 112
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L      
Sbjct: 113 ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 172
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                Y+ ++ P   L+    V  A  VARG+EYL   A    IHRD+ + N+L+ +   
Sbjct: 173 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNV 229
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVLL+E+   
Sbjct: 230 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 289
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 290 GGSPYPGV-PVEELFKLLKEGH---------RMDKPSNCT--NELYMMMRDCWHAVPSQR 337
Query: 368 PSMRDIVQVLSRILKMRHNRK 388
           P+ + +V+ L RI+ +  N++
Sbjct: 338 PTFKQLVEDLDRIVALTSNQE 358

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 94/321 (29%), Positives = 162/321 (50%), Gaps = 43/321 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD 147
           VS   +PE    +L +        +G+GAFG V  A+         +    VAVK+L +D
Sbjct: 12  VSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD 71
Query: 148 SKQGE-KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL------ 199
           + + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L      
Sbjct: 72  ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 131
Query: 200 -----YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR 251
                ++ ++ P   L+    V  A  VARG+EYL   A    IHRD+ + N+L+ +   
Sbjct: 132 GLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNV 188
Query: 252 ARVADFGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA- 307
            ++ADFGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVLL+E+   
Sbjct: 189 MKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 248
Query: 308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR 367
           G SP  G+    EL  +  EG          R+D   +    NE+  +   C +  P +R
Sbjct: 249 GGSPYPGV-PVEELFKLLKEG---------HRMDKPSNCT--NELYMMMRDCWHAVPSQR 296
Query: 368 PSMRDIVQVLSRILKMRHNRK 388
           P+ + +V+ L RI+ +  N++
Sbjct: 297 PTFKQLVEDLDRIVALTSNQE 317

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 160/316 (50%), Gaps = 43/316 (13%)
Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATDSKQGE 152
           +PE    +L +        +G+GAFG V  A+         +    VAVK+L +D+ + +
Sbjct: 6   LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 65
Query: 153 -KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL----------- 199
             +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L           
Sbjct: 66  LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 125
Query: 200 YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVAD 256
           Y+ ++ P   L+    V  A  VARG+EYL   A    IHRD+ + N+L+ +    ++AD
Sbjct: 126 YNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIAD 182
Query: 257 FGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPL 312
           FGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVLL+E+   G SP 
Sbjct: 183 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 242
Query: 313 QGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRD 372
            G+    EL  +  EG          R+D   +    NE+  +   C +  P +RP+ + 
Sbjct: 243 PGV-PVEELFKLLKEG---------HRMDKPSNCT--NELYMMMRDCWHAVPSQRPTFKQ 290
Query: 373 IVQVLSRILKMRHNRK 388
           +V+ L RI+ +  N++
Sbjct: 291 LVEDLDRIVALTSNQE 306

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 93/316 (29%), Positives = 160/316 (50%), Gaps = 43/316 (13%)
Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATDSKQGE 152
           +PE    +L +        +G+GAFG V  A+         +    VAVK+L +D+ + +
Sbjct: 2   LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 61
Query: 153 -KEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL----------- 199
             +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+L  +L           
Sbjct: 62  LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYC 121
Query: 200 YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVAD 256
           Y+ ++ P   L+    V  A  VARG+EYL   A    IHRD+ + N+L+ +    ++AD
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIAD 178
Query: 257 FGLSRE-EMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPL 312
           FGL+R+   +D  K   N R    ++ PE +  R +T +SDV+SFGVLL+E+   G SP 
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238
Query: 313 QGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRD 372
            G+    EL  +  EG          R+D   +    NE+  +   C +  P +RP+ + 
Sbjct: 239 PGV-PVEELFKLLKEG---------HRMDKPSNCT--NELYMMMRDCWHAVPSQRPTFKQ 286
Query: 373 IVQVLSRILKMRHNRK 388
           +V+ L RI+ +  N++
Sbjct: 287 LVEDLDRIVALTSNQE 302

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 146/312 (46%), Gaps = 35/312 (11%)
Query: 100 GIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE-TVAVKVLATDSKQGEKEFQTE 158
           G P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 59
Query: 159 VMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALD 218
             ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   ++  + +++A  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-- 276
           ++  +EYL        IHRD+ + N L+ ++   +VADFGLSR    D + A+    F  
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWE 333
            +  PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL            
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--------- 227
Query: 334 EIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKS 393
              D R++      E  +V  L   C    P  RPS  +I Q    + +           
Sbjct: 228 ---DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ----------- 271
Query: 394 QSTTADEVSIDM 405
           +S+ +DEV  ++
Sbjct: 272 ESSISDEVEKEL 283

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 146/312 (46%), Gaps = 35/312 (11%)
Query: 100 GIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE-TVAVKVLATDSKQGEKEFQTE 158
           G P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 59
Query: 159 VMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALD 218
             ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   ++  + +++A  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-- 276
           ++  +EYL        IHRD+ + N L+ ++   +VADFGLSR    D + A+    F  
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWE 333
            +  PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL            
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--------- 227
Query: 334 EIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKS 393
              D R++      E  +V  L   C    P  RPS  +I Q    + +           
Sbjct: 228 ---DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ----------- 271
Query: 394 QSTTADEVSIDM 405
           +S+ +DEV  ++
Sbjct: 272 ESSISDEVEKEL 283

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 143/279 (51%), Gaps = 28/279 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQM--STGETV--AVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
           +F  +IG+G FG VY   +  + G+ +  AVK L   +  GE  +F TE +++    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 170 LVNLVGYCA-EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+G C   +G  ++V  +M  G L + + +E + P   +L +   L VA+G++YL  
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL-- 148
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPE 282
            A    +HRD+ + N +LD+    +VADFGL+R+ M DK   ++    G      ++  E
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEXXSVHNKTGAKLPVKWMALE 206
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
            + T+ FT KSDV+SFGVLL+EL+   +P    +   ++     +G+          L  
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 258
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            +  + L EV     KC +     RPS  ++V  +S I 
Sbjct: 259 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIF 294

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 146/312 (46%), Gaps = 35/312 (11%)
Query: 100 GIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMST-GETVAVKVLATDSKQGEKEFQTE 158
           G P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 59
Query: 159 VMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALD 218
             ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   ++  + +++A  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-- 276
           ++  +EYL        IHRD+ + N L+ ++   +VADFGLSR    D + A+    F  
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWE 333
            +  PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL            
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--------- 227
Query: 334 EIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKS 393
              D R++      E  +V  L   C    P  RPS  +I Q    + +           
Sbjct: 228 ---DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ----------- 271
Query: 394 QSTTADEVSIDM 405
           +S+ +DEV  ++
Sbjct: 272 ESSISDEVEKEL 283

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 146/312 (46%), Gaps = 35/312 (11%)
Query: 100 GIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMST-GETVAVKVLATDSKQGEKEFQTE 158
           G P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 59
Query: 159 VMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALD 218
             ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   ++  + +++A  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-- 276
           ++  +EYL        IHRD+ + N L+ ++   +VADFGLSR    D + A+    F  
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWE 333
            +  PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL            
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--------- 227
Query: 334 EIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKS 393
              D R++      E  +V  L   C    P  RPS  +I Q    + +           
Sbjct: 228 ---DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ----------- 271
Query: 394 QSTTADEVSIDM 405
           +S+ +DEV  ++
Sbjct: 272 ESSISDEVEKEL 283

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 139/268 (51%), Gaps = 23/268 (8%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           ++G+GAFG V KA+    + VA+K + ++S++  K F  E+  L R++H N+V L G C 
Sbjct: 16  VVGRGAFGVVCKAKWRAKD-VAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 72
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVH---IALDVARGLEYLHDGAVPPVI 235
                 LV  +   GSL + L+     PL +    H     L  ++G+ YLH      +I
Sbjct: 73  NPV--CLVMEYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 236 HRDIKSSNILLDQSMRA-RVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
           HRD+K  N+LL       ++ DFG + +  +  H  N +G+  ++ PE     N+++K D
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 186
Query: 295 VYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVAS 354
           V+S+G++L+E+I  R P   +             +  W     +R   I ++ +   + S
Sbjct: 187 VFSWGIILWEVITRRKPFDEI--------GGPAFRIMWAVHNGTRPPLIKNLPK--PIES 236
Query: 355 LAYKCVNRAPRKRPSMRDIVQVLSRILK 382
           L  +C ++ P +RPSM +IV++++ +++
Sbjct: 237 LMTRCWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 139/268 (51%), Gaps = 23/268 (8%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           ++G+GAFG V KA+    + VA+K + ++S++  K F  E+  L R++H N+V L G C 
Sbjct: 15  VVGRGAFGVVCKAKWRAKD-VAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVH---IALDVARGLEYLHDGAVPPVI 235
                 LV  +   GSL + L+     PL +    H     L  ++G+ YLH      +I
Sbjct: 72  NPV--CLVMEYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 236 HRDIKSSNILLDQSMRA-RVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
           HRD+K  N+LL       ++ DFG + +  +  H  N +G+  ++ PE     N+++K D
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 295 VYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVAS 354
           V+S+G++L+E+I  R P   +             +  W     +R   I ++ +   + S
Sbjct: 186 VFSWGIILWEVITRRKPFDEI--------GGPAFRIMWAVHNGTRPPLIKNLPK--PIES 235
Query: 355 LAYKCVNRAPRKRPSMRDIVQVLSRILK 382
           L  +C ++ P +RPSM +IV++++ +++
Sbjct: 236 LMTRCWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 145/312 (46%), Gaps = 35/312 (11%)
Query: 100 GIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE-TVAVKVLATDSKQGEKEFQTE 158
           G P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E
Sbjct: 14  GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKE 72
Query: 159 VMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALD 218
             ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   +   + +++A  
Sbjct: 73  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 132
Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-- 276
           ++  +EYL        IHRD+ + N L+ ++   +VADFGLSR    D + A+    F  
Sbjct: 133 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 189
Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWE 333
            +  PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL            
Sbjct: 190 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--------- 240
Query: 334 EIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKS 393
              D R++      E  +V  L   C    P  RPS  +I Q    + +           
Sbjct: 241 ---DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ----------- 284
Query: 394 QSTTADEVSIDM 405
           +S+ +DEV  ++
Sbjct: 285 ESSISDEVEKEL 296

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 143/279 (51%), Gaps = 28/279 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQM--STGETV--AVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
           +F  +IG+G FG VY   +  + G+ +  AVK L   +  GE  +F TE +++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 170 LVNLVGYCA-EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+G C   +G  ++V  +M  G L + + +E + P   +L +   L VA+G++YL  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL-- 149
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPE 282
            A    +HRD+ + N +LD+    +VADFGL+R+ M DK   ++    G      ++  E
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
            + T+ FT KSDV+SFGVLL+EL+   +P    +   ++     +G+          L  
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 259
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            +  + L EV     KC +     RPS  ++V  +S I 
Sbjct: 260 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIF 295

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 145/310 (46%), Gaps = 35/310 (11%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE-TVAVKVLATDSKQGEKEFQTEVM 160
           P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E  
Sbjct: 8   PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAA 66
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   ++  + +++A  ++
Sbjct: 67  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 126
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
             +EYL        IHRD+ + N L+ ++   +VADFGLSR    D + A+    F   +
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWEEI 335
             PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL              
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 232
Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQS 395
            D R++      E  +V  L   C    P  RPS  +I Q    + +           +S
Sbjct: 233 -DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ-----------ES 278
Query: 396 TTADEVSIDM 405
           + +DEV  ++
Sbjct: 279 SISDEVEKEL 288

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 144/299 (48%), Gaps = 35/299 (11%)
Query: 106 YKDLQKATCNFTTLIGQGAFGPVYKAQMSTG----ETVAVKVLATDSKQGEKEFQTEVML 161
           Y  L      F  +IG+G FG V KA++       +    ++    SK   ++F  E+ +
Sbjct: 19  YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 78
Query: 162 LGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSL--------------ASHLYDENYGP 206
           L +L HH N++NL+G C  +G   L   +   G+L              A  + +     
Sbjct: 79  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266
           L+    +H A DVARG++YL        IHRD+ + NIL+ ++  A++ADFGLSR + V 
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQEVY 195
Query: 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMN 325
                 R    ++  E ++   +T  SDV+S+GVLL+E+++ G +P  G M   EL    
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKL 254
Query: 326 TEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR 384
            +G          RL+   + ++  EV  L  +C    P +RPS   I+  L+R+L+ R
Sbjct: 255 PQG---------YRLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 143/279 (51%), Gaps = 28/279 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQM--STGETV--AVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
           +F  +IG+G FG VY   +  + G+ +  AVK L   +  GE  +F TE +++    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 170 LVNLVGYCA-EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+G C   +G  ++V  +M  G L + + +E + P   +L +   L VA+G++YL  
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL-- 144
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPE 282
            A    +HRD+ + N +LD+    +VADFGL+R+ M DK   ++    G      ++  E
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
            + T+ FT KSDV+SFGVLL+EL+   +P    +   ++     +G+          L  
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 254
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            +  + L EV     KC +     RPS  ++V  +S I 
Sbjct: 255 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIF 290

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 143/279 (51%), Gaps = 28/279 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQM--STGETV--AVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
           +F  +IG+G FG VY   +  + G+ +  AVK L   +  GE  +F TE +++    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 170 LVNLVGYCA-EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+G C   +G  ++V  +M  G L + + +E + P   +L +   L VA+G++YL  
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL-- 147
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPE 282
            A    +HRD+ + N +LD+    +VADFGL+R+ M DK   ++    G      ++  E
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALE 205
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
            + T+ FT KSDV+SFGVLL+EL+   +P    +   ++     +G+          L  
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 257
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            +  + L EV     KC +     RPS  ++V  +S I 
Sbjct: 258 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIF 293

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 143/279 (51%), Gaps = 28/279 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQM--STGETV--AVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
           +F  +IG+G FG VY   +  + G+ +  AVK L   +  GE  +F TE +++    H N
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 170 LVNLVGYCA-EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+G C   +G  ++V  +M  G L + + +E + P   +L +   L VA+G++YL  
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL-- 168
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPE 282
            A    +HRD+ + N +LD+    +VADFGL+R+ M DK   ++    G      ++  E
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALE 226
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
            + T+ FT KSDV+SFGVLL+EL+   +P    +   ++     +G+          L  
Sbjct: 227 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 278
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            +  + L EV     KC +     RPS  ++V  +S I 
Sbjct: 279 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIF 314

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 143/279 (51%), Gaps = 28/279 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQM--STGETV--AVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
           +F  +IG+G FG VY   +  + G+ +  AVK L   +  GE  +F TE +++    H N
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 170 LVNLVGYCA-EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+G C   +G  ++V  +M  G L + + +E + P   +L +   L VA+G++YL  
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL-- 141
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPE 282
            A    +HRD+ + N +LD+    +VADFGL+R+ M DK   ++    G      ++  E
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALE 199
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
            + T+ FT KSDV+SFGVLL+EL+   +P    +   ++     +G+          L  
Sbjct: 200 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 251
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            +  + L EV     KC +     RPS  ++V  +S I 
Sbjct: 252 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIF 287

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 143/279 (51%), Gaps = 28/279 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQM--STGETV--AVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
           +F  +IG+G FG VY   +  + G+ +  AVK L   +  GE  +F TE +++    H N
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 170 LVNLVGYCA-EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+G C   +G  ++V  +M  G L + + +E + P   +L +   L VA+G++YL  
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL-- 167
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPE 282
            A    +HRD+ + N +LD+    +VADFGL+R+ M DK   ++    G      ++  E
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALE 225
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
            + T+ FT KSDV+SFGVLL+EL+   +P    +   ++     +G+          L  
Sbjct: 226 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 277
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            +  + L EV     KC +     RPS  ++V  +S I 
Sbjct: 278 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIF 313

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 144/299 (48%), Gaps = 35/299 (11%)
Query: 106 YKDLQKATCNFTTLIGQGAFGPVYKAQMSTG----ETVAVKVLATDSKQGEKEFQTEVML 161
           Y  L      F  +IG+G FG V KA++       +    ++    SK   ++F  E+ +
Sbjct: 9   YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 68
Query: 162 LGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSL--------------ASHLYDENYGP 206
           L +L HH N++NL+G C  +G   L   +   G+L              A  + +     
Sbjct: 69  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 128
Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266
           L+    +H A DVARG++YL        IHRD+ + NIL+ ++  A++ADFGLSR + V 
Sbjct: 129 LSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQEVY 185
Query: 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMN 325
                 R    ++  E ++   +T  SDV+S+GVLL+E+++ G +P  G M   EL    
Sbjct: 186 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKL 244
Query: 326 TEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR 384
            +G          RL+   + ++  EV  L  +C    P +RPS   I+  L+R+L+ R
Sbjct: 245 PQG---------YRLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 292

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 143/279 (51%), Gaps = 28/279 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQM--STGETV--AVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
           +F  +IG+G FG VY   +  + G+ +  AVK L   +  GE  +F TE +++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 170 LVNLVGYCA-EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+G C   +G  ++V  +M  G L + + +E + P   +L +   L VA+G++YL  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL-- 149
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPE 282
            A    +HRD+ + N +LD+    +VADFGL+R+ M DK   ++    G      ++  E
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
            + T+ FT KSDV+SFGVLL+EL+   +P    +   ++     +G+          L  
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 259
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            +  + L EV     KC +     RPS  ++V  +S I 
Sbjct: 260 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIF 295

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 143/279 (51%), Gaps = 28/279 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQM--STGETV--AVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
           +F  +IG+G FG VY   +  + G+ +  AVK L   +  GE  +F TE +++    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 170 LVNLVGYCA-EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+G C   +G  ++V  +M  G L + + +E + P   +L +   L VA+G++YL  
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL-- 148
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPE 282
            A    +HRD+ + N +LD+    +VADFGL+R+ M DK   ++    G      ++  E
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALE 206
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
            + T+ FT KSDV+SFGVLL+EL+   +P    +   ++     +G+          L  
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 258
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            +  + L EV     KC +     RPS  ++V  +S I 
Sbjct: 259 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIF 294

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 143/279 (51%), Gaps = 28/279 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQM--STGETV--AVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
           +F  +IG+G FG VY   +  + G+ +  AVK L   +  GE  +F TE +++    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 170 LVNLVGYCA-EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+G C   +G  ++V  +M  G L + + +E + P   +L +   L VA+G++YL  
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKYL-- 146
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPE 282
            A    +HRD+ + N +LD+    +VADFGL+R+ M DK   ++    G      ++  E
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKWMALE 204
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
            + T+ FT KSDV+SFGVLL+EL+   +P    +   ++     +G+          L  
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 256
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            +  + L EV     KC +     RPS  ++V  +S I 
Sbjct: 257 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIF 292

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 144/279 (51%), Gaps = 28/279 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQM--STGETV--AVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
           +F  +IG+G FG VY   +  + G+ +  AVK L   +  GE  +F TE +++    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 170 LVNLVGYCA-EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+G C   +G  ++V  +M  G L + + +E + P   +L +   L VA+G+++L  
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL-- 150
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPE 282
            A    +HRD+ + N +LD+    +VADFGL+R+ M+DK   ++    G      ++  E
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MLDKEFDSVHNKTGAKLPVKWMALE 208
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
            + T+ FT KSDV+SFGVLL+EL+   +P    +   ++     +G+          L  
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 260
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            +  + L EV     KC +     RPS  ++V  +S I 
Sbjct: 261 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIF 296

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 144/310 (46%), Gaps = 35/310 (11%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE-TVAVKVLATDSKQGEKEFQTEVM 160
           P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E  
Sbjct: 8   PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAA 66
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   +   + +++A  ++
Sbjct: 67  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 126
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
             +EYL        IHRD+ + N L+ ++   +VADFGLSR    D + A+    F   +
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWEEI 335
             PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL              
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 232
Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQS 395
            D R++      E  +V  L   C    P  RPS  +I Q    + +           +S
Sbjct: 233 -DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ-----------ES 278
Query: 396 TTADEVSIDM 405
           + +DEV  ++
Sbjct: 279 SISDEVEKEL 288

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 87/310 (28%), Positives = 145/310 (46%), Gaps = 35/310 (11%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE-TVAVKVLATDSKQGEKEFQTEVM 160
           P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E  
Sbjct: 210 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAA 268
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   ++  + +++A  ++
Sbjct: 269 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 328
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
             +EYL        IHR++ + N L+ ++   +VADFGLSR    D + A+    F   +
Sbjct: 329 SAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 385
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWEEI 335
             PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL              
Sbjct: 386 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 434
Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQS 395
            D R++      E  +V  L   C    P  RPS  +I Q    + +           +S
Sbjct: 435 -DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ-----------ES 480
Query: 396 TTADEVSIDM 405
           + +DEV  ++
Sbjct: 481 SISDEVEKEL 490

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 144/310 (46%), Gaps = 35/310 (11%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE-TVAVKVLATDSKQGEKEFQTEVM 160
           P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E  
Sbjct: 5   PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAA 63
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   +   + +++A  ++
Sbjct: 64  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 123
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
             +EYL        IHRD+ + N L+ ++   +VADFGLSR    D + A+    F   +
Sbjct: 124 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 180
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWEEI 335
             PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL              
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 229
Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQS 395
            D R++      E  +V  L   C    P  RPS  +I Q    + +           +S
Sbjct: 230 -DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ-----------ES 275
Query: 396 TTADEVSIDM 405
           + +DEV  ++
Sbjct: 276 SISDEVEKEL 285

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 144/310 (46%), Gaps = 35/310 (11%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMST-GETVAVKVLATDSKQGEKEFQTEVM 160
           P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E  
Sbjct: 5   PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAA 63
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   +   + +++A  ++
Sbjct: 64  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 123
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
             +EYL        IHRD+ + N L+ ++   +VADFGLSR    D + A+    F   +
Sbjct: 124 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 180
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWEEI 335
             PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL              
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 229
Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQS 395
            D R++      E  +V  L   C    P  RPS  +I Q    + +           +S
Sbjct: 230 -DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ-----------ES 275
Query: 396 TTADEVSIDM 405
           + +DEV  ++
Sbjct: 276 SISDEVEKEL 285

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 135/287 (47%), Gaps = 24/287 (8%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE-TVAVKVLATDSKQGEKEFQTEVM 160
           P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E  
Sbjct: 8   PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAA 66
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   +   + +++A  ++
Sbjct: 67  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 126
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
             +EYL        IHRD+ + N L+ ++   +VADFGLSR    D + A+    F   +
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWEEI 335
             PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL              
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 232
Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
            D R++      E  +V  L   C    P  RPS  +I Q    + +
Sbjct: 233 -DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 135/287 (47%), Gaps = 24/287 (8%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE-TVAVKVLATDSKQGEKEFQTEVM 160
           P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E  
Sbjct: 8   PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAA 66
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   +   + +++A  ++
Sbjct: 67  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 126
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
             +EYL        IHRD+ + N L+ ++   +VADFGLSR    D + A+    F   +
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWEEI 335
             PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL              
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 232
Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
            D R++      E  +V  L   C    P  RPS  +I Q    + +
Sbjct: 233 -DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 143/279 (51%), Gaps = 28/279 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQM--STGETV--AVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
           +F  +IG+G FG VY   +  + G+ +  AVK L   +  GE  +F TE +++    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 170 LVNLVGYCA-EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+G C   +G  ++V  +M  G L + + +E + P   +L +   L VA+G+++L  
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL-- 150
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPE 282
            A    +HRD+ + N +LD+    +VADFGL+R+ M DK   ++    G      ++  E
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEFDSVHNKTGAKLPVKWMALE 208
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
            + T+ FT KSDV+SFGVLL+EL+   +P    +   ++     +G+          L  
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 260
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            +  + L EV     KC +     RPS  ++V  +S I 
Sbjct: 261 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIF 296

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 87/310 (28%), Positives = 144/310 (46%), Gaps = 35/310 (11%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE-TVAVKVLATDSKQGEKEFQTEVM 160
           P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E  
Sbjct: 249 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAA 307
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   +   + +++A  ++
Sbjct: 308 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 367
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
             +EYL        IHR++ + N L+ ++   +VADFGLSR    D + A+    F   +
Sbjct: 368 SAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 424
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWEEI 335
             PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL              
Sbjct: 425 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 473
Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQS 395
            D R++      E  +V  L   C    P  RPS  +I Q    + +           +S
Sbjct: 474 -DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ-----------ES 519
Query: 396 TTADEVSIDM 405
           + +DEV  ++
Sbjct: 520 SISDEVEKEL 529

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 143/279 (51%), Gaps = 28/279 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQM--STGETV--AVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
           +F  +IG+G FG VY   +  + G+ +  AVK L   +  GE  +F TE +++    H N
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 170 LVNLVGYCA-EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+G C   +G  ++V  +M  G L + + +E + P   +L +   L VA+G+++L  
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL-- 154
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPE 282
            A    +HRD+ + N +LD+    +VADFGL+R+ M DK   ++    G      ++  E
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEFDSVHNKTGAKLPVKWMALE 212
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
            + T+ FT KSDV+SFGVLL+EL+   +P    +   ++     +G+          L  
Sbjct: 213 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 264
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            +  + L EV     KC +     RPS  ++V  +S I 
Sbjct: 265 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIF 300

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 143/279 (51%), Gaps = 28/279 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQM--STGETV--AVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
           +F  +IG+G FG VY   +  + G+ +  AVK L   +  GE  +F TE +++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 170 LVNLVGYCA-EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+G C   +G  ++V  +M  G L + + +E + P   +L +   L VA+G+++L  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL-- 149
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPE 282
            A    +HRD+ + N +LD+    +VADFGL+R+ M DK   ++    G      ++  E
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
            + T+ FT KSDV+SFGVLL+EL+   +P    +   ++     +G+          L  
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 259
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            +  + L EV     KC +     RPS  ++V  +S I 
Sbjct: 260 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIF 295

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 135/287 (47%), Gaps = 24/287 (8%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE-TVAVKVLATDSKQGEKEFQTEVM 160
           P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E  
Sbjct: 7   PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAA 65
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   +   + +++A  ++
Sbjct: 66  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 125
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
             +EYL        IHRD+ + N L+ ++   +VADFGLSR    D + A+    F   +
Sbjct: 126 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWEEI 335
             PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL              
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 231
Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
            D R++      E  +V  L   C    P  RPS  +I Q    + +
Sbjct: 232 -DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 143/279 (51%), Gaps = 28/279 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQM--STGETV--AVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
           +F  +IG+G FG VY   +  + G+ +  AVK L   +  GE  +F TE +++    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 170 LVNLVGYCA-EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+G C   +G  ++V  +M  G L + + +E + P   +L +   L VA+G+++L  
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL-- 147
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPE 282
            A    +HRD+ + N +LD+    +VADFGL+R+ M DK   ++    G      ++  E
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEFDSVHNKTGAKLPVKWMALE 205
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
            + T+ FT KSDV+SFGVLL+EL+   +P    +   ++     +G+          L  
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 257
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            +  + L EV     KC +     RPS  ++V  +S I 
Sbjct: 258 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIF 293

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 143/279 (51%), Gaps = 28/279 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQM--STGETV--AVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
           +F  +IG+G FG VY   +  + G+ +  AVK L   +  GE  +F TE +++    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 170 LVNLVGYCA-EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+G C   +G  ++V  +M  G L + + +E + P   +L +   L VA+G+++L  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL-- 149
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPE 282
            A    +HRD+ + N +LD+    +VADFGL+R+ M DK   ++    G      ++  E
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
            + T+ FT KSDV+SFGVLL+EL+   +P    +   ++     +G+          L  
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 259
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            +  + L EV     KC +     RPS  ++V  +S I 
Sbjct: 260 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIF 295

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 143/279 (51%), Gaps = 28/279 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQM--STGETV--AVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
           +F  +IG+G FG VY   +  + G+ +  AVK L   +  GE  +F TE +++    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 170 LVNLVGYCA-EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+G C   +G  ++V  +M  G L + + +E + P   +L +   L VA+G+++L  
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-IGFGLQVAKGMKFL-- 208
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG------YLDPE 282
            A    +HRD+ + N +LD+    +VADFGL+R+ M DK   ++    G      ++  E
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MYDKEFDSVHNKTGAKLPVKWMALE 266
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
            + T+ FT KSDV+SFGVLL+EL+   +P    +   ++     +G+          L  
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQP 318
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            +  + L EV     KC +     RPS  ++V  +S I 
Sbjct: 319 EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIF 354

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 143/310 (46%), Gaps = 35/310 (11%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMST-GETVAVKVLATDSKQGEKEFQTEVM 160
           P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E  
Sbjct: 5   PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAA 63
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   +   + +++A  ++
Sbjct: 64  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 123
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
             +EYL        IHRD+ + N L+ ++   +VADFGLSR    D + A     F   +
Sbjct: 124 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKW 180
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWEEI 335
             PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL              
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 229
Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQS 395
            D R++      E  +V  L   C    P  RPS  +I Q    + +           +S
Sbjct: 230 -DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ-----------ES 275
Query: 396 TTADEVSIDM 405
           + +DEV  ++
Sbjct: 276 SISDEVEKEL 285

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 143/310 (46%), Gaps = 35/310 (11%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMST-GETVAVKVLATDSKQGEKEFQTEVM 160
           P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E  
Sbjct: 4   PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAA 62
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   +   + +++A  ++
Sbjct: 63  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 122
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
             +EYL        IHRD+ + N L+ ++   +VADFGLSR    D   A+    F   +
Sbjct: 123 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 179
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWEEI 335
             PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL              
Sbjct: 180 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 228
Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQS 395
            D R++      E  +V  L   C    P  RPS  +I Q    + +           +S
Sbjct: 229 -DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ-----------ES 274
Query: 396 TTADEVSIDM 405
           + +DEV  ++
Sbjct: 275 SISDEVEKEL 284

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 143/310 (46%), Gaps = 35/310 (11%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE-TVAVKVLATDSKQGEKEFQTEVM 160
           P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E  
Sbjct: 4   PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAA 62
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   +   + +++A  ++
Sbjct: 63  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 122
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
             +EYL        IHRD+ + N L+ ++   +VADFGLSR    D + A     F   +
Sbjct: 123 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKW 179
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWEEI 335
             PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL              
Sbjct: 180 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 228
Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQS 395
            D R++      E  +V  L   C    P  RPS  +I Q    + +           +S
Sbjct: 229 -DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ-----------ES 274
Query: 396 TTADEVSIDM 405
           + +DEV  ++
Sbjct: 275 SISDEVEKEL 284

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 135/287 (47%), Gaps = 24/287 (8%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE-TVAVKVLATDSKQGEKEFQTEVM 160
           P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E  
Sbjct: 3   PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAA 61
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   +   + +++A  ++
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 121
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
             +EYL        IHRD+ + N L+ ++   +VADFGLSR    D + A+    F   +
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWEEI 335
             PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL              
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 227
Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
            D R++      E  +V  L   C    P  RPS  +I Q    + +
Sbjct: 228 -DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 88/299 (29%), Positives = 144/299 (48%), Gaps = 35/299 (11%)
Query: 106 YKDLQKATCNFTTLIGQGAFGPVYKAQMSTG----ETVAVKVLATDSKQGEKEFQTEVML 161
           Y  L      F  +IG+G FG V KA++       +    ++    SK   ++F  E+ +
Sbjct: 16  YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 75
Query: 162 LGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSL--------------ASHLYDENYGP 206
           L +L HH N++NL+G C  +G   L   +   G+L              A  + +     
Sbjct: 76  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 135
Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266
           L+    +H A DVARG++YL        IHR++ + NIL+ ++  A++ADFGLSR + V 
Sbjct: 136 LSSQQLLHFAADVARGMDYLSQKQF---IHRNLAARNILVGENYVAKIADFGLSRGQEVY 192
Query: 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMN 325
                 R    ++  E ++   +T  SDV+S+GVLL+E+++ G +P  G M   EL    
Sbjct: 193 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKL 251
Query: 326 TEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR 384
            +G          RL+   + ++  EV  L  +C    P +RPS   I+  L+R+L+ R
Sbjct: 252 PQG---------YRLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 299

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 134/286 (46%), Gaps = 24/286 (8%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE-TVAVKVLATDSKQGEKEFQTEVM 160
           P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E  
Sbjct: 3   PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAA 61
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   +   + +++A  ++
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 121
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
             +EYL        IHRD+ + N L+ ++   +VADFGLSR    D + A+    F   +
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWEEI 335
             PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL              
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 227
Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
            D R++      E  +V  L   C    P  RPS  +I Q    + 
Sbjct: 228 -DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 134/287 (46%), Gaps = 24/287 (8%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMST-GETVAVKVLATDSKQGEKEFQTEVM 160
           P Y   ++++        +G G +G VY+        TVAVK L  D+ + E EF  E  
Sbjct: 8   PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAA 66
Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++  + H NLV L+G C  +    ++  FM+ G+L  +L + N   +   + +++A  ++
Sbjct: 67  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 126
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GY 278
             +EYL        IHRD+ + N L+ ++   +VADFGLSR    D   A+    F   +
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 183
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQG--LMEYVELAAMNTEGKTGWEEI 335
             PE ++   F+ KSDV++FGVLL+E+   G SP  G  L +  EL              
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 232
Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
            D R++      E  +V  L   C    P  RPS  +I Q    + +
Sbjct: 233 -DYRMERPEGCPE--KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 86/292 (29%), Positives = 138/292 (47%), Gaps = 35/292 (11%)
Query: 120 IGQGAFGPVYKAQMST-GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G G FG VY+        TVAVK L  D+ + E EF  E  ++  + H NLV L+G C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            +    ++  FM+ G+L  +L + N   ++  + +++A  ++  +EYL        IHRD
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 134
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVY 296
           + + N L+ ++   +VADFGLSR    D   A+    F   +  PE ++   F+ KSDV+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 297 SFGVLLFELIA-GRSPLQGL--MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVA 353
           +FGVLL+E+   G SP  G+   +  EL               D R++      E  +V 
Sbjct: 195 AFGVLLWEIATYGMSPYPGIDPSQVYELLEK------------DYRMERPEGCPE--KVY 240
Query: 354 SLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDM 405
            L   C    P  RPS  +I Q    + +           +S+ +DEV  ++
Sbjct: 241 ELMRACWQWNPSDRPSFAEIHQAFETMFQ-----------ESSISDEVEKEL 281

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 132/275 (48%), Gaps = 35/275 (12%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
            F   IG G FG V+       + VA+K +  +    E++F  E  ++ +L H  LV L 
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLY 71
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E+    LV+ FM  G L+ +L  +  G       + + LDV  G+ YL +     V
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---V 127
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKK 292
           IHRD+ + N L+ ++   +V+DFG++R  + D++ ++    F   +  PE  S   ++ K
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 187
Query: 293 SDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWE-----EIVDSRLDGIFDVE 347
           SDV+SFGVL++E+                    +EGK  +E     E+V+    G F + 
Sbjct: 188 SDVWSFGVLMWEVF-------------------SEGKIPYENRSNSEVVEDISTG-FRLY 227
Query: 348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
           +    ++  Y+ +N   R+RP  R      SR+L+
Sbjct: 228 KPRLASTHVYQIMNHCWRERPEDRP---AFSRLLR 259

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 130/284 (45%), Gaps = 52/284 (18%)
Query: 120 IGQGAFGPVYKAQMST------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+GAFG V+ A+            VAVK L   S+   ++FQ E  LL  L H+++V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLY-------------DENYGPLTWNLRVHIALDVA 220
            G C E    ++V+ +M  G L   L              D   GPL     + +A  VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFG-- 277
            G+ YL   A    +HRD+ + N L+ Q +  ++ DFG+SR+    D +    R      
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD 337
           ++ PE I  R FT +SDV+SFGV+L+E+                    T GK  W ++ +
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIF-------------------TYGKQPWYQLSN 237
Query: 338 SR-LDGIFDVEELN-------EVASLAYKCVNRAPRKRPSMRDI 373
           +  +D I    EL        EV ++   C  R P++R S++D+
Sbjct: 238 TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 281

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 130/284 (45%), Gaps = 52/284 (18%)
Query: 120 IGQGAFGPVYKAQMST------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+GAFG V+ A+            VAVK L   S+   ++FQ E  LL  L H+++V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLY-------------DENYGPLTWNLRVHIALDVA 220
            G C E    ++V+ +M  G L   L              D   GPL     + +A  VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFG-- 277
            G+ YL   A    +HRD+ + N L+ Q +  ++ DFG+SR+    D +    R      
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD 337
           ++ PE I  R FT +SDV+SFGV+L+E+                    T GK  W ++ +
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIF-------------------TYGKQPWYQLSN 243
Query: 338 SR-LDGIFDVEELN-------EVASLAYKCVNRAPRKRPSMRDI 373
           +  +D I    EL        EV ++   C  R P++R S++D+
Sbjct: 244 TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 287

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 130/284 (45%), Gaps = 52/284 (18%)
Query: 120 IGQGAFGPVYKAQMST------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+GAFG V+ A+            VAVK L   S+   ++FQ E  LL  L H+++V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLY-------------DENYGPLTWNLRVHIALDVA 220
            G C E    ++V+ +M  G L   L              D   GPL     + +A  VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFG-- 277
            G+ YL   A    +HRD+ + N L+ Q +  ++ DFG+SR+    D +    R      
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD 337
           ++ PE I  R FT +SDV+SFGV+L+E+                    T GK  W ++ +
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIF-------------------TYGKQPWYQLSN 266
Query: 338 SR-LDGIFDVEELN-------EVASLAYKCVNRAPRKRPSMRDI 373
           +  +D I    EL        EV ++   C  R P++R S++D+
Sbjct: 267 TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 310

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 145/289 (50%), Gaps = 41/289 (14%)
Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRL-HHRNLV 171
           +G+GAFG V +A      + +T  TVAVK+L   +   E +   +E+ +L  + HH N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 172 NLVGYCAEKGQHMLVYV-FMSKGSLASHLYDEN-----YGP-------LTWNLRVHIALD 218
           NL+G C + G  ++V V F   G+L+++L  +      Y P       LT    +  +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGT 275
           VA+G+E+L   A    IHRD+ + NILL +    ++ DFGL+R+   D       + R  
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 276 FGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             ++ PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E      EG      
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG------ 267
Query: 335 IVDSRLDGI-FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
              +R+    +   E+ +       C +  P +RP+  ++V+ L  +L+
Sbjct: 268 ---TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 108/202 (53%), Gaps = 8/202 (3%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
            F   IG G FG V+       + VA+K +  +    E++F  E  ++ +L H  LV L 
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E+    LV+ FM  G L+ +L  +  G       + + LDV  G+ YL + +   V
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAS---V 124
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKK 292
           IHRD+ + N L+ ++   +V+DFG++R  + D++ ++    F   +  PE  S   ++ K
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 293 SDVYSFGVLLFELIA-GRSPLQ 313
           SDV+SFGVL++E+ + G+ P +
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYE 206

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 8/202 (3%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
            F   IG G FG V+       + VA+K +  +    E++F  E  ++ +L H  LV L 
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E+    LV+ FM  G L+ +L  +  G       + + LDV  G+ YL +     V
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---V 124
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKK 292
           IHRD+ + N L+ ++   +V+DFG++R  + D++ ++    F   +  PE  S   ++ K
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 293 SDVYSFGVLLFELIA-GRSPLQ 313
           SDV+SFGVL++E+ + G+ P +
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYE 206

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 8/202 (3%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
            F   IG G FG V+       + VA+K +  +    E++F  E  ++ +L H  LV L 
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E+    LV+ FM  G L+ +L  +  G       + + LDV  G+ YL +     V
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKK 292
           IHRD+ + N L+ ++   +V+DFG++R  + D++ ++    F   +  PE  S   ++ K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 293 SDVYSFGVLLFELIA-GRSPLQ 313
           SDV+SFGVL++E+ + G+ P +
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYE 204

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/292 (30%), Positives = 146/292 (50%), Gaps = 39/292 (13%)
Query: 115 NFTTLIGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRL-H 166
           N    +G+GAFG V +A      + +T  TVAVK+L   +   E +   +E+ +L  + H
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 167 HRNLVNLVGYCAEKGQHMLVYV-FMSKGSLASHL---------YDENYGP-LTWNLRVHI 215
           H N+VNL+G C + G  ++V V F   G+L+++L         Y + Y   LT    +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 216 ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANI 272
           +  VA+G+E+L   A    IHRD+ + NILL +    ++ DFGL+R+   D       + 
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTG 331
           R    ++ PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E      EG   
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG--- 263
Query: 332 WEEIVDSRLDGI-FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                 +R+    +   E+ +       C +  P +RP+  ++V+ L  +L+
Sbjct: 264 ------TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 106/202 (52%), Gaps = 8/202 (3%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
            F   IG G FG V+       + VA+K +   S   E +F  E  ++ +L H  LV L 
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLY 88
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E+    LV+ FM  G L+ +L  +  G       + + LDV  G+ YL +     V
Sbjct: 89  GVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---V 144
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKK 292
           IHRD+ + N L+ ++   +V+DFG++R  + D++ ++    F   +  PE  S   ++ K
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 204
Query: 293 SDVYSFGVLLFELIA-GRSPLQ 313
           SDV+SFGVL++E+ + G+ P +
Sbjct: 205 SDVWSFGVLMWEVFSEGKIPYE 226

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 138/292 (47%), Gaps = 35/292 (11%)
Query: 120 IGQGAFGPVYKAQMST-GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G G +G VY+        TVAVK L  D+ + E EF  E  ++  + H NLV L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            +    ++  FM+ G+L  +L + N   ++  + +++A  ++  +EYL        IHRD
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 134
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVY 296
           + + N L+ ++   +VADFGLSR    D   A+    F   +  PE ++   F+ KSDV+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 297 SFGVLLFELIA-GRSPLQGL--MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVA 353
           +FGVLL+E+   G SP  G+   +  EL               D R++      E  +V 
Sbjct: 195 AFGVLLWEIATYGMSPYPGIDPSQVYELLEK------------DYRMERPEGCPE--KVY 240
Query: 354 SLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDM 405
            L   C    P  RPS  +I Q    + +           +S+ +DEV  ++
Sbjct: 241 ELMRACWQWNPSDRPSFAEIHQAFETMFQ-----------ESSISDEVEKEL 281

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 89/292 (30%), Positives = 146/292 (50%), Gaps = 39/292 (13%)
Query: 115 NFTTLIGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRL-H 166
           N    +G+GAFG V +A      + +T  TVAVK+L   +   E +   +E+ +L  + H
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 167 HRNLVNLVGYCAEKGQHMLVYV-FMSKGSLASHL---------YDENYGP-LTWNLRVHI 215
           H N+VNL+G C + G  ++V V F   G+L+++L         Y + Y   LT    +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 216 ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANI 272
           +  VA+G+E+L   A    IHRD+ + NILL +    ++ DFGL+R+   D       + 
Sbjct: 150 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTG 331
           R    ++ PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E      EG   
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEG--- 263
Query: 332 WEEIVDSRLDGI-FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                 +R+    +   E+ +       C +  P +RP+  ++V+ L  +L+
Sbjct: 264 ------TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 146/295 (49%), Gaps = 42/295 (14%)
Query: 115 NFTTLIGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRL-H 166
           N    +G+GAFG V +A      + +T  TVAVK+L   +   E +   +E+ +L  + H
Sbjct: 31  NLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 167 HRNLVNLVGYCAEKGQHMLVYV-FMSKGSLASHLYDE--NYGP-----------LTWNLR 212
           H N+VNL+G C + G  ++V V F   G+L+++L  +   + P           LT    
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 213 VHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HA 269
           +  +  VA+G+E+L   A    IHRD+ + NILL +    ++ DFGL+R+   D      
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEG 328
            + R    ++ PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E      EG
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
Query: 329 KTGWEEIVDSRLDGI-FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                    +R+    +   E+ +       C +  P +RP+  ++V+ L  +L+
Sbjct: 268 ---------TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 129/269 (47%), Gaps = 24/269 (8%)
Query: 120 IGQGAFGPVYKAQMST-GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G G +G VY+        TVAVK L  D+ + E EF  E  ++  + H NLV L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            +    ++  FM+ G+L  +L + N   ++  + +++A  ++  +EYL        IHRD
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 134
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVY 296
           + + N L+ ++   +VADFGLSR    D   A+    F   +  PE ++   F+ KSDV+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 297 SFGVLLFELIA-GRSPLQGL--MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVA 353
           +FGVLL+E+   G SP  G+   +  EL               D R++      E  +V 
Sbjct: 195 AFGVLLWEIATYGMSPYPGIDPSQVYELLEK------------DYRMERPEGCPE--KVY 240
Query: 354 SLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
            L   C    P  RPS  +I Q    + +
Sbjct: 241 ELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 131/275 (47%), Gaps = 35/275 (12%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
            F   IG G FG V+       + VA+K +  +    E++F  E  ++ +L H  LV L 
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E+    LV  FM  G L+ +L  +  G       + + LDV  G+ YL +     V
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---V 125
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKK 292
           IHRD+ + N L+ ++   +V+DFG++R  + D++ ++    F   +  PE  S   ++ K
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 293 SDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWE-----EIVDSRLDGIFDVE 347
           SDV+SFGVL++E+                    +EGK  +E     E+V+    G F + 
Sbjct: 186 SDVWSFGVLMWEVF-------------------SEGKIPYENRSNSEVVEDISTG-FRLY 225
Query: 348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
           +    ++  Y+ +N   R+RP  R      SR+L+
Sbjct: 226 KPRLASTHVYQIMNHCWRERPEDRP---AFSRLLR 257

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 140/297 (47%), Gaps = 38/297 (12%)
Query: 108 DLQKATCNFTT-----------LIGQGAFGPVYKAQMSTGE-----TVAVKVLATDSKQG 151
           D  +A   FTT           +IG G FG VYK  + T        VA+K L     + 
Sbjct: 29  DPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK 88
Query: 152 EK-EFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWN 210
           ++ +F  E  ++G+  H N++ L G  ++    M++  +M  G+L   L +++ G  +  
Sbjct: 89  QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVL 147
Query: 211 LRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA 270
             V +   +A G++YL +      +HRD+ + NIL++ ++  +V+DFGLSR    D  A 
Sbjct: 148 QLVGMLRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 204
Query: 271 NI----RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMN 325
                 +    +  PE IS R FT  SDV+SFG++++E++  G  P   L  +  + A+N
Sbjct: 205 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
Query: 326 TEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                        RL    D    + +  L  +C  +   +RP   DIV +L ++++
Sbjct: 265 D----------GFRLPTPMDCP--SAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 145/291 (49%), Gaps = 43/291 (14%)
Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRL-HHRNLV 171
           +G+GAFG V +A      + +T  TVAVK+L   +   E +   +E+ +L  + HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 172 NLVGYCAEKGQHMLVYV-FMSKGSLASHLYDE--NYGP------------LTWNLRVHIA 216
           NL+G C + G  ++V V F   G+L+++L  +   + P            LT    +  +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIR 273
             VA+G+E+L   A    IHRD+ + NILL +    ++ DFGL+R+   D       + R
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 274 GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGW 332
               ++ PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E      EG    
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG---- 258
Query: 333 EEIVDSRLDGI-FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                +R+    +   E+ +       C +  P +RP+  ++V+ L  +L+
Sbjct: 259 -----TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 145/291 (49%), Gaps = 43/291 (14%)
Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRL-HHRNLV 171
           +G+GAFG V +A      + +T  TVAVK+L   +   E +   +E+ +L  + HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 172 NLVGYCAEKGQHMLVYV-FMSKGSLASHLYDE--NYGP------------LTWNLRVHIA 216
           NL+G C + G  ++V V F   G+L+++L  +   + P            LT    +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIR 273
             VA+G+E+L   A    IHRD+ + NILL +    ++ DFGL+R+   D       + R
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 274 GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGW 332
               ++ PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E      EG    
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG---- 267
Query: 333 EEIVDSRLDGI-FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                +R+    +   E+ +       C +  P +RP+  ++V+ L  +L+
Sbjct: 268 -----TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 145/291 (49%), Gaps = 43/291 (14%)
Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRL-HHRNLV 171
           +G+GAFG V +A      + +T  TVAVK+L   +   E +   +E+ +L  + HH N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 172 NLVGYCAEKGQHMLVYV-FMSKGSLASHLYDE--NYGP------------LTWNLRVHIA 216
           NL+G C + G  ++V V F   G+L+++L  +   + P            LT    +  +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIR 273
             VA+G+E+L   A    IHRD+ + NILL +    ++ DFGL+R+   D       + R
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 274 GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGW 332
               ++ PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E      EG    
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG---- 269
Query: 333 EEIVDSRLDGI-FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                +R+    +   E+ +       C +  P +RP+  ++V+ L  +L+
Sbjct: 270 -----TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQ 312

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 145/291 (49%), Gaps = 43/291 (14%)
Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRL-HHRNLV 171
           +G+GAFG V +A      + +T  TVAVK+L   +   E +   +E+ +L  + HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 172 NLVGYCAEKGQHMLVYV-FMSKGSLASHLYDE--NYGP------------LTWNLRVHIA 216
           NL+G C + G  ++V V F   G+L+++L  +   + P            LT    +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIR 273
             VA+G+E+L   A    IHRD+ + NILL +    ++ DFGL+R+   D       + R
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 274 GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGW 332
               ++ PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E      EG    
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG---- 267
Query: 333 EEIVDSRLDGI-FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                +R+    +   E+ +       C +  P +RP+  ++V+ L  +L+
Sbjct: 268 -----TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 145/291 (49%), Gaps = 43/291 (14%)
Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRL-HHRNLV 171
           +G+GAFG V +A      + +T  TVAVK+L   +   E +   +E+ +L  + HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 172 NLVGYCAEKGQHMLVYV-FMSKGSLASHLYDE--NYGP------------LTWNLRVHIA 216
           NL+G C + G  ++V V F   G+L+++L  +   + P            LT    +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIR 273
             VA+G+E+L   A    IHRD+ + NILL +    ++ DFGL+R+   D       + R
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 274 GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGW 332
               ++ PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E      EG    
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG---- 267
Query: 333 EEIVDSRLDGI-FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                +R+    +   E+ +       C +  P +RP+  ++V+ L  +L+
Sbjct: 268 -----TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 145/291 (49%), Gaps = 43/291 (14%)
Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRL-HHRNLV 171
           +G+GAFG V +A      + +T  TVAVK+L   +   E +   +E+ +L  + HH N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 172 NLVGYCAEKGQHMLVYV-FMSKGSLASHLYDE--NYGP------------LTWNLRVHIA 216
           NL+G C + G  ++V V F   G+L+++L  +   + P            LT    +  +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIR 273
             VA+G+E+L   A    IHRD+ + NILL +    ++ DFGL+R+   D       + R
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 274 GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGW 332
               ++ PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E      EG    
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG---- 304
Query: 333 EEIVDSRLDGI-FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                +R+    +   E+ +       C +  P +RP+  ++V+ L  +L+
Sbjct: 305 -----TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQ 347

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 75/206 (36%), Positives = 107/206 (51%), Gaps = 28/206 (13%)
Query: 121 GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180
            +G FG V+KAQ+   E VAVK+     KQ  +  + EV  L  + H N++  +G  AEK
Sbjct: 33  ARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIG--AEK 88
Query: 181 G------QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH------- 227
                     L+  F  KGSL+  L       ++WN   HIA  +ARGL YLH       
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG---YLDPEYI 284
           DG  P + HRDIKS N+LL  ++ A +ADFGL+ +    K A +  G  G   Y+ PE +
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205
Query: 285 -STRNFTKKS----DVYSFGVLLFEL 305
               NF + +    D+Y+ G++L+EL
Sbjct: 206 EGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 144/291 (49%), Gaps = 43/291 (14%)
Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRL-HHRNLV 171
           +G+GAFG V +A      + +T  TVAVK+L   +   E +   +E+ +L  + HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 172 NLVGYCAEKGQHMLVYV-FMSKGSLASHLYDE--NYGP------------LTWNLRVHIA 216
           NL+G C + G  ++V   F   G+L+++L  +   + P            LT    +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIR 273
             VA+G+E+L   A    IHRD+ + NILL +    ++ DFGL+R+   D       + R
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 274 GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGW 332
               ++ PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E      EG    
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG---- 258
Query: 333 EEIVDSRLDGI-FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                +R+    +   E+ +       C +  P +RP+  ++V+ L  +L+
Sbjct: 259 -----TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 144/291 (49%), Gaps = 43/291 (14%)
Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRL-HHRNLV 171
           +G+GAFG V +A      + +T  TVAVK+L   +   E +   +E+ +L  + HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 172 NLVGYCAEKGQHMLVYV-FMSKGSLASHLYDE--NYGP------------LTWNLRVHIA 216
           NL+G C + G  ++V   F   G+L+++L  +   + P            LT    +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIR 273
             VA+G+E+L   A    IHRD+ + NILL +    ++ DFGL+R+   D       + R
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 274 GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGW 332
               ++ PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E      EG    
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG---- 258
Query: 333 EEIVDSRLDGI-FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                +R+    +   E+ +       C +  P +RP+  ++V+ L  +L+
Sbjct: 259 -----TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 137/294 (46%), Gaps = 47/294 (15%)
Query: 116 FTTLIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
           F   +G+G FG V        Q +TGE VAVK L   +++  ++F+ E+ +L  L H N+
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 171 VNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIAL-----DVARG 222
           V   G C   G+    L+  F+  GSL  +L            R+ HI L      + +G
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKE-------RIDHIKLLQYTSQICKG 129
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGY 278
           +EYL        IHRD+ + NIL++   R ++ DFGL++    DK    ++        +
Sbjct: 130 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 186
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA----GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             PE ++   F+  SDV+SFGV+L+EL       +SP     E++ +   + +G+     
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP---PAEFMRMIGNDKQGQMIVFH 243
Query: 335 IVD--------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           +++         R DG  D     E+  +  +C N    +RPS RD+   + +I
Sbjct: 244 LIELLKNNGRLPRPDGCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 107/200 (53%), Gaps = 8/200 (4%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G G +G VY         TVAVK L  D+ + E EF  E  ++  + H NLV L+G C 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            +    +V  +M  G+L  +L + N   +T  + +++A  ++  +EYL        IHRD
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKN---FIHRD 155
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVY 296
           + + N L+ ++   +VADFGLSR    D + A+    F   +  PE ++   F+ KSDV+
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVW 215
Query: 297 SFGVLLFELIA-GRSPLQGL 315
           +FGVLL+E+   G SP  G+
Sbjct: 216 AFGVLLWEIATYGMSPYPGI 235

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 144/291 (49%), Gaps = 43/291 (14%)
Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRL-HHRNLV 171
           +G+GAFG V +A      + +T  TVAVK+L   +   E +   +E+ +L  + HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 172 NLVGYCAEKGQHMLVYV-FMSKGSLASHLYDE--NYGP------------LTWNLRVHIA 216
           NL+G C + G  ++V   F   G+L+++L  +   + P            LT    +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIR 273
             VA+G+E+L   A    IHRD+ + NILL +    ++ DFGL+R+   D       + R
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 274 GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGW 332
               ++ PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E      EG    
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG---- 258
Query: 333 EEIVDSRLDGI-FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                +R+    +   E+ +       C +  P +RP+  ++V+ L  +L+
Sbjct: 259 -----TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 103/194 (53%), Gaps = 10/194 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG+G FG V       G  VAVK +  D+    + F  E  ++ +L H NLV L+G   E
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 180 -KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            KG   +V  +M+KGSL  +L       L  +  +  +LDV   +EYL        +HRD
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRD 314
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSF 298
           + + N+L+ +   A+V+DFGL++E    +    +     +  PE +  + F+ KSDV+SF
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWSF 372
Query: 299 GVLLFELIA-GRSP 311
           G+LL+E+ + GR P
Sbjct: 373 GILLWEIYSFGRVP 386

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 103/194 (53%), Gaps = 10/194 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG+G FG V       G  VAVK +  D+    + F  E  ++ +L H NLV L+G   E
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 180 -KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            KG   +V  +M+KGSL  +L       L  +  +  +LDV   +EYL        +HRD
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRD 142
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSF 298
           + + N+L+ +   A+V+DFGL++E    +    +     +  PE +  + F+ KSDV+SF
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWSF 200
Query: 299 GVLLFELIA-GRSP 311
           G+LL+E+ + GR P
Sbjct: 201 GILLWEIYSFGRVP 214

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 103/194 (53%), Gaps = 10/194 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG+G FG V       G  VAVK +  D+    + F  E  ++ +L H NLV L+G   E
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 180 -KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            KG   +V  +M+KGSL  +L       L  +  +  +LDV   +EYL        +HRD
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRD 127
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSF 298
           + + N+L+ +   A+V+DFGL++E    +    +     +  PE +  + F+ KSDV+SF
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWSF 185
Query: 299 GVLLFELIA-GRSP 311
           G+LL+E+ + GR P
Sbjct: 186 GILLWEIYSFGRVP 199

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 137/294 (46%), Gaps = 47/294 (15%)
Query: 116 FTTLIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
           F   +G+G FG V        Q +TGE VAVK L   +++  ++F+ E+ +L  L H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 171 VNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIAL-----DVARG 222
           V   G C   G+    L+  ++  GSL  +L            R+ HI L      + +G
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-------RIDHIKLLQYTSQICKG 126
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGY 278
           +EYL        IHRD+ + NIL++   R ++ DFGL++    DK    ++        +
Sbjct: 127 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 183
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA----GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             PE ++   F+  SDV+SFGV+L+EL       +SP     E++ +   + +G+     
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP---PAEFMRMIGNDKQGQMIVFH 240
Query: 335 IVD--------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           +++         R DG  D     E+  +  +C N    +RPS RD+   + +I
Sbjct: 241 LIELLKNNGRLPRPDGCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 137/294 (46%), Gaps = 47/294 (15%)
Query: 116 FTTLIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
           F   +G+G FG V        Q +TGE VAVK L   +++  ++F+ E+ +L  L H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 171 VNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIAL-----DVARG 222
           V   G C   G+    L+  ++  GSL  +L            R+ HI L      + +G
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-------RIDHIKLLQYTSQICKG 129
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGY 278
           +EYL        IHRD+ + NIL++   R ++ DFGL++    DK    ++        +
Sbjct: 130 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 186
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA----GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             PE ++   F+  SDV+SFGV+L+EL       +SP     E++ +   + +G+     
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP---PAEFMRMIGNDKQGQMIVFH 243
Query: 335 IVD--------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           +++         R DG  D     E+  +  +C N    +RPS RD+   + +I
Sbjct: 244 LIELLKNNGRLPRPDGCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 137/294 (46%), Gaps = 47/294 (15%)
Query: 116 FTTLIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
           F   +G+G FG V        Q +TGE VAVK L   +++  ++F+ E+ +L  L H N+
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 171 VNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIAL-----DVARG 222
           V   G C   G+    L+  ++  GSL  +L            R+ HI L      + +G
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-------RIDHIKLLQYTSQICKG 124
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGY 278
           +EYL        IHRD+ + NIL++   R ++ DFGL++    DK    ++        +
Sbjct: 125 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 181
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA----GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             PE ++   F+  SDV+SFGV+L+EL       +SP     E++ +   + +G+     
Sbjct: 182 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP---PAEFMRMIGNDKQGQMIVFH 238
Query: 335 IVD--------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           +++         R DG  D     E+  +  +C N    +RPS RD+   + +I
Sbjct: 239 LIELLKNNGRLPRPDGCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQI 287

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 137/294 (46%), Gaps = 47/294 (15%)
Query: 116 FTTLIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
           F   +G+G FG V        Q +TGE VAVK L   +++  ++F+ E+ +L  L H N+
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 171 VNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIAL-----DVARG 222
           V   G C   G+    L+  ++  GSL  +L            R+ HI L      + +G
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-------RIDHIKLLQYTSQICKG 131
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGY 278
           +EYL        IHRD+ + NIL++   R ++ DFGL++    DK    ++        +
Sbjct: 132 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 188
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA----GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             PE ++   F+  SDV+SFGV+L+EL       +SP     E++ +   + +G+     
Sbjct: 189 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP---PAEFMRMIGNDKQGQMIVFH 245
Query: 335 IVD--------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           +++         R DG  D     E+  +  +C N    +RPS RD+   + +I
Sbjct: 246 LIELLKNNGRLPRPDGCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQI 294

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 137/294 (46%), Gaps = 47/294 (15%)
Query: 116 FTTLIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
           F   +G+G FG V        Q +TGE VAVK L   +++  ++F+ E+ +L  L H N+
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 171 VNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIAL-----DVARG 222
           V   G C   G+    L+  ++  GSL  +L            R+ HI L      + +G
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-------RIDHIKLLQYTSQICKG 133
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGY 278
           +EYL        IHRD+ + NIL++   R ++ DFGL++    DK    ++        +
Sbjct: 134 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 190
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA----GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             PE ++   F+  SDV+SFGV+L+EL       +SP     E++ +   + +G+     
Sbjct: 191 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP---PAEFMRMIGNDKQGQMIVFH 247
Query: 335 IVD--------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           +++         R DG  D     E+  +  +C N    +RPS RD+   + +I
Sbjct: 248 LIELLKNNGRLPRPDGCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQI 296

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 137/294 (46%), Gaps = 47/294 (15%)
Query: 116 FTTLIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
           F   +G+G FG V        Q +TGE VAVK L   +++  ++F+ E+ +L  L H N+
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 171 VNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIAL-----DVARG 222
           V   G C   G+    L+  ++  GSL  +L            R+ HI L      + +G
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-------RIDHIKLLQYTSQICKG 125
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGY 278
           +EYL        IHRD+ + NIL++   R ++ DFGL++    DK    ++        +
Sbjct: 126 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 182
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA----GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             PE ++   F+  SDV+SFGV+L+EL       +SP     E++ +   + +G+     
Sbjct: 183 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP---PAEFMRMIGNDKQGQMIVFH 239
Query: 335 IVD--------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           +++         R DG  D     E+  +  +C N    +RPS RD+   + +I
Sbjct: 240 LIELLKNNGRLPRPDGCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQI 288

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 137/294 (46%), Gaps = 47/294 (15%)
Query: 116 FTTLIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
           F   +G+G FG V        Q +TGE VAVK L   +++  ++F+ E+ +L  L H N+
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 171 VNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIAL-----DVARG 222
           V   G C   G+    L+  ++  GSL  +L            R+ HI L      + +G
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-------RIDHIKLLQYTSQICKG 132
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGY 278
           +EYL        IHRD+ + NIL++   R ++ DFGL++    DK    ++        +
Sbjct: 133 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 189
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA----GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             PE ++   F+  SDV+SFGV+L+EL       +SP     E++ +   + +G+     
Sbjct: 190 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP---PAEFMRMIGNDKQGQMIVFH 246
Query: 335 IVD--------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           +++         R DG  D     E+  +  +C N    +RPS RD+   + +I
Sbjct: 247 LIELLKNNGRLPRPDGCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQI 295

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 137/294 (46%), Gaps = 47/294 (15%)
Query: 116 FTTLIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
           F   +G+G FG V        Q +TGE VAVK L   +++  ++F+ E+ +L  L H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 171 VNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIAL-----DVARG 222
           V   G C   G+    L+  ++  GSL  +L            R+ HI L      + +G
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-------RIDHIKLLQYTSQICKG 126
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGY 278
           +EYL        IHRD+ + NIL++   R ++ DFGL++    DK    ++        +
Sbjct: 127 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 183
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA----GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             PE ++   F+  SDV+SFGV+L+EL       +SP     E++ +   + +G+     
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP---PAEFMRMIGNDKQGQMIVFH 240
Query: 335 IVD--------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           +++         R DG  D     E+  +  +C N    +RPS RD+   + +I
Sbjct: 241 LIELLKNNGRLPRPDGCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 137/294 (46%), Gaps = 47/294 (15%)
Query: 116 FTTLIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
           F   +G+G FG V        Q +TGE VAVK L   +++  ++F+ E+ +L  L H N+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 171 VNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIAL-----DVARG 222
           V   G C   G+    L+  ++  GSL  +L            R+ HI L      + +G
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-------RIDHIKLLQYTSQICKG 144
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGY 278
           +EYL        IHRD+ + NIL++   R ++ DFGL++    DK    ++        +
Sbjct: 145 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 201
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA----GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             PE ++   F+  SDV+SFGV+L+EL       +SP     E++ +   + +G+     
Sbjct: 202 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP---PAEFMRMIGNDKQGQMIVFH 258
Query: 335 IVD--------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           +++         R DG  D     E+  +  +C N    +RPS RD+   + +I
Sbjct: 259 LIELLKNNGRLPRPDGCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQI 307

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 137/294 (46%), Gaps = 47/294 (15%)
Query: 116 FTTLIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
           F   +G+G FG V        Q +TGE VAVK L   +++  ++F+ E+ +L  L H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 171 VNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIAL-----DVARG 222
           V   G C   G+    L+  ++  GSL  +L            R+ HI L      + +G
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-------RIDHIKLLQYTSQICKG 157
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGY 278
           +EYL        IHRD+ + NIL++   R ++ DFGL++    DK    ++        +
Sbjct: 158 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 214
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA----GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             PE ++   F+  SDV+SFGV+L+EL       +SP     E++ +   + +G+     
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP---PAEFMRMIGNDKQGQMIVFH 271
Query: 335 IVD--------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           +++         R DG  D     E+  +  +C N    +RPS RD+   + +I
Sbjct: 272 LIELLKNNGRLPRPDGCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQI 320

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 137/294 (46%), Gaps = 47/294 (15%)
Query: 116 FTTLIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
           F   +G+G FG V        Q +TGE VAVK L   +++  ++F+ E+ +L  L H N+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 171 VNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIAL-----DVARG 222
           V   G C   G+    L+  ++  GSL  +L            R+ HI L      + +G
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-------RIDHIKLLQYTSQICKG 144
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGY 278
           +EYL        IHRD+ + NIL++   R ++ DFGL++    DK    ++        +
Sbjct: 145 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 201
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA----GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             PE ++   F+  SDV+SFGV+L+EL       +SP     E++ +   + +G+     
Sbjct: 202 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP---PAEFMRMIGNDKQGQMIVFH 258
Query: 335 IVD--------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           +++         R DG  D     E+  +  +C N    +RPS RD+   + +I
Sbjct: 259 LIELLKNNGRLPRPDGCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQI 307

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 137/294 (46%), Gaps = 47/294 (15%)
Query: 116 FTTLIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
           F   +G+G FG V        Q +TGE VAVK L   +++  ++F+ E+ +L  L H N+
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 171 VNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIAL-----DVARG 222
           V   G C   G+    L+  ++  GSL  +L            R+ HI L      + +G
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-------RIDHIKLLQYTSQICKG 130
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGY 278
           +EYL        IHRD+ + NIL++   R ++ DFGL++    DK    ++        +
Sbjct: 131 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 187
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA----GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             PE ++   F+  SDV+SFGV+L+EL       +SP     E++ +   + +G+     
Sbjct: 188 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP---PAEFMRMIGNDKQGQMIVFH 244
Query: 335 IVD--------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           +++         R DG  D     E+  +  +C N    +RPS RD+   + +I
Sbjct: 245 LIELLKNNGRLPRPDGCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQI 293

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 131/282 (46%), Gaps = 39/282 (13%)
Query: 120 IGQGAFGPVYKAQM------STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+GAFG V+ A+            VAVK L   +    K+FQ E  LL  L H ++V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 174 VGYCAEKGQHMLVYVFMSKGSL----------ASHLYD----ENYGPLTWNLRVHIALDV 219
            G C +    ++V+ +M  G L          A  L D    +  G L  +  +HIA  +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH---AANIRGTF 276
           A G+ YL   A    +HRD+ + N L+  ++  ++ DFG+SR+     +     +     
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEI 335
            ++ PE I  R FT +SDV+SFGV+L+E+   G+ P   L    E+    T+G+      
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-TEVIECITQGRVLERPR 258
Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
           V  +           EV  +   C  R P++R ++++I ++L
Sbjct: 259 VCPK-----------EVYDVMLGCWQREPQQRLNIKEIYKIL 289

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 137/294 (46%), Gaps = 47/294 (15%)
Query: 116 FTTLIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
           F   +G+G FG V        Q +TGE VAVK L   +++  ++F+ E+ +L  L H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 171 VNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIAL-----DVARG 222
           V   G C   G+    L+  ++  GSL  +L            R+ HI L      + +G
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-------RIDHIKLLQYTSQICKG 126
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGY 278
           +EYL        IHRD+ + NIL++   R ++ DFGL++    DK    ++        +
Sbjct: 127 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA----GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             PE ++   F+  SDV+SFGV+L+EL       +SP     E++ +   + +G+     
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP---PAEFMRMIGNDKQGQMIVFH 240
Query: 335 IVD--------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           +++         R DG  D     E+  +  +C N    +RPS RD+   + +I
Sbjct: 241 LIELLKNNGRLPRPDGCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 137/294 (46%), Gaps = 47/294 (15%)
Query: 116 FTTLIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
           F   +G+G FG V        Q +TGE VAVK L   +++  ++F+ E+ +L  L H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 171 VNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIAL-----DVARG 222
           V   G C   G+    L+  ++  GSL  +L            R+ HI L      + +G
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAE-------RIDHIKLLQYTSQICKG 129
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGY 278
           +EYL        IHRD+ + NIL++   R ++ DFGL++    DK    ++        +
Sbjct: 130 MEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 186
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA----GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             PE ++   F+  SDV+SFGV+L+EL       +SP     E++ +   + +G+     
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP---PAEFMRMIGNDKQGQMIVFH 243
Query: 335 IVD--------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           +++         R DG  D     E+  +  +C N    +RPS RD+   + +I
Sbjct: 244 LIELLKNNGRLPRPDGCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQI 292

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 137/285 (48%), Gaps = 23/285 (8%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           +L++        +G G FG V   +      VAVK++   S   E EF  E   + +L H
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSH 62
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
             LV   G C+++    +V  ++S G L ++L     G L  +  + +  DV  G+ +L 
Sbjct: 63  PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLE 121
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYIS 285
                  IHRD+ + N L+D+ +  +V+DFG++R  + D++ +++   F   +  PE   
Sbjct: 122 SHQF---IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFH 178
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF 344
              ++ KSDV++FG+L++E+ + G+ P   L    E+    ++G   +   + S  D I+
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYD-LYTNSEVVLKVSQGHRLYRPHLAS--DTIY 235
Query: 345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKH 389
            +          Y C +  P KRP+ +   Q+LS I  +R   KH
Sbjct: 236 QI---------MYSCWHELPEKRPTFQ---QLLSSIEPLREKDKH 268

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 102/194 (52%), Gaps = 10/194 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG+G FG V       G  VAVK +  D+    + F  E  ++ +L H NLV L+G   E
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 180 -KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            KG   +V  +M+KGSL  +L       L  +  +  +LDV   +EYL        +HRD
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRD 133
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSF 298
           + + N+L+ +   A+V+DFGL++E    +    +     +  PE +    F+ KSDV+SF
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREAAFSTKSDVWSF 191
Query: 299 GVLLFELIA-GRSP 311
           G+LL+E+ + GR P
Sbjct: 192 GILLWEIYSFGRVP 205

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 127/286 (44%), Gaps = 40/286 (13%)
Query: 120 IGQGAFGPVYKAQM------STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+GAFG V+ A+            VAVK L   S    K+F  E  LL  L H ++V  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP-------------LTWNLRVHIALDVA 220
            G C E    ++V+ +M  G L   L    +GP             LT +  +HIA  +A
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFL--RAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH---AANIRGTFG 277
            G+ YL   A    +HRD+ + N L+ +++  ++ DFG+SR+     +     +      
Sbjct: 139 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 195
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           ++ PE I  R FT +SDV+S GV+L+E+   G+ P   L    E+    T+G+       
Sbjct: 196 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EVIECITQGRVLQRPRT 254
Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             +           EV  L   C  R P  R +++ I  +L  + K
Sbjct: 255 CPQ-----------EVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 139/302 (46%), Gaps = 34/302 (11%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGE-----TVAVKVLATDSK 149
           +  + +P     +  +    F   +G GAFG V +A     G+      VAVK+L + + 
Sbjct: 22  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 81
Query: 150 QGEKE-FQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-------Y 200
             EKE   +E+ ++  L  H N+VNL+G C   G  +++  +   G L + L        
Sbjct: 82  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADL 141
Query: 201 DENYG-PLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL 259
           D+  G PL     +H +  VA+G+ +L   A    IHRD+ + N+LL     A++ DFGL
Sbjct: 142 DKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGL 198
Query: 260 SREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
           +R+ M D +     N R    ++ PE I    +T +SDV+S+G+LL+E+ + G +P  G+
Sbjct: 199 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 258
Query: 316 MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
           +   +   +  +G    +     +            + S+   C    P  RP+ + I  
Sbjct: 259 LVNSKFYKLVKDGYQMAQPAFAPK-----------NIYSIMQACWALEPTHRPTFQQICS 307
Query: 376 VL 377
            L
Sbjct: 308 FL 309

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 139/302 (46%), Gaps = 34/302 (11%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGE-----TVAVKVLATDSK 149
           +  + +P     +  +    F   +G GAFG V +A     G+      VAVK+L + + 
Sbjct: 30  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 150 QGEKE-FQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-------Y 200
             EKE   +E+ ++  L  H N+VNL+G C   G  +++  +   G L + L        
Sbjct: 90  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADL 149
Query: 201 DENYG-PLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL 259
           D+  G PL     +H +  VA+G+ +L   A    IHRD+ + N+LL     A++ DFGL
Sbjct: 150 DKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGL 206
Query: 260 SREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
           +R+ M D +     N R    ++ PE I    +T +SDV+S+G+LL+E+ + G +P  G+
Sbjct: 207 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 266
Query: 316 MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
           +   +   +  +G    +     +            + S+   C    P  RP+ + I  
Sbjct: 267 LVNSKFYKLVKDGYQMAQPAFAPK-----------NIYSIMQACWALEPTHRPTFQQICS 315
Query: 376 VL 377
            L
Sbjct: 316 FL 317

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 141/286 (49%), Gaps = 26/286 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMS-TGE---TVAVKVLATD-SKQGEKEFQTEVML 161
           K+++ +      +IG G FG V   ++   G+    VA+K L    +++  ++F  E  +
Sbjct: 17  KEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASI 76
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N+++L G   +    M+V  +M  GSL + L  +N G  T    V +   ++ 
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL-KKNDGQFTVIQLVGMLRGISA 135
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TFG 277
           G++YL D      +HRD+ + NIL++ ++  +V+DFGLSR    D  AA   RG      
Sbjct: 136 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 192
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           +  PE I+ R FT  SDV+S+G++++E+++ G  P      Y E+   N +     EE  
Sbjct: 193 WTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP------YWEMT--NQDVIKAVEE-- 242
Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             RL    D      +  L   C  +    RP   +IV +L ++++
Sbjct: 243 GYRLPSPMDCPA--ALYQLMLDCWQKERNSRPKFDEIVNMLDKLIR 286

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 26/286 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAVKVLATD-SKQGEKEFQTEVML 161
           K+L     +   ++G G FG V   ++        +VA+K L    +++  ++F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N++ L G   +    M+V  +M  GSL S L   +    T    V +   +A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIAS 158
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TFG 277
           G++YL D      +HRD+ + NIL++ ++  +V+DFGLSR    D  AA   RG      
Sbjct: 159 GMKYLSDMGF---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           +  PE I+ R FT  SDV+S+G++L+E+++ G  P   +     + A++ EG        
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EG-------- 266
Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             RL    D      +  L   C  +    RP    IV +L ++++
Sbjct: 267 -YRLPPPMDCPA--ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 26/286 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAVKVLATD-SKQGEKEFQTEVML 161
           K+L     +   ++G G FG V   ++        +VA+K L    +++  ++F  E  +
Sbjct: 38  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 97
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N++ L G   +    M+V  +M  GSL S L   +    T    V +   +A 
Sbjct: 98  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIAS 156
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TFG 277
           G++YL D      +HRD+ + NIL++ ++  +V+DFGLSR    D  AA   RG      
Sbjct: 157 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 213
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           +  PE I+ R FT  SDV+S+G++L+E+++ G  P   +     + A++ EG        
Sbjct: 214 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EG-------- 264
Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             RL    D      +  L   C  +    RP    IV +L ++++
Sbjct: 265 -YRLPPPMDCPA--ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 307

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 137/294 (46%), Gaps = 47/294 (15%)
Query: 116 FTTLIGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
           F   +G+G FG V        Q +TGE VAVK L   +++  ++F+ E+ +L  L H N+
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 171 VNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIAL-----DVARG 222
           V   G C   G+    L+  ++  GSL  +L            R+ HI L      + +G
Sbjct: 75  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-------RIDHIKLLQYTSQICKG 127
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGY 278
           +EYL        IHR++ + NIL++   R ++ DFGL++    DK    ++        +
Sbjct: 128 MEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 184
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA----GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             PE ++   F+  SDV+SFGV+L+EL       +SP     E++ +   + +G+     
Sbjct: 185 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP---PAEFMRMIGNDKQGQMIVFH 241
Query: 335 IVD--------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           +++         R DG  D     E+  +  +C N    +RPS RD+   + +I
Sbjct: 242 LIELLKNNGRLPRPDGCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQI 290

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 26/286 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAVKVLATD-SKQGEKEFQTEVML 161
           K+L     +   ++G G FG V   ++        +VA+K L    +++  ++F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N++ L G   +    M+V  +M  GSL S L   +    T    V +   +A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIAS 158
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TFG 277
           G++YL D      +HRD+ + NIL++ ++  +V+DFGLSR    D  AA   RG      
Sbjct: 159 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           +  PE I+ R FT  SDV+S+G++L+E+++ G  P   +     + A++ EG        
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EG-------- 266
Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             RL    D      +  L   C  +    RP    IV +L ++++
Sbjct: 267 -YRLPPPMDCPA--ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 26/286 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAVKVLATD-SKQGEKEFQTEVML 161
           K+L     +   ++G G FG V   ++        +VA+K L    +++  ++F  E  +
Sbjct: 28  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 87
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N++ L G   +    M+V  +M  GSL S L   +    T    V +   +A 
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIAS 146
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TFG 277
           G++YL D      +HRD+ + NIL++ ++  +V+DFGLSR    D  AA   RG      
Sbjct: 147 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 203
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           +  PE I+ R FT  SDV+S+G++L+E+++ G  P   +     + A++ EG        
Sbjct: 204 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EG-------- 254
Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             RL    D      +  L   C  +    RP    IV +L ++++
Sbjct: 255 -YRLPPPMDCPA--ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 297

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 26/286 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAVKVLATD-SKQGEKEFQTEVML 161
           K+L     +   ++G G FG V   ++        +VA+K L    +++  ++F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N++ L G   +    M+V  +M  GSL S L   +    T    V +   +A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIAS 158
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TFG 277
           G++YL D      +HRD+ + NIL++ ++  +V+DFGLSR    D  AA   RG      
Sbjct: 159 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           +  PE I+ R FT  SDV+S+G++L+E+++ G  P   +     + A++ EG        
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EG-------- 266
Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             RL    D      +  L   C  +    RP    IV +L ++++
Sbjct: 267 -YRLPPPMDCPA--ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 26/286 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAVKVLATD-SKQGEKEFQTEVML 161
           K+L     +   ++G G FG V   ++        +VA+K L    +++  ++F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N++ L G   +    M+V  +M  GSL S L   +    T    V +   +A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIAS 158
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TFG 277
           G++YL D      +HRD+ + NIL++ ++  +V+DFGLSR    D  AA   RG      
Sbjct: 159 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           +  PE I+ R FT  SDV+S+G++L+E+++ G  P   +     + A++ EG        
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EG-------- 266
Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             RL    D      +  L   C  +    RP    IV +L ++++
Sbjct: 267 -YRLPPPMDCPA--ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 26/286 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAVKVLATD-SKQGEKEFQTEVML 161
           K+L     +   ++G G FG V   ++        +VA+K L    +++  ++F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N++ L G   +    M+V  +M  GSL S L   +    T    V +   +A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIAS 158
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TFG 277
           G++YL D      +HRD+ + NIL++ ++  +V+DFGLSR    D  AA   RG      
Sbjct: 159 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           +  PE I+ R FT  SDV+S+G++L+E+++ G  P   +     + A++ EG        
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EG-------- 266
Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             RL    D      +  L   C  +    RP    IV +L ++++
Sbjct: 267 -YRLPPPMDCPA--ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 26/286 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAVKVLATD-SKQGEKEFQTEVML 161
           K+L     +   ++G G FG V   ++        +VA+K L    +++  ++F  E  +
Sbjct: 11  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N++ L G   +    M+V  +M  GSL S L   +    T    V +   +A 
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIAS 129
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TFG 277
           G++YL D      +HRD+ + NIL++ ++  +V+DFGLSR    D  AA   RG      
Sbjct: 130 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           +  PE I+ R FT  SDV+S+G++L+E+++ G  P   +     + A++ EG        
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EG-------- 237
Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             RL    D      +  L   C  +    RP    IV +L ++++
Sbjct: 238 -YRLPPPMDCPA--ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 141/308 (45%), Gaps = 40/308 (12%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGE-----TVAVKVLATDSK 149
           +  + +P     +  +    F   +G GAFG V +A     G+      VAVK+L + + 
Sbjct: 30  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 150 QGEKE-FQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-------- 199
             EKE   +E+ ++  L  H N+VNL+G C   G  +++  +   G L + L        
Sbjct: 90  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGL 149
Query: 200 ---YDENYGP---LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR 253
              Y+ ++ P   L+    +H +  VA+G+ +L   A    IHRD+ + N+LL     A+
Sbjct: 150 EYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAK 206
Query: 254 VADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GR 309
           + DFGL+R+ M D +     N R    ++ PE I    +T +SDV+S+G+LL+E+ + G 
Sbjct: 207 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 266
Query: 310 SPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPS 369
           +P  G++   +   +  +G    +     +            + S+   C    P  RP+
Sbjct: 267 NPYPGILVNSKFYKLVKDGYQMAQPAFAPK-----------NIYSIMQACWALEPTHRPT 315
Query: 370 MRDIVQVL 377
            + I   L
Sbjct: 316 FQQICSFL 323

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 114/214 (53%), Gaps = 15/214 (7%)
Query: 106 YKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGE--KEFQTEVMLLG 163
           Y +++ +    +T IG G+FG VYK +      VAVK+L       E  + F+ EV +L 
Sbjct: 30  YWEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLR 87
Query: 164 RLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
           +  H N++  +GY   K    +V  +    SL  HL+ +      + L + IA   A+G+
Sbjct: 88  KTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQL-IDIARQTAQGM 145
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLD 280
           +YLH      +IHRD+KS+NI L + +  ++ DFGL+  +     +  +    G+  ++ 
Sbjct: 146 DYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMA 202
Query: 281 PEYISTRN---FTKKSDVYSFGVLLFELIAGRSP 311
           PE I  ++   F+ +SDVYS+G++L+EL+ G  P
Sbjct: 203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 84/311 (27%), Positives = 140/311 (45%), Gaps = 50/311 (16%)
Query: 103 EYSYK---DLQKATCNFTTLIGQGAFGPVYKAQM----STGET--VAVKVLATDSKQGEK 153
           EY Y    +  +    F  ++G GAFG V  A       TG +  VAVK+L   +   E+
Sbjct: 33  EYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER 92
Query: 154 E-FQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLY----------- 200
           E   +E+ ++ +L  H N+VNL+G C   G   L++ +   G L ++L            
Sbjct: 93  EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 152
Query: 201 ----------DENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM 250
                     +E+   LT+   +  A  VA+G+E+L        +HRD+ + N+L+    
Sbjct: 153 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGK 209
Query: 251 RARVADFGLSREEMVDKHAA---NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
             ++ DFGL+R+ M D +     N R    ++ PE +    +T KSDV+S+G+LL+E+ +
Sbjct: 210 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
Query: 308 -GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRK 366
            G +P  G+        +   G          ++D  F   E  E+  +   C     RK
Sbjct: 270 LGVNPYPGIPVDANFYKLIQNG---------FKMDQPFYATE--EIYIIMQSCWAFDSRK 318
Query: 367 RPSMRDIVQVL 377
           RPS  ++   L
Sbjct: 319 RPSFPNLTSFL 329

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 136/287 (47%), Gaps = 28/287 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAVKVLATD-SKQGEKEFQTEVML 161
           K+L     +   ++G G FG V   ++        +VA+K L    +++  ++F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N++ L G   +    M+V   M  GSL S L   +    T    V +   +A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD-AQFTVIQLVGMLRGIAS 158
Query: 222 GLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TF 276
           G++YL D GAV    HRD+ + NIL++ ++  +V+DFGLSR    D  AA   RG     
Sbjct: 159 GMKYLSDMGAV----HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEI 335
            +  PE I+ R FT  SDV+S+G++L+E+++ G  P   +     + A++ EG       
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EG------- 266
Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
              RL    D      +  L   C  +    RP    IV +L ++++
Sbjct: 267 --YRLPPPMDCPA--ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 93/314 (29%), Positives = 139/314 (44%), Gaps = 43/314 (13%)
Query: 91  KRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGET-VAVK----VLA 145
           K+S VV    +P+  +  L          IG+G FG V+  ++    T VAVK     L 
Sbjct: 94  KKSGVVLHRAVPKDKWV-LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP 152
Query: 146 TDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYG 205
            D K    +F  E  +L +  H N+V L+G C +K    +V   +  G   + L  E   
Sbjct: 153 PDLK---AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA- 208
Query: 206 PLTWNLRVHIAL----DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261
                LRV   L    D A G+EYL        IHRD+ + N L+ +    +++DFG+SR
Sbjct: 209 ----RLRVKTLLQMVGDAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSR 261
Query: 262 EEMVDKHAAN--IRGT-FGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317
           EE    +AA+  +R     +  PE ++   ++ +SDV+SFG+LL+E  + G SP   L  
Sbjct: 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321
Query: 318 YVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
                 +   G+    E+     D +F + E         +C    P +RPS   I Q L
Sbjct: 322 QQTREFVEKGGRLPCPELCP---DAVFRLME---------QCWAYEPGQRPSFSTIYQEL 369
Query: 378 SRILKMRHNRKHHR 391
             I      RK HR
Sbjct: 370 QSI------RKRHR 377

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 135/286 (47%), Gaps = 26/286 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAVKVLATD-SKQGEKEFQTEVML 161
           K+L     +   ++G G FG V   ++        +VA+K L    +++  ++F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N++ L G   +    M+V  +M  GSL S L   +    T    V +   +A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIAS 158
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TFG 277
           G++YL D      +HRD+ + NIL++ ++  +V+DFGL+R    D  AA   RG      
Sbjct: 159 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIR 215
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           +  PE I+ R FT  SDV+S+G++L+E+++ G  P   +     + A++ EG        
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EG-------- 266
Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             RL    D      +  L   C  +    RP    IV +L ++++
Sbjct: 267 -YRLPPPMDCPA--ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 113/217 (52%), Gaps = 15/217 (6%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG G+FG VYK +      VAVK+L     + Q  + F+ EV +L +  H N++  +GY 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 88
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
           + K Q  +V  +    SL  HL+            + IA   ARG++YLH  ++   IHR
Sbjct: 89  STKPQLAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLHAKSI---IHR 144
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMV---DKHAANIRGTFGYLDPEYISTRN---FTK 291
           D+KS+NI L +    ++ DFGL+ E+           + G+  ++ PE I  ++   ++ 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG 328
           +SDVY+FG++L+EL+ G+ P   +    ++  M   G
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG 241

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 8/200 (4%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  + +V  +MSKGSL   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 334 EPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 389
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYISTRNFTKKSDVYS 297
           +++NIL+ +++  +VADFGL+R    +++ A     F   +  PE      FT KSDV+S
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 298 FGVLLFELIA-GRSPLQGLM 316
           FG+LL EL   GR P  G++
Sbjct: 450 FGILLTELTTKGRVPYPGMV 469

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 8/200 (4%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  + +V  +MSKGSL   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 78  EPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 133
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYISTRNFTKKSDVYS 297
           +++NIL+ +++  +VADFGL+R    +++ A     F   +  PE      FT KSDV+S
Sbjct: 134 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 193
Query: 298 FGVLLFELIA-GRSPLQGLM 316
           FG+LL EL   GR P  G++
Sbjct: 194 FGILLTELTTKGRVPYPGMV 213

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 8/200 (4%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  + +V  +MSKGSL   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 251 EPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 306
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVYS 297
           +++NIL+ +++  +VADFGL+R    +++ A     F   +  PE      FT KSDV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 298 FGVLLFELIA-GRSPLQGLM 316
           FG+LL EL   GR P  G++
Sbjct: 367 FGILLTELTTKGRVPYPGMV 386

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 8/200 (4%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  + +V  +MSKGSL   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 251 EPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 306
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVYS 297
           +++NIL+ +++  +VADFGL+R    +++ A     F   +  PE      FT KSDV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 298 FGVLLFELIA-GRSPLQGLM 316
           FG+LL EL   GR P  G++
Sbjct: 367 FGILLTELTTKGRVPYPGMV 386

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 134/286 (46%), Gaps = 26/286 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAVKVLATD-SKQGEKEFQTEVML 161
           K+L     +   ++G G FG V   ++        +VA+K L    +++  ++F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N++ L G   +    M+V  +M  GSL S L   +    T    V +   +A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIAS 158
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TFG 277
           G++YL D      +HRD+ + NIL++ ++  +V+DFGL R    D  AA   RG      
Sbjct: 159 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           +  PE I+ R FT  SDV+S+G++L+E+++ G  P   +     + A++ EG        
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EG-------- 266
Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             RL    D      +  L   C  +    RP    IV +L ++++
Sbjct: 267 -YRLPPPMDCPA--ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 26/286 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAVKVLATD-SKQGEKEFQTEVML 161
           K+L     +   ++G G FG V   ++        +VA+K L    +++  ++F  E  +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N++ L G   +    M+V   M  GSL S L   +    T    V +   +A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD-AQFTVIQLVGMLRGIAS 158
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TFG 277
           G++YL D      +HRD+ + NIL++ ++  +V+DFGLSR    D  AA   RG      
Sbjct: 159 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           +  PE I+ R FT  SDV+S+G++L+E+++ G  P   +     + A++ EG        
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EG-------- 266
Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             RL    D      +  L   C  +    RP    IV +L ++++
Sbjct: 267 -YRLPPPMDCPA--ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 134/286 (46%), Gaps = 26/286 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAVKVLATD-SKQGEKEFQTEVML 161
           K+L     +   ++G G FG V   ++        +VA+K L    +++  ++F  E  +
Sbjct: 11  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N++ L G   +    M+V   M  GSL S L   +    T    V +   +A 
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD-AQFTVIQLVGMLRGIAS 129
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TFG 277
           G++YL D      +HRD+ + NIL++ ++  +V+DFGLSR    D  AA   RG      
Sbjct: 130 GMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           +  PE I+ R FT  SDV+S+G++L+E+++ G  P   +     + A++ EG        
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EG-------- 237
Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             RL    D      +  L   C  +    RP    IV +L ++++
Sbjct: 238 -YRLPPPMDCPA--ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 280

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 8/200 (4%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  + +V  +MSKGSL   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 251 EPIY-IVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 306
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVYS 297
           +++NIL+ +++  +VADFGL+R    +++ A     F   +  PE      FT KSDV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 298 FGVLLFELIA-GRSPLQGLM 316
           FG+LL EL   GR P  G++
Sbjct: 367 FGILLTELTTKGRVPYPGMV 386

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 92/314 (29%), Positives = 137/314 (43%), Gaps = 43/314 (13%)
Query: 91  KRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGET-VAVK----VLA 145
           K+S VV    +P+  +  L          IG+G FG V+  ++    T VAVK     L 
Sbjct: 94  KKSGVVLHRAVPKDKWV-LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP 152
Query: 146 TDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYG 205
            D K    +F  E  +L +  H N+V L+G C +K    +V   +  G   + L  E   
Sbjct: 153 PDLK---AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA- 208
Query: 206 PLTWNLRVHIAL----DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261
                LRV   L    D A G+EYL        IHRD+ + N L+ +    +++DFG+SR
Sbjct: 209 ----RLRVKTLLQMVGDAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSR 261
Query: 262 EEM--VDKHAANIRGT-FGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME 317
           EE   V   +  +R     +  PE ++   ++ +SDV+SFG+LL+E  + G SP   L  
Sbjct: 262 EEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321
Query: 318 YVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
                 +   G+    E+     D +F + E         +C    P +RPS   I Q L
Sbjct: 322 QQTREFVEKGGRLPCPELCP---DAVFRLME---------QCWAYEPGQRPSFSTIYQEL 369
Query: 378 SRILKMRHNRKHHR 391
             I      RK HR
Sbjct: 370 QSI------RKRHR 377

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 105/200 (52%), Gaps = 8/200 (4%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  ++++  +MSKGSL   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 85  EPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 140
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYISTRNFTKKSDVYS 297
           +++NIL+ +++  +VADFGL+R    +++ A     F   +  PE      FT KSDV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 298 FGVLLFELIA-GRSPLQGLM 316
           FG+LL EL   GR P  G++
Sbjct: 201 FGILLTELTTKGRVPYPGMV 220

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 8/200 (4%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  + +V  +MSKGSL   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 76  EPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 131
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYISTRNFTKKSDVYS 297
           +++NIL+ +++  +VADFGL+R    +++ A     F   +  PE      FT KSDV+S
Sbjct: 132 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 191
Query: 298 FGVLLFELIA-GRSPLQGLM 316
           FG+LL EL   GR P  G++
Sbjct: 192 FGILLTELTTKGRVPYPGMV 211

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 132/288 (45%), Gaps = 28/288 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGET----VAVKVLATD-SKQGEKEFQTEVML 161
           K++  +      +IG G FG V    +         VA+K L +  +++  ++F +E  +
Sbjct: 28  KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 87
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N+++L G   +    M++  FM  GSL S L  +N G  T    V +   +A 
Sbjct: 88  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAA 146
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG---- 277
           G++YL D      +HRD+ + NIL++ ++  +V+DFGLSR    D          G    
Sbjct: 147 GMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 203
Query: 278 --YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             +  PE I  R FT  SDV+S+G++++E+++ G  P   +     + A+          
Sbjct: 204 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-------- 255
Query: 335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             D RL    D    + +  L   C  +    RP    IV  L ++++
Sbjct: 256 --DYRLPPPMDCP--SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 299

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 8/200 (4%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  + +V  +MSKGSL   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 74  EPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 129
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYISTRNFTKKSDVYS 297
           +++NIL+ +++  +VADFGL+R    +++ A     F   +  PE      FT KSDV+S
Sbjct: 130 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 189
Query: 298 FGVLLFELIA-GRSPLQGLM 316
           FG+LL EL   GR P  G++
Sbjct: 190 FGILLTELTTKGRVPYPGMV 209

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 109/211 (51%), Gaps = 8/211 (3%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + T      +G G FG V+    +    VAVK L   S   +  F  E  L+ +L H
Sbjct: 14  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQH 72
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           + LV L     ++  +++   +M  GSL   L   +   LT N  + +A  +A G+ ++ 
Sbjct: 73  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 131
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYIS 285
           +      IHRD++++NIL+  ++  ++ADFGL+R    +++ A     F   +  PE I+
Sbjct: 132 ERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 188
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
              FT KSDV+SFG+LL E++  GR P  G+
Sbjct: 189 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 219

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 8/200 (4%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  + +V  +MSKGSL   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 85  EPIY-IVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 140
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYISTRNFTKKSDVYS 297
           +++NIL+ +++  +VADFGL+R    +++ A     F   +  PE      FT KSDV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 298 FGVLLFELIA-GRSPLQGLM 316
           FG+LL EL   GR P  G++
Sbjct: 201 FGILLTELTTKGRVPYPGMV 220

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 109/211 (51%), Gaps = 8/211 (3%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + T      +G G FG V+    +    VAVK L   S   +  F  E  L+ +L H
Sbjct: 19  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQH 77
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           + LV L     ++  +++   +M  GSL   L   +   LT N  + +A  +A G+ ++ 
Sbjct: 78  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 136
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYIS 285
           +      IHRD++++NIL+  ++  ++ADFGL+R    +++ A     F   +  PE I+
Sbjct: 137 ERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 193
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
              FT KSDV+SFG+LL E++  GR P  G+
Sbjct: 194 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 224

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 8/200 (4%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  + +V  +MSKGSL   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 85  EPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 140
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYISTRNFTKKSDVYS 297
           +++NIL+ +++  +VADFGL+R    +++ A     F   +  PE      FT KSDV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 298 FGVLLFELIA-GRSPLQGLM 316
           FG+LL EL   GR P  G++
Sbjct: 201 FGILLTELTTKGRVPYPGMV 220

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 109/211 (51%), Gaps = 8/211 (3%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + T      +G G FG V+    +    VAVK L   S   +  F  E  L+ +L H
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQH 73
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           + LV L     ++  +++   +M  GSL   L   +   LT N  + +A  +A G+ ++ 
Sbjct: 74  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 132
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYIS 285
           +      IHRD++++NIL+  ++  ++ADFGL+R    +++ A     F   +  PE I+
Sbjct: 133 ERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 189
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
              FT KSDV+SFG+LL E++  GR P  G+
Sbjct: 190 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 220

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 110/215 (51%), Gaps = 11/215 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG G+FG VYK +      V +  +   + Q  + F+ EV +L +  H N++  +GY + 
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 78
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           K Q  +V  +    SL  HL+            + IA   ARG++YLH  +   +IHRD+
Sbjct: 79  KPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDL 134
Query: 240 KSSNILLDQSMRARVADFGLS--REEMVDKHA-ANIRGTFGYLDPEYISTRN---FTKKS 293
           KS+NI L +    ++ DFGL+  +      H    + G+  ++ PE I  ++   ++ +S
Sbjct: 135 KSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 194
Query: 294 DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG 328
           DVY+FG++L+EL+ G+ P   +    ++  M   G
Sbjct: 195 DVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG 229

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG G+FG VYK +      V +  +   + Q  + F+ EV +L +  H N++  +GY + 
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 94
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           K Q  +V  +    SL  HL+          L + IA   A+G++YLH  ++   IHRD+
Sbjct: 95  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKSI---IHRDL 150
Query: 240 KSSNILLDQSMRARVADFGLSREEMV---DKHAANIRGTFGYLDPEYISTRN---FTKKS 293
           KS+NI L + +  ++ DFGL+ E+           + G+  ++ PE I  ++   ++ +S
Sbjct: 151 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 210
Query: 294 DVYSFGVLLFELIAGRSP 311
           DVY+FG++L+EL+ G+ P
Sbjct: 211 DVYAFGIVLYELMTGQLP 228

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 109/211 (51%), Gaps = 8/211 (3%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + T      +G G FG V+    +    VAVK L   S   +  F  E  L+ +L H
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQH 67
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           + LV L     ++  +++   +M  GSL   L   +   LT N  + +A  +A G+ ++ 
Sbjct: 68  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYIS 285
           +      IHRD++++NIL+  ++  ++ADFGL+R    +++ A     F   +  PE I+
Sbjct: 127 ERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
              FT KSDV+SFG+LL E++  GR P  G+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 7/210 (3%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + +      +G G FG V+    +    VAVK L   +    + F  E  L+  L H
Sbjct: 9   EIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQH 67
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
             LV L      +    ++  +M+KGSL   L  +  G +     +  +  +A G+ Y+ 
Sbjct: 68  DKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 127
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYIS 285
                  IHRD++++N+L+ +S+  ++ADFGL+R    +++ A     F   +  PE I+
Sbjct: 128 RKNY---IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 184
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQG 314
              FT KSDV+SFG+LL+E++  G+ P  G
Sbjct: 185 FGCFTIKSDVWSFGILLYEIVTYGKIPYPG 214

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG G+FG VYK +      V +  +   + Q  + F+ EV +L +  H N++  +GY + 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 102
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           K Q  +V  +    SL  HL+          L + IA   A+G++YLH  ++   IHRD+
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKSI---IHRDL 158
Query: 240 KSSNILLDQSMRARVADFGLSREEMV---DKHAANIRGTFGYLDPEYISTRN---FTKKS 293
           KS+NI L + +  ++ DFGL+ E+           + G+  ++ PE I  ++   ++ +S
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 218
Query: 294 DVYSFGVLLFELIAGRSP 311
           DVY+FG++L+EL+ G+ P
Sbjct: 219 DVYAFGIVLYELMTGQLP 236

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG G+FG VYK +      V +  +   + Q  + F+ EV +L +  H N++  +GY + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 74
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           K Q  +V  +    SL  HL+          L + IA   A+G++YLH  ++   IHRD+
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKSI---IHRDL 130
Query: 240 KSSNILLDQSMRARVADFGLSREEMV---DKHAANIRGTFGYLDPEYISTRN---FTKKS 293
           KS+NI L + +  ++ DFGL+ E+           + G+  ++ PE I  ++   ++ +S
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 294 DVYSFGVLLFELIAGRSP 311
           DVY+FG++L+EL+ G+ P
Sbjct: 191 DVYAFGIVLYELMTGQLP 208

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  ++++  +MSKGSL   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 85  EPIYIVIE-YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 140
Query: 240 KSSNILLDQSMRARVADFGLSR----EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +++NIL+ +++  +VADFGL+R     E   +  A       +  PE      FT KSDV
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF--PIKWTAPEAALYGRFTIKSDV 198
Query: 296 YSFGVLLFELIA-GRSPLQGLM 316
           +SFG+LL EL   GR P  G++
Sbjct: 199 WSFGILLTELTTKGRVPYPGMV 220

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 134/283 (47%), Gaps = 29/283 (10%)
Query: 120 IGQGAFGPVYKAQM-----STGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNL 173
           +G+G FG V   +      +TGE VAVK L  +S      + + E+ +L  L+H N+V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 174 VGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            G C E G +   L+  F+  GSL  +L  +N   +    ++  A+ + +G++YL     
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLGSRQY 147
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG-----TFGYLDPEYIST 286
              +HRD+ + N+L++   + ++ DFGL++    DK    ++       F Y  PE +  
Sbjct: 148 ---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA-PECLMQ 203
Query: 287 RNFTKKSDVYSFGVLLFELI----AGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
             F   SDV+SFGV L EL+    +  SP+   ++ +      T G+     +V++  +G
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG----PTHGQMTVTRLVNTLKEG 259
Query: 343 ---IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                     +EV  L  KC    P  R S +++++    +LK
Sbjct: 260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 7/210 (3%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + +      +G G FG V+    +    VAVK L   +    + F  E  L+  L H
Sbjct: 8   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQH 66
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
             LV L     ++    ++  FM+KGSL   L  +  G +     +  +  +A G+ Y+ 
Sbjct: 67  DKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 126
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYIS 285
                  IHRD++++N+L+ +S+  ++ADFGL+R    +++ A     F   +  PE I+
Sbjct: 127 RKNY---IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQG 314
              FT KS+V+SFG+LL+E++  G+ P  G
Sbjct: 184 FGCFTIKSNVWSFGILLYEIVTYGKIPYPG 213

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 109/211 (51%), Gaps = 8/211 (3%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + T      +G G FG V+    +    VAVK L   S   +  F  E  L+ +L H
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQH 62
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           + LV L     ++  +++   +M  GSL   L   +   LT N  + +A  +A G+ ++ 
Sbjct: 63  QRLVRLYAVVTQEPIYIITE-YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 121
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYIS 285
           +      IHRD++++NIL+  ++  ++ADFGL+R    +++ A     F   +  PE I+
Sbjct: 122 ERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 178
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
              FT KSDV+SFG+LL E++  GR P  G+
Sbjct: 179 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 209

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 101/202 (50%), Gaps = 12/202 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +    +V  +MSKGSL   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 75  E-PIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 130
Query: 240 KSSNILLDQSMRARVADFGLSR----EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +++NIL+ +++  +VADFGL+R     E   +  A       +  PE      FT KSDV
Sbjct: 131 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF--PIKWTAPEAALYGRFTIKSDV 188
Query: 296 YSFGVLLFELIA-GRSPLQGLM 316
           +SFG+LL EL   GR P  G++
Sbjct: 189 WSFGILLTELTTKGRVPYPGMV 210

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 136/298 (45%), Gaps = 52/298 (17%)
Query: 120 IGQGAFGPVYKAQMS------TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVN 172
           IG+GAFG V++A+            VAVK+L  + S   + +FQ E  L+    + N+V 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL----------------------YDENYGPLTWN 210
           L+G CA      L++ +M+ G L   L                            PL+  
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 211 LRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHA 269
            ++ IA  VA G+ YL +      +HRD+ + N L+ ++M  ++ADFGLSR     D + 
Sbjct: 175 EQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 270 A--NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE 327
           A  N      ++ PE I    +T +SDV+++GV+L+E+ +      GL  Y  +A     
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS-----YGLQPYYGMAH---- 282
Query: 328 GKTGWEEIVDSRLDGIFDVEELN---EVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                EE++    DG       N   E+ +L   C ++ P  RPS   I ++L R+ +
Sbjct: 283 -----EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 103/200 (51%), Gaps = 8/200 (4%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  + +V  +MSKGSL   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 252 EPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 307
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVYS 297
           +++NIL+ +++  +VADFGL R    +++ A     F   +  PE      FT KSDV+S
Sbjct: 308 RAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 367
Query: 298 FGVLLFELIA-GRSPLQGLM 316
           FG+LL EL   GR P  G++
Sbjct: 368 FGILLTELTTKGRVPYPGMV 387

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 134/283 (47%), Gaps = 29/283 (10%)
Query: 120 IGQGAFGPVYKAQM-----STGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNL 173
           +G+G FG V   +      +TGE VAVK L  +S      + + E+ +L  L+H N+V  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 174 VGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            G C E G +   L+  F+  GSL  +L  +N   +    ++  A+ + +G++YL     
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLGSRQY 135
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG-----TFGYLDPEYIST 286
              +HRD+ + N+L++   + ++ DFGL++    DK    ++       F Y  PE +  
Sbjct: 136 ---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA-PECLMQ 191
Query: 287 RNFTKKSDVYSFGVLLFELI----AGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
             F   SDV+SFGV L EL+    +  SP+   ++ +      T G+     +V++  +G
Sbjct: 192 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG----PTHGQMTVTRLVNTLKEG 247
Query: 343 ---IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                     +EV  L  KC    P  R S +++++    +LK
Sbjct: 248 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 290

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 11/198 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG G+FG VYK +      V +  +   + Q  + F+ EV +L +  H N++  +GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
             Q  +V  +    SL  HL+            + IA   ARG++YLH  ++   IHRD+
Sbjct: 92  P-QLAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLHAKSI---IHRDL 146
Query: 240 KSSNILLDQSMRARVADFGLSREEMV---DKHAANIRGTFGYLDPEYISTRN---FTKKS 293
           KS+NI L +    ++ DFGL+ E+           + G+  ++ PE I  ++   ++ +S
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 206
Query: 294 DVYSFGVLLFELIAGRSP 311
           DVY+FG++L+EL+ G+ P
Sbjct: 207 DVYAFGIVLYELMTGQLP 224

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 104/200 (52%), Gaps = 8/200 (4%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ ++ H  LV L    +E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  + +V  +MSKGSL   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 85  EPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 140
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYISTRNFTKKSDVYS 297
           +++NIL+ +++  +VADFGL+R    +++ A     F   +  PE      FT KSDV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 298 FGVLLFELIA-GRSPLQGLM 316
           FG+LL EL   GR P  G++
Sbjct: 201 FGILLTELTTKGRVPYPGMV 220

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 78/248 (31%), Positives = 119/248 (47%), Gaps = 39/248 (15%)
Query: 92  RSNVVSASGIPEYSY-------KDLQKATCNFTTLI---GQGAFGPVYKAQMS------T 135
           R++ +     P YS+        DL++      TLI   G GAFG VY+ Q+S      +
Sbjct: 1   RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 60
Query: 136 GETVAVKVLA-TDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS 194
              VAVK L    S+Q E +F  E +++ +L+H+N+V  +G   +     ++   M+ G 
Sbjct: 61  PLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 195 LASHLYDENYGP-----LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS 249
           L S L +    P     L     +H+A D+A G +YL +      IHRDI + N LL   
Sbjct: 121 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCP 177
Query: 250 MRARVA---DFGLSREEMVDKHAANIRGTFG-------YLDPEYISTRNFTKKSDVYSFG 299
              RVA   DFG++R    D + A+     G       ++ PE      FT K+D +SFG
Sbjct: 178 GPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 233
Query: 300 VLLFELIA 307
           VLL+E+ +
Sbjct: 234 VLLWEIFS 241

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 8/211 (3%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + T      +G G FG V+    +    VAVK L   S   +  F  E  L+ +L H
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQH 73
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           + LV L     ++  +++   +M  GSL   L   +   LT N  + +A  +A G+ ++ 
Sbjct: 74  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 132
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYIS 285
           +      IHRD++++NIL+  ++  ++ADFGL+R    ++  A     F   +  PE I+
Sbjct: 133 ERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 189
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
              FT KSDV+SFG+LL E++  GR P  G+
Sbjct: 190 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 220

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 68/200 (34%), Positives = 103/200 (51%), Gaps = 8/200 (4%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  + +V  +MSKGSL   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 85  EPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 140
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYISTRNFTKKSDVYS 297
            ++NIL+ +++  +VADFGL+R    +++ A     F   +  PE      FT KSDV+S
Sbjct: 141 AAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 298 FGVLLFELIA-GRSPLQGLM 316
           FG+LL EL   GR P  G++
Sbjct: 201 FGILLTELTTKGRVPYPGMV 220

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 8/211 (3%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + T      +G G FG V+    +    VAVK L   S   +  F  E  L+ +L H
Sbjct: 17  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQH 75
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           + LV L     ++  +++   +M  GSL   L   +   LT N  + +A  +A G+ ++ 
Sbjct: 76  QRLVRLYAVVTQEPIYIITE-YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 134
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYIS 285
           +      IHRD++++NIL+  ++  ++ADFGL+R    ++  A     F   +  PE I+
Sbjct: 135 ERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 191
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
              FT KSDV+SFG+LL E++  GR P  G+
Sbjct: 192 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 222

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 8/200 (4%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  + +V  +MSKG L   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 85  EPIY-IVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 140
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYISTRNFTKKSDVYS 297
           +++NIL+ +++  +VADFGL+R    +++ A     F   +  PE      FT KSDV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 298 FGVLLFELIA-GRSPLQGLM 316
           FG+LL EL   GR P  G++
Sbjct: 201 FGILLTELTTKGRVPYPGMV 220

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 8/211 (3%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + T      +G G FG V+    +    VAVK L   S   +  F  E  L+ +L H
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQH 67
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           + LV L     ++  +++   +M  GSL   L   +   LT N  + +A  +A G+ ++ 
Sbjct: 68  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYIS 285
           +      IHRD++++NIL+  ++  ++ADFGL+R    ++  A     F   +  PE I+
Sbjct: 127 ERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 183
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
              FT KSDV+SFG+LL E++  GR P  G+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 8/211 (3%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + T      +G G FG V+    +    VAVK L   S   +  F  E  L+ +L H
Sbjct: 11  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQH 69
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           + LV L     ++  +++   +M  GSL   L   +   LT N  + +A  +A G+ ++ 
Sbjct: 70  QRLVRLYAVVTQEPIYIITE-YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 128
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYIS 285
           +      IHRD++++NIL+  ++  ++ADFGL+R    ++  A     F   +  PE I+
Sbjct: 129 ERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 185
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
              FT KSDV+SFG+LL E++  GR P  G+
Sbjct: 186 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 216

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 8/211 (3%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + T      +G G FG V+    +    VAVK L   S   +  F  E  L+ +L H
Sbjct: 18  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQH 76
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           + LV L     ++  +++   +M  GSL   L   +   LT N  + +A  +A G+ ++ 
Sbjct: 77  QRLVRLYAVVTQEPIYIITE-YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 135
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYIS 285
           +      IHRD++++NIL+  ++  ++ADFGL+R    ++  A     F   +  PE I+
Sbjct: 136 ERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 192
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
              FT KSDV+SFG+LL E++  GR P  G+
Sbjct: 193 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 223

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 8/211 (3%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + T      +G G FG V+    +    VAVK L   S   +  F  E  L+ +L H
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQH 67
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           + LV L     ++  +++   +M  GSL   L   +   LT N  + +A  +A G+ ++ 
Sbjct: 68  QRLVRLYAVVTQEPIYIITE-YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYIS 285
           +      IHRD++++NIL+  ++  ++ADFGL+R    ++  A     F   +  PE I+
Sbjct: 127 ERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 183
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
              FT KSDV+SFG+LL E++  GR P  G+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 81/315 (25%), Positives = 139/315 (44%), Gaps = 47/315 (14%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGE-----TVAVKVLATDSK 149
           +  + +P     +  +    F   +G GAFG V +A     G+      VAVK+L + + 
Sbjct: 15  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 74
Query: 150 QGEKE-FQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-------- 199
             EKE   +E+ ++  L  H N+VNL+G C   G  +++  +   G L + L        
Sbjct: 75  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAML 134
Query: 200 ------------YDENYG-PLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL 246
                        D+  G PL     +H +  VA+G+ +L   A    IHRD+ + N+LL
Sbjct: 135 GPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLL 191
Query: 247 DQSMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLF 303
                A++ DFGL+R+ M D +     N R    ++ PE I    +T +SDV+S+G+LL+
Sbjct: 192 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 251
Query: 304 ELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNR 362
           E+ + G +P  G++   +   +  +G    +     +            + S+   C   
Sbjct: 252 EIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPK-----------NIYSIMQACWAL 300
Query: 363 APRKRPSMRDIVQVL 377
            P  RP+ + I   L
Sbjct: 301 EPTHRPTFQQICSFL 315

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 8/211 (3%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + T      +G G FG V+    +    VAVK L   S   +  F  E  L+ +L H
Sbjct: 10  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQH 68
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           + LV L     ++  +++   +M  GSL   L   +   LT N  + +A  +A G+ ++ 
Sbjct: 69  QRLVRLYAVVTQEPIYIITE-YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 127
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYIS 285
           +      IHRD++++NIL+  ++  ++ADFGL+R    ++  A     F   +  PE I+
Sbjct: 128 ERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 184
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
              FT KSDV+SFG+LL E++  GR P  G+
Sbjct: 185 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 215

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 8/200 (4%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  + +V  +M+KGSL   L  E    L     V ++  +A G+ Y+        +HRD+
Sbjct: 82  EPIY-IVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY---VHRDL 137
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYISTRNFTKKSDVYS 297
           +++NIL+ +++  +VADFGL+R    +++ A     F   +  PE      FT KSDV+S
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 197
Query: 298 FGVLLFELIA-GRSPLQGLM 316
           FG+LL EL   GR P  G++
Sbjct: 198 FGILLTELTTKGRVPYPGMV 217

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 137/279 (49%), Gaps = 32/279 (11%)
Query: 119 LIGQGAFGPVYKA----QMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNL 173
           +IG+G FG VY      Q       A+K L+  ++  + E F  E +L+  L+H N++ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 174 VG-YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           +G     +G   ++  +M  G L   +      P   +L +   L VARG+EYL +    
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-ISFGLQVARGMEYLAEQKF- 145
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI------RGTFGYLDPEYIST 286
             +HRD+ + N +LD+S   +VADFGL+R +++D+   ++      R    +   E + T
Sbjct: 146 --VHRDLAARNCMLDESFTVKVADFGLAR-DILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV 346
             FT KSDV+SFGVLL+EL+   +P    ++  +L     +G+   +   +   D ++ V
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQP--EYCPDSLYQV 260
Query: 347 EELNEVASLAYKCVNRAPRKRPSMRDIV----QVLSRIL 381
            +         +C    P  RP+ R +V    Q++S +L
Sbjct: 261 MQ---------QCWEADPAVRPTFRVLVGEVEQIVSALL 290

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 8/200 (4%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  + +V  +MSKG L   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 85  EPIY-IVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 140
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYISTRNFTKKSDVYS 297
           +++NIL+ +++  +VADFGL+R    +++ A     F   +  PE      FT KSDV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 298 FGVLLFELIA-GRSPLQGLM 316
           FG+LL EL   GR P  G++
Sbjct: 201 FGILLTELTTKGRVPYPGMV 220

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 91/310 (29%), Positives = 144/310 (46%), Gaps = 42/310 (13%)
Query: 119 LIGQGAFGPVYKAQMSTGE----TVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G+G FG V +AQ+   +     VAVK+L  D  +    +EF  E   +    H ++  
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 173 LVGYCAE---KGQ---HMLVYVFMSKGSLASHLYDENYGPLTWNLR----VHIALDVARG 222
           LVG       KG+    M++  FM  G L + L     G   +NL     V   +D+A G
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD---KHAANIRGTFGYL 279
           +EYL        IHRD+ + N +L + M   VADFGLSR+       +     +    +L
Sbjct: 150 MEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDS 338
             E ++   +T  SDV++FGV ++E++  G++P  G+ E  E+      G         +
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-ENAEIYNYLIGG---------N 256
Query: 339 RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTA 398
           RL      E + EV  L Y+C +  P++RPS   +   L  IL        H    ST+ 
Sbjct: 257 RLKQ--PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG-------HLSVLSTSQ 307
Query: 399 DEVSIDMEQA 408
           D + I++E+A
Sbjct: 308 DPLYINIERA 317

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG G+FG VYK +      V +  +   + Q  + F+ EV +L +  H N++  +GY + 
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 101
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           K Q  +V  +    SL  HL+          L + IA   A+G++YLH  ++   IHRD+
Sbjct: 102 KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKSI---IHRDL 157
Query: 240 KSSNILLDQSMRARVADFGLS--REEMVDKHA-ANIRGTFGYLDPEYISTRN---FTKKS 293
           KS+NI L + +  ++ DFGL+  +      H    + G+  ++ PE I  ++   ++ +S
Sbjct: 158 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 217
Query: 294 DVYSFGVLLFELIAGRSP 311
           DVY+FG++L+EL+ G+ P
Sbjct: 218 DVYAFGIVLYELMTGQLP 235

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG G+FG VYK +      V +  +   + Q  + F+ EV +L +  H N++  +GY + 
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 76
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           K Q  +V  +    SL  HL+          L + IA   A+G++YLH  ++   IHRD+
Sbjct: 77  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKSI---IHRDL 132
Query: 240 KSSNILLDQSMRARVADFGLS--REEMVDKHA-ANIRGTFGYLDPEYISTRN---FTKKS 293
           KS+NI L + +  ++ DFGL+  +      H    + G+  ++ PE I  ++   ++ +S
Sbjct: 133 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 192
Query: 294 DVYSFGVLLFELIAGRSP 311
           DVY+FG++L+EL+ G+ P
Sbjct: 193 DVYAFGIVLYELMTGQLP 210

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 112/217 (51%), Gaps = 11/217 (5%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVML 161
           PE+   ++ + T      +G G FG V+    +    VAVK L   S   +  F  E  L
Sbjct: 2   PEW---EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANL 57
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           + +L H+ LV L     ++  +++   +M  GSL   L   +   LT N  + +A  +A 
Sbjct: 58  MKQLQHQRLVRLYAVVTQEPIYIITE-YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 116
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YL 279
           G+ ++ +      IHR+++++NIL+  ++  ++ADFGL+R    +++ A     F   + 
Sbjct: 117 GMAFIEERNY---IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 173
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
            PE I+   FT KSDV+SFG+LL E++  GR P  G+
Sbjct: 174 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 210

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG G+FG VYK +      V +  +   + Q  + F+ EV +L +  H N++  +GY + 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 102
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           K Q  +V  +    SL  HL+          L + IA   A+G++YLH  ++   IHRD+
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKSI---IHRDL 158
Query: 240 KSSNILLDQSMRARVADFGLS--REEMVDKHA-ANIRGTFGYLDPEYISTRN---FTKKS 293
           KS+NI L + +  ++ DFGL+  +      H    + G+  ++ PE I  ++   ++ +S
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 218
Query: 294 DVYSFGVLLFELIAGRSP 311
           DVY+FG++L+EL+ G+ P
Sbjct: 219 DVYAFGIVLYELMTGQLP 236

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 137/306 (44%), Gaps = 38/306 (12%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGE-----TVAVKVLATDSK 149
           +  + +P     +  +    F   +G GAFG V +A     G+      VAVK+L + + 
Sbjct: 30  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 150 QGEKE-FQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-------- 199
             EKE   +E+ ++  L  H N+VNL+G C   G  +++  +   G L + L        
Sbjct: 90  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLE 149
Query: 200 YDENYGPLTWNLR----VHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA 255
            D  +      L     +H +  VA+G+ +L   A    IHRD+ + N+LL     A++ 
Sbjct: 150 TDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIG 206
Query: 256 DFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSP 311
           DFGL+R+ M D +     N R    ++ PE I    +T +SDV+S+G+LL+E+ + G +P
Sbjct: 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
Query: 312 LQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMR 371
             G++   +   +  +G    +     +            + S+   C    P  RP+ +
Sbjct: 267 YPGILVNSKFYKLVKDGYQMAQPAFAPK-----------NIYSIMQACWALEPTHRPTFQ 315
Query: 372 DIVQVL 377
            I   L
Sbjct: 316 QICSFL 321

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 112/219 (51%), Gaps = 19/219 (8%)
Query: 109 LQKATCNFTTLIGQGAFGPVYKA-QMSTGETV----AVKVL-ATDSKQGEKEFQTEVMLL 162
           L++       ++G GAFG VYK   +  GETV    A+K+L  T   +   EF  E +++
Sbjct: 35  LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 94
Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVA 220
             + H +LV L+G C       LV   M  G L  ++++  +N G     L ++  + +A
Sbjct: 95  ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGS---QLLLNWCVQIA 150
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG---TFG 277
           +G+ YL +  +   +HRD+ + N+L+      ++ DFGL+R    D+   N  G      
Sbjct: 151 KGMMYLEERRL---VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 207
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
           ++  E I  R FT +SDV+S+GV ++EL+  G  P  G+
Sbjct: 208 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 246

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG G+FG VYK +      V +  +   + Q  + F+ EV +L +  H N++  +GY + 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 79
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           K Q  +V  +    SL  HL+          L + IA   A+G++YLH  ++   IHRD+
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKSI---IHRDL 135
Query: 240 KSSNILLDQSMRARVADFGLS--REEMVDKHA-ANIRGTFGYLDPEYISTRN---FTKKS 293
           KS+NI L + +  ++ DFGL+  +      H    + G+  ++ PE I  ++   ++ +S
Sbjct: 136 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 195
Query: 294 DVYSFGVLLFELIAGRSP 311
           DVY+FG++L+EL+ G+ P
Sbjct: 196 DVYAFGIVLYELMTGQLP 213

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 137/286 (47%), Gaps = 26/286 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAVKVL-ATDSKQGEKEFQTEVML 161
           K++  +      +IG G FG V   ++         VA+K L A  + +  ++F +E  +
Sbjct: 24  KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 83
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N+++L G   +    M++  +M  GSL + L  +N G  T    V +   +  
Sbjct: 84  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR-KNDGRFTVIQLVGMLRGIGS 142
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TFG 277
           G++YL D +    +HRD+ + NIL++ ++  +V+DFG+SR    D  AA   RG      
Sbjct: 143 GMKYLSDMSA---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIR 199
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           +  PE I+ R FT  SDV+S+G++++E+++ G  P   +     + A+  EG        
Sbjct: 200 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-EG-------- 250
Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             RL    D      +  L   C  +    RP    IV +L ++++
Sbjct: 251 -YRLPPPMDCP--IALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR 293

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + +      +G G FG V+    +    VA+K L   +   E  F  E  ++ +L H
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPES-FLEEAQIMKKLKH 63
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
             LV L    +E+  + +V  +M+KGSL   L D     L     V +A  VA G+ Y+ 
Sbjct: 64  DKLVQLYAVVSEEPIY-IVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 122
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR----EEMVDKHAANIRGTFGYLDPEY 283
                  IHRD++S+NIL+   +  ++ADFGL+R     E   +  A       +  PE 
Sbjct: 123 RMNY---IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKF--PIKWTAPEA 177
Query: 284 ISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
                FT KSDV+SFG+LL EL+  GR P  G+
Sbjct: 178 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 210

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG G+FG VYK +      V +  +   + Q  + F+ EV +L +  H N++  +GY + 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 79
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           K Q  +V  +    SL  HL+          L + IA   A+G++YLH  ++   IHRD+
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKSI---IHRDL 135
Query: 240 KSSNILLDQSMRARVADFGLS--REEMVDKHA-ANIRGTFGYLDPEYISTRN---FTKKS 293
           KS+NI L + +  ++ DFGL+  +      H    + G+  ++ PE I  ++   ++ +S
Sbjct: 136 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 195
Query: 294 DVYSFGVLLFELIAGRSP 311
           DVY+FG++L+EL+ G+ P
Sbjct: 196 DVYAFGIVLYELMTGQLP 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG G+FG VYK +      V +  +   + Q  + F+ EV +L +  H N++  +GY + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 74
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           K Q  +V  +    SL  HL+          L + IA   A+G++YLH  ++   IHRD+
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKSI---IHRDL 130
Query: 240 KSSNILLDQSMRARVADFGLS--REEMVDKHA-ANIRGTFGYLDPEYISTRN---FTKKS 293
           KS+NI L + +  ++ DFGL+  +      H    + G+  ++ PE I  ++   ++ +S
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 294 DVYSFGVLLFELIAGRSP 311
           DVY+FG++L+EL+ G+ P
Sbjct: 191 DVYAFGIVLYELMTGQLP 208

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  + +V  +M+KGSL   L  E    L     V ++  +A G+ Y+        +HRD+
Sbjct: 82  EPIY-IVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY---VHRDL 137
Query: 240 KSSNILLDQSMRARVADFGLSR----EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +++NIL+ +++  +VADFGL+R     E   +  A       +  PE      FT KSDV
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEWTARQGAKF--PIKWTAPEAALYGRFTIKSDV 195
Query: 296 YSFGVLLFELIA-GRSPLQGLM 316
           +SFG+LL EL   GR P  G++
Sbjct: 196 WSFGILLTELTTKGRVPYPGMV 217

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 112/219 (51%), Gaps = 19/219 (8%)
Query: 109 LQKATCNFTTLIGQGAFGPVYKA-QMSTGETV----AVKVL-ATDSKQGEKEFQTEVMLL 162
           L++       ++G GAFG VYK   +  GETV    A+K+L  T   +   EF  E +++
Sbjct: 12  LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 71
Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVA 220
             + H +LV L+G C       LV   M  G L  ++++  +N G     L ++  + +A
Sbjct: 72  ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGS---QLLLNWCVQIA 127
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG---TFG 277
           +G+ YL +  +   +HRD+ + N+L+      ++ DFGL+R    D+   N  G      
Sbjct: 128 KGMMYLEERRL---VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 184
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
           ++  E I  R FT +SDV+S+GV ++EL+  G  P  G+
Sbjct: 185 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 223

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 90/318 (28%), Positives = 142/318 (44%), Gaps = 54/318 (16%)
Query: 92  RSNVVSASGIPEYSY-------KDLQKATCNFTTLI---GQGAFGPVYKAQMS------T 135
           R++ +     P YS+        DL++      TLI   G GAFG VY+ Q+S      +
Sbjct: 27  RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 86
Query: 136 GETVAVKVLA-TDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS 194
              VAVK L    S+Q E +F  E +++ + +H+N+V  +G   +     ++   M+ G 
Sbjct: 87  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 146
Query: 195 LASHLYDENYGP-----LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS 249
           L S L +    P     L     +H+A D+A G +YL +      IHRDI + N LL   
Sbjct: 147 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCP 203
Query: 250 MRARVA---DFGLSREEMVDKHAANIRG-----TFGYLDPEYISTRNFTKKSDVYSFGVL 301
              RVA   DFG++R+  + + +   +G        ++ PE      FT K+D +SFGVL
Sbjct: 204 GPGRVAKIGDFGMARD--IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 261
Query: 302 LFELIAGRSPLQGLMEYVELAAMNTEGKTGWE--EIVDS--RLDGIFDVEELNEVASLAY 357
           L+E+ +             L  M    K+  E  E V S  R+D   +      V  +  
Sbjct: 262 LWEIFS-------------LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCP--GPVYRIMT 306
Query: 358 KCVNRAPRKRPSMRDIVQ 375
           +C    P  RP+   I++
Sbjct: 307 QCWQHQPEDRPNFAIILE 324

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 113/226 (50%), Gaps = 28/226 (12%)
Query: 105 SYKDLQKATCNFTTLI---GQGAFGPVYKAQMS------TGETVAVKVLA-TDSKQGEKE 154
           S  DL++      TLI   G GAFG VY+ Q+S      +   VAVK L    S+Q E +
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 94
Query: 155 FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP-----LTW 209
           F  E +++ +L+H+N+V  +G   +     ++   M+ G L S L +    P     L  
Sbjct: 95  FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 154
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA---DFGLSREEMVD 266
              +H+A D+A G +YL +      IHRDI + N LL      RVA   DFG++R+  + 
Sbjct: 155 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IY 209
Query: 267 KHAANIRG-----TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
           + +   +G        ++ PE      FT K+D +SFGVLL+E+ +
Sbjct: 210 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 139/307 (45%), Gaps = 40/307 (13%)
Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGE-----TVAVKVLATDSK 149
           +  + +P     +  +    F   +G GAFG V +A     G+      VAVK+L + + 
Sbjct: 30  IDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH 89
Query: 150 QGEKE-FQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDE----- 202
             EKE   +E+ ++  L  H N+VNL+G C   G  +++  +   G L + L  +     
Sbjct: 90  ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLE 149
Query: 203 --------NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV 254
                   N    T +L +H +  VA+G+ +L   A    IHRD+ + N+LL     A++
Sbjct: 150 TDPAFAIANSTASTRDL-LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKI 205
Query: 255 ADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRS 310
            DFGL+R+ M D +     N R    ++ PE I    +T +SDV+S+G+LL+E+ + G +
Sbjct: 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 265
Query: 311 PLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSM 370
           P  G++   +   +  +G    +     +            + S+   C    P  RP+ 
Sbjct: 266 PYPGILVNSKFYKLVKDGYQMAQPAFAPK-----------NIYSIMQACWALEPTHRPTF 314
Query: 371 RDIVQVL 377
           + I   L
Sbjct: 315 QQICSFL 321

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 134/288 (46%), Gaps = 30/288 (10%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMST----GETVAVKVLATD-SKQGEKEFQTEVML 161
           K+L  +      +IG G FG V   ++         VA+K L    +++  ++F  E  +
Sbjct: 38  KELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASI 97
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N+V+L G        M+V  FM  G+L + L   + G  T    V +   +A 
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHD-GQFTVIQLVGMLRGIAA 156
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG---- 277
           G+ YL D      +HRD+ + NIL++ ++  +V+DFGLSR  +++     +  T G    
Sbjct: 157 GMRYLADMGY---VHRDLAARNILVNSNLVCKVSDFGLSR--VIEDDPEAVYTTTGGKIP 211
Query: 278 --YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             +  PE I  R FT  SDV+S+G++++E+++ G  P   +     + A+  EG      
Sbjct: 212 VRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-EG------ 264
Query: 335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
               RL    D      +  L   C  +   +RP    IV +L ++++
Sbjct: 265 ---YRLPAPMDCPA--GLHQLMLDCWQKERAERPKFEQIVGILDKMIR 307

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 114/215 (53%), Gaps = 14/215 (6%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAVKVL-ATDSKQGEKEFQTEVML 161
           K++  +      +IG G FG V   ++         VA+K L A  + +  ++F +E  +
Sbjct: 9   KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 68
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N+++L G   +    M++  +M  GSL + L  +N G  T    V +   +  
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR-KNDGRFTVIQLVGMLRGIGS 127
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TFG 277
           G++YL D +    +HRD+ + NIL++ ++  +V+DFG+SR    D  AA   RG      
Sbjct: 128 GMKYLSDMSY---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIR 184
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSP 311
           +  PE I+ R FT  SDV+S+G++++E+++ G  P
Sbjct: 185 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/246 (30%), Positives = 119/246 (48%), Gaps = 35/246 (14%)
Query: 92  RSNVVSASGIPEYSY-------KDLQKATCNFTTLI---GQGAFGPVYKAQMS------T 135
           R++ +     P YS+        DL++      TLI   G GAFG VY+ Q+S      +
Sbjct: 1   RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 60
Query: 136 GETVAVKVLA-TDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS 194
              VAVK L    S+Q E +F  E +++ + +H+N+V  +G   +     ++   M+ G 
Sbjct: 61  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 195 LASHLYDENYGP-----LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS 249
           L S L +    P     L     +H+A D+A G +YL +      IHRDI + N LL   
Sbjct: 121 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCP 177
Query: 250 MRARVA---DFGLSREEMVDKHAANIRG-----TFGYLDPEYISTRNFTKKSDVYSFGVL 301
              RVA   DFG++R+  + + +   +G        ++ PE      FT K+D +SFGVL
Sbjct: 178 GPGRVAKIGDFGMARD--IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 235
Query: 302 LFELIA 307
           L+E+ +
Sbjct: 236 LWEIFS 241

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 113/203 (55%), Gaps = 12/203 (5%)
Query: 119 LIGQGAFGPVYKAQMSTG----ETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++GQG+FG V+  +  +G    +  A+KVL  AT   +     + E  +L  ++H  +V 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      +G+  L+  F+  G L + L  E       +++ ++A ++A  L++LH   + 
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF-TEEDVKFYLA-ELALALDHLHSLGI- 147
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPEYISTRNFTK 291
             I+RD+K  NILLD+    ++ DFGLS+E +  +K A +  GT  Y+ PE ++ R  T+
Sbjct: 148 --IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 205
Query: 292 KSDVYSFGVLLFELIAGRSPLQG 314
            +D +SFGVL+FE++ G  P QG
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQG 228

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 114/215 (53%), Gaps = 14/215 (6%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAVKVL-ATDSKQGEKEFQTEVML 161
           K++  +      +IG G FG V   ++         VA+K L A  + +  ++F +E  +
Sbjct: 3   KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI 62
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N+++L G   +    M++  +M  GSL + L  +N G  T    V +   +  
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR-KNDGRFTVIQLVGMLRGIGS 121
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRG---TFG 277
           G++YL D +    +HRD+ + NIL++ ++  +V+DFG+SR    D  AA   RG      
Sbjct: 122 GMKYLSDMSY---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIR 178
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSP 311
           +  PE I+ R FT  SDV+S+G++++E+++ G  P
Sbjct: 179 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 112/223 (50%), Gaps = 9/223 (4%)
Query: 94  NVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEK 153
           N  S +G+  Y   ++      F   +G G FG V   +      VA+K++   S   E 
Sbjct: 7   NAPSTAGLG-YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSED 64
Query: 154 EFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV 213
           EF  E  ++  L H  LV L G C ++    ++  +M+ G L ++L +  +   T  L +
Sbjct: 65  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-L 123
Query: 214 HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR 273
            +  DV   +EYL        +HRD+ + N L++     +V+DFGLSR  + D++ +++ 
Sbjct: 124 EMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180
Query: 274 GTFG--YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQ 313
             F   +  PE +    F+ KSD+++FGVL++E+ + G+ P +
Sbjct: 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 131/288 (45%), Gaps = 28/288 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTGET----VAVKVLATD-SKQGEKEFQTEVML 161
           K++  +      +IG G FG V    +         VA+K L +  +++  ++F +E  +
Sbjct: 2   KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 61
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N+++L G   +    M++  FM  GSL S L  +N G  T    V +   +A 
Sbjct: 62  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAA 120
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG---- 277
           G++YL D      +HR + + NIL++ ++  +V+DFGLSR    D          G    
Sbjct: 121 GMKYLADMN---YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 177
Query: 278 --YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             +  PE I  R FT  SDV+S+G++++E+++ G  P   +     + A+          
Sbjct: 178 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-------- 229
Query: 335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             D RL    D    + +  L   C  +    RP    IV  L ++++
Sbjct: 230 --DYRLPPPMDCP--SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 273

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/246 (30%), Positives = 119/246 (48%), Gaps = 35/246 (14%)
Query: 92  RSNVVSASGIPEYSY-------KDLQKATCNFTTLI---GQGAFGPVYKAQMS------T 135
           R++ +     P YS+        DL++      TLI   G GAFG VY+ Q+S      +
Sbjct: 7   RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 66
Query: 136 GETVAVKVLA-TDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS 194
              VAVK L    S+Q E +F  E +++ + +H+N+V  +G   +     ++   M+ G 
Sbjct: 67  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 126
Query: 195 LASHLYDENYGP-----LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS 249
           L S L +    P     L     +H+A D+A G +YL +      IHRDI + N LL   
Sbjct: 127 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCP 183
Query: 250 MRARVA---DFGLSREEMVDKHAANIRG-----TFGYLDPEYISTRNFTKKSDVYSFGVL 301
              RVA   DFG++R+  + + +   +G        ++ PE      FT K+D +SFGVL
Sbjct: 184 GPGRVAKIGDFGMARD--IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 241
Query: 302 LFELIA 307
           L+E+ +
Sbjct: 242 LWEIFS 247

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 133/277 (48%), Gaps = 41/277 (14%)
Query: 119 LIGQGAFGPVYKAQMST-GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG-- 175
           LIG G FG V+KA+    G+T  +K +  ++++ E+E    V  L +L H N+V+  G  
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGCW 73
Query: 176 ----YCAE---------KGQHMLVYV-FMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
               Y  E         K + + + + F  KG+L   +       L   L + +   + +
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
           G++Y+H      +I+RD+K SNI L  + + ++ DFGL      D      +GT  Y+ P
Sbjct: 134 GVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSP 190
Query: 282 EYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD 341
           E IS++++ K+ D+Y+ G++L EL+              +     E    + ++ D  + 
Sbjct: 191 EQISSQDYGKEVDLYALGLILAELL-------------HVCDTAFETSKFFTDLRDGIIS 237
Query: 342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS 378
            IFD +E     +L  K +++ P  RP+  +I++ L+
Sbjct: 238 DIFDKKE----KTLLQKLLSKKPEDRPNTSEILRTLT 270

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 113/203 (55%), Gaps = 12/203 (5%)
Query: 119 LIGQGAFGPVYKAQMSTG----ETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++GQG+FG V+  +  +G    +  A+KVL  AT   +     + E  +L  ++H  +V 
Sbjct: 32  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 91
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      +G+  L+  F+  G L + L  E       +++ ++A ++A  L++LH   + 
Sbjct: 92  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-EEDVKFYLA-ELALALDHLHSLGI- 148
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPEYISTRNFTK 291
             I+RD+K  NILLD+    ++ DFGLS+E +  +K A +  GT  Y+ PE ++ R  T+
Sbjct: 149 --IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 206
Query: 292 KSDVYSFGVLLFELIAGRSPLQG 314
            +D +SFGVL+FE++ G  P QG
Sbjct: 207 SADWWSFGVLMFEMLTGTLPFQG 229

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 113/203 (55%), Gaps = 12/203 (5%)
Query: 119 LIGQGAFGPVYKAQMSTG----ETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++GQG+FG V+  +  +G    +  A+KVL  AT   +     + E  +L  ++H  +V 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      +G+  L+  F+  G L + L  E       +++ ++A ++A  L++LH   + 
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-EEDVKFYLA-ELALALDHLHSLGI- 147
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPEYISTRNFTK 291
             I+RD+K  NILLD+    ++ DFGLS+E +  +K A +  GT  Y+ PE ++ R  T+
Sbjct: 148 --IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ 205
Query: 292 KSDVYSFGVLLFELIAGRSPLQG 314
            +D +SFGVL+FE++ G  P QG
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQG 228

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 109/219 (49%), Gaps = 29/219 (13%)
Query: 111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL 170
           + +     +  +G FG V+KAQ+   + VAVK+     KQ  +  + E+     + H NL
Sbjct: 14  RGSLQLLEIKARGRFGCVWKAQL-MNDFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENL 71
Query: 171 VNLVGYCAEK-GQHM-----LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLE 224
           +  +   AEK G ++     L+  F  KGSL  +L       +TWN   H+A  ++RGL 
Sbjct: 72  LQFIA--AEKRGSNLEVELWLITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGLS 126
Query: 225 YLHD--------GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF 276
           YLH+        G  P + HRD KS N+LL   + A +ADFGL+      K   +  G  
Sbjct: 127 YLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV 186
Query: 277 G---YLDPEYIS-TRNFTKKS----DVYSFGVLLFELIA 307
           G   Y+ PE +    NF + +    D+Y+ G++L+EL++
Sbjct: 187 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 105 SYKDLQKATCNFTTLI---GQGAFGPVYKAQMS------TGETVAVKVLA-TDSKQGEKE 154
           S  DL++      TLI   G GAFG VY+ Q+S      +   VAVK L    S+Q E +
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 79
Query: 155 FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP-----LTW 209
           F  E +++ + +H+N+V  +G   +     ++   M+ G L S L +    P     L  
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA---DFGLSREEMVD 266
              +H+A D+A G +YL +      IHRDI + N LL      RVA   DFG++R    D
Sbjct: 140 LDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR----D 192
Query: 267 KHAANIRGTFG-------YLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
            + A+     G       ++ PE      FT K+D +SFGVLL+E+ +
Sbjct: 193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 130/273 (47%), Gaps = 20/273 (7%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + +      +G G FG V+ A  +    VAVK +   S   E  F  E  ++  L H
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQH 242
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
             LV L     ++  +++   FM+KGSL   L  +          +  +  +A G+ ++ 
Sbjct: 243 DKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYIS 285
                  IHRD++++NIL+  S+  ++ADFGL+R    +++ A     F   +  PE I+
Sbjct: 302 QRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 358
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF 344
             +FT KSDV+SFG+LL E++  GR P  G+     + A+    + G+      R+    
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL----ERGY------RMPRPE 408
Query: 345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
           +  E  E+ ++  +C    P +RP+   I  VL
Sbjct: 409 NCPE--ELYNIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 127/273 (46%), Gaps = 20/273 (7%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + +      +G G FG V+ A  +    VAVK +   S   E  F  E  ++  L H
Sbjct: 11  EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQH 69
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
             LV L     ++  +++   FM+KGSL   L  +          +  +  +A G+ ++ 
Sbjct: 70  DKLVKLHAVVTKEPIYIITE-FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 128
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYIS 285
                  IHRD++++NIL+  S+  ++ADFGL+R    +++ A     F   +  PE I+
Sbjct: 129 QRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 185
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF 344
             +FT KSDV+SFG+LL E++  GR P  G+     + A+              R+    
Sbjct: 186 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER----------GYRMPRPE 235
Query: 345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
           +  E  E+ ++  +C    P +RP+   I  VL
Sbjct: 236 NCPE--ELYNIMMRCWKNRPEERPTFEYIQSVL 266

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 112/226 (49%), Gaps = 28/226 (12%)
Query: 105 SYKDLQKATCNFTTLI---GQGAFGPVYKAQMS------TGETVAVKVLA-TDSKQGEKE 154
           S  DL++      TLI   G GAFG VY+ Q+S      +   VAVK L    S+Q E +
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 79
Query: 155 FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP-----LTW 209
           F  E +++ + +H+N+V  +G   +     ++   M+ G L S L +    P     L  
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA---DFGLSREEMVD 266
              +H+A D+A G +YL +      IHRDI + N LL      RVA   DFG++R+  + 
Sbjct: 140 LDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IY 194
Query: 267 KHAANIRG-----TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
           + +   +G        ++ PE      FT K+D +SFGVLL+E+ +
Sbjct: 195 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 112/226 (49%), Gaps = 28/226 (12%)
Query: 105 SYKDLQKATCNFTTLI---GQGAFGPVYKAQMS------TGETVAVKVLA-TDSKQGEKE 154
           S  DL++      TLI   G GAFG VY+ Q+S      +   VAVK L    S+Q E +
Sbjct: 37  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 96
Query: 155 FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP-----LTW 209
           F  E +++ + +H+N+V  +G   +     ++   M+ G L S L +    P     L  
Sbjct: 97  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 156
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA---DFGLSREEMVD 266
              +H+A D+A G +YL +      IHRDI + N LL      RVA   DFG++R+  + 
Sbjct: 157 LDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IY 211
Query: 267 KHAANIRG-----TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
           + +   +G        ++ PE      FT K+D +SFGVLL+E+ +
Sbjct: 212 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 111/223 (49%), Gaps = 9/223 (4%)
Query: 94  NVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEK 153
           N  S +G+  Y   ++      F   +G G FG V   +      VA+K++   S   E 
Sbjct: 7   NAPSTAGLG-YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSED 64
Query: 154 EFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV 213
           EF  E  ++  L H  LV L G C ++    ++  +M+ G L ++L +  +   T  L +
Sbjct: 65  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-L 123
Query: 214 HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR 273
            +  DV   +EYL        +HRD+ + N L++     +V+DFGLSR  + D+  +++ 
Sbjct: 124 EMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVG 180
Query: 274 GTFG--YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQ 313
             F   +  PE +    F+ KSD+++FGVL++E+ + G+ P +
Sbjct: 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 105/201 (52%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE---KEFQTEVMLLGRLHHRNLVNLVG 175
           +G G    VY A+ +     VA+K +    ++ E   K F+ EV    +L H+N+V+++ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              E   + LV  ++   +L+ ++  E++GPL+ +  ++    +  G+++ HD  +   +
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHDMRI---V 133
Query: 236 HRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTRNFTKKS 293
           HRDIK  NIL+D +   ++ DFG+++   E       ++ GT  Y  PE        + +
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECT 193
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D+YS G++L+E++ G  P  G
Sbjct: 194 DIYSIGIVLYEMLVGEPPFNG 214

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 110/228 (48%), Gaps = 32/228 (14%)
Query: 105 SYKDLQKATCNFTTLI---GQGAFGPVYKAQMS------TGETVAVKVLA-TDSKQGEKE 154
           S  DL++      TLI   G GAFG VY+ Q+S      +   VAVK L    S+Q E +
Sbjct: 38  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 97
Query: 155 FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP-----LTW 209
           F  E +++ + +H+N+V  +G   +     ++   M+ G L S L +    P     L  
Sbjct: 98  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 157
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA---DFGLSREEMVD 266
              +H+A D+A G +YL +      IHRDI + N LL      RVA   DFG++R    D
Sbjct: 158 LDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR----D 210
Query: 267 KHAANIRGTFG-------YLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
            + A      G       ++ PE      FT K+D +SFGVLL+E+ +
Sbjct: 211 IYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 8/202 (3%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
            F   +G G FG V   +      VA+K++   S   E EF  E  ++  L H  LV L 
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C ++    ++  +M+ G L ++L +  +   T  L + +  DV   +EYL        
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEAMEYLESKQF--- 121
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYISTRNFTKK 292
           +HRD+ + N L++     +V+DFGLSR  + D++ +++   F   +  PE +    F+ K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 293 SDVYSFGVLLFELIA-GRSPLQ 313
           SD+++FGVL++E+ + G+ P +
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYE 203

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 112/226 (49%), Gaps = 28/226 (12%)
Query: 105 SYKDLQKATCNFTTLI---GQGAFGPVYKAQMS------TGETVAVKVLA-TDSKQGEKE 154
           S  DL++      TLI   G GAFG VY+ Q+S      +   VAVK L    S+Q E +
Sbjct: 12  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 71
Query: 155 FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP-----LTW 209
           F  E +++ + +H+N+V  +G   +     ++   M+ G L S L +    P     L  
Sbjct: 72  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 131
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA---DFGLSREEMVD 266
              +H+A D+A G +YL +      IHRDI + N LL      RVA   DFG++R+  + 
Sbjct: 132 LDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IY 186
Query: 267 KHAANIRG-----TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
           + +   +G        ++ PE      FT K+D +SFGVLL+E+ +
Sbjct: 187 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 26/208 (12%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           ++G+G FG   K     TGE + +K L    ++ ++ F  EV ++  L H N++  +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 178 AEKGQHMLVYVFMSKGSLASHL--YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
            +  +   +  ++  G+L   +   D  Y    W+ RV  A D+A G+ YLH   +   I
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQY---PWSQRVSFAKDIASGMAYLHSMNI---I 130
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVD----------------KHAANIRGTFGYL 279
           HRD+ S N L+ ++    VADFGL+R  MVD                K    + G   ++
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLAR-LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIA 307
            PE I+ R++ +K DV+SFG++L E+I 
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIG 217

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 8/202 (3%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
            F   +G G FG V   +      VA+K++   S   E EF  E  ++  L H  LV L 
Sbjct: 11  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLY 69
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C ++    ++  +M+ G L ++L +  +   T  L + +  DV   +EYL        
Sbjct: 70  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEAMEYLESKQF--- 125
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYISTRNFTKK 292
           +HRD+ + N L++     +V+DFGLSR  + D++ +++   F   +  PE +    F+ K
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 185
Query: 293 SDVYSFGVLLFELIA-GRSPLQ 313
           SD+++FGVL++E+ + G+ P +
Sbjct: 186 SDIWAFGVLMWEIYSLGKMPYE 207

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 111/226 (49%), Gaps = 28/226 (12%)
Query: 105 SYKDLQKATCNFTTLI---GQGAFGPVYKAQMS------TGETVAVKVLA-TDSKQGEKE 154
           S  DL++      TLI   G GAFG VY+ Q+S      +   VAVK L    S+Q E +
Sbjct: 61  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 120
Query: 155 FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP-----LTW 209
           F  E +++ + +H+N+V  +G   +     ++   M+ G L S L +    P     L  
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA---DFGLSREEMVD 266
              +H+A D+A G +YL +      IHRDI + N LL      RVA   DFG++R+  + 
Sbjct: 181 LDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IY 235
Query: 267 KHAANIRG-----TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
           +     +G        ++ PE      FT K+D +SFGVLL+E+ +
Sbjct: 236 RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 112/226 (49%), Gaps = 28/226 (12%)
Query: 105 SYKDLQKATCNFTTLI---GQGAFGPVYKAQMS------TGETVAVKVLA-TDSKQGEKE 154
           S  DL++      TLI   G GAFG VY+ Q+S      +   VAVK L    S+Q E +
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 94
Query: 155 FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP-----LTW 209
           F  E +++ + +H+N+V  +G   +     ++   M+ G L S L +    P     L  
Sbjct: 95  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 154
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA---DFGLSREEMVD 266
              +H+A D+A G +YL +      IHRDI + N LL      RVA   DFG++R+  + 
Sbjct: 155 LDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IY 209
Query: 267 KHAANIRG-----TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
           + +   +G        ++ PE      FT K+D +SFGVLL+E+ +
Sbjct: 210 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 8/202 (3%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
            F   +G G FG V   +      VA+K++   S   E EF  E  ++  L H  LV L 
Sbjct: 18  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLY 76
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C ++    ++  +M+ G L ++L +  +   T  L + +  DV   +EYL        
Sbjct: 77  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEAMEYLES---KQF 132
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYISTRNFTKK 292
           +HRD+ + N L++     +V+DFGLSR  + D++ +++   F   +  PE +    F+ K
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 192
Query: 293 SDVYSFGVLLFELIA-GRSPLQ 313
           SD+++FGVL++E+ + G+ P +
Sbjct: 193 SDIWAFGVLMWEIYSLGKMPYE 214

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 105/198 (53%), Gaps = 11/198 (5%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG G+FG VYK +      V +  +   + Q  + F+ EV +L +  H N++  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
             Q  +V  +    SL  HL+          L + IA   A+G++YLH  ++   IHRD+
Sbjct: 76  P-QLAIVTQWCEGSSLYHHLHIIETKFEMIKL-IDIARQTAQGMDYLHAKSI---IHRDL 130
Query: 240 KSSNILLDQSMRARVADFGLS--REEMVDKHA-ANIRGTFGYLDPEYISTRN---FTKKS 293
           KS+NI L + +  ++ DFGL+  +      H    + G+  ++ PE I  ++   ++ +S
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 294 DVYSFGVLLFELIAGRSP 311
           DVY+FG++L+EL+ G+ P
Sbjct: 191 DVYAFGIVLYELMTGQLP 208

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 125/265 (47%), Gaps = 33/265 (12%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKK 128
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT 290
           V   IHRDIK  N+LL  +   ++ADFG S      + AA + GT  YL PE I  R   
Sbjct: 129 V---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA-LCGTLDYLPPEMIEGRMHD 184
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
           +K D++S GVL +E + G+ P +           NT   T ++ I  SR++  F      
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEA----------NTYQDT-YKRI--SRVEFTFPDFVTE 231
Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQ 375
               L  + +   P +RP +R++++
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 126/265 (47%), Gaps = 33/265 (12%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 131
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT 290
           V   IHRDIK  N+LL  +   ++ADFG S      + AA + GT  YL PE I  R   
Sbjct: 132 V---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA-LCGTLDYLPPEMIEGRMHD 187
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
           +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F      
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFPDFVTE 234
Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQ 375
               L  + +   P +RP +R++++
Sbjct: 235 GARDLISRLLKHNPSQRPMLREVLE 259

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 8/202 (3%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
            F   +G G FG V   +      VA+K++   S   E EF  E  ++  L H  LV L 
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLY 70
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C ++    ++  +M+ G L ++L +  +   T  L + +  DV   +EYL        
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEAMEYLESKQF--- 126
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYISTRNFTKK 292
           +HRD+ + N L++     +V+DFGLSR  + D++ +++   F   +  PE +    F+ K
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 186
Query: 293 SDVYSFGVLLFELIA-GRSPLQ 313
           SD+++FGVL++E+ + G+ P +
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 112/226 (49%), Gaps = 28/226 (12%)
Query: 105 SYKDLQKATCNFTTLI---GQGAFGPVYKAQMS------TGETVAVKVLA-TDSKQGEKE 154
           S  DL++      TLI   G GAFG VY+ Q+S      +   VAVK L    S+Q E +
Sbjct: 35  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELD 94
Query: 155 FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP-----LTW 209
           F  E +++ + +H+N+V  +G   +     ++   M+ G L S L +    P     L  
Sbjct: 95  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 154
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA---DFGLSREEMVD 266
              +H+A D+A G +YL +      IHRDI + N LL      RVA   DFG++R+  + 
Sbjct: 155 LDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IY 209
Query: 267 KHAANIRG-----TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
           + +   +G        ++ PE      FT K+D +SFGVLL+E+ +
Sbjct: 210 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 126/265 (47%), Gaps = 33/265 (12%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 128
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT 290
           V   IHRDIK  N+LL  +   ++ADFG S      + AA + GT  YL PE I  R   
Sbjct: 129 V---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA-LCGTLDYLPPEMIEGRMHD 184
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
           +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F      
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFPDFVTE 231
Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQ 375
               L  + +   P +RP +R++++
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVLE 256

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/246 (30%), Positives = 119/246 (48%), Gaps = 35/246 (14%)
Query: 92  RSNVVSASGIPEYSY-------KDLQKATCNFTTLI---GQGAFGPVYKAQMS------T 135
           R++ +     P YS+        DL++      TLI   G GAFG VY+ Q+S      +
Sbjct: 1   RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 60
Query: 136 GETVAVKVLA-TDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS 194
              VAVK L    S+Q E +F  E +++ + +H+N+V  +G   +     ++   M+ G 
Sbjct: 61  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 195 LASHLYDENYGP-----LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS 249
           L S L +    P     L     +H+A D+A G +YL +      IHRDI + N LL   
Sbjct: 121 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCP 177
Query: 250 MRARVA---DFGLSREEMVDKHAANIRG-----TFGYLDPEYISTRNFTKKSDVYSFGVL 301
              RVA   DFG++++  + + +   +G        ++ PE      FT K+D +SFGVL
Sbjct: 178 GPGRVAKIGDFGMAQD--IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 235
Query: 302 LFELIA 307
           L+E+ +
Sbjct: 236 LWEIFS 241

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 117/239 (48%), Gaps = 16/239 (6%)
Query: 115 NFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVN 172
           +F  ++G GAF  V  A+   T + VA+K +A ++ +G E   + E+ +L ++ H N+V 
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L       G   L+   +S G L   + ++ +   T      +   V   ++YLHD  + 
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLGI- 137
Query: 233 PVIHRDIKSSNIL---LDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNF 289
             +HRD+K  N+L   LD+  +  ++DFGLS+ E      +   GT GY+ PE ++ + +
Sbjct: 138 --VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 290 TKKSDVYSFGVLLFELIAGRSPLQG-----LMEYVELAAMNTEGKTGWEEIVDSRLDGI 343
           +K  D +S GV+ + L+ G  P        L E + L A        W++I DS  D I
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-LKAEYEFDSPYWDDISDSAKDFI 253

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 117/239 (48%), Gaps = 16/239 (6%)
Query: 115 NFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVN 172
           +F  ++G GAF  V  A+   T + VA+K +A ++ +G E   + E+ +L ++ H N+V 
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L       G   L+   +S G L   + ++ +   T      +   V   ++YLHD  + 
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLGI- 137
Query: 233 PVIHRDIKSSNIL---LDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNF 289
             +HRD+K  N+L   LD+  +  ++DFGLS+ E      +   GT GY+ PE ++ + +
Sbjct: 138 --VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 290 TKKSDVYSFGVLLFELIAGRSPLQG-----LMEYVELAAMNTEGKTGWEEIVDSRLDGI 343
           +K  D +S GV+ + L+ G  P        L E + L A        W++I DS  D I
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-LKAEYEFDSPYWDDISDSAKDFI 253

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 117/239 (48%), Gaps = 16/239 (6%)
Query: 115 NFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVN 172
           +F  ++G GAF  V  A+   T + VA+K +A ++ +G E   + E+ +L ++ H N+V 
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L       G   L+   +S G L   + ++ +   T      +   V   ++YLHD  + 
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLGI- 137
Query: 233 PVIHRDIKSSNIL---LDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNF 289
             +HRD+K  N+L   LD+  +  ++DFGLS+ E      +   GT GY+ PE ++ + +
Sbjct: 138 --VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 290 TKKSDVYSFGVLLFELIAGRSPLQG-----LMEYVELAAMNTEGKTGWEEIVDSRLDGI 343
           +K  D +S GV+ + L+ G  P        L E + L A        W++I DS  D I
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-LKAEYEFDSPYWDDISDSAKDFI 253

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 124/280 (44%), Gaps = 27/280 (9%)
Query: 118 TLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
            ++G+G +G VY  + +S    +A+K +     +  +    E+ L   L H+N+V  +G 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 177 CAEKGQHMLVYVFMSK--GSLASHLYDENYGPLTWNLRV--HIALDVARGLEYLHDGAVP 232
            +E G    + +FM +  G   S L    +GPL  N +        +  GL+YLHD    
Sbjct: 88  FSENG---FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ-- 142
Query: 233 PVIHRDIKSSNILLDQ-SMRARVADFGLS-REEMVDKHAANIRGTFGYLDPEYIS--TRN 288
            ++HRDIK  N+L++  S   +++DFG S R   ++       GT  Y+ PE I    R 
Sbjct: 143 -IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
           + K +D++S G  + E+  G+ P   L E    AAM   G       +   +        
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPFYELGE--PQAAMFKVGMFKVHPEIPESMSA------ 253
Query: 349 LNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRK 388
             E  +   KC    P KR    D+  ++   LK+   +K
Sbjct: 254 --EAKAFILKCFEPDPDKRACANDL--LVDEFLKVSSKKK 289

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 8/211 (3%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH 167
           ++ + T      +G G  G V+    +    VAVK L   S   +  F  E  L+ +L H
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQH 67
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           + LV L     ++  +++   +M  GSL   L   +   LT N  + +A  +A G+ ++ 
Sbjct: 68  QRLVRLYAVVTQEPIYIITE-YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYIS 285
           +      IHRD++++NIL+  ++  ++ADFGL+R  E+         +    +  PE I+
Sbjct: 127 ERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAIN 183
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
              FT KSDV+SFG+LL E++  GR P  G+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 128/268 (47%), Gaps = 33/268 (12%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVM----LLGRLHHRNLVNL 173
           ++G+G+FG V+ A+   T +  A+K L  D    + + +  ++    L     H  L ++
Sbjct: 25  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 84
Query: 174 VGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
             +C  + +  L +V  +++ G L  H+  ++      +     A ++  GL++LH   +
Sbjct: 85  --FCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKGI 140
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPEYISTRNFT 290
              ++RD+K  NILLD+    ++ADFG+ +E M+ D       GT  Y+ PE +  + + 
Sbjct: 141 ---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYN 197
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDS-RLDGIFDVEEL 349
              D +SFGVLL+E++ G+SP  G  E               EE+  S R+D  F    L
Sbjct: 198 HSVDWWSFGVLLYEMLIGQSPFHGQDE---------------EELFHSIRMDNPFYPRWL 242
Query: 350 -NEVASLAYKCVNRAPRKRPSMR-DIVQ 375
             E   L  K   R P KR  +R DI Q
Sbjct: 243 EKEAKDLLVKLFVREPEKRLGVRGDIRQ 270

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 122/259 (47%), Gaps = 26/259 (10%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +G G FG V+ A  +    VAVK +   S   E  F  E  ++  L H  LV L     +
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +  +++   FM+KGSL   L  +          +  +  +A G+ ++        IHRD+
Sbjct: 249 EPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRDL 304
Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFG 299
           +++NIL+  S+  ++ADFGL+R           +    +  PE I+  +FT KSDV+SFG
Sbjct: 305 RAANILVSASLVCKIADFGLAR--------VGAKFPIKWTAPEAINFGSFTIKSDVWSFG 356
Query: 300 VLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYK 358
           +LL E++  GR P  G+     + A+    + G+      R+    +  E  E+ ++  +
Sbjct: 357 ILLMEIVTYGRIPYPGMSNPEVIRAL----ERGY------RMPRPENCPE--ELYNIMMR 404
Query: 359 CVNRAPRKRPSMRDIVQVL 377
           C    P +RP+   I  VL
Sbjct: 405 CWKNRPEERPTFEYIQSVL 423

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 116/239 (48%), Gaps = 16/239 (6%)
Query: 115 NFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVN 172
           +F  ++G GAF  V  A+   T + VA+K +A  + +G E   + E+ +L ++ H N+V 
Sbjct: 21  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L       G   L+   +S G L   + ++ +   T      +   V   ++YLHD  + 
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLGI- 137
Query: 233 PVIHRDIKSSNIL---LDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNF 289
             +HRD+K  N+L   LD+  +  ++DFGLS+ E      +   GT GY+ PE ++ + +
Sbjct: 138 --VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 290 TKKSDVYSFGVLLFELIAGRSPL-----QGLMEYVELAAMNTEGKTGWEEIVDSRLDGI 343
           +K  D +S GV+ + L+ G  P        L E + L A        W++I DS  D I
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-LKAEYEFDSPYWDDISDSAKDFI 253

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 149/300 (49%), Gaps = 52/300 (17%)
Query: 120 IGQGAFGPVYKAQM------STGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVN 172
           +G+G FG V KA        +   TVAVK+L  ++   E ++  +E  +L +++H +++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYD-ENYGP---------------------LTWN 210
           L G C++ G  +L+  +   GSL   L +    GP                     LT  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 211 LRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA 270
             +  A  +++G++YL + ++   +HRD+ + NIL+ +  + +++DFGLSR+  V +  +
Sbjct: 151 DLISFAWQISQGMQYLAEMSL---VHRDLAARNILVAEGRKMKISDFGLSRD--VYEEDS 205
Query: 271 NIRGTFGYLDPEYISTRN-----FTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAM 324
            ++ + G +  ++++  +     +T +SDV+SFGVLL+E++  G +P  G    +    +
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG----IPPERL 261
Query: 325 NTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR 384
               KTG       R++   +  E  E+  L  +C  + P KRP   DI + L +++  R
Sbjct: 262 FNLLKTG------HRMERPDNCSE--EMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 128/268 (47%), Gaps = 33/268 (12%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVM----LLGRLHHRNLVNL 173
           ++G+G+FG V+ A+   T +  A+K L  D    + + +  ++    L     H  L ++
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 174 VGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
             +C  + +  L +V  +++ G L  H+  ++      +     A ++  GL++LH   +
Sbjct: 84  --FCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKGI 139
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPEYISTRNFT 290
              ++RD+K  NILLD+    ++ADFG+ +E M+ D       GT  Y+ PE +  + + 
Sbjct: 140 ---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYN 196
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDS-RLDGIFDVEEL 349
              D +SFGVLL+E++ G+SP  G  E               EE+  S R+D  F    L
Sbjct: 197 HSVDWWSFGVLLYEMLIGQSPFHGQDE---------------EELFHSIRMDNPFYPRWL 241
Query: 350 -NEVASLAYKCVNRAPRKRPSMR-DIVQ 375
             E   L  K   R P KR  +R DI Q
Sbjct: 242 EKEAKDLLVKLFVREPEKRLGVRGDIRQ 269

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 42/293 (14%)
Query: 115 NFTTLIGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRL-H 166
           +F   +G GAFG V +A      +     TVAVK+L   +   E+E   +E+ +L  L +
Sbjct: 42  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 101
Query: 167 HRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHI----------- 215
           H N+VNL+G C   G  +++  +   G L + L  +    +       I           
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 216 -----ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH-- 268
                +  VA+G+ +L   A    IHRD+ + NILL      ++ DFGL+R+   D +  
Sbjct: 162 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 218
Query: 269 -AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNT 326
              N R    ++ PE I    +T +SDV+S+G+ L+EL + G SP  G+    +   M  
Sbjct: 219 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 278
Query: 327 EGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR 379
           EG              +       E+  +   C +  P KRP+ + IVQ++ +
Sbjct: 279 EG-----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 320

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 42/293 (14%)
Query: 115 NFTTLIGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRL-H 166
           +F   +G GAFG V +A      +     TVAVK+L   +   E+E   +E+ +L  L +
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 167 HRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHI----------- 215
           H N+VNL+G C   G  +++  +   G L + L  +    +       I           
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 216 -----ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH-- 268
                +  VA+G+ +L   A    IHRD+ + NILL      ++ DFGL+R+   D +  
Sbjct: 146 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 269 -AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNT 326
              N R    ++ PE I    +T +SDV+S+G+ L+EL + G SP  G+    +   M  
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262
Query: 327 EGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR 379
           EG              +       E+  +   C +  P KRP+ + IVQ++ +
Sbjct: 263 EG-----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 42/293 (14%)
Query: 115 NFTTLIGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRL-H 166
           +F   +G GAFG V +A      +     TVAVK+L   +   E+E   +E+ +L  L +
Sbjct: 44  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 103
Query: 167 HRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHI----------- 215
           H N+VNL+G C   G  +++  +   G L + L  +    +       I           
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 163
Query: 216 -----ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH-- 268
                +  VA+G+ +L   A    IHRD+ + NILL      ++ DFGL+R+   D +  
Sbjct: 164 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 220
Query: 269 -AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNT 326
              N R    ++ PE I    +T +SDV+S+G+ L+EL + G SP  G+    +   M  
Sbjct: 221 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 280
Query: 327 EGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR 379
           EG              +       E+  +   C +  P KRP+ + IVQ++ +
Sbjct: 281 EG-----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 322

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 124/265 (46%), Gaps = 33/265 (12%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +  +G +   L     +DE           +I  ++A  L Y H   
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 133
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT 290
           V   IHRDIK  N+LL  +   ++ADFG S      +    + GT  YL PE I  R   
Sbjct: 134 V---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX-LXGTLDYLPPEMIEGRMHD 189
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
           +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F      
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFPDFVTE 236
Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQ 375
               L  + +   P +RP +R++++
Sbjct: 237 GARDLISRLLKHNPSQRPMLREVLE 261

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +  +G +   L     +DE           +I  ++A  L Y H   
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 133
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 134 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTLDYLPPEMIE 184
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 231
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 232 DFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 42/293 (14%)
Query: 115 NFTTLIGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRL-H 166
           +F   +G GAFG V +A      +     TVAVK+L   +   E+E   +E+ +L  L +
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 167 HRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHI----------- 215
           H N+VNL+G C   G  +++  +   G L + L  +    +       I           
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 216 -----ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH-- 268
                +  VA+G+ +L   A    IHRD+ + NILL      ++ DFGL+R+   D +  
Sbjct: 169 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 225
Query: 269 -AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNT 326
              N R    ++ PE I    +T +SDV+S+G+ L+EL + G SP  G+    +   M  
Sbjct: 226 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285
Query: 327 EGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR 379
           EG              +       E+  +   C +  P KRP+ + IVQ++ +
Sbjct: 286 EG-----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
           NF  ++G+G+FG V  A +  T E  A+K+L  D    + + +    E  +L  L     
Sbjct: 22  NFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPF 81
Query: 171 VNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +  +  C +    +  V  +++ G L  H+  +  G       V  A +++ GL +LH  
Sbjct: 82  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISIGLFFLHKR 139
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRGTFGYLDPEYISTRN 288
            +   I+RD+K  N++LD     ++ADFG+ +E M+D        GT  Y+ PE I+ + 
Sbjct: 140 GI---IYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQP 196
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
           + K  D +++GVLL+E++AG+ P  G
Sbjct: 197 YGKSVDWWAYGVLLYEMLAGQPPFDG 222

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 112/203 (55%), Gaps = 12/203 (5%)
Query: 119 LIGQGAFGPVYKAQMST----GETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++GQG+FG V+  +  T    G   A+KVL  AT   +     + E  +L  ++H  +V 
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVK 94
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      +G+  L+  F+  G L + L  E       +++ ++A ++A GL++LH   + 
Sbjct: 95  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-EEDVKFYLA-ELALGLDHLHSLGI- 151
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPEYISTRNFTK 291
             I+RD+K  NILLD+    ++ DFGLS+E +  +K A +  GT  Y+ PE ++ +  + 
Sbjct: 152 --IYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSH 209
Query: 292 KSDVYSFGVLLFELIAGRSPLQG 314
            +D +S+GVL+FE++ G  P QG
Sbjct: 210 SADWWSYGVLMFEMLTGSLPFQG 232

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 131/290 (45%), Gaps = 54/290 (18%)
Query: 119 LIGQGAFGPVYKAQMST-GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG-- 175
           LIG G FG V+KA+    G+T  ++ +  ++++ E+E    V  L +L H N+V+  G  
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIVHYNGCW 74
Query: 176 ------------------YCAEKGQH---------MLVYVFMSKGSLASHLYDENYGPLT 208
                             Y  E  ++          +   F  KG+L   +       L 
Sbjct: 75  DGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 134
Query: 209 WNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268
             L + +   + +G++Y+H      +IHRD+K SNI L  + + ++ DFGL      D  
Sbjct: 135 KVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 191
Query: 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG 328
               +GT  Y+ PE IS++++ K+ D+Y+ G++L EL+              +     E 
Sbjct: 192 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL-------------HVCDTAFET 238
Query: 329 KTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS 378
              + ++ D  +  IFD +E     +L  K +++ P  RP+  +I++ L+
Sbjct: 239 SKFFTDLRDGIISDIFDKKE----KTLLQKLLSKKPEDRPNTSEILRTLT 284

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 148/300 (49%), Gaps = 52/300 (17%)
Query: 120 IGQGAFGPVYKAQM------STGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVN 172
           +G+G FG V KA        +   TVAVK+L  ++   E ++  +E  +L +++H +++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYD-ENYGP---------------------LTWN 210
           L G C++ G  +L+  +   GSL   L +    GP                     LT  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 211 LRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA 270
             +  A  +++G++YL +  +   +HRD+ + NIL+ +  + +++DFGLSR+  V +  +
Sbjct: 151 DLISFAWQISQGMQYLAEMKL---VHRDLAARNILVAEGRKMKISDFGLSRD--VYEEDS 205
Query: 271 NIRGTFGYLDPEYISTRN-----FTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAM 324
            ++ + G +  ++++  +     +T +SDV+SFGVLL+E++  G +P  G    +    +
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG----IPPERL 261
Query: 325 NTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR 384
               KTG       R++   +  E  E+  L  +C  + P KRP   DI + L +++  R
Sbjct: 262 FNLLKTG------HRMERPDNCSE--EMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 110/210 (52%), Gaps = 13/210 (6%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMST-GE---TVAVKVL-ATDSKQGEKEFQTEVML 161
           ++++ +  +   +IG G  G V   ++   G+    VA+K L A  +++  ++F +E  +
Sbjct: 44  REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI 103
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N++ L G        M+V  +M  GSL + L   + G  T    V +   V  
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGA 162
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI----RGTFG 277
           G+ YL D      +HRD+ + N+L+D ++  +V+DFGLSR    D  AA      +    
Sbjct: 163 GMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIR 219
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
           +  PE I+ R F+  SDV+SFGV+++E++A
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 133
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 134 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTLDYLPPEXIE 184
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 185 GRXHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 231
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 232 DFVTEGARDLISRLLKHNPSQRPXLREVLE 261

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 154
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 155 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTLDYLPPEMIE 205
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 252
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 253 DFVTEGARDLISRLLKHNPSQRPMLREVLE 282

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 96/199 (48%), Gaps = 7/199 (3%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDSKQ---GEKEFQTEVMLLGRLHHRNLVNLV 174
           ++G+G FG V   Q+ +TG+  A K L     +   GE     E  +L +++ R +V+L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
                K    LV   M+ G L  H+Y            V  A ++  GLE LH   +   
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI--- 307
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
           ++RD+K  NILLD     R++D GL+      +      GT GY+ PE +    +T   D
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 367
Query: 295 VYSFGVLLFELIAGRSPLQ 313
            ++ G LL+E+IAG+SP Q
Sbjct: 368 WWALGCLLYEMIAGQSPFQ 386

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 130/293 (44%), Gaps = 42/293 (14%)
Query: 115 NFTTLIGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRL-H 166
           +F   +G GAFG V +A      +     TVAVK+L   +   E+E   +E+ +L  L +
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 167 HRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHI----------- 215
           H N+VNL+G C   G  +++  +   G L + L  +    +       I           
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 216 -----ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH-- 268
                +  VA+G+ +L   A    IHRD+ + NILL      ++ DFGL+R    D +  
Sbjct: 169 DLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYV 225
Query: 269 -AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNT 326
              N R    ++ PE I    +T +SDV+S+G+ L+EL + G SP  G+    +   M  
Sbjct: 226 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285
Query: 327 EGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR 379
           EG              +       E+  +   C +  P KRP+ + IVQ++ +
Sbjct: 286 EG-----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 148/300 (49%), Gaps = 52/300 (17%)
Query: 120 IGQGAFGPVYKAQM------STGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVN 172
           +G+G FG V KA        +   TVAVK+L  ++   E ++  +E  +L +++H +++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYD-ENYGP---------------------LTWN 210
           L G C++ G  +L+  +   GSL   L +    GP                     LT  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 211 LRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA 270
             +  A  +++G++YL +  +   +HRD+ + NIL+ +  + +++DFGLSR+  V +  +
Sbjct: 151 DLISFAWQISQGMQYLAEMKL---VHRDLAARNILVAEGRKMKISDFGLSRD--VYEEDS 205
Query: 271 NIRGTFGYLDPEYISTRN-----FTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAM 324
            ++ + G +  ++++  +     +T +SDV+SFGVLL+E++  G +P  G    +    +
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG----IPPERL 261
Query: 325 NTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR 384
               KTG       R++   +  E  E+  L  +C  + P KRP   DI + L +++  R
Sbjct: 262 FNLLKTG------HRMERPDNCSE--EMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 118/266 (44%), Gaps = 25/266 (9%)
Query: 118 TLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
            ++G+G +G VY  + +S    +A+K +     +  +    E+ L   L H+N+V  +G 
Sbjct: 14  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 177 CAEKGQHMLVYVFMSK--GSLASHLYDENYGPLTWNLRV--HIALDVARGLEYLHDGAVP 232
            +E G    + +FM +  G   S L    +GPL  N +        +  GL+YLHD    
Sbjct: 74  FSENG---FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ-- 128
Query: 233 PVIHRDIKSSNILLDQ-SMRARVADFGLS-REEMVDKHAANIRGTFGYLDPEYI--STRN 288
            ++HRDIK  N+L++  S   +++DFG S R   ++       GT  Y+ PE I    R 
Sbjct: 129 -IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 187
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
           + K +D++S G  + E+  G+ P   L E    AAM   G       +   +        
Sbjct: 188 YGKAADIWSLGCTIIEMATGKPPFYELGE--PQAAMFKVGMFKVHPEIPESMSA------ 239
Query: 349 LNEVASLAYKCVNRAPRKRPSMRDIV 374
             E  +   KC    P KR    D++
Sbjct: 240 --EAKAFILKCFEPDPDKRACANDLL 263

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 110/210 (52%), Gaps = 13/210 (6%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMST-GE---TVAVKVL-ATDSKQGEKEFQTEVML 161
           ++++ +  +   +IG G  G V   ++   G+    VA+K L A  +++  ++F +E  +
Sbjct: 44  REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI 103
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N++ L G        M+V  +M  GSL + L   + G  T    V +   V  
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGA 162
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI----RGTFG 277
           G+ YL D      +HRD+ + N+L+D ++  +V+DFGLSR    D  AA      +    
Sbjct: 163 GMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
           +  PE I+ R F+  SDV+SFGV+++E++A
Sbjct: 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 96/199 (48%), Gaps = 7/199 (3%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDSKQ---GEKEFQTEVMLLGRLHHRNLVNLV 174
           ++G+G FG V   Q+ +TG+  A K L     +   GE     E  +L +++ R +V+L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
                K    LV   M+ G L  H+Y            V  A ++  GLE LH   +   
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI--- 307
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
           ++RD+K  NILLD     R++D GL+      +      GT GY+ PE +    +T   D
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 367
Query: 295 VYSFGVLLFELIAGRSPLQ 313
            ++ G LL+E+IAG+SP Q
Sbjct: 368 WWALGCLLYEMIAGQSPFQ 386

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 154
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 155 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRDDLCGTLDYLPPEMIE 205
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 252
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 253 DFVTEGARDLISRLLKHNPSQRPMLREVLE 282

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 8/202 (3%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
            F   +G G FG V   +      VA+K++   S   E EF  E  ++  L H  LV L 
Sbjct: 12  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLY 70
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C ++    ++  +M+ G L ++L +  +   T  L + +  DV   +EYL        
Sbjct: 71  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-LEMCKDVCEAMEYLESKQ---F 126
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG--YLDPEYISTRNFTKK 292
           +HRD+ + N L++     +V+DFGLSR  + D++ ++    F   +  PE +    F+ K
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSK 186
Query: 293 SDVYSFGVLLFELIA-GRSPLQ 313
           SD+++FGVL++E+ + G+ P +
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 145
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 146 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTLDYLPPEMIE 196
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 197 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 243
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 244 DFVTEGARDLISRLLKHNPSQRPMLREVLE 273

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 124/265 (46%), Gaps = 33/265 (12%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 129
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT 290
           V   IHRDIK  N+LL  +   ++ADFG S      +    + GT  YL PE I  R   
Sbjct: 130 V---IHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRT-TLSGTLDYLPPEMIEGRMHD 185
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
           +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F      
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFPDFVTE 232
Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQ 375
               L  + +   P +RP +R++++
Sbjct: 233 GARDLISRLLKHNPSQRPMLREVLE 257

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 125/265 (47%), Gaps = 33/265 (12%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 128
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT 290
           V   IHRDIK  N+LL  +   ++ADFG S      +   ++ GT  YL PE I  R   
Sbjct: 129 V---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-DLCGTLDYLPPEMIEGRMHD 184
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
           +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F      
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFPDFVTE 231
Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQ 375
               L  + +   P +RP +R++++
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 125/265 (47%), Gaps = 33/265 (12%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 133
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT 290
           V   IHRDIK  N+LL  +   ++ADFG S      +   ++ GT  YL PE I  R   
Sbjct: 134 V---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-DLCGTLDYLPPEMIEGRMHD 189
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
           +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F      
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFPDFVTE 236
Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQ 375
               L  + +   P +RP +R++++
Sbjct: 237 GARDLISRLLKHNPSQRPMLREVLE 261

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 131
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 132 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTLDYLPPEMIE 182
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 229
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 130
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 131 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRXXLCGTLDYLPPEMIE 181
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 228
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 229 DFVTEGARDLISRLLKHNPSQRPMLREVLE 258

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 133
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 134 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTLDYLPPEMIE 184
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 231
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 232 DFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 125/265 (47%), Gaps = 33/265 (12%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 129
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT 290
           V   IHRDIK  N+LL  +   ++ADFG S      +   ++ GT  YL PE I  R   
Sbjct: 130 V---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-DLCGTLDYLPPEMIEGRMHD 185
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
           +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F      
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFPDFVTE 232
Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQ 375
               L  + +   P +RP +R++++
Sbjct: 233 GARDLISRLLKHNPSQRPMLREVLE 257

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 125/265 (47%), Gaps = 33/265 (12%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 128
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT 290
           V   IHRDIK  N+LL  +   ++ADFG S      +   ++ GT  YL PE I  R   
Sbjct: 129 V---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-DLCGTLDYLPPEMIEGRMHD 184
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
           +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F      
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFPDFVTE 231
Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQ 375
               L  + +   P +RP +R++++
Sbjct: 232 GARDLISRLLKHNPSQRPMLREVLE 256

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 130/288 (45%), Gaps = 28/288 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTG----ETVAVKVLATD-SKQGEKEFQTEVML 161
           K++  +      +IG G FG V + ++         VA+K L    +++  +EF +E  +
Sbjct: 9   KEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASI 68
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N++ L G        M++  FM  G+L S L   N G  T    V +   +A 
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL-RLNDGQFTVIQLVGMLRGIAS 127
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG---- 277
           G+ YL + +    +HRD+ + NIL++ ++  +V+DFGLSR    +        + G    
Sbjct: 128 GMRYLAEMSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIP 184
Query: 278 --YLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             +  PE I+ R FT  SD +S+G++++E+++ G  P   +     + A+          
Sbjct: 185 IRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQ-------- 236
Query: 335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             D RL    D      +  L   C  +    RP    +V  L ++++
Sbjct: 237 --DYRLPPPPDCP--TSLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 280

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 131/288 (45%), Gaps = 28/288 (9%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQMSTG----ETVAVKVLATD-SKQGEKEFQTEVML 161
           K++  +      +IG G FG V + ++         VA+K L    +++  +EF +E  +
Sbjct: 11  KEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASI 70
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +G+  H N++ L G        M++  FM  G+L S L   N G  T    V +   +A 
Sbjct: 71  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR-LNDGQFTVIQLVGMLRGIAS 129
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRG---T 275
           G+ YL + +    +HRD+ + NIL++ ++  +V+DFGLSR   E   D    +  G    
Sbjct: 130 GMRYLAEMSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIP 186
Query: 276 FGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEE 334
             +  PE I+ R FT  SD +S+G++++E+++ G  P   +     + A+          
Sbjct: 187 IRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQ-------- 238
Query: 335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             D RL    D      +  L   C  +    RP    +V  L ++++
Sbjct: 239 --DYRLPPPPDCP--TSLHQLMLDCWQKDRNARPRFPQVVSALDKMIR 282

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 129
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 130 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRDTLCGTLDYLPPEMIE 180
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 227
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 228 DFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 128
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 129 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTLDYLPPEMIE 179
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 226
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 128
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 129 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTELCGTLDYLPPEMIE 179
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 226
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 127
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 128 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTLDYLPPEMIE 178
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 179 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 225
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 226 DFVTEGARDLISRLLKHNPSQRPMLREVLE 255

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 132
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 133 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTLDYLPPEMIE 183
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 230
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 231 DFVTEGARDLISRLLKHNPSQRPMLREVLE 260

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 131
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 132 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTLDYLPPEMIE 182
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 229
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 20/212 (9%)
Query: 116 FTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNL 173
              L+G G +G VYK + + TG+  A+KV+     + E+E + E+ +L +  HHRN+   
Sbjct: 28  LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATY 86
Query: 174 VGYCAEKG------QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
            G   +K       Q  LV  F   GS+   + +     L      +I  ++ RGL +LH
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 146
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGYLDPEYIS 285
              V   IHRDIK  N+LL ++   ++ DFG+S +    V +    I GT  ++ PE I+
Sbjct: 147 QHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIA 202
Query: 286 T-----RNFTKKSDVYSFGVLLFELIAGRSPL 312
                   +  KSD++S G+   E+  G  PL
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 128
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 129 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTXLCGTLDYLPPEMIE 179
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 226
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 131
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 132 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRDDLCGTLDYLPPEMIE 182
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 229
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 131
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 132 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRXXLCGTLDYLPPEMIE 182
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 229
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 9/199 (4%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQGE-KEFQTEVMLLGRLHHRNLVNLV 174
           L+G+G+F  VY+A+ + TG  VA+K++   +  K G  +  Q EV +  +L H +++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
            Y  +     LV      G +  +L +    P + N   H    +  G+ YLH   +   
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGI--- 133
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANIRGTFGYLDPEYISTRNFTKKS 293
           +HRD+  SN+LL ++M  ++ADFGL+ + +M  +    + GT  Y+ PE  +      +S
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLES 193
Query: 294 DVYSFGVLLFELIAGRSPL 312
           DV+S G + + L+ GR P 
Sbjct: 194 DVWSLGCMFYTLLIGRPPF 212

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 128
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 129 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRXXLCGTLDYLPPEMIE 179
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 226
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 227 DFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 125
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 126 V---IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTTLCGTLDYLPPEMIE 176
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 177 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 223
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 224 DFVTEGARDLISRLLKHNPSQRPMLREVLE 253

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 10/209 (4%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLV 174
           ++G+G FG V+  QM +TG+  A K L     +  K +Q    E  +L ++H R +V+L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLY--DENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
                K    LV   M+ G +  H+Y  DE+         +     +  GLE+LH   + 
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI- 310
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRGTFGYLDPEYISTRNFTK 291
             I+RD+K  N+LLD     R++D GL+ E    +       GT G++ PE +    +  
Sbjct: 311 --IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVE 320
             D ++ GV L+E+IA R P +   E VE
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 10/209 (4%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLV 174
           ++G+G FG V+  QM +TG+  A K L     +  K +Q    E  +L ++H R +V+L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLY--DENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
                K    LV   M+ G +  H+Y  DE+         +     +  GLE+LH   + 
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI- 310
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRGTFGYLDPEYISTRNFTK 291
             I+RD+K  N+LLD     R++D GL+ E    +       GT G++ PE +    +  
Sbjct: 311 --IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVE 320
             D ++ GV L+E+IA R P +   E VE
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 119 LIGQGAFGPVYKA-QMSTGETV----AVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V    A+KVL  + S +  KE   E  ++  +    +  
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L+G C       LV   M  G L  H+  EN G L     ++  + +A+G+ YL D  + 
Sbjct: 84  LLGICLTSTVQ-LVTQLMPYGCLLDHVR-ENRGRLGSQDLLNWCMQIAKGMSYLEDVRL- 140
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNF 289
             +HRD+ + N+L+      ++ DFGL+R   +D+   HA   +    ++  E I  R F
Sbjct: 141 --VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRF 198
Query: 290 TKKSDVYSFGVLLFELIA-GRSPLQGL 315
           T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 199 THQSDVWSYGVTVWELMTFGAKPYDGI 225

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 130
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++A+FG S       HA + R     GT  YL PE I 
Sbjct: 131 V---IHRDIKPENLLLGSAGELKIANFGWS------VHAPSSRRTTLCGTLDYLPPEMIE 181
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 228
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 229 DFVTEGARDLISRLLKHNPSQRPMLREVLE 258

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 10/209 (4%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLV 174
           ++G+G FG V+  QM +TG+  A K L     +  K +Q    E  +L ++H R +V+L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLY--DENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
                K    LV   M+ G +  H+Y  DE+         +     +  GLE+LH   + 
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI- 310
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRGTFGYLDPEYISTRNFTK 291
             I+RD+K  N+LLD     R++D GL+ E    +       GT G++ PE +    +  
Sbjct: 311 --IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVE 320
             D ++ GV L+E+IA R P +   E VE
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 126/270 (46%), Gaps = 43/270 (15%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVL--ATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL  A   K G E + + EV +   L H N++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------RTATYIT-ELANALSYCHSKR 131
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++A+FG S       HA + R     GT  YL PE I 
Sbjct: 132 V---IHRDIKPENLLLGSAGELKIANFGWS------VHAPSSRRTTLCGTLDYLPPEMIE 182
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            R   +K D++S GVL +E + G+ P +           NT  +T ++ I  SR++  F 
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----------NTYQET-YKRI--SRVEFTFP 229
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                    L  + +   P +RP +R++++
Sbjct: 230 DFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 10/209 (4%)
Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLV 174
           ++G+G FG V+  QM +TG+  A K L     +  K +Q    E  +L ++H R +V+L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLY--DENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
                K    LV   M+ G +  H+Y  DE+         +     +  GLE+LH   + 
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI- 310
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRGTFGYLDPEYISTRNFTK 291
             I+RD+K  N+LLD     R++D GL+ E    +       GT G++ PE +    +  
Sbjct: 311 --IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVE 320
             D ++ GV L+E+IA R P +   E VE
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 134/296 (45%), Gaps = 48/296 (16%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQM---STGE---TVAVKVLATDSKQG--EKEFQTE 158
           K++  +   F   +G+  FG VYK  +   + GE    VA+K L  D  +G   +EF+ E
Sbjct: 21  KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHE 79
Query: 159 VMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLY-----------DEN---Y 204
            ML  RL H N+V L+G   +     +++ + S G L   L            D++    
Sbjct: 80  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 139
Query: 205 GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264
             L     VH+   +A G+EYL       V+H+D+ + N+L+   +  +++D GL RE  
Sbjct: 140 SALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFRE-- 194
Query: 265 VDKHAANIRGTFG-------YLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
              +AA+     G       ++ PE I    F+  SD++S+GV+L+E+ +      GL  
Sbjct: 195 --VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS-----YGLQP 247
Query: 318 YVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDI 373
           Y   +  +        E++ +R       +    V +L  +C N  P +RP  +DI
Sbjct: 248 YCGYSNQDV------VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 297

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 133/295 (45%), Gaps = 28/295 (9%)
Query: 100 GIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMST--GE--TVAVKVLATDSKQGEKE- 154
           G P+Y    + +       ++G+G FG VY+   +   GE   VAVK    D     KE 
Sbjct: 15  GSPQYG---IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK 71
Query: 155 FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVH 214
           F +E +++  L H ++V L+G   E+   +++ ++   G L  H  + N   L     V 
Sbjct: 72  FMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELY-PYGELG-HYLERNKNSLKVLTLVL 129
Query: 215 IALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANI- 272
            +L + + + YL        +HRDI   NIL+      ++ DFGLSR  E  D + A++ 
Sbjct: 130 YSLQICKAMAYLESINC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 186
Query: 273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTG 331
           R    ++ PE I+ R FT  SDV+ F V ++E+++ G+ P   L     +  +    +  
Sbjct: 187 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP 246
Query: 332 WEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHN 386
             ++    L             +L  +C +  P  RP   ++V  LS + +M  +
Sbjct: 247 KPDLCPPVL------------YTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 289

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 134/296 (45%), Gaps = 48/296 (16%)
Query: 107 KDLQKATCNFTTLIGQGAFGPVYKAQM---STGE---TVAVKVLATDSKQG--EKEFQTE 158
           K++  +   F   +G+  FG VYK  +   + GE    VA+K L  D  +G   +EF+ E
Sbjct: 4   KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHE 62
Query: 159 VMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLY-----------DEN---Y 204
            ML  RL H N+V L+G   +     +++ + S G L   L            D++    
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 205 GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264
             L     VH+   +A G+EYL       V+H+D+ + N+L+   +  +++D GL RE  
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFRE-- 177
Query: 265 VDKHAANIRGTFG-------YLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
              +AA+     G       ++ PE I    F+  SD++S+GV+L+E+ +      GL  
Sbjct: 178 --VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS-----YGLQP 230
Query: 318 YVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDI 373
           Y   +  +        E++ +R       +    V +L  +C N  P +RP  +DI
Sbjct: 231 YCGYSNQDV------VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 280

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 128/276 (46%), Gaps = 25/276 (9%)
Query: 119 LIGQGAFGPVYKAQMST--GE--TVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNL 173
           ++G+G FG VY+   +   GE   VAVK    D     KE F +E +++  L H ++V L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           +G   E+   +++ ++   G L  +L + N   L     V  +L + + + YL       
Sbjct: 75  IGIIEEEPTWIIMELY-PYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESINC-- 130
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANI-RGTFGYLDPEYISTRNFTK 291
            +HRDI   NIL+      ++ DFGLSR  E  D + A++ R    ++ PE I+ R FT 
Sbjct: 131 -VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 189
Query: 292 KSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
            SDV+ F V ++E+++ G+ P   L     +  +    +    ++    L          
Sbjct: 190 ASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVL---------- 239
Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHN 386
              +L  +C +  P  RP   ++V  LS + +M  +
Sbjct: 240 --YTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 273

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDS----KQGEKEFQ 156
           P+YS +D Q         +G G+FG V+  +    G   A+KVL  +     KQ E    
Sbjct: 1   PKYSLQDFQ-----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-N 54
Query: 157 TEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIA 216
            E ++L  + H  ++ + G   +  Q  ++  ++  G L S L      P    +    A
Sbjct: 55  DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP--VAKFYA 112
Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF 276
            +V   LEYLH   +   I+RD+K  NILLD++   ++ DFG ++   V      + GT 
Sbjct: 113 AEVCLALEYLHSKDI---IYRDLKPENILLDKNGHIKITDFGFAK--YVPDVTYXLCGTP 167
Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
            Y+ PE +ST+ + K  D +SFG+L++E++AG +P 
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 132/286 (46%), Gaps = 40/286 (13%)
Query: 119 LIGQGAFGPVYKAQMS----TGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G+G FG V +  +     T   VAVK +  D  S++  +EF +E   +    H N++ 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 173 LVGYCAEKGQH-----MLVYVFMSKGSLASHLYDENY--GP--LTWNLRVHIALDVARGL 223
           L+G C E         M++  FM  G L ++L       GP  +     +   +D+A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLD 280
           EYL +      +HRD+ + N +L   M   VADFGLS++     +    R       ++ 
Sbjct: 161 EYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
            E ++ R +T KSDV++FGV ++E+   G +P  G+  +               E+ D  
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---------------EMYDYL 262
Query: 340 LDG--IFDVEE-LNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
           L G  +   E+ L+E+  + Y C    P  RP+   +   L ++L+
Sbjct: 263 LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 128/276 (46%), Gaps = 25/276 (9%)
Query: 119 LIGQGAFGPVYKAQMST--GE--TVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNL 173
           ++G+G FG VY+   +   GE   VAVK    D     KE F +E +++  L H ++V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           +G   E+   +++ ++   G L  +L + N   L     V  +L + + + YL       
Sbjct: 79  IGIIEEEPTWIIMELY-PYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESINC-- 134
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANI-RGTFGYLDPEYISTRNFTK 291
            +HRDI   NIL+      ++ DFGLSR  E  D + A++ R    ++ PE I+ R FT 
Sbjct: 135 -VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 193
Query: 292 KSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
            SDV+ F V ++E+++ G+ P   L     +  +    +    ++    L          
Sbjct: 194 ASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVL---------- 243
Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHN 386
              +L  +C +  P  RP   ++V  LS + +M  +
Sbjct: 244 --YTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 109/228 (47%), Gaps = 24/228 (10%)
Query: 97  SASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE-TVAVKVL--ATDSKQG-E 152
           ++SG P+   +            +G+G FG VY A+       VA+KVL  +   K+G E
Sbjct: 8   NSSGTPDILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVE 67
Query: 153 KEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLR 212
            + + E+ +   LHH N++ L  Y  ++ +  L+  +  +G L    Y E     T++ +
Sbjct: 68  HQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGEL----YKELQKSCTFDEQ 123
Query: 213 --VHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA 270
               I  ++A  L Y H   V   IHRDIK  N+LL      ++ADFG S       HA 
Sbjct: 124 RTATIMEELADALMYCHGKKV---IHRDIKPENLLLGLKGELKIADFGWS------VHAP 174
Query: 271 NIR-----GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
           ++R     GT  YL PE I  R   +K D++  GVL +EL+ G  P +
Sbjct: 175 SLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 115 NFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNL 170
           NF  ++G+G+FG V  ++   T E  AVK+L  D    + + +    E  +L        
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 171 VNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +  +  C +    +  V  +++ G L  H+  +  G       V  A ++A GL +L   
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRN 288
            +   I+RD+K  N++LD     ++ADFG+ +E + D        GT  Y+ PE I+ + 
Sbjct: 462 GI---IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP 518
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
           + K  D ++FGVLL+E++AG++P +G
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPFEG 544

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 105/205 (51%), Gaps = 7/205 (3%)
Query: 113 TCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLV 171
           T + T ++G G FG V+K +  +TG  +A K++ T   + ++E + E+ ++ +L H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            L      K   +LV  ++  G L   + DE+Y  LT    +     +  G+ ++H    
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN-LTELDTILFMKQICEGIRHMHQMY- 207
Query: 232 PPVIHRDIKSSNILL--DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNF 289
             ++H D+K  NIL     + + ++ DFGL+R     +      GT  +L PE ++    
Sbjct: 208 --ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV 265
Query: 290 TKKSDVYSFGVLLFELIAGRSPLQG 314
           +  +D++S GV+ + L++G SP  G
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSPFLG 290

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 130/298 (43%), Gaps = 44/298 (14%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLA---TDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           ++G+G+FG V   +   TG+  AVKV++      K  ++    EV LL +L H N++ L 
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
            +  +KG   LV    + G L   +            R  I   V  G+ Y+H      +
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYMHKN---KI 171
Query: 235 IHRDIKSSNILLDQSMR---ARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTK 291
           +HRD+K  N+LL+   +    R+ DFGLS      K   +  GT  Y+ PE +    + +
Sbjct: 172 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDE 230
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT----GWEEIVDSRLDGIFDVE 347
           K DV+S GV+L+ L++G  P  G  EY  L  +     T     W+++ +S  D      
Sbjct: 231 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD------ 284
Query: 348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDM 405
                  L  K +   P  R S RD +               H   Q+ T +++S+D+
Sbjct: 285 -------LIRKMLTYVPSMRISARDALD--------------HEWIQTYTKEQISVDV 321

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 130/298 (43%), Gaps = 44/298 (14%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLA---TDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           ++G+G+FG V   +   TG+  AVKV++      K  ++    EV LL +L H N++ L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
            +  +KG   LV    + G L   +            R  I   V  G+ Y+H      +
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYMHKN---KI 147
Query: 235 IHRDIKSSNILLDQSMR---ARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTK 291
           +HRD+K  N+LL+   +    R+ DFGLS      K   +  GT  Y+ PE +    + +
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDE 206
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT----GWEEIVDSRLDGIFDVE 347
           K DV+S GV+L+ L++G  P  G  EY  L  +     T     W+++ +S  D      
Sbjct: 207 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD------ 260
Query: 348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDM 405
                  L  K +   P  R S RD +               H   Q+ T +++S+D+
Sbjct: 261 -------LIRKMLTYVPSMRISARDALD--------------HEWIQTYTKEQISVDV 297

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 115 NFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
           NF  ++G+G+FG V  ++   T E  AVK+L  D    + + +    E  +L        
Sbjct: 23  NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 82
Query: 171 VNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +  +  C +    +  V  +++ G L  H+  +  G       V  A ++A GL +L   
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRN 288
            +   I+RD+K  N++LD     ++ADFG+ +E + D        GT  Y+ PE I+ + 
Sbjct: 141 GI---IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP 197
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
           + K  D ++FGVLL+E++AG++P +G
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQAPFEG 223

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 130/298 (43%), Gaps = 44/298 (14%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLA---TDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           ++G+G+FG V   +   TG+  AVKV++      K  ++    EV LL +L H N++ L 
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
            +  +KG   LV    + G L   +            R  I   V  G+ Y+H      +
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYMHKN---KI 170
Query: 235 IHRDIKSSNILLDQSMR---ARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTK 291
           +HRD+K  N+LL+   +    R+ DFGLS      K   +  GT  Y+ PE +    + +
Sbjct: 171 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDE 229
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT----GWEEIVDSRLDGIFDVE 347
           K DV+S GV+L+ L++G  P  G  EY  L  +     T     W+++ +S  D      
Sbjct: 230 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD------ 283
Query: 348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDM 405
                  L  K +   P  R S RD +               H   Q+ T +++S+D+
Sbjct: 284 -------LIRKMLTYVPSMRISARDALD--------------HEWIQTYTKEQISVDV 320

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVLATDS--KQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL      K+G E + + E+ +   L H N++ +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           Y  ++ +  L+  F  +G L   L  + +G            ++A  L Y H+  V   I
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHYCHERKV---I 136
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYISTRNFT 290
           HRDIK  N+L+      ++ADFG S       HA ++R     GT  YL PE I  +   
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWS------VHAPSLRRRXMCGTLDYLPPEMIEGKTHD 190
Query: 291 KKSDVYSFGVLLFELIAGRSPL 312
           +K D++  GVL +E + G  P 
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPF 212

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVLATDS--KQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL      K+G E + + E+ +   L H N++ +  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           Y  ++ +  L+  F  +G L   L  + +G            ++A  L Y H+  V   I
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHYCHERKV---I 137
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYISTRNFT 290
           HRDIK  N+L+      ++ADFG S       HA ++R     GT  YL PE I  +   
Sbjct: 138 HRDIKPENLLMGYKGELKIADFGWS------VHAPSLRRRXMCGTLDYLPPEMIEGKTHD 191
Query: 291 KKSDVYSFGVLLFELIAGRSPL 312
           +K D++  GVL +E + G  P 
Sbjct: 192 EKVDLWCAGVLCYEFLVGMPPF 213

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 132/285 (46%), Gaps = 34/285 (11%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G GAFG V++  + +TG     K + T     +   + E+ ++ +LHH  L+NL     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
           +K + +L+  F+S G L   +  E+Y  ++    ++       GL+++H+ +   ++H D
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEHS---IVHLD 174
Query: 239 IKSSNILLD--QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVY 296
           IK  NI+ +  ++   ++ DFGL+ +   D+       T  +  PE +        +D++
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMW 234
Query: 297 SFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLA 356
           + GVL + L++G SP  G     +L  +    +  WE          FD +  + V+  A
Sbjct: 235 AIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDWE----------FDEDAFSSVSPEA 281
Query: 357 YKCV----NRAPRKRPSMRDIVQ----------VLSRILKMRHNR 387
              +     + PRKR ++ D ++          + SRI   R+N+
Sbjct: 282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNK 326

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 128/298 (42%), Gaps = 44/298 (14%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLA---TDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           ++G+G+FG V   +   TG+  AVKV++      K  ++    EV LL +L H N+  L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
            +  +KG   LV    + G L   +            R  I   V  G+ Y H      +
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYXHKN---KI 147
Query: 235 IHRDIKSSNILLD---QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTK 291
           +HRD+K  N+LL+   +    R+ DFGLS      K   +  GT  Y+ PE +    + +
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHG-TYDE 206
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT----GWEEIVDSRLDGIFDVE 347
           K DV+S GV+L+ L++G  P  G  EY  L  +     T     W+++ +S  D      
Sbjct: 207 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD------ 260
Query: 348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDM 405
                  L  K +   P  R S RD +               H   Q+ T +++S+D+
Sbjct: 261 -------LIRKXLTYVPSXRISARDALD--------------HEWIQTYTKEQISVDV 297

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 115 NFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN 169
            + + +G+G FG V   +      +TG  VAVK L       +++FQ E+ +L  LH   
Sbjct: 10  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 69
Query: 170 LVNL--VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           +V    V Y   + +  LV  ++  G L   L   +   L  +  +  +  + +G+EYL 
Sbjct: 70  IVKYRGVSYGPGRPELRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLG 128
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGYLDPEY 283
                  +HRD+ + NIL++     ++ADFGL++   +DK    +R        +  PE 
Sbjct: 129 SRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPES 185
Query: 284 ISTRNFTKKSDVYSFGVLLFELI 306
           +S   F+++SDV+SFGV+L+EL 
Sbjct: 186 LSDNIFSRQSDVWSFGVVLYELF 208

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 118/265 (44%), Gaps = 30/265 (11%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLA---TDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           ++G+G+FG V   +   TG+  AVKV++      K  ++    EV LL +L H N++ L 
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
            +  +KG   LV    + G L   +            R  I   V  G+ Y+H   +   
Sbjct: 99  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYMHKNKI--- 153
Query: 235 IHRDIKSSNILLDQSMR---ARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTK 291
           +HRD+K  N+LL+   +    R+ DFGLS      K   +  GT  Y+ PE +    + +
Sbjct: 154 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDE 212
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT----GWEEIVDSRLDGIFDVE 347
           K DV+S GV+L+ L++G  P  G  EY  L  +     T     W+++ +S  D      
Sbjct: 213 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD------ 266
Query: 348 ELNEVASLAYKCVNRAPRKRPSMRD 372
                  L  K +   P  R S RD
Sbjct: 267 -------LIRKMLTYVPSMRISARD 284

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 132/281 (46%), Gaps = 42/281 (14%)
Query: 120 IGQGAFGPVYKAQ---MSTGET---VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
           +GQG+FG VY+     +  GE    VAVK +   +   E+ EF  E  ++      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 173 LVGYCAEKGQHMLVYV-FMSKGSLASHL------YDENYG--PLTWNLRVHIALDVARGL 223
           L+G  + KGQ  LV +  M+ G L S+L       + N G  P T    + +A ++A G+
Sbjct: 85  LLGVVS-KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFG--YLD 280
            YL+       +HRD+ + N ++      ++ DFG++R+    D +    +G     ++ 
Sbjct: 144 AYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SD++SFGV+L+E+ +    P QGL                 E+++   
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------------EQVLKFV 245
Query: 340 LDGIFDVEELN---EVASLAYKCVNRAPRKRPSMRDIVQVL 377
           +DG +  +  N    V  L   C    P+ RP+  +IV +L
Sbjct: 246 MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 132/281 (46%), Gaps = 42/281 (14%)
Query: 120 IGQGAFGPVYKAQ---MSTGET---VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
           +GQG+FG VY+     +  GE    VAVK +   +   E+ EF  E  ++      ++V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 173 LVGYCAEKGQHMLVYV-FMSKGSLASHL------YDENYG--PLTWNLRVHIALDVARGL 223
           L+G  + KGQ  LV +  M+ G L S+L       + N G  P T    + +A ++A G+
Sbjct: 84  LLGVVS-KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFG--YLD 280
            YL+       +HRD+ + N ++      ++ DFG++R+    D +    +G     ++ 
Sbjct: 143 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 199
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SD++SFGV+L+E+ +    P QGL                 E+++   
Sbjct: 200 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------------EQVLKFV 244
Query: 340 LDGIFDVEELN---EVASLAYKCVNRAPRKRPSMRDIVQVL 377
           +DG +  +  N    V  L   C    P+ RP+  +IV +L
Sbjct: 245 MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 285

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 134/283 (47%), Gaps = 46/283 (16%)
Query: 120 IGQGAFGPVYKAQ---MSTGET---VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
           +GQG+FG VY+     +  GE    VAVK +   +   E+ EF  E  ++      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 173 LVGYCAEKGQHMLVYV-FMSKGSLASHL------YDENYG--PLTWNLRVHIALDVARGL 223
           L+G  + KGQ  LV +  M+ G L S+L       + N G  P T    + +A ++A G+
Sbjct: 85  LLGVVS-KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG-----Y 278
            YL+       +HRD+ + N ++      ++ DFG++R+  + + A   +G  G     +
Sbjct: 144 AYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRD--IYETAYYRKGGKGLLPVRW 198
Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVD 337
           + PE +    FT  SD++SFGV+L+E+ +    P QGL                 E+++ 
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------------EQVLK 243
Query: 338 SRLDGIFDVEELN---EVASLAYKCVNRAPRKRPSMRDIVQVL 377
             +DG +  +  N    V  L   C    P+ RP+  +IV +L
Sbjct: 244 FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 131/281 (46%), Gaps = 42/281 (14%)
Query: 120 IGQGAFGPVYKAQ---MSTGET---VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
           +GQG+FG VY+     +  GE    VAVK +   +   E+ EF  E  ++      ++V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 173 LVGYCAEKGQHMLVYV-FMSKGSLASHL------YDENYG--PLTWNLRVHIALDVARGL 223
           L+G  + KGQ  LV +  M+ G L S+L       + N G  P T    + +A ++A G+
Sbjct: 82  LLGVVS-KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANIRGTFG--YLD 280
            YL+       +HRD+ + N ++      ++ DFG++R+    D      +G     ++ 
Sbjct: 141 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 197
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SD++SFGV+L+E+ +    P QGL                 E+++   
Sbjct: 198 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------------EQVLKFV 242
Query: 340 LDGIFDVEELN---EVASLAYKCVNRAPRKRPSMRDIVQVL 377
           +DG +  +  N    V  L   C    P+ RP+  +IV +L
Sbjct: 243 MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 283

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 114/248 (45%), Gaps = 16/248 (6%)
Query: 111 KATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHR 168
           K    F   +G GAF  V  A+  +TG+  AVK +   + +G E   + E+ +L ++ H 
Sbjct: 21  KKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           N+V L           LV   +S G L   + ++  G  T      +   V   + YLH 
Sbjct: 81  NIVALEDIYESPNHLYLVMQLVSGGELFDRIVEK--GFYTEKDASTLIRQVLDAVYYLHR 138
Query: 229 GAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIS 285
             +   +HRD+K  N+L    D+  +  ++DFGLS+ E      +   GT GY+ PE ++
Sbjct: 139 MGI---VHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLA 195
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPL-----QGLMEYVELAAMNTEGKTGWEEIVDSRL 340
            + ++K  D +S GV+ + L+ G  P        L E + L A        W++I DS  
Sbjct: 196 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQI-LKAEYEFDSPYWDDISDSAK 254
Query: 341 DGIFDVEE 348
           D I ++ E
Sbjct: 255 DFIRNLME 262

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 131/281 (46%), Gaps = 42/281 (14%)
Query: 120 IGQGAFGPVYKAQ---MSTGET---VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
           +GQG+FG VY+     +  GE    VAVK +   +   E+ EF  E  ++      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 173 LVGYCAEKGQHMLVYV-FMSKGSLASHL------YDENYG--PLTWNLRVHIALDVARGL 223
           L+G  + KGQ  LV +  M+ G L S+L       + N G  P T    + +A ++A G+
Sbjct: 85  LLGVVS-KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANIRGTFG--YLD 280
            YL+       +HRD+ + N ++      ++ DFG++R+    D      +G     ++ 
Sbjct: 144 AYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SD++SFGV+L+E+ +    P QGL                 E+++   
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------------EQVLKFV 245
Query: 340 LDGIFDVEELN---EVASLAYKCVNRAPRKRPSMRDIVQVL 377
           +DG +  +  N    V  L   C    P+ RP+  +IV +L
Sbjct: 246 MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 13/208 (6%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH 166
           D ++   NF   IG+G+ G V  A +  TG+ VAVK +    +Q  +    EV+++   H
Sbjct: 42  DPREYLANFIK-IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 100
Query: 167 HRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYL 226
           H N+V++        +  +V  F+  G+L   +    +  +       + L V R L YL
Sbjct: 101 HDNVVDMYSSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYL 157
Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN---IRGTFGYLDPEY 283
           H+  V   IHRDIKS +ILL    R +++DFG   +  V K       + GT  ++ PE 
Sbjct: 158 HNQGV---IHRDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKXLVGTPYWMAPEV 212
Query: 284 ISTRNFTKKSDVYSFGVLLFELIAGRSP 311
           IS   +  + D++S G+++ E+I G  P
Sbjct: 213 ISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG+GAF  V +  ++ TG   A K++ T   S +  ++ + E  +   L H N+V L   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
            +E+G H LV+  ++ G L   +    Y   +     H    +   + + H   V   +H
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMGV---VH 126
Query: 237 RDIKSSNILLDQSMRA---RVADFGLSREEMVDKHAA-NIRGTFGYLDPEYISTRNFTKK 292
           RD+K  N+LL    +    ++ADFGL+ E   D+ A     GT GYL PE +    + K 
Sbjct: 127 RDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKP 186
Query: 293 SDVYSFGVLLFELIAGRSPL 312
            D+++ GV+L+ L+ G  P 
Sbjct: 187 VDIWACGVILYILLVGYPPF 206

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 115 NFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN 169
            + + +G+G FG V   +      +TG  VAVK L       +++FQ E+ +L  LH   
Sbjct: 13  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 72
Query: 170 LVNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           +V   G     G+    LV  ++  G L   L   +   L  +  +  +  + +G+EYL 
Sbjct: 73  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLG 131
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGYLDPEY 283
                  +HRD+ + NIL++     ++ADFGL++   +DK    +R        +  PE 
Sbjct: 132 SRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 188
Query: 284 ISTRNFTKKSDVYSFGVLLFELI 306
           +S   F+++SDV+SFGV+L+EL 
Sbjct: 189 LSDNIFSRQSDVWSFGVVLYELF 211

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVL--ATDSKQGEKEFQ--TEVML-LGRLHHRNLVN 172
           ++G G FG V+K   +  GE++ + V     + K G + FQ  T+ ML +G L H ++V 
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 97
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L+G C       LV  ++  GSL  H+  ++ G L   L ++  + +A+G+ YL +  + 
Sbjct: 98  LLGLCPGSSLQ-LVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLEEHGM- 154
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA---ANIRGTFGYLDPEYISTRNF 289
             +HR++ + N+LL    + +VADFG++     D      +  +    ++  E I    +
Sbjct: 155 --VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 212
Query: 290 TKKSDVYSFGVLLFELIA-GRSPLQGL 315
           T +SDV+S+GV ++EL+  G  P  GL
Sbjct: 213 THQSDVWSYGVTVWELMTFGAEPYAGL 239

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 115 NFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN 169
            + + +G+G FG V   +      +TG  VAVK L       +++FQ E+ +L  LH   
Sbjct: 14  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 73
Query: 170 LVNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           +V   G     G+    LV  ++  G L   L   +   L  +  +  +  + +G+EYL 
Sbjct: 74  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLG 132
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGYLDPEY 283
                  +HRD+ + NIL++     ++ADFGL++   +DK    +R        +  PE 
Sbjct: 133 SRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 189
Query: 284 ISTRNFTKKSDVYSFGVLLFELI 306
           +S   F+++SDV+SFGV+L+EL 
Sbjct: 190 LSDNIFSRQSDVWSFGVVLYELF 212

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 30/209 (14%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVLATDS--KQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL      K G E + + EV +   L H N++ L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQ------RTATYIT-ELANALSYCHSKR 132
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 133 V---IHRDIKPENLLLGSNGELKIADFGWS------VHAPSSRRTTLCGTLDYLPPEMIE 183
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            R   +K D++S GVL +E + G  P + 
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPPFEA 212

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 130/281 (46%), Gaps = 42/281 (14%)
Query: 120 IGQGAFGPVYKAQ---MSTGET---VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
           +GQG+FG VY+     +  GE    VAVK +   +   E+ EF  E  ++      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 173 LVGYCAEKGQHMLVYV-FMSKGSLASHL------YDENYG--PLTWNLRVHIALDVARGL 223
           L+G  + KGQ  LV +  M+ G L S+L       + N G  P T    + +A ++A G+
Sbjct: 85  LLGVVS-KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANIRGTFG--YLD 280
            YL+       +HRD+ + N ++      ++ DFG++R+    D      +G     ++ 
Sbjct: 144 AYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SD++SFGV+L+E+ +    P QGL                 E+++   
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------------EQVLKFV 245
Query: 340 LDGIFDVEELN---EVASLAYKCVNRAPRKRPSMRDIVQVL 377
           +DG +  +  N    V  L   C    P  RP+  +IV +L
Sbjct: 246 MDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 24/220 (10%)
Query: 120 IGQGAFGPVY-----KAQMSTGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+G FG V           TGE VAVK L  D   Q    ++ E+ +L  L+H +++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 174 VGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            G C ++G+    LV  ++  GSL  +L   + G     L    A  +  G+ YLH    
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL---FAQQICEGMAYLHSQHY 138
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIST 286
              IHR++ + N+LLD     ++ DFGL++          +R       F Y  PE +  
Sbjct: 139 ---IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-PECLKE 194
Query: 287 RNFTKKSDVYSFGVLLFELI----AGRSPLQGLMEYVELA 322
             F   SDV+SFGV L+EL+    + +SP    +E + +A
Sbjct: 195 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 234

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 30/209 (14%)
Query: 120 IGQGAFGPVYKAQMSTGETV-AVKVLATDS--KQG-EKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G FG VY A+    + + A+KVL      K G E + + EV +   L H N++ L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 176 YCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           Y  +  +  L+  +   G++   L     +DE           +I  ++A  L Y H   
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQ------RTATYIT-ELANALSYCHSKR 132
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I 
Sbjct: 133 V---IHRDIKPENLLLGSNGELKIADFGWS------VHAPSSRRDTLCGTLDYLPPEMIE 183
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            R   +K D++S GVL +E + G  P + 
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPPFEA 212

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVL--ATDSKQGEKEFQ--TEVML-LGRLHHRNLVN 172
           ++G G FG V+K   +  GE++ + V     + K G + FQ  T+ ML +G L H ++V 
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L+G C       LV  ++  GSL  H+  ++ G L   L ++  + +A+G+ YL +  + 
Sbjct: 80  LLGLCPGSSLQ-LVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLEEHGM- 136
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA---ANIRGTFGYLDPEYISTRNF 289
             +HR++ + N+LL    + +VADFG++     D      +  +    ++  E I    +
Sbjct: 137 --VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 290 TKKSDVYSFGVLLFELIA-GRSPLQGL 315
           T +SDV+S+GV ++EL+  G  P  GL
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEPYAGL 221

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 115 NFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN 169
            + + +G+G FG V   +      +TG  VAVK L       +++FQ E+ +L  LH   
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85
Query: 170 LVNLVGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
           +V   G     G+    LV  ++  G L   L   +   L  +  +  +  + +G+EYL 
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGYLDPEY 283
                  +HRD+ + NIL++     ++ADFGL++   +DK    +R        +  PE 
Sbjct: 145 SRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 284 ISTRNFTKKSDVYSFGVLLFELI 306
           +S   F+++SDV+SFGV+L+EL 
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELF 224

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 124/267 (46%), Gaps = 27/267 (10%)
Query: 116 FTTL--IGQGAFGPVYKA-QMSTGETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLV 171
           FT L  IG+G+FG VYK     T E VA+K++   +++   ++ Q E+ +L +     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
              G   +  +  ++  ++  GS    L     GPL       I  ++ +GL+YLH    
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSERK 137
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRNFT 290
              IHRDIK++N+LL +    ++ADFG++ +    +   N   GT  ++ PE I    + 
Sbjct: 138 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 194
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
            K+D++S G+   EL  G  P   L  M  + L   N+             L+G    + 
Sbjct: 195 FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP----------PTLEG----QH 240
Query: 349 LNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                     C+N+ PR RP+ +++++
Sbjct: 241 SKPFKEFVEACLNKDPRFRPTAKELLK 267

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 112/242 (46%), Gaps = 16/242 (6%)
Query: 111 KATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN 169
           + T  F  ++G GAF  V+   Q  TG+  A+K +       +   + E+ +L ++ H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V L         + LV   +S G L   + +   G  T      +   V   ++YLH+ 
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 230 AVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
            +   +HRD+K  N+L    +++ +  + DFGLS+ E  +   +   GT GY+ PE ++ 
Sbjct: 126 GI---VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMSTACGTPGYVAPEVLAQ 181
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPL-----QGLMEYVELAAMNTEGKTGWEEIVDSRLD 341
           + ++K  D +S GV+ + L+ G  P        L E ++      E    W++I +S  D
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF-WDDISESAKD 240
Query: 342 GI 343
            I
Sbjct: 241 FI 242

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 24/220 (10%)
Query: 120 IGQGAFGPVY-----KAQMSTGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+G FG V           TGE VAVK L  D   Q    ++ E+ +L  L+H +++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 174 VGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            G C ++G+    LV  ++  GSL  +L   + G     L    A  +  G+ YLH    
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL---FAQQICEGMAYLHAQHY 138
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIST 286
              IHR++ + N+LLD     ++ DFGL++          +R       F Y  PE +  
Sbjct: 139 ---IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-PECLKE 194
Query: 287 RNFTKKSDVYSFGVLLFELI----AGRSPLQGLMEYVELA 322
             F   SDV+SFGV L+EL+    + +SP    +E + +A
Sbjct: 195 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 234

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 102/220 (46%), Gaps = 24/220 (10%)
Query: 120 IGQGAFGPVY-----KAQMSTGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+G FG V           TGE VAVK L  D+  Q    ++ E+ +L  L+H +++  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 174 VGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            G C + G     LV  ++  GSL  +L   + G     L    A  +  G+ YLH    
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL---FAQQICEGMAYLH---A 152
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIST 286
              IHRD+ + N+LLD     ++ DFGL++          +R       F Y  PE +  
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYA-PECLKE 211
Query: 287 RNFTKKSDVYSFGVLLFELI----AGRSPLQGLMEYVELA 322
             F   SDV+SFGV L+EL+    + +SP    +E + +A
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G GAFG VYKAQ   T    A KV+ T S++  +++  E+ +L    H N+V L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            +    ++  F + G++ + +  E   PLT +    +       L YLHD  +   IHRD
Sbjct: 105 YENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLHDNKI---IHRD 160
Query: 239 IKSSNILLDQSMRARVADFGLS-REEMVDKHAANIRGTFGYLDPEYI-----STRNFTKK 292
           +K+ NIL       ++ADFG+S +     +   +  GT  ++ PE +       R +  K
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 220
Query: 293 SDVYSFGVLLFELIAGRSP 311
           +DV+S G+ L E+     P
Sbjct: 221 ADVWSLGITLIEMAEIEPP 239

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 135/293 (46%), Gaps = 32/293 (10%)
Query: 88  EGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLAT 146
           E  ++  ++ + G P+  Y   +K        IGQGA G VY A  ++TG+ VA++ +  
Sbjct: 5   EILEKLRIIVSVGDPKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQMNL 56
Query: 147 DSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDE--NY 204
             +  ++    E++++    + N+VN +       +  +V  +++ GSL   + +   + 
Sbjct: 57  QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE 116
Query: 205 GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM 264
           G +    R     +  + LE+LH   V   IHR+IKS NILL      ++ DFG   +  
Sbjct: 117 GQIAAVCR-----ECLQALEFLHSNQV---IHRNIKSDNILLGMDGSVKLTDFGFCAQIT 168
Query: 265 VDKHA-ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAA 323
            ++   + + GT  ++ PE ++ + +  K D++S G++  E+I G  P    +    L A
Sbjct: 169 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP---YLNENPLRA 225
Query: 324 MNTEGKTGWEEIVD-SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
           +      G  E+ +  +L  IF             +C+     KR S ++++Q
Sbjct: 226 LYLIATNGTPELQNPEKLSAIF--------RDFLNRCLEMDVEKRGSAKELIQ 270

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 27/213 (12%)
Query: 116 FTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQT-----EVMLLGRLHHRN 169
           F  ++G+G+FG V  A++  TG+  AVKVL  D    + + +       ++ L R +H  
Sbjct: 27  FIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPF 85
Query: 170 LVNLVGYCAEKGQHMLVYV--FMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARG 222
           L  L  +C  +    L +V  F++ G L  H+     +DE         R + A ++   
Sbjct: 86  LTQL--FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA------RFYAA-EIISA 136
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRGTFGYLDP 281
           L +LHD  +   I+RD+K  N+LLD     ++ADFG+ +E + +    A   GT  Y+ P
Sbjct: 137 LMFLHDKGI---IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAP 193
Query: 282 EYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           E +    +    D ++ GVLL+E++ G +P + 
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 135/290 (46%), Gaps = 33/290 (11%)
Query: 91  KRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK 149
           K  ++VS  G P+  Y   +K        IGQGA G VY A  ++TG+ VA++ +    +
Sbjct: 8   KLRSIVSV-GDPKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 150 QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDE--NYGPL 207
             ++    E++++    + N+VN +       +  +V  +++ GSL   + +   + G +
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 118
Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267
               R     +  + LE+LH   V   IHRDIKS NILL      ++ DFG   +   ++
Sbjct: 119 AAVCR-----ECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 268 HA-ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT 326
              + + GT  ++ PE ++ + +  K D++S G++  E+I G  P    +    L A+  
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP---YLNENPLRALYL 227
Query: 327 EGKTGWEEIVD-SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
               G  E+ +  +L  IF             +C++    KR S ++++Q
Sbjct: 228 IATNGTPELQNPEKLSAIF--------RDFLNRCLDMDVEKRGSAKELLQ 269

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 86/340 (25%), Positives = 139/340 (40%), Gaps = 92/340 (27%)
Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRL-HHRNLV 171
           +G+GAFG V +A      +  T  TVAVK+L   +   E K   TE+ +L  + HH N+V
Sbjct: 35  LGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVV 94
Query: 172 NL--------------VGYCA------------------------------------EKG 181
           NL              V YC                                     E+G
Sbjct: 95  NLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAALHMEPKKEKMEPGLEQG 154
Query: 182 QHMLVYVFMSKGSLASHLYDENYG----------------PLTWNLRVHIALDVARGLEY 225
           +   +    S  S AS  + E+                  P+T    +  +  VARG+E+
Sbjct: 155 KKPRLDSVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPITMEDLISYSFQVARGMEF 214
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPE 282
           L        IHRD+ + NILL ++   ++ DFGL+R+   +       + R    ++ PE
Sbjct: 215 LSSRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPE 271
Query: 283 YISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD 341
            I  + ++ KSDV+S+GVLL+E+ + G SP  G+    +  +   EG          R+ 
Sbjct: 272 SIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREG---------MRMR 322
Query: 342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
                    E+  +   C +R P++RP   ++V+ L  +L
Sbjct: 323 A--PEYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGDLL 360

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G GAFG VYKAQ   T    A KV+ T S++  +++  E+ +L    H N+V L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            +    ++  F + G++ + +  E   PLT +    +       L YLHD  +   IHRD
Sbjct: 105 YENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLHDNKI---IHRD 160
Query: 239 IKSSNILLDQSMRARVADFGLSREE--MVDKHAANIRGTFGYLDPEYI-----STRNFTK 291
           +K+ NIL       ++ADFG+S +    + +  + I GT  ++ PE +       R +  
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI-GTPYWMAPEVVMCETSKDRPYDY 219
Query: 292 KSDVYSFGVLLFELIAGRSP 311
           K+DV+S G+ L E+     P
Sbjct: 220 KADVWSLGITLIEMAEIEPP 239

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 135/290 (46%), Gaps = 33/290 (11%)
Query: 91  KRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK 149
           K  ++VS  G P+  Y   +K        IGQGA G VY A  ++TG+ VA++ +    +
Sbjct: 8   KLRSIVSV-GDPKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 150 QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDE--NYGPL 207
             ++    E++++    + N+VN +       +  +V  +++ GSL   + +   + G +
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 118
Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267
               R     +  + LE+LH   V   IHRDIKS NILL      ++ DFG   +   ++
Sbjct: 119 AAVCR-----ECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 268 HA-ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT 326
              + + GT  ++ PE ++ + +  K D++S G++  E+I G  P    +    L A+  
Sbjct: 171 SKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP---YLNENPLRALYL 227
Query: 327 EGKTGWEEIVD-SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
               G  E+ +  +L  IF             +C++    KR S ++++Q
Sbjct: 228 IATNGTPELQNPEKLSAIF--------RDFLNRCLDMDVEKRGSAKELLQ 269

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 122/286 (42%), Gaps = 40/286 (13%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           L+G+G++G V K +   TG  VA+K    + D K  +K    E+ LL +L H NLVNL+ 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGP--LTWNLRVHIALDVARGLEYLHDGAVPP 233
            C +K +  LV+ F+    L     D    P  L + +       +  G+ + H      
Sbjct: 92  VCKKKKRWYLVFEFVDHTILD----DLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--- 144
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSRE-----EMVDKHAANIRGTFGYLDPE-YISTR 287
           +IHRDIK  NIL+ QS   ++ DFG +R      E+ D   A    T  Y  PE  +   
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA----TRWYRAPELLVGDV 200
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQG----------LMEYVELAAMNTEGKTGWEEIVD 337
            + K  DV++ G L+ E+  G     G          +M    L   + E          
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260
Query: 338 SRLDGIFDVEELNE--------VASLAYKCVNRAPRKRPSMRDIVQ 375
            RL  I + E L          V  LA KC++  P KRP   +++ 
Sbjct: 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 134/290 (46%), Gaps = 33/290 (11%)
Query: 91  KRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK 149
           K  ++VS  G P+  Y   +K        IGQGA G VY A  ++TG+ VA++ +    +
Sbjct: 9   KLRSIVSV-GDPKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 59
Query: 150 QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDE--NYGPL 207
             ++    E++++    + N+VN +       +  +V  +++ GSL   + +   + G +
Sbjct: 60  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 119
Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267
               R     +  + LE+LH   V   IHRDIKS NILL      ++ DFG   +   ++
Sbjct: 120 AAVCR-----ECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 171
Query: 268 HA-ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT 326
              + + GT  ++ PE ++ + +  K D++S G++  E+I G  P    +    L A+  
Sbjct: 172 SKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP---YLNENPLRALYL 228
Query: 327 EGKTGWEEIVD-SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
               G  E+ +  +L  IF             +C+     KR S ++++Q
Sbjct: 229 IATNGTPELQNPEKLSAIF--------RDFLNRCLEMDVEKRGSAKELIQ 270

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 131/281 (46%), Gaps = 42/281 (14%)
Query: 120 IGQGAFGPVYKAQ---MSTGET---VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
           +GQG+FG VY+     +  GE    VAVK +   +   E+ EF  E  ++      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 173 LVGYCAEKGQHMLVYV-FMSKGSLASHL------YDENYG--PLTWNLRVHIALDVARGL 223
           L+G  + KGQ  LV +  M+ G L S+L       + N G  P T    + +A ++A G+
Sbjct: 85  LLGVVS-KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFG--YLD 280
            YL+       +HR++ + N ++      ++ DFG++R+    D +    +G     ++ 
Sbjct: 144 AYLNAKKF---VHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SD++SFGV+L+E+ +    P QGL                 E+++   
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------------EQVLKFV 245
Query: 340 LDGIFDVEELN---EVASLAYKCVNRAPRKRPSMRDIVQVL 377
           +DG +  +  N    V  L   C    P  RP+  +IV +L
Sbjct: 246 MDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 110/218 (50%), Gaps = 24/218 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 40  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 99
Query: 171 VNLVGYCAEKGQHMLVYVFMSK-GSLASHL-----YDENYGPLTWNLRVHIALDVARGLE 224
           V L  +C +  + +   +  +K G L  ++     +DE         R + A ++   LE
Sbjct: 100 VKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALE 151
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDP 281
           YLH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A    GT  Y+ P
Sbjct: 152 YLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 208
Query: 282 EYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
           E ++ ++  K SD+++ G ++++L+AG  P +   EY+
Sbjct: 209 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 246

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 131/281 (46%), Gaps = 42/281 (14%)
Query: 120 IGQGAFGPVYKAQ---MSTGET---VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
           +GQG+FG VY+     +  GE    VAVK +   +   E+ EF  E  ++      ++V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 173 LVGYCAEKGQHMLVYV-FMSKGSLASHL------YDENYG--PLTWNLRVHIALDVARGL 223
           L+G  + KGQ  LV +  M+ G L S+L       + N G  P T    + +A ++A G+
Sbjct: 86  LLGVVS-KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFG--YLD 280
            YL+       +HR++ + N ++      ++ DFG++R+    D +    +G     ++ 
Sbjct: 145 AYLNAKKF---VHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 201
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SD++SFGV+L+E+ +    P QGL                 E+++   
Sbjct: 202 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------------EQVLKFV 246
Query: 340 LDGIFDVEELN---EVASLAYKCVNRAPRKRPSMRDIVQVL 377
           +DG +  +  N    V  L   C    P  RP+  +IV +L
Sbjct: 247 MDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 287

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 111/225 (49%), Gaps = 21/225 (9%)
Query: 91  KRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK 149
           K  ++VS  G P+  Y   +K        IGQGA G VY A  ++TG+ VA++ +    +
Sbjct: 8   KLRSIVSV-GDPKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 150 QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDE--NYGPL 207
             ++    E++++    + N+VN +       +  +V  +++ GSL   + +   + G +
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 118
Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267
               R     +  + LE+LH   V   IHRDIKS NILL      ++ DFG   +   ++
Sbjct: 119 AAVCR-----ECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 268 HA-ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
              + + GT  ++ PE ++ + +  K D++S G++  E+I G  P
Sbjct: 171 SKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G GAFG VYKAQ   T    A KV+ T S++  +++  E+ +L    H N+V L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            +    ++  F + G++ + +  E   PLT +    +       L YLHD  +   IHRD
Sbjct: 105 YENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLHDNKI---IHRD 160
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---------GTFGYLDPEYI----- 284
           +K+ NIL       ++ADFG+S        A N R         GT  ++ PE +     
Sbjct: 161 LKAGNILFTLDGDIKLADFGVS--------AKNTRXIQRRDXFIGTPYWMAPEVVMCETS 212
Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSP 311
             R +  K+DV+S G+ L E+     P
Sbjct: 213 KDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G GAFG VYKA+   TG   A KV+ T S++  +++  E+ +L    H  +V L+G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
             G+  ++  F   G++ + + + + G     ++V +   +   L +LH   +   IHRD
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNFLHSKRI---IHRD 142
Query: 239 IKSSNILLDQSMRARVADFGLSREEM--VDKHAANIRGTFGYLDPEYISTRN-----FTK 291
           +K+ N+L+      R+ADFG+S + +  + K  + I GT  ++ PE +         +  
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPYDY 201
Query: 292 KSDVYSFGVLLFELIAGRSP 311
           K+D++S G+ L E+     P
Sbjct: 202 KADIWSLGITLIEMAQIEPP 221

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 123/288 (42%), Gaps = 38/288 (13%)
Query: 109 LQKATC-------NFTTLIGQGAFGPVYKAQMS--TGETV--AVKVLATD---SKQGEKE 154
           LQ  TC            +G G+FG V + +    +G+TV  AVK L  D     +   +
Sbjct: 8   LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 155 FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVH 214
           F  EV  +  L HRNL+ L G        M V      GSL   L  ++ G         
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLSR 125
Query: 215 IALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAA--- 270
            A+ VA G+ YL        IHRD+ + N+LL      ++ DFGL R     D H     
Sbjct: 126 YAVQVAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQE 182
Query: 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
           + +  F +  PE + TR F+  SD + FGV L+E+   G+ P  GL     L  ++ EG+
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 242
Query: 330 TGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPS---MRDIV 374
                    RL    D  +  ++ ++  +C    P  RP+   +RD +
Sbjct: 243 ---------RLPRPEDCPQ--DIYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G GAFG VYKA+   TG   A KV+ T S++  +++  E+ +L    H  +V L+G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
             G+  ++  F   G++ + + + + G     ++V +   +   L +LH   +   IHRD
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNFLHSKRI---IHRD 134
Query: 239 IKSSNILLDQSMRARVADFGLSREEM--VDKHAANIRGTFGYLDPEYISTRN-----FTK 291
           +K+ N+L+      R+ADFG+S + +  + K  + I GT  ++ PE +         +  
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPYDY 193
Query: 292 KSDVYSFGVLLFELIAGRSP 311
           K+D++S G+ L E+     P
Sbjct: 194 KADIWSLGITLIEMAQIEPP 213

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 119/270 (44%), Gaps = 31/270 (11%)
Query: 120 IGQGAFGPVYKAQMS--TGETV--AVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVN 172
           +G G+FG V + +    +G+TV  AVK L  D     +   +F  EV  +  L HRNL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L G        M V      GSL   L  ++ G          A+ VA G+ YL      
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYLESKRF- 136
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAA---NIRGTFGYLDPEYISTRN 288
             IHRD+ + N+LL      ++ DFGL R     D H     + +  F +  PE + TR 
Sbjct: 137 --IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 194
Query: 289 FTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
           F+  SD + FGV L+E+   G+ P  GL     L  ++ EG+         RL    D  
Sbjct: 195 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE---------RLPRPEDCP 245
Query: 348 ELNEVASLAYKCVNRAPRKRPS---MRDIV 374
           +  ++ ++  +C    P  RP+   +RD +
Sbjct: 246 Q--DIYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 119/270 (44%), Gaps = 31/270 (11%)
Query: 120 IGQGAFGPVYKAQMS--TGETV--AVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVN 172
           +G G+FG V + +    +G+TV  AVK L  D     +   +F  EV  +  L HRNL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L G        M V      GSL   L  ++ G          A+ VA G+ YL      
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYLESKRF- 132
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAA---NIRGTFGYLDPEYISTRN 288
             IHRD+ + N+LL      ++ DFGL R     D H     + +  F +  PE + TR 
Sbjct: 133 --IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRT 190
Query: 289 FTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
           F+  SD + FGV L+E+   G+ P  GL     L  ++ EG+         RL    D  
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE---------RLPRPEDCP 241
Query: 348 ELNEVASLAYKCVNRAPRKRPS---MRDIV 374
           +  ++ ++  +C    P  RP+   +RD +
Sbjct: 242 Q--DIYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 133/275 (48%), Gaps = 36/275 (13%)
Query: 120 IGQGAFGPVYKAQMSTG------ET-VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLV 171
           +GQG+FG VY+  ++ G      ET VA+K +   +   E+ EF  E  ++   +  ++V
Sbjct: 24  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 82
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYD-----EN---YGPLTWNLRVHIALDVARGL 223
            L+G  ++    +++   M++G L S+L       EN     P + +  + +A ++A G+
Sbjct: 83  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 142
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFG--YLD 280
            YL+       +HRD+ + N ++ +    ++ DFG++R+    D +    +G     ++ 
Sbjct: 143 AYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 199
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SDV+SFGV+L+E+      P QGL    ++     EG  G  +  D+ 
Sbjct: 200 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEG--GLLDKPDNC 256
Query: 340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIV 374
            D +F+         L   C    P+ RPS  +I+
Sbjct: 257 PDMLFE---------LMRMCWQYNPKMRPSFLEII 282

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 133/275 (48%), Gaps = 36/275 (13%)
Query: 120 IGQGAFGPVYKAQMSTG------ET-VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLV 171
           +GQG+FG VY+  ++ G      ET VA+K +   +   E+ EF  E  ++   +  ++V
Sbjct: 33  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYD-----EN---YGPLTWNLRVHIALDVARGL 223
            L+G  ++    +++   M++G L S+L       EN     P + +  + +A ++A G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 151
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFG--YLD 280
            YL+       +HRD+ + N ++ +    ++ DFG++R+    D +    +G     ++ 
Sbjct: 152 AYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SDV+SFGV+L+E+      P QGL    ++     EG  G  +  D+ 
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEG--GLLDKPDNC 265
Query: 340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIV 374
            D +F+         L   C    P+ RPS  +I+
Sbjct: 266 PDMLFE---------LMRMCWQYNPKMRPSFLEII 291

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 133/275 (48%), Gaps = 36/275 (13%)
Query: 120 IGQGAFGPVYKAQMSTG------ET-VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLV 171
           +GQG+FG VY+  ++ G      ET VA+K +   +   E+ EF  E  ++   +  ++V
Sbjct: 20  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYD-----EN---YGPLTWNLRVHIALDVARGL 223
            L+G  ++    +++   M++G L S+L       EN     P + +  + +A ++A G+
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFG--YLD 280
            YL+       +HRD+ + N ++ +    ++ DFG++R+    D +    +G     ++ 
Sbjct: 139 AYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 195
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SDV+SFGV+L+E+      P QGL    ++     EG  G  +  D+ 
Sbjct: 196 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEG--GLLDKPDNC 252
Query: 340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIV 374
            D +F+         L   C    P+ RPS  +I+
Sbjct: 253 PDMLFE---------LMRMCWQYNPKMRPSFLEII 278

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 133/275 (48%), Gaps = 36/275 (13%)
Query: 120 IGQGAFGPVYKAQMSTG------ET-VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLV 171
           +GQG+FG VY+  ++ G      ET VA+K +   +   E+ EF  E  ++   +  ++V
Sbjct: 27  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYD-----EN---YGPLTWNLRVHIALDVARGL 223
            L+G  ++    +++   M++G L S+L       EN     P + +  + +A ++A G+
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFG--YLD 280
            YL+       +HRD+ + N ++ +    ++ DFG++R+    D +    +G     ++ 
Sbjct: 146 AYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 202
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SDV+SFGV+L+E+      P QGL    ++     EG  G  +  D+ 
Sbjct: 203 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEG--GLLDKPDNC 259
Query: 340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIV 374
            D +F+         L   C    P+ RPS  +I+
Sbjct: 260 PDMLFE---------LMRMCWQYNPKMRPSFLEII 285

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 132/275 (48%), Gaps = 36/275 (13%)
Query: 120 IGQGAFGPVYKAQMSTG------ET-VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLV 171
           +GQG+FG VY+  ++ G      ET VA+K +   +   E+ EF  E  ++   +  ++V
Sbjct: 27  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYD-----EN---YGPLTWNLRVHIALDVARGL 223
            L+G  ++    +++   M++G L S+L       EN     P + +  + +A ++A G+
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANIRGTFG--YLD 280
            YL+       +HRD+ + N ++ +    ++ DFG++R+    D      +G     ++ 
Sbjct: 146 AYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 202
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SDV+SFGV+L+E+      P QGL    ++     EG  G  +  D+ 
Sbjct: 203 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEG--GLLDKPDNC 259
Query: 340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIV 374
            D +F+         L   C    P+ RPS  +I+
Sbjct: 260 PDMLFE---------LMRMCWQYNPKMRPSFLEII 285

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 133/275 (48%), Gaps = 36/275 (13%)
Query: 120 IGQGAFGPVYKAQMSTG------ET-VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLV 171
           +GQG+FG VY+  ++ G      ET VA+K +   +   E+ EF  E  ++   +  ++V
Sbjct: 26  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYD-----EN---YGPLTWNLRVHIALDVARGL 223
            L+G  ++    +++   M++G L S+L       EN     P + +  + +A ++A G+
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFG--YLD 280
            YL+       +HRD+ + N ++ +    ++ DFG++R+    D +    +G     ++ 
Sbjct: 145 AYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 201
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SDV+SFGV+L+E+      P QGL    ++     EG  G  +  D+ 
Sbjct: 202 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEG--GLLDKPDNC 258
Query: 340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIV 374
            D +F+         L   C    P+ RPS  +I+
Sbjct: 259 PDMLFE---------LMRMCWQYNPKMRPSFLEII 284

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 133/275 (48%), Gaps = 36/275 (13%)
Query: 120 IGQGAFGPVYKAQMSTG------ET-VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLV 171
           +GQG+FG VY+  ++ G      ET VA+K +   +   E+ EF  E  ++   +  ++V
Sbjct: 26  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYD-----EN---YGPLTWNLRVHIALDVARGL 223
            L+G  ++    +++   M++G L S+L       EN     P + +  + +A ++A G+
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFG--YLD 280
            YL+       +HRD+ + N ++ +    ++ DFG++R+    D +    +G     ++ 
Sbjct: 145 AYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 201
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SDV+SFGV+L+E+      P QGL    ++     EG  G  +  D+ 
Sbjct: 202 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEG--GLLDKPDNC 258
Query: 340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIV 374
            D +F+         L   C    P+ RPS  +I+
Sbjct: 259 PDMLFE---------LMRMCWQYNPKMRPSFLEII 284

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           +G+GAF  V +  ++ TG+  A K++ T   S +  ++ + E  +   L H N+V L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
            +E+G H LV+  ++ G L   +    Y   +     H    +   + + H   +   +H
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREY--YSEADASHCIQQILESVNHCHLNGI---VH 126
Query: 237 RDIKSSNILLDQSMRA---RVADFGLSREEMVDKHAA-NIRGTFGYLDPEYISTRNFTKK 292
           RD+K  N+LL    +    ++ADFGL+ E   D+ A     GT GYL PE +    + K 
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKP 186
Query: 293 SDVYSFGVLLFELIAGRSPL 312
            D+++ GV+L+ L+ G  P 
Sbjct: 187 VDMWACGVILYILLVGYPPF 206

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 123/288 (42%), Gaps = 38/288 (13%)
Query: 109 LQKATC-------NFTTLIGQGAFGPVYKAQMS--TGETV--AVKVLATD---SKQGEKE 154
           LQ  TC            +G G+FG V + +    +G+TV  AVK L  D     +   +
Sbjct: 8   LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 155 FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVH 214
           F  EV  +  L HRNL+ L G        M V      GSL   L  ++ G         
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLSR 125
Query: 215 IALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAA--- 270
            A+ VA G+ YL        IHRD+ + N+LL      ++ DFGL R     D H     
Sbjct: 126 YAVQVAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182
Query: 271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
           + +  F +  PE + TR F+  SD + FGV L+E+   G+ P  GL     L  ++ EG+
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 242
Query: 330 TGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPS---MRDIV 374
                    RL    D  +  ++ ++  +C    P  RP+   +RD +
Sbjct: 243 ---------RLPRPEDCPQ--DIYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDET------CTRFYTA-EIVSALEY 147
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A +  GT  Y+ PE
Sbjct: 148 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 204
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
            ++ ++ +K SD+++ G ++++L+AG  P +   EY+
Sbjct: 205 LLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYL 241

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 134/275 (48%), Gaps = 36/275 (13%)
Query: 120 IGQGAFGPVYKAQMSTG------ET-VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLV 171
           +GQG+FG VY+  ++ G      ET VA+K +   +   E+ EF  E  ++   +  ++V
Sbjct: 55  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 113
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYD-----EN---YGPLTWNLRVHIALDVARGL 223
            L+G  ++    +++   M++G L S+L       EN     P + +  + +A ++A G+
Sbjct: 114 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 173
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFG--YLD 280
            YL+       +HRD+ + N ++ +    ++ DFG++R+    D +    +G     ++ 
Sbjct: 174 AYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 230
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SDV+SFGV+L+E+      P QGL    ++     EG  G  +  D+ 
Sbjct: 231 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEG--GLLDKPDNC 287
Query: 340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIV 374
            D +F++  +         C    P+ RPS  +I+
Sbjct: 288 PDMLFELMRM---------CWQYNPKMRPSFLEII 313

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 97/198 (48%), Gaps = 7/198 (3%)
Query: 120 IGQGAFGPVYK-AQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G GAFG V++  + +TG   A K + T  +  ++  + E+  +  L H  LVNL     
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
           +  + +++Y FMS G L   + DE +  ++ +  V     V +GL ++H+      +H D
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLD 280
Query: 239 IKSSNILL--DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVY 296
           +K  NI+    +S   ++ DFGL+      +      GT  +  PE    +     +D++
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMW 340
Query: 297 SFGVLLFELIAGRSPLQG 314
           S GVL + L++G SP  G
Sbjct: 341 SVGVLSYILLSGLSPFGG 358

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 133/275 (48%), Gaps = 36/275 (13%)
Query: 120 IGQGAFGPVYKAQMSTG------ET-VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLV 171
           +GQG+FG VY+  ++ G      ET VA+K +   +   E+ EF  E  ++   +  ++V
Sbjct: 23  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 81
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLY--------DENYGPLTWNLRVHIALDVARGL 223
            L+G  ++    +++   M++G L S+L         +    P + +  + +A ++A G+
Sbjct: 82  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFG--YLD 280
            YL+       +HRD+ + N ++ +    ++ DFG++R+    D +    +G     ++ 
Sbjct: 142 AYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 198
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SDV+SFGV+L+E+      P QGL    ++     EG  G  +  D+ 
Sbjct: 199 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEG--GLLDKPDNC 255
Query: 340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIV 374
            D +F++  +         C    P+ RPS  +I+
Sbjct: 256 PDMLFELMRM---------CWQYNPKMRPSFLEII 281

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 119/270 (44%), Gaps = 31/270 (11%)
Query: 120 IGQGAFGPVYKAQMS--TGETV--AVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVN 172
           +G G+FG V + +    +G+TV  AVK L  D     +   +F  EV  +  L HRNL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L G        M V      GSL   L  ++ G          A+ VA G+ YL      
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYLESKRF- 132
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAA---NIRGTFGYLDPEYISTRN 288
             IHRD+ + N+LL      ++ DFGL R     D H     + +  F +  PE + TR 
Sbjct: 133 --IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 289 FTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
           F+  SD + FGV L+E+   G+ P  GL     L  ++ EG+         RL    D  
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE---------RLPRPEDCP 241
Query: 348 ELNEVASLAYKCVNRAPRKRPS---MRDIV 374
           +  ++ ++  +C    P  RP+   +RD +
Sbjct: 242 Q--DIYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 12/200 (6%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           +G+GAF  V +  ++ TG+  A K++ T   S +  ++ + E  +   L H N+V L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
            +E+G H LV+  ++ G L   +    Y           +  + + LE ++   +  ++H
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYS-----EADASHCIQQILESVNHCHLNGIVH 126
Query: 237 RDIKSSNILL---DQSMRARVADFGLSREEMVDKHAA-NIRGTFGYLDPEYISTRNFTKK 292
           RD+K  N+LL    +    ++ADFGL+ E   D+ A     GT GYL PE +    + K 
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKP 186
Query: 293 SDVYSFGVLLFELIAGRSPL 312
            D+++ GV+L+ L+ G  P 
Sbjct: 187 VDMWACGVILYILLVGYPPF 206

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 132/275 (48%), Gaps = 36/275 (13%)
Query: 120 IGQGAFGPVYKAQMSTG------ET-VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLV 171
           +GQG+FG VY+  ++ G      ET VA+K +   +   E+ EF  E  ++   +  ++V
Sbjct: 33  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLY--------DENYGPLTWNLRVHIALDVARGL 223
            L+G  ++    +++   M++G L S+L         +    P + +  + +A ++A G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFG--YLD 280
            YL+       +HRD+ + N ++ +    ++ DFG++R+    D +    +G     ++ 
Sbjct: 152 AYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SDV+SFGV+L+E+      P QGL    ++     EG  G  +  D+ 
Sbjct: 209 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-QVLRFVMEG--GLLDKPDNC 265
Query: 340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIV 374
            D +F+         L   C    P+ RPS  +I+
Sbjct: 266 PDMLFE---------LMRMCWQYNPKMRPSFLEII 291

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 97/198 (48%), Gaps = 7/198 (3%)
Query: 120 IGQGAFGPVYK-AQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G GAFG V++  + +TG   A K + T  +  ++  + E+  +  L H  LVNL     
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
           +  + +++Y FMS G L   + DE +  ++ +  V     V +GL ++H+      +H D
Sbjct: 119 DDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLD 174
Query: 239 IKSSNILL--DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVY 296
           +K  NI+    +S   ++ DFGL+      +      GT  +  PE    +     +D++
Sbjct: 175 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMW 234
Query: 297 SFGVLLFELIAGRSPLQG 314
           S GVL + L++G SP  G
Sbjct: 235 SVGVLSYILLSGLSPFGG 252

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 119/270 (44%), Gaps = 31/270 (11%)
Query: 120 IGQGAFGPVYKAQMS--TGETV--AVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVN 172
           +G G+FG V + +    +G+TV  AVK L  D     +   +F  EV  +  L HRNL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L G        M V      GSL   L  ++ G          A+ VA G+ YL      
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYLESKRF- 136
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAA---NIRGTFGYLDPEYISTRN 288
             IHRD+ + N+LL      ++ DFGL R     D H     + +  F +  PE + TR 
Sbjct: 137 --IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 194
Query: 289 FTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
           F+  SD + FGV L+E+   G+ P  GL     L  ++ EG+         RL    D  
Sbjct: 195 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE---------RLPRPEDCP 245
Query: 348 ELNEVASLAYKCVNRAPRKRPS---MRDIV 374
           +  ++ ++  +C    P  RP+   +RD +
Sbjct: 246 Q--DIYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 30/276 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVN 172
           NF T + +   G ++K +   G  + VKVL     S +  ++F  E   L    H N++ 
Sbjct: 13  NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 173 LVGYC-AEKGQH-MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           ++G C +    H  L+  +M  GSL + L++     +  +  V  ALD+ARG+ +LH   
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--T 129
Query: 231 VPPVIHRD-IKSSNILLDQSMRARV--ADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
           + P+I R  + S ++++D+ M AR+  AD   S +     +A        ++ PE +  +
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAP------AWVAPEALQKK 183
Query: 288 ---NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF 344
                 + +D++SF VLL+EL+    P      + +L+ M    K   E +  +   GI 
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVP------FADLSNMEIGMKVALEGLRPTIPPGIS 237
Query: 345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
                  V+ L   C+N  P KRP    IV +L ++
Sbjct: 238 P-----HVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 13  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 72
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 73  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 125
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A    GT  Y+ PE
Sbjct: 126 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 182
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
            ++ ++  K SD+++ G ++++L+AG  P +   EY+
Sbjct: 183 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 219

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 120 IGQGAFGPVYK-AQMSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNL---- 173
           +G G FG V +     TGE VA+K    + S +  + +  E+ ++ +L+H N+V+     
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 174 --VGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGPLTWNLRVHIALDVARGLEYLHDG 229
             +   A     +L   +   G L  +L  ++   G     +R  ++ D++  L YLH+ 
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSALRYLHEN 141
Query: 230 AVPPVIHRDIKSSNILLD---QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
            +   IHRD+K  NI+L    Q +  ++ D G ++E    +      GT  YL PE +  
Sbjct: 142 RI---IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ 198
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPL 312
           + +T   D +SFG L FE I G  P 
Sbjct: 199 KKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 120 IGQGAFGPVYK-AQMSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNL---- 173
           +G G FG V +     TGE VA+K    + S +  + +  E+ ++ +L+H N+V+     
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 174 --VGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGPLTWNLRVHIALDVARGLEYLHDG 229
             +   A     +L   +   G L  +L  ++   G     +R  ++ D++  L YLH+ 
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSALRYLHEN 140
Query: 230 AVPPVIHRDIKSSNILLD---QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
            +   IHRD+K  NI+L    Q +  ++ D G ++E    +      GT  YL PE +  
Sbjct: 141 RI---IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ 197
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPL 312
           + +T   D +SFG L FE I G  P 
Sbjct: 198 KKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 22/217 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 96  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 148
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A +  GT  Y+ PE
Sbjct: 149 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 205
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
            ++ ++  K SD+++ G ++++L+AG  P +   EY+
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 242

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 119/270 (44%), Gaps = 31/270 (11%)
Query: 120 IGQGAFGPVYKAQMS--TGETV--AVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVN 172
           +G G+FG V + +    +G+TV  AVK L  D     +   +F  EV  +  L HRNL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L G        M V      GSL   L  ++ G          A+ VA G+ YL      
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYLESKRF- 132
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAA---NIRGTFGYLDPEYISTRN 288
             IHRD+ + N+LL      ++ DFGL R     D H     + +  F +  PE + TR 
Sbjct: 133 --IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 289 FTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
           F+  SD + FGV L+E+   G+ P  GL     L  ++ EG+         RL    D  
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE---------RLPRPEDCP 241
Query: 348 ELNEVASLAYKCVNRAPRKRPS---MRDIV 374
           +  ++ ++  +C    P  RP+   +RD +
Sbjct: 242 Q--DIYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 83  LLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 135
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 136 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 193 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 224

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 114/225 (50%), Gaps = 15/225 (6%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGYC 177
           +G+G +G VYKA+ S G  VA+K +  D++ +G       E+ LL  LHH N+V+L+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL-DVARGLEYLHDGAVPPVIH 236
             +    LV+ FM K      + DEN   L  + ++ I L  + RG+ + H   +   +H
Sbjct: 89  HSERCLTLVFEFMEKD--LKKVLDENKTGLQ-DSQIKIYLYQLLRGVAHCHQHRI---LH 142
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYI-STRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   +  +   +   T  Y  P+ +  ++ ++   D
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVD 202
Query: 295 VYSFGVLLFELIAGRSPLQGLMEYVEL----AAMNTEGKTGWEEI 335
           ++S G +  E+I G+    G+ +  +L    + + T     W ++
Sbjct: 203 IWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 12  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 71
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 72  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 124
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A    GT  Y+ PE
Sbjct: 125 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 181
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
            ++ ++  K SD+++ G ++++L+AG  P +   EY+
Sbjct: 182 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 218

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 86  LLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 138
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 139 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 227

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 82  LLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 134
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 135 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 10  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 69
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 70  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 122
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A    GT  Y+ PE
Sbjct: 123 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 179
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
            ++ ++  K SD+++ G ++++L+AG  P +   EY+
Sbjct: 180 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 216

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 84  LLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 136
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 137 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 56  VLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCR 115
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 116 LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 168
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 169 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 225
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 226 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 257

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 114/225 (50%), Gaps = 15/225 (6%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGYC 177
           +G+G +G VYKA+ S G  VA+K +  D++ +G       E+ LL  LHH N+V+L+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL-DVARGLEYLHDGAVPPVIH 236
             +    LV+ FM K      + DEN   L  + ++ I L  + RG+ + H   +   +H
Sbjct: 89  HSERCLTLVFEFMEKD--LKKVLDENKTGLQ-DSQIKIYLYQLLRGVAHCHQHRI---LH 142
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYI-STRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   +  +   +   T  Y  P+ +  ++ ++   D
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVD 202
Query: 295 VYSFGVLLFELIAGRSPLQGLMEYVEL----AAMNTEGKTGWEEI 335
           ++S G +  E+I G+    G+ +  +L    + + T     W ++
Sbjct: 203 IWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 123
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A    GT  Y+ PE
Sbjct: 124 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 180
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
            ++ ++  K SD+++ G ++++L+AG  P +   EY+
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 85  LLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 137
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 138 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 226

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 82  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 134
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 135 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 76  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 128
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 129 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 82  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 134
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 135 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 145
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A    GT  Y+ PE
Sbjct: 146 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
            ++ ++  K SD+++ G ++++L+AG  P +   EY+
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 32  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 91
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 92  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 144
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 145 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 201
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 202 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 233

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 28  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 87
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 88  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 140
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 141 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 197
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 198 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 229

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 147
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A    GT  Y+ PE
Sbjct: 148 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
            ++ ++  K SD+++ G ++++L+AG  P +   EY+
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 241

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 19/219 (8%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-----EKEFQTEVMLL 162
           ++Q+        IG+G FG V++    + E  A+ V     K        ++F  E + +
Sbjct: 8   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 67
Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDV 219
            +  H ++V L+G   E      V++ M   + G L S L    Y  L     +  A  +
Sbjct: 68  RQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQL 122
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFG 277
           +  L YL        +HRDI + N+L+  +   ++ DFGLSR  E+     A+  +    
Sbjct: 123 STALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 179
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFE-LIAGRSPLQGL 315
           ++ PE I+ R FT  SDV+ FGV ++E L+ G  P QG+
Sbjct: 180 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 218

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 83  LLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 135
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 136 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 193 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 224

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 147
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A    GT  Y+ PE
Sbjct: 148 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
            ++ ++  K SD+++ G ++++L+AG  P +   EY+
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 241

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 19/219 (8%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-----EKEFQTEVMLL 162
           ++Q+        IG+G FG V++    + E  A+ V     K        ++F  E + +
Sbjct: 3   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDV 219
            +  H ++V L+G   E      V++ M   + G L S L    Y  L     +  A  +
Sbjct: 63  RQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQL 117
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFG 277
           +  L YL        +HRDI + N+L+  +   ++ DFGLSR  E+     A+  +    
Sbjct: 118 STALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFE-LIAGRSPLQGL 315
           ++ PE I+ R FT  SDV+ FGV ++E L+ G  P QG+
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 145
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A    GT  Y+ PE
Sbjct: 146 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
            ++ ++  K SD+++ G ++++L+AG  P +   EY+
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 19/219 (8%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-----EKEFQTEVMLL 162
           ++Q+        IG+G FG V++    + E  A+ V     K        ++F  E + +
Sbjct: 11  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDV 219
            +  H ++V L+G   E      V++ M   + G L S L    Y  L     +  A  +
Sbjct: 71  RQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQL 125
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFG 277
           +  L YL        +HRDI + N+L+  +   ++ DFGLSR  E+     A+  +    
Sbjct: 126 STALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFE-LIAGRSPLQGL 315
           ++ PE I+ R FT  SDV+ FGV ++E L+ G  P QG+
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 95
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 96  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 148
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A    GT  Y+ PE
Sbjct: 149 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 205
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
            ++ ++  K SD+++ G ++++L+AG  P +   EY+
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 242

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 84  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 136
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 137 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 147
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A    GT  Y+ PE
Sbjct: 148 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
            ++ ++  K SD+++ G ++++L+AG  P +   EY+
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 241

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 85  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 137
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 138 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 226

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 19/219 (8%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-----EKEFQTEVMLL 162
           ++Q+        IG+G FG V++    + E  A+ V     K        ++F  E + +
Sbjct: 9   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 68
Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDV 219
            +  H ++V L+G   E      V++ M   + G L S L    Y  L     +  A  +
Sbjct: 69  RQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQL 123
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFG 277
           +  L YL        +HRDI + N+L+  +   ++ DFGLSR  E+     A+  +    
Sbjct: 124 STALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 180
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFE-LIAGRSPLQGL 315
           ++ PE I+ R FT  SDV+ FGV ++E L+ G  P QG+
Sbjct: 181 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 219

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 19/219 (8%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-----EKEFQTEVMLL 162
           ++Q+        IG+G FG V++    + E  A+ V     K        ++F  E + +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDV 219
            +  H ++V L+G   E      V++ M   + G L S L    Y  L     +  A  +
Sbjct: 66  RQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQL 120
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFG 277
           +  L YL        +HRDI + N+L+  +   ++ DFGLSR  E+     A+  +    
Sbjct: 121 STALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFE-LIAGRSPLQGL 315
           ++ PE I+ R FT  SDV+ FGV ++E L+ G  P QG+
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 89  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 141
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 142 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 145
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A    GT  Y+ PE
Sbjct: 146 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE 202
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
            ++ ++  K SD+++ G ++++L+AG  P +   EY+
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 22/217 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 92  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 144
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A +  GT  Y+ PE
Sbjct: 145 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 201
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
            ++ ++  K SD+++ G ++++L+AG  P +   EY+
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 238

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 85  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 137
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 138 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 226

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 19/219 (8%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-----EKEFQTEVMLL 162
           ++Q+        IG+G FG V++    + E  A+ V     K        ++F  E + +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDV 219
            +  H ++V L+G   E      V++ M   + G L S L    Y  L     +  A  +
Sbjct: 66  RQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQL 120
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFG 277
           +  L YL        +HRDI + N+L+  +   ++ DFGLSR  E+     A+  +    
Sbjct: 121 STALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFE-LIAGRSPLQGL 315
           ++ PE I+ R FT  SDV+ FGV ++E L+ G  P QG+
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 216

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 38  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 97
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 98  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 150
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A    GT  Y+ PE
Sbjct: 151 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
            ++ ++  K SD+++ G ++++L+AG  P +   EY+
Sbjct: 208 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 244

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 47  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 106
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 107 LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 159
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 160 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 216
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 217 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 248

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 120/248 (48%), Gaps = 33/248 (13%)
Query: 97  SASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG---EK 153
           S SG+P    + + + T      IG+G FG V++ +   GE VAVK+ ++  ++    E 
Sbjct: 15  SGSGLPLLVQRTIAR-TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREA 72
Query: 154 EFQTEVMLLGRLHHRNLVNLVGYCAEKG----QHMLVYVFMSKGSLASHLYDENYGPLTW 209
           E    VML     H N++  +    +      Q  LV  +   GSL  +L   N   +T 
Sbjct: 73  EIYQTVML----RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTV 125
Query: 210 NLRVHIALDVARGLEYLHDGAV-----PPVIHRDIKSSNILLDQSMRARVADFGL----- 259
              + +AL  A GL +LH   V     P + HRD+KS NIL+ ++    +AD GL     
Sbjct: 126 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 185
Query: 260 SREEMVDKHAANIRGTFGYLDPEY----ISTRNFT--KKSDVYSFGVLLFELIAGRSPLQ 313
           S  + +D    +  GT  Y+ PE     I+ ++F   K++D+Y+ G++ +E IA R  + 
Sbjct: 186 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG 244
Query: 314 GLMEYVEL 321
           G+ E  +L
Sbjct: 245 GIHEDYQL 252

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 85  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 137
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 138 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 226

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLVG 175
           +G+GAF  V +    +TG   A K++ T  K   ++FQ    E  +  +L H N+V L  
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 176 YCAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
              E+  H LV+  ++ G L     A   Y E           H    +   + Y H   
Sbjct: 96  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESIAYCHSNG 148
Query: 231 VPPVIHRDIKSSNILLDQSMRA---RVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
           +   +HR++K  N+LL    +    ++ADFGL+ E    +      GT GYL PE +   
Sbjct: 149 I---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPL 312
            ++K  D+++ GV+L+ L+ G  P 
Sbjct: 206 PYSKPVDIWACGVILYILLVGYPPF 230

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 19/219 (8%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-----EKEFQTEVMLL 162
           ++Q+        IG+G FG V++    + E  A+ V     K        ++F  E + +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDV 219
            +  H ++V L+G   E      V++ M   + G L S L    +  L     +  A  +
Sbjct: 66  RQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQL 120
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFG 277
           +  L YL        +HRDI + N+L+  +   ++ DFGLSR  E+     A+  +    
Sbjct: 121 STALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK 177
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFE-LIAGRSPLQGL 315
           ++ PE I+ R FT  SDV+ FGV ++E L+ G  P QG+
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 216

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 129/269 (47%), Gaps = 28/269 (10%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDS-KQGEKE-FQTEVMLLGRLHHRNLVNLVGY 176
           IG G++G   K +  S G+ +  K L   S  + EK+   +EV LL  L H N+V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 177 CAEKGQHMLVYV--FMSKGSLASHLY----DENYGPLTWNLRVHIALDVARGLEYLH--- 227
             ++    L  V  +   G LAS +     +  Y    + LRV   L +A  L+  H   
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA--LKECHRRS 131
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAANIRGTFGYLDPEYIST 286
           DG    V+HRD+K +N+ LD     ++ DFGL+R    D+  A    GT  Y+ PE ++ 
Sbjct: 132 DGG-HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNR 190
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV 346
            ++ +KSD++S G LL+EL A   P     +  ELA    EGK         R+   +  
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-KELAGKIREGKF-------RRIPYRYS- 241
Query: 347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
           +ELNE+ +   + +N     RPS+ +I++
Sbjct: 242 DELNEIIT---RMLNLKDYHRPSVEEILE 267

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 19/219 (8%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-----EKEFQTEVMLL 162
           ++Q+        IG+G FG V++    + E  A+ V     K        ++F  E + +
Sbjct: 34  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 93
Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDV 219
            +  H ++V L+G   E      V++ M   + G L S L    Y  L     +  A  +
Sbjct: 94  RQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQL 148
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFG 277
           +  L YL        +HRDI + N+L+  +   ++ DFGLSR  E+     A+  +    
Sbjct: 149 STALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 205
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFE-LIAGRSPLQGL 315
           ++ PE I+ R FT  SDV+ FGV ++E L+ G  P QG+
Sbjct: 206 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 244

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 82  LLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 134
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 135 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 17  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 76
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 77  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 129
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A    GT  Y+ PE
Sbjct: 130 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 186
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
            ++ ++  K SD+++ G ++++L+AG  P +   EY+
Sbjct: 187 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 223

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 120/248 (48%), Gaps = 33/248 (13%)
Query: 97  SASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG---EK 153
           S SG+P    + + + T      IG+G FG V++ +   GE VAVK+ ++  ++    E 
Sbjct: 28  SGSGLPLLVQRTIAR-TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREA 85
Query: 154 EFQTEVMLLGRLHHRNLVNLVGYCAEKG----QHMLVYVFMSKGSLASHLYDENYGPLTW 209
           E    VML     H N++  +    +      Q  LV  +   GSL  +L   N   +T 
Sbjct: 86  EIYQTVML----RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTV 138
Query: 210 NLRVHIALDVARGLEYLHDGAV-----PPVIHRDIKSSNILLDQSMRARVADFGL----- 259
              + +AL  A GL +LH   V     P + HRD+KS NIL+ ++    +AD GL     
Sbjct: 139 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 198
Query: 260 SREEMVDKHAANIRGTFGYLDPEY----ISTRNFT--KKSDVYSFGVLLFELIAGRSPLQ 313
           S  + +D    +  GT  Y+ PE     I+ ++F   K++D+Y+ G++ +E IA R  + 
Sbjct: 199 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIG 257
Query: 314 GLMEYVEL 321
           G+ E  +L
Sbjct: 258 GIHEDYQL 265

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 128/269 (47%), Gaps = 28/269 (10%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDS-KQGEKE-FQTEVMLLGRLHHRNLVNLVGY 176
           IG G++G   K +  S G+ +  K L   S  + EK+   +EV LL  L H N+V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 177 CAEKGQHMLVYV--FMSKGSLASHLY----DENYGPLTWNLRVHIALDVARGLEYLH--- 227
             ++    L  V  +   G LAS +     +  Y    + LRV   L +A  L+  H   
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA--LKECHRRS 131
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYIST 286
           DG    V+HRD+K +N+ LD     ++ DFGL+R    D   A    GT  Y+ PE ++ 
Sbjct: 132 DGG-HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV 346
            ++ +KSD++S G LL+EL A   P     +  ELA    EGK         R+   +  
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-KELAGKIREGKF-------RRIPYRYS- 241
Query: 347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
           +ELNE+ +   + +N     RPS+ +I++
Sbjct: 242 DELNEIIT---RMLNLKDYHRPSVEEILE 267

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 131/275 (47%), Gaps = 36/275 (13%)
Query: 120 IGQGAFGPVYKAQMSTG------ET-VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLV 171
           +GQG+FG VY+  ++ G      ET VA+K +   +   E+ EF  E  ++   +  ++V
Sbjct: 18  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 76
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYD-----EN---YGPLTWNLRVHIALDVARGL 223
            L+G  ++    +++   M++G L S+L       EN     P + +  + +A ++A G+
Sbjct: 77  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 136
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANIRGTFG--YLD 280
            YL+       +HRD+ + N ++ +    ++ DFG++R+    D      +G     ++ 
Sbjct: 137 AYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 193
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +    FT  SDV+SFGV+L+E+      P QGL     L  +   G      ++D +
Sbjct: 194 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG------LLD-K 246
Query: 340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIV 374
            D   D+     +  L   C    P+ RPS  +I+
Sbjct: 247 PDNCPDM-----LLELMRMCWQYNPKMRPSFLEII 276

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLVG 175
           +G+GAF  V +    +TG   A K++ T  K   ++FQ    E  +  +L H N+V L  
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLHD 71
Query: 176 YCAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
              E+  H LV+  ++ G L     A   Y E           H    +   + Y H   
Sbjct: 72  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESIAYCHSNG 124
Query: 231 VPPVIHRDIKSSNILLDQSMR---ARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
           +   +HR++K  N+LL    +    ++ADFGL+ E    +      GT GYL PE +   
Sbjct: 125 I---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 181
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPL 312
            ++K  D+++ GV+L+ L+ G  P 
Sbjct: 182 PYSKPVDIWACGVILYILLVGYPPF 206

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLVG 175
           +G+GAF  V +    +TG   A K++ T  K   ++FQ    E  +  +L H N+V L  
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 176 YCAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
              E+  H LV+  ++ G L     A   Y E           H    +   + Y H   
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESIAYCHSNG 125
Query: 231 VPPVIHRDIKSSNILLDQSMR---ARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
           +   +HR++K  N+LL    +    ++ADFGL+ E    +      GT GYL PE +   
Sbjct: 126 I---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPL 312
            ++K  D+++ GV+L+ L+ G  P 
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLVG 175
           +G+GAF  V +    +TG   A K++ T  K   ++FQ    E  +  +L H N+V L  
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 176 YCAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
              E+  H LV+  ++ G L     A   Y E           H    +   + Y H   
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESIAYCHSNG 125
Query: 231 VPPVIHRDIKSSNILLDQSMR---ARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
           +   +HR++K  N+LL    +    ++ADFGL+ E    +      GT GYL PE +   
Sbjct: 126 I---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPL 312
            ++K  D+++ GV+L+ L+ G  P 
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 124/268 (46%), Gaps = 29/268 (10%)
Query: 116 FTTL--IGQGAFGPVYKA-QMSTGETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLV 171
           FT L  IG+G+FG V+K     T + VA+K++   +++   ++ Q E+ +L +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
              G   +  +  ++  ++  GS    L     GPL       I  ++ +GL+YLH    
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA--NIRGTFGYLDPEYISTRNF 289
              IHRDIK++N+LL +    ++ADFG++  ++ D         GT  ++ PE I    +
Sbjct: 126 ---IHRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIKQSAY 181
Query: 290 TKKSDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
             K+D++S G+   EL  G  P   L  M+ + L   N              L+G +   
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN----------PPTLEGNYS-- 229
Query: 348 ELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
               +      C+N+ P  RP+ +++++
Sbjct: 230 --KPLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 122/278 (43%), Gaps = 33/278 (11%)
Query: 119 LIGQGAFGPVYKAQMSTG-ETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGY 176
           +IG GA   V  A  +   E VA+K +  +  Q    E   E+  + + HH N+V+    
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 177 CAEKGQHMLVYVFMSKGS---LASHLY---DENYGPLTWNLRVHIALDVARGLEYLHDGA 230
              K +  LV   +S GS   +  H+    +   G L  +    I  +V  GLEYLH   
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSR------EEMVDKHAANIRGTFGYLDPEYI 284
               IHRD+K+ NILL +    ++ADFG+S       +   +K      GT  ++ PE +
Sbjct: 142 Q---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 285 -STRNFTKKSDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMNTEGKTGWEEIVDSRLD 341
              R +  K+D++SFG+   EL  G +P      M+ + L   N            S   
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP---------PSLET 249
Query: 342 GIFDVEELNEVASLAYK----CVNRAPRKRPSMRDIVQ 375
           G+ D E L +      K    C+ + P KRP+  ++++
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 124/267 (46%), Gaps = 27/267 (10%)
Query: 116 FTTL--IGQGAFGPVYKA-QMSTGETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLV 171
           FT L  IG+G+FG V+K     T + VA+K++   +++   ++ Q E+ +L +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
              G   +  +  ++  ++  GS    L     GPL       I  ++ +GL+YLH    
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRNFT 290
              IHRDIK++N+LL +    ++ADFG++ +    +   N   GT  ++ PE I    + 
Sbjct: 141 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 197
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
            K+D++S G+   EL  G  P   L  M+ + L   N              L+G +    
Sbjct: 198 SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP----------PTLEGNYS--- 244
Query: 349 LNEVASLAYKCVNRAPRKRPSMRDIVQ 375
              +      C+N+ P  RP+ +++++
Sbjct: 245 -KPLKEFVEACLNKEPSFRPTAKELLK 270

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 122/278 (43%), Gaps = 33/278 (11%)
Query: 119 LIGQGAFGPVYKAQMSTG-ETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGY 176
           +IG GA   V  A  +   E VA+K +  +  Q    E   E+  + + HH N+V+    
Sbjct: 17  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 76
Query: 177 CAEKGQHMLVYVFMSKGS---LASHLY---DENYGPLTWNLRVHIALDVARGLEYLHDGA 230
              K +  LV   +S GS   +  H+    +   G L  +    I  +V  GLEYLH   
Sbjct: 77  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 136
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSR------EEMVDKHAANIRGTFGYLDPEYI 284
               IHRD+K+ NILL +    ++ADFG+S       +   +K      GT  ++ PE +
Sbjct: 137 Q---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 193
Query: 285 -STRNFTKKSDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMNTEGKTGWEEIVDSRLD 341
              R +  K+D++SFG+   EL  G +P      M+ + L   N            S   
Sbjct: 194 EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP---------PSLET 244
Query: 342 GIFDVEELNEVASLAYK----CVNRAPRKRPSMRDIVQ 375
           G+ D E L +      K    C+ + P KRP+  ++++
Sbjct: 245 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 282

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 92  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 144
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A    GT  Y+ PE
Sbjct: 145 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 201
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
            ++ ++  K SD+++ G ++++L+AG  P +   EY+
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 238

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 124/267 (46%), Gaps = 27/267 (10%)
Query: 116 FTTL--IGQGAFGPVYKA-QMSTGETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLV 171
           FT L  IG+G+FG V+K     T + VA+K++   +++   ++ Q E+ +L +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
              G   +  +  ++  ++  GS    L     GPL       I  ++ +GL+YLH    
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRNFT 290
              IHRDIK++N+LL +    ++ADFG++ +    +   N   GT  ++ PE I    + 
Sbjct: 126 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 182
Query: 291 KKSDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
            K+D++S G+   EL  G  P   L  M+ + L   N              L+G +    
Sbjct: 183 SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN----------PPTLEGNYS--- 229
Query: 349 LNEVASLAYKCVNRAPRKRPSMRDIVQ 375
              +      C+N+ P  RP+ +++++
Sbjct: 230 -KPLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 131/310 (42%), Gaps = 37/310 (11%)
Query: 91  KRSNVVSASGIPEYSYKDLQKATCNFTTL--------IGQGAFGPVYKAQ-MSTGETVAV 141
           ++S  +    +P++  +   +    + TL        IG+G F  VY+A  +  G  VA+
Sbjct: 3   EQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVAL 62
Query: 142 K---VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASH 198
           K   +      +   +   E+ LL +L+H N++       E  +  +V      G L+  
Sbjct: 63  KKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRM 122
Query: 199 LY----DENYGP--LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA 252
           +      +   P    W   V +       LE++H   V   +HRDIK +N+ +  +   
Sbjct: 123 IKHFKKQKRLIPERTVWKYFVQLC----SALEHMHSRRV---MHRDIKPANVFITATGVV 175
Query: 253 RVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
           ++ D GL R       AA+ + GT  Y+ PE I    +  KSD++S G LL+E+ A +SP
Sbjct: 176 KLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
Query: 312 LQGLMEYVELAAMNTEGKTGWEEIVD-SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSM 370
             G         MN        E  D   L      EEL ++ ++   C+N  P KRP +
Sbjct: 236 FYG-------DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM---CINPDPEKRPDV 285
Query: 371 RDIVQVLSRI 380
             +  V  R+
Sbjct: 286 TYVYDVAKRM 295

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 128/269 (47%), Gaps = 28/269 (10%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDS-KQGEKE-FQTEVMLLGRLHHRNLVNLVGY 176
           IG G++G   K +  S G+ +  K L   S  + EK+   +EV LL  L H N+V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 177 CAEKGQHMLVYV--FMSKGSLASHLY----DENYGPLTWNLRVHIALDVARGLEYLH--- 227
             ++    L  V  +   G LAS +     +  Y    + LRV   L +A  L+  H   
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA--LKECHRRS 131
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYIST 286
           DG    V+HRD+K +N+ LD     ++ DFGL+R    D   A    GT  Y+ PE ++ 
Sbjct: 132 DGG-HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 190
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV 346
            ++ +KSD++S G LL+EL A   P     +  ELA    EGK         R+   +  
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-KELAGKIREGKF-------RRIPYRYS- 241
Query: 347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
           +ELNE+ +   + +N     RPS+ +I++
Sbjct: 242 DELNEIIT---RMLNLKDYHRPSVEEILE 267

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 108 DLQKATCNFTTL--IGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVML 161
           D Q    N+  L  IG+G F  V  A+ + TG+ VAVK++     +S   +K F+ EV +
Sbjct: 8   DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRI 66
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +  L+H N+V L      +    LV  + S G +  +L    +G +           +  
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVS 124
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
            ++Y H   +   +HRD+K+ N+LLD  M  ++ADFG S E           G+  Y  P
Sbjct: 125 AVQYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAP 181
Query: 282 EYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQG 314
           E    + +   + DV+S GV+L+ L++G  P  G
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 19  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 78
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A G+ YL 
Sbjct: 79  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAEGMNYLE 131
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 132 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 188
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 189 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 220

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 11/212 (5%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVMLLG 163
           DL          IG+G F  V  A+ + TG+ VAVK++     +S   +K F+ EV ++ 
Sbjct: 3   DLHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMK 61
Query: 164 RLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
            L+H N+V L      +    LV  + S G +  +L    +G +           +   +
Sbjct: 62  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV--AHGWMKEKEARAKFRQIVSAV 119
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEY 283
           +Y H   +   +HRD+K+ N+LLD  M  ++ADFG S E           G+  Y  PE 
Sbjct: 120 QYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPEL 176
Query: 284 ISTRNFT-KKSDVYSFGVLLFELIAGRSPLQG 314
              + +   + DV+S GV+L+ L++G  P  G
Sbjct: 177 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 208

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 108 DLQKATCNFTTL--IGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVML 161
           D Q    N+  L  IG+G F  V  A+ + TG+ VAVK++     +S   +K F+ EV +
Sbjct: 8   DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRI 66
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +  L+H N+V L      +    LV  + S G +  +L    +G +           +  
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVS 124
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
            ++Y H   +   +HRD+K+ N+LLD  M  ++ADFG S E           G+  Y  P
Sbjct: 125 AVQYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAP 181
Query: 282 EYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQG 314
           E    + +   + DV+S GV+L+ L++G  P  G
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 124/268 (46%), Gaps = 29/268 (10%)
Query: 116 FTTL--IGQGAFGPVYKA-QMSTGETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLV 171
           FT L  IG+G+FG V+K     T + VA+K++   +++   ++ Q E+ +L +     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
              G   +  +  ++  ++  GS    L     GPL       I  ++ +GL+YLH    
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK 145
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA--NIRGTFGYLDPEYISTRNF 289
              IHRDIK++N+LL +    ++ADFG++  ++ D         GT  ++ PE I    +
Sbjct: 146 ---IHRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIKQSAY 201
Query: 290 TKKSDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
             K+D++S G+   EL  G  P   L  M+ + L   N              L+G +   
Sbjct: 202 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP----------PTLEGNYS-- 249
Query: 348 ELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
               +      C+N+ P  RP+ +++++
Sbjct: 250 --KPLKEFVEACLNKEPSFRPTAKELLK 275

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 19/219 (8%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-----EKEFQTEVMLL 162
           ++Q+        IG+G FG V++    + E  A+ V     K        ++F  E + +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDV 219
            +  H ++V L+G   E      V++ M   + G L S L    +  L     +  A  +
Sbjct: 66  RQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQL 120
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFG 277
           +  L YL        +HRDI + N+L+  +   ++ DFGLSR  E+     A+  +    
Sbjct: 121 STALAYLESKRF---VHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFE-LIAGRSPLQGL 315
           ++ PE I+ R FT  SDV+ FGV ++E L+ G  P QG+
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 216

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 115 NFTTLIGQGAFGP-VYKAQMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F   V   +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 33  KFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 93  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 145
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A    GT  Y+ PE
Sbjct: 146 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV 319
            ++ ++  K SD+++ G ++++L+AG  P +   EY+
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G+G++G VYKA    TG+ VA+K +  +S    +E   E+ ++ +    ++V   G   
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
           +     +V  +   GS++  +   N   LT +    I     +GLEYLH       IHRD
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATILQSTLKGLEYLHFMRK---IHRD 150
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAAN--IRGTFGYLDPEYISTRNFTKKSDVY 296
           IK+ NILL+    A++ADFG++  ++ D  A    + GT  ++ PE I    +   +D++
Sbjct: 151 IKAGNILLNTEGHAKLADFGVAG-QLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIW 209
Query: 297 SFGVLLFELIAGRSP 311
           S G+   E+  G+ P
Sbjct: 210 SLGITAIEMAEGKPP 224

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 113/240 (47%), Gaps = 18/240 (7%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKAQ + GET A+K +  + K+ E    T   E+ +L  L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLE-KEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              K + +LV+  + +      L D   G L         L +  G+ Y HD  V   +H
Sbjct: 69  IHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV---LH 123
Query: 237 RDIKSSNILLDQSMRARVADFGLSREE--MVDKHAANIRGTFGYLDPEYI-STRNFTKKS 293
           RD+K  N+L+++    ++ADFGL+R     V K+   I  T  Y  P+ +  ++ ++   
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTI 182
Query: 294 DVYSFGVLLFELIAGRSPLQGLMEYVELA----AMNTEGKTGWEEIVD-SRLDGIFDVEE 348
           D++S G +  E++ G     G+ E  +L      + T     W  + +  + D  F V E
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 19/219 (8%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-----EKEFQTEVMLL 162
           ++Q+        IG+G FG V++    + E  A+ V     K        ++F  E + +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDV 219
            +  H ++V L+G   E      V++ M   + G L S L    +  L     +  A  +
Sbjct: 446 RQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQL 500
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFG 277
           +  L YL        +HRDI + N+L+  +   ++ DFGLSR  E+     A+  +    
Sbjct: 501 STALAYLESKRF---VHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFE-LIAGRSPLQGL 315
           ++ PE I+ R FT  SDV+ FGV ++E L+ G  P QG+
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 33/217 (15%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVL----------ATDSKQGEK---EFQTEVMLLGRL 165
           +G GA+G V   +   G +  A+KV+          + D+K  EK   E   E+ LL  L
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLAS-----HLYDENYGPLTWNLRVHIALDVA 220
            H N++ L     +K    LV  F   G L       H +DE           +I   + 
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA-------NIMKQIL 156
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQS---MRARVADFGLSREEMVDKHAANIRGTFG 277
            G+ YLH      ++HRDIK  NILL+     +  ++ DFGLS     D    +  GT  
Sbjct: 157 SGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAY 213
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           Y+ PE +  + + +K DV+S GV+++ L+ G  P  G
Sbjct: 214 YIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGG 249

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 19/219 (8%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-----EKEFQTEVMLL 162
           ++Q+        IG+G FG V++    + E  A+ V     K        ++F  E + +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDV 219
            +  H ++V L+G   E      V++ M   + G L S L    +  L     +  A  +
Sbjct: 446 RQFDHPHIVKLIGVITENP----VWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQL 500
Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFG 277
           +  L YL        +HRDI + N+L+  +   ++ DFGLSR  E+     A+  +    
Sbjct: 501 STALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFE-LIAGRSPLQGL 315
           ++ PE I+ R FT  SDV+ FGV ++E L+ G  P QG+
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 22/207 (10%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +IG+G FG VY  + + TG+  A+K L    K+  K  Q E + L   + R +++LV   
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLAL---NERIMLSLVSTG 248
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVH----------IALDVARGLEYLH 227
                  + Y F +   L+  L   N G L ++L  H           A ++  GLE++H
Sbjct: 249 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 308
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST- 286
           +  V   ++RD+K +NILLD+    R++D GL+ +    K  A++ GT GY+ PE +   
Sbjct: 309 NRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKG 364
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQ 313
             +   +D +S G +LF+L+ G SP +
Sbjct: 365 VAYDSSADWFSLGCMLFKLLRGHSPFR 391

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 22/207 (10%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +IG+G FG VY  + + TG+  A+K L    K+  K  Q E + L   + R +++LV   
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLAL---NERIMLSLVSTG 249
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVH----------IALDVARGLEYLH 227
                  + Y F +   L+  L   N G L ++L  H           A ++  GLE++H
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST- 286
           +  V   ++RD+K +NILLD+    R++D GL+ +    K  A++ GT GY+ PE +   
Sbjct: 310 NRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKG 365
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQ 313
             +   +D +S G +LF+L+ G SP +
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFR 392

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++  GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 89  LLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 141
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 142 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 230

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 110/216 (50%), Gaps = 24/216 (11%)
Query: 120 IGQGAFGPVYKAQMSTG------ET-VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLV 171
           +GQG+FG VY+  ++ G      ET VA+K +   +   E+ EF  E  ++   +  ++V
Sbjct: 20  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYD-----EN---YGPLTWNLRVHIALDVARGL 223
            L+G  ++    +++   M++G L S+L       EN     P + +  + +A ++A G+
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFG--YLD 280
            YL+       +HRD+ + N  + +    ++ DFG++R+    D +    +G     ++ 
Sbjct: 139 AYLNANKF---VHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 195
Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
           PE +    FT  SDV+SFGV+L+E+      P QGL
Sbjct: 196 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 231

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 22/207 (10%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +IG+G FG VY  + + TG+  A+K L    K+  K  Q E + L   + R +++LV   
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLAL---NERIMLSLVSTG 249
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVH----------IALDVARGLEYLH 227
                  + Y F +   L+  L   N G L ++L  H           A ++  GLE++H
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST- 286
           +  V   ++RD+K +NILLD+    R++D GL+ +    K  A++ GT GY+ PE +   
Sbjct: 310 NRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKG 365
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQ 313
             +   +D +S G +LF+L+ G SP +
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFR 392

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 22/207 (10%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +IG+G FG VY  + + TG+  A+K L    K+  K  Q E + L   + R +++LV   
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLAL---NERIMLSLVSTG 249
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVH----------IALDVARGLEYLH 227
                  + Y F +   L+  L   N G L ++L  H           A ++  GLE++H
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 309
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST- 286
           +  V   ++RD+K +NILLD+    R++D GL+ +    K  A++ GT GY+ PE +   
Sbjct: 310 NRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKG 365
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQ 313
             +   +D +S G +LF+L+ G SP +
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFR 392

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 18/240 (7%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKAQ + GET A+K +  + K+ E    T   E+ +L  L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLE-KEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              K + +LV+  + +      L D   G L         L +  G+ Y HD  V   +H
Sbjct: 69  IHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV---LH 123
Query: 237 RDIKSSNILLDQSMRARVADFGLSREE--MVDKHAANIRGTFGYLDPEYI-STRNFTKKS 293
           RD+K  N+L+++    ++ADFGL+R     V K+   +  T  Y  P+ +  ++ ++   
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTI 182
Query: 294 DVYSFGVLLFELIAGRSPLQGLMEYVELA----AMNTEGKTGWEEIVD-SRLDGIFDVEE 348
           D++S G +  E++ G     G+ E  +L      + T     W  + +  + D  F V E
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 86  LLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 138
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFG ++    E  + HA   +    ++  E I
Sbjct: 139 DRRL---VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 227

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           +G+GAF  V +  ++  G+  A K++ T   S +  ++ + E  +   L H N+V L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
            +E+G H L++  ++ G L   +    Y   +     H    +   + + H   V   +H
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMGV---VH 144
Query: 237 RDIKSSNILLDQSMRA---RVADFGLSREEMVDKHAA-NIRGTFGYLDPEYISTRNFTKK 292
           RD+K  N+LL   ++    ++ADFGL+ E   ++ A     GT GYL PE +    + K 
Sbjct: 145 RDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKP 204
Query: 293 SDVYSFGVLLFELIAGRSPL 312
            D+++ GV+L+ L+ G  P 
Sbjct: 205 VDLWACGVILYILLVGYPPF 224

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 84  LLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 136
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFG ++    E  + HA   +    ++  E I
Sbjct: 137 DRRL---VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 111/225 (49%), Gaps = 32/225 (14%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQG---EKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG+G FG V++ +   GE VAVK+ ++  ++    E E    VML     H N++  +  
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML----RHENILGFIAA 65
Query: 177 CAEKG----QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV- 231
             +      Q  LV  +   GSL  +L   N   +T    + +AL  A GL +LH   V 
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 232 ----PPVIHRDIKSSNILLDQSMRARVADFGL-----SREEMVDKHAANIRGTFGYLDPE 282
               P + HRD+KS NIL+ ++    +AD GL     S  + +D    +  GT  Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 283 Y----ISTRNFT--KKSDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
                I+ ++F   K++D+Y+ G++ +E IA R  + G+ E  +L
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQL 226

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 108 DLQKATCNFTTL--IGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVML 161
           D Q    N+  L  IG+G F  V  A+ + TG+ VAV+++     +S   +K F+ EV +
Sbjct: 8   DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRI 66
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +  L+H N+V L      +    LV  + S G +  +L    +G +           +  
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVS 124
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
            ++Y H   +   +HRD+K+ N+LLD  M  ++ADFG S E           G+  Y  P
Sbjct: 125 AVQYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAP 181
Query: 282 EYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQG 314
           E    + +   + DV+S GV+L+ L++G  P  G
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++  GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 22  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 82  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 134
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 135 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 108 DLQKATCNFTTL--IGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVML 161
           D Q    N+  L  IG+G F  V  A+ + TG+ VAV+++     +S   +K F+ EV +
Sbjct: 8   DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRI 66
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +  L+H N+V L      +    LV  + S G +  +L    +G +           +  
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVS 124
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
            ++Y H   +   +HRD+K+ N+LLD  M  ++ADFG S E           G+  Y  P
Sbjct: 125 AVQYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAP 181
Query: 282 EYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQG 314
           E    + +   + DV+S GV+L+ L++G  P  G
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 108/240 (45%), Gaps = 18/240 (7%)
Query: 115 NFTTLIGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLV 171
           N   ++G+G+FG V K +   T +  AVKV+  A+   +       EV LL +L H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            L     +     +V    + G L   +        + +    I   V  G+ Y+H   +
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 232 PPVIHRDIKSSNILLDQSMR---ARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              +HRD+K  NILL+   +    ++ DFGLS     +    +  GT  Y+ PE +    
Sbjct: 143 ---VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-T 198
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG-----WEEIVDSRLDGI 343
           + +K DV+S GV+L+ L++G  P  G  EY  L  + T GK       W  I D   D I
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET-GKYAFDLPQWRTISDDAKDLI 257

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 84  LLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 136
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFG ++    E  + HA   +    ++  E I
Sbjct: 137 DRRL---VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 111/225 (49%), Gaps = 32/225 (14%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQG---EKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG+G FG V++ +   GE VAVK+ ++  ++    E E    VML     H N++  +  
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML----RHENILGFIAA 66
Query: 177 CAEKG----QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV- 231
             +      Q  LV  +   GSL  +L   N   +T    + +AL  A GL +LH   V 
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVG 123
Query: 232 ----PPVIHRDIKSSNILLDQSMRARVADFGL-----SREEMVDKHAANIRGTFGYLDPE 282
               P + HRD+KS NIL+ ++    +AD GL     S  + +D    +  GT  Y+ PE
Sbjct: 124 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 183
Query: 283 Y----ISTRNFT--KKSDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
                I+ ++F   K++D+Y+ G++ +E IA R  + G+ E  +L
Sbjct: 184 VLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQL 227

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           IG+G F  V  A+ + TG  VAVK++     +    +K F+ EV ++  L+H N+V L  
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
               +    LV  + S G +  +L    +G +           +   ++Y H   +   +
Sbjct: 82  VIETEKTLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVSAVQYCHQKYI---V 136
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT-KKSD 294
           HRD+K+ N+LLD  M  ++ADFG S E  V        G+  Y  PE    + +   + D
Sbjct: 137 HRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVD 196
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           V+S GV+L+ L++G  P  G
Sbjct: 197 VWSLGVILYTLVSGSLPFDG 216

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 13/214 (6%)
Query: 108 DLQKATCNFTTL--IGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVML 161
           D Q    N+  L  IG+G F  V  A+ + TG+ VAVK++     +S   +K F+ EV +
Sbjct: 8   DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRI 66
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +  L+H N+V L      +    LV  + S G +  +L    +G +           +  
Sbjct: 67  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV--AHGRMKEKEARAKFRQIVS 124
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
            ++Y H   +   +HRD+K+ N+LLD  M  ++ADFG S E           G   Y  P
Sbjct: 125 AVQYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAP 181
Query: 282 EYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQG 314
           E    + +   + DV+S GV+L+ L++G  P  G
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 147
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A    GT  Y+ PE
Sbjct: 148 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            ++ ++  K SD+++ G ++++L+AG  P + 
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 18/240 (7%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKAQ + GET A+K +  + K+ E    T   E+ +L  L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLE-KEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              K + +LV+  + +      L D   G L         L +  G+ Y HD  V   +H
Sbjct: 69  IHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV---LH 123
Query: 237 RDIKSSNILLDQSMRARVADFGLSREE--MVDKHAANIRGTFGYLDPEYI-STRNFTKKS 293
           RD+K  N+L+++    ++ADFGL+R     V K+   +  T  Y  P+ +  ++ ++   
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTI 182
Query: 294 DVYSFGVLLFELIAGRSPLQGLMEYVELA----AMNTEGKTGWEEIVD-SRLDGIFDVEE 348
           D++S G +  E++ G     G+ E  +L      + T     W  + +  + D  F V E
Sbjct: 183 DIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 111/225 (49%), Gaps = 32/225 (14%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQG---EKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG+G FG V++ +   GE VAVK+ ++  ++    E E    VML     H N++  +  
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML----RHENILGFIAA 68
Query: 177 CAEKG----QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV- 231
             +      Q  LV  +   GSL  +L   N   +T    + +AL  A GL +LH   V 
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVG 125
Query: 232 ----PPVIHRDIKSSNILLDQSMRARVADFGL-----SREEMVDKHAANIRGTFGYLDPE 282
               P + HRD+KS NIL+ ++    +AD GL     S  + +D    +  GT  Y+ PE
Sbjct: 126 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 185
Query: 283 Y----ISTRNFT--KKSDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
                I+ ++F   K++D+Y+ G++ +E IA R  + G+ E  +L
Sbjct: 186 VLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQL 229

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 111/225 (49%), Gaps = 32/225 (14%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQG---EKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG+G FG V++ +   GE VAVK+ ++  ++    E E    VML     H N++  +  
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML----RHENILGFIAA 71
Query: 177 CAEKG----QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV- 231
             +      Q  LV  +   GSL  +L   N   +T    + +AL  A GL +LH   V 
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVG 128
Query: 232 ----PPVIHRDIKSSNILLDQSMRARVADFGL-----SREEMVDKHAANIRGTFGYLDPE 282
               P + HRD+KS NIL+ ++    +AD GL     S  + +D    +  GT  Y+ PE
Sbjct: 129 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 188
Query: 283 Y----ISTRNFT--KKSDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
                I+ ++F   K++D+Y+ G++ +E IA R  + G+ E  +L
Sbjct: 189 VLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQL 232

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++  GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 89  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 141
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I
Sbjct: 142 DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 230

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           IG G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +M  G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +VADFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 108/240 (45%), Gaps = 18/240 (7%)
Query: 115 NFTTLIGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLV 171
           N   ++G+G+FG V K +   T +  AVKV+  A+   +       EV LL +L H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            L     +     +V    + G L   +        + +    I   V  G+ Y+H   +
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 232 PPVIHRDIKSSNILLDQSMR---ARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              +HRD+K  NILL+   +    ++ DFGLS     +    +  GT  Y+ PE +    
Sbjct: 143 ---VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-T 198
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG-----WEEIVDSRLDGI 343
           + +K DV+S GV+L+ L++G  P  G  EY  L  + T GK       W  I D   D I
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET-GKYAFDLPQWRTISDDAKDLI 257

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           IG G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +M  G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +VADFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 82  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 134
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFG ++    E  + HA   +    ++  E I
Sbjct: 135 DRRL---VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 38/271 (14%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQT-EVMLLGRLHHRNLVNLVGYC 177
           +G G +  VYK    +TG  VA+K +  DS++G       E+ L+  L H N+V L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 178 AEKGQHMLVYVFMS---KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
             + +  LV+ FM    K  + S         L  NL  +    + +GL + H+  +   
Sbjct: 73  HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKI--- 129
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREE--MVDKHAANIRGTFGYLDPEYI-STRNFTK 291
           +HRD+K  N+L+++  + ++ DFGL+R     V+  ++ +  T  Y  P+ +  +R ++ 
Sbjct: 130 LHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGSRTYST 188
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE 351
             D++S G +L E+I G+    G  +                   + +L  IFD+  +  
Sbjct: 189 SIDIWSCGCILAEMITGKPLFPGTND-------------------EEQLKLIFDI--MGT 227
Query: 352 VASLAYKCVNRAPRKRPSM-----RDIVQVL 377
                +  V + P+  P++     RD+ QVL
Sbjct: 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVL 258

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 84  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 136
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFG ++    E  + HA   +    ++  E I
Sbjct: 137 DRRL---VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 225

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 130/298 (43%), Gaps = 24/298 (8%)
Query: 115 NFTTLIGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLV 171
           N   ++G+G+FG V K +   T +  AVKV+  A+   +       EV LL +L H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            L     +     +V    + G L   +        + +    I   V  G+ Y+H   +
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 232 PPVIHRDIKSSNILLDQSMR---ARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              +HRD+K  NILL+   +    ++ DFGLS     +    +  GT  Y+ PE +    
Sbjct: 143 ---VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-T 198
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG-----WEEIVDSRLDGI 343
           + +K DV+S GV+L+ L++G  P  G  EY  L  + T GK       W  I D   D I
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET-GKYAFDLPQWRTISDDAKDLI 257
Query: 344 FDV------EELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQS 395
             +        +     L +  + +   + P++ D+  + S +  +R  +   + +Q+
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQA 315

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDS--KQGEKEFQT-EVMLLGRLHHRNL 170
            F  ++G+G+F  V  A +++T    A+K+L      K+ +  + T E  ++ RL H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEY 225
           V L     +  +      +   G L  ++     +DE         R + A ++   LEY
Sbjct: 95  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTA-EIVSALEY 147
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPE 282
           LH   +   IHRD+K  NILL++ M  ++ DFG ++    E     A    GT  Y+ PE
Sbjct: 148 LHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            ++ ++  K SD+++ G ++++L+AG  P + 
Sbjct: 205 LLTEKSAXKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V   +     S +  KE   E  ++  + + ++  
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--YDENYGP---LTWNLRVHIALDVARGLEYLH 227
           L+G C       L+   M  G L  ++  + +N G    L W       + +A+G+ YL 
Sbjct: 89  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 141
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYI 284
           D  +   +HRD+ + N+L+      ++ DFG ++    E  + HA   +    ++  E I
Sbjct: 142 DRRL---VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 285 STRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
             R +T +SDV+S+GV ++EL+  G  P  G+
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 230

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINAMLNHEN 66
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 124
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K      GT  Y+ PE
Sbjct: 125 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPE 177
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 123
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K    + GT  Y+ PE
Sbjct: 124 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK----MXGTLPYVAPE 176
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 91/200 (45%), Gaps = 20/200 (10%)
Query: 120 IGQGAFGPVY-----KAQMSTGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+G FG V           TGE VAVK L      Q    +Q E+ +L  L+H ++V  
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 174 VGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            G C ++G+    LV  ++  GSL  +L     G     L    A  +  G+ YLH    
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL---FAQQICEGMAYLH---A 129
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIST 286
              IHR + + N+LLD     ++ DFGL++          +R       F Y  PE +  
Sbjct: 130 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKE 188
Query: 287 RNFTKKSDVYSFGVLLFELI 306
             F   SDV+SFGV L+EL+
Sbjct: 189 CKFYYASDVWSFGVTLYELL 208

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 39/281 (13%)
Query: 41  NSSSRRAATLPIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLEGFKRS-NVVSAS 99
           NS  R +   P RA   +    + +   GP SP +  +  +      E F+ +  +V   
Sbjct: 95  NSLRRDSPPPPARARQENG---MPEKPPGPRSPQREPQRVSH-----EQFRAALQLVVDP 146
Query: 100 GIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTE 158
           G P  SY D      NF   IG+G+ G V  A + S+G+ VAVK +    +Q  +    E
Sbjct: 147 GDPR-SYLD------NFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNE 198
Query: 159 VMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLA-----SHLYDENYGPLTWNLRV 213
           V+++    H N+V +        +  +V  F+  G+L      + + +E           
Sbjct: 199 VVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------- 250
Query: 214 HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-- 271
            + L V + L  LH   V   IHRDIKS +ILL    R +++DFG   +  V K      
Sbjct: 251 AVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRK 305
Query: 272 -IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
            + GT  ++ PE IS   +  + D++S G+++ E++ G  P
Sbjct: 306 XLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 13/214 (6%)
Query: 108 DLQKATCNFTTL--IGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVML 161
           D Q    N+  L  IG+G F  V  A+ + TG  VA+K++     +    +K F+ EV +
Sbjct: 6   DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRI 64
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +  L+H N+V L      +    L+  + S G +  +L    +G +           +  
Sbjct: 65  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV--AHGRMKEKEARSKFRQIVS 122
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
            ++Y H   +   +HRD+K+ N+LLD  M  ++ADFG S E  V        G+  Y  P
Sbjct: 123 AVQYCHQKRI---VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAP 179
Query: 282 EYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQG 314
           E    + +   + DV+S GV+L+ L++G  P  G
Sbjct: 180 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 213

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 91/200 (45%), Gaps = 20/200 (10%)
Query: 120 IGQGAFGPVY-----KAQMSTGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+G FG V           TGE VAVK L      Q    +Q E+ +L  L+H ++V  
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 174 VGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            G C ++G+    LV  ++  GSL  +L     G     L    A  +  G+ YLH    
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL---FAQQICEGMAYLH---A 130
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIST 286
              IHR + + N+LLD     ++ DFGL++          +R       F Y  PE +  
Sbjct: 131 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKE 189
Query: 287 RNFTKKSDVYSFGVLLFELI 306
             F   SDV+SFGV L+EL+
Sbjct: 190 CKFYYASDVWSFGVTLYELL 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 123
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K      GT  Y+ PE
Sbjct: 124 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPE 176
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIXINKMLNHEN 65
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 123
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K    + GT  Y+ PE
Sbjct: 124 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK----MXGTLPYVAPE 176
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEK---EFQTEVMLLGRLHHRNLVNLV 174
           ++G G    V+ A+ +     VAVKVL  D  +       F+ E      L+H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 175 GYC-AEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
               AE     L Y+ M      +L   ++ E  GP+T    + +  D  + L + H   
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG 136
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSRE-----EMVDKHAANIRGTFGYLDPEYIS 285
           +   IHRD+K +NIL+  +   +V DFG++R        V + AA I GT  YL PE   
Sbjct: 137 I---IHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVI-GTAQYLSPEQAR 192
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
             +   +SDVYS G +L+E++ G  P  G
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 123
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K    + GT  Y+ PE
Sbjct: 124 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK----MXGTLPYVAPE 176
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 123
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K      GT  Y+ PE
Sbjct: 124 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPE 176
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 66
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 124
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K      GT  Y+ PE
Sbjct: 125 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPE 177
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 64
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 122
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K      GT  Y+ PE
Sbjct: 123 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPE 175
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 205

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 124/288 (43%), Gaps = 31/288 (10%)
Query: 41  NSSSRRAATLPIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASG 100
           N   RRA    +R +   S ++L+++    ++  K   N   +SM  E        +   
Sbjct: 33  NREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEF 92
Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEV 159
             +Y  KD+          IG+G    V +    +TG   AVK++   +++   E   EV
Sbjct: 93  YQKYDPKDV----------IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEV 142
Query: 160 ---------MLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWN 210
                    +L     H +++ L+          LV+  M KG L  +L ++    L+  
Sbjct: 143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEK 200
Query: 211 LRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA 270
               I   +   + +LH   +   +HRD+K  NILLD +M+ R++DFG S      +   
Sbjct: 201 ETRSIMRSLLEAVSFLHANNI---VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR 257
Query: 271 NIRGTFGYLDPEYISTR------NFTKKSDVYSFGVLLFELIAGRSPL 312
            + GT GYL PE +          + K+ D+++ GV+LF L+AG  P 
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIXINKMLNHEN 65
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 123
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K      GT  Y+ PE
Sbjct: 124 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPE 176
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 123
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K    + GT  Y+ PE
Sbjct: 124 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK----MXGTLPYVAPE 176
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIXINKMLNHEN 66
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 124
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K    + GT  Y+ PE
Sbjct: 125 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK----MXGTLPYVAPE 177
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 66
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 124
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K      GT  Y+ PE
Sbjct: 125 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPE 177
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 66
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 124
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K      GT  Y+ PE
Sbjct: 125 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPE 177
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 66
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 124
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K      GT  Y+ PE
Sbjct: 125 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPE 177
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 66
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 124
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K      GT  Y+ PE
Sbjct: 125 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPE 177
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 123
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K      GT  Y+ PE
Sbjct: 124 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPE 176
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 123
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K      GT  Y+ PE
Sbjct: 124 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPE 176
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 123
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K      GT  Y+ PE
Sbjct: 124 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPE 176
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 9   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 123
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K      GT  Y+ PE
Sbjct: 124 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPE 176
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA+G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 66
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 124
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K      GT  Y+ PE
Sbjct: 125 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPE 177
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEK---EFQTEVMLLGRLHHRNLVNLV 174
           ++G G    V+ A+ +     VAVKVL  D  +       F+ E      L+H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 175 GYC-AEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
               AE     L Y+ M      +L   ++ E  GP+T    + +  D  + L + H   
Sbjct: 79  ATGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG 136
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSRE-----EMVDKHAANIRGTFGYLDPEYIS 285
           +   IHRD+K +NI++  +   +V DFG++R        V + AA I GT  YL PE   
Sbjct: 137 I---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPEQAR 192
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
             +   +SDVYS G +L+E++ G  P  G
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 13/217 (5%)
Query: 105 SYKDLQKATCNFTTL--IGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTE 158
           S  D Q    N+  L  IG+G F  V  A+ + TG  VA+K++     +    +K F+ E
Sbjct: 6   SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-E 64
Query: 159 VMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALD 218
           V ++  L+H N+V L      +    L+  + S G +  +L    +G +           
Sbjct: 65  VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV--AHGRMKEKEARSKFRQ 122
Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY 278
           +   ++Y H   +   +HRD+K+ N+LLD  M  ++ADFG S E  V        G   Y
Sbjct: 123 IVSAVQYCHQKRI---VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPY 179
Query: 279 LDPEYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQG 314
             PE    + +   + DV+S GV+L+ L++G  P  G
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 41/271 (15%)
Query: 120 IGQGAFG-PVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG+G+FG  +       G    +K +     S +  +E + EV +L  + H N+V     
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 177 CAEKGQHMLVYVFMSKGSLASH-------LYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
             E G   +V  +   G L          L+ E+   L W +++ +AL      +++HD 
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED-QILDWFVQICLAL------KHVHDR 144
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTR 287
            +   +HRDIKS NI L +    ++ DFG++R     V+   A I GT  YL PE    +
Sbjct: 145 KI---LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENK 200
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
            +  KSD+++ G +L+EL         L    E  +M        + +V   + G F   
Sbjct: 201 PYNNKSDIWALGCVLYELCT-------LKHAFEAGSM--------KNLVLKIISGSFPPV 245
Query: 348 ELN---EVASLAYKCVNRAPRKRPSMRDIVQ 375
            L+   ++ SL  +   R PR RPS+  I++
Sbjct: 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 120 IGQGAFGPVYKAQMST-GETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           +G+GAF  V +    T  +  A K++ T   S +  ++ + E  +   L H N+V L   
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
            +E+G H LV+  ++ G L   +   E Y     +  +H  L+    + + HD     ++
Sbjct: 99  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHI-HQHD-----IV 152
Query: 236 HRDIKSSNILLDQSMR---ARVADFGLSREEMVDKHAA-NIRGTFGYLDPEYISTRNFTK 291
           HRD+K  N+LL    +    ++ADFGL+ E   ++ A     GT GYL PE +    + K
Sbjct: 153 HRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGK 212
Query: 292 KSDVYSFGVLLFELIAGRSPL 312
             D+++ GV+L+ L+ G  P 
Sbjct: 213 PVDIWACGVILYILLVGYPPF 233

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 7/195 (3%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +G G  G V K Q   +G  +A K++  + K     +   E+ +L   +   +V   G  
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 83
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
              G+  +    M  GSL   L +    P     +V IA  V RGL YL +     ++HR
Sbjct: 84  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQ--IMHR 139
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
           D+K SNIL++     ++ DFG+S + ++D  A +  GT  Y+ PE +   +++ +SD++S
Sbjct: 140 DVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMAPERLQGTHYSVQSDIWS 198
Query: 298 FGVLLFELIAGRSPL 312
            G+ L EL  GR P+
Sbjct: 199 MGLSLVELAVGRYPI 213

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEK---EFQTEVMLLGRLHHRNLVNLV 174
           ++G G    V+ A+ +     VAVKVL  D  +       F+ E      L+H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 175 GYC-AEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
               AE     L Y+ M      +L   ++ E  GP+T    + +  D  + L + H   
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG 136
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSRE-----EMVDKHAANIRGTFGYLDPEYIS 285
           +   IHRD+K +NI++  +   +V DFG++R        V + AA I GT  YL PE   
Sbjct: 137 I---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPEQAR 192
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
             +   +SDVYS G +L+E++ G  P  G
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 86/178 (48%), Gaps = 15/178 (8%)
Query: 154 EFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV 213
           +F+ E+ ++  + +   +   G      +  ++Y +M   S+    +DE +  L  N   
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILK--FDEYFFVLDKNYTC 146
Query: 214 HIALDVAR--------GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV 265
            I + V +           Y+H+     + HRD+K SNIL+D++ R +++DFG S E MV
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGES-EYMV 203
Query: 266 DKHAANIRGTFGYLDPEYISTRNFTK--KSDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
           DK     RGT+ ++ PE+ S  +     K D++S G+ L+ +     P    +  VEL
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 116/261 (44%), Gaps = 27/261 (10%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVL---ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           +G G FG V   +   TG  VAVK+L      S     + + E+  L    H +++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
             +      +V  ++S G L  ++     G L       +   +  G++Y H   V   +
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMV---V 138
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT-KKSD 294
           HRD+K  N+LLD  M A++ADFGLS      +      G+  Y  PE IS R +   + D
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVD 198
Query: 295 VYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE-LN-EV 352
           ++S GV+L+ L+ G  P             +    T +++I     DGIF   + LN  V
Sbjct: 199 IWSSGVILYALLCGTLPFD-----------DDHVPTLFKKIC----DGIFYTPQYLNPSV 243
Query: 353 ASLAYKCVNRAPRKRPSMRDI 373
            SL    +   P KR +++DI
Sbjct: 244 ISLLKHMLQVDPMKRATIKDI 264

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEK---EFQTEVMLLGRLHHRNLVNLV 174
           ++G G    V+ A+ +     VAVKVL  D  +       F+ E      L+H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 175 GYC-AEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
               AE     L Y+ M      +L   ++ E  GP+T    + +  D  + L + H   
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG 136
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSRE-----EMVDKHAANIRGTFGYLDPEYIS 285
           +   IHRD+K +NI++  +   +V DFG++R        V + AA I GT  YL PE   
Sbjct: 137 I---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPEQAR 192
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
             +   +SDVYS G +L+E++ G  P  G
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETV-AVKVL---ATDSKQGEKEFQTE-VMLLGRLHHRN 169
           +F  +IG+G+FG V  A+    E   AVKVL   A   K+ EK   +E  +LL  + H  
Sbjct: 41  HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           LV L        +   V  +++ G L  HL  E    L    R + A ++A  L YLH  
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCF-LEPRARFYAA-EIASALGYLHSL 158
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPEYISTRN 288
            +   ++RD+K  NILLD      + DFGL +E +  +   +   GT  YL PE +  + 
Sbjct: 159 NI---VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP 215
Query: 289 FTKKSDVYSFGVLLFELIAGRSPL 312
           + +  D +  G +L+E++ G  P 
Sbjct: 216 YDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEK---EFQTEVMLLGRLHHRNLVNLV 174
           ++G G    V+ A+ +     VAVKVL  D  +       F+ E      L+H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 175 GYC-AEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
               AE     L Y+ M      +L   ++ E  GP+T    + +  D  + L + H   
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG 136
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSRE-----EMVDKHAANIRGTFGYLDPEYIS 285
           +   IHRD+K +NI++  +   +V DFG++R        V + AA I GT  YL PE   
Sbjct: 137 I---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPEQAR 192
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
             +   +SDVYS G +L+E++ G  P  G
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           IG G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +VADFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---T 157
           PE  + DL++        IG G+FG VY A+ +   E VA+K ++   KQ  +++Q    
Sbjct: 13  PEKLFSDLRE--------IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL 217
           EV  L +L H N +   G C  +     + +    GS AS L + +  PL       +  
Sbjct: 65  EVRFLQKLRHPNTIQYRG-CYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTH 122
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
              +GL YLH   +   IHRD+K+ NILL +    ++ DFG +    +   A    GT  
Sbjct: 123 GALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSAS---IMAPANXFVGTPY 176
Query: 278 YLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPL 312
           ++ PE I   +   +  K DV+S G+   EL   + PL
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---T 157
           PE  + DL++        IG G+FG VY A+ +   E VA+K ++   KQ  +++Q    
Sbjct: 52  PEKLFSDLRE--------IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 103
Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL 217
           EV  L +L H N +   G C  +     + +    GS AS L + +  PL       +  
Sbjct: 104 EVRFLQKLRHPNTIQYRG-CYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTH 161
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
              +GL YLH   +   IHRD+K+ NILL +    ++ DFG +    +   A    GT  
Sbjct: 162 GALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSAS---IMAPANXFVGTPY 215
Query: 278 YLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPL 312
           ++ PE I   +   +  K DV+S G+   EL   + PL
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 121/287 (42%), Gaps = 32/287 (11%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           LIG+G FG VY  +      + +  +  D++   K F+ EVM   +  H N+V  +G C 
Sbjct: 40  LIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
               H+ +   + KG     +  +    L  N    IA ++ +G+ YLH      ++H+D
Sbjct: 100 SP-PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 239 IKSSNILLDQSMRARVADFGL---SREEMVDKHAANIR---GTFGYLDPEYISTRN---- 288
           +KS N+  D   +  + DFGL   S      +    +R   G   +L PE I   +    
Sbjct: 156 LKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 289 -----FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI 343
                F+K SDV++ G + +EL A   P +       +  M T  K    +I   +    
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK---- 270
Query: 344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHH 390
                  E++ +   C      +RP+   ++ +L ++ K R+ R  H
Sbjct: 271 -------EISDILLFCWAFEQEERPTFTKLMDMLEKLPK-RNRRLSH 309

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 111/226 (49%), Gaps = 28/226 (12%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGY 176
           IGQG FG V+KA+   TG+ VA+K VL  + K+G       E+ +L  L H N+VNL+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 177 CAEKGQHMLVYVFMSKGS--LASHLYDENYGPLTWNLRVHIALD--------VARGLEYL 226
           C  K           KGS  L     + +   L  N+ V   L         +  GL Y+
Sbjct: 86  CRTKASPY----NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 141
Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG-----TFGYLDP 281
           H   +   +HRD+K++N+L+ +    ++ADFGL+R   + K++   R      T  Y  P
Sbjct: 142 HRNKI---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 282 E-YISTRNFTKKSDVYSFGVLLFELIAGRSP-LQGLMEYVELAAMN 325
           E  +  R++    D++  G ++ E+   RSP +QG  E  +LA ++
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALIS 243

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 115/261 (44%), Gaps = 27/261 (10%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVL---ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           +G G FG V   +   TG  VAVK+L      S     + + E+  L    H +++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
             +      +V  ++S G L    Y   +G +       +   +   ++Y H   V   +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFD--YICKHGRVEEMEARRLFQQILSAVDYCHRHMV---V 133
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT-KKSD 294
           HRD+K  N+LLD  M A++ADFGLS      +   +  G+  Y  PE IS R +   + D
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVD 193
Query: 295 VYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE-LNE-V 352
           ++S GV+L+ L+ G  P     E+V        G             G+F + E LN  V
Sbjct: 194 IWSCGVILYALLCGTLPFDD--EHVPTLFKKIRG-------------GVFYIPEYLNRSV 238
Query: 353 ASLAYKCVNRAPRKRPSMRDI 373
           A+L    +   P KR +++DI
Sbjct: 239 ATLLMHMLQVDPLKRATIKDI 259

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 120/260 (46%), Gaps = 20/260 (7%)
Query: 120 IGQGAFGPVYK-AQMSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +G G  G V+K +   +G  +A K++  + K     +   E+ +L   +   +V   G  
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
              G+  +    M  GSL   L  +  G +   +   +++ V +GL YL +     ++HR
Sbjct: 93  YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 148
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
           D+K SNIL++     ++ DFG+S + ++D  A +  GT  Y+ PE +   +++ +SD++S
Sbjct: 149 DVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 207
Query: 298 FGVLLFELIAGRSPL---QGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVAS 354
            G+ L E+  GR P+    G M   EL            E       G+F +    E   
Sbjct: 208 MGLSLVEMAVGRYPIGSGSGSMAIFELLDYIV------NEPPPKLPSGVFSL----EFQD 257
Query: 355 LAYKCVNRAPRKRPSMRDIV 374
              KC+ + P +R  ++ ++
Sbjct: 258 FVNKCLIKNPAERADLKQLM 277

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 17/220 (7%)
Query: 120 IGQGAFGPVYKA--QMSTGETVAVKVLATDSKQG---EKEFQTEVMLLGRLHHRNLVNLV 174
           +G G FG V K   QM          +  +       + E   E  ++ +L +  +V ++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E    MLV      G L  +L  +N      N+ + +   V+ G++YL +      
Sbjct: 438 GIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNI-IELVHQVSMGMKYLEESNF--- 491
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANIRGTF--GYLDPEYISTRNFT 290
           +HRD+ + N+LL     A+++DFGLS+    D+  + A   G +   +  PE I+   F+
Sbjct: 492 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 551
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
            KSDV+SFGVL++E  + G+ P +G M+  E+ AM  +G+
Sbjct: 552 SKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGE 590

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRN 169
           +    +G+GA G V  A    T E VAVK++    A D  +  K+   E+ +   L+H N
Sbjct: 9   DLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 65
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V   G+  E     L   + S G L   +  +   P     R    L    G+ YLH  
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL--MAGVVYLHGI 123
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLS-------REEMVDKHAANIRGTFGYLDPE 282
            +    HRDIK  N+LLD+    +++DFGL+       RE +++K      GT  Y+ PE
Sbjct: 124 GI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPE 176
Query: 283 YISTRNF-TKKSDVYSFGVLLFELIAGRSP 311
            +  R F  +  DV+S G++L  ++AG  P
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           NF   IG+G+ G V  A + S+G+ VAVK +    +Q  +    EV+++    H N+V +
Sbjct: 35  NFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM 93
Query: 174 VGYCAEKGQHMLVYVFMSKGSLA-----SHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
                   +  +V  F+  G+L      + + +E            + L V + L  LH 
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--------AVCLAVLQALSVLHA 145
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN---IRGTFGYLDPEYIS 285
             V   IHRDIKS +ILL    R +++DFG   +  V K       + GT  ++ PE IS
Sbjct: 146 QGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELIS 200
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSP 311
              +  + D++S G+++ E++ G  P
Sbjct: 201 RLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEK---EFQTEVMLLGRLHHRNLVNLV 174
           ++G G    V+ A+ +     VAVKVL  D  +       F+ E      L+H  +V + 
Sbjct: 36  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 95
Query: 175 GYC-AEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
               AE     L Y+ M      +L   ++ E  GP+T    + +  D  + L + H   
Sbjct: 96  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG 153
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSRE-----EMVDKHAANIRGTFGYLDPEYIS 285
           +   IHRD+K +NI++  +   +V DFG++R        V + AA I GT  YL PE   
Sbjct: 154 I---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPEQAR 209
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
             +   +SDVYS G +L+E++ G  P  G
Sbjct: 210 GDSVDARSDVYSLGCVLYEVLTGEPPFTG 238

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           NF   IG+G+ G V  A + S+G+ VAVK +    +Q  +    EV+++    H N+V +
Sbjct: 33  NFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM 91
Query: 174 VGYCAEKGQHMLVYVFMSKGSLA-----SHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
                   +  +V  F+  G+L      + + +E            + L V + L  LH 
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--------AVCLAVLQALSVLHA 143
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN---IRGTFGYLDPEYIS 285
             V   IHRDIKS +ILL    R +++DFG   +  V K       + GT  ++ PE IS
Sbjct: 144 QGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELIS 198
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSP 311
              +  + D++S G+++ E++ G  P
Sbjct: 199 RLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 17/220 (7%)
Query: 120 IGQGAFGPVYKA--QMSTGETVAVKVLATDSKQG---EKEFQTEVMLLGRLHHRNLVNLV 174
           +G G FG V K   QM          +  +       + E   E  ++ +L +  +V ++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E    MLV      G L  +L  +N      N+ + +   V+ G++YL +      
Sbjct: 437 GIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNI-IELVHQVSMGMKYLEESNF--- 490
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANIRGTF--GYLDPEYISTRNFT 290
           +HRD+ + N+LL     A+++DFGLS+    D+  + A   G +   +  PE I+   F+
Sbjct: 491 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 550
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
            KSDV+SFGVL++E  + G+ P +G M+  E+ AM  +G+
Sbjct: 551 SKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGE 589

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 120 IGQGAFGPVYK-AQMSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +G G  G V+K +   +G  +A K++  + K     +   E+ +L   +   +V   G  
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 135
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
              G+  +    M  GSL   L  +  G +   +   +++ V +GL YL +     ++HR
Sbjct: 136 YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHR 191
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
           D+K SNIL++     ++ DFG+S + ++D  A +  GT  Y+ PE +   +++ +SD++S
Sbjct: 192 DVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 250
Query: 298 FGVLLFELIAGRSPL 312
            G+ L E+  GR P+
Sbjct: 251 MGLSLVEMAVGRYPI 265

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           NF   IG+G+ G V  A + S+G+ VAVK +    +Q  +    EV+++    H N+V +
Sbjct: 24  NFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM 82
Query: 174 VGYCAEKGQHMLVYVFMSKGSLA-----SHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
                   +  +V  F+  G+L      + + +E            + L V + L  LH 
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--------AVCLAVLQALSVLHA 134
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN---IRGTFGYLDPEYIS 285
             V   IHRDIKS +ILL    R +++DFG   +  V K       + GT  ++ PE IS
Sbjct: 135 QGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELIS 189
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSP 311
              +  + D++S G+++ E++ G  P
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 111/240 (46%), Gaps = 31/240 (12%)
Query: 82  GKSMWLEGFKRS-NVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM-STGETV 139
           G  M  E F+ +  +V   G P  SY D      NF   IG+G+ G V  A + S+G+ V
Sbjct: 1   GSHMSHEQFRAALQLVVDPGDPR-SYLD------NFIK-IGEGSTGIVCIATVRSSGKLV 52
Query: 140 AVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLA--- 196
           AVK +    +Q  +    EV+++    H N+V +        +  +V  F+  G+L    
Sbjct: 53  AVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV 112
Query: 197 --SHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV 254
             + + +E            + L V + L  LH   V   IHRDIKS +ILL    R ++
Sbjct: 113 THTRMNEEQIA--------AVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKL 161
Query: 255 ADFGLSREEMVDKHAAN---IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
           +DFG   +  V K       + GT  ++ PE IS   +  + D++S G+++ E++ G  P
Sbjct: 162 SDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 119 LIGQGAFGPVYKAQ----MSTGETVAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNL 170
           ++G+G +G V++ +     +TG+  A+KVL       + +     + E  +L  + H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           V+L+      G+  L+  ++S G L   L  E  G    +       +++  L +LH   
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRNF 289
           +   I+RD+K  NI+L+     ++ DFGL +E + D    +   GT  Y+ PE +     
Sbjct: 142 I---IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGH 198
Query: 290 TKKSDVYSFGVLLFELIAGRSPLQG 314
            +  D +S G L+++++ G  P  G
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTG 223

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 114/261 (43%), Gaps = 27/261 (10%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVL---ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           +G G FG V   +   TG  VAVK+L      S     + + E+  L    H +++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
             +      +V  ++S G L    Y   +G +       +   +   ++Y H   V   +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFD--YICKHGRVEEMEARRLFQQILSAVDYCHRHMV---V 133
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT-KKSD 294
           HRD+K  N+LLD  M A++ADFGLS      +      G+  Y  PE IS R +   + D
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVD 193
Query: 295 VYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE-LNE-V 352
           ++S GV+L+ L+ G  P     E+V        G             G+F + E LN  V
Sbjct: 194 IWSCGVILYALLCGTLPFDD--EHVPTLFKKIRG-------------GVFYIPEYLNRSV 238
Query: 353 ASLAYKCVNRAPRKRPSMRDI 373
           A+L    +   P KR +++DI
Sbjct: 239 ATLLMHMLQVDPLKRATIKDI 259

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 111/226 (49%), Gaps = 28/226 (12%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGY 176
           IGQG FG V+KA+   TG+ VA+K VL  + K+G       E+ +L  L H N+VNL+  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 177 CAEKGQHMLVYVFMSKGS--LASHLYDENYGPLTWNLRVHIALD--------VARGLEYL 226
           C  K           KGS  L     + +   L  N+ V   L         +  GL Y+
Sbjct: 85  CRTKASP----YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 140
Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDP 281
           H   +   +HRD+K++N+L+ +    ++ADFGL+R   + K++   R      T  Y  P
Sbjct: 141 HRNKI---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 282 E-YISTRNFTKKSDVYSFGVLLFELIAGRSP-LQGLMEYVELAAMN 325
           E  +  R++    D++  G ++ E+   RSP +QG  E  +LA ++
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALIS 242

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 111/226 (49%), Gaps = 28/226 (12%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGY 176
           IGQG FG V+KA+   TG+ VA+K VL  + K+G       E+ +L  L H N+VNL+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 177 CAEKGQHMLVYVFMSKGS--LASHLYDENYGPLTWNLRVHIALD--------VARGLEYL 226
           C  K           KGS  L     + +   L  N+ V   L         +  GL Y+
Sbjct: 86  CRTKASPY----NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 141
Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDP 281
           H   +   +HRD+K++N+L+ +    ++ADFGL+R   + K++   R      T  Y  P
Sbjct: 142 HRNKI---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 282 E-YISTRNFTKKSDVYSFGVLLFELIAGRSP-LQGLMEYVELAAMN 325
           E  +  R++    D++  G ++ E+   RSP +QG  E  +LA ++
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALIS 243

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 119 LIGQGAFGPVYKAQ----MSTGETVAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNL 170
           ++G+G +G V++ +     +TG+  A+KVL       + +     + E  +L  + H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           V+L+      G+  L+  ++S G L   L  E  G    +       +++  L +LH   
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRNF 289
           +   I+RD+K  NI+L+     ++ DFGL +E + D    +   GT  Y+ PE +     
Sbjct: 142 I---IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH 198
Query: 290 TKKSDVYSFGVLLFELIAGRSPLQG 314
            +  D +S G L+++++ G  P  G
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTG 223

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 110/224 (49%), Gaps = 36/224 (16%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLA---TDSKQGEKEFQTEVMLLGRLH-HRNLVNLV 174
           +G+GA+G V+K+    TGE VAVK +     +S   ++ F+ E+M+L  L  H N+VNL+
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 175 GYCAEKGQHMLVYVF-MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                     +  VF   +  L + +      P+    + ++   + + ++YLH G +  
Sbjct: 76  NVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH---KQYVVYQLIKVIKYLHSGGL-- 130
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANI-----RGTFGYLDPE----- 282
            +HRD+K SNILL+     +VADFGLSR  + + +   NI       T  + D +     
Sbjct: 131 -LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 283 YISTR------------NFTKKSDVYSFGVLLFELIAGRSPLQG 314
           Y++TR             +TK  D++S G +L E++ G+    G
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 118/259 (45%), Gaps = 36/259 (13%)
Query: 63  LSDSTVGPESPVKSGRNGNGKSMWLEGFKRS-NVVSASGIPEYSYKDLQKATCNFTTLIG 121
           + +   GP SP +  +  +      E F+ +  +V   G P  SY D      NF   IG
Sbjct: 37  MPEKPPGPRSPQREPQRVSH-----EQFRAALQLVVDPGDPR-SYLD------NFIK-IG 83
Query: 122 QGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK 180
           +G+ G V  A + S+G+ VAVK +    +Q  +    EV+++    H N+V +       
Sbjct: 84  EGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG 143
Query: 181 GQHMLVYVFMSKGSLA-----SHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
            +  +V  F+  G+L      + + +E            + L V + L  LH   V   I
Sbjct: 144 DELWVVMEFLEGGALTDIVTHTRMNEEQIA--------AVCLAVLQALSVLHAQGV---I 192
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN---IRGTFGYLDPEYISTRNFTKK 292
           HRDIKS +ILL    R +++DFG   +  V K       + GT  ++ PE IS   +  +
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPYGPE 250
Query: 293 SDVYSFGVLLFELIAGRSP 311
            D++S G+++ E++ G  P
Sbjct: 251 VDIWSLGIMVIEMVDGEPP 269

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLA-TDSKQGEKEFQTEVMLLGRLHH-RNLVNLVGY 176
           +G G  G V+K +   TG  +AVK +  + +K+  K    ++ ++ + H    +V   G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                   +    M  G+ A  L     GP+   +   + + + + L YL +     VIH
Sbjct: 93  FITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH--GVIH 148
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTK----- 291
           RD+K SNILLD+  + ++ DFG+S   + DK      G   Y+ PE I   + TK     
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDI 208
Query: 292 KSDVYSFGVLLFELIAGRSPLQ 313
           ++DV+S G+ L EL  G+ P +
Sbjct: 209 RADVWSLGISLVELATGQFPYK 230

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 120 IGQGAFGPVYK-AQMSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +G G  G V+K +   +G  +A K++  + K     +   E+ +L   +   +V   G  
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
              G+  +    M  GSL   L  +  G +   +   +++ V +GL YL +     ++HR
Sbjct: 101 YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 156
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
           D+K SNIL++     ++ DFG+S + ++D  A +  GT  Y+ PE +   +++ +SD++S
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 215
Query: 298 FGVLLFELIAGRSPL 312
            G+ L E+  GR P+
Sbjct: 216 MGLSLVEMAVGRYPI 230

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 17/220 (7%)
Query: 120 IGQGAFGPVYKA--QMSTGETVAVKVLATDSKQG---EKEFQTEVMLLGRLHHRNLVNLV 174
           +G G FG V K   QM          +  +       + E   E  ++ +L +  +V ++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E    MLV      G L  +L  +N      N+ + +   V+ G++YL +      
Sbjct: 93  GIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNI-IELVHQVSMGMKYLEESNF--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANIRGTF--GYLDPEYISTRNFT 290
           +HRD+ + N+LL     A+++DFGLS+    D+  + A   G +   +  PE I+   F+
Sbjct: 147 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 206
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
            KSDV+SFGVL++E  + G+ P +G M+  E+ AM  +G+
Sbjct: 207 SKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGE 245

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 17/220 (7%)
Query: 120 IGQGAFGPVYKA--QMSTGETVAVKVLATDSKQG---EKEFQTEVMLLGRLHHRNLVNLV 174
           +G G FG V K   QM          +  +       + E   E  ++ +L +  +V ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E    MLV      G L  +L  +N      N+ + +   V+ G++YL +      
Sbjct: 95  GIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNI-IELVHQVSMGMKYLEESNF--- 148
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANIRGTF--GYLDPEYISTRNFT 290
           +HRD+ + N+LL     A+++DFGLS+    D+  + A   G +   +  PE I+   F+
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
            KSDV+SFGVL++E  + G+ P +G M+  E+ AM  +G+
Sbjct: 209 SKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGE 247

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 17/220 (7%)
Query: 120 IGQGAFGPVYKA--QMSTGETVAVKVLATDSKQG---EKEFQTEVMLLGRLHHRNLVNLV 174
           +G G FG V K   QM          +  +       + E   E  ++ +L +  +V ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E    MLV      G L  +L  +N      N+ + +   V+ G++YL +      
Sbjct: 95  GIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNI-IELVHQVSMGMKYLEESNF--- 148
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANIRGTF--GYLDPEYISTRNFT 290
           +HRD+ + N+LL     A+++DFGLS+    D+  + A   G +   +  PE I+   F+
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
            KSDV+SFGVL++E  + G+ P +G M+  E+ AM  +G+
Sbjct: 209 SKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGE 247

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 120 IGQGAFGPVYK-AQMSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +G G  G V+K +   +G  +A K++  + K     +   E+ +L   +   +V   G  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
              G+  +    M  GSL   L  +  G +   +   +++ V +GL YL +     ++HR
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
           D+K SNIL++     ++ DFG+S + ++D  A +  GT  Y+ PE +   +++ +SD++S
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 188
Query: 298 FGVLLFELIAGRSPL 312
            G+ L E+  GR P+
Sbjct: 189 MGLSLVEMAVGRYPI 203

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 17/220 (7%)
Query: 120 IGQGAFGPVYKA--QMSTGETVAVKVLATDSKQG---EKEFQTEVMLLGRLHHRNLVNLV 174
           +G G FG V K   QM          +  +       + E   E  ++ +L +  +V ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E    MLV      G L  +L  +N      N+ + +   V+ G++YL +      
Sbjct: 79  GIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNI-IELVHQVSMGMKYLEESNF--- 132
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANIRGTF--GYLDPEYISTRNFT 290
           +HRD+ + N+LL     A+++DFGLS+    D+  + A   G +   +  PE I+   F+
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
            KSDV+SFGVL++E  + G+ P +G M+  E+ AM  +G+
Sbjct: 193 SKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGE 231

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 120 IGQGAFGPVYK-AQMSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +G G  G V+K +   +G  +A K++  + K     +   E+ +L   +   +V   G  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
              G+  +    M  GSL   L  +  G +   +   +++ V +GL YL +     ++HR
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
           D+K SNIL++     ++ DFG+S + ++D  A +  GT  Y+ PE +   +++ +SD++S
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 188
Query: 298 FGVLLFELIAGRSPL 312
            G+ L E+  GR P+
Sbjct: 189 MGLSLVEMAVGRYPI 203

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 17/220 (7%)
Query: 120 IGQGAFGPVYKA--QMSTGETVAVKVLATDSKQG---EKEFQTEVMLLGRLHHRNLVNLV 174
           +G G FG V K   QM          +  +       + E   E  ++ +L +  +V ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E    MLV      G L  +L  +N      N+ + +   V+ G++YL +      
Sbjct: 79  GIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNI-IELVHQVSMGMKYLEESNF--- 132
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANIRGTF--GYLDPEYISTRNFT 290
           +HRD+ + N+LL     A+++DFGLS+    D+  + A   G +   +  PE I+   F+
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
            KSDV+SFGVL++E  + G+ P +G M+  E+ AM  +G+
Sbjct: 193 SKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGE 231

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 120 IGQGAFGPVYK-AQMSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +G G  G V+K +   +G  +A K++  + K     +   E+ +L   +   +V   G  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
              G+  +    M  GSL   L  +  G +   +   +++ V +GL YL +     ++HR
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
           D+K SNIL++     ++ DFG+S + ++D  A +  GT  Y+ PE +   +++ +SD++S
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 188
Query: 298 FGVLLFELIAGRSPL 312
            G+ L E+  GR P+
Sbjct: 189 MGLSLVEMAVGRYPI 203

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 17/220 (7%)
Query: 120 IGQGAFGPVYKA--QMSTGETVAVKVLATDSKQG---EKEFQTEVMLLGRLHHRNLVNLV 174
           +G G FG V K   QM          +  +       + E   E  ++ +L +  +V ++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E    MLV      G L  +L  +N      N+ + +   V+ G++YL +      
Sbjct: 75  GIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNI-IELVHQVSMGMKYLEESNF--- 128
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANIRGTF--GYLDPEYISTRNFT 290
           +HRD+ + N+LL     A+++DFGLS+    D+  + A   G +   +  PE I+   F+
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
            KSDV+SFGVL++E  + G+ P +G M+  E+ AM  +G+
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGE 227

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 17/220 (7%)
Query: 120 IGQGAFGPVYKA--QMSTGETVAVKVLATDSKQG---EKEFQTEVMLLGRLHHRNLVNLV 174
           +G G FG V K   QM          +  +       + E   E  ++ +L +  +V ++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E    MLV      G L  +L  +N      N+ + +   V+ G++YL +      
Sbjct: 85  GIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNI-IELVHQVSMGMKYLEESNF--- 138
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANIRGTF--GYLDPEYISTRNFT 290
           +HRD+ + N+LL     A+++DFGLS+    D+  + A   G +   +  PE I+   F+
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
            KSDV+SFGVL++E  + G+ P +G M+  E+ AM  +G+
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGE 237

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 10/203 (4%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
           ++  L+G+G FG V    + +TG   A+K+L  +    + E     TE  +L    H  L
Sbjct: 11  DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 70
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
             L        +   V  + + G L  HL  E     T         ++   LEYLH   
Sbjct: 71  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRD 128
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTRNF 289
           V   ++RDIK  N++LD+    ++ DFGL +E + D        GT  YL PE +   ++
Sbjct: 129 V---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 185
Query: 290 TKKSDVYSFGVLLFELIAGRSPL 312
            +  D +  GV+++E++ GR P 
Sbjct: 186 GRAVDWWGLGVVMYEMMCGRLPF 208

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 17/220 (7%)
Query: 120 IGQGAFGPVYKA--QMSTGETVAVKVLATDSKQG---EKEFQTEVMLLGRLHHRNLVNLV 174
           +G G FG V K   QM          +  +       + E   E  ++ +L +  +V ++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E    MLV      G L  +L  +N      N+ + +   V+ G++YL +      
Sbjct: 73  GIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNI-IELVHQVSMGMKYLEESNF--- 126
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANIRGTF--GYLDPEYISTRNFT 290
           +HRD+ + N+LL     A+++DFGLS+    D+  + A   G +   +  PE I+   F+
Sbjct: 127 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 186
Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
            KSDV+SFGVL++E  + G+ P +G M+  E+ AM  +G+
Sbjct: 187 SKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGE 225

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 124/274 (45%), Gaps = 41/274 (14%)
Query: 116 FTTL--IGQGAFGPVYKA-QMSTGETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLV 171
           FT L  IG+G+FG V+K     T + VA+K++   +++   ++ Q E+ +L +     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
              G   +  +  ++  ++  GS    L     GP        +  ++ +GL+YLH    
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLL---RAGPFDEFQIATMLKEILKGLDYLHSEKK 141
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA--NIRGTFGYLDPEYISTRNF 289
              IHRDIK++N+LL +    ++ADFG++  ++ D         GT  ++ PE I    +
Sbjct: 142 ---IHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIQQSAY 197
Query: 290 TKKSDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMNT------EGKTGWEEIVDSRLD 341
             K+D++S G+   EL  G  P   +  M  + L   N       +    ++E +D+   
Sbjct: 198 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDA--- 254
Query: 342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                            C+N+ P  RP+ +++++
Sbjct: 255 -----------------CLNKDPSFRPTAKELLK 271

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 10/203 (4%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
           ++  L+G+G FG V    + +TG   A+K+L  +    + E     TE  +L    H  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
             L        +   V  + + G L  HL  E     T         ++   LEYLH   
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRD 125
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTRNF 289
           V   ++RDIK  N++LD+    ++ DFGL +E + D        GT  YL PE +   ++
Sbjct: 126 V---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 290 TKKSDVYSFGVLLFELIAGRSPL 312
            +  D +  GV+++E++ GR P 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 120 IGQGAFGPVYK-AQMSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +G G  G V+K +   +G  +A K++  + K     +   E+ +L   +   +V   G  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
              G+  +    M  GSL   L  +  G +   +   +++ V +GL YL +     ++HR
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
           D+K SNIL++     ++ DFG+S + ++D  A +  GT  Y+ PE +   +++ +SD++S
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 188
Query: 298 FGVLLFELIAGRSPL 312
            G+ L E+  GR P+
Sbjct: 189 MGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 7/195 (3%)
Query: 120 IGQGAFGPVYK-AQMSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +G G  G V+K +   +G  +A K++  + K     +   E+ +L   +   +V   G  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
              G+  +    M  GSL   L  +  G +   +   +++ V +GL YL +     ++HR
Sbjct: 74  YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
           D+K SNIL++     ++ DFG+S + ++D  A +  GT  Y+ PE +   +++ +SD++S
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 188
Query: 298 FGVLLFELIAGRSPL 312
            G+ L E+  GR P+
Sbjct: 189 MGLSLVEMAVGRYPI 203

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 10/203 (4%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
           ++  L+G+G FG V    + +TG   A+K+L  +    + E     TE  +L    H  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
             L        +   V  + + G L  HL  E     T         ++   LEYLH   
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRD 125
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTRNF 289
           V   ++RDIK  N++LD+    ++ DFGL +E + D        GT  YL PE +   ++
Sbjct: 126 V---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 290 TKKSDVYSFGVLLFELIAGRSPL 312
            +  D +  GV+++E++ GR P 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 120/264 (45%), Gaps = 31/264 (11%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLA----TDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  Q  TG+  A K +     + S++G   +E + EV +L  + H N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   +S G L   L ++    LT +        +  G+ YLH   + 
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIA 130
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++   R ++ DFG++ +        NI GT  ++ PE ++   
Sbjct: 131 ---HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP 187
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD-SRLDGIFDVE 347
              ++D++S GV+ + L++G SP                G+T  E + + S ++  FD E
Sbjct: 188 LGLEADMWSIGVITYILLSGASPFL--------------GETKQETLTNISAVNYDFDEE 233
Query: 348 ELNEVASLAYKCVNRAPRKRPSMR 371
             +  + LA   + R   K P  R
Sbjct: 234 YFSNTSELAKDFIRRLLVKDPKRR 257

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
           ++  L+G+G FG V    + +TG   A+K+L  +    + E     TE  +L    H  L
Sbjct: 13  DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 72
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
             L        +   V  + + G L  HL  E     T         ++   LEYLH   
Sbjct: 73  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRD 130
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLDPEYISTR 287
           V   ++RDIK  N++LD+    ++ DFGL +E + D   A ++   GT  YL PE +   
Sbjct: 131 V---VYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPEVLEDN 185
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPL 312
           ++ +  D +  GV+++E++ GR P 
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   + M TG   A+K+L        KE +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +   G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+++DQ    +V DFGL++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGLAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 12/200 (6%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           +G+GAF  V +  ++  G+  A  ++ T   S +  ++ + E  +   L H N+V L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
            +E+G H L++  ++ G L   +    Y   +     H    +   + + H   V   +H
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMGV---VH 133
Query: 237 RDIKSSNILLDQSMRA---RVADFGLSREEMVDKHAA-NIRGTFGYLDPEYISTRNFTKK 292
           R++K  N+LL   ++    ++ADFGL+ E   ++ A     GT GYL PE +    + K 
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKP 193
Query: 293 SDVYSFGVLLFELIAGRSPL 312
            D+++ GV+L+ L+ G  P 
Sbjct: 194 VDLWACGVILYILLVGYPPF 213

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
           ++  L+G+G FG V    + +TG   A+K+L  +    + E     TE  +L    H  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
             L        +   V  + + G L  HL  E     T         ++   LEYLH   
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRD 125
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLDPEYISTR 287
           V   ++RDIK  N++LD+    ++ DFGL +E + D   A ++   GT  YL PE +   
Sbjct: 126 V---VYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPEVLEDN 180
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPL 312
           ++ +  D +  GV+++E++ GR P 
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
           ++  L+G+G FG V    + +TG   A+K+L  +    + E     TE  +L    H  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
             L        +   V  + + G L  HL  E     T         ++   LEYLH   
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRD 125
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLDPEYISTR 287
           V   ++RDIK  N++LD+    ++ DFGL +E + D   A ++   GT  YL PE +   
Sbjct: 126 V---VYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPEVLEDN 180
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPL 312
           ++ +  D +  GV+++E++ GR P 
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 115 NFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
           ++  L+G+G FG V    + +TG   A+K+L  +    + E     TE  +L    H  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
             L        +   V  + + G L  HL  E     T         ++   LEYLH   
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRD 125
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLDPEYISTR 287
           V   ++RDIK  N++LD+    ++ DFGL +E + D   A ++   GT  YL PE +   
Sbjct: 126 V---VYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPEVLEDN 180
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPL 312
           ++ +  D +  GV+++E++ GR P 
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 108/218 (49%), Gaps = 26/218 (11%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA- 178
           +G+G +G V++  +  GE+VAVK+ ++  +Q     +TE+     L H N++  +     
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIASDMT 73
Query: 179 ---EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH-----DGA 230
                 Q  L+  +   GSL   L  +   P   +L + +A+  A GL +LH        
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFLQRQTLEP---HLALRLAVSAACGLAHLHVEIFGTQG 130
Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSR-----EEMVDKHAANIRGTFGYLDPEYIS 285
            P + HRD KS N+L+  +++  +AD GL+       + +D       GT  Y+ PE + 
Sbjct: 131 KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLD 190
Query: 286 TRNFT------KKSDVYSFGVLLFELIAGRSPLQGLME 317
            +  T      K +D+++FG++L+E IA R+ + G++E
Sbjct: 191 EQIRTDCFESYKWTDIWAFGLVLWE-IARRTIVNGIVE 227

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 120/264 (45%), Gaps = 31/264 (11%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLA----TDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  Q  TG+  A K +     + S++G   +E + EV +L  + H N++ 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   +S G L   L ++    LT +        +  G+ YLH   + 
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIA 137
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++   R ++ DFG++ +        NI GT  ++ PE ++   
Sbjct: 138 ---HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP 194
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD-SRLDGIFDVE 347
              ++D++S GV+ + L++G SP                G+T  E + + S ++  FD E
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFL--------------GETKQETLTNISAVNYDFDEE 240
Query: 348 ELNEVASLAYKCVNRAPRKRPSMR 371
             +  + LA   + R   K P  R
Sbjct: 241 YFSNTSELAKDFIRRLLVKDPKRR 264

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 131/285 (45%), Gaps = 30/285 (10%)
Query: 51  PIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQ 110
           P R    D    +   T   ESP         K ++L   KR N++ A         D++
Sbjct: 296 PARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFL---KRDNLLIA---------DIE 343
Query: 111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
               NF + + QG +  + K Q+     VA+KVL   +++ + +E   E  ++ +L +  
Sbjct: 344 LGCGNFGS-VRQGVYR-MRKKQID----VAIKVLKQGTEKADTEEMMREAQIMHQLDNPY 397
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V L+G C  +   MLV      G L   L  +       N+   +   V+ G++YL + 
Sbjct: 398 IVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYLEEK 455
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT----FGYLDPEYIS 285
                +HR++ + N+LL     A+++DFGLS+    D      R        +  PE I+
Sbjct: 456 NF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512
Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
            R F+ +SDV+S+GV ++E ++ G+ P +  M+  E+ A   +GK
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKK-MKGPEVMAFIEQGK 556

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   + M TG   A+K+L        KE +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +   G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+++DQ    +V DFGL++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLMIDQQGYIQVTDFGLAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 98/194 (50%), Gaps = 7/194 (3%)
Query: 120 IGQGAFGPVYK-AQMSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGYC 177
           +G G  G V+K +   +G  +A K++  + K     +   E+ +L   +   +V   G  
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
              G+  +    M  GSL   L  +  G +   +   +++ V +GL YL +     ++HR
Sbjct: 77  YSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 132
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
           D+K SNIL++     ++ DFG+S + ++D+ A    GT  Y+ PE +   +++ +SD++S
Sbjct: 133 DVKPSNILVNSRGEIKLCDFGVSGQ-LIDEMANEFVGTRSYMSPERLQGTHYSVQSDIWS 191
Query: 298 FGVLLFELIAGRSP 311
            G+ L E+  GR P
Sbjct: 192 MGLSLVEMAVGRYP 205

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 91/167 (54%), Gaps = 13/167 (7%)
Query: 152 EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF--MSKGSLASHLYDENYGPLTW 209
           E+ +Q E+ +L +L H N+V LV    +  +  L  VF  +++G +          PL+ 
Sbjct: 81  EQVYQ-EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---PTLKPLSE 136
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKH 268
           +       D+ +G+EYLH      +IHRDIK SN+L+ +    ++ADFG+S E +  D  
Sbjct: 137 DQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 269 AANIRGTFGYLDPEYIS-TRN-FTKKS-DVYSFGVLLFELIAGRSPL 312
            +N  GT  ++ PE +S TR  F+ K+ DV++ GV L+  + G+ P 
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 104/238 (43%), Gaps = 31/238 (13%)
Query: 89  GFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVL--A 145
           GF R  V   +      Y+DLQ         +G GA+G V  A    TG  VA+K L   
Sbjct: 10  GFYRQEVTKTAWEVRAVYRDLQP--------VGSGAYGAVCSAVDGRTGAKVAIKKLYRP 61
Query: 146 TDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA------EKGQHMLVYVFMSK--GSLAS 197
             S+   K    E+ LL  + H N++ L+          +     LV  FM    G L  
Sbjct: 62  FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK 121
Query: 198 HLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADF 257
           H   E  G       V+  L   +GL Y+H   +   IHRD+K  N+ +++    ++ DF
Sbjct: 122 H---EKLGEDRIQFLVYQML---KGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDF 172
Query: 258 GLSREEMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           GL+R+   D        T  Y  PE I +   +T+  D++S G ++ E+I G++  +G
Sbjct: 173 GLARQ--ADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 125/274 (45%), Gaps = 39/274 (14%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +       S++G   ++ + EV +L  + H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   ++ G L   L ++    LT          +  G+ YLH   + 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIA 136
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++   R ++ DFGL+ +        NI GT  ++ PE ++   
Sbjct: 137 ---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYEP 193
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA---AMNTEGKTGWEEIVDSRLDGIFD 345
              ++D++S GV+ + L++G SP  G  +   LA   A+N E                F+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----------------FE 237
Query: 346 VEELNEVASLAYKCVNRA----PRKRPSMRDIVQ 375
            E  +  ++LA   + R     P+KR +++D +Q
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVL-----ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
           +IG+GAF  V +     TG+  AVK++      +      ++ + E  +   L H ++V 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV--HIALDVARGLEYLHDGA 230
           L+   +  G   +V+ FM    L   +         ++  V  H    +   L Y HD  
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 231 VPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYIST 286
           +   IHRD+K  N+LL   + S   ++ DFG++ +       A  R GT  ++ PE +  
Sbjct: 151 I---IHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR 207
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
             + K  DV+  GV+LF L++G  P  G  E
Sbjct: 208 EPYGKPVDVWGCGVILFILLSGCLPFYGTKE 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 119/264 (45%), Gaps = 31/264 (11%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLA----TDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  Q  TG+  A K +       S++G   +E + EV +L  + H N++ 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   +S G L   L ++    LT +        +  G+ YLH   + 
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIA 151
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++   R ++ DFG++ +        NI GT  ++ PE ++   
Sbjct: 152 ---HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP 208
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD-SRLDGIFDVE 347
              ++D++S GV+ + L++G SP                G+T  E + + S ++  FD E
Sbjct: 209 LGLEADMWSIGVITYILLSGASPFL--------------GETKQETLTNISAVNYDFDEE 254
Query: 348 ELNEVASLAYKCVNRAPRKRPSMR 371
             +  + LA   + R   K P  R
Sbjct: 255 YFSNTSELAKDFIRRLLVKDPKRR 278

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G  +       A  +    EYLH      +I
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 164
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWTLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 108 DLQKATCNFTTL--IGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVML 161
           D Q    N+  L  IG+G F  V  A+ + TG+ VAVK++     +S   +K F+ EV +
Sbjct: 8   DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRI 66
Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
              L+H N+V L      +    LV  + S G +  +L    +G             +  
Sbjct: 67  XKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLV--AHGRXKEKEARAKFRQIVS 124
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
            ++Y H   +   +HRD+K+ N+LLD     ++ADFG S E           G   Y  P
Sbjct: 125 AVQYCHQKFI---VHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAP 181
Query: 282 EYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQG 314
           E    + +   + DV+S GV+L+ L++G  P  G
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLV---NL 173
           IG GA+G V  A+   TG+ VA+K +  A D     K    E+ +L    H N++   ++
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           +      G+   VYV +       H    +  PLT     +    + RGL+Y+H   V  
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQV-- 180
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR------ 287
            IHRD+K SN+L++++   ++ DFG++R                Y   EY++TR      
Sbjct: 181 -IHRDLKPSNLLVNENCELKIGDFGMARGLCTSP------AEHQYFMTEYVATRWYRAPE 233
Query: 288 ------NFTKKSDVYSFGVLLFELIAGRSPLQG 314
                  +T+  D++S G +  E++A R    G
Sbjct: 234 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 266

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266
           LT    +  +  VA+G+E+L   A    IHRD+ + NILL +    ++ DFGL+R+   D
Sbjct: 190 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 267 K---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELA 322
                  + R    ++ PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E  
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306
Query: 323 AMNTEGKTGWEEIVDSRLDGI-FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
               EG         +R+    +   E+ +       C +  P +RP+  ++V+ L  +L
Sbjct: 307 RRLKEG---------TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLL 354
Query: 382 K 382
           +
Sbjct: 355 Q 355

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266
           LT    +  +  VA+G+E+L   A    IHRD+ + NILL +    ++ DFGL+R+   D
Sbjct: 188 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 267 K---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELA 322
                  + R    ++ PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E  
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 304
Query: 323 AMNTEGKTGWEEIVDSRLDGI-FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
               EG         +R+    +   E+ +       C +  P +RP+  ++V+ L  +L
Sbjct: 305 RRLKEG---------TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLL 352
Query: 382 K 382
           +
Sbjct: 353 Q 353

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 110/226 (48%), Gaps = 28/226 (12%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGY 176
           IGQG FG V+KA+   TG+ VA+K VL  + K+G       E+ +L  L H N+VNL+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 177 CAEKGQHMLVYVFMSKGS--LASHLYDENYGPLTWNLRVHIALD--------VARGLEYL 226
           C  K           K S  L     + +   L  N+ V   L         +  GL Y+
Sbjct: 86  CRTKASPY----NRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 141
Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDP 281
           H   +   +HRD+K++N+L+ +    ++ADFGL+R   + K++   R      T  Y  P
Sbjct: 142 HRNKI---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 282 E-YISTRNFTKKSDVYSFGVLLFELIAGRSP-LQGLMEYVELAAMN 325
           E  +  R++    D++  G ++ E+   RSP +QG  E  +LA ++
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALIS 243

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLV---NL 173
           IG GA+G V  A+   TG+ VA+K +  A D     K    E+ +L    H N++   ++
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           +      G+   VYV +       H    +  PLT     +    + RGL+Y+H   V  
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQV-- 179
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR------ 287
            IHRD+K SN+L++++   ++ DFG++R                Y   EY++TR      
Sbjct: 180 -IHRDLKPSNLLVNENCELKIGDFGMARGLCTSP------AEHQYFMTEYVATRWYRAPE 232
Query: 288 ------NFTKKSDVYSFGVLLFELIAGRSPLQG 314
                  +T+  D++S G +  E++A R    G
Sbjct: 233 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266
           LT    +  +  VA+G+E+L   A    IHRD+ + NILL +    ++ DFGL+R+   D
Sbjct: 195 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 267 K---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELA 322
                  + R    ++ PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E  
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 311
Query: 323 AMNTEGKTGWEEIVDSRLDGI-FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
               EG         +R+    +   E+ +       C +  P +RP+  ++V+ L  +L
Sbjct: 312 RRLKEG---------TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLL 359
Query: 382 K 382
           +
Sbjct: 360 Q 360

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G  +       A  +    EYLH   +   I
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDL---I 149
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 150 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWTLCGTPEYLAPEIILSKGYNKAVDW 207
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 208 WALGVLIYEMAAGYPPF 224

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 109/219 (49%), Gaps = 15/219 (6%)
Query: 120 IGQGAFGPVYKA--QMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVG 175
           +G G FG V +   +M   +  VA+KVL   +++ + +E   E  ++ +L +  +V L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
            C  +   MLV      G L   L  +       N+   +   V+ G++YL +      +
Sbjct: 78  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYLEEKNF---V 132
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT----FGYLDPEYISTRNFTK 291
           HRD+ + N+LL     A+++DFGLS+    D      R        +  PE I+ R F+ 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 292 KSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
           +SDV+S+GV ++E ++ G+ P +  M+  E+ A   +GK
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKK-MKGPEVMAFIEQGK 230

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266
           LT    +  +  VA+G+E+L   A    IHRD+ + NILL +    ++ DFGL+R+   D
Sbjct: 197 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 267 K---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELA 322
                  + R    ++ PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E  
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 313
Query: 323 AMNTEGKTGWEEIVDSRLDGI-FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
               EG         +R+    +   E+ +       C +  P +RP+  ++V+ L  +L
Sbjct: 314 RRLKEG---------TRMRAPDYTTPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLL 361
Query: 382 K 382
           +
Sbjct: 362 Q 362

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 125/274 (45%), Gaps = 39/274 (14%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +       S++G   ++ + EV +L  + H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   ++ G L   L ++    LT          +  G+ YLH   + 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIA 136
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++   R ++ DFGL+ +        NI GT  ++ PE ++   
Sbjct: 137 ---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 193
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA---AMNTEGKTGWEEIVDSRLDGIFD 345
              ++D++S GV+ + L++G SP  G  +   LA   A+N E                F+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----------------FE 237
Query: 346 VEELNEVASLAYKCVNRA----PRKRPSMRDIVQ 375
            E  +  ++LA   + R     P+KR +++D +Q
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G  +       A  +    EYLH      +I
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 164
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 125/274 (45%), Gaps = 39/274 (14%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +       S++G   ++ + EV +L  + H N++ 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   ++ G L   L ++    LT          +  G+ YLH   + 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIA 136
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++   R ++ DFGL+ +        NI GT  ++ PE ++   
Sbjct: 137 ---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 193
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA---AMNTEGKTGWEEIVDSRLDGIFD 345
              ++D++S GV+ + L++G SP  G  +   LA   A+N E                F+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----------------FE 237
Query: 346 VEELNEVASLAYKCVNRA----PRKRPSMRDIVQ 375
            E  +  ++LA   + R     P+KR +++D +Q
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 125/274 (45%), Gaps = 39/274 (14%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +       S++G   ++ + EV +L  + H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   ++ G L   L ++    LT          +  G+ YLH   + 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIA 136
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++   R ++ DFGL+ +        NI GT  ++ PE ++   
Sbjct: 137 ---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 193
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA---AMNTEGKTGWEEIVDSRLDGIFD 345
              ++D++S GV+ + L++G SP  G  +   LA   A+N E                F+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----------------FE 237
Query: 346 VEELNEVASLAYKCVNRA----PRKRPSMRDIVQ 375
            E  +  ++LA   + R     P+KR +++D +Q
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 125/274 (45%), Gaps = 39/274 (14%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +       S++G   ++ + EV +L  + H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   ++ G L   L ++    LT          +  G+ YLH   + 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIA 135
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++   R ++ DFGL+ +        NI GT  ++ PE ++   
Sbjct: 136 ---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 192
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA---AMNTEGKTGWEEIVDSRLDGIFD 345
              ++D++S GV+ + L++G SP  G  +   LA   A+N E                F+
Sbjct: 193 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----------------FE 236
Query: 346 VEELNEVASLAYKCVNRA----PRKRPSMRDIVQ 375
            E  +  ++LA   + R     P+KR +++D +Q
Sbjct: 237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 119 LIGQGAFGPVYK-AQMSTGETVAVKVLATDS--KQGEKE-FQTEVMLLGRLHHRNLVNLV 174
            +G+G F   Y+   M T E  A KV+      K  +KE   TE+ +   L + ++V   
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHL-YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           G+  +      VYV +      S L   +    +T     +      +G++YLH+  V  
Sbjct: 109 GFFEDDD---FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRV-- 163
Query: 234 VIHRDIKSSNILLDQSMRARVADFGL-SREEMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
            IHRD+K  N+ L+  M  ++ DFGL ++ E   +   ++ GT  Y+ PE +  +  + +
Sbjct: 164 -IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFE 222
Query: 293 SDVYSFGVLLFELIAGRSPLQ 313
            D++S G +L+ L+ G+ P +
Sbjct: 223 VDIWSLGCILYTLLVGKPPFE 243

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 125/274 (45%), Gaps = 39/274 (14%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +       S++G   ++ + EV +L  + H N++ 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   ++ G L   L ++    LT          +  G+ YLH   + 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIA 136
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++   R ++ DFGL+ +        NI GT  ++ PE ++   
Sbjct: 137 ---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 193
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA---AMNTEGKTGWEEIVDSRLDGIFD 345
              ++D++S GV+ + L++G SP  G  +   LA   A+N E                F+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----------------FE 237
Query: 346 VEELNEVASLAYKCVNRA----PRKRPSMRDIVQ 375
            E  +  ++LA   + R     P+KR +++D +Q
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 125/274 (45%), Gaps = 39/274 (14%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +       S++G   ++ + EV +L  + H N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   ++ G L   L ++    LT          +  G+ YLH   + 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIA 135
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++   R ++ DFGL+ +        NI GT  ++ PE ++   
Sbjct: 136 ---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 192
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA---AMNTEGKTGWEEIVDSRLDGIFD 345
              ++D++S GV+ + L++G SP  G  +   LA   A+N E                F+
Sbjct: 193 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----------------FE 236
Query: 346 VEELNEVASLAYKCVNRA----PRKRPSMRDIVQ 375
            E  +  ++LA   + R     P+KR +++D +Q
Sbjct: 237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 125/274 (45%), Gaps = 39/274 (14%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +       S++G   ++ + EV +L  + H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   ++ G L   L ++    LT          +  G+ YLH   + 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIA 136
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++   R ++ DFGL+ +        NI GT  ++ PE ++   
Sbjct: 137 ---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 193
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA---AMNTEGKTGWEEIVDSRLDGIFD 345
              ++D++S GV+ + L++G SP  G  +   LA   A+N E                F+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----------------FE 237
Query: 346 VEELNEVASLAYKCVNRA----PRKRPSMRDIVQ 375
            E  +  ++LA   + R     P+KR +++D +Q
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 125/274 (45%), Gaps = 39/274 (14%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +       S++G   ++ + EV +L  + H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   ++ G L   L ++    LT          +  G+ YLH   + 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIA 136
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++   R ++ DFGL+ +        NI GT  ++ PE ++   
Sbjct: 137 ---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 193
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA---AMNTEGKTGWEEIVDSRLDGIFD 345
              ++D++S GV+ + L++G SP  G  +   LA   A+N E                F+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----------------FE 237
Query: 346 VEELNEVASLAYKCVNRA----PRKRPSMRDIVQ 375
            E  +  ++LA   + R     P+KR +++D +Q
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 125/274 (45%), Gaps = 39/274 (14%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +       S++G   ++ + EV +L  + H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   ++ G L   L ++    LT          +  G+ YLH   + 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIA 136
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++   R ++ DFGL+ +        NI GT  ++ PE ++   
Sbjct: 137 ---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 193
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA---AMNTEGKTGWEEIVDSRLDGIFD 345
              ++D++S GV+ + L++G SP  G  +   LA   A+N E                F+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----------------FE 237
Query: 346 VEELNEVASLAYKCVNRA----PRKRPSMRDIVQ 375
            E  +  ++LA   + R     P+KR +++D +Q
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 119 LIGQGAFGPVYK-AQMSTGETVAVKVLATDS--KQGEKE-FQTEVMLLGRLHHRNLVNLV 174
            +G+G F   Y+   M T E  A KV+      K  +KE   TE+ +   L + ++V   
Sbjct: 33  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 92
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHL-YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           G+  +      VYV +      S L   +    +T     +      +G++YLH+  V  
Sbjct: 93  GFFEDDD---FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRV-- 147
Query: 234 VIHRDIKSSNILLDQSMRARVADFGL-SREEMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
            IHRD+K  N+ L+  M  ++ DFGL ++ E   +   ++ GT  Y+ PE +  +  + +
Sbjct: 148 -IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFE 206
Query: 293 SDVYSFGVLLFELIAGRSPLQ 313
            D++S G +L+ L+ G+ P +
Sbjct: 207 VDIWSLGCILYTLLVGKPPFE 227

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 113/243 (46%), Gaps = 32/243 (13%)
Query: 88  EGFKRSNVVSASG-----IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAV 141
           +G K + VV+  G       E SY D        T +IG G+FG VY+A++  +GE VA+
Sbjct: 33  DGSKVTTVVATPGQGPDRPQEVSYTD--------TKVIGNGSFGVVYQAKLCDSGELVAI 84
Query: 142 KVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKG 193
           K +  D +   +E Q    ++ +L H N+V L  +    G+         +L YV  +  
Sbjct: 85  KKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 140
Query: 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA- 252
            +A H            +++++   + R L Y+H      + HRDIK  N+LLD      
Sbjct: 141 RVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 196
Query: 253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSP 311
           ++ DFG +++ +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+  
Sbjct: 197 KLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 256
Query: 312 LQG 314
             G
Sbjct: 257 FPG 259

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 125/274 (45%), Gaps = 39/274 (14%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +       S++G   ++ + EV +L  + H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   ++ G L   L ++    LT          +  G+ YLH   + 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIA 136
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++   R ++ DFGL+ +        NI GT  ++ PE ++   
Sbjct: 137 ---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 193
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA---AMNTEGKTGWEEIVDSRLDGIFD 345
              ++D++S GV+ + L++G SP  G  +   LA   A+N E                F+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----------------FE 237
Query: 346 VEELNEVASLAYKCVNRA----PRKRPSMRDIVQ 375
            E  +  ++LA   + R     P+KR +++D +Q
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 125/274 (45%), Gaps = 39/274 (14%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +       S++G   ++ + EV +L  + H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   ++ G L   L ++    LT          +  G+ YLH   + 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIA 136
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++   R ++ DFGL+ +        NI GT  ++ PE ++   
Sbjct: 137 ---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 193
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA---AMNTEGKTGWEEIVDSRLDGIFD 345
              ++D++S GV+ + L++G SP  G  +   LA   A+N E                F+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----------------FE 237
Query: 346 VEELNEVASLAYKCVNRA----PRKRPSMRDIVQ 375
            E  +  ++LA   + R     P+KR +++D +Q
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 125/274 (45%), Gaps = 39/274 (14%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +       S++G   ++ + EV +L  + H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   ++ G L   L ++    LT          +  G+ YLH   + 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIA 136
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++   R ++ DFGL+ +        NI GT  ++ PE ++   
Sbjct: 137 ---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 193
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA---AMNTEGKTGWEEIVDSRLDGIFD 345
              ++D++S GV+ + L++G SP  G  +   LA   A+N E                F+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----------------FE 237
Query: 346 VEELNEVASLAYKCVNRA----PRKRPSMRDIVQ 375
            E  +  ++LA   + R     P+KR +++D +Q
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           +G GA+G V   +   T    A+K++   + S     +   EV +L  L H N++ L  +
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL---DVARGLEYLHDGAVPP 233
             +K  + LV      G     L+DE    + +N  V  A+    V  G+ YLH      
Sbjct: 105 FEDKRNYYLVMECYKGG----ELFDEIIHRMKFN-EVDAAVIIKQVLSGVTYLHK---HN 156
Query: 234 VIHRDIKSSNILLDQSMR---ARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT 290
           ++HRD+K  N+LL+   +    ++ DFGLS      K      GT  Y+ PE +  + + 
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYD 215
Query: 291 KKSDVYSFGVLLFELIAGRSPLQG 314
           +K DV+S GV+LF L+AG  P  G
Sbjct: 216 EKCDVWSIGVILFILLAGYPPFGG 239

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 119 LIGQGAFGPVYK-AQMSTGETVAVKVLATDS--KQGEKE-FQTEVMLLGRLHHRNLVNLV 174
            +G+G F   Y+   M T E  A KV+      K  +KE   TE+ +   L + ++V   
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHL-YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           G+  +      VYV +      S L   +    +T     +      +G++YLH+  V  
Sbjct: 109 GFFEDDD---FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRV-- 163
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
            IHRD+K  N+ L+  M  ++ DFGL+ + E   +    + GT  Y+ PE +  +  + +
Sbjct: 164 -IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFE 222
Query: 293 SDVYSFGVLLFELIAGRSPLQ 313
            D++S G +L+ L+ G+ P +
Sbjct: 223 VDIWSLGCILYTLLVGKPPFE 243

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G          A  +    EYLH      +I
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLI 164
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 113/243 (46%), Gaps = 32/243 (13%)
Query: 88  EGFKRSNVVSASG-----IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAV 141
           +G K + VV+  G       E SY D        T +IG G+FG VY+A++  +GE VA+
Sbjct: 18  DGSKVTTVVATPGQGPDRPQEVSYTD--------TKVIGNGSFGVVYQAKLCDSGELVAI 69
Query: 142 KVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKG 193
           K +  D +   +E Q    ++ +L H N+V L  +    G+         +L YV  +  
Sbjct: 70  KKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 125
Query: 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA- 252
            +A H            +++++   + R L Y+H      + HRDIK  N+LLD      
Sbjct: 126 RVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 181
Query: 253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSP 311
           ++ DFG +++ +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+  
Sbjct: 182 KLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 241
Query: 312 LQG 314
             G
Sbjct: 242 FPG 244

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G          A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 113/243 (46%), Gaps = 32/243 (13%)
Query: 88  EGFKRSNVVSASG-----IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAV 141
           +G K + VV+  G       E SY D        T +IG G+FG VY+A++  +GE VA+
Sbjct: 35  DGSKVTTVVATPGQGPDRPQEVSYTD--------TKVIGNGSFGVVYQAKLCDSGELVAI 86
Query: 142 KVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKG 193
           K +  D +   +E Q    ++ +L H N+V L  +    G+         +L YV  +  
Sbjct: 87  KKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 142
Query: 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA- 252
            +A H            +++++   + R L Y+H      + HRDIK  N+LLD      
Sbjct: 143 RVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 198
Query: 253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSP 311
           ++ DFG +++ +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+  
Sbjct: 199 KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 258
Query: 312 LQG 314
             G
Sbjct: 259 FPG 261

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 113/243 (46%), Gaps = 32/243 (13%)
Query: 88  EGFKRSNVVSASG-----IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAV 141
           +G K + VV+  G       E SY D        T +IG G+FG VY+A++  +GE VA+
Sbjct: 33  DGSKVTTVVATPGQGPDRPQEVSYTD--------TKVIGNGSFGVVYQAKLCDSGELVAI 84
Query: 142 KVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKG 193
           K +  D +   +E Q    ++ +L H N+V L  +    G+         +L YV  +  
Sbjct: 85  KKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 140
Query: 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA- 252
            +A H            +++++   + R L Y+H      + HRDIK  N+LLD      
Sbjct: 141 RVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 196
Query: 253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSP 311
           ++ DFG +++ +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+  
Sbjct: 197 KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 256
Query: 312 LQG 314
             G
Sbjct: 257 FPG 259

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 113/243 (46%), Gaps = 32/243 (13%)
Query: 88  EGFKRSNVVSASG-----IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAV 141
           +G K + VV+  G       E SY D        T +IG G+FG VY+A++  +GE VA+
Sbjct: 11  DGSKVTTVVATPGQGPDRPQEVSYTD--------TKVIGNGSFGVVYQAKLCDSGELVAI 62
Query: 142 KVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKG 193
           K +  D +   +E Q    ++ +L H N+V L  +    G+         +L YV  +  
Sbjct: 63  KKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 118
Query: 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA- 252
            +A H            +++++   + R L Y+H      + HRDIK  N+LLD      
Sbjct: 119 RVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 174
Query: 253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSP 311
           ++ DFG +++ +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+  
Sbjct: 175 KLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 234
Query: 312 LQG 314
             G
Sbjct: 235 FPG 237

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 120 IGQGAFGPVYK-AQMSTGETVAVK-VLATDSKQGEKEFQTEVMLLGRLHH-RNLVNLVGY 176
           IG+GA+G V K     +G+ +AVK + +T  ++ +K+   ++ ++ R      +V   G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 177 CAEKGQHMLVYVFMSKG--SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
              +G   +    MS        ++Y      +   +   I L   + L +L +     +
Sbjct: 90  LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KI 147
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA-ANIRGTFGYLDPEYI----STRNF 289
           IHRDIK SNILLD+S   ++ DFG+S  ++VD  A     G   Y+ PE I    S + +
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISG-QLVDSIAKTRDAGCRPYMAPERIDPSASRQGY 206
Query: 290 TKKSDVYSFGVLLFELIAGRSP 311
             +SDV+S G+ L+EL  GR P
Sbjct: 207 DVRSDVWSLGITLYELATGRFP 228

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 113/243 (46%), Gaps = 32/243 (13%)
Query: 88  EGFKRSNVVSASG-----IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAV 141
           +G K + VV+  G       E SY D        T +IG G+FG VY+A++  +GE VA+
Sbjct: 27  DGSKVTTVVATPGQGPDRPQEVSYTD--------TKVIGNGSFGVVYQAKLCDSGELVAI 78
Query: 142 KVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKG 193
           K +  D +   +E Q    ++ +L H N+V L  +    G+         +L YV  +  
Sbjct: 79  KKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 134
Query: 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA- 252
            +A H            +++++   + R L Y+H      + HRDIK  N+LLD      
Sbjct: 135 RVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 190
Query: 253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSP 311
           ++ DFG +++ +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+  
Sbjct: 191 KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 250
Query: 312 LQG 314
             G
Sbjct: 251 FPG 253

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G          A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 113/243 (46%), Gaps = 32/243 (13%)
Query: 88  EGFKRSNVVSASG-----IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAV 141
           +G K + VV+  G       E SY D        T +IG G+FG VY+A++  +GE VA+
Sbjct: 37  DGSKVTTVVATPGQGPDRPQEVSYTD--------TKVIGNGSFGVVYQAKLCDSGELVAI 88
Query: 142 KVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKG 193
           K +  D +   +E Q    ++ +L H N+V L  +    G+         +L YV  +  
Sbjct: 89  KKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 144
Query: 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA- 252
            +A H            +++++   + R L Y+H      + HRDIK  N+LLD      
Sbjct: 145 RVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 200
Query: 253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSP 311
           ++ DFG +++ +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+  
Sbjct: 201 KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 260
Query: 312 LQG 314
             G
Sbjct: 261 FPG 263

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 113/243 (46%), Gaps = 32/243 (13%)
Query: 88  EGFKRSNVVSASG-----IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAV 141
           +G K + VV+  G       E SY D        T +IG G+FG VY+A++  +GE VA+
Sbjct: 11  DGSKVTTVVATPGQGPDRPQEVSYTD--------TKVIGNGSFGVVYQAKLCDSGELVAI 62
Query: 142 KVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKG 193
           K +  D +   +E Q    ++ +L H N+V L  +    G+         +L YV  +  
Sbjct: 63  KKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 118
Query: 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA- 252
            +A H            +++++   + R L Y+H      + HRDIK  N+LLD      
Sbjct: 119 RVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 174
Query: 253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSP 311
           ++ DFG +++ +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+  
Sbjct: 175 KLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 234
Query: 312 LQG 314
             G
Sbjct: 235 FPG 237

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 113/243 (46%), Gaps = 32/243 (13%)
Query: 88  EGFKRSNVVSASG-----IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAV 141
           +G K + VV+  G       E SY D        T +IG G+FG VY+A++  +GE VA+
Sbjct: 7   DGSKVTTVVATPGQGPDRPQEVSYTD--------TKVIGNGSFGVVYQAKLCDSGELVAI 58
Query: 142 KVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKG 193
           K +  D +   +E Q    ++ +L H N+V L  +    G+         +L YV  +  
Sbjct: 59  KKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 114
Query: 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA- 252
            +A H            +++++   + R L Y+H      + HRDIK  N+LLD      
Sbjct: 115 RVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 170
Query: 253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSP 311
           ++ DFG +++ +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+  
Sbjct: 171 KLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 230
Query: 312 LQG 314
             G
Sbjct: 231 FPG 233

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 113/243 (46%), Gaps = 32/243 (13%)
Query: 88  EGFKRSNVVSASG-----IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAV 141
           +G K + VV+  G       E SY D        T +IG G+FG VY+A++  +GE VA+
Sbjct: 78  DGSKVTTVVATPGQGPDRPQEVSYTD--------TKVIGNGSFGVVYQAKLCDSGELVAI 129
Query: 142 KVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKG 193
           K +  D +   +E Q    ++ +L H N+V L  +    G+         +L YV  +  
Sbjct: 130 KKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 185
Query: 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA- 252
            +A H            +++++   + R L Y+H      + HRDIK  N+LLD      
Sbjct: 186 RVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 241
Query: 253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSP 311
           ++ DFG +++ +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+  
Sbjct: 242 KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 301
Query: 312 LQG 314
             G
Sbjct: 302 FPG 304

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 12/201 (5%)
Query: 119 LIGQGAFGPVYK-AQMSTGETVAVKVLATDS--KQGEKE-FQTEVMLLGRLHHRNLVNLV 174
            +G+G F   Y+   M T E  A KV+      K  +KE   TE+ +   L + ++V   
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHL-YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           G+  +      VYV +      S L   +    +T     +      +G++YLH+  V  
Sbjct: 109 GFFEDDD---FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRV-- 163
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
            IHRD+K  N+ L+  M  ++ DFGL+ + E   +    + GT  Y+ PE +  +  + +
Sbjct: 164 -IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFE 222
Query: 293 SDVYSFGVLLFELIAGRSPLQ 313
            D++S G +L+ L+ G+ P +
Sbjct: 223 VDIWSLGCILYTLLVGKPPFE 243

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 125/274 (45%), Gaps = 39/274 (14%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +       S++G   ++ + EV +L  + H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   ++ G L   L ++    LT          +  G+ YLH   + 
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIA 136
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++   R ++ DFGL+ +        NI GT  ++ PE ++   
Sbjct: 137 ---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 193
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA---AMNTEGKTGWEEIVDSRLDGIFD 345
              ++D++S GV+ + L++G SP  G  +   LA   A+N E                F+
Sbjct: 194 LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE----------------FE 237
Query: 346 VEELNEVASLAYKCVNRA----PRKRPSMRDIVQ 375
            E  +  ++LA   + R     P+KR +++D +Q
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 113/243 (46%), Gaps = 32/243 (13%)
Query: 88  EGFKRSNVVSASG-----IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAV 141
           +G K + VV+  G       E SY D        T +IG G+FG VY+A++  +GE VA+
Sbjct: 12  DGSKVTTVVATPGQGPDRPQEVSYTD--------TKVIGNGSFGVVYQAKLCDSGELVAI 63
Query: 142 KVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKG 193
           K +  D +   +E Q    ++ +L H N+V L  +    G+         +L YV  +  
Sbjct: 64  KKVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 119
Query: 194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA- 252
            +A H            +++++   + R L Y+H      + HRDIK  N+LLD      
Sbjct: 120 RVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL 175
Query: 253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSP 311
           ++ DFG +++ +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+  
Sbjct: 176 KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 235
Query: 312 LQG 314
             G
Sbjct: 236 FPG 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +   G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+++DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 13/204 (6%)
Query: 116 FTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLV 171
           +  L+G+G FG V    + +TG   A+K+L  +    + E     TE  +L    H  L 
Sbjct: 155 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 214
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            L        +   V  + + G L  HL  E     + +       ++   L+YLH  + 
Sbjct: 215 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLH--SE 270
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLDPEYISTRN 288
             V++RD+K  N++LD+    ++ DFGL +E + D   A ++   GT  YL PE +   +
Sbjct: 271 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDND 328
Query: 289 FTKKSDVYSFGVLLFELIAGRSPL 312
           + +  D +  GV+++E++ GR P 
Sbjct: 329 YGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 110/232 (47%), Gaps = 17/232 (7%)
Query: 93  SNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQG 151
           S V +    P       Q+ +   T +IG G+FG VY+A++  +GE VA+K +  D +  
Sbjct: 1   SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK 60
Query: 152 EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLY--DENYGPLT 208
            +E Q    ++ +L H N+V L  +    G+   +VY+ +    +   +Y    +Y    
Sbjct: 61  NRELQ----IMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAK 116
Query: 209 WNLRV-HIAL---DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA-RVADFGLSREE 263
             L V ++ L    + R L Y+H      + HRDIK  N+LLD      ++ DFG +++ 
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 264 MVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+    G
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 13/204 (6%)
Query: 116 FTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLV 171
           +  L+G+G FG V    + +TG   A+K+L  +    + E     TE  +L    H  L 
Sbjct: 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            L        +   V  + + G L  HL  E     + +       ++   L+YLH  + 
Sbjct: 212 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLH--SE 267
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLDPEYISTRN 288
             V++RD+K  N++LD+    ++ DFGL +E + D   A ++   GT  YL PE +   +
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDND 325
Query: 289 FTKKSDVYSFGVLLFELIAGRSPL 312
           + +  D +  GV+++E++ GR P 
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +   G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+++DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLMIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 109/214 (50%), Gaps = 22/214 (10%)
Query: 115 NFTTL--IGQGAFGPVYKAQM----STGETVAVKVL--ATDSKQGE--KEFQTEVMLLGR 164
           NF  L  +G GA+G V+  +      TG+  A+KVL  AT  ++ +  +  +TE  +L  
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 165 LHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARG 222
           +     +  + Y  +    + L+  +++ G L +HL   E +      +++++  ++   
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF--TEHEVQIYVG-EIVLA 171
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--KHAANIRGTFGYLD 280
           LE+LH   +   I+RDIK  NILLD +    + DFGLS+E + D  + A +  GT  Y+ 
Sbjct: 172 LEHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 281 PEYI--STRNFTKKSDVYSFGVLLFELIAGRSPL 312
           P+ +        K  D +S GVL++EL+ G SP 
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +   G + SHL     G          A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+++DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 108/233 (46%), Gaps = 19/233 (8%)
Query: 93  SNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQG 151
           S V +    P       Q+ +   T +IG G+FG VY+A++  +GE VA+K +  D +  
Sbjct: 6   SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK 65
Query: 152 EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKGSLASHLYDEN 203
            +E Q    ++ +L H N+V L  +    G+         +L YV  +   +A H     
Sbjct: 66  NRELQ----IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 121
Query: 204 YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA-RVADFGLSRE 262
                  +++++   + R L Y+H      + HRDIK  N+LLD      ++ DFG +++
Sbjct: 122 QTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 177
Query: 263 EMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+    G
Sbjct: 178 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 230

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 108/233 (46%), Gaps = 19/233 (8%)
Query: 93  SNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQG 151
           S V +    P       Q+ +   T +IG G+FG VY+A++  +GE VA+K +  D +  
Sbjct: 1   SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK 60
Query: 152 EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKGSLASHLYDEN 203
            +E Q    ++ +L H N+V L  +    G+         +L YV  +   +A H     
Sbjct: 61  NRELQ----IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116
Query: 204 YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA-RVADFGLSRE 262
                  +++++   + R L Y+H      + HRDIK  N+LLD      ++ DFG +++
Sbjct: 117 QTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 263 EMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+    G
Sbjct: 173 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 13/204 (6%)
Query: 116 FTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLV 171
           +  L+G+G FG V    + +TG   A+K+L  +    + E     TE  +L    H  L 
Sbjct: 12  YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 71
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            L        +   V  + + G L  HL  E     + +       ++   L+YLH  + 
Sbjct: 72  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLH--SE 127
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLDPEYISTRN 288
             V++RD+K  N++LD+    ++ DFGL +E + D   A ++   GT  YL PE +   +
Sbjct: 128 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCGTPEYLAPEVLEDND 185
Query: 289 FTKKSDVYSFGVLLFELIAGRSPL 312
           + +  D +  GV+++E++ GR P 
Sbjct: 186 YGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 13/204 (6%)
Query: 116 FTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLV 171
           +  L+G+G FG V    + +TG   A+K+L  +    + E     TE  +L    H  L 
Sbjct: 13  YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 72
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            L        +   V  + + G L  HL  E     + +       ++   L+YLH  + 
Sbjct: 73  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLH--SE 128
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLDPEYISTRN 288
             V++RD+K  N++LD+    ++ DFGL +E + D   A ++   GT  YL PE +   +
Sbjct: 129 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCGTPEYLAPEVLEDND 186
Query: 289 FTKKSDVYSFGVLLFELIAGRSPL 312
           + +  D +  GV+++E++ GR P 
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 13/204 (6%)
Query: 116 FTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLV 171
           +  L+G+G FG V    + +TG   A+K+L  +    + E     TE  +L    H  L 
Sbjct: 14  YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 73
Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            L        +   V  + + G L  HL  E     + +       ++   L+YLH  + 
Sbjct: 74  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLH--SE 129
Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLDPEYISTRN 288
             V++RD+K  N++LD+    ++ DFGL +E + D   A ++   GT  YL PE +   +
Sbjct: 130 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCGTPEYLAPEVLEDND 187
Query: 289 FTKKSDVYSFGVLLFELIAGRSPL 312
           + +  D +  GV+++E++ GR P 
Sbjct: 188 YGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 112/242 (46%), Gaps = 32/242 (13%)
Query: 89  GFKRSNVVSASG-----IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVK 142
           G K + VV+  G       E SY D        T +IG G+FG VY+A++  +GE VA+K
Sbjct: 4   GSKVTTVVATPGQGPDRPQEVSYTD--------TKVIGNGSFGVVYQAKLCDSGELVAIK 55
Query: 143 VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKGS 194
            +  D +   +E Q    ++ +L H N+V L  +    G+         +L YV  +   
Sbjct: 56  KVLQDKRFKNRELQ----IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR 111
Query: 195 LASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA-R 253
           +A H            +++++   + R L Y+H      + HRDIK  N+LLD      +
Sbjct: 112 VARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLK 167
Query: 254 VADFGLSREEMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPL 312
           + DFG +++ +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+   
Sbjct: 168 LCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 227
Query: 313 QG 314
            G
Sbjct: 228 PG 229

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 108/233 (46%), Gaps = 19/233 (8%)
Query: 93  SNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQG 151
           S V +    P       Q+ +   T +IG G+FG VY+A++  +GE VA+K +  D +  
Sbjct: 1   SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK 60
Query: 152 EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKGSLASHLYDEN 203
            +E Q    ++ +L H N+V L  +    G+         +L YV  +   +A H     
Sbjct: 61  NRELQ----IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116
Query: 204 YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA-RVADFGLSRE 262
                  +++++   + R L Y+H      + HRDIK  N+LLD      ++ DFG +++
Sbjct: 117 QTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 263 EMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+    G
Sbjct: 173 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 108/233 (46%), Gaps = 19/233 (8%)
Query: 93  SNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQG 151
           S V +    P       Q+ +   T +IG G+FG VY+A++  +GE VA+K +  D +  
Sbjct: 2   SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK 61
Query: 152 EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKGSLASHLYDEN 203
            +E Q    ++ +L H N+V L  +    G+         +L YV  +   +A H     
Sbjct: 62  NRELQ----IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 117
Query: 204 YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA-RVADFGLSRE 262
                  +++++   + R L Y+H      + HRDIK  N+LLD      ++ DFG +++
Sbjct: 118 QTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 173
Query: 263 EMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+    G
Sbjct: 174 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 226

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 108/233 (46%), Gaps = 19/233 (8%)
Query: 93  SNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQG 151
           S V +    P       Q+ +   T +IG G+FG VY+A++  +GE VA+K +  D +  
Sbjct: 1   SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK 60
Query: 152 EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKGSLASHLYDEN 203
            +E Q    ++ +L H N+V L  +    G+         +L YV  +   +A H     
Sbjct: 61  NRELQ----IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116
Query: 204 YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA-RVADFGLSRE 262
                  +++++   + R L Y+H      + HRDIK  N+LLD      ++ DFG +++
Sbjct: 117 QTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 263 EMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+    G
Sbjct: 173 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 120/275 (43%), Gaps = 30/275 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVN 172
           NF T + +   G ++K +   G  + VKVL     S +  ++F  E   L    H N++ 
Sbjct: 13  NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 173 LVGYC-AEKGQH-MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           ++G C +    H  L+  +   GSL + L++     +  +  V  ALD ARG  +LH   
Sbjct: 72  VLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH--T 129
Query: 231 VPPVIHRD-IKSSNILLDQSMRARV--ADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
           + P+I R  + S ++ +D+   AR+  AD   S +     +A        ++ PE +  +
Sbjct: 130 LEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAP------AWVAPEALQKK 183
Query: 288 ---NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF 344
                 + +D +SF VLL+EL+    P      + +L+      K   E +  +   GI 
Sbjct: 184 PEDTNRRSADXWSFAVLLWELVTREVP------FADLSNXEIGXKVALEGLRPTIPPGIS 237
Query: 345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR 379
                  V+ L   C N  P KRP    IV +L +
Sbjct: 238 P-----HVSKLXKICXNEDPAKRPKFDXIVPILEK 267

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 11/206 (5%)
Query: 116 FTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNL 173
           F   +G GAFG V+  +  S+G    +K +  D  Q   E  + E+ +L  L H N++ +
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENY--GPLTWNLRVHIALDVARGLEYLHDGAV 231
                +     +V      G L   +         L+      +   +   L Y H   V
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHV 145
Query: 232 PPVIHRDIKSSNILL-DQSMRA--RVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              +H+D+K  NIL  D S  +  ++ DFGL+     D+H+ N  GT  Y+ PE +  R+
Sbjct: 146 ---VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE-VFKRD 201
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
            T K D++S GV+++ L+ G  P  G
Sbjct: 202 VTFKCDIWSAGVVMYFLLTGCLPFTG 227

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 116 FTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           F   +G+G F  V   + +  G   A+K +    +Q  +E Q E  +    +H N++ LV
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 175 GYC----AEKGQHMLVYVFMSKGSLASHL--YDENYGPLTWNLRVHIALDVARGLEYLHD 228
            YC      K +  L+  F  +G+L + +    +    LT +  + + L + RGLE +H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGL----------SREEMVDKHAANIRGTFGY 278
                  HRD+K +NILL    +  + D G           SR+ +  +  A  R T  Y
Sbjct: 153 KGYA---HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 279 LDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSP 311
             PE  S ++     +++DV+S G +L+ ++ G  P
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 8/194 (4%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           IG+G+ G V  A +  +G  VAVK++    +Q  +    EV+++    H N+V +     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
              +  ++  F+  G+L   +       L       +   V + L YLH   V   IHRD
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQGV---IHRD 166
Query: 239 IKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
           IKS +ILL    R +++DFG   +   D      + GT  ++ PE IS   +  + D++S
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWS 226
Query: 298 FGVLLFELIAGRSP 311
            G+++ E++ G  P
Sbjct: 227 LGIMVIEMVDGEPP 240

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 106/241 (43%), Gaps = 41/241 (17%)
Query: 108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGEKE-FQTEVMLLGRL 165
           D +   C     +G+G FG V++A+    +   A+K +   +++  +E    EV  L +L
Sbjct: 6   DFEPIQC-----LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 60
Query: 166 HHRNLVNLVGYCAEKG-------QHMLVYVFMS-KGSLASHLYDENYGPLTWNLR----- 212
            H  +V       EK            VY+++  +     +L D   G  T   R     
Sbjct: 61  EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 213 VHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL-------SREEMV 265
           +HI L +A  +E+LH   +   +HRD+K SNI        +V DFGL         E+ V
Sbjct: 121 LHIFLQIAEAVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 266 -------DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEY 318
                   +H   + GT  Y+ PE I   +++ K D++S G++LFEL+    P    ME 
Sbjct: 178 LTPMPAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER 233
Query: 319 V 319
           V
Sbjct: 234 V 234

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+S   L   +       +   L       + +GL + H   V   +H
Sbjct: 74  IHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 129
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 189
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 190 IWSLGCIFAEMVTRRALFPG 209

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+S   L   +       +   L       + +GL + H   V   +H
Sbjct: 74  IHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 129
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 130 RDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 189
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 190 IWSLGCIFAEMVTRRALFPG 209

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G  +       A  +    EYLH      +I
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 164
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLXGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 125/273 (45%), Gaps = 38/273 (13%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQGEKEFQTEVMLLGR-LHHRNLVNLVGY 176
           +G+GA+G V K + + +G+ +AVK + AT + Q +K    ++ +  R +     V   G 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 177 CAEKGQHMLVYVFM--SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
              +G   +    M  S       + D+    +  ++   IA+ + + LE+LH      V
Sbjct: 119 LFREGDVWICMELMDTSLDKFYKQVIDKGQT-IPEDILGKIAVSIVKALEHLHSKLS--V 175
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI-RGTFGYLDPEYIST----RNF 289
           IHRD+K SN+L++   + ++ DFG+S   +VD  A  I  G   Y+ PE I+     + +
Sbjct: 176 IHRDVKPSNVLINALGQVKMCDFGISG-YLVDSVAKTIDAGCKPYMAPERINPELNQKGY 234
Query: 290 TKKSDVYSFGVLLFELIAGR-------SPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
           + KSD++S G+ + EL   R       +P Q L + VE  +          E VD     
Sbjct: 235 SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD----- 289
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                          +C+ +  ++RP+  +++Q
Sbjct: 290 ------------FTSQCLKKNSKERPTYPELMQ 310

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G  +       A  +    EYLH      +I
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 164
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G  +       A  +    EYLH   +   I
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDL---I 156
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 157 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 214
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 215 WALGVLIYEMAAGYPPF 231

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGY 176
           ++ +G F  VY+AQ + +G   A+K L ++ ++  +    EV  + +L  H N+V     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 177 CA------EKGQ-HMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHD 228
            +      + GQ   L+   + KG L   L   E+ GPL+ +  + I     R ++++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFG--------------LSREEMVDKHAANIRG 274
              PP+IHRD+K  N+LL      ++ DFG                R  +V++       
Sbjct: 155 QK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR-NT 212
Query: 275 TFGYLDPEYIST-RNFT--KKSDVYSFGVLLFELIAGRSPLQ 313
           T  Y  PE I    NF   +K D+++ G +L+ L   + P +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+S   L   +       +   L       + +GL + H   V   +H
Sbjct: 73  IHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 128
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 129 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 188
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 189 IWSLGCIFAEMVTRRALFPG 208

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   L  L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +   G + SHL     G  +       A  +    EYLH      +I
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 164
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+++DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+S   L   +       +   L       + +GL + H   V   +H
Sbjct: 72  IHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 127
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 128 RDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 187
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 188 IWSLGCIFAEMVTRRALFPG 207

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 122/256 (47%), Gaps = 17/256 (6%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 145
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE 351
             D++S G +L E+++ R    G     +L   +  G  G  E  D  L+ I +++  N 
Sbjct: 206 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLN--HILGILGSPEQED--LNCIINLKARNY 261
Query: 352 VASLAYKCVNRAPRKR 367
           + SL +K  N+ P  R
Sbjct: 262 LLSLPHK--NKVPWNR 275

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G  +       A  +    EYLH      +I
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 164
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 12/227 (5%)
Query: 93  SNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYK-AQMSTGETVAVKV----LATD 147
           S    A  IPE       +        +G+G F   ++ +   T E  A K+    L   
Sbjct: 2   SAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK 61
Query: 148 SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPL 207
             Q EK    E+ +   L H+++V   G+  +     +V     + SL   L+       
Sbjct: 62  PHQREK-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALT 119
Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD- 266
               R ++   +  G +YLH   V   IHRD+K  N+ L++ +  ++ DFGL+ +   D 
Sbjct: 120 EPEARYYLR-QIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 175
Query: 267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
           +    + GT  Y+ PE +S +  + + DV+S G +++ L+ G+ P +
Sbjct: 176 ERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   L  L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +   G + SHL     G  +       A  +    EYLH      +I
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 164
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+++DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 118/271 (43%), Gaps = 41/271 (15%)
Query: 119 LIGQGAFGPVYKAQMSTGE-TVAVKVLATDSKQGEKEF------QTEVMLLGRLH----H 167
           L+G+G FG V+     T    VA+KV+  +   G            EV LL ++     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEY 225
             ++ L+ +   +   MLV   + +   A  L+D     GPL           V   +++
Sbjct: 98  PGVIRLLDWFETQEGFMLV---LERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQH 154
Query: 226 LHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYI 284
            H   V   +HRDIK  NIL+D +   A++ DFG S   + D+   +  GT  Y  PE+I
Sbjct: 155 CHSRGV---VHRDIKDENILIDLRRGCAKLIDFG-SGALLHDEPYTDFDGTRVYSPPEWI 210
Query: 285 STRNF-TKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI 343
           S   +    + V+S G+LL++++ G  P +                   +EI+++ L   
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGDIPFERD-----------------QEILEAELH-- 251
Query: 344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIV 374
           F      +  +L  +C+   P  RPS+ +I+
Sbjct: 252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G  +       A  +    EYLH      +I
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 184
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 242
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 243 WALGVLIYEMAAGYPPF 259

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L + +       +   L       + +GL + H   V   +H
Sbjct: 74  IHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 129
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 189
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 190 IWSLGCIFAEMVTRRALFPG 209

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVL-----ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G GA+G V   +   TG   A+K++      T S  G      EV +L +L H N++ L
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGA--LLDEVAVLKQLDHPNIMKL 86
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHL-YDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
             +  +K  + LV      G L   +   + +  +   +   I   V  G  YLH   + 
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---IMKQVLSGTTYLHKHNI- 142
Query: 233 PVIHRDIKSSNILLDQSMR---ARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNF 289
             +HRD+K  N+LL+   R    ++ DFGLS    V        GT  Y+ PE +  + +
Sbjct: 143 --VHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE-VLRKKY 199
Query: 290 TKKSDVYSFGVLLFELIAGRSPLQG 314
            +K DV+S GV+L+ L+ G  P  G
Sbjct: 200 DEKCDVWSCGVILYILLCGYPPFGG 224

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLAGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 99/222 (44%), Gaps = 12/222 (5%)
Query: 98  ASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYK-AQMSTGETVAVKV----LATDSKQGE 152
           A  IPE       +        +G+G F   ++ +   T E  A K+    L     Q E
Sbjct: 3   AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 62
Query: 153 KEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLR 212
           K    E+ +   L H+++V   G+  +     +V     + SL   L+           R
Sbjct: 63  K-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR 120
Query: 213 VHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAAN 271
            ++   +  G +YLH   V   IHRD+K  N+ L++ +  ++ DFGL+ +   D +    
Sbjct: 121 YYLR-QIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT 176
Query: 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
           + GT  Y+ PE +S +  + + DV+S G +++ L+ G+ P +
Sbjct: 177 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 149
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 264
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 265 YLLSLPHK--NKVPWNR 279

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLVG 175
           IG+G+FG V   Q + T +  A+K +         E +    E+ ++  L H  LVNL  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              ++    +V   +  G L  HL  +N       +++ I  ++   L+YL +  +   I
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFKEETVKLFIC-ELVMALDYLQNQRI---I 137
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN---FTKK 292
           HRD+K  NILLD+     + DF ++     +     + GT  Y+ PE  S+R    ++  
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFA 197
Query: 293 SDVYSFGVLLFELIAGRSP 311
            D +S GV  +EL+ GR P
Sbjct: 198 VDWWSLGVTAYELLRGRRP 216

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSANV---LH 151
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 266
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 267 YLLSLPHK--NKVPWNR 281

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEF---QTEVMLLGRL-HHRNLVNL 173
           +IG+G++  V   ++  T    A+KV+  +    +++    QTE  +  +  +H  LV L
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                 + +   V  +++ G L  H+  +   P   + R + A +++  L YLH+  +  
Sbjct: 87  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-HARFYSA-EISLALNYLHERGI-- 142
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYLDPEYISTRNFTKK 292
            I+RD+K  N+LLD     ++ D+G+ +E +      +   GT  Y+ PE +   ++   
Sbjct: 143 -IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFS 201
Query: 293 SDVYSFGVLLFELIAGRSPL 312
            D ++ GVL+FE++AGRSP 
Sbjct: 202 VDWWALGVLMFEMMAGRSPF 221

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRV---LH 126
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 187 IWSLGCIFAEMVTRRALFPG 206

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D   A    T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 167
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 228 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 282
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 283 YLLSLPHK--NKVPWNR 297

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 99/222 (44%), Gaps = 12/222 (5%)
Query: 98  ASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYK-AQMSTGETVAVKV----LATDSKQGE 152
           A  IPE       +        +G+G F   ++ +   T E  A K+    L     Q E
Sbjct: 3   AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 62
Query: 153 KEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLR 212
           K    E+ +   L H+++V   G+  +     +V     + SL   L+           R
Sbjct: 63  K-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR 120
Query: 213 VHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAAN 271
            ++   +  G +YLH   V   IHRD+K  N+ L++ +  ++ DFGL+ +   D +    
Sbjct: 121 YYLR-QIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT 176
Query: 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
           + GT  Y+ PE +S +  + + DV+S G +++ L+ G+ P +
Sbjct: 177 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 147
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 262
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 263 YLLSLPHK--NKVPWNR 277

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 107/229 (46%), Gaps = 30/229 (13%)
Query: 106 YKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGR 164
           ++D+ K T   + L+G+GA+  V  A  +  G+  AVK++   +         EV  L +
Sbjct: 10  FEDMYKLT---SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQ 66
Query: 165 LH-HRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLR--VHIALDVAR 221
              ++N++ L+ +  +  +  LV+  +  GS+ +H+  + +    +N R    +  DVA 
Sbjct: 67  CQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH----FNEREASRVVRDVAA 122
Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMR---ARVADFGLSREEMVDKHAANIR----- 273
            L++LH      + HRD+K  NIL +   +    ++ DF L     ++     I      
Sbjct: 123 ALDFLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELT 179
Query: 274 ---GTFGYLDPEYISTRN-----FTKKSDVYSFGVLLFELIAGRSPLQG 314
              G+  Y+ PE +         + K+ D++S GV+L+ +++G  P  G
Sbjct: 180 TPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVG 228

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D   A    T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 147
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNXIINLKARN 262
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 263 YLLSLPHK--NKVPWNR 277

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 151
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 266
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 267 YLLSLPHK--NKVPWNR 281

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 152
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 213 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 267
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 268 YLLSLPHK--NKVPWNR 282

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 147
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 262
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 263 YLLSLPHK--NKVPWNR 277

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 126
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 187 IWSLGCIFAEMVTRRALFPG 206

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 125
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 185
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 186 IWSLGCIFAEMVTRRALFPG 205

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVL-----ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G GA+G V   +   TG   A+K++      T S  G      EV +L +L H N++ L
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGA--LLDEVAVLKQLDHPNIMKL 69
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHL-YDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
             +  +K  + LV      G L   +   + +  +   +   I   V  G  YLH     
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---IMKQVLSGTTYLHK---H 123
Query: 233 PVIHRDIKSSNILLDQSMR---ARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNF 289
            ++HRD+K  N+LL+   R    ++ DFGLS    V        GT  Y+ PE +  + +
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLR-KKY 182
Query: 290 TKKSDVYSFGVLLFELIAGRSPLQG 314
            +K DV+S GV+L+ L+ G  P  G
Sbjct: 183 DEKCDVWSCGVILYILLCGYPPFGG 207

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 155
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 215
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 216 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 270
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 271 YLLSLPHK--NKVPWNR 285

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 147
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 262
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 263 YLLSLPHK--NKVPWNR 277

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 125
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 185
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 186 IWSLGCIFAEMVTRRALFPG 205

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGEKEFQT-EVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 151
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 266
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 267 YLLSLPHK--NKVPWNR 281

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 72  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 127
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 187
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 188 IWSLGCIFAEMVTRRALFPG 207

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 126
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 187 IWSLGCIFAEMVTRRALFPG 206

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 142
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D   A    T  Y  PE  ++  ++ +  
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMHYNQTV 200
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 201 DIWSVGCIMAELLTGRTLFPG 221

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 126
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 187 IWSLGCIFAEMVTRRALFPG 206

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 152
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 213 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 267
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 268 YLLSLPHK--NKVPWNR 282

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 153
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 214 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 268
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 269 YLLSLPHK--NKVPWNR 283

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 144
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 205 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 259
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 260 YLLSLPHK--NKVPWNR 274

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 151
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 266
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 267 YLLSLPHK--NKVPWNR 281

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   + M TG   A+K+L        K+ +    E  +L  ++   L  L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +   G + SHL     G          A  +    EYLH      +I
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLI 164
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+++DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G  +       A  +    EYLH      +I
Sbjct: 110 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 164
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 139/315 (44%), Gaps = 39/315 (12%)
Query: 97  SASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLAT-DSKQGEKEF 155
           S SG+P    + + +        +G+G +G V++     GE VAVK+ ++ D K   +E 
Sbjct: 23  SGSGLPFLVQRTVARQI-TLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRE- 79
Query: 156 QTEVMLLGRLHHRNLVNLVGYCA----EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNL 211
            TE+     L H N++  +           Q  L+  +   GSL  +L       ++   
Sbjct: 80  -TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS--- 135
Query: 212 RVHIALDVARGLEYLH-----DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266
            + I L +A GL +LH         P + HRD+KS NIL+ ++ +  +AD GL+      
Sbjct: 136 CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS 195
Query: 267 KHAANI-----RGTFGYLDPEY------ISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
            +  ++      GT  Y+ PE       +   +  K+ D+++FG++L+E +A R    G+
Sbjct: 196 TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWE-VARRMVSNGI 254
Query: 316 MEYVELAAMN-TEGKTGWEEI-----VDSRLDGI----FDVEELNEVASLAYKCVNRAPR 365
           +E  +    +       +E++     VD +   I    F    L  +A L  +C  + P 
Sbjct: 255 VEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPS 314
Query: 366 KRPSMRDIVQVLSRI 380
            R +   I + L++I
Sbjct: 315 ARLTALRIKKTLTKI 329

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 126
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 187 IWSLGCIFAEMVTRRALFPG 206

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 75  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 130
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 131 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 190
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 191 IWSLGCIFAEMVTRRALFPG 210

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 78  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 133
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 134 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 193
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 194 IWSLGCIFAEMVTRRALFPG 213

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 126/273 (46%), Gaps = 38/273 (13%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQGEKEFQTEVMLLGR-LHHRNLVNLVGY 176
           +G+GA+G V K + + +G+ +AVK + AT + Q +K    ++ +  R +     V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 177 CAEKGQHMLVYVFM--SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
              +G   +    M  S       + D+    +  ++   IA+ + + LE+LH      V
Sbjct: 75  LFREGDVWICMELMDTSLDKFYKQVIDKGQT-IPEDILGKIAVSIVKALEHLHSKL--SV 131
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI-RGTFGYLDPEYIST----RNF 289
           IHRD+K SN+L++   + ++ DFG+S   +VD  A +I  G   Y+ PE I+     + +
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDIDAGCKPYMAPERINPELNQKGY 190
Query: 290 TKKSDVYSFGVLLFELIAGR-------SPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
           + KSD++S G+ + EL   R       +P Q L + VE  +          E VD     
Sbjct: 191 SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD----- 245
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                          +C+ +  ++RP+  +++Q
Sbjct: 246 ------------FTSQCLKKNSKERPTYPELMQ 266

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 145
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 206 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 260
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 261 YLLSLPHK--NKVPWNR 275

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 74  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 129
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 189
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 190 IWSLGCIFAEMVTRRALFPG 209

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 126
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 127 RDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 187 IWSLGCIFAEMVTRRALFPG 206

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 73  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 128
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 129 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 188
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 189 IWSLGCIFAEMVTRRALFPG 208

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  ++  G + SHL     G          A  +    EYLH   +   I
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHSLDL---I 156
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 157 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 214
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 215 WALGVLIYEMAAGYPPF 231

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 73  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 128
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 129 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 188
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 189 IWSLGCIFAEMVTRRALFPG 208

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 74  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 129
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 189
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 190 IWSLGCIFAEMVTRRALFPG 209

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEF---QTEVMLLGRL-HHRNLVNL 173
           +IG+G++  V   ++  T    A+KV+  +    +++    QTE  +  +  +H  LV L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                 + +   V  +++ G L  H+  +   P   + R + A +++  L YLH+  +  
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-HARFYSA-EISLALNYLHERGI-- 131
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYLDPEYISTRNFTKK 292
            I+RD+K  N+LLD     ++ D+G+ +E +      +   GT  Y+ PE +   ++   
Sbjct: 132 -IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFS 190
Query: 293 SDVYSFGVLLFELIAGRSPL 312
            D ++ GVL+FE++AGRSP 
Sbjct: 191 VDWWALGVLMFEMMAGRSPF 210

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 126
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 187 IWSLGCIFAEMVTRRALFPG 206

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 72  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 127
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 187
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 188 IWSLGCIFAEMVTRRALFPG 207

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 73  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 128
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 129 RDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 188
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 189 IWSLGCIFAEMVTRRALFPG 208

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 46/278 (16%)
Query: 118 TLIGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           T +G GA+G V  A    +GE VA+K L+    S+   K    E++LL  + H N++ L+
Sbjct: 48  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 175 GYCAEKG------QHMLVYVFMS---KGSLASHLYDENYGPLTWNLRVHIALDVARGLEY 225
                           LV  FM    +  +     +E    L + +         +GL+Y
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQM--------LKGLKY 159
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYI- 284
           +H   V   +HRD+K  N+ +++    ++ DFGL+R    D        T  Y  PE I 
Sbjct: 160 IHSAGV---VHRDLKPGNLAVNEDCELKILDFGLARH--ADAEMTGYVVTRWYRAPEVIL 214
Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVE--LAAMNTEGKTGWEEIVDSRLDG 342
           S  ++ +  D++S G ++ E++ G++  +G  +Y++     +   G  G E         
Sbjct: 215 SWMHYNQTVDIWSVGCIMAEMLTGKTLFKG-KDYLDQLTQILKVTGVPGTEF-------- 265
Query: 343 IFDVEELNEVASLAY-KCVNRAPRKRPSMRDIVQVLSR 379
              V++LN+ A+ +Y + + + PRK     D  Q+  R
Sbjct: 266 ---VQKLNDKAAKSYIQSLPQTPRK-----DFTQLFPR 295

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 126
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVD 186
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 187 IWSLGCIFAEMVTRRALFPG 206

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 125
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 185
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 186 IWSLGCIFAEMVTRRALFPG 205

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEF---QTEVMLLGRL-HHRNLVNL 173
           +IG+G++  V   ++  T    A+KV+  +    +++    QTE  +  +  +H  LV L
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                 + +   V  +++ G L  H+  +   P   + R + A +++  L YLH+  +  
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-HARFYSA-EISLALNYLHERGI-- 127
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYLDPEYISTRNFTKK 292
            I+RD+K  N+LLD     ++ D+G+ +E +      +   GT  Y+ PE +   ++   
Sbjct: 128 -IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFS 186
Query: 293 SDVYSFGVLLFELIAGRSPL 312
            D ++ GVL+FE++AGRSP 
Sbjct: 187 VDWWALGVLMFEMMAGRSPF 206

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 72  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 127
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 128 RDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 187
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 188 IWSLGCIFAEMVTRRALFPG 207

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 151
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 266
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 267 YLLSLPHK--NKVPWNR 281

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G  +       A  +    EYLH      +I
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 184
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGATWTLCGTPEYLAPEIILSKGYNKAVDW 242
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 243 WALGVLIYEMAAGYPPF 259

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   TG   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +   G + SHL     G  +       A  +    EYLH      +I
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 164
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+++DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 75  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 130
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 131 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 190
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 191 IWSLGCIFAEMVTRRALFPG 210

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 125
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 185
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 186 IWSLGCIFAEMVTRRALFPG 205

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 126
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 187 IWSLGCIFAEMVTRRALFPG 206

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 72  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 127
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 187
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 188 IWSLGCIFAEMVTRRALFPG 207

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 12/222 (5%)
Query: 98  ASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYK-AQMSTGETVAVKV----LATDSKQGE 152
           A  IPE       +        +G+G F   ++ +   T E  A K+    L     Q E
Sbjct: 1   AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 153 KEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLR 212
           K    E+ +   L H+++V   G+  +     +V     + SL   L+           R
Sbjct: 61  K-MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR 118
Query: 213 VHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI 272
            ++   +  G +YLH   V   IHRD+K  N+ L++ +  ++ DFGL+ +   D     +
Sbjct: 119 YYLR-QIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174
Query: 273 R-GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
             GT  Y+ PE +S +  + + DV+S G +++ L+ G+ P +
Sbjct: 175 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 78  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 133
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 134 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVD 193
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 194 IWSLGCIFAEMVTRRALFPG 213

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 114/231 (49%), Gaps = 21/231 (9%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLA----TDSKQG-EKEFQTEVMLLGRLHHRNLVN 172
            +G+G F  VYKA+  +T + VA+K +     +++K G  +    E+ LL  L H N++ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L+     K    LV+ FM +  L   + D +      +++ ++ + + +GLEYLH   + 
Sbjct: 77  LLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTL-QGLEYLHQHWI- 133
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYI-STRNFT 290
             +HRD+K +N+LLD++   ++ADFGL++       A   +  T  Y  PE +   R + 
Sbjct: 134 --LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYG 191
Query: 291 KKSDVYSFGVLLFEL------IAGRSPLQGLMEYVELAAMNTEGKTGWEEI 335
              D+++ G +L EL      + G S L  L    E     TE +  W ++
Sbjct: 192 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ--WPDM 240

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 119 LIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEF---QTEVMLLGRL-HHRNLVNL 173
           +IG+G++  V   ++  T    A++V+  +    +++    QTE  +  +  +H  LV L
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                 + +   V  +++ G L  H+  +   P   + R + A +++  L YLH+  +  
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-HARFYSA-EISLALNYLHERGI-- 174
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYLDPEYISTRNFTKK 292
            I+RD+K  N+LLD     ++ D+G+ +E +      +   GT  Y+ PE +   ++   
Sbjct: 175 -IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 233
Query: 293 SDVYSFGVLLFELIAGRSPL 312
            D ++ GVL+FE++AGRSP 
Sbjct: 234 VDWWALGVLMFEMMAGRSPF 253

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 9/199 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQT-EVMLLGRLHHRNLVNLVGYC 177
           +G+G +  VYK +   T   VA+K +  + ++G       EV LL  L H N+V L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
             +    LV+ ++ K  L  +L D        N+++ +   + RGL Y H   V   +HR
Sbjct: 70  HTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFL-FQLLRGLAYCHRQKV---LHR 124
Query: 238 DIKSSNILLDQSMRARVADFGLSREEMV-DKHAANIRGTFGYLDPE-YISTRNFTKKSDV 295
           D+K  N+L+++    ++ADFGL+R + +  K   N   T  Y  P+  + + +++ + D+
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDM 184
Query: 296 YSFGVLLFELIAGRSPLQG 314
           +  G + +E+  GR    G
Sbjct: 185 WGVGCIFYEMATGRPLFPG 203

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT--EVMLLGRLH---HRNLVNL 173
           IG GA+G VYKA+   +G  VA+K +   + +      T  EV LL RL    H N+V L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 174 VGYCA-----EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +  CA      + +  LV+  + +  L ++L       L       +     RGL++LH 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
             +   +HRD+K  NIL+      ++ADFGL+R        A +  T  Y  PE +    
Sbjct: 131 NCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQST 187
Query: 289 FTKKSDVYSFGVLLFELIAGRSPL 312
           +    D++S G +  E+   R PL
Sbjct: 188 YATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 120/257 (46%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++    + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 167
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 168 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 228 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 282
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 283 YLLSLPHK--NKVPWNR 297

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G          A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 147
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 148 RDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNXIINLKARN 262
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 263 YLLSLPHK--NKVPWNR 277

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 108/233 (46%), Gaps = 19/233 (8%)
Query: 93  SNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQG 151
           S V +    P       Q+ +   T +IG G+FG VY+A++  +GE VA+K +     QG
Sbjct: 1   SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QG 56
Query: 152 EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKGSLASHLYDEN 203
           +     E+ ++ +L H N+V L  +    G+         +L YV  +   +A H     
Sbjct: 57  KAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAK 116
Query: 204 YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA-RVADFGLSRE 262
                  +++++   + R L Y+H      + HRDIK  N+LLD      ++ DFG +++
Sbjct: 117 QTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 263 EMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+    G
Sbjct: 173 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 26/222 (11%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY--- 176
           IG+G +G V+  +   GE VAVKV  T +++     +TE+     + H N++  +     
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFT-TEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 177 -CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV---- 231
                 Q  L+  +   GSL  +L       L     + +A     GL +LH        
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQG 159
Query: 232 -PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
            P + HRD+KS NIL+ ++    +AD GL+ + + D +  +I      GT  Y+ PE + 
Sbjct: 160 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD 219
Query: 286 ---TRNFTKK---SDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
               RN  +    +D+YSFG++L+E +A R    G++E  +L
Sbjct: 220 ESLNRNHFQSYIMADMYSFGLILWE-VARRCVSGGIVEEYQL 260

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G          A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFAEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   TG   A+K+L        K+ +    E  +   ++   LV L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEF 109
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +   G + SHL     G  +       A  +    EYLH      +I
Sbjct: 110 SFKDNSNLYMVLEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 164
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +VADFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 165 YRDLKPENLLIDQQGYIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 223 WALGVLIYEMAAGYPPF 239

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G          A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G          A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 119/290 (41%), Gaps = 54/290 (18%)
Query: 119 LIGQGAFGPVYKAQ--MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH--------- 167
           ++GQGAFG V KA+  + +      K+  T+ K       +EVMLL  L+H         
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST--ILSEVMLLASLNHQYVVRYYAA 70
Query: 168 ----RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLT---WNLRVHIALDVA 220
               RN V  +    +K    +   +   G+L   ++ EN        W L   I     
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL---- 126
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-----EMVDKHAANIR-- 273
             L Y+H   +   IHRD+K  NI +D+S   ++ DFGL++      +++   + N+   
Sbjct: 127 EALSYIHSQGI---IHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 274 --------GTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM 324
                   GT  Y+  E +  T ++ +K D+YS G++ FE+I    P    ME V +   
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK 240
Query: 325 NTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIV 374
                      V       FD  ++     +    ++  P KRP  R ++
Sbjct: 241 LRS--------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+++DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLIIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIIISKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G          A  +    EYLH      +I
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLI 184
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 242
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 243 WALGVLIYEMAAGYPPF 259

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 12/219 (5%)
Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYK-AQMSTGETVAVKV----LATDSKQGEKEF 155
           IPE       +        +G+G F   ++ +   T E  A K+    L     Q EK  
Sbjct: 30  IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-M 88
Query: 156 QTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHI 215
             E+ +   L H+++V   G+  +     +V     + SL   L+           R ++
Sbjct: 89  SMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYL 147
Query: 216 ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-G 274
              +  G +YLH   V   IHRD+K  N+ L++ +  ++ DFGL+ +   D     +  G
Sbjct: 148 R-QIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 203
Query: 275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
           T  Y+ PE +S +  + + DV+S G +++ L+ G+ P +
Sbjct: 204 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 103
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G          A  +    EYLH      +I
Sbjct: 104 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLI 158
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 159 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 216
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 217 WALGVLIYEMAAGYPPF 233

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 46/278 (16%)
Query: 118 TLIGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           T +G GA+G V  A    +GE VA+K L+    S+   K    E++LL  + H N++ L+
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 175 GYCAEKG------QHMLVYVFMS---KGSLASHLYDENYGPLTWNLRVHIALDVARGLEY 225
                           LV  FM    +  +     +E    L + +         +GL+Y
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM--------LKGLKY 141
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYI- 284
           +H   V   +HRD+K  N+ +++    ++ DFGL+R    D        T  Y  PE I 
Sbjct: 142 IHSAGV---VHRDLKPGNLAVNEDCELKILDFGLARH--ADAEMTGYVVTRWYRAPEVIL 196
Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVE--LAAMNTEGKTGWEEIVDSRLDG 342
           S  ++ +  D++S G ++ E++ G++  +G  +Y++     +   G  G E         
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGKTLFKG-KDYLDQLTQILKVTGVPGTEF-------- 247
Query: 343 IFDVEELNEVASLAY-KCVNRAPRKRPSMRDIVQVLSR 379
              V++LN+ A+ +Y + + + PRK     D  Q+  R
Sbjct: 248 ---VQKLNDKAAKSYIQSLPQTPRK-----DFTQLFPR 277

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 12/219 (5%)
Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYK-AQMSTGETVAVKV----LATDSKQGEKEF 155
           IPE       +        +G+G F   ++ +   T E  A K+    L     Q EK  
Sbjct: 28  IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-M 86
Query: 156 QTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHI 215
             E+ +   L H+++V   G+  +     +V     + SL   L+           R ++
Sbjct: 87  SMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYL 145
Query: 216 ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-G 274
              +  G +YLH   V   IHRD+K  N+ L++ +  ++ DFGL+ +   D     +  G
Sbjct: 146 R-QIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 201
Query: 275 TFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
           T  Y+ PE +S +  + + DV+S G +++ L+ G+ P +
Sbjct: 202 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA++ ++    Q   +    E+ +L R  H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 151
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 266
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 267 YLLSLPHK--NKVPWNR 281

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 108/233 (46%), Gaps = 19/233 (8%)
Query: 93  SNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQG 151
           S V +    P       Q+ +   T +IG G+FG VY+A++  +GE VA+K +     QG
Sbjct: 1   SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QG 56
Query: 152 EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKGSLASHLYDEN 203
           +     E+ ++ +L H N+V L  +    G+         +L YV  +   +A H     
Sbjct: 57  KAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116
Query: 204 YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA-RVADFGLSRE 262
                  +++++   + R L Y+H      + HRDIK  N+LLD      ++ DFG +++
Sbjct: 117 QTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 263 EMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+    G
Sbjct: 173 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 108/233 (46%), Gaps = 19/233 (8%)
Query: 93  SNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQG 151
           S V +    P       Q+ +   T +IG G+FG VY+A++  +GE VA+K +     QG
Sbjct: 1   SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QG 56
Query: 152 EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--------MLVYVFMSKGSLASHLYDEN 203
           +     E+ ++ +L H N+V L  +    G+         +L YV  +   +A H     
Sbjct: 57  KAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116
Query: 204 YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA-RVADFGLSRE 262
                  +++++   + R L Y+H      + HRDIK  N+LLD      ++ DFG +++
Sbjct: 117 QTLPVIYVKLYM-YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172
Query: 263 EMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            +  +   +   +  Y  PE I    ++T   DV+S G +L EL+ G+    G
Sbjct: 173 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++++ AG  P 
Sbjct: 222 WALGVLIYQMAAGYPPF 238

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 110/233 (47%), Gaps = 31/233 (13%)
Query: 109 LQKATCNFTTL---IGQGAFGPVYKAQMSTGETVAVKVLAT-DSKQGEKEFQTEVMLLGR 164
           +Q+   +  TL   +G+G +G V++     GE VAVK+ ++ D K   +E  TE+     
Sbjct: 2   MQRTVAHQITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRE--TELYNTVM 58
Query: 165 LHHRNLVNLVGYCA----EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           L H N++  +           Q  L+  +   GSL  +L       ++    + I L +A
Sbjct: 59  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSIA 115
Query: 221 RGLEYLH-----DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI--- 272
            GL +LH         P + HRD+KS NIL+ ++ +  +AD GL+       +  ++   
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 273 --RGTFGYLDPEY------ISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
              GT  Y+ PE       +   +  K+ D+++FG++L+E +A R    G++E
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWE-VARRMVSNGIVE 227

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 28/219 (12%)
Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLAT-DSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G+G +G V++     GE VAVK+ ++ D K   +E  TE+     L H N++  +    
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 72
Query: 179 ----EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH-----DG 229
                  Q  L+  +   GSL  +L       ++    + I L +A GL +LH       
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSIASGLAHLHIEIFGTQ 129
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI-----RGTFGYLDPEY- 283
             P + HRD+KS NIL+ ++ +  +AD GL+       +  ++      GT  Y+ PE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 284 -----ISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
                +   +  K+ D+++FG++L+E +A R    G++E
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWE-VARRMVSNGIVE 227

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSADI--- 142
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 201 DIWSVGCIMAELLTGRTLFPG 221

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVK-----VLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+G+FG V  A   +TG+ VA+K     VLA    QG  E   E+  L  L H +++ L
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 79
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                 K + ++V  + +   L  ++   +   ++          +   +EY H   +  
Sbjct: 80  YDVIKSKDEIIMVIEY-AGNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKI-- 134
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT-KK 292
            +HRD+K  N+LLD+ +  ++ADFGLS             G+  Y  PE IS + +   +
Sbjct: 135 -VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 193
Query: 293 SDVYSFGVLLFELIAGRSPL 312
            DV+S GV+L+ ++  R P 
Sbjct: 194 VDVWSCGVILYVMLCRRLPF 213

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVK-----VLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+G+FG V  A   +TG+ VA+K     VLA    QG  E   E+  L  L H +++ L
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 69
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                 K + ++V  + +   L  ++   +   ++          +   +EY H   +  
Sbjct: 70  YDVIKSKDEIIMVIEY-AGNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKI-- 124
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT-KK 292
            +HRD+K  N+LLD+ +  ++ADFGLS             G+  Y  PE IS + +   +
Sbjct: 125 -VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 183
Query: 293 SDVYSFGVLLFELIAGRSPL 312
            DV+S GV+L+ ++  R P 
Sbjct: 184 VDVWSCGVILYVMLCRRLPF 203

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVK-----VLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+G+FG V  A   +TG+ VA+K     VLA    QG  E   E+  L  L H +++ L
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 78
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                 K + ++V  + +   L  ++   +   ++          +   +EY H   +  
Sbjct: 79  YDVIKSKDEIIMVIEY-AGNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKI-- 133
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT-KK 292
            +HRD+K  N+LLD+ +  ++ADFGLS             G+  Y  PE IS + +   +
Sbjct: 134 -VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 192
Query: 293 SDVYSFGVLLFELIAGRSPL 312
            DV+S GV+L+ ++  R P 
Sbjct: 193 VDVWSCGVILYVMLCRRLPF 212

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           +IG+GAFG V   +  ST +  A+K+L+     K+ +  F  E   +    +   V  + 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 176 YCAEKGQHM-LVYVFMSKGSLASHLYDENYG-PLTWNLRVHIALDVARGLEYLHDGAVPP 233
           Y  +  +++ +V  +M  G L + +   NY  P  W  R + A +V   L+ +H      
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EVVLALDAIHSMGF-- 189
Query: 234 VIHRDIKSSNILLDQSMRARVADFG----LSREEMVDKHAANIRGTFGYLDPEYISTRN- 288
            IHRD+K  N+LLD+S   ++ADFG    +++E MV    A   GT  Y+ PE + ++  
Sbjct: 190 -IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGG 246
Query: 289 ---FTKKSDVYSFGVLLFELIAGRSPL 312
              + ++ D +S GV L+E++ G +P 
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 15/224 (6%)
Query: 97  SASGIPEY----SYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQG 151
           +AS +P+Y    S +D         + +G+GA   VY+  Q  T +  A+KVL     + 
Sbjct: 34  TASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK- 92
Query: 152 EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNL 211
            K  +TE+ +L RL H N++ L        +  LV   ++ G L   + ++ Y   +   
Sbjct: 93  -KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY--YSERD 149
Query: 212 RVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---SMRARVADFGLSREEMVDKH 268
                  +   + YLH+  +   +HRD+K  N+L          ++ADFGLS+       
Sbjct: 150 AADAVKQILEAVAYLHENGI---VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206
Query: 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
              + GT GY  PE +    +  + D++S G++ + L+ G  P 
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVK-----VLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+G+FG V  A   +TG+ VA+K     VLA    QG  E   E+  L  L H +++ L
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 73
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                 K + ++V  + +   L  ++   +   ++          +   +EY H   +  
Sbjct: 74  YDVIKSKDEIIMVIEY-AGNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKI-- 128
Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT-KK 292
            +HRD+K  N+LLD+ +  ++ADFGLS             G+  Y  PE IS + +   +
Sbjct: 129 -VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 187
Query: 293 SDVYSFGVLLFELIAGRSPL 312
            DV+S GV+L+ ++  R P 
Sbjct: 188 VDVWSCGVILYVMLCRRLPF 207

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           +IG+GAFG V   +  ST +  A+K+L+     K+ +  F  E   +    +   V  + 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 176 YCAEKGQHM-LVYVFMSKGSLASHLYDENYG-PLTWNLRVHIALDVARGLEYLHDGAVPP 233
           Y  +  +++ +V  +M  G L + +   NY  P  W  R + A +V   L+ +H      
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EVVLALDAIHSMGF-- 194
Query: 234 VIHRDIKSSNILLDQSMRARVADFG----LSREEMVDKHAANIRGTFGYLDPEYISTRN- 288
            IHRD+K  N+LLD+S   ++ADFG    +++E MV    A   GT  Y+ PE + ++  
Sbjct: 195 -IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGG 251
Query: 289 ---FTKKSDVYSFGVLLFELIAGRSPL 312
              + ++ D +S GV L+E++ G +P 
Sbjct: 252 DGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 95
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G  +       A  +    EYLH      +I
Sbjct: 96  SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 150
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+D+    +V DFG ++   V      + GT  YL PE I ++ + K  D 
Sbjct: 151 YRDLKPENLLIDEQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 208
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 209 WALGVLIYEMAAGYPPF 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           +IG+GAFG V   +  ST +  A+K+L+     K+ +  F  E   +    +   V  + 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 176 YCAEKGQHM-LVYVFMSKGSLASHLYDENYG-PLTWNLRVHIALDVARGLEYLHDGAVPP 233
           Y  +  +++ +V  +M  G L + +   NY  P  W  R + A +V   L+ +H      
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EVVLALDAIHSMGF-- 194
Query: 234 VIHRDIKSSNILLDQSMRARVADFG----LSREEMVDKHAANIRGTFGYLDPEYISTRN- 288
            IHRD+K  N+LLD+S   ++ADFG    +++E MV    A   GT  Y+ PE + ++  
Sbjct: 195 -IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGG 251
Query: 289 ---FTKKSDVYSFGVLLFELIAGRSPL 312
              + ++ D +S GV L+E++ G +P 
Sbjct: 252 DGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 156
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 157 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 214
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 215 DIWSVGCIMAELLTGRTLFPG 235

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 35/231 (15%)
Query: 106 YKDLQKATCNFTTL--------IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKE 154
           +  +Q A   FT L        IG GA G V  A     G  VAVK L+    ++   K 
Sbjct: 8   FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKR 67
Query: 155 FQTEVMLLGRLHHRNLVNLVG-YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV 213
              E++LL  ++H+N+++L+  +  +K       V+     L   L D N   +     +
Sbjct: 68  AYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVY-----LVMELMDANLCQV-----I 117
Query: 214 HIALDVAR----------GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263
           H+ LD  R          G+++LH   +   IHRD+K SNI++      ++ DFGL+R  
Sbjct: 118 HMELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA 174
Query: 264 MVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
             +        T  Y  PE I    + +  D++S G ++ EL+ G    QG
Sbjct: 175 STNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 225

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 166
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 224
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 225 DIWSVGCIMAELLTGRTLFPG 245

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 165
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 166 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 223
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 224 DIWSVGCIMAELLTGRTLFPG 244

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+  +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 126
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 186
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 187 IWSLGCIFAEMVTRRALFPG 206

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+  +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+ F+ +  L   +       +   L       + +GL + H   V   +H
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 125
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 185
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 186 IWSLGCIFAEMVTRRALFPG 205

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 166
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMXGXVATRWYRAPEIMLNWMHYNQTV 224
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 225 DIWSVGCIMAELLTGRTLFPG 245

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 36/217 (16%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTE--VMLLGRLHHRNLVN-LVG 175
           LIG+G +G VYK  +     VAVKV +  ++Q    F  E  +  +  + H N+   +VG
Sbjct: 20  LIGRGRYGAVYKGSLDE-RPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFIVG 75
Query: 176 ----YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH---- 227
                   + +++LV  +   GSL  +L   +     W     +A  V RGL YLH    
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAYLHTELP 132
Query: 228 --DGAVPPVIHRDIKSSNILLDQSMRARVADFGLS---------REEMVDKHAANIRGTF 276
             D   P + HRD+ S N+L+       ++DFGLS         R    D  A +  GT 
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192
Query: 277 GYLDPEYI-------STRNFTKKSDVYSFGVLLFELI 306
            Y+ PE +          +  K+ D+Y+ G++ +E+ 
Sbjct: 193 RYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 152
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 211 DIWSVGCIMAELLTGRTLFPG 231

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 142
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 201 DIWSVGCIMAELLTGRTLFPG 221

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 151
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 152 IHRDLKPSNLAVNEDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 209
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 210 DIWSVGCIMAELLTGRTLFPG 230

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 129/285 (45%), Gaps = 41/285 (14%)
Query: 116 FTTLIGQGAFGPVYKA---------QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH 166
           F   +GQG F  ++K          Q+   E V +KVL    +   + F     ++ +L 
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETE-VLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 167 HRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-YDENYGPLTWNLRVHIALDVARGLEY 225
           H++LV   G C    +++LV  F+  GSL ++L  ++N   + W L V  A  +A  + +
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV--AKQLAAAMHF 128
Query: 226 LHDGAVPPVIHRDIKSSNILL--------DQSMRARVADFGLSREEMVDKHAANIRGTFG 277
           L +     +IH ++ + NILL              +++D G+S   ++ K     R    
Sbjct: 129 LEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI-TVLPKDILQER--IP 182
Query: 278 YLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           ++ PE I + +N    +D +SFG  L+E+ +G            L+A++++ K  + E  
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK--------PLSALDSQRKLQFYEDR 234
Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
                      +  E+A+L   C++  P  RPS R I++ L+ + 
Sbjct: 235 HQ-----LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 116/277 (41%), Gaps = 32/277 (11%)
Query: 120 IGQGAFGPVYKAQ--MSTGETVAVKVLATDSKQGEKEFQT--EVMLLGRLH---HRNLVN 172
           IG+GA+G V+KA+   + G  VA+K +   + +      T  EV +L  L    H N+V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 173 LVGYCA---EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVH-IALDVARGLEYLHD 228
           L   C       +  L  VF       +   D+   P      +  +   + RGL++LH 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
             V   +HRD+K  NIL+  S + ++ADFGL+R         ++  T  Y  PE +   +
Sbjct: 139 HRV---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 195
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA----AMNTEGKTGWEEIVDSRLDG-- 342
           +    D++S G +  E+   +   +G  +  +L      +   G+  W   V        
Sbjct: 196 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH 255
Query: 343 ----------IFDVEELNEVASLAYKCVNRAPRKRPS 369
                     + D++EL +   L  KC+   P KR S
Sbjct: 256 SKSAQPIEKFVTDIDELGK--DLLLKCLTFNPAKRIS 290

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 120/257 (46%), Gaps = 19/257 (7%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 149
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELA-AMNTEGKTGWEEIVDSRLDGIFDVEELN 350
             D++S G +L E+++ R    G     +L   +   G    E+     L+ I +++  N
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-----LNCIINLKARN 264
Query: 351 EVASLAYKCVNRAPRKR 367
            + SL +K  N+ P  R
Sbjct: 265 YLLSLPHK--NKVPWNR 279

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNAMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT  YL P  I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPAIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 158
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 216
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 217 DIWSVGCIMAELLTGRTLFPG 237

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 110/269 (40%), Gaps = 25/269 (9%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD----SKQGEKEFQTEVMLLGRLHHRNL 170
            F   IG+G+F  VYK  + T  TV V          +K   + F+ E   L  L H N+
Sbjct: 29  KFDIEIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNI 87
Query: 171 VNLVGYCAE--KGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYL 226
           V          KG+  +V V    + G+L ++L  + +      +       + +GL++L
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELXTSGTLKTYL--KRFKVXKIKVLRSWCRQILKGLQFL 145
Query: 227 HDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIS 285
           H    PP+IHRD+K  NI +   +   ++ D GL+  +     A  + GT  +  PE   
Sbjct: 146 HT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFXAPEXYE 203
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            + + +  DVY+FG    E      P        ++    T G               FD
Sbjct: 204 EK-YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVK----------PASFD 252
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIV 374
              + EV  +   C+ +   +R S++D++
Sbjct: 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLL 281

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG+G +G V+KA+   T E VA+K V   D  +G       E+ LL  L H+N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                +  LV+ F  +       +D   G L   +       + +GL + H   V   +H
Sbjct: 70  LHSDKKLTLVFEFCDQD--LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV---LH 124
Query: 237 RDIKSSNILLDQSMRARVADFGLSREE--MVDKHAANIRGTFGYLDPEYI-STRNFTKKS 293
           RD+K  N+L++++   ++ADFGL+R     V  ++A +  T  Y  P+ +   + ++   
Sbjct: 125 RDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSI 183
Query: 294 DVYSFGVLLFELIAGRSPL 312
           D++S G +  EL     PL
Sbjct: 184 DMWSAGCIFAELANAARPL 202

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 158
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 216
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 217 DIWSVGCIMAELLTGRTLFPG 237

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 158
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 216
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 217 DIWSVGCIMAELLTGRTLFPG 237

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGY 176
           ++G+GA   V     + T +  AVK++             EV +L +   HRN++ L+ +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
             E+ +  LV+  M  GS+ SH++   ++  L  ++ V    DVA  L++LH+     + 
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ---DVASALDFLHNKG---IA 133
Query: 236 HRDIKSSNILLD---QSMRARVADFGLSREEMVDKHAANIR--------GTFGYLDPEYI 284
           HRD+K  NIL +   Q    ++ DFGL     ++   + I         G+  Y+ PE +
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 285 STRN-----FTKKSDVYSFGVLLFELIAGRSPLQG 314
              +     + K+ D++S GV+L+ L++G  P  G
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 148
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 206
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 207 DIWSVGCIMAELLTGRTLFPG 227

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 116/277 (41%), Gaps = 32/277 (11%)
Query: 120 IGQGAFGPVYKAQ--MSTGETVAVKVLATDSKQGEKEFQT--EVMLLGRLH---HRNLVN 172
           IG+GA+G V+KA+   + G  VA+K +   + +      T  EV +L  L    H N+V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 173 LVGYCA---EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVH-IALDVARGLEYLHD 228
           L   C       +  L  VF       +   D+   P      +  +   + RGL++LH 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
             V   +HRD+K  NIL+  S + ++ADFGL+R         ++  T  Y  PE +   +
Sbjct: 139 HRV---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 195
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA----AMNTEGKTGWEEIVDSRLDG-- 342
           +    D++S G +  E+   +   +G  +  +L      +   G+  W   V        
Sbjct: 196 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH 255
Query: 343 ----------IFDVEELNEVASLAYKCVNRAPRKRPS 369
                     + D++EL +   L  KC+   P KR S
Sbjct: 256 SKSAQPIEKFVTDIDELGK--DLLLKCLTFNPAKRIS 290

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 148
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 206
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 207 DIWSVGCIMAELLTGRTLFPG 227

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 157
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 158 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 215
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 216 DIWSVGCIMAELLTGRTLFPG 236

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 17/186 (9%)
Query: 167 HRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL-DVARGLEY 225
           H N++ L           LV+  M KG L  +L ++         ++  AL +V   L  
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIS 285
           L+      ++HRD+K  NILLD  M  ++ DFG S +    +   ++ GT  YL PE I 
Sbjct: 143 LN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIE 196
Query: 286 TR------NFTKKSDVYSFGVLLFELIAGRSPL----QGLMEYVELAAMNTEGKTGWEEI 335
                    + K+ D++S GV+++ L+AG  P     Q LM  + ++     G   W++ 
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 256
Query: 336 VDSRLD 341
            D+  D
Sbjct: 257 SDTVKD 262

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGXVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 11/203 (5%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A     +T VA+K ++    Q   +    E+ +L R  H N++ +    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANV---LH 167
Query: 237 RDIKSSNILLDQSMRARVADFGLSR----EEMVDKHAANIRGTFGYLDPE-YISTRNFTK 291
           RD+K SN+L++ +   ++ DFGL+R    E            T  Y  PE  ++++ +TK
Sbjct: 168 RDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTK 227
Query: 292 KSDVYSFGVLLFELIAGRSPLQG 314
             D++S G +L E+++ R    G
Sbjct: 228 SIDIWSVGCILAEMLSNRPIFPG 250

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 177 CAEKGQHMLVY--------VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
              + +  LV+         FM   +L           +   L       + +GL + H 
Sbjct: 70  IHTENKLYLVFEHVHQDLKTFMDASALTG---------IPLPLIKSYLFQLLQGLAFCHS 120
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YIST 286
             V   +HRD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  
Sbjct: 121 HRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           + ++   D++S G +  E++  R+   G
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPG 205

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 151
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 152 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 209
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 210 DIWSVGCIMAELLTGRTLFPG 230

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 148
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 206
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 207 DIWSVGCIMAELLTGRTLFPG 227

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 89  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 145
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 146 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 203
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 204 DIWSVGCIMAELLTGRTLFPG 224

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT--EVMLLGRLH---HRNLVNL 173
           IG GA+G VYKA+   +G  VA+K +   + +      T  EV LL RL    H N+V L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 174 VGYCA-----EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +  CA      + +  LV+  + +  L ++L       L       +     RGL++LH 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
             +   +HRD+K  NIL+      ++ADFGL+R          +  T  Y  PE +    
Sbjct: 131 NCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQST 187
Query: 289 FTKKSDVYSFGVLLFELIAGRSPL 312
           +    D++S G +  E+   R PL
Sbjct: 188 YATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 116/277 (41%), Gaps = 32/277 (11%)
Query: 120 IGQGAFGPVYKAQ--MSTGETVAVKVLATDSKQGEKEFQT--EVMLLGRLH---HRNLVN 172
           IG+GA+G V+KA+   + G  VA+K +   + +      T  EV +L  L    H N+V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 173 LVGYCA---EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVH-IALDVARGLEYLHD 228
           L   C       +  L  VF       +   D+   P      +  +   + RGL++LH 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
             V   +HRD+K  NIL+  S + ++ADFGL+R         ++  T  Y  PE +   +
Sbjct: 139 HRV---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 195
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA----AMNTEGKTGWEEIVDSRLDG-- 342
           +    D++S G +  E+   +   +G  +  +L      +   G+  W   V        
Sbjct: 196 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH 255
Query: 343 ----------IFDVEELNEVASLAYKCVNRAPRKRPS 369
                     + D++EL +   L  KC+   P KR S
Sbjct: 256 SKSAQPIEKFVTDIDELGK--DLLLKCLTFNPAKRIS 290

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 153
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 211
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 212 DIWSVGCIMAELLTGRTLFPG 232

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 157
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 158 IHRDLKPSNLAVNEDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 215
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 216 DIWSVGCIMAELLTGRTLFPG 236

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 143
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 144 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 201
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 202 DIWSVGCIMAELLTGRTLFPG 222

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 111/248 (44%), Gaps = 38/248 (15%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT------DSKQGEKEF--QTEVMLLGRLHHRNL 170
           +G GA G V  A +  T + VA+K+++        +++ +     +TE+ +L +L+H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIA------LDVARGLE 224
           + +  +  +   + +V   M  G     L+D+  G    N R+  A        +   ++
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGG----ELFDKVVG----NKRLKEATCKLYFYQMLLAVQ 128
Query: 225 YLHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
           YLH+  +   IHRD+K  N+LL   ++    ++ DFG S+          + GT  YL P
Sbjct: 129 YLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 282 EY---ISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG-----WE 333
           E    + T  + +  D +S GV+LF  ++G  P       V L    T GK       W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 334 EIVDSRLD 341
           E+ +  LD
Sbjct: 246 EVSEKALD 253

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT--EVMLLGRLH---HRNLVNL 173
           IG GA+G VYKA+   +G  VA+K +   + +      T  EV LL RL    H N+V L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 174 VGYCA-----EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +  CA      + +  LV+  + +  L ++L       L       +     RGL++LH 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
             +   +HRD+K  NIL+      ++ADFGL+R          +  T  Y  PE +    
Sbjct: 131 NCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQST 187
Query: 289 FTKKSDVYSFGVLLFELIAGRSPL 312
           +    D++S G +  E+   R PL
Sbjct: 188 YATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 109/243 (44%), Gaps = 28/243 (11%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT------DSKQGEKEF--QTEVMLLGRLHHRNL 170
           +G GA G V  A +  T + VA+K+++        +++ +     +TE+ +L +L+H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLY-DENYGPLTWNLRVHIALDVARGLEYLHDG 229
           + +  +  +   + +V   M  G L   +  ++     T  L  +  L     ++YLH+ 
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---LAVQYLHEN 133
Query: 230 AVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEY--- 283
            +   IHRD+K  N+LL   ++    ++ DFG S+          + GT  YL PE    
Sbjct: 134 GI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 190
Query: 284 ISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG-----WEEIVDS 338
           + T  + +  D +S GV+LF  ++G  P       V L    T GK       W E+ + 
Sbjct: 191 VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK 250
Query: 339 RLD 341
            LD
Sbjct: 251 ALD 253

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 152
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 211 DIWSVGCIMAELLTGRTLFPG 231

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 111/248 (44%), Gaps = 38/248 (15%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT------DSKQGEKEF--QTEVMLLGRLHHRNL 170
           +G GA G V  A +  T + VA+K+++        +++ +     +TE+ +L +L+H  +
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIA------LDVARGLE 224
           + +  +  +   + +V   M  G     L+D+  G    N R+  A        +   ++
Sbjct: 77  IKIKNF-FDAEDYYIVLELMEGG----ELFDKVVG----NKRLKEATCKLYFYQMLLAVQ 127
Query: 225 YLHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
           YLH+  +   IHRD+K  N+LL   ++    ++ DFG S+          + GT  YL P
Sbjct: 128 YLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 184
Query: 282 EY---ISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG-----WE 333
           E    + T  + +  D +S GV+LF  ++G  P       V L    T GK       W 
Sbjct: 185 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 244
Query: 334 EIVDSRLD 341
           E+ +  LD
Sbjct: 245 EVSEKALD 252

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 151
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 152 IHRDLKPSNLAVNEDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 209
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 210 DIWSVGCIMAELLTGRTLFPG 230

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 143
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 144 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 201
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 202 DIWSVGCIMAELLTGRTLFPG 222

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 109/243 (44%), Gaps = 28/243 (11%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT------DSKQGEKEF--QTEVMLLGRLHHRNL 170
           +G GA G V  A +  T + VA+K+++        +++ +     +TE+ +L +L+H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLY-DENYGPLTWNLRVHIALDVARGLEYLHDG 229
           + +  +  +   + +V   M  G L   +  ++     T  L  +  L     ++YLH+ 
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---LAVQYLHEN 133
Query: 230 AVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEY--- 283
            +   IHRD+K  N+LL   ++    ++ DFG S+          + GT  YL PE    
Sbjct: 134 GI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 190
Query: 284 ISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG-----WEEIVDS 338
           + T  + +  D +S GV+LF  ++G  P       V L    T GK       W E+ + 
Sbjct: 191 VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK 250
Query: 339 RLD 341
            LD
Sbjct: 251 ALD 253

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 165
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 166 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 223
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 224 DIWSVGCIMAELLTGRTLFPG 244

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 169
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 170 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 227
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 228 DIWSVGCIMAELLTGRTLFPG 248

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 151
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 152 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 209
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 210 DIWSVGCIMAELLTGRTLFPG 230

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 17/186 (9%)
Query: 167 HRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL-DVARGLEY 225
           H N++ L           LV+  M KG L  +L ++         ++  AL +V   L  
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIS 285
           L+      ++HRD+K  NILLD  M  ++ DFG S +    +    + GT  YL PE I 
Sbjct: 143 LN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 196
Query: 286 TR------NFTKKSDVYSFGVLLFELIAGRSPL----QGLMEYVELAAMNTEGKTGWEEI 335
                    + K+ D++S GV+++ L+AG  P     Q LM  + ++     G   W++ 
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 256
Query: 336 VDSRLD 341
            D+  D
Sbjct: 257 SDTVKD 262

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 142
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 201 DIWSVGCIMAELLTGRTLFPG 221

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 169
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 170 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMXGYVATRWYRAPEIMLNWMHYNQTV 227
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 228 DIWSVGCIMAELLTGRTLFPG 248

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 166
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 224
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 225 DIWSVGCIMAELLTGRTLFPG 245

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 17/186 (9%)
Query: 167 HRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL-DVARGLEY 225
           H N++ L           LV+  M KG L  +L ++         ++  AL +V   L  
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 129
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIS 285
           L+      ++HRD+K  NILLD  M  ++ DFG S +    +    + GT  YL PE I 
Sbjct: 130 LN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 183
Query: 286 TR------NFTKKSDVYSFGVLLFELIAGRSPL----QGLMEYVELAAMNTEGKTGWEEI 335
                    + K+ D++S GV+++ L+AG  P     Q LM  + ++     G   W++ 
Sbjct: 184 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 243
Query: 336 VDSRLD 341
            D+  D
Sbjct: 244 SDTVKD 249

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 111/248 (44%), Gaps = 38/248 (15%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT------DSKQGEKEF--QTEVMLLGRLHHRNL 170
           +G GA G V  A +  T + VA+K+++        +++ +     +TE+ +L +L+H  +
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIA------LDVARGLE 224
           + +  +  +   + +V   M  G     L+D+  G    N R+  A        +   ++
Sbjct: 84  IKIKNF-FDAEDYYIVLELMEGG----ELFDKVVG----NKRLKEATCKLYFYQMLLAVQ 134
Query: 225 YLHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
           YLH+  +   IHRD+K  N+LL   ++    ++ DFG S+          + GT  YL P
Sbjct: 135 YLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 191
Query: 282 EY---ISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG-----WE 333
           E    + T  + +  D +S GV+LF  ++G  P       V L    T GK       W 
Sbjct: 192 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 251
Query: 334 EIVDSRLD 341
           E+ +  LD
Sbjct: 252 EVSEKALD 259

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVL-----ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
           +IG+G F  V +     TG+  AVK++      +      ++ + E  +   L H ++V 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV--HIALDVARGLEYLHDGA 230
           L+   +  G   +V+ FM    L   +         ++  V  H    +   L Y HD  
Sbjct: 93  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 152
Query: 231 VPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYIST 286
           +   IHRD+K   +LL   + S   ++  FG++ +       A  R GT  ++ PE +  
Sbjct: 153 I---IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR 209
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
             + K  DV+  GV+LF L++G  P  G  E
Sbjct: 210 EPYGKPVDVWGCGVILFILLSGCLPFYGTKE 240

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 144
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 145 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 202
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 203 DIWSVGCIMAELLTGRTLFPG 223

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 152
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 211 DIWSVGCIMAELLTGRTLFPG 231

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 129/285 (45%), Gaps = 41/285 (14%)
Query: 116 FTTLIGQGAFGPVYKA---------QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH 166
           F   +GQG F  ++K          Q+   E V +KVL    +   + F     ++ +L 
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETE-VLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 167 HRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-YDENYGPLTWNLRVHIALDVARGLEY 225
           H++LV   G C    +++LV  F+  GSL ++L  ++N   + W L V  A  +A  + +
Sbjct: 71  HKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV--AKQLAWAMHF 128
Query: 226 LHDGAVPPVIHRDIKSSNILL--------DQSMRARVADFGLSREEMVDKHAANIRGTFG 277
           L +     +IH ++ + NILL              +++D G+S   ++ K     R    
Sbjct: 129 LEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI-TVLPKDILQER--IP 182
Query: 278 YLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
           ++ PE I + +N    +D +SFG  L+E+ +G            L+A++++ K  + E  
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK--------PLSALDSQRKLQFYEDR 234
Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
                      +  E+A+L   C++  P  RPS R I++ L+ + 
Sbjct: 235 HQ-----LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 35/231 (15%)
Query: 106 YKDLQKATCNFTTL--------IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKE 154
           +  ++ A   FT L        IG GA G V  A     G  VAVK L+    ++   K 
Sbjct: 10  FYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKR 69
Query: 155 FQTEVMLLGRLHHRNLVNLVG-YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV 213
              E++LL  ++H+N+++L+  +  +K       V+     L   L D N   +     +
Sbjct: 70  AYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVY-----LVMELMDANLCQV-----I 119
Query: 214 HIALDVAR----------GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263
           H+ LD  R          G+++LH   +   IHRD+K SNI++      ++ DFGL+R  
Sbjct: 120 HMELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA 176
Query: 264 MVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
             +        T  Y  PE I    +    D++S G ++ EL+ G    QG
Sbjct: 177 CTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQG 227

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 152
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 153 IHRDLKPSNLAVNEDSELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 211 DIWSVGCIMAELLTGRTLFPG 231

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 148
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 149 IHRDLKPSNLAVNEDSELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 206
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 207 DIWSVGCIMAELLTGRTLFPG 227

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 115 NFTTLIGQGAFGPVYKAQMSTGETV-AVKVLA---TDSKQGEKEFQTEVMLLGRLHHRNL 170
           +   +IG+GAFG V   +    + V A+K+L+      +     F  E  ++   +   +
Sbjct: 78  DVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 137
Query: 171 VNLVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYG-PLTWNLRVHIALDVARGLEYLH 227
           V L  +CA +    L  V  +M  G L + +   NY  P  W  + + A +V   L+ +H
Sbjct: 138 VQL--FCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKW-AKFYTA-EVVLALDAIH 191
Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFG--LSREEMVDKHAANIRGTFGYLDPEYIS 285
              +   IHRD+K  N+LLD+    ++ADFG  +  +E    H     GT  Y+ PE + 
Sbjct: 192 SMGL---IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLK 248
Query: 286 TRN----FTKKSDVYSFGVLLFELIAGRSPL 312
           ++     + ++ D +S GV LFE++ G +P 
Sbjct: 249 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVL-----ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
           +IG+G F  V +     TG+  AVK++      +      ++ + E  +   L H ++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV--HIALDVARGLEYLHDGA 230
           L+   +  G   +V+ FM    L   +         ++  V  H    +   L Y HD  
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 231 VPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYIST 286
           +   IHRD+K   +LL   + S   ++  FG++ +       A  R GT  ++ PE +  
Sbjct: 151 I---IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR 207
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
             + K  DV+  GV+LF L++G  P  G  E
Sbjct: 208 EPYGKPVDVWGCGVILFILLSGCLPFYGTKE 238

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 11/197 (5%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++   V      + GT   L PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWXLCGTPEALAPEIILSKGYNKAVDW 221
Query: 296 YSFGVLLFELIAGRSPL 312
           ++ GVL++E+ AG  P 
Sbjct: 222 WALGVLIYEMAAGYPPF 238

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV---HIAL---DVARGLEYLHDG 229
           +   +       V+     L +HL   +   +  + ++   H+      + RGL+Y+H  
Sbjct: 90  FTPARSLEEFNDVY-----LVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRN 288
            +   IHRD+K SN+ +++    ++ DFGL R    D        T  Y  PE  ++  +
Sbjct: 145 DI---IHRDLKPSNLAVNEDSELKILDFGLCRH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
           + +  D++S G ++ EL+ GR+   G
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPG 225

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 9/200 (4%)
Query: 120 IGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGEKEFQT-EVMLLGRLHHRNLVNLVGY 176
           IG+G +G VYKA+   TGE VA+K +  D++ +G       E+ LL  L+H N+V L+  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              + +  LV+  + +  L   +       +   L       + +GL + H   V   +H
Sbjct: 74  IHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LH 129
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTRNFTKKSD 294
           RD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  + ++   D
Sbjct: 130 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVD 189
Query: 295 VYSFGVLLFELIAGRSPLQG 314
           ++S G +  E++  R+   G
Sbjct: 190 IWSLGCIFAEMVTRRALFPG 209

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +    +  S++G   +E + EV +L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      +   +L+   +S G L   L  +    L+          +  G+ YLH   + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIA 137
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++     ++ DFGL+ E        NI GT  ++ PE ++   
Sbjct: 138 ---HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP 194
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
              ++D++S GV+ + L++G SP  G
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLG 220

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 118/290 (40%), Gaps = 54/290 (18%)
Query: 119 LIGQGAFGPVYKAQ--MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH--------- 167
           ++GQGAFG V KA+  + +      K+  T+ K       +EVMLL  L+H         
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST--ILSEVMLLASLNHQYVVRYYAA 70
Query: 168 ----RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLT---WNLRVHIALDVA 220
               RN V  +    +K    +   +    +L   ++ EN        W L   I     
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL---- 126
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-----EMVDKHAANIR-- 273
             L Y+H   +   IHRD+K  NI +D+S   ++ DFGL++      +++   + N+   
Sbjct: 127 EALSYIHSQGI---IHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 274 --------GTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM 324
                   GT  Y+  E +  T ++ +K D+YS G++ FE+I    P    ME V +   
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK 240
Query: 325 NTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIV 374
                      V       FD  ++     +    ++  P KRP  R ++
Sbjct: 241 LRS--------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ D+GL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDYGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 109/243 (44%), Gaps = 28/243 (11%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT------DSKQGEKEF--QTEVMLLGRLHHRNL 170
           +G GA G V  A +  T + VA+++++        +++ +     +TE+ +L +L+H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLY-DENYGPLTWNLRVHIALDVARGLEYLHDG 229
           + +  +  +   + +V   M  G L   +  ++     T  L  +  L     ++YLH+ 
Sbjct: 203 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---LAVQYLHEN 258
Query: 230 AVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEY--- 283
            +   IHRD+K  N+LL   ++    ++ DFG S+          + GT  YL PE    
Sbjct: 259 GI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 315
Query: 284 ISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG-----WEEIVDS 338
           + T  + +  D +S GV+LF  ++G  P       V L    T GK       W E+ + 
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK 375
Query: 339 RLD 341
            LD
Sbjct: 376 ALD 378

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +    +  S++G   +E + EV +L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      +   +L+   +S G L   L  +    L+          +  G+ YLH   + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIA 137
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++     ++ DFGL+ E        NI GT  ++ PE ++   
Sbjct: 138 ---HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP 194
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
              ++D++S GV+ + L++G SP  G
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLG 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 45/218 (20%)
Query: 120 IGQGAFGPV---YKAQMSTGETVAVKVLATDSKQGEKEFQT---------EVMLLGRLHH 167
           +G GA+G V   Y A++   + VAVK L+       + FQ+         E+ LL  L H
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLS-------RPFQSLIHARRTYRELRLLKHLKH 78
Query: 168 RNLVNLVGY------CAEKGQHMLVYVFMSKG----SLASHLYDENYGPLTWNLRVHIAL 217
            N++ L+          +  +  LV   M            L DE+   L + L      
Sbjct: 79  ENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL------ 132
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
              RGL+Y+H   +   IHRD+K SN+ +++    R+ DFGL+R+   D+       T  
Sbjct: 133 --LRGLKYIHSAGI---IHRDLKPSNVAVNEDCELRILDFGLARQ--ADEEMTGYVATRW 185
Query: 278 YLDPE-YISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           Y  PE  ++  ++ +  D++S G ++ EL+ G++   G
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG 223

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +    +  S++G   +E + EV +L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      +   +L+   +S G L   L  +    L+          +  G+ YLH   + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIA 137
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++     ++ DFGL+ E        NI GT  ++ PE ++   
Sbjct: 138 ---HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP 194
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
              ++D++S GV+ + L++G SP  G
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLG 220

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +    +  S++G   +E + EV +L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      +   +L+   +S G L   L  +    L+          +  G+ YLH   + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIA 137
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++     ++ DFGL+ E        NI GT  ++ PE ++   
Sbjct: 138 ---HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP 194
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
              ++D++S GV+ + L++G SP  G
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLG 220

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +    +  S++G   +E + EV +L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      +   +L+   +S G L   L  +    L+          +  G+ YLH   + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIA 137
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++     ++ DFGL+ E        NI GT  ++ PE ++   
Sbjct: 138 ---HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP 194
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
              ++D++S GV+ + L++G SP  G
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLG 220

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 45/218 (20%)
Query: 120 IGQGAFGPV---YKAQMSTGETVAVKVLATDSKQGEKEFQT---------EVMLLGRLHH 167
           +G GA+G V   Y A++   + VAVK L+       + FQ+         E+ LL  L H
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLS-------RPFQSLIHARRTYRELRLLKHLKH 86
Query: 168 RNLVNLVGY------CAEKGQHMLVYVFMSKG----SLASHLYDENYGPLTWNLRVHIAL 217
            N++ L+          +  +  LV   M         +  L DE+   L + L      
Sbjct: 87  ENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQL------ 140
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
              RGL+Y+H   +   IHRD+K SN+ +++    R+ DFGL+R+   D+       T  
Sbjct: 141 --LRGLKYIHSAGI---IHRDLKPSNVAVNEDSELRILDFGLARQ--ADEEMTGYVATRW 193
Query: 278 YLDPE-YISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           Y  PE  ++  ++ +  D++S G ++ EL+ G++   G
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG 231

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+GA+G V  A  +  +  VA+K ++    Q   +    E+ +L    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                  +  V++ +  + + LY       L+ +   +    + RGL+Y+H   V   +H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 149
Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIR---GTFGYLDPE-YISTRNFTK 291
           RD+K SN+LL+ +   ++ DFGL+R    D  H   +     T  Y  PE  ++++ +TK
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 292 KSDVYSFGVLLFELIAGRSPLQG 314
             D++S G +L E+++ R    G
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPG 232

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 109/243 (44%), Gaps = 28/243 (11%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT------DSKQGEKEF--QTEVMLLGRLHHRNL 170
           +G GA G V  A +  T + VA+++++        +++ +     +TE+ +L +L+H  +
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLY-DENYGPLTWNLRVHIALDVARGLEYLHDG 229
           + +  +  +   + +V   M  G L   +  ++     T  L  +  L     ++YLH+ 
Sbjct: 217 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML---LAVQYLHEN 272
Query: 230 AVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEY--- 283
            +   IHRD+K  N+LL   ++    ++ DFG S+          + GT  YL PE    
Sbjct: 273 GI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 329
Query: 284 ISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG-----WEEIVDS 338
           + T  + +  D +S GV+LF  ++G  P       V L    T GK       W E+ + 
Sbjct: 330 VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK 389
Query: 339 RLD 341
            LD
Sbjct: 390 ALD 392

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 93/200 (46%), Gaps = 14/200 (7%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYC 177
           +G+G+F    K     + +  AVK++   SK+ E   Q E+  L     H N+V L    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
            ++    LV   ++ G L   +  + +   +     +I   +   + ++HD  V   +HR
Sbjct: 76  HDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDVGV---VHR 130
Query: 238 DIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRG-TFGYLDPEYISTRNFTKKS 293
           D+K  N+L    + ++  ++ DFG +R +  D         T  Y  PE ++   + +  
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESC 190
Query: 294 DVYSFGVLLFELIAGRSPLQ 313
           D++S GV+L+ +++G+ P Q
Sbjct: 191 DLWSLGVILYTMLSGQVPFQ 210

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL----ATDSKQG--EKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +    +  S++G   +E + EV +L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      +   +L+   +S G L   L  +    L+          +  G+ YLH   + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIA 137
Query: 233 PVIHRDIKSSNI-LLDQSM---RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI LLD+++     ++ DFGL+ E        NI GT  ++ PE ++   
Sbjct: 138 ---HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP 194
Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG 314
              ++D++S GV+ + L++G SP  G
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLG 220

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 153
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D+    +  T  Y  PE  ++  ++ +  
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGYV-ATRWYRAPEIMLNWMHYNQTV 211
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 212 DIWSVGCIMAELLTGRTLFPG 232

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQG-EKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG+G +G V+KA+   T E VA+K V   D  +G       E+ LL  L H+N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                +  LV+ F  +       +D   G L   +       + +GL + H   V   +H
Sbjct: 70  LHSDKKLTLVFEFCDQD--LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV---LH 124
Query: 237 RDIKSSNILLDQSMRARVADFGLSREE--MVDKHAANIRGTFGYLDPEYI-STRNFTKKS 293
           RD+K  N+L++++   ++A+FGL+R     V  ++A +  T  Y  P+ +   + ++   
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSI 183
Query: 294 DVYSFGVLLFELIAGRSPL 312
           D++S G +  EL     PL
Sbjct: 184 DMWSAGCIFAELANAGRPL 202

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 45/218 (20%)
Query: 120 IGQGAFGPV---YKAQMSTGETVAVKVLATDSKQGEKEFQT---------EVMLLGRLHH 167
           +G GA+G V   Y A++   + VAVK L+       + FQ+         E+ LL  L H
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLS-------RPFQSLIHARRTYRELRLLKHLKH 86
Query: 168 RNLVNLVGY------CAEKGQHMLVYVFMSKG----SLASHLYDENYGPLTWNLRVHIAL 217
            N++ L+          +  +  LV   M            L DE+   L + L      
Sbjct: 87  ENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL------ 140
Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
              RGL+Y+H   +   IHRD+K SN+ +++    R+ DFGL+R+   D+       T  
Sbjct: 141 --LRGLKYIHSAGI---IHRDLKPSNVAVNEDSELRILDFGLARQ--ADEEMTGYVATRW 193
Query: 278 YLDPE-YISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           Y  PE  ++  ++ +  D++S G ++ EL+ G++   G
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG 231

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 153
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D+    +  T  Y  PE  ++  ++ +  
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGYV-ATRWYRAPEIMLNWMHYNQTV 211
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 212 DIWSVGCIMAELLTGRTLFPG 232

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 153
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DFGL+R    D+    +  T  Y  PE  ++  ++ +  
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGYV-ATRWYRAPEIMLNWMHYNQTV 211
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 212 DIWSVGCIMAELLTGRTLFPG 232

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ DF L+R    D        T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFYLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 115 NFTTLIGQGAFGPV-YKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +F   IG G FG         T E VAVK +   +   E   Q E++    L H N+V  
Sbjct: 23  DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRF 81
Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                      ++  + S G L   +   N G  + +        +  G+ Y H   +  
Sbjct: 82  KEVILTPTHLAIIMEYASGGELYERIC--NAGRFSEDEARFFFQQLLSGVSYCHSMQI-- 137
Query: 234 VIHRDIKSSNILLDQSM--RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTK 291
             HRD+K  N LLD S   R ++ DFG S+  ++     +  GT  Y+ PE +  + +  
Sbjct: 138 -CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDG 196
Query: 292 K-SDVYSFGVLLFELIAGRSPLQ 313
           K +DV+S GV L+ ++ G  P +
Sbjct: 197 KIADVWSCGVTLYVMLVGAYPFE 219

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGY 176
           ++G+GA   V     + T +  AVK++             EV +L +   HRN++ L+ +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
             E+ +  LV+  M  GS+ SH++   ++  L  ++ V    DVA  L++LH+     + 
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ---DVASALDFLHNKG---IA 133
Query: 236 HRDIKSSNILLD---QSMRARVADFGLSREEMVDKHAANIR--------GTFGYLDPEYI 284
           HRD+K  NIL +   Q    ++ DF L     ++   + I         G+  Y+ PE +
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 285 STRN-----FTKKSDVYSFGVLLFELIAGRSPLQG 314
              +     + K+ D++S GV+L+ L++G  P  G
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT-----EVMLLGRLH---HRNL 170
           IG GA+G VYKA+   +G  VA+K +   +  G           EV LL RL    H N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 171 VNLVGYCA-----EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEY 225
           V L+  CA      + +  LV+  + +  L ++L       L       +     RGL++
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIS 285
           LH   +   +HRD+K  NIL+      ++ADFGL+R          +  T  Y  PE + 
Sbjct: 136 LHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLL 192
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPL 312
              +    D++S G +  E+   R PL
Sbjct: 193 QSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 129/277 (46%), Gaps = 29/277 (10%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC- 177
           +IG G+FG V++A++   + VA+K +  D +   +E Q    ++  + H N+V+L  +  
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNVVDLKAFFY 102
Query: 178 --AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHI----ALDVARGLEYLHDGAV 231
              +K   + + + +       +    +Y  L   + + +       + R L Y+H    
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG- 161
Query: 232 PPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYI-STRNF 289
             + HRDIK  N+LLD  S   ++ DFG ++  +  +   +   +  Y  PE I    N+
Sbjct: 162 --ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATNY 219
Query: 290 TKKSDVYSFGVLLFELIAGRSPL----QGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
           T   D++S G ++ EL+ G+ PL     G+ + VE+  +   G    E+I    ++  + 
Sbjct: 220 TTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEI--IKVLGTPSREQI--KTMNPNYM 274
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             +  ++    +  V R PR  P   D + ++SR+L+
Sbjct: 275 EHKFPQIRPHPFSKVFR-PRTPP---DAIDLISRLLE 307

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 120/273 (43%), Gaps = 38/273 (13%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQGEKEFQTEVMLLGR-LHHRNLVNLVGY 176
           +G+GA+G V K + + +G+  AVK + AT + Q +K    ++ +  R +     V   G 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 177 CAEKGQHMLVYVF--MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
              +G   +       S       + D+    +  ++   IA+ + + LE+LH      V
Sbjct: 102 LFREGDVWICXELXDTSLDKFYKQVIDKGQT-IPEDILGKIAVSIVKALEHLHSKL--SV 158
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI-RGTFGYLDPEYIST----RNF 289
           IHRD+K SN+L++   + +  DFG+S   +VD  A +I  G   Y  PE I+     + +
Sbjct: 159 IHRDVKPSNVLINALGQVKXCDFGISG-YLVDDVAKDIDAGCKPYXAPERINPELNQKGY 217
Query: 290 TKKSDVYSFGVLLFELIAGR-------SPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
           + KSD++S G+   EL   R       +P Q L + VE  +          E VD     
Sbjct: 218 SVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD----- 272
Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                          +C+ +  ++RP+  ++ Q
Sbjct: 273 ------------FTSQCLKKNSKERPTYPELXQ 293

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++  FGL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILGFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 54/111 (48%), Gaps = 16/111 (14%)
Query: 213 VHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI 272
           +HI + +A  +E+LH   +   +HRD+K SNI        +V DFGL      D+    +
Sbjct: 167 LHIFIQIAEAVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 273 R-------------GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRS 310
                         GT  Y+ PE I   N++ K D++S G++LFEL+   S
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 18/198 (9%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG+G++G V+K +   TG+ VA+K    + D    +K    E+ +L +L H NLVNL+  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              K +  LV+ +     L  H  D     +  +L   I     + + + H       IH
Sbjct: 71  FRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC---IH 125
Query: 237 RDIKSSNILLDQSMRARVADFGLSR-----EEMVDKHAANIRGTFGYLDPE-YISTRNFT 290
           RD+K  NIL+ +    ++ DFG +R      +  D   A    T  Y  PE  +    + 
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA----TRWYRSPELLVGDTQYG 181
Query: 291 KKSDVYSFGVLLFELIAG 308
              DV++ G +  EL++G
Sbjct: 182 PPVDVWAIGCVFAELLSG 199

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 20/219 (9%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGE-----------KEFQTEVMLLGRLHH 167
            I  G++G V     S G  VA+K +      G            K    E+ LL   HH
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 168 RNLVNL---VGYCAEKGQHMLVYVF-MSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
            N++ L     +  E   H L  V  + +  LA  ++D+       +++ +    +  GL
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQ-YFMYHILLGL 147
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEY 283
             LH+  V   +HRD+   NILL  +    + DF L+RE+  D +  +      Y  PE 
Sbjct: 148 HVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPEL 204
Query: 284 I-STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
           +   + FTK  D++S G ++ E+   ++  +G   Y +L
Sbjct: 205 VMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 35/213 (16%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           +G GA+G V  +  + +G  +AVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 117
Query: 177 CAEKGQHMLVYVFMSKGSL--------ASHLYDENYG------PLTWNLRVHIALDVARG 222
                      VF    SL         +HL   +         LT +    +   + RG
Sbjct: 118 -----------VFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 166
Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE 282
           L+Y+H   +   IHRD+K SN+ +++    ++ DFGL+R    D        T  Y  PE
Sbjct: 167 LKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPE 221
Query: 283 -YISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
             ++  ++    D++S G ++ EL+ GR+   G
Sbjct: 222 IMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPG 254

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 20/219 (9%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGE-----------KEFQTEVMLLGRLHH 167
            I  G++G V     S G  VA+K +      G            K    E+ LL   HH
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 168 RNLVNL---VGYCAEKGQHMLVYVF-MSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
            N++ L     +  E   H L  V  + +  LA  ++D+       +++ +    +  GL
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQ-YFMYHILLGL 147
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEY 283
             LH+  V   +HRD+   NILL  +    + DF L+RE+  D +  +      Y  PE 
Sbjct: 148 HVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPEL 204
Query: 284 I-STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
           +   + FTK  D++S G ++ E+   ++  +G   Y +L
Sbjct: 205 VMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ D GL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDAGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 119 LIGQGAFGPV-YKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           + GQG FG V    + STG +VA+K +  D +   +E Q  +  L  LHH N+V L  Y 
Sbjct: 30  MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNIVQLQSYF 88
Query: 178 AEKGQH---------MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
              G+          ++ YV  +      + Y     P    ++V +   + R +  LH 
Sbjct: 89  YTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL-FQLIRSIGCLHL 147
Query: 229 GAVPPVIHRDIKSSNILLDQS-MRARVADFGLSRE-EMVDKHAANIRGTFGYLDPEYI-S 285
            +V  V HRDIK  N+L++++    ++ DFG +++    + + A I   + Y  PE I  
Sbjct: 148 PSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-YRAPELIFG 205
Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            +++T   D++S G +  E++ G    +G
Sbjct: 206 NQHYTTAVDIWSVGCIFAEMMLGEPIFRG 234

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 28/206 (13%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           IG G++    +    +T    AVKV+    +   +E +   +LL    H N++ L     
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKD-VY 90
Query: 179 EKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
           + G+H+ LV   M  G L   +  + +   +      +   + + +EYLH   V   +HR
Sbjct: 91  DDGKHVYLVTELMRGGELLDKILRQKF--FSEREASFVLHTIGKTVEYLHSQGV---VHR 145
Query: 238 DIKSSNIL-LDQSMRA---RVADFGLSREE-------MVDKHAANIRGTFGYLDPEYIST 286
           D+K SNIL +D+S      R+ DFG +++        M   + AN      ++ PE +  
Sbjct: 146 DLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN------FVAPEVLKR 199
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPL 312
           + + +  D++S G+LL+ ++AG +P 
Sbjct: 200 QGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ D GL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDRGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 10/198 (5%)
Query: 120 IGQGAFGPV-YKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           IG G FG         + E VAVK +    K  E   + E++    L H N+V       
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN-VKREIINHRSLRHPNIVRFKEVIL 84
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
                 +V  + S G L   +   N G  + +        +  G+ Y H   V    HRD
Sbjct: 85  TPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHAMQV---CHRD 139
Query: 239 IKSSNILLDQSM--RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKK-SDV 295
           +K  N LLD S   R ++ DFG S+  ++     +  GT  Y+ PE +  + +  K +DV
Sbjct: 140 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADV 199
Query: 296 YSFGVLLFELIAGRSPLQ 313
           +S GV L+ ++ G  P +
Sbjct: 200 WSCGVTLYVMLVGAYPFE 217

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 28/206 (13%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           IG G++    +    +T    AVKV+    +   +E +   +LL    H N++ L     
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKD-VY 90
Query: 179 EKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
           + G+H+ LV   M  G L   +  + +   +      +   + + +EYLH   V   +HR
Sbjct: 91  DDGKHVYLVTELMRGGELLDKILRQKF--FSEREASFVLHTIGKTVEYLHSQGV---VHR 145
Query: 238 DIKSSNIL-LDQSMRA---RVADFGLSREE-------MVDKHAANIRGTFGYLDPEYIST 286
           D+K SNIL +D+S      R+ DFG +++        M   + AN      ++ PE +  
Sbjct: 146 DLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN------FVAPEVLKR 199
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPL 312
           + + +  D++S G+LL+ ++AG +P 
Sbjct: 200 QGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           +G GA+G V  A    TG  VAVK L+    S    K    E+ LL  + H N++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           +   +       V++    + + L +      LT +    +   + RGL+Y+H   +   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI--- 146
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKKS 293
           IHRD+K SN+ +++    ++ D GL+R    D        T  Y  PE  ++  ++ +  
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDGGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTV 204
Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S G ++ EL+ GR+   G
Sbjct: 205 DIWSVGCIMAELLTGRTLFPG 225

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKE------FQTEVMLLGRLHHRNLVN 172
           +G+G+FG V  A    T + VA+K +   S+Q  K+       + E+  L  L H +++ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFI---SRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L          ++V  + + G L  ++ ++    +T +        +   +EY H   + 
Sbjct: 74  LYDVITTPTDIVMVIEY-AGGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRHKI- 129
Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT-K 291
             +HRD+K  N+LLD ++  ++ADFGLS             G+  Y  PE I+ + +   
Sbjct: 130 --VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 292 KSDVYSFGVLLFELIAGRSPL 312
           + DV+S G++L+ ++ GR P 
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPF 208

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 103/254 (40%), Gaps = 34/254 (13%)
Query: 98  ASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKA--QMSTGETVAVKVLATDSKQGEKEF 155
           A G   Y   D  +      + +G+G FG V +       G  VA+K++    K  E   
Sbjct: 19  AEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAA- 77
Query: 156 QTEVMLLGRLHHRN------LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTW 209
           + E+ +L +++ ++       V +  +    G HM +   +   S    L D NY P   
Sbjct: 78  RLEINVLEKINEKDPDNKNLCVQMFDWFDYHG-HMCISFELLGLSTFDFLKDNNYLPYPI 136
Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-------------------QSM 250
           +   H+A  + + +++LHD  +    H D+K  NIL                     +S 
Sbjct: 137 HQVRHMAFQLCQAVKFLHDNKL---THTDLKPENILFVNSDYELTYNLEKKRDERSVKST 193
Query: 251 RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRS 310
             RV DFG +  +   +H + I  T  Y  PE I    +++  DV+S G ++FE   G +
Sbjct: 194 AVRVVDFGSATFD--HEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFT 251
Query: 311 PLQGLMEYVELAAM 324
             Q       LA M
Sbjct: 252 LFQTHDNREHLAMM 265

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 85/198 (42%), Gaps = 10/198 (5%)
Query: 120 IGQGAFGPV-YKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           IG G FG           E VAVK +    K  E   + E++    L H N+V       
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDEN-VKREIINHRSLRHPNIVRFKEVIL 85
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
                 +V  + S G L   +   N G  + +        +  G+ Y H   V    HRD
Sbjct: 86  TPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYAHAMQV---AHRD 140
Query: 239 IKSSNILLDQSM--RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKK-SDV 295
           +K  N LLD S   R ++ADFG S+  ++     +  GT  Y+ PE +  + +  K +DV
Sbjct: 141 LKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADV 200
Query: 296 YSFGVLLFELIAGRSPLQ 313
           +S GV L+ ++ G  P +
Sbjct: 201 WSCGVTLYVMLVGAYPFE 218

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 11/204 (5%)
Query: 128 VYKAQMSTGETVAVKVLATDSKQGEKEFQT----EVMLLGRLHHRNLVNLVGYCAEKGQH 183
           VY+A+ +  E +    L +++   +  F+T    E    GRL   ++V +  +    GQ 
Sbjct: 50  VYEAEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQL 109
Query: 184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSN 243
            +    ++   LA+ L     GPL     V I   +   L+  H        HRD+K  N
Sbjct: 110 YVDXRLINGVDLAAXL--RRQGPLAPPRAVAIVRQIGSALDAAHAAGA---THRDVKPEN 164
Query: 244 ILLDQSMRARVADFGLSREEMVDK--HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVL 301
           IL+     A + DFG++     +K     N  GT  Y  PE  S  + T ++D+Y+   +
Sbjct: 165 ILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCV 224
Query: 302 LFELIAGRSPLQGLMEYVELAAMN 325
           L+E + G  P QG    V  A +N
Sbjct: 225 LYECLTGSPPYQGDQLSVXGAHIN 248

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 120 IGQGAFGPV-YKAQMSTGETVAVKVLATDSKQGEK---EFQTEVMLLGRLHHRNLVNLVG 175
           IG G FG         + E VAVK +    ++GEK     + E++    L H N+V    
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYI----ERGEKIAANVKREIINHRSLRHPNIVRFKE 82
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
                    +V  + S G L   +   N G  + +        +  G+ Y H   V    
Sbjct: 83  VILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHAMQV---C 137
Query: 236 HRDIKSSNILLDQSM--RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKK- 292
           HRD+K  N LLD S   R ++ DFG S+  ++     +  GT  Y+ PE +  + +  K 
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 197
Query: 293 SDVYSFGVLLFELIAGRSPLQ 313
           +DV+S GV L+ ++ G  P +
Sbjct: 198 ADVWSCGVTLYVMLVGAYPFE 218

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 104/232 (44%), Gaps = 34/232 (14%)
Query: 106 YKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGR 164
           Y DL+   C        G  G V+ A      + VA+K +     Q  K    E+ ++ R
Sbjct: 13  YMDLKPLGC--------GGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRR 64
Query: 165 LHHRNLVNLVGYCAEKGQHM---------LVYVFMSKGSLASHLYDE-NYGPLTWNLRVH 214
           L H N+V +       G  +         L  V++ +  + + L +    GPL       
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL 124
Query: 215 IALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVDKHAANIR 273
               + RGL+Y+H      V+HRD+K +N+ ++ + +  ++ DFGL+R  ++D H ++ +
Sbjct: 125 FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR--IMDPHYSH-K 178
Query: 274 G-------TFGYLDPE-YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
           G       T  Y  P   +S  N+TK  D+++ G +  E++ G++   G  E
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 116 FTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT-EVMLLGRLHHRNLVNL 173
            + ++GQGA   V++ +   TG+  A+KV    S     + Q  E  +L +L+H+N+V L
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 174 VGYCAEKG--QHMLVYVFMSKGSLASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDG 229
                E      +L+  F   GSL + L + +  YG L  +  + +  DV  G+ +L + 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGMNHLREN 131
Query: 230 AVPPVIHRDIKSSNILL----DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIS 285
            +   +HR+IK  NI+     D     ++ DFG +RE   D+    + GT  YL P+   
Sbjct: 132 GI---VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYE 188
Query: 286 --------TRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
                    + +    D++S GV  +    G  P +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 116 FTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT-EVMLLGRLHHRNLVNL 173
            + ++GQGA   V++ +   TG+  A+KV    S     + Q  E  +L +L+H+N+V L
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 174 VGYCAEKG--QHMLVYVFMSKGSLASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDG 229
                E      +L+  F   GSL + L + +  YG L  +  + +  DV  G+ +L + 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPESEFLIVLRDVVGGMNHLREN 131
Query: 230 AVPPVIHRDIKSSNILL----DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIS 285
            +   +HR+IK  NI+     D     ++ DFG +RE   D+   ++ GT  YL P+   
Sbjct: 132 GI---VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 286 --------TRNFTKKSDVYSFGVLLFELIAGRSPLQ 313
                    + +    D++S GV  +    G  P +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 22/214 (10%)
Query: 118 TLIGQGAFGPVYKA-QMSTGETVAVK-VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           +L+G+GA+G V  A    TGE VA+K +   D          E+ +L    H N++ +  
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIALDVARGLEYLHDGAVPPV 234
                       V++ +  + + L+      +  +  + +      R ++ LH   V   
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNV--- 133
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLD--PEYISTR----- 287
           IHRD+K SN+L++ +   +V DFGL+R  ++D+ AA+     G      EY++TR     
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLAR--IIDESAADNSEPTGQQSGMTEYVATRWYRAP 191
Query: 288 -------NFTKKSDVYSFGVLLFELIAGRSPLQG 314
                   +++  DV+S G +L EL   R    G
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 22/214 (10%)
Query: 118 TLIGQGAFGPVYKA-QMSTGETVAVK-VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           +L+G+GA+G V  A    TGE VA+K +   D          E+ +L    H N++ +  
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIALDVARGLEYLHDGAVPPV 234
                       V++ +  + + L+      +  +  + +      R ++ LH   V   
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNV--- 133
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-------------IRGTFGYLDP 281
           IHRD+K SN+L++ +   +V DFGL+R  ++D+ AA+                T  Y  P
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLAR--IIDESAADNSEPTGQQSGMVEFVATRWYRAP 191
Query: 282 E-YISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           E  +++  +++  DV+S G +L EL   R    G
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 103/249 (41%), Gaps = 56/249 (22%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVNL 173
           IGQG++G V  A +  T    A+K++  +     + +  +  +TEV L+ +LHH N+  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 174 VGYCAEK-----------GQHML----VYVFMSKGSLASHLYDENYGPL------TWNLR 212
                ++           G H+L    V++  S G  A  +      P         N  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 213 VH-----------------IALDVARGLEYLHDGAVPPVIHRDIKSSNILL--DQSMRAR 253
           +H                 I   +   L YLH+  +    HRDIK  N L   ++S   +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGI---CHRDIKPENFLFSTNKSFEIK 210
Query: 254 VADFGLSREEMVDKHA-----ANIRGTFGYLDPEYISTRN--FTKKSDVYSFGVLLFELI 306
           + DFGLS+E     +          GT  ++ PE ++T N  +  K D +S GVLL  L+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 307 AGRSPLQGL 315
            G  P  G+
Sbjct: 271 MGAVPFPGV 279

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 22/214 (10%)
Query: 118 TLIGQGAFGPVYKA-QMSTGETVAVK-VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           +L+G+GA+G V  A    TGE VA+K +   D          E+ +L    H N++ +  
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV-HIALDVARGLEYLHDGAVPPV 234
                       V++ +  + + L+      +  +  + +      R ++ LH   V   
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNV--- 133
Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-------------IRGTFGYLDP 281
           IHRD+K SN+L++ +   +V DFGL+R  ++D+ AA+                T  Y  P
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLAR--IIDESAADNSEPTGQQSGMTEXVATRWYRAP 191
Query: 282 E-YISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           E  +++  +++  DV+S G +L EL   R    G
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 115 NFTTL----IGQGAFGPVYKA-QMSTGETVAVKVLATDSK----QGEKEFQTEVMLLGRL 165
           NF  L    +G+G F  V +    STG+  A K L    +    + E   +  V+ L + 
Sbjct: 28  NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEY 225
             R ++NL        + +L+  + + G + S    E    ++ N  + +   +  G+ Y
Sbjct: 88  CPR-VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSM---RARVADFGLSREEMVDKHAANIR---GTFGYL 279
           LH   +   +H D+K  NILL         ++ DFG+SR+     HA  +R   GT  YL
Sbjct: 147 LHQNNI---VHLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHACELREIMGTPEYL 200
Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            PE ++    T  +D+++ G++ + L+   SP  G
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 84/198 (42%), Gaps = 10/198 (5%)
Query: 120 IGQGAFGPV-YKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           IG G FG         + E VAVK +    K  E   + E++    L H N+V       
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN-VKREIINHRSLRHPNIVRFKEVIL 85
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
                 +V  + S G L   +   N G  + +        +  G+ Y H   V    HRD
Sbjct: 86  TPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHAMQV---CHRD 140
Query: 239 IKSSNILLDQSM--RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKK-SDV 295
           +K  N LLD S   R ++  FG S+  ++     +  GT  Y+ PE +  + +  K +DV
Sbjct: 141 LKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADV 200
Query: 296 YSFGVLLFELIAGRSPLQ 313
           +S GV L+ ++ G  P +
Sbjct: 201 WSCGVTLYVMLVGAYPFE 218

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVK-VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           ++G GA G +    M     VAVK +L       ++E Q   +L     H N++    +C
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQ---LLRESDEHPNVIRY--FC 85
Query: 178 AEKG-QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
            EK  Q   + + +   +L  ++  +++  L     + +      GL +LH   +   +H
Sbjct: 86  TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE-PITLLQQTTSGLAHLHSLNI---VH 141
Query: 237 RDIKSSNILLDQ-----SMRARVADFGLSREEMVDKHA----ANIRGTFGYLDPEYIS-- 285
           RD+K  NIL+        ++A ++DFGL ++  V +H+    + + GT G++ PE +S  
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 286 -TRNFTKKSDVYSFGVLLFELIA-GRSPL 312
              N T   D++S G + + +I+ G  P 
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVISEGSHPF 230

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 7/193 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  E  VA+K L+    ++   K    E++L+  ++H+N++ L+  
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGI---I 148
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 296 YSFGVLLFELIAG 308
           +S GV++ E+I G
Sbjct: 209 WSVGVIMGEMIKG 221

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 84/198 (42%), Gaps = 10/198 (5%)
Query: 120 IGQGAFGPV-YKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           IG G FG         + E VAVK +    K  E   + E++    L H N+V       
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN-VKREIINHRSLRHPNIVRFKEVIL 85
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
                 +V  + S G L   +   N G  + +        +  G+ Y H   V    HRD
Sbjct: 86  TPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHAMQV---CHRD 140
Query: 239 IKSSNILLDQSM--RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKK-SDV 295
           +K  N LLD S   R ++  FG S+  ++     +  GT  Y+ PE +  + +  K +DV
Sbjct: 141 LKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADV 200
Query: 296 YSFGVLLFELIAGRSPLQ 313
           +S GV L+ ++ G  P +
Sbjct: 201 WSCGVTLYVMLVGAYPFE 218

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 7/193 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  E  VA+K L+    ++   K    E++L+  ++H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGI---I 148
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 296 YSFGVLLFELIAG 308
           +S GV++ E+I G
Sbjct: 209 WSVGVIMGEMIKG 221

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 39/268 (14%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 75  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 131
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 132 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 187
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             +  +S  V+S G+LL++++ G  P +   E +        G+  + + V S       
Sbjct: 188 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------RGQVFFRQRVSS------- 233
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDI 373
                E   L   C+   P  RP+  +I
Sbjct: 234 -----ECQHLIRWCLALRPSDRPTFEEI 256

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 90/193 (46%), Gaps = 7/193 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  E  VA+K L+    ++   K    E++L+  ++H+N++ L+  
Sbjct: 34  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 93
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 94  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 150
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 151 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDI 210
Query: 296 YSFGVLLFELIAG 308
           +S G ++ E+I G
Sbjct: 211 WSVGCIMGEMIKG 223

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 39/268 (14%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 76  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 132
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 133 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 188
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             +  +S  V+S G+LL++++ G  P +   E +        G+  + + V S       
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------RGQVFFRQRVSS------- 234
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDI 373
                E   L   C+   P  RP+  +I
Sbjct: 235 -----ECQHLIRWCLALRPSDRPTFEEI 257

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 39/268 (14%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 118 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 174
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 175 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 230
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             +  +S  V+S G+LL++++ G  P +   E +        G+  + + V S       
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------RGQVFFRQRVSS------- 276
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDI 373
                E   L   C+   P  RP+  +I
Sbjct: 277 -----ECQHLIRWCLALRPSDRPTFEEI 299

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 39/268 (14%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 76  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 132
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 133 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 188
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             +  +S  V+S G+LL++++ G  P +   E +        G+  + + V S       
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------RGQVFFRQRVSS------- 234
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDI 373
                E   L   C+   P  RP+  +I
Sbjct: 235 -----ECQHLIRWCLALRPSDRPTFEEI 257

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 39/268 (14%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 90  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 146
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 147 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 202
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             +  +S  V+S G+LL++++ G  P +   E +        G+  + + V S       
Sbjct: 203 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------RGQVFFRQRVSS------- 248
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDI 373
                E   L   C+   P  RP+  +I
Sbjct: 249 -----ECQHLIRWCLALRPSDRPTFEEI 271

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 39/268 (14%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 76  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 132
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 133 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 188
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             +  +S  V+S G+LL++++ G  P +   E +        G+  + + V S       
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------RGQVFFRQRVSS------- 234
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDI 373
                E   L   C+   P  RP+  +I
Sbjct: 235 -----ECQHLIRWCLALRPSDRPTFEEI 257

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 39/268 (14%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 91  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 148 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 203
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             +  +S  V+S G+LL++++ G  P +   E +        G+  + + V S       
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------RGQVFFRQRVSS------- 249
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDI 373
                E   L   C+   P  RP+  +I
Sbjct: 250 -----ECQHLIRWCLALRPSDRPTFEEI 272

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 113/268 (42%), Gaps = 39/268 (14%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQT----EVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE    T    EV+LL ++      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 110 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 167 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 222
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             +  +S  V+S G+LL++++ G  P +   E +        G+  + + V S       
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------RGQVFFRQRVSS------- 268
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDI 373
                E   L   C+   P  RP+  +I
Sbjct: 269 -----ECQHLIRWCLALRPSDRPTFEEI 291

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 20/225 (8%)
Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KE 154
           P    K+  ++      L+G G FG VY   ++S    VA+K +  D  S  GE      
Sbjct: 21  PHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR 80
Query: 155 FQTEVMLLGRLH--HRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWN 210
              EV+LL ++      ++ L+ +       +L+   + +      L+D     G L   
Sbjct: 81  VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEE 137
Query: 211 LRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHA 269
           L       V   + + H+  V   +HRDIK  NIL+D +    ++ DFG S   + D   
Sbjct: 138 LARSFFWQVLEAVRHCHNCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVY 193
Query: 270 ANIRGTFGYLDPEYISTRNFTKKS-DVYSFGVLLFELIAGRSPLQ 313
            +  GT  Y  PE+I    +  +S  V+S G+LL++++ G  P +
Sbjct: 194 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 238

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 113/268 (42%), Gaps = 39/268 (14%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQT----EVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE    T    EV+LL ++      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 104 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 161 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 216
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             +  +S  V+S G+LL++++ G  P +                   EEI+  ++   F 
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----------------EEIIGGQV--FFR 257
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDI 373
               +E   L   C+   P  RP+  +I
Sbjct: 258 QRVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 39/268 (14%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 103 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 160 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 215
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             +  +S  V+S G+LL++++ G  P +   E +        G+  + + V S       
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------RGQVFFRQRVSS------- 261
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDI 373
                E   L   C+   P  RP+  +I
Sbjct: 262 -----ECQHLIRWCLALRPSDRPTFEEI 284

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 39/268 (14%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 74  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 130
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 131 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 186
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             +  +S  V+S G+LL++++ G  P +   E +        G+  + + V S       
Sbjct: 187 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------RGQVFFRQRVSS------- 232
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDI 373
                E   L   C+   P  RP+  +I
Sbjct: 233 -----ECQHLIRWCLALRPSDRPTFEEI 255

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 39/268 (14%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 71  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 128 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             +  +S  V+S G+LL++++ G  P +   E +        G+  + + V S       
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------RGQVFFRQRVSS------- 229
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDI 373
                E   L   C+   P  RP+  +I
Sbjct: 230 -----ECQHLIRWCLALRPSDRPTFEEI 252

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 39/268 (14%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 103 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 160 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 215
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             +  +S  V+S G+LL++++ G  P +                   EEI+  ++   F 
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----------------EEIIGGQV--FFR 256
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDI 373
               +E   L   C+   P  RP+  +I
Sbjct: 257 QRVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 43/222 (19%)
Query: 119 LIGQGAFGPVYKAQ--MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH--------- 167
           ++GQGAFG V KA+  + +      K+  T+ K       +EV LL  L+H         
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST--ILSEVXLLASLNHQYVVRYYAA 70
Query: 168 ----RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLT---WNLRVHIALDVA 220
               RN V       +K    +   +    +L   ++ EN        W L   I     
Sbjct: 71  WLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL---- 126
Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-----EMVDKHAANIR-- 273
             L Y+H   +   IHR++K  NI +D+S   ++ DFGL++      +++   + N+   
Sbjct: 127 EALSYIHSQGI---IHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 274 --------GTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELI 306
                   GT  Y+  E +  T ++ +K D YS G++ FE I
Sbjct: 184 SDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 39/268 (14%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 103 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 160 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 215
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             +  +S  V+S G+LL++++ G  P +                   EEI+  ++   F 
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----------------EEIIGGQV--FFR 256
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDI 373
               +E   L   C+   P  RP+  +I
Sbjct: 257 QRVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 39/268 (14%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 75  VIRLLDWFERPDSFVLI---LERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 131
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 132 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 187
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             +  +S  V+S G+LL++++ G  P +   E +        G+  + + V S       
Sbjct: 188 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------RGQVFFRQRVSS------- 233
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDI 373
                E   L   C+   P  RP+  +I
Sbjct: 234 -----ECQHLIRWCLALRPSDRPTFEEI 256

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 39/268 (14%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 104 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 161 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 216
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             +  +S  V+S G+LL++++ G  P +                   EEI+  ++   F 
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----------------EEIIGGQV--FFR 257
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDI 373
               +E   L   C+   P  RP+  +I
Sbjct: 258 QRVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 90  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 146
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 147 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 202
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQ 313
             +  +S  V+S G+LL++++ G  P +
Sbjct: 203 HRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 112/268 (41%), Gaps = 39/268 (14%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 71  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 128 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             +  +S  V+S G+LL++++ G  P +                   EEI+  ++   F 
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----------------EEIIGGQV--FFR 224
Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDI 373
               +E   L   C+   P  RP+  +I
Sbjct: 225 QRVSSECQHLIRWCLALRPSDRPTFEEI 252

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQT----EVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE    T    EV+LL ++      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 91  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 148 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 203
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQ 313
             +  +S  V+S G+LL++++ G  P +
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 91  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 148 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 203
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQ 313
             +  +S  V+S G+LL++++ G  P +
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 90/193 (46%), Gaps = 7/193 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  E  VA+K L+    ++   K    E++L+  ++H+N++ L+  
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 93  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 149
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 209
Query: 296 YSFGVLLFELIAG 308
           +S G ++ E+I G
Sbjct: 210 WSVGCIMGEMIKG 222

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 118 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 174
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 175 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 230
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQ 313
             +  +S  V+S G+LL++++ G  P +
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 90/193 (46%), Gaps = 7/193 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  E  VA+K L+    ++   K    E++L+  ++H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 148
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 296 YSFGVLLFELIAG 308
           +S G ++ E+I G
Sbjct: 209 WSVGCIMGEMIKG 221

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 104 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 161 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 216
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQ 313
             +  +S  V+S G+LL++++ G  P +
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 90/193 (46%), Gaps = 7/193 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  E  VA+K L+    ++   K    E++L+  ++H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 148
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 296 YSFGVLLFELIAG 308
           +S G ++ E+I G
Sbjct: 209 WSVGCIMGEMIKG 221

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 103 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 160 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 215
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQ 313
             +  +S  V+S G+LL++++ G  P +
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 104 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 161 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 216
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQ 313
             +  +S  V+S G+LL++++ G  P +
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 71  VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 128 NXGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQ 313
             +  +S  V+S G+LL++++ G  P +
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           IG G++    +    +T    AVK++    +   +E +   +LL    H N++ L     
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPNIITLKDVYD 86
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
           +     +V   M  G L   +  + +   +      +   + + +EYLH   V   +HRD
Sbjct: 87  DGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHAQGV---VHRD 141
Query: 239 IKSSNIL-LDQSMRA---RVADFGLSREE-------MVDKHAANIRGTFGYLDPEYISTR 287
           +K SNIL +D+S      R+ DFG +++        M   + AN      ++ PE +  +
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN------FVAPEVLERQ 195
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPL 312
            +    D++S GVLL+ ++ G +P 
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTPF 220

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGE----KEFQTEVMLLGRLH--HRN 169
           L+G G FG VY   ++S    VA+K +  D  S  GE         EV+LL ++      
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 123 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 179
Query: 228 DGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D +    ++ DFG S   + D    +  GT  Y  PE+I  
Sbjct: 180 NCGV---LHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRY 235
Query: 287 RNFTKKS-DVYSFGVLLFELIAGRSPLQ 313
             +  +S  V+S G+LL++++ G  P +
Sbjct: 236 HRYHGRSAAVWSLGILLYDMVCGDIPFE 263

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 90/193 (46%), Gaps = 7/193 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  E  VA+K L+    ++   K    E++L+  ++H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 148
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 296 YSFGVLLFELIAG 308
           +S G ++ E+I G
Sbjct: 209 WSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 90/193 (46%), Gaps = 7/193 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  E  VA+K L+    ++   K    E++L+  ++H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 148
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDI 208
Query: 296 YSFGVLLFELIAG 308
           +S G ++ E+I G
Sbjct: 209 WSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 90/193 (46%), Gaps = 7/193 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  E  VA+K L+    ++   K    E++L+  ++H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 148
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 296 YSFGVLLFELIAG 308
           +S G ++ E+I G
Sbjct: 209 WSVGCIMGEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 90/193 (46%), Gaps = 7/193 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  E  VA+K L+    ++   K    E++L+  ++H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGI---I 148
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 296 YSFGVLLFELIAG 308
           +S G ++ E+I G
Sbjct: 209 WSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 31/205 (15%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  E  VA+K L+    ++   K    E++L+  ++H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 176 YCAEKG--QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR----------GL 223
           +  +K   +   VY+ M        L D N   +     + + LD  R          G+
Sbjct: 92  FTPQKSLEEFQDVYIVME-------LMDANLSQV-----IQMELDHERMSYLLYQMLCGI 139
Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEY 283
           ++LH   +   IHRD+K SNI++      ++ DFGL+R             T  Y  PE 
Sbjct: 140 KHLHSAGI---IHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 284 ISTRNFTKKSDVYSFGVLLFELIAG 308
           I    + +  D++S G ++ E+I G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 18/215 (8%)
Query: 120 IGQGAFGPVYKA-----------QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR 168
           +G GAFG V+ A           +    E V       D K G+     E+ +L R+ H 
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK--VTLEIAILSRVEHA 89
Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           N++ ++     +G   LV      G L    + + +  L   L  +I   +   + YL  
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR- 147
Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
             +  +IHRDIK  NI++ +    ++ DFG +      K      GT  Y  PE +    
Sbjct: 148 --LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNP 205
Query: 289 FT-KKSDVYSFGVLLFELIAGRSPLQGLMEYVELA 322
           +   + +++S GV L+ L+   +P   L E VE A
Sbjct: 206 YRGPELEMWSLGVTLYTLVFEENPFCELEETVEAA 240

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           IG G++    +    +T    AVK++    +   +E +   +LL    H N++ L     
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIE---ILLRYGQHPNIITLKD-VY 85
Query: 179 EKGQHMLVYVFMSKGS-LASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
           + G+++ V   + KG  L   +  + +   +      +   + + +EYLH   V   +HR
Sbjct: 86  DDGKYVYVVTELXKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHAQGV---VHR 140
Query: 238 DIKSSNIL-LDQSMRA---RVADFGLSREEMVDKHAANIRG-TFGYLDPEYISTRNFTKK 292
           D+K SNIL +D+S      R+ DFG +++   +         T  ++ PE +  + +   
Sbjct: 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGYDAA 200
Query: 293 SDVYSFGVLLFELIAGRSPL 312
            D++S GVLL+  + G +P 
Sbjct: 201 CDIWSLGVLLYTXLTGYTPF 220

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 30/222 (13%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR---NLVNLV 174
           +IG+G+FG V KA      + VA+K +  + K+  ++   E+ +L  L  +   N +N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALK-MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 175 GYCAEKGQHMLV------YVFMSKGSLASHLYD----ENYGPLTWNLRVHIALDVARGLE 224
                   HML       ++ M+   L+ +LY+      +   +  L    A  + + L+
Sbjct: 163 --------HMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRA--RVADFGLSREEMVDKHAANIRGTFGYLDPE 282
            LH   +   IH D+K  NILL Q  R+  +V DFG S  E   +    I+  F Y  PE
Sbjct: 215 ALHKNRI---IHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-QRVYTXIQSRF-YRAPE 269
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM 324
            I    +    D++S G +L EL+ G   L G  E  +LA M
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM 311

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDS-------KQGEKEFQTEVMLLGRLHHRNLV 171
           L+G+G++G V   ++   ET+  + +             GE   + E+ LL RL H+N++
Sbjct: 12  LLGEGSYGKV--KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 172 NLVG--YCAEKGQHMLV--YVFMSKGSLASHLYDENYGPLTWNLRVH-IALDVARGLEYL 226
            LV   Y  EK +  +V  Y       +   + ++ + P+    + H     +  GLEYL
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRF-PVC---QAHGYFCQLIDGLEYL 125
Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-----IRGTFGYLDP 281
           H      ++H+DIK  N+LL      +++  G++  E +   AA+      +G+  +  P
Sbjct: 126 HSQG---IVHKDIKPGNLLLTTGGTLKISALGVA--EALHPFAADDTCRTSQGSPAFQPP 180
Query: 282 EYISTRN-FTK-KSDVYSFGVLLFELIAGRSPLQG 314
           E  +  + F+  K D++S GV L+ +  G  P +G
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 118 TLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           +LIG+G+FG V KA      E VA+K++  + K    + Q EV LL  L +++   +  Y
Sbjct: 41  SLIGKGSFGQVVKAYDRVEQEWVAIKIIK-NKKAFLNQAQIEVRLL-ELMNKHDTEMKYY 98
Query: 177 CAEKGQHMLV--YVFMSKGSLASHLYD----ENYGPLTWNLRVHIALDVARGLEYLHDGA 230
                +H +   ++ +    L+ +LYD     N+  ++ NL    A  +   L +L   A
Sbjct: 99  IVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL---A 155
Query: 231 VP--PVIHRDIKSSNILLDQSMRA--RVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
            P   +IH D+K  NILL    R+  ++ DFG S  ++  +    I+  F Y  PE +  
Sbjct: 156 TPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQRIYQXIQSRF-YRSPEVLLG 213
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
             +    D++S G +L E+  G     G  E
Sbjct: 214 MPYDLAIDMWSLGCILVEMHTGEPLFSGANE 244

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 118 TLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           +LIG+G+FG V KA      E VA+K++  + K    + Q EV LL  L +++   +  Y
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIK-NKKAFLNQAQIEVRLL-ELMNKHDTEMKYY 117
Query: 177 CAEKGQHMLV--YVFMSKGSLASHLYD----ENYGPLTWNLRVHIALDVARGLEYLHDGA 230
                +H +   ++ +    L+ +LYD     N+  ++ NL    A  +   L +L   A
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL---A 174
Query: 231 VP--PVIHRDIKSSNILLDQSMRA--RVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
            P   +IH D+K  NILL    R+  ++ DFG S  ++  +    I+  F Y  PE +  
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQRIYQXIQSRF-YRSPEVLLG 232
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
             +    D++S G +L E+  G     G  E
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 30/222 (13%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR---NLVNLV 174
           +IG+G+FG V KA      + VA+K +  + K+  ++   E+ +L  L  +   N +N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALK-MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 175 GYCAEKGQHMLV------YVFMSKGSLASHLYD----ENYGPLTWNLRVHIALDVARGLE 224
                   HML       ++ M+   L+ +LY+      +   +  L    A  + + L+
Sbjct: 163 --------HMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRA--RVADFGLSREEMVDKHAANIRGTFGYLDPE 282
            LH   +   IH D+K  NILL Q  R+  +V DFG S  E   +    I+  F Y  PE
Sbjct: 215 ALHKNRI---IHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-QRVYTXIQSRF-YRAPE 269
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM 324
            I    +    D++S G +L EL+ G   L G  E  +LA M
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM 311

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 87/199 (43%), Gaps = 10/199 (5%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           ++G G  G V +     TG+  A+K+L  DS +  +E        G  H   ++++    
Sbjct: 17  VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQEVDHHWQASGGPHIVCILDVYENM 75
Query: 178 AEKGQHMLVYV-FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
               + +L+ +  M  G L S + +      T      I  D+   +++LH   +    H
Sbjct: 76  HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI---AH 132
Query: 237 RDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKS 293
           RD+K  N+L    ++    ++ DFG ++E   +         + Y+ PE +    + K  
Sbjct: 133 RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-YVAPEVLGPEKYDKSC 191
Query: 294 DVYSFGVLLFELIAGRSPL 312
           D++S GV+++ L+ G  P 
Sbjct: 192 DMWSLGVIMYILLCGFPPF 210

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 30/222 (13%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR---NLVNLV 174
           +IG+G FG V KA      + VA+K +  + K+  ++   E+ +L  L  +   N +N++
Sbjct: 104 VIGKGXFGQVVKAYDHKVHQHVALK-MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 175 GYCAEKGQHMLV------YVFMSKGSLASHLYD----ENYGPLTWNLRVHIALDVARGLE 224
                   HML       ++ M+   L+ +LY+      +   +  L    A  + + L+
Sbjct: 163 --------HMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRA--RVADFGLSREEMVDKHAANIRGTFGYLDPE 282
            LH   +   IH D+K  NILL Q  R+  +V DFG S  E   +    I+  F Y  PE
Sbjct: 215 ALHKNRI---IHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-QRVYXXIQSRF-YRAPE 269
Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM 324
            I    +    D++S G +L EL+ G   L G  E  +LA M
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM 311

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 118 TLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           +LIG+G+FG V KA      E VA+K++  + K    + Q EV LL  L +++   +  Y
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIK-NKKAFLNQAQIEVRLL-ELMNKHDTEMKYY 117
Query: 177 CAEKGQHMLV--YVFMSKGSLASHLYD----ENYGPLTWNLRVHIALDVARGLEYLHDGA 230
                +H +   ++ +    L+ +LYD     N+  ++ NL    A  +   L +L   A
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL---A 174
Query: 231 VP--PVIHRDIKSSNILLDQSMRA--RVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
            P   +IH D+K  NILL    R   ++ DFG S  ++  +    I+  F Y  PE +  
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRXAIKIVDFG-SSCQLGQRIYQXIQSRF-YRSPEVLLG 232
Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
             +    D++S G +L E+  G     G  E
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 91/199 (45%), Gaps = 7/199 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  E  VA+K L+    ++   K    E++L+  ++H+N++ L+  
Sbjct: 37  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 96
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 97  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 153
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 154 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDL 213
Query: 296 YSFGVLLFELIAGRSPLQG 314
           +S G ++ E++  +    G
Sbjct: 214 WSVGCIMGEMVCHKILFPG 232

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 87/199 (43%), Gaps = 10/199 (5%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           ++G G  G V +     TG+  A+K+L  DS +  +E        G  H   ++++    
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQEVDHHWQASGGPHIVCILDVYENM 94
Query: 178 AEKGQHMLVYV-FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
               + +L+ +  M  G L S + +      T      I  D+   +++LH   +    H
Sbjct: 95  HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI---AH 151
Query: 237 RDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKS 293
           RD+K  N+L    ++    ++ DFG ++E   +         + Y+ PE +    + K  
Sbjct: 152 RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-YVAPEVLGPEKYDKSC 210
Query: 294 DVYSFGVLLFELIAGRSPL 312
           D++S GV+++ L+ G  P 
Sbjct: 211 DMWSLGVIMYILLCGFPPF 229

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 89/191 (46%), Gaps = 7/191 (3%)
Query: 120 IGQGAFGPVYKAQMST-GETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +     VA+K L+    ++   K    E++L+  ++H+N+++L+  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGI---I 148
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 296 YSFGVLLFELI 306
           +S G ++ E++
Sbjct: 209 WSVGCIMGEMV 219

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 91/199 (45%), Gaps = 7/199 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  E  VA+K L+    ++   K    E++L+  ++H+N++ L+  
Sbjct: 26  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 85
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 86  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 142
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 143 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDL 202
Query: 296 YSFGVLLFELIAGRSPLQG 314
           +S G ++ E++  +    G
Sbjct: 203 WSVGCIMGEMVCHKILFPG 221

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 89/191 (46%), Gaps = 7/191 (3%)
Query: 120 IGQGAFGPVYKAQMST-GETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +     VA+K L+    ++   K    E++L+  ++H+N+++L+  
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 186
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
Query: 296 YSFGVLLFELI 306
           +S G ++ E++
Sbjct: 247 WSVGCIMGEMV 257

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 91/199 (45%), Gaps = 7/199 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  E  VA+K L+    ++   K    E++L+  ++H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 148
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDI 208
Query: 296 YSFGVLLFELIAGRSPLQG 314
           +S G ++ E++  +    G
Sbjct: 209 WSVGCIMGEMVCHKILFPG 227

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 89/191 (46%), Gaps = 7/191 (3%)
Query: 120 IGQGAFGPVYKAQMST-GETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +     VA+K L+    ++   K    E++L+  ++H+N+++L+  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 148
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 296 YSFGVLLFELI 306
           +S G ++ E++
Sbjct: 209 WSVGCIMGEMV 219

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 7/191 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  +  VA+K L+    ++   K    E++L+  ++H+N+++L+  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGI---I 148
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 296 YSFGVLLFELI 306
           +S G ++ E++
Sbjct: 209 WSVGCIMGEMV 219

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 16/105 (15%)
Query: 215 IALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANI 272
           IA+D    L Y         +HRDIK  NIL+D +   R+ADFG   + M D    ++  
Sbjct: 186 IAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 273 RGTFGYLDPEYISTRN-----FTKKSDVYSFGVLLFELIAGRSPL 312
            GT  Y+ PE +         +  + D +S GV ++E++ G +P 
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 7/191 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  +  VA+K L+    ++   K    E++L+  ++H+N+++L+  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGI---I 141
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 142 HRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 201
Query: 296 YSFGVLLFELI 306
           +S G ++ E++
Sbjct: 202 WSVGCIMGEMV 212

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 7/191 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  +  VA+K L+    ++   K    E++L+  ++H+N+++L+  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 148
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 296 YSFGVLLFELI 306
           +S G ++ E++
Sbjct: 209 WSVGCIMGEMV 219

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 118 TLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQT--EVMLLGRLHHRNLVNLV 174
           T +G+G +G VYKA    T ETVA+K +  + ++         EV LL  L HRN++ L 
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
                  +  L++ + ++  L  ++ D+N   ++  +       +  G+ + H       
Sbjct: 100 SVIHHNHRLHLIFEY-AENDLKKYM-DKNPD-VSMRVIKSFLYQLINGVNFCHSRR---C 153
Query: 235 IHRDIKSSNILLDQSMRA-----RVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTR 287
           +HRD+K  N+LL  S  +     ++ DFGL+R   +  +   +   T  Y  PE  + +R
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSR 213
Query: 288 NFTKKSDVYSFGVLLFELIAGRSPL 312
           +++   D++S   +  E++  ++PL
Sbjct: 214 HYSTSVDIWSIACIWAEMLM-KTPL 237

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 89/191 (46%), Gaps = 7/191 (3%)
Query: 120 IGQGAFGPVYKAQMST-GETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +     VA+K L+    ++   K    E++L+  ++H+N+++L+  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 148
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 296 YSFGVLLFELI 306
           +S G ++ E++
Sbjct: 209 WSVGCIMGEMV 219

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 7/191 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  +  VA+K L+    ++   K    E++L+  ++H+N+++L+  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 148
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 296 YSFGVLLFELI 306
           +S G ++ E++
Sbjct: 209 WSVGCIMGEMV 219

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 7/191 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  +  VA+K L+    ++   K    E++L+  ++H+N+++L+  
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 149
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 209
Query: 296 YSFGVLLFELI 306
           +S G ++ E++
Sbjct: 210 WSVGCIMGEMV 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 7/191 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  +  VA+K L+    ++   K    E++L+  ++H+N+++L+  
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 90
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 91  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 147
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 148 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 207
Query: 296 YSFGVLLFELI 306
           +S G ++ E++
Sbjct: 208 WSVGCIMGEMV 218

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 89/191 (46%), Gaps = 7/191 (3%)
Query: 120 IGQGAFGPVYKAQMST-GETVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +     VA+K L+    ++   K    E++L+  ++H+N+++L+  
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 186
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
Query: 296 YSFGVLLFELI 306
           +S G ++ E++
Sbjct: 247 WSVGCIMGEMV 257

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 7/191 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  +  VA+K L+    ++   K    E++L+  ++H+N+++L+  
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 93  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 149
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 209
Query: 296 YSFGVLLFELI 306
           +S G ++ E++
Sbjct: 210 WSVGCIMGEMV 220

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 91/199 (45%), Gaps = 7/199 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  E  VA+K L+    ++   K    E++L+  ++H+N++ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 148
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDL 208
Query: 296 YSFGVLLFELIAGRSPLQG 314
           +S G ++ E++  +    G
Sbjct: 209 WSVGCIMGEMVCHKILFPG 227

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 7/191 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  +  VA+K L+    ++   K    E++L+  ++H+N+++L+  
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 142
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 143 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 202
Query: 296 YSFGVLLFELI 306
           +S G ++ E++
Sbjct: 203 WSVGCIMGEMV 213

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 7/191 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  +  VA+K L+    ++   K    E++L+  ++H+N+++L+  
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 142
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 143 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 202
Query: 296 YSFGVLLFELI 306
           +S G ++ E++
Sbjct: 203 WSVGCIMGEMV 213

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 7/191 (3%)
Query: 120 IGQGAFGPVYKAQMSTGE-TVAVKVLAT--DSKQGEKEFQTEVMLLGRLHHRNLVNLVG- 175
           IG GA G V  A  +  +  VA+K L+    ++   K    E++L+  ++H+N+++L+  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +K       V++    + ++L       L      ++   +  G+++LH   +   I
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI---I 141
Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           HRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D+
Sbjct: 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 201
Query: 296 YSFGVLLFELI 306
           +S G ++ E++
Sbjct: 202 WSVGCIMGEMV 212

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 48/225 (21%)
Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           LIG+G++G VY A   +T + VA+K +    +     K    E+ +L RL    ++ L  
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 176 YCAE----KGQHMLVYVFMSKGSLAS------HLYDENYGPLTWNLRVHIALDVARGLEY 225
                   K   + + + ++   L         L +E+   + +NL +        G  +
Sbjct: 93  LIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLL--------GENF 144
Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR----------------EEMVDKHA 269
           +H+  +   IHRD+K +N LL+Q    +V DFGL+R                 E    H 
Sbjct: 145 IHESGI---IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 270 ANIRG-------TFGYLDPEYISTR-NFTKKSDVYSFGVLLFELI 306
            N++        T  Y  PE I  + N+TK  D++S G +  EL+
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G+G+FG V++ +   TG   AVK +  +  + E     E+M    L    +V L G   
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPLYGAVR 136
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
           E G  + +++ + +G     L  E  G L  +  ++       GLEYLH   +   +H D
Sbjct: 137 E-GPWVNIFMELLEGGSLGQLVKEQ-GCLPEDRALYYLGQALEGLEYLHSRRI---LHGD 191
Query: 239 IKSSNILLDQ-SMRARVADFGLSREEMVDKHAAN------IRGTFGYLDPEYISTRNFTK 291
           +K+ N+LL      A + DFG +     D    +      I GT  ++ PE +  R+   
Sbjct: 192 VKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDA 251
Query: 292 KSDVYSFGVLLFELIAGRSP 311
           K DV+S   ++  ++ G  P
Sbjct: 252 KVDVWSSCCMMLHMLNGCHP 271

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G+G+FG V++ +   TG   AVK +  +  + E     E+M    L    +V L G   
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPLYGAVR 155
Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
           E G  + +++ + +G     L  E  G L  +  ++       GLEYLH   +   +H D
Sbjct: 156 E-GPWVNIFMELLEGGSLGQLVKEQ-GCLPEDRALYYLGQALEGLEYLHSRRI---LHGD 210
Query: 239 IKSSNILLDQ-SMRARVADFGLSREEMVDKHAAN------IRGTFGYLDPEYISTRNFTK 291
           +K+ N+LL      A + DFG +     D    +      I GT  ++ PE +  R+   
Sbjct: 211 VKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDA 270
Query: 292 KSDVYSFGVLLFELIAGRSP 311
           K DV+S   ++  ++ G  P
Sbjct: 271 KVDVWSSCCMMLHMLNGCHP 290

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 17/217 (7%)
Query: 109 LQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKE-FQTEVMLLGR 164
           LQ+       +IG+GAF  V   +M  TG+  A+K++      K+GE   F+ E  +L  
Sbjct: 58  LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 165 LHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLE 224
              R +  L     ++    LV  +   G L + L            R ++A ++   ++
Sbjct: 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAID 176
Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI--RGTFGYLDPE 282
            +H       +HRDIK  NILLD+    R+ADFG   +   D    ++   GT  YL PE
Sbjct: 177 SVHRLGY---VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233
Query: 283 YIST-------RNFTKKSDVYSFGVLLFELIAGRSPL 312
            +          ++  + D ++ GV  +E+  G++P 
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	432
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-129
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-120
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-120
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-83
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-76
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-75
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-75
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-72
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-71
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-69
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	9e-69
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-67
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-66
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-65
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-64
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-62
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-61
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-61
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-50
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-48
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-47
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-47
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-47
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-46
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-46
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-46
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-45
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-45
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-45
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-45
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-45
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-45
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-45
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-45
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-44
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-44
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-44
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-44
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-44
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-44
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-44
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-44
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-44
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-43
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-43
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-43
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-43
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-43
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-43
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-43
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-43
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-42
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-42
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-42
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-42
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-42
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-42
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-42
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-42
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-42
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-42
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-42
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-42
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-42
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-41
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-41
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-41
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-41
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-41
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-41
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-40
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-40
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-40
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-40
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-40
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-40
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-40
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-39
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-39
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-39
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-38
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-38
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-37
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-37
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-36
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-36
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-36
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-35
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-35
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-35
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-35
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-34
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-34
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-34
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-34
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-34
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-34
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-33
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-33
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-33
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-33
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-33
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-33
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-32
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-32
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-32
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-32
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-32
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-32
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-31
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-31
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-31
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-31
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-30
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-29
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-29
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-28
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-28
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-28
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-28
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-06
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-27
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-27
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-27
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	7e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-27
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-26
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-26
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-26
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-26
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-26
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-26
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-26
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-26
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-26
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-26
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-26
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-26
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-25
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-25
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-25
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-25
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-24
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-24
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-24
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-24
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-24
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-24
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-24
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-24
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-24
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-24
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-24
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-23
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-23
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-23
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-23
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-23
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-23
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-23
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-22
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-22
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-22
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-22
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-22
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-20
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-19
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-19
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-18
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-18
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-18
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-18
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-18
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-18
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-17
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-17
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-17
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-16
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-12
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-12
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-11
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-11

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  375 bits (964), Expect = e-129
 Identities = 114/291 (39%), Positives = 166/291 (57%), Gaps = 14/291 (4%)

Query: 104 YSYKDLQKATCNF--TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVML 161
               DL++AT NF    LIG G FG VYK  +  G  VA+K    +S QG +EF+TE+  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDEN--YGPLTWNLRVHIALDV 219
           L    H +LV+L+G+C E+ + +L+Y +M  G+L  HLY  +     ++W  R+ I +  
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAA-NIRGTF 276
           ARGL YLH      +IHRD+KS NILLD++   ++ DFG+S++  E+   H +  ++GT 
Sbjct: 149 ARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205

Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL--QGLMEYVELA--AMNTEGKTGW 332
           GY+DPEY      T+KSDVYSFGV+LFE++  RS +      E V LA  A+ +      
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265

Query: 333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM 383
           E+IVD  L      E L +    A KC+  +   RPSM D++  L   L++
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  352 bits (905), Expect = e-120
 Identities = 102/308 (33%), Positives = 165/308 (53%), Gaps = 31/308 (10%)

Query: 96  VSASGIPEYSYKDLQKATCNF--------TTLIGQGAFGPVYKAQMSTGETVAVKVLAT- 146
           VS +    +S+ +L+  T NF           +G+G FG VYK  ++   TVAVK LA  
Sbjct: 7   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAM 65

Query: 147 ---DSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD-E 202
               +++ +++F  E+ ++ +  H NLV L+G+ ++     LVYV+M  GSL   L   +
Sbjct: 66  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125

Query: 203 NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262
              PL+W++R  IA   A G+ +LH+      IHRDIKS+NILLD++  A+++DFGL+R 
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARA 182

Query: 263 EMVDKHAAN---IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL------Q 313
                       I GT  Y+ PE +     T KSD+YSFGV+L E+I G   +      Q
Sbjct: 183 SEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241

Query: 314 GLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDI 373
            L++  E   +  E KT  E+ +D +++   D   +  + S+A +C++    KRP ++ +
Sbjct: 242 LLLDIKE--EIEDEEKT-IEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297

Query: 374 VQVLSRIL 381
            Q+L  + 
Sbjct: 298 QQLLQEMT 305

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  352 bits (906), Expect = e-120
 Identities = 114/291 (39%), Positives = 172/291 (59%), Gaps = 21/291 (7%)

Query: 104 YSYKDLQKATCNFTT--LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-EKEFQTEVM 160
           +S ++LQ A+ NF+   ++G+G FG VYK +++ G  VAVK L  +  QG E +FQTEV 
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYG--PLTWNLRVHIALD 218
           ++    HRNL+ L G+C    + +LVY +M+ GS+AS L +      PL W  R  IAL 
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HAAN-IRGTF 276
            ARGL YLHD   P +IHRD+K++NILLD+   A V DFGL++       H    +RGT 
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199

Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL----------QGLMEYVELAAMNT 326
           G++ PEY+ST   ++K+DV+ +GV+L ELI G+               L+++V+   +  
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK--GLLK 257

Query: 327 EGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL 377
           E K   E +VD  L G +  EE+ ++  +A  C   +P +RP M ++V++L
Sbjct: 258 EKK--LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  257 bits (658), Expect = 3e-83
 Identities = 81/320 (25%), Positives = 140/320 (43%), Gaps = 36/320 (11%)

Query: 97  SASGIPEYSYKDLQKATCNFT--TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKE 154
             S   +   ++L   +       +  +G FG V+KAQ+   E VAVK+     KQ   +
Sbjct: 7   HHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW-Q 64

Query: 155 FQTEVMLLGRLHHRNLVNLVGYCAE----KGQHMLVYVFMSKGSLASHLYDENYGPLTWN 210
            + EV  L  + H N++  +G             L+  F  KGSL+  L       ++WN
Sbjct: 65  NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWN 121

Query: 211 LRVHIALDVARGLEYLH-------DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE 263
              HIA  +ARGL YLH       DG  P + HRDIKS N+LL  ++ A +ADFGL+ + 
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181

Query: 264 MVDKHAANIR---GTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
              K A +     GT  Y+ PE +       R+   + D+Y+ G++L+EL +  +   G 
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

Query: 316 ME-----YVELAAMNTEGKTGWEEIVDSRL-----DGIFDVEELNEVASLAYKCVNRAPR 365
           ++     + E    +   +   E +V  +      D       +  +     +C +    
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301

Query: 366 KRPSMRDIVQVLSRILKMRH 385
            R S   + + ++++ ++ +
Sbjct: 302 ARLSAGCVGERITQMQRLTN 321

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  238 bits (610), Expect = 4e-76
 Identities = 87/281 (30%), Positives = 140/281 (49%), Gaps = 21/281 (7%)

Query: 116 FTTLIGQGAFGPVYKAQMSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
               IG G+FG V++A+   G  VAVK+L       +   EF  EV ++ RL H N+V  
Sbjct: 41  IKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYG-PLTWNLRVHIALDVARGLEYLHDGAVP 232
           +G   +     +V  ++S+GSL   L+       L    R+ +A DVA+G+ YLH+   P
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-P 158

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA-NIRGTFGYLDPEYISTRNFTK 291
           P++HR++KS N+L+D+    +V DFGLSR +     ++ +  GT  ++ PE +      +
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218

Query: 292 KSDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL 349
           KSDVYSFGV+L+EL   + P   L   + V       +           RL+   ++   
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK-----------RLEIPRNLNP- 266

Query: 350 NEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHH 390
            +VA++   C    P KRPS   I+ +L  ++K      + 
Sbjct: 267 -QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  237 bits (606), Expect = 1e-75
 Identities = 78/280 (27%), Positives = 141/280 (50%), Gaps = 24/280 (8%)

Query: 106 YKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL 165
           YK+++        ++G+GAFG V KA+    + VA+K + ++S+   K F  E+  L R+
Sbjct: 7   YKEIE-----VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRV 58

Query: 166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLE 224
           +H N+V L G C       LV  +   GSL + L+  E     T    +   L  ++G+ 
Sbjct: 59  NHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116

Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMR-ARVADFGLSREEMVDKHAANIRGTFGYLDPEY 283
           YLH      +IHRD+K  N+LL       ++ DFG + +  +  H  N +G+  ++ PE 
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNKGSAAWMAPEV 174

Query: 284 ISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI 343
               N+++K DV+S+G++L+E+I  R P    +       M             +R   I
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDE-IGGPAFRIMWAVHN-------GTRPPLI 226

Query: 344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM 383
            ++ +   + SL  +C ++ P +RPSM +IV++++ +++ 
Sbjct: 227 KNLPK--PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  234 bits (600), Expect = 6e-75
 Identities = 85/300 (28%), Positives = 146/300 (48%), Gaps = 35/300 (11%)

Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE-- 152
              S +P  +  +++     +   IG+G FG V+K + +     VA+K L     +GE  
Sbjct: 8   FPKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62

Query: 153 -----KEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPL 207
                +EFQ EV ++  L+H N+V L G         +V  F+  G L   L D+   P+
Sbjct: 63  MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKA-HPI 119

Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-----MRARVADFGLSRE 262
            W++++ + LD+A G+EY+ +   PP++HRD++S NI L        + A+VADFGLS++
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178

Query: 263 EMVDKHAANIRGTFGYLDPEYISTRN--FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVE 320
                  + + G F ++ PE I      +T+K+D YSF ++L+ ++ G  P      Y +
Sbjct: 179 S--VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE-YSYGK 235

Query: 321 LAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           +  +N   + G       R     D      + ++   C +  P+KRP    IV+ LS +
Sbjct: 236 IKFINMIREEG------LRPTIPEDCPP--RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  227 bits (581), Expect = 3e-72
 Identities = 92/275 (33%), Positives = 130/275 (47%), Gaps = 32/275 (11%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           IG G FG VY+A    G+ VAVK        D  Q  +  + E  L   L H N++ L G
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
            C ++    LV  F   G L   L  +    +  ++ V+ A+ +ARG+ YLHD A+ P+I
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPII 130

Query: 236 HRDIKSSNILLDQSMRAR--------VADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
           HRD+KSSNIL+ Q +           + DFGL+RE       +   G + ++ PE I   
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA-GAYAWMAPEVIRAS 189

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
            F+K SDV+S+GVLL+EL+ G  P +G+  +      AMN              L     
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL-----------ALPIPST 238

Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
             E    A L   C N  P  RPS  +I+  L+ I
Sbjct: 239 CPE--PFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  224 bits (573), Expect = 4e-71
 Identities = 65/277 (23%), Positives = 115/277 (41%), Gaps = 28/277 (10%)

Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVN 172
           NF T + +   G ++K +   G  + VKVL     S +  ++F  E   L    H N++ 
Sbjct: 13  NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 173 LVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
           ++G C          +  +M  GSL + L++     +  +  V  ALD+ARG+ +LH   
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE 131

Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR--- 287
            P +    + S ++++D+ M AR++   +                  ++ PE +  +   
Sbjct: 132 -PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP----GRMYAPAWVAPEALQKKPED 186

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
              + +D++SF VLL+EL+    P   L  ME     A+              R      
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL-----------RPTIPPG 235

Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
           +     V+ L   C+N  P KRP    IV +L ++  
Sbjct: 236 ISP--HVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  220 bits (562), Expect = 7e-69
 Identities = 72/333 (21%), Positives = 131/333 (39%), Gaps = 42/333 (12%)

Query: 77  GRNGNGKSMWLEGFKRSNVVSASGIPEY--SYKDLQKATCNFTTLIGQGAFGPVYKAQMS 134
           G   N   +    F R    ++  + E+   ++ L+        LIG+G FG VY  +  
Sbjct: 1   GPEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLE-----IGELIGKGRFGQVYHGRWH 55

Query: 135 TGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK 192
               VA++++    D++   K F+ EVM   +  H N+V  +G C       ++      
Sbjct: 56  --GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKG 113

Query: 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA 252
            +L S + D     L  N    IA ++ +G+ YLH      ++H+D+KS N+  D   + 
Sbjct: 114 RTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDN-GKV 168

Query: 253 RVADFGLSREEMVDKHAANI------RGTFGYLDPEYISTRN---------FTKKSDVYS 297
            + DFGL     V +            G   +L PE I   +         F+K SDV++
Sbjct: 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228

Query: 298 FGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAY 357
            G + +EL A   P +       +      G          + + +  +    E++ +  
Sbjct: 229 LGTIWYELHAREWPFKT-QPAEAIIWQMGTGM---------KPN-LSQIGMGKEISDILL 277

Query: 358 KCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHH 390
            C      +RP+   ++ +L ++ K      H 
Sbjct: 278 FCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  219 bits (561), Expect = 9e-69
 Identities = 67/279 (24%), Positives = 119/279 (42%), Gaps = 30/279 (10%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G+G FG   K     TGE + +K L    ++ ++ F  EV ++  L H N++  +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
           +  +   +  ++  G+L   +   +     W+ RV  A D+A G+ YLH      +IHRD
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRD 133

Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAAN---------------IRGTFGYLDPEY 283
           + S N L+ ++    VADFGL+R  + +K                   + G   ++ PE 
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193

Query: 284 ISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI 343
           I+ R++ +K DV+SFG++L E+I   +     +       +N  G               
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG--------FLDRYCP 245

Query: 344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
            +         +  +C +  P KRPS   +   L  +  
Sbjct: 246 PNCPP--SFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  216 bits (551), Expect = 5e-67
 Identities = 62/330 (18%), Positives = 118/330 (35%), Gaps = 51/330 (15%)

Query: 103 EYSYKDLQKATCNFT--TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTE-- 158
           E +  +      N     LIG+G +G VYK  +     VAVKV    S    + F  E  
Sbjct: 2   EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVF---SFANRQNFINEKN 57

Query: 159 VMLLGRLHHRNLVNLVGYCAE-----KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV 213
           +  +  + H N+   +          + +++LV  +   GSL  +L         W    
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSC 114

Query: 214 HIALDVARGLEYLH------DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK 267
            +A  V RGL YLH      D   P + HRD+ S N+L+       ++DFGLS     ++
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 268 HAANIR---------GTFGYLDPEYI-------STRNFTKKSDVYSFGVLLFELIAGRSP 311
                          GT  Y+ PE +          +  K+ D+Y+ G++ +E+    + 
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 312 LQ--GLME-----YVELAAMNTEGKTGWEEIVDSRL------DGIFDVEELNEVASLAYK 358
           L     +      +      +   +     +   +           +   +  +      
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294

Query: 359 CVNRAPRKRPSMRDIVQVLSRILKMRHNRK 388
           C ++    R + +   + ++ ++ +    K
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNK 324

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  211 bits (539), Expect = 8e-66
 Identities = 74/272 (27%), Positives = 126/272 (46%), Gaps = 24/272 (8%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG G+FG VYK +      VAVK+L     + Q  + F+ EV +L +  H N++  +GY 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
               Q  +V  +    SL  HL+            + IA   ARG++YLH      +IHR
Sbjct: 90  -TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KSIIHR 144

Query: 238 DIKSSNILLDQSMRARVADFGLSREE---MVDKHAANIRGTFGYLDPEYISTRN---FTK 291
           D+KS+NI L +    ++ DFGL+ E+           + G+  ++ PE I  ++   ++ 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204

Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN- 350
           +SDVY+FG++L+EL+ G+ P   +    ++  M   G            D          
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL--------SPDLSKVRSNCPK 256

Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
            +  L  +C+ +   +RPS   I+  +  + +
Sbjct: 257 RMKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  208 bits (531), Expect = 5e-64
 Identities = 75/320 (23%), Positives = 132/320 (41%), Gaps = 43/320 (13%)

Query: 97  SASGIPEYSY----KDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGE 152
           S SG+P        K +Q         IG+G +G V+  +   GE VAVKV  T  +   
Sbjct: 23  SGSGLPLLVQRTIAKQIQ-----MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA-S 75

Query: 153 KEFQTEVMLLGRLHHRNLVNLVGYC----AEKGQHMLVYVFMSKGSLASHLYDENYGPLT 208
              +TE+     + H N++  +           Q  L+  +   GSL  +L       L 
Sbjct: 76  WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLD 132

Query: 209 WNLRVHIALDVARGLEYLHDGAV-----PPVIHRDIKSSNILLDQSMRARVADFGLSREE 263
               + +A     GL +LH         P + HRD+KS NIL+ ++    +AD GL+ + 
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192

Query: 264 MVDKHAANI-----RGTFGYLDPE----YISTRNF--TKKSDVYSFGVLLFELIAGRSPL 312
           + D +  +I      GT  Y+ PE     ++  +F     +D+YSFG++L+E+       
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252

Query: 313 QGLMEY----VELAAMNTEGKTGWEEIVDSRL-----DGIFDVEELNEVASLAYKCVNRA 363
             + EY     +L   +   +   E +   +L     +     E L ++  L  +C    
Sbjct: 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN 312

Query: 364 PRKRPSMRDIVQVLSRILKM 383
           P  R +   + + L+++ + 
Sbjct: 313 PASRLTALRVKKTLAKMSES 332

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  202 bits (516), Expect = 1e-61
 Identities = 74/322 (22%), Positives = 132/322 (40%), Gaps = 47/322 (14%)

Query: 97  SASGIPEYSY----KDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGE 152
           S SG+P        + +          IG+G FG V++ +   GE VAVK+    S + E
Sbjct: 28  SGSGLPLLVQRTIARTIV-----LQESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREE 78

Query: 153 KEFQTE--VMLLGRLHHRNLVNLVGYCAEKG----QHMLVYVFMSKGSLASHLYDENYGP 206
           + +  E  +     L H N++  +    +      Q  LV  +   GSL  +L       
Sbjct: 79  RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---T 135

Query: 207 LTWNLRVHIALDVARGLEYLHDGAV-----PPVIHRDIKSSNILLDQSMRARVADFGLSR 261
           +T    + +AL  A GL +LH   V     P + HRD+KS NIL+ ++    +AD GL+ 
Sbjct: 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195

Query: 262 EE-----MVDKHAANIRGTFGYLDPE------YISTRNFTKKSDVYSFGVLLFELIAGRS 310
                   +D    +  GT  Y+ PE       +      K++D+Y+ G++ +E+    S
Sbjct: 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255

Query: 311 PLQGLMEYV----ELAAMNTEGKTGWEEIVDSRL-----DGIFDVEELNEVASLAYKCVN 361
                 +Y     +L   +   +   + + + +L     +     E L  +A +  +C  
Sbjct: 256 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 315

Query: 362 RAPRKRPSMRDIVQVLSRILKM 383
                R +   I + LS++ + 
Sbjct: 316 ANGAARLTALRIKKTLSQLSQQ 337

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  201 bits (512), Expect = 1e-61
 Identities = 68/296 (22%), Positives = 123/296 (41%), Gaps = 38/296 (12%)

Query: 116 FTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQ--TEVMLLGRLHHRNLVNL 173
               +G+G +G V++     GE VAVK+    S + EK +   TE+     L H N++  
Sbjct: 12  LLECVGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGF 67

Query: 174 VGYC----AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +           Q  L+  +   GSL  +L       L     + I L +A GL +LH  
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIE 124

Query: 230 AV-----PPVIHRDIKSSNILLDQSMRARVADFGLSREE-----MVDKHAANIRGTFGYL 279
                  P + HRD+KS NIL+ ++ +  +AD GL+         +D       GT  Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 280 DPE------YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYV----ELAAMNTEGK 329
            PE       +   +  K+ D+++FG++L+E+         + +Y     ++   +   +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 330 TGWEEIVDSRL-----DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
              + +   +      +  F    L  +A L  +C  + P  R +   I + L++I
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  172 bits (438), Expect = 6e-50
 Identities = 76/273 (27%), Positives = 120/273 (43%), Gaps = 30/273 (10%)

Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+G FG V+  ++    T VAVK          + +F  E  +L +  H N+V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
            +K    +V   +  G   + L       L     + +  D A G+EYL        IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHR 237

Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-------IRGTFGYLDPEYISTRNFT 290
           D+ + N L+ +    +++DFG+SREE    +AA+       ++ T     PE ++   ++
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNYGRYS 293

Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL 349
            +SDV+SFG+LL+E  + G SP    +   +      +G          RL       + 
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPN-LSNQQTREFVEKGG---------RLPCPELCPD- 342

Query: 350 NEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             V  L  +C    P +RPS   I Q L  I K
Sbjct: 343 -AVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  164 bits (418), Expect = 7e-48
 Identities = 64/262 (24%), Positives = 111/262 (42%), Gaps = 23/262 (8%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
            IG+G+F  VYK     T   VA   L     +K   + F+ E  +L  L H N+V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 176 YC--AEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
                 KG+  +V V   M+ G+L ++L  + +  +   +       + +GL++LH    
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTRT- 149

Query: 232 PPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT 290
           PP+IHRD+K  NI +   +   ++ D GL+        A  + GT  ++ PE      + 
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMY-EEKYD 207

Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
           +  DVY+FG+ + E+     P      Y E        +     +  +  D +       
Sbjct: 208 ESVDVYAFGMCMLEMATSEYP------YSECQNAAQIYRRVTSGVKPASFDKVAI----P 257

Query: 351 EVASLAYKCVNRAPRKRPSMRD 372
           EV  +   C+ +   +R S++D
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKD 279

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  167 bits (425), Expect = 3e-47
 Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 36/273 (13%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC-A 178
           IG+G FG V       G  VAVK +  D+    + F  E  ++ +L H NLV L+G    
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
           EKG   +V  +M+KGSL  +L       L  +  +  +LDV   +EYL        +HRD
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRD 314

Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAAN--IRGTFGYLDPEYISTRNFTKKSDVY 296
           + + N+L+ +   A+V+DFGL++E    +      ++ T     PE +  + F+ KSDV+
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVW 370

Query: 297 SFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
           SFG+LL+E+ + GR P   +     +  VE      +G          ++D         
Sbjct: 371 SFGILLWEIYSFGRVPYPRIPLKDVVPRVE------KGY---------KMDAPDGCPP-- 413

Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM 383
            V  +   C +     RP+   + + L  I   
Sbjct: 414 AVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  168 bits (427), Expect = 3e-47
 Identities = 75/267 (28%), Positives = 129/267 (48%), Gaps = 20/267 (7%)

Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G G +G VY+         VAVK L  D+ +  +EF  E  ++  + H NLV L+G C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 286

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            +    ++  FM+ G+L  +L + N   ++  + +++A  ++  +EYL        IHR+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRN 343

Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY--LDPEYISTRNFTKKSDVY 296
           + + N L+ ++   +VADFGLSR    D + A+    F      PE ++   F+ KSDV+
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 403

Query: 297 SFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASL 355
           +FGVLL+E+   G SP  G ++  ++  +  +           R++      E  +V  L
Sbjct: 404 AFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDY---------RMERPEGCPE--KVYEL 451

Query: 356 AYKCVNRAPRKRPSMRDIVQVLSRILK 382
              C    P  RPS  +I Q    + +
Sbjct: 452 MRACWQWNPSDRPSFAEIHQAFETMFQ 478

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  163 bits (414), Expect = 6e-47
 Identities = 73/304 (24%), Positives = 127/304 (41%), Gaps = 28/304 (9%)

Query: 120 IGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           +G+G FG V          +TG  VAVK L       +++FQ E+ +L  LH   +V   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 175 GYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           G     G+    LV  ++  G L   L   +   L  +  +  +  + +G+EYL      
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSRR-- 147

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT----FGYLDPEYISTRN 288
             +HRD+ + NIL++     ++ADFGL++   +DK    +R        +  PE +S   
Sbjct: 148 -CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206

Query: 289 FTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
           F+++SDV+SFGV+L+EL            E++ +     +       +++   +G    +
Sbjct: 207 FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL-SRLLELLEEG----Q 261

Query: 348 EL-------NEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADE 400
            L        EV  L   C   +P+ RPS   +   L  +       + H  +       
Sbjct: 262 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKH 321

Query: 401 VSID 404
            S+ 
Sbjct: 322 HSLS 325

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  163 bits (415), Expect = 7e-46
 Identities = 79/271 (29%), Positives = 120/271 (44%), Gaps = 20/271 (7%)

Query: 116 FTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
               +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L  
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYA 246

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
             +E+    +V  +MSKGSL   L  E    L     V +A  +A G+ Y+        +
Sbjct: 247 VVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---V 302

Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY--LDPEYISTRNFTKKS 293
           HRD++++NIL+ +++  +VADFGL+R    +++ A     F      PE      FT KS
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362

Query: 294 DVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEV 352
           DV+SFG+LL EL   GR P  G M   E+      G          R+    +  E   +
Sbjct: 363 DVWSFGILLTELTTKGRVPYPG-MVNREVLDQVERGY---------RMPCPPECPE--SL 410

Query: 353 ASLAYKCVNRAPRKRPSMRDIVQVLSRILKM 383
             L  +C  + P +RP+   +   L      
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  158 bits (403), Expect = 9e-46
 Identities = 78/273 (28%), Positives = 124/273 (45%), Gaps = 36/273 (13%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC-A 178
           IG+G FG V       G  VAVK +  D+    + F  E  ++ +L H NLV L+G    
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
           EKG   +V  +M+KGSL  +L       L  +  +  +LDV   +EYL        +HRD
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRD 142

Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAAN--IRGTFGYLDPEYISTRNFTKKSDVY 296
           + + N+L+ +   A+V+DFGL++E    +      ++ T     PE +  + F+ KSDV+
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVW 198

Query: 297 SFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
           SFG+LL+E+ + GR P   +     +  VE      +G          ++D         
Sbjct: 199 SFGILLWEIYSFGRVPYPRIPLKDVVPRVE------KGY---------KMDAPDGCPP-- 241

Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM 383
            V  +   C +     RPS   + + L  I   
Sbjct: 242 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  158 bits (403), Expect = 9e-46
 Identities = 78/272 (28%), Positives = 128/272 (47%), Gaps = 30/272 (11%)

Query: 120 IGQGAFGPVYKAQMSTGET-VAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G G +G VY+         VAVK L  D+ +  +EF  E  ++  + H NLV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            +    ++  FM+ G+L  +L + N   ++  + +++A  ++  +EYL        IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 136

Query: 239 IKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY--LDPEYISTRNFTKKSDVY 296
           + + N L+ ++   +VADFGLSR    D + A+    F      PE ++   F+ KSDV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196

Query: 297 SFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
           +FGVLL+E+   G SP  G+      E +E      +           R++      E  
Sbjct: 197 AFGVLLWEIATYGMSPYPGIDLSQVYELLE------KDY---------RMERPEGCPE-- 239

Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
           +V  L   C    P  RPS  +I Q    + +
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  160 bits (406), Expect = 1e-45
 Identities = 83/319 (26%), Positives = 135/319 (42%), Gaps = 57/319 (17%)

Query: 94  NVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE------TVAVKVLATD 147
              S + +     +D+          +G+GAFG V+ A+            VAVK L   
Sbjct: 28  QYFSDACVHHIKRRDIV-----LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA 82

Query: 148 SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-------- 199
           S+   ++FQ E  LL  L H+++V   G C E    ++V+ +M  G L   L        
Sbjct: 83  SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAK 142

Query: 200 -----YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV 254
                 D   GPL     + +A  VA G+ YL        +HRD+ + N L+ Q +  ++
Sbjct: 143 LLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKI 199

Query: 255 ADFGLSREEMVDKHAANIRGTFGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-G 308
            DFG+SR+  +        G    L      PE I  R FT +SDV+SFGV+L+E+   G
Sbjct: 200 GDFGMSRD--IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257

Query: 309 RSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRA 363
           + P   L     ++ +       +G+          L+         EV ++   C  R 
Sbjct: 258 KQPWYQLSNTEAIDCIT------QGR---------ELERPRACPP--EVYAIMRGCWQRE 300

Query: 364 PRKRPSMRDIVQVLSRILK 382
           P++R S++D+   L  + +
Sbjct: 301 PQQRHSIKDVHARLQALAQ 319

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  159 bits (405), Expect = 1e-45
 Identities = 90/314 (28%), Positives = 140/314 (44%), Gaps = 50/314 (15%)

Query: 120 IGQGAFGPVYKAQMSTGE----TVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+G FG V +AQ+   +     VAVK+L  D  +    +EF  E   +    H ++  L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 174 VGYCAEKG---QHMLVYV---FMSKGSLASHL----YDENYGPLTWNLRVHIALDVARGL 223
           VG         +  +  V   FM  G L + L      EN   L     V   +D+A G+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI--RGTFGYL-- 279
           EYL   +    IHRD+ + N +L + M   VADFGLSR      ++ +   +G    L  
Sbjct: 151 EYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQGCASKLPV 203

Query: 280 ---DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEI 335
                E ++   +T  SDV++FGV ++E++  G++P  G +E  E+      G       
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG-IENAEIYNYLIGGN------ 256

Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQS 395
              RL    +  E  EV  L Y+C +  P++RPS   +   L  IL        H    S
Sbjct: 257 ---RLKQPPECME--EVYDLMYQCWSADPKQRPSFTCLRMELENILG-------HLSVLS 304

Query: 396 TTADEVSIDMEQAE 409
           T+ D + I++E+A 
Sbjct: 305 TSQDPLYINIERAH 318

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  157 bits (399), Expect = 2e-45
 Identities = 74/266 (27%), Positives = 123/266 (46%), Gaps = 20/266 (7%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG G FG V+       + VA+K +   +   E++F  E  ++ +L H  LV L G C E
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 74

Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +    LV  FM  G L+ +L     G       + + LDV  G+ YL +     VIHRD+
Sbjct: 75  QAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 130

Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY--LDPEYISTRNFTKKSDVYS 297
            + N L+ ++   +V+DFG++R  + D++ ++    F      PE  S   ++ KSDV+S
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190

Query: 298 FGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLA 356
           FGVL++E+ + G+ P +      E+    + G          RL           V  + 
Sbjct: 191 FGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGF---------RLYKPRLAST--HVYQIM 238

Query: 357 YKCVNRAPRKRPSMRDIVQVLSRILK 382
             C    P  RP+   +++ L+ I +
Sbjct: 239 NHCWRERPEDRPAFSRLLRQLAEIAE 264

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  160 bits (407), Expect = 2e-45
 Identities = 88/374 (23%), Positives = 156/374 (41%), Gaps = 50/374 (13%)

Query: 32  YHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLEGFK 91
           +H        +S      +P  + G+D    + + +        S      ++++ +G  
Sbjct: 9   HHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGS------ENLYFQGAN 62

Query: 92  RSNVVSASGIPEYS------YKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAV 141
             ++  ++  PE                 +F  +IG+G FG VY   +   +      AV
Sbjct: 63  TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 122

Query: 142 KVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVGYCAEK-GQHMLVYVFMSKGSLASHL 199
           K L   +  GE  +F TE +++    H N+++L+G C    G  ++V  +M  G L + +
Sbjct: 123 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 182

Query: 200 YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL 259
            +E     T    +   L VA+G+++L        +HRD+ + N +LD+    +VADFGL
Sbjct: 183 RNET-HNPTVKDLIGFGLQVAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGL 238

Query: 260 SREEMVDKHAANIRGTFGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQ 313
           +R+    +  +    T   L       E + T+ FT KSDV+SFGVLL+EL+  G  P  
Sbjct: 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298

Query: 314 GL-----MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRP 368
            +       Y+       +G+         RL       +   +  +  KC +     RP
Sbjct: 299 DVNTFDITVYLL------QGR---------RLLQPEYCPD--PLYEVMLKCWHPKAEMRP 341

Query: 369 SMRDIVQVLSRILK 382
           S  ++V  +S I  
Sbjct: 342 SFSELVSRISAIFS 355

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  163 bits (415), Expect = 3e-45
 Identities = 79/267 (29%), Positives = 120/267 (44%), Gaps = 20/267 (7%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +GQG FG V+    +    VA+K L   +   E  F  E  ++ +L H  LV L    +E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 333

Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +    +V  +MSKGSL   L  E    L     V +A  +A G+ Y+        +HRD+
Sbjct: 334 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDL 389

Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY--LDPEYISTRNFTKKSDVYS 297
           +++NIL+ +++  +VADFGL+R    +++ A     F      PE      FT KSDV+S
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449

Query: 298 FGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLA 356
           FG+LL EL   GR P  G M   E+      G          R+    +  E   +  L 
Sbjct: 450 FGILLTELTTKGRVPYPG-MVNREVLDQVERGY---------RMPCPPECPE--SLHDLM 497

Query: 357 YKCVNRAPRKRPSMRDIVQVLSRILKM 383
            +C  + P +RP+   +   L      
Sbjct: 498 CQCWRKEPEERPTFEYLQAFLEDYFTS 524

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  158 bits (401), Expect = 5e-45
 Identities = 69/290 (23%), Positives = 127/290 (43%), Gaps = 52/290 (17%)

Query: 120 IGQGAFGPVYKAQMSTGE------TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
           +GQG+FG VY+              VA+K +   +   E+ EF  E  ++   +  ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL--------YDENYGPLTWNLRVHIALDVARGLE 224
           L+G  ++    +++   M++G L S+L         +    P + +  + +A ++A G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI--RGTFGYL--- 279
           YL+       +HRD+ + N ++ +    ++ DFG++R    D +  +   +G  G L   
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 205

Query: 280 --DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTG 331
              PE +    FT  SDV+SFGV+L+E+      P QGL     + +V       EG   
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM------EGG-- 257

Query: 332 WEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
                   LD   +  +   +  L   C    P+ RPS  +I+  +   +
Sbjct: 258 -------LLDKPDNCPD--MLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  157 bits (399), Expect = 5e-45
 Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 31/284 (10%)

Query: 120 IGQGAFGPVYKAQM-----STGETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+G FG V   +      +TGE VAVK L          + + E+ +L  L+H N+V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 174 VGYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            G C E G +   L+  F+  GSL  +L   N   +    ++  A+ + +G++YL     
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSRQY 147

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL-----DPEYIST 286
              +HRD+ + N+L++   + ++ DFGL++    DK    ++            PE +  
Sbjct: 148 ---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD-RDSPVFWYAPECLMQ 203

Query: 287 RNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             F   SDV+SFGV L EL+    S    +  ++++        T    +V++  +G   
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV-TRLVNTLKEG--- 259

Query: 346 VEEL-------NEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
            + L       +EV  L  KC    P  R S +++++    +LK
Sbjct: 260 -KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  157 bits (398), Expect = 6e-45
 Identities = 82/316 (25%), Positives = 138/316 (43%), Gaps = 44/316 (13%)

Query: 94  NVVSASGIPEYS------YKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE----TVAVKV 143
           ++  ++  PE                 +F  +IG+G FG VY   +   +      AVK 
Sbjct: 1   HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 60

Query: 144 LATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVGYCAE-KGQHMLVYVFMSKGSLASHLYD 201
           L   +  GE  +F TE +++    H N+++L+G C   +G  ++V  +M  G L + + +
Sbjct: 61  LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 120

Query: 202 ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261
           E     T    +   L VA+G++YL        +HRD+ + N +LD+    +VADFGL+R
Sbjct: 121 ET-HNPTVKDLIGFGLQVAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLAR 176

Query: 262 EEMVDKHAANIRGTFGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL 315
           +    ++ +    T   L       E + T+ FT KSDV+SFGVLL+EL+  G  P   +
Sbjct: 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236

Query: 316 -----MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSM 370
                  Y+       +G+         RL       +   +  +  KC +     RPS 
Sbjct: 237 NTFDITVYLL------QGR---------RLLQPEYCPD--PLYEVMLKCWHPKAEMRPSF 279

Query: 371 RDIVQVLSRILKMRHN 386
            ++V  +S I      
Sbjct: 280 SELVSRISAIFSTFIG 295

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  155 bits (395), Expect = 1e-44
 Identities = 67/276 (24%), Positives = 125/276 (45%), Gaps = 38/276 (13%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +G G FG V   +      VA+K++   S   E EF  E  ++  L H  LV L G C +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK 90

Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +    ++  +M+ G L ++L  E          + +  DV   +EYL        +HRD+
Sbjct: 91  QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDL 146

Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAAN------IRGTFGYLDPEYISTRNFTKKS 293
            + N L++     +V+DFGLSR  + D++ ++      +R +     PE +    F+ KS
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYSKFSSKS 202

Query: 294 DVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
           D+++FGVL++E+ + G+ P +        E++       +G          RL       
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA------QGL---------RLYRPHLAS 247

Query: 348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM 383
           E  +V ++ Y C +    +RP+ + ++  +  ++  
Sbjct: 248 E--KVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  155 bits (394), Expect = 2e-44
 Identities = 72/292 (24%), Positives = 130/292 (44%), Gaps = 43/292 (14%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           LIG G FG V+KA+    G+T  +K +       EK  + EV  L +L H N+V+  G  
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAER-EVKALAKLDHVNIVHYNGCW 73

Query: 178 AEKGQHML-------------VYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
                                +++ M    KG+L   +       L   L + +   + +
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133

Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
           G++Y+H      +I+RD+K SNI L  + + ++ DFGL      D      +GT  Y+ P
Sbjct: 134 GVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSP 190

Query: 282 EYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD 341
           E IS++++ K+ D+Y+ G++L EL+                A  T     + ++ D  + 
Sbjct: 191 EQISSQDYGKEVDLYALGLILAELLHVCDT-----------AFETSKF--FTDLRDGIIS 237

Query: 342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKS 393
            IFD     +  +L  K +++ P  RP+  +I++  +  +  +   K+ R +
Sbjct: 238 DIFD----KKEKTLLQKLLSKKPEDRPNTSEILR--TLTVWKKSPEKNERHT 283

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  155 bits (394), Expect = 2e-44
 Identities = 76/280 (27%), Positives = 129/280 (46%), Gaps = 38/280 (13%)

Query: 120 IGQGAFGPVYKAQMSTGE----TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLV 174
           IG+G FG VY  +           A+K L+  ++  +   F  E +L+  L+H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88

Query: 175 GYC-AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           G     +G   ++  +M  G L   +      P   +L +   L VARG+EYL   A   
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-ISFGLQVARGMEYL---AEQK 144

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL-----DPEYISTRN 288
            +HRD+ + N +LD+S   +VADFGL+R+ +  ++ +  +     L       E + T  
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR 204

Query: 289 FTKKSDVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRLDG 342
           FT KSDV+SFGVLL+EL+  G  P + +       ++       +G+         RL  
Sbjct: 205 FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA------QGR---------RLPQ 249

Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                +   +  +  +C    P  RP+ R +V  + +I+ 
Sbjct: 250 PEYCPD--SLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  155 bits (395), Expect = 3e-44
 Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 51/285 (17%)

Query: 120 IGQGAFGPVYKAQMSTGE-----TVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G GAFG VYK             VA+K L    S +  KE   E  ++  + + ++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           +G C       L+   M  G L  ++  E+   +     ++  + +A+G+ YL D  +  
Sbjct: 83  LGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDRRL-- 138

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT---FGYLDPEYISTRNFT 290
            +HRD+ + N+L+      ++ DFGL++    ++   +  G      ++  E I  R +T
Sbjct: 139 -VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197

Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRL---- 340
            +SDV+S+GV ++EL+  G  P  G+        +E      +G+         RL    
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE------KGE---------RLPQPP 242

Query: 341 ---DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                ++          +  KC       RP  R+++   S++ +
Sbjct: 243 ICTIDVYM---------IMRKCWMIDADSRPKFRELIIEFSKMAR 278

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  155 bits (393), Expect = 3e-44
 Identities = 72/282 (25%), Positives = 130/282 (46%), Gaps = 27/282 (9%)

Query: 120 IGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           +G+G FG V        Q +TGE VAVK L   +++  ++F+ E+ +L  L H N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 175 GYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           G C   G+    L+  ++  GSL  +L   +   +     +     + +G+EYL      
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTKR-- 134

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT----FGYLDPEYISTRN 288
             IHRD+ + NIL++   R ++ DFGL++    DK    ++        +  PE ++   
Sbjct: 135 -YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193

Query: 289 FTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
           F+  SDV+SFGV+L+EL            E++ +   + +G+     +++   +      
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN----G 249

Query: 348 EL-------NEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
            L       +E+  +  +C N    +RPS RD+   + +I  
Sbjct: 250 RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  154 bits (392), Expect = 5e-44
 Identities = 82/325 (25%), Positives = 135/325 (41%), Gaps = 72/325 (22%)

Query: 97  SASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ------MSTGETVAVKVLATDSKQ 150
           S   +     +D+          +G+GAFG V+ A+            VAVK L   +  
Sbjct: 5   SGIHVQHIKRRDIV-----LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA 59

Query: 151 GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL----------- 199
             K+FQ E  LL  L H ++V   G C +    ++V+ +M  G L   L           
Sbjct: 60  ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 119

Query: 200 ---YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVAD 256
                +  G L  +  +HIA  +A G+ YL   A    +HRD+ + N L+  ++  ++ D
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGD 176

Query: 257 FGLSREEMVDKHAANIRGTFGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRS 310
           FG+SR+  V        G    L      PE I  R FT +SDV+SFGV+L+E+   G+ 
Sbjct: 177 FGMSRD--VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

Query: 311 PLQGL-----MEYVELAAMNTEGKTGWEEIVDSRL-------DGIFDVEELNEVASLAYK 358
           P   L     +E +       +G+          L         ++D         +   
Sbjct: 235 PWFQLSNTEVIECIT------QGR---------VLERPRVCPKEVYD---------VMLG 270

Query: 359 CVNRAPRKRPSMRDIVQVLSRILKM 383
           C  R P++R ++++I ++L  + K 
Sbjct: 271 CWQREPQQRLNIKEIYKILHALGKA 295

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  155 bits (394), Expect = 6e-44
 Identities = 88/292 (30%), Positives = 143/292 (48%), Gaps = 45/292 (15%)

Query: 116 FTTLIGQGAFGPVYKAQMSTGE---TVAVKVLATDSKQGEK-EFQTEVMLLGRL-HHRNL 170
           F  +IG+G FG V KA++         A+K +   + + +  +F  E+ +L +L HH N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHL--------------YDENYGPLTWNLRVHIA 216
           +NL+G C  +G   L   +   G+L   L               +     L+    +H A
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF 276
            DVARG++YL   +    IHRD+ + NIL+ ++  A++ADFGLSR + V       + T 
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-----KKTM 200

Query: 277 GYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKT 330
           G L       E ++   +T  SDV+S+GVLL+E+++ G +P  G M   EL     +G  
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGY- 258

Query: 331 GWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                   RL+   + ++  EV  L  +C    P +RPS   I+  L+R+L+
Sbjct: 259 --------RLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  154 bits (392), Expect = 6e-44
 Identities = 73/286 (25%), Positives = 128/286 (44%), Gaps = 42/286 (14%)

Query: 120 IGQGAFGPVYKAQMSTGE----TVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+G FG V +  +   +     VAVK +  D  S++  +EF +E   +    H N++ L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 174 VGYCAEKGQH-----MLVYVFMSKGSLASHL----YDENYGPLTWNLRVHIALDVARGLE 224
           +G C E         M++  FM  G L ++L     +     +     +   +D+A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161

Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANI--RGTFGYL--- 279
           YL   +    +HRD+ + N +L   M   VADFGLS+      ++ +   +G    +   
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYRQGRIAKMPVK 214

Query: 280 --DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
               E ++ R +T KSDV++FGV ++E+   G +P  G ++  E+      G        
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG-VQNHEMYDYLLHGH------- 266

Query: 337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             RL    D  +  E+  + Y C    P  RP+   +   L ++L+
Sbjct: 267 --RLKQPEDCLD--ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  155 bits (393), Expect = 7e-44
 Identities = 72/282 (25%), Positives = 130/282 (46%), Gaps = 27/282 (9%)

Query: 120 IGQGAFGPVYKA-----QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           +G+G FG V        Q +TGE VAVK L   +++  ++F+ E+ +L  L H N+V   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 175 GYCAEKGQH--MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           G C   G+    L+  ++  GSL  +L   +   +     +     + +G+EYL      
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLGTKR-- 165

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT----FGYLDPEYISTRN 288
             IHRD+ + NIL++   R ++ DFGL++    DK    ++        +  PE ++   
Sbjct: 166 -YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224

Query: 289 FTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
           F+  SDV+SFGV+L+EL            E++ +   + +G+     +++   +      
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN----G 280

Query: 348 EL-------NEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
            L       +E+  +  +C N    +RPS RD+   + +I  
Sbjct: 281 RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  154 bits (391), Expect = 1e-43
 Identities = 74/284 (26%), Positives = 118/284 (41%), Gaps = 33/284 (11%)

Query: 120 IGQGAFGPVYKA-----QMSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G+G FG V           TGE VAVK L  D   Q    ++ E+ +L  L+H +++  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 174 VGYCAEKGQ--HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            G C + G     LV  ++  GSL  +L   +   +     +  A  +  G+ YLH    
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHY 155

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL-----DPEYIST 286
              IHRD+ + N+LLD     ++ DFGL++          +R   G        PE +  
Sbjct: 156 ---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED-GDSPVFWYAPECLKE 211

Query: 287 RNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             F   SDV+SFGV L+EL+    S      +++EL  +     T    + +    G   
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV-LRLTELLERG--- 267

Query: 346 VEEL-------NEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
            E L        EV  L   C       RP+  +++ +L  + +
Sbjct: 268 -ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  154 bits (391), Expect = 1e-43
 Identities = 88/296 (29%), Positives = 138/296 (46%), Gaps = 45/296 (15%)

Query: 120 IGQGAFGPVYKAQ------MSTGETVAVKVLATDSKQGEK-EFQTEVMLLGRL-HHRNLV 171
           +G+GAFG V +A        +T  TVAVK+L   +   E     +E+ +L  + HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 172 NLVGYCAEKGQHMLVYV-FMSKGSLASHL--------------YDENYGPLTWNLRVHIA 216
           NL+G C + G  ++V V F   G+L+++L               D     LT    +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF 276
             VA+G+E+L   A    IHRD+ + NILL +    ++ DFGL+R+  + K    +R   
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD--IYKDPDYVRKGD 209

Query: 277 GYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKT 330
             L      PE I  R +T +SDV+SFGVLL+E+ + G SP  G+    E      EG  
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT- 268

Query: 331 GWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHN 386
                   R+          E+      C +  P +RP+  ++V+ L  +L+    
Sbjct: 269 --------RMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  152 bits (387), Expect = 1e-43
 Identities = 65/279 (23%), Positives = 125/279 (44%), Gaps = 38/279 (13%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +G G FG V   +      VAVK++   S   E EF  E   + +L H  LV   G C++
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSK 74

Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +    +V  ++S G L ++L       L  +  + +  DV  G+ +L        IHRD+
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDL 130

Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAAN------IRGTFGYLDPEYISTRNFTKKS 293
            + N L+D+ +  +V+DFG++R  + D++ ++      ++ +     PE      ++ KS
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHYFKYSSKS 186

Query: 294 DVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
           DV++FG+L++E+ + G+ P         +  V       +G          RL       
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS------QGH---------RLYRPHLAS 231

Query: 348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHN 386
           +   +  + Y C +  P KRP+ + ++  +  + +   +
Sbjct: 232 D--TIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDKH 268

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  153 bits (389), Expect = 3e-43
 Identities = 75/289 (25%), Positives = 123/289 (42%), Gaps = 48/289 (16%)

Query: 120 IGQGAFGPVYKAQMSTGE------TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
           +G GAFG VY+ Q+S          VAVK L     + ++ +F  E +++ + +H+N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLH 227
            +G   +     ++   M+ G L S L            L     +H+A D+A G +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARV---ADFGLSREEMVDKHAANIRGTFGYL----- 279
           +      IHRDI + N LL      RV    DFG++R+  + + +   +G    L     
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRASYYRKGGCAMLPVKWM 212

Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWE 333
            PE      FT K+D +SFGVLL+E+ + G  P         +E+V        G     
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT------SGG---- 262

Query: 334 EIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                R+D   +      V  +  +C    P  RP+   I++ +    +
Sbjct: 263 -----RMDPPKNCPG--PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  156 bits (395), Expect = 5e-43
 Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 30/272 (11%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +G G FG V+ A  +    VAVK +   S    + F  E  ++  L H  LV L     +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK 254

Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +    ++  FM+KGSL   L  +          +  +  +A G+ ++        IHRD+
Sbjct: 255 EPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRDL 310

Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY--LDPEYISTRNFTKKSDVYS 297
           +++NIL+  S+  ++ADFGL+R    +++ A     F      PE I+  +FT KSDV+S
Sbjct: 311 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 370

Query: 298 FGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE 351
           FG+LL E++  GR P  G+     +  +E       G          R+    +  E  E
Sbjct: 371 FGILLMEIVTYGRIPYPGMSNPEVIRALE------RGY---------RMPRPENCPE--E 413

Query: 352 VASLAYKCVNRAPRKRPSMRDIVQVLSRILKM 383
           + ++  +C    P +RP+   I  VL      
Sbjct: 414 LYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  151 bits (383), Expect = 6e-43
 Identities = 76/272 (27%), Positives = 122/272 (44%), Gaps = 30/272 (11%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           +G G FG V+    +    VAVK L   S      F  E  L+ +L H+ LV L     +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 79

Query: 180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI 239
           +    ++  +M  GSL   L   +   LT N  + +A  +A G+ ++ +      IHRD+
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDL 135

Query: 240 KSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGY--LDPEYISTRNFTKKSDVYS 297
           +++NIL+  ++  ++ADFGL+R    +++ A     F      PE I+   FT KSDV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195

Query: 298 FGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE 351
           FG+LL E++  GR P  G+     ++ +E       G          R+    +  E  E
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLE------RGY---------RMVRPDNCPE--E 238

Query: 352 VASLAYKCVNRAPRKRPSMRDIVQVLSRILKM 383
           +  L   C    P  RP+   +  VL      
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  153 bits (389), Expect = 6e-43
 Identities = 79/329 (24%), Positives = 129/329 (39%), Gaps = 62/329 (18%)

Query: 92  RSNVVSASGIPEYSYKDLQKATC----------NFTTLIGQGAFGPVYKAQ------MST 135
           R++ +     P Y +     +                 +G GAFG VY+ Q        +
Sbjct: 41  RTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 100

Query: 136 GETVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS 194
              VAVK L     + ++ +F  E +++ + +H+N+V  +G   +     ++   M+ G 
Sbjct: 101 PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 160

Query: 195 LASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS 249
           L S L            L     +H+A D+A G +YL +      IHRDI + N LL   
Sbjct: 161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCP 217

Query: 250 MRARV---ADFGLSREEMVDKHAANI--RGTFGYL-----DPEYISTRNFTKKSDVYSFG 299
              RV    DFG++R    D + A    +G    L      PE      FT K+D +SFG
Sbjct: 218 GPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 273

Query: 300 VLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVA 353
           VLL+E+ + G  P         +E+V        G          R+D   +      V 
Sbjct: 274 VLLWEIFSLGYMPYPSKSNQEVLEFVT------SGG---------RMDPPKNCPG--PVY 316

Query: 354 SLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
            +  +C    P  RP+   I++ +    +
Sbjct: 317 RIMTQCWQHQPEDRPNFAIILERIEYCTQ 345

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  152 bits (385), Expect = 8e-43
 Identities = 62/287 (21%), Positives = 119/287 (41%), Gaps = 36/287 (12%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
            +G+G F  V   + +  G   A+K +    +Q  +E Q E  +    +H N++ LV YC
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 178 A-EKGQHMLVYVFM---SKGSLASHL--YDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
             E+G     ++ +    +G+L + +    +    LT +  + + L + RGLE +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSR----------EEMVDKHAANIRGTFGYLDP 281
               HRD+K +NILL    +  + D G             + +  +  A  R T  Y  P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 282 EYISTR---NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDS 338
           E  S +      +++DV+S G +L+ ++ G  P   + +  +  A+  + +         
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ--LSIPQSP 270

Query: 339 RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH 385
           R          + +  L    +   P +RP    I  +LS++  ++ 
Sbjct: 271 RHS--------SALWQLLNSMMTVDPHQRPH---IPLLLSQLEALQP 306

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  152 bits (385), Expect = 1e-42
 Identities = 85/297 (28%), Positives = 145/297 (48%), Gaps = 47/297 (15%)

Query: 120 IGQGAFGPVYKA--------QMSTGETVAVKVLATDSKQGEK-EFQTEVMLLGRL-HHRN 169
           +G+GAFG V  A        +     TVAVK+L  D+ + +  +  +E+ ++  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHL--------------YDENYGPLTWNLRVHI 215
           ++NL+G C + G   ++  + SKG+L  +L                     +T+   V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 216 ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT 275
              +ARG+EYL   A    IHRD+ + N+L+ ++   ++ADFGL+R+  ++      + T
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD--INNIDYYKKTT 217

Query: 276 FGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
            G L      PE +  R +T +SDV+SFGVL++E+   G SP  G +   EL  +  EG 
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLKEGH 276

Query: 330 TGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHN 386
                    R+D   +     E+  +   C +  P +RP+ + +V+ L RIL +  N
Sbjct: 277 ---------RMDKPANCTN--ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  151 bits (384), Expect = 1e-42
 Identities = 80/289 (27%), Positives = 125/289 (43%), Gaps = 58/289 (20%)

Query: 120 IGQGAFGPVYKAQMSTGE----TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLV 174
           IG G  G V   ++         VA+K L     + ++ +F +E  ++G+  H N++ L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G        M+V  +M  GSL + L   + G  T    V +   V  G+ YL D      
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLG---Y 172

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN--------IRGTFGYLDPEYIST 286
           +HRD+ + N+L+D ++  +V+DFGLSR    D  AA         IR T     PE I+ 
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEAIAF 228

Query: 287 RNFTKKSDVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRL 340
           R F+  SDV+SFGV+++E++A G  P   +     +  VE      EG          RL
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE------EGY---------RL 273

Query: 341 -------DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                    +           L   C ++   +RP    IV VL  +++
Sbjct: 274 PAPMGCPHALHQ---------LMLDCWHKDRAQRPRFSQIVSVLDALIR 313

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  150 bits (381), Expect = 2e-42
 Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 57/301 (18%)

Query: 120 IGQGAFGPVYKA-------QMSTGET-VAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLV 171
           +GQG F  ++K             ET V +KVL    +   + F     ++ +L H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
              G C    +++LV  F+  GSL ++L  +N   +    ++ +A  +A  + +L +   
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFLEENT- 133

Query: 232 PPVIHRDIKSSNILLDQSMRAR--------VADFGLSRE-EMVDKHAANIRGTFGYLDPE 282
             +IH ++ + NILL +    +        ++D G+S      D     I        PE
Sbjct: 134 --LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV----PPE 187

Query: 283 YIS-TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEI 335
            I   +N    +D +SFG  L+E+ + G  PL  L     +++ E      +        
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE------DRH------ 235

Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL------KMRHNRKH 389
              +L       +  E+A+L   C++  P  RPS R I++ L+ +       +  H+  H
Sbjct: 236 ---QL----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHH 288

Query: 390 H 390
           H
Sbjct: 289 H 289

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  152 bits (386), Expect = 2e-42
 Identities = 99/389 (25%), Positives = 173/389 (44%), Gaps = 64/389 (16%)

Query: 31  RYHRKRSQIGNSSSRRAATLPI-RANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLEG 89
            +H   SQ   +  +    +P+ R   V + S  S ++  P   + +  +    +  L G
Sbjct: 5   HHHHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAG 64

Query: 90  FKRSNVVSASGIP-----EYSYKDLQKATCNFTTLIGQGAFGPVYKA--------QMSTG 136
                 VS   +P     E+    L          +G+G FG V  A        +    
Sbjct: 65  ------VSEYELPEDPKWEFPRDKLT-----LGKPLGEGCFGQVVMAEAVGIDKDKPKEA 113

Query: 137 ETVAVKVLATDSKQGEK-EFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGS 194
            TVAVK+L  D+ + +  +  +E+ ++  +  H+N++NL+G C + G   ++  + SKG+
Sbjct: 114 VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 173

Query: 195 LASHL--------------YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIK 240
           L  +L                     +T+   V     +ARG+EYL   A    IHRD+ 
Sbjct: 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLA 230

Query: 241 SSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL-----DPEYISTRNFTKKSDV 295
           + N+L+ ++   ++ADFGL+R+  ++      + T G L      PE +  R +T +SDV
Sbjct: 231 ARNVLVTENNVMKIADFGLARD--INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 288

Query: 296 YSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVAS 354
           +SFGVL++E+   G SP  G +   EL  +  EG          R+D   +     E+  
Sbjct: 289 WSFGVLMWEIFTLGGSPYPG-IPVEELFKLLKEGH---------RMDKPANCTN--ELYM 336

Query: 355 LAYKCVNRAPRKRPSMRDIVQVLSRILKM 383
           +   C +  P +RP+ + +V+ L RIL +
Sbjct: 337 MMRDCWHAVPSQRPTFKQLVEDLDRILTL 365

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  151 bits (383), Expect = 2e-42
 Identities = 80/309 (25%), Positives = 136/309 (44%), Gaps = 66/309 (21%)

Query: 116 FTTLIGQGAFGPVYKAQ------MSTGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHR 168
           +   IG+GAFG V++A+            VAVK+L  + S   + +FQ E  L+    + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110

Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHL----------------------YDENYGP 206
           N+V L+G CA      L++ +M+ G L   L                            P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD 266
           L+   ++ IA  VA G+ YL +      +HRD+ + N L+ ++M  ++ADFGLSR    +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSR----N 223

Query: 267 KHAANI--RGTFGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL--- 315
            ++A+         +      PE I    +T +SDV+++GV+L+E+ + G  P  G+   
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283

Query: 316 --MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDI 373
             + YV       +G           L    +     E+ +L   C ++ P  RPS   I
Sbjct: 284 EVIYYVR------DGN---------ILACPENCPL--ELYNLMRLCWSKLPADRPSFCSI 326

Query: 374 VQVLSRILK 382
            ++L R+ +
Sbjct: 327 HRILQRMCE 335

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  151 bits (383), Expect = 3e-42
 Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 42/288 (14%)

Query: 120 IGQGAFGPVYKAQM------STGETVAVKVLATDSKQGEK-EFQTEVMLLGRL-HHRNLV 171
           +G GAFG V +A             VAVK+L + +   EK    +E+ ++  L  H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113

Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHL------------YDENYGPLTWNLRVHIALDV 219
           NL+G C   G  +++  +   G L + L            +       +    +H +  V
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173

Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL 279
           A+G+ +L   A    IHRD+ + N+LL     A++ DFGL+R+  +   +  I      L
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD--IMNDSNYIVKGNARL 228

Query: 280 -----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWE 333
                 PE I    +T +SDV+S+G+LL+E+ + G +P  G++   +   +  +G     
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY---- 284

Query: 334 EIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
                ++       +   + S+   C    P  RP+ + I   L    
Sbjct: 285 -----QMAQPAFAPK--NIYSIMQACWALEPTHRPTFQQICSFLQEQA 325

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  151 bits (383), Expect = 3e-42
 Identities = 70/315 (22%), Positives = 123/315 (39%), Gaps = 30/315 (9%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKV--LATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
            IG+G+FG     +    G    +K   ++  S +  +E + EV +L  + H N+V    
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 176 YCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
              E G    +Y+ M     G L   +  +       +  +   + +   L+++HD    
Sbjct: 91  SFEENGS---LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---R 144

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRNFTK 291
            ++HRDIKS NI L +    ++ DFG++R        A    GT  YL PE    + +  
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNN 204

Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE 351
           KSD+++ G +L+EL   +   +       L      G           +   +      +
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEAG-SMKNLVLKIISGSF-------PPVSLHYS----YD 252

Query: 352 VASLAYKCVNRAPRKRPSMRDIVQ---VLSRILKMRHNRKHHRKSQSTTADEVSIDMEQA 408
           + SL  +   R PR RPS+  I++   +  RI K    +    +    T  +     +  
Sbjct: 253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGS--QPI 310

Query: 409 EAKTPTSTHLREESV 423
            AK P S       +
Sbjct: 311 PAKRPASGQNSISVM 325

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  150 bits (380), Expect = 3e-42
 Identities = 77/292 (26%), Positives = 129/292 (44%), Gaps = 46/292 (15%)

Query: 120 IGQGAFGPVYKAQ------MSTGETVAVKVLATDSKQGEK-EFQTEVMLLGRL-HHRNLV 171
           +G GAFG V +A            TVAVK+L   +   E+    +E+ +L  L +H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHL----------------YDENYGPLTWNLRVHI 215
           NL+G C   G  +++  +   G L + L                 +++   L     +  
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 216 ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT 275
           +  VA+G+ +L   A    IHRD+ + NILL      ++ DFGL+R+  +   +  +   
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD--IKNDSNYVVKG 205

Query: 276 FGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
              L      PE I    +T +SDV+S+G+ L+EL + G SP  G+    +   M  EG 
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 265

Query: 330 TGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
                    R+          E+  +   C +  P KRP+ + IVQ++ + +
Sbjct: 266 ---------RMLSPEHAPA--EMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  149 bits (378), Expect = 3e-42
 Identities = 76/283 (26%), Positives = 126/283 (44%), Gaps = 27/283 (9%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
            IG G++G   K +  S G+ +  K L     ++  ++   +EV LL  L H N+V    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 176 YCAEKGQHMLVYVFM---SKGSLASHL--YDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
              ++    L Y+ M     G LAS +    +    L     + +   +   L+  H  +
Sbjct: 73  RIIDRTNTTL-YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131

Query: 231 VPP--VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTR 287
                V+HRD+K +N+ LD     ++ DFGL+R    D   A    GT  Y+ PE ++  
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM 191

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
           ++ +KSD++S G LL+EL A   P        ELA    EGK         R+   +   
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKF-------RRIPYRYS-- 241

Query: 348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHH 390
             +E+  +  + +N     RPS+ +I++    IL+  H+  HH
Sbjct: 242 --DELNEIITRMLNLKDYHRPSVEEILE-NPLILE--HHHHHH 279

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  149 bits (378), Expect = 5e-42
 Identities = 71/301 (23%), Positives = 120/301 (39%), Gaps = 60/301 (19%)

Query: 120 IGQGAFGPVYKAQMSTGE---TVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           +G G FG V K      +   TVAVK+L    +    + E   E  ++ +L +  +V ++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E    MLV      G L  +L  +    +     + +   V+ G++YL +      
Sbjct: 85  GIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESNF--- 138

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN--------IRGTFGYLDPEYIST 286
           +HRD+ + N+LL     A+++DFGLS+    D++           ++       PE I+ 
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APECINY 194

Query: 287 RNFTKKSDVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRL 340
             F+ KSDV+SFGVL++E  + G+ P +G+        +E      +G+         R+
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE------KGE---------RM 239

Query: 341 -------DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKS 393
                    ++D         L   C       RP    +   L        N  HH   
Sbjct: 240 GCPAGCPREMYD---------LMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHH 290

Query: 394 Q 394
            
Sbjct: 291 H 291

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  150 bits (382), Expect = 7e-42
 Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 58/290 (20%)

Query: 120 IGQGAFGPVYKAQMSTGE----TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLV 174
           +G G FG V   ++        +VA+K L     + ++ +F  E  ++G+  H N++ L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G   +    M+V  +M  GSL S L  ++    T    V +   +A G++YL D      
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYLSDMG---Y 168

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN--------IRGTFGYLDPEYIST 286
           +HRD+ + NIL++ ++  +V+DFGL R    D  AA         IR T     PE I+ 
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPEAIAY 224

Query: 287 RNFTKKSDVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRL 340
           R FT  SDV+S+G++L+E+++ G  P   +     ++ V+      EG          RL
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD------EGY---------RL 269

Query: 341 -------DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM 383
                    ++          L   C  +    RP    IV +L ++++ 
Sbjct: 270 PPPMDCPAALYQ---------LMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  149 bits (379), Expect = 8e-42
 Identities = 65/273 (23%), Positives = 123/273 (45%), Gaps = 27/273 (9%)

Query: 120 IGQGAFGPVYKAQMSTGE-----TVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G GAFG VYK             VA+K L    S +  KE   E  ++  + + ++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           +G C       L+   M  G L  ++  E+   +     ++  + +A+G+ YL D  +  
Sbjct: 83  LGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDRRL-- 138

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT---FGYLDPEYISTRNFT 290
            +HRD+ + N+L+      ++ DFGL++    ++   +  G      ++  E I  R +T
Sbjct: 139 -VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197

Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL 349
            +SDV+S+GV ++EL+  G  P  G +   E++++  +G+         RL         
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGE---------RLPQPPIC--T 245

Query: 350 NEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
            +V  +  KC       RP  R+++   S++ +
Sbjct: 246 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  150 bits (380), Expect = 9e-42
 Identities = 83/340 (24%), Positives = 141/340 (41%), Gaps = 62/340 (18%)

Query: 88  EGFKRSNVVSASGIPEYSYKDLQKATCN-----------FTTLIGQGAFGPVYKAQ---- 132
           E   +   V+ S   EY Y D ++   +           F  ++G GAFG V  A     
Sbjct: 10  ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 69

Query: 133 --MSTGETVAVKVLATDSKQGEK-EFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYV 188
                   VAVK+L   +   E+    +E+ ++ +L  H N+VNL+G C   G   L++ 
Sbjct: 70  SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129

Query: 189 FMSKGSLASHL---------------------YDENYGPLTWNLRVHIALDVARGLEYLH 227
           +   G L ++L                      +E+   LT+   +  A  VA+G+E+L 
Sbjct: 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL- 188

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL-----DPE 282
                  +HRD+ + N+L+      ++ DFGL+R+  +   +  +      L      PE
Sbjct: 189 --EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD--IMSDSNYVVRGNARLPVKWMAPE 244

Query: 283 YISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD 341
            +    +T KSDV+S+G+LL+E+ + G +P  G+        +   G          ++D
Sbjct: 245 SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGF---------KMD 295

Query: 342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
             F   E  E+  +   C     RKRPS  ++   L   L
Sbjct: 296 QPFYATE--EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  149 bits (378), Expect = 1e-41
 Identities = 69/324 (21%), Positives = 128/324 (39%), Gaps = 52/324 (16%)

Query: 120 IGQGAFGPVYKAQMSTGE-----TVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           +G G FG V+K             V +KV+     +Q  +     ++ +G L H ++V L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           +G C       LV  ++  GSL  H+  ++ G L   L ++  + +A+G+ YL +  +  
Sbjct: 81  LGLCPGS-SLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEHGM-- 136

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT---FGYLDPEYISTRNFT 290
            +HR++ + N+LL    + +VADFG++     D              ++  E I    +T
Sbjct: 137 -VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195

Query: 291 KKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL 349
            +SDV+S+GV ++EL+  G  P  G         +         E+ D    G    E L
Sbjct: 196 HQSDVWSYGVTVWELMTFGAEPYAG---------LRL------AEVPDLLEKG----ERL 236

Query: 350 -------NEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVS 402
                   +V  +  KC       RP+ +++    +R+ +                  + 
Sbjct: 237 AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR-----------DPPRYLVIK 285

Query: 403 IDMEQAEAKTPTSTHLREESVDST 426
            +     A  P    L  + ++  
Sbjct: 286 RESGPGIAPGPEPHGLTNKKLEEV 309

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  147 bits (373), Expect = 2e-41
 Identities = 74/316 (23%), Positives = 119/316 (37%), Gaps = 73/316 (23%)

Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGE------TVAVKVL-ATDSKQGEK 153
           + E S   ++     F   +G+  FG VYK  +           VA+K L         +
Sbjct: 3   LKEISLSAVR-----FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE 57

Query: 154 EFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHL-------------- 199
           EF+ E ML  RL H N+V L+G   +     +++ + S G L   L              
Sbjct: 58  EFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117

Query: 200 YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL 259
                  L     VH+   +A G+EYL       V+H+D+ + N+L+   +  +++D GL
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGL 174

Query: 260 SREEMVDKHAANIRGTFGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQ 313
            RE  V             L      PE I    F+  SD++S+GV+L+E+ + G  P  
Sbjct: 175 FRE--VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 232

Query: 314 GL-----MEYVELAAMNTEGKTGWEEIVDSRL-------DGIFDVEELNEVASLAYKCVN 361
           G      +E +         +          L         ++          L  +C N
Sbjct: 233 GYSNQDVVEMIR------NRQ---------VLPCPDDCPAWVYA---------LMIECWN 268

Query: 362 RAPRKRPSMRDIVQVL 377
             P +RP  +DI   L
Sbjct: 269 EFPSRRPRFKDIHSRL 284

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  148 bits (375), Expect = 2e-41
 Identities = 76/297 (25%), Positives = 140/297 (47%), Gaps = 52/297 (17%)

Query: 120 IGQGAFGPVYKAQMSTGE------TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
           +G+G FG V KA     +      TVAVK+L  ++   E  +  +E  +L +++H +++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHL----------------------YDENYGPLTWN 210
           L G C++ G  +L+  +   GSL   L                         +   LT  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 211 LRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA 270
             +  A  +++G++YL   A   ++HRD+ + NIL+ +  + +++DFGLSR+  V +  +
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD--VYEEDS 205

Query: 271 NIRGTFGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAM 324
            ++ + G +       E +    +T +SDV+SFGVLL+E++  G +P  G +    L  +
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG-IPPERLFNL 264

Query: 325 NTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
              G          R++   +  E  E+  L  +C  + P KRP   DI + L +++
Sbjct: 265 LKTGH---------RMERPDNCSE--EMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  147 bits (374), Expect = 2e-41
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 32/288 (11%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE---FQTEVMLLGRLHHRNLVNLV 174
            IG+G F  VY+A  +  G  VA+K +        K       E+ LL +L+H N++   
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 175 GYCAEKGQHMLVYVFM---SKGSLASHL--YDENYGPLTWNLRVHIALDVARGLEYLHDG 229
               E  +   + + +     G L+  +  + +    +         + +   LE++H  
Sbjct: 99  ASFIEDNE---LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR 155

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRN 288
            V   +HRDIK +N+ +  +   ++ D GL R       AA+ + GT  Y+ PE I    
Sbjct: 156 RV---MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 212

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQG-LMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
           +  KSD++S G LL+E+ A +SP  G  M    L             I       +    
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----------IEQCDYPPLPSDH 262

Query: 348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI-----LKMRHNRKHH 390
              E+  L   C+N  P KRP +  +  V  R+       + H+  HH
Sbjct: 263 YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHHH 310

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  147 bits (372), Expect = 3e-41
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 57/299 (19%)

Query: 120 IGQGAFGPVYKAQ--MSTGET-VAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVG 175
           +G G FG V +    M   +  VA+KVL   +++ +  E   E  ++ +L +  +V L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
            C  +   MLV      G L   L       +  +    +   V+ G++YL +      +
Sbjct: 78  VCQAE-ALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNF---V 132

Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHA--ANIRGTF--GYLDPEYISTRNFTK 291
           HRD+ + N+LL     A+++DFGLS+    D     A   G +   +  PE I+ R F+ 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192

Query: 292 KSDVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRL----- 340
           +SDV+S+GV ++E ++ G+ P + +     M ++E      +GK         R+     
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE------QGK---------RMECPPE 237

Query: 341 --DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM-------RHNRKHH 390
               ++          L   C       RP    + Q +              H+  HH
Sbjct: 238 CPPELYA---------LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHHHH 287

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  147 bits (374), Expect = 5e-41
 Identities = 82/290 (28%), Positives = 135/290 (46%), Gaps = 59/290 (20%)

Query: 120 IGQGAFGPVYKA--QMSTGE---TVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           IG G FG VYK   + S+G+    VA+K L A  +++   +F  E  ++G+  H N++ L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
            G  ++    M++  +M  G+L   L  E  G  +    V +   +A G++YL +     
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLANMN--- 167

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN--------IRGTFGYLDPEYIS 285
            +HRD+ + NIL++ ++  +V+DFGLSR    D  A          IR T     PE IS
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APEAIS 223

Query: 286 TRNFTKKSDVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSR 339
            R FT  SDV+SFG++++E++  G  P   L     M+ +       +G          R
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN------DGF---------R 268

Query: 340 L-------DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
           L         I+          L  +C  +   +RP   DIV +L ++++
Sbjct: 269 LPTPMDCPSAIYQ---------LMMQCWQQERARRPKFADIVSILDKLIR 309

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  148 bits (376), Expect = 6e-41
 Identities = 86/298 (28%), Positives = 145/298 (48%), Gaps = 47/298 (15%)

Query: 120 IGQGAFGPVYKA--------QMSTGETVAVKVLATDSKQGEK-EFQTEVMLLGRL-HHRN 169
           +G+GAFG V  A        + +    VAVK+L +D+ + +  +  +E+ ++  +  H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHL--------------YDENYGPLTWNLRVHI 215
           ++NL+G C + G   ++  + SKG+L  +L                     L+    V  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 216 ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT 275
           A  VARG+EYL   A    IHRD+ + N+L+ +    ++ADFGL+R+  +       + T
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD--IHHIDYYKKTT 251

Query: 276 FGYL-----DPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK 329
            G L      PE +  R +T +SDV+SFGVLL+E+   G SP  G +   EL  +  EG 
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLKEGH 310

Query: 330 TGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNR 387
                    R+D   +     E+  +   C +  P +RP+ + +V+ L RI+ +  N+
Sbjct: 311 ---------RMDKPSNCTN--ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  145 bits (369), Expect = 1e-40
 Identities = 63/285 (22%), Positives = 117/285 (41%), Gaps = 45/285 (15%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLV----- 171
            +G+G FG V++A+        A+K +   +++  +E    EV  L +L H  +V     
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 172 ----NLVGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLT-WNLRVHIALDVARGL 223
               N           + +Y+ M    K +L   +           ++ +HI L +A  +
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---------- 273
           E+LH   +   +HRD+K SNI        +V DFGL      D+    +           
Sbjct: 132 EFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188

Query: 274 ---GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT 330
              GT  Y+ PE I   +++ K D++S G++LFEL+    P    ME V           
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRT--------- 236

Query: 331 GWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
              ++ + +   +F  ++      +    ++ +P +RP   +I++
Sbjct: 237 -LTDVRNLKFPPLFT-QKYPCEYVMVQDMLSPSPMERPEAINIIE 279

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  145 bits (367), Expect = 1e-40
 Identities = 70/285 (24%), Positives = 121/285 (42%), Gaps = 51/285 (17%)

Query: 120 IGQGAFGPVYKAQMSTGE----TVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           +G+G FG VY+   +  +     VAVK      +   +++F +E +++  L H ++V L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G   E+    ++      G L  +L   N   L     V  +L + + + YL        
Sbjct: 80  GII-EEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESINC--- 134

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT---FGYLDPEYISTRNFTK 291
           +HRDI   NIL+      ++ DFGLSR  + D+       T     ++ PE I+ R FT 
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRFTT 193

Query: 292 KSDVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRL----- 340
            SDV+ F V ++E+++ G+ P   L     +  +E      +G          RL     
Sbjct: 194 ASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE------KGD---------RLPKPDL 238

Query: 341 --DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM 383
               ++          L  +C +  P  RP   ++V  LS + +M
Sbjct: 239 CPPVLYT---------LMTRCWDYDPSDRPRFTELVCSLSDVYQM 274

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  143 bits (364), Expect = 3e-40
 Identities = 71/277 (25%), Positives = 118/277 (42%), Gaps = 35/277 (12%)

Query: 120 IGQGAFGPVYKAQMSTGE----TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLV 174
           IG+G FG V++    + E     VA+K     +    + +F  E + + +  H ++V L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G   E     ++    + G L S L       L     +  A  ++  L YL        
Sbjct: 83  GVITEN-PVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKRF--- 137

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKK 292
           +HRDI + N+L+  +   ++ DFGLSR      +    +G     ++ PE I+ R FT  
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 197

Query: 293 SDVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRLDGIFDV 346
           SDV+ FGV ++E++  G  P QG+     +  +E       G+         RL    + 
Sbjct: 198 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE------NGE---------RLPMPPNC 242

Query: 347 EELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM 383
                + SL  KC    P +RP   ++   LS IL+ 
Sbjct: 243 PP--TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  150 bits (380), Expect = 6e-40
 Identities = 83/382 (21%), Positives = 146/382 (38%), Gaps = 43/382 (11%)

Query: 16  VVIGVLLAIS-ALFCFRYHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDSTVGPESPV 74
               + +A + A     Y R  +    S   R    P +       SI   +    +   
Sbjct: 300 TAPSLTIAENMADLIDGYCRLVNGATQSFIIR----PQKEGERALPSIPKLANNEKQGVR 355

Query: 75  KSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMS 134
               + +    + E     +  +     +Y   ++Q+        IG+G FG V++    
Sbjct: 356 SHTVSVSETDDYAEIIDEEDTYTMPSTRDY---EIQRERIELGRCIGEGQFGDVHQGIYM 412

Query: 135 TGE----TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF 189
           + E     VA+K     +    + +F  E + + +  H ++V L+G   E     ++   
Sbjct: 413 SPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMEL 471

Query: 190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS 249
            + G L S L       L     +  A  ++  L YL        +HRDI + N+L+  +
Sbjct: 472 CTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSN 527

Query: 250 MRARVADFGLSREEMVDKHAANIRGTF--GYLDPEYISTRNFTKKSDVYSFGVLLFELIA 307
              ++ DFGLSR      +    +G     ++ PE I+ R FT  SDV+ FGV ++E++ 
Sbjct: 528 DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587

Query: 308 -GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVN 361
            G  P QG+     +  +E       G+         RL    +      + SL  KC  
Sbjct: 588 HGVKPFQGVKNNDVIGRIE------NGE---------RLPMPPNCPP--TLYSLMTKCWA 630

Query: 362 RAPRKRPSMRDIVQVLSRILKM 383
             P +RP   ++   LS IL+ 
Sbjct: 631 YDPSRRPRFTELKAQLSTILEE 652

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  144 bits (366), Expect = 7e-40
 Identities = 54/280 (19%), Positives = 111/280 (39%), Gaps = 45/280 (16%)

Query: 119 LIGQGAFGPVYKAQMSTGETVAVKV--LATDSKQGEKEFQTEVMLLGRL--HHRNLVNLV 174
            IG G    V++      +  A+K   L     Q    ++ E+  L +L  H   ++ L 
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75

Query: 175 GYCAEKGQHMLVYVFM--SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAV 231
            Y         +Y+ M      L S L  +    +    R     ++   +  +H  G  
Sbjct: 76  DYEITDQY---IYMVMECGNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 128

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRN 288
             ++H D+K +N L+   M  ++ DFG++     +       +  GT  Y+ PE I   +
Sbjct: 129 --IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185

Query: 289 -----------FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVEL--AAMNTEGKTGWEEI 335
                       + KSDV+S G +L+ +  G++P Q ++  +    A ++   +  + +I
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245

Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
            +             ++  +   C+ R P++R S+ +++ 
Sbjct: 246 PEK------------DLQDVLKCCLKRDPKQRISIPELLA 273

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  143 bits (364), Expect = 7e-40
 Identities = 53/280 (18%), Positives = 110/280 (39%), Gaps = 45/280 (16%)

Query: 119 LIGQGAFGPVYKAQMSTGETVAVKV--LATDSKQGEKEFQTEVMLLGRLHHRNL--VNLV 174
            IG G    V++      +  A+K   L     Q    ++ E+  L +L   +   + L 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94

Query: 175 GYCAEKGQHMLVYVFM--SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAV 231
            Y         +Y+ M      L S L  +    +    R     ++   +  +H  G  
Sbjct: 95  DYEITDQY---IYMVMECGNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 147

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRN 288
             ++H D+K +N L+   M  ++ DFG++     +       +  GT  Y+ PE I   +
Sbjct: 148 --IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 289 -----------FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVEL--AAMNTEGKTGWEEI 335
                       + KSDV+S G +L+ +  G++P Q ++  +    A ++   +  + +I
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264

Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
            +             ++  +   C+ R P++R S+ +++ 
Sbjct: 265 PEK------------DLQDVLKCCLKRDPKQRISIPELLA 292

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  143 bits (362), Expect = 8e-40
 Identities = 73/285 (25%), Positives = 110/285 (38%), Gaps = 52/285 (18%)

Query: 120 IGQGAFGPVYKA--QMSTGET--VAVKVL---ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
           +G G+FG V +      +G+T  VAVK L        +   +F  EV  +  L HRNL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L G         +V      GSL   L  ++ G          A+ VA G+ YL      
Sbjct: 86  LYGVVLTP-PMKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYLESKRF- 142

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGY--LDPEYISTRN 288
             IHRD+ + N+LL      ++ DFGL R   +  D +         +    PE + TR 
Sbjct: 143 --IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200

Query: 289 FTKKSDVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRL-- 340
           F+  SD + FGV L+E+   G+ P  GL     +  ++        K G       RL  
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID--------KEGE------RLPR 246

Query: 341 -----DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
                  I++         +  +C    P  RP+   +   L   
Sbjct: 247 PEDCPQDIYN---------VMVQCWAHKPEDRPTFVALRDFLLEA 282

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  143 bits (363), Expect = 1e-39
 Identities = 64/332 (19%), Positives = 110/332 (33%), Gaps = 42/332 (12%)

Query: 51  PIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQ 110
               +                  V S R    +++   G+  S   S     + S++ L 
Sbjct: 8   SSGVDLGTENLYFQSMHQLQPRRV-SFRGEASETLQSPGYDPSRPESFF---QQSFQRLS 63

Query: 111 KATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKV--LATDSKQGEKEFQTEVMLLGRL-H 166
           +        +G G++G V+K +    G   AVK         +       EV    ++  
Sbjct: 64  R--------LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 167 HRNLVNLVGYCAEKGQHMLVYVFM--SKGSLASHLYDENYGPLTWNLRVHIALDVARGLE 224
           H   V L     E G    +Y+       SL  H        L          D    L 
Sbjct: 116 HPCCVRLEQAWEEGGI---LYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALA 171

Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYI 284
           +LH   +   +H D+K +NI L    R ++ DFGL  E           G   Y+ PE +
Sbjct: 172 HLHSQGL---VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE-L 227

Query: 285 STRNFTKKSDVYSFGVLLFELIAGRS-PLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI 343
              ++   +DV+S G+ + E+      P  G                GW+++    L   
Sbjct: 228 LQGSYGTAADVFSLGLTILEVACNMELPHGG---------------EGWQQLRQGYLPPE 272

Query: 344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
           F     +E+ S+    +   P+ R +   ++ 
Sbjct: 273 FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  142 bits (360), Expect = 5e-39
 Identities = 68/321 (21%), Positives = 123/321 (38%), Gaps = 45/321 (14%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGY 176
           ++ +G F  VY+AQ + +G   A+K L ++ ++  +    EV  + +L  H N+V     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 177 CAEKGQHM-----LVYVFM--SKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHD 228
            +   +          +     KG L   L   E+ GPL+ +  + I     R ++++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSR-------------EEMVDKHAANIRGT 275
              PP+IHRD+K  N+LL      ++ DFG +                 + +       T
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 276 FGYLDPEYIST-RNF--TKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW 332
             Y  PE I    NF   +K D+++ G +L+ L   + P +                   
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED---------------GAK 258

Query: 333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRK 392
             IV+ +        +     SL    +   P +R S   I +V+ ++ ++   R  + K
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLS---IAEVVHQLQEIAAARNVNPK 315

Query: 393 SQSTTADEVSIDMEQAEAKTP 413
           S  T   E +     A     
Sbjct: 316 SPITELLEQNGGYGSATLSRG 336

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  147 bits (372), Expect = 6e-39
 Identities = 67/284 (23%), Positives = 116/284 (40%), Gaps = 50/284 (17%)

Query: 120 IGQGAFGPVYKAQ--MSTGET-VAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           +G G FG V +    M   +  VA+KVL     K   +E   E  ++ +L +  +V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
            C  +   MLV      G L   L       +  +    +   V+ G++YL +      +
Sbjct: 404 VCQAE-ALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLEEKNF---V 458

Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHA--ANIRGTFGY--LDPEYISTRNFTK 291
           HR++ + N+LL     A+++DFGLS+    D     A   G +      PE I+ R F+ 
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518

Query: 292 KSDVYSFGVLLFELIA-GRSPLQGL-----MEYVELAAMNTEGKTGWEEIVDSRL----- 340
           +SDV+S+GV ++E ++ G+ P + +     M ++E      +GK         R+     
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE------QGK---------RMECPPE 563

Query: 341 --DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
               ++          L   C       RP    + Q +     
Sbjct: 564 CPPELYA---------LMSDCWIYKWEDRPDFLTVEQRMRACYY 598

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  143 bits (361), Expect = 1e-38
 Identities = 52/280 (18%), Positives = 109/280 (38%), Gaps = 45/280 (16%)

Query: 119 LIGQGAFGPVYKAQMSTGETVAVKV--LATDSKQGEKEFQTEVMLLGRLHHRNL--VNLV 174
            IG G    V++      +  A+K   L     Q    ++ E+  L +L   +   + L 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 175 GYCAEKGQHMLVYVFM--SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAV 231
            Y         +Y+ M      L S L  +    +    R     ++   +  +H  G  
Sbjct: 123 DYEITDQY---IYMVMECGNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 175

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRN 288
             ++H D+K +N L+   M  ++ DFG++     +       +  G   Y+ PE I   +
Sbjct: 176 --IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 289 -----------FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVEL--AAMNTEGKTGWEEI 335
                       + KSDV+S G +L+ +  G++P Q ++  +    A ++   +  + +I
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292

Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
            +             ++  +   C+ R P++R S+ +++ 
Sbjct: 293 PEK------------DLQDVLKCCLKRDPKQRISIPELLA 320

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  138 bits (351), Expect = 3e-38
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 24/242 (9%)

Query: 93  SNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQG 151
            +  S     +Y Y +          ++G+G +G VY    +S    +A+K +     + 
Sbjct: 8   GDCESDLLEYDYEYDENGDRV-----VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY 62

Query: 152 EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLT 208
            +    E+ L   L H+N+V  +G  +E G    + +FM     GSL++ L    +GPL 
Sbjct: 63  SQPLHEEIALHKHLKHKNIVQYLGSFSENGF---IKIFMEQVPGGSLSA-LLRSKWGPLK 118

Query: 209 WNLRV--HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSRE-EM 264
            N +        +  GL+YLHD     ++HRDIK  N+L++      +++DFG S+    
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175

Query: 265 VDKHAANIRGTFGYLDPEYI--STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA 322
           ++       GT  Y+ PE I    R + K +D++S G  + E+  G+ P   L E    A
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE--PQA 233

Query: 323 AM 324
           AM
Sbjct: 234 AM 235

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  138 bits (349), Expect = 2e-37
 Identities = 58/283 (20%), Positives = 106/283 (37%), Gaps = 36/283 (12%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
            +G+G+FG V++ +   TG   AVK +  +  +       E++    L    +V L G  
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYG-A 118

Query: 178 AEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
             +G    V +FM     GSL   +  +  G L  +  ++       GLEYLH   +   
Sbjct: 119 VREGPW--VNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRRI--- 171

Query: 235 IHRDIKSSNILLDQS-MRARVADFGLSR------EEMVDKHAANIRGTFGYLDPEYISTR 287
           +H D+K+ N+LL     RA + DFG +                 I GT  ++ PE +  +
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
               K D++S   ++  ++ G  P     +Y               +I            
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHP---WTQYFRGPLCL--------KIASEPPPIREIPP 280

Query: 348 ELNEVA-SLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKH 389
               +      + + + P  R S  ++ + + + L+     K 
Sbjct: 281 SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKS 323

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  135 bits (342), Expect = 5e-37
 Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 22/203 (10%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
            +G+G FG VY A+   +   +A+KVL       +   E + + EV +   L H N++ L
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLRHPNILRL 74

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
            GY  +  +  L+  +   G++   L  +               ++A  L Y H   V  
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHSKRV-- 130

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYISTRN 288
            IHRDIK  N+LL  +   ++ADFG S       HA + R     GT  YL PE I  R 
Sbjct: 131 -IHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRTDLCGTLDYLPPEMIEGRM 183

Query: 289 FTKKSDVYSFGVLLFELIAGRSP 311
             +K D++S GVL +E + G+ P
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPP 206

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  135 bits (341), Expect = 2e-36
 Identities = 62/324 (19%), Positives = 120/324 (37%), Gaps = 48/324 (14%)

Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE 154
           + +     + +          + ++GQGA   V++ +   TG+  A+KV    S     +
Sbjct: 1   MGSQSTSNHLWL--------LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD 52

Query: 155 -FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM---SKGSLASHLYD-ENYGPLTW 209
               E  +L +L+H+N+V L     E+       + M     GSL + L +  N   L  
Sbjct: 53  VQMREFEVLKKLNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE 111

Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL----DQSMRARVADFGLSREEMV 265
           +  + +  DV  G+ +L +  +   +HR+IK  NI+     D     ++ DFG +RE   
Sbjct: 112 SEFLIVLRDVVGGMNHLRENGI---VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168

Query: 266 DKHAANIRGTFGYLDPEYIS--------TRNFTKKSDVYSFGVLLFELIAGRSP------ 311
           D+   ++ GT  YL P+            + +    D++S GV  +    G  P      
Sbjct: 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

Query: 312 ---LQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAY--------KCV 360
               + +M  + +    +   +G ++  +  +D   D+     ++              +
Sbjct: 229 PRRNKEVMYKI-ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287

Query: 361 NRAPRKRPSMRDIVQVLSRILKMR 384
                K           S IL   
Sbjct: 288 EADQEKCWGFDQFFAETSDILHRG 311

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  136 bits (344), Expect = 3e-36
 Identities = 68/346 (19%), Positives = 127/346 (36%), Gaps = 48/346 (13%)

Query: 96  VSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE 154
           + +     + +          + ++GQGA   V++ +   TG+  A+KV    S     +
Sbjct: 1   MGSQSTSNHLWL--------LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD 52

Query: 155 -FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV--FMSKGSLASHLYD-ENYGPLTWN 210
               E  +L +L+H+N+V L     E      V +  F   GSL + L +  N   L  +
Sbjct: 53  VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112

Query: 211 LRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL----DQSMRARVADFGLSREEMVD 266
             + +  DV  G+ +L +  +   +HR+IK  NI+     D     ++ DFG +RE   D
Sbjct: 113 EFLIVLRDVVGGMNHLRENGI---VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169

Query: 267 KHAANIRGTFGYLDPEYIST--------RNFTKKSDVYSFGVLLFELIAGRSP------- 311
           +   ++ GT  YL P+            + +    D++S GV  +    G  P       
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229

Query: 312 --LQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN--------EVASLAYKCVN 361
              + +M  + +    +   +G ++  +  +D   D+             +  +    + 
Sbjct: 230 RRNKEVMYKI-ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE 288

Query: 362 RAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDMEQ 407
               K           S IL       H    Q  TA ++ I    
Sbjct: 289 ADQEKCWGFDQFFAETSDILHRM--VIHVFSLQQMTAHKIYIHSYN 332

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  132 bits (334), Expect = 8e-36
 Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 20/202 (9%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATD--SKQG-EKEFQTEVMLLGRLHHRNLVNLV 174
            +G+G FG VY A+       +A+KVL      K+G E + + E+ +   L H N++ + 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
            Y  ++ +  L+  F  +G L   L  + +G            ++A  L Y H+  V   
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHYCHERKV--- 135

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYISTRNF 289
           IHRDIK  N+L+      ++ADFG S       HA ++R     GT  YL PE I  +  
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWS------VHAPSLRRRTMCGTLDYLPPEMIEGKTH 189

Query: 290 TKKSDVYSFGVLLFELIAGRSP 311
            +K D++  GVL +E + G  P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  132 bits (334), Expect = 1e-35
 Identities = 66/288 (22%), Positives = 115/288 (39%), Gaps = 48/288 (16%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           ++GQGAFG V KA+        A+K +    ++      +EVMLL  L+H+ +V      
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAW 71

Query: 178 AEKGQHML----------VYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLE 224
            E+   +           +++ M     G+L   ++ EN      +    +   +   L 
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALS 130

Query: 225 YLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---------- 273
           Y+H  G    +IHRD+K  NI +D+S   ++ DFGL++          +           
Sbjct: 131 YIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186

Query: 274 -----GTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE 327
                GT  Y+  E +  T ++ +K D+YS G++ FE+I    P    ME V +      
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRS 243

Query: 328 GKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                           FD  ++     +    ++  P KRP  R ++ 
Sbjct: 244 VSI--------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  131 bits (332), Expect = 2e-35
 Identities = 57/205 (27%), Positives = 106/205 (51%), Gaps = 17/205 (8%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE---KEFQTEVMLLGRLHHRNLVNLV 174
            +G G    VY A+       VA+K +    ++ E   K F+ EV    +L H+N+V+++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 175 GYCAEKGQHMLV--YVFMSKG-SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
               E   + LV  Y+   +G +L+ ++  E++GPL+ +  ++    +  G+++ HD  +
Sbjct: 78  DVDEEDDCYYLVMEYI---EGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTRNF 289
              +HRDIK  NIL+D +   ++ DFG+++   E       ++ GT  Y  PE       
Sbjct: 133 ---VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189

Query: 290 TKKSDVYSFGVLLFELIAGRSPLQG 314
            + +D+YS G++L+E++ G  P  G
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNG 214

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  131 bits (332), Expect = 3e-35
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 17/205 (8%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE---KEFQTEVMLLGRLHHRNLVNLV 174
           L+G+G  G VY+A+       VA+K+++             Q E    GRL   ++V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 175 GYCAEKGQHMLV--YVFMSKG-SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            +    GQ  +    +    G  LA+ L  +  GPL     V I   +   L+  H    
Sbjct: 101 DFGEIDGQLYVDMRLI---NGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGA 155

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTRNF 289
               HRD+K  NIL+     A + DFG++    +       N  GT  Y+ PE  S  + 
Sbjct: 156 ---THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 290 TKKSDVYSFGVLLFELIAGRSPLQG 314
           T ++D+Y+   +L+E + G  P QG
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQG 237

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  130 bits (328), Expect = 6e-35
 Identities = 57/288 (19%), Positives = 94/288 (32%), Gaps = 57/288 (19%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKV--LATDSKQGEKEFQTEVMLLGRL-HHRNLVNLV 174
            IG G FG V+K      G   A+K           E+    EV     L  H ++V   
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77

Query: 175 GYCAEKGQHMLVYVFM---SKGSLASHL--YDENYGPLTWNLRVHIALDVARGLEYLHDG 229
              AE      + +     + GSLA  +                 + L V RGL Y+H  
Sbjct: 78  SAWAEDDH---MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134

Query: 230 AVPPVIHRDIKSSNILLDQS-------------------MRARVADFGLSREEMVDKHAA 270
           ++   +H DIK SNI + ++                   +  ++ D G            
Sbjct: 135 SL---VHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISSPQ 188

Query: 271 NIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGK 329
              G   +L  E +        K+D+++  + +          +   +            
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ------------ 236

Query: 330 TGWEEIVDSRLDGIFDV--EELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
             W EI   RL  I  V  +E  E+       ++  P +RPS   +V+
Sbjct: 237 --WHEIRQGRLPRIPQVLSQEFTELLK---VMIHPDPERRPSAMALVK 279

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  131 bits (331), Expect = 9e-35
 Identities = 35/296 (11%), Positives = 75/296 (25%), Gaps = 51/296 (17%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKE---FQTEVMLLGRLHHRNLVNLV 174
            +  G    V+    +   E  A+KV    ++    E            RL   +     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 175 GYC--------------------------AEKGQHMLVYVFMSKGSLAS-----HLYDEN 203
                                             ++L+    S   L             
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187

Query: 204 YGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262
            G         +   + R    L   G    ++H      N+ +    R  + D     +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALWK 243

Query: 263 EMVDKHAANIRGTFGYLDPEYI--STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVE 320
                          Y   E++  ST  FT   + +  G+ ++ +     P   +   ++
Sbjct: 244 V--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301

Query: 321 -LAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                 +    G + +       + D      V +L  + +N   R+R    + ++
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPD-----FVKTLIGRFLNFDRRRRLLPLEAME 352

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  132 bits (333), Expect = 1e-34
 Identities = 63/274 (22%), Positives = 114/274 (41%), Gaps = 38/274 (13%)

Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYC 177
           ++G GA G +    M     VAVK +     +       EV LL     H N++    +C
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIRY--FC 85

Query: 178 AEKGQHMLVYVFMS--KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPV 234
            EK +    Y+ +     +L     ++          + +      GL +LH       +
Sbjct: 86  TEKDRQF-QYIAIELCAATLQ-EYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN----I 139

Query: 235 IHRDIKSSNILL-----DQSMRARVADFGLSREEMVDKHAANIR----GTFGYLDPEYIS 285
           +HRD+K  NIL+        ++A ++DFGL ++  V +H+ + R    GT G++ PE +S
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199

Query: 286 ---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
                N T   D++S G + + +I+  S   G     +   +               LD 
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS----------LDC 249

Query: 343 IFDVEELNEVAS-LAYKCVNRAPRKRPSMRDIVQ 375
           +   +  + +A  L  K +   P+KRPS + +++
Sbjct: 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  130 bits (328), Expect = 2e-34
 Identities = 58/290 (20%), Positives = 107/290 (36%), Gaps = 40/290 (13%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVL-----------------ATDSKQGEKEFQTEVMLL 162
           + QG F  +   +    +  A+K                       K    +F+ E+ ++
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 163 GRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR- 221
             + +   +   G      +  ++Y +M   S+      E +  L  N    I + V + 
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD--EYFFVLDKNYTCFIPIQVIKC 155

Query: 222 -------GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRG 274
                     Y+H      + HRD+K SNIL+D++ R +++DFG S E MVDK     RG
Sbjct: 156 IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGES-EYMVDKKIKGSRG 212

Query: 275 TFGYLDPEYISTRNFT--KKSDVYSFGVLLFELIAGRSP------LQGLMEYVELAAMNT 326
           T+ ++ PE+ S  +     K D++S G+ L+ +     P      L  L   +    +  
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEY 272

Query: 327 EGKTGWEEIVDSRLDGIFDVEEL-NEVASLAYKCVNRAPRKRPSMRDIVQ 375
                      +          L NE        + + P +R +  D ++
Sbjct: 273 PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  133 bits (336), Expect = 6e-34
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 15/214 (7%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNLV--- 174
           +G G FG V +     TGE VA+K    +     +E +  E+ ++ +L+H N+V+     
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 175 ---GYCAEKGQHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGA 230
                 A     +L   +   G L  +L   EN   L       +  D++  L YLH+  
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141

Query: 231 VPPVIHRDIKSSNILLD---QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
           +   IHRD+K  NI+L    Q +  ++ D G ++E    +      GT  YL PE +  +
Sbjct: 142 I---IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQK 198

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
            +T   D +SFG L FE I G  P     + V+ 
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 232

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  129 bits (326), Expect = 6e-34
 Identities = 38/304 (12%), Positives = 84/304 (27%), Gaps = 71/304 (23%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE----------------------- 154
           ++GQ       +A    TGE+  V V     +                            
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 155 -----FQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM----SKGSLASHLYD--EN 203
                F     L+     + ++ +     +       +++     +  +    L      
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 204 YGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262
           +  L  + R+ + L V R L  LH  G    ++H  ++  +I+LDQ     +  F     
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 263 EMVDKHAANIRGTFGYLDPEYISTRN-----------FTKKSDVYSFGVLLFELIAGRSP 311
              D        + G+  PE  + R             T   D ++ G++++ +     P
Sbjct: 256 ---DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

Query: 312 LQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMR 371
           +                        +       ++ +   V +L    +      R    
Sbjct: 313 ITK---------------DAALGGSEWIFRSCKNIPQ--PVRALLEGFLRYPKEDRLLPL 355

Query: 372 DIVQ 375
             ++
Sbjct: 356 QAME 359

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  127 bits (321), Expect = 8e-34
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 41/229 (17%)

Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVM 160
           P   ++ + +        +G GAFG VYKA+   TG   A KV+ T S++  +++  E+ 
Sbjct: 17  PNEVWEIVGE--------LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIE 68

Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL--- 217
           +L    H  +V L+G     G+  ++  F   G++ + +  E    LT      I +   
Sbjct: 69  ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLT---EPQIQVVCR 124

Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS---------REEMVDKH 268
            +   L +LH   +   IHRD+K+ N+L+      R+ADFG+S         R+  +   
Sbjct: 125 QMLEALNFLHSKRI---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--- 178

Query: 269 AANIRGTFGYLDPEYISTRNFTK-----KSDVYSFGVLLFELIAGRSPL 312
                GT  ++ PE +            K+D++S G+ L E+     P 
Sbjct: 179 -----GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 222

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  127 bits (321), Expect = 8e-34
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 38/224 (16%)

Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVM 160
           P+  Y   +K        IGQGA G VY A  ++TG+ VA++ +    +  ++    E++
Sbjct: 18  PKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL 69

Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL--- 217
           ++    + N+VN +       +  +V  +++ GSL   +  E    +       IA    
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTE--TCMD---EGQIAAVCR 123

Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS---------REEMVDKH 268
           +  + LE+LH   V   IHRDIKS NILL      ++ DFG           R  MV   
Sbjct: 124 ECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--- 177

Query: 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
                GT  ++ PE ++ + +  K D++S G++  E+I G  P 
Sbjct: 178 -----GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  127 bits (320), Expect = 2e-33
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 26/206 (12%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
            +G+G F   ++     T E  A K++         Q EK    E+ +   L H+++V  
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 106

Query: 174 VGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
            G+  +      V+V +    + SL      +    LT     +    +  G +YLH   
Sbjct: 107 HGFFEDNDF---VFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVLGCQYLHRNR 161

Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRD+K  N+ L++ +  ++ DFGL+ +   D      R     GT  Y+ PE +S
Sbjct: 162 V---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE----RKKVLCGTPNYIAPEVLS 214

Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSP 311
            +  + + DV+S G +++ L+ G+ P
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPP 240

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  125 bits (317), Expect = 3e-33
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 26/206 (12%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
            +G+G F   ++     T E  A K++         Q EK    E+ +   L H+++V  
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 80

Query: 174 VGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
            G+  +      V+V +    + SL      +    LT     +    +  G +YLH   
Sbjct: 81  HGFFEDNDF---VFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVLGCQYLHRNR 135

Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS 285
           V   IHRD+K  N+ L++ +  ++ DFGL+ +   D      R     GT  Y+ PE +S
Sbjct: 136 V---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE----RKKVLCGTPNYIAPEVLS 188

Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSP 311
            +  + + DV+S G +++ L+ G+ P
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPP 214

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  128 bits (323), Expect = 3e-33
 Identities = 41/303 (13%), Positives = 86/303 (28%), Gaps = 70/303 (23%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGE---KEFQTEVMLLGRL--------- 165
           ++GQ       +A    TGE+  V V     +      K+ + EV+ L  L         
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 166 -------------HHRNLVNLVGYCAEKGQHMLVYVF-------MSKGSLASHLYD--EN 203
                               ++    ++    ++  F        +  +    L      
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 204 YGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262
           +  L  + R+ + L V R L  LH  G    ++H  ++  +I+LDQ     +  F     
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 263 EMVDKHAANIRGTFGYLDPEYIS----------TRNFTKKSDVYSFGVLLFELIAGRSPL 312
           +     +A      G+  PE  +              T   D ++ G+ ++ +     P 
Sbjct: 261 DG---ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317

Query: 313 QGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRD 372
                                   +       ++ +   V +L    +      R     
Sbjct: 318 TD---------------DAALGGSEWIFRSCKNIPQ--PVRALLEGFLRYPKEDRLLPLQ 360

Query: 373 IVQ 375
            ++
Sbjct: 361 AME 363

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  126 bits (318), Expect = 4e-33
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 32/221 (14%)

Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVM 160
           P        K        IG+G+ G V  A+   +G  VAVK++    +Q  +    EV+
Sbjct: 43  PRLLLDSYVK--------IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVV 94

Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++    H N+V +        +  ++  F+  G+L   +  +    L       +   V 
Sbjct: 95  IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQ--VRLNEEQIATVCEAVL 151

Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS---------REEMVDKHAAN 271
           + L YLH      VIHRDIKS +ILL    R +++DFG           R+ +V      
Sbjct: 152 QALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------ 202

Query: 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
             GT  ++ PE IS   +  + D++S G+++ E++ G  P 
Sbjct: 203 --GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  125 bits (317), Expect = 4e-33
 Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 41/237 (17%)

Query: 91  KRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK 149
               + +    PE  +  L+K        IG+G+FG V+K     T + VA+K++  +  
Sbjct: 9   GLPGMQNLKADPEELFTKLEK--------IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA 60

Query: 150 QGEKE-FQTEVMLLGRLHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPL 207
           + E E  Q E+ +L +     +    G    K   + ++  ++  GS    L +   GPL
Sbjct: 61  EDEIEDIQQEITVLSQCDSPYVTKYYG-SYLKDTKLWIIMEYLGGGSA-LDLLEP--GPL 116

Query: 208 TWNLRVHIAL---DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS---- 260
                  IA    ++ +GL+YLH       IHRDIK++N+LL +    ++ADFG++    
Sbjct: 117 D---ETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT 170

Query: 261 -----REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
                R   V        GT  ++ PE I    +  K+D++S G+   EL  G  P 
Sbjct: 171 DTQIKRNTFV--------GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPH 219

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  125 bits (317), Expect = 4e-33
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 19/209 (9%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE---KEFQTEVMLLGRLHHRNLVNL- 173
           ++G G    V+ A+ +     VAVKVL  D  +       F+ E      L+H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 174 -VGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
             G  AE     L Y+ M      +L   ++ E  GP+T    + +  D  + L + H  
Sbjct: 79  DTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN 135

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSR----EEMVDKHAANIRGTFGYLDPEYIS 285
            +   IHRD+K +NI++  +   +V DFG++R            A + GT  YL PE   
Sbjct: 136 GI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 286 TRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
             +   +SDVYS G +L+E++ G  P  G
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  125 bits (316), Expect = 5e-33
 Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 38/224 (16%)

Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVM 160
           PE  +  L+K        +G+G++G VYKA    TG+ VA+K +    +   +E   E+ 
Sbjct: 27  PEEVFDVLEK--------LGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEIS 76

Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL--- 217
           ++ +    ++V   G   +     +V  +   GS++  +       LT      IA    
Sbjct: 77  IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLT---EDEIATILQ 132

Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS---------REEMVDKH 268
              +GLEYLH       IHRDIK+ NILL+    A++ADFG++         R  ++   
Sbjct: 133 STLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI--- 186

Query: 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL 312
                GT  ++ PE I    +   +D++S G+   E+  G+ P 
Sbjct: 187 -----GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  124 bits (313), Expect = 1e-32
 Identities = 73/273 (26%), Positives = 115/273 (42%), Gaps = 37/273 (13%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNLVGYC 177
           IG GA   V  A      E VA+K +  +  Q   +    E+  + + HH N+V+     
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV----HIAL---DVARGLEYLHDGA 230
             K +  LV   +S GS+   +             V     IA    +V  GLEYLH   
Sbjct: 83  VVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141

Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTF-G---YLDPEYI 284
               IHRD+K+ NILL +    ++ADFG+S       D     +R TF G   ++ PE +
Sbjct: 142 Q---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198

Query: 285 S-TRNFTKKSDVYSFGVLLFELIAGRSPLQGL--MEYVELAAMNTEGKTGWEEIVDSRLD 341
              R +  K+D++SFG+   EL  G +P      M+ + L   N              L+
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP----------PSLE 248

Query: 342 GIFDVEELNEVASLAYK-----CVNRAPRKRPS 369
                +E+ +    +++     C+ + P KRP+
Sbjct: 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  125 bits (314), Expect = 2e-32
 Identities = 53/297 (17%), Positives = 98/297 (32%), Gaps = 50/297 (16%)

Query: 119 LIGQGAFGPVYKAQ------MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL---HHRN 169
           L+G+GAF  VY+A           +   +KV          EF     L+ RL       
Sbjct: 72  LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ---KPANPWEFYIGTQLMERLKPSMQHM 128

Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHL---YDENYGPLTWNLRVHIALDVARGLEYL 226
            +        +   +LV    S G+L + +    +     +   L +  A+ +   +E +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188

Query: 227 HDGAVPPVIHRDIKSSNILL-----------DQSMRARVADFGLSRE---EMVDKHAANI 272
           HD  +   IH DIK  N +L           D S    + D G S +             
Sbjct: 189 HDCEI---IHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245

Query: 273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW 332
             T G+   E +S + +  + D +     ++ ++ G                      G 
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV--------------KNEGG 291

Query: 333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR-PSMRDIVQVLSRILKMRHNRK 388
           E   +     +  ++  NE     +  +N       PS+  + Q L ++ +  +  K
Sbjct: 292 ECKPEGLFRRLPHLDMWNE---FFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNK 345

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  122 bits (309), Expect = 3e-32
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 21/204 (10%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDS--KQG-EKEFQTEVMLLGRLHHRNLVNLV 174
           L+G+G+F  VY+A+ + TG  VA+K++   +  K G  +  Q EV +  +L H +++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 175 GYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            Y  +      VY+ +     G +  +L      P + N   H    +  G+ YLH   +
Sbjct: 78  NYFEDSNY---VYLVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIITGMLYLHSHGI 133

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGYLDPEYISTR 287
              +HRD+  SN+LL ++M  ++ADFGL+ +  +            GT  Y+ PE  +  
Sbjct: 134 ---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMP---HEKHYTLCGTPNYISPEIATRS 187

Query: 288 NFTKKSDVYSFGVLLFELIAGRSP 311
               +SDV+S G + + L+ GR P
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPP 211

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  125 bits (317), Expect = 6e-32
 Identities = 69/274 (25%), Positives = 112/274 (40%), Gaps = 42/274 (15%)

Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           +G GA+G V   +   T    A+K++     S     +   EV +L  L H N++ L  +
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 177 CAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
             +K  + LV      G L         ++E            I   V  G+ YLH   +
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA-------AVIIKQVLSGVTYLHKHNI 157

Query: 232 PPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              +HRD+K  N+LL   ++    ++ DFGLS      K      GT  Y+ PE +  + 
Sbjct: 158 ---VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KK 213

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
           + +K DV+S GV+LF L+AG  P  G           T+ +    ++   +    FD  E
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGG----------QTDQEI-LRKVEKGKYT--FDSPE 260

Query: 349 LNEVASLA----YKCVNRAPRKRPSMRDIVQVLS 378
              V+  A     + +    ++R S +   Q L 
Sbjct: 261 WKNVSEGAKDLIKQMLQFDSQRRISAQ---QALE 291

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  125 bits (316), Expect = 8e-32
 Identities = 71/270 (26%), Positives = 116/270 (42%), Gaps = 33/270 (12%)

Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
           +G+G+FG V   +   TG+  AVKV++      K  ++    EV LL +L H N++ L  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           +  +KG   LV    + G L   +        +      I   V  G+ Y+H   +   +
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKI---V 148

Query: 236 HRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
           HRD+K  N+LL    +    R+ DFGLS      K   +  GT  Y+ PE +    + +K
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYDEK 207

Query: 293 SDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEV 352
            DV+S GV+L+ L++G  P  G            E     +++   +    F++ +  +V
Sbjct: 208 CDVWSTGVILYILLSGCPPFNG----------ANEYDI-LKKVEKGKYT--FELPQWKKV 254

Query: 353 ASLA----YKCVNRAPRKRPSMRDIVQVLS 378
           +  A     K +   P  R S R     L 
Sbjct: 255 SESAKDLIRKMLTYVPSMRISAR---DALD 281

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  126 bits (318), Expect = 8e-32
 Identities = 75/283 (26%), Positives = 115/283 (40%), Gaps = 31/283 (10%)

Query: 52  IRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKD--- 108
           +   G D    +    V   +               +   R      S  P   Y D   
Sbjct: 110 LSHTGPDLIPEVPRQLV---TNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIY 166

Query: 109 -----------LQKATCN---FTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQ 150
                       Q  T N      ++G+G FG V   Q+ +TG+  A K L       ++
Sbjct: 167 FNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK 226

Query: 151 GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTW 209
           GE     E  +L +++ R +V+L  Y  E    + LV   M+ G L  H+Y         
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE 285

Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269
              V  A ++  GLE LH   +   ++RD+K  NILLD     R++D GL+   + +   
Sbjct: 286 ARAVFYAAEICCGLEDLHRERI---VYRDLKPENILLDDHGHIRISDLGLAV-HVPEGQT 341

Query: 270 ANIR-GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
              R GT GY+ PE +    +T   D ++ G LL+E+IAG+SP
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  122 bits (308), Expect = 1e-31
 Identities = 61/286 (21%), Positives = 120/286 (41%), Gaps = 38/286 (13%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGYC 177
           +G G  G V+K     +G  +A K++  + K     +   E+ +L   +   +V   G  
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
              G+  +    M  GSL   +  +  G +   +   +++ V +GL YL +     ++HR
Sbjct: 101 YSDGEISICMEHMDGGSLDQ-VLKKA-GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHR 156

Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
           D+K SNIL++     ++ DFG+S  +++D  A +  GT  Y+ PE +   +++ +SD++S
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWS 215

Query: 298 FGVLLFELIAGRSPL----------------QGLMEYVELAAMNTEGKTGWEEIVDSRLD 341
            G+ L E+  GR P+                +G                    +      
Sbjct: 216 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPM 275

Query: 342 GIFDVEEL----------NEVASLAYK-----CVNRAPRKRPSMRD 372
            IF++ +           + V SL ++     C+ + P +R  ++ 
Sbjct: 276 AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  121 bits (305), Expect = 3e-31
 Identities = 67/226 (29%), Positives = 100/226 (44%), Gaps = 39/226 (17%)

Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE---KEFQT 157
           PE  + DL++        IG G+FG VY A+ +   E VA+K ++   KQ     ++   
Sbjct: 52  PEKLFSDLRE--------IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 103

Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL 217
           EV  L +L H N +   G    +    LV  +   GS +  L + +  PL     V IA 
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQ---EVEIAA 158

Query: 218 ---DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS-----REEMVDKHA 269
                 +GL YLH   +   IHRD+K+ NILL +    ++ DFG +         V    
Sbjct: 159 VTHGALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV---- 211

Query: 270 ANIRGTFGYLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPL 312
               GT  ++ PE I   +   +  K DV+S G+   EL   + PL
Sbjct: 212 ----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  124 bits (313), Expect = 4e-31
 Identities = 67/301 (22%), Positives = 121/301 (40%), Gaps = 40/301 (13%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G GAFG V++  + +TG   A K + T  +  ++  + E+  +  L H  LVNL     
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
           +  + +++Y FMS G L   + DE+   ++ +  V     V +GL ++H+      +H D
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNY---VHLD 280

Query: 239 IKSSNILL--DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVY 296
           +K  NI+    +S   ++ DFGL+      +      GT  +  PE    +     +D++
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMW 340

Query: 297 SFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLA 356
           S GVL + L++G SP  G            + +T    +     +   D    + ++   
Sbjct: 341 SVGVLSYILLSGLSPFGG----------ENDDET-LRNVKSCDWN--MDDSAFSGISEDG 387

Query: 357 ----YKCVNRAPRKRPS----------------MRDIVQVLSRILKMRHNRKHHRKSQST 396
                K +   P  R +                 RD     SR  K+R + K    +   
Sbjct: 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPE 447

Query: 397 T 397
            
Sbjct: 448 P 448

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  123 bits (311), Expect = 5e-31
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 12/205 (5%)

Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNL 170
               ++G+G FG V+  QM +TG+  A K L       ++G +    E  +L ++H R +
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247

Query: 171 VNLVGYCAEKGQHM-LVYVFMSKGSLASHLY--DENYGPLTWNLRVHIALDVARGLEYLH 227
           V+L  Y  E    + LV   M+ G +  H+Y  DE+         +     +  GLE+LH
Sbjct: 248 VSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYIST 286
              +   I+RD+K  N+LLD     R++D GL+ E    +       GT G++ PE +  
Sbjct: 307 QRNI---IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363

Query: 287 RNFTKKSDVYSFGVLLFELIAGRSP 311
             +    D ++ GV L+E+IA R P
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGP 388

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  121 bits (305), Expect = 6e-31
 Identities = 51/239 (21%), Positives = 91/239 (38%), Gaps = 26/239 (10%)

Query: 92  RSNVVSASGIPEYSYKDLQKATCNFTTLIGQGA--FGPVYKAQ-MSTGETVAVKV--LAT 146
               +S+       Y+ L          IG+G      V  A+   TGE V V+   L  
Sbjct: 13  YFQGMSSFLPEGGCYELLTV--------IGKGFEDLMTVNLARYKPTGEYVTVRRINLEA 64

Query: 147 DSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGP 206
            S +     Q E+ +    +H N+V          +  +V  FM+ GS    +       
Sbjct: 65  CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG 124

Query: 207 LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS------ 260
           +      +I   V + L+Y+H       +HR +K+S+IL+    +  ++    +      
Sbjct: 125 MNELAIAYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISH 181

Query: 261 --REEMVDKHAANIRGTFGYLDPEYI--STRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
             R+ +V            +L PE +  + + +  KSD+YS G+   EL  G  P + +
Sbjct: 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  122 bits (309), Expect = 8e-31
 Identities = 66/286 (23%), Positives = 113/286 (39%), Gaps = 55/286 (19%)

Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLA-------------TDSKQGEKEFQTEVMLLGRL 165
           +G GA+G V   +  +     A+KV+               + ++  +E   E+ LL  L
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103

Query: 166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVA 220
            H N++ L     +K    LV  F   G L       H +DE           +I   + 
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA-------ANIMKQIL 156

Query: 221 RGLEYLHD-GAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTF 276
            G+ YLH       ++HRDIK  NILL   +  +  ++ DFGLS     D    +  GT 
Sbjct: 157 SGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212

Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIV 336
            Y+ PE +  + + +K DV+S GV+++ L+ G  P  G            +     +++ 
Sbjct: 213 YYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPFGG----------QNDQDI-IKKVE 260

Query: 337 DSRLDGIFDVEELNEVASLA----YKCVNRAPRKRPSMRDIVQVLS 378
             +    FD  +   ++  A       +     KR +     + L+
Sbjct: 261 KGKYY--FDFNDWKNISDEAKELIKLMLTYDYNKRCTAE---EALN 301

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  120 bits (303), Expect = 1e-30
 Identities = 61/266 (22%), Positives = 121/266 (45%), Gaps = 27/266 (10%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G GAFG V++  + +TG     K + T     +   + E+ ++ +LHH  L+NL     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
           +K + +L+  F+S G L   +  E+Y  ++    ++       GL+++H+ +   ++H D
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEHS---IVHLD 174

Query: 239 IKSSNILL--DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVY 296
           IK  NI+    ++   ++ DFGL+ +   D+       T  +  PE +        +D++
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMW 234

Query: 297 SFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLA 356
           + GVL + L++G SP  G            + +T  + +     +  FD +  + V+  A
Sbjct: 235 AIGVLGYVLLSGLSPFAG----------EDDLET-LQNVKRCDWE--FDEDAFSSVSPEA 281

Query: 357 ----YKCVNRAPRKRPSMRDIVQVLS 378
                  + + PRKR +   +   L 
Sbjct: 282 KDFIKNLLQKEPRKRLT---VHDALE 304

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  117 bits (295), Expect = 3e-30
 Identities = 64/271 (23%), Positives = 122/271 (45%), Gaps = 34/271 (12%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE-KEFQTEV-MLLGRLHHRNLVNLVGY 176
           +G+GA+G V K + + +G+ +AVK +       E K    ++ + +  +     V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENY---GPLTWNLRVHIALDVARGLEYLHDGAVPP 233
              +G   +    M   SL    Y +       +  ++   IA+ + + LE+LH      
Sbjct: 75  LFREGDVWICMELMD-TSLDK-FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 130

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYISTR----N 288
           VIHRD+K SN+L++   + ++ DFG+S   +VD  A +I  G   Y+ PE I+       
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDIDAGCKPYMAPERINPELNQKG 189

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDS---RL-DGIF 344
           ++ KSD++S G+ + EL   R P        +              +V+    +L    F
Sbjct: 190 YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ----------VVEEPSPQLPADKF 239

Query: 345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
             E ++  +    +C+ +  ++RP+  +++Q
Sbjct: 240 SAEFVDFTS----QCLKKNSKERPTYPELMQ 266

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  122 bits (307), Expect = 3e-30
 Identities = 43/204 (21%), Positives = 75/204 (36%), Gaps = 20/204 (9%)

Query: 119 LIGQGAFGPVYKA--QMSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNL-- 173
            I  G  G +Y A  +   G  V +K L        +     E   L  + H ++V +  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 174 VGYCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
                ++    + Y+ M      SL           L     +   L++   L YLH   
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEILPALSYLHS-- 200

Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT 290
              +++ D+K  NI+L +  + ++ D G      ++     + GT G+  PE + T   T
Sbjct: 201 -IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR--IN-SFGYLYGTPGFQAPEIVRTG-PT 254

Query: 291 KKSDVYSFGVLLFELIAGRSPLQG 314
             +D+Y+ G  L  L        G
Sbjct: 255 VATDIYTVGRTLAALTLDLPTRNG 278

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  120 bits (304), Expect = 4e-30
 Identities = 67/275 (24%), Positives = 112/275 (40%), Gaps = 44/275 (16%)

Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATDSKQGE--KEFQTEVMLLGRLHHRNLVNLVGY 176
           +G+G+FG V K +   T +  AVKV+   S + +       EV LL +L H N++ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 177 CAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GA 230
             +     +V    + G L         + E+           I   V  G+ Y+H    
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-------ARIIKQVFSGITYMHKHN- 141

Query: 231 VPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
              ++HRD+K  NILL   ++    ++ DFGLS     +    +  GT  Y+ PE +   
Sbjct: 142 ---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-G 197

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
            + +K DV+S GV+L+ L++G  P  G            E     + +   +    FD+ 
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYG----------KNEYDI-LKRVETGKYA--FDLP 244

Query: 348 ELNEVASLA----YKCVNRAPRKRPSMRDIVQVLS 378
           +   ++  A     K +   P  R +     Q L 
Sbjct: 245 QWRTISDDAKDLIRKMLTFHPSLRITAT---QCLE 276

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  119 bits (300), Expect = 5e-30
 Identities = 60/292 (20%), Positives = 111/292 (38%), Gaps = 53/292 (18%)

Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYC 177
           ++G G+ G V       G  VAVK +             E+ LL     H N++    YC
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNVIRY--YC 76

Query: 178 AEKGQHMLVYVFMS--KGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-G 229
           +E     L Y+ +     +L     + ++ DEN         + +   +A G+ +LH   
Sbjct: 77  SETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135

Query: 230 AVPPVIHRDIKSSNILLD-------------QSMRARVADFGLSREEMVDKHAANIR--- 273
               +IHRD+K  NIL+              +++R  ++DFGL ++    + +       
Sbjct: 136 ----IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191

Query: 274 --GTFGYLDPEYIS-------TRNFTKKSDVYSFGVLLFELI-AGRSPLQGLMEYVELAA 323
             GT G+  PE +         R  T+  D++S G + + ++  G+ P            
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS------ 245

Query: 324 MNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
              E            +  + D   + E   L  + ++  P KRP+   +++
Sbjct: 246 --RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  117 bits (295), Expect = 7e-30
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 38/234 (16%)

Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVM 160
           P   ++ ++         +G G +G VYK + + TG+  A+KV+       E+E + E+ 
Sbjct: 22  PAGIFELVEL--------VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEIN 72

Query: 161 LLGRL-HHRNLVNLVG------YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV 213
           +L +  HHRN+    G            Q  LV  F   GS+   + +     L      
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK---EE 129

Query: 214 HIAL---DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA 270
            IA    ++ RGL +LH   V   IHRDIK  N+LL ++   ++ DFG+S +        
Sbjct: 130 WIAYICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTV 183

Query: 271 NIRGTF-G---YLDPEYISTRNFTK-----KSDVYSFGVLLFELIAGRSPLQGL 315
             R TF G   ++ PE I+           KSD++S G+   E+  G  PL  +
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  114 bits (288), Expect = 5e-29
 Identities = 66/267 (24%), Positives = 110/267 (41%), Gaps = 33/267 (12%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRLH-HRNLVNLVGY 176
           +G G  G V+K +   TG  +AVK +     + E K    ++ ++ + H    +V   G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                   +    M   +    L     GP+   +   + + + + L YL +     VIH
Sbjct: 93  FITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIH 148

Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYISTRNFTK---- 291
           RD+K SNILLD+  + ++ DFG+S   +VD  A +   G   Y+ PE I   + TK    
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISG-RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207

Query: 292 -KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDS---RL--DGIFD 345
            ++DV+S G+ L EL  G+ P +      E+             ++      L     F 
Sbjct: 208 IRADVWSLGISLVELATGQFPYKNCKTDFEVLTK----------VLQEEPPLLPGHMGFS 257

Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRD 372
            +  + V      C+ +  RKRP    
Sbjct: 258 GDFQSFVK----DCLTKDHRKRPKYNK 280

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  114 bits (287), Expect = 7e-29
 Identities = 51/266 (19%), Positives = 109/266 (40%), Gaps = 28/266 (10%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G+G FG V++  + S+ +T   K +       +   + E+ +L    HRN+++L     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
              + ++++ F+S   +   +    +  L     V     V   L++LH   +    H D
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSHNI---GHFD 127

Query: 239 IKSSNILL--DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVY 296
           I+  NI+    +S   ++ +FG +R+     +   +     Y  PE       +  +D++
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMW 187

Query: 297 SFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLA 356
           S G L++ L++G +P              T  +   E I+++     FD E   E++  A
Sbjct: 188 SLGTLVYVLLSGINPFLA----------ETNQQI-IENIMNAEYT--FDEEAFKEISIEA 234

Query: 357 ----YKCVNRAPRKRPSMRDIVQVLS 378
                + + +  + R +     + L 
Sbjct: 235 MDFVDRLLVKERKSRMT---ASEALQ 257

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  113 bits (285), Expect = 1e-28
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           ++G GAF  V+   Q  TG+  A+K +       +   + E+ +L ++ H N+V L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 178 AEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAV 231
                + LV   +S G L        +Y E            +   V   ++YLH+ G  
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYTEKDA-------SLVIQQVLSAVKYLHENG-- 126

Query: 232 PPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
             ++HRD+K  N+L    +++ +  + DFGLS+ E  +   +   GT GY+ PE ++ + 
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQKP 183

Query: 289 FTKKSDVYSFGVLLFELIAGRSP 311
           ++K  D +S GV+ + L+ G  P
Sbjct: 184 YSKAVDCWSIGVITYILLCGYPP 206

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  114 bits (288), Expect = 1e-28
 Identities = 65/257 (25%), Positives = 119/257 (46%), Gaps = 24/257 (9%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           +G G FG V+K  + +TG  +A K++ T   + ++E + E+ ++ +L H NL+ L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156

Query: 179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRD 238
            K   +LV  ++  G L   + DE+Y  LT    +     +  G+ ++H      ++H D
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQICEGIRHMHQMY---ILHLD 212

Query: 239 IKSSNILLDQSMRARV--ADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVY 296
           +K  NIL       ++   DFGL+R     +      GT  +L PE ++    +  +D++
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMW 272

Query: 297 SFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLA 356
           S GV+ + L++G SP  G          + + +T    I+  R D   + EE  +++  A
Sbjct: 273 SVGVIAYMLLSGLSPFLG----------DNDAET-LNNILACRWD--LEDEEFQDISEEA 319

Query: 357 ----YKCVNRAPRKRPS 369
                K + +    R S
Sbjct: 320 KEFISKLLIKEKSWRIS 336

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  112 bits (283), Expect = 2e-28
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 32/214 (14%)

Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
            F  ++G+G+F  V  A+  +T    A+K+L       E +      E  ++ RL H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92

Query: 171 VNLVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVAR------- 221
           V L  Y   +    L +   +   G L  ++                     R       
Sbjct: 93  VKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIG----------SFDETCTRFYTAEIV 140

Query: 222 -GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFG 277
             LEYLH   +   IHRD+K  NILL++ M  ++ DFG ++    +   A      GT  
Sbjct: 141 SALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197

Query: 278 YLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
           Y+ PE ++ ++  K SD+++ G ++++L+AG  P
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  113 bits (284), Expect = 2e-28
 Identities = 64/308 (20%), Positives = 116/308 (37%), Gaps = 48/308 (15%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRL-HHRNLVNLVG 175
           +G+G F  V +    STG+  A K L      +    E   E+ +L        ++NL  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPV 234
                 + +L+  + + G + S    E    ++ N  + +   +  G+ YLH       +
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN----I 152

Query: 235 IHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTK 291
           +H D+K  NILL         ++ DFG+SR+         I GT  YL PE ++    T 
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITT 212

Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE 351
            +D+++ G++ + L+   SP  G              +T +  I    +D  +  E  + 
Sbjct: 213 ATDMWNIGIIAYMLLTHTSPFVG----------EDNQET-YLNISQVNVD--YSEETFSS 259

Query: 352 VASLA----YKCVNRAPRKRPSMRDIVQ-------------------VLSRILKMRHNRK 388
           V+ LA       + + P KRP+    +                      S+         
Sbjct: 260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSS 319

Query: 389 HHRKSQST 396
             + S+S+
Sbjct: 320 EDKTSKSS 327

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  112 bits (282), Expect = 4e-28
 Identities = 66/287 (22%), Positives = 120/287 (41%), Gaps = 41/287 (14%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGY 176
           ++G+GA   V     + T +  AVK++             EV +L +   HRN++ L+ +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 177 CAEKGQHMLVYVFMSKGSLASHL-----YDENYGPLTWNLRVHIALDVARGLEYLHD-GA 230
             E+ +  LV+  M  GS+ SH+     ++E            +  DVA  L++LH+ G 
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA-------SVVVQDVASALDFLHNKG- 131

Query: 231 VPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIR--------GTFGYL 279
              + HRD+K  NIL    +Q    ++ DF L     ++   + I         G+  Y+
Sbjct: 132 ---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 280 DPE-----YISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEE 334
            PE           + K+ D++S GV+L+ L++G  P  G                    
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248

Query: 335 IVDSRLDGI--FDVEELNEVASLA----YKCVNRAPRKRPSMRDIVQ 375
           + +S  +G   F  ++   ++  A     K + R  ++R S   ++Q
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  112 bits (281), Expect = 6e-28
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 15/204 (7%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE-KEFQTEV-MLLGRLHHRNLVNLVGY 176
           IG+GA+G V K     +G+ +AVK + +   + E K+   ++ +++       +V   G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 177 CAEKGQHMLVYVFMSKGSLAS---HLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
              +G   +    MS  S      ++Y      +   +   I L   + L +L +     
Sbjct: 90  LFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLK 146

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA-ANIRGTFGYLDPEYI----STRN 288
           +IHRDIK SNILLD+S   ++ DFG+S  ++VD  A     G   Y+ PE I    S + 
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISG-QLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205

Query: 289 FTKKSDVYSFGVLLFELIAGRSPL 312
           +  +SDV+S G+ L+EL  GR P 
Sbjct: 206 YDVRSDVWSLGITLYELATGRFPY 229

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  111 bits (280), Expect = 8e-28
 Identities = 55/283 (19%), Positives = 100/283 (35%), Gaps = 44/283 (15%)

Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
                       P  K Q    E                      + + R+   +  N V
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124

Query: 175 GYCAEKGQHMLVYVFM---SKGSLASHLYDENYGP-----LTWNLRVHIALDVARGLEYL 226
           G        + +Y+ M    K +L   +            +  ++ + IA      +E+L
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAE----AVEFL 180

Query: 227 HD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR------------ 273
           H  G    ++HRD+K SNI        +V DFGL      D+    +             
Sbjct: 181 HSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236

Query: 274 -GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW 332
            GT  Y+ PE I   N++ K D++S G++LFEL+         ME V +           
Sbjct: 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQMERVRI----------I 283

Query: 333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
            ++ + +   +F  ++  +   +    ++ +P +RP   DI++
Sbjct: 284 TDVRNLKFPLLFT-QKYPQEHMMVQDMLSPSPTERPEATDIIE 325

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 16/75 (21%), Positives = 29/75 (38%), Gaps = 2/75 (2%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNLVGY 176
            +G+G FG V++A+        A+K +   +++  +E    EV  L +L H  +V     
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 177 CAEKGQHMLVYVFMS 191
             E            
Sbjct: 73  WLETPPEKWQEEMDE 87

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  109 bits (276), Expect = 1e-27
 Identities = 56/270 (20%), Positives = 103/270 (38%), Gaps = 39/270 (14%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           IG+G++G V  A Q  T    A K +     +    F+ E+ ++  L H N++ L     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 179 EKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVP 232
           +     LV    + G L        ++ E+           I  DV   + Y H      
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHKRVFRESDA-------ARIMKDVLSAVAYCHKLN--- 126

Query: 233 PVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNF 289
            V HRD+K  N L          ++ DFGL+      K      GT  Y+ P+ +    +
Sbjct: 127 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE-GLY 184

Query: 290 TKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL 349
             + D +S GV+++ L+ G  P              T+ +    +I +      F  ++ 
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSA----------PTDSEV-MLKIREGTFT--FPEKDW 231

Query: 350 NEVASLA----YKCVNRAPRKRPSMRDIVQ 375
             V+  A     + + ++P++R +    ++
Sbjct: 232 LNVSPQAESLIRRLLTKSPKQRITSLQALE 261

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  110 bits (277), Expect = 1e-27
 Identities = 69/276 (25%), Positives = 110/276 (39%), Gaps = 46/276 (16%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKE--FQTEVMLLGRLHHRNLVNLVGY 176
           +G+G+FG V K     T +  AVKV+   S + +       EV LL +L H N++ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 177 CAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GA 230
             +     +V    + G L         + E+           I   V  G+ Y+H    
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-------ARIIKQVFSGITYMHKHN- 141

Query: 231 VPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
              ++HRD+K  NILL   ++    ++ DFGLS     +    +  GT  Y+ PE +   
Sbjct: 142 ---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRG 197

Query: 288 NFTKKSDVYSFGVLLFELIAGRSP-----LQGLMEYVELAAMNTEGKTGWEEIVDSRLDG 342
            + +K DV+S GV+L+ L++G  P        +++ VE      +    W  I D   D 
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ-WRTISDDAKD- 255

Query: 343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS 378
                       L  K +   P  R +     Q L 
Sbjct: 256 ------------LIRKMLTFHPSLRITAT---QCLE 276

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  110 bits (277), Expect = 3e-27
 Identities = 72/325 (22%), Positives = 122/325 (37%), Gaps = 56/325 (17%)

Query: 69  GPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPV 128
           GP     +G    G+         +          Y  K+           +G+GAF  V
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNASTKFSD-----NYDVKEE----------LGKGAFSVV 45

Query: 129 YKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML 185
            +    +TG   A K++ T   S +  ++ + E  +  +L H N+V L     E+  H L
Sbjct: 46  RRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105

Query: 186 VYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIK 240
           V+  ++ G L     A   Y E           H    +   + Y H   +   +HR++K
Sbjct: 106 VFDLVTGGELFEDIVAREFYSEADA-------SHCIQQILESIAYCHSNGI---VHRNLK 155

Query: 241 SSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
             N+LL    +    ++ADFGL+ E    +      GT GYL PE +    ++K  D+++
Sbjct: 156 PENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 215

Query: 298 FGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLA- 356
            GV+L+ L+ G  P     ++               +I     D  +   E + V   A 
Sbjct: 216 CGVILYILLVGYPPFWDEDQHRLY-----------AQIKAGAYD--YPSPEWDTVTPEAK 262

Query: 357 ---YKCVNRAPRKRPSMRDIVQVLS 378
                 +   P+KR +     Q L 
Sbjct: 263 SLIDSMLTVNPKKRIT---ADQALK 284

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  108 bits (272), Expect = 5e-27
 Identities = 61/273 (22%), Positives = 105/273 (38%), Gaps = 41/273 (15%)

Query: 120 IGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNLVGYC 177
           +G GAFG V+  +  S+G    +K +  D  Q   E  + E+ +L  L H N++ +    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 178 AEKGQHMLVYVFMSKGSLASHLYD------ENYGPLTWNLRVHIALDVARGLEYLHD-GA 230
            +     +V      G L     +           L+      +   +   L Y H    
Sbjct: 90  EDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH- 144

Query: 231 VPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
              V+H+D+K  NIL          ++ DFGL+     D+H+ N  GT  Y+ PE    R
Sbjct: 145 ---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-R 200

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
           + T K D++S GV+++ L+ G  P  G           +      EE+         +  
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLPFTG----------TSL-----EEVQQKATYKEPNYA 245

Query: 348 EL-----NEVASLAYKCVNRAPRKRPSMRDIVQ 375
                   +   L  + + + P +RPS   ++ 
Sbjct: 246 VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  109 bits (275), Expect = 6e-27
 Identities = 68/274 (24%), Positives = 114/274 (41%), Gaps = 36/274 (13%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT------DSKQGEKEFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +              +E + EV +L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      +   +L+   +S G L   L  +    L+          +  G+ YLH   + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKI- 136

Query: 233 PVIHRDIKSSNILL----DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI+L          ++ DFGL+ E        NI GT  ++ PE ++   
Sbjct: 137 --AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP 194

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
              ++D++S GV+ + L++G SP  G          +T+ +T    I     D  FD E 
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLG----------DTKQET-LANITAVSYD--FDEEF 241

Query: 349 LNEVASLA----YKCVNRAPRKRPSMRDIVQVLS 378
            ++ + LA     K + +  RKR +   I + L 
Sbjct: 242 FSQTSELAKDFIRKLLVKETRKRLT---IQEALR 272

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  108 bits (273), Expect = 7e-27
 Identities = 68/274 (24%), Positives = 114/274 (41%), Gaps = 36/274 (13%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEK------EFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +     +  +      E + EV +L ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      +   +L+   +S G L   L  +    L+          +  G+ YLH   + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKI- 136

Query: 233 PVIHRDIKSSNILL----DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI+L          ++ DFGL+ E        NI GT  ++ PE ++   
Sbjct: 137 --AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP 194

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
              ++D++S GV+ + L++G SP  G          +T+ +T    I     D  FD E 
Sbjct: 195 LGLEADMWSIGVITYILLSGASPFLG----------DTKQET-LANITSVSYD--FDEEF 241

Query: 349 LNEVASLA----YKCVNRAPRKRPSMRDIVQVLS 378
            +  + LA     K + +  RKR +   I + L 
Sbjct: 242 FSHTSELAKDFIRKLLVKETRKRLT---IQEALR 272

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  109 bits (273), Expect = 7e-27
 Identities = 68/312 (21%), Positives = 112/312 (35%), Gaps = 75/312 (24%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKV-----LATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           IGQG++G V  A +  T    A+K+     +   + +  +  +TEV L+ +LHH N+  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV-------------------- 213
                ++    LV      G L   L                                  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 214 ------------------HIALDVARGLEYLHD-GAVPPVIHRDIKSSNILL--DQSMRA 252
                             +I   +   L YLH+ G    + HRDIK  N L   ++S   
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFLFSTNKSFEI 209

Query: 253 RVADFGLSREEMVDKHAANIR-----GTFGYLDPEYIS--TRNFTKKSDVYSFGVLLFEL 305
           ++ DFGLS+E     +          GT  ++ PE ++    ++  K D +S GVLL  L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269

Query: 306 IAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAY----KCVN 361
           + G  P  G            +  T   ++++ +L   F+    N ++ LA       +N
Sbjct: 270 LMGAVPFPG----------VNDADT-ISQVLNKKLC--FENPNYNVLSPLARDLLSNLLN 316

Query: 362 RAPRKRPSMRDI 373
           R   +R      
Sbjct: 317 RNVDERFDAMRA 328

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  107 bits (270), Expect = 1e-26
 Identities = 66/274 (24%), Positives = 112/274 (40%), Gaps = 41/274 (14%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           +G+GAF  V +    +TG   A K++ T   S +  ++ + E  +  +L H N+V L   
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 177 CAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
             E+  H LV+  ++ G L     A   Y E           H    +   + Y H   +
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADA-------SHCIQQILESIAYCHSNGI 126

Query: 232 PPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              +HR++K  N+LL    +    ++ADFGL+ E    +      GT GYL PE +    
Sbjct: 127 ---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
           ++K  D+++ GV+L+ L+ G  P     ++               +I     D  +   E
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-----------AQIKAGAYD--YPSPE 230

Query: 349 LNEVASLA----YKCVNRAPRKRPSMRDIVQVLS 378
            + V   A       +   P+KR +     Q L 
Sbjct: 231 WDTVTPEAKSLIDSMLTVNPKKRIT---ADQALK 261

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  107 bits (270), Expect = 1e-26
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 39/226 (17%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL------------------------ATDSKQGEK 153
            IG+G++G V  A   +     A+KVL                            +    
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 154 EFQT--EVMLLGRLHHRNLVNL--VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTW 209
             Q   E+ +L +L H N+V L  V     +    +V+  +++G +   +      PL+ 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSE 136

Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKH 268
           +       D+ +G+EYLH   +   IHRDIK SN+L+ +    ++ADFG+S E +  D  
Sbjct: 137 DQARFYFQDLIKGIEYLHYQKI---IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193

Query: 269 AANIRGTFGYLDPEYISTRNFT---KKSDVYSFGVLLFELIAGRSP 311
            +N  GT  ++ PE +S        K  DV++ GV L+  + G+ P
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  107 bits (269), Expect = 1e-26
 Identities = 68/274 (24%), Positives = 116/274 (42%), Gaps = 36/274 (13%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEK------EFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  Q  TG+  A K +        +      E + EV +L  + H N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   +S G L   L ++    LT +        +  G+ YLH   + 
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSKRI- 129

Query: 233 PVIHRDIKSSNILL----DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI+L      + R ++ DFG++ +        NI GT  ++ PE ++   
Sbjct: 130 --AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP 187

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
              ++D++S GV+ + L++G SP  G           T+ +T    I     D  FD E 
Sbjct: 188 LGLEADMWSIGVITYILLSGASPFLG----------ETKQET-LTNISAVNYD--FDEEY 234

Query: 349 LNEVASLA----YKCVNRAPRKRPSMRDIVQVLS 378
            +  + LA     + + + P++R +   I Q L 
Sbjct: 235 FSNTSELAKDFIRRLLVKDPKRRMT---IAQSLE 265

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  111 bits (278), Expect = 2e-26
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 18/207 (8%)

Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLH---H 167
           +   +IG+G FG VY  +   TG+  A+K L       KQGE     E ++L  +     
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251

Query: 168 RNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYL 226
             +V +  Y       +  +   M+ G L  HL     G  +       A ++  GLE++
Sbjct: 252 PFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHM 308

Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYIS 285
           H+  V   ++RD+K +NILLD+    R++D GL+ +    K   +   GT GY+ PE + 
Sbjct: 309 HNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAPEVLQ 363

Query: 286 TRN-FTKKSDVYSFGVLLFELIAGRSP 311
               +   +D +S G +LF+L+ G SP
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  108 bits (270), Expect = 2e-26
 Identities = 83/342 (24%), Positives = 128/342 (37%), Gaps = 95/342 (27%)

Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTE-------------V 159
           +G+GAFG V +A      + +T  TVAVK+L   +   E +   +E             V
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 160 MLLG--------------------------------------RLHHRNLVNLVGYCAEKG 181
            LLG                                          R   + VG      
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149

Query: 182 QHMLVYVFMSKGSLASHLYDENY---------------GPLTWNLRVHIALDVARGLEYL 226
           +  L  +  S+ S +S   +E                   LT    +  +  VA+G+E+L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLD-----P 281
              A    IHRD+ + NILL +    ++ DFGL+R+   D     +R     L      P
Sbjct: 210 ---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAP 264

Query: 282 EYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL 340
           E I  R +T +SDV+SFGVLL+E+ + G SP  G+    E      EG          R+
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---------RM 315

Query: 341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                     E+      C +  P +RP+  ++V+ L  +L+
Sbjct: 316 RAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  107 bits (269), Expect = 3e-26
 Identities = 64/274 (23%), Positives = 116/274 (42%), Gaps = 36/274 (13%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEK------EFQTEVMLLGRLHHRNLVN 172
           +G G F  V K  + STG   A K +     +  +      + + EV +L  + H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L      K   +L+   ++ G L   L ++    LT          +  G+ YLH   + 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQI- 135

Query: 233 PVIHRDIKSSNILL----DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
              H D+K  NI+L        R ++ DFGL+ +        NI GT  ++ PE ++   
Sbjct: 136 --AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 193

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
              ++D++S GV+ + L++G SP  G          +T+ +T    +     +  F+ E 
Sbjct: 194 LGLEADMWSIGVITYILLSGASPFLG----------DTKQET-LANVSAVNYE--FEDEY 240

Query: 349 LNEVASLA----YKCVNRAPRKRPSMRDIVQVLS 378
            +  ++LA     + + + P+KR +   I   L 
Sbjct: 241 FSNTSALAKDFIRRLLVKDPKKRMT---IQDSLQ 271

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  107 bits (270), Expect = 3e-26
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 14/207 (6%)

Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEF---QTEVMLLGRLHHRNL 170
           ++  L+G+G FG V   +  +TG   A+K+L  +    + E     TE  +L    H  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67

Query: 171 VNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHI-ALDVARGLEYLHD 228
             L  Y  +    +  V  + + G L  HL  E         R      ++   LEYLH 
Sbjct: 68  TALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGAEIVSALEYLHS 123

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTR 287
             V   ++RDIK  N++LD+    ++ DFGL +E + D        GT  YL PE +   
Sbjct: 124 RDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQG 314
           ++ +  D +  GV+++E++ GR P   
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  108 bits (271), Expect = 3e-26
 Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 30/213 (14%)

Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
                IG+G+FG V   Q   T +  A+K +         E +    E+ ++  L H  L
Sbjct: 18  EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77

Query: 171 VNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR-------- 221
           VNL  Y  +  + M +V   +  G L  HL             VH   +  +        
Sbjct: 78  VNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQN----------VHFKEETVKLFICELVM 126

Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
            L+YL +  +   IHRD+K  NILLD+     + DF ++     +     + GT  Y+ P
Sbjct: 127 ALDYLQNQRI---IHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAP 183

Query: 282 EYISTRNF---TKKSDVYSFGVLLFELIAGRSP 311
           E  S+R     +   D +S GV  +EL+ GR P
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  106 bits (267), Expect = 5e-26
 Identities = 58/270 (21%), Positives = 101/270 (37%), Gaps = 41/270 (15%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL--------ATDSKQGEKEFQTEVMLLGRLHHRNL 170
           +G GAFG V+ A      + V VK +                 +   E+ +L R+ H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHD 228
           + ++     +G   LV      G     L+   + +  L   L  +I   +   + YL  
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
             +   IHRDIK  NI++ +    ++ DFG +      K      GT  Y  PE +    
Sbjct: 149 KDI---IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNP 205

Query: 289 FT-KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
           +   + +++S GV L+ L+   +P   L                 EE     ++      
Sbjct: 206 YRGPELEMWSLGVTLYTLVFEENPFCEL-----------------EET----VEAAIHPP 244

Query: 348 EL--NEVASLAYKCVNRAPRKRPSMRDIVQ 375
            L   E+ SL    +   P +R ++  +V 
Sbjct: 245 YLVSKELMSLVSGLLQPVPERRTTLEKLVT 274

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  108 bits (271), Expect = 5e-26
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 13/207 (6%)

Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEF---QTEVMLLGRLHHRNL 170
            +  L+G+G FG V   +  +TG   A+K+L  +    + E     TE  +L    H  L
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210

Query: 171 VNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHI-ALDVARGLEYLHD 228
             L  Y  +    +  V  + + G L  HL  E         R      ++   L+YLH 
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGAEIVSALDYLHS 266

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTR 287
                V++RD+K  N++LD+    ++ DFGL +E + D        GT  YL PE +   
Sbjct: 267 EK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQG 314
           ++ +  D +  GV+++E++ GR P   
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYN 351

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  105 bits (265), Expect = 5e-26
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 34/215 (15%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVL---------ATDSKQGEKEFQTEVMLLGRL-HHR 168
           +G+G    V +     T +  AVK++         A + ++  +    EV +L ++  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGL 223
           N++ L           LV+  M KG L           E            I   +   +
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET-------RKIMRALLEVI 137

Query: 224 EYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE 282
             LH       ++HRD+K  NILLD  M  ++ DFG S +    +    + GT  YL PE
Sbjct: 138 CALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193

Query: 283 ------YISTRNFTKKSDVYSFGVLLFELIAGRSP 311
                   +   + K+ D++S GV+++ L+AG  P
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  108 bits (271), Expect = 6e-26
 Identities = 67/276 (24%), Positives = 117/276 (42%), Gaps = 44/276 (15%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           +G+GAF  V +  ++  G+  A  ++ T   S +  ++ + E  +   L H N+V L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 177 CAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GA 230
            +E+G H L++  ++ G L     A   Y E           H    +   + + H  G 
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADA-------SHCIQQILEAVLHCHQMG- 130

Query: 231 VPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHA-ANIRGTFGYLDPEYIST 286
              V+HR++K  N+LL    +    ++ADFGL+ E   ++ A     GT GYL PE +  
Sbjct: 131 ---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187

Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV 346
             + K  D+++ GV+L+ L+ G  P               + +  +++I     D  F  
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPPFWD----------EDQHRL-YQQIKAGAYD--FPS 234

Query: 347 EELNEVASLA----YKCVNRAPRKRPSMRDIVQVLS 378
            E + V   A     K +   P KR +     + L 
Sbjct: 235 PEWDTVTPEAKDLINKMLTINPSKRITAA---EALK 267

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  106 bits (267), Expect = 7e-26
 Identities = 65/274 (23%), Positives = 107/274 (39%), Gaps = 42/274 (15%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
            +G+GA   VY+  Q  T +  A+KVL       +K  +TE+ +L RL H N++ L    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 178 AEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAV 231
               +  LV   ++ G L         Y E                +   + YLH+ G  
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDA-------ADAVKQILEAVAYLHENG-- 168

Query: 232 PPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
             ++HRD+K  N+L          ++ADFGLS+          + GT GY  PE +    
Sbjct: 169 --IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA 226

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
           +  + D++S G++ + L+ G  P         +             I++      F    
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF----------RRILNCEYY--FISPW 274

Query: 349 LNEVASLA----YKCVNRAPRKRPSMRDIVQVLS 378
            +EV+  A     K +   P+KR +     Q L 
Sbjct: 275 WDEVSLNAKDLVRKLIVLDPKKRLTTF---QALQ 305

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  106 bits (266), Expect = 7e-26
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 30/216 (13%)

Query: 115 NFTTLIGQGAFGPVY----KAQMSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHR 168
               ++GQG+FG V+     +     +  A+KVL   +   +     + E  +L  ++H 
Sbjct: 27  ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHP 86

Query: 169 NLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR------ 221
            +V L  Y  +    + L+  F+  G L + L  E          V    +  +      
Sbjct: 87  FIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKE----------VMFTEEDVKFYLAEL 135

Query: 222 --GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGY 278
              L++LH   +   I+RD+K  NILLD+    ++ DFGLS+E +  +  A    GT  Y
Sbjct: 136 ALALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192

Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           + PE ++ R  T+ +D +SFGVL+FE++ G  P QG
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  105 bits (265), Expect = 8e-26
 Identities = 75/324 (23%), Positives = 133/324 (41%), Gaps = 33/324 (10%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG+G F  V  A+ + TG  VA+K++     +    ++   EV ++  L+H N+V L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
              +    L+  + S G +  +L    +G +           +   ++Y H   +   +H
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQKRI---VH 137

Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT-KKSDV 295
           RD+K+ N+LLD  M  ++ADFG S E  V        G   Y  PE    + +   + DV
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDV 197

Query: 296 YSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL--NEVA 353
           +S GV+L+ L++G  P  G      L  +        E +    L G + +      +  
Sbjct: 198 WSLGVILYTLVSGSLPFDG----QNLKEL-------RERV----LRGKYRIPFYMSTDCE 242

Query: 354 SLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNR---KHHRKSQSTTADEVSIDMEQAEA 410
           +L  + +   P KR ++  I++   R +   H     K   + +   +D+  ID+     
Sbjct: 243 NLLKRFLVLNPIKRGTLEQIMK--DRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMG 300

Query: 411 KTPTSTH--LREESVDSTADTYEL 432
            +       L +   D    TY L
Sbjct: 301 YSQEEIQESLSKMKYDEITATYLL 324

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  105 bits (264), Expect = 2e-25
 Identities = 64/283 (22%), Positives = 109/283 (38%), Gaps = 52/283 (18%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKV-----LATDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           IG+G F  V +     TG+  AVK+       +      ++ + E  +   L H ++V L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 174 VGYCAEKGQHMLVYVFMSKGSL---------ASHLYDENYGPLTWNLRVHIALDVARGLE 224
           +   +  G   +V+ FM    L         A  +Y E           H    +   L 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA-------SHYMRQILEALR 144

Query: 225 YLHD-GAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIR-GTFGYL 279
           Y HD      +IHRD+K   +LL   + S   ++  FG++ +       A  R GT  ++
Sbjct: 145 YCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200

Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPL----QGLMEYVELAAMNTEGKTGWEEI 335
            PE +    + K  DV+  GV+LF L++G  P     + L E +         +  W  I
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQ-WSHI 259

Query: 336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLS 378
            +S  D             L  + +   P +R +   + + L+
Sbjct: 260 SESAKD-------------LVRRMLMLDPAERIT---VYEALN 286

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  103 bits (260), Expect = 2e-25
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 27/207 (13%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNLVGY 176
            +G+GA+G V  A    T E VAVK++         E  + E+ +   L+H N+V   G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR--------GLEYLHD 228
             E     L   + S G L   +  E    +            A+        G+ YLH 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI--EPDIGMP--------EPDAQRFFHQLMAGVVYLHG 123

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLS---REEMVDKHAANIRGTFGYLDPEYIS 285
             +    HRDIK  N+LLD+    +++DFGL+   R    ++    + GT  Y+ PE + 
Sbjct: 124 IGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 286 TRNFT-KKSDVYSFGVLLFELIAGRSP 311
            R F  +  DV+S G++L  ++AG  P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  105 bits (263), Expect = 3e-25
 Identities = 62/304 (20%), Positives = 120/304 (39%), Gaps = 34/304 (11%)

Query: 30  FRYHRKRSQIGNSSSRRAATLPIRANGVDSCSILSDSTVGPESPVKSGRNGNGKSMWLEG 89
            +++++R +      R    L          S+  D +       ++ +  + +    E 
Sbjct: 13  NKFNKERRR-ARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTEN 71

Query: 90  FKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKA-QMSTGETVAVKVLA--- 145
               ++     +P+++         +   +IG+G    V +    +TG   AVK++    
Sbjct: 72  LYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTA 131

Query: 146 -----TDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFMSKGSL---- 195
                   ++  +  + E  +L ++  H +++ L+          LV+  M KG L    
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL 191

Query: 196 -ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRAR 253
                  E            I   +   + +LH       ++HRD+K  NILLD +M+ R
Sbjct: 192 TEKVALSEKET-------RSIMRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIR 240

Query: 254 VADFGLSREEMVDKHAANIRGTFGYLDPE------YISTRNFTKKSDVYSFGVLLFELIA 307
           ++DFG S      +    + GT GYL PE        +   + K+ D+++ GV+LF L+A
Sbjct: 241 LSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300

Query: 308 GRSP 311
           G  P
Sbjct: 301 GSPP 304

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  105 bits (264), Expect = 4e-25
 Identities = 49/212 (23%), Positives = 90/212 (42%), Gaps = 31/212 (14%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATD--------SKQGEKEFQTEVMLLGRLHHRNL 170
           +G GA G V  A +  T + VA+++++                  +TE+ +L +L+H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEY 225
           + +  +  +   + +V   M  G L      +    E                +   ++Y
Sbjct: 203 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC-------KLYFYQMLLAVQY 254

Query: 226 LHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE 282
           LH+  +   IHRD+K  N+LL   ++    ++ DFG S+          + GT  YL PE
Sbjct: 255 LHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 311

Query: 283 YIS---TRNFTKKSDVYSFGVLLFELIAGRSP 311
            +    T  + +  D +S GV+LF  ++G  P
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  103 bits (259), Expect = 5e-25
 Identities = 64/272 (23%), Positives = 113/272 (41%), Gaps = 41/272 (15%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL------ATDSKQGEKEFQTEVMLLGRLH----H 167
           L+G+G FG V+    ++    VA+KV+                   EV LL ++     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEY 225
             ++ L+ +   +       + + +   A  L+D     GPL           V   +++
Sbjct: 98  PGVIRLLDWFETQEG---FMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQH 154

Query: 226 LHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAANIRGTFGYLDPEYI 284
            H   V   +HRDIK  NIL+D     A++ DFG     + D+   +  GT  Y  PE+I
Sbjct: 155 CHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGA-LLHDEPYTDFDGTRVYSPPEWI 210

Query: 285 STRNFT-KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI 343
           S   +    + V+S G+LL++++ G  P +                   +EI+++ L   
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGDIPFERD-----------------QEILEAELHFP 253

Query: 344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
             V    +  +L  +C+   P  RPS+ +I+ 
Sbjct: 254 AHVSP--DCCALIRRCLAPKPSSRPSLEEILL 283

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  103 bits (259), Expect = 5e-25
 Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 40/274 (14%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYC 177
           +G+G+F    K     + +  AVK++   SK+ E   Q E+  L     H N+V L    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 178 AEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAV 231
            ++    LV   ++ G L         + E           +I   +   + ++HD G  
Sbjct: 76  HDQLHTFLVMELLNGGELFERIKKKKHFSETEA-------SYIMRKLVSAVSHMHDVG-- 126

Query: 232 PPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYISTR 287
             V+HRD+K  N+L    + ++  ++ DFG +R +  D         T  Y  PE ++  
Sbjct: 127 --VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI--FD 345
            + +  D++S GV+L+ +++G+ P Q            +   T   EI+     G   F+
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQS--------HDRSLTCTSAVEIMKKIKKGDFSFE 236

Query: 346 VEELNEVASLA----YKCVNRAPRKRPSMRDIVQ 375
            E    V+  A       +   P KR  M  +  
Sbjct: 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  103 bits (258), Expect = 8e-25
 Identities = 64/272 (23%), Positives = 106/272 (38%), Gaps = 43/272 (15%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEF------QTEVMLLGRLHHR--N 169
           L+G G FG VY    +S    VA+K +  D      E         EV+LL ++      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH 227
           ++ L+ +       +L+   + +      L+D     G L   L       V   + + H
Sbjct: 110 VIRLLDWFERPDSFVLI---LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 166

Query: 228 DGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           +  V   +HRDIK  NIL+D      ++ DFG     + D    +  GT  Y  PE+I  
Sbjct: 167 NCGV---LHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWIRY 222

Query: 287 RNFT-KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
             +  + + V+S G+LL++++ G  P +                   EEI    + G   
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----------------EEI----IRGQVF 261

Query: 346 VEEL--NEVASLAYKCVNRAPRKRPSMRDIVQ 375
             +   +E   L   C+   P  RP+  +I  
Sbjct: 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  102 bits (256), Expect = 1e-24
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 27/207 (13%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNLVGY 176
            +G+GA+G V  A    T E VAVK++         E  + E+ +   L+H N+V   G+
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR--------GLEYLHD 228
             E     L   + S G L   +  E    +            A+        G+ YLH 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRI--EPDIGMP--------EPDAQRFFHQLMAGVVYLHG 123

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR---GTFGYLDPEYIS 285
             +    HRDIK  N+LLD+    +++DFGL+     +     +    GT  Y+ PE + 
Sbjct: 124 IGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 286 TRNFT-KKSDVYSFGVLLFELIAGRSP 311
            R F  +  DV+S G++L  ++AG  P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  101 bits (255), Expect = 2e-24
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 34/217 (15%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
           L+G+G++G V +     T    AVK+L          GE   + E+ LL RL H+N++ L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 174 --VGYCAEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVAR--------G 222
             V Y  EK +  +V  +   G     + D                +  A         G
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEKRFP--------VCQAHGYFCQLIDG 121

Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS---REEMVDKHAANIRGTFGYL 279
           LEYLH   +   +H+DIK  N+LL      +++  G++        D      +G+  + 
Sbjct: 122 LEYLHSQGI---VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 280 DPEYIS-TRNFT-KKSDVYSFGVLLFELIAGRSPLQG 314
            PE  +    F+  K D++S GV L+ +  G  P +G
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  103 bits (259), Expect = 2e-24
 Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 37/220 (16%)

Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKE-FQTEVMLLGRLHHRNL 170
               +IG+GAF  V   +M  TG+  A+K++      K+GE   F+ E  +L     R +
Sbjct: 64  EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123

Query: 171 VNLVGYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVAR------- 221
             L  + A + ++ L  V  +   G L + L    +G         I  ++AR       
Sbjct: 124 TQL--HFAFQDENYLYLVMEYYVGGDLLTLLS--KFGE-------RIPAEMARFYLAEIV 172

Query: 222 -GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAANIRGTFGY 278
             ++ +H       +HRDIK  NILLD+    R+ADFG   +   D    +    GT  Y
Sbjct: 173 MAIDSVHRLGY---VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229

Query: 279 LDPEYISTRNFTKKSDVY-------SFGVLLFELIAGRSP 311
           L PE +        +  Y       + GV  +E+  G++P
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  101 bits (255), Expect = 2e-24
 Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 14/150 (9%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEF-QT---EVMLLGRLHHRNLVNLV 174
           +G G +  VYK    +TG  VA+K +  DS++G      T   E+ L+  L H N+V L 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKELKHENIVRLY 69

Query: 175 GYCAEKGQHMLVYVFMS---KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
                + +  LV+ FM    K  + S         L  NL  +    + +GL + H+  +
Sbjct: 70  DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKI 129

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSR 261
              +HRD+K  N+L+++  + ++ DFGL+R
Sbjct: 130 ---LHRDLKPQNLLINKRGQLKLGDFGLAR 156

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  101 bits (254), Expect = 2e-24
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 13/147 (8%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKE---FQT--EVMLLGRLHHRNLVNLV 174
           +G+G +G VYKA+ S G  VA+K +  D+   E E        E+ LL  LHH N+V+L+
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHPNIVSLI 85

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
                +    LV+ FM K  L   L DEN   L  +        + RG+ + H   +   
Sbjct: 86  DVIHSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQIKIYLYQLLRGVAHCHQHRI--- 140

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSR 261
           +HRD+K  N+L++     ++ADFGL+R
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLAR 167

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  101 bits (255), Expect = 3e-24
 Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 32/218 (14%)

Query: 115 NFTTLIGQGAFGPVYKAQM----STGETVAVKVLATDS---KQGEKEF-QTEVMLLGRLH 166
               ++G+G +G V++ +     +TG+  A+KVL          +    + E  +L  + 
Sbjct: 20  ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79

Query: 167 HRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR---- 221
           H  +V+L+ Y  + G  + L+  ++S G L   L  E               D A     
Sbjct: 80  HPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLERE----------GIFMEDTACFYLA 128

Query: 222 ----GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTF 276
                L +LH   +   I+RD+K  NI+L+     ++ DFGL +E + D    +   GT 
Sbjct: 129 EISMALGHLHQKGI---IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTI 185

Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            Y+ PE +      +  D +S G L+++++ G  P  G
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  104 bits (261), Expect = 3e-24
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 23/212 (10%)

Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVL---------ATDSKQGEKEFQTEVMLLGR 164
           NF  ++G+G+FG V  ++   T E  AVK+L           +    EK      +L   
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR-----VLALP 398

Query: 165 LHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
                L  L   C +    +  V  +++ G L  H+     G       V  A ++A GL
Sbjct: 399 GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGL 455

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPE 282
            +L    +   I+RD+K  N++LD     ++ADFG+ +E + D        GT  Y+ PE
Sbjct: 456 FFLQSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 512

Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            I+ + + K  D ++FGVLL+E++AG++P +G
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  101 bits (254), Expect = 4e-24
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 29/215 (13%)

Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVL---------ATDSKQGEKEFQTEVMLLGR 164
               ++G+G+FG V+ A+   T +  A+K L           +    EK      +L   
Sbjct: 20  ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR-----VLSLA 74

Query: 165 LHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
             H  L ++     +  +++  V  +++ G L  H+          +     A ++  GL
Sbjct: 75  WEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGL 131

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-G---YL 279
           ++LH   +   ++RD+K  NILLD+    ++ADFG+ +E M+     N   TF G   Y+
Sbjct: 132 QFLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN---TFCGTPDYI 185

Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            PE +  + +    D +SFGVLL+E++ G+SP  G
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  100 bits (252), Expect = 4e-24
 Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 13/148 (8%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE---FQT--EVMLLGRLHHRNLVNL 173
           IG+G +G VYKA+   TGE VA+K +  D+   E E        E+ LL  L+H N+V L
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDT---ETEGVPSTAIREISLLKELNHPNIVKL 67

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           +     + +  LV+ F+ +  L   +       +   L       + +GL + H   V  
Sbjct: 68  LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV-- 124

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSR 261
            +HRD+K  N+L++     ++ADFGL+R
Sbjct: 125 -LHRDLKPQNLLINTEGAIKLADFGLAR 151

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  100 bits (251), Expect = 6e-24
 Identities = 50/212 (23%), Positives = 90/212 (42%), Gaps = 31/212 (14%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLAT--------DSKQGEKEFQTEVMLLGRLHHRNL 170
           +G GA G V  A +  T + VA+K+++                  +TE+ +L +L+H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEY 225
           + +  +  +   + +V   M  G L      +    E                +   ++Y
Sbjct: 78  IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC-------KLYFYQMLLAVQY 129

Query: 226 LHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE 282
           LH+  +   IHRD+K  N+LL   ++    ++ DFG S+          + GT  YL PE
Sbjct: 130 LHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186

Query: 283 YIS---TRNFTKKSDVYSFGVLLFELIAGRSP 311
            +    T  + +  D +S GV+LF  ++G  P
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  101 bits (253), Expect = 7e-24
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 29/215 (13%)

Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVL---------ATDSKQGEKEFQTEVMLLGR 164
            F  ++G+G+FG V  A++  TG+  AVKVL           +    EK      +L   
Sbjct: 26  EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR-----ILSLA 80

Query: 165 LHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
            +H  L  L   C +    +  V  F++ G L  H+                A ++   L
Sbjct: 81  RNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISAL 137

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-G---YL 279
            +LHD  +   I+RD+K  N+LLD     ++ADFG+ +E + +        TF G   Y+
Sbjct: 138 MFLHDKGI---IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA---TFCGTPDYI 191

Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            PE +    +    D ++ GVLL+E++ G +P + 
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  100 bits (252), Expect = 8e-24
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 29/215 (13%)

Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVL---------ATDSKQGEKEFQTEVMLLGR 164
           NF  ++G+G+FG V  ++   T E  AVK+L           +    EK      +L   
Sbjct: 23  NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR-----VLALP 77

Query: 165 LHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
                L  L   C +    +  V  +++ G L  H+     G       V  A ++A GL
Sbjct: 78  GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGL 134

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-G---YL 279
            +L    +   I+RD+K  N++LD     ++ADFG+ +E + D        TF G   Y+
Sbjct: 135 FFLQSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK---TFCGTPDYI 188

Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
            PE I+ + + K  D ++FGVLL+E++AG++P +G
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 99.1 bits (248), Expect = 1e-23
 Identities = 50/147 (34%), Positives = 75/147 (51%), Gaps = 13/147 (8%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKE---FQT--EVMLLGRLHHRNLVNLV 174
           IG+G +G VYKAQ + GET A+K +  +    E E     T  E+ +L  L H N+V L 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
                K + +LV+  + +  L   L D   G L         L +  G+ Y HD  V   
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDRRV--- 121

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSR 261
           +HRD+K  N+L+++    ++ADFGL+R
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLAR 148

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 99.1 bits (248), Expect = 1e-23
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 34/210 (16%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE---FQT--EVMLLGRLHHRNLVNL 173
           IG+G +G V+KA+   T E VA+K +  D    + E        E+ LL  L H+N+V L
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVRL 66

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                   +  LV+ F  +  L  +  D   G L   +       + +GL + H   V  
Sbjct: 67  HDVLHSDKKLTLVFEFCDQ-DLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV-- 122

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSRE----------EMVDKHAANIRGTFGYLDPEY 283
            +HRD+K  N+L++++   ++A+FGL+R           E+V         T  Y  P+ 
Sbjct: 123 -LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV---------TLWYRPPDV 172

Query: 284 I-STRNFTKKSDVYSFGVLLFELIAGRSPL 312
           +   + ++   D++S G +  EL     PL
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 61/265 (23%), Positives = 119/265 (44%), Gaps = 27/265 (10%)

Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEF---QTEVMLLGR-LHHRN 169
           +   +IG+G++  V   ++  T    A+KV+  +    +++    QTE  +  +  +H  
Sbjct: 12  DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 71

Query: 170 LVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           LV L   C +    +  V  +++ G L  H+  +   P     R + A +++  L YLH+
Sbjct: 72  LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSA-EISLALNYLHE 128

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-G---YLDPEYI 284
             +   I+RD+K  N+LLD     ++ D+G+ +E +      +   TF G   Y+ PE +
Sbjct: 129 RGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS---TFCGTPNYIAPEIL 182

Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG-- 342
              ++    D ++ GVL+FE++AGRSP   +                 + +    L+   
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE------DYLFQVILEKQI 236

Query: 343 IFDVEELNEVASLAYKCVNRAPRKR 367
                   + AS+    +N+ P++R
Sbjct: 237 RIPRSLSVKAASVLKSFLNKDPKER 261

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 21/211 (9%)

Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVM-----LLGRLHHR 168
           +F  +IG+G+FG V  A+  +     AVKVL   +   +KE +  +M     LL  + H 
Sbjct: 41  HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE-EKHIMSERNVLLKNVKHP 99

Query: 169 NLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
            LV L  +  +    +  V  +++ G L  HL  E         R + A ++A  L YLH
Sbjct: 100 FLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAA-EIASALGYLH 156

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-G---YLDPEY 283
              +   ++RD+K  NILLD      + DFGL +E +      +   TF G   YL PE 
Sbjct: 157 SLNI---VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS---TFCGTPEYLAPEV 210

Query: 284 ISTRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           +  + + +  D +  G +L+E++ G  P   
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  100 bits (251), Expect = 3e-23
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 35/214 (16%)

Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKE-FQTEVMLLGRLHHRNLVNLV 174
           +IG+GAFG V   ++ +  +  A+K+L      K+ E   F+ E  +L     + +  L 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL- 139

Query: 175 GYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVAR--------GLE 224
            + A +  + L  V  +   G L + L               +  ++AR         ++
Sbjct: 140 -HYAFQDDNNLYLVMDYYVGGDLLTLLS---------KFEDRLPEEMARFYLAEMVIAID 189

Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--KHAANIRGTFGYLDPE 282
            +H       +HRDIK  NIL+D +   R+ADFG   + M D    ++   GT  Y+ PE
Sbjct: 190 SVHQLHY---VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246

Query: 283 YISTRNFTKKS-----DVYSFGVLLFELIAGRSP 311
            +      K       D +S GV ++E++ G +P
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 54/272 (19%), Positives = 102/272 (37%), Gaps = 40/272 (14%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA 178
           IG G++    +    +T    AVK++    +   +E +   +LL    H N++ L     
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPNIITLKDVYD 86

Query: 179 EKGQHMLVYVFMSKGSL-----ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVP 232
           +     +V   M  G L         + E            +   + + +EYLH  G   
Sbjct: 87  DGKYVYVVTELMKGGELLDKILRQKFFSEREA-------SAVLFTITKTVEYLHAQG--- 136

Query: 233 PVIHRDIKSSNILL----DQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYISTR 287
            V+HRD+K SNIL           R+ DFG +++   +         T  ++ PE +  +
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ 195

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
            +    D++S GVLL+ ++ G +P     +      +          I   +        
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL--------ARIGSGKFS--LSGG 245

Query: 348 ELNEVASLA----YKCVNRAPRKRPSMRDIVQ 375
             N V+  A     K ++  P +R +   +++
Sbjct: 246 YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 98.5 bits (246), Expect = 4e-23
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 27/209 (12%)

Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---TEVMLLGRLHHRNL 170
           +    +G G+FG V   +   +G   A+K+L        K+ +    E  +L  ++   L
Sbjct: 44  DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103

Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR--------G 222
           V L     +     +V  +++ G + SHL                +   AR         
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----------RFSEPHARFYAAQIVLT 153

Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE 282
            EYLH   +   I+RD+K  N+L+DQ    +V DFG ++   V      + GT   L PE
Sbjct: 154 FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWTLCGTPEALAPE 208

Query: 283 YISTRNFTKKSDVYSFGVLLFELIAGRSP 311
            I ++ + K  D ++ GVL++E+ AG  P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 98.2 bits (245), Expect = 5e-23
 Identities = 53/271 (19%), Positives = 100/271 (36%), Gaps = 33/271 (12%)

Query: 119 LIGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVG- 175
           ++G G  G V +     TG+  A+K+L         + + EV    +     ++V ++  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILDV 90

Query: 176 YCAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAV 231
           Y         + + M     G L S + +      T      I  D+   +++LH     
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN-- 148

Query: 232 PPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
             + HRD+K  N+L    ++    ++ DFG ++E            T  Y+ PE +    
Sbjct: 149 --IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE-TTQNALQTPCYTPYYVAPEVLGPEK 205

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
           + K  D++S GV+++ L+ G  P            M          I   +    F   E
Sbjct: 206 YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-------KRRIRLGQYG--FPNPE 256

Query: 349 LNEVASLA----YKCVNRAPRKRPSMRDIVQ 375
            +EV+  A       +   P +R ++   + 
Sbjct: 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 97.1 bits (242), Expect = 5e-23
 Identities = 23/200 (11%), Positives = 53/200 (26%), Gaps = 37/200 (18%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE---KEFQTEVMLLGRLHHRNLVNLV 174
             G       ++A   +    VA+  +       +   +E  +  + L R+    +  ++
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
                +   ++V  ++  GSL            +    +     +A   +  H      V
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVAD----TSPSPVGAIRAMQSLAAAADAAHRA---GV 150

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
                  S + +       +A                       +            + D
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA-------------------TMPDA-------NPQDD 184

Query: 295 VYSFGVLLFELIAGRSPLQG 314
           +   G  L+ L+  R PL  
Sbjct: 185 IRGIGASLYALLVNRWPLPE 204

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 99.0 bits (247), Expect = 6e-23
 Identities = 61/270 (22%), Positives = 115/270 (42%), Gaps = 37/270 (13%)

Query: 115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVL---------ATDSKQGEKEFQTEVMLLGR 164
           +   +IG+G++  V   ++  T    A++V+           D  Q EK      +    
Sbjct: 55  DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH-----VFEQA 109

Query: 165 LHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
            +H  LV L   C +    +  V  +++ G L  H+  +   P     R + A +++  L
Sbjct: 110 SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSA-EISLAL 166

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF-G---YL 279
            YLH+  +   I+RD+K  N+LLD     ++ D+G+ +E +      +   TF G   Y+
Sbjct: 167 NYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS---TFCGTPNYI 220

Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
            PE +   ++    D ++ GVL+FE++AGRSP   +                 + +    
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE------DYLFQVI 274

Query: 340 LDG--IFDVEELNEVASLAYKCVNRAPRKR 367
           L+           + AS+    +N+ P++R
Sbjct: 275 LEKQIRIPRSLSVKAASVLKSFLNKDPKER 304

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 57/205 (27%), Positives = 86/205 (41%), Gaps = 26/205 (12%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
            IG G FG     +   T E VAVK +   +   E   Q E++    L H N+V      
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVI 85

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR--------GLEYLHDG 229
                  ++  + S G L   +   N G  +         D AR        G+ Y H  
Sbjct: 86  LTPTHLAIIMEYASGGELYERI--CNAGRFS--------EDEARFFFQQLLSGVSYCHSM 135

Query: 230 AVPPVIHRDIKSSNILLDQS--MRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
            +    HRD+K  N LLD S   R ++ DFG S+  ++     +  GT  Y+ PE +  +
Sbjct: 136 QI---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQ 192

Query: 288 NFT-KKSDVYSFGVLLFELIAGRSP 311
            +  K +DV+S GV L+ ++ G  P
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYP 217

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 96.1 bits (240), Expect = 1e-22
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 10/201 (4%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
            +G G FG V   +   TG  VAVK+L      S     + + E+  L    H +++ L 
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
              +      +V  ++S G L  ++    +G +       +   +   ++Y H   V   
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYIC--KHGRVEEMEARRLFQQILSAVDYCHRHMV--- 132

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT-KKS 293
           +HRD+K  N+LLD  M A++ADFGLS      +      G+  Y  PE IS R +   + 
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEV 192

Query: 294 DVYSFGVLLFELIAGRSPLQG 314
           D++S GV+L+ L+ G  P   
Sbjct: 193 DIWSCGVILYALLCGTLPFDD 213

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 98.3 bits (245), Expect = 1e-22
 Identities = 65/311 (20%), Positives = 111/311 (35%), Gaps = 53/311 (17%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYC 177
           +G G  G V +     T E  A+K+L         + + EV L  R     ++V +V   
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKML---QDC--PKARREVELHWRASQCPHIVRIVDVY 124

Query: 178 ----AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVP 232
               A +   ++V   +  G L S + D      T      I   +   ++YLH      
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--- 181

Query: 233 PVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNF 289
            + HRD+K  N+L      +   ++ DFG ++E            T  Y+ PE +    +
Sbjct: 182 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 240

Query: 290 TKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL 349
            K  D++S GV+++ L+ G  P            M          I   + +  F   E 
Sbjct: 241 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------KTRIRMGQYE--FPNPEW 291

Query: 350 NEVASLA----YKCVNRAPRKRPSMRDIVQVL------------------SRILKMRHNR 387
           +EV+          +   P +R +   I + +                  SR+LK    R
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKER 348

Query: 388 KHHRKSQSTTA 398
               K + T+A
Sbjct: 349 WEDVKEEMTSA 359

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 96.8 bits (242), Expect = 1e-22
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)

Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQ---T 157
           P+YS +D           +G G+FG V+  +    G   A+KVL  +     K+ +    
Sbjct: 1   PKYSLQDF-----QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 55

Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL 217
           E ++L  + H  ++ + G   +  Q  ++  ++  G L S L                  
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ----------RFPN 105

Query: 218 DVAR--------GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA 269
            VA+         LEYLH   +   I+RD+K  NILLD++   ++ DFG ++   V    
Sbjct: 106 PVAKFYAAEVCLALEYLHSKDI---IYRDLKPENILLDKNGHIKITDFGFAKY--VPDVT 160

Query: 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP 311
             + GT  Y+ PE +ST+ + K  D +SFG+L++E++AG +P
Sbjct: 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 72/282 (25%), Positives = 122/282 (43%), Gaps = 65/282 (23%)

Query: 64  SDSTVGPESPVK--SGRNGNGKSMWLEGFKRSNVVSASG-----IPEYSYKDLQKATCNF 116
           + S      PV+  S       S   +G K + VV+  G       E SY D +      
Sbjct: 7   TTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV----- 61

Query: 117 TTLIGQGAFGPVYKAQMS-TGETVAVK-VLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
              IG G+FG VY+A++  +GE VA+K VL     Q ++    E+ ++ +L H N+V L 
Sbjct: 62  ---IGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLR 113

Query: 175 GYCAEKGQHM------LVYVFMSKGSLASHL--YDENYGPLTWNLRVHIAL---DVARGL 223
            +    G+        LV  ++ + ++      Y      L     +++ L    + R L
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP---VIYVKLYMYQLFRSL 169

Query: 224 EYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE 282
            Y+H   +    HRDIK  N+LLD  +   ++ DFG +++  + +   N+          
Sbjct: 170 AYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNV---------S 215

Query: 283 YISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
           YI +R            ++T   DV+S G +L EL+ G+ P+
Sbjct: 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 41/153 (26%), Positives = 69/153 (45%), Gaps = 20/153 (13%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE---FQT--EVMLLGRLHHRNLVNL 173
           +G+G +G VYKA    T ETVA+K +  +    E+E        EV LL  L HRN++ L
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIREVSLLKELQHRNIIEL 98

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                   +  L++ +     L  ++  +    ++  +       +  G+ + H      
Sbjct: 99  KSVIHHNHRLHLIFEYAEN-DLKKYM--DKNPDVSMRVIKSFLYQLINGVNFCHSRRC-- 153

Query: 234 VIHRDIKSSNILLDQSMRAR-----VADFGLSR 261
            +HRD+K  N+LL  S  +      + DFGL+R
Sbjct: 154 -LHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 28/215 (13%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-F-QT---EVMLLGRLHHRNLVNL 173
           IGQG FG V+KA+   TG+ VA+K +  ++   EKE F  T   E+ +L  L H N+VNL
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLLKHENVVNL 81

Query: 174 VGYCAEKGQHM--------LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEY 225
           +  C  K            LV+ F     LA  L        T +    +   +  GL Y
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYY 139

Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG-----YLD 280
           +H   +   +HRD+K++N+L+ +    ++ADFGL+R   + K++   R T       Y  
Sbjct: 140 IHRNKI---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 196

Query: 281 PEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQG 314
           PE +   R++    D++  G ++ E+      +QG
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 231

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 96.1 bits (240), Expect = 3e-22
 Identities = 48/148 (32%), Positives = 77/148 (52%), Gaps = 11/148 (7%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE---FQT--EVMLLGRLHHRNLVNL 173
           +G+G F  VYKA+  +T + VA+K +    +   K+        E+ LL  L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           +     K    LV+ FM    L   +  +N   LT +      L   +GLEYLH   +  
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLEVII-KDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI-- 133

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSR 261
            +HRD+K +N+LLD++   ++ADFGL++
Sbjct: 134 -LHRDLKPNNLLLDENGVLKLADFGLAK 160

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 96.7 bits (241), Expect = 4e-22
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 36/213 (16%)

Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKE-FQTEVMLLGRLHHRNLVNLV 174
           +IG+GAFG V   +  ST +  A+K+L+     K+ +   F  E  ++   +   +V L 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 134

Query: 175 GYCAEKGQHMLVYV--FMSKGSLASHLYDENYGPLTWNLRVHIALDVAR--------GLE 224
            + A +    L  V  +M  G L + +               +    AR         L+
Sbjct: 135 -FYAFQDDRYLYMVMEYMPGGDLVNLMS-----------NYDVPEKWARFYTAEVVLALD 182

Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH--AANIRGTFGYLDPE 282
            +H       IHRD+K  N+LLD+S   ++ADFG   +   +         GT  Y+ PE
Sbjct: 183 AIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239

Query: 283 YISTR----NFTKKSDVYSFGVLLFELIAGRSP 311
            + ++     + ++ D +S GV L+E++ G +P
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 95.0 bits (237), Expect = 7e-22
 Identities = 47/148 (31%), Positives = 76/148 (51%), Gaps = 12/148 (8%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLV 174
           +G+G++G V K +   TG  VA+K  L +D  +  K+      E+ LL +L H NLVNL+
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK--IAMREIKLLKQLRHENLVNLL 90

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
             C +K +  LV+ F+   ++   L +     L + +       +  G+ + H   +   
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCHSHNI--- 145

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSRE 262
           IHRDIK  NIL+ QS   ++ DFG +R 
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFART 173

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 95.1 bits (237), Expect = 8e-22
 Identities = 50/218 (22%), Positives = 82/218 (37%), Gaps = 39/218 (17%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVK--VLATDSKQGEKEFQT---------EVMLLGRLHHR 168
           I  G++G V     S G  VA+K         +                E+ LL   HH 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89

Query: 169 NLVNL--VGYCAEKGQHMLVYVFMSKGSLASHLYD--------ENYGPLTWNLRVHIAL- 217
           N++ L  +    E+     +Y+          L          +    ++     HI   
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVT-------ELMRTDLAQVIHDQRIVIS---PQHIQYF 139

Query: 218 --DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT 275
              +  GL  LH+  V   +HRD+   NILL  +    + DF L+RE+  D +  +    
Sbjct: 140 MYHILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH 196

Query: 276 FGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPL 312
             Y  PE +   + FTK  D++S G ++ E+   +  L
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-AL 233

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 94.2 bits (235), Expect = 9e-22
 Identities = 44/146 (30%), Positives = 71/146 (48%), Gaps = 11/146 (7%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLVG 175
           +G+G +  VYK     T   VA+K +  + ++G     T   EV LL  L H N+V L  
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP--CTAIREVSLLKDLKHANIVTLHD 67

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
               +    LV+ ++ K  L  +L D+    +  +        + RGL Y H      V+
Sbjct: 68  IIHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVL 122

Query: 236 HRDIKSSNILLDQSMRARVADFGLSR 261
           HRD+K  N+L+++    ++ADFGL+R
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLAR 148

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 42/148 (28%), Positives = 72/148 (48%), Gaps = 12/148 (8%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVK-VLATDSKQGEKEFQT---EVMLLGRLHHRNLVNLV 174
           IG+G++G V+K +   TG+ VA+K  L ++     K  +    E+ +L +L H NLVNL+
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK--KIALREIRMLKQLKHPNLVNLL 68

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
                K +  LV+ +    ++   L D     +  +L   I     + + + H       
Sbjct: 69  EVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCHKHNC--- 123

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSRE 262
           IHRD+K  NIL+ +    ++ DFG +R 
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARL 151

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 52/234 (22%), Positives = 94/234 (40%), Gaps = 52/234 (22%)

Query: 105 SYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLG 163
            ++  +          GQG FG V   +   TG +VA+K +  D +   +E Q  +  L 
Sbjct: 24  RFQVERM--------AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLA 74

Query: 164 RLHHRNLVNL--VGYCAEKGQHMLVYV-----FMSKGSLASHL--YDENYGPLTWNLRVH 214
            LHH N+V L    Y   +     +Y+     ++   +L      Y            + 
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP---PIL 130

Query: 215 IAL---DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDKHAA 270
           I +    + R +  LH  +V  V HRDIK  N+L++++    ++ DFG ++   +     
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAK--KLSPSEP 187

Query: 271 NIRGTFGYLDPEYISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
           N+          YI +R            ++T   D++S G +  E++ G  P+
Sbjct: 188 NV---------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 92.3 bits (230), Expect = 5e-21
 Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 17/204 (8%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLA----TDSKQGEKEFQTEVMLLGRLHHRNLVNL 173
            +G+G+FG V  A    T + VA+K ++      S    +  + E+  L  L H +++ L
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHIIKL 74

Query: 174 VGYCAEKGQHMLVYVFM--SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
                       + + +  + G L  ++       +T +        +   +EY H   +
Sbjct: 75  YDVITTPTD---IVMVIEYAGGELFDYIV--EKKRMTEDEGRRFFQQIICAIEYCHRHKI 129

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT- 290
              +HRD+K  N+LLD ++  ++ADFGLS             G+  Y  PE I+ + +  
Sbjct: 130 ---VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAG 186

Query: 291 KKSDVYSFGVLLFELIAGRSPLQG 314
            + DV+S G++L+ ++ GR P   
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFDD 210

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 93.7 bits (233), Expect = 6e-21
 Identities = 85/340 (25%), Positives = 131/340 (38%), Gaps = 60/340 (17%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
            +G G FG V   +   TG  VAVK+L      S     + + E+  L    H +++ L 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR--------GLEYL 226
              +      +V  ++S G L  ++     G L            +R        G++Y 
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYI--CKNGRLD--------EKESRRLFQQILSGVDYC 132

Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
           H   V   +HRD+K  N+LLD  M A++ADFGLS      +      G+  Y  PE IS 
Sbjct: 133 HRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG 189

Query: 287 RNFT-KKSDVYSFGVLLFELIAGRSP-----LQGLMEYVELAAMNTEGKTGWEEIVDSRL 340
           R +   + D++S GV+L+ L+ G  P     +  L + +                     
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--------------------C 229

Query: 341 DGIFDV-EELN-EVASLAYKCVNRAPRKRPSMRDIVQ------VLSRILKMRHNRKHHRK 392
           DGIF   + LN  V SL    +   P KR +++DI +       L + L           
Sbjct: 230 DGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTM 289

Query: 393 SQSTTADEVSIDMEQAEAKTPTSTHLREESVDSTADTYEL 432
                  EV    E +E +  +  + R    D  A  Y L
Sbjct: 290 IDDEALKEVCEKFECSEEEVLSCLYNRNHQ-DPLAVAYHL 328

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 46/224 (20%)

Query: 115 NFTTLIGQGAFGPVYKAQMS----TGETVAVKVL----------ATDSKQGEKEFQTEVM 160
               ++G GA+G V+  +      TG+  A+KVL           T+  + E++     +
Sbjct: 57  ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ-----V 111

Query: 161 LLGRLHHRNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDV 219
           L        LV L  Y  +    + L+  +++ G L +HL                    
Sbjct: 112 LEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQR----------ERFTEHE 160

Query: 220 AR--------GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--KHA 269
            +         LE+LH   +   I+RDIK  NILLD +    + DFGLS+E + D  + A
Sbjct: 161 VQIYVGEIVLALEHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 217

Query: 270 ANIRGTFGYLDPEYISTRN--FTKKSDVYSFGVLLFELIAGRSP 311
            +  GT  Y+ P+ +   +    K  D +S GVL++EL+ G SP
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 18/156 (11%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDS-KQGEKEF-QT---EVMLLGRLH---HRNL 170
           IG GA+G VYKA+   +G  VA+K +   +   G      +   EV LL RL    H N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 171 VNLV-----GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEY 225
           V L+          + +  LV+  + +  L ++L       L       +     RGL++
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135

Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261
           LH   +   +HRD+K  NIL+      ++ADFGL+R
Sbjct: 136 LHANCI---VHRDLKPENILVTSGGTVKLADFGLAR 168

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 63/275 (22%), Positives = 114/275 (41%), Gaps = 64/275 (23%)

Query: 65  DSTVGPESPVKSGRNGNGKSMWLEGFKRSNVVSASGIP-EYSYKDLQKATCNFTTLIGQG 123
             +  P + VK     +      +  K       +G   E +Y + +         IG G
Sbjct: 4   TMSNAPLNGVKLNPLDDPN----KVIKVLASDGKTGEQREIAYTNCKV--------IGNG 51

Query: 124 AFGPVYKAQMSTGETVAVK-VLATDSKQGEKEFQT-EVMLLGRLHHRNLVNLVGYCAEKG 181
           +FG V++A++   + VA+K VL       +K F+  E+ ++  + H N+V+L  +    G
Sbjct: 52  SFGVVFQAKLVESDEVAIKKVLQ------DKRFKNRELQIMRIVKHPNVVDLKAFFYSNG 105

Query: 182 QHM------LVYVFMSKGSLASHL--YDENYGPLTWNLRVHIAL---DVARGLEYLHDGA 230
                    LV  ++ + ++      Y +    +     + I L    + R L Y+H   
Sbjct: 106 DKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP---MLLIKLYMYQLLRSLAYIHSIG 161

Query: 231 VPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR-- 287
           +    HRDIK  N+LLD  S   ++ DFG ++  ++     N+          YI +R  
Sbjct: 162 I---CHRDIKPQNLLLDPPSGVLKLIDFGSAK--ILIAGEPNV---------SYICSRYY 207

Query: 288 ----------NFTKKSDVYSFGVLLFELIAGRSPL 312
                     N+T   D++S G ++ EL+ G+ PL
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQ-PL 241

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 58/268 (21%), Positives = 105/268 (39%), Gaps = 50/268 (18%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT---------EVMLLGRLHHRN 169
           IG GA G V  A        VA+K L+       + FQ          E++L+  ++H+N
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNHKN 85

Query: 170 LVNLV-----GYCAEKGQHM-LVYVFMS---KGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++ L+         E+ Q + +V   M       +   L  E    L + +         
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM--------L 137

Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLD 280
            G+++LH   +   IHRD+K SNI++      ++ DFGL+R             T  Y  
Sbjct: 138 CGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194

Query: 281 PEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL 340
           PE I    + +  D++S G ++ E+I G     G  ++++           W ++++   
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHIDQ----------WNKVIE--Q 241

Query: 341 DGIFDVEELNEVASLAYKCVNRAPRKRP 368
            G    E + ++       V   P+   
Sbjct: 242 LGTPCPEFMKKLQPTVRTYVENRPKYAG 269

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 90.6 bits (225), Expect = 4e-20
 Identities = 54/247 (21%), Positives = 92/247 (37%), Gaps = 35/247 (14%)

Query: 120 IGQGAFGPVYKAQ---MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           +G+G +G VYKA+       +  A+K +             E+ LL  L H N+++L   
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86

Query: 177 CAEKGQH--MLVYVFMS---KGSLASHLYDENYG---PLTWNLRVHIALDVARGLEYLHD 228
                     L++ +        +  H   +       L   +   +   +  G+ YLH 
Sbjct: 87  FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146

Query: 229 GAVPPVIHRDIKSSNILLDQSMRAR----VADFGLSRE--EMVDK--HAANIRGTFGYLD 280
             V   +HRD+K +NIL+      R    +AD G +R     +        +  TF Y  
Sbjct: 147 NWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 203

Query: 281 PEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
           PE +   R++TK  D+++ G +  EL+                    E           +
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC----------RQEDIKTSNPYHHDQ 253

Query: 340 LDGIFDV 346
           LD IF+V
Sbjct: 254 LDRIFNV 260

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 90.7 bits (225), Expect = 6e-20
 Identities = 54/260 (20%), Positives = 107/260 (41%), Gaps = 34/260 (13%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT---------EVMLLGRLHHRN 169
           IG GA G V  A        VA+K L+       + FQ          E++L+  ++H+N
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNHKN 122

Query: 170 LVNLVG-YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+  +  +K       V++    + ++L       L      ++   +  G+++LH 
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 182

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
             +   IHRD+K SNI++      ++ DFGL+R             T  Y  PE I    
Sbjct: 183 AGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 239

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
           + +  D++S G ++ E++  +    G  +Y++           W ++++    G    E 
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQ----------WNKVIE--QLGTPCPEF 286

Query: 349 LNEVASLAYKCVNRAPRKRP 368
           + ++       V   P+   
Sbjct: 287 MKKLQPTVRNYVENRPKYAG 306

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 43/261 (16%), Positives = 82/261 (31%), Gaps = 80/261 (30%)

Query: 105 SYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLG 163
            Y   +         +G G+FG V +     +G+  A+K +  D +   +E      ++ 
Sbjct: 8   KYSLGKT--------LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMK 55

Query: 164 RLHHRNLVNL--VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDV-- 219
            L H N++ L    Y     +            L       N    +  +       +  
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115

Query: 220 -----------------------------------ARGLEYLHDGAVPPVIHRDIKSSNI 244
                                               R + ++H   +    HRDIK  N+
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI---CHRDIKPQNL 172

Query: 245 LLD-QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR------------NFTK 291
           L++ +    ++ DFG ++   +     ++          YI +R             +T 
Sbjct: 173 LVNSKDNTLKLCDFGSAK--KLIPSEPSV---------AYICSRFYRAPELMLGATEYTP 221

Query: 292 KSDVYSFGVLLFELIAGRSPL 312
             D++S G +  ELI G+ PL
Sbjct: 222 SIDLWSIGCVFGELILGK-PL 241

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 53/234 (22%), Positives = 96/234 (41%), Gaps = 49/234 (20%)

Query: 106 YKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGR 164
           Y DL+         +G G  G V+ A      + VA+K +     Q  K    E+ ++ R
Sbjct: 13  YMDLKP--------LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRR 64

Query: 165 LHHRNLVNLVG-YCAEKGQHMLVYVFMSKGS---LASHLYDEN------YGPLTWNLRVH 214
           L H N+V +         Q       +++ +   +     + +       GPL      H
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLL---EEH 121

Query: 215 IAL---DVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVDKHAA 270
             L    + RGL+Y+H   V   +HRD+K +N+ ++ + +  ++ DFGL+R         
Sbjct: 122 ARLFMYQLLRGLKYIHSANV---LHRDLKPANLFINTEDLVLKIGDFGLAR------IMD 172

Query: 271 NIRGTFGYLDPEYISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
                 G+L  E + T+            N+TK  D+++ G +  E++ G+  L
Sbjct: 173 PHYSHKGHL-SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TL 224

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 22/157 (14%)

Query: 120 IGQGAFGPVYKAQ--MSTGETVAVKVLATDSKQGEKE---FQT--EVMLLGRLH---HRN 169
           IG+GA+G V+KA+   + G  VA+K +   +    +E     T  EV +L  L    H N
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRHLETFEHPN 75

Query: 170 LVNL-----VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLE 224
           +V L     V     + +  LV+  + +  L ++L       +       +   + RGL+
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 134

Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR 261
           +LH   V   +HRD+K  NIL+  S + ++ADFGL+R
Sbjct: 135 FLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLAR 168

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 47/212 (22%), Positives = 90/212 (42%), Gaps = 23/212 (10%)

Query: 106 YKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGR 164
           Y+ ++K        +G+G +  V++A  ++  E V VK+L    K   K+ + E+ +L  
Sbjct: 38  YQLVRK--------LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILEN 86

Query: 165 L-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
           L    N++ L     +        VF    +         Y  LT         ++ + L
Sbjct: 87  LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKAL 143

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRA-RVADFGLSREEMVDKHAANIR-GTFGYLDP 281
           +Y H   +   +HRD+K  N+++D   R  R+ D+GL+          N+R  +  +  P
Sbjct: 144 DYCHSMGI---MHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGP 199

Query: 282 EYI-STRNFTKKSDVYSFGVLLFELIAGRSPL 312
           E +   + +    D++S G +L  +I  + P 
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 50/222 (22%), Positives = 90/222 (40%), Gaps = 47/222 (21%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL-----ATDSKQGEKEFQT--EVMLLGRLHHRNLV 171
           +G+GA+G V  A    TGE VA+K +        + +      T  E+ +L    H N++
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR------TLREIKILKHFKHENII 72

Query: 172 NLVG-YCAEKGQHM----LVYVFM----SKGSLASHLYDENYGPLTWNLRVHIALDVARG 222
            +      +  ++     ++   M     +      L D++     +           R 
Sbjct: 73  TIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT--------LRA 124

Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE 282
           ++ LH   V   IHRD+K SN+L++ +   +V DFGL+R         +          E
Sbjct: 125 VKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 283 YISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
           +++TR             +++  DV+S G +L EL   R P+
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PI 222

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 63/224 (28%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT---------EVMLLGRLHHRN 169
           +G GA+G V  A    +GE VA+K L+       + FQ+         E++LL  + H N
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELLLLKHMQHEN 84

Query: 170 LVNL--VGYCAEKGQHM----LVYVFMSK---GSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++ L  V   A   ++     LV  FM       +     +E    L + +         
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM--------L 136

Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLD 280
           +GL+Y+H   V   +HRD+K  N+ +++    ++ DFGL+R    +              
Sbjct: 137 KGLKYIHSAGV---VHRDLKPGNLAVNEDCELKILDFGLARHADAEM------------- 180

Query: 281 PEYISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
             Y+ TR            ++ +  D++S G ++ E++ G+  L
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-TL 223

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 85.2 bits (211), Expect = 4e-18
 Identities = 65/314 (20%), Positives = 116/314 (36%), Gaps = 88/314 (28%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLA------TDSKQGEKEFQT--EVMLLGRLHHRNL 170
           IG+G++G VY A   +T + VA+K +        D K+         E+ +L RL    +
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR------ILREITILNRLKSDYI 87

Query: 171 VNLVG-YCAEKGQHM----LVYVFM---------SKGSLASHLYDENYGPLTWNLRVHIA 216
           + L      +         +V             +       L +E+   + +NL     
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP----IFLTEEHIKTILYNL----- 138

Query: 217 LDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF 276
           L    G  ++H+  +   IHRD+K +N LL+Q    +V DFGL+R    +K    +    
Sbjct: 139 L---LGENFIHESGI---IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192

Query: 277 GYLDP------------EYISTR------------NFTKKSDVYSFGVLLFELIAG---- 308
              +P             ++ TR            N+TK  D++S G +  EL+      
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252

Query: 309 ------RSPL-QGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV------EELNEVAS- 354
                 R PL  G   +      N++           +L+ IF++      ++L  +   
Sbjct: 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNR--DQLNIIFNIIGTPTEDDLKNINKP 310

Query: 355 LAYKCVNRAPRKRP 368
              K +   P ++P
Sbjct: 311 EVIKYIKLFPHRKP 324

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 58/304 (19%), Positives = 114/304 (37%), Gaps = 50/304 (16%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH----------- 166
            +G G F  V+ A+ M     VA+K++    K   +  + E+ LL R++           
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 167 HRNLVNLVG---YCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARG 222
             +++ L+    +    G H+ +V+  + + +L + +    +  +       I+  +  G
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLG 143

Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRA------RVADFGLSREEMVDKHAANIRGTF 276
           L+Y+H      +IH DIK  N+L++           ++AD G +     D+H  N   T 
Sbjct: 144 LDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC--WYDEHYTNSIQTR 199

Query: 277 GYLDPEYISTRNFTKKSDVYSFGVLLFELIAG------RSPLQGLMEYVELAAMNTEGKT 330
            Y  PE +    +   +D++S   L+FELI G              +   +A +      
Sbjct: 200 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI------ 253

Query: 331 GWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL--KMRHNRK 388
              E++     G      L           N     R   +     L  +L  K + ++ 
Sbjct: 254 --IELL-----GELP-SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305

Query: 389 HHRK 392
             ++
Sbjct: 306 EAKE 309

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 60/313 (19%), Positives = 113/313 (36%), Gaps = 78/313 (24%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT---------EVMLLGRLHHRN 169
           IG G++G V +A        VA+K +        + F+          E+ +L RL+H +
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHDH 113

Query: 170 LVNLVG-YCAEKGQHM----LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLE 224
           +V ++     +  +      +V                    LT      +  ++  G++
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPV--YLTELHIKTLLYNLLVGVK 170

Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP--- 281
           Y+H   +   +HRD+K +N L++Q    +V DFGL+R     ++  +        D    
Sbjct: 171 YVHSAGI---LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227

Query: 282 --------------EYISTR------------NFTKKSDVYSFGVLLFELI--------- 306
                          ++ TR            N+T+  DV+S G +  EL+         
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287

Query: 307 -AGRSPL-QGLMEYVELAAMNTEGKTGWEEIVDSR--LDGIFDV------EELNEVAS-L 355
            A R PL  G      L+     G         +R  L+ IF++      E++  +    
Sbjct: 288 HADRGPLFPG-SSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED 346

Query: 356 AYKCVNRAPRKRP 368
           A + +   P++  
Sbjct: 347 AKRYIRIFPKREG 359

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 84.4 bits (209), Expect = 6e-18
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 22/218 (10%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVMLLGRLHHR------ 168
           +IG+G+FG V KA      + VA+K++       +Q       E+ +L  L  +      
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTM 159

Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           N+++++     +    + +  +S  +L   +    +   +  L    A  + + L+ LH 
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218

Query: 229 GAVPPVIHRDIKSSNILLDQSMRA--RVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
                +IH D+K  NILL Q  R+  +V DFG S  E   +    I+  F Y  PE I  
Sbjct: 219 ---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-QRVYTYIQSRF-YRAPEVILG 273

Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM 324
             +    D++S G +L EL+ G   L G  E  +LA M
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM 311

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 54/222 (24%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL-----ATDSKQGEKEFQT--EVMLLGRLHHRNLV 171
           IG+GA+G V  A        VA+K +      T  ++      T  E+ +L R  H N++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR------TLREIKILLRFRHENII 88

Query: 172 NLVG-YCAEKGQHM----LVYVFM----SKGSLASHLYDENYGPLTWNLRVHIALDVARG 222
            +     A   + M    +V   M     K     HL +++     + +         RG
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI--------LRG 140

Query: 223 LEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE 282
           L+Y+H   V   +HRD+K SN+LL+ +   ++ DFGL+R       A       G+L  E
Sbjct: 141 LKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLAR------VADPDHDHTGFL-TE 190

Query: 283 YISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
           Y++TR             +TK  D++S G +L E+++ R P+
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI 231

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 66/232 (28%), Positives = 110/232 (47%), Gaps = 57/232 (24%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLA------TDSKQGEKEFQT--EVMLLGRLH-HRN 169
           +G+GA+G V+K+    TGE VAVK +       TD+++      T  E+M+L  L  H N
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQR------TFREIMILTELSGHEN 70

Query: 170 LVNLVG-YCAEKGQHM-LVYVFM----SKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
           +VNL+    A+  + + LV+ +M         A+ L   +   + + L         + +
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQL--------IKVI 122

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP-- 281
           +YLH G +   +HRD+K SNILL+     +VADFGLSR  +  +   N        +   
Sbjct: 123 KYLHSGGL---LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179

Query: 282 ---------EYISTR------------NFTKKSDVYSFGVLLFELIAGRSPL 312
                    +Y++TR             +TK  D++S G +L E++ G+ P+
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PI 230

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 52/270 (19%), Positives = 93/270 (34%), Gaps = 53/270 (19%)

Query: 120 IGQGAFGPVYKA-QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVG-Y 176
           +G G  G V +     T E  A+K+L         + + EV L  R     ++V +V  Y
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKML---QDC--PKARREVELHWRASQCPHIVRIVDVY 80

Query: 177 CAEKGQHMLVYVFM---SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVP 232
                    + + M     G L S + D      T      I   +   ++YLH      
Sbjct: 81  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--- 137

Query: 233 PVIHRDIKSSNILL---DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNF 289
            + HRD+K  N+L      +   ++ DFG ++E                      +   +
Sbjct: 138 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---------------------TTGEKY 175

Query: 290 TKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL 349
            K  D++S GV+++ L+ G  P            M          I   + +  F   E 
Sbjct: 176 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------KTRIRMGQYE--FPNPEW 226

Query: 350 NEVASLA----YKCVNRAPRKRPSMRDIVQ 375
           +EV+          +   P +R ++ + + 
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 63/252 (25%), Positives = 100/252 (39%), Gaps = 64/252 (25%)

Query: 89  GFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD 147
           GF R  V   +      Y+DLQ         +G GA+G V  A    TG  VA+K L   
Sbjct: 10  GFYRQEVTKTAWEVRAVYRDLQP--------VGSGAYGAVCSAVDGRTGAKVAIKKLY-- 59

Query: 148 SKQGEKEFQT---------EVMLLGRLHHRNLVNL--VGYCAEKGQHM----LVYVFMSK 192
                + FQ+         E+ LL  + H N++ L  V    E         LV  FM  
Sbjct: 60  -----RPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT 114

Query: 193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA 252
             L   +  E    L  +    +   + +GL Y+H   +   IHRD+K  N+ +++    
Sbjct: 115 -DLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCEL 167

Query: 253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR------------NFTKKSDVYSFGV 300
           ++ DFGL+R+   +                Y+ TR             +T+  D++S G 
Sbjct: 168 KILDFGLARQADSEM-------------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC 214

Query: 301 LLFELIAGRSPL 312
           ++ E+I G+  L
Sbjct: 215 IMAEMITGK-TL 225

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 81.3 bits (201), Expect = 6e-17
 Identities = 67/299 (22%), Positives = 115/299 (38%), Gaps = 21/299 (7%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVMLLGRLHHR------ 168
           LIG+G+FG V KA      E VA+K++        Q     Q EV LL  ++        
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKY 116

Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
            +V+L  +   +    LV+  +S  +L   L + N+  ++ NL    A  +   L +L  
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175

Query: 229 GAVPPVIHRDIKSSNILLDQSMRA--RVADFGLSREEMVDKHAANIRGTFGYLDPEYIST 286
             +  +IH D+K  NILL    R+  ++ DFG S +    +    I+  F Y  PE +  
Sbjct: 176 PELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG-QRIYQYIQSRF-YRSPEVLLG 232

Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM-NTEGKTGWEEIVDSRLDGIFD 345
             +    D++S G +L E+  G     G  E  ++  +    G      +  +     F 
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFF 292

Query: 346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSID 404
            +  +   +L      +   K P  R +  +L         R+      +        D
Sbjct: 293 EKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD 351

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 48/217 (22%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT---------EVMLLGRLHHRN 169
           +G GA+G V  A    TG  VAVK L+       + FQ+         E+ LL  + H N
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHEN 89

Query: 170 LVNL--VGYCAEKGQHM----LVYVFM----SKGSLASHLYDENYGPLTWNLRVHIALDV 219
           ++ L  V   A   +      LV   M    +       L D++   L + +        
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI-------- 141

Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTF 276
            RGL+Y+H   +   IHRD+K SN+ +++    ++ DFGL+R   +EM    A     T 
Sbjct: 142 LRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA-----TR 193

Query: 277 GYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPL 312
            Y  PE + +  ++ +  D++S G ++ EL+ GR  L
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-TL 229

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 62/353 (17%), Positives = 106/353 (30%), Gaps = 103/353 (29%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLL-----------GRLHH 167
           +G G F  V+ +  +   + VA+KV+ +     E     E+ LL            R   
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103

Query: 168 RNLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYL 226
             L++        G H+ +V+  +    L   +   NY  L       I   V +GL+YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL 162

Query: 227 HDGAVPPVIHRDIKSSNILL---------------------------------------- 246
           H      +IH DIK  NILL                                        
Sbjct: 163 HTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220

Query: 247 ---------DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYS 297
                     + ++ ++AD G +    V KH      T  Y   E +    +   +D++S
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWS 278

Query: 298 FGVLLFELIAGR---SPLQGLMEYVE---LAAM----------------------NTEGK 329
              + FEL  G     P  G     +   +A +                        +G 
Sbjct: 279 TACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338

Query: 330 -TGWEEIVDSRLDGI------FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                ++    L  +      +  EE           +   P KR +  + ++
Sbjct: 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 50/232 (21%), Positives = 85/232 (36%), Gaps = 44/232 (18%)

Query: 119 LIGQGAFGPVYKAQMSTGE------TVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
            IGQG FG +Y A M++ E         VKV  +D+     E +           +  + 
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 173 LVG----------YCAEKGQHMLVYVFM---SKG-SLASHLYDENYGPLTWNLRVHIALD 218
                              ++   Y FM     G  L   +Y+ N    +    + ++L 
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDL-QKIYEANAKRFSRKTVLQLSLR 160

Query: 219 VARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV--ADFGLS---REEMVDKH----- 268
           +   LEY+H+      +H DIK+SN+LL+     +V   D+GL+     E V K      
Sbjct: 161 ILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217

Query: 269 AANIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
                GT      E+ S         +++ D+   G  + + + G  P +  
Sbjct: 218 KRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 68.0 bits (165), Expect = 1e-12
 Identities = 36/265 (13%), Positives = 73/265 (27%), Gaps = 73/265 (27%)

Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK--------QGE 152
           +P    +  +K        IG+G FG V++   +    VA+K++A +          +  
Sbjct: 17  LPTEKLQRCEK--------IGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTF 67

Query: 153 KEFQTEVMLLGRLH---------HRNLVNLVGYCAEKG---------------------- 181
           +E   E+++   L              + L      +G                      
Sbjct: 68  EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127

Query: 182 --------QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                   Q  +V  F   G     L        +      I   +   L          
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLR 182

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKS 293
             HRD+   N+LL ++   ++      +   +         + G      +S  ++T   
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI--------PSCGL----QVSIIDYTLSR 230

Query: 294 DVYSFGVLLFELIAGRSPLQGLMEY 318
                 V+  ++        G  +Y
Sbjct: 231 LERDGIVVFCDVSMDEDLFTGDGDY 255

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 52/242 (21%), Positives = 81/242 (33%), Gaps = 48/242 (19%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK---QGEKEFQTEVMLLGRL-----HHRN 169
            +G G FG V   Q +   +  AVKV+    K         + E  +L ++     ++ N
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97

Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD----ENYGPLTWNLRVHIALDVARGLEY 225
           +V   G       HM     +    L   LY+     NY            +++ + L Y
Sbjct: 98  IVKYHGKFMYYD-HM----CLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152

Query: 226 LHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGT------FG-- 277
           L       + H D+K  NILLD     +         +         + T      FG  
Sbjct: 153 LRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209

Query: 278 -YLD---PEYISTR-----------NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA 322
            +        I+TR            +   SD++SFG +L EL  G    +       LA
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLA 269

Query: 323 AM 324
            M
Sbjct: 270 MM 271

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 57/315 (18%), Positives = 111/315 (35%), Gaps = 71/315 (22%)

Query: 119 LIGQGAFGPVYKA--QMSTGETVAVKVL-ATDS--KQGEKEFQTEVMLLGRLHHR----- 168
            +G+G FG V +          VA+K++       +      + E+ +L ++  +     
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENK 81

Query: 169 -NLVNLVGYCAEKGQHM-LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYL 226
              V +  +    G HM + +  + K +    L + N+ P       H+A  +   L +L
Sbjct: 82  FLCVLMSDWFNFHG-HMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139

Query: 227 HDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGYLD-- 280
           H+     + H D+K  NIL   S    + +   S EE   K+ + IR    G+  +    
Sbjct: 140 HE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS-IRVADFGSATFDHEH 195

Query: 281 -PEYISTR-----------NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM---- 324
               ++TR            + +  DV+S G +LFE   G +  Q       L  M    
Sbjct: 196 HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKIL 255

Query: 325 ---------------------------NTEGKTGWEEIVDSRLDGIFDVEELNEVASLAY 357
                                      +++G+   E     +   + D  E  ++  L  
Sbjct: 256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR 315

Query: 358 KCVNRAPRKRPSMRD 372
           + +   P +R ++ +
Sbjct: 316 RMLEFDPAQRITLAE 330

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 65.1 bits (159), Expect = 5e-12
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 32/215 (14%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG G+FG +Y    ++ GE VA+K+    +K  Q   E +   M+ G +    +  +   
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVG---IPTIRWC 73

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
            AE   +++V   +   SL   L++      +    + +A  +   +EY+H       IH
Sbjct: 74  GAEGDYNVMVMELLGP-SL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF---IH 128

Query: 237 RDIKSSNILLDQSMRA---RVADFGLS---REEMVDKH-----AANIRGTFGYLDPEYIS 285
           RD+K  N L+    +     + DFGL+   R+    +H       N+ GT       Y S
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT-----ARYAS 183

Query: 286 TRNF-----TKKSDVYSFGVLLFELIAGRSPLQGL 315
                    +++ D+ S G +L     G  P QGL
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 46/217 (21%), Positives = 85/217 (39%), Gaps = 34/217 (15%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG G FG +   + + T E VA+K+    S+  Q   E++    L        +  +  +
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IPQVYYF 73

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                 + +V   +   SL   L+D      +    + IA+ +   +EY+H   +   I+
Sbjct: 74  GPCGKYNAMVLELLGP-SL-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL---IY 128

Query: 237 RDIKSSNILLDQSMRAR-----VADFGLS---REEMVDKH-----AANIRGTFGYLDPEY 283
           RD+K  N L+ +          + DF L+    +    KH       ++ GT       Y
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT-----ARY 183

Query: 284 ISTRN-----FTKKSDVYSFGVLLFELIAGRSPLQGL 315
           +S         +++ D+ + G +    + G  P QGL
Sbjct: 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 49/232 (21%), Positives = 84/232 (36%), Gaps = 43/232 (18%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVA---VKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
            IG G FG +Y A   +  E  A   VKV   ++     E +    +  +   +  +   
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 175 -------------GYCAEKGQHMLVYVFMSKG-SLASHLYDENYGPLTWNLRVHIALDVA 220
                        G    KG+     V    G  L   +  +N G    +  + + + + 
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDL-QKISGQN-GTFKKSTVLQLGIRML 161

Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV--ADFGLS---REEMVDKH-----AA 270
             LEY+H+      +H DIK++N+LL      +V  AD+GLS         K        
Sbjct: 162 DVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRK 218

Query: 271 NIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLME 317
              GT      E+ S         +++SDV   G  +   + G+ P +  ++
Sbjct: 219 GHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 53/243 (21%), Positives = 89/243 (36%), Gaps = 54/243 (22%)

Query: 119 LIGQGAFGPVYKAQ--MSTGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHR---NL 170
            +G+GAFG V +     + G  VAVK++    +         ++E+ +L  L+     + 
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76

Query: 171 VNLVGYCAEKGQHMLVYVFMSKG-------SLASHLYD----ENYGPLTWNLRVHIALDV 219
              V         ML + F   G        L    YD      + P   +    +A  +
Sbjct: 77  FRCV--------QMLEW-FEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQI 127

Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GT 275
            + + +LH   +    H D+K  NIL  QS      +  + R+E    +   I+    G+
Sbjct: 128 CKSVNFLHSNKL---THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD-IKVVDFGS 183

Query: 276 FGYLD---PEYISTR-----------NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
             Y D      +STR            +++  DV+S G +L E   G +          L
Sbjct: 184 ATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243

Query: 322 AAM 324
           A M
Sbjct: 244 AMM 246

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 32/215 (14%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG G+FG +Y    + T E VA+K+    +K  Q   E +   +L G      + N+  +
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTG---IPNVRWF 71

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
             E   ++LV   +   SL   L++     L+    + +A  +   +E++H  +    +H
Sbjct: 72  GVEGDYNVLVMDLLGP-SL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF---LH 126

Query: 237 RDIKSSNILLDQSMRAR---VADFGLS---REEMVDKH-----AANIRGTFGYLDPEYIS 285
           RDIK  N L+    RA    + DFGL+   R+    +H       N+ GT       Y S
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT-----ARYAS 181

Query: 286 TRN-----FTKKSDVYSFGVLLFELIAGRSPLQGL 315
                    +++ D+ S G +L   + G  P QGL
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 38/231 (16%), Positives = 82/231 (35%), Gaps = 44/231 (19%)

Query: 120 IGQGAFGPVYKAQ---------MSTGETVAVKVLATDSK----------QGEKEFQTEVM 160
             +   G +Y+A              +  ++K+ A D +            +     +  
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 161 LLGRLHHRNLVNLVGYCAEKGQH-MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDV 219
            L       +   +G+   + ++  LV   + + SL S L       L+    + +A  +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACRL 168

Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV--ADFGLSRE--------EMVDKHA 269
              LE+LH+      +H ++ + NI +D   +++V  A +G +            V+   
Sbjct: 169 LDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSR 225

Query: 270 ANIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
           +   G       E+IS         +++SD+ S G  + + + G  P    
Sbjct: 226 SPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 48/217 (22%), Positives = 90/217 (41%), Gaps = 34/217 (15%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG+G+FG +++   +   + VA+K     S   Q   E++T  +L G      + N+  +
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG---IPNVYYF 74

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
             E   ++LV   +   SL   L D      +       A  +   ++ +H+ ++   ++
Sbjct: 75  GQEGLHNVLVIDLLGP-SL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL---VY 129

Query: 237 RDIKSSNILLDQSMRAR-----VADFGLS---REEMVDKH-----AANIRGTFGYLDPEY 283
           RDIK  N L+ +          V DFG+    R+ +  +H       N+ GT       Y
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT-----ARY 184

Query: 284 ISTRN-----FTKKSDVYSFGVLLFELIAGRSPLQGL 315
           +S         +++ D+ + G +    + G  P QGL
Sbjct: 185 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	432
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.45
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.22
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.12
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.77
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.77
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.67
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.57
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.56
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.55
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.24
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.22
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.22
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.12
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.88
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.61
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.6
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.57
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.54
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.52
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.42
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.39
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.37
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.26
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.18
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	97.09
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	97.01
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	96.96
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.9
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	96.84
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.29
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.1
2l34_A	33	TYRO protein tyrosine kinase-binding protein; immu	94.0
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.61
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.37
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	90.65
1iij_A	35	ERBB-2 receptor protein-tyrosine kinase; alpha-hel	90.24
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	90.2
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	88.42
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	88.38
2klu_A	70	T-cell surface glycoprotein CD4; cell membrane, di	86.54
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	86.23
1afo_A	40	Glycophorin A; integral membrane protein, transmem	83.3
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	83.18
1cja_A	342	Protein (actin-fragmin kinase); transferase; HET:	82.77

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9.4e-61  Score=452.28  Aligned_cols=259  Identities=27%  Similarity=0.450  Sum_probs=214.7

Q ss_pred             HHHHHHhccccccccccCceeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeee
Q 014038          107 KDLQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE  179 (432)
Q Consensus       107 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  179 (432)
                      .++..+++.|.+.||+|+||+||+|.+.      +++.||||++.... ....++|.+|+.++++++|||||+++|+|.+
T Consensus        21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  100 (308)
T 4gt4_A           21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK  100 (308)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence            3444456788999999999999999762      56789999997643 3445789999999999999999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCee
Q 014038          180 KGQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNIL  245 (432)
Q Consensus       180 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nil  245 (432)
                      .+..++|||||++|+|.++|....              ...++|..+++|+.|||.||+|||+++   |+||||||+|||
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NIL  177 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVL  177 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceE
Confidence            999999999999999999996432              246999999999999999999999999   999999999999


Q ss_pred             ecCCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHH
Q 014038          246 LDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVEL  321 (432)
Q Consensus       246 l~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~  321 (432)
                      |++++.+||+|||+++......   ......||+.|||||++.++.|+.++|||||||++|||+| |+.||.+.......
T Consensus       178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~  257 (308)
T 4gt4_A          178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV  257 (308)
T ss_dssp             ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred             ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999998643322   2345679999999999999999999999999999999999 89999876554333


Q ss_pred             HHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          322 AAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      .......            ..+.+..++.++.+||.+||+.||++||||.+|++.|+..
T Consensus       258 ~~i~~~~------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          258 EMIRNRQ------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHTTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHcCC------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            2222111            1122334456899999999999999999999999998754

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.6e-60  Score=451.68  Aligned_cols=256  Identities=30%  Similarity=0.489  Sum_probs=211.0

Q ss_pred             hccccccccccCceeEEEEEeC------CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      .+.+.+.||+|+||+||+|++.      +++.||||+++.......++|.+|+.+|++++|||||+++|+|.+.+..++|
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV  121 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV  121 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4567789999999999999764      4788999999877777778999999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEE
Q 014038          187 YVFMSKGSLASHLYDEN-------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR  253 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~-------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~k  253 (432)
                      ||||++|+|.++++...             ..+++|.+++.|+.||+.||+|||+++   |+||||||+||||++++.+|
T Consensus       122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~K  198 (329)
T 4aoj_A          122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVK  198 (329)
T ss_dssp             EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEE
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEE
Confidence            99999999999986432             356999999999999999999999998   99999999999999999999


Q ss_pred             EeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCC
Q 014038          254 VADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGK  329 (432)
Q Consensus       254 l~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  329 (432)
                      |+|||+++......   ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.........+.....
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~  278 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE  278 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC
T ss_pred             EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999998543322   2334679999999999999999999999999999999999 9999987655433332222111


Q ss_pred             CchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          330 TGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                                  ...+...+.++.+|+.+||+.||++||||.+|++.|+.+.+.
T Consensus       279 ------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          279 ------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             ------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence                        112233446899999999999999999999999999988653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.1e-60  Score=448.01  Aligned_cols=257  Identities=29%  Similarity=0.479  Sum_probs=215.4

Q ss_pred             HhccccccccccCceeEEEEEeC------CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      ..+.+.+.||+|+||+||+|++.      ++..||||+++.......++|.+|+.+|++++|||||+++|+|.+++..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            35667899999999999999753      477899999987777777899999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEE
Q 014038          186 VYVFMSKGSLASHLYDE-----------NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV  254 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~-----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl  254 (432)
                      |||||++|+|.++|+..           ....++|..++.|+.||+.||+|||+++   |+||||||+||||+.++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            99999999999999643           2357999999999999999999999998   999999999999999999999


Q ss_pred             eecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCC
Q 014038          255 ADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKT  330 (432)
Q Consensus       255 ~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  330 (432)
                      +|||+|+......   ......||+.|||||++.++.|+.++|||||||++|||+| |+.||.+............... 
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~-  248 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-  248 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC-
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-
Confidence            9999997543322   2234568999999999999999999999999999999999 9999987654433332222111 


Q ss_pred             chhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          331 GWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                                 ...+...+.++.+|+.+||+.||++||||.+|++.|+++.+.
T Consensus       249 -----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          249 -----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                       112233446899999999999999999999999999988653

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-59  Score=441.09  Aligned_cols=256  Identities=28%  Similarity=0.484  Sum_probs=204.8

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ..+.+.+.||+|+||+||+|++.  ..||||+++..  .....+.|.+|+.+|++++|||||+++|+|.+ +..++||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            34567889999999999999874  36999998754  34455789999999999999999999999865 568999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc---
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD---  266 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~---  266 (432)
                      |++|+|.++|+.. ..+++|..++.|+.||+.||+|||+++   |+||||||+||||++++.+||+|||+|+.....   
T Consensus       113 ~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          113 CEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             CCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            9999999999654 357999999999999999999999998   999999999999999999999999999754322   


Q ss_pred             ccccccccCCCCCCcccccc---CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCC
Q 014038          267 KHAANIRGTFGYLDPEYIST---RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                      ......+||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+......+......+.      ..+.+. .
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~------~~p~~~-~  261 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGY------ASPDLS-K  261 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTC------CCCCST-T
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC------CCCCcc-c
Confidence            23345689999999999864   4699999999999999999999999987544333322222111      011111 1


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL  381 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~  381 (432)
                      .+...+.++.+|+.+||+.||++||||.+|++.|+.+.
T Consensus       262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            22234468999999999999999999999999998763

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.9e-58  Score=439.79  Aligned_cols=248  Identities=24%  Similarity=0.360  Sum_probs=206.3

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      +|.+.+.||+|+||+||+|+. .+|+.||||++...  .....+.|.+|+.+|++++|||||++++++.+.+..|+||||
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy  104 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY  104 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            577889999999999999965 57999999999754  334456899999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-c
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-H  268 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~  268 (432)
                      |++|+|.+++.......+++..++.|+.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+...... .
T Consensus       105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  181 (350)
T 4b9d_A          105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL  181 (350)
T ss_dssp             CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred             CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence            99999999998776677899999999999999999999999   9999999999999999999999999998654332 2


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      ....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+......+..+......            ..+...
T Consensus       182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~------------~~~~~~  249 (350)
T 4b9d_A          182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP------------PVSLHY  249 (350)
T ss_dssp             HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC------------CCCTTS
T ss_pred             ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC------------CCCccC
Confidence            34568999999999999999999999999999999999999999876544333332221110            112223


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +.++.+|+.+||+.||++|||+.|+++
T Consensus       250 s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          250 SYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            457899999999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-57  Score=435.18  Aligned_cols=247  Identities=24%  Similarity=0.371  Sum_probs=209.9

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|+|||||+
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  154 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  154 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence            467778999999999999965 4799999999976655556678999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~  270 (432)
                      +|+|.+++..   +.+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+..... ....
T Consensus       155 gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          155 GGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             TEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             CCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence            9999999854   35999999999999999999999999   999999999999999999999999999865433 3455


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN  350 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (432)
                      ..+||+.|||||++.+..|+.++|||||||++|||++|+.||.+......+..+......        .+  ......+.
T Consensus       229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~--------~~--~~~~~~s~  298 (346)
T 4fih_A          229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP--------RL--KNLHKVSP  298 (346)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC--------CC--SCGGGSCH
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC--------CC--CccccCCH
Confidence            678999999999999999999999999999999999999999876554433332221110        00  11122345


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          351 EVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       351 ~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ++.+|+.+||+.||++|||+.|+++
T Consensus       299 ~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          299 SLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhc
Confidence            7899999999999999999999875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.8e-57  Score=423.92  Aligned_cols=246  Identities=26%  Similarity=0.457  Sum_probs=200.2

Q ss_pred             cccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeee----CCeEEEEE
Q 014038          115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE----KGQHMLVY  187 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  187 (432)
                      .+.+.||+|+||+||+|.. .++..||+|.+...  .....+.|.+|+.+|++++|||||+++++|.+    .+..++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            4567899999999999965 47889999998654  34445689999999999999999999999865    34679999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec-CCCcEEEeecCCccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVD  266 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~-~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||++|+|.+++..  .+.+++..+..++.||+.||+|||+++ ++|+||||||+||||+ .++.+||+|||+|+... .
T Consensus       109 Ey~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~-~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-A  184 (290)
T ss_dssp             ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-T
T ss_pred             eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC-C
Confidence            99999999999964  357999999999999999999999976 4599999999999997 47999999999997532 3


Q ss_pred             ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+..+...+......+..+      ...    +.
T Consensus       185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~------~~~----~~  253 (290)
T 3fpq_A          185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------ASF----DK  253 (290)
T ss_dssp             TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC------GGG----GG
T ss_pred             CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC------CCC----Cc
Confidence            34456789999999999875 69999999999999999999999997654433333322222111      001    11


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..++++.+|+.+||+.||++|||+.++++
T Consensus       254 ~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          254 VAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            12247899999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.1e-57  Score=431.95  Aligned_cols=259  Identities=21%  Similarity=0.252  Sum_probs=209.2

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .+.+.++||+|+||.||+|+. .+|+.||||+++....     +.+|+.++++++|||||++++++.+++..|+|||||+
T Consensus        59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  133 (336)
T 4g3f_A           59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE  133 (336)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            355667899999999999965 4789999999975422     2469999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC-cEEEeecCCcccccccc---
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVDK---  267 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~~---  267 (432)
                      +|+|.+++...  +++++..+..++.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+|+......   
T Consensus       134 gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          134 GGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             TCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            99999999643  57999999999999999999999999   99999999999999987 69999999998643221   


Q ss_pred             ---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCC
Q 014038          268 ---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       268 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                         .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.........+.. ....+.         ..
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-~~~~~~---------~~  278 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-EPPPIR---------EI  278 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH-SCCGGG---------GS
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc-CCCCch---------hc
Confidence               12345799999999999999999999999999999999999999976432111111111 111111         12


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcccccccc
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHR  391 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~~~~~~  391 (432)
                      +...+.++.+++.+||+.||.+|||+.|+++.|...+.....-.+++
T Consensus       279 ~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw  325 (336)
T 4g3f_A          279 PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW  325 (336)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCS
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCC
Confidence            22334678999999999999999999999999999887655444333

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.8e-58  Score=439.79  Aligned_cols=263  Identities=31%  Similarity=0.506  Sum_probs=214.6

Q ss_pred             HHHHHhccccccccccCceeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCC-CccceEEeeeee
Q 014038          108 DLQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHH-RNLVNLVGYCAE  179 (432)
Q Consensus       108 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~  179 (432)
                      |+....+.+.+.||+|+||+||+|.+.      .++.||||.+.... ....+.|.+|+.+|.+++| ||||+++|+|.+
T Consensus        60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            445567888899999999999999653      23589999997653 3445679999999999965 999999999976


Q ss_pred             C-CeEEEEEEeccCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCe
Q 014038          180 K-GQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNI  244 (432)
Q Consensus       180 ~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Ni  244 (432)
                      . +..++|||||++|+|.++|+...              ...++|..++.++.|||.||+|||+++   ||||||||+||
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NI  216 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI  216 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccce
Confidence            4 56899999999999999996432              345899999999999999999999999   99999999999


Q ss_pred             eecCCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHH
Q 014038          245 LLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVE  320 (432)
Q Consensus       245 ll~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~  320 (432)
                      ||++++.+||+|||+|+......   ......||+.|||||++.++.|+.++|||||||++|||+| |+.||.+......
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999998643322   2345678999999999999999999999999999999998 9999986432222


Q ss_pred             HHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          321 LAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      +......+           .+...+...+.++.++|.+||+.||++||||.+|++.|+.+++..
T Consensus       297 ~~~~i~~g-----------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          297 FCRRLKEG-----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             HHHHHHHT-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHcC-----------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            22111111           111222334468999999999999999999999999999998754

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.6e-56  Score=415.20  Aligned_cols=245  Identities=24%  Similarity=0.383  Sum_probs=192.3

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      +.|.+.+.||+|+||+||+|.. .+|+.||||++....   ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            4688889999999999999965 579999999997542   333567999999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+ +|+|.+++...  +++++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+......
T Consensus        93 Ey~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             ECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             eCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            999 68999998543  57999999999999999999999999   9999999999999999999999999998655555


Q ss_pred             cccccccCCCCCCccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          268 HAANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      .....+||+.|||||++.+..| +.++|||||||++|||+||+.||.+............ +...            ++.
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~-~~~~------------~p~  233 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN-GVYT------------LPK  233 (275)
T ss_dssp             --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCC------------CCT
T ss_pred             ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-CCCC------------CCC
Confidence            5566789999999999988876 5899999999999999999999987543322222211 1111            112


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.++.+|+.+||+.||++|||+.|+++
T Consensus       234 ~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          234 FLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            23457899999999999999999999886

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.9e-57  Score=425.98  Aligned_cols=245  Identities=24%  Similarity=0.386  Sum_probs=208.0

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||+||+|+. .+|+.||||++...   .....+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE  112 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS  112 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999964 57899999999653   22345678999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc--
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--  266 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~--  266 (432)
                      |+++|+|.+++..  .+.+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.....  
T Consensus       113 y~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          113 YAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             cCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            9999999999954  357999999999999999999999999   999999999999999999999999999864322  


Q ss_pred             -ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          267 -KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       267 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                       ....+.+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.........+.... .            .++
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~------------~~p  254 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE-Y------------DFP  254 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-C------------CCC
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-C------------CCC
Confidence             23456789999999999999999999999999999999999999998755433332222111 1            112


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...+.++.+|+.+||+.||++|||+.|++.
T Consensus       255 ~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          255 EKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             TTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             cccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence            223457899999999999999999998753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.1e-56  Score=436.53  Aligned_cols=247  Identities=24%  Similarity=0.374  Sum_probs=210.2

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .|.+.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.+|++++|||||+++++|.+.+..|+|||||+
T Consensus       152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~  231 (423)
T 4fie_A          152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  231 (423)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence            367778999999999999965 4799999999987665666778999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~  270 (432)
                      +|+|.+++..   +.+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+..... ....
T Consensus       232 gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          232 GGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             TEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred             CCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence            9999999854   35999999999999999999999999   999999999999999999999999999865433 3455


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN  350 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (432)
                      ..+||+.|||||++.+..|+.++|||||||++|||++|+.||.+......+..+......        .+.  .....+.
T Consensus       306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~--------~~~--~~~~~s~  375 (423)
T 4fie_A          306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP--------RLK--NLHKVSP  375 (423)
T ss_dssp             CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--------CCS--CTTSSCH
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC--------CCc--ccccCCH
Confidence            678999999999999999999999999999999999999999876554433333221110        111  1112335


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          351 EVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       351 ~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ++.+|+.+||+.||++|||+.|+++
T Consensus       376 ~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          376 SLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhc
Confidence            7899999999999999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1e-56  Score=425.30  Aligned_cols=266  Identities=25%  Similarity=0.334  Sum_probs=199.1

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC----eEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG----QHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e  188 (432)
                      ++.+.+.||+|+||+||+|++ +|+.||||++..... ....+..|+..+.+++|||||+++|+|.+++    ..++|||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            456778999999999999988 689999999965322 1223345666777899999999999998754    5799999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA-----VPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ||++|+|.++++..   +++|..+.+++.|++.||+|||++.     .++|+||||||+||||+.++++||+|||+++..
T Consensus        82 y~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           82 YHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             CCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            99999999999643   5999999999999999999999871     234999999999999999999999999999754


Q ss_pred             cccc-----cccccccCCCCCCccccccC------CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCch
Q 014038          264 MVDK-----HAANIRGTFGYLDPEYISTR------NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW  332 (432)
Q Consensus       264 ~~~~-----~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  332 (432)
                      ....     .....+||+.|||||++.+.      .|+.++|||||||++|||+||+.||....+...............
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            3322     12345799999999998754      467899999999999999999877643111000000000000000


Q ss_pred             ----hhhccccCCCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          333 ----EEIVDSRLDGIF-----DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       333 ----~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                          ..+....+++..     +.+.+..+.+|+.+||+.||++||||.+|++.|+++.+.
T Consensus       239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence                011122222222     234567899999999999999999999999999998654

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.3e-56  Score=419.79  Aligned_cols=240  Identities=29%  Similarity=0.406  Sum_probs=196.1

Q ss_pred             hccccccccccCceeEEEEEe----CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM----STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      .|++.+.||+|+||+||+|+.    .+++.||||++....  ......+.+|+.+|++++|||||++++++.+++..|+|
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv  104 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI  104 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            588899999999999999964    257899999996542  22334688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-  265 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-  265 (432)
                      ||||++|+|.+++..  .+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.... 
T Consensus       105 mEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          105 LDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             ECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999964  357999999999999999999999999   99999999999999999999999999985433 


Q ss_pred             cccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      .......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.........+... ..            .++
T Consensus       180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-~~------------~~p  246 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA-KL------------GMP  246 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CC------------CCC
T ss_pred             CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC-CC------------CCC
Confidence            23445678999999999999999999999999999999999999999876544333322211 11            112


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSM  370 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~  370 (432)
                      ...+.++.+|+.+||+.||++|||+
T Consensus       247 ~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          247 QFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             CcCCHHHHHHHHHHcccCHHHCCCC
Confidence            2234578999999999999999985

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.8e-54  Score=403.80  Aligned_cols=247  Identities=25%  Similarity=0.383  Sum_probs=190.5

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC--------
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG--------  181 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  181 (432)
                      ..|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            3578889999999999999965 478999999987543 344567999999999999999999999987644        


Q ss_pred             ----eEEEEEEeccCCChhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEee
Q 014038          182 ----QHMLVYVFMSKGSLASHLYDENY-GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVAD  256 (432)
Q Consensus       182 ----~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~D  256 (432)
                          ..|+|||||++|+|.+++..... ...++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999965432 23566778999999999999999999   99999999999999999999999


Q ss_pred             cCCcccccccc-------------cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHH
Q 014038          257 FGLSREEMVDK-------------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAA  323 (432)
Q Consensus       257 fgl~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~  323 (432)
                      ||+|+......             .....+||+.|||||++.+..|+.++|||||||++|||++   ||....+......
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~  238 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT  238 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence            99997543221             1234579999999999999999999999999999999996   8876543322221


Q ss_pred             hhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          324 MNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ......          .+ .......+.+.+|+.+||+.||++|||+.++++
T Consensus       239 ~~~~~~----------~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          239 DVRNLK----------FP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHTTC----------CC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHhcCC----------CC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111111          00 011123346788999999999999999999875

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-51  Score=403.78  Aligned_cols=257  Identities=24%  Similarity=0.317  Sum_probs=202.4

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeee------CCeE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE------KGQH  183 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~  183 (432)
                      .|.+.+.||+|+||+||+|.. .+|+.||||++...  .....+.+.+|+.+|+.++|||||++++++..      .+..
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~  134 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV  134 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence            578889999999999999965 57999999999754  23445678899999999999999999998754      3678


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      |+|||||+ |+|.+++..  .+++++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       135 ~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          135 YVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeec
Confidence            99999996 689999854  467999999999999999999999999   999999999999999999999999999754


Q ss_pred             ccc-----ccccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhh---
Q 014038          264 MVD-----KHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEE---  334 (432)
Q Consensus       264 ~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  334 (432)
                      ...     ......+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+......+..+..........   
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            322     234467899999999998765 57999999999999999999999998866554443332111100000   


Q ss_pred             ---------hccccC-CCCCCH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 ---------IVDSRL-DGIFDV-----EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 ---------~~~~~~-~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                               ...... ....+.     ..+.++.+|+.+||+.||++|||+.|+++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                     000000 001111     11357889999999999999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.8e-50  Score=413.57  Aligned_cols=251  Identities=24%  Similarity=0.359  Sum_probs=213.1

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      ..|.+.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+.+|+.++|||||++++++.+.+..++|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            3678889999999999999965 579999999998776666778999999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC--CcEEEeecCCccccccccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS--MRARVADFGLSREEMVDKH  268 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~--~~~kl~Dfgl~~~~~~~~~  268 (432)
                      ++|+|.+++... .+.+++..+..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+++.......
T Consensus       237 ~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          237 SGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             CCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             CCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            999999988543 357999999999999999999999999   9999999999999854  8999999999987655555


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+......+..+...... +        ........
T Consensus       313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~-~--------~~~~~~~~  383 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN-M--------DDSAFSGI  383 (573)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC-C--------CSGGGTTS
T ss_pred             eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC-C--------CcccccCC
Confidence            56678999999999999999999999999999999999999999876654443333221111 0        00001112


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +.++.+|+.+||+.||.+|||+.|+++
T Consensus       384 s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          384 SEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            357889999999999999999999886

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.2e-50  Score=387.63  Aligned_cols=193  Identities=25%  Similarity=0.407  Sum_probs=166.4

Q ss_pred             HhccccccccccCceeEEEEEe----CCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM----STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ..|.+.+.||+|+||+||+|+.    .+++.||||.+....  ....+.+|+++|..+ +||||+++++++.+.+..++|
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv   98 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA   98 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence            4578889999999999999964    256789999986543  345688999999998 699999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC-CcEEEeecCCcccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-MRARVADFGLSREEMV  265 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~-~~~kl~Dfgl~~~~~~  265 (432)
                      |||+++|+|.+++.     .+++..+..++.||+.||+|||+++   |+||||||+|||++.+ +.+||+|||+|+....
T Consensus        99 mE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A           99 MPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             EECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             EeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            99999999999982     4899999999999999999999999   9999999999999877 7999999999974321


Q ss_pred             c-----------------------------ccccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCC
Q 014038          266 D-----------------------------KHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQG  314 (432)
Q Consensus       266 ~-----------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~  314 (432)
                      .                             ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            1                             112345799999999998765 589999999999999999999999954

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.7e-48  Score=372.88  Aligned_cols=268  Identities=39%  Similarity=0.705  Sum_probs=224.6

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      .|.+.+.||+|+||.||+|...+|+.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus        40 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  119 (321)
T 2qkw_B           40 NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN  119 (321)
T ss_dssp             CCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTT
T ss_pred             ccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCC
Confidence            45667899999999999999888999999998877666678899999999999999999999999999999999999999


Q ss_pred             CChhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc---c
Q 014038          193 GSLASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD---K  267 (432)
Q Consensus       193 g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~---~  267 (432)
                      |+|.+++....  ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....   .
T Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  196 (321)
T 2qkw_B          120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH  196 (321)
T ss_dssp             CBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred             CcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            99999996543  235999999999999999999999999   999999999999999999999999998753321   1


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhH-----HHHHHHhhhcCCCchhhhccccCCC
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME-----YVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.+...     ...+.. .......+...+++.+..
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  275 (321)
T 2qkw_B          197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV-ESHNNGQLEQIVDPNLAD  275 (321)
T ss_dssp             CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH-HHHTTTCCCSSSSSSCTT
T ss_pred             cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh-hccccccHHHhcChhhcc
Confidence            22345689999999999888999999999999999999999999964321     111100 011122234445556666


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      ..+...+..+.+++.+||+.||++|||+.++++.|+.+++..
T Consensus       276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          276 KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            677888899999999999999999999999999999997643

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.1e-49  Score=401.96  Aligned_cols=245  Identities=27%  Similarity=0.376  Sum_probs=197.3

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHH---HHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQ---TEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      .|.+.++||+|+||.||+|+. .+|+.||||++....   ......+.   .++.+++.++|||||++++++.+.+..|+
T Consensus       190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl  269 (689)
T 3v5w_A          190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF  269 (689)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence            467788999999999999965 479999999996431   12222333   34667777899999999999999999999


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      |||||+||+|.++|..  .+.+++..+..++.||+.||+|||+++   ||||||||+||||+.+|++||+|||+|+....
T Consensus       270 VmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          270 ILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            9999999999999964  357999999999999999999999999   99999999999999999999999999986433


Q ss_pred             cccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhH--HHHHHHhhhcCCCchhhhccccCCC
Q 014038          266 DKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME--YVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                       ....+.+||+.|||||++.. ..|+.++|+|||||++|||++|+.||.+...  ...+........            .
T Consensus       345 -~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~------------~  411 (689)
T 3v5w_A          345 -KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA------------V  411 (689)
T ss_dssp             -CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC------------C
T ss_pred             -CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC------------C
Confidence             33456789999999999964 5799999999999999999999999975321  111111111111            1


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPS-----MRDIVQ  375 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~~vl~  375 (432)
                      .++...+.++.+|+.+||+.||.+|++     +.+|++
T Consensus       412 ~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          412 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            122233457899999999999999998     677664

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.1e-48  Score=368.28  Aligned_cols=259  Identities=25%  Similarity=0.429  Sum_probs=212.5

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      ..|.+.+.||+|+||.||+|.. .+++.||+|.+........+.|.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            3567788999999999999975 468999999987767777788999999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc--
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH--  268 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~--  268 (432)
                      ++|+|.+++... ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......  
T Consensus        90 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           90 KGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             TTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             CCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            999999999653 356999999999999999999999999   99999999999999999999999999975332211  


Q ss_pred             -------------ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhh
Q 014038          269 -------------AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEI  335 (432)
Q Consensus       269 -------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (432)
                                   .....||+.|+|||++.+..++.++||||||+++|||++|..||......      ...........
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~------~~~~~~~~~~~  239 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR------TMDFGLNVRGF  239 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCB------CTTSSBCHHHH
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhh------HHHHhhhhhcc
Confidence                         11457999999999999999999999999999999999999998642110      00000011111


Q ss_pred             ccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      .+....    ...+.++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       240 ~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          240 LDRYCP----PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             HHHTCC----TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccccCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            111111    122347899999999999999999999999999987543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1e-47  Score=374.48  Aligned_cols=260  Identities=29%  Similarity=0.506  Sum_probs=212.9

Q ss_pred             HHHhccccccccccCceeEEEEEe--------CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEeeeee
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE  179 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  179 (432)
                      ....|.+.+.||+|+||.||+|..        .++..||||++.... ....+.+.+|+.+++++ +||||++++++|.+
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            345677889999999999999964        245679999997653 34456799999999999 89999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCee
Q 014038          180 KGQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNIL  245 (432)
Q Consensus       180 ~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nil  245 (432)
                      .+..++||||+++|+|.+++....              ...+++..++.++.||+.||.|||+++   |+||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence            999999999999999999996543              235899999999999999999999999   999999999999


Q ss_pred             ecCCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHH
Q 014038          246 LDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVEL  321 (432)
Q Consensus       246 l~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~  321 (432)
                      ++.++.+||+|||+++......   ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.......
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~  315 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  315 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9999999999999997543221   2234567889999999999999999999999999999999 99999764321111


Q ss_pred             HHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          322 AAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      ....            .......+...+.++.+++.+||+.||.+||++.++++.|++++...
T Consensus       316 ~~~~------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          316 KLLK------------EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             HHHH------------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHh------------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            1111            11111222334468999999999999999999999999999998654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-47  Score=364.61  Aligned_cols=259  Identities=34%  Similarity=0.531  Sum_probs=206.3

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ..|.+.+.||+|+||.||+|+. +|+.||||++....  ....+.|.+|+.++++++||||+++++++.+.+..++||||
T Consensus        37 ~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  115 (309)
T 3p86_A           37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY  115 (309)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred             hHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence            4677889999999999999987 68899999987653  34456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-
Q 014038          190 MSKGSLASHLYDEN-YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-  267 (432)
Q Consensus       190 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-  267 (432)
                      +++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++...... 
T Consensus       116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~  194 (309)
T 3p86_A          116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL  194 (309)
T ss_dssp             CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred             CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc
Confidence            99999999996432 123999999999999999999999986 459999999999999999999999999987533322 


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...............           ....+..
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-----------~~~~~~~  263 (309)
T 3p86_A          195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK-----------RLEIPRN  263 (309)
T ss_dssp             -------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC-----------CCCCCTT
T ss_pred             ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-----------CCCCCcc
Confidence            23456799999999999999999999999999999999999999987654333322211111           1112223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      .+.++.+++.+||+.||.+|||+.++++.|+.+++.
T Consensus       264 ~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            345789999999999999999999999999999764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.3e-48  Score=369.08  Aligned_cols=279  Identities=38%  Similarity=0.670  Sum_probs=225.0

Q ss_pred             CCCcCHHHHHHHh--ccccccccccCceeEEEEEeCCCcEEEEEEeccCCh-hhHHHHHHHHHHHhhcCCCccceEEeee
Q 014038          101 IPEYSYKDLQKAT--CNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK-QGEKEFQTEVMLLGRLHHRNLVNLVGYC  177 (432)
Q Consensus       101 ~~~~~~~~l~~~~--~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~  177 (432)
                      ...+++.++....  |.+.+.||+|+||.||+|+..+|+.||||++..... .....+.+|+.+++.++||||++++++|
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            3456666666544  455689999999999999888899999999976532 2334789999999999999999999999


Q ss_pred             eeCCeEEEEEEeccCCChhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEe
Q 014038          178 AEKGQHMLVYVFMSKGSLASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA  255 (432)
Q Consensus       178 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~  255 (432)
                      .+.+..++||||+++|+|.+++....  ..++++..+..++.|++.||.|||+...++|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999996543  3459999999999999999999999922229999999999999999999999


Q ss_pred             ecCCccccccc--ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhH-------HHHHHHhhh
Q 014038          256 DFGLSREEMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME-------YVELAAMNT  326 (432)
Q Consensus       256 Dfgl~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~-------~~~~~~~~~  326 (432)
                      |||++......  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....       ...+. ...
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~  255 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV-KGL  255 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH-TTT
T ss_pred             cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH-HHH
Confidence            99999754322  223345699999999999888999999999999999999999999963210       00111 111


Q ss_pred             cCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          327 EGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      .....+..+.+..+...++...+..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            122234455566667778888899999999999999999999999999999753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.2e-47  Score=362.97  Aligned_cols=248  Identities=24%  Similarity=0.390  Sum_probs=209.0

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      ..|.+.+.||+|+||+||+|.. .+|+.||||.+........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   99 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence            3577788999999999999964 578999999997665556678899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-ccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~  269 (432)
                      ++|+|.+++...   .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++...... ...
T Consensus       100 ~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  173 (297)
T 3fxz_A          100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (297)
T ss_dssp             TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             CCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence            999999999643   5899999999999999999999999   999999999999999999999999998754332 233


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.................          ...+...+
T Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----------~~~~~~~~  243 (297)
T 3fxz_A          174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE----------LQNPEKLS  243 (297)
T ss_dssp             CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC----------CSCGGGSC
T ss_pred             CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------CCCccccC
Confidence            45679999999999999999999999999999999999999998755443333222211111          01122234


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.+++.+||+.||++|||+.++++
T Consensus       244 ~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          244 AIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhh
Confidence            57899999999999999999999885

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1e-47  Score=368.30  Aligned_cols=245  Identities=25%  Similarity=0.398  Sum_probs=207.2

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      .|.+.+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~   95 (328)
T 3fe3_A           16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY   95 (328)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence            577889999999999999975 68999999998654  334456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHA  269 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~  269 (432)
                      +++|+|.+++...  +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.........
T Consensus        96 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  170 (328)
T 3fe3_A           96 ASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL  170 (328)
T ss_dssp             CTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred             CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence            9999999998543  46999999999999999999999999   999999999999999999999999999865555555


Q ss_pred             cccccCCCCCCccccccCCCC-chhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      ...+||+.|+|||++.+..++ .++|||||||++|||++|+.||.+............. .          .  ..+...
T Consensus       171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~----------~--~~p~~~  237 (328)
T 3fe3_A          171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-K----------Y--RIPFYM  237 (328)
T ss_dssp             GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-C----------C--CCCTTS
T ss_pred             ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-C----------C--CCCCCC
Confidence            667899999999999888775 8999999999999999999999875433222221111 1          0  111123


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +.++.+++.+||+.||.+|||+.++++
T Consensus       238 s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          238 STDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             CHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            357889999999999999999999885

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3e-47  Score=364.82  Aligned_cols=259  Identities=27%  Similarity=0.461  Sum_probs=212.9

Q ss_pred             HHHhccccccccccCceeEEEEEeC----CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEE
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  184 (432)
                      ...+|.+.+.||+|+||.||+|...    .+..||||.+... .....+.|.+|+.++++++||||+++++++.+.+..+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            3457788899999999999999763    3456999999765 3445578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      +||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       127 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            999999999999999543 356999999999999999999999999   9999999999999999999999999997543


Q ss_pred             ccc----cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          265 VDK----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       265 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ...    ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+..............           
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-----------  271 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY-----------  271 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-----------
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-----------
Confidence            321    1223346778999999998999999999999999999999 999998765443332222111           


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                       ....+...+.++.+++.+||+.||++|||+.+|++.|+.+++..
T Consensus       272 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          272 -RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             -CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence             11122233457999999999999999999999999999997643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2e-46  Score=358.51  Aligned_cols=257  Identities=23%  Similarity=0.361  Sum_probs=212.3

Q ss_pred             CcCHHHHHHHh------------ccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCc
Q 014038          103 EYSYKDLQKAT------------CNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN  169 (432)
Q Consensus       103 ~~~~~~l~~~~------------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  169 (432)
                      .++++++..++            +...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            46666666554            344568999999999999765 79999999998766666778999999999999999


Q ss_pred             cceEEeeeeeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC
Q 014038          170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS  249 (432)
Q Consensus       170 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~  249 (432)
                      |+++++++...+..++||||+++|+|.+++..   ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLD  177 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC
Confidence            99999999999999999999999999998843   46999999999999999999999999   9999999999999999


Q ss_pred             CcEEEeecCCccccccc-ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcC
Q 014038          250 MRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG  328 (432)
Q Consensus       250 ~~~kl~Dfgl~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  328 (432)
                      +.+||+|||++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||................
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  257 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP  257 (321)
T ss_dssp             CCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS
T ss_pred             CcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence            99999999998754332 23345679999999999999999999999999999999999999997654433322222111


Q ss_pred             CCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          329 KTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...        +.  .....+.++.+++.+||+.||++|||+.++++
T Consensus       258 ~~~--------~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          258 PPK--------LK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             CCC--------CT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCC--------cC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            110        00  11122357899999999999999999999886

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.1e-46  Score=365.48  Aligned_cols=250  Identities=24%  Similarity=0.359  Sum_probs=207.9

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCChh------hHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQ------GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  184 (432)
                      ..|.+.+.||+|+||.||+|... +|+.||+|.+......      ..+.+.+|+.++++++||||+++++++.+....+
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            35778899999999999999654 7899999999764321      3467899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC----cEEEeecCCc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM----RARVADFGLS  260 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~----~~kl~Dfgl~  260 (432)
                      +||||+++|+|.+++..  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++    .+||+|||++
T Consensus        92 lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           92 LILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            99999999999999943  457999999999999999999999999   99999999999998877    7999999999


Q ss_pred             ccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          261 REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .............||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+............    
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----  242 (361)
T 2yab_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF----  242 (361)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH----
T ss_pred             eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc----
Confidence            8655444455678999999999999999999999999999999999999999876544333322211110000000    


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                           ...+.++.+|+.+||..||.+|||+.++++
T Consensus       243 -----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          243 -----SQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             -----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -----cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 012357899999999999999999999885

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.5e-47  Score=361.75  Aligned_cols=269  Identities=26%  Similarity=0.397  Sum_probs=211.6

Q ss_pred             HHhccccccccccCceeEEEEEe-----CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeee--CCeE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQH  183 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  183 (432)
                      ...|.+.+.||+|+||.||+|++     .+++.||||++........+.+.+|+.++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            45778889999999999999974     3688999999987776667889999999999999999999999865  3568


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        89 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             EEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            9999999999999999654 245999999999999999999999999   999999999999999999999999999754


Q ss_pred             cccc----cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcC-CC---chhhh
Q 014038          264 MVDK----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG-KT---GWEEI  335 (432)
Q Consensus       264 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~-~~---~~~~~  335 (432)
                      ....    ......++..|+|||.+.+..++.++||||||+++|||++|..|+................ ..   .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  244 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence            3321    1223456778999999999999999999999999999999999987644321111000000 00   00111


Q ss_pred             ccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      +........+...+.++.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            111222223334456899999999999999999999999999998754

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=358.82  Aligned_cols=251  Identities=24%  Similarity=0.364  Sum_probs=208.7

Q ss_pred             HHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh------hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK------QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH  183 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  183 (432)
                      ...|.+.+.||+|+||.||+|... +|+.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356888999999999999999764 689999999875422      2357799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC----cEEEeecCC
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM----RARVADFGL  259 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~----~~kl~Dfgl  259 (432)
                      ++||||+++|+|.+++..  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||+
T Consensus        90 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            999999999999999953  457999999999999999999999999   99999999999999887    899999999


Q ss_pred             cccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          260 SREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ++............||+.|+|||++.+..++.++|||||||++|||++|+.||.+......................   
T Consensus       165 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---  241 (326)
T 2y0a_A          165 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF---  241 (326)
T ss_dssp             CEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH---
T ss_pred             CeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc---
Confidence            98655444455667999999999999999999999999999999999999999875543333322211111000000   


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                            ...+..+.+++.+||+.||++|||+.++++
T Consensus       242 ------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          242 ------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             ------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                  012357889999999999999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-46  Score=351.27  Aligned_cols=255  Identities=28%  Similarity=0.479  Sum_probs=213.3

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      ..|.+.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            3677889999999999999998888999999997643 334679999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--cc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HA  269 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--~~  269 (432)
                      +|+|.+++... ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++......  ..
T Consensus        89 ~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  164 (269)
T 4hcu_A           89 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  164 (269)
T ss_dssp             TCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             CCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence            99999999543 356999999999999999999999999   9999999999999999999999999987543221  22


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.................            ...+...
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~------------~~~~~~~  232 (269)
T 4hcu_A          165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------------LYKPRLA  232 (269)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC------------CCCCTTS
T ss_pred             cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc------------CCCCCcC
Confidence            34456788999999999999999999999999999999 9999987554333222221111            1111222


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      +.++.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          233 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            35789999999999999999999999999998753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.7e-47  Score=374.12  Aligned_cols=257  Identities=28%  Similarity=0.420  Sum_probs=212.0

Q ss_pred             HHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      ...+.+.+.||+|+||.||+|... +++.||||.+.... ......|.+|+.++++++||||++++++|.+.+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            446778899999999999999875 78999999987543 3334578899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+++|+|.+++... ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       193 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          193 LVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             CCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            99999999999643 346899999999999999999999999   99999999999999999999999999875332211


Q ss_pred             ---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCC
Q 014038          269 ---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       269 ---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                         .....+++.|+|||.+....++.++|||||||++|||++ |+.||.+..............            ....
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~------------~~~~  336 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG------------RLPC  336 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC------------CCCC
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------CCCC
Confidence               112235778999999998899999999999999999998 999998765433222221111            1112


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      +...+.++.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus       337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            222345789999999999999999999999999998764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=369.31  Aligned_cols=265  Identities=31%  Similarity=0.496  Sum_probs=217.2

Q ss_pred             HHHHHHhccccccccccCceeEEEEEe--------CCCcEEEEEEeccC-ChhhHHHHHHHHHHHhhc-CCCccceEEee
Q 014038          107 KDLQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGY  176 (432)
Q Consensus       107 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  176 (432)
                      .++....+.+.+.||+|+||.||+|..        ..+..||||++... .......+.+|+.+++++ +||||++++++
T Consensus        64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            345556788889999999999999964        23357999999765 334457899999999999 89999999999


Q ss_pred             eeeCCeEEEEEEeccCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCC
Q 014038          177 CAEKGQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSS  242 (432)
Q Consensus       177 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~  242 (432)
                      |.+.+..++||||+++|+|.+++....              ...+++..++.++.||+.||.|||+.+   |+||||||+
T Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~  220 (382)
T 3tt0_A          144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR  220 (382)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred             eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcc
Confidence            999999999999999999999996543              245999999999999999999999999   999999999


Q ss_pred             CeeecCCCcEEEeecCCccccccc---ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHH
Q 014038          243 NILLDQSMRARVADFGLSREEMVD---KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEY  318 (432)
Q Consensus       243 Nill~~~~~~kl~Dfgl~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~  318 (432)
                      |||++.++.+||+|||+++.....   .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999754322   22334567889999999999999999999999999999999 99999865433


Q ss_pred             HHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhccc
Q 014038          319 VELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHN  386 (432)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~  386 (432)
                      ..........            ....+...+.++.+++.+||+.||++|||+.+|++.|+.+......
T Consensus       301 ~~~~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  356 (382)
T 3tt0_A          301 ELFKLLKEGH------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN  356 (382)
T ss_dssp             HHHHHHHTTC------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred             HHHHHHHcCC------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            2222221111            1111222345799999999999999999999999999999876543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.8e-47  Score=377.37  Aligned_cols=251  Identities=28%  Similarity=0.446  Sum_probs=208.1

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC-eEEEEEEec
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG-QHMLVYVFM  190 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~  190 (432)
                      ..+.+.+.||+|+||.||+|.. .|+.||||.++...  ..+.|.+|+.+|++++||||+++++++.+.. ..++||||+
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             HHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            4566778999999999999988 47899999997643  4578999999999999999999999987665 789999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA  270 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  270 (432)
                      ++|+|.+++.......+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....  ..
T Consensus       270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~  344 (450)
T 1k9a_A          270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QD  344 (450)
T ss_dssp             TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--cc
Confidence            9999999997665556899999999999999999999999   999999999999999999999999999753222  22


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ...+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+............            ......+...+
T Consensus       345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~------------~~~~~~p~~~~  412 (450)
T 1k9a_A          345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------GYKMDAPDGCP  412 (450)
T ss_dssp             --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT------------TCCCCCCTTCC
T ss_pred             CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------CCCCCCCCcCC
Confidence            3467889999999999999999999999999999998 9999976432211111111            11112233345


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      .++.++|.+||+.||.+|||+.++++.|+.+..
T Consensus       413 ~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          413 PAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            689999999999999999999999999999865

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.4e-46  Score=355.14  Aligned_cols=259  Identities=22%  Similarity=0.395  Sum_probs=208.2

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      .+|.+.+.||+|+||.||+|.. .+++.||+|.+...   .....+.|.+|+.++.+++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            4677889999999999999965 47899999998653   2334567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+++|+|.+++...  +++++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        91 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           91 EYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            999999999999543  47999999999999999999999999   9999999999999999999999999997543322


Q ss_pred             --cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          268 --HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       268 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                        ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.+....................    ..    .
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~----~  237 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTT----DV----R  237 (294)
T ss_dssp             ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHH----HS----C
T ss_pred             ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcch----hc----c
Confidence              2334579999999999999999999999999999999999999998765433322222221111111    01    1


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHHhh
Q 014038          346 VEELNEVASLAYKCVNRAPRKRP-SMRDIVQVLSRILKM  383 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RP-s~~~vl~~L~~i~~~  383 (432)
                      ...+..+.+++.+||+.||.+|| ++.++.+.|+.++..
T Consensus       238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            12235789999999999999998 899999999877543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5e-46  Score=353.21  Aligned_cols=276  Identities=34%  Similarity=0.624  Sum_probs=225.4

Q ss_pred             CCCCcCHHHHHHHhcccc--------ccccccCceeEEEEEeCCCcEEEEEEeccC----ChhhHHHHHHHHHHHhhcCC
Q 014038          100 GIPEYSYKDLQKATCNFT--------TLIGQGAFGPVYKAQMSTGETVAVKVLATD----SKQGEKEFQTEVMLLGRLHH  167 (432)
Q Consensus       100 ~~~~~~~~~l~~~~~~~~--------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h  167 (432)
                      ....|++.++...+.+|.        +.||+|+||.||+|.. +++.||||.+...    .....+.+.+|+.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            346688999999988876        4599999999999987 6889999998653    23345679999999999999


Q ss_pred             CccceEEeeeeeCCeEEEEEEeccCCChhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee
Q 014038          168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL  246 (432)
Q Consensus       168 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill  246 (432)
                      |||+++++++.+.+..++||||+++|+|.+++... ...++++..++.++.|++.||.|||+.+   |+||||||+|||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            99999999999999999999999999999998642 3456999999999999999999999999   9999999999999


Q ss_pred             cCCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHH---HH
Q 014038          247 DQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEY---VE  320 (432)
Q Consensus       247 ~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~---~~  320 (432)
                      +.++.+||+|||++.......   ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......   ..
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            999999999999987543221   2234578999999998865 5899999999999999999999999753221   11


Q ss_pred             HHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 014038          321 LAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL  381 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~  381 (432)
                      +..........+...+++.+. ..+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            111112223334444444443 346677789999999999999999999999999999874

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.6e-47  Score=370.25  Aligned_cols=259  Identities=26%  Similarity=0.468  Sum_probs=203.4

Q ss_pred             HHhccccccccccCceeEEEEEeC----CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      ...+.+.+.||+|+||.||+|+..    ++..||||.+... .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            346777889999999999999764    5678999999765 34445689999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       124 v~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            99999999999999643 356999999999999999999999999   99999999999999999999999999975433


Q ss_pred             ccc----ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          266 DKH----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       266 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ...    .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...............            .
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~------------~  267 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG------------Y  267 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT------------E
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------C
Confidence            211    122345778999999999999999999999999999998 99999765443222221111            1


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                      ....+...+.++.+++.+||+.||.+||++.+|++.|+.+.....
T Consensus       268 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~  312 (373)
T 2qol_A          268 RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG  312 (373)
T ss_dssp             ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred             CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence            111222334679999999999999999999999999999987543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.3e-46  Score=361.79  Aligned_cols=247  Identities=26%  Similarity=0.409  Sum_probs=206.2

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||+|+.. +|+.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            35778899999999999999754 7899999999653   2234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-c
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-D  266 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~  266 (432)
                      ||+++|+|..++...  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.... .
T Consensus        85 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           85 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            999999999988543  46899999999999999999999999   99999999999999999999999999975332 3


Q ss_pred             ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+... .          .  .++.
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~----------~--~~p~  226 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-E----------I--RFPR  226 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-C----------C--CCCT
T ss_pred             CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-C----------C--CCCC
Confidence            3445678999999999999999999999999999999999999999765432222221111 1          0  1122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRP-----SMRDIVQV  376 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RP-----s~~~vl~~  376 (432)
                      ..+.++.+++.+||+.||++||     ++.++++.
T Consensus       227 ~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            2345789999999999999999     89988763

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-46  Score=358.21  Aligned_cols=250  Identities=19%  Similarity=0.264  Sum_probs=207.7

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .|.+.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus         6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~   84 (321)
T 1tki_A            6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence            5778899999999999999654 68899999987543 345678899999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC--CCcEEEeecCCcccccccccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ--SMRARVADFGLSREEMVDKHA  269 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~--~~~~kl~Dfgl~~~~~~~~~~  269 (432)
                      +|+|.+++... ...+++..+..++.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||++.........
T Consensus        85 g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~  160 (321)
T 1tki_A           85 GLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence            99999998543 346999999999999999999999999   999999999999987  789999999999865544445


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....||+.|+|||++.+..++.++|||||||++|||++|..||.+......................         ...+
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~---------~~~s  231 (321)
T 1tki_A          161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF---------KEIS  231 (321)
T ss_dssp             EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH---------TTSC
T ss_pred             ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhh---------ccCC
Confidence            5667999999999999888999999999999999999999999876544333222221111000000         0123


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      .++.+++.+||+.||.+|||+.++++.
T Consensus       232 ~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          232 IEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            578999999999999999999999873

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.5e-46  Score=357.44  Aligned_cols=261  Identities=17%  Similarity=0.241  Sum_probs=209.5

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .|.+.+.||+|+||.||+|.. .+|+.||||++.....  ...+.+|+.+++++ +||||+++++++...+..++||||+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~   87 (330)
T 2izr_A           10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL   87 (330)
T ss_dssp             TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred             CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence            567788999999999999975 5789999999865432  34588999999999 9999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc-----EEEeecCCcccccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR-----ARVADFGLSREEMV  265 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~-----~kl~Dfgl~~~~~~  265 (432)
                       +++|.+++... ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.     +||+|||+++....
T Consensus        88 -~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           88 -GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             -CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             -CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence             99999998653 457999999999999999999999999   999999999999999887     99999999975432


Q ss_pred             ccc--------ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhH--H-HHHHHhhhcCCCchhh
Q 014038          266 DKH--------AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME--Y-VELAAMNTEGKTGWEE  334 (432)
Q Consensus       266 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~--~-~~~~~~~~~~~~~~~~  334 (432)
                      ...        .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+...  . ...........    .
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~----~  238 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR----A  238 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH----H
T ss_pred             CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc----c
Confidence            221        2456799999999999999999999999999999999999999976321  1 11111100000    0


Q ss_pred             hccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcccccc
Q 014038          335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKH  389 (432)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~~~~  389 (432)
                      .....+..    ..+ ++.+++..||+.||.+||++.+|++.|+.+.++......
T Consensus       239 ~~~~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~  288 (330)
T 2izr_A          239 TPIEVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFD  288 (330)
T ss_dssp             SCHHHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCS
T ss_pred             CCHHHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Confidence            00000000    112 799999999999999999999999999999887654433

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.1e-47  Score=362.82  Aligned_cols=265  Identities=28%  Similarity=0.443  Sum_probs=204.5

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC----eEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG----QHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||+|+.. ++.||||++.... .....+.+|+.++.+++||||+++++++....    ..++||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            36778899999999999999874 7999999996543 23345667999999999999999999998754    479999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeeeccCCCCCeeecCCCcEEEeec
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG----------AVPPVIHRDIKSSNILLDQSMRARVADF  257 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~----------~~~~iiH~dlkp~Nill~~~~~~kl~Df  257 (432)
                      ||+++|+|.+++...   .+++..+..++.|++.||.|||+.          +   |+||||||+|||++.++.+||+||
T Consensus       102 e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          102 AFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             ecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccC
Confidence            999999999999543   499999999999999999999998          7   999999999999999999999999


Q ss_pred             CCcccccccc---cccccccCCCCCCcccccc-----CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHh-hhcC
Q 014038          258 GLSREEMVDK---HAANIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM-NTEG  328 (432)
Q Consensus       258 gl~~~~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~-~~~~  328 (432)
                      |+++......   ......||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+..+....... ....
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            9997543322   2334578999999999876     34567899999999999999999999753210000000 0000


Q ss_pred             CCchhh----hccccCCCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          329 KTGWEE----IVDSRLDGIF-----DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       329 ~~~~~~----~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      ......    ..........     ....+.++.+++.+||+.||++|||+.+|++.|+.+.+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            000000    0111111111     1234567999999999999999999999999999987653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.2e-46  Score=362.00  Aligned_cols=252  Identities=24%  Similarity=0.364  Sum_probs=207.9

Q ss_pred             HHHhccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ....|.+.+.||+|+||.||+|.. .+|+.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            356788999999999999999965 46899999999754  234456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC---CcEEEeecCCcccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS---MRARVADFGLSREE  263 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~---~~~kl~Dfgl~~~~  263 (432)
                      |||+++|+|.+++..  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.+   +.+||+|||++...
T Consensus       107 ~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          107 FDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             ECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            999999999998854  356999999999999999999999999   9999999999999765   45999999999865


Q ss_pred             cccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCC
Q 014038          264 MVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                      ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.+................ +        ...
T Consensus       182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~--------~~~  252 (362)
T 2bdw_A          182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-Y--------PSP  252 (362)
T ss_dssp             TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-C--------CTT
T ss_pred             cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-C--------Ccc
Confidence            5444445678999999999999999999999999999999999999999875443322222211110 0        000


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .....+.++.+|+.+||+.||++||++.++++
T Consensus       253 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          253 EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00122357899999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6.2e-47  Score=352.39  Aligned_cols=256  Identities=24%  Similarity=0.427  Sum_probs=212.1

Q ss_pred             HHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      ...|.+.+.||+|+||.||+|+..++..||+|++.... ...+.+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            35678889999999999999998888899999997643 23467899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--c
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--H  268 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--~  268 (432)
                      ++++|.+++... ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  .
T Consensus        86 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  161 (268)
T 3sxs_A           86 SNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS  161 (268)
T ss_dssp             TTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred             CCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence            999999998643 345999999999999999999999999   9999999999999999999999999987543322  1


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.................            ...+..
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------~~~~~~  229 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR------------LYRPHL  229 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC------------CCCCTT
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC------------CCCCCc
Confidence            223456778999999998899999999999999999999 9999986554333322221111            011111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      .+.++.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus       230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          230 ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            234789999999999999999999999999887543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.3e-46  Score=350.32  Aligned_cols=255  Identities=24%  Similarity=0.424  Sum_probs=210.5

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      ..|.+.+.||+|+||.||+|+..++..||+|++..... ..+++.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  102 (283)
T 3gen_A           24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA  102 (283)
T ss_dssp             GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred             HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence            46778899999999999999988888999999976432 34678999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--cc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HA  269 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--~~  269 (432)
                      +|+|.+++... ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus       103 ~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  178 (283)
T 3gen_A          103 NGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS  178 (283)
T ss_dssp             TCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred             CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence            99999999642 346999999999999999999999999   9999999999999999999999999987543221  22


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.................            ...+...
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~------------~~~~~~~  246 (283)
T 3gen_A          179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------------LYRPHLA  246 (283)
T ss_dssp             TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC------------CCCCTTC
T ss_pred             cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC------------CCCCCcC
Confidence            33456788999999998999999999999999999998 9999987554333322221111            1111122


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      +..+.+++.+||+.||.+|||+.++++.|.+++..
T Consensus       247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          247 SEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            35789999999999999999999999999998764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=365.92  Aligned_cols=261  Identities=28%  Similarity=0.434  Sum_probs=213.2

Q ss_pred             HHHhccccccccccCceeEEEEEeC------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  182 (432)
                      ....|.+.+.||+|+||.||+|.+.      +++.||||++... .......+.+|+.++++++||||+++++++.+...
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            3456788899999999999999742      4668999999654 34555678999999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC---cEEE
Q 014038          183 HMLVYVFMSKGSLASHLYDEN-----YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM---RARV  254 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~---~~kl  254 (432)
                      .++||||+++|+|.+++....     ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++   .+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999996532     245899999999999999999999999   99999999999999555   5999


Q ss_pred             eecCCccccccc---ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCC
Q 014038          255 ADFGLSREEMVD---KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKT  330 (432)
Q Consensus       255 ~Dfgl~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  330 (432)
                      +|||+++.....   .......+|+.|+|||++.+..++.++|||||||++|||++ |..||................. 
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~-  304 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR-  304 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-
Confidence            999998743221   22334567999999999999999999999999999999998 9999987554333222221111 


Q ss_pred             chhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          331 GWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                                 ...+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.+...
T Consensus       305 -----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          305 -----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             -----------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence                       11122234578999999999999999999999999999876543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=9.6e-47  Score=358.91  Aligned_cols=262  Identities=29%  Similarity=0.488  Sum_probs=214.0

Q ss_pred             HHHHhccccccccccCceeEEEEEe------CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeC
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK  180 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  180 (432)
                      +....|.+.+.||+|+||.||+|..      .+++.||||.+.... ....+.+.+|+.++.++ +||||+++++++.+.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            3445778889999999999999974      356789999997653 34457799999999999 999999999999999


Q ss_pred             CeEEEEEEeccCCChhhhcccCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCe
Q 014038          181 GQHMLVYVFMSKGSLASHLYDENY----------------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNI  244 (432)
Q Consensus       181 ~~~~lv~e~~~~g~L~~~l~~~~~----------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Ni  244 (432)
                      +..++||||+++|+|.+++.....                ..+++..++.++.|++.||.|||+++   |+||||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence            999999999999999999965432                25899999999999999999999999   99999999999


Q ss_pred             eecCCCcEEEeecCCccccccccc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHH
Q 014038          245 LLDQSMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVE  320 (432)
Q Consensus       245 ll~~~~~~kl~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~  320 (432)
                      |++.++.+||+|||++........   .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+......
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            999999999999999875433321   233457889999999999999999999999999999999 9999976432211


Q ss_pred             HHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          321 LAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      .......           ......+...+.++.+++.+||+.||.+|||+.++++.|++++...
T Consensus       257 ~~~~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          257 FYKMIKE-----------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             HHHHHHH-----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHHhcc-----------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            1111111           1111112223457999999999999999999999999999987653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.6e-47  Score=370.09  Aligned_cols=262  Identities=31%  Similarity=0.520  Sum_probs=210.4

Q ss_pred             HHHHhccccccccccCceeEEEEEe------CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeC
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK  180 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  180 (432)
                      +....|.+.+.||+|+||.||+|.+      .+++.||||++.... ....+.+.+|+.++.++ +||||++++++|.+.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~   98 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   98 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence            3445778889999999999999963      356789999997643 34456799999999999 799999999999875


Q ss_pred             C-eEEEEEEeccCCChhhhcccCCC-------------------------------------------------------
Q 014038          181 G-QHMLVYVFMSKGSLASHLYDENY-------------------------------------------------------  204 (432)
Q Consensus       181 ~-~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  204 (432)
                      + ..++||||+++|+|.+++.....                                                       
T Consensus        99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A           99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence            5 48999999999999999965432                                                       


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc---ccccc
Q 014038          205 ---------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANI  272 (432)
Q Consensus       205 ---------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~~~  272 (432)
                               ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......   .....
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  255 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA  255 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence                     12899999999999999999999999   9999999999999999999999999997543222   23345


Q ss_pred             ccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      .||+.|+|||++.+..++.++|||||||++|||++ |+.||.+..............           .....+...+.+
T Consensus       256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~  324 (359)
T 3vhe_A          256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-----------TRMRAPDYTTPE  324 (359)
T ss_dssp             EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT-----------CCCCCCTTCCHH
T ss_pred             CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC-----------CCCCCCCCCCHH
Confidence            68899999999999999999999999999999998 999997643221111111111           111112223357


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          352 VASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      +.+++.+||+.||.+|||+.++++.|+.+++..
T Consensus       325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence            899999999999999999999999999998653

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.9e-47  Score=378.20  Aligned_cols=258  Identities=27%  Similarity=0.455  Sum_probs=214.2

Q ss_pred             HHHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       108 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ++....+.+.+.||+|+||.||+|...++..||||.+.... ...+.|.+|+.+|++++||||+++++++. .+..++||
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~  261 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT  261 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence            44456678889999999999999998888999999997644 34678999999999999999999999986 56789999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+++|+|.+++.......+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            9999999999997544446899999999999999999999999   9999999999999999999999999997643221


Q ss_pred             --cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCC
Q 014038          268 --HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       268 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                        ......+++.|+|||++....++.++|||||||++|||+| |+.||.+..............            ....
T Consensus       339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~------------~~~~  406 (454)
T 1qcf_A          339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY------------RMPR  406 (454)
T ss_dssp             HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC------------CCCC
T ss_pred             eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------CCCC
Confidence              1223446788999999998999999999999999999999 999998765433322222111            1111


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      +...+.++.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       407 ~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          407 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            22334689999999999999999999999999988754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3e-47  Score=385.05  Aligned_cols=260  Identities=28%  Similarity=0.449  Sum_probs=215.7

Q ss_pred             HHHHHHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          107 KDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       107 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      .++....+.+.+.||+|+||.||+|... ++..||||.+.... ...+.|.+|+.+|++++||||++++++|.+.+..++
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            3444567788899999999999999775 47899999997653 346789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+++|+|.+++.......+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            999999999999997766677999999999999999999999999   99999999999999999999999999976432


Q ss_pred             cc--cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          266 DK--HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       266 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ..  ......++..|+|||++....++.++|||||||++|||++ |+.||.+.........            +......
T Consensus       371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~------------~~~~~~~  438 (495)
T 1opk_A          371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL------------LEKDYRM  438 (495)
T ss_dssp             CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH------------HHTTCCC
T ss_pred             CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH------------HHcCCCC
Confidence            22  1223446788999999998999999999999999999999 9999976432111111            1111122


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      ..+...+.++.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            2233344689999999999999999999999999987753

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=356.35  Aligned_cols=251  Identities=22%  Similarity=0.262  Sum_probs=200.3

Q ss_pred             CHHHHHHHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeC
Q 014038          105 SYKDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK  180 (432)
Q Consensus       105 ~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  180 (432)
                      ...++....|.+.++||+|+||+||+|... +|+.||||++....  ......+..|+..+.++ +||||++++++|.+.
T Consensus        50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~  129 (311)
T 3p1a_A           50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG  129 (311)
T ss_dssp             SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence            345667778999999999999999999765 78999999986542  33344556666666665 899999999999999


Q ss_pred             CeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCc
Q 014038          181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS  260 (432)
Q Consensus       181 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~  260 (432)
                      +..++||||+ +++|.+++... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       130 ~~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a  204 (311)
T 3p1a_A          130 GILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLL  204 (311)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred             CEEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceee
Confidence            9999999999 67999888654 356999999999999999999999999   999999999999999999999999998


Q ss_pred             ccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          261 REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .............||+.|+|||++.+ .++.++|||||||++|||++|..|+.+...+..+..              ...
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~--------------~~~  269 (311)
T 3p1a_A          205 VELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ--------------GYL  269 (311)
T ss_dssp             EECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTT--------------TCC
T ss_pred             eecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhc--------------cCC
Confidence            76554444555679999999999875 799999999999999999999877765433222111              000


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ....+...+.++.+++.+||+.||++|||+.++++
T Consensus       270 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          270 PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            00001112357999999999999999999999985

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.6e-46  Score=357.47  Aligned_cols=259  Identities=28%  Similarity=0.478  Sum_probs=212.4

Q ss_pred             HHhccccccccccCceeEEEEEe------CCCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH  183 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  183 (432)
                      ...|.+.+.||+|+||.||+|..      .+++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            34677889999999999999964      34578999999764 334457889999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhcccCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCC
Q 014038          184 MLVYVFMSKGSLASHLYDENY----------------------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKS  241 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp  241 (432)
                      ++||||+++|+|.+++.....                      ..+++..++.++.||+.||.|||+++   |+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            999999999999999965432                      34899999999999999999999999   99999999


Q ss_pred             CCeeecCCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhH
Q 014038          242 SNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME  317 (432)
Q Consensus       242 ~Nill~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~  317 (432)
                      +|||++.++.+||+|||++.......   ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+...
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999987543222   2233457888999999998899999999999999999999 9999976432


Q ss_pred             HHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          318 YVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      .........            ......+...+.++.+++.+||+.||.+||++.++++.|++++..+
T Consensus       259 ~~~~~~~~~------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  313 (314)
T 2ivs_A          259 ERLFNLLKT------------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR  313 (314)
T ss_dssp             GGHHHHHHT------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             HHHHHHhhc------------CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence            211111111            1111122233457999999999999999999999999999997653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2e-46  Score=361.43  Aligned_cols=259  Identities=29%  Similarity=0.485  Sum_probs=211.3

Q ss_pred             HHhccccccccccCceeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH  183 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  183 (432)
                      ...|.+.+.||+|+||.||+|...      +++.||||.+.... ....+.|.+|+.++++++||||+++++++.+.+..
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  125 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM  125 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence            356778899999999999999763      34789999997653 34456799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhcccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCC
Q 014038          184 MLVYVFMSKGSLASHLYDEN----------------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKS  241 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp  241 (432)
                      ++||||+++|+|.+++....                      ...+++..++.++.||+.||.|||+++   |+||||||
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp  202 (343)
T 1luf_A          126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT  202 (343)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCc
Confidence            99999999999999986532                      257999999999999999999999999   99999999


Q ss_pred             CCeeecCCCcEEEeecCCccccccc---ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhH
Q 014038          242 SNILLDQSMRARVADFGLSREEMVD---KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLME  317 (432)
Q Consensus       242 ~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~  317 (432)
                      +|||++.++.+||+|||+++.....   .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+...
T Consensus       203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  282 (343)
T 1luf_A          203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  282 (343)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence            9999999999999999998753322   12234567899999999998999999999999999999999 9999987544


Q ss_pred             HHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          318 YVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      ............            ...+...+.++.+++.+||+.||++||++.++++.|+++.+..
T Consensus       283 ~~~~~~~~~~~~------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          283 EEVIYYVRDGNI------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             HHHHHHHHTTCC------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             HHHHHHHhCCCc------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            332222211111            0112223457999999999999999999999999999986543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-46  Score=365.32  Aligned_cols=251  Identities=23%  Similarity=0.361  Sum_probs=210.1

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      ..|.+.+.||+|+||.||+|.. .+|+.||+|.+..........+.+|+.+++.++||||+++++++.+....++||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            3678889999999999999965 478999999998766666678999999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC--CCcEEEeecCCccccccccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ--SMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~--~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      ++|+|.+++... ...+++..+..++.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||+++.......
T Consensus       131 ~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          131 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            999999998543 346999999999999999999999999   999999999999974  57899999999986554444


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+................         .........
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~---------~~~~~~~~~  277 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE---------FDEDAFSSV  277 (387)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC---------CCSSTTTTS
T ss_pred             eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------CCccccccC
Confidence            45567999999999999999999999999999999999999999876554333332221110         011111122


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +.++.+++.+||+.||++|||+.++++
T Consensus       278 s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          278 SPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            357899999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2e-46  Score=349.37  Aligned_cols=252  Identities=35%  Similarity=0.567  Sum_probs=198.5

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCCh----hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK----QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+|.. .++.||||++.....    ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         8 ~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (271)
T 3dtc_A            8 ELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME   86 (271)
T ss_dssp             SEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred             heeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence            567788999999999999987 489999999875432    334678999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC--------CCcEEEeecCCc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ--------SMRARVADFGLS  260 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~--------~~~~kl~Dfgl~  260 (432)
                      |+++++|.+++.   ...+++..+..++.|++.||.|||+++..+|+||||||+|||++.        ++.+||+|||++
T Consensus        87 ~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~  163 (271)
T 3dtc_A           87 FARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA  163 (271)
T ss_dssp             CCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred             cCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence            999999999984   346999999999999999999999988666899999999999986        778999999998


Q ss_pred             ccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          261 REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.+.............           ..
T Consensus       164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------~~  231 (271)
T 3dtc_A          164 REWHRT-TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN-----------KL  231 (271)
T ss_dssp             -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS-----------CC
T ss_pred             cccccc-cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC-----------CC
Confidence            754322 223457899999999999999999999999999999999999999875543332222111           11


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      ....+...+.++.+++.+||+.||.+|||+.++++.|+.+
T Consensus       232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          232 ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            1122223345799999999999999999999999998753

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2e-46  Score=348.97  Aligned_cols=254  Identities=26%  Similarity=0.409  Sum_probs=209.3

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC--CeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||+|.. +++.||||++...  .....+.|.+|+.++++++||||+++++++.+.  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            3567889999999999999988 4889999999765  334456799999999999999999999999877  7889999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+++|+|.+++.......+++..++.++.|++.||.|||+.+ ++++||||||+|||++.++.++|+|||++...    
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~----  163 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF----  163 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT----
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee----
Confidence            9999999999997665557999999999999999999999976 45999999999999999999999999886532    


Q ss_pred             cccccccCCCCCCccccccCCCC---chhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCC
Q 014038          268 HAANIRGTFGYLDPEYISTRNFT---KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                      ......+|+.|+|||.+.+..++   .++||||||+++|||++|+.||.+..............           .....
T Consensus       164 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-----------~~~~~  232 (271)
T 3kmu_A          164 QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG-----------LRPTI  232 (271)
T ss_dssp             SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC-----------CCCCC
T ss_pred             cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC-----------CCCCC
Confidence            22345689999999999866544   48999999999999999999998755433322221111           11122


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      +...+.++.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            22334579999999999999999999999999998743

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.4e-46  Score=353.58  Aligned_cols=263  Identities=28%  Similarity=0.444  Sum_probs=217.9

Q ss_pred             HHHHHHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          107 KDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       107 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      .++....|.+.+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            3344567788899999999999999765 57899999997543 345688999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+++++|.+++.......+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            999999999999997766677999999999999999999999999   99999999999999999999999999875433


Q ss_pred             cc--cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          266 DK--HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       266 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ..  ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...........            +......
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~------------~~~~~~~  231 (288)
T 3kfa_A          164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL------------LEKDYRM  231 (288)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH------------HHTTCCC
T ss_pred             CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------------HhccCCC
Confidence            22  2233457889999999999999999999999999999999 9999975432111111            1111111


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                      ..+...+.++.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus       232 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          232 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            2222334679999999999999999999999999999877543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=6.2e-46  Score=362.17  Aligned_cols=246  Identities=24%  Similarity=0.359  Sum_probs=201.7

Q ss_pred             cccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCCh
Q 014038          117 TTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  195 (432)
                      .+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            46799999999999965 57899999999877666677899999999999999999999999999999999999999999


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee--cCCCcEEEeecCCcccccccccccccc
Q 014038          196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL--DQSMRARVADFGLSREEMVDKHAANIR  273 (432)
Q Consensus       196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill--~~~~~~kl~Dfgl~~~~~~~~~~~~~~  273 (432)
                      .+++... ...+++..+..++.||+.||.|||+.+   |+||||||+|||+  +.++.+||+|||+++............
T Consensus       174 ~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~  249 (373)
T 2x4f_A          174 FDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF  249 (373)
T ss_dssp             HHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCC
T ss_pred             HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccccc
Confidence            9988643 346899999999999999999999999   9999999999999  677899999999998655444445567


Q ss_pred             cCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHH
Q 014038          274 GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVA  353 (432)
Q Consensus       274 gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  353 (432)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+.........    ...     ...+.++.
T Consensus       250 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~----~~~-----~~~~~~~~  320 (373)
T 2x4f_A          250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED----EEF-----QDISEEAK  320 (373)
T ss_dssp             SSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS----GGG-----TTSCHHHH
T ss_pred             CCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh----hhh-----ccCCHHHH
Confidence            999999999999899999999999999999999999999876554433333222111000    000     11235789


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 014038          354 SLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       354 ~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +|+.+||+.||.+|||+.++++
T Consensus       321 ~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          321 EFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCChhhCCCHHHHhc
Confidence            9999999999999999999987

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.6e-46  Score=361.16  Aligned_cols=274  Identities=17%  Similarity=0.239  Sum_probs=210.0

Q ss_pred             HhccccccccccCceeEEEEEeCC------CcEEEEEEeccCChhh-----------HHHHHHHHHHHhhcCCCccceEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMST------GETVAVKVLATDSKQG-----------EKEFQTEVMLLGRLHHRNLVNLV  174 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~  174 (432)
                      ..|.+.+.||+|+||.||+|....      ++.||||++.......           ...+..|+..+..++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            467788999999999999997654      4789999987654211           12344566677788999999999


Q ss_pred             eeeeeC----CeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec--C
Q 014038          175 GYCAEK----GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD--Q  248 (432)
Q Consensus       175 ~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~--~  248 (432)
                      +++...    ...++||||+ +++|.+++... ...+++..++.++.||+.||.|||+++   |+||||||+|||++  .
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSC
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCC
Confidence            998764    4589999999 99999998653 357999999999999999999999999   99999999999999  8


Q ss_pred             CCcEEEeecCCccccccccc--------ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHH
Q 014038          249 SMRARVADFGLSREEMVDKH--------AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVE  320 (432)
Q Consensus       249 ~~~~kl~Dfgl~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~  320 (432)
                      ++.+||+|||+++.......        .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+......
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            89999999999975432211        1334599999999999999999999999999999999999999985322111


Q ss_pred             HH-HhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhccccccccCC
Q 014038          321 LA-AMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKS  393 (432)
Q Consensus       321 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~~~~~~~~  393 (432)
                      .. .........+..+.++.+..   ...+.++.+++..||+.||.+||++.+|++.|+.+++...........
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~d  340 (364)
T 3op5_A          270 YVRDSKIRYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLD  340 (364)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCC
T ss_pred             HHHHHHHHhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccc
Confidence            11 11111111223333333221   112357899999999999999999999999999999876655443333

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-46  Score=363.09  Aligned_cols=261  Identities=28%  Similarity=0.480  Sum_probs=208.6

Q ss_pred             HHHhccccccccccCceeEEEEEe------CCCcEEEEEEeccC-ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCC
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKG  181 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  181 (432)
                      ....|.+.+.||+|+||.||+|..      .++..||||.+... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            345778889999999999999975      24568999999754 234456899999999999 8999999999999999


Q ss_pred             eEEEEEEeccCCChhhhcccCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 014038          182 QHMLVYVFMSKGSLASHLYDENY---------------------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIK  240 (432)
Q Consensus       182 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlk  240 (432)
                      ..++||||+++|+|.+++.....                     ..+++..++.++.||+.||.|||+++   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            99999999999999999965432                     34899999999999999999999999   9999999


Q ss_pred             CCCeeecCCCcEEEeecCCccccccccc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChh
Q 014038          241 SSNILLDQSMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLM  316 (432)
Q Consensus       241 p~Nill~~~~~~kl~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~  316 (432)
                      |+|||++.++.+||+|||++........   .....+|+.|+|||.+.+..++.++||||||+++|||+| |..||.+..
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999975433221   234557889999999998999999999999999999998 999997643


Q ss_pred             HHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          317 EYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      ...........           ......+...+.++.+++.+||+.||.+|||+.++++.|+.++...
T Consensus       280 ~~~~~~~~~~~-----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          280 VDANFYKLIQN-----------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CSHHHHHHHHT-----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             cHHHHHHHHhc-----------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            22111111111           1111122223457999999999999999999999999999886543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=351.74  Aligned_cols=267  Identities=22%  Similarity=0.311  Sum_probs=211.8

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC--eEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG--QHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++....  ..++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (319)
T 4euu_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME   89 (319)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence            5778899999999999999765 58999999997543 334567889999999999999999999988755  7899999


Q ss_pred             eccCCChhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee----cCCCcEEEeecCCcccc
Q 014038          189 FMSKGSLASHLYDEN-YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL----DQSMRARVADFGLSREE  263 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill----~~~~~~kl~Dfgl~~~~  263 (432)
                      |+++|+|.+++.... ...+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++..
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~  166 (319)
T 4euu_A           90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (319)
T ss_dssp             CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred             CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence            999999999996532 234999999999999999999999999   9999999999999    88888999999999865


Q ss_pred             cccccccccccCCCCCCccccc--------cCCCCchhHhHHHHHHHHHHHhCCCCCCChhH----HHHHHHhhhcCC-C
Q 014038          264 MVDKHAANIRGTFGYLDPEYIS--------TRNFTKKSDVYSFGVLLFELIAGRSPLQGLME----YVELAAMNTEGK-T  330 (432)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~----~~~~~~~~~~~~-~  330 (432)
                      ..........||+.|+|||++.        +..++.++|||||||++|||++|+.||.....    ............ .
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~  246 (319)
T 4euu_A          167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG  246 (319)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTT
T ss_pred             CCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcc
Confidence            5555555667999999999886        57889999999999999999999999963211    111111111110 0


Q ss_pred             chhhh---------ccc--cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          331 GWEEI---------VDS--RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       331 ~~~~~---------~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      .+..+         ...  .............+.+++.+||+.||++|||+.|+++...+..-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            00000         000  11123456777899999999999999999999999998876643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7.9e-46  Score=368.76  Aligned_cols=251  Identities=22%  Similarity=0.344  Sum_probs=205.9

Q ss_pred             HHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ...|.+.+.||+|+||.||+|.. .+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            45788899999999999999954 578999999987643  334567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec---CCCcEEEeecCCccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD---QSMRARVADFGLSREEM  264 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~---~~~~~kl~Dfgl~~~~~  264 (432)
                      ||+++|+|.+.+...  ..+++..+..++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||++....
T Consensus        90 E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           90 DLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             CCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            999999999988654  46999999999999999999999999   99999999999998   56789999999997544


Q ss_pred             ccc-cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCC
Q 014038          265 VDK-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       265 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                      ... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+................ +        ...
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-~--------~~~  235 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD-F--------PSP  235 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-C--------CTT
T ss_pred             CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-C--------Ccc
Confidence            332 234567999999999999999999999999999999999999999875543333322221110 0        000


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .....+.++.+|+.+||+.||.+|||+.++++
T Consensus       236 ~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          236 EWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11122357899999999999999999999986

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=364.68  Aligned_cols=249  Identities=26%  Similarity=0.422  Sum_probs=201.2

Q ss_pred             HHHHhccccccccccCceeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeE
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQH  183 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  183 (432)
                      +....|.+.+.||+|+||.||+|+.. +|+.||||++...   .....+.+.+|..++..+ +||||+++++++.+.+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            33456788899999999999999754 6899999999753   223445688999999988 799999999999999999


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ++||||+++|+|..++...  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       100 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            9999999999999998543  46999999999999999999999999   999999999999999999999999999753


Q ss_pred             cc-cccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          264 MV-DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       264 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+... ..            
T Consensus       175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~------------  241 (353)
T 3txo_A          175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-EV------------  241 (353)
T ss_dssp             CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CC------------
T ss_pred             ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CC------------
Confidence            32 23445678999999999999889999999999999999999999999876543333222211 10            


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHH
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSM------RDIVQ  375 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~------~~vl~  375 (432)
                      .++...+.++.+++.+||+.||.+||++      .++++
T Consensus       242 ~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            1122233578999999999999999998      66664

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.1e-46  Score=358.15  Aligned_cols=255  Identities=25%  Similarity=0.433  Sum_probs=201.2

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcE----EEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGET----VAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      ..|.+.+.||+|+||.||+|... +++.    ||+|.+... .....+.|.+|+.++++++||||++++++|.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            46778899999999999999753 4443    688887543 3345578999999999999999999999998754 789


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      |++|+.+|+|.+++... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        94 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            99999999999999654 356999999999999999999999999   99999999999999999999999999875432


Q ss_pred             cc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCC
Q 014038          266 DK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       266 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ..   ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.+........            .+.....
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------------~~~~~~~  237 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------------ILEKGER  237 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH------------HHHTTCC
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH------------HHHcCCC
Confidence            22   2223456889999999999999999999999999999999 999997643221111            1111111


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      ...+...+.++.+++.+||+.||.+||++.++++.|+.+...
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          238 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            122233445799999999999999999999999999998764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.5e-46  Score=349.92  Aligned_cols=257  Identities=26%  Similarity=0.400  Sum_probs=200.3

Q ss_pred             HHhccccccccccCceeEEEEEeC----CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      ...|.+.+.||+|+||.||+|...    .+..||+|.+... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            357788899999999999999753    2457999998764 3344567999999999999999999999985 567899


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+++|+|.+++... ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence            99999999999999643 346999999999999999999999999   99999999999999999999999999875433


Q ss_pred             cc--cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          266 DK--HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       266 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ..  ......+|+.|+|||.+....++.++||||||+++|||++ |..||.+..............            ..
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~------------~~  236 (281)
T 1mp8_A          169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE------------RL  236 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC------------CC
T ss_pred             ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC------------CC
Confidence            22  1233456789999999998999999999999999999997 999997644322221111111            11


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      ..+...+.++.+++.+||+.||++|||+.++++.|+.+++..
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          237 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            122233457899999999999999999999999999997654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.5e-46  Score=357.15  Aligned_cols=247  Identities=25%  Similarity=0.348  Sum_probs=199.2

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   87 (323)
T 3tki_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   87 (323)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence            5778899999999999999754 78999999986543 233456889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc---c
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD---K  267 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~---~  267 (432)
                      ++|+|.+++.  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....   .
T Consensus        88 ~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           88 SGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             TTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             CCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            9999999994  3456999999999999999999999999   999999999999999999999999999753322   2


Q ss_pred             cccccccCCCCCCccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCChhHHHH-HHHhhhcCCCchhhhccccCCCCCC
Q 014038          268 HAANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLMEYVE-LAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ...... ..          ......
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~----------~~~~~~  231 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KK----------TYLNPW  231 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT-TC----------TTSTTG
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-cc----------ccCCcc
Confidence            2345679999999999987765 7899999999999999999999975432111 111111 00          000001


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...+.++.+|+.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          232 KKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            122357889999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=9.1e-46  Score=355.90  Aligned_cols=262  Identities=29%  Similarity=0.508  Sum_probs=212.6

Q ss_pred             HHHHhccccccccccCceeEEEEEe--------CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEeeee
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQM--------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCA  178 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  178 (432)
                      +....|.+.+.||+|+||.||+|..        .++..||||++.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            3445788889999999999999975        356789999997653 34456789999999999 8999999999999


Q ss_pred             eCCeEEEEEEeccCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCe
Q 014038          179 EKGQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNI  244 (432)
Q Consensus       179 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Ni  244 (432)
                      +.+..++||||+++|+|.+++....              ...+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI  188 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV  188 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence            9999999999999999999996533              134899999999999999999999999   99999999999


Q ss_pred             eecCCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHH
Q 014038          245 LLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVE  320 (432)
Q Consensus       245 ll~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~  320 (432)
                      |++.++.+||+|||+++......   ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+......
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  268 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  268 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence            99999999999999987543321   2233457889999999988899999999999999999999 9999986543222


Q ss_pred             HHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          321 LAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                      ........            ....+...+.++.+++.+||+.||.+|||+.++++.|++++....
T Consensus       269 ~~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          269 FKLLKEGH------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHHHHHTC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHhcCC------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            21111111            111122234578999999999999999999999999999987644

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.4e-46  Score=373.35  Aligned_cols=257  Identities=28%  Similarity=0.452  Sum_probs=209.4

Q ss_pred             HHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      +....+.+.+.||+|+||.||+|...++..||||.+.... ...+.|.+|+.+|++++||||+++++++.+ +..++|||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence            4445677889999999999999998888889999997644 335689999999999999999999999876 67899999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-  267 (432)
                      |+++|+|.+++.......+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            999999999996544456999999999999999999999999   9999999999999999999999999997543222 


Q ss_pred             -cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          268 -HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       268 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                       ......++..|+|||.+....++.++|||||||++|||++ |+.||.+.............            .....+
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~------------~~~~~~  403 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG------------YRMPCP  403 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------------CCCCCC
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------CCCCCC
Confidence             1223456788999999999999999999999999999999 99999876543332222211            111122


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      ...+..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            2344679999999999999999999999999988754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.3e-46  Score=353.38  Aligned_cols=264  Identities=27%  Similarity=0.358  Sum_probs=204.7

Q ss_pred             HHHHHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-----hhhHHHHHHHHHHHhhcC---CCccceEEeeee
Q 014038          108 DLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-----KQGEKEFQTEVMLLGRLH---HRNLVNLVGYCA  178 (432)
Q Consensus       108 ~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~  178 (432)
                      ++...+|.+.+.||+|+||+||+|.. .+++.||||++....     ......+.+|+.++++++   ||||++++++|.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            34556788899999999999999975 578999999986432     122346677887777664   999999999998


Q ss_pred             eCC-----eEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEE
Q 014038          179 EKG-----QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR  253 (432)
Q Consensus       179 ~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~k  253 (432)
                      ...     ..++||||+. |+|.+++.......+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence            755     5799999997 69999997766666999999999999999999999999   99999999999999999999


Q ss_pred             EeecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc----CC
Q 014038          254 VADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE----GK  329 (432)
Q Consensus       254 l~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~  329 (432)
                      |+|||+++............||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+...    ..
T Consensus       161 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          161 LADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             ECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             EeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            99999998655555556678999999999999999999999999999999999999999876554443332111    11


Q ss_pred             Cchhhhc---cccCC--CCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          330 TGWEEIV---DSRLD--GIFD-----VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       330 ~~~~~~~---~~~~~--~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..|....   .....  ...+     ...+.++.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            1111000   00000  0000     012357899999999999999999999885

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5e-46  Score=352.26  Aligned_cols=268  Identities=26%  Similarity=0.405  Sum_probs=209.1

Q ss_pred             HHhccccccccccCceeEEEEEe-----CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeC--Ce
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQ  182 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  182 (432)
                      ...|.+.+.||+|+||.||+|.+     .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            34577789999999999999983     468899999997543 34457889999999999999999999999876  66


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .++||||+++|+|.+++... ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            89999999999999998543 356999999999999999999999999   99999999999999999999999999975


Q ss_pred             ccccc----cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCch---hhh
Q 014038          263 EMVDK----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW---EEI  335 (432)
Q Consensus       263 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~  335 (432)
                      .....    ......+|..|+|||.+.+..++.++||||||+++|||++|..|+....................   ...
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            43322    23345678889999999999999999999999999999999998754332211111000000000   111


Q ss_pred             ccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      .........+...+.++.+++.+||+.||.+|||+.++++.|+.+++
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            11111222333445689999999999999999999999999998763

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.1e-45  Score=354.55  Aligned_cols=253  Identities=21%  Similarity=0.341  Sum_probs=204.5

Q ss_pred             HHHhccccccccccCceeEEEEEe-CCCcEEEEEEeccC-----ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeE
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH  183 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  183 (432)
                      ....|.+.+.||+|+||.||+|.. .+|+.||||++...     .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            456788999999999999999965 47899999998542     122457799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc---EEEeecC
Q 014038          184 MLVYVFMSKGSLASHLYDE--NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR---ARVADFG  258 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~---~kl~Dfg  258 (432)
                      ++||||+++|+|.+.+...  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999998877542  3346899999999999999999999999   999999999999986654   9999999


Q ss_pred             Ccccccccc-cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcc
Q 014038          259 LSREEMVDK-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD  337 (432)
Q Consensus       259 l~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      ++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..+.. ................ 
T Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~i~~~~~~~~~~~~-  256 (351)
T 3c0i_A          179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL-FEGIIKGKYKMNPRQW-  256 (351)
T ss_dssp             TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHH-HHHHHHTCCCCCHHHH-
T ss_pred             ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHH-HHHHHcCCCCCCcccc-
Confidence            997644332 2345679999999999999999999999999999999999999998754321 1111111100000000 


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          338 SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       338 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                          .    ..+.++.+++.+||+.||++|||+.++++
T Consensus       257 ----~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          257 ----S----HISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             ----T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----c----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                0    12357899999999999999999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.8e-45  Score=351.37  Aligned_cols=260  Identities=32%  Similarity=0.530  Sum_probs=209.6

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcE--EEEEEeccC-ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGET--VAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ..|.+.+.||+|+||.||+|... ++..  +|+|.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            35678899999999999999653 5654  499988753 334456789999999999 899999999999999999999


Q ss_pred             EEeccCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcE
Q 014038          187 YVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRA  252 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~  252 (432)
                      |||+++|+|.+++....              ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999996532              347999999999999999999999999   9999999999999999999


Q ss_pred             EEeecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCc
Q 014038          253 RVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTG  331 (432)
Q Consensus       253 kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  331 (432)
                      ||+|||+++............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+.............    
T Consensus       182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~----  257 (327)
T 1fvr_A          182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----  257 (327)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT----
T ss_pred             EEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC----
Confidence            9999999875433333344567889999999998889999999999999999998 99999865433222222111    


Q ss_pred             hhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhccc
Q 014038          332 WEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHN  386 (432)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~  386 (432)
                              .....+...+.++.+++.+||+.||.+|||+.++++.|+.++..+..
T Consensus       258 --------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  304 (327)
T 1fvr_A          258 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  304 (327)
T ss_dssp             --------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence                    11112222345799999999999999999999999999999876543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.9e-46  Score=349.82  Aligned_cols=252  Identities=32%  Similarity=0.604  Sum_probs=202.2

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhh-------HHHHHHHHHHHhhcCCCccceEEeeeeeCCeE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQG-------EKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH  183 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  183 (432)
                      ..|.+.+.||+|+||.||+|.. .+++.||+|++.......       .+.+.+|+.++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            4677889999999999999976 578999999986543221       167899999999999999999999987655  


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc-----EEEeecC
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR-----ARVADFG  258 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~-----~kl~Dfg  258 (432)
                      ++||||+++|+|.+++... ...+++..++.++.|++.||.|||+++ ++|+||||||+|||++.++.     +||+|||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG  174 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred             eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence            6999999999999888643 357999999999999999999999976 45999999999999988776     9999999


Q ss_pred             CcccccccccccccccCCCCCCcccc--ccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHH-HHHhhhcCCCchhhh
Q 014038          259 LSREEMVDKHAANIRGTFGYLDPEYI--STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVE-LAAMNTEGKTGWEEI  335 (432)
Q Consensus       259 l~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~  335 (432)
                      +++...  .......||+.|+|||.+  ....++.++|||||||++|||++|+.||........ ....          .
T Consensus       175 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----------~  242 (287)
T 4f0f_A          175 LSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM----------I  242 (287)
T ss_dssp             TCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH----------H
T ss_pred             cccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH----------H
Confidence            987432  233456799999999998  455678999999999999999999999975321110 0110          0


Q ss_pred             ccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 014038          336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR  379 (432)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~  379 (432)
                      .........+...+.++.+++.+||+.||.+|||+.++++.|++
T Consensus       243 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            11111122233344689999999999999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.7e-45  Score=349.09  Aligned_cols=258  Identities=25%  Similarity=0.383  Sum_probs=200.5

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .|.+.+.||+|+||+||+|+..+|+.||+|++....  ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        22 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  101 (311)
T 3niz_A           22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM  101 (311)
T ss_dssp             EEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECC
T ss_pred             hhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCC
Confidence            677889999999999999998889999999987543  233467889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-ccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~  269 (432)
                      ++ +|.+.+... ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..... ...
T Consensus       102 ~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  176 (311)
T 3niz_A          102 EK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY  176 (311)
T ss_dssp             SE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred             CC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence            85 888877543 356999999999999999999999999   999999999999999999999999999764322 233


Q ss_pred             cccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh----cCCCchhhhcc------c
Q 014038          270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT----EGKTGWEEIVD------S  338 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~------~  338 (432)
                      ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..+......+..    .....|....+      .
T Consensus       177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  256 (311)
T 3niz_A          177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR  256 (311)
T ss_dssp             -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSC
T ss_pred             cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhc
Confidence            44578999999999875 5689999999999999999999999976443322222111    11111111100      0


Q ss_pred             cCC--CCCCH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          339 RLD--GIFDV-----EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       339 ~~~--~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...  ...+.     ..+.++.+|+.+||+.||++|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            000  00010     12357889999999999999999999885

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=9e-46  Score=346.60  Aligned_cols=258  Identities=28%  Similarity=0.443  Sum_probs=212.2

Q ss_pred             HHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      ..+|.+.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            34678889999999999999998888899999987543 34568999999999999999999999987 45689999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--c
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--H  268 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--~  268 (432)
                      ++++|.+++.......+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.......  .
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  166 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA  166 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence            9999999996543346999999999999999999999999   9999999999999999999999999987543322  2


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+..............            ....+..
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------------~~~~~~~  234 (279)
T 1qpc_A          167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------RMVRPDN  234 (279)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------CCCCCTT
T ss_pred             ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc------------CCCCccc
Confidence            233456789999999998899999999999999999999 999998654433222221111            1111222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                      .+.++.+++.+||+.||++|||+.++++.|+.+.....
T Consensus       235 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence            34579999999999999999999999999999976543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.5e-46  Score=359.52  Aligned_cols=245  Identities=22%  Similarity=0.359  Sum_probs=203.2

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+|.. .+++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE   89 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence            577889999999999999975 678999999986431   2234578999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+ +|+|.+++...  +.+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        90 ~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~  163 (336)
T 3h4j_B           90 YA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF  163 (336)
T ss_dssp             CC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred             CC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence            99 78999888543  46999999999999999999999999   99999999999999999999999999986555555


Q ss_pred             ccccccCCCCCCccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          269 AANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+...           ......+...  ....+..
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----------~~~~~~i~~~--~~~~p~~  230 (336)
T 3h4j_B          164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI-----------PNLFKKVNSC--VYVMPDF  230 (336)
T ss_dssp             TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS-----------TTCBCCCCSS--CCCCCTT
T ss_pred             cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH-----------HHHHHHHHcC--CCCCccc
Confidence            566789999999999988776 7899999999999999999999975321           0000111000  1112223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      .+.++.+++.+||+.||.+|||+.++++.
T Consensus       231 ~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          231 LSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            34578999999999999999999999863

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.9e-46  Score=361.49  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=192.0

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      +|.+.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   99 (361)
T 3uc3_A           21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS   99 (361)
T ss_dssp             TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence            6788899999999999999765 78999999997543 234678899999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc--EEEeecCCcccccccccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR--ARVADFGLSREEMVDKHA  269 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~--~kl~Dfgl~~~~~~~~~~  269 (432)
                      +|+|.+++...  +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.  +||+|||+++........
T Consensus       100 ~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~  174 (361)
T 3uc3_A          100 GGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  174 (361)
T ss_dssp             SCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence            99999998543  46999999999999999999999999   999999999999987765  999999999754444445


Q ss_pred             cccccCCCCCCccccccCCCCch-hHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKK-SDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~-~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      ....||+.|+|||++.+..++.+ +|||||||++|||++|+.||.+..........       ...+.......+.....
T Consensus       175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~  247 (361)
T 3uc3_A          175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT-------IQRILSVKYSIPDDIRI  247 (361)
T ss_dssp             ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH-------HHHHHTTCCCCCTTSCC
T ss_pred             CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH-------HHHHhcCCCCCCCcCCC
Confidence            56679999999999988887765 89999999999999999999764321000000       00011111111111112


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      +.++.+|+.+||+.||++|||+.++++.
T Consensus       248 s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          248 SPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            3578999999999999999999999864

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.9e-45  Score=341.96  Aligned_cols=254  Identities=28%  Similarity=0.473  Sum_probs=211.9

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      ..|.+.+.||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            35677889999999999999988889999999976533 34678999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--cc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HA  269 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--~~  269 (432)
                      +++|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......  ..
T Consensus        87 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  162 (267)
T 3t9t_A           87 HGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  162 (267)
T ss_dssp             TCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             CCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence            99999999653 356899999999999999999999999   9999999999999999999999999987543221  22


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.................            ...+...
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~------------~~~~~~~  230 (267)
T 3t9t_A          163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------------LYKPRLA  230 (267)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC------------CCCCTTS
T ss_pred             ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc------------CCCCccC
Confidence            33456788999999998999999999999999999999 8999986543322222211111            1111122


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      +..+.+++.+||+.||++||++.++++.|+++.+
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          231 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            3578999999999999999999999999999865

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3e-46  Score=351.88  Aligned_cols=261  Identities=28%  Similarity=0.515  Sum_probs=199.2

Q ss_pred             HHHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          108 DLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       108 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      |+....|.+.+.||+|+||.||+|...  ..||+|++...  .....+.|.+|+.++++++||||+++++++. .+..++
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~l   96 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI   96 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEE
Confidence            344456788899999999999999863  46999998754  3444577999999999999999999999664 567899


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+++++|.+++... ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        97 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             EEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             EEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence            99999999999998543 456999999999999999999999999   99999999999999999999999999875332


Q ss_pred             ---cccccccccCCCCCCccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          266 ---DKHAANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       266 ---~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                         ........||+.|+|||.+.   ...++.++||||||+++|||++|+.||.+................      .+.
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------~~~  246 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL------SPD  246 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSC------CCC
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccccc------Ccc
Confidence               12233457899999999986   667899999999999999999999999865443333222211110      000


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      . .......+.++.+++.+||+.||.+|||+.++++.|+++.+
T Consensus       247 ~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          247 L-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             T-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             h-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            0 01112234579999999999999999999999999998753

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.7e-45  Score=348.99  Aligned_cols=251  Identities=24%  Similarity=0.360  Sum_probs=208.7

Q ss_pred             HHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh------hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK------QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH  183 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  183 (432)
                      ...|.+.+.||+|+||.||+|... +|+.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            457888999999999999999764 689999999875432      1356799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC----cEEEeecCC
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM----RARVADFGL  259 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~----~~kl~Dfgl  259 (432)
                      ++||||+++++|.+++..  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++    .+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            999999999999999954  356999999999999999999999999   99999999999999888    799999999


Q ss_pred             cccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          260 SREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      +.............||+.|+|||.+.+..++.++||||||+++|||++|+.||.+......................   
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~---  242 (321)
T 2a2a_A          166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF---  242 (321)
T ss_dssp             CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH---
T ss_pred             ceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh---
Confidence            97655444445667999999999999999999999999999999999999999875543333322211110000000   


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                        .    ..+..+.+++.+||+.||++|||+.++++
T Consensus       243 --~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          243 --S----HTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             --T----TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             --c----ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              0    12347899999999999999999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.7e-45  Score=342.07  Aligned_cols=250  Identities=21%  Similarity=0.299  Sum_probs=208.1

Q ss_pred             HHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ...|.+.+.||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            356888899999999999999654 5779999999776556677899999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee---cCCCcEEEeecCCccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill---~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||++......
T Consensus        88 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           88 CTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            9999999988543  46899999999999999999999999   9999999999999   88899999999999765545


Q ss_pred             ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      .......+|+.|+|||.+.+. ++.++||||||+++|||++|+.||........................         .
T Consensus       163 ~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~  232 (277)
T 3f3z_A          163 KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW---------L  232 (277)
T ss_dssp             SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH---------T
T ss_pred             cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh---------h
Confidence            555566799999999998654 899999999999999999999999875544333332221111000000         0


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.++.+++.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          233 NVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            12357899999999999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.8e-45  Score=348.12  Aligned_cols=254  Identities=26%  Similarity=0.438  Sum_probs=198.3

Q ss_pred             HHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhh--cCCCccceEEeeeeeC----CeEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGR--LHHRNLVNLVGYCAEK----GQHM  184 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~  184 (432)
                      ...|.+.+.||+|+||.||+|.. +++.||||++...   ....+.+|.+++..  ++||||+++++++...    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            34677889999999999999987 7899999998643   34556667777766  7999999999987543    4689


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeccCCCCCeeecCCCcEEEee
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH--------DGAVPPVIHRDIKSSNILLDQSMRARVAD  256 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~iiH~dlkp~Nill~~~~~~kl~D  256 (432)
                      +||||+++|+|.+++..   ..+++..++.++.|++.||+|||        +.+   |+||||||+|||++.++.+||+|
T Consensus        83 lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             EEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred             EehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence            99999999999999943   46999999999999999999999        777   99999999999999999999999


Q ss_pred             cCCccccccccc-----ccccccCCCCCCccccccC------CCCchhHhHHHHHHHHHHHhC----------CCCCCCh
Q 014038          257 FGLSREEMVDKH-----AANIRGTFGYLDPEYISTR------NFTKKSDVYSFGVLLFELIAG----------RSPLQGL  315 (432)
Q Consensus       257 fgl~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvil~elltg----------~~p~~~~  315 (432)
                      ||+++.......     .....||+.|+|||++.+.      .++.++|||||||++|||++|          +.||...
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            999865332221     2334799999999999876      455799999999999999999          8888542


Q ss_pred             hH----HHHHHHhhhcCCCchhhhccccC-CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          316 ME----YVELAAMNTEGKTGWEEIVDSRL-DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       316 ~~----~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      ..    ............      ..+.. ....+...+.++.+++.+||+.||++|||+.+|++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          237 VPNDPSFEDMRKVVCVDQ------QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SCSSCCHHHHHHHHTTSC------CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcchhhhhHHHhccC------CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            11    111111100000      00000 0112234667899999999999999999999999999876

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.9e-46  Score=348.93  Aligned_cols=253  Identities=26%  Similarity=0.455  Sum_probs=210.9

Q ss_pred             HHHHHHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeee------
Q 014038          107 KDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE------  179 (432)
Q Consensus       107 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  179 (432)
                      .......|.+.+.||+|+||.||+|... +++.||+|.+....    +.+.+|+.++++++||||+++++++..      
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            3455678889999999999999999765 78999999997543    356789999999999999999998854      


Q ss_pred             ----------CCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC
Q 014038          180 ----------KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS  249 (432)
Q Consensus       180 ----------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~  249 (432)
                                ....++||||+++|+|.+++.......+++..++.++.|++.||.|||+++   |+||||||+|||++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT  158 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCC
Confidence                      445799999999999999997655567999999999999999999999999   9999999999999999


Q ss_pred             CcEEEeecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCC
Q 014038          250 MRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGK  329 (432)
Q Consensus       250 ~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  329 (432)
                      +.+||+|||++.............+|+.|+|||.+.+..++.++||||||+++|||++|..|+........         
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---------  229 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT---------  229 (284)
T ss_dssp             TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHH---------
T ss_pred             CCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHH---------
Confidence            99999999998765544444556799999999999999999999999999999999999998753322111         


Q ss_pred             CchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          330 TGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                          .+........+    +..+.+++.+||+.||.+|||+.++++.|..+.+.
T Consensus       230 ----~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          230 ----DLRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             ----HHHTTCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             ----HhhcccccccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence                11111122222    24688999999999999999999999999888543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.3e-45  Score=362.23  Aligned_cols=261  Identities=20%  Similarity=0.298  Sum_probs=203.9

Q ss_pred             Hhcccccccccc--CceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          112 ATCNFTTLIGQG--AFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       112 ~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ..|.+.+.||+|  +||.||+|+.. +|+.||||++....  ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            367888999999  99999999765 78999999997542  34456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||+++|+|.+++.......+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||.+......
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~  181 (389)
T 3gni_B          105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISH  181 (389)
T ss_dssp             EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred             EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence            99999999999997766677999999999999999999999999   999999999999999999999999987543211


Q ss_pred             --------ccccccccCCCCCCcccccc--CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCch----
Q 014038          267 --------KHAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW----  332 (432)
Q Consensus       267 --------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----  332 (432)
                              .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.................+    
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (389)
T 3gni_B          182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS  261 (389)
T ss_dssp             TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred             cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence                    11223478999999999987  6799999999999999999999999976432221111110000000    


Q ss_pred             ----h----------------hhc---------cccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          333 ----E----------------EIV---------DSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       333 ----~----------------~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                          .                ...         ........+...+.++.+|+.+||+.||++|||+.++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                0                000         000000112223467999999999999999999999985

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.2e-46  Score=354.53  Aligned_cols=255  Identities=25%  Similarity=0.437  Sum_probs=202.4

Q ss_pred             hccccccccccCceeEEEEEeC-CCcE----EEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGET----VAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      .|.+.+.||+|+||.||+|... +++.    ||+|.+.... ......+.+|+.++++++||||++++++|. .+..++|
T Consensus        14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v   92 (325)
T 3kex_A           14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV   92 (325)
T ss_dssp             TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred             HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence            5677889999999999999753 4443    7888875432 233456788999999999999999999986 5678999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||+++|+|.+++... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           93 TQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            9999999999998643 357999999999999999999999999   999999999999999999999999999764332


Q ss_pred             c---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          267 K---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       267 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .   ......+|..|+|||.+.+..++.++|||||||++|||++ |+.||.+..............            ..
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------~~  236 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE------------RL  236 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC------------BC
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC------------CC
Confidence            2   2234567889999999999999999999999999999999 999998643222111111111            11


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      ..+...+.++.+++.+||+.||.+||++.++++.|+.+....
T Consensus       237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          237 AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            111122336789999999999999999999999999986543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.9e-46  Score=356.70  Aligned_cols=269  Identities=25%  Similarity=0.360  Sum_probs=213.0

Q ss_pred             HhccccccccccCceeEEEEEe-----CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeee--eCCeEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA--EKGQHM  184 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  184 (432)
                      ..|.+.+.||+|+||.||+|.+     .+++.||||++........+.+.+|+.++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            4677889999999999999973     468899999998777666778999999999999999999999886  456789


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      +||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            999999999999998643 246999999999999999999999999   9999999999999999999999999997543


Q ss_pred             ccc----cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCc---hhhhcc
Q 014038          265 VDK----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG---WEEIVD  337 (432)
Q Consensus       265 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~  337 (432)
                      ...    ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||...................   +.....
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            222    2233457888999999998899999999999999999999999987644321111000000000   111122


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          338 SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       338 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      .......+...+.++.+++.+||+.||++|||+.++++.|+.+....
T Consensus       259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            22222334444568999999999999999999999999999886544

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=347.52  Aligned_cols=246  Identities=25%  Similarity=0.391  Sum_probs=195.2

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCCh--------------------------hhHHHHHHHHHHHhhc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK--------------------------QGEKEFQTEVMLLGRL  165 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l  165 (432)
                      .|.+.+.||+|+||.||+|.. .+++.||||++.....                          ...+.+.+|+.+++++
T Consensus        14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            577889999999999999965 4788999999865421                          1134688999999999


Q ss_pred             CCCccceEEeeeee--CCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCC
Q 014038          166 HHRNLVNLVGYCAE--KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSN  243 (432)
Q Consensus       166 ~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~N  243 (432)
                      +||||+++++++.+  .+..++||||+++|+|.+++.   ..++++..+..++.||+.||.|||+++   |+||||||+|
T Consensus        94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N  167 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSN  167 (298)
T ss_dssp             CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred             CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence            99999999999986  568899999999999998763   346999999999999999999999999   9999999999


Q ss_pred             eeecCCCcEEEeecCCccccccc-ccccccccCCCCCCccccccCC---CCchhHhHHHHHHHHHHHhCCCCCCChhHHH
Q 014038          244 ILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPLQGLMEYV  319 (432)
Q Consensus       244 ill~~~~~~kl~Dfgl~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~elltg~~p~~~~~~~~  319 (432)
                      ||++.++.+||+|||+++..... .......||+.|+|||.+.+..   ++.++|||||||++|||++|+.||.......
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  247 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC  247 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence            99999999999999999754332 2234567999999999997655   4789999999999999999999998654322


Q ss_pred             HHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          320 ELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .........           .........+.++.+++.+||+.||++|||+.++++
T Consensus       248 ~~~~~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          248 LHSKIKSQA-----------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHHHCC-----------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHhccc-----------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            111111110           000001122357899999999999999999999875

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.4e-45  Score=350.86  Aligned_cols=260  Identities=21%  Similarity=0.298  Sum_probs=208.7

Q ss_pred             cCHHHHHHHhcccc-ccccccCceeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhhc-CCCccceEEeeee
Q 014038          104 YSYKDLQKATCNFT-TLIGQGAFGPVYKAQMS-TGETVAVKVLATD--SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCA  178 (432)
Q Consensus       104 ~~~~~l~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  178 (432)
                      |...+.....|.+. +.||+|+||.||+|... +++.||+|++...  .......+.+|+.++..+ +||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            44455556677776 88999999999999654 6899999998754  233457889999999999 5799999999999


Q ss_pred             eCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC---CCcEEEe
Q 014038          179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---SMRARVA  255 (432)
Q Consensus       179 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~---~~~~kl~  255 (432)
                      +.+..++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+   |+||||||+|||++.   ++.+||+
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence            9999999999999999999997666678999999999999999999999999   999999999999988   7899999


Q ss_pred             ecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhh
Q 014038          256 DFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEI  335 (432)
Q Consensus       256 Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (432)
                      |||+++............||+.|+|||++.+..++.++||||||+++|||++|+.||.+................     
T Consensus       177 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-----  251 (327)
T 3lm5_A          177 DFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD-----  251 (327)
T ss_dssp             CGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----
T ss_pred             eCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc-----
Confidence            999998655444445567999999999999999999999999999999999999999875544333222211110     


Q ss_pred             ccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                          .........+..+.+++.+||+.||.+|||+.++++
T Consensus       252 ----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          252 ----YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             ----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ----cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence                111111123357899999999999999999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6e-45  Score=344.09  Aligned_cols=259  Identities=19%  Similarity=0.242  Sum_probs=209.3

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEe
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ..|.+.+.||+|+||.||+|.. .+|+.||||++....  ..+.+.+|+.++..+ +|+|++++++++.+....++||||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   87 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   87 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence            4677889999999999999974 578999999986543  234578899999999 799999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc-----EEEeecCCccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR-----ARVADFGLSREEM  264 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~-----~kl~Dfgl~~~~~  264 (432)
                      + +++|.+++... ..++++..+..++.||+.||.|||+++   |+||||||+|||++.++.     +||+|||+++...
T Consensus        88 ~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           88 L-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             c-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            9 99999999653 346999999999999999999999999   999999999999987776     9999999997543


Q ss_pred             ccc--------cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChh---HHHHHHHhhhc-CCCch
Q 014038          265 VDK--------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM---EYVELAAMNTE-GKTGW  332 (432)
Q Consensus       265 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~---~~~~~~~~~~~-~~~~~  332 (432)
                      ...        ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.+..   ........... .....
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  242 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence            321        1345579999999999999999999999999999999999999997632   11111111000 00001


Q ss_pred             hhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhccc
Q 014038          333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHN  386 (432)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~  386 (432)
                      ...     ..    ..+.++.+++.+||+.||++||++.+|++.|+++.+....
T Consensus       243 ~~~-----~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~  287 (298)
T 1csn_A          243 REL-----CA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  287 (298)
T ss_dssp             HHH-----TT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HHH-----Hh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence            111     11    1235789999999999999999999999999999876543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.4e-45  Score=352.21  Aligned_cols=265  Identities=25%  Similarity=0.368  Sum_probs=210.8

Q ss_pred             cccccccccCceeEEEEEeC-----CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeC--CeEEEE
Q 014038          115 NFTTLIGQGAFGPVYKAQMS-----TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK--GQHMLV  186 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  186 (432)
                      .+.+.||+|+||.||++.+.     +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            67789999999999988642     67899999997653 34456799999999999999999999999874  678999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||+++|+|.+++...   .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       114 ~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             ECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            9999999999999543   4899999999999999999999999   999999999999999999999999999764332


Q ss_pred             c----cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcC---CCchhhhcccc
Q 014038          267 K----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG---KTGWEEIVDSR  339 (432)
Q Consensus       267 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  339 (432)
                      .    ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||................   ...+...+...
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG  267 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence            2    2234467888999999999899999999999999999999999997643221110000000   00011222222


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                      .....+...+.++.+++.+||+.||.+|||+.++++.|+.+.+...
T Consensus       268 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            2223333445689999999999999999999999999999987654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.5e-45  Score=360.99  Aligned_cols=249  Identities=22%  Similarity=0.398  Sum_probs=198.2

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ..|.+.++||+|+||.||+|+.. +++.||+|++....   ......+.+|..++.++ +||||+++++++.+.+..++|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            35778899999999999999764 67899999997542   22334678899999887 899999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc-c
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-V  265 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~-~  265 (432)
                      |||+++|+|..++...  +.+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++... .
T Consensus       132 ~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            9999999999998543  46999999999999999999999999   9999999999999999999999999998532 3


Q ss_pred             cccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCC-chhhhccccCCCCC
Q 014038          266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT-GWEEIVDSRLDGIF  344 (432)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  344 (432)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........   .... ....+.....  .+
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~---~~~~~~~~~i~~~~~--~~  281 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---NTEDYLFQVILEKQI--RI  281 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------CCHHHHHHHHHHCCC--CC
T ss_pred             CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch---hhHHHHHHHHhcccc--CC
Confidence            3445667899999999999999999999999999999999999999964211000000   0000 0011111111  12


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCH
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSM  370 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~  370 (432)
                      +...+.++.+|+.+||+.||.+||++
T Consensus       282 p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          282 PRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            22334578999999999999999995

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-45  Score=351.45  Aligned_cols=244  Identities=25%  Similarity=0.404  Sum_probs=204.4

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            35778899999999999999764 78999999986532   233467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+++|+|.+++...  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...  .
T Consensus        86 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~--~  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP--D  158 (318)
T ss_dssp             CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS--S
T ss_pred             eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC--C
Confidence            999999999999643  46999999999999999999999999   9999999999999999999999999997543  2


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+....           .  .++..
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----------~--~~p~~  225 (318)
T 1fot_A          159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-----------L--RFPPF  225 (318)
T ss_dssp             CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----------C--CCCTT
T ss_pred             ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------C--CCCCC
Confidence            3345689999999999999999999999999999999999999997654433222221111           0  11222


Q ss_pred             HHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRP-----SMRDIVQ  375 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RP-----s~~~vl~  375 (432)
                      .+.++.+++.+||+.||.+||     ++.++++
T Consensus       226 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          226 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            335789999999999999999     8888875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.3e-46  Score=354.70  Aligned_cols=258  Identities=29%  Similarity=0.469  Sum_probs=196.6

Q ss_pred             HhccccccccccCceeEEEEEeCCC-c---EEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeE--
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTG-E---TVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH--  183 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--  183 (432)
                      ..|.+.+.||+|+||.||+|..... +   .||||.+...  .....+.+.+|+.++++++||||+++++++......  
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            4677889999999999999975433 2   7999999764  344567899999999999999999999999876655  


Q ss_pred             ----EEEEEeccCCChhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEe
Q 014038          184 ----MLVYVFMSKGSLASHLYDE----NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA  255 (432)
Q Consensus       184 ----~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~  255 (432)
                          ++||||+++|+|.+++...    ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~  179 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVA  179 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEEC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEe
Confidence                9999999999999998542    2235999999999999999999999999   9999999999999999999999


Q ss_pred             ecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCc
Q 014038          256 DFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTG  331 (432)
Q Consensus       256 Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  331 (432)
                      |||+++......   ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+..............   
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~---  256 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN---  256 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC---
T ss_pred             eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC---
Confidence            999997543322   1223456788999999999999999999999999999999 999997644322211111111   


Q ss_pred             hhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          332 WEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                               ....+...+.++.+++.+||+.||++|||+.++++.|++++...
T Consensus       257 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          257 ---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                     11122233457999999999999999999999999999998743

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=355.70  Aligned_cols=249  Identities=23%  Similarity=0.318  Sum_probs=188.7

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      ..|.+.+.||+|+||.||+|... +++.||||++....  ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  130 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV  130 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence            45778899999999999999765 67899999987543  3456889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC---CCcEEEeecCCcccccccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---SMRARVADFGLSREEMVDK  267 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~---~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ++|+|.+++..  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++......
T Consensus       131 ~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          131 TGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             CSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            99999999854  356999999999999999999999999   999999999999975   8899999999997654444


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...................        ........
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~--------~~~~~~~~  277 (349)
T 2w4o_A          206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY--------FISPWWDE  277 (349)
T ss_dssp             -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC--------CCTTTTTT
T ss_pred             ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc--------cCCchhhh
Confidence            4455679999999999999999999999999999999999999997644322221111111100        00111112


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+.++.+++.+||+.||++|||+.++++
T Consensus       278 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          278 VSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            3457899999999999999999999886

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.5e-45  Score=347.01  Aligned_cols=258  Identities=25%  Similarity=0.391  Sum_probs=200.9

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCCh--hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .|.+.+.||+|+||.||+|...+|+.||+|.+.....  .....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence            4677889999999999999888899999999865432  23467889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-ccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~  269 (432)
                      ++ +|.+++... ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..... ...
T Consensus        83 ~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           83 DQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             SE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             CC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence            75 898888543 356999999999999999999999999   999999999999999999999999998754322 223


Q ss_pred             cccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh----cCCCchhhhc-----ccc
Q 014038          270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT----EGKTGWEEIV-----DSR  339 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~~~~-----~~~  339 (432)
                      ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+............    .....|....     ++.
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            34578999999999865 4589999999999999999999999987655433332211    1111111110     000


Q ss_pred             CC-------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          340 LD-------GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       340 ~~-------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..       .......+.++.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00       0001123457889999999999999999999875

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=358.86  Aligned_cols=247  Identities=25%  Similarity=0.356  Sum_probs=203.2

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||+|.. .+++.||+|.+....   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            4677889999999999999965 468899999986532   233467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+.+|+|..++..  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        95 e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             CCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            99999999999954  456999999999999999999999999   9999999999999999999999999998665555


Q ss_pred             cccccccCCCCCCcccccc---CCCCchhHhHHHHHHHHHHHhCCCCCCChhH--HHHHHHhhhcCCCchhhhccccCCC
Q 014038          268 HAANIRGTFGYLDPEYIST---RNFTKKSDVYSFGVLLFELIAGRSPLQGLME--YVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ......||+.|+|||++..   ..|+.++|||||||++|||++|+.||.....  ...........            ..
T Consensus       170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------------~~  237 (384)
T 4fr4_A          170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT------------VV  237 (384)
T ss_dssp             CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC------------CC
T ss_pred             ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc------------cc
Confidence            5667789999999999864   4589999999999999999999999974221  11111110000            01


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPS-MRDIVQ  375 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs-~~~vl~  375 (432)
                      .++...+.++.+|+.+||+.||.+||+ +.++++
T Consensus       238 ~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            122233457899999999999999998 666654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.2e-45  Score=351.04  Aligned_cols=247  Identities=23%  Similarity=0.366  Sum_probs=197.0

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC--------
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG--------  181 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  181 (432)
                      ..|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||++++++|.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            46788899999999999999765 78999999997543 345578999999999999999999999986543        


Q ss_pred             -------------------------------------------------eEEEEEEeccCCChhhhcccCC-CCCCCHHH
Q 014038          182 -------------------------------------------------QHMLVYVFMSKGSLASHLYDEN-YGPLTWNL  211 (432)
Q Consensus       182 -------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~  211 (432)
                                                                       ..++||||+++|+|.+++.... ....++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             3799999999999999996533 23466778


Q ss_pred             HHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-------------cccccccCCCC
Q 014038          212 RVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-------------HAANIRGTFGY  278 (432)
Q Consensus       212 ~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-------------~~~~~~gt~~y  278 (432)
                      ++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......             ......||+.|
T Consensus       166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            8999999999999999999   9999999999999999999999999987543321             22345699999


Q ss_pred             CCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHH
Q 014038          279 LDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYK  358 (432)
Q Consensus       279 ~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  358 (432)
                      +|||.+.+..++.++|||||||++|||++|..|+......   ........           ..........++.+++.+
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~---~~~~~~~~-----------~~~~~~~~~~~~~~li~~  308 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI---ITDVRNLK-----------FPLLFTQKYPQEHMMVQD  308 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH---HHHHHTTC-----------CCHHHHHHCHHHHHHHHH
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH---HHHhhccC-----------CCcccccCChhHHHHHHH
Confidence            9999999999999999999999999999998775432211   11111100           000112334578999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 014038          359 CVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       359 cl~~dp~~RPs~~~vl~  375 (432)
                      ||+.||++|||+.++++
T Consensus       309 ~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          309 MLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHCSSGGGSCCHHHHHH
T ss_pred             HccCCCCcCCCHHHHhh
Confidence            99999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-45  Score=349.00  Aligned_cols=259  Identities=28%  Similarity=0.482  Sum_probs=206.5

Q ss_pred             HhccccccccccCceeEEEEEeCC-----CcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMST-----GETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      ..+.+.+.||+|+||.||+|....     +..||||.+.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456677899999999999996532     2369999997653 3445678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+++|+|.+++... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       124 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            99999999999998643 357999999999999999999999999   99999999999999999999999999875432


Q ss_pred             cc----cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          266 DK----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       266 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ..    ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+..............            
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~------------  267 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------------  267 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------------
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC------------
Confidence            21    1222346788999999999999999999999999999999 999997654432222221111            


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhccc
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHN  386 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~  386 (432)
                      ....+...+.++.+++.+||+.||.+||++.++++.|+.+......
T Consensus       268 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  313 (333)
T 1mqb_A          268 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS  313 (333)
T ss_dssp             CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence            1111223345799999999999999999999999999999875443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.7e-46  Score=358.26  Aligned_cols=259  Identities=28%  Similarity=0.497  Sum_probs=209.6

Q ss_pred             HhccccccccccCceeEEEEEeC-CC-----cEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TG-----ETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQH  183 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  183 (432)
                      ..|.+.+.||+|+||.||+|... ++     ..||+|.+.... ....+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus        46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  125 (333)
T 2i1m_A           46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV  125 (333)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence            46778899999999999999753 22     479999997653 34456799999999999 899999999999999999


Q ss_pred             EEEEEeccCCChhhhcccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc
Q 014038          184 MLVYVFMSKGSLASHLYDEN------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR  251 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~  251 (432)
                      ++||||+++|+|.+++....            ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.
T Consensus       126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~  202 (333)
T 2i1m_A          126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHV  202 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGE
T ss_pred             EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCe
Confidence            99999999999999986421            346899999999999999999999999   999999999999999999


Q ss_pred             EEEeecCCccccccccc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhc
Q 014038          252 ARVADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTE  327 (432)
Q Consensus       252 ~kl~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  327 (432)
                      +||+|||++........   .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+.............
T Consensus       203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  282 (333)
T 2i1m_A          203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD  282 (333)
T ss_dssp             EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH
T ss_pred             EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc
Confidence            99999999975433221   233457889999999998999999999999999999999 99999764322111111111


Q ss_pred             CCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          328 GKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      .           .....+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       283 ~-----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          283 G-----------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             T-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             C-----------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            1           111112222357899999999999999999999999999887654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.4e-45  Score=351.99  Aligned_cols=246  Identities=23%  Similarity=0.407  Sum_probs=195.5

Q ss_pred             HhccccccccccCceeEEEEEe----CCCcEEEEEEeccCC----hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM----STGETVAVKVLATDS----KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH  183 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  183 (432)
                      ..|.+.+.||+|+||.||+++.    .+|+.||+|++....    ......+.+|+.+++.++||||+++++++.+.+..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            4678889999999999999976    478999999997542    23345678999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ++||||+++|+|.+++...  +.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           97 YLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            9999999999999998543  46899999999999999999999999   999999999999999999999999998753


Q ss_pred             ccc-ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          264 MVD-KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       264 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+....           .  
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-----------~--  238 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-----------L--  238 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----------C--
T ss_pred             ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-----------C--
Confidence            322 23345679999999999999999999999999999999999999998754433222221111           0  


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRP-----SMRDIVQ  375 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~~vl~  375 (432)
                      .++...+.++.+++.+||+.||.+||     ++.++++
T Consensus       239 ~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          239 NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            11122335789999999999999999     6777765

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.2e-45  Score=347.56  Aligned_cols=255  Identities=23%  Similarity=0.379  Sum_probs=192.1

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .|.+.+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   85 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM   85 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence            566778999999999999965 468999999997653 333467889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          191 SKGSLASHLYDE----NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       191 ~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      + |+|.+++...    ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            8 6999888542    2245899999999999999999999999   999999999999999999999999999754322


Q ss_pred             -ccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc----CCCchhh------
Q 014038          267 -KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE----GKTGWEE------  334 (432)
Q Consensus       267 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~~------  334 (432)
                       .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......+..+...    ....|..      
T Consensus       162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  241 (317)
T 2pmi_A          162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK  241 (317)
T ss_dssp             CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred             cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence             22345578999999999876 46899999999999999999999999876554333322110    1111111      


Q ss_pred             ---------------hccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 ---------------IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 ---------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                                     .+.+....    ..+.++.+|+.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          242 YNPNIQQRPPRDLRQVLQPHTKE----PLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CCTTCCCCCCCCSHHHHGGGCSS----CCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccchhHHHhhcccccc----cCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                           01111111    12357899999999999999999999875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.2e-45  Score=355.05  Aligned_cols=244  Identities=24%  Similarity=0.337  Sum_probs=204.7

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            36778899999999999999764 78999999986532   233467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+++|+|.+++...  +.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....  
T Consensus       121 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--  193 (350)
T ss_dssp             ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC--
Confidence            999999999999643  46999999999999999999999999   99999999999999999999999999975432  


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+... ..            .++..
T Consensus       194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~~------------~~p~~  260 (350)
T 1rdq_E          194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-KV------------RFPSH  260 (350)
T ss_dssp             CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CC------------CCCTT
T ss_pred             CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-CC------------CCCCC
Confidence            334568999999999999999999999999999999999999999875443322222211 11            11222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPS-----MRDIVQ  375 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs-----~~~vl~  375 (432)
                      .+.++.+++.+||+.||.+||+     +.+|++
T Consensus       261 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            3457899999999999999998     777765

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6e-46  Score=358.13  Aligned_cols=245  Identities=28%  Similarity=0.469  Sum_probs=203.8

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ..|.+.+.||+|+||.||+|+.. +|+.||||++....   ......+..|..++..+ +||||+++++++.+.+..++|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            46778899999999999999764 68999999997532   23345678899999887 899999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-  265 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-  265 (432)
                      |||+++|+|.+++...  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.... 
T Consensus        97 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            9999999999999543  46999999999999999999999999   99999999999999999999999999975432 


Q ss_pred             cccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+... ..            .++
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~~------------~~p  238 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-NP------------FYP  238 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CC------------CCC
T ss_pred             CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC-CC------------CCC
Confidence            23445678999999999999999999999999999999999999999875443322222111 11            112


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMR-DIV  374 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~-~vl  374 (432)
                      ...+.++.+++.+||+.||++||++. +++
T Consensus       239 ~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          239 RWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            22335789999999999999999997 554

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4e-45  Score=342.97  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=207.1

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      ..|.+.+.||+|+||.||+|.. .+++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            3577889999999999999965 46899999998654  33445678899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc---EEEeecCCcccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR---ARVADFGLSREEMV  265 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~---~kl~Dfgl~~~~~~  265 (432)
                      |+++|+|.+.+...  ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||++.....
T Consensus        86 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           86 LVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            99999999888543  46999999999999999999999999   999999999999976655   99999999976554


Q ss_pred             cccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      ........||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+................         ......
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~~~~~~  231 (284)
T 3kk8_A          161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD---------YPSPEW  231 (284)
T ss_dssp             SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------CCTTTT
T ss_pred             CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc---------CCchhh
Confidence            44445667999999999999999999999999999999999999999875544333322221110         000011


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ...+.++.+++.+||+.||++|||+.++++.
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          232 DTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            1223578999999999999999999999873

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.2e-45  Score=364.73  Aligned_cols=245  Identities=27%  Similarity=0.387  Sum_probs=205.3

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+|... +|+.||||++....   ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E   96 (476)
T 2y94_A           17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME   96 (476)
T ss_dssp             TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5778899999999999999764 79999999986532   2234678999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+++|+|.+++..  .+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        97 ~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           97 YVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             CCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred             CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence            9999999999953  457999999999999999999999999   99999999999999999999999999986554444


Q ss_pred             ccccccCCCCCCccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          269 AANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+............           ....  .+..
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-----------~~~~--~p~~  238 (476)
T 2y94_A          172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD-----------GIFY--TPQY  238 (476)
T ss_dssp             BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT-----------TCCC--CCTT
T ss_pred             ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc-----------CCcC--CCcc
Confidence            556789999999999988765 6899999999999999999999986433222211111           1110  1112


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+.++.+++.+||+.||.+|||+.++++
T Consensus       239 ~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          239 LNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            2357899999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.8e-46  Score=349.60  Aligned_cols=251  Identities=25%  Similarity=0.455  Sum_probs=204.3

Q ss_pred             HHhccccccccccCceeEEEEEeC-CC-------cEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-TG-------ETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  182 (432)
                      ...|.+.+.||+|+||.||+|... ++       ..||+|.+........+.+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            456788899999999999999643 33       4799999977666667889999999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc--------EEE
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR--------ARV  254 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~--------~kl  254 (432)
                      .++||||+++|+|.+++... ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.        +||
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence            99999999999999999653 344899999999999999999999999   999999999999998887        999


Q ss_pred             eecCCcccccccccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCC-CCCCChhHHHHHHHhhhcCCCch
Q 014038          255 ADFGLSREEMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGR-SPLQGLMEYVELAAMNTEGKTGW  332 (432)
Q Consensus       255 ~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~  332 (432)
                      +|||++.....   .....+|+.|+|||.+.+ ..++.++||||||+++|||++|. .||................    
T Consensus       163 ~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~----  235 (289)
T 4fvq_A          163 SDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH----  235 (289)
T ss_dssp             CCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC----
T ss_pred             ccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccC----
Confidence            99999864322   233457899999999987 77999999999999999999954 5554433222211111100    


Q ss_pred             hhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                            ....    ..+.++.+++.+||+.||.+|||+.++++.|+.++.
T Consensus       236 ------~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          236 ------QLPA----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             ------CCCC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             ------CCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                  0111    112368899999999999999999999999998865

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1e-44  Score=340.10  Aligned_cols=252  Identities=23%  Similarity=0.373  Sum_probs=204.5

Q ss_pred             HHHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh------hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK------QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  182 (432)
                      ....|.+.+.||+|+||.||+|... +|+.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+...
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            3457888999999999999999765 689999999865421      235789999999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC----cEEEeecC
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM----RARVADFG  258 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~----~~kl~Dfg  258 (432)
                      .++||||+++++|.+++..  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++    .+||+|||
T Consensus        83 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            9999999999999999854  346999999999999999999999999   99999999999998877    89999999


Q ss_pred             CcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccc
Q 014038          259 LSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDS  338 (432)
Q Consensus       259 l~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      ++.............+|+.|+|||.+.+..++.++||||||+++|||++|+.||.+......................  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  235 (283)
T 3bhy_A          158 IAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF--  235 (283)
T ss_dssp             TCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHH--
T ss_pred             cceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhc--
Confidence            997654444445567899999999999999999999999999999999999999875543333222211110000000  


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          339 RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       339 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                             ...+..+.+++.+||+.||++|||+.++++
T Consensus       236 -------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          236 -------SNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             -------TTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -------ccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence                   012347899999999999999999999997

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.3e-46  Score=379.27  Aligned_cols=257  Identities=28%  Similarity=0.447  Sum_probs=213.1

Q ss_pred             HHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      +....+.+.+.||+|+||.||+|.+.++..||||++.... ...+.|.+|+.+|++++||||+++++++.+ +..++|||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            4445677888999999999999998888889999997654 335689999999999999999999999876 67899999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-  267 (432)
                      |+++|+|.+++.......+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            999999999996544456999999999999999999999999   9999999999999999999999999997543221 


Q ss_pred             -cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          268 -HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       268 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                       ......++..|+|||++....++.++|||||||++|||++ |+.||.+..............            ....+
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~------------~~~~~  486 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------------RMPCP  486 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC------------CCCCC
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------CCCCC
Confidence             1223456788999999998999999999999999999999 999998765433322222111            11122


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      ...+.++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            2334579999999999999999999999999988754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.1e-45  Score=352.64  Aligned_cols=249  Identities=23%  Similarity=0.399  Sum_probs=198.6

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      .|.+.+.||+|+||.||+|+.. +++.||+|++...   .....+.+.+|..++.++ +||||+++++++.+.+..++||
T Consensus        10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~   89 (345)
T 3a8x_A           10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   89 (345)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence            5678899999999999999764 6889999999754   233446688999999988 8999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc-cc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VD  266 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~-~~  266 (432)
                      ||+++|+|.+++...  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++... ..
T Consensus        90 e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           90 EYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            999999999998543  46999999999999999999999999   9999999999999999999999999997532 23


Q ss_pred             ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........  .........+.....  .++.
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~~~~~~i~~~~~--~~p~  240 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--NTEDYLFQVILEKQI--RIPR  240 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------CHHHHHHHHHHCCC--CCCT
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc--ccHHHHHHHHHcCCC--CCCC
Confidence            344567899999999999999999999999999999999999999964211000000  000000001111111  1222


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSM  370 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~  370 (432)
                      ..+.++.+++.+||+.||.+||++
T Consensus       241 ~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          241 SLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCCHHHHHHHHHHhcCCHhHCCCC
Confidence            334578999999999999999996

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=346.89  Aligned_cols=253  Identities=28%  Similarity=0.506  Sum_probs=197.6

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      .|.+.+.||+|+||.||+|.. .++.||||.+...  ...+.|.+|+.++++++||||+++++++.+  ..++||||+++
T Consensus         9 ~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~   83 (307)
T 2eva_A            9 EIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG   83 (307)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred             HeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence            567788999999999999987 4789999998643  345689999999999999999999998874  47899999999


Q ss_pred             CChhhhcccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc-EEEeecCCccccccccccc
Q 014038          193 GSLASHLYDENY-GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR-ARVADFGLSREEMVDKHAA  270 (432)
Q Consensus       193 g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~-~kl~Dfgl~~~~~~~~~~~  270 (432)
                      |+|.+++..... ..+++..++.++.|++.||.|||+.+..+|+||||||+|||++.++. +||+|||++.....  ...
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~--~~~  161 (307)
T 2eva_A           84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HMT  161 (307)
T ss_dssp             CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred             CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc--ccc
Confidence            999999965432 24788999999999999999999932222999999999999998886 79999999875322  223


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhH--HHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME--YVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      ...||+.|+|||++.+..++.++||||||+++|||++|+.||.....  ...........            ........
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------~~~~~~~~  229 (307)
T 2eva_A          162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT------------RPPLIKNL  229 (307)
T ss_dssp             ---CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC------------CCCCBTTC
T ss_pred             cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC------------CCCccccc
Confidence            45689999999999999999999999999999999999999975321  11111111111            01111122


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      +..+.+++.+||+.||.+|||+.++++.|+.+.+..
T Consensus       230 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            357899999999999999999999999999986543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.7e-45  Score=356.13  Aligned_cols=246  Identities=27%  Similarity=0.437  Sum_probs=203.9

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ..|.+.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+..|..++..+ +||||+++++++.+.+..++|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            46788899999999999999765 57899999987542   23446788999999988 799999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-  265 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-  265 (432)
                      |||+++|+|.+++...  +.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.... 
T Consensus       100 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            9999999999999543  46999999999999999999999999   99999999999999999999999999985332 


Q ss_pred             cccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+... .          .  .++
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~----------~--~~p  241 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-N----------V--AYP  241 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-C----------C--CCC
T ss_pred             CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-C----------C--CCC
Confidence            23445678999999999999999999999999999999999999999875443222222111 1          0  112


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPS-----MRDIVQ  375 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs-----~~~vl~  375 (432)
                      ...+.++.+++.+||+.||.+||+     +.++++
T Consensus       242 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          242 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            223457899999999999999995     466654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-44  Score=340.14  Aligned_cols=257  Identities=25%  Similarity=0.376  Sum_probs=210.3

Q ss_pred             hccccc-cccccCceeEEEEEeC---CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          113 TCNFTT-LIGQGAFGPVYKAQMS---TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       113 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      .+.+.+ .||+|+||.||+|...   ++..||||.+... .....+.+.+|+.++++++||||+++++++ ..+..++||
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   88 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM   88 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence            445555 8999999999999653   6788999999765 344567899999999999999999999999 556789999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+++++|.+++.. ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        89 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           89 EMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             ECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            99999999999854 3456999999999999999999999999   9999999999999999999999999987543222


Q ss_pred             ----cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          268 ----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       268 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                          ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||................            ..
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~------------~~  232 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK------------RM  232 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC------------CC
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC------------cC
Confidence                1223456889999999988899999999999999999998 999997654332222221111            11


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhccc
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHN  386 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~  386 (432)
                      ..+...+.++.+++.+||+.||.+||++.++++.|+.+......
T Consensus       233 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          233 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence            12223346899999999999999999999999999999876554

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.3e-45  Score=350.97  Aligned_cols=259  Identities=24%  Similarity=0.421  Sum_probs=211.2

Q ss_pred             HHHhccccccccccCceeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  182 (432)
                      ....|.+.+.||+|+||.||+|...      +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  102 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP  102 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence            3456788899999999999999643      46789999997543 3445678999999999999999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEE
Q 014038          183 HMLVYVFMSKGSLASHLYDEN--------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARV  254 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl  254 (432)
                      .++||||+++|+|.+++....        ..++++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||
T Consensus       103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl  179 (322)
T 1p4o_A          103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  179 (322)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred             cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEE
Confidence            999999999999999986421        246799999999999999999999999   999999999999999999999


Q ss_pred             eecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCC
Q 014038          255 ADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKT  330 (432)
Q Consensus       255 ~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  330 (432)
                      +|||+++......   ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+............... 
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-  258 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-  258 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-
T ss_pred             CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc-
Confidence            9999987543222   2233456889999999999999999999999999999999 8999986544322222211111 


Q ss_pred             chhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          331 GWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                                 ...+...+..+.+++.+||+.||.+|||+.++++.|++++..
T Consensus       259 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          259 -----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence                       011222345789999999999999999999999999877553

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.7e-45  Score=364.15  Aligned_cols=256  Identities=23%  Similarity=0.279  Sum_probs=197.8

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC------Ce
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQ  182 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  182 (432)
                      .+|.+.+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...      ..
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            3577788999999999999964 47899999999754  344456789999999999999999999998654      46


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .++||||+++ +|.+.+.    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       142 ~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          142 VYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             EEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            7999999976 5666663    24899999999999999999999999   99999999999999999999999999986


Q ss_pred             ccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCC------------
Q 014038          263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT------------  330 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~------------  330 (432)
                      ...........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+......+..+......            
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~  293 (464)
T 3ttj_A          214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  293 (464)
T ss_dssp             ---CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred             cCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence            65544556678999999999999999999999999999999999999999876544433332211111            


Q ss_pred             --------------chhhhccccCCCCCC---HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          331 --------------GWEEIVDSRLDGIFD---VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       331 --------------~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                                    .+...+.........   ...+.++.+|+.+||+.||++|||+.|+++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                          011111111100001   112567999999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-45  Score=357.94  Aligned_cols=257  Identities=28%  Similarity=0.483  Sum_probs=197.5

Q ss_pred             hccccccccccCceeEEEEEeC--CC--cEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeee-CCeEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS--TG--ETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-KGQHMLV  186 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv  186 (432)
                      .+.+.+.||+|+||.||+|...  ++  ..||+|.+... .....+.|.+|+.++++++||||++++++|.. .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3556789999999999999653  22  36899998654 33456789999999999999999999998754 5678999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||+++|+|.+++... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       170 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence            9999999999999643 356899999999999999999999999   999999999999999999999999999754322


Q ss_pred             c-----cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          267 K-----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       267 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .     ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.............. +           .
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~-~-----------~  313 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-G-----------R  313 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT-T-----------C
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc-C-----------C
Confidence            1     1223457788999999999999999999999999999999 6778865322111111111 1           0


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                      ....+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus       314 ~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          314 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            111122234579999999999999999999999999999987544

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3e-45  Score=348.75  Aligned_cols=255  Identities=24%  Similarity=0.360  Sum_probs=197.9

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC----eE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG----QH  183 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  183 (432)
                      ..|.+.+.||+|+||.||+|.. .+++.||||++....   ......+.+|+.++++++||||+++++++....    ..
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            3677889999999999999975 578999999997653   233457899999999999999999999987654    34


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ++||||+++|+|.+++...  +++++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        92 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            9999999999999999643  46999999999999999999999999   999999999999999999999999998754


Q ss_pred             ccc----ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          264 MVD----KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       264 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ...    .......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.....................    
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----  242 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR----  242 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH----
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc----
Confidence            322    122345689999999999999999999999999999999999999987654333322222211111100    


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH-HHHHHH
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIV-QVLSRI  380 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl-~~L~~i  380 (432)
                       .    ...+.++.+++.+||+.||.+||++.+++ ..|..+
T Consensus       243 -~----~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          243 -H----EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             -S----TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -c----CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence             0    01235789999999999999999766544 455544

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8.3e-45  Score=341.36  Aligned_cols=250  Identities=23%  Similarity=0.374  Sum_probs=198.9

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ..|.+.+.||+|+||.||++.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            5788899999999999999965 468899999987643 33457899999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee---cCCCcEEEeecCCccccc
Q 014038          190 MSKGSLASHLYDE--NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEM  264 (432)
Q Consensus       190 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill---~~~~~~kl~Dfgl~~~~~  264 (432)
                      +++|+|.+++...  ....+++..+..++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||++....
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999988542  2457999999999999999999999999   9999999999999   556889999999997654


Q ss_pred             ccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCC
Q 014038          265 VDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                      .........||+.|+|||.+. ..++.++||||||+++|||++|+.||.+............... ...     ..... 
T Consensus       179 ~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~-----~~~~~-  250 (285)
T 3is5_A          179 SDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP-NYA-----VECRP-  250 (285)
T ss_dssp             --------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCC-----C--CC-
T ss_pred             CcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc-ccc-----cccCc-
Confidence            444455667999999999886 5789999999999999999999999986543222211111110 000     00001 


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                         .+.++.+++.+||+.||++|||+.++++
T Consensus       251 ---~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          251 ---LTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ---CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ---CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               2347889999999999999999999885

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=353.80  Aligned_cols=242  Identities=24%  Similarity=0.356  Sum_probs=203.3

Q ss_pred             HHHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCCh--------hhHHHHHHHHHHHhhcCCCccceEEeeeeeC
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK--------QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK  180 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  180 (432)
                      ....|.+.+.||+|+||.||+|.. .+++.||||++.....        .....+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            345788889999999999999964 5788999999876421        1234577899999999999999999999999


Q ss_pred             CeEEEEEEeccCC-ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCC
Q 014038          181 GQHMLVYVFMSKG-SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL  259 (432)
Q Consensus       181 ~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl  259 (432)
                      +..++||||+.+| +|.+++..  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence            9999999999777 99998853  356999999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccccccccccCCCCCCccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccc
Q 014038          260 SREEMVDKHAANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDS  338 (432)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      +.............||+.|+|||++.+..+ +.++|||||||++|||++|+.||....+.                 ...
T Consensus       177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------~~~  239 (335)
T 3dls_A          177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------------VEA  239 (335)
T ss_dssp             CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------TTT
T ss_pred             ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------Hhh
Confidence            986555555556779999999999988776 88999999999999999999999763220                 011


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          339 RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       339 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...  .+...+.++.+++.+||+.||++|||+.++++
T Consensus       240 ~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          240 AIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             CCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111  11112357899999999999999999999987

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=348.92  Aligned_cols=257  Identities=24%  Similarity=0.380  Sum_probs=204.2

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeee----CCeEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE----KGQHMLV  186 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  186 (432)
                      ..|.+.+.||+|+||.||++.. .+++.||||++........+.+.+|+.+++.++||||+++++++..    ....++|
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            4677889999999999999975 5789999999877666667789999999999999999999999873    3478999


Q ss_pred             EEeccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          187 YVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      |||+++|+|.+++..  .....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~  185 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQAC  185 (317)
T ss_dssp             EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred             EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence            999999999998864  23467999999999999999999999999   9999999999999999999999999886432


Q ss_pred             ccc----------cccccccCCCCCCccccccCC---CCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCc
Q 014038          265 VDK----------HAANIRGTFGYLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG  331 (432)
Q Consensus       265 ~~~----------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  331 (432)
                      ...          ......||+.|+|||.+....   ++.++||||||+++|||++|+.||......          ...
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------~~~  255 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK----------GDS  255 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT----------TSC
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc----------cch
Confidence            211          112345799999999987554   689999999999999999999999542110          000


Q ss_pred             hhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 014038          332 WEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL  381 (432)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~  381 (432)
                      .............+...+.++.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          256 VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            01111111111112223457999999999999999999999999998773

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.1e-45  Score=369.11  Aligned_cols=246  Identities=25%  Similarity=0.398  Sum_probs=195.6

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||+|.. .+|+.||||++...   .......+.+|+.+++.++||||++++++|.+.+..++||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            4577889999999999999965 57899999998753   2333456789999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-  265 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-  265 (432)
                      ||+++|+|.+++...  ..+++..+..++.||+.||+|||+ .+   |+||||||+||||+.++.+||+|||+++.... 
T Consensus       228 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          228 EYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             CCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             eeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            999999999988543  469999999999999999999998 88   99999999999999999999999999975332 


Q ss_pred             cccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+...............             .++
T Consensus       303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-------------~~p  369 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-------------RFP  369 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------CCC
T ss_pred             CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-------------CCC
Confidence            2334567899999999999999999999999999999999999999976544322222211110             112


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRP-----SMRDIVQ  375 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RP-----s~~~vl~  375 (432)
                      ...+.++.+|+.+||+.||.+||     ++.++++
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          370 RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            22335789999999999999999     9999886

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=355.54  Aligned_cols=264  Identities=15%  Similarity=0.194  Sum_probs=206.9

Q ss_pred             HhccccccccccCceeEEEEEeCC---------CcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccce----------
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMST---------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVN----------  172 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------  172 (432)
                      ..|.+.+.||+|+||.||+|....         ++.||+|.+...     +.+.+|+.++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            467788999999999999997653         789999998643     36789999999999999998          


Q ss_pred             -----EEeeeee-CCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee
Q 014038          173 -----LVGYCAE-KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL  246 (432)
Q Consensus       173 -----l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill  246 (432)
                           +++++.. .+..++||||+ +++|.+++.......+++..++.++.||+.||.|||+++   |+||||||+|||+
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~  192 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFV  192 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEE
Confidence                 5677766 67899999999 999999997654567999999999999999999999999   9999999999999


Q ss_pred             cCCC--cEEEeecCCcccccccc--------cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChh
Q 014038          247 DQSM--RARVADFGLSREEMVDK--------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM  316 (432)
Q Consensus       247 ~~~~--~~kl~Dfgl~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~  316 (432)
                      +.++  .+||+|||+++......        ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  99999999997543221        1233479999999999999999999999999999999999999997643


Q ss_pred             -HHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcccc
Q 014038          317 -EYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNR  387 (432)
Q Consensus       317 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~~  387 (432)
                       ..................+......   ....+.++.+++.+||+.||++|||+.+|++.|+.+++.....
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  341 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS  341 (352)
T ss_dssp             TCHHHHHHHHHHHHHSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             cCHHHHHHHHHhccCChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence             1111111110000000001110000   0011357999999999999999999999999999998776543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.9e-45  Score=344.36  Aligned_cols=252  Identities=29%  Similarity=0.451  Sum_probs=200.9

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC-CeEEEEEEec
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-GQHMLVYVFM  190 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~  190 (432)
                      ..|.+.+.||+|+||.||+|.. +|+.||||.+....  ..+.+.+|+.++++++||||+++++++.+. +..++||||+
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             hhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            4677889999999999999987 58899999987543  456789999999999999999999987654 4789999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA  270 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  270 (432)
                      ++|+|.+++.......+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++......  ..
T Consensus        98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~  172 (278)
T 1byg_A           98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QD  172 (278)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--cc
Confidence            9999999996544344899999999999999999999999   999999999999999999999999998753322  23


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ...+++.|+|||.+.+..++.++||||||+++|||++ |+.||..............            ......+...+
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~------------~~~~~~~~~~~  240 (278)
T 1byg_A          173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------GYKMDAPDGCP  240 (278)
T ss_dssp             ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT------------TCCCCCCTTCC
T ss_pred             CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------------CCCCCCcccCC
Confidence            3467889999999999999999999999999999998 9999976432111111111            11111222334


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      .++.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       241 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          241 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            6799999999999999999999999999998653

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=351.54  Aligned_cols=257  Identities=24%  Similarity=0.388  Sum_probs=191.4

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC-CCccceEEeeee--------eCC
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCA--------EKG  181 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~~  181 (432)
                      .+|.+.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++.++. ||||+++++++.        ...
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            3677889999999999999975 478999999997776666778999999999995 999999999984        344


Q ss_pred             eEEEEEEeccCCChhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCc
Q 014038          182 QHMLVYVFMSKGSLASHLYD-ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS  260 (432)
Q Consensus       182 ~~~lv~e~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~  260 (432)
                      ..++||||+. |+|.+++.. ....++++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  185 (337)
T 3ll6_A          108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSA  185 (337)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred             eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccc
Confidence            6899999996 799888854 23457999999999999999999999976 45999999999999999999999999998


Q ss_pred             cccccccc-------------ccccccCCCCCCcccc---ccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHh
Q 014038          261 REEMVDKH-------------AANIRGTFGYLDPEYI---STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM  324 (432)
Q Consensus       261 ~~~~~~~~-------------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~  324 (432)
                      +.......             .....+|+.|+|||++   .+..++.++|||||||++|||++|+.||.........   
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---  262 (337)
T 3ll6_A          186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV---  262 (337)
T ss_dssp             BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred             eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh---
Confidence            75432211             1144689999999998   5667899999999999999999999999753321110   


Q ss_pred             hhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          325 NTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                                  ............+..+.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus       263 ------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          263 ------------NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             ---------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             ------------cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence                        0011111111112358899999999999999999999999999977544

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-44  Score=349.10  Aligned_cols=253  Identities=25%  Similarity=0.325  Sum_probs=200.3

Q ss_pred             HHhccccccccccCceeEEEEEe-CCCcEEEEEEeccC-----ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-----SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  184 (432)
                      ...|.+.+.||+|+||.||+|.. .+++.||+|++...     .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            45788999999999999999965 57889999998643     2344578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhcccC--------------------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 014038          185 LVYVFMSKGSLASHLYDE--------------------------------------NYGPLTWNLRVHIALDVARGLEYL  226 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~i~~~l~yL  226 (432)
                      +||||+++|+|.+++...                                      ....+++..+..++.||+.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            999999999999988420                                      012246778889999999999999


Q ss_pred             HhCCCCCeeeccCCCCCeeecCCC--cEEEeecCCcccccccc-----cccccccCCCCCCcccccc--CCCCchhHhHH
Q 014038          227 HDGAVPPVIHRDIKSSNILLDQSM--RARVADFGLSREEMVDK-----HAANIRGTFGYLDPEYIST--RNFTKKSDVYS  297 (432)
Q Consensus       227 H~~~~~~iiH~dlkp~Nill~~~~--~~kl~Dfgl~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~S  297 (432)
                      |+.+   |+||||||+|||++.++  .+||+|||+++......     ......||+.|+|||.+.+  ..++.++||||
T Consensus       185 H~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          185 HNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            9999   99999999999998776  89999999997532211     2345679999999999865  67899999999


Q ss_pred             HHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          298 FGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       298 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      |||++|||++|+.||.+................ +        ........+.++.+++.+||+.||.+||++.++++
T Consensus       262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC-F--------ENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-T--------TSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc-c--------CCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            999999999999999876554433332221110 0        00000112357899999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.7e-45  Score=357.98  Aligned_cols=269  Identities=22%  Similarity=0.309  Sum_probs=213.8

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC--eEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG--QHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+  ..++|||
T Consensus        10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e   89 (396)
T 4eut_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME   89 (396)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred             ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence            5778899999999999999764 58999999997543 234567889999999999999999999988755  7899999


Q ss_pred             eccCCChhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee----cCCCcEEEeecCCcccc
Q 014038          189 FMSKGSLASHLYDEN-YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL----DQSMRARVADFGLSREE  263 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill----~~~~~~kl~Dfgl~~~~  263 (432)
                      |+++|+|.+++.... ...+++..++.++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||+++..
T Consensus        90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~  166 (396)
T 4eut_A           90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (396)
T ss_dssp             CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred             cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence            999999999996532 234999999999999999999999999   9999999999999    78888999999999865


Q ss_pred             cccccccccccCCCCCCcccccc--------CCCCchhHhHHHHHHHHHHHhCCCCCCChh----HHHHHHHhhhcCCC-
Q 014038          264 MVDKHAANIRGTFGYLDPEYIST--------RNFTKKSDVYSFGVLLFELIAGRSPLQGLM----EYVELAAMNTEGKT-  330 (432)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlGvil~elltg~~p~~~~~----~~~~~~~~~~~~~~-  330 (432)
                      ..........||+.|+|||++.+        ..++.++|||||||++|||++|+.||....    ....+......... 
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~  246 (396)
T 4eut_A          167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG  246 (396)
T ss_dssp             CCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTT
T ss_pred             cCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcc
Confidence            55555556779999999999864        567889999999999999999999996321    11111111111110 


Q ss_pred             chhhh---------ccc--cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          331 GWEEI---------VDS--RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       331 ~~~~~---------~~~--~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      .+..+         ...  .............+.+++.+||+.||++||++.++++.+..++...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             cchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence            00000         000  1112344677789999999999999999999999999999998754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.5e-45  Score=352.41  Aligned_cols=247  Identities=21%  Similarity=0.363  Sum_probs=196.9

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCC--CccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHH--RNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++|  |||+++++++.+.+..++|||
T Consensus        10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e   89 (343)
T 3dbq_A           10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME   89 (343)
T ss_dssp             EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence            57778999999999999998888999999998754  33445778999999999976  999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-  267 (432)
                       +.+|+|.+++...  ..+++..+..++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||+++...... 
T Consensus        90 -~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~  162 (343)
T 3dbq_A           90 -CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  162 (343)
T ss_dssp             -CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred             -CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence             5688999999653  56999999999999999999999999   99999999999997 5789999999997643322 


Q ss_pred             --cccccccCCCCCCcccccc-----------CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhh
Q 014038          268 --HAANIRGTFGYLDPEYIST-----------RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEE  334 (432)
Q Consensus       268 --~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  334 (432)
                        ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||....+......          .
T Consensus       163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----------~  232 (343)
T 3dbq_A          163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH----------A  232 (343)
T ss_dssp             -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH----------H
T ss_pred             cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHH----------H
Confidence              2235679999999999864           6789999999999999999999999976433211111          1


Q ss_pred             hccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ..++.....++...+.++.+++.+||+.||.+|||+.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          233 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            111111222222223578999999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.7e-45  Score=349.41  Aligned_cols=261  Identities=31%  Similarity=0.520  Sum_probs=209.9

Q ss_pred             HHhccccccccccCceeEEEEEe------CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCC-
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKG-  181 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-  181 (432)
                      ...|.+.+.||+|+||.||+|..      .+++.||||.+.... ....+.+.+|+.++.++ +||||+++++++...+ 
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  105 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  105 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence            45778889999999999999963      356899999997653 33456789999999999 7999999999987754 


Q ss_pred             eEEEEEEeccCCChhhhcccCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec
Q 014038          182 QHMLVYVFMSKGSLASHLYDENY--------------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD  247 (432)
Q Consensus       182 ~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~  247 (432)
                      ..++||||+++|+|.+++.....              ..+++..++.++.|++.||.|||+.+   |+||||||+|||++
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~  182 (316)
T 2xir_A          106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  182 (316)
T ss_dssp             CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEEC
Confidence            58999999999999999965432              22889999999999999999999999   99999999999999


Q ss_pred             CCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHH
Q 014038          248 QSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAA  323 (432)
Q Consensus       248 ~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~  323 (432)
                      .++.+||+|||+++......   ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+.........
T Consensus       183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~  262 (316)
T 2xir_A          183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  262 (316)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence            99999999999987543222   2234567889999999999999999999999999999998 9999976432111111


Q ss_pred             hhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          324 MNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                      ....+.           ....+...+.++.+++.+||+.||.+|||+.++++.|+.+++...
T Consensus       263 ~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          263 RLKEGT-----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             HHHHTC-----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HhccCc-----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            111110           011112233578999999999999999999999999999987543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.3e-44  Score=343.05  Aligned_cols=250  Identities=23%  Similarity=0.422  Sum_probs=204.4

Q ss_pred             HHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ...|.+.+.||+|+||.||++... +|+.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            457888999999999999999764 7899999999866555556789999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee---cCCCcEEEeecCCccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill---~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      +++++|.+++...  +.+++..+..++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||++..... 
T Consensus        88 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-  161 (304)
T 2jam_A           88 VSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-  161 (304)
T ss_dssp             CCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred             CCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence            9999999988543  46899999999999999999999999   9999999999999   7889999999999875332 


Q ss_pred             ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||................. .        .......
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~--------~~~~~~~  232 (304)
T 2jam_A          162 GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY-E--------FESPFWD  232 (304)
T ss_dssp             BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCC-C--------CCTTTTT
T ss_pred             CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-C--------CCccccc
Confidence            223345689999999999999999999999999999999999999986544332222221110 0        0111112


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.++.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          233 DISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             TSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            23457899999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=351.09  Aligned_cols=257  Identities=25%  Similarity=0.425  Sum_probs=202.4

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcE----EEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGET----VAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      ..|.+.+.||+|+||.||+|... +++.    ||+|.+... .....+.+.+|+.++++++||||++++++|.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            35777899999999999999753 4543    577777543 3445678999999999999999999999998754 889


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      |++|+.+|+|.+++... ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        94 v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            99999999999998654 356999999999999999999999999   99999999999999999999999999975432


Q ss_pred             cc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCC
Q 014038          266 DK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       266 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ..   ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.+..........            .....
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~------------~~~~~  237 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL------------EKGER  237 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH------------HTTCC
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH------------HcCCC
Confidence            22   2223456788999999999999999999999999999999 99999764322111111            11111


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                      ...+...+.++.+++.+||+.||.+||++.++++.|+++.....
T Consensus       238 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  281 (327)
T 3lzb_A          238 LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ  281 (327)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence            12222334579999999999999999999999999999976543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=351.04  Aligned_cols=267  Identities=27%  Similarity=0.418  Sum_probs=212.0

Q ss_pred             HHhccccccccccCceeEEEEEe-----CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC--eE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM-----STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG--QH  183 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  183 (432)
                      ...+.+.+.||+|+||.||+|..     .+++.||||.+........+.+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            34677889999999999999973     368899999998766666778999999999999999999999987654  68


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       120 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            9999999999999999654 346999999999999999999999999   999999999999999999999999999754


Q ss_pred             ccccc----ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCC------chh
Q 014038          264 MVDKH----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT------GWE  333 (432)
Q Consensus       264 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~------~~~  333 (432)
                      .....    .....++..|+|||.+.+..++.++||||||+++|||++|..||........  ........      .+.
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM--RMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH--HHHCTTCCTHHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH--HhhccccchhhhHHHHH
Confidence            33221    2234567789999999988899999999999999999999999875432111  00000000      011


Q ss_pred             hhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          334 EIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      +.+........+...+.++.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            11111111222333456899999999999999999999999999998654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.3e-45  Score=359.52  Aligned_cols=249  Identities=22%  Similarity=0.311  Sum_probs=189.2

Q ss_pred             hcccc-ccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhh-cCCCccceEEeeeee----CCeEEE
Q 014038          113 TCNFT-TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGR-LHHRNLVNLVGYCAE----KGQHML  185 (432)
Q Consensus       113 ~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~l  185 (432)
                      .|.+. +.||+|+||.||+|.. .+|+.||||++..     ...+.+|+.++.+ .+||||+++++++..    ....++
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l  136 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI  136 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence            34444 6899999999999965 4789999999853     2456788888755 489999999998875    567899


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC---CCcEEEeecCCccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---SMRARVADFGLSRE  262 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~---~~~~kl~Dfgl~~~  262 (432)
                      ||||+++|+|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++.
T Consensus       137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            999999999999997655567999999999999999999999999   999999999999987   78999999999986


Q ss_pred             ccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcccc--C
Q 014038          263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR--L  340 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  340 (432)
                      ..........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+......       .......+....  .
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~~~~~i~~~~~~~  286 (400)
T 1nxk_A          214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------SPGMKTRIRMGQYEF  286 (400)
T ss_dssp             CC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS-------CCSHHHHHHHTCCCC
T ss_pred             cCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc-------cHHHHHHHHcCcccC
Confidence            5544445567899999999999999999999999999999999999999975321100       000000000000  0


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ........+.++.+|+.+||+.||++|||+.++++.
T Consensus       287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            000111234578999999999999999999999874

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.8e-45  Score=342.68  Aligned_cols=258  Identities=23%  Similarity=0.327  Sum_probs=199.4

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      .|.+.+.||+|+||+||+|... +++.||+|++....  ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   82 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence            4677889999999999999764 68999999997543  33346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KH  268 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~  268 (432)
                      +++ +|.+.+.. ..+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..... ..
T Consensus        83 ~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           83 CDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             CSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred             CCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence            975 66665543 2357999999999999999999999999   999999999999999999999999999754322 23


Q ss_pred             ccccccCCCCCCccccccCC-CCchhHhHHHHHHHHHHHhCCCCC-CChhHHHHHHHhhh----cCCCchhhhcc---cc
Q 014038          269 AANIRGTFGYLDPEYISTRN-FTKKSDVYSFGVLLFELIAGRSPL-QGLMEYVELAAMNT----EGKTGWEEIVD---SR  339 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~-~~~~~~~~~~~~~~----~~~~~~~~~~~---~~  339 (432)
                      .....||+.|+|||++.+.. ++.++|||||||++|||++|..|| .+......+..+..    .....|.....   ..
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence            34567899999999987665 899999999999999999988875 33322222222111    11111111100   00


Q ss_pred             ---------CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          340 ---------LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       340 ---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                               .........+.++.+|+.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                     000111123457899999999999999999999885

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.5e-44  Score=343.51  Aligned_cols=262  Identities=25%  Similarity=0.372  Sum_probs=201.1

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||+|.. .+|+.||+|++...   .......+.+|+.++++++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            3678889999999999999975 57899999998753   3344567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          188 VFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       188 e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||+++|+|.+++..  .....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999998853  23456999999999999999999999999   99999999999999999999999999875433


Q ss_pred             cc-cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhH-HHHHHHhhhcCCCchhhhccccCCCC
Q 014038          266 DK-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME-YVELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       266 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                      .. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.+... ...........          .....
T Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------~~~~~  258 (310)
T 2wqm_A          189 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC----------DYPPL  258 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT----------CSCCC
T ss_pred             CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc----------cCCCC
Confidence            22 23345689999999999999999999999999999999999999975321 11111111110          01111


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhccc
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHN  386 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~  386 (432)
                      .....+.++.+++.+||+.||.+|||+.+|++.|+++......
T Consensus       259 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~  301 (310)
T 2wqm_A          259 PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS  301 (310)
T ss_dssp             CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence            1112335789999999999999999999999999999776543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-44  Score=340.79  Aligned_cols=256  Identities=27%  Similarity=0.413  Sum_probs=203.9

Q ss_pred             ccccccccccCceeEEEEEeC-CC---cEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeE-EEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQMS-TG---ETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH-MLVY  187 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv~  187 (432)
                      +...+.||+|+||.||+|... ++   ..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++||
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            445588999999999999642 33   379999987543 34457899999999999999999999999876654 9999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-  266 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-  266 (432)
                      ||+.+|+|.+++.. ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..... 
T Consensus       103 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          103 PYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             CCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             ecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            99999999999965 3456899999999999999999999999   999999999999999999999999999743221 


Q ss_pred             ----ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCC-CCChhHHHHHHHhhhcCCCchhhhccccCC
Q 014038          267 ----KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP-LQGLMEYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       267 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                          .......+|+.|+|||.+.+..++.++||||||+++|||++|..| |..............            ...
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~------------~~~  246 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ------------GRR  246 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT------------TCC
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc------------CCC
Confidence                222345678999999999999999999999999999999996555 443221111111111            111


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                      ...+...+..+.+++.+||+.||.+|||+.++++.|+++.+...
T Consensus       247 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            11222234579999999999999999999999999999987644

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.1e-44  Score=339.75  Aligned_cols=256  Identities=26%  Similarity=0.422  Sum_probs=204.7

Q ss_pred             HhccccccccccCceeEEEEEeCC----CcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMST----GETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ..|.+.+.||+|+||.||+|...+    +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   90 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII   90 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence            467788999999999999996532    346999998765 33456789999999999999999999999875 456899


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||+++++|.+++... ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        91 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           91 MELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            9999999999999643 346899999999999999999999999   999999999999999999999999998754332


Q ss_pred             c--cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCC
Q 014038          267 K--HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       267 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                      .  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.................            ..
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~------------~~  234 (281)
T 3cc6_A          167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR------------LP  234 (281)
T ss_dssp             ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC------------CC
T ss_pred             cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC------------CC
Confidence            2  2233456889999999998999999999999999999998 9999964332211111111110            11


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      .+...+..+.+++.+||+.||++|||+.++++.|+.+.+..
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          235 KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence            11223357899999999999999999999999999987653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9.3e-45  Score=341.95  Aligned_cols=256  Identities=26%  Similarity=0.397  Sum_probs=206.5

Q ss_pred             Hhccccc-cccccCceeEEEEEe---CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          112 ATCNFTT-LIGQGAFGPVYKAQM---STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       112 ~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      ..|.+.+ .||+|+||.||+|..   .+++.||||++....  ....+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            3566666 899999999999953   346789999997543  23356899999999999999999999999 5677899


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+++++|.+++...  ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        95 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            99999999999999653  46999999999999999999999999   99999999999999999999999999875433


Q ss_pred             ccc----ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          266 DKH----AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       266 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ...    .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+..............            
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------------  237 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE------------  237 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------
Confidence            221    222346788999999998889999999999999999999 999998754432222221111            


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                      ....+...+.++.+++.+||+.||.+||++.++++.|+.++....
T Consensus       238 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          238 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            111222334579999999999999999999999999999987544

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9.2e-45  Score=350.68  Aligned_cols=246  Identities=26%  Similarity=0.378  Sum_probs=202.1

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|...+.||+|+||.||+|.. .+|+.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4577788999999999999975 578999999987543   233457899999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+. |+|.+++... ..++++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.....  
T Consensus       134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  206 (348)
T ss_dssp             ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence            9997 6888877533 357999999999999999999999999   99999999999999999999999999875432  


Q ss_pred             cccccccCCCCCCccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCC
Q 014038          268 HAANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                       .....||+.|+|||++.   ...++.++|||||||++|||++|+.||.+................           ...
T Consensus       207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-----------~~~  274 (348)
T 1u5q_A          207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-----------ALQ  274 (348)
T ss_dssp             -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-----------CCC
T ss_pred             -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-----------CCC
Confidence             23457999999999984   567899999999999999999999999865543333322221111           011


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      +...+..+.+++.+||+.||++|||+.++++.
T Consensus       275 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          275 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            11223578999999999999999999999864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8.2e-45  Score=345.89  Aligned_cols=258  Identities=27%  Similarity=0.466  Sum_probs=199.5

Q ss_pred             HHhccccccccccCceeEEEEEeC----CCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC---
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG---  181 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  181 (432)
                      ...|.+.+.||+|+||.||+|...    ++..||+|.+...  .....+.+.+|+.++++++||||+++++++.+.+   
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  112 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG  112 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence            346778899999999999999653    3458999998754  3344567999999999999999999999998754   


Q ss_pred             --eEEEEEEeccCCChhhhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEe
Q 014038          182 --QHMLVYVFMSKGSLASHLYD----ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA  255 (432)
Q Consensus       182 --~~~lv~e~~~~g~L~~~l~~----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~  255 (432)
                        ..++||||+++|+|.+++..    .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+
T Consensus       113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~  189 (313)
T 3brb_A          113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVA  189 (313)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEEC
T ss_pred             CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEe
Confidence              35999999999999998843    23457999999999999999999999999   9999999999999999999999


Q ss_pred             ecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCc
Q 014038          256 DFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTG  331 (432)
Q Consensus       256 Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  331 (432)
                      |||++.......   ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+..............   
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~---  266 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH---  266 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC---
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC---
Confidence            999987543221   2233457889999999999999999999999999999999 899997643321111111110   


Q ss_pred             hhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          332 WEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                               ....+...+.++.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus       267 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          267 ---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             ---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                     1111223345799999999999999999999999999999764

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=7.6e-45  Score=356.69  Aligned_cols=247  Identities=20%  Similarity=0.358  Sum_probs=197.4

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcC--CCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLH--HRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+|...+++.||||++...  .....+.+.+|+.+|.+++  ||||+++++++...+..++|||
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E  136 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME  136 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence            47788999999999999998878999999998654  3445578999999999996  5999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-  267 (432)
                       +.+++|.+++...  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++...... 
T Consensus       137 -~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          137 -CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             -CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             -cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence             5688999999654  47899999999999999999999999   99999999999996 5799999999997643322 


Q ss_pred             --cccccccCCCCCCcccccc-----------CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhh
Q 014038          268 --HAANIRGTFGYLDPEYIST-----------RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEE  334 (432)
Q Consensus       268 --~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  334 (432)
                        ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||....+......          .
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~----------~  279 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH----------A  279 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH----------H
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHH----------H
Confidence              2345679999999999864           4689999999999999999999999976432211111          1


Q ss_pred             hccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ++++.....++...+.++.+|+.+||+.||.+|||+.++++.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          280 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            111111111121123578999999999999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.7e-45  Score=352.97  Aligned_cols=260  Identities=23%  Similarity=0.312  Sum_probs=206.0

Q ss_pred             HHHHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC-----CCccceEEeeeeeCCe
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-----HRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~  182 (432)
                      +....|.+.+.||+|+||.||+|.. .+++.||||++... ......+..|+.+++.++     ||||+++++++...+.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~  110 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH  110 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence            3345788889999999999999976 57899999998643 344556788999999986     9999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC--------------
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ--------------  248 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~--------------  248 (432)
                      .++||||+ +++|.+++.......+++..+..++.||+.||+|||+.+   |+||||||+|||++.              
T Consensus       111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccc
Confidence            99999999 899999998776667999999999999999999999999   999999999999975              


Q ss_pred             -----------CCcEEEeecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhH
Q 014038          249 -----------SMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME  317 (432)
Q Consensus       249 -----------~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~  317 (432)
                                 ++.+||+|||++....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  264 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH  264 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence                       7899999999997532  233456789999999999999999999999999999999999999987554


Q ss_pred             HHHHHHhhhcCCCchhh------------hccc-c----CCC-CCCH---------------HHHHHHHHHHHHhhccCC
Q 014038          318 YVELAAMNTEGKTGWEE------------IVDS-R----LDG-IFDV---------------EELNEVASLAYKCVNRAP  364 (432)
Q Consensus       318 ~~~~~~~~~~~~~~~~~------------~~~~-~----~~~-~~~~---------------~~~~~l~~li~~cl~~dp  364 (432)
                      ...+..+..........            .... .    ... ....               .....+.+|+.+||+.||
T Consensus       265 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  344 (360)
T 3llt_A          265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP  344 (360)
T ss_dssp             HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence            33332221111100000            0000 0    000 0000               011568899999999999


Q ss_pred             CCCCCHHHHHH
Q 014038          365 RKRPSMRDIVQ  375 (432)
Q Consensus       365 ~~RPs~~~vl~  375 (432)
                      ++|||+.++++
T Consensus       345 ~~Rpta~elL~  355 (360)
T 3llt_A          345 TLRPSPAELLK  355 (360)
T ss_dssp             GGSCCHHHHTT
T ss_pred             hhCCCHHHHhc
Confidence            99999999874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=372.71  Aligned_cols=251  Identities=25%  Similarity=0.386  Sum_probs=204.2

Q ss_pred             cccccCceeEEEEEeC---CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCC
Q 014038          119 LIGQGAFGPVYKAQMS---TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGS  194 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  194 (432)
                      .||+|+||.||+|.+.   ++..||||++.... ....+.|.+|+.+|++++||||++++++|.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999653   45679999997653 3456789999999999999999999999976 56899999999999


Q ss_pred             hhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc----cc
Q 014038          195 LASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH----AA  270 (432)
Q Consensus       195 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~----~~  270 (432)
                      |.+++... ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.......    ..
T Consensus       422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  497 (613)
T 2ozo_A          422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  497 (613)
T ss_dssp             HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred             HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence            99999643 456999999999999999999999999   99999999999999999999999999976432221    12


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ...+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+....            ....+...+
T Consensus       498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~------------~~~~p~~~~  565 (613)
T 2ozo_A          498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK------------RMECPPECP  565 (613)
T ss_dssp             ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC------------CCCCCTTCC
T ss_pred             CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC------------CCCCCCcCC
Confidence            2345689999999999999999999999999999998 999998754433222222111            112223344


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhccc
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHN  386 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~  386 (432)
                      .++.+||.+||+.||++||++.+|++.|+.+......
T Consensus       566 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~  602 (613)
T 2ozo_A          566 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  602 (613)
T ss_dssp             HHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence            6899999999999999999999999999998765443

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.3e-44  Score=341.91  Aligned_cols=256  Identities=28%  Similarity=0.469  Sum_probs=202.9

Q ss_pred             hccccccccccCceeEEEEEeCC----CcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeee-eCCeEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMST----GETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA-EKGQHMLV  186 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv  186 (432)
                      .|.+.+.||+|+||.||+|...+    ...||+|.+... .....+.+.+|+.++++++||||++++++|. ..+..++|
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  105 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  105 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence            46677899999999999997532    236899998764 3344578999999999999999999999865 45678999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||+++|+|.+++.. ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       106 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          106 LPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             EECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             EeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccccc
Confidence            999999999999964 3456899999999999999999999999   999999999999999999999999999754322


Q ss_pred             c-----cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          267 K-----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       267 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .     ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||................            
T Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~------------  249 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR------------  249 (298)
T ss_dssp             GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC------------
T ss_pred             chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC------------
Confidence            1     1233457889999999999999999999999999999999 566665432211111111110            


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      ....+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus       250 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          250 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            11111222357999999999999999999999999999997754

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-44  Score=346.30  Aligned_cols=261  Identities=26%  Similarity=0.414  Sum_probs=204.3

Q ss_pred             CHHHHHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhc--CCCccceEEeeeeeC--
Q 014038          105 SYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL--HHRNLVNLVGYCAEK--  180 (432)
Q Consensus       105 ~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~--  180 (432)
                      ...+.....|.+.+.||+|+||.||+|+.. ++.||||++...   ....+.+|.+++..+  +||||+++++++...  
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            344556678999999999999999999874 899999998543   233445566665554  899999999999887  


Q ss_pred             --CeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeeeccCCCCCeeecCCC
Q 014038          181 --GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG--------AVPPVIHRDIKSSNILLDQSM  250 (432)
Q Consensus       181 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~--------~~~~iiH~dlkp~Nill~~~~  250 (432)
                        ...++||||+++|+|.+++...   .+++..++.++.|++.||.|||+.        +   |+||||||+|||++.++
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTS
T ss_pred             CCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCC
Confidence              7899999999999999999543   599999999999999999999998        6   99999999999999999


Q ss_pred             cEEEeecCCccccccccc-----ccccccCCCCCCccccccCCCCch------hHhHHHHHHHHHHHhC----------C
Q 014038          251 RARVADFGLSREEMVDKH-----AANIRGTFGYLDPEYISTRNFTKK------SDVYSFGVLLFELIAG----------R  309 (432)
Q Consensus       251 ~~kl~Dfgl~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~SlGvil~elltg----------~  309 (432)
                      .+||+|||++........     .....||+.|+|||++.+..++.+      +|||||||++|||++|          +
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            999999999965432221     124579999999999987766554      9999999999999999          6


Q ss_pred             CCCCChhH----HHHHHHhhhcCCCchhhhccccCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          310 SPLQGLME----YVELAAMNTEGKTGWEEIVDSRLDGIFD-----VEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       310 ~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      .||.....    .......          ..........+     ...+.++.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       260 ~p~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  329 (337)
T 3mdy_A          260 LPYHDLVPSDPSYEDMREI----------VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM  329 (337)
T ss_dssp             CTTTTTSCSSCCHHHHHHH----------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccHhhhcCCCCchhhhHHH----------HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence            66653210    0111100          00111112222     25677899999999999999999999999999999


Q ss_pred             Hhhcc
Q 014038          381 LKMRH  385 (432)
Q Consensus       381 ~~~~~  385 (432)
                      .+...
T Consensus       330 ~~~~~  334 (337)
T 3mdy_A          330 SESQD  334 (337)
T ss_dssp             HHTTT
T ss_pred             Hhhcc
Confidence            87543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.7e-45  Score=370.33  Aligned_cols=249  Identities=29%  Similarity=0.433  Sum_probs=206.6

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||+|... +|+.||+|++...   .......+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            34666789999999999999764 7899999998653   1233466889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+++|+|.+++.......+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus       264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            9999999999997665566999999999999999999999999   9999999999999999999999999998655444


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhH---HHHHHHhhhcCCCchhhhccccCCCCC
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME---YVELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+...   ...+.......            ...+
T Consensus       341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~------------~~~~  408 (576)
T 2acx_A          341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------------PEEY  408 (576)
T ss_dssp             CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC------------CCCC
T ss_pred             cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc------------cccC
Confidence            44556899999999999998999999999999999999999999976421   11111111111            1112


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRP-----SMRDIVQ  375 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RP-----s~~~vl~  375 (432)
                      +...+.++.+|+.+||+.||.+||     ++.+|++
T Consensus       409 p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            222345789999999999999999     6788775

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.4e-44  Score=349.09  Aligned_cols=252  Identities=25%  Similarity=0.388  Sum_probs=205.5

Q ss_pred             HHHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh--------hhHHHHHHHHHHHhhc-CCCccceEEeeeee
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK--------QGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE  179 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  179 (432)
                      ....|.+.+.||+|+||.||+|... +|+.||||++.....        ...+.+.+|+.++.++ +||||+++++++..
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            3456888899999999999999775 799999999865431        1235678999999999 79999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCC
Q 014038          180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL  259 (432)
Q Consensus       180 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl  259 (432)
                      .+..++||||+++++|.+++...  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~  246 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGF  246 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCc
Confidence            99999999999999999998643  46999999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccccccccccCCCCCCcccccc------CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchh
Q 014038          260 SREEMVDKHAANIRGTFGYLDPEYIST------RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWE  333 (432)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  333 (432)
                      +.............||+.|+|||++.+      ..++.++|||||||++|||++|+.||.....................
T Consensus       247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  326 (365)
T 2y7j_A          247 SCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS  326 (365)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred             ccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            876554444556789999999999853      35889999999999999999999999765443322222111110000


Q ss_pred             hhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          334 EIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...     .    ..+..+.+++.+||+.||++|||+.++++
T Consensus       327 ~~~-----~----~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          327 PEW-----D----DRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHH-----S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccc-----c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            000     0    11347899999999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.1e-45  Score=356.69  Aligned_cols=243  Identities=27%  Similarity=0.384  Sum_probs=193.3

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHH-HhhcCCCccceEEeeeeeCCeEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVML-LGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ..|.+.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            36788899999999999999764 68899999997542   2233456677776 5678999999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-  265 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-  265 (432)
                      |||+++|+|.+++...  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.... 
T Consensus       118 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          118 LDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            9999999999998543  46899999999999999999999999   99999999999999999999999999975332 


Q ss_pred             cccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+...           .+  .++
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------~~--~~~  259 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-----------PL--QLK  259 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-----------CC--CCC
T ss_pred             CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----------cc--CCC
Confidence            33455678999999999999999999999999999999999999999865443222222111           00  011


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRD  372 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~  372 (432)
                      ...+.++.+++.+||+.||.+||++.+
T Consensus       260 ~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          260 PNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             SSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             CCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence            122357899999999999999999854

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.2e-45  Score=348.57  Aligned_cols=260  Identities=27%  Similarity=0.436  Sum_probs=207.8

Q ss_pred             HHhccccccccccCceeEEEEEe------CCCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH  183 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  183 (432)
                      ...|.+.+.||+|+||.||+|..      .++..||||.+... .......+.+|+.++++++||||+++++++.+.+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            45778889999999999999973      35678999999754 344556899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhcccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC---CCcEEEe
Q 014038          184 MLVYVFMSKGSLASHLYDENY-----GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---SMRARVA  255 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~---~~~~kl~  255 (432)
                      ++||||+++|+|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999965432     45899999999999999999999999   999999999999984   4569999


Q ss_pred             ecCCccccccc---ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCc
Q 014038          256 DFGLSREEMVD---KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTG  331 (432)
Q Consensus       256 Dfgl~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  331 (432)
                      |||++......   .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.................  
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--  263 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR--  263 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC--
Confidence            99998643222   12234567899999999998999999999999999999998 9999976543322222211111  


Q ss_pred             hhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          332 WEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                                ...+...+..+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus       264 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  307 (327)
T 2yfx_A          264 ----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  307 (327)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             ----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence                      11122233578999999999999999999999999998876443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.7e-45  Score=351.49  Aligned_cols=262  Identities=18%  Similarity=0.241  Sum_probs=197.3

Q ss_pred             HHHhccccccccccCceeEEEEEeC----CCcEEEEEEeccCChh-----------hHHHHHHHHHHHhhcCCCccceEE
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATDSKQ-----------GEKEFQTEVMLLGRLHHRNLVNLV  174 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~  174 (432)
                      ....|.+.+.||+|+||.||+|...    ++..||+|.+......           ....+.+|+..+..++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            3456788899999999999999765    5778999998765321           123467888999999999999999


Q ss_pred             eeeee----CCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC
Q 014038          175 GYCAE----KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM  250 (432)
Q Consensus       175 ~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~  250 (432)
                      +++..    ....++||||+ +++|.+++...  +.+++..++.++.||+.||+|||+++   |+||||||+|||++.++
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            99987    67899999999 99999999644  37999999999999999999999999   99999999999998887


Q ss_pred             --cEEEeecCCcccccccc--------cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChh-HHH
Q 014038          251 --RARVADFGLSREEMVDK--------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM-EYV  319 (432)
Q Consensus       251 --~~kl~Dfgl~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~-~~~  319 (432)
                        .+||+|||+++......        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ...
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              99999999997543221        1234579999999999999999999999999999999999999995421 111


Q ss_pred             HHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          320 ELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      ............+.........   ....+.++.+++.+||+.||++||++.+|++.|+.+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          269 AVQTAKTNLLDELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHHHHHTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHHHHhhcccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            1111110000001111111000   001234799999999999999999999999998765

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.8e-45  Score=357.05  Aligned_cols=259  Identities=29%  Similarity=0.406  Sum_probs=192.7

Q ss_pred             HHHhccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcC-CCccceEEeeeeeCC--eE
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKG--QH  183 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~  183 (432)
                      ....|.+.+.||+|+||.||+|.. .+|+.||||++...  .......+.+|+.++.++. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            345788889999999999999964 57899999998643  3445567889999999997 999999999997544  78


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ++||||++ |+|..++..   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            99999997 589988854   36899999999999999999999999   999999999999999999999999999743


Q ss_pred             cc----------------------cccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHH
Q 014038          264 MV----------------------DKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVE  320 (432)
Q Consensus       264 ~~----------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~  320 (432)
                      ..                      .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            21                      111234579999999999876 6799999999999999999999999987655444


Q ss_pred             HHHhhhcCCCchhhhcc----------------------ccCCCCCC------------HHHHHHHHHHHHHhhccCCCC
Q 014038          321 LAAMNTEGKTGWEEIVD----------------------SRLDGIFD------------VEELNEVASLAYKCVNRAPRK  366 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~----------------------~~~~~~~~------------~~~~~~l~~li~~cl~~dp~~  366 (432)
                      +..+......+..+.+.                      ......++            ...+.++.+|+.+||+.||++
T Consensus       240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~  319 (388)
T 3oz6_A          240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK  319 (388)
T ss_dssp             HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence            33322111000000000                      00000000            012357899999999999999


Q ss_pred             CCCHHHHHH
Q 014038          367 RPSMRDIVQ  375 (432)
Q Consensus       367 RPs~~~vl~  375 (432)
                      |||+.++++
T Consensus       320 R~t~~e~l~  328 (388)
T 3oz6_A          320 RISANDALK  328 (388)
T ss_dssp             SCCHHHHTT
T ss_pred             CCCHHHHhC
Confidence            999999885

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.4e-44  Score=358.17  Aligned_cols=253  Identities=24%  Similarity=0.373  Sum_probs=191.5

Q ss_pred             HHHHHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC--------hhhHHHHHHHHHHHhhcCCCccceEEeeee
Q 014038          108 DLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--------KQGEKEFQTEVMLLGRLHHRNLVNLVGYCA  178 (432)
Q Consensus       108 ~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  178 (432)
                      ......|.+.+.||+|+||.||+|.. .+++.||||++....        ......+.+|+.+|++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            34566788889999999999999965 468999999986532        111235789999999999999999999975


Q ss_pred             eCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC---CcEEEe
Q 014038          179 EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS---MRARVA  255 (432)
Q Consensus       179 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~---~~~kl~  255 (432)
                       .+..++||||+++|+|.+++..  ...+++..+..++.|++.||.|||+++   |+||||||+|||++.+   +.+||+
T Consensus       211 -~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 -AEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             -SSEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             -cCceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence             5568999999999999998853  457999999999999999999999999   9999999999999654   459999


Q ss_pred             ecCCcccccccccccccccCCCCCCccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCch
Q 014038          256 DFGLSREEMVDKHAANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW  332 (432)
Q Consensus       256 Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  332 (432)
                      |||+++............||+.|+|||++.   ...++.++|||||||++|||++|+.||........+......+...+
T Consensus       285 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~  364 (419)
T 3i6u_A          285 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF  364 (419)
T ss_dssp             CSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC
T ss_pred             ecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC
Confidence            999998765544455678999999999985   36788999999999999999999999975322111111111110000


Q ss_pred             -hhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          333 -EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       333 -~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                       ....         ...+.++.+++.+||+.||++|||+.++++
T Consensus       365 ~~~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          365 IPEVW---------AEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             CHHHH---------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             Cchhh---------cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence             0000         012357899999999999999999999886

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.4e-45  Score=361.40  Aligned_cols=250  Identities=22%  Similarity=0.330  Sum_probs=202.0

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||++++++|.+.+..++||
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~  148 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  148 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            35677789999999999999764 68899999986421   122345789999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+++|+|.+++..   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       149 E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          149 EYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             CCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             eCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence            99999999999854   35899999999999999999999999   9999999999999999999999999997644332


Q ss_pred             --cccccccCCCCCCccccccCC----CCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCC
Q 014038          268 --HAANIRGTFGYLDPEYISTRN----FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       268 --~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                        .....+||+.|+|||++.+..    ++.++|||||||++|||++|+.||.+.........+.....    .+   ..+
T Consensus       223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~----~~---~~p  295 (410)
T 3v8s_A          223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN----SL---TFP  295 (410)
T ss_dssp             EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----HC---CCC
T ss_pred             cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc----cc---cCC
Confidence              234678999999999997655    88999999999999999999999986544332222211000    00   000


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRK--RPSMRDIVQV  376 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~~vl~~  376 (432)
                        .....+.++.+|+.+||+.+|.+  ||++.+|++.
T Consensus       296 --~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          296 --DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             --TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             --CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence              01112357899999999999988  9999998863

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.2e-45  Score=347.89  Aligned_cols=245  Identities=22%  Similarity=0.344  Sum_probs=179.8

Q ss_pred             hcccc---ccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcC-CCccceEEeeeeeCCeEEEEE
Q 014038          113 TCNFT---TLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       113 ~~~~~---~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  187 (432)
                      .|++.   +.||+|+||.||+|... +++.||||++..   .....+.+|+.++..+. ||||+++++++.+....++||
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~   85 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM   85 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence            45554   68999999999999764 689999999864   33467789999999996 999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC---cEEEeecCCccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM---RARVADFGLSREEM  264 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~---~~kl~Dfgl~~~~~  264 (432)
                      ||+++|+|.+++...  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++   .+||+|||+++...
T Consensus        86 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~  160 (325)
T 3kn6_A           86 ELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP  160 (325)
T ss_dssp             CCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred             EccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence            999999999999653  57999999999999999999999999   99999999999997765   89999999997543


Q ss_pred             cc-ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHH------HHHHHhhhcCCCchhhhcc
Q 014038          265 VD-KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEY------VELAAMNTEGKTGWEEIVD  337 (432)
Q Consensus       265 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~  337 (432)
                      .. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......      ......          +..
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----------i~~  230 (325)
T 3kn6_A          161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK----------IKK  230 (325)
T ss_dssp             C----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH----------HTT
T ss_pred             CCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH----------HHc
Confidence            32 2334567899999999999999999999999999999999999999764321      011111          111


Q ss_pred             ccCCCCC--CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          338 SRLDGIF--DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       338 ~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .......  ....+.++.+|+.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          231 GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             TCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            1110000  0123468999999999999999999998874

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.7e-44  Score=363.07  Aligned_cols=252  Identities=26%  Similarity=0.402  Sum_probs=205.7

Q ss_pred             HHHhccccccccccCceeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ....|.+.+.||+|+||+||+|... +++.||||++...  .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3468899999999999999999764 7899999998643  223456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec---CCCcEEEeecCCcccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD---QSMRARVADFGLSREE  263 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~---~~~~~kl~Dfgl~~~~  263 (432)
                      |||+.+|+|.+.+...  ..+++..+..++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||+++..
T Consensus       100 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          100 GELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            9999999999988543  46999999999999999999999999   99999999999994   5668999999999865


Q ss_pred             cccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCC
Q 014038          264 MVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                      ..........||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+................ +        ..+
T Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~--------~~~  244 (486)
T 3mwu_A          175 QQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA-F--------DLP  244 (486)
T ss_dssp             CCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-S--------CSG
T ss_pred             CCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-C--------CCc
Confidence            54444556679999999999875 5999999999999999999999999876554433333221110 0        000


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      .....+.++.+++.+||+.||.+|||+.++++.
T Consensus       245 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            001223578999999999999999999999873

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-44  Score=339.39  Aligned_cols=246  Identities=26%  Similarity=0.435  Sum_probs=201.2

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||+|... ++..||+|++....   ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   88 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence            35778899999999999999654 67799999986432   223467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..... .
T Consensus        89 e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-~  162 (279)
T 3fdn_A           89 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-S  162 (279)
T ss_dssp             CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc-c
Confidence            999999999998543  46999999999999999999999998   99999999999999999999999998864332 2


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||................             ..++..
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------~~~~~~  229 (279)
T 3fdn_A          163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-------------FTFPDF  229 (279)
T ss_dssp             -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-------------CCCCTT
T ss_pred             cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-------------CCCCCc
Confidence            2345578999999999999999999999999999999999999998654332222221111             111222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      .+..+.+++.+||+.||.+|||+.++++.
T Consensus       230 ~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          230 VTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            33578999999999999999999999974

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=344.20  Aligned_cols=258  Identities=22%  Similarity=0.290  Sum_probs=198.4

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      .|.+.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY   83 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence            5677889999999999999764 68999999986543  23356788999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KH  268 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~  268 (432)
                      +++++|.+++..  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...... ..
T Consensus        84 ~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           84 CDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             CSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence            999999888743  356999999999999999999999999   999999999999999999999999999754322 22


Q ss_pred             ccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCch-------------hh
Q 014038          269 AANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW-------------EE  334 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------------~~  334 (432)
                      .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.+..................             ..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence            345578999999999875 6789999999999999999999999987654433322211100000             00


Q ss_pred             hccccCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 IVDSRLDGIFD-----VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 ~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...+......+     ...+.++.+++.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            00000000000     112356899999999999999999999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.9e-44  Score=338.88  Aligned_cols=262  Identities=21%  Similarity=0.323  Sum_probs=203.3

Q ss_pred             HHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeee-eeCCeEEEEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC-AEKGQHMLVYV  188 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  188 (432)
                      ...|.+.+.||+|+||.||+|.. .+++.||||++.....  ...+.+|+.+++.++|+|++..++++ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence            35678889999999999999975 5789999998755432  23578899999999988877777665 56778899999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee---cCCCcEEEeecCCcccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMV  265 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill---~~~~~~kl~Dfgl~~~~~~  265 (432)
                      |+ +++|.+++... ...+++..+..++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++....
T Consensus        86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           86 LL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             CC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             cc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            99 99999998643 346999999999999999999999999   9999999999999   7899999999999975433


Q ss_pred             cc--------cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcc
Q 014038          266 DK--------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD  337 (432)
Q Consensus       266 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      ..        ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.....        ....+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~  232 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT--------KRQKYERISE  232 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS--------SSSHHHHHHH
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhh--------hhhhhhhhhc
Confidence            21        1234578999999999999999999999999999999999999997532100        0000000000


Q ss_pred             ccCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcccc
Q 014038          338 SRLDGI---FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNR  387 (432)
Q Consensus       338 ~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~~  387 (432)
                      ......   .....+.++.+++.+||+.||++|||+.++++.|+.+.+.....
T Consensus       233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~  285 (296)
T 4hgt_A          233 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred             ccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence            000000   00011357999999999999999999999999999998876543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.1e-44  Score=334.56  Aligned_cols=249  Identities=26%  Similarity=0.354  Sum_probs=202.8

Q ss_pred             HHhccccccccccCceeEEEEEeC-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      ...|.+.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            357888899999999999999764 7899999998654 23445788999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc--
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--  266 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~--  266 (432)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++......  
T Consensus        86 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           86 YCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             CCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             ecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            9999999999853  457999999999999999999999999   999999999999999999999999998754322  


Q ss_pred             -ccccccccCCCCCCccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCChhHH-HHHHHhhhcCCCchhhhccccCCCC
Q 014038          267 -KHAANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLMEY-VELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       267 -~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                       .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...... .....+... ..          ...
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~----------~~~  229 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KT----------YLN  229 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-CT----------TST
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-cc----------ccC
Confidence             22345678999999999987665 78999999999999999999999764321 111111110 00          000


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .....+..+.+++.+||+.||++|||+.++++
T Consensus       230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          230 PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            01122357889999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.3e-44  Score=337.85  Aligned_cols=258  Identities=21%  Similarity=0.321  Sum_probs=205.3

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeee-eeCCeEEEEEEe
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC-AEKGQHMLVYVF  189 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~  189 (432)
                      ..|.+.+.||+|+||.||+|.. .+|+.||||++.....  ...+.+|+.+++.++|+|++..+.++ ...+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence            3577789999999999999975 6889999999865432  34688999999999988877766665 556788999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee---cCCCcEEEeecCCccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill---~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      + +++|.+++... ...+++..++.++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||++......
T Consensus        87 ~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           87 L-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             c-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            9 89999998633 356999999999999999999999999   9999999999999   58889999999998754332


Q ss_pred             cc--------ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhH------HHHHHHhhhcCCCch
Q 014038          267 KH--------AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME------YVELAAMNTEGKTGW  332 (432)
Q Consensus       267 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~------~~~~~~~~~~~~~~~  332 (432)
                      ..        .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.+...      ...........  ..
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~  239 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--PI  239 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS--CH
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC--ch
Confidence            21        2455799999999999999999999999999999999999999975321      00000000000  00


Q ss_pred             hhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcccc
Q 014038          333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNR  387 (432)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~~  387 (432)
                      .     .+..    ..+.++.+++.+||+.||++|||+.+|++.|+.+.......
T Consensus       240 ~-----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  285 (296)
T 3uzp_A          240 E-----VLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             H-----HHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             H-----HHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence            0     0001    12357899999999999999999999999999998776543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.2e-44  Score=340.57  Aligned_cols=258  Identities=24%  Similarity=0.354  Sum_probs=201.1

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM  113 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence            46788899999999999999764 78899999987542   233467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+++++|.+++...  .++++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus       114 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          114 RLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             ECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            999999999999643  46999999999999999999999999   9999999999999999999999999987543322


Q ss_pred             --cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          268 --HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       268 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                        ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||.+........... ...... .    .    .+
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~-~----~----~~  258 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-QAIPRP-S----T----VR  258 (309)
T ss_dssp             --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-SCCCCG-G----G----TS
T ss_pred             cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-cCCCCc-c----c----cC
Confidence              2234568999999999999999999999999999999999999998755432111111 111000 0    0    11


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHHhhc
Q 014038          346 VEELNEVASLAYKCVNRAPRKRP-SMRDIVQVLSRILKMR  384 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RP-s~~~vl~~L~~i~~~~  384 (432)
                      ...+.++.+++.+||+.||++|| ++.++++.|+..+...
T Consensus       259 ~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          259 PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            12234789999999999999999 9999999998886543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5e-44  Score=361.73  Aligned_cols=250  Identities=25%  Similarity=0.389  Sum_probs=202.3

Q ss_pred             HHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ...|.+.+.||+|+||.||+|... ++..||+|++....  ......+.+|+.+++.++||||++++++|.+.+..++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457888999999999999999764 78899999987542  334567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC---CCcEEEeecCCccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---SMRARVADFGLSREEM  264 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~---~~~~kl~Dfgl~~~~~  264 (432)
                      ||+++|+|.+.+...  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||++....
T Consensus       116 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          116 ECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            999999999888543  46999999999999999999999999   999999999999976   4559999999998655


Q ss_pred             ccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCC
Q 014038          265 VDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                      .........||+.|+|||++. ..|+.++|||||||++|+|++|..||.+................ +.   .+..    
T Consensus       191 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~---~~~~----  261 (494)
T 3lij_A          191 NQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT-FD---SPEW----  261 (494)
T ss_dssp             TTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-CC---SGGG----
T ss_pred             CCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CC---chhc----
Confidence            555555678999999999986 56999999999999999999999999876544333332221111 00   0000    


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                       ...+.++.+++.+||+.||.+|||+.++++
T Consensus       262 -~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          262 -KNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence             112357899999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.4e-44  Score=363.27  Aligned_cols=251  Identities=29%  Similarity=0.425  Sum_probs=209.0

Q ss_pred             HHHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      ....|.+.+.||+|+||.||+|... +|+.||||++....   ......+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4567889999999999999999764 78999999986542   3456789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee---cCCCcEEEeecCCccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSRE  262 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill---~~~~~~kl~Dfgl~~~  262 (432)
                      ||||+.+|+|.+.+..  ...+++..+..++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.
T Consensus       104 v~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          104 VGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             EECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            9999999999998854  356999999999999999999999999   9999999999999   5678999999999876


Q ss_pred             ccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ...........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+.......         ..
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---------~~  248 (484)
T 3nyv_A          179 FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF---------EL  248 (484)
T ss_dssp             BCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------CS
T ss_pred             cccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---------CC
Confidence            544444456679999999999875 69999999999999999999999998766544433332221110         00


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +.....+.++.+|+.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          249 PQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            000122357899999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.9e-44  Score=373.98  Aligned_cols=248  Identities=26%  Similarity=0.406  Sum_probs=201.7

Q ss_pred             ccccccCceeEEEEEe---CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQM---STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      +.||+|+||.||+|.+   ..++.||||++....  ....++|.+|+.+|++++||||++++++|.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999954   246789999997643  3345789999999999999999999999964 568899999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc----c
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK----H  268 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~----~  268 (432)
                      |+|.+++..  ...+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++......    .
T Consensus       454 g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          454 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            999999954  356999999999999999999999999   9999999999999999999999999987543221    1


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+..............            ....+..
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~------------~~~~p~~  596 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE------------RMGCPAG  596 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------CCCCCTT
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------CCCCCCC
Confidence            223456788999999999999999999999999999998 999998765433322222211            1112223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      .+.++.++|.+||+.||++||++.+|++.|+.+...
T Consensus       597 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          597 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            446899999999999999999999999999988653

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.2e-44  Score=345.11  Aligned_cols=262  Identities=26%  Similarity=0.405  Sum_probs=210.8

Q ss_pred             cCHHHHHHHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhh--cCCCccceEEeeeeeCC
Q 014038          104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGR--LHHRNLVNLVGYCAEKG  181 (432)
Q Consensus       104 ~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~  181 (432)
                      +...+.....|.+.+.||+|+||.||+|.. +|+.||||.+..   .....+.+|.+++..  ++||||+++++++....
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            445566778899999999999999999987 689999999854   334567889988887  78999999999998775


Q ss_pred             ----eEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeccCCCCCeeecCC
Q 014038          182 ----QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH--------DGAVPPVIHRDIKSSNILLDQS  249 (432)
Q Consensus       182 ----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~iiH~dlkp~Nill~~~  249 (432)
                          ..++||||+++|+|.+++..   ..+++..++.++.|++.||.|||        +.+   |+||||||+|||++.+
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~  183 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKN  183 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTT
T ss_pred             CccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCC
Confidence                78999999999999999954   35999999999999999999999        777   9999999999999999


Q ss_pred             CcEEEeecCCcccccccc-----cccccccCCCCCCccccccC------CCCchhHhHHHHHHHHHHHhC----------
Q 014038          250 MRARVADFGLSREEMVDK-----HAANIRGTFGYLDPEYISTR------NFTKKSDVYSFGVLLFELIAG----------  308 (432)
Q Consensus       250 ~~~kl~Dfgl~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvil~elltg----------  308 (432)
                      +.+||+|||++.......     ......||+.|+|||++.+.      .++.++|||||||++|||++|          
T Consensus       184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~  263 (342)
T 1b6c_B          184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  263 (342)
T ss_dssp             SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence            999999999997543322     22445799999999998765      234789999999999999999          


Q ss_pred             CCCCCChhH----HHHHHHhhhcCCCchhhhccccCCCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 014038          309 RSPLQGLME----YVELAAMNTEGKTGWEEIVDSRLDGIF-----DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR  379 (432)
Q Consensus       309 ~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~  379 (432)
                      +.||.....    ...+...          +.........     ....+..+.+++.+||+.||++|||+.+|++.|+.
T Consensus       264 ~~p~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~  333 (342)
T 1b6c_B          264 QLPYYDLVPSDPSVEEMRKV----------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  333 (342)
T ss_dssp             CCTTTTTSCSSCCHHHHHHH----------HTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccCccccCcCcccHHHHHHH----------HHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            778864311    1111111          1111111111     23566789999999999999999999999999999


Q ss_pred             HHhhcc
Q 014038          380 ILKMRH  385 (432)
Q Consensus       380 i~~~~~  385 (432)
                      +.+..+
T Consensus       334 i~~~~~  339 (342)
T 1b6c_B          334 LSQQEG  339 (342)
T ss_dssp             HHHTTC
T ss_pred             HHHHhc
Confidence            976543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.2e-44  Score=341.67  Aligned_cols=247  Identities=22%  Similarity=0.380  Sum_probs=205.4

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||+|... +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            35777899999999999999765 6789999998654   2344567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-  266 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-  266 (432)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++...... 
T Consensus        95 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           95 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             ECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            999999999988543  46999999999999999999999999   999999999999999999999999998754322 


Q ss_pred             ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.................             ..+.
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------~~~~  236 (294)
T 2rku_A          170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-------------SIPK  236 (294)
T ss_dssp             CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-------------CCCT
T ss_pred             cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC-------------CCcc
Confidence            233446789999999999988999999999999999999999999987543322222211110             1111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ..+..+.+++.+||+.||++|||+.++++.
T Consensus       237 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          237 HINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            223578999999999999999999998863

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.1e-44  Score=348.72  Aligned_cols=255  Identities=22%  Similarity=0.271  Sum_probs=194.3

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC------eE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG------QH  183 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~  183 (432)
                      .|.+.+.||+|+||.||+|.. .+++.||||++...  .....+.+.+|+.+++.++||||+++++++...+      ..
T Consensus        26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  105 (371)
T 2xrw_A           26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  105 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred             heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence            577788999999999999965 47889999998753  3344567889999999999999999999987654      78


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ++||||+++ +|.+.+.    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       106 ~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          106 YIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             EEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             EEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence            999999974 7888774    34899999999999999999999999   999999999999999999999999999765


Q ss_pred             cccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchh----------
Q 014038          264 MVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWE----------  333 (432)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------  333 (432)
                      ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+.........          
T Consensus       178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  257 (371)
T 2xrw_A          178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  257 (371)
T ss_dssp             ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred             ccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence            4444445567999999999999999999999999999999999999999876554443333221111111          


Q ss_pred             ----------------hhccccCCCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          334 ----------------EIVDSRLDGIF---DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       334 ----------------~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                                      ...........   +...+.++.+|+.+||+.||++|||+.++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                            11111110000   1123568999999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.6e-44  Score=337.25  Aligned_cols=246  Identities=25%  Similarity=0.454  Sum_probs=206.0

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  102 (303)
T 3a7i_A           23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL  102 (303)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence            466778999999999999965 478999999997553 344578999999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~  269 (432)
                      ++++|.+++..   .++++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++....... ..
T Consensus       103 ~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  176 (303)
T 3a7i_A          103 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  176 (303)
T ss_dssp             TTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred             CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence            99999999843   46999999999999999999999999   9999999999999999999999999987543322 23


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.................        +.+..    ..+
T Consensus       177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~----~~~  244 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP--------PTLEG----NYS  244 (303)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--------CCCCS----SCC
T ss_pred             CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC--------CCCcc----ccC
Confidence            456789999999999999999999999999999999999999986544332222211111        11111    223


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      ..+.+++.+||+.||.+|||+.++++.
T Consensus       245 ~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          245 KPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            478999999999999999999999874

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.9e-45  Score=353.34  Aligned_cols=260  Identities=22%  Similarity=0.360  Sum_probs=204.2

Q ss_pred             HHhccccccccccCceeEEEEEeC-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      ...|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            346778899999999999999764 7899999999765 34445678999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      |+++|+|.+++...  ..+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++..... .
T Consensus       112 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-S  185 (360)
T ss_dssp             CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-H
T ss_pred             CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc-c
Confidence            99999999999543  4689999999999999999999985 7   99999999999999999999999999864322 2


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc--------------------
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE--------------------  327 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~--------------------  327 (432)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...............                    
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence            334567899999999999999999999999999999999999999754322111100000                    


Q ss_pred             -------CCCch----hhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          328 -------GKTGW----EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       328 -------~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                             .....    ..+.............+.++.+|+.+||+.||++|||+.++++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                   00000    00111111111111234579999999999999999999999863

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=348.30  Aligned_cols=251  Identities=20%  Similarity=0.237  Sum_probs=204.4

Q ss_pred             HHhccccccccccCceeEEEE------EeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC---CCccceEEeeeeeCC
Q 014038          111 KATCNFTTLIGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH---HRNLVNLVGYCAEKG  181 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~  181 (432)
                      ...|.+.+.||+|+||.||+|      ...+++.||||++....   ..++..|+.++..++   |+||+++++++...+
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            346777889999999999999      34578899999996543   456777888887776   999999999999999


Q ss_pred             eEEEEEEeccCCChhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC----------
Q 014038          182 QHMLVYVFMSKGSLASHLYDE---NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ----------  248 (432)
Q Consensus       182 ~~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~----------  248 (432)
                      ..++||||+++|+|.+++...   ....+++..++.++.||+.||+|||+++   |+||||||+||||+.          
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-----
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccccc
Confidence            999999999999999999641   3467999999999999999999999999   999999999999998          


Q ss_pred             -CCcEEEeecCCccccc---ccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHh
Q 014038          249 -SMRARVADFGLSREEM---VDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM  324 (432)
Q Consensus       249 -~~~~kl~Dfgl~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~  324 (432)
                       ++.+||+|||+++...   .........||+.|+|||++.+..++.++|||||||++|||+||+.||.....       
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------  290 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-------  290 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET-------
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC-------
Confidence             8999999999996432   22234456799999999999999999999999999999999999999864211       


Q ss_pred             hhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHHHHHhhc
Q 014038          325 NTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKR-PSMRDIVQVLSRILKMR  384 (432)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-Ps~~~vl~~L~~i~~~~  384 (432)
                         +.    ......+....   ....+.+++..|++.+|.+| |++.++.+.|++++...
T Consensus       291 ---~~----~~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          291 ---GE----CKPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             ---TE----EEECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ---Cc----eeechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence               00    00111122111   13467889999999999999 68889999999887653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=336.39  Aligned_cols=246  Identities=26%  Similarity=0.448  Sum_probs=181.6

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+|.. .+|+.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (278)
T 3cok_A           12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE   91 (278)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence            567788999999999999975 578999999986432   1224678999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-c
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-K  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~  267 (432)
                      |+++++|.+++... ..++++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...... .
T Consensus        92 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           92 MCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             CCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             cCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            99999999998643 357999999999999999999999999   999999999999999999999999998754322 2


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........           ........  ..+..
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----------~~~~~~~~--~~~~~  234 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-----------NKVVLADY--EMPSF  234 (278)
T ss_dssp             ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------CCSSCC--CCCTT
T ss_pred             cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-----------HHHhhccc--CCccc
Confidence            233457899999999999889999999999999999999999999753211110           11111010  11222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+.++.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          235 LSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            3457899999999999999999999885

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.9e-44  Score=341.54  Aligned_cols=246  Identities=26%  Similarity=0.407  Sum_probs=195.2

Q ss_pred             hcccc-ccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFT-TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      .|.+. +.||+|+||.||+|.. .+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++||||
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   92 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK   92 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence            45553 6899999999999964 47899999999776656667899999999985 799999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc---EEEeecCCccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR---ARVADFGLSREEMVD  266 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~---~kl~Dfgl~~~~~~~  266 (432)
                      +++|+|.+++...  ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.   +||+|||++......
T Consensus        93 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           93 MRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             CTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             CCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            9999999999653  46899999999999999999999999   999999999999988776   999999998753221


Q ss_pred             --------ccccccccCCCCCCcccccc-----CCCCchhHhHHHHHHHHHHHhCCCCCCChhH--------------HH
Q 014038          267 --------KHAANIRGTFGYLDPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLME--------------YV  319 (432)
Q Consensus       267 --------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltg~~p~~~~~~--------------~~  319 (432)
                              .......||+.|+|||++..     ..++.++|||||||++|||++|+.||.+...              ..
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence                    11223468999999999865     5588999999999999999999999975321              00


Q ss_pred             HHHHhhhcCCCchhhhccccCCCCCCH----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          320 ELAAMNTEGKTGWEEIVDSRLDGIFDV----EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+........          .  .++.    ..+.++.+++.+||+.||++|||+.++++
T Consensus       248 ~~~~~i~~~~----------~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          248 MLFESIQEGK----------Y--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHCC----------C--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhccC----------c--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            0000000110          0  1111    12357899999999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.3e-45  Score=348.58  Aligned_cols=258  Identities=24%  Similarity=0.362  Sum_probs=195.7

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCChh-hHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQ-GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      +|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   82 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence            4677889999999999999764 7899999998654322 1224567999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-ccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~  269 (432)
                      + |+|.+++... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..... ...
T Consensus        83 ~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           83 D-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             S-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             c-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence            7 5898888653 356999999999999999999999999   999999999999999999999999998754322 223


Q ss_pred             cccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc----CCCchhhhccc------
Q 014038          270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE----GKTGWEEIVDS------  338 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~------  338 (432)
                      ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+...    ....|......      
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY  237 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence            44578999999999876 57899999999999999999999999876544433332111    11111111110      


Q ss_pred             ---cCCCCC----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          339 ---RLDGIF----DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       339 ---~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                         ......    ....+.++.+|+.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence               000000    0012357889999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=8.1e-45  Score=360.32  Aligned_cols=252  Identities=21%  Similarity=0.298  Sum_probs=202.0

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|.+.++||+|+||.||+|+.. +++.||+|++....   ......+.+|+.++..++||||++++++|.+.+..++||
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~  153 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM  153 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence            35677789999999999999765 57899999986532   122234889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+++|+|.+++... ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++......
T Consensus       154 Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          154 DYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             CCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             ecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            999999999999642 356999999999999999999999999   9999999999999999999999999997543332


Q ss_pred             c--ccccccCCCCCCccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          268 H--AANIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       268 ~--~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .  ....+||+.|+|||++.     ...|+.++|||||||++|||++|+.||.+.........+....    ..+.-+..
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----~~~~~p~~  305 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK----ERFQFPTQ  305 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH----HHCCCCSS
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc----ccccCCcc
Confidence            2  23468999999999986     5678999999999999999999999998755433322221100    00000000


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRK--RPSMRDIVQ  375 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~~vl~  375 (432)
                      .    ...+.++.+|+.+||..+|++  ||+++++++
T Consensus       306 ~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          306 V----TDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             C----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             c----ccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            0    112357899999999888887  999999876

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-44  Score=348.56  Aligned_cols=246  Identities=22%  Similarity=0.390  Sum_probs=205.0

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||++... +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            46777899999999999999764 6789999998654   2344567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-  266 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-  266 (432)
                      ||+++++|.+++...  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++...... 
T Consensus       121 e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          121 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             CCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             ecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            999999999988543  46999999999999999999999999   999999999999999999999999999754322 


Q ss_pred             ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      .......||+.|+|||++.+..++.++||||||+++|||++|+.||.................         .+    +.
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---------~~----~~  262 (335)
T 2owb_A          196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY---------SI----PK  262 (335)
T ss_dssp             CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---------CC----CT
T ss_pred             ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC---------CC----Cc
Confidence            233456789999999999998999999999999999999999999986543322222211110         11    11


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ....++.+++.+||+.||++|||+.++++
T Consensus       263 ~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          263 HINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            22347889999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-44  Score=352.77  Aligned_cols=256  Identities=20%  Similarity=0.308  Sum_probs=198.9

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC----------
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK----------  180 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----------  180 (432)
                      .+|.+.+.||+|+||.||+|.. .+|+.||||++..+...    ..+|+.+++.++||||+++++++...          
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~   82 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP   82 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence            4677889999999999999965 58899999998654322    24799999999999999999998543          


Q ss_pred             ----------------------------CeEEEEEEeccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 014038          181 ----------------------------GQHMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGA  230 (432)
Q Consensus       181 ----------------------------~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~  230 (432)
                                                  ...++||||++ |+|.+.+..  .....+++..+..++.||+.||.|||+.+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  161 (383)
T 3eb0_A           83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG  161 (383)
T ss_dssp             ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence                                        34889999998 588777753  34567999999999999999999999999


Q ss_pred             CCCeeeccCCCCCeeec-CCCcEEEeecCCcccccccccccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhC
Q 014038          231 VPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAG  308 (432)
Q Consensus       231 ~~~iiH~dlkp~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg  308 (432)
                         |+||||||+|||++ .++.+||+|||+++............+|+.|+|||.+.+. .++.++|||||||++|||++|
T Consensus       162 ---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  238 (383)
T 3eb0_A          162 ---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG  238 (383)
T ss_dssp             ---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred             ---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence               99999999999998 6889999999999865555555566789999999998764 599999999999999999999


Q ss_pred             CCCCCChhHHHHHHHhhhcCCCc-hhhhc--c--------ccC-----CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 014038          309 RSPLQGLMEYVELAAMNTEGKTG-WEEIV--D--------SRL-----DGIFDVEELNEVASLAYKCVNRAPRKRPSMRD  372 (432)
Q Consensus       309 ~~p~~~~~~~~~~~~~~~~~~~~-~~~~~--~--------~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~  372 (432)
                      +.||.+......+..+......+ ...+.  +        +..     ...++...+.++.+|+.+||+.||.+|||+.+
T Consensus       239 ~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  318 (383)
T 3eb0_A          239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE  318 (383)
T ss_dssp             SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            99998765544443332111100 00000  0        000     00011223457899999999999999999999


Q ss_pred             HHH
Q 014038          373 IVQ  375 (432)
Q Consensus       373 vl~  375 (432)
                      +++
T Consensus       319 ~l~  321 (383)
T 3eb0_A          319 AMA  321 (383)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            985

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.8e-44  Score=347.25  Aligned_cols=259  Identities=19%  Similarity=0.323  Sum_probs=205.0

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhh-----------------HHHHHHHHHHHhhcCCCccceEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQG-----------------EKEFQTEVMLLGRLHHRNLVNLV  174 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l~  174 (432)
                      ..|.+.+.||+|+||.||+|.. +|+.||||.+.......                 .+.+.+|+.++++++||||++++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            3677889999999999999988 89999999986432111                 17899999999999999999999


Q ss_pred             eeeeeCCeEEEEEEeccCCChhhh------cccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCeeec
Q 014038          175 GYCAEKGQHMLVYVFMSKGSLASH------LYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLD  247 (432)
Q Consensus       175 ~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlkp~Nill~  247 (432)
                      +++.+.+..++||||+++|+|.++      +.......+++..+..++.|++.||.|||+ .+   |+||||||+|||++
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~  186 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMD  186 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEEC
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEc
Confidence            999999999999999999999998      655446789999999999999999999999 88   99999999999999


Q ss_pred             CCCcEEEeecCCcccccccccccccccCCCCCCccccccC-CCCc-hhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhh
Q 014038          248 QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR-NFTK-KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMN  325 (432)
Q Consensus       248 ~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~  325 (432)
                      .++.+||+|||++...... ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||.............
T Consensus       187 ~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i  265 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI  265 (348)
T ss_dssp             TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHH
T ss_pred             CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            9999999999998754332 33456789999999999877 6666 9999999999999999999998654312222111


Q ss_pred             hcCCCchhh----hccccCC---CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          326 TEGKTGWEE----IVDSRLD---GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       326 ~~~~~~~~~----~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ......+..    ...+...   .......+.++.+++.+||+.||.+|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111111110    0000000   0001223457899999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.9e-44  Score=334.80  Aligned_cols=246  Identities=26%  Similarity=0.387  Sum_probs=195.3

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||+|... +|+.||||.+....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            35777889999999999999765 78999999986532   233467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++.......
T Consensus        91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           91 EYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             eccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            999999999998543  46899999999999999999999999   9999999999999999999999999987654444


Q ss_pred             cccccccCCCCCCccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          268 HAANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      ......+|+.|+|||.+.+..+ +.++||||||+++|||++|+.||............... ..            ..+.
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~------------~~~~  232 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG-VF------------YIPE  232 (276)
T ss_dssp             -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CC------------CCCT
T ss_pred             ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-cc------------cCch
Confidence            4445678999999999987765 68999999999999999999999764432222211111 00            0111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.++.+++.+||+.||.+|||+.++++
T Consensus       233 ~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          233 YLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            22357899999999999999999999987

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.4e-44  Score=347.14  Aligned_cols=258  Identities=27%  Similarity=0.393  Sum_probs=200.3

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      .|.+.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  105 (331)
T 4aaa_A           26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF  105 (331)
T ss_dssp             GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence            6778899999999999999764 58999999986543  33346688999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KH  268 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~  268 (432)
                      +++++|..++..  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...... ..
T Consensus       106 ~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          106 VDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             CSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             CCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            999999887643  346999999999999999999999999   999999999999999999999999999754332 23


Q ss_pred             ccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCC-------------chhh
Q 014038          269 AANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT-------------GWEE  334 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------------~~~~  334 (432)
                      .....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||.+................             .+..
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG  260 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence            3456789999999998765 7899999999999999999999999876544333222110000             0000


Q ss_pred             hccccCCCCCCH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 IVDSRLDGIFDV-----EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 ~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...+......+.     ..+.++.+|+.+||+.||++|||+.++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            011111111111     12467999999999999999999999886

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2e-44  Score=338.47  Aligned_cols=245  Identities=25%  Similarity=0.407  Sum_probs=204.2

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||+|... +++.||+|.+....   ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46778899999999999999764 67899999986432   223467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..... .
T Consensus        94 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~-~  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS-L  167 (284)
T ss_dssp             CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS-S
T ss_pred             EeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc-c
Confidence            999999999998643  46899999999999999999999999   99999999999999999999999999865432 2


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      ......|++.|+|||.+.+..++.++||||||+++|||++|+.||................             ..++..
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------------~~~~~~  234 (284)
T 2vgo_A          168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-------------LKFPPF  234 (284)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-------------CCCCTT
T ss_pred             ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-------------cCCCCc
Confidence            2345678999999999999999999999999999999999999998654332222211110             011222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+.++.+++.+||+.||.+||++.++++
T Consensus       235 ~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          235 LSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            3357899999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.1e-43  Score=359.98  Aligned_cols=249  Identities=24%  Similarity=0.338  Sum_probs=202.6

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh-------------hhHHHHHHHHHHHhhcCCCccceEEeee
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK-------------QGEKEFQTEVMLLGRLHHRNLVNLVGYC  177 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~~~  177 (432)
                      ..|.+.+.||+|+||+||+|... +++.||+|++.....             ...+.+.+|+.++++++||||+++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            46788899999999999999754 678999999865421             2346789999999999999999999999


Q ss_pred             eeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC---cEEE
Q 014038          178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM---RARV  254 (432)
Q Consensus       178 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~---~~kl  254 (432)
                      .+....++||||+++|+|.+.+...  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+||
T Consensus       116 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          116 EDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEE
Confidence            9999999999999999999988543  46999999999999999999999999   99999999999998776   6999


Q ss_pred             eecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhh
Q 014038          255 ADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEE  334 (432)
Q Consensus       255 ~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  334 (432)
                      +|||++.............||+.|+|||++. +.++.++|||||||++|+|++|..||.+....................
T Consensus       191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  269 (504)
T 3q5i_A          191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN  269 (504)
T ss_dssp             CCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred             EECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence            9999998655554555678999999999987 469999999999999999999999998765443333322211100000


Q ss_pred             hccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..         ...+.++.+|+.+||+.||.+|||+.++++
T Consensus       270 ~~---------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          270 DW---------KNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HH---------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cc---------CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            00         012357899999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.5e-44  Score=335.35  Aligned_cols=244  Identities=21%  Similarity=0.306  Sum_probs=199.7

Q ss_pred             HHhccccccccccCceeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD--SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ...|.+.+.||+|+||.||+|... +++.||+|.+...  .......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            457888899999999999999765 7899999998764  334456788999999999 999999999999999999999


Q ss_pred             EEeccCCChhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC----------------
Q 014038          187 YVFMSKGSLASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ----------------  248 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~----------------  248 (432)
                      |||+++|+|.+++....  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999996432  256899999999999999999999999   999999999999984                


Q ss_pred             ---CCcEEEeecCCcccccccccccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHh
Q 014038          249 ---SMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM  324 (432)
Q Consensus       249 ---~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~  324 (432)
                         ...+||+|||++......   ....||+.|+|||.+.+. .++.++|||||||++|||++|..|+........... 
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~-  242 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ-  242 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHT-
T ss_pred             cCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHc-
Confidence               447999999998754322   234589999999999765 667899999999999999999988765433222111 


Q ss_pred             hhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          325 NTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                        ...        +.    .+...+.++.+++.+||+.||++|||+.++++
T Consensus       243 --~~~--------~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          243 --GRL--------PR----IPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             --TCC--------CC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCC--------CC----CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence              100        11    11122357899999999999999999999885

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.2e-44  Score=355.71  Aligned_cols=257  Identities=24%  Similarity=0.316  Sum_probs=203.5

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhc------CCCccceEEeeeeeCCeEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL------HHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~~  184 (432)
                      .+|.+.+.||+|+||.||+|.. .+++.||||++... ......+.+|+.+++.+      +|+||+++++++...+..+
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  175 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC  175 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence            3577889999999999999965 46899999999653 33345677888888877      5779999999999999999


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc--EEEeecCCccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR--ARVADFGLSRE  262 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~--~kl~Dfgl~~~  262 (432)
                      +||||+. ++|.+++.......+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.  +||+|||+++.
T Consensus       176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY  251 (429)
T ss_dssp             EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccccee
Confidence            9999996 69999997766667999999999999999999999999   999999999999999887  99999999865


Q ss_pred             ccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhh--------
Q 014038          263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEE--------  334 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------  334 (432)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..+...+..+..........        
T Consensus       252 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~  329 (429)
T 3kvw_A          252 EH--QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA  329 (429)
T ss_dssp             TT--CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTH
T ss_pred             cC--CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhh
Confidence            32  23345678999999999999999999999999999999999999998765544333222111000000        


Q ss_pred             --hcccc---------------------------C---CCCCC------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 --IVDSR---------------------------L---DGIFD------VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 --~~~~~---------------------------~---~~~~~------~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                        +++..                           .   .....      .....++.+|+.+||+.||++|||+.|+++
T Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          330 KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR  408 (429)
T ss_dssp             HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence              00000                           0   00000      001357899999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.8e-43  Score=332.91  Aligned_cols=247  Identities=26%  Similarity=0.442  Sum_probs=198.7

Q ss_pred             ccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeee----CCeEEEE
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE----KGQHMLV  186 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  186 (432)
                      +.+.+.||+|+||.||+|.. .++..||+|.+...  .....+.+.+|+.++++++||||+++++++..    ....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            56677899999999999965 46789999998654  34455678999999999999999999998865    3568999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec-CCCcEEEeecCCcccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMV  265 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~-~~~~~kl~Dfgl~~~~~~  265 (432)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||+.+ ++|+||||||+|||++ .++.+||+|||++.....
T Consensus       108 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~  184 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence            9999999999999543  56899999999999999999999976 4599999999999997 789999999999864322


Q ss_pred             cccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                       .......||+.|+|||.+. +.++.++||||||+++|+|++|+.||...................      ...    +
T Consensus       185 -~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------~~~----~  252 (290)
T 1t4h_A          185 -SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------ASF----D  252 (290)
T ss_dssp             -TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC------GGG----G
T ss_pred             -cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc------ccc----C
Confidence             2334457899999999887 459999999999999999999999998644433332222211110      001    1


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...+.++.+++.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            111247899999999999999999999885

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.5e-44  Score=341.16  Aligned_cols=252  Identities=24%  Similarity=0.379  Sum_probs=197.1

Q ss_pred             HHHHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC--------hhhHHHHHHHHHHHhhcCCCccceEEeeeee
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--------KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE  179 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  179 (432)
                      .....|.+.+.||+|+||.||+|.. .+++.||||.+....        ......+.+|+.++++++||||+++++++..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            3456889999999999999999965 467899999986532        1223458899999999999999999999876


Q ss_pred             CCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc---EEEee
Q 014038          180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR---ARVAD  256 (432)
Q Consensus       180 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~---~kl~D  256 (432)
                      .. .++||||+++|+|.+++..  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.   +||+|
T Consensus        87 ~~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           87 ED-YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             SS-EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             Cc-eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            54 8999999999999998853  457999999999999999999999999   999999999999987664   99999


Q ss_pred             cCCcccccccccccccccCCCCCCccccc---cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCch-
Q 014038          257 FGLSREEMVDKHAANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW-  332 (432)
Q Consensus       257 fgl~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-  332 (432)
                      ||++.............||+.|+|||++.   ...++.++|||||||++|||++|+.||........+......+...+ 
T Consensus       161 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (322)
T 2ycf_A          161 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI  240 (322)
T ss_dssp             CTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred             CccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence            99997654433334567899999999873   56789999999999999999999999975322111111111111000 


Q ss_pred             hhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ....         ...+.++.+++.+||+.||++||++.++++
T Consensus       241 ~~~~---------~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          241 PEVW---------AEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHH---------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhh---------hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            0000         012357899999999999999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.4e-44  Score=345.00  Aligned_cols=249  Identities=22%  Similarity=0.348  Sum_probs=198.6

Q ss_pred             HHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      ...|.+.+.||+|+||.||+|... +|+.||||++.....    .+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            457888899999999999999654 688999999975432    234688888888 79999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC----CcEEEeecCCccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS----MRARVADFGLSREEM  264 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~----~~~kl~Dfgl~~~~~  264 (432)
                      |+++|+|.+++..  .+.+++..+..++.||+.||.|||+++   |+||||||+|||+.++    +.+||+|||+++...
T Consensus        97 ~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           97 LMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999854  356999999999999999999999999   9999999999998433    359999999997543


Q ss_pred             cc-ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChh--HHHHHHHhhhcCCCchhhhccccCC
Q 014038          265 VD-KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM--EYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       265 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      .. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..  ....+......+..        .+.
T Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~--------~~~  243 (342)
T 2qr7_A          172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF--------SLS  243 (342)
T ss_dssp             CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC--------CCC
T ss_pred             CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc--------ccC
Confidence            32 23445678999999999988889999999999999999999999997521  11111111111110        011


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                      .......+.++.+|+.+||+.||++||++.++++.
T Consensus       244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11112234578999999999999999999998863

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.7e-44  Score=353.25  Aligned_cols=267  Identities=22%  Similarity=0.282  Sum_probs=207.2

Q ss_pred             CCcCHHHHHHHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC--------CCccce
Q 014038          102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLH--------HRNLVN  172 (432)
Q Consensus       102 ~~~~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~  172 (432)
                      ..+...++....|.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.+++.++        |+||++
T Consensus        27 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           27 HLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             CSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             eEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            34444555566888999999999999999964 57889999999643 344567889999999985        788999


Q ss_pred             EEeeee----eCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCeeec
Q 014038          173 LVGYCA----EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLD  247 (432)
Q Consensus       173 l~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlkp~Nill~  247 (432)
                      +++++.    .....++||||+ +++|.+.+.......+++..+..++.||+.||.|||++ +   |+||||||+|||++
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~  181 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLS  181 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEEC
T ss_pred             eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEe
Confidence            999987    456889999999 66787777666556799999999999999999999998 8   99999999999999


Q ss_pred             CCC-------------------------------------------------cEEEeecCCcccccccccccccccCCCC
Q 014038          248 QSM-------------------------------------------------RARVADFGLSREEMVDKHAANIRGTFGY  278 (432)
Q Consensus       248 ~~~-------------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~gt~~y  278 (432)
                      .++                                                 .+||+|||++.....  ......||+.|
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y  259 (397)
T 1wak_A          182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQY  259 (397)
T ss_dssp             CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGG
T ss_pred             ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcc
Confidence            775                                                 799999999875432  23445789999


Q ss_pred             CCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChh------HHHHHHHhhh-cCCCchh---------hhcccc---
Q 014038          279 LDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLM------EYVELAAMNT-EGKTGWE---------EIVDSR---  339 (432)
Q Consensus       279 ~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~------~~~~~~~~~~-~~~~~~~---------~~~~~~---  339 (432)
                      +|||++.+..++.++|||||||++|||++|+.||....      +...+..+.. .+..+..         .++...   
T Consensus       260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  339 (397)
T 1wak_A          260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL  339 (397)
T ss_dssp             CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred             cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence            99999999999999999999999999999999997422      1111111100 0000000         000000   


Q ss_pred             ----------------CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          340 ----------------LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       340 ----------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                                      -....+...+..+.+|+.+||+.||++|||+.++++
T Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                            001235667788999999999999999999999985

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=354.93  Aligned_cols=251  Identities=23%  Similarity=0.302  Sum_probs=200.7

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|..++..++||||+++++++.+.+..++||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            45677789999999999999764 78999999996432   222345889999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      ||+++|+|.+++... ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++......
T Consensus       141 E~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             CCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             cCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            999999999999643 246999999999999999999999999   9999999999999999999999999997644332


Q ss_pred             c--ccccccCCCCCCccccc-------cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccc
Q 014038          268 H--AANIRGTFGYLDPEYIS-------TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDS  338 (432)
Q Consensus       268 ~--~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .  ....+||+.|+|||++.       ...|+.++|||||||++|||++|+.||.+.........+....    ..+..+
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~----~~~~~p  292 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK----EHLSLP  292 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH----HHCCCC
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----cCcCCC
Confidence            2  23468999999999987       4578999999999999999999999998754433222221100    000001


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhhccCCCCC---CCHHHHHH
Q 014038          339 RLDGIFDVEELNEVASLAYKCVNRAPRKR---PSMRDIVQ  375 (432)
Q Consensus       339 ~~~~~~~~~~~~~l~~li~~cl~~dp~~R---Ps~~~vl~  375 (432)
                      .    .+...+.++.+|+.+||. +|.+|   |+++++++
T Consensus       293 ~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          293 L----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             --------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             c----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            0    111234578999999999 99998   58888764

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-44  Score=348.82  Aligned_cols=254  Identities=24%  Similarity=0.334  Sum_probs=195.3

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC------eE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG------QH  183 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~  183 (432)
                      .|.+.+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...+      ..
T Consensus        26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  105 (367)
T 1cm8_A           26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF  105 (367)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence            567788999999999999965 57899999998653  3344567899999999999999999999987653      46


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ++||||+ +++|.+++..   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       106 ~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  178 (367)
T 1cm8_A          106 YLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA  178 (367)
T ss_dssp             EEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence            9999999 7899999854   46899999999999999999999999   999999999999999999999999999764


Q ss_pred             cccccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcc-----
Q 014038          264 MVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD-----  337 (432)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  337 (432)
                      .  .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......+..+.........++..     
T Consensus       179 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  256 (367)
T 1cm8_A          179 D--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  256 (367)
T ss_dssp             C--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             c--cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence            3  23345678999999999876 689999999999999999999999998765443333221111111010000     


Q ss_pred             ----------ccCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          338 ----------SRLDG---IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       338 ----------~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                                .....   ......+.++.+|+.+||+.||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                      00000   001122357899999999999999999999886

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.9e-44  Score=361.34  Aligned_cols=243  Identities=26%  Similarity=0.418  Sum_probs=199.8

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|+.++++++||||+++++++.+....++|||
T Consensus       186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE  265 (543)
T 3c4z_A          186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT  265 (543)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEE
Confidence            4556678999999999999764 78999999996532   2334678899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          189 FMSKGSLASHLYDEN--YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |+++|+|.+++....  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~  342 (543)
T 3c4z_A          266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG  342 (543)
T ss_dssp             CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence            999999999986533  456999999999999999999999999   999999999999999999999999999764433


Q ss_pred             c-cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhH---HHHHHHhhhcCCCchhhhccccCCC
Q 014038          267 K-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME---YVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       267 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      . .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+...   ...+....          ....  .
T Consensus       343 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i----------~~~~--~  410 (543)
T 3c4z_A          343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV----------LEQA--V  410 (543)
T ss_dssp             CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH----------HHCC--C
T ss_pred             CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH----------hhcc--c
Confidence            2 23445899999999999999999999999999999999999999976421   11111111          1111  1


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSM  370 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~  370 (432)
                      .++...+.++.+++.+||+.||.+||++
T Consensus       411 ~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          411 TYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence            1222334578999999999999999975

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.3e-44  Score=345.40  Aligned_cols=258  Identities=22%  Similarity=0.347  Sum_probs=193.5

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCCh--hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK--QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      ..|.+.+.||+|+||.||+|.. .+++.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  113 (329)
T 3gbz_A           34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE  113 (329)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence            3678889999999999999964 5789999999975432  234567899999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee-----cCCCcEEEeecCCcccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL-----DQSMRARVADFGLSREE  263 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill-----~~~~~~kl~Dfgl~~~~  263 (432)
                      |++ |+|.+++...  ..+++..+..++.||+.||.|||+++   |+||||||+|||+     +.++.+||+|||+++..
T Consensus       114 ~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          114 YAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             CCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             cCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            998 5999998543  46999999999999999999999999   9999999999999     45556999999998754


Q ss_pred             ccc-ccccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc----CCCchhhhcc
Q 014038          264 MVD-KHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE----GKTGWEEIVD  337 (432)
Q Consensus       264 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~  337 (432)
                      ... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+......+......    ....|.....
T Consensus       188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (329)
T 3gbz_A          188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA  267 (329)
T ss_dssp             C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence            322 233445689999999998764 5899999999999999999999999876554443332111    1111111000


Q ss_pred             --------ccCCCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          338 --------SRLDGIF-----DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       338 --------~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                              +......     +...+.++.+|+.+||+.||++|||+.++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                    0000000     0012357899999999999999999999885

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=9.7e-44  Score=340.24  Aligned_cols=260  Identities=25%  Similarity=0.387  Sum_probs=203.5

Q ss_pred             HhccccccccccCceeEEEEEe--CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhc---CCCccceEEeeee-----e
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM--STGETVAVKVLATDS--KQGEKEFQTEVMLLGRL---HHRNLVNLVGYCA-----E  179 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~  179 (432)
                      ..|.+.+.||+|+||.||+|..  .+|+.||+|++....  ......+.+|+.+++.+   +||||+++++++.     .
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            3577889999999999999976  467899999986432  22233566777777766   8999999999987     4


Q ss_pred             CCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCC
Q 014038          180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL  259 (432)
Q Consensus       180 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl  259 (432)
                      ....++||||++ |+|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~  166 (326)
T 1blx_A           91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL  166 (326)
T ss_dssp             EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcc
Confidence            567899999998 69999997766667999999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh----cCCCchhhh
Q 014038          260 SREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT----EGKTGWEEI  335 (432)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~~~  335 (432)
                      +.............+|+.|+|||.+.+..++.++||||||+++|||++|+.||.+......+..+..    .....|...
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (326)
T 1blx_A          167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  246 (326)
T ss_dssp             CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             cccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence            9765444444556789999999999999999999999999999999999999987655433332211    011111100


Q ss_pred             -------ccccC---CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 -------VDSRL---DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 -------~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                             .....   ........+..+.+++.+||+.||++|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                   00000   00011123457899999999999999999999885

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1e-44  Score=341.11  Aligned_cols=250  Identities=23%  Similarity=0.367  Sum_probs=187.0

Q ss_pred             HHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhH-HHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGE-KEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ...|.+.+.||+|+||.||+|.. .+|+.||+|++.... .... +.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            34677889999999999999975 578999999997642 2222 33455555678889999999999999999999999


Q ss_pred             EeccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          188 VFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       188 e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      ||++ |+|.+++..  .....+++..+..++.|++.||.|||++ +   |+||||||+|||++.++.+||+|||++....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 588777643  2446799999999999999999999997 8   9999999999999999999999999997654


Q ss_pred             ccccccccccCCCCCCcccc----ccCCCCchhHhHHHHHHHHHHHhCCCCCCChhH-HHHHHHhhhcCCCchhhhcccc
Q 014038          265 VDKHAANIRGTFGYLDPEYI----STRNFTKKSDVYSFGVLLFELIAGRSPLQGLME-YVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      .........||+.|+|||.+    .+..++.++||||||+++|||++|+.||..... ............          
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------  231 (290)
T 3fme_A          162 DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS----------  231 (290)
T ss_dssp             --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC----------
T ss_pred             ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC----------
Confidence            44444555799999999996    566789999999999999999999999975322 222221111111          


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                       ........+.++.+++.+||+.||++|||+.++++
T Consensus       232 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          232 -PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence             11111123457899999999999999999999987

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=346.07  Aligned_cols=264  Identities=23%  Similarity=0.388  Sum_probs=194.6

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHH--HhhcCCCccceEEeeeee-----CCeEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVML--LGRLHHRNLVNLVGYCAE-----KGQHML  185 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~~l  185 (432)
                      .|.+.+.||+|+||.||+|+. +++.||||++....   ...+..|..+  +..++||||+++++++..     ....++
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           14 NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             SEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             HhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            567789999999999999977 78999999986432   2344444444  556899999999985532     236789


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeeeccCCCCCeeecCCCcEEEee
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG---------AVPPVIHRDIKSSNILLDQSMRARVAD  256 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~---------~~~~iiH~dlkp~Nill~~~~~~kl~D  256 (432)
                      ||||+++|+|.+++...   .+++..+..++.||+.||.|||+.         +   |+||||||+|||++.++.+||+|
T Consensus        90 v~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECC
T ss_pred             EEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEee
Confidence            99999999999999543   358999999999999999999998         7   99999999999999999999999


Q ss_pred             cCCccccccc---------ccccccccCCCCCCcccccc-------CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHH
Q 014038          257 FGLSREEMVD---------KHAANIRGTFGYLDPEYIST-------RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVE  320 (432)
Q Consensus       257 fgl~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~  320 (432)
                      ||+++.....         .......||+.|+|||++.+       ..++.++|||||||++|||++|..||........
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            9999754321         12234569999999999876       4567899999999999999999776532110000


Q ss_pred             ---HHHhhhcCCCchhh----hc----cccCCCC--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhccc
Q 014038          321 ---LAAMNTEGKTGWEE----IV----DSRLDGI--FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHN  386 (432)
Q Consensus       321 ---~~~~~~~~~~~~~~----~~----~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~  386 (432)
                         ..............    ..    .+.+...  .....+.++.+++.+||+.||++|||+.++++.|+.++.....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~  322 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER  322 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence               00000000000000    00    0111111  1223566899999999999999999999999999999875543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.2e-44  Score=357.36  Aligned_cols=197  Identities=25%  Similarity=0.371  Sum_probs=155.8

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeee-----CCeE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-----KGQH  183 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~  183 (432)
                      ..|.+.+.||+|+||.||+|.. .+++.||||++...  .....+.+.+|+.+|++++||||+++++++..     ....
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            3678889999999999999964 47899999998653  34455789999999999999999999999844     3578


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ++||||+ +|+|.+++..  ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus       133 ~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhc
Confidence            9999998 4699988853  356999999999999999999999999   999999999999999999999999999754


Q ss_pred             ccc----------------------------ccccccccCCCCCCcccc-ccCCCCchhHhHHHHHHHHHHHh-------
Q 014038          264 MVD----------------------------KHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIA-------  307 (432)
Q Consensus       264 ~~~----------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~ellt-------  307 (432)
                      ...                            ......+||+.|+|||++ ....|+.++|||||||++|||++       
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~  286 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA  286 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence            321                            122345789999999976 56679999999999999999999       


Q ss_pred             ----CCCCCCC
Q 014038          308 ----GRSPLQG  314 (432)
Q Consensus       308 ----g~~p~~~  314 (432)
                          |+++|.+
T Consensus       287 ~~~~~~p~f~g  297 (458)
T 3rp9_A          287 YHADRGPLFPG  297 (458)
T ss_dssp             SGGGCCCSCC-
T ss_pred             ccccccccCCC
Confidence                6666755

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.2e-44  Score=335.44  Aligned_cols=245  Identities=25%  Similarity=0.403  Sum_probs=196.4

Q ss_pred             ccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccCCChh
Q 014038          118 TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLA  196 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  196 (432)
                      ..||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            4899999999999975 578899999998766666678999999999999999999999999999999999999999999


Q ss_pred             hhcccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC-CCcEEEeecCCccccccc-ccccccc
Q 014038          197 SHLYDEN-YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLSREEMVD-KHAANIR  273 (432)
Q Consensus       197 ~~l~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~-~~~~kl~Dfgl~~~~~~~-~~~~~~~  273 (432)
                      +++.... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++. ++.+||+|||++...... .......
T Consensus       108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  184 (295)
T 2clq_A          108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT  184 (295)
T ss_dssp             HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCC
T ss_pred             HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccC
Confidence            9996542 335778999999999999999999999   999999999999987 899999999998754322 2234567


Q ss_pred             cCCCCCCccccccC--CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHH
Q 014038          274 GTFGYLDPEYISTR--NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE  351 (432)
Q Consensus       274 gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (432)
                      ||+.|+|||++.+.  .++.++||||||+++|||++|+.||..............          ........+...+.+
T Consensus       185 ~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~  254 (295)
T 2clq_A          185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG----------MFKVHPEIPESMSAE  254 (295)
T ss_dssp             CCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH----------HHCCCCCCCTTSCHH
T ss_pred             CCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc----------cccccccccccCCHH
Confidence            89999999998764  389999999999999999999999975332211110000          000111122233457


Q ss_pred             HHHHHHHhhccCCCCCCCHHHHHH
Q 014038          352 VASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       352 l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +.+++.+||+.||++||++.++++
T Consensus       255 ~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          255 AKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHccCChhhCCCHHHHhc
Confidence            899999999999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1e-43  Score=335.71  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=204.3

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---------hhhHHHHHHHHHHHhhcC-CCccceEEeeeeeC
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---------KQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEK  180 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  180 (432)
                      ..|.+.+.||+|+||.||+|... +|+.||||++....         ....+.+.+|+.+++++. ||||+++++++...
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (298)
T 1phk_A           17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   96 (298)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence            36777889999999999999764 68899999986542         122356889999999995 99999999999999


Q ss_pred             CeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCc
Q 014038          181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS  260 (432)
Q Consensus       181 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~  260 (432)
                      +..++||||+++++|.+++...  ..+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  171 (298)
T 1phk_A           97 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS  171 (298)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccch
Confidence            9999999999999999999643  46999999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccccccccccCCCCCCccccc------cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhh
Q 014038          261 REEMVDKHAANIRGTFGYLDPEYIS------TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEE  334 (432)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  334 (432)
                      .............+|+.|+|||++.      ...++.++||||||+++|||++|+.||..................    
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----  247 (298)
T 1phk_A          172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ----  247 (298)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----
T ss_pred             hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc----
Confidence            7654444445567899999999884      456889999999999999999999999765443322222111110    


Q ss_pred             hccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                           .........+.++.+++.+||+.||.+|||+.++++
T Consensus       248 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          248 -----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             -----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -----cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                 000011123457999999999999999999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-44  Score=344.51  Aligned_cols=259  Identities=25%  Similarity=0.331  Sum_probs=199.5

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCChh-----hHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQ-----GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      ..|.+.+.||+|+||.||+|... +|+.||||.+......     ....+.+|+.++++++||||+++++++.+.+..++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            46778899999999999999764 6899999998753221     12468899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+++ +|.+++.. ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        90 v~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (346)
T 1ua2_A           90 VFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  164 (346)
T ss_dssp             EEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             EEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence            9999986 88888754 3356899999999999999999999999   99999999999999999999999999976433


Q ss_pred             c-ccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc----CCCchhhhcc--
Q 014038          266 D-KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE----GKTGWEEIVD--  337 (432)
Q Consensus       266 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~--  337 (432)
                      . .......+|+.|+|||++.+ ..++.++|||||||++|||++|..||.+......+......    ....|.....  
T Consensus       165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  244 (346)
T 1ua2_A          165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP  244 (346)
T ss_dssp             CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence            2 23345678999999999865 45899999999999999999999999876554443332211    1111111100  


Q ss_pred             -c---cCCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          338 -S---RLDGIFD-----VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       338 -~---~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                       .   ......+     ...+.++.+++.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence             0   0000011     112357999999999999999999999886

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.1e-44  Score=333.58  Aligned_cols=253  Identities=24%  Similarity=0.356  Sum_probs=201.5

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeee--CCeEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHMLVY  187 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  187 (432)
                      .|.+.+.||+|+||.||+|... +++.||+|.+...  .....+.+.+|+.++++++||||+++++++.+  ....++||
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   86 (279)
T 2w5a_A            7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   86 (279)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred             heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence            5777899999999999999764 7899999999754  33445678999999999999999999998754  67899999


Q ss_pred             EeccCCChhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          188 VFMSKGSLASHLYDE--NYGPLTWNLRVHIALDVARGLEYLHDGA--VPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       188 e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ||+++|+|.+++...  ....+++..++.++.|++.||.|||+.+  ..+|+||||||+|||++.++.+||+|||++...
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~  166 (279)
T 2w5a_A           87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  166 (279)
T ss_dssp             ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred             eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence            999999999998642  3345999999999999999999999976  234999999999999999999999999998754


Q ss_pred             cccc-cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          264 MVDK-HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       264 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.................            .
T Consensus       167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~------------~  234 (279)
T 2w5a_A          167 NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF------------R  234 (279)
T ss_dssp             ---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC------------C
T ss_pred             ccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc------------c
Confidence            3222 12345789999999999998999999999999999999999999987543322222111111            0


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVL  377 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L  377 (432)
                      ..+...+.++.+++.+||+.||.+||++.+|++.+
T Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            11222345799999999999999999999998743

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.2e-43  Score=343.31  Aligned_cols=259  Identities=27%  Similarity=0.381  Sum_probs=200.2

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeee--------C
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--------K  180 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  180 (432)
                      ..|.+.+.||+|+||.||+|.. .+|+.||||++....  ......+.+|+.+++.++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            3678889999999999999976 578999999986543  2334678899999999999999999999877        4


Q ss_pred             CeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCc
Q 014038          181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS  260 (432)
Q Consensus       181 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~  260 (432)
                      +..++||||+++ +|...+... ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            468999999975 777777543 356999999999999999999999999   999999999999999999999999998


Q ss_pred             ccccc-----cccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc----CCC
Q 014038          261 REEMV-----DKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE----GKT  330 (432)
Q Consensus       261 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~  330 (432)
                      +....     ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+...    ...
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            75431     122344578999999998875 56899999999999999999999999876554333322111    111


Q ss_pred             chhhhcccc--------CCCCCCH-H------HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          331 GWEEIVDSR--------LDGIFDV-E------ELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       331 ~~~~~~~~~--------~~~~~~~-~------~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+.......        ....... .      ....+.+|+.+||+.||++|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            111110000        0000011 0      1246889999999999999999999886

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.5e-43  Score=338.11  Aligned_cols=249  Identities=20%  Similarity=0.336  Sum_probs=199.4

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC-CCccceEEeeeee--CCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAE--KGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  187 (432)
                      ..|.+.+.||+|+||.||+|.. .+++.||||++...   ..+.+.+|+.++++++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            4677889999999999999964 57899999998643   3467899999999997 9999999999987  66789999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC-cEEEeecCCccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVD  266 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~  266 (432)
                      ||+++++|.+++.     .+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++.....
T Consensus       113 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             ECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            9999999999883     3899999999999999999999999   99999999999999776 8999999999765544


Q ss_pred             ccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChh-HHHHHHHhhh------------------
Q 014038          267 KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLM-EYVELAAMNT------------------  326 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~-~~~~~~~~~~------------------  326 (432)
                      .......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... ....+.....                  
T Consensus       185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  264 (330)
T 3nsz_A          185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  264 (330)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence            45556678999999999876 679999999999999999999999994321 1111111000                  


Q ss_pred             ----------cCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          327 ----------EGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       327 ----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                                .....|..+..    ...+...+.++.+|+.+||+.||++|||+.++++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          265 DPRFNDILGRHSRKRWERFVH----SENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CTHHHHHHCCCCCCCGGGGCC----TTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccchhhhhhhccccchhhhcc----ccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                      00011111111    1111123468999999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.3e-44  Score=353.09  Aligned_cols=255  Identities=24%  Similarity=0.348  Sum_probs=195.5

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC------CeEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQHML  185 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  185 (432)
                      .|.+.+.||+|+||.||+|... +|+.||||++.....    .+.+|+.+|+.++||||++++++|...      ...++
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            5677889999999999999764 689999999865432    234799999999999999999988542      23678


Q ss_pred             EEEeccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC-CcEEEeecCCccc
Q 014038          186 VYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-MRARVADFGLSRE  262 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~-~~~kl~Dfgl~~~  262 (432)
                      ||||+++ +|.+.+..  .....+++..+..++.||+.||.|||+++   |+||||||+||||+.+ +.+||+|||+++.
T Consensus       131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            9999985 66655532  33467999999999999999999999999   9999999999999965 6789999999986


Q ss_pred             ccccccccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc-CCCc---hhhh--
Q 014038          263 EMVDKHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE-GKTG---WEEI--  335 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~-~~~~---~~~~--  335 (432)
                      ...........+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+......+..+... +...   +...  
T Consensus       207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~  286 (420)
T 1j1b_A          207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  286 (420)
T ss_dssp             CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred             cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence            5444445566789999999998764 7999999999999999999999999876554443332211 1000   1000  


Q ss_pred             -----ccccCCC-----CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 -----VDSRLDG-----IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 -----~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                           ..+....     .++...+.++.+|+.+||+.||.+|||+.++++
T Consensus       287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                 0000000     011122457999999999999999999999885

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.5e-44  Score=338.22  Aligned_cols=250  Identities=24%  Similarity=0.402  Sum_probs=199.9

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      ..|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   98 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC   98 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence            36778899999999999999765 68999999997766666788999999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-ccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~  269 (432)
                      ++++|.+++... ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++...... ...
T Consensus        99 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (302)
T 2j7t_A           99 PGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR  174 (302)
T ss_dssp             TTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred             CCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence            999999988542 346999999999999999999999999   999999999999999999999999987542221 223


Q ss_pred             cccccCCCCCCcccc-----ccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCC
Q 014038          270 ANIRGTFGYLDPEYI-----STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                      ....||+.|+|||++     ....++.++||||||+++|||++|+.||...................          ...
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------~~~  244 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT----------LLT  244 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----------CSS
T ss_pred             ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc----------cCC
Confidence            345789999999988     46778999999999999999999999998755433322222111100          011


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +...+.++.+++.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1223357899999999999999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.7e-43  Score=354.98  Aligned_cols=258  Identities=21%  Similarity=0.298  Sum_probs=204.7

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCC-CccceEEeeeeeCCeEEEEEEe
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH-RNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ..|.+.+.||+|+||.||+|.. .+++.||||++.....  ...+.+|+.+++.++| +++..+..++...+..++||||
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~   84 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL   84 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence            3577889999999999999975 5789999998765432  2357889999999976 5566666677778899999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee---cCCCcEEEeecCCccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL---DQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill---~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      + +++|.+++... ...+++..++.|+.||+.||.|||+++   |+||||||+||||   +.++.+||+|||+++.....
T Consensus        85 ~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             C-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            9 99999998643 356999999999999999999999999   9999999999999   68899999999999754332


Q ss_pred             cc--------ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhH---HHHHHHhhhc-CCCchhh
Q 014038          267 KH--------AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME---YVELAAMNTE-GKTGWEE  334 (432)
Q Consensus       267 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~---~~~~~~~~~~-~~~~~~~  334 (432)
                      ..        .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.+...   ......+... .......
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA  239 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence            21        2256799999999999999999999999999999999999999976322   1111111000 0000111


Q ss_pred             hccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                      +.     ..    .+.++.+++..||+.||++||++.+|++.|+.++....
T Consensus       240 l~-----~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~  281 (483)
T 3sv0_A          240 LC-----RG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG  281 (483)
T ss_dssp             HH-----TT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             Hh-----cC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence            11     11    13579999999999999999999999999999987654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.7e-44  Score=336.18  Aligned_cols=255  Identities=28%  Similarity=0.453  Sum_probs=197.7

Q ss_pred             HhccccccccccCceeEEEEEeC--CCc--EEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS--TGE--TVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  184 (432)
                      ..|.+.+.||+|+||.||+|...  +++  .||||.+...   .....+.+.+|+.++++++||||+++++++.... .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            46778899999999999999742  333  6899998754   2344578999999999999999999999998754 88


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      +||||+++|+|.+++... ...+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++....
T Consensus        97 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence            999999999999998643 346899999999999999999999999   9999999999999999999999999987543


Q ss_pred             ccc----cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          265 VDK----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       265 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ...    ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+...............          
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------  242 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE----------  242 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC----------
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC----------
Confidence            322    1223457888999999998889999999999999999999 9999987554333222221111          


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                       ....+...+.++.+++.+||+.||.+|||+.++++.|+++..
T Consensus       243 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          243 -RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             -CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence             111122234579999999999999999999999999988743

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5e-44  Score=351.44  Aligned_cols=256  Identities=22%  Similarity=0.350  Sum_probs=196.2

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC------eEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG------QHMLV  186 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv  186 (432)
                      +|.+.+.||+|+||.||+|+...+..||+|++......    ..+|+.+++.++||||+++++++...+      ..++|
T Consensus        41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            57788999999999999998877777999988654322    236999999999999999999986543      37899


Q ss_pred             EEeccCCChhhhcc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec-CCCcEEEeecCCccccc
Q 014038          187 YVFMSKGSLASHLY-DENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEM  264 (432)
Q Consensus       187 ~e~~~~g~L~~~l~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~-~~~~~kl~Dfgl~~~~~  264 (432)
                      |||++++.+..... ......+++..+..++.||+.||.|||+.+   |+||||||+|||++ .++.+||+|||+++...
T Consensus       117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            99998754433221 123457999999999999999999999999   99999999999999 79999999999998655


Q ss_pred             ccccccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc-CCCchh---h----h
Q 014038          265 VDKHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE-GKTGWE---E----I  335 (432)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~---~----~  335 (432)
                      .........+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+......+..+... +.....   .    .
T Consensus       194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~  273 (394)
T 4e7w_A          194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY  273 (394)
T ss_dssp             TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred             CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence            55555567789999999998654 5999999999999999999999999876544433332211 000000   0    0


Q ss_pred             ccccCCC--------CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 VDSRLDG--------IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 ~~~~~~~--------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ....+..        .++...+.++.+|+.+||+.||.+|||+.++++
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            0000000        011113458999999999999999999999886

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.8e-43  Score=338.37  Aligned_cols=258  Identities=22%  Similarity=0.333  Sum_probs=205.2

Q ss_pred             HHhccccccccccCceeEEEEEe--CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCc------cceEEeeeeeCCe
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM--STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN------LVNLVGYCAEKGQ  182 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  182 (432)
                      ..+|.+.+.||+|+||.||+|..  .+++.||||++... ....+.+.+|+.+++.++|+|      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            34788889999999999999975  36889999998643 344567889999999887664      9999999999999


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC--------------
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ--------------  248 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~--------------  248 (432)
                      .++||||+ +++|.+++......++++..+..++.||+.||+|||+++   |+||||||+|||++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 889999997766667999999999999999999999999   999999999999987              


Q ss_pred             -----CCcEEEeecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHH
Q 014038          249 -----SMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAA  323 (432)
Q Consensus       249 -----~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~  323 (432)
                           ++.+||+|||+++...  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  245 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM  245 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred             cccccCCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                 6689999999987532  233456789999999999999999999999999999999999999986544322222


Q ss_pred             hhhcCCCchhhh------------------------------cccc-CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 014038          324 MNTEGKTGWEEI------------------------------VDSR-LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRD  372 (432)
Q Consensus       324 ~~~~~~~~~~~~------------------------------~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~  372 (432)
                      +..........+                              ..+. .....+...+.++.+++.+||+.||.+|||+.+
T Consensus       246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e  325 (339)
T 1z57_A          246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE  325 (339)
T ss_dssp             HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence            111000000000                              0000 001123345678999999999999999999999


Q ss_pred             HHH
Q 014038          373 IVQ  375 (432)
Q Consensus       373 vl~  375 (432)
                      +++
T Consensus       326 ll~  328 (339)
T 1z57_A          326 ALK  328 (339)
T ss_dssp             HTT
T ss_pred             Hhc
Confidence            885

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8.2e-44  Score=371.66  Aligned_cols=242  Identities=26%  Similarity=0.419  Sum_probs=202.8

Q ss_pred             HHhccccccccccCceeEEEEEeC-CCcEEEEEEeccC---ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD---SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  185 (432)
                      ...|++.+.||+|+||.||+|... +++.||||++...   .....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            345677889999999999999654 6889999998753   223446788899999988 79999999999999999999


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+++|+|..++...  +.+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus       420 V~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            99999999999999643  46999999999999999999999999   99999999999999999999999999985332


Q ss_pred             -cccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCC
Q 014038          266 -DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       266 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                       .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+... .            ..+
T Consensus       495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-~------------~~~  561 (674)
T 3pfq_A          495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-N------------VAY  561 (674)
T ss_dssp             TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-C------------CCC
T ss_pred             CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-C------------CCC
Confidence             33455678999999999999999999999999999999999999999876543332222211 1            112


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCH
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSM  370 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~  370 (432)
                      +...+.++.+|+.+||+.||.+||++
T Consensus       562 p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          562 PKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             CTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             CccCCHHHHHHHHHHccCCHHHCCCC
Confidence            22334689999999999999999997

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=335.88  Aligned_cols=251  Identities=24%  Similarity=0.389  Sum_probs=201.5

Q ss_pred             HHHHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      .....|.+.+.||+|+||.||+|... +|+.||+|.+....  ..+.+.+|+.++.+++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34456778899999999999999764 68999999987543  3467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-  266 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-  266 (432)
                      ||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++...... 
T Consensus       104 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          104 EYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             ECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             ecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            99999999999853 2356999999999999999999999999   999999999999999999999999998754332 


Q ss_pred             ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...................+          ..+.
T Consensus       180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~  249 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF----------RKPE  249 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC----------SSGG
T ss_pred             cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc----------CCcc
Confidence            223445789999999999998999999999999999999999999987554333322211111100          0111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+..+.+++.+||+.||.+|||+.++++
T Consensus       250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          250 LWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            22357899999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.8e-44  Score=346.59  Aligned_cols=255  Identities=25%  Similarity=0.331  Sum_probs=184.6

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC------Ce
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQ  182 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  182 (432)
                      ..|.+.+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            3577788999999999999964 57899999998653  334456788999999999999999999998654      56


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .++|+||+ +++|.+++..   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       109 ~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC------
T ss_pred             EEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            79999999 6899988853   46999999999999999999999999   99999999999999999999999999975


Q ss_pred             ccccccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhh-------
Q 014038          263 EMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEE-------  334 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------  334 (432)
                      ...  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......+..+......+..+       
T Consensus       182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            332  2345678999999999876 689999999999999999999999998765544333222111111011       


Q ss_pred             -----hccccCC-CCCCH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 -----IVDSRLD-GIFDV-----EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 -----~~~~~~~-~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                           ++..... ...+.     ..+..+.+|+.+||+.||.+|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                 0000000 00111     11357899999999999999999999885

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1e-44  Score=354.50  Aligned_cols=239  Identities=20%  Similarity=0.208  Sum_probs=187.2

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHH---HHHhhcCCCccceEE-------eeee
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEV---MLLGRLHHRNLVNLV-------GYCA  178 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~~~  178 (432)
                      .|.+.+.||+|+||.||+|.. .+|+.||||++...   .....+.+.+|+   ..+++++||||++++       +++.
T Consensus        74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~  153 (377)
T 3byv_A           74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  153 (377)
T ss_dssp             EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred             eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence            456678999999999999975 57899999999743   334557889999   455566899999998       5555


Q ss_pred             eCC-----------------eEEEEEEeccCCChhhhcccCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 014038          179 EKG-----------------QHMLVYVFMSKGSLASHLYDEN-----YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH  236 (432)
Q Consensus       179 ~~~-----------------~~~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH  236 (432)
                      +.+                 ..++||||+ +|+|.+++....     ...+++..++.++.||+.||+|||+++   |+|
T Consensus       154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH  229 (377)
T 3byv_A          154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVH  229 (377)
T ss_dssp             CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred             ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence            443                 278999999 689999986421     123446888999999999999999999   999


Q ss_pred             ccCCCCCeeecCCCcEEEeecCCcccccccccccccccCCCCCCccccccC-----------CCCchhHhHHHHHHHHHH
Q 014038          237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR-----------NFTKKSDVYSFGVLLFEL  305 (432)
Q Consensus       237 ~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlGvil~el  305 (432)
                      |||||+|||++.++.+||+|||+++...  .......| +.|+|||++.+.           .++.++|||||||++|||
T Consensus       230 rDikp~NIll~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          230 TYLRPVDIVLDQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999999999999999997532  23344567 999999999877           899999999999999999


Q ss_pred             HhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          306 IAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       306 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ++|+.||.+....           ..+..+... . ...    +.++.+++.+||+.||++|||+.++++
T Consensus       307 ltg~~Pf~~~~~~-----------~~~~~~~~~-~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          307 WCADLPITKDAAL-----------GGSEWIFRS-C-KNI----PQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHSSCCC-----------------CCSGGGGSS-C-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHCCCCCcccccc-----------cchhhhhhh-c-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999753221           011111110 1 112    357899999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.6e-44  Score=347.15  Aligned_cols=259  Identities=24%  Similarity=0.328  Sum_probs=193.9

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccCCh-----------hhHHHHHHHHHHHhhcCCCccceEEeeeee-
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK-----------QGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-  179 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  179 (432)
                      ..|.+.+.||+|+||.||+|...+|+.||||++.....           ...+.+.+|+.++++++||||+++++++.. 
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  101 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF  101 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred             cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence            45677799999999999999888899999999854321           123678999999999999999999999854 


Q ss_pred             ----CCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEe
Q 014038          180 ----KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA  255 (432)
Q Consensus       180 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~  255 (432)
                          ....++||||++ |+|.+.+.. ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+
T Consensus       102 ~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~  176 (362)
T 3pg1_A          102 EEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITIC  176 (362)
T ss_dssp             CTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEE
Confidence                346899999998 688888864 3457999999999999999999999999   9999999999999999999999


Q ss_pred             ecCCcccccccccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc-CCCch-
Q 014038          256 DFGLSREEMVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE-GKTGW-  332 (432)
Q Consensus       256 Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~-~~~~~-  332 (432)
                      |||++.............+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+... +.... 
T Consensus       177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (362)
T 3pg1_A          177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE  256 (362)
T ss_dssp             CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence            9999976554445556678999999999876 67999999999999999999999999875544333222110 10000 


Q ss_pred             ----------hhhccccCCCCC-------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          333 ----------EEIVDSRLDGIF-------DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       333 ----------~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                                ............       ....+..+.+|+.+||+.||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence                      011111110000       0112357899999999999999999999885

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.5e-43  Score=329.19  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=206.8

Q ss_pred             HHHHHHhccccccccccCceeEEEEEeC-CCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeE
Q 014038          107 KDLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH  183 (432)
Q Consensus       107 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  183 (432)
                      .......|.+.+.||+|+||.||+|... +++.||+|++...  .......+.+|+.++++++||||+++++++.+.+..
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            4455678999999999999999999764 7899999998654  234457889999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC---CcEEEeecCCc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS---MRARVADFGLS  260 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~---~~~kl~Dfgl~  260 (432)
                      ++||||+++++|.+.+...  ..+++..+..++.||+.||.|||+.+   ++||||||+||+++.+   +.+||+|||++
T Consensus        97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            9999999999999888543  46899999999999999999999999   9999999999999754   47999999998


Q ss_pred             ccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          261 REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .............+|+.|+|||.+.+ .++.++||||||+++|+|++|+.||.+............... .+.   .+..
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~---~~~~  246 (287)
T 2wei_A          172 TCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY-AFD---LPQW  246 (287)
T ss_dssp             GTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCC---SGGG
T ss_pred             eeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCC---chhh
Confidence            76544444445568999999999875 489999999999999999999999987554332222221110 000   0000


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                           ...+.++.+++.+||+.||++|||+.++++
T Consensus       247 -----~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          247 -----RTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                 112357899999999999999999999987

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-44  Score=349.68  Aligned_cols=248  Identities=27%  Similarity=0.395  Sum_probs=198.9

Q ss_pred             HhccccccccccCceeEEEEEe----CCCcEEEEEEeccCC----hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCe
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM----STGETVAVKVLATDS----KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  182 (432)
                      ..|.+.+.||+|+||.||+|+.    .+++.||||++....    ....+.+.+|+.++..+ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            4678889999999999999976    478999999986432    23345677899999999 69999999999999999


Q ss_pred             EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          183 HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       183 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             EEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999643  46999999999999999999999999   99999999999999999999999999875


Q ss_pred             cccc--ccccccccCCCCCCcccccc--CCCCchhHhHHHHHHHHHHHhCCCCCCChhH---HHHHHHhhhcCCCchhhh
Q 014038          263 EMVD--KHAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQGLME---YVELAAMNTEGKTGWEEI  335 (432)
Q Consensus       263 ~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~  335 (432)
                      ....  .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.....   ...+.......       
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------  281 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-------  281 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-------
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-------
Confidence            4322  22344679999999999975  3578999999999999999999999964221   11111110000       


Q ss_pred             ccccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 014038          336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRP-----SMRDIVQV  376 (432)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~~vl~~  376 (432)
                           ...++...+..+.+|+.+||+.||.+||     ++.++++.
T Consensus       282 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          282 -----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -----CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                 1112223345789999999999999999     88888763

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=333.64  Aligned_cols=248  Identities=25%  Similarity=0.355  Sum_probs=198.8

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC----hhhHHHHHHHHHHHhhcCCCccceEEeeee--eCCeEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS----KQGEKEFQTEVMLLGRLHHRNLVNLVGYCA--EKGQHM  184 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  184 (432)
                      ..|.+.+.||+|+||.||+|.. .+++.||+|++....    ......+.+|+.++++++||||+++++++.  +....+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            3577889999999999999976 478899999986532    234567999999999999999999999984  456789


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      +||||++++ |.+++.......+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            999999876 777776655678999999999999999999999999   9999999999999999999999999987543


Q ss_pred             c---cccccccccCCCCCCccccccCC--CCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          265 V---DKHAANIRGTFGYLDPEYISTRN--FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       265 ~---~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      .   ........||+.|+|||++.+..  ++.++||||||+++|||++|+.||.+...............         .
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~---------~  231 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY---------A  231 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC---------C
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC---------C
Confidence            2   12233456899999999987644  47899999999999999999999987543322222211110         1


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                          .+...+..+.+++.+||+.||.+|||+.++++.
T Consensus       232 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          232 ----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ----CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                111223578899999999999999999999863

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.1e-43  Score=347.81  Aligned_cols=194  Identities=28%  Similarity=0.375  Sum_probs=164.4

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC-----CeEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-----GQHM  184 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  184 (432)
                      .|.+.+.||+|+||.||+|.. .+++.||||++...  .....+.+.+|+.+|++++||||+++++++...     ...+
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  106 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY  106 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence            677889999999999999965 46889999999753  334457899999999999999999999999766     5789


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      +||||++ |+|.+++..  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       107 lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          107 IVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             EEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             EEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence            9999996 599999854  356999999999999999999999999   9999999999999999999999999997543


Q ss_pred             ccc-----------------------cccccccCCCCCCcccc-ccCCCCchhHhHHHHHHHHHHHhCCCCC
Q 014038          265 VDK-----------------------HAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPL  312 (432)
Q Consensus       265 ~~~-----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~elltg~~p~  312 (432)
                      ...                       .....+||+.|+|||++ ....|+.++|||||||++|||++|..||
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            221                       12456799999999986 5667999999999999999999854443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.6e-44  Score=340.41  Aligned_cols=257  Identities=27%  Similarity=0.407  Sum_probs=185.1

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ..|.+.+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   94 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL   94 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence            3567788999999999999964 478999999986543 33456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhccc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          190 MSKGSLASHLYD------ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       190 ~~~g~L~~~l~~------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      +++|+|.+++..      .....+++..+..++.||+.||.|||+++   ++||||||+||+++.++.+||+|||++...
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  171 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFL  171 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence            999999998853      13456999999999999999999999999   999999999999999999999999988643


Q ss_pred             ccc------ccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchh-hh
Q 014038          264 MVD------KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWE-EI  335 (432)
Q Consensus       264 ~~~------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~  335 (432)
                      ...      .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..................... ..
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  251 (303)
T 2vwi_A          172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV  251 (303)
T ss_dssp             C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC--
T ss_pred             ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccccc
Confidence            221      12234578999999999865 56899999999999999999999999764432222221111111111 01


Q ss_pred             ccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+......    .+.++.+++.+||+.||.+|||+.++++
T Consensus       252 ~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          252 QDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             ---CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            11111111    2347899999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=337.73  Aligned_cols=248  Identities=27%  Similarity=0.466  Sum_probs=197.2

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeee------CCeEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE------KGQHM  184 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~  184 (432)
                      .|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.+++++ +||||+++++++..      .+..+
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~  103 (326)
T 2x7f_A           25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW  103 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence            567789999999999999976 578999999986543 3356789999999999 79999999999977      46889


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      +||||+++|+|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  180 (326)
T ss_dssp             EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred             EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence            9999999999999997655567999999999999999999999999   9999999999999999999999999987543


Q ss_pred             cc-ccccccccCCCCCCccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccc
Q 014038          265 VD-KHAANIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDS  338 (432)
Q Consensus       265 ~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                      .. .......||+.|+|||++.     ...++.++|||||||++|||++|+.||..................        
T Consensus       181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  252 (326)
T 2x7f_A          181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP--------  252 (326)
T ss_dssp             ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--------
T ss_pred             cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc--------
Confidence            22 2234457899999999986     567899999999999999999999999865543333222211110        


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          339 RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       339 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .   ..+...+..+.+++.+||+.||.+||++.++++
T Consensus       253 ~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          253 R---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             C---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             c---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0   011112357899999999999999999999987

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.8e-43  Score=341.78  Aligned_cols=261  Identities=21%  Similarity=0.276  Sum_probs=190.2

Q ss_pred             HHHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe------
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ------  182 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  182 (432)
                      ....|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+++..+..++||||+++++++...+.      
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   99 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI   99 (360)
T ss_dssp             HHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred             hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence            345778889999999999999976 478999999986543 223456778888999999999999999876443      


Q ss_pred             -EEEEEEeccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeeccCCCCCeeecC-CCcEEEee
Q 014038          183 -HMLVYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLH--DGAVPPVIHRDIKSSNILLDQ-SMRARVAD  256 (432)
Q Consensus       183 -~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH--~~~~~~iiH~dlkp~Nill~~-~~~~kl~D  256 (432)
                       .++||||+++ +|...+..  .....+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.+||+|
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~D  175 (360)
T 3e3p_A          100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCD  175 (360)
T ss_dssp             EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECC
T ss_pred             eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEee
Confidence             7899999986 55544432  34567899999999999999999999  888   999999999999997 89999999


Q ss_pred             cCCcccccccccccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhh
Q 014038          257 FGLSREEMVDKHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEI  335 (432)
Q Consensus       257 fgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (432)
                      ||+++............||+.|+|||++.+. .++.++|||||||++|||++|+.||.+......+..+.........+.
T Consensus       176 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (360)
T 3e3p_A          176 FGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV  255 (360)
T ss_dssp             CTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             CCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence            9999866555555566789999999998654 489999999999999999999999987654433332221100000000


Q ss_pred             ---cccc----------------CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 ---VDSR----------------LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 ---~~~~----------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                         .++.                .........+.++.+|+.+||+.||.+|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence               0000                000111123568999999999999999999999885

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.2e-43  Score=335.39  Aligned_cols=257  Identities=23%  Similarity=0.344  Sum_probs=195.4

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeee------------
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCA------------  178 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~------------  178 (432)
                      ..|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            35777889999999999999765 58999999998776666788999999999999999999999873            


Q ss_pred             --eCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec-CCCcEEEe
Q 014038          179 --EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVA  255 (432)
Q Consensus       179 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~-~~~~~kl~  255 (432)
                        +....++||||++ |+|.+++..   +++++..+..++.|++.||+|||+++   |+||||||+|||++ +++.+||+
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEEC
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEc
Confidence              3468899999997 699998843   56899999999999999999999999   99999999999997 56799999


Q ss_pred             ecCCccccccc----ccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCC
Q 014038          256 DFGLSREEMVD----KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT  330 (432)
Q Consensus       256 Dfgl~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  330 (432)
                      |||+++.....    .......+|+.|+|||.+.. ..++.++||||||+++|||++|+.||.+................
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  243 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV  243 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99998754321    22334567999999998865 67999999999999999999999999876544333222111110


Q ss_pred             c----hhhhc-------cccCC-CCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          331 G----WEEIV-------DSRLD-GIFD-----VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       331 ~----~~~~~-------~~~~~-~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .    +.++.       ..... ...+     ...+.++.+++.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            0    00000       00000 0001     112457999999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.3e-43  Score=364.49  Aligned_cols=259  Identities=26%  Similarity=0.403  Sum_probs=209.1

Q ss_pred             HHHHhccccccccccCceeEEEEEeC----CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeE
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQMS----TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH  183 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  183 (432)
                      +....|.+.+.||+|+||.||+|...    .+..||||.+... .....+.|.+|+.++++++||||+++++++. .+..
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            34457788899999999999999763    2457999998754 3344578999999999999999999999985 4568


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ++||||+++|+|.+++... ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       466 ~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            9999999999999999643 346899999999999999999999999   999999999999999999999999999764


Q ss_pred             ccccc--ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          264 MVDKH--AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       264 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .....  .....+|+.|+|||.+.+..++.++|||||||++|||++ |..||.+...............           
T Consensus       542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~-----------  610 (656)
T 2j0j_A          542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-----------  610 (656)
T ss_dssp             CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC-----------
T ss_pred             CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            33221  223456789999999998999999999999999999997 9999987554333322222111           


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                       ...+...+..+.+++.+||+.||.+|||+.++++.|+.+++..
T Consensus       611 -~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          611 -LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence             1112233457899999999999999999999999999997653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.4e-44  Score=349.20  Aligned_cols=252  Identities=12%  Similarity=0.084  Sum_probs=179.4

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh---hhHHHHHHHHHHHhhc--CCCccceEE-------eeeee
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK---QGEKEFQTEVMLLGRL--HHRNLVNLV-------GYCAE  179 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~~  179 (432)
                      +|.+.+.||+|+||.||+|... +|+.||||++.....   ...+.+.+|+.+++.+  +||||++++       +++..
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~  142 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV  142 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence            3567789999999999999754 789999999987542   3345677885555444  699988755       33332


Q ss_pred             C-----------------CeEEEEEEeccCCChhhhcccCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeee
Q 014038          180 K-----------------GQHMLVYVFMSKGSLASHLYDENYGPLTWNLR------VHIALDVARGLEYLHDGAVPPVIH  236 (432)
Q Consensus       180 ~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~------~~i~~~i~~~l~yLH~~~~~~iiH  236 (432)
                      .                 ...++||||++ |+|.+++.... ..+++..+      ..++.||+.||+|||+++   |+|
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivH  217 (371)
T 3q60_A          143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVH  217 (371)
T ss_dssp             TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Ccc
Confidence            2                 34799999998 89999996532 23566666      788899999999999999   999


Q ss_pred             ccCCCCCeeecCCCcEEEeecCCcccccccccccccccCCCCCCcccccc--CCCCchhHhHHHHHHHHHHHhCCCCCCC
Q 014038          237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQG  314 (432)
Q Consensus       237 ~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~~  314 (432)
                      |||||+|||++.++.+||+|||+++....  ......+|+.|+|||++.+  ..++.++|||||||++|||++|+.||.+
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999975432  2224557799999999987  6799999999999999999999999976


Q ss_pred             hhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          315 LMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ......    ........................+..+.+|+.+||+.||++|||+.++++
T Consensus       296 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          296 VTPGIK----GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CCTTCT----TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             cCcccc----cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            421100    000000000000001111111123468999999999999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.7e-42  Score=339.36  Aligned_cols=257  Identities=24%  Similarity=0.300  Sum_probs=201.8

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcC-CC-----ccceEEeeeeeCCeEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HR-----NLVNLVGYCAEKGQHM  184 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~~  184 (432)
                      ..|.+.+.||+|+||.||+|... +++.||||++... ......+..|+.+++.++ |+     +|+++++++...+..+
T Consensus        54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            46778899999999999999654 6889999999643 334567788999988885 55     4999999999999999


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeeeccCCCCCeeec--CCCcEEEeecCCc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD--GAVPPVIHRDIKSSNILLD--QSMRARVADFGLS  260 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~--~~~~~iiH~dlkp~Nill~--~~~~~kl~Dfgl~  260 (432)
                      +||||++ |+|.+++.......+++..+..++.|++.||.|||+  .+   |+||||||+|||++  .++.+||+|||++
T Consensus       133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            9999996 599999977666679999999999999999999995  45   99999999999994  5788999999999


Q ss_pred             ccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCch--------
Q 014038          261 REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW--------  332 (432)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------  332 (432)
                      +...  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+........        
T Consensus       209 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  286 (382)
T 2vx3_A          209 CQLG--QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP  286 (382)
T ss_dssp             EETT--CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT
T ss_pred             eecc--cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH
Confidence            7643  233456789999999999999999999999999999999999999987654433322211100000        


Q ss_pred             --hhhccccC-----------------------------------------CCCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 014038          333 --EEIVDSRL-----------------------------------------DGIFDVEELNEVASLAYKCVNRAPRKRPS  369 (432)
Q Consensus       333 --~~~~~~~~-----------------------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs  369 (432)
                        ..++....                                         ..........++.+|+.+||+.||++|||
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt  366 (382)
T 2vx3_A          287 KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ  366 (382)
T ss_dssp             THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC
T ss_pred             HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC
Confidence              00000000                                         00112234458999999999999999999


Q ss_pred             HHHHHH
Q 014038          370 MRDIVQ  375 (432)
Q Consensus       370 ~~~vl~  375 (432)
                      +.++++
T Consensus       367 a~e~L~  372 (382)
T 2vx3_A          367 PYYALQ  372 (382)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.6e-42  Score=327.75  Aligned_cols=249  Identities=25%  Similarity=0.414  Sum_probs=194.1

Q ss_pred             HHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeee----------
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE----------  179 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  179 (432)
                      ...|.+.+.||+|+||.||+|.. .+++.||||.+... ....+.+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            35678889999999999999975 47899999998643 3445678999999999999999999998865          


Q ss_pred             ---CCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEee
Q 014038          180 ---KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVAD  256 (432)
Q Consensus       180 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~D  256 (432)
                         .+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence               35789999999999999999653 346888999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccccc---------------ccccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHH
Q 014038          257 FGLSREEMVD---------------KHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVE  320 (432)
Q Consensus       257 fgl~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~  320 (432)
                      ||++......               .......||+.|+|||.+.+. .++.++|||||||++|||++   ||....+...
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9998753211               122345689999999998754 78999999999999999998   6654333222


Q ss_pred             HHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          321 LAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..........        .....++...+..+.+++.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          237 ILKKLRSVSI--------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHSTTC--------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcccccc--------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            2221111111        1122233334457899999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=9e-44  Score=339.43  Aligned_cols=256  Identities=26%  Similarity=0.427  Sum_probs=199.8

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ..|.+.+.||+|+||.||+|....  .+|+|.+....  ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        33 ~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  110 (319)
T 2y4i_B           33 EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL  110 (319)
T ss_dssp             SCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred             HHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence            356778899999999999998743  49999986542  23345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc----
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV----  265 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~----  265 (432)
                      +++++|.+++... ...+++..+..++.||+.||.|||+++   ++||||||+|||++ ++.+||+|||++.....    
T Consensus       111 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~  185 (319)
T 2y4i_B          111 CKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG  185 (319)
T ss_dssp             CCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred             ccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence            9999999999543 346999999999999999999999999   99999999999998 67999999999764321    


Q ss_pred             --cccccccccCCCCCCcccccc---------CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhh
Q 014038          266 --DKHAANIRGTFGYLDPEYIST---------RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEE  334 (432)
Q Consensus       266 --~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  334 (432)
                        ........||+.|+|||.+..         ..++.++||||||+++|||++|+.||..................    
T Consensus       186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----  261 (319)
T 2y4i_B          186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP----  261 (319)
T ss_dssp             --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC----
T ss_pred             ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC----
Confidence              122233468999999999864         45899999999999999999999999875543332222211110    


Q ss_pred             hccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                          ..   .....+.++.+++.+||+.||.+|||+.++++.|+.+.+...
T Consensus       262 ----~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~  305 (319)
T 2y4i_B          262 ----NL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR  305 (319)
T ss_dssp             ----CC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred             ----CC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence                00   011122468899999999999999999999999998876543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.2e-43  Score=337.41  Aligned_cols=259  Identities=22%  Similarity=0.339  Sum_probs=203.5

Q ss_pred             HHHhccccccccccCceeEEEEEeC-CC-cEEEEEEeccCChhhHHHHHHHHHHHhhcCCCc------cceEEeeeeeCC
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQMS-TG-ETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN------LVNLVGYCAEKG  181 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~  181 (432)
                      ....|.+.+.||+|+||.||+|... ++ +.||+|++... ....+.+.+|+.++++++|+|      ++.+++++...+
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            3457888899999999999999753 44 68999999643 344567889999999997766      899999999999


Q ss_pred             eEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee---------------
Q 014038          182 QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL---------------  246 (432)
Q Consensus       182 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill---------------  246 (432)
                      ..++||||+ +++|.+++......++++..+..++.||+.||.|||+++   |+||||||+|||+               
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            999999999 678888887666567999999999999999999999999   9999999999999               


Q ss_pred             ----cCCCcEEEeecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHH
Q 014038          247 ----DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA  322 (432)
Q Consensus       247 ----~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~  322 (432)
                          +.++.+||+|||+++...  .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  249 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV  249 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccccCCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                668899999999997532  23345679999999999999999999999999999999999999998755433222


Q ss_pred             HhhhcCCCchhhhc------------------------------cc-cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 014038          323 AMNTEGKTGWEEIV------------------------------DS-RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMR  371 (432)
Q Consensus       323 ~~~~~~~~~~~~~~------------------------------~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  371 (432)
                      .+..........+.                              .+ ..........+.++.+|+.+||+.||++|||+.
T Consensus       250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  329 (355)
T 2eu9_A          250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA  329 (355)
T ss_dssp             HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence            21111000000000                              00 000011223456899999999999999999999


Q ss_pred             HHHH
Q 014038          372 DIVQ  375 (432)
Q Consensus       372 ~vl~  375 (432)
                      ++++
T Consensus       330 e~l~  333 (355)
T 2eu9_A          330 EALL  333 (355)
T ss_dssp             HHTT
T ss_pred             HHhc
Confidence            9875

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.5e-43  Score=340.43  Aligned_cols=253  Identities=25%  Similarity=0.350  Sum_probs=196.1

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeE------
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH------  183 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------  183 (432)
                      +|.+.+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...+..      
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  122 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  122 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred             cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence            567778999999999999965 47899999999764  333456789999999999999999999999876654      


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ++||||+. ++|.+.+.    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       123 ~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          123 YLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA  194 (371)
T ss_dssp             EEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred             EEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence            99999997 68888772    34999999999999999999999999   999999999999999999999999999753


Q ss_pred             cccccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcc-----
Q 014038          264 MVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD-----  337 (432)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  337 (432)
                      .  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......+..+.........++..     
T Consensus       195 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          195 D--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             c--cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            2  23345678999999999876 789999999999999999999999998755443333221111111011000     


Q ss_pred             -------c---cCCCCC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          338 -------S---RLDGIF---DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       338 -------~---~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                             .   .....+   ....+.++.+|+.+||+.||++|||+.++++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                   0   000000   0112457999999999999999999999885

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.4e-43  Score=341.22  Aligned_cols=256  Identities=24%  Similarity=0.314  Sum_probs=198.1

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeC-----CeEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-----GQHML  185 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l  185 (432)
                      +|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++...     ...++
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  107 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI  107 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence            577889999999999999965 478899999997543 34446789999999999999999999998754     46899


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||++ |+|.+++..   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus       108 v~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          108 VQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             EEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence            999997 599998854   35999999999999999999999999   99999999999999999999999999975433


Q ss_pred             ccc----ccccccCCCCCCccccc-cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhh------
Q 014038          266 DKH----AANIRGTFGYLDPEYIS-TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEE------  334 (432)
Q Consensus       266 ~~~----~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------  334 (432)
                      ...    .....||+.|+|||++. ...++.++|||||||++|||++|+.||.+......+..+.........+      
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            221    23457999999999865 4568999999999999999999999997654322222211100000000      


Q ss_pred             ------hcccc-CCCCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 ------IVDSR-LDGIFD-----VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 ------~~~~~-~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                            ..... .....+     ...+.++.+|+.+||+.||++|||+.++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                  00000 000011     112357899999999999999999999885

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.3e-43  Score=343.80  Aligned_cols=256  Identities=23%  Similarity=0.359  Sum_probs=181.5

Q ss_pred             hccc-cccccccCceeEEEEEeC---CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeee--CCeEEEE
Q 014038          113 TCNF-TTLIGQGAFGPVYKAQMS---TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHMLV  186 (432)
Q Consensus       113 ~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  186 (432)
                      .|.+ .++||+|+||.||+|...   +++.||||.+....  ....+.+|+.+|++++||||+++++++..  ....++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            4555 358999999999999864   57899999996542  23568899999999999999999999954  6789999


Q ss_pred             EEeccCCChhhhccc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeee----cCCCcEEEe
Q 014038          187 YVFMSKGSLASHLYD-------ENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILL----DQSMRARVA  255 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~-------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill----~~~~~~kl~  255 (432)
                      |||++ |+|.+++..       .....+++..+..++.||+.||.|||+.+   |+||||||+||||    +.++.+||+
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99997 488777742       12235999999999999999999999999   9999999999999    778899999


Q ss_pred             ecCCccccccc----ccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHH---------HHH
Q 014038          256 DFGLSREEMVD----KHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEY---------VEL  321 (432)
Q Consensus       256 Dfgl~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~---------~~~  321 (432)
                      |||+++.....    .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....         ..+
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            99999754322    22345678999999999876 45999999999999999999999999653221         111


Q ss_pred             HHh----hhcCCCchhhhcc-------------ccCCCCCCH---------HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          322 AAM----NTEGKTGWEEIVD-------------SRLDGIFDV---------EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       322 ~~~----~~~~~~~~~~~~~-------------~~~~~~~~~---------~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+    .......|..+..             ..... ...         ....++.+|+.+||+.||.+|||+.++++
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTN-CSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTT-CCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCc-chhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111    1111111111100             00000 000         01346889999999999999999999886

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.4e-43  Score=336.06  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=177.4

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHH-HHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVM-LLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      .|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+..|+. +++.++||||+++++++.+.+..++||||
T Consensus        23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~  102 (327)
T 3aln_A           23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL  102 (327)
T ss_dssp             SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence            556678999999999999976 478999999997653 333455666666 67778999999999999999999999999


Q ss_pred             ccCCChhhhccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          190 MSKGSLASHLYD---ENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       190 ~~~g~L~~~l~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      +++ +|.+++..   .....+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  178 (327)
T 3aln_A          103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD  178 (327)
T ss_dssp             CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred             cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence            985 77776642   2356799999999999999999999998 8   99999999999999999999999999976544


Q ss_pred             cccccccccCCCCCCcccc----ccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCC
Q 014038          266 DKHAANIRGTFGYLDPEYI----STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ........||+.|+|||++    .+..++.++||||||+++|||++|+.||...............+.       .+.+.
T Consensus       179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------~~~~~  251 (327)
T 3aln_A          179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD-------PPQLS  251 (327)
T ss_dssp             ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSC-------CCCCC
T ss_pred             ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC-------CCCCC
Confidence            4344445799999999998    466789999999999999999999999976432211111000000       00111


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .......+.++.+++.+||+.||++|||+.++++
T Consensus       252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            1111123357999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.1e-42  Score=331.20  Aligned_cols=249  Identities=20%  Similarity=0.356  Sum_probs=196.2

Q ss_pred             HHhccccccccccCceeEEEEEeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcC--CCccceEEeeeeeCCeEEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLH--HRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv  186 (432)
                      ...|.+.+.||+|+||.||++...+++.||||.+...  .....+.+.+|+.++.+++  ||||+++++++.+.+..++|
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            3457788999999999999998888999999998754  3344578899999999997  59999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      || +.+++|.+++...  ..+++..+..++.|++.||.|||+.+   |+||||||+|||+++ +.+||+|||++......
T Consensus       107 ~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          107 ME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred             Ee-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence            99 5688999999643  47899999999999999999999999   999999999999975 79999999999754332


Q ss_pred             c---cccccccCCCCCCcccccc-----------CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCch
Q 014038          267 K---HAANIRGTFGYLDPEYIST-----------RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW  332 (432)
Q Consensus       267 ~---~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  332 (432)
                      .   ......||+.|+|||.+.+           ..++.++||||||+++|||++|+.||...........         
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~---------  250 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---------  250 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH---------
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH---------
Confidence            2   1234568999999999865           4788999999999999999999999976432211111         


Q ss_pred             hhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 014038          333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQV  376 (432)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~  376 (432)
                       ...++.....++...+.++.+++.+||+.||.+||++.++++.
T Consensus       251 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          251 -AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             -HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence             1111111111222223578999999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=335.81  Aligned_cols=253  Identities=24%  Similarity=0.340  Sum_probs=195.2

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCe------E
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ------H  183 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~  183 (432)
                      +|.+.+.||+|+||.||+|.. .+|+.||||.+...  .....+.+.+|+.+++.++||||+++++++...+.      .
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  104 (353)
T 3coi_A           25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  104 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence            567778999999999999965 47899999998654  33345678999999999999999999999987653      4


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ++||||+. |+|.+++.    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       105 ~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          105 YLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             EEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             EEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCC
Confidence            99999997 58888773    24899999999999999999999999   999999999999999999999999998753


Q ss_pred             cccccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhh--------
Q 014038          264 MVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEE--------  334 (432)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------  334 (432)
                      .  .......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+......+............+        
T Consensus       177 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  254 (353)
T 3coi_A          177 D--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  254 (353)
T ss_dssp             ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred             C--CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence            2  22344578999999999876 678999999999999999999999998754433222221100000000        


Q ss_pred             ----hc---cccCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 ----IV---DSRLDG---IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 ----~~---~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                          ..   ......   ......+.++.+++.+||+.||++|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                00   000000   111233468999999999999999999999885

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=7.2e-43  Score=340.46  Aligned_cols=256  Identities=23%  Similarity=0.349  Sum_probs=200.9

Q ss_pred             HHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC-----------CCccceEEeeee
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-----------HRNLVNLVGYCA  178 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  178 (432)
                      ...|.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            35688889999999999999975 57899999998643 334567889999999886           899999999987


Q ss_pred             eCC----eEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCeeec------
Q 014038          179 EKG----QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLD------  247 (432)
Q Consensus       179 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlkp~Nill~------  247 (432)
                      ..+    ..++||||+ +++|.+++.......+++..+..++.||+.||.|||++ +   |+||||||+|||++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence            654    789999999 88999999776666799999999999999999999998 8   99999999999994      


Q ss_pred             CCCcEEEeecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhH------HHHH
Q 014038          248 QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLME------YVEL  321 (432)
Q Consensus       248 ~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~------~~~~  321 (432)
                      ..+.+||+|||++.....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ...+
T Consensus       173 ~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             CcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence            445899999999975432  23445789999999999999999999999999999999999999975321      1111


Q ss_pred             HHhhh-cCCCc------------------------------hhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 014038          322 AAMNT-EGKTG------------------------------WEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSM  370 (432)
Q Consensus       322 ~~~~~-~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  370 (432)
                      ..+.. .+..+                              +......  ...++...+.++.+|+.+||+.||++|||+
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            11100 00000                              0000000  113456677899999999999999999999


Q ss_pred             HHHHH
Q 014038          371 RDIVQ  375 (432)
Q Consensus       371 ~~vl~  375 (432)
                      .++++
T Consensus       329 ~ell~  333 (373)
T 1q8y_A          329 GGLVN  333 (373)
T ss_dssp             HHHHT
T ss_pred             HHHhh
Confidence            99886

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.8e-42  Score=333.18  Aligned_cols=250  Identities=20%  Similarity=0.298  Sum_probs=171.4

Q ss_pred             hcccc-ccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeee----CCeEEEE
Q 014038          113 TCNFT-TLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE----KGQHMLV  186 (432)
Q Consensus       113 ~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  186 (432)
                      .|.+. ++||+|+||.||+|... +|+.||||++....    ....+....++.++||||+++++++..    ....++|
T Consensus        29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  104 (336)
T 3fhr_A           29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII  104 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence            56664 46999999999999765 78999999986432    112222334566799999999999876    4458999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC---CCcEEEeecCCcccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---SMRARVADFGLSREE  263 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~---~~~~kl~Dfgl~~~~  263 (432)
                      |||+++|+|.+++.......+++..++.++.|++.||.|||+++   |+||||||+|||++.   ++.+||+|||++...
T Consensus       105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~  181 (336)
T 3fhr_A          105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET  181 (336)
T ss_dssp             EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence            99999999999997766667999999999999999999999999   999999999999976   455999999999754


Q ss_pred             cccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCC
Q 014038          264 MVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                      .. .......+|+.|+|||++.+..++.++||||||+++|||++|+.||.................     .........
T Consensus       182 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~~~~~~~~  255 (336)
T 3fhr_A          182 TQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR-----LGQYGFPNP  255 (336)
T ss_dssp             -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------CCCTT
T ss_pred             cc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh-----ccccccCch
Confidence            32 233455789999999999888999999999999999999999999975432211100000000     000001111


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .....+.++.+++.+||+.||.+|||+.++++
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11123457899999999999999999999987

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.3e-42  Score=334.45  Aligned_cols=256  Identities=23%  Similarity=0.296  Sum_probs=197.9

Q ss_pred             hccccccccccCceeEEEEEeC-CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC-----CeEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK-----GQHML  185 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l  185 (432)
                      .|.+.+.||+|+||.||+|... +|+.||||.+... .......+.+|+.++++++||||+++++++...     ...++
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   91 (353)
T 2b9h_A           12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI   91 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred             ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence            5677899999999999999764 6899999999654 334456788999999999999999999988754     67899


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+. |+|.+++..   ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        92 v~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           92 IQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             EECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            999997 589988854   36999999999999999999999999   99999999999999999999999999875332


Q ss_pred             cc-----------cccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc-CCCc-
Q 014038          266 DK-----------HAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE-GKTG-  331 (432)
Q Consensus       266 ~~-----------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~-~~~~-  331 (432)
                      ..           ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.+......+..+... +... 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  244 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS  244 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence            11           1223468999999998754 78999999999999999999999999876543332221110 0000 


Q ss_pred             -----------hhhhccccCC-CCCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          332 -----------WEEIVDSRLD-GIFD-----VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       332 -----------~~~~~~~~~~-~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                                 ..+....... ...+     ...+.++.+++.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                       0000000000 0000     122357899999999999999999999886

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=329.97  Aligned_cols=249  Identities=24%  Similarity=0.407  Sum_probs=178.5

Q ss_pred             HhccccccccccCceeEEEEEeC-CCcEEEEEEeccCCh-hhH-HHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK-QGE-KEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      ..|.+.+.||+|+||.||+|... +|+.||||.+..... ... +.+.++..+++.++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            35677889999999999999764 789999999976532 222 334455567888899999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG-AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~-~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      |+ ++.+..+. ......+++..+..++.|++.||.|||+. +   ++||||||+|||++.++.+||+|||++.......
T Consensus       105 ~~-~~~~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          105 LM-GTCAEKLK-KRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CC-SEEHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             cc-CCcHHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            99 44444443 33346799999999999999999999995 8   9999999999999999999999999987654444


Q ss_pred             cccccccCCCCCCccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHH-HHHHHhhhcCCCchhhhccccCC
Q 014038          268 HAANIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEY-VELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      ......+|+.|+|||.+.     ...++.++||||||+++|||++|+.||...... ..+.........        ...
T Consensus       180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~  251 (318)
T 2dyl_A          180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP--------LLP  251 (318)
T ss_dssp             -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC--------CCC
T ss_pred             cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC--------CCC
Confidence            444567999999999984     557899999999999999999999999763222 222221111110        010


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .  ....+.++.+++.+||+.||.+||++.++++
T Consensus       252 ~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          252 G--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             S--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             c--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            0  0112347899999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.3e-42  Score=339.76  Aligned_cols=245  Identities=23%  Similarity=0.346  Sum_probs=186.2

Q ss_pred             ccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEeccCCC
Q 014038          116 FTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGS  194 (432)
Q Consensus       116 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~  194 (432)
                      ..+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+.++.++ +||||+++++++.+.+..++||||+. |+
T Consensus        19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs   94 (434)
T 2rio_A           19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN   94 (434)
T ss_dssp             EEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred             ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence            45789999999998877678999999998643   235678999999887 89999999999999999999999995 69


Q ss_pred             hhhhcccCCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC-------------CcEEEee
Q 014038          195 LASHLYDENYGP-----LTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS-------------MRARVAD  256 (432)
Q Consensus       195 L~~~l~~~~~~~-----l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~-------------~~~kl~D  256 (432)
                      |.+++.......     .++..++.++.||+.||+|||+++   |+||||||+|||++.+             +.+||+|
T Consensus        95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D  171 (434)
T 2rio_A           95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD  171 (434)
T ss_dssp             HHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred             HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence            999996533211     123345789999999999999999   9999999999999754             4899999


Q ss_pred             cCCcccccccc-----cccccccCCCCCCcccccc-------CCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHH
Q 014038          257 FGLSREEMVDK-----HAANIRGTFGYLDPEYIST-------RNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAA  323 (432)
Q Consensus       257 fgl~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~  323 (432)
                      ||+++......     ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.........  
T Consensus       172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~--  249 (434)
T 2rio_A          172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN--  249 (434)
T ss_dssp             CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHH--
T ss_pred             cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHH--
Confidence            99997643322     1234579999999999865       678999999999999999999 99999764322111  


Q ss_pred             hhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          324 MNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ... ....     .+......+...+.++.+++.+||+.||.+|||+.++++
T Consensus       250 i~~-~~~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          250 IIR-GIFS-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHH-TCCC-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             Hhc-CCCC-----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            100 0000     011122234566778999999999999999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.1e-43  Score=335.41  Aligned_cols=241  Identities=24%  Similarity=0.413  Sum_probs=198.4

Q ss_pred             HHHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCCh------hhHHHHHHHHHHHhhcC--CCccceEEeeeeeC
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK------QGEKEFQTEVMLLGRLH--HRNLVNLVGYCAEK  180 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~  180 (432)
                      ....|.+.+.||+|+||.||+|.. .+++.||||.+.....      .....+.+|+.++++++  ||||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            345688889999999999999964 5789999999865421      12245678999999996  59999999999999


Q ss_pred             CeEEEEEEeccC-CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec-CCCcEEEeecC
Q 014038          181 GQHMLVYVFMSK-GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFG  258 (432)
Q Consensus       181 ~~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~-~~~~~kl~Dfg  258 (432)
                      +..++||||+.+ ++|.+++..  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++ +++.+||+|||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             CcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            999999999986 899999854  356999999999999999999999999   99999999999999 78999999999


Q ss_pred             CcccccccccccccccCCCCCCccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcc
Q 014038          259 LSREEMVDKHAANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD  337 (432)
Q Consensus       259 l~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (432)
                      +++.... .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........       ...       
T Consensus       196 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-------~~~-------  260 (320)
T 3a99_A          196 SGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-------GQV-------  260 (320)
T ss_dssp             TCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH-------CCC-------
T ss_pred             ccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhc-------ccc-------
Confidence            9875432 23344578999999999877665 6889999999999999999999986432110       000       


Q ss_pred             ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          338 SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       338 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                       .....    .+.++.+++.+||+.||++|||+.++++
T Consensus       261 -~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          261 -FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             -CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -ccccc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             01111    2347899999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=330.04  Aligned_cols=244  Identities=27%  Similarity=0.455  Sum_probs=191.9

Q ss_pred             HHHHHHhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChh------hHHHHHHHHHHHhhc----CCCccceEEe
Q 014038          107 KDLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQ------GEKEFQTEVMLLGRL----HHRNLVNLVG  175 (432)
Q Consensus       107 ~~l~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~  175 (432)
                      .+.....|.+.+.||+|+||.||+|.. .+++.||||++......      ....+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            344456788999999999999999965 47889999999654321      223456799999988    8999999999


Q ss_pred             eeeeCCeEEEEEEe-ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec-CCCcEE
Q 014038          176 YCAEKGQHMLVYVF-MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRAR  253 (432)
Q Consensus       176 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~-~~~~~k  253 (432)
                      ++...+..++|||| +.+++|.+++...  ..+++..++.++.||+.||.|||+++   |+||||||+||+++ .++.+|
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence            99999999999999 7899999999653  46999999999999999999999999   99999999999999 889999


Q ss_pred             EeecCCcccccccccccccccCCCCCCccccccCCCC-chhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCch
Q 014038          254 VADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFT-KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW  332 (432)
Q Consensus       254 l~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  332 (432)
                      |+|||++...... ......||+.|+|||++.+..+. .++||||||+++|||++|+.||....+...       ..   
T Consensus       181 l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~---  249 (312)
T 2iwi_A          181 LIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE-------AE---  249 (312)
T ss_dssp             ECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH-------TC---
T ss_pred             EEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhh-------hc---
Confidence            9999998754332 33456689999999998776664 599999999999999999999986432110       00   


Q ss_pred             hhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                             .  .++...+.++.+++.+||+.||++|||+.++++
T Consensus       250 -------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          250 -------L--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             -------C--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------c--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   0  011122357899999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=335.59  Aligned_cols=245  Identities=23%  Similarity=0.333  Sum_probs=186.3

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      +|.+.++||+|+||+||.....+|+.||||++.....   ..+.+|+.+|+++ +||||+++++++.+....++||||+.
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  101 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA  101 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence            4566789999999997766666899999999865432   2356899999999 79999999999999999999999996


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC-----CCcEEEeecCCccccccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-----SMRARVADFGLSREEMVD  266 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~-----~~~~kl~Dfgl~~~~~~~  266 (432)
                       |+|.+++.... ..+.+..+..++.||+.||.|||+.+   |+||||||+|||++.     ...+||+|||+++.....
T Consensus       102 -g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A          102 -ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             -EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             -CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence             59999986543 34555567789999999999999999   999999999999943     346889999999764332


Q ss_pred             ----ccccccccCCCCCCccccc---cCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccc
Q 014038          267 ----KHAANIRGTFGYLDPEYIS---TRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDS  338 (432)
Q Consensus       267 ----~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (432)
                          .......||+.|+|||++.   ...++.++|||||||++|||++ |..||.................        .
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~--------~  248 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL--------D  248 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCC--------T
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCc--------c
Confidence                2234467999999999997   4577889999999999999999 9999965432211111110000        0


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          339 RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       339 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..  .........+.+|+.+||+.||.+|||+.++++
T Consensus       249 ~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          249 CL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            00  111234456889999999999999999999984

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.3e-42  Score=351.52  Aligned_cols=270  Identities=24%  Similarity=0.335  Sum_probs=208.4

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeee------CCeE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE------KGQH  183 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~  183 (432)
                      ..|.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            4678889999999999999965 47899999998764 34456779999999999999999999998765      6678


Q ss_pred             EEEEEeccCCChhhhcccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCc---EEEeecCC
Q 014038          184 MLVYVFMSKGSLASHLYDEN-YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMR---ARVADFGL  259 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~---~kl~Dfgl  259 (432)
                      ++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence            99999999999999996532 346999999999999999999999999   999999999999987665   99999999


Q ss_pred             cccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCC---chhhh-
Q 014038          260 SREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKT---GWEEI-  335 (432)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~-  335 (432)
                      +.............||+.|+|||.+.+..++.++|||||||++|||++|+.||........+.........   ..... 
T Consensus       171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l  250 (676)
T 3qa8_A          171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL  250 (676)
T ss_dssp             CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred             ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence            98765555555678999999999999999999999999999999999999999764332221110000000   00000 


Q ss_pred             -----cccc--CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHH-----HHHHHHHHHhhc
Q 014038          336 -----VDSR--LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRD-----IVQVLSRILKMR  384 (432)
Q Consensus       336 -----~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~-----vl~~L~~i~~~~  384 (432)
                           +...  .........+..+.+++.+||+.||++|||+.+     ..+.+..++...
T Consensus       251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence                 0000  111233446678999999999999999999988     556777777654

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.2e-41  Score=354.99  Aligned_cols=247  Identities=20%  Similarity=0.313  Sum_probs=198.5

Q ss_pred             CHHHHHHHhccccccccccCceeEEEEEeC--CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC
Q 014038          105 SYKDLQKATCNFTTLIGQGAFGPVYKAQMS--TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG  181 (432)
Q Consensus       105 ~~~~l~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  181 (432)
                      ...++....|.+.+.||+|+||.||+|...  +|+.||||.+... .......+.+|+.++.+++||||+++++++...+
T Consensus        73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD  152 (681)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred             CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence            334455568889999999999999999764  6899999998654 3344567899999999999999999999998766


Q ss_pred             e-----EEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEee
Q 014038          182 Q-----HMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVAD  256 (432)
Q Consensus       182 ~-----~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~D  256 (432)
                      .     .++||||+++++|.+++..    .+++..++.++.||+.||.|||+++   |+||||||+|||++.+ .+||+|
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~D  224 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLID  224 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECC
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEe
Confidence            5     7999999999999987732    6999999999999999999999999   9999999999999986 899999


Q ss_pred             cCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhc
Q 014038          257 FGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIV  336 (432)
Q Consensus       257 fgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  336 (432)
                      ||+++.....   ....||+.|+|||++.+.. +.++|||||||++|||++|..||.+...                   
T Consensus       225 FG~a~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~-------------------  281 (681)
T 2pzi_A          225 LGAVSRINSF---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV-------------------  281 (681)
T ss_dssp             CTTCEETTCC---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC-------------------
T ss_pred             cccchhcccC---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc-------------------
Confidence            9999754322   4557999999999987654 8999999999999999999988864210                   


Q ss_pred             cccCCCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHHh
Q 014038          337 DSRLDGIFDVEELNEVASLAYKCVNRAPRKRP-SMRDIVQVLSRILK  382 (432)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~~vl~~L~~i~~  382 (432)
                      +...........+..+.+++.+||+.||++|| +++++.+.|..++.
T Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          282 DGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             SSCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             ccccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence            00000111112345789999999999999999 46677777776654

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.9e-40  Score=310.52  Aligned_cols=232  Identities=13%  Similarity=0.114  Sum_probs=183.9

Q ss_pred             HHHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          110 QKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       110 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      ....|.+.+.||+|+||.||+|... +++.||||++....   ....+.|.+|+.++.+++||||+++++++.+.+..++
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            3456888899999999999999764 58999999997653   2334689999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+++++|.+++..   + .....+.+++.|++.||.|||+++   |+||||||+|||++.++.+||+++|       
T Consensus       109 v~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence            9999999999999842   2 355678899999999999999999   9999999999999999999998543       


Q ss_pred             cccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC--C
Q 014038          266 DKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG--I  343 (432)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  343 (432)
                                  |++|       ++.++|||||||++|||++|+.||.+......+..        ...........  .
T Consensus       175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~  227 (286)
T 3uqc_A          175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--------AERDTAGQPIEPAD  227 (286)
T ss_dssp             ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--------CCBCTTSCBCCHHH
T ss_pred             ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--------HHHHhccCCCChhh
Confidence                        3433       68999999999999999999999976321100000        00000000000  0


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      .....+.++.+++.+||+.||++| |+.++++.|+.+...
T Consensus       228 ~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          228 IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            011234579999999999999999 999999999998654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-40  Score=328.54  Aligned_cols=238  Identities=20%  Similarity=0.198  Sum_probs=179.3

Q ss_pred             ccccccccccCceeEEEEE-eCCCcEEEEEEeccCCh---hhHHHHHHHHHHHhhcCC-CccceEE--------------
Q 014038          114 CNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHH-RNLVNLV--------------  174 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l~--------------  174 (432)
                      +.+.+.||+|+||.||+|. ..+|+.||||++.....   ...+.|.+|+.+++.++| +|...+.              
T Consensus        80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  159 (413)
T 3dzo_A           80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD  159 (413)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred             EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence            3456789999999999997 45799999999874322   335789999999999987 3221111              


Q ss_pred             -------eeeee-----CCeEEEEEEeccCCChhhhcc-----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 014038          175 -------GYCAE-----KGQHMLVYVFMSKGSLASHLY-----DENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR  237 (432)
Q Consensus       175 -------~~~~~-----~~~~~lv~e~~~~g~L~~~l~-----~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~  237 (432)
                             .++..     ....+++|+++ +++|.+++.     ......+++..++.++.||+.||+|||+++   |+||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHr  235 (413)
T 3dzo_A          160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHT  235 (413)
T ss_dssp             CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred             CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence                   11111     12346666655 689998884     233456889999999999999999999999   9999


Q ss_pred             cCCCCCeeecCCCcEEEeecCCcccccccccccccccCCCCCCcccc----------ccCCCCchhHhHHHHHHHHHHHh
Q 014038          238 DIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYI----------STRNFTKKSDVYSFGVLLFELIA  307 (432)
Q Consensus       238 dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~SlGvil~ellt  307 (432)
                      ||||+||||+.++.+||+|||+++.....  .....| +.|+|||++          ....++.++|||||||++|||++
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            99999999999999999999998754332  344567 999999999          55668999999999999999999


Q ss_pred             CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          308 GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       308 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      |+.||......           ..+..++...  ...    +.++.+|+.+||+.||++||++.++++
T Consensus       313 g~~Pf~~~~~~-----------~~~~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          313 ADLPNTDDAAL-----------GGSEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             SSCCCCTTGGG-----------SCSGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCcchh-----------hhHHHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99999764321           1111111111  112    257999999999999999999888764

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.8e-40  Score=310.02  Aligned_cols=225  Identities=24%  Similarity=0.363  Sum_probs=178.0

Q ss_pred             hcccc-ccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHH-hhcCCCccceEEeeeee----CCeEEE
Q 014038          113 TCNFT-TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLL-GRLHHRNLVNLVGYCAE----KGQHML  185 (432)
Q Consensus       113 ~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~l  185 (432)
                      .|.+. +.||+|+||.||+|.. .+++.||+|++..     ...+.+|+.++ +..+||||+++++++..    ....++
T Consensus        18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l   92 (299)
T 3m2w_A           18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI   92 (299)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence            45555 6799999999999965 5789999999853     24567888888 55589999999999877    677899


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC---CCcEEEeecCCccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---SMRARVADFGLSRE  262 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~---~~~~kl~Dfgl~~~  262 (432)
                      ||||+++|+|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||++..
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            999999999999998766667999999999999999999999999   999999999999998   78999999998853


Q ss_pred             ccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ..                     +..++.++|||||||++|||++|+.||..............       .+...  ..
T Consensus       170 ~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-------~~~~~--~~  219 (299)
T 3m2w_A          170 TT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-------RIRMG--QY  219 (299)
T ss_dssp             CT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC-------SSCTT--CC
T ss_pred             cc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH-------HHhhc--cc
Confidence            21                     24578899999999999999999999976432211100000       00000  00


Q ss_pred             CCCH----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          343 IFDV----EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       343 ~~~~----~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.    ..+.++.+++.+||+.||.+|||+.++++
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1111    12468999999999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.8e-40  Score=314.78  Aligned_cols=242  Identities=16%  Similarity=0.181  Sum_probs=183.9

Q ss_pred             HHhccccccccccCceeEEEEEeCCCcEEEEEEeccCC--------hhhHHHHHHHHHHHhhcC---------CCccceE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS--------KQGEKEFQTEVMLLGRLH---------HRNLVNL  173 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l  173 (432)
                      ...|.+.+.||+|+||.||+|+. +|+.||||++....        ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            45678889999999999999987 78999999997542        222367889999998886         6666666


Q ss_pred             Eee-----------------eee-------------CCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHH
Q 014038          174 VGY-----------------CAE-------------KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL  223 (432)
Q Consensus       174 ~~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l  223 (432)
                      .+.                 +.+             .+..++||||+++|++.+.+..   ..+++..+..++.||+.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence            654                 332             6789999999999987777733   4689999999999999999


Q ss_pred             HHHH-hCCCCCeeeccCCCCCeeecCCC--------------------cEEEeecCCcccccccccccccccCCCCCCcc
Q 014038          224 EYLH-DGAVPPVIHRDIKSSNILLDQSM--------------------RARVADFGLSREEMVDKHAANIRGTFGYLDPE  282 (432)
Q Consensus       224 ~yLH-~~~~~~iiH~dlkp~Nill~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE  282 (432)
                      +||| +.+   |+||||||+|||++.++                    .+||+|||+++....    ....||+.|+|||
T Consensus       175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE  247 (336)
T 2vuw_A          175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSG
T ss_pred             HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChh
Confidence            9999 888   99999999999999887                    899999999985432    2347999999999


Q ss_pred             ccccCCCCchhHhHHHHHH-HHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhc
Q 014038          283 YISTRNFTKKSDVYSFGVL-LFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVN  361 (432)
Q Consensus       283 ~~~~~~~~~~~Dv~SlGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  361 (432)
                      ++.+.. +.++||||||++ .+++++|..||.+...............     ..............+.++.+|+.+||+
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~s~~~~dli~~~L~  321 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM-----TFKTKCNTPAMKQIKRKIQEFHRTMLN  321 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC-----CCSSCCCSHHHHHHHHHHHHHHHHGGG
T ss_pred             hhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh-----ccCcccchhhhhhcCHHHHHHHHHHhc
Confidence            998766 899999998777 7778889999864321111111000000     000011111223467789999999999


Q ss_pred             cCCCCCCCHHHHH
Q 014038          362 RAPRKRPSMRDIV  374 (432)
Q Consensus       362 ~dp~~RPs~~~vl  374 (432)
                      .|     |+.+++
T Consensus       322 ~d-----sa~e~l  329 (336)
T 2vuw_A          322 FS-----SATDLL  329 (336)
T ss_dssp             SS-----SHHHHH
T ss_pred             cC-----CHHHHH
Confidence            76     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=6.2e-34  Score=291.12  Aligned_cols=185  Identities=19%  Similarity=0.146  Sum_probs=132.1

Q ss_pred             ccccccCceeEEEE-EeCCCcEEEEEEeccCC----------hhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEE
Q 014038          118 TLIGQGAFGPVYKA-QMSTGETVAVKVLATDS----------KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  185 (432)
                      ...+.|++|.+..+ +.-.|+.+|+|.+....          ....++|.+|+++|+++ +|+||+++++++.+++..||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            35677888877766 34468999999986541          23345799999999999 79999999999999999999


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||++|++|.+.|..  .++++..   +|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+++....
T Consensus       320 VMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            9999999999999954  3567654   47899999999999999   99999999999999999999999999986543


Q ss_pred             c-ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCC
Q 014038          266 D-KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP  311 (432)
Q Consensus       266 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p  311 (432)
                      . ....+.+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus       392 ~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            3 33456789999999999875 467789999999998887665433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.9e-29  Score=256.46  Aligned_cols=181  Identities=17%  Similarity=0.223  Sum_probs=146.2

Q ss_pred             cccccccCceeEEEEEeCCCcEEEEEEeccCCh--------hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          117 TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK--------QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .+.||+|+||.||+|.. .++.+++|.......        ...+.|.+|+.++++++||||+++..++...+..++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            35899999999999955 678899998654321        113458999999999999999977777777788899999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+++++|.+++..          +..++.|++.||.|||+++   |+||||||+|||++.  .+||+|||+++.......
T Consensus       420 ~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~  484 (540)
T 3en9_A          420 YINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED  484 (540)
T ss_dssp             CCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred             CCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence            9999999999954          5689999999999999999   999999999999998  999999999986543221


Q ss_pred             --------ccccccCCCCCCcccccc--CCCCchhHhHHHHHHHHHHHhCCCCCC
Q 014038          269 --------AANIRGTFGYLDPEYIST--RNFTKKSDVYSFGVLLFELIAGRSPLQ  313 (432)
Q Consensus       269 --------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltg~~p~~  313 (432)
                              .....||+.|||||++..  ..|+..+|+||..+-.++.+.++.+|.
T Consensus       485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                    235679999999999976  568889999999999999888877763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.1e-25  Score=210.26  Aligned_cols=141  Identities=13%  Similarity=0.111  Sum_probs=115.4

Q ss_pred             ccccccccCceeEEEEEeCCCcEEEEEEeccCCh------------------hhHHHHHHHHHHHhhcCCCccceEEeee
Q 014038          116 FTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK------------------QGEKEFQTEVMLLGRLHHRNLVNLVGYC  177 (432)
Q Consensus       116 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~~  177 (432)
                      +.+.||+|+||.||+|...+|+.||+|.+.....                  .....+.+|+.++++++  | +++.+++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~  170 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY  170 (282)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred             ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence            4589999999999999887899999999864321                  13456899999999999  5 6666655


Q ss_pred             eeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeec
Q 014038          178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADF  257 (432)
Q Consensus       178 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Df  257 (432)
                      .. +..++||||+++|+|.+ +..        .....++.|++.||.|||+.+   |+||||||+|||++ ++.+||+||
T Consensus       171 ~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DF  236 (282)
T 1zar_A          171 AW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDF  236 (282)
T ss_dssp             EE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCC
T ss_pred             ec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEEC
Confidence            43 55699999999999998 521        123469999999999999999   99999999999999 999999999


Q ss_pred             CCcccccccccccccccCCCCCCccccc
Q 014038          258 GLSREEMVDKHAANIRGTFGYLDPEYIS  285 (432)
Q Consensus       258 gl~~~~~~~~~~~~~~gt~~y~aPE~~~  285 (432)
                      |+++            .+..|+|||++.
T Consensus       237 G~a~------------~~~~~~a~e~l~  252 (282)
T 1zar_A          237 PQSV------------EVGEEGWREILE  252 (282)
T ss_dssp             TTCE------------ETTSTTHHHHHH
T ss_pred             CCCe------------ECCCCCHHHHHH
Confidence            9985            345578999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=3.1e-21  Score=177.84  Aligned_cols=135  Identities=19%  Similarity=0.210  Sum_probs=104.5

Q ss_pred             ccccccccccCceeEEEEEe-CCCcE--EEEEEeccCChh------------------------hHHHHHHHHHHHhhcC
Q 014038          114 CNFTTLIGQGAFGPVYKAQM-STGET--VAVKVLATDSKQ------------------------GEKEFQTEVMLLGRLH  166 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  166 (432)
                      +.+.+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|+.+|.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            34567899999999999976 68888  999987543111                        1136789999999998


Q ss_pred             CCcc--ceEEeeeeeCCeEEEEEEeccC-C----ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeecc
Q 014038          167 HRNL--VNLVGYCAEKGQHMLVYVFMSK-G----SLASHLYDENYGPLTWNLRVHIALDVARGLEYLH-DGAVPPVIHRD  238 (432)
Q Consensus       167 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~iiH~d  238 (432)
                      |+|+  ..++++    +..++||||+.+ |    +|.+....     .++..+..++.|++.||.||| +.+   |+|||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD  196 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---LVHAD  196 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence            8764  334432    356899999953 4    55554421     234567889999999999999 888   99999


Q ss_pred             CCCCCeeecCCCcEEEeecCCccc
Q 014038          239 IKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       239 lkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      |||.|||++.  .++|+|||++..
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEE
T ss_pred             CCHHHEEEcC--cEEEEECccccc
Confidence            9999999998  999999999864

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=5.4e-19  Score=169.71  Aligned_cols=135  Identities=13%  Similarity=0.115  Sum_probs=96.8

Q ss_pred             ccccccccccCceeEEEEEeCCCcEEEEEEeccCCh--------------hhHHH--------HHHHHHHHhhcCCCccc
Q 014038          114 CNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK--------------QGEKE--------FQTEVMLLGRLHHRNLV  171 (432)
Q Consensus       114 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~h~niv  171 (432)
                      |.+...||+|+||.||+|...+|+.||||+++....              .....        ..+|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            566789999999999999988999999998753210              00111        13455666666444332


Q ss_pred             eEEeeeeeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC-
Q 014038          172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-  250 (432)
Q Consensus       172 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~-  250 (432)
                      -..-+..  ...++||||+++++|.++...      +  ....++.|++.+|.|||..+   ||||||||.|||+++++ 
T Consensus       177 vp~p~~~--~~~~LVME~i~G~~L~~l~~~------~--~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          177 VPEPIAQ--SRHTIVMSLVDALPMRQVSSV------P--DPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             CCCEEEE--ETTEEEEECCSCEEGGGCCCC------S--CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred             CCeeeec--cCceEEEEecCCccHhhhccc------H--HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence            1111111  234799999999888765421      1  23567899999999999999   99999999999998876 


Q ss_pred             ---------cEEEeecCCcc
Q 014038          251 ---------RARVADFGLSR  261 (432)
Q Consensus       251 ---------~~kl~Dfgl~~  261 (432)
                               .+.|+||+.+-
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCE
T ss_pred             cccccccccceEEEEeCCcc
Confidence                     38999999764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.45  E-value=3e-13  Score=124.42  Aligned_cols=141  Identities=15%  Similarity=0.069  Sum_probs=110.6

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC-CCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .+.+...++.|+.+.||++.. +++.+++|............+.+|+.+++.+. +.++.++++++...+..++||||++
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~   93 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD   93 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred             cceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence            355667788889999999976 46899999986532222346889999999984 6778899999998899999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA-----------------------------------------  230 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----------------------------------------  230 (432)
                      |.+|.+.+.       +......++.+++.+|..||+..                                         
T Consensus        94 G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T 3tm0_A           94 GVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             SEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred             CeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence            999987642       11223467889999999999811                                         


Q ss_pred             ---------------CCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          231 ---------------VPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       231 ---------------~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                                     .+.++|+|++|.|||++++..+.|+||+.+.
T Consensus       167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                           1348999999999999876667799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.32  E-value=5.5e-12  Score=115.51  Aligned_cols=128  Identities=18%  Similarity=0.124  Sum_probs=97.9

Q ss_pred             cccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCc--cceEEeeeeeCCeEEEEEEeccCCChhhh
Q 014038          121 GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN--LVNLVGYCAEKGQHMLVYVFMSKGSLASH  198 (432)
Q Consensus       121 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~  198 (432)
                      +.|..+.||++...+|..+++|.....   ....+.+|+.+++.+.+.+  +.+++++....+..++||||++|.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            456669999998777888999997543   2245778999999885444  456888888778899999999998884  


Q ss_pred             cccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------------
Q 014038          199 LYDENYGPLTWNLRVHIALDVARGLEYLHDGA------------------------------------------------  230 (432)
Q Consensus       199 l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------------------  230 (432)
                      ...     .+   ...++.+++..|..||+..                                                
T Consensus       104 ~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  175 (264)
T 1nd4_A          104 SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK  175 (264)
T ss_dssp             TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred             cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence            211     12   2356788888888888743                                                


Q ss_pred             -------CCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          231 -------VPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       231 -------~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                             .+.++|+|++|.|||+++++.+.|+|||.+.
T Consensus       176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                   1229999999999999887667799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.22  E-value=4.7e-11  Score=115.01  Aligned_cols=140  Identities=16%  Similarity=0.282  Sum_probs=106.4

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEec--cCC-hhhHHHHHHHHHHHhhcC--CCccceEEeeeeeC---CeEEEEEEe
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLA--TDS-KQGEKEFQTEVMLLGRLH--HRNLVNLVGYCAEK---GQHMLVYVF  189 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e~  189 (432)
                      +.|+.|.++.||+.... +..+++|+..  ... ......+.+|+.+++.+.  +..+.++++++.+.   +..++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            57899999999999875 4678888775  322 122346788999999996  45678899988776   458999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA---------------------------------------  230 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~---------------------------------------  230 (432)
                      ++|..+.+..    ...++...+..++.+++..|..||...                                       
T Consensus       123 v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          123 VSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             CCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             cCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            9998775422    234778888999999999999999731                                       


Q ss_pred             ----------------CCCeeeccCCCCCeeecCCCc--EEEeecCCccc
Q 014038          231 ----------------VPPVIHRDIKSSNILLDQSMR--ARVADFGLSRE  262 (432)
Q Consensus       231 ----------------~~~iiH~dlkp~Nill~~~~~--~kl~Dfgl~~~  262 (432)
                                      .+.++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                            245999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.12  E-value=4.8e-11  Score=112.20  Aligned_cols=183  Identities=21%  Similarity=0.262  Sum_probs=122.1

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCc--cceEEeeeeeCC---eEEEEEEecc
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRN--LVNLVGYCAEKG---QHMLVYVFMS  191 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~e~~~  191 (432)
                      +.++.|.+..||+..    ..+++|+...  ......+.+|..+|+.+ .+..  +.+++.+....+   ..|+||+|++
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            458999999999874    4588888643  23456788999999888 3433  344555443332   4588999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA-----------------------------------------  230 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----------------------------------------  230 (432)
                      |.+|.....    ..++..++..++.+++..|..||+..                                         
T Consensus       100 G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A          100 GVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            988875332    24677788888899999999888621                                         


Q ss_pred             --------------CCCeeeccCCCCCeeecC--CCcEEEeecCCccccccccccccc---------------ccCCCCC
Q 014038          231 --------------VPPVIHRDIKSSNILLDQ--SMRARVADFGLSREEMVDKHAANI---------------RGTFGYL  279 (432)
Q Consensus       231 --------------~~~iiH~dlkp~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~~~---------------~gt~~y~  279 (432)
                                    .+.++|+|++|.||++++  +..+.|+||+.+............               ....++.
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~  255 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK  255 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence                          135899999999999998  556889999987542111000000               0000111


Q ss_pred             C-ccccccCCCCchhHhHHHHHHHHHHHhCCCCC
Q 014038          280 D-PEYISTRNFTKKSDVYSFGVLLFELIAGRSPL  312 (432)
Q Consensus       280 a-PE~~~~~~~~~~~Dv~SlGvil~elltg~~p~  312 (432)
                      . |+....  .....+.|+++.++|++.+|..+|
T Consensus       256 ~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          256 DIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            2 222211  123368999999999999998876

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.67  E-value=2.1e-07  Score=87.22  Aligned_cols=134  Identities=21%  Similarity=0.232  Sum_probs=94.4

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCC---ccceEEeeee-eCCeEEEEEEeccCC
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR---NLVNLVGYCA-EKGQHMLVYVFMSKG  193 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~g  193 (432)
                      +.++.|....||+.    |..+++|+..  .......+.+|..+|+.+.+.   .+.+++.++. ..+..++||+|++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            45788888999988    5678888853  233456788999999999642   3556666664 455678999999998


Q ss_pred             ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 014038          194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG--------------------------------------------  229 (432)
Q Consensus       194 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~--------------------------------------------  229 (432)
                      +|.....    ..++......++.+++..|..||+.                                            
T Consensus        99 ~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           99 ILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             ECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             ECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            8865321    1245555555666666666666642                                            


Q ss_pred             -------------CCCCeeeccCCCCCeeecC---CCc-EEEeecCCcc
Q 014038          230 -------------AVPPVIHRDIKSSNILLDQ---SMR-ARVADFGLSR  261 (432)
Q Consensus       230 -------------~~~~iiH~dlkp~Nill~~---~~~-~kl~Dfgl~~  261 (432)
                                   ..+.++|+|++|.|||++.   ++. +.|+||+.+.
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                         2234799999999999987   455 5899999765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.57  E-value=3e-07  Score=84.36  Aligned_cols=134  Identities=16%  Similarity=0.120  Sum_probs=95.8

Q ss_pred             cccccCce-eEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcC-CCccceEEeeeeeCCeEEEEEEeccCCCh
Q 014038          119 LIGQGAFG-PVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       119 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L  195 (432)
                      .+..|..| .||+.... ++..+++|+-..   .....+.+|...|+.+. +--+.++++++.+.+..++||+++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556555 68988654 456789998643   23456888999998884 43467889999999999999999999887


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 014038          196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA---------------------------------------------  230 (432)
Q Consensus       196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~---------------------------------------------  230 (432)
                      .+....      .......++.+++..|.-||...                                             
T Consensus       108 ~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          108 FQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            665421      11223345566666666666421                                             


Q ss_pred             ----------CCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          231 ----------VPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       231 ----------~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                                .+.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                      1237999999999999988777899999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.56  E-value=2.1e-07  Score=89.22  Aligned_cols=80  Identities=4%  Similarity=-0.006  Sum_probs=56.3

Q ss_pred             ccc-cccCceeEEEEEeC-------CCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcC-C--CccceEEeeeeeC---
Q 014038          118 TLI-GQGAFGPVYKAQMS-------TGETVAVKVLATDS---KQGEKEFQTEVMLLGRLH-H--RNLVNLVGYCAEK---  180 (432)
Q Consensus       118 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~---  180 (432)
                      +.| +.|....+|+....       +++.+++|......   ......+.+|+.+++.+. +  -.+.++++++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 88889999998764       26788899865422   101245778888888884 3  3567788887665   


Q ss_pred             CeEEEEEEeccCCChhh
Q 014038          181 GQHMLVYVFMSKGSLAS  197 (432)
Q Consensus       181 ~~~~lv~e~~~~g~L~~  197 (432)
                      +..++||||++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            45789999999877654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.24  E-value=9.1e-06  Score=76.06  Aligned_cols=136  Identities=16%  Similarity=0.170  Sum_probs=92.1

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC---CCccceEEeeeeeCCeEEEEEEeccCCC
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH---HRNLVNLVGYCAEKGQHMLVYVFMSKGS  194 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g~  194 (432)
                      +.|+.|....+|+... ++..+++|+....   ....|..|...|+.+.   ...+.++++++...+..++||||+++..
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~  117 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK  117 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence            4689999999999986 5678889987532   3557889999998883   3567888988888889999999999876


Q ss_pred             hhh-----------hcccCCC-C-------------------CCCHHHHH---HHH----------------HHHHHH-H
Q 014038          195 LAS-----------HLYDENY-G-------------------PLTWNLRV---HIA----------------LDVARG-L  223 (432)
Q Consensus       195 L~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~----------------~~i~~~-l  223 (432)
                      +..           .|+.... .                   .-+|....   ++.                ..++.- .
T Consensus       118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~  197 (312)
T 3jr1_A          118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA  197 (312)
T ss_dssp             CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred             CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence            532           1222111 0                   12454321   111                111211 2


Q ss_pred             HHHHh-CCCCCeeeccCCCCCeeecCCCcEEEeecC
Q 014038          224 EYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFG  258 (432)
Q Consensus       224 ~yLH~-~~~~~iiH~dlkp~Nill~~~~~~kl~Dfg  258 (432)
                      ..|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus       198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            23432 2346799999999999999887 8899974

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.22  E-value=1.7e-05  Score=74.95  Aligned_cols=138  Identities=19%  Similarity=0.258  Sum_probs=78.6

Q ss_pred             cccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCC--CccceEEe------eeeeCCeEEEEEEec
Q 014038          119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH--RNLVNLVG------YCAEKGQHMLVYVFM  190 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~~  190 (432)
                      .|+.|..+.||+....+| .+++|+....    ...+..|+.+++.+..  -.+.+++.      +....+..+++|+|+
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            466677899999987554 5889988652    2333445555554421  12333332      123467789999999


Q ss_pred             cCCChh--------------hhccc--CCC----------CCCCHHHH-------------------------------H
Q 014038          191 SKGSLA--------------SHLYD--ENY----------GPLTWNLR-------------------------------V  213 (432)
Q Consensus       191 ~~g~L~--------------~~l~~--~~~----------~~l~~~~~-------------------------------~  213 (432)
                      +|..+.              ..+|.  ...          ..-.|...                               .
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            986553              01111  100          01123211                               0


Q ss_pred             HHHHHHHHHHHHHHh--------C--CCCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          214 HIALDVARGLEYLHD--------G--AVPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       214 ~i~~~i~~~l~yLH~--------~--~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                      .+...+..++.+|+.        .  ..+.++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            111223445667763        0  22449999999999999888899999999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.22  E-value=5.3e-06  Score=80.57  Aligned_cols=74  Identities=18%  Similarity=0.108  Sum_probs=48.9

Q ss_pred             ccccccCceeEEEEEeC-CCcEEEEEEeccCCh-------hhHHHHHHHHHHHhhcCC--Cccc-eEEeeeeeCCeEEEE
Q 014038          118 TLIGQGAFGPVYKAQMS-TGETVAVKVLATDSK-------QGEKEFQTEVMLLGRLHH--RNLV-NLVGYCAEKGQHMLV  186 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~niv-~l~~~~~~~~~~~lv  186 (432)
                      +.||.|.++.||++... +++.++||.......       .....+..|.++++.+..  +..+ +++.+  +.+..++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            57899999999999653 468899997643211       123456788888888742  4444 45543  34456899


Q ss_pred             EEeccCC
Q 014038          187 YVFMSKG  193 (432)
Q Consensus       187 ~e~~~~g  193 (432)
                      |||+++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999763

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.12  E-value=1e-05  Score=74.87  Aligned_cols=74  Identities=18%  Similarity=0.280  Sum_probs=55.1

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCC---ccceEEeeeeeCCeEEEEEEeccCCC
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHR---NLVNLVGYCAEKGQHMLVYVFMSKGS  194 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e~~~~g~  194 (432)
                      +.+|.|..+.||+.++.+|+.|.+|+...........|..|...|+.+...   -+.+++++.    ..++||||++++.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence            568999999999999999999999987655444445688999999988422   234455432    3478999998765


Q ss_pred             h
Q 014038          195 L  195 (432)
Q Consensus       195 L  195 (432)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.88  E-value=5.6e-05  Score=73.95  Aligned_cols=76  Identities=13%  Similarity=0.111  Sum_probs=46.1

Q ss_pred             CCeeeccCCCCCeeecCCCcEEEeecCCcccccccccccccc--cCCCCCCccccccC---CCCchhHhHHHHHHHHHHH
Q 014038          232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR--GTFGYLDPEYISTR---NFTKKSDVYSFGVLLFELI  306 (432)
Q Consensus       232 ~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~~Dv~SlGvil~ell  306 (432)
                      +.++|+|++|.|||++.++ ++|+||+.+.............  -...|.+|+.....   .-....++.+....+|+.+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            4499999999999998876 9999999886432111111110  01234555444211   1123456667888888876


Q ss_pred             hC
Q 014038          307 AG  308 (432)
Q Consensus       307 tg  308 (432)
                      ++
T Consensus       311 ~~  312 (420)
T 2pyw_A          311 NK  312 (420)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.61  E-value=0.00032  Score=67.31  Aligned_cols=139  Identities=15%  Similarity=0.169  Sum_probs=83.1

Q ss_pred             ccccccCceeEEEEEeC--------CCcEEEEEEeccCChhhHHHHHHHHHHHhhcC-CCccceEEeeeeeCCeEEEEEE
Q 014038          118 TLIGQGAFGPVYKAQMS--------TGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      +.|..|-...+|+....        +++.+++|+.... ......+.+|..+++.+. +.-..++++++.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            35777888999999764        2478999986332 223456678999998884 3333566766653    28999


Q ss_pred             eccCCChhhh-----------------cccCC---CCCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 014038          189 FMSKGSLASH-----------------LYDEN---YGPLT--WNLRVHIALDVAR-------------------GLEYL-  226 (432)
Q Consensus       189 ~~~~g~L~~~-----------------l~~~~---~~~l~--~~~~~~i~~~i~~-------------------~l~yL-  226 (432)
                      |++|.+|...                 ||...   ..+..  |.++.++..++..                   .+..| 
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998665421                 11111   11122  4555555544322                   22333 


Q ss_pred             ---HhC-CCCCeeeccCCCCCeeecCC----CcEEEeecCCcc
Q 014038          227 ---HDG-AVPPVIHRDIKSSNILLDQS----MRARVADFGLSR  261 (432)
Q Consensus       227 ---H~~-~~~~iiH~dlkp~Nill~~~----~~~kl~Dfgl~~  261 (432)
                         ... ....++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               222 22458999999999999876    789999999875

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.60  E-value=0.00018  Score=67.46  Aligned_cols=141  Identities=12%  Similarity=0.147  Sum_probs=78.8

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCc--cceEEee------eeeCCeEEEEEEe
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN--LVNLVGY------CAEKGQHMLVYVF  189 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~  189 (432)
                      +.|+.|....+|+....+| .+++|.....  .....+..|+.++..+...+  +.+++..      ....+..+++|+|
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~  104 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  104 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence            3567788899999987655 6788987652  12234556777777663212  2333321      1234677899999


Q ss_pred             ccCCChhh--------------hcccC--C--CC---C---CCHHHHHH------------HHHHHHHHHHHHHhC----
Q 014038          190 MSKGSLAS--------------HLYDE--N--YG---P---LTWNLRVH------------IALDVARGLEYLHDG----  229 (432)
Q Consensus       190 ~~~g~L~~--------------~l~~~--~--~~---~---l~~~~~~~------------i~~~i~~~l~yLH~~----  229 (432)
                      ++|..+..              .++..  .  ..   .   ..|.....            +...+...+.+|+..    
T Consensus       105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~  184 (322)
T 2ppq_A          105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  184 (322)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence            99865421              01110  0  00   0   11222110            011234445555531    


Q ss_pred             CCCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       230 ~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                      ....++|+|+.+.|||++++..+.|+||+.+.
T Consensus       185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            12358999999999999987666899999764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.57  E-value=0.00031  Score=68.77  Aligned_cols=72  Identities=18%  Similarity=0.265  Sum_probs=49.6

Q ss_pred             ccccccCceeEEEEEeCC--------CcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCcc-ceEEeeeeeCCeEEEEEE
Q 014038          118 TLIGQGAFGPVYKAQMST--------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL-VNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  188 (432)
                      +.|+.|....+|+....+        ++.+++|+....  .....+.+|..+++.+...++ .++++.+.+    .+|++
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            467888889999998753        578999987432  112455689999888853334 567766542    38999


Q ss_pred             eccCCCh
Q 014038          189 FMSKGSL  195 (432)
Q Consensus       189 ~~~~g~L  195 (432)
                      |++|.+|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9986444

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.54  E-value=0.0005  Score=64.52  Aligned_cols=139  Identities=13%  Similarity=0.112  Sum_probs=80.2

Q ss_pred             cccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCc--cceEEee-----eeeCCeEEEEEEecc
Q 014038          119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN--LVNLVGY-----CAEKGQHMLVYVFMS  191 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~~~  191 (432)
                      .++ |....||+....+|+.+++|...... .....+..|..++..+....  +.+++..     ....+..+++|+|++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            466 88889999987777789999986331 12446677888887774222  3444432     123456788999998


Q ss_pred             CCChhh----h----------ccc--C--C---CCCCCHHHH----HHH---------------HHHHHHHHHHHHh---
Q 014038          192 KGSLAS----H----------LYD--E--N---YGPLTWNLR----VHI---------------ALDVARGLEYLHD---  228 (432)
Q Consensus       192 ~g~L~~----~----------l~~--~--~---~~~l~~~~~----~~i---------------~~~i~~~l~yLH~---  228 (432)
                      |..+..    .          ++.  .  .   ...+++...    ..+               ...+...+..+..   
T Consensus       111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  190 (328)
T 1zyl_A          111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR  190 (328)
T ss_dssp             CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence            755421    0          111  0  0   011222211    001               0111112223221   


Q ss_pred             -CCCCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          229 -GAVPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       229 -~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                       .....++|+|+++.|||++ + .+.|+||+.+.
T Consensus       191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence             1224489999999999999 4 89999998765

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.52  E-value=0.00055  Score=64.49  Aligned_cols=139  Identities=14%  Similarity=0.096  Sum_probs=71.5

Q ss_pred             cccccCcee-EEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC-C-CccceEEeeeeeCCeEEEEEEeccCCCh
Q 014038          119 LIGQGAFGP-VYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-H-RNLVNLVGYCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       119 ~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~niv~l~~~~~~~~~~~lv~e~~~~g~L  195 (432)
                      .|+.|+... +|+....+|..+++|.......   ..+..|+.+++.+. + -.+.+++.+....+  +++||++.+..+
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l   99 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF   99 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence            455554444 6677654467777776543221   23445666666663 2 23456676644444  789999976655


Q ss_pred             hhhcc---------------------cCCC---CCCCHHHHH-------HH-------------HHHHHHHHHHHH---h
Q 014038          196 ASHLY---------------------DENY---GPLTWNLRV-------HI-------------ALDVARGLEYLH---D  228 (432)
Q Consensus       196 ~~~l~---------------------~~~~---~~l~~~~~~-------~i-------------~~~i~~~l~yLH---~  228 (432)
                      .+.+.                     ....   ..++.....       .+             ...+...+..|.   .
T Consensus       100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~  179 (333)
T 3csv_A          100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL  179 (333)
T ss_dssp             HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred             HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence            43321                     1100   112211110       00             001112222221   1


Q ss_pred             CCCCCeeeccCCCCCeeecCC----CcEEEeecCCccc
Q 014038          229 GAVPPVIHRDIKSSNILLDQS----MRARVADFGLSRE  262 (432)
Q Consensus       229 ~~~~~iiH~dlkp~Nill~~~----~~~kl~Dfgl~~~  262 (432)
                      ...+.++|||+.+.|||++.+    +.+.|+||+.+..
T Consensus       180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            123459999999999999875    6899999998764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.42  E-value=0.00073  Score=58.72  Aligned_cols=100  Identities=13%  Similarity=0.087  Sum_probs=65.5

Q ss_pred             ChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccccccc
Q 014038          194 SLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR  273 (432)
Q Consensus       194 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~  273 (432)
                      +|.+.|... ..++++.+++.++.|.+.+|.-+-....+  ..+=+.|..|+|..+|.|.+.+ +.+.           .
T Consensus        34 SL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~   98 (229)
T 2yle_A           34 SLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-----------A   98 (229)
T ss_dssp             EHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             cHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------c
Confidence            677877543 47899999999999999998776221111  1233457999999999988874 2111           1


Q ss_pred             cCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCC
Q 014038          274 GTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGR  309 (432)
Q Consensus       274 gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~  309 (432)
                      ....+.|||... ...+.+.=|||||+++|.-+-=.
T Consensus        99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             --------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence            122456888763 35578999999999999988633

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.39  E-value=0.00042  Score=64.31  Aligned_cols=70  Identities=7%  Similarity=0.096  Sum_probs=43.3

Q ss_pred             ccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCcc-ceEEeeeeeCCeEEEEEEec-cCCCh
Q 014038          118 TLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL-VNLVGYCAEKGQHMLVYVFM-SKGSL  195 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~L  195 (432)
                      +.|+.|....+|+.     +.+++|+........ ....+|+.+++.+...++ .++++++  .+.-+++++|+ ++.++
T Consensus        24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             EEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred             eEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence            56888999999998     558888875432111 123467777777743233 4566544  33346899999 55444

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.37  E-value=0.0013  Score=64.90  Aligned_cols=73  Identities=12%  Similarity=0.134  Sum_probs=47.2

Q ss_pred             ccccccCceeEEEEEeCC-CcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCcc-ceEEeeeeeCCeEEEEEEeccCCCh
Q 014038          118 TLIGQGAFGPVYKAQMST-GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL-VNLVGYCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L  195 (432)
                      +.|+.|-...+|+....+ +..+++|+........ -+..+|..+++.+...++ .++++++.  +  ..||+|++|.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            467888889999998765 4788898874332111 112578889988865555 56777663  2  259999987555

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.26  E-value=0.00074  Score=64.60  Aligned_cols=73  Identities=8%  Similarity=0.093  Sum_probs=44.0

Q ss_pred             ccccccCceeEEEEEeCC---------CcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCc-cceEEeeeeeCCeEEEEE
Q 014038          118 TLIGQGAFGPVYKAQMST---------GETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRN-LVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  187 (432)
                      +.|+.|....+|+....+         ++.+++|+....... ..+...|..+++.+...+ ..++++..  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            457888889999997654         268888887543221 112357888888774333 34566544  2  26899


Q ss_pred             EeccCCCh
Q 014038          188 VFMSKGSL  195 (432)
Q Consensus       188 e~~~~g~L  195 (432)
                      +|++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.18  E-value=0.0042  Score=58.65  Aligned_cols=68  Identities=13%  Similarity=0.183  Sum_probs=43.7

Q ss_pred             cccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC---CCccceEEee------eeeCCeEEEEEEecc
Q 014038          121 GQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH---HRNLVNLVGY------CAEKGQHMLVYVFMS  191 (432)
Q Consensus       121 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~  191 (432)
                      |.|....||+....+| .+++|+......      ..|+.++..|.   -|++.+++..      ....+..+++|+|++
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            4444689999987777 899998765432      24555555542   2224444432      233577899999999


Q ss_pred             CCCh
Q 014038          192 KGSL  195 (432)
Q Consensus       192 ~g~L  195 (432)
                      |..+
T Consensus       105 G~~~  108 (339)
T 3i1a_A          105 APNG  108 (339)
T ss_dssp             CCBT
T ss_pred             CCcC
Confidence            8766

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=97.09  E-value=0.00021  Score=43.30  Aligned_cols=31  Identities=23%  Similarity=0.450  Sum_probs=22.0

Q ss_pred             CCCcceeeehhHHHHHHHHHHHHHHHHHhhh
Q 014038            3 GESSGLIIGISIGVVIGVLLAISALFCFRYH   33 (432)
Q Consensus         3 ~~~~~~ii~i~~~~~~~~~~~~~~~~~~~~~   33 (432)
                      +.+.+.|+||++|+++++++++.+++++++|
T Consensus         7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr   37 (38)
T 2k1k_A            7 GLTGGEIVAVIFGLLLGAALLLGILVFRSRR   37 (38)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence            4567788999999888877666655544433

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=97.01  E-value=0.00043  Score=43.07  Aligned_cols=29  Identities=17%  Similarity=0.265  Sum_probs=14.5

Q ss_pred             CcceeeehhHHHHHHHHHHHHHHHHHhhh
Q 014038            5 SSGLIIGISIGVVIGVLLAISALFCFRYH   33 (432)
Q Consensus         5 ~~~~ii~i~~~~~~~~~~~~~~~~~~~~~   33 (432)
                      ....++++++|+++++++++++++++|||
T Consensus        10 ~~~~Ia~~vVGvll~vi~~l~~~~~~RRR   38 (44)
T 2jwa_A           10 PLTSIISAVVGILLVVVLGVVFGILIKRR   38 (44)
T ss_dssp             SHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccchHHHHHHHHHHHHHHHHHHhheehh
Confidence            33457788888544333333333333333

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=96.96  E-value=0.00082  Score=42.03  Aligned_cols=19  Identities=16%  Similarity=0.130  Sum_probs=7.4

Q ss_pred             ceeeehhHHHHHHHHHHHH
Q 014038            7 GLIIGISIGVVIGVLLAIS   25 (432)
Q Consensus         7 ~~ii~i~~~~~~~~~~~~~   25 (432)
                      +.|++.++|.+++++++++
T Consensus        11 ~~IA~gVVgGv~~~~ii~~   29 (44)
T 2ks1_B           11 PSIATGMVGALLLLLVVAL   29 (44)
T ss_dssp             SSSTHHHHHHHHHHHHHHH
T ss_pred             ceEEeehhHHHHHHHHHHH
Confidence            3444444443333333333

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=96.84  E-value=0.00094  Score=41.63  Aligned_cols=28  Identities=14%  Similarity=0.119  Sum_probs=10.9

Q ss_pred             cceeeehhHHHHHHHHHHHHHHHHHhhh
Q 014038            6 SGLIIGISIGVVIGVLLAISALFCFRYH   33 (432)
Q Consensus         6 ~~~ii~i~~~~~~~~~~~~~~~~~~~~~   33 (432)
                      .+.|++.++|.+++++++++++++|.+|
T Consensus         9 ~~aIA~gVVgGv~~v~ii~~~~~~~~RR   36 (44)
T 2l2t_A            9 TPLIAAGVIGGLFILVIVGLTFAVYVRR   36 (44)
T ss_dssp             SHHHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cceEEEeehHHHHHHHHHHHHHHHHhhh
Confidence            3344444444333333333333333333

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.29  E-value=0.024  Score=55.10  Aligned_cols=139  Identities=12%  Similarity=0.161  Sum_probs=83.6

Q ss_pred             ccccccCceeEEEEEeCC--------CcEEEEEEeccCChhhHHHHHHHHHHHhhcC-CCccceEEeeeeeCCeEEEEEE
Q 014038          118 TLIGQGAFGPVYKAQMST--------GETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      +.+..|-...+|+....+        ++.+++|+....... .-+..+|..+++.+. +.-..++++.+.    -++||+
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            457778889999998753        578999986443211 112357888888874 332345565332    278999


Q ss_pred             eccCCChhhh-c----------------cc----C-------CCCCCCHHHHHHHHHHH-------------------HH
Q 014038          189 FMSKGSLASH-L----------------YD----E-------NYGPLTWNLRVHIALDV-------------------AR  221 (432)
Q Consensus       189 ~~~~g~L~~~-l----------------~~----~-------~~~~l~~~~~~~i~~~i-------------------~~  221 (432)
                      |++|..|... +                |.    .       ...+.-|.++.++..++                   ..
T Consensus       151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  230 (424)
T 3mes_A          151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE  230 (424)
T ss_dssp             CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred             EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence            9998664310 1                10    0       11122244444443322                   22


Q ss_pred             HHHHHHh---------------------CCCCCeeeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          222 GLEYLHD---------------------GAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       222 ~l~yLH~---------------------~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      .+.+|..                     .....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            2333321                     11235899999999999 8888999999998753

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.10  E-value=0.41  Score=45.95  Aligned_cols=29  Identities=31%  Similarity=0.450  Sum_probs=24.8

Q ss_pred             eeeccCCCCCeee------cCCCcEEEeecCCccc
Q 014038          234 VIHRDIKSSNILL------DQSMRARVADFGLSRE  262 (432)
Q Consensus       234 iiH~dlkp~Nill------~~~~~~kl~Dfgl~~~  262 (432)
                      ++|+|+.+.|||+      +++..+.++||-+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4567799999998753

>2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B

Probab=94.00  E-value=0.027  Score=32.79  Aligned_cols=30  Identities=23%  Similarity=0.409  Sum_probs=23.2

Q ss_pred             CCCcceeeehhHHHHHHHHHHHHHHHHHhh
Q 014038            3 GESSGLIIGISIGVVIGVLLAISALFCFRY   32 (432)
Q Consensus         3 ~~~~~~ii~i~~~~~~~~~~~~~~~~~~~~   32 (432)
                      +.+.+.++||++|.+++.++++.++|++.|
T Consensus         3 ~L~~gaIaGIVvgdi~~t~~i~~~vy~~~r   32 (33)
T 2l34_A            3 TVSPGVLAGIVVGDLVLTVLIALAVYFLGR   32 (33)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             ccCcceEEeEeHHHHHHHHHHHHHHhheec
Confidence            356778899999999888877777777643

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.61  E-value=0.25  Score=42.74  Aligned_cols=117  Identities=9%  Similarity=0.105  Sum_probs=79.8

Q ss_pred             CCCccceEEeeeeeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCee
Q 014038          166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNIL  245 (432)
Q Consensus       166 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nil  245 (432)
                      .||++++. .+-.+.+...+.|+.-+.  ...+-.   -..++...+++++..|+....+++.     -+|--|.|+|++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~~---ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDN--HTPFDN---IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTT--SEEGGG---GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcc--cCCHHH---HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence            58888876 455555665555554432  222221   1347889999999999988766654     368889999999


Q ss_pred             ecCCCcEEEeecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCC
Q 014038          246 LDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG  314 (432)
Q Consensus       246 l~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~  314 (432)
                      ++.++.+++.-.|+-..                ++|.     .++...=.-.+=+++..+++++..|..
T Consensus       112 f~~~~~p~i~~RGik~~----------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNV----------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             ECTTSCEEESCCEETTT----------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             EcCCCCEEEEEccCccC----------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            99999999987775321                2232     123333334688899999999999864

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.37  E-value=0.83  Score=39.62  Aligned_cols=116  Identities=9%  Similarity=0.087  Sum_probs=78.6

Q ss_pred             CCCccceEEeeeeeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeeeccCCCCCe
Q 014038          166 HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLE-YLHDGAVPPVIHRDIKSSNI  244 (432)
Q Consensus       166 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~-yLH~~~~~~iiH~dlkp~Ni  244 (432)
                      .||++  -..+-.+++...+.|+.-+++.-...+     ..++...+++++..|+.... +++.     -+|--|.|+|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence            57887  333446667777777765444333333     24788899999998887666 5544     46888999999


Q ss_pred             eecCCCcEEEeecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCC
Q 014038          245 LLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG  314 (432)
Q Consensus       245 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~  314 (432)
                      ++|.++.++|.-.|+-.                -++|.-     .+..-=.-++=+++..++.++..|..
T Consensus       116 ~f~~~~~p~i~hRGi~~----------------~lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKE----------------SLPPDE-----WDDERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             EECTTCCEEESCCEETT----------------TBSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             EEeCCCcEEEEEcCCcc----------------cCCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            99999999998777532                233432     12222233678889999999888754

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=90.65  E-value=0.3  Score=30.39  Aligned_cols=24  Identities=25%  Similarity=0.286  Sum_probs=19.3

Q ss_pred             ceeeehhHHHHHHHHHHHHHHHHH
Q 014038            7 GLIIGISIGVVIGVLLAISALFCF   30 (432)
Q Consensus         7 ~~ii~i~~~~~~~~~~~~~~~~~~   30 (432)
                      +-..+|++|++.++++++++++.+
T Consensus         8 s~~~~IA~gVVgGv~~~~ii~~~~   31 (44)
T 2ks1_B            8 PKIPSIATGMVGALLLLLVVALGI   31 (44)
T ss_dssp             SCSSSSTHHHHHHHHHHHHHHHHH
T ss_pred             CCcceEEeehhHHHHHHHHHHHHH
Confidence            556678888888899999988863

>1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1

Probab=90.24  E-value=0.019  Score=33.69  Aligned_cols=8  Identities=38%  Similarity=0.775  Sum_probs=3.7

Q ss_pred             eeeehhHH
Q 014038            8 LIIGISIG   15 (432)
Q Consensus         8 ~ii~i~~~   15 (432)
                      .+++.++|
T Consensus         9 sIaagVvg   16 (35)
T 1iij_A            9 FIIATVVG   16 (35)
T ss_dssp             HHHHHHHH
T ss_pred             EeHHHHHH
Confidence            34444555

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=90.20  E-value=0.2  Score=30.74  Aligned_cols=14  Identities=36%  Similarity=0.627  Sum_probs=6.4

Q ss_pred             eeehhHHHHHHHHH
Q 014038            9 IIGISIGVVIGVLL   22 (432)
Q Consensus         9 ii~i~~~~~~~~~~   22 (432)
                      +.+|+++++.++++
T Consensus        12 ~~~I~~~vv~Gv~l   25 (41)
T 2k9y_A           12 NLAVIGGVAVGVVL   25 (41)
T ss_dssp             STHHHHHHHHHHHH
T ss_pred             eEEEEeehhHHHHH
Confidence            34445555544443

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=88.42  E-value=0.12  Score=31.86  Aligned_cols=19  Identities=37%  Similarity=0.562  Sum_probs=8.9

Q ss_pred             ceeeehhHHHHHHHHHHHH
Q 014038            7 GLIIGISIGVVIGVLLAIS   25 (432)
Q Consensus         7 ~~ii~i~~~~~~~~~~~~~   25 (432)
                      .+++++++|++++++++++
T Consensus        14 ~I~~~vv~Gv~ll~~iv~~   32 (41)
T 2k9y_A           14 AVIGGVAVGVVLLLVLAGV   32 (41)
T ss_dssp             HHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeehhHHHHHHHHHHHH
Confidence            3344555555554434433

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=88.38  E-value=0.05  Score=53.53  Aligned_cols=60  Identities=7%  Similarity=0.067  Sum_probs=17.6

Q ss_pred             ccccccccCceeEEEEEeCC-CcEEEE------EEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeee
Q 014038          116 FTTLIGQGAFGPVYKAQMST-GETVAV------KVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCA  178 (432)
Q Consensus       116 ~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  178 (432)
                      +.+.||   ||.||+|.+.. ..+|||      |......  ......|.+|..++..++|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345676   99999997753 357888      7665432  233356888999999999999999988754

>2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens}

Probab=86.54  E-value=0.71  Score=31.00  Aligned_cols=27  Identities=41%  Similarity=0.618  Sum_probs=12.1

Q ss_pred             hhHHHHHHHHHHH-H-HHHHHhhhccccC
Q 014038           12 ISIGVVIGVLLAI-S-ALFCFRYHRKRSQ   38 (432)
Q Consensus        12 i~~~~~~~~~~~~-~-~~~~~~~~r~~~~   38 (432)
                      |++|.++++++++ + +++|.++++++++
T Consensus        12 ivlGg~~~lll~~glcI~ccvkcrhRrrq   40 (70)
T 2klu_A           12 IVLGGVAGLLLFIGLGIFFSVRSRHRRRQ   40 (70)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHSSCCSSS
T ss_pred             HHHhHHHHHHHHHHHHHHHhhHHHHHHHH
Confidence            5555555444333 3 3335544444444

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=86.23  E-value=0.87  Score=28.25  Aligned_cols=34  Identities=21%  Similarity=0.255  Sum_probs=27.0

Q ss_pred             ceeeehhHHHHHHHHHHHHHHHHHhhhccccCCC
Q 014038            7 GLIIGISIGVVIGVLLAISALFCFRYHRKRSQIG   40 (432)
Q Consensus         7 ~~ii~i~~~~~~~~~~~~~~~~~~~~~r~~~~~~   40 (432)
                      +-.-+|+.|++.++++++++...++...||++..
T Consensus         7 s~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A            7 ARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             CSSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             CCcceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            3445677788888899999999999999988754

>1afo_A Glycophorin A; integral membrane protein, transmembrane helix interactions, membrane protein folding; NMR {Homo sapiens} SCOP: j.35.1.1 PDB: 2kpf_A

Probab=83.30  E-value=1.2  Score=26.46  Aligned_cols=32  Identities=28%  Similarity=0.194  Sum_probs=19.1

Q ss_pred             CCcceeeehhHHHHHHHHH-HHHHHHHHhhhcc
Q 014038            4 ESSGLIIGISIGVVIGVLL-AISALFCFRYHRK   35 (432)
Q Consensus         4 ~~~~~ii~i~~~~~~~~~~-~~~~~~~~~~~r~   35 (432)
                      ++...++.|+.|++.+++- ++++.+|.++-+|
T Consensus         7 fs~p~i~lII~~vmaGiIG~IllI~y~I~rl~K   39 (40)
T 1afo_A            7 FSEPEITLIIFGVMAGVIGTILLISYGIRRLIK   39 (40)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSC
T ss_pred             CCCchhHHHHHHHHHHHHHHHHHHHHHHHHHhh
Confidence            4455667777777776653 4444566665544

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=83.18  E-value=1.4  Score=27.23  Aligned_cols=31  Identities=19%  Similarity=0.139  Sum_probs=19.3

Q ss_pred             eeehhHHHHHHHHHHHHHHHHHhhhccccCC
Q 014038            9 IIGISIGVVIGVLLAISALFCFRYHRKRSQI   39 (432)
Q Consensus         9 ii~i~~~~~~~~~~~~~~~~~~~~~r~~~~~   39 (432)
                      +-.|+.+++.+++++++++.++.+.|||+..
T Consensus        11 ~~~Ia~~vVGvll~vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           11 LTSIISAVVGILLVVVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred             ccchHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence            3345555555444555666777888888763

>1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3

Probab=82.77  E-value=6.6  Score=36.22  Aligned_cols=134  Identities=13%  Similarity=0.084  Sum_probs=71.9

Q ss_pred             cccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeee---------------------
Q 014038          119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC---------------------  177 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~---------------------  177 (432)
                      ....| .+-||.+.. ++..|+||-.   .....+.|..++...-.+.-|+.- ++.+.                     
T Consensus        76 ~s~~G-stgvff~~t-d~~~~VVK~s---~~l~~E~l~s~LA~~LGlpiP~~R-iv~~~~~E~~e~~~~L~~~~~~~~~l  149 (342)
T 1cja_A           76 RSEKG-TEGLFFVET-ESGVFIVKRS---TNIESETFCSLLCMRLGLHAPKVR-VVSSNSEEGTNMLECLAAIDKSFRVI  149 (342)
T ss_dssp             ECCST-TSCEEEEEE-SSCEEEEECC---TTHHHHHHHHHHHHHHTCCCCCEE-EEESSSHHHHHHHHHHHHHCSSSCHH
T ss_pred             eccCC-CCCeEEEEe-CCCEEEEeCc---HHHHHHHHHHHHHHHhCCCCCCee-EEeeCcHHHHHHHHHHHHhhhhhHHH
Confidence            34445 455666655 5788999944   223344455555555555666532 22111                     


Q ss_pred             --eeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHH--HHHHHHHHhCCC-CCeee-ccCCCCCeeecCCCc
Q 014038          178 --AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDV--ARGLEYLHDGAV-PPVIH-RDIKSSNILLDQSMR  251 (432)
Q Consensus       178 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i--~~~l~yLH~~~~-~~iiH-~dlkp~Nill~~~~~  251 (432)
                        ...+..+++|+|.+|..|.+.-...-...+...    .+.++  +-++.++..+.. .|.+. .--.+.|||+++++.
T Consensus       150 ~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~----~~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~~n~  225 (342)
T 1cja_A          150 TTLANQANILLMELVRGITLNKLTTTSAPEVLTKS----TMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGA  225 (342)
T ss_dssp             HHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHH----HHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTT
T ss_pred             HHhhcccceehhhhcCCCccccchhhhhhhhcCHH----HHHhhchhheehhhhcCCccCcccccCCCChhheEEeCCCC
Confidence              012356799999997666543221100112222    23332  335666665542 12222 235789999977555


Q ss_pred             -EEEeecCCccc
Q 014038          252 -ARVADFGLSRE  262 (432)
Q Consensus       252 -~kl~Dfgl~~~  262 (432)
                       +.++|-+++..
T Consensus       226 ~~~~IDhn~af~  237 (342)
T 1cja_A          226 TVVPIDSKIIPL  237 (342)
T ss_dssp             CEEECSCCCCCC
T ss_pred             eEEEEcCCcccc
Confidence             88899988754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	432
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-73
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-69
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-69
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-68
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-67
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-66
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-66
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-66
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-66
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-66
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-65
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-65
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-64
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-63
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-63
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-62
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-62
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-62
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-62
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-62
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-61
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-61
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-61
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-59
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-59
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-57
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-57
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-56
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-55
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-54
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-54
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-53
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-51
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-51
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-51
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-51
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-50
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-49
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-49
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-49
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-49
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-48
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-48
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-48
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-47
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-47
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-46
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-46
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-44
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-44
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-43
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-43
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-41
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-38
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-38
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-38
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-35
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-30
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-22

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (582), Expect = 6e-73
 Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 22/272 (8%)

Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
            IG G+FG VYK +      VAVK+L     + Q  + F+ EV +L +  H N++  +GY
Sbjct: 15  RIGSGSFGTVYKGK--WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                Q  +V  +    SL  HL+            + IA   A+G++YLH      +IH
Sbjct: 73  S-TAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127

Query: 237 RDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRN---FT 290
           RD+KS+NI L + +  ++ DFGL+              + G+  ++ PE I  ++   ++
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187

Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
            +SDVY+FG++L+EL+ G+ P   +    ++  M   G       +   L  +       
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG------YLSPDLSKVRS-NCPK 240

Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
            +  L  +C+ +   +RP    I+  +  + +
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 2e-69
 Identities = 71/283 (25%), Positives = 120/283 (42%), Gaps = 26/283 (9%)

Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVM 160
           +P  + K +++        +G G FG V+    +    VAVK L   S      F  E  
Sbjct: 10  VPRETLKLVER--------LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEAN 60

Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           L+ +L H+ LV L      +    ++  +M  GSL   L   +   LT N  + +A  +A
Sbjct: 61  LMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119

Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGY 278
            G+ ++ +      IHRD++++NIL+  ++  ++ADFGL+R  E+         +    +
Sbjct: 120 EGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176

Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDS 338
             PE I+   FT KSDV+SFG+LL E++         M   E+            + ++ 
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-----------QNLER 225

Query: 339 RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL 381
               +       E+  L   C    P  RP+   +  VL    
Sbjct: 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 2e-69
 Identities = 69/270 (25%), Positives = 119/270 (44%), Gaps = 18/270 (6%)

Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
            F   IG G FG V+       + VA+K +  +    E++F  E  ++ +L H  LV L 
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLY 66

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E+    LV+ FM  G L+ +      G       + + LDV  G+ YL +     V
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACV 122

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
           IHRD+ + N L+ ++   +V+DFG++R   +     +   +    +  PE  S   ++ K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182

Query: 293 SDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEV 352
           SDV+SFGVL++E+ +            E+    + G   ++  + S             V
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS-----------THV 231

Query: 353 ASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
             +   C    P  RP+   +++ L+ I +
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  216 bits (551), Expect = 4e-68
 Identities = 76/308 (24%), Positives = 137/308 (44%), Gaps = 39/308 (12%)

Query: 104 YSYKDLQKATCNFTT-----------LIGQGAFGPVYKAQM----STGETVAVKVLATD- 147
           ++++D  +A   F             +IG G FG V    +         VA+K L +  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 148 SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPL 207
           +++  ++F +E  ++G+  H N+++L G   +    M++  FM  GSL      +N G  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQF 125

Query: 208 TWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR------ 261
           T    V +   +A G++YL D      +HRD+ + NIL++ ++  +V+DFGLSR      
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 262 EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVE 320
            +     A   +    +  PE I  R FT  SDV+S+G++++E+++ G  P   +     
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242

Query: 321 LAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           + A+            D RL    D      +  L   C  +    RP    IV  L ++
Sbjct: 243 INAIEQ----------DYRLPPPMDCPS--ALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290

Query: 381 LKMRHNRK 388
           ++  ++ K
Sbjct: 291 IRNPNSLK 298

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 2e-67
 Identities = 73/279 (26%), Positives = 122/279 (43%), Gaps = 25/279 (8%)

Query: 103 EYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLL 162
             + K+L+         IG+G FG V       G  VAVK +   +    + F  E  ++
Sbjct: 3   ALNMKELK-----LLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVM 54

Query: 163 GRLHHRNLVNLVGYCAE-KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
            +L H NLV L+G   E KG   +V  +M+KGSL  +L       L  +  +  +LDV  
Sbjct: 55  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114

Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDP 281
            +EYL        +HRD+ + N+L+ +   A+V+DFGL++E          +    +  P
Sbjct: 115 AMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVKWTAP 169

Query: 282 EYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD 341
           E +  + F+ KSDV+SFG+LL+E+ +        +   ++     +G          ++D
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------KMD 220

Query: 342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
                     V  +   C +     RPS   + + L  I
Sbjct: 221 APDGCPP--AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 1e-66
 Identities = 63/302 (20%), Positives = 122/302 (40%), Gaps = 40/302 (13%)

Query: 109 LQKATCNFTTL--IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQG-EKEFQTEVMLLGR 164
           ++    +F  +  +G G  G V+K     +G  +A K++  + K     +   E+ +L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 165 LHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLE 224
            +   +V   G     G+  +    M  GSL   L     G +   +   +++ V +GL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLT 118

Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYI 284
           YL +     ++HRD+K SNIL++     ++ DFG+S + ++D  A +  GT  Y+ PE +
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERL 175

Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSPLQG------------------------------ 314
              +++ +SD++S G+ L E+  GR P+                                
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235

Query: 315 -LMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDI 373
            L  Y   +          + IV+     +       E      KC+ + P +R  ++ +
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

Query: 374 VQ 375
           + 
Sbjct: 296 MV 297

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  212 bits (540), Expect = 2e-66
 Identities = 74/283 (26%), Positives = 128/283 (45%), Gaps = 23/283 (8%)

Query: 103 EYSYKDLQKATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVML 161
           E    D+          +G G +G VY+        TVAVK L  D+ + E EF  E  +
Sbjct: 13  EMERTDIT-----MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 66

Query: 162 LGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVAR 221
           +  + H NLV L+G C  +    ++  FM+ G+L  +L + N   ++  + +++A  ++ 
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126

Query: 222 GLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN--IRGTFGYL 279
            +EYL        IHRD+ + N L+ ++   +VADFGLSR    D + A+   +    + 
Sbjct: 127 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183

Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
            PE ++   F+ KSDV++FGVLL+E+          ++  ++            E+++  
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-----------ELLEKD 232

Query: 340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                      +V  L   C    P  RPS  +I Q    + +
Sbjct: 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 2e-66
 Identities = 69/293 (23%), Positives = 120/293 (40%), Gaps = 34/293 (11%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE 179
           IG+G FG V++ +   GE VAVK+ ++  ++     + E+     L H N++  +    +
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 180 KGQH----MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV---- 231
                    LV  +   GSL  +L   N   +T    + +AL  A GL +LH   V    
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125

Query: 232 -PPVIHRDIKSSNILLDQSMRARVADFGL-----SREEMVDKHAANIRGTFGYLDPEYIS 285
            P + HRD+KS NIL+ ++    +AD GL     S  + +D    +  GT  Y+ PE + 
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185

Query: 286 TRN------FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
                      K++D+Y+ G++ +E+    S      +Y              EE+    
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245

Query: 340 LDGIFD---------VEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM 383
            +              E L  +A +  +C       R +   I + LS++ + 
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (539), Expect = 4e-66
 Identities = 91/323 (28%), Positives = 147/323 (45%), Gaps = 41/323 (12%)

Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGET---VAVKVLATD-SKQGEKEFQT 157
           P   + D++     F  +IG+G FG V KA++         A+K +    SK   ++F  
Sbjct: 5   PVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG 59

Query: 158 EVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENY------------ 204
           E+ +L +L HH N++NL+G C  +G   L   +   G+L   L                 
Sbjct: 60  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 119

Query: 205 --GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262
               L+    +H A DVARG++YL        IHRD+ + NIL+ ++  A++ADFGLSR 
Sbjct: 120 TASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG 176

Query: 263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELA 322
           + V       R    ++  E ++   +T  SDV+S+GVLL+E+++        M   EL 
Sbjct: 177 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236

Query: 323 AMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
               +G          RL+   + ++  EV  L  +C    P +RPS   I+  L+R+L+
Sbjct: 237 EKLPQGY---------RLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285

Query: 383 MRH---NRKHHRKSQSTTADEVS 402
            R    N   + K      D  +
Sbjct: 286 ERKTYVNTTLYEKFTYAGIDCSA 308

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 4e-66
 Identities = 61/268 (22%), Positives = 113/268 (42%), Gaps = 18/268 (6%)

Query: 115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
            F   +G G FG V   +      VA+K++  +    E EF  E  ++  L H  LV L 
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLY 65

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C ++    ++  +M+ G L ++L +           + +  DV   +EYL        
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQF 121

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
           +HRD+ + N L++     +V+DFGLSR   +     +   +    +  PE +    F+ K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181

Query: 293 SDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEV 352
           SD+++FGVL++E+ +            E A           E +   L          +V
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETA-----------EHIAQGLRLYRPHLASEKV 230

Query: 353 ASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
            ++ Y C +    +RP+ + ++  +  +
Sbjct: 231 YTIMYSCWHEKADERPTFKILLSNILDV 258

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 2e-65
 Identities = 67/261 (25%), Positives = 112/261 (42%), Gaps = 23/261 (8%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
            +G+G FG VY A+   +   +A+KVL     +    E + + EV +   L H N++ L 
Sbjct: 13  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           GY  +  +  L+  +   G++   L  +               ++A  L Y H      V
Sbjct: 73  GYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHS---KRV 127

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
           IHRDIK  N+LL  +   ++ADFG S           + GT  YL PE I  R   +K D
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 186

Query: 295 VYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVAS 354
           ++S GVL +E + G+ P +    Y E     +  +  + + V                  
Sbjct: 187 LWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEFTFPDFVTE------------GARD 233

Query: 355 LAYKCVNRAPRKRPSMRDIVQ 375
           L  + +   P +RP +R++++
Sbjct: 234 LISRLLKHNPSQRPMLREVLE 254

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 2e-65
 Identities = 75/284 (26%), Positives = 116/284 (40%), Gaps = 26/284 (9%)

Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVM 160
           IP  S +   K        +GQG FG V+    +    VA+K L        + F  E  
Sbjct: 14  IPRESLRLEVK--------LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQ 64

Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           ++ +L H  LV L      +    +V  +MSKGSL   L  E    L     V +A  +A
Sbjct: 65  VMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 123

Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGY 278
            G+ Y+        +HRD++++NIL+ +++  +VADFGL+R  E+         +    +
Sbjct: 124 SGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180

Query: 279 LDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDS 338
             PE      FT KSDV+SFG+LL EL          M   E+            + V+ 
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-----------DQVER 229

Query: 339 RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
                   E    +  L  +C  + P +RP+   +   L     
Sbjct: 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  206 bits (525), Expect = 5e-64
 Identities = 68/281 (24%), Positives = 115/281 (40%), Gaps = 34/281 (12%)

Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE---KEFQT 157
           PE  + DL++        IG G+FG VY A+ +   E VA+K ++   KQ     ++   
Sbjct: 13  PEKLFSDLRE--------IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64

Query: 158 EVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIAL 217
           EV  L +L H N +   G    +    LV  +    +    L + +  PL       +  
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAAVTH 122

Query: 218 DVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFG 277
              +GL YLH      +IHRD+K+ NILL +    ++ DFG +    +   A +  GT  
Sbjct: 123 GALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSAS---IMAPANSFVGTPY 176

Query: 278 YLDPEYISTRN---FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEE 334
           ++ PE I   +   +  K DV+S G+   EL   + PL  +     L             
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----------YH 225

Query: 335 IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
           I  +    +          +    C+ + P+ RP+   +++
Sbjct: 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (521), Expect = 2e-63
 Identities = 76/279 (27%), Positives = 130/279 (46%), Gaps = 26/279 (9%)

Query: 115 NFTTLIGQGAFGPVYKAQM----STGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRN 169
           +F  +IG+G FG VY   +          AVK L   +  GE  +F TE +++    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 170 LVNLVGYCAE-KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           +++L+G C   +G  ++V  +M  G L + + +E     T    +   L VA+G+++L  
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS 148

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSR-----EEMVDKHAANIRGTFGYLDPEY 283
                 +HRD+ + N +LD+    +VADFGL+R     E     +    +    ++  E 
Sbjct: 149 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205

Query: 284 ISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI 343
           + T+ FT KSDV+SFGVLL+EL+   +P    +   ++     +G+         RL   
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---------RLLQP 256

Query: 344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
               +   +  +  KC +     RPS  ++V  +S I  
Sbjct: 257 EYCPD--PLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 2e-63
 Identities = 72/280 (25%), Positives = 117/280 (41%), Gaps = 26/280 (9%)

Query: 120 IGQGAFGPVYKAQM---STGETVAVKVLATDSKQGE--KEFQTEVMLLGRLHHRNLVNLV 174
           +G G FG V K         +TVAVK+L  ++       E   E  ++ +L +  +V ++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
           G C E    MLV      G L  +L       +     + +   V+ G++YL +      
Sbjct: 75  GIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNF 128

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSR----EEMVDKHAANIRGTFGYLDPEYISTRNFT 290
           +HRD+ + N+LL     A+++DFGLS+    +E   K   + +    +  PE I+   F+
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188

Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
            KSDV+SFGVL++E  +        M+  E+ AM  +G+         R+          
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---------RMGCPAGCPR-- 237

Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHH 390
           E+  L   C       RP    +   L        N  HH
Sbjct: 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH 277

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 9e-63
 Identities = 63/268 (23%), Positives = 113/268 (42%), Gaps = 23/268 (8%)

Query: 116 FTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVN 172
           F   IG+G+F  VYK     T   VA   L     +K   + F+ E  +L  L H N+V 
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 173 LVGYCAE----KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
                      K   +LV   M+ G+L ++L  + +  +   +       + +GL++LH 
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 229 GAVPPVIHRDIKSSNILL-DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
              PP+IHRD+K  NI +   +   ++ D GL+        A  + GT  ++ PE    +
Sbjct: 131 RT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMYEEK 188

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
            + +  DVY+FG+ + E+     P        ++          +  +        FD  
Sbjct: 189 -YDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----------YRRVTSGVKPASFDKV 237

Query: 348 ELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
            + EV  +   C+ +   +R S++D++ 
Sbjct: 238 AIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 1e-62
 Identities = 71/286 (24%), Positives = 124/286 (43%), Gaps = 32/286 (11%)

Query: 120 IGQGAFGPVYKAQM---STGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVG 175
           +G G FG V +           VA+KVL   +++ + +E   E  ++ +L +  +V L+G
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
            C +    MLV      G L   L  +    +  +    +   V+ G++YL +      +
Sbjct: 77  VC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFV 131

Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR----GTFGYLDPEYISTRNFTK 291
           HRD+ + N+LL     A+++DFGLS+    D      R        +  PE I+ R F+ 
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191

Query: 292 KSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
           +SDV+S+GV ++E ++ G+ P +  M+  E+ A   +GK         R++     E   
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKK-MKGPEVMAFIEQGK---------RME--CPPECPP 239

Query: 351 EVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM------RHNRKHH 390
           E+ +L   C       RP    + Q +             H+  HH
Sbjct: 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHHH 285

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 1e-62
 Identities = 81/326 (24%), Positives = 140/326 (42%), Gaps = 58/326 (17%)

Query: 96  VSASGIPEYSYKDLQKATCN-----------FTTLIGQGAFGPVYKA------QMSTGET 138
           V+ S   EY Y D ++   +           F  ++G GAFG V  A      +      
Sbjct: 10  VTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQ 69

Query: 139 VAVKVLATDSKQGEKE-FQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVYVFMSKGSLA 196
           VAVK+L   +   E+E   +E+ ++ +L  H N+VNL+G C   G   L++ +   G L 
Sbjct: 70  VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 129

Query: 197 SHLY---------------------DENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
           ++L                      +E+   LT+   +  A  VA+G+E+L        +
Sbjct: 130 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCV 186

Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAA---NIRGTFGYLDPEYISTRNFTKK 292
           HRD+ + N+L+      ++ DFGL+R+ M D +     N R    ++ PE +    +T K
Sbjct: 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246

Query: 293 SDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE 351
           SDV+S+G+LL+E+ + G +P  G+                  +++ +            E
Sbjct: 247 SDVWSYGILLWEIFSLGVNPYPGIPVDANF-----------YKLIQNGFKMDQPFYATEE 295

Query: 352 VASLAYKCVNRAPRKRPSMRDIVQVL 377
           +  +   C     RKRPS  ++   L
Sbjct: 296 IYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  202 bits (513), Expect = 2e-62
 Identities = 79/312 (25%), Positives = 135/312 (43%), Gaps = 48/312 (15%)

Query: 105 SYKDLQKATCNFTTL--IGQGAFGPVYKAQ------MSTGETVAVKVLATD-SKQGEKEF 155
               L+    N   +  IG+GAFG V++A+            VAVK+L  + S   + +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 156 QTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENY----------- 204
           Q E  L+    + N+V L+G CA      L++ +M+ G L   L   +            
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 205 -----------GPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR 253
                       PL+   ++ IA  VA G+ YL +      +HRD+ + N L+ ++M  +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180

Query: 254 VADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRS 310
           +ADFGLSR        K   N      ++ PE I    +T +SDV+++GV+L+E+ +   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 311 PLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSM 370
                M + E+             + D  +    +     E+ +L   C ++ P  RPS 
Sbjct: 241 QPYYGMAHEEV----------IYYVRDGNILACPE-NCPLELYNLMRLCWSKLPADRPSF 289

Query: 371 RDIVQVLSRILK 382
             I ++L R+ +
Sbjct: 290 CSIHRILQRMCE 301

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 2e-62
 Identities = 68/282 (24%), Positives = 119/282 (42%), Gaps = 31/282 (10%)

Query: 102 PEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVM 160
           PE  ++ + +        +G GAFG VYKAQ   T    A KV+ T S++  +++  E+ 
Sbjct: 10  PEDFWEIIGE--------LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEID 61

Query: 161 LLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVA 220
           +L    H N+V L+     +    ++  F + G++ + + +    PLT +    +     
Sbjct: 62  ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTL 120

Query: 221 RGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM-VDKHAANIRGTFGYL 279
             L YLHD     +IHRD+K+ NIL       ++ADFG+S +     +   +  GT  ++
Sbjct: 121 DALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 177

Query: 280 DPEYIST-----RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEE 334
            PE +       R +  K+DV+S G+ L E+     P   L     L            +
Sbjct: 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL-----------LK 226

Query: 335 IVDSRLDGIFDVEEL-NEVASLAYKCVNRAPRKRPSMRDIVQ 375
           I  S    +       +       KC+ +    R +   ++Q
Sbjct: 227 IAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 2e-62
 Identities = 74/295 (25%), Positives = 128/295 (43%), Gaps = 40/295 (13%)

Query: 119 LIGQGAFGPVYKAQM------STGETVAVKVLATDSKQGEKE-FQTEVMLLGRL-HHRNL 170
            +G GAFG V +A            TVAVK+L   +   E+E   +E+ +L  L +H N+
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 171 VNLVGYCAEKGQHMLVYVFMSKGSLASHLY----------------DENYGPLTWNLRVH 214
           VNL+G C   G  +++  +   G L + L                 +++   L     + 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 215 IALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH---AAN 271
            +  VA+G+ +L        IHRD+ + NILL      ++ DFGL+R+   D +     N
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG 331
            R    ++ PE I    +T +SDV+S+G+ L+EL +  S     M               
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---------- 256

Query: 332 WEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHN 386
           + +++      +       E+  +   C +  P KRP+ + IVQ++ + +    N
Sbjct: 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 4e-62
 Identities = 69/280 (24%), Positives = 129/280 (46%), Gaps = 25/280 (8%)

Query: 119 LIGQGAFGPVYKAQMSTGE-----TVAVKVLATDSKQGEK-EFQTEVMLLGRLHHRNLVN 172
           +IG G FG VYK  + T        VA+K L     + ++ +F  E  ++G+  H N++ 
Sbjct: 14  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L G  ++    M++  +M  G+       E  G  +    V +   +A G++YL +    
Sbjct: 74  LEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---M 129

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN----IRGTFGYLDPEYISTRN 288
             +HRD+ + NIL++ ++  +V+DFGLSR    D  A       +    +  PE IS R 
Sbjct: 130 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 189

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
           FT  SDV+SFG++++E++         +   E+            + ++        ++ 
Sbjct: 190 FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-----------KAINDGFRLPTPMDC 238

Query: 349 LNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRK 388
            + +  L  +C  +   +RP   DIV +L ++++   + K
Sbjct: 239 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK 278

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 2e-61
 Identities = 70/267 (26%), Positives = 118/267 (44%), Gaps = 22/267 (8%)

Query: 119 LIGQGAFGPVYKAQM-STGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
            IG G++G   K +  S G+ +  K L   + ++  ++   +EV LL  L H N+V    
Sbjct: 11  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70

Query: 176 YCAEKGQHML--VYVFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHD--G 229
              ++    L  V  +   G LAS +    +    L     + +   +   L+  H    
Sbjct: 71  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRN 288
               V+HRD+K +N+ LD     ++ DFGL+R    D   A    GT  Y+ PE ++  +
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS 190

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
           + +KSD++S G LL+EL A   P        ELA    EGK         R+   +    
Sbjct: 191 YNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGK-------FRRIPYRYS--- 239

Query: 349 LNEVASLAYKCVNRAPRKRPSMRDIVQ 375
            +E+  +  + +N     RPS+ +I++
Sbjct: 240 -DELNEIITRMLNLKDYHRPSVEEILE 265

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  199 bits (508), Expect = 5e-61
 Identities = 60/260 (23%), Positives = 110/260 (42%), Gaps = 16/260 (6%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
            +G GAFG V++    +TG   A K + T  +  ++  + E+  +  L H  LVNL    
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
            +  + +++Y FMS G L   + DE+   ++ +  V     V +GL ++H+      +H 
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHL 148

Query: 238 DIKSSNILL--DQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           D+K  NI+    +S   ++ DFGL+      +      GT  +  PE    +     +D+
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDM 208

Query: 296 YSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASL 355
           +S GVL + L++G SP  G     E            ++   S +          +    
Sbjct: 209 WSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGIS--------EDGKDF 259

Query: 356 AYKCVNRAPRKRPSMRDIVQ 375
             K +   P  R ++   ++
Sbjct: 260 IRKLLLADPNTRMTIHQALE 279

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 5e-61
 Identities = 68/287 (23%), Positives = 125/287 (43%), Gaps = 27/287 (9%)

Query: 91  KRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSK 149
           K  ++VS  G P+  Y   +K        IGQGA G VY A  ++TG+ VA++ +    +
Sbjct: 8   KLRSIVSV-GDPKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58

Query: 150 QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTW 209
             ++    E++++    + N+VN +       +  +V  +++ GSL   + +     +  
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDE 115

Query: 210 NLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-EMVDKH 268
                +  +  + LE+LH      VIHRDIKS NILL      ++ DFG   +       
Sbjct: 116 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172

Query: 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG 328
            + + GT  ++ PE ++ + +  K D++S G++  E+I G  P         L  + T G
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232

Query: 329 KTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                      L     +           +C++    KR S ++++Q
Sbjct: 233 T--------PELQNPEKLSA--IFRDFLNRCLDMDVEKRGSAKELLQ 269

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 3e-59
 Identities = 70/322 (21%), Positives = 133/322 (41%), Gaps = 32/322 (9%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL-----ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
           ++G GAFG VYK   +  GE V + V         S +  KE   E  ++  + + ++  
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L+G C       L+   M  G L  +   E+   +     ++  + +A+G+ YL D    
Sbjct: 76  LLGIC-LTSTVQLITQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNYLED---R 130

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRNF 289
            ++HRD+ + N+L+      ++ DFGL++    E  + HA   +    ++  E I  R +
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190

Query: 290 TKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL 349
           T +SDV+S+GV ++EL+   S     +   E++++  +G+         RL         
Sbjct: 191 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---------RLP--QPPICT 239

Query: 350 NEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDMEQAE 409
            +V  +  KC       RP  R+++   S++ +                 +  + +    
Sbjct: 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY-------LVIQGDERMHLPSPT 292

Query: 410 AKTPTSTHLREESVDSTADTYE 431
                   + EE +D   D  E
Sbjct: 293 DSNFYRALMDEEDMDDVVDADE 314

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 7e-59
 Identities = 66/263 (25%), Positives = 114/263 (43%), Gaps = 21/263 (7%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
            +G+GA+G V  A    T E VAVK++    +    +  + E+ +   L+H N+V   G+
Sbjct: 12  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
             E     L   + S G L   +  E    +           +  G+ YLH      + H
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITH 126

Query: 237 RDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDPEYISTRNF-TKK 292
           RDIK  N+LLD+    +++DFGL+        ++    + GT  Y+ PE +  R F  + 
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186

Query: 293 SDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEV 352
            DV+S G++L  ++AG  P     +  +  +   E KT         L+    ++     
Sbjct: 187 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--------YLNPWKKIDS--AP 236

Query: 353 ASLAYKCVNRAPRKRPSMRDIVQ 375
            +L +K +   P  R ++ DI +
Sbjct: 237 LALLHKILVENPSARITIPDIKK 259

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  191 bits (485), Expect = 1e-57
 Identities = 61/260 (23%), Positives = 116/260 (44%), Gaps = 16/260 (6%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
            +G GAFG V++    +TG     K + T     +   + E+ ++ +LHH  L+NL    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
            +K + +L+  F+S G L   +  E+Y  ++    ++       GL+++H+     ++H 
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHE---HSIVHL 151

Query: 238 DIKSSNILLDQSMRARV--ADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           DIK  NI+ +    + V   DFGL+ +   D+       T  +  PE +        +D+
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDM 211

Query: 296 YSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASL 355
           ++ GVL + L++G SP  G  + +E           ++E   S +          E    
Sbjct: 212 WAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFDEDAFSSVS--------PEAKDF 262

Query: 356 AYKCVNRAPRKRPSMRDIVQ 375
               + + PRKR ++ D ++
Sbjct: 263 IKNLLQKEPRKRLTVHDALE 282

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 3e-57
 Identities = 65/271 (23%), Positives = 114/271 (42%), Gaps = 23/271 (8%)

Query: 119 LIGQGAFGPVYKAQM----STGETVAVKVLATDSKQGEKE-FQTEVMLLGRLHHRNLVNL 173
            IG+G FG V++       +    VA+K     +    +E F  E + + +  H ++V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
           +G    +    ++    + G L S         L     +  A  ++  L YL       
Sbjct: 74  IGVI-TENPVWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTALAYLES---KR 128

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSR--EEMVDKHAANIRGTFGYLDPEYISTRNFTK 291
            +HRDI + N+L+  +   ++ DFGLSR  E+     A+  +    ++ PE I+ R FT 
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188

Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE 351
            SDV+ FGV ++E++         ++  ++      G+         RL    +      
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---------RLPMPPNCPP--T 237

Query: 352 VASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
           + SL  KC    P +RP   ++   LS IL+
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 4e-57
 Identities = 77/292 (26%), Positives = 117/292 (40%), Gaps = 36/292 (12%)

Query: 101 IPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQM----STGETVAVKVLATD---SKQGEK 153
           I E   + L+K        +G G+FG V + +         +VAVK L  D     +   
Sbjct: 5   IGEKDLRLLEK--------LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD 56

Query: 154 EFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRV 213
           +F  EV  +  L HRNL+ L G         +V      GSL   L     G        
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLS 114

Query: 214 HIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH----A 269
             A+ VA G+ YL        IHRD+ + N+LL      ++ DFGL R    +       
Sbjct: 115 RYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 171

Query: 270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEG 328
            + +  F +  PE + TR F+  SD + FGV L+E+   G+ P  GL     L  ++ EG
Sbjct: 172 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 231

Query: 329 KTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI 380
           +         RL    D  +  ++ ++  +C    P  RP+   +   L   
Sbjct: 232 E---------RLPRPEDCPQ--DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 5e-56
 Identities = 59/262 (22%), Positives = 111/262 (42%), Gaps = 25/262 (9%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           ++G+G+F  V  A+ ++T    A+K+L       +        E  ++ RL H   V L 
Sbjct: 15  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
               +  +      +   G L  ++     G            ++   LEYLH      +
Sbjct: 75  FTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHG---KGI 129

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTK 291
           IHRD+K  NILL++ M  ++ DFG ++    +     A +  GT  Y+ PE ++ ++  K
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189

Query: 292 KSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNE 351
            SD+++ G ++++L+AG  P +   EY+             ++I+    D  F  +   +
Sbjct: 190 SSDLWALGCIIYQLVAGLPPFRAGNEYLIF-----------QKIIKLEYD--FPEKFFPK 236

Query: 352 VASLAYKCVNRAPRKRPSMRDI 373
              L  K +     KR    ++
Sbjct: 237 ARDLVEKLLVLDATKRLGCEEM 258

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 6e-55
 Identities = 81/292 (27%), Positives = 137/292 (46%), Gaps = 41/292 (14%)

Query: 119 LIGQGAFGPVYKAQM--------STGETVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHR 168
            +G+GAFG V  A+         +    VAVK+L +D +++   +  +E+ ++  +  H+
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYD--------------ENYGPLTWNLRVH 214
           N++NL+G C + G   ++  + SKG+L  +L                     L+    V 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 215 IALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAAN 271
            A  VARG+EYL        IHRD+ + N+L+ +    ++ADFGL+R        K   N
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196

Query: 272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG 331
            R    ++ PE +  R +T +SDV+SFGVLL+E+          +   EL  +  EG   
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-- 254

Query: 332 WEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM 383
                  R+D        NE+  +   C +  P +RP+ + +V+ L RI+ +
Sbjct: 255 -------RMD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 3e-54
 Identities = 77/290 (26%), Positives = 133/290 (45%), Gaps = 39/290 (13%)

Query: 119 LIGQGAFGPVYKA------QMSTGETVAVKVLATDSKQGE-KEFQTEVMLLGR-LHHRNL 170
            +G+GAFG V +A      + +T  TVAVK+L   +   E +   +E+ +L    HH N+
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 171 VNLVGYCAEKGQH-MLVYVFMSKGSLASHLYDENY--------------GPLTWNLRVHI 215
           VNL+G C + G   M++  F   G+L+++L  +                  LT    +  
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 216 ALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK---HAANI 272
           +  VA+G+E+L        IHRD+ + NILL +    ++ DFGL+R+   D       + 
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196

Query: 273 RGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW 332
           R    ++ PE I  R +T +SDV+SFGVLL+E+ +  +     ++  E           +
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----------F 246

Query: 333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
              +              E+      C +  P +RP+  ++V+ L  +L+
Sbjct: 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 9e-54
 Identities = 50/300 (16%), Positives = 117/300 (39%), Gaps = 24/300 (8%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
            +G+G FG V++    S+ +T   K +       +   + E+ +L    HRN+++L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
               + ++++ F+S   +   + + +   L     V     V   L++LH      + H 
Sbjct: 71  ESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHF 126

Query: 238 DIKSSNILLDQSMRARV--ADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           DI+  NI+      + +   +FG +R+     +   +     Y  PE       +  +D+
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDM 186

Query: 296 YSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASL 355
           +S G L++ L++G +P        ++       +  ++E     +          E    
Sbjct: 187 WSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEIS--------IEAMDF 237

Query: 356 AYKCVNRAPRKRPSMRDIV------QVLSRIL-KMRHNRKHHRKSQSTTADEVSIDMEQA 408
             + + +  + R +  + +      Q + R+  K+    KH R   +    ++++ +  A
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAA 297

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  179 bits (454), Expect = 1e-53
 Identities = 59/263 (22%), Positives = 111/263 (42%), Gaps = 13/263 (4%)

Query: 115 NFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQG-EKEFQTEVMLLGRLHHRNLVN 172
           +F  ++G GAF  V  A+   T + VA+K +A  + +G E   + E+ +L ++ H N+V 
Sbjct: 12  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L       G   L+   +S G L   + ++  G  T      +   V   ++YLHD  + 
Sbjct: 72  LDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIV 129

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKK 292
               +        LD+  +  ++DFGLS+ E      +   GT GY+ PE ++ + ++K 
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189

Query: 293 SDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEV 352
            D +S GV+ + L+ G  P        +L     + +  ++      +         +  
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDIS--------DSA 240

Query: 353 ASLAYKCVNRAPRKRPSMRDIVQ 375
                  + + P KR +    +Q
Sbjct: 241 KDFIRHLMEKDPEKRFTCEQALQ 263

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 5e-53
 Identities = 59/281 (20%), Positives = 121/281 (43%), Gaps = 32/281 (11%)

Query: 120 IGQGAFGPVYKA------QMSTGETVAVKVL-ATDSKQGEKEFQTEVMLLGRLHHRNLVN 172
           +GQG+FG VY+       +      VA+K +    S +   EF  E  ++   +  ++V 
Sbjct: 28  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLY--------DENYGPLTWNLRVHIALDVARGLE 224
           L+G  ++    +++   M++G L S+L         +    P + +  + +A ++A G+ 
Sbjct: 88  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147

Query: 225 YLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR---EEMVDKHAANIRGTFGYLDP 281
           YL+       +HRD+ + N ++ +    ++ DFG++R   E    +          ++ P
Sbjct: 148 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204

Query: 282 EYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD 341
           E +    FT  SDV+SFGV+L+E+          +   ++             +++  L 
Sbjct: 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----------LRFVMEGGLL 254

Query: 342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
              D    + +  L   C    P+ RPS  +I+  +   ++
Sbjct: 255 DKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 2e-51
 Identities = 58/266 (21%), Positives = 103/266 (38%), Gaps = 22/266 (8%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGY 176
           ++G G  G V +     T E  A+K+L     Q   + + EV L  R     ++V +V  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73

Query: 177 C----AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
                A +   ++V   +  G L S + D      T      I   +   ++YLH   + 
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI- 132

Query: 233 PVIHRDIKSSNILLD---QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNF 289
              HRD+K  N+L      +   ++ DFG ++E            T  Y+ PE +    +
Sbjct: 133 --AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 190

Query: 290 TKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL 349
            K  D++S GV+++ L+ G  P            M T  + G  E  +     + +    
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE---- 246

Query: 350 NEVASLAYKCVNRAPRKRPSMRDIVQ 375
            EV  L    +   P +R ++ + + 
Sbjct: 247 -EVKMLIRNLLKTEPTQRMTITEFMN 271

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 2e-51
 Identities = 66/262 (25%), Positives = 117/262 (44%), Gaps = 24/262 (9%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQT----EVMLLGRLHHRNLVNL 173
           ++G+G+FG V+ A+   T +  A+K L  D    + + +     + +L     H  L ++
Sbjct: 9   MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68

Query: 174 VGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPP 233
                 K     V  +++ G L  H+  ++      +     A ++  GL++LH      
Sbjct: 69  FCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHS---KG 123

Query: 234 VIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN-IRGTFGYLDPEYISTRNFTKK 292
           +++RD+K  NILLD+    ++ADFG+ +E M+     N   GT  Y+ PE +  + +   
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 183

Query: 293 SDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEV 352
            D +SFGVLL+E++ G+SP  G  +  EL          +   ++             E 
Sbjct: 184 VDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPFYPRWLEK------------EA 230

Query: 353 ASLAYKCVNRAPRKRPSMRDIV 374
             L  K   R P KR  +R  +
Sbjct: 231 KDLLVKLFVREPEKRLGVRGDI 252

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  171 bits (435), Expect = 4e-51
 Identities = 62/276 (22%), Positives = 112/276 (40%), Gaps = 27/276 (9%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE---KEFQTEVMLLGRLHHRNLVNLV 174
           ++G G    V+ A+ +     VAVKVL  D  +       F+ E      L+H  +V + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 175 GYCAEK----GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA 230
                +        +V  ++   +L   ++    GP+T    + +  D  + L + H   
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQ-- 129

Query: 231 VPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD----KHAANIRGTFGYLDPEYIST 286
              +IHRD+K +NI++  +   +V DFG++R            A + GT  YL PE    
Sbjct: 130 -NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188

Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV 346
            +   +SDVYS G +L+E++ G  P  G    V +A  +              L      
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPPSARHEGLS----- 242

Query: 347 EELNEVASLAYKCVNRAPRKRP-SMRDIVQVLSRIL 381
               ++ ++  K + + P  R  +  ++   L R+ 
Sbjct: 243 ---ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  171 bits (433), Expect = 8e-51
 Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 31/274 (11%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL---------ATDSKQGEKEFQTEVMLLGRLH-H 167
           ++G+G    V +     T +  AVK++         A + ++  +    EV +L ++  H
Sbjct: 10  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69

Query: 168 RNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLH 227
            N++ L           LV+  M KG L  +L       L+      I   +   +  LH
Sbjct: 70  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICALH 127

Query: 228 DGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST- 286
                 ++HRD+K  NILLD  M  ++ DFG S +    +    + GT  YL PE I   
Sbjct: 128 K---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184

Query: 287 -----RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD 341
                  + K+ D++S GV+++ L+AG  P     + + +  M   G   +         
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYS 243

Query: 342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                   + V  L  + +   P+KR +  + + 
Sbjct: 244 --------DTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 7e-50
 Identities = 74/359 (20%), Positives = 131/359 (36%), Gaps = 48/359 (13%)

Query: 91  KRSNVVSASGIP-----EYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVL 144
           K + VV+  G       E SY D +        +IG G+FG VY+A+   +GE VA+K +
Sbjct: 2   KVTTVVATPGQGPDRPQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKV 53

Query: 145 ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM------LVYVFMSKGSLASH 198
                Q ++    E+ ++ +L H N+V L  +    G+        LV  ++ +      
Sbjct: 54  ----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109

Query: 199 L-YDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVAD 256
             Y      L           + R L Y+H      + HRDIK  N+LLD  +   ++ D
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCD 166

Query: 257 FGLSREEMVDKHAANIRGTFGYLDP-EYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGL 315
           FG +++ +  +   +   +  Y  P       ++T   DV+S G +L EL+ G+    G 
Sbjct: 167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

Query: 316 MEYVELAAMNTEGKTGWEE----------------IVDSRLDGIFDVEELNEVASLAYKC 359
               +L  +     T   E                I       +F      E  +L  + 
Sbjct: 227 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRL 286

Query: 360 VNRAPRKRPSMRDIVQVLSRILKMRHNRKHHRKSQSTTADEVSIDMEQAEAKTPTSTHL 418
           +   P  R +  +             +      +   T    +   ++  +  P +T L
Sbjct: 287 LEYTPTARLTPLEACA--HSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATIL 343

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  169 bits (428), Expect = 1e-49
 Identities = 65/272 (23%), Positives = 117/272 (43%), Gaps = 29/272 (10%)

Query: 104 YSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVLATD---SKQGEKEFQTEV 159
           YS +D Q         +G G+FG V+  +    G   A+KVL  +     +  +    E 
Sbjct: 1   YSLQDFQ-----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 55

Query: 160 MLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDV 219
           ++L  + H  ++ + G   +  Q  ++  ++  G L S L      P    +    A +V
Sbjct: 56  LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP--NPVAKFYAAEV 113

Query: 220 ARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYL 279
              LEYLH      +I+RD+K  NILLD++   ++ DFG ++   V      + GT  Y+
Sbjct: 114 CLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYTLCGTPDYI 168

Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR 339
            PE +ST+ + K  D +SFG+L++E++AG +P       ++        +  +    +  
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAELRFPPFFNE- 226

Query: 340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMR 371
                      +V  L  + + R   +R    
Sbjct: 227 -----------DVKDLLSRLITRDLSQRLGNL 247

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 4e-49
 Identities = 64/281 (22%), Positives = 107/281 (38%), Gaps = 28/281 (9%)

Query: 120 IGQGAFGPVYKAQ--MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRL---HHRNLVN 172
           IG+GA+G V+KA+   + G  VA+K +   T  +        EV +L  L    H N+V 
Sbjct: 15  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74

Query: 173 LVGYCAEKGQHMLVYVFM----SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           L   C          + +        L ++L       +       +   + RGL++LH 
Sbjct: 75  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRN 288
                V+HRD+K  NIL+  S + ++ADFGL+R         ++  T  Y  PE +   +
Sbjct: 135 ---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 191

Query: 289 FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM----NTEGKTGWEEIVDSRLDGIF 344
           +    D++S G +  E+   +   +G  +  +L  +       G+  W   V        
Sbjct: 192 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH 251

Query: 345 DVEELN----------EVASLAYKCVNRAPRKRPSMRDIVQ 375
                               L  KC+   P KR S    + 
Sbjct: 252 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  168 bits (426), Expect = 6e-49
 Identities = 66/263 (25%), Positives = 109/263 (41%), Gaps = 28/263 (10%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL---ATDSKQGEKEFQTEVM---LLGRLHHRNLV 171
           +IG+G FG VY  +   TG+  A+K L       KQGE     E +   L+       +V
Sbjct: 11  IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70

Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            +        +   +   M+ G L  HL    +G  +       A ++  GLE++H+   
Sbjct: 71  CMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHMHN--- 125

Query: 232 PPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST-RNFT 290
             V++RD+K +NILLD+    R++D GL+  +   K      GT GY+ PE +     + 
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYD 184

Query: 291 KKSDVYSFGVLLFELIAGRSPLQG--LMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE 348
             +D +S G +LF+L+ G SP +     +  E+  M         +              
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP---------- 234

Query: 349 LNEVASLAYKCVNRAPRKRPSMR 371
             E+ SL    + R   +R    
Sbjct: 235 --ELRSLLEGLLQRDVNRRLGCL 255

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 7e-49
 Identities = 67/280 (23%), Positives = 116/280 (41%), Gaps = 28/280 (10%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE-----FQTEVMLLGRLHHRNLVN 172
            +G+G F  VYKA+  +T + VA+K +    +   K+        E+ LL  L H N++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 173 LVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVP 232
           L+     K    LV+ FM        +  +N   LT +      L   +GLEYLH     
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---H 119

Query: 233 PVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIR-GTFGYLDPEYIST-RNFT 290
            ++HRD+K +N+LLD++   ++ADFGL++       A   +  T  Y  PE +   R + 
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM----NTEGKTGWEEIVDSRLDGIFDV 346
              D+++ G +L EL+     L G  +  +L  +     T  +  W ++        F  
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 347 EEL-----------NEVASLAYKCVNRAPRKRPSMRDIVQ 375
                         +++  L        P  R +    ++
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-48
 Identities = 62/268 (23%), Positives = 109/268 (40%), Gaps = 25/268 (9%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE------KEFQTEVMLLGRLHHRNLV 171
            +G G F  V K +  STG   A K +     +        ++ + EV +L  + H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 172 NLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAV 231
            L      K   +L+   ++ G L   L       LT          +  G+ YLH    
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHS--- 131

Query: 232 PPVIHRDIKSSNILLDQ----SMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTR 287
             + H D+K  NI+L        R ++ DFGL+ +        NI GT  ++ PE ++  
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
               ++D++S GV+ + L++G SP  G     E  A  +     +E+   S         
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTS------ 244

Query: 348 ELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                     + + + P+KR +++D +Q
Sbjct: 245 --ALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (417), Expect = 2e-48
 Identities = 52/276 (18%), Positives = 103/276 (37%), Gaps = 23/276 (8%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
            IG G+FG +Y    ++ GE VA+K+    +K    +   E  +   +     +  + +C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
             +G + ++ + +   SL   L++      +    + +A  +   +EY+H       IHR
Sbjct: 72  GAEGDYNVMVMELLGPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHR 127

Query: 238 DIKSSNIL---LDQSMRARVADFGLSR--------EEMVDKHAANIRGTFGYLDPEYIST 286
           D+K  N L     +     + DFGL++        + +  +   N+ GT  Y        
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187

Query: 287 RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV 346
              +++ D+ S G +L     G  P QGL    +        +      ++    G    
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPS- 246

Query: 347 EELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
               E A+    C +     +P    + Q+   +  
Sbjct: 247 ----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  163 bits (413), Expect = 8e-48
 Identities = 49/278 (17%), Positives = 101/278 (36%), Gaps = 25/278 (8%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
            IG+G+FG +++   +   + VA+K      +    + + E      L     +  V Y 
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
            ++G H ++ + +  G     L D      +       A  +   ++ +H+     +++R
Sbjct: 70  GQEGLHNVLVIDL-LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYR 125

Query: 238 DIKSSNILLDQSMR-----ARVADFGLSR--------EEMVDKHAANIRGTFGYLDPEYI 284
           DIK  N L+ +          V DFG+ +        + +  +   N+ GT  Y+     
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185

Query: 285 STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF 344
             R  +++ D+ + G +    + G  P QGL            G+      +     G  
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP 245

Query: 345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK 382
           +     E     +   N A    P    +  + S++L+
Sbjct: 246 E-----EFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  162 bits (410), Expect = 2e-47
 Identities = 66/276 (23%), Positives = 117/276 (42%), Gaps = 25/276 (9%)

Query: 120 IGQGAFGPVYKAQMSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
           IG+G +G VYKAQ + GET A+K +    + +        E+ +L  L H N+V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69

Query: 178 AEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHR 237
             K + +LV+  + +      L D   G L         L +  G+ Y HD     V+HR
Sbjct: 70  HTKKRLVLVFEHLDQDLK--KLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHR 124

Query: 238 DIKSSNILLDQSMRARVADFGLSREEMVD--KHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           D+K  N+L+++    ++ADFGL+R   +   K+   I   +       + ++ ++   D+
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184

Query: 296 YSFGVLLFELIAGRSPLQGLMEYVELAAM----NTEGKTGWEEIVD-SRLDGIFDVEEL- 349
           +S G +  E++ G     G+ E  +L  +     T     W  + +  + D  F V E  
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL 244

Query: 350 ----------NEVASLAYKCVNRAPRKRPSMRDIVQ 375
                          L  K +   P +R + +  ++
Sbjct: 245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 4e-47
 Identities = 64/268 (23%), Positives = 104/268 (38%), Gaps = 35/268 (13%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE------FQTEVMLLGRLH--HRN 169
           L+G G FG VY    +S    VA+K +  D      E         EV+LL ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           ++ L+ +       +L+               E  G L   L       V   + + H+ 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHN- 128

Query: 230 AVPPVIHRDIKSSNILLDQS-MRARVADFGLSREEMVDKHAANIRGTFGYLDPEYIST-R 287
               V+HRDIK  NIL+D +    ++ DFG     + D    +  GT  Y  PE+I   R
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWIRYHR 185

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
              + + V+S G+LL++++ G  P +                   EEI+  ++   F   
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFE-----------------HDEEIIRGQV--FFRQR 226

Query: 348 ELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
             +E   L   C+   P  RP+  +I  
Sbjct: 227 VSSECQHLIRWCLALRPSDRPTFEEIQN 254

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-46
 Identities = 66/284 (23%), Positives = 118/284 (41%), Gaps = 27/284 (9%)

Query: 115 NFTTL--IGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRN 169
           NF  +  IG+G +G VYKA+   TGE VA+K +   T+++        E+ LL  L+H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           +V L+     + +  LV+ F+ +      +       +   L       + +GL + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPE-YISTR 287
               V+HRD+K  N+L++     ++ADFGL+R   V  +   +   T  Y  PE  +  +
Sbjct: 121 --HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 288 NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE 347
            ++   D++S G +  E++  R+   G  E  +L  +     T  E +            
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238

Query: 348 EL----------------NEVASLAYKCVNRAPRKRPSMRDIVQ 375
                              +  SL  + ++  P KR S +  + 
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 3e-46
 Identities = 60/283 (21%), Positives = 113/283 (39%), Gaps = 29/283 (10%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGE-KEFQTEVMLLGRLHHRNLVNLVGY 176
            IG+GA+G V  A        VA+K ++    Q   +    E+ +L R  H N++ +   
Sbjct: 15  YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDE-NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
                   +  V++    + + LY       L+ +   +    + RGL+Y+H      V+
Sbjct: 75  IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 131

Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTF----GYLDPEYIST-RNFT 290
           HRD+K SN+LL+ +   ++ DFGL+R    D         +     Y  PE +   + +T
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 191

Query: 291 KKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN 350
           K  D++S G +L E+++ R    G     +L  +     +  +E ++  ++       L+
Sbjct: 192 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 251

Query: 351 ------------------EVASLAYKCVNRAPRKRPSMRDIVQ 375
                             +   L  K +   P KR  +   + 
Sbjct: 252 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 1e-44
 Identities = 64/267 (23%), Positives = 109/267 (40%), Gaps = 25/267 (9%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLV 174
           L+G+G FG V   +  +TG   A+K+L  +   +K       TE  +L    H  L  L 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 175 GYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
                  +   V  + + G L  HL        T         ++   LEYLH      V
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHS---RDV 126

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAANIRGTFGYLDPEYISTRNFTKKS 293
           ++RDIK  N++LD+    ++ DFGL +E + D        GT  YL PE +   ++ +  
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186

Query: 294 DVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVA 353
           D +  GV+++E++ GR P     ++  L  +    +  +   +              E  
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSP------------EAK 233

Query: 354 SLAYKCVNRAPRKRPSM--RDIVQVLS 378
           SL    + + P++R      D  +V+ 
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVME 260

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  155 bits (393), Expect = 3e-44
 Identities = 59/253 (23%), Positives = 102/253 (40%), Gaps = 24/253 (9%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKE---FQTEVMLLGRLHHRNLVNLVG 175
           +G G+FG V   +   +G   A+K+L        K+      E  +L  ++   LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 176 YCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVI 235
              +     +V  +++ G + SHL     G  +       A  +    EYLH      +I
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163

Query: 236 HRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDV 295
           +RD+K  N+L+DQ    +V DFG ++          + GT   L PE I ++ + K  D 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEALAPEIILSKGYNKAVDW 221

Query: 296 YSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASL 355
           ++ GVL++E+ AG  P     + +++      GK  +     S            ++  L
Sbjct: 222 WALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVRFPSHFSS------------DLKDL 268

Query: 356 AYKCVNRAPRKRP 368
               +     KR 
Sbjct: 269 LRNLLQVDLTKRF 281

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 3e-43
 Identities = 56/278 (20%), Positives = 104/278 (37%), Gaps = 27/278 (9%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           IG+G +G V+KA+   T E VA+K +    D +        E+ LL  L H+N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIH 236
                +  LV+ F  +       +D   G L   +       + +GL + H      V+H
Sbjct: 70  LHSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLH 124

Query: 237 RDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN--IRGTFGYLDPEYISTRNFTKKSD 294
           RD+K  N+L++++   ++A+FGL+R   +     +  +   +          + ++   D
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184

Query: 295 VYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN---- 350
           ++S G +  EL     PL    +  +             E     +  + D +       
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244

Query: 351 -------------EVASLAYKCVNRAPRKRPSMRDIVQ 375
                            L    +   P +R S  + +Q
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 6e-43
 Identities = 68/292 (23%), Positives = 114/292 (39%), Gaps = 41/292 (14%)

Query: 120 IGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGY 176
           IGQG FG V+KA+   TG+ VA+K +    + +        E+ +L  L H N+VNL+  
Sbjct: 18  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77

Query: 177 CAE--------KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
           C          KG   LV+ F         L        T +    +   +  GL Y+H 
Sbjct: 78  CRTKASPYNRCKGSIYLVFDFCEHDLA--GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSR-----EEMVDKHAANIRGTFGYLDPEY 283
                ++HRD+K++N+L+ +    ++ADFGL+R     +        N   T  Y  PE 
Sbjct: 136 ---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192

Query: 284 I-STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAM----NTEGKTGWEEIVDS 338
           +   R++    D++  G ++ E+      +QG  E  +LA +     +     W  + + 
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252

Query: 339 RL---------------DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
            L               D +           L  K +   P +R    D + 
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 4e-41
 Identities = 68/312 (21%), Positives = 122/312 (39%), Gaps = 37/312 (11%)

Query: 88  EGFKRSNVVSASGIPEYSYKDLQKATCNFTTLIGQGAFGPVYKAQ-MSTGETVAVKVL-- 144
            GF R  V   +      Y+DLQ         +G GA+G V  A    TG  VA+K L  
Sbjct: 2   SGFYRQEVTKTAWEVRAVYRDLQP--------VGSGAYGAVCSAVDGRTGAKVAIKKLYR 53

Query: 145 ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDE-- 202
              S+   K    E+ LL  + H N++ L+              F            +  
Sbjct: 54  PFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM 113

Query: 203 NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE 262
            +  L  +    +   + +GL Y+H      +IHRD+K  N+ +++    ++ DFGL+R+
Sbjct: 114 KHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170

Query: 263 EMVDKHAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVEL 321
              D        T  Y  PE I +   +T+  D++S G ++ E+I G++  +G     +L
Sbjct: 171 --ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 228

Query: 322 AAMNTEGKTGWEEIVD--------SRLDGIFDVEELN----------EVASLAYKCVNRA 363
             +     T   E V         + + G+ ++E+ +             +L  K +   
Sbjct: 229 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLD 288

Query: 364 PRKRPSMRDIVQ 375
             +R +  + + 
Sbjct: 289 AEQRVTAGEALA 300

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 1e-38
 Identities = 66/341 (19%), Positives = 122/341 (35%), Gaps = 48/341 (14%)

Query: 102 PEYSYKDLQKATCNFT------TLIGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGE 152
           P +  ++L K            + +G GA+G V  A    TG  VAVK L     S    
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61

Query: 153 KEFQTEVMLLGRLHHRNLVNLVGYCAEKGQ----HMLVYVFMSKGSLASHLYDENYGPLT 208
           K    E+ LL  + H N++ L+            + +  V    G+  +++       LT
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLT 119

Query: 209 WNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH 268
            +    +   + RGL+Y+H      +IHRD+K SN+ +++    ++ DFGL+R    D+ 
Sbjct: 120 DDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-TDDEM 175

Query: 269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG 328
              +   +       ++  ++ +  D++S G ++ EL+ GR+   G     +L  +    
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

Query: 329 KTGWEEIVDSRLDGIFDVEELN------------------EVASLAYKCVNRAPRKRPSM 370
            T   E++             +                      L  K +     KR + 
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295

Query: 371 RDIVQVLSRILKMRHN--RKHHRKSQSTTADEVSIDMEQAE 409
                       + H    ++H       AD      E  +
Sbjct: 296 AQA---------LAHAYFAQYHDPDDEPVADPYDQSFESRD 327

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  139 bits (351), Expect = 2e-38
 Identities = 50/288 (17%), Positives = 107/288 (37%), Gaps = 42/288 (14%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGY 176
            +G+G +  V++A  ++  E V VK+L       +K+ + E+ +L  L    N++ L   
Sbjct: 42  KLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLADI 98

Query: 177 CAEKGQHMLVYVF--MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
             +        VF  ++            Y  LT         ++ + L+Y H      +
Sbjct: 99  VKDPVSRTPALVFEHVNNTDFKQL-----YQTLTDYDIRFYMYEILKALDYCHS---MGI 150

Query: 235 IHRDIKSSNILLD-QSMRARVADFGLSREEMVDKHAANIRGTFGYLDPE-YISTRNFTKK 292
           +HRD+K  N+++D +  + R+ D+GL+      +       +  +  PE  +  + +   
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYS 210

Query: 293 SDVYSFGVLLFELIAGRSPLQGLMEYVELAAM--NTEGKTGWEEIVDS------------ 338
            D++S G +L  +I  + P     +  +         G     + +D             
Sbjct: 211 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI 270

Query: 339 -------RLDGIFDVEELNEVASLAY----KCVNRAPRKRPSMRDIVQ 375
                  R +     E  + V+  A     K +    + R + R+ ++
Sbjct: 271 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 7e-38
 Identities = 65/266 (24%), Positives = 108/266 (40%), Gaps = 27/266 (10%)

Query: 119 LIGQGAFGPVYKAQ----MSTGETVAVKVL----ATDSKQGEKEFQTEVMLLGRL-HHRN 169
           ++G GA+G V+  +      TG+  A+KVL         +  +  +TE  +L  +     
Sbjct: 31  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90

Query: 170 LVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDG 229
           LV L      + +  L+  +++ G L +HL        T +       ++   LE+LH  
Sbjct: 91  LVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK- 147

Query: 230 AVPPVIHRDIKSSNILLDQSMRARVADFGLSRE--EMVDKHAANIRGTFGYLDPEYIST- 286
               +I+RDIK  NILLD +    + DFGLS+E      + A +  GT  Y+ P+ +   
Sbjct: 148 --LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205

Query: 287 -RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD 345
                K  D +S GVL++EL+ G SP     E    A ++                    
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA---- 261

Query: 346 VEELNEVASLAYKCVNRAPRKRPSMR 371
                    L  + + + P+KR    
Sbjct: 262 -----LAKDLIQRLLMKDPKKRLGCG 282

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-35
 Identities = 57/290 (19%), Positives = 109/290 (37%), Gaps = 36/290 (12%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVL--ATDSKQGEKEFQTEVMLLGRLHHRNLVNLVG 175
            IG GA G V  A        VA+K L     ++   K    E++L+  ++H+N+++L+ 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 176 YCAEKGQHMLV-YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPV 234
               +        V++    + ++L       L      ++   +  G+++LH      +
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGI 140

Query: 235 IHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSD 294
           IHRD+K SNI++      ++ DFGL+R             T  Y  PE I    + +  D
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 200

Query: 295 VYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVD----------------- 337
           ++S G ++ E++  +    G     +   +  +  T   E +                  
Sbjct: 201 IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA 260

Query: 338 ------------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ 375
                          D   +  + ++   L  K +   P KR S+ D +Q
Sbjct: 261 GLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  118 bits (297), Expect = 1e-30
 Identities = 58/311 (18%), Positives = 107/311 (34%), Gaps = 57/311 (18%)

Query: 119 LIGQGAFGPVYKAQ-MSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYC 177
            +G G F  V+ A+ M     VA+K++  D K   +  + E+ LL R++  +        
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 178 A--------------EKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGL 223
           A                G H+++   +   +L + +    +  +       I+  +  GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 224 EYLHDGAVPPVIHRDIKSSNILLDQS----MRARVADFGLSREEMVDKHAANIRGTFGYL 279
           +Y+H      +IH DIK  N+L++         ++    L      D+H  N   T  Y 
Sbjct: 139 DYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 280 DPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQG------------------------- 314
            PE +    +   +D++S   L+FELI G    +                          
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256

Query: 315 -LMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV---------EELNEVASLAYKCVNRAP 364
            L+   +        +     I   +   + DV         +E  E++      +   P
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316

Query: 365 RKRPSMRDIVQ 375
           RKR     +V 
Sbjct: 317 RKRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 91.8 bits (227), Expect = 3e-22
 Identities = 31/196 (15%), Positives = 58/196 (29%), Gaps = 35/196 (17%)

Query: 119 LIGQGAFGPVYKAQMSTGETVAVKVLATDS----------KQGEKEFQTEVMLLGRLHHR 168
           L+G+G    V+           VK                  G+  F    +   R   R
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 169 NLVNLVGYCAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD 228
            L  L G          VY +     L   +  +    +       +   +   +   + 
Sbjct: 67  ALQKLQGLA-----VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121

Query: 229 GAVPPVIHRDIKSSNILLDQSMRARVADFGLSRE-------EMVDKHAANIRGTFGYLDP 281
                ++H D+   N+L+ +     + DF  S E       E++++   NI   F     
Sbjct: 122 ---RGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS---- 173

Query: 282 EYISTRNFTKKSDVYS 297
                R +  + D+ S
Sbjct: 174 -----RTYRTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	432
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.66
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.2
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.8
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.24
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.11
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.78
d1cjaa_	342	Actin-fragmin kinase, catalytic domain {Physarum p	81.4

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=414.74  Aligned_cols=253  Identities=28%  Similarity=0.480  Sum_probs=202.9

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      .+.+.+.||+|+||+||+|.+.+++.||||++.... ...++|.+|+.++++++|||||+++|+|.+.+..++||||+++
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~   84 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   84 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence            456788999999999999999888999999997543 3456899999999999999999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--ccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAA  270 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~  270 (432)
                      |+|.+++... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        85 g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  160 (263)
T d1sm2a_          85 GCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  160 (263)
T ss_dssp             CBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence            9999988643 356899999999999999999999999   9999999999999999999999999997643332  223


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ...||+.|+|||++.+..|+.++|||||||++|||+| |++||................            ....+...+
T Consensus       161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~------------~~~~p~~~~  228 (263)
T d1sm2a_         161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------------RLYKPRLAS  228 (263)
T ss_dssp             ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC------------CCCCCTTSC
T ss_pred             ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC------------CCCCccccC
Confidence            4578999999999999999999999999999999999 566665543322222221111            111122234


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      .++.+++.+||+.||++|||+++|++.|+++.+
T Consensus       229 ~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         229 THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            578999999999999999999999999999865

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-56  Score=420.12  Aligned_cols=255  Identities=28%  Similarity=0.502  Sum_probs=202.0

Q ss_pred             hccccccccccCceeEEEEEeC-CC---cEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TG---ETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      .+.+.+.||+|+||+||+|... ++   ..||||.+... .....+.|.+|+.+|++++|||||+++|+|.+.+..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            3455678999999999999764 23   26899998654 4445578999999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      |||++|+|.+++.. ..+.++|..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus       107 Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         107 EFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             ECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            99999999998864 3457999999999999999999999998   9999999999999999999999999997543221


Q ss_pred             c------ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          268 H------AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       268 ~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .      .....||+.|||||.+.++.|+.++|||||||++|||+| |+.||.+.............            .
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~------------~  250 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD------------Y  250 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT------------C
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------C
Confidence            1      122457899999999999999999999999999999998 89999876543322222211            1


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      ..+.+...+.++.+|+.+||+.||++|||+.+|++.|+++++.
T Consensus       251 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         251 RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            1122333456899999999999999999999999999998764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3e-57  Score=423.33  Aligned_cols=260  Identities=27%  Similarity=0.424  Sum_probs=215.8

Q ss_pred             HHHHHhccccccccccCceeEEEEEeC-CCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          108 DLQKATCNFTTLIGQGAFGPVYKAQMS-TGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       108 ~l~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      ++....+.+.+.||+|+||+||+|... +|+.||||++..+. ...++|.+|+.+|++++|||||+++|+|.+++..++|
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence            344456788899999999999999764 68899999987543 3456899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||+++|+|.+++.......+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            99999999999998777778999999999999999999999999   999999999999999999999999999864433


Q ss_pred             c--cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCC
Q 014038          267 K--HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       267 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                      .  ......||+.|+|||++.+..|+.++|||||||++|||++|..||....+..........           ......
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~-----------~~~~~~  237 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-----------DYRMER  237 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-----------TCCCCC
T ss_pred             CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc-----------CCCCCC
Confidence            2  223346889999999999999999999999999999999977665433322222222111           112222


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      +...+.++.+|+.+||+.||++|||+.+|++.|+.+.+
T Consensus       238 ~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            33344689999999999999999999999999988754

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-57  Score=419.95  Aligned_cols=257  Identities=28%  Similarity=0.476  Sum_probs=204.5

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ..+.+.+.||+|+||+||+|+..  ..||||+++..  .....+.|.+|+.+|++++|||||+++|++.+ +..++||||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey   84 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW   84 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence            35667789999999999999864  46999998654  34556789999999999999999999998764 568999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc---
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD---  266 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~---  266 (432)
                      +++|+|.+++... ..++++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....   
T Consensus        85 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          85 CEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             CCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            9999999999643 356999999999999999999999998   999999999999999999999999999754322   


Q ss_pred             ccccccccCCCCCCcccccc---CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCC
Q 014038          267 KHAANIRGTFGYLDPEYIST---RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                      .......||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+.............+..      .+.+ ..
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~------~p~~-~~  233 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL------SPDL-SK  233 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC------CCCG-GG
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC------CCcc-hh
Confidence            23345679999999999864   35899999999999999999999999875443333222211110      0000 01


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      .+...+.++.+|+.+||+.||++|||+.+|++.|+.+.+
T Consensus       234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            122234579999999999999999999999999998864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-57  Score=417.56  Aligned_cols=256  Identities=27%  Similarity=0.432  Sum_probs=210.4

Q ss_pred             HHhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      ...+.+.+.||+|+||.||+|.+++++.||||++.... ...+.|.+|+.++++++|||||+++|+|.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            34677889999999999999999888899999997543 345689999999999999999999998864 5679999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--c
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--H  268 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--~  268 (432)
                      ++|+|.+++......++++..+++|+.||+.||.|||+++   |+||||||+||||++++.+||+|||+++......  .
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~  166 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA  166 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcccc
Confidence            9999999886655556999999999999999999999999   9999999999999999999999999998643322  2


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCC-CCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSP-LQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      .....||+.|+|||++.++.++.++|||||||++|||+||..| +.............. +           .+...+..
T Consensus       167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~-~-----------~~~~~p~~  234 (272)
T d1qpca_         167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-G-----------YRMVRPDN  234 (272)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-T-----------CCCCCCTT
T ss_pred             ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-c-----------CCCCCccc
Confidence            3445789999999999999999999999999999999996554 444332222222111 1           11112223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      .+.++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       235 ~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            345789999999999999999999999999988653

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=411.72  Aligned_cols=247  Identities=24%  Similarity=0.392  Sum_probs=209.6

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .|.+.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||++
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~  100 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence            467788999999999999964 5799999999976655556789999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~  270 (432)
                      +|+|.+++..   +.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..... ....
T Consensus       101 gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1         101 GGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             TCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             CCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence            9999998754   35999999999999999999999999   999999999999999999999999999864332 3445


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN  350 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (432)
                      ...||+.|+|||++.+..|+.++|||||||++|||++|+.||.+......+..........          ...+...+.
T Consensus       175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~----------~~~~~~~s~  244 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE----------LQNPEKLSA  244 (293)
T ss_dssp             CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC----------CSSGGGSCH
T ss_pred             ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC----------CCCcccCCH
Confidence            6679999999999999999999999999999999999999998765444333332221111          111222345


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          351 EVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       351 ~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ++.+|+.+||+.||++|||+.|+++
T Consensus       245 ~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         245 IFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhc
Confidence            7899999999999999999999874

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-56  Score=410.15  Aligned_cols=248  Identities=25%  Similarity=0.336  Sum_probs=201.1

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+++..++||||+
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~   85 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   85 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence            577889999999999999975 478999999987643 233457899999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc---c
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD---K  267 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~---~  267 (432)
                      ++|+|.+++.  ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.....   .
T Consensus        86 ~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          86 SGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             TTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             CCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            9999999995  3457999999999999999999999999   999999999999999999999999999864322   2


Q ss_pred             cccccccCCCCCCccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          268 HAANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      .....+||+.|||||++.+..+ +.++|||||||++|||++|+.||....+............          .......
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~----------~~~~~~~  230 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK----------TYLNPWK  230 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC----------TTSTTGG
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC----------CCCCccc
Confidence            2345689999999999988776 5789999999999999999999975432211111111110          0001111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.++.+|+.+||+.||++|||++|+++
T Consensus       231 ~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         231 KIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            22357889999999999999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-56  Score=407.35  Aligned_cols=244  Identities=27%  Similarity=0.445  Sum_probs=207.0

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||+||+|.. .+|+.||+|++...   .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence            578889999999999999976 47899999998643   22345678999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+++|+|.+++..  .+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.... ..
T Consensus        87 y~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~-~~  160 (263)
T d2j4za1          87 YAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SR  160 (263)
T ss_dssp             CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-CC
T ss_pred             ecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC-Cc
Confidence            9999999999854  346999999999999999999999999   99999999999999999999999999976433 23


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      .....||+.|||||++.+..|+.++|||||||++|||++|+.||.+............. .            ..++...
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-~------------~~~p~~~  227 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-E------------FTFPDFV  227 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-C------------CCCCTTS
T ss_pred             ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-C------------CCCCccC
Confidence            44567999999999999999999999999999999999999999875543333222211 1            0112223


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +.++.+|+.+||+.||++|||+.|+++
T Consensus       228 s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         228 TEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            457899999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-55  Score=401.60  Aligned_cols=250  Identities=24%  Similarity=0.423  Sum_probs=210.5

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      .+.+.+.||+|+||+||+|+.++++.||||.++.... ..++|.+|+.++++++||||++++|+|.+++..++||||+++
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~   83 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN   83 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred             HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence            3567789999999999999998888999999976543 456899999999999999999999999999999999999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc--ccc
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK--HAA  270 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~--~~~  270 (432)
                      |+|.+++... ...+++..+.+++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        84 g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (258)
T d1k2pa_          84 GCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  159 (258)
T ss_dssp             EEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred             CcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence            9999987543 356899999999999999999999998   9999999999999999999999999997543322  223


Q ss_pred             ccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          271 NIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ...+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+..............            +...+...+
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~------------~~~~p~~~~  227 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL------------RLYRPHLAS  227 (258)
T ss_dssp             CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC------------CCCCCTTCC
T ss_pred             ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC------------CCCCccccc
Confidence            4568999999999999999999999999999999998 899998765443322222111            111222334


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQVLSR  379 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~~L~~  379 (432)
                      .++.+|+.+||+.||++|||+.+|++.|.+
T Consensus       228 ~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         228 EKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            589999999999999999999999998753

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-55  Score=407.27  Aligned_cols=253  Identities=25%  Similarity=0.383  Sum_probs=207.3

Q ss_pred             ccccc-cccccCceeEEEEEeC---CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          114 CNFTT-LIGQGAFGPVYKAQMS---TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       114 ~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      +.+.+ .||+|+||+||+|.+.   ++..||||++... .....+.|.+|+.+|++++|||||+++|+|.+ +..++|||
T Consensus        10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE   88 (285)
T d1u59a_          10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME   88 (285)
T ss_dssp             EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEE
Confidence            34455 4999999999999653   4557999999765 34456789999999999999999999999865 56899999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-  267 (432)
                      |+++|+|.+++... ...+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...... 
T Consensus        89 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          89 MAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  164 (285)
T ss_dssp             CCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             eCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccccc
Confidence            99999999987533 357999999999999999999999999   9999999999999999999999999998543322 


Q ss_pred             ---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCC
Q 014038          268 ---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGI  343 (432)
Q Consensus       268 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (432)
                         ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+..............            +..
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~------------~~~  232 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK------------RME  232 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC------------CCC
T ss_pred             ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------CCC
Confidence               2234568999999999999999999999999999999998 999998754332222221111            112


Q ss_pred             CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          344 FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      .+...+.++.+|+.+||+.||++||||.+|++.|+.+...
T Consensus       233 ~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            2333446899999999999999999999999999887654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=409.97  Aligned_cols=256  Identities=27%  Similarity=0.459  Sum_probs=202.6

Q ss_pred             hccccccccccCceeEEEEEeCCC-----cEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTG-----ETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      .+.+.++||+|+||.||+|.+.+.     ..||||.+... ......+|.+|+.++++++|||||+++|+|.+.+..++|
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v   87 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII   87 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence            456778999999999999976432     37999998754 334456799999999999999999999999999999999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      |||+.+|++.+.+... ...+++..+.+++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        88 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          88 TEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            9999999999887543 357999999999999999999999999   999999999999999999999999999754332


Q ss_pred             c----cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          267 K----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       267 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .    ......||+.|+|||++.++.++.++|||||||++|||++|..|+........+......           ..+.
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-----------~~~~  232 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-----------GFRL  232 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-----------TCCC
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc-----------cCCC
Confidence            1    223356899999999999999999999999999999999965554432222222211111           1122


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      +.+...+.++.+|+.+||+.||++||||.+|++.|+++.+.
T Consensus       233 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            23333456899999999999999999999999999998764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=411.79  Aligned_cols=249  Identities=26%  Similarity=0.384  Sum_probs=207.5

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .|++.+.||+|+||+||+|.. .+|+.||||++........+.|.+|+.+|++++|||||++++++.+.+..++||||++
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~   92 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   92 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence            467788999999999999975 4789999999987766667789999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KHAA  270 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~  270 (432)
                      +|+|.+++... ..++++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..... ....
T Consensus        93 ~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~  168 (288)
T d2jfla1          93 GGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  168 (288)
T ss_dssp             TEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred             CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence            99999987543 356999999999999999999999999   999999999999999999999999999754332 2334


Q ss_pred             ccccCCCCCCccccc-----cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          271 NIRGTFGYLDPEYIS-----TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       271 ~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                      ...||+.|+|||++.     ...|+.++|||||||++|||+||+.||.+......+.........          ....+
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~----------~~~~~  238 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP----------TLAQP  238 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC----------CCSSG
T ss_pred             ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC----------CCCcc
Confidence            568999999999983     456899999999999999999999999865433322222221110          01112


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...+.++.+|+.+||+.||++|||+.|+++
T Consensus       239 ~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            233468999999999999999999999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-55  Score=405.68  Aligned_cols=251  Identities=25%  Similarity=0.370  Sum_probs=194.7

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeee--CCeEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--KGQHMLVY  187 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  187 (432)
                      .|++.+.||+|+||+||+|+. .+|+.||||.+....  ....+.+.+|+.++++++|||||++++++.+  .+..++||
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm   84 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   84 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence            577889999999999999965 578999999987643  3445678999999999999999999999865  45689999


Q ss_pred             EeccCCChhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          188 VFMSKGSLASHLYD--ENYGPLTWNLRVHIALDVARGLEYLHDGA--VPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       188 e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ||+++|+|.+++..  .....+++..++.++.||+.||.|||+.+  ..+|+||||||+||||+.++.+||+|||+++..
T Consensus        85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~  164 (269)
T d2java1          85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  164 (269)
T ss_dssp             ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred             ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence            99999999998853  23467999999999999999999999854  134999999999999999999999999999764


Q ss_pred             ccc-ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          264 MVD-KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       264 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      ... .......||+.|||||++.+..|+.++|||||||++|||+||+.||.+...............            .
T Consensus       165 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~------------~  232 (269)
T d2java1         165 NHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF------------R  232 (269)
T ss_dssp             -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC------------C
T ss_pred             ccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC------------C
Confidence            433 233457899999999999999999999999999999999999999987554332222211111            0


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            112233457999999999999999999999875

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.1e-55  Score=411.64  Aligned_cols=250  Identities=25%  Similarity=0.416  Sum_probs=192.2

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ..|++.+.||+|+||+||+|.. .+|+.||||++.... ......+.+|+.+|++++||||+++++++.+++..++||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            4588889999999999999975 478999999997543 23345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec---CCCcEEEeecCCccccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD---QSMRARVADFGLSREEMVD  266 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~---~~~~~kl~Dfgl~~~~~~~  266 (432)
                      +++|+|.+++..  .+.+++..+..++.||+.||+|||+++   |+||||||+|||+.   +++.+||+|||+++.....
T Consensus        89 ~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          89 VSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             cCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            999999999954  457999999999999999999999999   99999999999994   5789999999999865555


Q ss_pred             ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+...............         ........
T Consensus       164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~---------~~~~~~~~  234 (307)
T d1a06a_         164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY---------EFDSPYWD  234 (307)
T ss_dssp             ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC---------CCCTTTTT
T ss_pred             CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC---------CCCCcccc
Confidence            555667899999999999999999999999999999999999999987654333322222111         11111122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..+.++.+|+.+||+.||++|||+.|+++
T Consensus       235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         235 DISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            33457899999999999999999999876

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-55  Score=417.70  Aligned_cols=257  Identities=28%  Similarity=0.492  Sum_probs=207.0

Q ss_pred             HHHHhccccccccccCceeEEEEEeCC-C-----cEEEEEEeccC-ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeC
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQMST-G-----ETVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK  180 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  180 (432)
                      +....+.+.+.||+|+||+||+|+... +     ..||+|.+... .......|.+|+.+|.++ +|||||+++++|.+.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            334567888999999999999997532 2     36999998654 334456789999999998 899999999999999


Q ss_pred             CeEEEEEEeccCCChhhhcccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC
Q 014038          181 GQHMLVYVFMSKGSLASHLYDEN---------------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI  239 (432)
Q Consensus       181 ~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dl  239 (432)
                      +..++||||+++|+|.+++....                     ...+++..++.++.||+.||+|||+++   |+||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence            99999999999999999996542                     235899999999999999999999999   999999


Q ss_pred             CCCCeeecCCCcEEEeecCCccccccccc---ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCCh
Q 014038          240 KSSNILLDQSMRARVADFGLSREEMVDKH---AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGL  315 (432)
Q Consensus       240 kp~Nill~~~~~~kl~Dfgl~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~  315 (432)
                      ||+|||++.++.+||+|||+|+.......   .....||+.|||||++.++.|+.++|||||||++|||+| |+.||.+.
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999976443322   234568999999999999999999999999999999998 89999864


Q ss_pred             hHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 014038          316 MEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSR  379 (432)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~  379 (432)
                      .....+......           ..+...+...+.++.+||.+||+.||++|||++||++.|..
T Consensus       271 ~~~~~~~~~~~~-----------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         271 PVDANFYKLIQN-----------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CCSHHHHHHHHT-----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHHHHHHHHhc-----------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            432222222111           11222233344689999999999999999999999999853

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=403.57  Aligned_cols=247  Identities=26%  Similarity=0.411  Sum_probs=200.9

Q ss_pred             ccccccCceeEEEEEeC---CCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEeccC
Q 014038          118 TLIGQGAFGPVYKAQMS---TGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMSK  192 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  192 (432)
                      ++||+|+||+||+|.+.   .++.||||++...  .....+.|.+|+.+|++++|||||+++|+|.+ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999653   3468999999654  23345689999999999999999999999865 567899999999


Q ss_pred             CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc----c
Q 014038          193 GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK----H  268 (432)
Q Consensus       193 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~----~  268 (432)
                      |+|.+++..  ..++++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++......    .
T Consensus        92 g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            999999854  356999999999999999999999999   9999999999999999999999999997543221    2


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+..............            +...+..
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~------------~~~~p~~  234 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE------------RMGCPAG  234 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------CCCCCTT
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC------------CCCCCcc
Confidence            234568999999999999999999999999999999998 899998765433222222111            1122233


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          348 ELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      .+.++.+|+.+||+.||++|||+.+|++.|+....
T Consensus       235 ~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            44689999999999999999999999999988754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-54  Score=399.01  Aligned_cols=246  Identities=26%  Similarity=0.445  Sum_probs=199.0

Q ss_pred             cccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeee----CCeEEEEE
Q 014038          115 NFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE----KGQHMLVY  187 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  187 (432)
                      .|.+.||+|+||+||+|.. .+++.||+|.+...  .....+.|.+|+++|++++|||||++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            5667899999999999965 47889999998654  34445679999999999999999999999865    34679999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec-CCCcEEEeecCCccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD-QSMRARVADFGLSREEMVD  266 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~-~~~~~kl~Dfgl~~~~~~~  266 (432)
                      ||+++|+|.+++...  ..+++..+..++.||+.||+|||+++ ++|+||||||+|||++ +++.+||+|||+++... .
T Consensus        92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~-~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-A  167 (270)
T ss_dssp             ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-T
T ss_pred             eCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc-C
Confidence            999999999999543  56999999999999999999999976 5599999999999996 57899999999997532 2


Q ss_pred             ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      .......||+.|||||++.+ .|+.++|||||||++|||++|+.||.+..+...+......+....      .    ++.
T Consensus       168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~------~----~~~  236 (270)
T d1t4ha_         168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA------S----FDK  236 (270)
T ss_dssp             TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG------G----GGG
T ss_pred             CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc------c----cCc
Confidence            33446789999999999875 599999999999999999999999976544333322222211110      0    111


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..++++.+|+.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         237 VAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            12346899999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=409.41  Aligned_cols=254  Identities=28%  Similarity=0.415  Sum_probs=205.5

Q ss_pred             HhccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      ..+.+.+.||+|+||.||+|...+++.||||++.... ...+.|.+|+.++++++|||||+++|+|.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            3678889999999999999999888899999996543 445789999999999999999999999864 56899999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc--ccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--KHA  269 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~--~~~  269 (432)
                      +|+|..++.......++|..++.++.||+.||+|||+++   |+||||||+||||+.++++||+|||+++.....  ...
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  171 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  171 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence            999999987665567999999999999999999999999   999999999999999999999999999754322  223


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCC-ChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQ-GLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      ....||+.|+|||++..+.++.++|||||||++|||++|..|+. .......+..+...            ...+.+...
T Consensus       172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~------------~~~~~~~~~  239 (285)
T d1fmka3         172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG------------YRMPCPPEC  239 (285)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------------CCCCCCTTS
T ss_pred             ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc------------CCCCCCccc
Confidence            34578999999999999999999999999999999999665554 33322222222111            111223334


Q ss_pred             HHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          349 LNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      +.++.+++.+||+.||++|||+.+|+++|+....
T Consensus       240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            4689999999999999999999999999887653

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.4e-54  Score=412.94  Aligned_cols=250  Identities=24%  Similarity=0.366  Sum_probs=212.1

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .|.+.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..++|||||+
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  106 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  106 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            688889999999999999975 5789999999987766667789999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec--CCCcEEEeecCCcccccccccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD--QSMRARVADFGLSREEMVDKHA  269 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~--~~~~~kl~Dfgl~~~~~~~~~~  269 (432)
                      +|+|.+++... .+.+++..+..++.||+.||.|||+++   |+||||||+|||++  .++.+||+|||+++........
T Consensus       107 gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~  182 (350)
T d1koaa2         107 GGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV  182 (350)
T ss_dssp             SCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred             CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence            99999988543 356999999999999999999999999   99999999999995  4678999999999876555555


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....||+.|||||++.+..|+.++|||||||++|||++|+.||.+......+..+...... +        ........+
T Consensus       183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-~--------~~~~~~~~s  253 (350)
T d1koaa2         183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN-M--------DDSAFSGIS  253 (350)
T ss_dssp             EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-S--------CCGGGGGCC
T ss_pred             ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-C--------CcccccCCC
Confidence            6678999999999999999999999999999999999999999876544333332221110 0        000111223


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .++.+|+.+||+.||++|||+.|+++
T Consensus       254 ~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         254 EDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            57899999999999999999999886

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-55  Score=415.99  Aligned_cols=259  Identities=24%  Similarity=0.376  Sum_probs=203.6

Q ss_pred             HHhccccccccccCceeEEEEEe-CCCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      ...|.+.+.||+|+||+||+|.. .+|+.||+|++... .......+.+|+.+|++++|||||+++++|.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            34677889999999999999975 57899999999765 33445688999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      |+++|+|.+++...  +.+++..+..++.|++.||.|||+ ++   |+||||||+||||+.++.+||+|||+|+.... .
T Consensus        85 y~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-~  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-S  158 (322)
T ss_dssp             CCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-H
T ss_pred             cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-C
Confidence            99999999999643  469999999999999999999997 47   99999999999999999999999999985432 2


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHH-HHHhh-hcC-----------------
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVE-LAAMN-TEG-----------------  328 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~-~~~~~-~~~-----------------  328 (432)
                      .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+...... ..... ..+                 
T Consensus       159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence            33457899999999999999999999999999999999999999975321110 00000 000                 


Q ss_pred             --------CCchhh----hccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          329 --------KTGWEE----IVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       329 --------~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                              .....+    +.............+.++.+|+.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                    000000    00000000011112357899999999999999999999987

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.1e-54  Score=410.59  Aligned_cols=250  Identities=23%  Similarity=0.362  Sum_probs=212.9

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      .|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++|||||+
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  109 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS  109 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            578889999999999999965 5799999999987666666788999999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec--CCCcEEEeecCCcccccccccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD--QSMRARVADFGLSREEMVDKHA  269 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~--~~~~~kl~Dfgl~~~~~~~~~~  269 (432)
                      +|+|.+++.. ...++++..+..|+.||+.||.|||+++   |+||||||+||||+  .++.+||+|||+++........
T Consensus       110 gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~  185 (352)
T d1koba_         110 GGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV  185 (352)
T ss_dssp             CCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred             CChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence            9999987743 3456999999999999999999999999   99999999999997  6789999999999876655556


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....||+.|+|||++.+..|+.++|||||||++|||+||+.||.+......+..+......         .........+
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~---------~~~~~~~~~s  256 (352)
T d1koba_         186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE---------FDEDAFSSVS  256 (352)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC---------CCSSTTTTSC
T ss_pred             eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------CCcccccCCC
Confidence            6678999999999999999999999999999999999999999876554443333222111         1111112234


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .++.+|+.+||+.||.+|||+.|+++
T Consensus       257 ~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         257 PEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            57899999999999999999999976

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.3e-54  Score=405.46  Aligned_cols=245  Identities=25%  Similarity=0.366  Sum_probs=203.7

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCCh---hhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---QGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      ..|...+.||+|+||+||+|.. .+|+.||||++.....   ...+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3577788999999999999965 5788999999876532   33457899999999999999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~  267 (432)
                      |||++|+|..++..  ..++++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...   
T Consensus        95 E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~---  166 (309)
T d1u5ra_          95 EYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA---  166 (309)
T ss_dssp             ECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS---
T ss_pred             EecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccC---
Confidence            99999999766643  357999999999999999999999999   9999999999999999999999999997543   


Q ss_pred             cccccccCCCCCCcccccc---CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCC
Q 014038          268 HAANIRGTFGYLDPEYIST---RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIF  344 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (432)
                      ......||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+......+.........           ...
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~-----------~~~  235 (309)
T d1u5ra_         167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-----------ALQ  235 (309)
T ss_dssp             SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-----------CCS
T ss_pred             CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-----------CCC
Confidence            2345679999999999853   46899999999999999999999999876554433333222111           111


Q ss_pred             CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          345 DVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       345 ~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +...+.++.+|+.+||+.||++|||+.++++
T Consensus       236 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1223457899999999999999999999976

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=404.81  Aligned_cols=245  Identities=24%  Similarity=0.399  Sum_probs=204.3

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|.+.+.||+|+||+||+|.. .+|+.||||++...   .....+.+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE   88 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS   88 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence            578889999999999999975 57899999998643   22334678999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc--
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD--  266 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~--  266 (432)
                      |+++|+|.+++...  +.+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.....  
T Consensus        89 y~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          89 YAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            99999999988543  57999999999999999999999999   999999999999999999999999999864322  


Q ss_pred             -ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCC
Q 014038          267 -KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFD  345 (432)
Q Consensus       267 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (432)
                       .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+... ..            .++
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-~~------------~~p  230 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-EY------------DFP  230 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-CC------------CCC
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC-CC------------CCC
Confidence             2234567999999999999999999999999999999999999999875543333222211 10            112


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          346 VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       346 ~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...+.++.+|+.+||+.||++|||++|++.
T Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         231 EKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            223457899999999999999999999765

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-53  Score=397.83  Aligned_cols=250  Identities=24%  Similarity=0.378  Sum_probs=209.4

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC------hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS------KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  184 (432)
                      ..|++.+.||+|+||+||+|.. .+|+.||||++....      ....+.|.+|+.+|++++|||||++++++.+.+..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            3678889999999999999975 578999999986432      223578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC----cEEEeecCCc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM----RARVADFGLS  260 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~----~~kl~Dfgl~  260 (432)
                      +|||||++|+|.+++...  +.+++..+..++.|++.||+|||+++   |+||||||+|||++.++    .+||+|||++
T Consensus        90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhh
Confidence            999999999999999543  46999999999999999999999999   99999999999998776    4999999999


Q ss_pred             ccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          261 REEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      .............||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+...... +.....   
T Consensus       165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~---  240 (293)
T d1jksa_         165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE-FEDEYF---  240 (293)
T ss_dssp             EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC-CCHHHH---
T ss_pred             hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-CCchhc---
Confidence            8765555566678999999999999999999999999999999999999999876554433333221111 110000   


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                           ...+.++.+|+.+||+.||++|||++++++
T Consensus       241 -----~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         241 -----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 112357889999999999999999999875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=398.81  Aligned_cols=250  Identities=29%  Similarity=0.460  Sum_probs=200.7

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeee-CCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-KGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~  191 (432)
                      .+.+.+.||+|+||.||+|++ .|+.||||+++.+  ...+.|.+|+.++++++||||++++|+|.+ .+..++||||++
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~   84 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   84 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             HeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence            457789999999999999998 5789999999654  334679999999999999999999999865 456899999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccccccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKHAAN  271 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~  271 (432)
                      +|+|.+++.......++|..+++++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....  ....
T Consensus        85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~--~~~~  159 (262)
T d1byga_          85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--TQDT  159 (262)
T ss_dssp             TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC--CCcc
Confidence            999999997655556999999999999999999999998   99999999999999999999999999975432  3334


Q ss_pred             cccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHHH
Q 014038          272 IRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEELN  350 (432)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (432)
                      ..+|+.|+|||++.+..++.++|||||||++|||+| |+.||............            ....+...+...+.
T Consensus       160 ~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i------------~~~~~~~~~~~~~~  227 (262)
T d1byga_         160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV------------EKGYKMDAPDGCPP  227 (262)
T ss_dssp             --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH------------TTTCCCCCCTTCCH
T ss_pred             ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH------------HcCCCCCCCccCCH
Confidence            568999999999999999999999999999999998 78888754322111111            11122223333446


Q ss_pred             HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          351 EVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       351 ~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                      ++.+|+.+||+.||.+|||+.+|++.|+++..
T Consensus       228 ~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         228 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            89999999999999999999999999998853

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-53  Score=400.14  Aligned_cols=258  Identities=33%  Similarity=0.530  Sum_probs=208.1

Q ss_pred             hccccccccccCceeEEEEEeC-CCc--EEEEEEeccC-ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeCCeEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGE--TVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      .+++.+.||+|+||.||+|.+. +|.  .||||.+... .....+.|.+|+++|.++ +|||||+++|+|.+.+..++||
T Consensus        11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~   90 (309)
T d1fvra_          11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI   90 (309)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEE
Confidence            4567889999999999999764 444  5788887543 344556799999999999 7999999999999999999999


Q ss_pred             EeccCCChhhhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEE
Q 014038          188 VFMSKGSLASHLYDE--------------NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRAR  253 (432)
Q Consensus       188 e~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~k  253 (432)
                      ||+++|+|.++++..              ....+++..+.+++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        91 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~k  167 (309)
T d1fvra_          91 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAK  167 (309)
T ss_dssp             CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEE
T ss_pred             EecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceE
Confidence            999999999998643              2467999999999999999999999998   99999999999999999999


Q ss_pred             EeecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCC-CCCCChhHHHHHHHhhhcCCCch
Q 014038          254 VADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGR-SPLQGLMEYVELAAMNTEGKTGW  332 (432)
Q Consensus       254 l~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~  332 (432)
                      |+|||+++............||..|+|||.+....|+.++|||||||++|||++|. .||.+............ +    
T Consensus       168 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~-~----  242 (309)
T d1fvra_         168 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-G----  242 (309)
T ss_dssp             ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-T----
T ss_pred             EccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh-c----
Confidence            99999998655444455667999999999999999999999999999999999965 56765443222222211 1    


Q ss_pred             hhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                             .+...+...+.++.+|+.+||+.||++||||.+|++.|+++.+.+.
T Consensus       243 -------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         243 -------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             -------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             -------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence                   1112233344689999999999999999999999999999976443

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=396.72  Aligned_cols=257  Identities=26%  Similarity=0.399  Sum_probs=201.2

Q ss_pred             HHhccccccccccCceeEEEEEeCC----CcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMST----GETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      ...|++.+.||+|+||.||+|....    +..||||.+... .....+.|.+|+.++++++||||++++|+|. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3467888999999999999997532    346899998654 3344567999999999999999999999986 467899


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+++|+|.+++... ..++++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++....
T Consensus        85 v~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence            99999999999987543 457999999999999999999999999   99999999999999999999999999976432


Q ss_pred             c--ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          266 D--KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       266 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .  .......||+.|+|||.+.+..|+.++|||||||++|||+| |..||.+..............            ..
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~------------~~  228 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE------------RL  228 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC------------CC
T ss_pred             CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------CC
Confidence            2  22344568999999999999999999999999999999998 899997654322222211111            11


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      ..+...+.++.+|+.+||+.||++|||+.+|++.|+.+++..
T Consensus       229 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            223334468999999999999999999999999999997653

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.5e-53  Score=398.24  Aligned_cols=255  Identities=29%  Similarity=0.475  Sum_probs=209.2

Q ss_pred             HhccccccccccCceeEEEEEeC------CCcEEEEEEeccCC-hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATDS-KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHM  184 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  184 (432)
                      ..+++.+.||+|+||+||+|+..      +++.||||++.... ....++|.+|+.+|++++||||++++++|.+.+..+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            35678899999999999999753      45789999997653 334567999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhcccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCC
Q 014038          185 LVYVFMSKGSLASHLYDEN----------------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSS  242 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~  242 (432)
                      ++|||+++|+|.+++....                      ...+++..++.++.|++.||+|||+++   |+||||||+
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~  169 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATR  169 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEccc
Confidence            9999999999999985421                      235899999999999999999999999   999999999


Q ss_pred             CeeecCCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCC-CCCCChhHH
Q 014038          243 NILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGR-SPLQGLMEY  318 (432)
Q Consensus       243 Nill~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~-~p~~~~~~~  318 (432)
                      |||||.++.+||+|||+++......   ......||+.|+|||.+.+..|+.++|||||||++|||++|. .||.+....
T Consensus       170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence            9999999999999999997543222   223457889999999999999999999999999999999985 678765544


Q ss_pred             HHHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q 014038          319 VELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRIL  381 (432)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~  381 (432)
                      ...........            ...+...+.++.+|+.+||+.||++||||.+|+++|+++.
T Consensus       250 e~~~~v~~~~~------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         250 EVIYYVRDGNI------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHHHHHHTTCC------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHHHHHcCCC------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            33322221111            1122233457999999999999999999999999999875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=399.49  Aligned_cols=262  Identities=31%  Similarity=0.501  Sum_probs=201.5

Q ss_pred             HHHHhccccccccccCceeEEEEEeC------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhc-CCCccceEEeeeeeC
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATD-SKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAEK  180 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  180 (432)
                      +....|.+.+.||+|+||.||+|...      +++.||||++... .....+.+.+|...+.++ +|+||+.+++++.+.
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            33456888899999999999999642      3468999999754 334456788888888887 689999999998764


Q ss_pred             -CeEEEEEEeccCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCee
Q 014038          181 -GQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNIL  245 (432)
Q Consensus       181 -~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nil  245 (432)
                       ...++|||||++|+|.+++....              ...+++..+..++.||+.||.|||+++   |+||||||+|||
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL  166 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL  166 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcccee
Confidence             46899999999999999986432              235899999999999999999999999   999999999999


Q ss_pred             ecCCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhC-CCCCCChhHHHHH
Q 014038          246 LDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAG-RSPLQGLMEYVEL  321 (432)
Q Consensus       246 l~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg-~~p~~~~~~~~~~  321 (432)
                      |+.++.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||+|| ..||.+......+
T Consensus       167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999997543222   23456799999999999999999999999999999999996 5678654322222


Q ss_pred             HHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhc
Q 014038          322 AAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMR  384 (432)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~  384 (432)
                      ......+           .....+...+.++.+++.+||+.||++|||+.+|++.|+++++..
T Consensus       247 ~~~~~~~-----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n  298 (299)
T d1ywna1         247 CRRLKEG-----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  298 (299)
T ss_dssp             HHHHHHT-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHhcC-----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence            1111111           111222233457999999999999999999999999999998653

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-52  Score=393.65  Aligned_cols=256  Identities=28%  Similarity=0.479  Sum_probs=205.9

Q ss_pred             hccccccccccCceeEEEEEeCCC----cEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeee-CCeEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTG----ETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-KGQHMLV  186 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv  186 (432)
                      +.+|.++||+|+||+||+|.+.++    ..||||++... .....++|.+|+++|++++||||++++|+|.+ ++..++|
T Consensus        28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred             eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence            345678999999999999976432    26999999753 45556789999999999999999999999876 4689999


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      ||||++|+|.+++... ...+++..+++++.|++.||.|||+.+   |+||||||+||||++++.+||+|||+++.....
T Consensus       108 ~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             EEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            9999999999988643 456788999999999999999999999   999999999999999999999999999754322


Q ss_pred             c-----cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCC
Q 014038          267 K-----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLD  341 (432)
Q Consensus       267 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (432)
                      .     ......||+.|+|||.+....++.++||||||+++|||+||+.||...............+.           +
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~-----------~  252 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-----------R  252 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC-----------C
T ss_pred             ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-----------C
Confidence            1     22335689999999999999999999999999999999998888765433222222111111           1


Q ss_pred             CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          342 GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      ...+...+.++.+|+.+||+.||++||++.||++.|+.+++.
T Consensus       253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            111222345799999999999999999999999999999764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=397.55  Aligned_cols=254  Identities=25%  Similarity=0.428  Sum_probs=202.5

Q ss_pred             hccccccccccCceeEEEEEeC-CCc----EEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS-TGE----TVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  186 (432)
                      .|++.++||+|+||+||+|... +|+    .||+|.+... .....+.|.+|+.++++++|||||+++|+|.++ ..+++
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v   88 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI   88 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence            4677899999999999999653 444    5899988653 345567899999999999999999999999864 56788


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      ++|+.+|+|.+++... ...+++..+++++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        89 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          89 TQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            9999999999988653 467999999999999999999999998   999999999999999999999999999764332


Q ss_pred             c---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccCCC
Q 014038          267 K---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       267 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                      .   ......||+.|+|||++.++.|+.++|||||||++|||+| |+.||.+............            ..+.
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~------------~~~~  232 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------------GERL  232 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH------------TCCC
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc------------CCCC
Confidence            2   2234568999999999999999999999999999999998 8899876432211111111            1111


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      ..+...+.++.+|+.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       233 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            22333446799999999999999999999999999888653

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.4e-52  Score=387.71  Aligned_cols=256  Identities=24%  Similarity=0.362  Sum_probs=203.6

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC----eE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG----QH  183 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  183 (432)
                      .+|.+.+.||+|+||+||+|.. .+|+.||||++....   ......|.+|+.++++++||||+++++++...+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            3578889999999999999965 579999999997543   334467999999999999999999999987654    47


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      |+||||+++|+|.+++...  +++++.++..++.||+.||+|||+++   |+||||||+|||++.++..+|+|||.+...
T Consensus        87 ~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhh
Confidence            8999999999999988543  57999999999999999999999999   999999999999999999999999988643


Q ss_pred             ccc----ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          264 MVD----KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       264 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ...    .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+....................     
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-----  236 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA-----  236 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGG-----
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCch-----
Confidence            222    23345679999999999999999999999999999999999999998765543333332222211111     


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHH
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRP-SMRDIVQVLSRIL  381 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~~vl~~L~~i~  381 (432)
                      .    ....+.++.+++.+||+.||.+|| |++++++.|.++.
T Consensus       237 ~----~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         237 R----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             T----SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             h----ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            1    112235789999999999999999 8999999888774

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=397.90  Aligned_cols=245  Identities=26%  Similarity=0.412  Sum_probs=207.1

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|++.+.||+|+||.||+|+. .+|+.||||++...   .....+.+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e   85 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence            578889999999999999965 57999999999753   23345678999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc-cc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV-DK  267 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~-~~  267 (432)
                      ||++|+|.+++...  +.+++..+..++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+++.... ..
T Consensus        86 y~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          86 YANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             CCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             ccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            99999999998543  46899999999999999999999999   99999999999999999999999999986443 33


Q ss_pred             cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHH
Q 014038          268 HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVE  347 (432)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (432)
                      .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+............. ..            .++..
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~-~~------------~~p~~  227 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EI------------RFPRT  227 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CC------------CCCTT
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC-CC------------CCCcc
Confidence            445678999999999999999999999999999999999999999876543322222111 11            12222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014038          348 ELNEVASLAYKCVNRAPRKRPS-----MRDIVQ  375 (432)
Q Consensus       348 ~~~~l~~li~~cl~~dp~~RPs-----~~~vl~  375 (432)
                      .+.++.+|+.+||+.||.+||+     +.++++
T Consensus       228 ~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            3457899999999999999995     777765

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=392.43  Aligned_cols=260  Identities=30%  Similarity=0.492  Sum_probs=209.0

Q ss_pred             HHHHhccccccccccCceeEEEEEeC--------CCcEEEEEEeccCCh-hhHHHHHHHHHHHhhc-CCCccceEEeeee
Q 014038          109 LQKATCNFTTLIGQGAFGPVYKAQMS--------TGETVAVKVLATDSK-QGEKEFQTEVMLLGRL-HHRNLVNLVGYCA  178 (432)
Q Consensus       109 l~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  178 (432)
                      +....|.+.+.||+|+||.||+|+..        ++..||||++..+.. ....++.+|...+.++ +|||||+++++|.
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            33457788899999999999999642        224799999976543 4457889999999888 7999999999999


Q ss_pred             eCCeEEEEEEeccCCChhhhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCe
Q 014038          179 EKGQHMLVYVFMSKGSLASHLYDEN--------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNI  244 (432)
Q Consensus       179 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Ni  244 (432)
                      +++..++||||+++|+|.+++....              ...+++..++.++.||+.||+|||+++   |+||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence            9999999999999999999996442              246899999999999999999999999   99999999999


Q ss_pred             eecCCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHH
Q 014038          245 LLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVE  320 (432)
Q Consensus       245 ll~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~  320 (432)
                      |++.++.+||+|||+++......   ......+|+.|+|||.+.++.|+.++|||||||++|||++ |..||.+......
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence            99999999999999998644332   2344678999999999999999999999999999999998 7889876554332


Q ss_pred             HHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          321 LAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      ...+...            .....+...+.++.+|+.+||+.||++|||+.+|++.|++++..
T Consensus       247 ~~~i~~~------------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         247 FKLLKEG------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             HHHHHTT------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcC------------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            2222211            11112222345799999999999999999999999999999764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-53  Score=390.19  Aligned_cols=252  Identities=28%  Similarity=0.458  Sum_probs=197.4

Q ss_pred             hccccccccccCceeEEEEEeC--CC--cEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMS--TG--ETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      .|++.+.||+|+||.||+|+..  ++  ..||||++...   .....++|.+|+.+|++++||||++++|+|.+ +..++
T Consensus         9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l   87 (273)
T d1u46a_           9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM   87 (273)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence            5678899999999999999653  23  37899998654   23445689999999999999999999999975 46789


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+++|+|.+.+... .+++++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus        88 v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          88 VTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence            99999999999887643 356999999999999999999999999   99999999999999999999999999986433


Q ss_pred             cc----cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHHHHHHhhhcCCCchhhhccccC
Q 014038          266 DK----HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL  340 (432)
Q Consensus       266 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (432)
                      ..    ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||.+.........+...+.           
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~-----------  232 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-----------  232 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC-----------
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC-----------
Confidence            22    2234467889999999999999999999999999999998 8999987655443333322211           


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRI  380 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i  380 (432)
                      ..+.+...+.++.+++.+||+.||++||||.+|++.|.+.
T Consensus       233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1112223345799999999999999999999999988764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4e-52  Score=386.11  Aligned_cols=249  Identities=24%  Similarity=0.343  Sum_probs=206.9

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCCh---------hhHHHHHHHHHHHhhcC-CCccceEEeeeeeCC
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK---------QGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKG  181 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  181 (432)
                      .|++.+.||+|+||+||+|+. .+|+.||||++.....         ...+.+.+|+.++++++ ||||+++++++.+++
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~   83 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   83 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence            577889999999999999975 5789999999865421         12346889999999996 999999999999999


Q ss_pred             eEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          182 QHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       182 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                      ..++||||+++|+|.+++..  .+++++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        84 ~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          84 FFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             EEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             ceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999964  357999999999999999999999999   9999999999999999999999999998


Q ss_pred             cccccccccccccCCCCCCccccc------cCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhh
Q 014038          262 EEMVDKHAANIRGTFGYLDPEYIS------TRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEI  335 (432)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  335 (432)
                      ............||+.|+|||.+.      ...++.++||||+||++|||++|+.||.+................     
T Consensus       159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~-----  233 (277)
T d1phka_         159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ-----  233 (277)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----
T ss_pred             EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC-----
Confidence            765555556678999999999885      345789999999999999999999999876654433322221110     


Q ss_pred             ccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 VDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                          .........++++.+|+.+||+.||++|||+.|+++
T Consensus       234 ----~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         234 ----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             ----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ----CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                111111233468999999999999999999999864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.5e-52  Score=393.06  Aligned_cols=243  Identities=25%  Similarity=0.400  Sum_probs=205.3

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|++.+.||+|+||+||+|+. .+|+.||||++...   .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   84 (316)
T d1fota_           5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   84 (316)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence            477889999999999999975 57899999998643   22345678999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+++|+|..++...  ..+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...  ..
T Consensus        85 ~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~--~~  157 (316)
T d1fota_          85 YIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP--DV  157 (316)
T ss_dssp             CCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS--SC
T ss_pred             ecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEec--cc
Confidence            99999999988543  46889999999999999999999999   9999999999999999999999999997643  23


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+...............             .++...
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-------------~~p~~~  224 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-------------RFPPFF  224 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-------------CCCTTS
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-------------CCCCCC
Confidence            3457899999999999999999999999999999999999999987654333322221111             112223


Q ss_pred             HHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRP-----SMRDIVQ  375 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RP-----s~~~vl~  375 (432)
                      +.++.+++.+||+.||.+|+     |++++++
T Consensus       225 s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         225 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            35789999999999999996     8888876

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=394.86  Aligned_cols=262  Identities=28%  Similarity=0.490  Sum_probs=213.2

Q ss_pred             HHHHHhccccccccccCceeEEEEEe------CCCcEEEEEEeccCC-hhhHHHHHHHHHHHhhc-CCCccceEEeeeee
Q 014038          108 DLQKATCNFTTLIGQGAFGPVYKAQM------STGETVAVKVLATDS-KQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE  179 (432)
Q Consensus       108 ~l~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  179 (432)
                      ++....+.+.+.||+|+||.||+|++      .+++.||||++.... ......|.+|+.++.++ +|||||+++|+|.+
T Consensus        19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            34445778889999999999999964      345689999997653 34456799999999999 79999999999999


Q ss_pred             CCeEEEEEEeccCCChhhhcccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCC
Q 014038          180 KGQHMLVYVFMSKGSLASHLYDEN----------------YGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSN  243 (432)
Q Consensus       180 ~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~N  243 (432)
                      .+..++|||||++|+|.++++...                ...+++..+..++.||+.||+|||+++   ++||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccc
Confidence            999999999999999999986432                236899999999999999999999999   9999999999


Q ss_pred             eeecCCCcEEEeecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHh-CCCCCCChhHHH
Q 014038          244 ILLDQSMRARVADFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIA-GRSPLQGLMEYV  319 (432)
Q Consensus       244 ill~~~~~~kl~Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-g~~p~~~~~~~~  319 (432)
                      ||++.++.+||+|||+++......   ......||+.|+|||.+.++.++.++|||||||++|||+| |.+||.......
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999998643322   2234578999999999999999999999999999999999 566665433222


Q ss_pred             HHHHhhhcCCCchhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhh
Q 014038          320 ELAAMNTEGKTGWEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKM  383 (432)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~  383 (432)
                      .+..           ++....+...+...+.++.+||.+||+.||++|||+.+|+++|++++..
T Consensus       256 ~~~~-----------~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         256 KFYK-----------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHH-----------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHH-----------HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            2211           1111222223333446899999999999999999999999999988654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-52  Score=390.73  Aligned_cols=268  Identities=25%  Similarity=0.326  Sum_probs=198.4

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC----eEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG----QHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e  188 (432)
                      ++.+.+.||+|+||.||+|+. +|+.||||++..... ....+..|+..+..++||||++++|+|.+.+    ..++|||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            456678999999999999987 689999999864322 1222334555666789999999999998654    6799999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA-----VPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ||++|+|.++++..   +++|..+++++.|++.||+|||+..     .++|+||||||+||||+.++.+||+|||+++..
T Consensus        82 y~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          82 YHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            99999999999653   5999999999999999999999741     134999999999999999999999999999764


Q ss_pred             cccc-----cccccccCCCCCCccccccCC------CCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCch
Q 014038          264 MVDK-----HAANIRGTFGYLDPEYISTRN------FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGW  332 (432)
Q Consensus       264 ~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  332 (432)
                      ....     ......||+.|+|||++.+..      ++.++|||||||++|||+||..||....................
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            3322     233567999999999987543      67899999999999999999887743110000000000000000


Q ss_pred             ----hhhccccCCCCC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          333 ----EEIVDSRLDGIF-----DVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       333 ----~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                          .......+++..     +.+.+..+.+++.+||+.||++|||+.||++.|+++.+...
T Consensus       239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~  300 (303)
T d1vjya_         239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence                111112222221     22455679999999999999999999999999999876543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=388.11  Aligned_cols=249  Identities=19%  Similarity=0.268  Sum_probs=207.5

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEecc
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFMS  191 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  191 (432)
                      +|.+.+.||+|+||+||+|.. .+|+.||||.+.... .....+.+|+.+|+.++|||||++++++.+.+..|+|||||+
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~   84 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence            578889999999999999965 478899999997654 334568899999999999999999999999999999999999


Q ss_pred             CCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCC--CcEEEeecCCcccccccccc
Q 014038          192 KGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQS--MRARVADFGLSREEMVDKHA  269 (432)
Q Consensus       192 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~--~~~kl~Dfgl~~~~~~~~~~  269 (432)
                      +|+|.+++... ..++++.++..++.||+.||+|||+++   |+||||||+|||++.+  ..+||+|||+++........
T Consensus        85 gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~  160 (321)
T d1tkia_          85 GLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             CCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence            99999999543 346999999999999999999999999   9999999999999854  58999999999876555555


Q ss_pred             cccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHHH
Q 014038          270 ANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEEL  349 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (432)
                      ....+|+.|+|||.+.+..|+.++|||||||++|||++|+.||.+.........+.............         ..+
T Consensus       161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~---------~~s  231 (321)
T d1tkia_         161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK---------EIS  231 (321)
T ss_dssp             EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT---------TSC
T ss_pred             cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhcc---------CCC
Confidence            66789999999999999999999999999999999999999998765543333322211110000000         123


Q ss_pred             HHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          350 NEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       350 ~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .++.+|+.+||+.||.+|||+.|+++
T Consensus       232 ~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         232 IEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            57899999999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-52  Score=393.94  Aligned_cols=248  Identities=23%  Similarity=0.333  Sum_probs=199.9

Q ss_pred             hcccc-ccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhc-CCCccceEEeeeee----CCeEEE
Q 014038          113 TCNFT-TLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRL-HHRNLVNLVGYCAE----KGQHML  185 (432)
Q Consensus       113 ~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~l  185 (432)
                      .|.+. ++||+|+||+||+|.. .+++.||||++..     ...+.+|+.++.++ +|||||++++++.+    ....|+
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i   86 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI   86 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence            56665 4699999999999965 5789999999853     34577899987665 89999999999865    457899


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC---CCcEEEeecCCccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ---SMRARVADFGLSRE  262 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~---~~~~kl~Dfgl~~~  262 (432)
                      |||||++|+|.+++.......+++.++..++.||+.||+|||+++   |+||||||+|||++.   ++.+||+|||+++.
T Consensus        87 vmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          87 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceeee
Confidence            999999999999997665567999999999999999999999999   999999999999975   56799999999987


Q ss_pred             ccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccC--
Q 014038          263 EMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRL--  340 (432)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  340 (432)
                      ...........||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.........+..       .+.....  
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~-------~i~~~~~~~  236 (335)
T d2ozaa1         164 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-------RIRMGQYEF  236 (335)
T ss_dssp             CCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCCSCSSSC
T ss_pred             ccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH-------HHhcCCCCC
Confidence            6655566677899999999999999999999999999999999999999975432111111100       0000111  


Q ss_pred             CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          341 DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      +.......+.++.+|+.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11111234568999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=387.51  Aligned_cols=257  Identities=24%  Similarity=0.420  Sum_probs=210.3

Q ss_pred             HHhccccccccccCceeEEEEEeC------CCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeE
Q 014038          111 KATCNFTTLIGQGAFGPVYKAQMS------TGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQH  183 (432)
Q Consensus       111 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  183 (432)
                      ...+.+.+.||+|+||+||+|.+.      +++.||||++... .......|.+|+.++++++||||++++|+|...+..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            346678899999999999999652      3578999999754 334456799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhcccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEe
Q 014038          184 MLVYVFMSKGSLASHLYDE--------NYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVA  255 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~--------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~  255 (432)
                      ++||||+++|+|.+++...        ....+++..+.+++.|++.||.|||+++   |+||||||+|||++.++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            9999999999999988532        2345799999999999999999999998   9999999999999999999999


Q ss_pred             ecCCcccccccc---cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhC-CCCCCChhHHHHHHHhhhcCCCc
Q 014038          256 DFGLSREEMVDK---HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAG-RSPLQGLMEYVELAAMNTEGKTG  331 (432)
Q Consensus       256 Dfgl~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~  331 (432)
                      |||+++......   ......+|+.|+|||.+.+..++.++||||||+++|||+|| +.||.+...............  
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~--  253 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL--  253 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC--
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC--
Confidence            999997543322   23345689999999999999999999999999999999998 577876544333322221111  


Q ss_pred             hhhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHh
Q 014038          332 WEEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILK  382 (432)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~  382 (432)
                                ...+...+..+.+++.+||+.||++|||+.+|++.|++.++
T Consensus       254 ----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         254 ----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                      11122234579999999999999999999999999876644

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-51  Score=392.28  Aligned_cols=243  Identities=24%  Similarity=0.333  Sum_probs=206.0

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC---ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD---SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  188 (432)
                      .|++.+.||+|+||.||+|.. .+|+.||||++...   .....+.+.+|+.+|+.++||||+++++++.+....++|||
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e  121 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence            678889999999999999975 57999999998643   22334678999999999999999999999999999999999


Q ss_pred             eccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccccc
Q 014038          189 FMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDKH  268 (432)
Q Consensus       189 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~  268 (432)
                      |+.+|+|..++...  +.+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...  ..
T Consensus       122 ~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~--~~  194 (350)
T d1rdqe_         122 YVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GR  194 (350)
T ss_dssp             CCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS--SC
T ss_pred             cccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecc--cc
Confidence            99999999998543  46999999999999999999999999   9999999999999999999999999998643  23


Q ss_pred             ccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCHHH
Q 014038          269 AANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDVEE  348 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (432)
                      .....||+.|||||++.+..|+.++|||||||++|||+||+.||.+.........+.....             ..+...
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-------------~~p~~~  261 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-------------RFPSHF  261 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------CCCTTC
T ss_pred             cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-------------CCCccC
Confidence            3457899999999999999999999999999999999999999987654333332222111             112223


Q ss_pred             HHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 014038          349 LNEVASLAYKCVNRAPRKRP-----SMRDIVQ  375 (432)
Q Consensus       349 ~~~l~~li~~cl~~dp~~RP-----s~~~vl~  375 (432)
                      +.++.+++.+||+.||.+|+     |++++++
T Consensus       262 s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            45789999999999999994     8898875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-51  Score=383.33  Aligned_cols=254  Identities=25%  Similarity=0.324  Sum_probs=197.5

Q ss_pred             cccccccCceeEEEEEe-CCCcEEEEEEeccCChh-----hHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          117 TTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQ-----GEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      .++||+|+||+||+|.. .+|+.||||++......     ..+.+.+|+.+|++++|||||++++++.+++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            36799999999999975 47899999998654321     1346889999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~  269 (432)
                      .++++....  .....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... ..
T Consensus        83 ~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          83 ETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             SEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCC
T ss_pred             cchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcccc
Confidence            988777665  34467999999999999999999999999   9999999999999999999999999997644332 33


Q ss_pred             cccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc----CCCchhhhccc------
Q 014038          270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE----GKTGWEEIVDS------  338 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~------  338 (432)
                      ...+||+.|+|||++.. ..|+.++|||||||++|||++|+.||.+..+...+..+...    ....+......      
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            45679999999998864 46899999999999999999999999876655444332211    11111100000      


Q ss_pred             cCCCCCCH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          339 RLDGIFDV-----EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       339 ~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ......+.     ..+.++.+|+.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00001111     12357899999999999999999999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=388.61  Aligned_cols=245  Identities=28%  Similarity=0.473  Sum_probs=202.8

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHHHHHHHh-hcCCCccceEEeeeeeCCeEEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQTEVMLLG-RLHHRNLVNLVGYCAEKGQHMLVY  187 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~  187 (432)
                      .|.+.+.||+|+||+||+|.. .+|+.||||++....   ....+.+..|..++. .++||||+++++++.+++..++||
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm   82 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   82 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence            577889999999999999965 478999999996532   233456667777665 689999999999999999999999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-  266 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-  266 (432)
                      ||+++|+|.+++..  ...+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++..... 
T Consensus        83 Ey~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          83 EYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             ECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             eecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc
Confidence            99999999999954  346899999999999999999999999   999999999999999999999999999864432 


Q ss_pred             ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhccccCCCCCCH
Q 014038          267 KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSRLDGIFDV  346 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (432)
                      .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+............. ..            .++.
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-~~------------~~p~  224 (320)
T d1xjda_         158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-NP------------FYPR  224 (320)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CC------------CCCT
T ss_pred             ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CC------------CCCc
Confidence            3344568999999999999999999999999999999999999999876544333322211 11            1122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 014038          347 EELNEVASLAYKCVNRAPRKRPSMR-DIVQ  375 (432)
Q Consensus       347 ~~~~~l~~li~~cl~~dp~~RPs~~-~vl~  375 (432)
                      ..+.++.+|+.+||+.||.+||++. ++++
T Consensus       225 ~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         225 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            2345789999999999999999995 6654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.7e-51  Score=391.46  Aligned_cols=245  Identities=27%  Similarity=0.382  Sum_probs=196.7

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC---hhhHHHHHH---HHHHHhhcCCCccceEEeeeeeCCeEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS---KQGEKEFQT---EVMLLGRLHHRNLVNLVGYCAEKGQHML  185 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~l  185 (432)
                      .|.+.+.||+|+||.||+|+. .+|+.||||++....   ......+.+   |+.+++.++|||||++++++.+.+..++
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i   84 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   84 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence            577889999999999999975 479999999986431   122233444   4667777889999999999999999999


Q ss_pred             EEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccc
Q 014038          186 VYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMV  265 (432)
Q Consensus       186 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~  265 (432)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 vmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          85 ILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            99999999999999543  56899999999999999999999999   99999999999999999999999999985433


Q ss_pred             cccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhH--HHHHHHhhhcCCCchhhhccccCCC
Q 014038          266 DKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLME--YVELAAMNTEGKTGWEEIVDSRLDG  342 (432)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  342 (432)
                       .......||+.|+|||++.. ..|+.++|||||||++|||+||+.||.+...  ...+.......            ..
T Consensus       160 -~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------------~~  226 (364)
T d1omwa3         160 -KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------------AV  226 (364)
T ss_dssp             -SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC------------CC
T ss_pred             -CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC------------CC
Confidence             23445679999999999864 5689999999999999999999999975321  11111111111            11


Q ss_pred             CCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014038          343 IFDVEELNEVASLAYKCVNRAPRKRPS-----MRDIVQ  375 (432)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~~vl~  375 (432)
                      ..+...+.++.+|+.+||+.||++|||     ++++++
T Consensus       227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         227 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            112223457899999999999999999     677765

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-50  Score=376.76  Aligned_cols=259  Identities=25%  Similarity=0.380  Sum_probs=202.5

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      .|.+.+.||+|+||+||+|.. .+|+.||||++....  ....+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~   82 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   82 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence            467788999999999999965 579999999996543  23356899999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc-cc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD-KH  268 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~-~~  268 (432)
                      +.+ ++.+++.......+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..... ..
T Consensus        83 ~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          83 LHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             CSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             cCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCccc
Confidence            975 5555555556677999999999999999999999999   999999999999999999999999999765433 33


Q ss_pred             ccccccCCCCCCccccccCC-CCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc----CCCchhhhcc-ccCCC
Q 014038          269 AANIRGTFGYLDPEYISTRN-FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE----GKTGWEEIVD-SRLDG  342 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~-~~~~~  342 (432)
                      .....||+.|+|||.+.... ++.++|||||||++|||++|+.||.+......+......    ....+..... +....
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP  238 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence            44567999999999876655 578999999999999999999999876554443332111    1111111100 00000


Q ss_pred             ------CCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          343 ------IFD-----VEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       343 ------~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                            ..+     ...+.++.+|+.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                  000     012357899999999999999999999885

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.6e-49  Score=371.48  Aligned_cols=258  Identities=24%  Similarity=0.365  Sum_probs=201.1

Q ss_pred             hccccccccccCceeEEEEEeCCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  190 (432)
                      +|++.+.||+|+||+||+|+.++|+.||||++....  ....+.+.+|+.+|++++||||+++++++...+..+++|+|+
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~   82 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence            467788999999999999998899999999996643  233578999999999999999999999999999999999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-cc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-HA  269 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~  269 (432)
                      .++.+..+.  ...+.+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....... ..
T Consensus        83 ~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~  157 (286)
T d1ob3a_          83 DQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (286)
T ss_dssp             SEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             hhhhHHHHH--hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence            887666665  33467999999999999999999999999   9999999999999999999999999987643322 23


Q ss_pred             cccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhh----cCCCchhhhcc-----cc
Q 014038          270 ANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNT----EGKTGWEEIVD-----SR  339 (432)
Q Consensus       270 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~-----~~  339 (432)
                      ....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+..+...+.....    .....+.....     ..
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence            45568999999999865 4578999999999999999999999987655444333211    01111111000     00


Q ss_pred             CC-------CCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          340 LD-------GIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       340 ~~-------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ..       .......+.++.+|+.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00       0011122357899999999999999999999874

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=375.75  Aligned_cols=239  Identities=25%  Similarity=0.416  Sum_probs=195.5

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCCh------hhHHHHHHHHHHHhhcC--CCccceEEeeeeeCCe
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSK------QGEKEFQTEVMLLGRLH--HRNLVNLVGYCAEKGQ  182 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  182 (432)
                      .+|.+.+.||+|+||+||+|.. .+|+.||||++.....      .....+.+|+.+|++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            3678889999999999999965 5789999999865321      11234678999999996  8999999999999999


Q ss_pred             EEEEEEeccC-CChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC-CCcEEEeecCCc
Q 014038          183 HMLVYVFMSK-GSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-SMRARVADFGLS  260 (432)
Q Consensus       183 ~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~-~~~~kl~Dfgl~  260 (432)
                      .++||||+.+ +++.+++..  ...+++..+..++.||+.||+|||+++   |+||||||+|||++. ++.+||+|||++
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccc
Confidence            9999999976 577777743  356999999999999999999999999   999999999999985 479999999999


Q ss_pred             ccccccccccccccCCCCCCccccccCCC-CchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          261 REEMVDKHAANIRGTFGYLDPEYISTRNF-TKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      +.... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+..+..   .    ...        .
T Consensus       159 ~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~---~----~~~--------~  222 (273)
T d1xwsa_         159 ALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII---R----GQV--------F  222 (273)
T ss_dssp             EECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH---H----CCC--------C
T ss_pred             eeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh---h----ccc--------C
Confidence            75432 33445789999999999987765 577999999999999999999998743211   0    110        1


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+.    ..+.++.+|+.+||+.||++|||++|+++
T Consensus       223 ~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         223 FRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC----CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            111    12357899999999999999999999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=374.18  Aligned_cols=260  Identities=25%  Similarity=0.370  Sum_probs=200.5

Q ss_pred             HhccccccccccCceeEEEEEe-CC-CcEEEEEEeccCC--hhhHHHHHHHHHHHhhc---CCCccceEEeeeee-----
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-ST-GETVAVKVLATDS--KQGEKEFQTEVMLLGRL---HHRNLVNLVGYCAE-----  179 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----  179 (432)
                      ..|++.+.||+|+||+||+|.. .+ ++.||||++....  ......+.+|+.+|+.+   +||||++++++|..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            3678889999999999999975 34 5679999986532  22233566777777665   79999999998853     


Q ss_pred             CCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCC
Q 014038          180 KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGL  259 (432)
Q Consensus       180 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl  259 (432)
                      ....+++|||++++++.... ......+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             CceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhh
Confidence            34689999999887665443 344567999999999999999999999999   99999999999999999999999999


Q ss_pred             cccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhc----CCCchhh-
Q 014038          260 SREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTE----GKTGWEE-  334 (432)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~~-  334 (432)
                      ++............||+.|+|||++.+..|+.++|||||||++|||++|+.||.+..+...+..+...    ....|.. 
T Consensus       163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             hhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence            98765556666788999999999999999999999999999999999999999876654443332111    1111100 


Q ss_pred             ------hccccC---CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 ------IVDSRL---DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 ------~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                            ......   ...+....+..+.+|+.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                  000000   00011122357889999999999999999999875

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=373.60  Aligned_cols=256  Identities=24%  Similarity=0.333  Sum_probs=196.1

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeeeC------CeEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEK------GQHML  185 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  185 (432)
                      +|+..++||+|+||+||+|+. .+|+.||||++......    +.+|+.+|++++||||++++++|...      ...++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            566678999999999999976 47899999999764322    34799999999999999999998543      35789


Q ss_pred             EEEeccCCChhhhcc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC-cEEEeecCCcccc
Q 014038          186 VYVFMSKGSLASHLY-DENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREE  263 (432)
Q Consensus       186 v~e~~~~g~L~~~l~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~-~~kl~Dfgl~~~~  263 (432)
                      ||||++++.+..+.. ......+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998654443332 234567999999999999999999999999   99999999999999775 8999999999876


Q ss_pred             cccccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCc----hhhhc--
Q 014038          264 MVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTG----WEEIV--  336 (432)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~--  336 (432)
                      ..........||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||........+..+.......    +....  
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  253 (350)
T d1q5ka_         174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  253 (350)
T ss_dssp             CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred             cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence            55555566789999999998764 578999999999999999999999998765444333321110000    00000  


Q ss_pred             --cccC--------CCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          337 --DSRL--------DGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       337 --~~~~--------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                        ....        ........+.++.+|+.+||+.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0000        00111123457899999999999999999999885

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=363.42  Aligned_cols=259  Identities=25%  Similarity=0.352  Sum_probs=197.0

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeee--------C
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--------K  180 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  180 (432)
                      .+|.+.+.||+|+||+||+|.. .+|+.||||++...  .......+.+|+.+|++++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            4778889999999999999975 58999999998654  33445678999999999999999999998855        3


Q ss_pred             CeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCc
Q 014038          181 GQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLS  260 (432)
Q Consensus       181 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~  260 (432)
                      +..++||||+.++.+....  .....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence            4679999999887776554  34457899999999999999999999999   999999999999999999999999999


Q ss_pred             cccccc-----ccccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcC----CC
Q 014038          261 REEMVD-----KHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG----KT  330 (432)
Q Consensus       261 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~----~~  330 (432)
                      +.....     .......||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+..+......+....    ..
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            653321     122345799999999998754 68999999999999999999999998765443333221110    00


Q ss_pred             chhhh--------ccccCCCCCCHH-------HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          331 GWEEI--------VDSRLDGIFDVE-------ELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       331 ~~~~~--------~~~~~~~~~~~~-------~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      .+...        ............       ....+.+|+.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            00000        000000011111       1246788999999999999999999885

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=9.4e-48  Score=360.23  Aligned_cols=260  Identities=20%  Similarity=0.254  Sum_probs=206.4

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCC-CccceEEeeeeeCCeEEEEEEe
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH-RNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      ..|.+.+.||+|+||+||+|+. .+|+.||||++....  ....+.+|++.++.++| +|++.+++++......++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            4678889999999999999975 478999999886543  22457789999999965 8999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecC-----CCcEEEeecCCccccc
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQ-----SMRARVADFGLSREEM  264 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~-----~~~~kl~Dfgl~~~~~  264 (432)
                      + +++|.+++... ...+++..+..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+++...
T Consensus        83 ~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          83 L-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             c-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            9 68999888543 357999999999999999999999999   999999999999964     5789999999997533


Q ss_pred             cc--------ccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHH---HHHHHhhh-cCCCch
Q 014038          265 VD--------KHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEY---VELAAMNT-EGKTGW  332 (432)
Q Consensus       265 ~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~---~~~~~~~~-~~~~~~  332 (432)
                      ..        .......||+.|||||++.+..++.++|||||||++|||+||+.||.+....   ........ ......
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  237 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence            21        1233567999999999999999999999999999999999999999753211   11111100 000111


Q ss_pred             hhhccccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcccc
Q 014038          333 EEIVDSRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRHNR  387 (432)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~~~  387 (432)
                      .++     ....    +.++.+++..||..+|++||+++.+.+.|++++++.+..
T Consensus       238 ~~l-----~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~  283 (293)
T d1csna_         238 REL-----CAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  283 (293)
T ss_dssp             HHH-----TTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHh-----cCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence            111     1112    247899999999999999999999999999998765543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-47  Score=359.54  Aligned_cols=261  Identities=20%  Similarity=0.264  Sum_probs=197.5

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceE-EeeeeeCCeEEEEEEec
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNL-VGYCAEKGQHMLVYVFM  190 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~~lv~e~~  190 (432)
                      +|.+.+.||+|+||.||+|.. .+|+.||||++.....  ..++..|+++++.++|+|++.. .+++.+.+..++||||+
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~   85 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   85 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence            578889999999999999965 5789999999876432  2457889999999987765555 55556778889999999


Q ss_pred             cCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeec---CCCcEEEeecCCcccccccc
Q 014038          191 SKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLD---QSMRARVADFGLSREEMVDK  267 (432)
Q Consensus       191 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~---~~~~~kl~Dfgl~~~~~~~~  267 (432)
                       +|+|...+.. ....+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+++......
T Consensus        86 -~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          86 -GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             -CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             -CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence             5577666543 3457999999999999999999999999   99999999999875   45679999999998543221


Q ss_pred             --------cccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          268 --------HAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       268 --------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                              ......||+.|||||.+.+..++.++|||||||++|||+||+.||.................... ....+.
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~  239 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STPIEV  239 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-HSCHHH
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC-CCChhH
Confidence                    22345799999999999999999999999999999999999999976432211111100000000 000000


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHhhcc
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQVLSRILKMRH  385 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~~L~~i~~~~~  385 (432)
                      +..    ..+.++.+++..||+.+|++||++.++.+.|+.+.....
T Consensus       240 ~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         240 LCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             HTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             hcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence            111    123578999999999999999999999999998876544

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-47  Score=364.65  Aligned_cols=257  Identities=23%  Similarity=0.320  Sum_probs=194.9

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC-ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC----eEEEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD-SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG----QHMLV  186 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv  186 (432)
                      +|.+.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+.+|++++||||+++++++....    ..+++
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l   88 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL   88 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence            477789999999999999964 58999999999754 3444568899999999999999999999987543    34566


Q ss_pred             EEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccccc
Q 014038          187 YVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVD  266 (432)
Q Consensus       187 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~  266 (432)
                      ++|+.+|+|.+++...   .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_          89 VTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             EEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            6777899999999543   5999999999999999999999999   999999999999999999999999999754322


Q ss_pred             c----cccccccCCCCCCcccc-ccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhh-------
Q 014038          267 K----HAANIRGTFGYLDPEYI-STRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEE-------  334 (432)
Q Consensus       267 ~----~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------  334 (432)
                      .    ......||+.|+|||++ ....++.++||||+||++|||++|+.||.+....................       
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (345)
T d1pmea_         163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  242 (345)
T ss_dssp             GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence            1    23456799999999998 45567899999999999999999999998654332222211100000000       


Q ss_pred             -----hc-cccCCCCCCH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 -----IV-DSRLDGIFDV-----EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 -----~~-~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                           .. ........+.     ..+.++.+|+.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 00 0000000111     11247889999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-47  Score=366.50  Aligned_cols=254  Identities=24%  Similarity=0.329  Sum_probs=192.7

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeeeCC------eE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKG------QH  183 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~  183 (432)
                      +|.+.+.||+|+||+||+|.. .+|+.||||++...  .....+.+.+|+.+|++++|||||+++++|...+      ..
T Consensus        19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~   98 (346)
T d1cm8a_          19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF   98 (346)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence            577788999999999999965 57999999999753  3344567899999999999999999999997654      56


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      ++||||+ +++|..++..   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+|++|||+++..
T Consensus        99 ~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_          99 YLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             EEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceecc
Confidence            9999999 5577776643   46999999999999999999999999   999999999999999999999999999754


Q ss_pred             cccccccccccCCCCCCcccccc-CCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhh-------
Q 014038          264 MVDKHAANIRGTFGYLDPEYIST-RNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEI-------  335 (432)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  335 (432)
                      .  .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+......+............+.       
T Consensus       172 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         172 D--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             C--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             C--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence            3  33445679999999999865 4578999999999999999999999987654433322211100000000       


Q ss_pred             --------ccccCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          336 --------VDSRLDG---IFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       336 --------~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                              .......   ......+.++.+|+.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                    0000000   001112346889999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.5e-46  Score=358.15  Aligned_cols=253  Identities=19%  Similarity=0.304  Sum_probs=197.3

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC-CCccceEEeeeee--CCeEEEEE
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAE--KGQHMLVY  187 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  187 (432)
                      ..|.+.++||+|+||+||+|+. .+|+.||||++...   ..+.+.+|+.+|+.++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            3688889999999999999965 57899999998643   3467889999999995 9999999999874  45689999


Q ss_pred             EeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCC-cEEEeecCCccccccc
Q 014038          188 VFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSM-RARVADFGLSREEMVD  266 (432)
Q Consensus       188 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~  266 (432)
                      ||+.+|+|....     +.+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++.....
T Consensus       112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence            999999997764     35999999999999999999999999   99999999999998655 6999999999866555


Q ss_pred             ccccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHH-HHHh-------------h---hcC
Q 014038          267 KHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVE-LAAM-------------N---TEG  328 (432)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~-~~~~-------------~---~~~  328 (432)
                      .......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||....+... ...+             .   ...
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  263 (328)
T d3bqca1         184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  263 (328)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence            556667899999999998764 579999999999999999999999965322111 0000             0   000


Q ss_pred             CCchhhhcc--------ccCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          329 KTGWEEIVD--------SRLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       329 ~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                      ...+.....        ...........+.++.+|+.+||+.||++|||++|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000001000        00111111223457899999999999999999999875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=361.92  Aligned_cols=255  Identities=22%  Similarity=0.267  Sum_probs=190.6

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeee------CCeE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE------KGQH  183 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~  183 (432)
                      .|.+.++||+|+||+||+|.. .+|+.||||++...  .......+.+|+.++++++||||+++++++..      ....
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~   97 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV   97 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence            467778999999999999975 47999999999754  33445678999999999999999999999864      3688


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      |+||||+.++.+ +.+.    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+|++|||+++..
T Consensus        98 ~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          98 YLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcc
Confidence            999999976544 4442    35899999999999999999999999   999999999999999999999999998876


Q ss_pred             cccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcC---------------
Q 014038          264 MVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEG---------------  328 (432)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~---------------  328 (432)
                      ..........+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+....               
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (355)
T d2b1pa1         170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_dssp             -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred             ccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence            65556667789999999999999999999999999999999999999998655433322221100               


Q ss_pred             -----------CCchhhhccccCCCC---CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          329 -----------KTGWEEIVDSRLDGI---FDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       329 -----------~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                                 ...+...........   .....+.++.+|+.+||+.||++|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                       001111111111111   11234678999999999999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=352.20  Aligned_cols=258  Identities=23%  Similarity=0.304  Sum_probs=201.2

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccCC--hhhHHHHHHHHHHHhhcCCCccceEEeeeeeCCeEEEEEEe
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDS--KQGEKEFQTEVMLLGRLHHRNLVNLVGYCAEKGQHMLVYVF  189 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  189 (432)
                      +|++.+.||+|+||+||+|+. .+|+.||||+++...  ....+.+.+|+.+|+.++||||++++++|.+....++++++
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~   82 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence            467789999999999999975 578999999986543  34457899999999999999999999999999999999999


Q ss_pred             ccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccccccc-c
Q 014038          190 MSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEMVDK-H  268 (432)
Q Consensus       190 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~  268 (432)
                      +.+++|..++.  ..+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++...... .
T Consensus        83 ~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          83 CDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             CSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred             ccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence            99998887774  4467899999999999999999999999   9999999999999999999999999998654332 3


Q ss_pred             ccccccCCCCCCccccccCC-CCchhHhHHHHHHHHHHHhCCCCCCChhHHHH-HHHhhh---c-CCCchh---hhcccc
Q 014038          269 AANIRGTFGYLDPEYISTRN-FTKKSDVYSFGVLLFELIAGRSPLQGLMEYVE-LAAMNT---E-GKTGWE---EIVDSR  339 (432)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~-~~~~~~---~-~~~~~~---~~~~~~  339 (432)
                      .....+++.|+|||.+.... ++.++|||||||++|||++|+.||....+... ......   . ....+.   ...+..
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            34456788999999987654 68999999999999999999999743322221 111110   0 000110   000000


Q ss_pred             ---------CCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          340 ---------LDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       340 ---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                               ...........++.+|+.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     000111223457889999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-47  Score=360.63  Aligned_cols=249  Identities=28%  Similarity=0.401  Sum_probs=197.2

Q ss_pred             hccccccccccCceeEEEEEe----CCCcEEEEEEeccCC----hhhHHHHHHHHHHHhhcCC-CccceEEeeeeeCCeE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM----STGETVAVKVLATDS----KQGEKEFQTEVMLLGRLHH-RNLVNLVGYCAEKGQH  183 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~  183 (432)
                      .|.+.+.||+|+||+||+|..    .+|+.||||.+....    ....+.+.+|+.++++++| |||+++++++.+....
T Consensus        25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~  104 (322)
T d1vzoa_          25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  104 (322)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence            588899999999999999964    257899999986431    2334568899999999976 8999999999999999


Q ss_pred             EEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCcccc
Q 014038          184 MLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREE  263 (432)
Q Consensus       184 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~  263 (432)
                      +++|||+.+|+|.+++...  +.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       105 ~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         105 HLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhh
Confidence            9999999999999998543  45788999999999999999999999   999999999999999999999999999754


Q ss_pred             ccc--ccccccccCCCCCCccccccC--CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhhhcccc
Q 014038          264 MVD--KHAANIRGTFGYLDPEYISTR--NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEEIVDSR  339 (432)
Q Consensus       264 ~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (432)
                      ...  .......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||.+...........       .....  
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~-------~~~~~--  250 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS-------RRILK--  250 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH-------HHHHH--
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------Hhccc--
Confidence            322  233456799999999998654  47889999999999999999999997643211000000       00000  


Q ss_pred             CCCCCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 014038          340 LDGIFDVEELNEVASLAYKCVNRAPRKRPS-----MRDIVQ  375 (432)
Q Consensus       340 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~~vl~  375 (432)
                      .....+...+.++.+|+.+||+.||.+|||     ++|+++
T Consensus       251 ~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         251 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            011122334568999999999999999995     777764

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-46  Score=356.72  Aligned_cols=255  Identities=24%  Similarity=0.327  Sum_probs=195.0

Q ss_pred             hccccccccccCceeEEEEEe-CCCcEEEEEEeccC--ChhhHHHHHHHHHHHhhcCCCccceEEeeeee-----CCeEE
Q 014038          113 TCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATD--SKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE-----KGQHM  184 (432)
Q Consensus       113 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~  184 (432)
                      +|.+.+.||+|+||+||+|+. .+|+.||||++...  .....+.+.+|+.+|++++||||+++++++..     ....+
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~   98 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   98 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence            577789999999999999964 57999999999754  33445678999999999999999999998864     33457


Q ss_pred             EEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEeecCCccccc
Q 014038          185 LVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVADFGLSREEM  264 (432)
Q Consensus       185 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~~~~  264 (432)
                      ++++|+.+|+|.+++..   +.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++... 
T Consensus        99 ~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~-  171 (348)
T d2gfsa1          99 YLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT-  171 (348)
T ss_dssp             EEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CC-
T ss_pred             EEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhccc-
Confidence            77888899999999843   46999999999999999999999999   999999999999999999999999998653 


Q ss_pred             ccccccccccCCCCCCccccccC-CCCchhHhHHHHHHHHHHHhCCCCCCChhHHHHHHHhhhcCCCchhh---------
Q 014038          265 VDKHAANIRGTFGYLDPEYISTR-NFTKKSDVYSFGVLLFELIAGRSPLQGLMEYVELAAMNTEGKTGWEE---------  334 (432)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------  334 (432)
                       ........||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+.........+.........+         
T Consensus       172 -~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  250 (348)
T d2gfsa1         172 -DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  250 (348)
T ss_dssp             -TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred             -CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence             2334456789999999987655 56899999999999999999999998755443332221111000000         


Q ss_pred             ---hccccC-CCCCCH-----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 014038          335 ---IVDSRL-DGIFDV-----EELNEVASLAYKCVNRAPRKRPSMRDIVQ  375 (432)
Q Consensus       335 ---~~~~~~-~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~~vl~  375 (432)
                         ...... ....+.     ..+.++.+|+.+||+.||.+|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence               000000 000010     12357889999999999999999999885

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.4e-40  Score=319.40  Aligned_cols=258  Identities=23%  Similarity=0.304  Sum_probs=190.5

Q ss_pred             HhccccccccccCceeEEEEEe-CCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC-----------CCccceEEeeeee
Q 014038          112 ATCNFTTLIGQGAFGPVYKAQM-STGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-----------HRNLVNLVGYCAE  179 (432)
Q Consensus       112 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  179 (432)
                      ++|.+.++||+|+||+||+|+. .+|+.||||+++.+. ...+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            3588899999999999999975 579999999997543 33456788999888775           4789999988754


Q ss_pred             --CCeEEEEEEeccCCCh-hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCCeeecCCC-----
Q 014038          180 --KGQHMLVYVFMSKGSL-ASHLYDENYGPLTWNLRVHIALDVARGLEYLHD-GAVPPVIHRDIKSSNILLDQSM-----  250 (432)
Q Consensus       180 --~~~~~lv~e~~~~g~L-~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~dlkp~Nill~~~~-----  250 (432)
                        ....+++++++..+.. ...........+++..+..++.||+.||+|||+ .+   |+||||||+||||+.++     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence              3466777777655443 333344556678999999999999999999998 77   99999999999998665     


Q ss_pred             -cEEEeecCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHHHHHhCCCCCCChhHH------HHHHH
Q 014038          251 -RARVADFGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLFELIAGRSPLQGLMEY------VELAA  323 (432)
Q Consensus       251 -~~kl~Dfgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltg~~p~~~~~~~------~~~~~  323 (432)
                       .++++|||.+....  .......||+.|+|||++....++.++||||+||+++||++|+.||......      ..+..
T Consensus       169 ~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         169 IQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             ceeeEeecccccccc--cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence             39999999987532  2334567999999999999999999999999999999999999999643211      01100


Q ss_pred             h-hhcCCCch---------hhhccc-------------------cCCCCCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 014038          324 M-NTEGKTGW---------EEIVDS-------------------RLDGIFDVEELNEVASLAYKCVNRAPRKRPSMRDIV  374 (432)
Q Consensus       324 ~-~~~~~~~~---------~~~~~~-------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~vl  374 (432)
                      . ..-+....         ....+.                   ..........+.++.+|+.+||+.||.+|||++|++
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            0 00000000         000000                   011223456678899999999999999999999987


Q ss_pred             H
Q 014038          375 Q  375 (432)
Q Consensus       375 ~  375 (432)
                      +
T Consensus       327 ~  327 (362)
T d1q8ya_         327 N  327 (362)
T ss_dssp             T
T ss_pred             c
Confidence            4

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=1.5e-25  Score=195.16  Aligned_cols=170  Identities=13%  Similarity=0.151  Sum_probs=119.8

Q ss_pred             cccccccccCceeEEEEEeCCCcEEEEEEeccCCh------------------hhHHHHHHHHHHHhhcCCCccceEEee
Q 014038          115 NFTTLIGQGAFGPVYKAQMSTGETVAVKVLATDSK------------------QGEKEFQTEVMLLGRLHHRNLVNLVGY  176 (432)
Q Consensus       115 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~  176 (432)
                      .+.++||+|+||+||+|...+|+.||||+++....                  .....+.+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            35678999999999999888999999998753210                  112345578889999999999988765


Q ss_pred             eeeCCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCCeeecCCCcEEEee
Q 014038          177 CAEKGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDIKSSNILLDQSMRARVAD  256 (432)
Q Consensus       177 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dlkp~Nill~~~~~~kl~D  256 (432)
                      ..    .+++|||++++.+.+         ++......++.|++.+|.|||+++   |+||||||+|||++++ .++|+|
T Consensus        83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred             cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence            32    379999998765543         233445678999999999999999   9999999999999976 589999


Q ss_pred             cCCcccccccccccccccCCCCCCccccccCCCCchhHhHHHHHHHH
Q 014038          257 FGLSREEMVDKHAANIRGTFGYLDPEYISTRNFTKKSDVYSFGVLLF  303 (432)
Q Consensus       257 fgl~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~  303 (432)
                      ||++..............+... -.+. -.+.|+.++|+||..--++
T Consensus       146 FG~a~~~~~~~~~~~l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         146 FPQSVEVGEEGWREILERDVRN-IITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CTTCEETTSTTHHHHHHHHHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             CCCcccCCCCCcHHHHHHHHHH-HHHH-HcCCCCCcccHHHHHHHHh
Confidence            9998653211110000000000 0011 1356788999999765443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.66  E-value=7.8e-08  Score=85.67  Aligned_cols=137  Identities=17%  Similarity=0.104  Sum_probs=94.1

Q ss_pred             cccccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcC-CCccceEEeeeeeCCeEEEEEEeccCCCh
Q 014038          117 TTLIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLH-HRNLVNLVGYCAEKGQHMLVYVFMSKGSL  195 (432)
Q Consensus       117 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L  195 (432)
                      .+..+-++.+.||+... +++.+.+|+...........+.+|...+..+. +--+.+++.++..++..++||+++++.++
T Consensus        19 ~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~   97 (263)
T d1j7la_          19 VKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLC   97 (263)
T ss_dssp             EECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEH
T ss_pred             EEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccc
Confidence            33333344468999875 56677888876544334445778888888774 43467788888888999999999999887


Q ss_pred             hhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 014038          196 ASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGA---------------------------------------------  230 (432)
Q Consensus       196 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~---------------------------------------------  230 (432)
                      .+.....       .....++.+++..+..||+..                                             
T Consensus        98 ~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (263)
T d1j7la_          98 SEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL  170 (263)
T ss_dssp             HHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHH
T ss_pred             ccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHH
Confidence            6554211       112234556666666666421                                             


Q ss_pred             -----------CCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          231 -----------VPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       231 -----------~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                                 .+.++|+|+.|.|||+++++.+-|.||+.+.
T Consensus       171 ~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                       0137899999999999987767799999764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.20  E-value=8.8e-06  Score=71.49  Aligned_cols=129  Identities=19%  Similarity=0.151  Sum_probs=85.3

Q ss_pred             ccccCc-eeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCC--CccceEEeeeeeCCeEEEEEEeccCCChh
Q 014038          120 IGQGAF-GPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH--RNLVNLVGYCAEKGQHMLVYVFMSKGSLA  196 (432)
Q Consensus       120 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~  196 (432)
                      +..|.. +.||+....++..+.+|.......   ..+..|...++.+..  -.+.++++++.+.+..++||+|++|.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            444543 689999888888899998654432   346678888777742  33567788888888999999999886664


Q ss_pred             hhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------------
Q 014038          197 SHLYDENYGPLTWNLRVHIALDVARGLEYLHD------------------------------------------------  228 (432)
Q Consensus       197 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~------------------------------------------------  228 (432)
                      +..       +..   ...+.++...|.-||+                                                
T Consensus        95 ~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          95 SSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             ccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            421       111   1112223333333332                                                


Q ss_pred             ---CC----CCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          229 ---GA----VPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       229 ---~~----~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                         ..    .+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence               11    1237999999999999988777899999764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.80  E-value=3.3e-05  Score=72.52  Aligned_cols=75  Identities=15%  Similarity=0.044  Sum_probs=47.5

Q ss_pred             ccccccCceeEEEEEeC-CCcEEEEEEeccC-------ChhhHHHHHHHHHHHhhcC-C-C-ccceEEeeeeeCCeEEEE
Q 014038          118 TLIGQGAFGPVYKAQMS-TGETVAVKVLATD-------SKQGEKEFQTEVMLLGRLH-H-R-NLVNLVGYCAEKGQHMLV  186 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h-~-niv~l~~~~~~~~~~~lv  186 (432)
                      +.||.|....||+.... +++.++||.-...       ......+...|...|+.+. + | .+.+++.+  +....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            46899999999999764 4678999964321       1122334556888887663 3 3 34555544  44566899


Q ss_pred             EEeccCCC
Q 014038          187 YVFMSKGS  194 (432)
Q Consensus       187 ~e~~~~g~  194 (432)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.24  E-value=0.00047  Score=62.57  Aligned_cols=134  Identities=13%  Similarity=0.142  Sum_probs=77.4

Q ss_pred             eeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCcc--ceEEe-----eeeeCCeEEEEEEeccCCChhhh
Q 014038          126 GPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL--VNLVG-----YCAEKGQHMLVYVFMSKGSLASH  198 (432)
Q Consensus       126 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~g~L~~~  198 (432)
                      -.||++...+|+.|++|+.+... ...+++..|...+..|...++  +..+.     .....+..+.++++++|..+...
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            57999999999999999976542 234567788888887743222  11111     23445678899999976443210


Q ss_pred             ----c----------cc-------CCCCCCCHH----------------------HHHHHHHHHHHHHHHH-HhCCCCCe
Q 014038          199 ----L----------YD-------ENYGPLTWN----------------------LRVHIALDVARGLEYL-HDGAVPPV  234 (432)
Q Consensus       199 ----l----------~~-------~~~~~l~~~----------------------~~~~i~~~i~~~l~yL-H~~~~~~i  234 (432)
                          +          +.       .....+++.                      .....+..+...+.-+ .+.....+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                0          10       001111211                      1112222333222222 12223458


Q ss_pred             eeccCCCCCeeecCCCcEEEeecCCccc
Q 014038          235 IHRDIKSSNILLDQSMRARVADFGLSRE  262 (432)
Q Consensus       235 iH~dlkp~Nill~~~~~~kl~Dfgl~~~  262 (432)
                      ||+|+.+.|||++++  ..+.||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  45899997753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.11  E-value=0.0017  Score=60.42  Aligned_cols=73  Identities=18%  Similarity=0.269  Sum_probs=49.2

Q ss_pred             ccccccCceeEEEEEeCCC--------cEEEEEEeccCChhhHHHHHHHHHHHhhcCCCcc-ceEEeeeeeCCeEEEEEE
Q 014038          118 TLIGQGAFGPVYKAQMSTG--------ETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNL-VNLVGYCAEKGQHMLVYV  188 (432)
Q Consensus       118 ~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  188 (432)
                      +.|+.|-.-.+|++..+++        +.|.+++.. ... ..-...+|..+++.+.-.++ .++++++.+    ..|++
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            4688888899999976543        456777654 222 23345688889888853344 467777643    57999


Q ss_pred             eccCCChh
Q 014038          189 FMSKGSLA  196 (432)
Q Consensus       189 ~~~~g~L~  196 (432)
                      |+++.+|.
T Consensus       122 fi~g~~l~  129 (395)
T d1nw1a_         122 YIPSRPLS  129 (395)
T ss_dssp             CCCEEECC
T ss_pred             EeccccCC
Confidence            99875543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.78  E-value=0.033  Score=49.33  Aligned_cols=140  Identities=13%  Similarity=0.045  Sum_probs=73.0

Q ss_pred             cccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCC-----CccceEE-e--eeeeCCeEEEEEEec
Q 014038          119 LIGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHH-----RNLVNLV-G--YCAEKGQHMLVYVFM  190 (432)
Q Consensus       119 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv~l~-~--~~~~~~~~~lv~e~~  190 (432)
                      .|..|---+.|+.+..+|+ +++|+.....  ..+++..|+.++..+..     |..+... |  +....+....++.++
T Consensus        25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~  101 (316)
T d2ppqa1          25 GIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL  101 (316)
T ss_dssp             EECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred             cCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeec
Confidence            3556767889999886655 8889875432  22344556666666642     2222111 0  122345667777777


Q ss_pred             cCCChhhhc--------------cc--C--C-CC--CCCH------------------HHHHHHHHHHHHHHHHHHhCC-
Q 014038          191 SKGSLASHL--------------YD--E--N-YG--PLTW------------------NLRVHIALDVARGLEYLHDGA-  230 (432)
Q Consensus       191 ~~g~L~~~l--------------~~--~--~-~~--~l~~------------------~~~~~i~~~i~~~l~yLH~~~-  230 (432)
                      .+......-              +.  .  . ..  ....                  ......+..+...+.-.+... 
T Consensus       102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L  181 (316)
T d2ppqa1         102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL  181 (316)
T ss_dssp             CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred             ccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccc
Confidence            664332211              00  0  0 00  0000                  001122223333333333221 


Q ss_pred             CCCeeeccCCCCCeeecCCCcEEEeecCCcc
Q 014038          231 VPPVIHRDIKSSNILLDQSMRARVADFGLSR  261 (432)
Q Consensus       231 ~~~iiH~dlkp~Nill~~~~~~kl~Dfgl~~  261 (432)
                      ..++||+|+.++||+++.+...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            2358999999999999998777899999875

>d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Actin-fragmin kinase, catalytic domain
domain: Actin-fragmin kinase, catalytic domain
species: Physarum polycephalum [TaxId: 5791]

Probab=81.40  E-value=4.8  Score=34.50  Aligned_cols=135  Identities=11%  Similarity=0.055  Sum_probs=76.5

Q ss_pred             ccccCceeEEEEEeCCCcEEEEEEeccCChhhHHHHHHHHHHHhhcCCCccceEEeeeee--------------------
Q 014038          120 IGQGAFGPVYKAQMSTGETVAVKVLATDSKQGEKEFQTEVMLLGRLHHRNLVNLVGYCAE--------------------  179 (432)
Q Consensus       120 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------------------  179 (432)
                      +..+|.+-|+-+.. ++..++||.-   +....+.|..|+...-.+.-|...-+. .+..                    
T Consensus        76 ~s~~Gs~Gv~FV~~-e~gaiVlK~s---~tta~E~y~~eLAr~LGvpvPqmRvI~-~~~~E~~~~~~~~l~~~e~d~~I~  150 (342)
T d1cjaa_          76 RSEKGTEGLFFVET-ESGVFIVKRS---TNIESETFCSLLCMRLGLHAPKVRVVS-SNSEEGTNMLECLAAIDKSFRVIT  150 (342)
T ss_dssp             ECCSTTSCEEEEEE-SSCEEEEECC---TTHHHHHHHHHHHHHHTCCCCCEEEEE-SSSHHHHHHHHHHHHHCSSSCHHH
T ss_pred             EeecCCceEEEEEc-CCceEEEecC---CchHHHHHHHHHHHHhCCCCCceEEec-CCCHHHHHHHHHHhcCCChhHHHH
Confidence            44555555666655 4567778862   234456677777777777788755432 2211                    


Q ss_pred             ---CCeEEEEEEeccCCChhhhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeccC-CCCCeeecCCC-cEEE
Q 014038          180 ---KGQHMLVYVFMSKGSLASHLYDENYGPLTWNLRVHIALDVARGLEYLHDGAVPPVIHRDI-KSSNILLDQSM-RARV  254 (432)
Q Consensus       180 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~dl-kp~Nill~~~~-~~kl  254 (432)
                         ....+++|||.+|..|.+.-.......+.......+. .|+.-=.+++....-|+++|+- .+.|++++.++ .+..
T Consensus       151 sel~~A~~liMeYvpG~~l~e~~~~~a~~~fs~~~l~~LG-kIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n~~~~~~  229 (342)
T d1cjaa_         151 TLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLG-SLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATVVP  229 (342)
T ss_dssp             HHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHH-HHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCEEE
T ss_pred             HHHhcccceeeeccCCccccccccccchhhhcHHHHHHhh-hHHHHHHHHcCCccccccccCCCCccceEEecCCcEEEE
Confidence               1356899999988776554311111112222222111 1222224667666556777742 78999998776 6777


Q ss_pred             eecCCc
Q 014038          255 ADFGLS  260 (432)
Q Consensus       255 ~Dfgl~  260 (432)
                      +|=|..
T Consensus       230 IDs~i~  235 (342)
T d1cjaa_         230 IDSKII  235 (342)
T ss_dssp             CSCCCC
T ss_pred             ecCCcc
Confidence            775554